PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Du, J; Cao, XQ; Zou, L; Chen, Y; Guo, J; Chen, ZJ; Hu, SS; Zheng, Z				Du, Juan; Cao, Xiaoqing; Zou, Liang; Chen, Yi; Guo, Jin; Chen, Zujun; Hu, Shengshou; Zheng, Zhe			MicroRNA-21 and Risk of Severe Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CIRCULATING MICRORNAS; BIOMARKERS; SERUM; IDENTIFICATION; PROGRESSION; EXPRESSION; MORTALITY; DISEASE; CANCER	Background: Severe acute kidney injury (AKI) after cardiac surgery is associated with poor clinical outcomes. This study evaluated the potential use of miR-21 as a risk marker for postoperative AKI progression and other poor outcomes. Methodology/Principal Findings: The study included 120 adult patients undergoing cardiac surgery: 40 non-AKI controls, 39 patients with progressive AKI, and 41 with non-progressive AKI. Urine and plasma levels of miR-21 were assessed by quantitative real-time PCR (RT-qPCR). Associations between miR-21 levels and AKI progression were determined by estimating areas under receiver operating characteristic curves (AUC). We demonstrated that up-regulated urine and plasma levels of miR-21 in patients with AKI were both associated with AKI progression. The AUCs for urine and plasma levels of miR-21 associated with established AKI were 0.68 (95% CI: 0.59-0.78) and 0.80 (95% CI: 0.73-0.88), respectively. Multiple logistic regression analysis, adjusting for clinical variables, indicated that the prognostic predictive power of urine and plasma miR-21 levels for AKI progression were represented by AUCs of 0.81 (95% CI: 0.72-0.91) and 0.83 (95% CI: 0.74-0.92), respectively. Urinary and plasma miR-21 levels also predicted the need for postoperative renal replacement therapy (RRT), development of Acute Kidney Injury Network (AKIN) stage 3 AKI, 30-day in-hospital mortality and prolonged stay in hospital or ICU. Urine miR-21 was a better outcome predictor than plasma miR-21, being associated with higher (1.4- to 2.6-fold) unadjusted odds ratio for progression of AKI and other poor outcomes. Conclusions: Urinary and plasma miR-21 are associated with severe AKI and other poor postoperative outcomes of cardiac surgery, indicating their potential use as prognostic markers.	[Du, Juan; Cao, Xiaoqing; Zou, Liang; Chen, Yi; Guo, Jin; Chen, Zujun; Hu, Shengshou; Zheng, Zhe] Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Fuwai Hosp,State Key Lab Cardiovasc Med, Beijing 100730, Peoples R China; [Du, Juan; Cao, Xiaoqing; Zou, Liang; Chen, Yi; Guo, Jin; Chen, Zujun; Hu, Shengshou; Zheng, Zhe] Chinese Acad Med Sci, Peking Union Med Coll, Fuwai Hosp, Dept Surg, Beijing 100730, Peoples R China; [Du, Juan; Cao, Xiaoqing; Zou, Liang; Chen, Yi; Guo, Jin; Chen, Zujun; Hu, Shengshou; Zheng, Zhe] Chinese Acad Med Sci, Peking Union Med Coll, Cardiovasc Inst, Beijing 100730, Peoples R China; [Du, Juan; Cao, Xiaoqing; Hu, Shengshou; Zheng, Zhe] Natl Ctr Cardiovasc Dis, Minist Hlth, Key Lab Cardiac Regenerat Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Hu, SS (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Fuwai Hosp,State Key Lab Cardiovasc Med, Beijing 100730, Peoples R China.	shengshouhu@yahoo.com; zhengzhe@fuwai.com			National High Technology Reseach and Development Program of China (863 Program) [2011AA020101]	National High Technology Reseach and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by a grant from the National High Technology Reseach and Development Program of China (863 Program) (Grant No. 2011AA020101). The URL of the funders website is: http://most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JR, 2007, CIRCULATION, V116, pI139, DOI 10.1161/CIRCULATIONAHA.106.677070; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang KP, 2012, ANN PLAS SURG, V69, P668, DOI 10.1097/SAP.0b013e3182742c45; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Demirjian S, 2012, AM J KIDNEY DIS, V59, P382, DOI 10.1053/j.ajkd.2011.10.046; Denby L, 2011, AM J PATHOL, V179, P661, DOI 10.1016/j.ajpath.2011.04.021; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Englberger L, 2010, AM J KIDNEY DIS, V56, P623, DOI 10.1053/j.ajkd.2010.04.017; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Hall IE, 2011, CLIN J AM SOC NEPHRO, V6, P2740, DOI 10.2215/CJN.04960511; Hoste EAJ, 2010, CONTRIB NEPHROL, V165, P1, DOI 10.1159/000313737; Ishani A, 2011, ARCH INTERN MED, V171, P226, DOI 10.1001/archinternmed.2010.514; James MT, 2010, KIDNEY INT, V78, P803, DOI 10.1038/ki.2010.258; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Koyner JL, 2012, J AM SOC NEPHROL, V23, P905, DOI 10.1681/ASN.2011090907; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mariscalco G, 2011, ANN THORAC SURG, V92, P1539, DOI 10.1016/j.athoracsur.2011.04.123; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Parolari A, 2012, ANN THORAC SURG, V93, P584, DOI 10.1016/j.athoracsur.2011.09.073; Pepe MS, 2004, STAT EVALUATION MED; Saikumar J, 2012, TOXICOL SCI, V129, P256, DOI 10.1093/toxsci/kfs210; Shaw A, 2012, J THORAC CARDIOV SUR, V143, P676, DOI 10.1016/j.jtcvs.2011.08.054; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Wang G, 2010, AM J HYPERTENS, V23, P78, DOI 10.1038/ajh.2009.208; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Xu XL, 2012, KIDNEY INT, V82, P1167, DOI 10.1038/ki.2012.241; Zampetaki A, 2012, J AM COLL CARDIOL, V60, P290, DOI 10.1016/j.jacc.2012.03.056	39	59	71	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63390	10.1371/journal.pone.0063390	http://dx.doi.org/10.1371/journal.pone.0063390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717419	Green Submitted, Green Published, gold			2022-12-27	WOS:000319435600014
J	Lv, XB; Lian, GY; Wang, HR; Song, EW; Yao, HR; Wang, MH				Lv, Xiao-Bin; Lian, Gui-Yong; Wang, Hao-Ran; Song, Erwei; Yao, Herui; Wang, Ming-Hui			Long Noncoding RNA HOTAIR Is a Prognostic Marker for Esophageal Squamous Cell Carcinoma Progression and Survival	PLOS ONE			English	Article							CANCER	Background: It is currently unclear whether the expression of HOX transcript antisense RNA (HOTAIR) correlates with the progression of esophageal cancer. The aim of this study was to examine HOTAIR expression in patients with esophageal squamous cell cancer (ESCC) and explore its clinical significance. Methods: Differences in the expression of HOTAIR were examined via in situ hybridization (ISH) and quantitative reverse transcriptase PCR (qRT-PCR). The prognostic significance was evaluated using Kaplan-Meier and Cox regression analyses. Proliferation, colony formation and migration assays were performed in ESCC cell lines to determine the function of HOTAIR in the progression of ESCC in vitro. Results: A notably higher level of HOTAIR expression was found in ESCC tissues. High expression levels of HOTAIR in ESCC patients correlated positively with clinical stage, TNM classification, histological differentiation and vital status. HOTAIR expression was found to be an independent prognostic factor in ESCC patients. ESCC patients who expressed high levels of HOTAIR had substantially lower overall 5-year survival rates than HOTAIR-negative patients. In vitro assays of ESCC cell lines demonstrated that HOTAIR mediated the proliferation, colony formation and migratory capacity of ESCC cells. Conclusion: HOTAIR is a potential biomarker for ESCC prognosis, and the dysregulation of HOTAIR may play an important role in ESCC progression.	[Lian, Gui-Yong; Wang, Hao-Ran; Wang, Ming-Hui] Sun Yat Sen Univ, Dept Thoracic Cardiac Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China; [Song, Erwei; Yao, Herui] Sun Yat Sen Univ, Breast Tumor Ctr, Dept Breast Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China; [Lv, Xiao-Bin] Sun Yat Sen Univ, Med Res Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Yao, HR (corresponding author), Sun Yat Sen Univ, Breast Tumor Ctr, Dept Breast Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China.	yaoherui@163.com; Wangminghui01@yahoo.com.cn	Lv, Xiao-Bin/T-7607-2019	Yao, Herui/0000-0001-5520-6469	National Natural Science Foundation of China [81102023, 30973505]; Foundation of Ministry of Education of the People's Republic of China [20120171110075]; Guangdong Natural Science Foundation [S2011040004481, 7001618]; Foundation of Guangzhou Science and Technology Bureau [2009Y-C011-1, 2008B030301135]; Sun Yat-Sen University [12ykpy32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Ministry of Education of the People's Republic of China(Ministry of Education, China); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Foundation of Guangzhou Science and Technology Bureau; Sun Yat-Sen University	This study was supported by the National Natural Science Foundation of China (81102023 and 30973505) (http://www.nsfc.gov.cn/Portal0/default152.htm), the Foundation of Ministry of Education of the People's Republic of China (20120171110075), the Guangdong Natural Science Foundation (S2011040004481 and 7001618), the Foundation of Guangzhou Science and Technology Bureau (2009Y-C011-1 and 2008B030301135) and the Sun Yat-Sen University Training Project (12ykpy32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daly JM, 2000, J AM COLL SURGEONS, V190, P562, DOI 10.1016/S1072-7515(00)00238-6; Geng YJ, 2011, J INT MED RES, V39, P2119, DOI 10.1177/147323001103900608; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; He S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-102; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Ishibashi M, 2013, ONCOL REP, V29, P946, DOI 10.3892/or.2012.2219; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kim K, 2013, ONCOGENE; Kim SH, 2006, CANCER RES, V66, P10415, DOI 10.1158/0008-5472.CAN-06-2104; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Li DD, 2013, AM J PATHOL, V182, P64, DOI 10.1016/j.ajpath.2012.08.042; Lu LG, 2012, BREAST CANCER RES TR, V136, P875, DOI 10.1007/s10549-012-2314-z; Mandard AM, 2000, MUTAT RES-REV MUTAT, V462, P335, DOI 10.1016/S1383-5742(00)00019-3; Nie Y, 2013, CANCER SCI, V104, P458, DOI 10.1111/cas.12092; Niinuma T, 2012, CANCER RES, V72, P1126, DOI 10.1158/0008-5472.CAN-11-1803; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qi YJ, 2012, J PROTEOMICS, V75, P3129, DOI 10.1016/j.jprot.2012.04.025; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Tano Keiko, 2012, Frontiers in Genetics, V3, P219, DOI 10.3389/fgene.2012.00219; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045622; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	26	155	167	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63516	10.1371/journal.pone.0063516	http://dx.doi.org/10.1371/journal.pone.0063516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717443	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600021
J	Thedrez, A; Lavoue, V; Dessarthe, B; Daniel, P; Henno, S; Jaffre, I; Leveque, J; Catros, V; Cabillic, F				Thedrez, Aurelie; Lavoue, Vincent; Dessarthe, Benoit; Daniel, Pascale; Henno, Sebastien; Jaffre, Isabelle; Leveque, Jean; Catros, Veronique; Cabillic, Florian			A Quantitative Deficiency in Peripheral Blood V gamma 9V delta 2 Cells Is a Negative Prognostic Biomarker in Ovarian Cancer Patients	PLOS ONE			English	Article							DELTA-T-CELLS; MULTIPLE-MYELOMA; ADOPTIVE IMMUNOTHERAPY; MEDIATED RECOGNITION; ZOLEDRONIC ACID; THERAPY PRODUCT; SOLID TUMORS; PHASE-I; CARCINOMA; LYMPHOCYTES	V gamma 9V delta 2 cells are cytotoxic T cells that are able to recognize epithelial ovarian carcinoma (EOC) cells. Therefore, V gamma 9V delta 2 cell-based adoptive transfer is an attractive therapy for EOC. However, the inefficient ex vivo expansion after specific stimulation of V gamma 9V delta 2 cells from some patients and the relationships between V gamma 9V delta 2 cells and clinical course of EOC are issues that remain to be clarified. Herein, peripheral blood mononuclear cells (PBMCs) from 60 EOC patients were stimulated with bromohydrin pyrophosphate (BrHPP) or zoledronate, which are specific agonists of V gamma 9V delta 2 cells. The compounds differed in their efficacies to induce ex vivo V gamma 9V delta 2 PBMC expansion, but 16/60 samples remained inefficiently expanded with both stimuli. Interestingly, the V gamma 9V delta 2 cells in these low-responding PBMCs displayed before expansion (ex vivo PBMCs) an altered production of the pro-inflammatory cytokines IFN-gamma and TNF-alpha, a decreased naive fraction and a reduced frequency. No evidence of an involvement of CD4(+)CD25(+)Foxp(3+) regulatory cells was observed. Importantly, our data also demonstrate that a V gamma 9V delta 2 cell frequency of 0.35% or less in EOC PBMCs could be used to predict low responses to both BrHPP and zoledronate. Moreover, our data highlight that such a deficiency is not correlated with advanced EOC stages but is associated with more refractory states to platinum-based chemotherapy and is an independent predictor of shorter disease-free survival after treatment. These results are the first to suggest a potential contribution of V gamma 9V delta 2 cells to the anti-tumor effects of chemotherapeutic agents and they strengthen interest in strategies that might increase V gamma 9V delta 2 cells in cancer patients.	[Thedrez, Aurelie; Lavoue, Vincent; Dessarthe, Benoit; Catros, Veronique; Cabillic, Florian] Univ Rennes 1, UMR 991, Inst Natl Sante & Rech Med, Rennes, France; [Thedrez, Aurelie; Lavoue, Vincent; Dessarthe, Benoit; Leveque, Jean; Catros, Veronique; Cabillic, Florian] Univ Rennes 1, Fac Med, Rennes, France; [Lavoue, Vincent; Leveque, Jean] Ctr Hosp Univ Rennes, Dept Gynecol & Obstet, Rennes, France; [Daniel, Pascale; Catros, Veronique; Cabillic, Florian] Ctr Hospitalier Univ Rennes, Serv Cytogenet & Biol Cellulaire, Rennes, France; [Henno, Sebastien] Ctr Hosp Univ Rennes, Dept Anat & Cytol Pathol, Rennes, France; Inst Cancerol Ouest Rene Gauducheau, Dept Oncol Chirurg, St Herblain, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; CHU Rennes; Universite de Rennes; UNICANCER; Institut de Cancerologie de l'Ouest (ICO)	Thedrez, A (corresponding author), Univ Rennes 1, UMR 991, Inst Natl Sante & Rech Med, Rennes, France.	aurelie.thedrez@univ-rennes1.fr	Cabillic, Florian/AAM-4296-2020; LAVOUE, Vincent/L-5644-2017	Cabillic, Florian/0000-0001-7204-5652; LAVOUE, Vincent/0000-0002-4682-2806; THEDREZ, Aurelie/0000-0003-1736-5244	Institut National du Cancer (INCA) [PL2008-034]; Canceropole Grand-Ouest; Medicine Faculty of Rennes University	Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Canceropole Grand-Ouest; Medicine Faculty of Rennes University	This work was supported by grants from Institut National du Cancer (INCA) PL2008-034, Canceropole Grand-Ouest and financial support from the Medicine Faculty of Rennes University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, EXP HEMATOL, V37, P956, DOI 10.1016/j.exphem.2009.04.008; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Battistini L, 2005, MICROBES INFECT, V7, P510, DOI 10.1016/j.micinf.2004.12.008; Bennouna J, 2008, CANCER IMMUNOL IMMUN, V57, P1599, DOI 10.1007/s00262-008-0491-8; Bennouna J, 2010, CANCER IMMUNOL IMMUN, V59, P1521, DOI 10.1007/s00262-010-0879-0; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; Bonneville M, 2005, MICROBES INFECT, V7, P503, DOI 10.1016/j.micinf.2005.03.004; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Bouet-Toussaint F, 2008, CANCER IMMUNOL IMMUN, V57, P531, DOI 10.1007/s00262-007-0391-3; Burjanadze M, 2007, BRIT J HAEMATOL, V139, P206, DOI 10.1111/j.1365-2141.2007.06754.x; Cabillic F, 2010, CANCER IMMUNOL IMMUN, V59, P1611, DOI 10.1007/s00262-010-0887-0; Caccamo N, 2006, J LEUKOCYTE BIOL, V79, P663, DOI 10.1189/jlb.1105640; Cairo C, 2010, HUM IMMUNOL, V71, P968, DOI 10.1016/j.humimm.2010.06.014; Capietto AH, 2011, CELL MOL LIFE SCI, V68, P2433, DOI 10.1007/s00018-011-0705-7; Dessarthe B, 2013, J IMMUNOL IN PRESS; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Kandalaft LE, 2011, J CLIN ONCOL, V29, P925, DOI 10.1200/JCO.2009.27.2369; Kobayashi H, 2011, CANCER IMMUNOL IMMUN, V60, P1075, DOI 10.1007/s00262-011-1021-7; Kobayashi H, 2010, ANTICANCER RES, V30, P575; Kunzmann V, 2009, IMMUNOLOGY, V126, P256, DOI 10.1111/j.1365-2567.2008.02894.x; Lang JM, 2011, CANCER IMMUNOL IMMUN, V60, P1447, DOI 10.1007/s00262-011-1049-8; Lavoue V, 2011, INT J CANC; Mariani S, 2005, LEUKEMIA, V19, P664, DOI 10.1038/sj.leu.2403693; Meraviglia S, 2010, CLIN EXP IMMUNOL, V161, P290, DOI 10.1111/j.1365-2249.2010.04167.x; Nicol AJ, 2011, BRIT J CANCER, V105, P778, DOI 10.1038/bjc.2011.293; Pecorelli S, 1999, INT J GYNECOL OBSTET, V65, P243, DOI 10.1016/S0020-7292(99)00070-3; Raspollini MR, 2005, ANN ONCOL, V16, P590, DOI 10.1093/annonc/mdi112; Sakamoto M, 2011, J IMMUNOTHER, V34, P202, DOI 10.1097/CJI.0b013e318207ecfb; Salot S, 2007, J IMMUNOL METHODS, V326, P63, DOI 10.1016/j.jim.2007.07.010; Scotet E, 2008, FRONT BIOSCI-LANDMRK, V13, P6872, DOI 10.2741/3195; Thedrez A, 2007, IMMUNOL REV, V215, P123, DOI 10.1111/j.1600-065X.2006.00468.x; Viey E, 2008, J IMMUNOTHER, V31, P313, DOI 10.1097/CJI.0b013e3181609988; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	37	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63322	10.1371/journal.pone.0063322	http://dx.doi.org/10.1371/journal.pone.0063322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717410	Green Published, gold			2022-12-27	WOS:000319435600009
J	Wang, SL; Wu, B; Leng, L; Bucala, R; Lu, LJ				Wang, Su-li; Wu, Bin; Leng, Lin; Bucala, Richard; Lu, Liang-jing			Validity of LupusQoL-China for the Assessment of Health Related Quality of Life in Chinese Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							DISEASE-ACTIVITY; INDEX; EPIDEMIOLOGY; VALIDATION; COHORT; LUMINA; DAMAGE; TIME	Objectives: To adapt and assess the validity and reliability of LupusQoL for use in Chinese patients with systemic lupus erythematosus (SLE). Methods: Debriefing interviews of subjects with SLE guided the language modifications of the tool. The process of adaptation proceeded according to the guideline and pre-testing results of LupusQoL-China. 220 SLE patients completed LupusQoL-China and a generic preference-based measurement of health EuroQoL scale (EQ-5D), and 20 patients repeated them after 2 weeks. Internal consistency (ICR) and test-retest (TRT) reliability, convergent and discriminant validity were examined. Factor analysis and Rasch analysis were performed. Results: The mean (SD) age of the 208 subjects with SLE was 33.93 (+/- 9.19) years. ICR and TRT of the eight domains ranged from 0.811 to 0.965 and 0.836 to 0.974, respectively. The LupusQoL-China domains demonstrated substantial evidence of construct validity when compared with equivalent domains on the EQ-5D (physical health and usual activities r = -0.63, pain and pain/discomfort r = -0.778, emotional health and anxiety/depression r = -0.761, planning and usual activities r = -0.560). Most LupusQoL-China domains could discriminate patients with varied disease activities and end-organ damage (according to SELENA-SLEDAI and SLICC-DI). The principal component analysis revealed six factors, and confirmatory factor analysis result of which is similar to eight factors model. Conclusions: These results provide evidence that the LupusQoL-China is valid as a disease-specific HRQoL assessment tool for Chinese patients with SLE.	[Wang, Su-li; Lu, Liang-jing] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Rheumatol, Shanghai 200030, Peoples R China; [Wu, Bin] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Clin Outcomes & Econ Grp,Dept Pharm, Shanghai 200030, Peoples R China; [Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Med, Rheumatol Sect,Anlyan Ctr, New Haven, CT 06510 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Yale University	Lu, LJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Rheumatol, Shanghai 200030, Peoples R China.	lu_liangjing@medmail.com.cn		Leng, Lin/0000-0002-0605-358X	National Natural Science Foundation of China [81072469, 30671946]; Shanghai Natural Science Foundation [09ZR1417600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This work was supported by grants from the National Natural Science Foundation of China (No. 81072469; No. 30671946) and Shanghai Natural Science Foundation (No. 09ZR1417600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon GS, 2006, ANN RHEUM DIS, V65, P1168, DOI 10.1136/ard.200X.046896; Alarcon GS, 2004, ARTHRIT RHEUM-ARTHR, V51, P465, DOI 10.1002/art.20409; Cervera R, 2009, LUPUS, V18, P869, DOI 10.1177/0961203309106831; Daleboudt GMN, 2011, PSYCHOL HEALTH MED, V16, P393, DOI 10.1080/13548506.2011.554566; Furukawa F, 2009, ARCH DERMATOL RES, V301, P111, DOI 10.1007/s00403-008-0897-3; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gothwal VK, 2009, OPTOMETRY VISION SCI, V86, P836, DOI 10.1097/OPX.0b013e3181ae1ec7; Group EQ, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9; Harrison MJ, 2012, J RHEUMATOL, V39, P735, DOI 10.3899/jrheum.110648; Haupt M, 2005, ANN RHEUM DIS, V64, P1618, DOI 10.1136/ard.2004.029926; Hays RD., 2005, ASSESSING QUALITY LI, V2, P25; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Jolly M, 2010, ANN RHEUM DIS, V69, P29, DOI 10.1136/ard.2008.094763; Kuriya B, 2008, ARTHRIT RHEUM-ARTHR, V59, P181, DOI 10.1002/art.23339; Leong KP, 2008, ARTHRIT RHEUM-ARTHR, V59, P1047, DOI 10.1002/art.23833; Leong KP, 2008, ARTHRITIS RHEUM, V59, P1048; Li R, 2012, RHEUMATOLOGY, V51, P721, DOI 10.1093/rheumatology/ker370; McElhone K, 2007, ARTHRIT RHEUM-ARTHR, V57, P972, DOI 10.1002/art.22881; Mok CC, 2005, MEDICINE, V84, P218, DOI 10.1097/01.md.0000170022.44998.d1; Murawski MM, 1998, QUAL LIFE RES, V7, P11; Navarrete-Navarrete N, 2010, LUPUS, V19, P1632, DOI 10.1177/0961203310378413; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Shen HN, 2013, LUPUS IN PRESS; Stoll T, 2004, RHEUMATOLOGY, V43, P1039, DOI 10.1093/rheumatology/keh238; Sullivan PW, 2006, MED DECIS MAKING, V26, P410, DOI 10.1177/0272989X06290495; Thumboo J, 1999, J RHEUMATOL, V26, P1512; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	29	23	26	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63795	10.1371/journal.pone.0063795	http://dx.doi.org/10.1371/journal.pone.0063795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	151BM	23717486	Green Published, Green Submitted, gold			2022-12-27	WOS:000319435600033
J	Cui, ZB; Cao, W; Li, J; Song, XM; Mao, L; Chen, WT				Cui, Zhibin; Cao, Wei; Li, Jiang; Song, Xiaomeng; Mao, Li; Chen, Wantao			TRIM24 Overexpression Is Common in Locally Advanced Head and Neck Squamous Cell Carcinoma and Correlates with Aggressive Malignant Phenotypes	PLOS ONE			English	Article							NUCLEAR RECEPTORS; BREAST-CANCER; GENE; TRANSCRIPTION; EXPRESSION; ALPHA; P53; COFACTORS; PROTEIN; TUMOR	Tripartite motif-containing 24 (TRIM24), a member of the transcriptional intermediary factor 1 family, functions as a coregulator that positively or negatively modulates the transcriptional activities of several nuclear receptors. The aim of this study was to investigate TRIM24 expression and its clinical significance in head and neck squamous cell carcinoma. The expression levels of TRIM24 variants were examined in head and neck squamous cell carcinoma (HNSCC) samples and cell lines by real-time PCR and WB. The expression levels of TRIM24 measured in 91 locally advanced HNSCC tumors were measured by immunohistochemistry and correlated with clinical and pathological parameters. The functional role of TRIM24 in HNSCC was further investigated by silencing its expression in HNSCC cell lines. TRIM24 variants were up-regulated in 56 HNSCC samples (P<.001) and 9 HNSCC cell lines (P<.05). TRIM24 protein was overexpressed in 6 of 8 HNSCC cell lines and in 2 of 3 HNSCC samples. Furthermore, 54.95% (50/91) of HNSCC samples exhibited remarkably elevated expression of TRIM24 by immunohistochemistry. Univariate analysis revealed that high TRIM24 expression was associated with worse overall survival (P=.020). In multivariate analysis, TRIM24 expression was identified as an independent predictor of overall survival (P=.030), after adjusting for other clinicopathological parameters. Upon TRIM24 silencing, the proliferation of HNSCC cells was notably inhibited due to the induction of apoptosis. These results suggest that aberrant TRIM24 expression may play an important role in the development of HNSCC and is a promising prognostic indicator for patients with locally advanced HNSCC.	[Cui, Zhibin; Cao, Wei; Li, Jiang; Song, Xiaomeng; Mao, Li; Chen, Wantao] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg, Shanghai 200030, Peoples R China; [Cui, Zhibin; Cao, Wei; Song, Xiaomeng; Chen, Wantao] Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Li, Jiang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral Pathol, Shanghai 200030, Peoples R China; [Mao, Li] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University System of Maryland; University of Maryland Baltimore	Mao, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg, Shanghai 200030, Peoples R China.	lmao@umaryland.edu; chenwantao2002@hotmail.com	Cao, Wei/ABE-1035-2021; Mao, Li/C-7570-2011	Cao, Wei/0000-0003-2184-9380; Mao, Li/0000-0001-7263-3358	National Natural Science Foundation of China [81072171, 30973343, 91229103]; Projects of the Shanghai Science and Technology Committee [08JC1414400, 10DZ1951300, 11DZ2291800, 10XD1402500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of the Shanghai Science and Technology Committee	This study was supported by the National Natural Science Foundation of China (81072171, 30973343 and 91229103), Projects of the Shanghai Science and Technology Committee (08JC1414400, 10DZ1951300, 11DZ2291800 and 10XD1402500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Ammerpoht Ole, 2011, Pediatr Endocrinol Rev, V9 Suppl 1, P511; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Cabanillas R, 2007, CANCER-AM CANCER SOC, V109, P1791, DOI 10.1002/cncr.22646; Cao W, 2012, CANCER-AM CANCER SOC, V118, P2858, DOI 10.1002/cncr.26575; Cao W, 2011, CANCER PREV RES, V4, P1816, DOI 10.1158/1940-6207.CAPR-11-0130; Cao W, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-296; Chambon M, 2011, AM J PATHOL, V178, P1461, DOI 10.1016/j.ajpath.2010.12.026; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Gandini D, 2002, LEUKEMIA, V16, P886, DOI 10.1038/sj.leu.2402452; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Jain AK, 2009, CELL CYCLE, V8, P3668, DOI 10.4161/cc.8.22.9979; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Kikuchi M, 2009, BBA-MOL CELL RES, V1793, P1828, DOI 10.1016/j.bbamcr.2009.11.001; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Martone T, 2007, CLIN CANCER RES, V13, P5089, DOI 10.1158/1078-0432.CCR-07-0119; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Matsubara N, 2012, DIS COLON RECTUM, V55, P96, DOI 10.1097/DCR.0b013e318233a1ef; ODA D, 1990, IN VITRO CELL DEV B, V26, P589; Patterson EE, 2011, CANCER-AM CANCER SOC, V117, P1630, DOI 10.1002/cncr.25724; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Perrone F, 2006, CLIN CANCER RES, V12, P6643, DOI 10.1158/1078-0432.CCR-06-1759; Popanda O, 2000, INT J CANCER, V86, P318, DOI 10.1002/(SICI)1097-0215(20000501)86:3<318::AID-IJC3>3.0.CO;2-B; Pulte D, 2010, ONCOLOGIST, V15, P994, DOI 10.1634/theoncologist.2009-0289; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Zhong LP, 2008, ARCH ORAL BIOL, V53, P443, DOI 10.1016/j.archoralbio.2007.12.002	29	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63887	10.1371/journal.pone.0063887	http://dx.doi.org/10.1371/journal.pone.0063887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717505	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700077
J	Han, MH; Park, C; Jin, CY; Kim, GY; Chang, YC; Moon, SK; Kim, WJ; Choi, YH				Han, Min Ho; Park, Cheol; Jin, Cheng-Yun; Kim, Gi-Young; Chang, Young-Chae; Moon, Sung-Kwon; Kim, Wun-Jae; Choi, Yung Hyun			Apoptosis Induction of Human Bladder Cancer Cells by Sanguinarine through Reactive Oxygen Species-Mediated Up-Regulation of Early Growth Response Gene-1	PLOS ONE			English	Article							EGR-1 TRANSCRIPTION; CARCINOMA-CELLS; KAPPA-B; ACTIVATION; EXPRESSION; PTEN; ROS; DEATH	Although the effects of sanguinarine, a benzophenanthridine alkaloid, on the inhibition of some kinds of cancer cell growth have been established, the underlying mechanisms are not completely understood. This study investigated possible mechanisms by which sanguinarine exerts its anticancer action in cultured human bladder cancer cell lines (T24, EJ, and 5637). Sanguinarine treatment resulted in concentration-response growth inhibition of the bladder cancer cells by inducing apoptosis. Sanguinarine-induced apoptosis was correlated with the up-regulation of Bax, the down-regulation of Bid and XIAP, the activation of caspases (-3, -8, and -9), and the generation of increased reactive oxygen species (ROS). The ROS scavenger N-acetyl cysteine (NAC) completely reversed the sanguinarine-triggered apoptotic events. In addition, sanguinarine effectively increased the activation of the c-Jun N-terminal kinase (JNK) and the expression of the early growth response gene-1 (Egr-1), which was recovered by pretreatment with NAC. Furthermore, knockdown of Egr-1 expression by small interfering RNA attenuated sanguinarine-induced apoptosis, but not the JNK inhibitor, indicating that the interception of ROS generation blocked the sanguinarine-induced apoptotic effects via deregulation of the expression of Egr-1 proteins. Taken together, the data provide evidence that sanguinarine is a potent anticancer agent, which inhibits the growth of bladder cancer cells and induces their apoptosis through the generation of free radicals.	[Han, Min Ho; Choi, Yung Hyun] Dong Eui Univ, Antiaging Res Ctr & Blue Bio Ind RIC, Busan, South Korea; [Han, Min Ho; Choi, Yung Hyun] Dong Eui Univ, Coll Oriental Med, Dept Biochem, Busan, South Korea; [Park, Cheol] Dong Eui Univ, Coll Nat Sci, Dept Mol Biol, Busan, South Korea; [Jin, Cheng-Yun] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou, Henan, Peoples R China; [Kim, Gi-Young] Jeju Natl Univ, Dept Marine Life Sci, Immunobiol Lab, Jeju, South Korea; [Chang, Young-Chae] Catholic Univ, Daegu Sch Med, Res Inst Biomed Engn, Daegu, South Korea; [Chang, Young-Chae] Catholic Univ, Daegu Sch Med, Dept Med, Daegu, South Korea; [Moon, Sung-Kwon] Chung Ang Univ, Sch Food Sci & Technol, Ansung, South Korea; [Kim, Wun-Jae] Chungbuk Natl Univ, Coll Med, Dept Urol, Cheongju, South Korea	Dong-Eui University; Dong-Eui University; Dong-Eui University; Zhengzhou University; Jeju National University; Catholic University of Daegu; Catholic University of Daegu; Chung Ang University; Chungbuk National University	Choi, YH (corresponding author), Dong Eui Univ, Antiaging Res Ctr & Blue Bio Ind RIC, Busan, South Korea.	choiyh@deu.ac.kr			National Research Foundation of Korea (NRF); Korea government [2012-0000476, 2012046358]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government(Korean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (2012-0000476 and 2012046358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami VM, 2004, MOL CANCER THER, V3, P933; Aggeli IKS, 2010, PHYSIOL RES, V59, P443, DOI 10.33549/physiolres.931806; Ahmad N, 2000, CLIN CANCER RES, V6, P1524; Ahmed MM, 2004, CURR CANCER DRUG TAR, V4, P43, DOI 10.2174/1568009043481704; Aicher WK, 1999, RHEUMATOL INT, V18, P207, DOI 10.1007/s002960050086; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Chang MC, 2007, TOXICOL APPL PHARM, V218, P143, DOI 10.1016/j.taap.2006.10.025; Choi WY, 2008, CHEMOTHERAPY, V54, P279, DOI 10.1159/000149719; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; DATTA R, 1993, P NATL ACAD SCI USA, V90, P2419, DOI 10.1073/pnas.90.6.2419; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Depre C, 2001, P NATL ACAD SCI USA, V98, P9336, DOI 10.1073/pnas.171297498; Downes CP, 2004, BIOCHEM SOC T, V32, P338, DOI 10.1042/BST0320338; Fantini D, 2008, FREE RADICAL RES, V42, P20, DOI 10.1080/10715760701765616; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Hussain AR, 2007, CANCER RES, V67, P3888, DOI 10.1158/0008-5472.CAN-06-3764; Jones N, 2003, J CELL PHYSIOL, V196, P326, DOI 10.1002/jcp.10308; Kang JM, 2010, AM J PHYSIOL-GASTR L, V299, pG1147, DOI 10.1152/ajpgi.00218.2010; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kim BC, 2005, BIOCHEM PHARMACOL, V70, P1398, DOI 10.1016/j.bcp.2005.07.025; Kim JH, 2011, BMB REP, V44, P452, DOI 10.5483/BMBRep.2011.44.7.452; Kim S, 2008, J CELL BIOCHEM, V104, P895, DOI 10.1002/jcb.21672; Kim SO, 2007, BIOSCI BIOTECH BIOCH, V71, P2169, DOI 10.1271/bbb.70103; LASTER LL, 1990, J CAN DENT ASSOC, V56, pS19; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee JS, 2012, INT J TOXICOL, V31, P70, DOI 10.1177/1091581811423845; MacKenzie SH, 2008, CURR CANCER DRUG TAR, V8, P98; MAHADY GB, 1994, PLANTA MED, V60, P553, DOI 10.1055/s-2006-959570; Matkar SS, 2008, CHEM-BIOL INTERACT, V172, P63, DOI 10.1016/j.cbi.2007.12.006; Mishra S, 2006, P NATL ACAD SCI USA, V103, P5191, DOI 10.1073/pnas.0600241103; MITSCHER LA, 1978, LLOYDIA, V41, P145; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Park H, 2010, BIOCHEM BIOPH RES CO, V399, P446, DOI 10.1016/j.bbrc.2010.07.114; RAUSCHER FJ, 1993, ADV EXP MED BIOL, V348, P23; Sakamoto K, 2009, MOL BIOL CELL, V20, P1606, DOI 10.1091/mbc.E08-07-0762; Shin DY, 2009, BIOMED PHARMACOTHER, V63, P86, DOI 10.1016/j.biopha.2008.08.001; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Tak JK, 2012, BMB REP, V45, P242, DOI 10.5483/BMBRep.2012.45.4.242; TANDON RK, 1975, AM J CLIN NUTR, V28, P883, DOI 10.1093/ajcn/28.8.883; Tsukamoto H, 2011, ANTICANCER RES, V31, P2841; Vavreckova Ctirada, 1994, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V138, P7; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; WALTEROVA D, 1981, J MED CHEM, V24, P1100, DOI 10.1021/jm00141a019; Wang MF, 2011, EXP MOL MED, V43, P189, DOI 10.3858/emm.2011.43.4.023; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027441	49	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63425	10.1371/journal.pone.0063425	http://dx.doi.org/10.1371/journal.pone.0063425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717422	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700020
J	Blair, JMA; Richmond, GE; Bailey, AM; Ivens, A; Piddock, LJV				Blair, Jessica M. A.; Richmond, Grace E.; Bailey, Andrew M.; Ivens, Al; Piddock, Laura J. V.			Choice of Bacterial Growth Medium Alters the Transcriptome and Phenotype of Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; EPITHELIAL-CELLS; SSRA-SSRB; EXPRESSION; INFECTION; GENES; INVASION; PROLIFERATION; VIRULENCE	The type of bacterial culture medium is an important consideration during design of any experimental protocol. The aim of this study was to understand the impact of medium choice on bacterial gene expression and physiology by comparing the transcriptome of Salmonella enterica SL1344 after growth in the widely used LB broth or the rationally designed MOPS minimal medium. Transcriptomics showed that after growth in MOPS minimal media, compared to LB, there was increased expression of 42 genes involved in amino acid synthesis and 23 genes coding for ABC transporters. Seven flagellar genes had decreased expression after growth in MOPS minimal medium and this correlated with a decreased motility. In both MOPS minimal medium and MEM expression of genes from SPI-2 was increased and the adhesion of S. Typhimurium to intestinal epithelial cells was higher compared to the levels after growth in LB. However, SL1344 invasion was not significantly altered by growth in either MOPs minimal media or MEM. Expression of SPI-2 was also measured using chromosomal GFP reporter fusions followed by flow cytometry which showed, for the first time, that the reduction in SPI-2 transcript after growth in different media related to a reduction in the proportion of the bacterial population expressing SPI-2. These data highlight the profound differences in the global transcriptome after in vitro growth in different media and show that choice of medium should be considered carefully during experimental design, particularly when virulence related phenotypes are being measured.	[Blair, Jessica M. A.; Richmond, Grace E.; Bailey, Andrew M.; Piddock, Laura J. V.] Univ Birmingham, Sch Immun & Infect, Antimicrobials Res Grp, Birmingham, W Midlands, England; [Blair, Jessica M. A.; Richmond, Grace E.; Bailey, Andrew M.; Piddock, Laura J. V.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Ivens, Al] Univ Edinburgh, Ctr Immun Infect & Evolut, Ashworth Labs, Edinburgh, Midlothian, Scotland	University of Birmingham; University of Birmingham; University of Edinburgh	Piddock, LJV (corresponding author), Univ Birmingham, Sch Immun & Infect, Antimicrobials Res Grp, Birmingham, W Midlands, England.	l.j.v.piddock@bham.ac.uk		Blair, Jessica/0000-0001-6904-4253; Ivens, Al/0000-0002-0112-3876; Piddock, Laura/0000-0003-1460-473X	Medical Research Council (MRC) DTG at the University of Birmingham; Wellcome Trust; MRC [G0501415]; Medical Research Council [G9818340, G0501415] Funding Source: researchfish; MRC [G9818340] Funding Source: UKRI	Medical Research Council (MRC) DTG at the University of Birmingham(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JB was funded by a Medical Research Council (MRC) DTG at the University of Birmingham, a Wellcome Trust VIP award and then by an MRC Programme grant (G0501415). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AM, 2006, ANTIMICROB AGENTS CH, V50, P1071, DOI 10.1128/AAC.50.3.1071-1074.2006; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Blair JMA, 2009, J ANTIMICROB CHEMOTH, V64, P965, DOI 10.1093/jac/dkp311; Buckley AM, 2006, CELL MICROBIOL, V8, P847, DOI 10.1111/j.1462-5822.2005.00671.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Christensen KA, 2002, J CELL SCI, V115, P599; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Clark L, 2011, MICROBIOL-SGM, V157, P2072, DOI 10.1099/mic.0.048496-0; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Dibb-Fuller MP, 1999, MICROBIOL-SGM, V145, P1023, DOI 10.1099/13500872-145-5-1023; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Webber MA, 2009, J BACTERIOL, V191, P4276, DOI 10.1128/JB.00363-09; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	28	25	25	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63912	10.1371/journal.pone.0063912	http://dx.doi.org/10.1371/journal.pone.0063912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704954	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200085
J	Brew, N; Hooper, SB; Zahra, V; Wallace, M; Harding, R				Brew, Nadine; Hooper, Stuart B.; Zahra, Valerie; Wallace, Megan; Harding, Richard			Mechanical Ventilation Injury and Repair in Extremely and Very Preterm Lungs	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BRONCHOPULMONARY DYSPLASIA; PREMATURE-INFANTS; METALLOTHIONEIN; EXPRESSION; CYTOKINES; EXPOSURE; ELASTIN; INFLAMMATION; MATURATION	Background: Extremely preterm infants often receive mechanical ventilation (MV), which can contribute to bronchopulmonary dysplasia (BPD). However, the effects of MV alone on the extremely preterm lung and the lung's capacity for repair are poorly understood. Aim: To characterise lung injury induced by MV alone, and mechanisms of injury and repair, in extremely preterm lungs and to compare them with very preterm lungs. Methods: Extremely preterm lambs (0.75 of term) were transiently exposed by hysterotomy and underwent 2 h of injurious MV. Lungs were collected 24 h and at 15 d after MV. Immunohistochemistry and morphometry were used to characterise injury and repair processes. qRT-PCR was performed on extremely and very preterm (0.85 of term) lungs 24 h after MV to assess molecular injury and repair responses. Results: 24 h after MV at 0.75 of term, lung parenchyma and bronchioles were severely injured; tissue space and myofibroblast density were increased, collagen and elastin fibres were deformed and secondary crest density was reduced. Bronchioles contained debris and their epithelium was injured and thickened. 24 h after MV at 0.75 and 0.85 of term, mRNA expression of potential mediators of lung repair were significantly increased. By 15 days after MV, most lung injury had resolved without treatment. Conclusions: Extremely immature lungs, particularly bronchioles, are severely injured by 2 h of MV. In the absence of continued ventilation these injured lungs are capable of repair. At 24 h after MV, genes associated with injurious MV are unaltered, while potential repair genes are activated in both extremely and very preterm lungs.	[Brew, Nadine; Harding, Richard] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Hooper, Stuart B.; Zahra, Valerie; Wallace, Megan] Monash Univ, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Hooper, Stuart B.; Wallace, Megan] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia	Monash University; Monash University; Monash University	Brew, N (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia.	Nadine.brew@monash.edu		Hooper, Stuart/0000-0003-1676-4825; Wallace, Megan/0000-0001-5785-5120	National Health and Medical research Council of Australia; Victorian Government's Operational Infrastructure Support Program	National Health and Medical research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work is supported by the National Health and Medical research Council of Australia and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertine KH, 1999, AM J RESP CRIT CARE, V159, P945, DOI 10.1164/ajrccm.159.3.9804027; Allison BJ, 2008, PEDIATR RES, V64, P387, DOI 10.1203/PDR.0b013e318181e05e; Allison BJ, 2010, PEDIATR RES, V67, P238, DOI 10.1203/PDR.0b013e3181cde9b3; Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Bach KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047044; BHUTANI VK, 1981, RESP PHYSIOL, V43, P221, DOI 10.1016/0034-5687(81)90104-3; Bland RD, 2008, AM J PHYSIOL-LUNG C, V294, pL3, DOI 10.1152/ajplung.00362.2007; Bose C, 2011, PEDIATR RES, V69, P347, DOI 10.1203/PDR.0b013e31820a58f3; Brass DM, 2008, IMMUNOGENETICS, V60, P353, DOI 10.1007/s00251-008-0293-3; Brew N, 2011, AM J PHYSIOL-LUNG C, V301, pL917, DOI 10.1152/ajplung.00207.2011; Capoluongo E, 2005, EUR CYTOKINE NETW, V16, P199; Chen ZM, 2007, FREE RADICAL BIO MED, V43, P628, DOI 10.1016/j.freeradbiomed.2007.05.024; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; COALSON JJ, 1992, AM REV RESPIR DIS, V145, P872, DOI 10.1164/ajrccm/145.4_Pt_1.872; Courtade M, 1998, CHEST, V113, P371, DOI 10.1378/chest.113.2.371; Cullen AB, 2006, BIOL NEONATE, V90, P17, DOI 10.1159/000091742; Doyle LW, 2006, PEDIATR PULM, V41, P570, DOI 10.1002/ppul.20412; Fakhoury KF, 2010, PEDIATRICS, V125, pE1441, DOI 10.1542/peds.2009-0668; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Farstad T, 2011, ACTA PAEDIATR, V100, P53, DOI 10.1111/j.1651-2227.2010.01959.x; Hennessy EM, 2008, ARCH DIS CHILD, V93, P1037, DOI 10.1136/adc.2008.140830; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V300, pL232, DOI 10.1152/ajplung.00294.2010; Hillman NH, 2010, PEDIATR RES, V67, P60, DOI 10.1203/PDR.0b013e3181c1b09e; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Inoue K, 2008, FREE RADICAL BIO MED, V45, P1714, DOI 10.1016/j.freeradbiomed.2008.09.008; Inoue KI, 2005, EXP BIOL MED, V230, P75; Kaarteenaho-Wiik R, 2002, J HISTOCHEM CYTOCHEM, V50, P423, DOI 10.1177/002215540205000313; KAGI JHR, 1960, J BIOL CHEM, V235, P3460; Kallapur SG, 2011, AM J PHYSL LUNG CELL; Kroon AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016910; Laughon MM, 2011, AM J RESP CRIT CARE, V183, P1715, DOI 10.1164/rccm.201101-0055OC; LEE RMKW, 1988, AM REV RESPIR DIS, V137, P450, DOI 10.1164/ajrccm/137.2.450; MARTIN C, 1995, CHEST, V107, P196, DOI 10.1378/chest.107.1.196; MOTOYAMA EK, 1987, AM REV RESPIR DIS, V136, P50, DOI 10.1164/ajrccm/136.1.50; Nie J, 2011, J SURG RES, V168, P281, DOI 10.1016/j.jss.2009.10.020; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603; O'Reilly M, 2009, AM J PHYSIOL-LUNG C, V297, pL992, DOI 10.1152/ajplung.00099.2009; Oh JH, 2009, INHAL TOXICOL, V21, P347, DOI [10.1080/08958370802464281 , 10.1080/08958370802464281]; PIEDBOEUF B, 1994, AM J RESP CELL MOL, V10, P123, DOI 10.1165/ajrcmb.10.2.8110467; Pierce RA, 1997, AM J PHYSIOL-LUNG C, V272, pL452, DOI 10.1152/ajplung.1997.272.3.L452; Pierce RA, 2007, PEDIATR RES, V61, P703, DOI 10.1203/pdr.0b013e318053661d; PITT BR, 1992, PEDIATR RES, V32, P424, DOI 10.1203/00006450-199210000-00011; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Sarafidis K, 2011, J PERINATOL, V31, P104, DOI 10.1038/jp.2010.78; Singhal KK, 1996, PEDIATR RES, V39, P229, DOI 10.1203/00006450-199602000-00007; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Takano H, 2004, THORAX, V59, P1057, DOI 10.1136/thx.2004.024232; Thibeault DW, 2003, PEDIATRICS, V111, P766, DOI 10.1542/peds.111.4.766; Thibeault DW, 2000, PEDIATRICS, V106, P1452, DOI 10.1542/peds.106.6.1452; Thirumoorthy N, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-54; Tiddens HAWM, 2008, PEDIATR PULM, V43, P1206, DOI 10.1002/ppul.20928; Toti P, 1997, PEDIATR PULM, V24, P22, DOI 10.1002/(SICI)1099-0496(199707)24:1<22::AID-PPUL4>3.0.CO;2-L; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Wallace MJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-19; Wilson A, 2000, PEDIATRICS, V105, P822, DOI 10.1542/peds.105.4.822	56	14	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63905	10.1371/journal.pone.0063905	http://dx.doi.org/10.1371/journal.pone.0063905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704953	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200084
J	Diersch, N; Mueller, K; Cross, ES; Stadler, W; Rieger, M; Schutz-Bosbach, S				Diersch, Nadine; Mueller, Karsten; Cross, Emily S.; Stadler, Waltraud; Rieger, Martina; Schuetz-Bosbach, Simone			Action Prediction in Younger versus Older Adults: Neural Correlates of Motor Familiarity	PLOS ONE			English	Article							SPORT-RELATED ANTICIPATION; EXPERT-NOVICE DIFFERENCES; POINT-LIGHT ACTIONS; MIRROR-NEURON; FUNCTIONAL CONNECTIVITY; HEMISPHERIC-ASYMMETRY; ORBITOFRONTAL CORTEX; BASKETBALL PLAYERS; UNDERSTAND OTHERS; BRAIN ACTIVATION	Generating predictions during action observation is essential for efficient navigation through our social environment. With age, the sensitivity in action prediction declines. In younger adults, the action observation network (AON), consisting of premotor, parietal and occipitotemporal cortices, has been implicated in transforming executed and observed actions into a common code. Much less is known about age-related changes in the neural representation of observed actions. Using fMRI, the present study measured brain activity in younger and older adults during the prediction of temporarily occluded actions (figure skating elements and simple movement exercises). All participants were highly familiar with the movement exercises whereas only some participants were experienced figure skaters. With respect to the AON, the results confirm that this network was preferentially engaged for the more familiar movement exercises. Compared to younger adults, older adults recruited visual regions to perform the task and, additionally, the hippocampus and caudate when the observed actions were familiar to them. Thus, instead of effectively exploiting the sensorimotor matching properties of the AON, older adults seemed to rely predominantly on the visual dynamics of the observed actions to perform the task. Our data further suggest that the caudate played an important role during the prediction of the less familiar figure skating elements in better-performing groups. Together, these findings show that action prediction engages a distributed network in the brain, which is modulated by the content of the observed actions and the age and experience of the observer.	[Diersch, Nadine; Mueller, Karsten; Cross, Emily S.; Stadler, Waltraud; Rieger, Martina; Schuetz-Bosbach, Simone] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Diersch, Nadine] Max Planck Inst Demog Res, MaxNetAging Res Sch, Rostock, Germany; [Cross, Emily S.] Bangor Univ, Sch Psychol, Wales Inst Cognit Neurosci, Bangor, Gwynedd, Wales; [Cross, Emily S.] Radboud Univ Nijmegen, Inst Behav Sci, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Stadler, Waltraud] Tech Univ Munich, Fac Sports & Hlth Sci, Movement Sci Unit, D-80290 Munich, Germany; [Rieger, Martina] Hlth & Life Sci Univ, UMIT, Med Sci & Management Dept, Inst Psychol, Hall Tyrol, Austria	Max Planck Society; Max Planck Society; Bangor University; Radboud University Nijmegen; Technical University of Munich	Diersch, N (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	diersch@cbs.mpg.de	Cross, Emily S./B-4565-2009	Cross, Emily S./0000-0002-1671-5698; Schutz-Bosbach, Simone/0000-0002-0937-9454; Rieger, Martina/0000-0002-2421-296X	Max Planck Society	Max Planck Society(Max Planck Society)	This work was supported by the Max Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy B, 2007, J MOTOR BEHAV, V39, P353, DOI 10.3200/JMBR.39.5.353-368; Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Addis DR, 2011, NEUROPSYCHOLOGIA, V49, P3656, DOI 10.1016/j.neuropsychologia.2011.09.021; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Babiloni C, 2010, BEHAV BRAIN RES, V207, P466, DOI 10.1016/j.bbr.2009.10.034; BADDELEY A, 1993, BRIT J CLIN PSYCHOL, V32, P55, DOI 10.1111/j.2044-8260.1993.tb01027.x; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bischoff M, 2012, NEUROPSYCHOLOGIA, V50, P2085, DOI 10.1016/j.neuropsychologia.2012.05.009; Brown EC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00147; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Carp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029411; Carp J, 2011, NEUROIMAGE, V56, P736, DOI 10.1016/j.neuroimage.2010.04.267; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Catmur C, 2009, PHILOS T R SOC B, V364, P2369, DOI 10.1098/rstb.2009.0048; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cooper JC, 2012, J COGNITIVE NEUROSCI, V24, P106, DOI 10.1162/jocn_a_00114; Costantini M, 2005, CEREB CORTEX, V15, P1761, DOI 10.1093/cercor/bhi053; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2013, HUM BRAIN MAPP, V34, P467, DOI 10.1002/hbm.21450; Cross ES, 2012, HUM BRAIN MAPP, V33, P2238, DOI 10.1002/hbm.21361; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Davis SW, 2012, CEREB CORTEX, V22, P232, DOI 10.1093/cercor/bhr123; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; Dennis N. A., 2008, HDB AGING COGNITION, P1, DOI DOI 10.4324/9780203837665.CH1; Dennis NA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.004; Diersch N, 2012, PSYCHOL RES-PSYCH FO, V76, P525, DOI 10.1007/s00426-011-0404-x; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Erickson KI, 2007, NEUROBIOL AGING, V28, P272, DOI 10.1016/j.neurobiolaging.2005.12.012; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002327; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gabbard C, 2011, ARCH GERONTOL GERIAT, V53, P206, DOI 10.1016/j.archger.2010.10.006; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Graf M, 2007, NEUROIMAGE, V36, pT22, DOI 10.1016/j.neuroimage.2007.03.017; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; Heuninckx S, 2005, J NEUROSCI, V25, P6787, DOI 10.1523/JNEUROSCI.1263-05.2005; Heuninckx S, 2010, NEUROBIOL AGING, V31, P301, DOI 10.1016/j.neurobiolaging.2008.03.021; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Jin H, 2011, NEUROSCI LETT, V492, P139, DOI 10.1016/j.neulet.2011.01.074; Johnson A, 2007, CURR OPIN NEUROBIOL, V17, P692, DOI 10.1016/j.conb.2008.01.003; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kilner JM, 2007, NEUROREPORT, V18, P619, DOI 10.1097/WNR.0b013e3281139ed0; Kokal I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013507; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; Langan J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00017; Leonard G, 2007, EXP BRAIN RES, V177, P167, DOI 10.1007/s00221-006-0657-6; Li SC, 1999, COGNITIVE NEUROSCIENCE OF MEMORY, P103; Liew SL, 2011, HUM BRAIN MAPP, V32, P1986, DOI 10.1002/hbm.21164; Lustig C., 2003, METH NE FRO NEUROSCI, P261; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Martin VC, 2011, P NATL ACAD SCI USA, V108, P13858, DOI 10.1073/pnas.1105816108; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Nedelko V, 2010, RESTOR NEUROL NEUROS, V28, P737, DOI 10.3233/RNN-2010-0542; O'Doherty JP, 2007, ANN NY ACAD SCI, V1121, P254, DOI 10.1196/annals.1401.036; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olsson C-J, 2008, Open Neuroimag J, V2, P5, DOI 10.2174/1874440000802010005; Oosterhof NN, 2010, J NEUROPHYSIOL, V104, P1077, DOI 10.1152/jn.00326.2010; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Parkinson J, 2012, PSYCHOL RES-PSYCH FO, V76, P421, DOI 10.1007/s00426-012-0422-3; Perrett DI, 2009, Q J EXP PSYCHOL, V62, P2081, DOI 10.1080/17470210902959279; Personnier P, 2008, BEHAV BRAIN RES, V186, P273, DOI 10.1016/j.bbr.2007.08.018; Personnier P, 2010, NEUROSCI LETT, V476, P146, DOI 10.1016/j.neulet.2010.04.017; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Press C, 2011, BIOL LETTERS, V7, P457, DOI 10.1098/rsbl.2010.0850; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Saimpont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006714; Saygin AP, 2012, PSYCHOL RES-PSYCH FO, V76, P388, DOI 10.1007/s00426-012-0426-z; Schacter DL, 2012, GERONTOLOGY; Schiffer AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036445; Schiffer AM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00038; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schutz-Bosbach Simone, 2007, Cogn Process, V8, P93, DOI 10.1007/s10339-007-0167-x; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; Smith Y, 2009, BRAIN RES BULL, V78, P60, DOI 10.1016/j.brainresbull.2008.08.015; Sparenberg P, 2012, PSYCHOL RES-PSYCH FO, V76, P41, DOI 10.1007/s00426-011-0321-z; Stadler W, 2012, PSYCHOL RES-PSYCH FO, V76, P395, DOI 10.1007/s00426-012-0431-2; Stadler W, 2011, HUM BRAIN MAPP, V32, P677, DOI 10.1002/hbm.20949; Urgesi C, 2012, PSYCHOL RES-PSYCH FO, V76, P542, DOI 10.1007/s00426-011-0383-y; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Wechsler D., 1997, WECHSLER ADULT INTEL; Weiler JA, 2010, BEHAV BRAIN RES, V212, P196, DOI 10.1016/j.bbr.2010.04.013; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Wright MJ, 2011, NEUROSCI LETT, V500, P216, DOI 10.1016/j.neulet.2011.06.045; Wright MJ, 2010, NEUROREPORT, V21, P94, DOI 10.1097/WNR.0b013e328333dff2; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	112	31	31	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64195	10.1371/journal.pone.0064195	http://dx.doi.org/10.1371/journal.pone.0064195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704980	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200122
J	Kaida, A; Matthews, LT; Kanters, S; Kabakyenga, J; Muzoora, C; Mocello, AR; Martin, JN; Hunt, P; Haberer, J; Hogg, RS; Bangsberg, DR				Kaida, Angela; Matthews, Lynn T.; Kanters, Steve; Kabakyenga, Jerome; Muzoora, Conrad; Mocello, A. Rain; Martin, Jeffrey N.; Hunt, Peter; Haberer, Jessica; Hogg, Robert S.; Bangsberg, David R.			Incidence and Predictors of Pregnancy among a Cohort of HIV-Positive Women Initiating Antiretroviral Therapy in Mbarara, Uganda	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REPRODUCTIVE HEALTH-CARE; INFECTED WOMEN; FERTILITY INTENTIONS; MALE CIRCUMCISION; PREEXPOSURE PROPHYLAXIS; MISSED OPPORTUNITIES; DISCORDANT COUPLES; EXPANDING ACCESS; RISK BEHAVIOR	Objective: Many people living with HIV in sub-Saharan Africa desire biological children. Implementation of HIV prevention strategies that support the reproductive goals of people living with HIV while minimizing HIV transmission risk to sexual partners and future children requires a comprehensive understanding of pregnancy in this population. We analyzed prospective cohort data to determine pregnancy incidence and predictors among HIV-positive women initiating antiretroviral therapy (ART) in a setting with high HIV prevalence and fertility. Methods: Participants were enrolled in the Uganda AIDS Rural Treatment Outcomes (UARTO) cohort of HIV-positive individuals initiating ART in Mbarara. Bloodwork (including CD4 cells/mm(3), HIV viral load) and questionnaires (including socio-demographics, health status, sexual behavior, partner dynamics, HIV history, and self-reported pregnancy) were completed at baseline and quarterly. Our analysis includes 351 HIV-positive women (18-49 years) who enrolled between 2005-2011. We measured pregnancy incidence by proximal and distal time relative to ART initiation and used multivariable Cox proportional hazards regression analysis (with repeated events) to identify baseline and time-dependent predictors of pregnancy post-ART initiation. Results: At baseline (pre-ART initiation), median age was 33 years [IQR: 27-37] and median prior livebirths was four [IQR: 2-6]. 38% were married with 61% reporting HIV-positive spouses. 73% of women had disclosed HIV status to a primary sexual partner. Median baseline CD4 was 137 cells/mm(3) [IQR: 81-207]. At enrolment, 9.1% (31/342) reported current pregnancy. After ART initiation, 84 women experienced 105 pregnancies over 3.8 median years of follow-up, yielding a pregnancy incidence of 9.40 per 100 WYs. Three years post-ART initiation, cumulative probability of at least one pregnancy was 28% and independently associated with younger age (Adjusted Hazard Ratio (AHR): 0.89/year increase; 95% CI: 0.86-0.92) and HIV serostatus disclosure to primary sexual partner (AHR: 2.45; 95% CI: 1.29-4.63). Conclusions: Nearly one-third of women became pregnant within three years of initiating ART, highlighting the need for integrated services to prevent unintended pregnancies and reduce periconception-related risks for HIV-infected women choosing to conceive. Association with younger age and disclosure suggests a role for early and couples-based safer conception counselling.	[Kaida, Angela; Hogg, Robert S.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Matthews, Lynn T.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Matthews, Lynn T.; Haberer, Jessica; Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA; [Matthews, Lynn T.; Haberer, Jessica; Bangsberg, David R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kanters, Steve] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Kabakyenga, Jerome; Muzoora, Conrad; Bangsberg, David R.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Mocello, A. Rain; Martin, Jeffrey N.; Hunt, Peter] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hogg, Robert S.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada	Simon Fraser University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of British Columbia; Mbarara University of Science & Technology; University of California System; University of California San Francisco; B.C. Centre for Excellence in HIV/AIDS	Kaida, A (corresponding author), Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada.	kangela@sfu.ca	Haberer, Jessica/AAH-7976-2019; Hunt, Peter W./P-2976-2017; Muzoora, Conrad/AAV-7023-2021	Haberer, Jessica/0000-0001-5845-3190; Hunt, Peter W./0000-0002-4571-4870; Muzoora, Conrad/0000-0002-7866-5198; Hogg, Robert/0000-0003-3463-5488	National Institute of Child Health and Human Development [NICHD R21-HD069194]; National Institute of Mental Health [NIMH R01-MH54907]; Sullivan Family Foundation;  [K-23 MH095655];  [K-24 MH87227]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD069194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227, R01MH054907, K23MH095655] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sullivan Family Foundation; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this study was provided by grants from the National Institute of Child Health and Human Development (NICHD R21-HD069194), the National Institute of Mental Health (NIMH R01-MH54907), and the Sullivan Family Foundation. LTM received support from K-23 MH095655 and DRB received support from K-24 MH87227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andia I, 2009, AM J PUBLIC HEALTH, V99, P340, DOI 10.2105/AJPH.2007.129528; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bekker L. G., 2011, Southern African Journal of HIV Medicine, V12, P31; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Blair JM, 2004, OBSTET GYNECOL, V103, P663, DOI 10.1097/01.AOG.0000117083.33239.b5; Brubaker SG, 2011, HIV MED, V12, P316, DOI 10.1111/j.1468-1293.2010.00884.x; Bujan L, 2007, AIDS, V21, P1909, DOI 10.1097/QAD.0b013e3282703879; Bussmann H, 2007, JAIDS-J ACQ IMM DEF, V45, P269; Chadwick Rachelle J, 2011, Top Antivir Med, V19, P148; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; DECHERNEY AH, 1982, NEW ENGL J MED, V306, P424, DOI 10.1056/NEJM198202183060712; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Desgrees-du-Lou A, 2002, INT J STD AIDS, V13, P462, DOI 10.1258/09564620260079617; Farrell B, 2007, FAMILY PLANNING INTE; Frodsham LCG, 2006, FERTIL STERIL, V85, P285, DOI 10.1016/j.fertnstert.2005.07.1326; Geng EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014098; Giaquinto C, 2005, BJOG-INT J OBSTET GY, V112, P881, DOI 10.1111/j.1471-0528.2005.00569.x; Gibb DM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001217; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gruskin S, 2007, REPROD HEALTH MATTER, V15, P4, DOI 10.1016/S0968-8080(07)29028-7; Guthrie BL, 2010, AIDS BEHAV, V14, P1066, DOI 10.1007/s10461-010-9716-x; Heard I, 2007, AIDS, V21, pS77, DOI 10.1097/01.aids.0000255089.44297.6f; Heffron R, 2010, SEX TRANSM DIS, V37, P621, DOI 10.1097/OLQ.0b013e3181e1a162; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Kabami J, 2011, 6 INT AIDS SOC IAS C; Kaida A, 2012, INFECT DIS OBSTET GY, V2012, P9; Kaida A, 2011, AM J PUBLIC HEALTH, V101, P350, DOI 10.2105/AJPH.2009.177469; Kaida A, 2009, AIDS BEHAV, V13, pS1, DOI 10.1007/s10461-009-9568-4; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kastner J, 2013, AFR FOR ENT UG JAN 1; Kharsany ABM, 2010, HIV MED, V11, P661, DOI 10.1111/j.1468-1293.2010.00838.x; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; King R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-530; Kisakye P, 2010, CULT HEALTH SEX, V12, P445, DOI 10.1080/13691051003628922; Lewis JJC, 2004, AIDS, V18, pS35, DOI 10.1097/00002030-200406002-00005; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Linas BS, 2011, AIDS, V25, P707, DOI 10.1097/QAD.0b013e3283445811; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; Makumbi FE, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/519492; Mantell JE, 2009, J PUBLIC HEALTH POL, V30, P367, DOI 10.1057/jphp.2009.35; Martinez P, 2008, AIDS BEHAV, V12, P605, DOI 10.1007/s10461-007-9312-x; Matthews LT, 2013, AIDS BEHAV, V17, P461, DOI 10.1007/s10461-011-0068-y; Matthews LT, 2012, CURR OPIN HIV AIDS, V7, P569, DOI 10.1097/COH.0b013e328358bac9; Matthews LT, 2009, AIDS BEHAV, V13, pS5, DOI 10.1007/s10461-009-9551-0; [Ministry of Health Uganda ORC Macro], 2006, UG HIV AIDS SER SURV; Mmeje Okeoma, 2012, Infect Dis Obstet Gynecol, V2012, P587651, DOI 10.1155/2012/587651; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Muyindike W, 2012, INFECT DIS OBSTET GY, V2012; Myer L, 2007, TROP MED INT HEALTH, V12, P1484, DOI 10.1111/j.1365-3156.2007.01955.x; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Myer L, 2009, JAIDS-J ACQ IMM DEF, V52, pS52, DOI 10.1097/QAI.0b013e3181bbc818; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; Ogilvie GS, 2007, AIDS, V21, pS83, DOI 10.1097/01.aids.0000255090.51921.60; Panozzo L, 2003, SWISS MED WKLY, V133, P124; Polis CB, 2011, CONTRACEPTION, V83, P549, DOI 10.1016/j.contraception.2010.10.002; Revicki DA, 1998, MED CARE, V36, P126, DOI 10.1097/00005650-199802000-00003; SAS, 2011, SAS VERS 9 3; Schwartz SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036039; Schwartz SR, 2012, AIDS BEHAV, V16, P69, DOI 10.1007/s10461-011-9981-3; Sharma A, 2007, AM J OBSTET GYNECOL, V196, P541, DOI 10.1016/j.ajog.2007.01.005; Simbayi LC, 2007, SEX TRANSM INFECT, V83, P29, DOI 10.1136/sti.2006.019893; Snow RC, 2013, AM J PUBLIC HEALTH, V103, P278, DOI 10.2105/AJPH.2012.300892; Taulo F, 2009, AIDS BEHAV, V13, pS20, DOI 10.1007/s10461-009-9547-9; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tweya H, 2012, AIDS BEHAV; Uganda Bureau of Statistics Macro International Inc, 2007, UG DEM HLTH SURV 200; Uganda Ministry of Health, 2008, NAT ANT TREATM CAR G; Uganda Ministry of Health, 2003, NAT ANT TREATM CAR G; Ugandan Ministry of Health, 2009, NAT ANT TREATM GUID; Ujiji OA, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-13; UNAIDS, 2010, REP GLOB AIDS EP; United Nations Population Division, 2009, WORLD FERT DAT 2008; US Census Bureau International Programs, 2008, GLOB POP PROF 2008 I; van Benthem BHB, 2000, AIDS, V14, P2171, DOI 10.1097/00002030-200009290-00014; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Vitorino RL, 2011, FERTIL STERIL, V95, P1684, DOI 10.1016/j.fertnstert.2011.01.127; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wilcher R, 2009, AIDS, V23, pS1, DOI 10.1097/01.aids.0000363772.45635.35; World Health Organization,, 2020, UNDERSTANDING SEXUAL; World Vision, 2017, INT LIV ASS TARG REF; Wu AW., 1999, MOS HIV HLTH SURVEY; Zaba B, 1998, AIDS, V12, pS41	90	43	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63411	10.1371/journal.pone.0063411	http://dx.doi.org/10.1371/journal.pone.0063411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23704906	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200036
J	Tian, NF; Wu, YS; Zhang, XL; Wu, XL; Chi, YL; Mao, FM				Tian, Nai-Feng; Wu, Yao-Sen; Zhang, Xiao-Lei; Wu, Xin-Lei; Chi, Yong-Long; Mao, Fang-Min			Fusion versus Nonfusion for Surgically Treated Thoracolumbar Burst Fractures: A Meta-Analysis	PLOS ONE			English	Article							SHORT-SEGMENT FIXATION; PEDICLE SCREW FIXATION; SPINE FRACTURES; NONOPERATIVE TREATMENT; NEUROLOGICAL DEFICIT; POSTERIOR FIXATION; INSTRUMENTATION; REMOVAL; LONG; CLASSIFICATION	Background: Posterior pedicle screw fixation has become a popular method for treating thoracolumbar burst fractures. However, it remains unclear whether additional fusion could improve clinical and radiological outcomes. This meta-analysis was performed to evaluate the effectiveness of fusion as a supplement to pedicle screw fixation for thoracolumbar burst fractures. Methodology/Principal Findings: MEDLINE, OVID, Springer, and Google Scholar were searched for relevant randomized and quasi-randomized controlled trials that compared the clinical and radiological efficacy of fusion versus nonfusion for thoracolumbar burst fractures managed by posterior pedicle screw fixation. Risk of bias in included studies was assessed using the Cochrane Risk of Bias tool. We generated pooled risk ratios or weighted mean differences across studies. Based on predefined inclusion criteria, 4 eligible trials with a total of 220 patients were included in this meta-analysis. The mean age of the patients was 35.1 years. 96.8% of the fractures were located at T12 to L1 level. Baseline characteristics were similar between the fusion and nonfusion groups. No significant difference was identified between the two groups regarding radiological outcome, functional outcome, neurologic improvement, and implant failure rate. The pooled data showed that the nonfusion group was associated with significantly reduced operative time (p<0.0001) and blood loss (p = 0.0003). Conclusions/Significances: The results of this meta-analysis suggested that fusion was not necessary when thoracolumbar burst fracture was treated by posterior pedicle screw fixation. More randomized controlled trials with high quality are still needed in the future.	[Tian, Nai-Feng; Zhang, Xiao-Lei; Chi, Yong-Long; Mao, Fang-Min] Wenzhou Med Coll, Affiliated Hosp 2, Dept Orthopaed Surg, Wenzhou, Peoples R China; [Wu, Yao-Sen] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xiao-Lei] Zhejiang Univ, Sch Med, Ctr Stem Cells & Tissue Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Xin-Lei] Wenzhou Med Coll, Inst Digitized Med, Wenzhou, Peoples R China	Wenzhou Medical University; Zhejiang University; Zhejiang University; Wenzhou Medical University	Chi, YL (corresponding author), Wenzhou Med Coll, Affiliated Hosp 2, Dept Orthopaed Surg, Wenzhou, Peoples R China.	spinechi@163.com; spinemao@163.com		Wu, Xinlei/0000-0001-7383-8961				Altay M, 2007, EUR SPINE J, V16, P1145, DOI 10.1007/s00586-007-0310-5; Boerger TO, 2000, J BONE JOINT SURG BR, V82B, P629, DOI 10.1302/0301-620X.82B5.11321; Bostman O, 1996, J TRAUMA, V41, P846, DOI 10.1097/00005373-199611000-00013; Dai LY, 2007, SURG NEUROL, V67, P221, DOI 10.1016/j.surneu.2006.08.081; Dai LY, 2009, J BONE JOINT SURG AM, V91A, P1033, DOI 10.2106/JBJS.H.00510; DENIS F, 1983, SPINE, V8, P817, DOI 10.1097/00007632-198311000-00003; Gnanenthiran SR, 2012, CLIN ORTHOP RELAT R, V470, P567, DOI 10.1007/s11999-011-2157-7; HOLDSWORTH F, 1970, J BONE JOINT SURG AM, VA 52, P1534, DOI 10.2106/00004623-197052080-00002; Hwang JH, 2009, ACTA ORTHOP BELG, V75, P822; Jindal N, 2012, J BONE JOINT SURG BR, V94B, P1101, DOI 10.1302/0301-620X.94B8.28311; MCCORMACK T, 1994, SPINE, V19, P1741, DOI 10.1097/00007632-199408000-00014; McLain RF, 2006, SPINE, V31, pS70, DOI 10.1097/01.brs.0000218221.47230.dd; Parker JW, 2000, SPINE, V25, P1157, DOI 10.1097/00007632-200005010-00018; Sanderson PL, 1999, EUR SPINE J, V8, P495, DOI 10.1007/s005860050212; Sjostrom L, 1994, Eur Spine J, V3, P312, DOI 10.1007/BF02200143; Tezeren G, 2005, J SPINAL DISORD TECH, V18, P485, DOI 10.1097/01.bsd.0000149874.61397.38; Tezeren G, 2009, J BACK MUSCULOSKELET, V22, P107, DOI 10.3233/BMR-2009-0224; Thomas KC, 2006, J NEUROSURG-SPINE, V4, P351, DOI 10.3171/spi.2006.4.5.351; Vanichkachorn JS, 1997, SPINE, V22, P110, DOI 10.1097/00007632-199701010-00018; Waelchli B, 2002, EUR SPINE J, V11, P504, DOI 10.1007/s00586-002-0417-7; Wang ST, 2006, SPINE, V31, P2646, DOI 10.1097/01.brs.0000244555.28310.40; Wang XY, 2008, J NEUROSURG-SPINE, V8, P246, DOI 10.3171/SPI/2008/8/3/246; Wessberg P, 2001, EUR SPINE J, V10, P55, DOI 10.1007/s005860000194; Wild A, 2003, ARCH ORTHOP TRAUM SU, V123, P414, DOI 10.1007/s00402-003-0561-5; Yi L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005079	25	27	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63995	10.1371/journal.pone.0063995	http://dx.doi.org/10.1371/journal.pone.0063995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704968	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200101
J	Ayoub, MA; See, HB; Seeber, RM; Armstrong, SP; Pfleger, KDG				Ayoub, Mohammed Akli; See, Heng B.; Seeber, Ruth M.; Armstrong, Stephen P.; Pfleger, Kevin D. G.			Profiling Epidermal Growth Factor Receptor and Heregulin Receptor 3 Heteromerization Using Receptor Tyrosine Kinase Heteromer Investigation Technology	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; PHOSPHATIDYLINOSITOL 3-KINASE; BREAST-CANCER; DEPENDENT ACTIVATION; SIGNALING NETWORK; HER3; DIMERIZATION; ERBB3; EGFR; HETERODIMERIZATION	Heteromerization can play an important role in regulating the activation and/or signal transduction of most forms of receptors, including receptor tyrosine kinases (RTKs). The study of receptor heteromerization has evolved extensively with the emergence of resonance energy transfer based approaches such as bioluminescence resonance energy transfer (BRET). Here, we report an adaptation of our Receptor-Heteromer Investigation Technology (Receptor-HIT) that has recently been published as the G protein-coupled receptor (GPCR) Heteromer Identification Technology (GPCR-HIT). We now demonstrate the utility of this approach for investigating RTK heteromerization by examining the functional interaction between the epidermal growth factor (EGF) receptor (EGFR; also known as erbB1/HER1) and heregulin (HRG) receptor 3 (HER3; also known as erbB3) in live HEK293FT cells using recruitment of growth factor receptor-bound protein 2 (Grb2) to the activated receptors. We found that EGFR and HER3 heteromerize specifically as demonstrated by HRG inducing a BRET signal between EGFR/Rluc8 and Grb2/Venus only when HER3 was co-expressed. Similarly, EGF stimulation promoted a specific BRET signal between HER3/Rluc8 and Grb2/Venus only when EGFR was co-expressed. Both EGF and HRG effects on Grb2 interaction are dose-dependent, and specifically blocked by EGFR inhibitor AG-1478. Furthermore, truncation of HER3 to remove the putative Grb2 binding sites appears to abolish EGF-induced Grb2 recruitment to the EGFR-HER3 heteromer. Our results support the concept that EGFR interacts with Grb2 in both constitutive and EGF-dependent manners and this interaction is independent of HER3 co-expression. In contrast, HER3-Grb2 interaction requires the heteromerization between EGFR and HER3. These findings clearly indicate the importance of EGFR-HER3 heteromerization in HER3-mediated Grb2-dependent signaling pathways and supports the central role of HER3 in the diversity and regulation of HER family functioning.	[Ayoub, Mohammed Akli; See, Heng B.; Seeber, Ruth M.; Armstrong, Stephen P.; Pfleger, Kevin D. G.] Univ Western Australia, Western Australian Inst Med Res, Lab Mol Endocrinol GPCRs, Nedlands, WA 6009, Australia; [Ayoub, Mohammed Akli; See, Heng B.; Seeber, Ruth M.; Armstrong, Stephen P.; Pfleger, Kevin D. G.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Pfleger, Kevin D. G.] Dimerix Biosci Pty Ltd, Nedlands, WA, Australia; [Ayoub, Mohammed Akli] King Saud Univ, Coll Sci, Dept Biochem, Prot Res Chair, Riyadh 11451, Saudi Arabia	University of Western Australia; University of Western Australia; King Saud University	Pfleger, KDG (corresponding author), Univ Western Australia, Western Australian Inst Med Res, Lab Mol Endocrinol GPCRs, Nedlands, WA 6009, Australia.	kevin.pfleger@waimr.uwa.edu.au	Seeber, Ruth/AAS-9411-2021; Pfleger, Kevin/H-5629-2014	Seeber, Ruth/0000-0003-3265-7931; AYOUB, Mohammed Akli/0000-0003-0022-578X; Pfleger, Kevin/0000-0001-8261-9189	Australian Research Council [FT100100271]; Dimerix Bioscience Pty Ltd	Australian Research Council(Australian Research Council); Dimerix Bioscience Pty Ltd	This research was funded by the Australian Research Council (www.arc.gov.au) Future Fellowship (FT100100271) awarded to KDGP, as well as Dimerix Bioscience Pty Ltd (www.dimerix.com). Other than KDGP, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub MA, 2010, CURR OPIN PHARMACOL, V10, P44, DOI 10.1016/j.coph.2009.09.012; Balz LM, 2012, J PATHOL, V227, P234, DOI 10.1002/path.3991; Banappagari S, 2012, J BIOMOL STRUCT DYN, V30, P594, DOI 10.1080/07391102.2012.687525; Berger MB, 2004, FEBS LETT, V569, P332, DOI 10.1016/j.febslet.2004.06.014; Bjorkelund H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024739; Britten CD, 2004, MOL CANCER THER, V3, P1335; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; CARRAWAY KL, 1995, J BIOL CHEM, V270, P7111, DOI 10.1074/jbc.270.13.7111; Choi BK, 2012, PROTEIN CELL, V3, P781, DOI 10.1007/s13238-012-2065-y; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clayton AHA, 2008, GROWTH FACTORS, V26, P316, DOI 10.1080/08977190802442187; EARP HS, 1995, BREAST CANCER RES TR, V35, P115, DOI 10.1007/BF00694752; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Freeman MR, 2004, CANCER CELL, V6, P427, DOI 10.1016/j.ccr.2004.10.018; Gamett DC, 1997, J BIOL CHEM, V272, P12052, DOI 10.1074/jbc.272.18.12052; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Johnstone Elizabeth K M, 2012, Front Endocrinol (Lausanne), V3, P101, DOI 10.3389/fendo.2012.00101; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kamath AV, 2012, CANCER CHEMOTH PHARM, V69, P1063, DOI 10.1007/s00280-011-1806-6; Kamath S, 2006, MED RES REV, V26, P569, DOI 10.1002/med.20070; KIM HH, 1994, J BIOL CHEM, V269, P24747; Klapper LN, 2000, ADV CANCER RES, V77, P25; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Mustafa S, 2012, J BIOL CHEM, V287, P12952, DOI 10.1074/jbc.M111.322834; Mustafa S, 2011, JALA-J LAB AUTOM, V16, P285, DOI 10.1016/j.jala.2011.03.002; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pfleger KDG, 2006, CELL SIGNAL, V18, P1664, DOI 10.1016/j.cellsig.2006.01.004; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Sakai K, 2007, CANCER SCI, V98, P1498, DOI 10.1111/j.1349-7006.2007.00553.x; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Sierke SL, 1997, BIOCHEM J, V322, P757, DOI 10.1042/bj3220757; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Suenaga A, 2005, J BIOL CHEM, V280, P1321, DOI 10.1074/jbc.M410436200; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; Vijapurkar U, 1998, J BIOL CHEM, V273, P20996, DOI 10.1074/jbc.273.33.20996; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; Watts AO, 2013, BRIT J PHARMACOL, V168, P1662, DOI 10.1111/bph.12064; Way Tzong-Der, 2005, Future Oncol, V1, P841, DOI 10.2217/14796694.1.6.841; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang K, 1996, J BIOL CHEM, V271, P3884; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P13237, DOI 10.1073/pnas.1200105109; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-78	53	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64672	10.1371/journal.pone.0064672	http://dx.doi.org/10.1371/journal.pone.0064672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700486	gold, Green Published, Green Submitted			2022-12-27	WOS:000319966400062
J	Trushina, E; Dutta, T; Persson, XMT; Mielke, MM; Petersen, RC				Trushina, Eugenia; Dutta, Tumpa; Persson, Xuan-Mai T.; Mielke, Michelle M.; Petersen, Ronald C.			Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer's Disease Using Metabolomics	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; CEREBROSPINAL-FLUID; AMYLOID-BETA; BIOMARKERS; BRAIN; NEURODEGENERATION; PROGRESSION; TRYPTOPHAN; DIAGNOSIS; STEROLS	Alzheimer's Disease (AD) currently affects more than 5 million Americans, with numbers expected to grow dramatically as the population ages. The pathophysiological changes in AD patients begin decades before the onset of dementia, highlighting the urgent need for the development of early diagnostic methods. Compelling data demonstrate that increased levels of amyloid-beta compromise multiple cellular pathways; thus, the investigation of changes in various cellular networks is essential to advance our understanding of early disease mechanisms and to identify novel therapeutic targets. We applied a liquid chromatography/mass spectrometry-based non-targeted metabolomics approach to determine global metabolic changes in plasma and cerebrospinal fluid (CSF) from the same individuals with different AD severity. Metabolic profiling detected a total of significantly altered 342 plasma and 351 CSF metabolites, of which 22% were identified. Based on the changes of <150 metabolites, we found 23 altered canonical pathways in plasma and 20 in CSF in mild cognitive impairment (MCI) vs. cognitively normal (CN) individuals with a false discovery rate <0.05. The number of affected pathways increased with disease severity in both fluids. Lysine metabolism in plasma and the Krebs cycle in CSF were significantly affected in MCI vs. CN. Cholesterol and sphingolipids transport was altered in both CSF and plasma of AD vs. CN. Other 30 canonical pathways significantly disturbed in MCI and AD patients included energy metabolism, Krebs cycle, mitochondrial function, neurotransmitter and amino acid metabolism, and lipid biosynthesis. Pathways in plasma that discriminated between all groups included polyamine, lysine, tryptophan metabolism, and aminoacyl-tRNA biosynthesis; and in CSF involved cortisone and prostaglandin 2 biosynthesis and metabolism. Our data suggest metabolomics could advance our understanding of the early disease mechanisms shared in progression from CN to MCI and to AD.	[Trushina, Eugenia; Petersen, Ronald C.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Trushina, Eugenia] Mayo Clin, Dept Pharmacol & Expt Therapeut, Rochester, MN USA; [Dutta, Tumpa; Persson, Xuan-Mai T.] Mayo Clin, Ctr Translat Sci Act Metabol Core Facil, Rochester, MN USA; [Dutta, Tumpa] Mayo Clin, Div Endocrinol, Rochester, MN USA; [Dutta, Tumpa] Mayo Clin, Endocrine Res Unit Rochester, Rochester, MN USA; [Mielke, Michelle M.; Petersen, Ronald C.] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Trushina, E (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	Trushina.Eugenia@mayo.edu		Dutta, Tumpa/0000-0003-0400-209X; Mielke, Michelle/0000-0001-7177-1185	National Institute of Environmental Health Sciences (NIEHS) [R01ES020715]; National Institute on Aging to the Mayo Clinic Study of Aging (MCSA) [AG006786]; National Institute on Aging award to the Mayo Clinic Alzheimer's Disease Research Center [AG016574]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016574, U01AG006786] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Aging to the Mayo Clinic Study of Aging (MCSA); National Institute on Aging award to the Mayo Clinic Alzheimer's Disease Research Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the National Institute of Environmental Health Sciences (NIEHS), grant number R01ES020715; the National Institute on Aging to the Mayo Clinic Study of Aging (MCSA), grant number AG006786; and the National Institute on Aging award to the Mayo Clinic Alzheimer's Disease Research Center, grant number AG016574. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI N, 2012, MOL MECH ASPECT ER S; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Bassett C N, 2003, J Nutr Health Aging, V7, P24; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bazan NG, 2002, PROSTAG OTH LIPID M, V68-9, P197, DOI 10.1016/S0090-6980(02)00031-X; Biessels GJ, 2005, BIOCHEM SOC T, V33, P1041, DOI 10.1042/BST0331041; Blennow K, 2012, ARCH NEUROL-CHICAGO, V69, P1002, DOI 10.1001/archneurol.2012.90; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; BONDAREFF W, 1982, NEUROLOGY, V32, P164, DOI 10.1212/WNL.32.2.164; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Cedazo-Minguez A, 2010, EXP GERONTOL, V45, P5, DOI 10.1016/j.exger.2009.09.008; Chen J, 2008, ANAL CHEM, V80, P1280, DOI 10.1021/ac702089h; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Combrinck M, 2006, J NEUROL NEUROSUR PS, V77, P85, DOI 10.1136/jnnp.2005.063131; Czech C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031501; Dragicevic N, 2011, J PINEAL RES, V51, P75, DOI 10.1111/j.1600-079X.2011.00864.x; Dutta T, 2012, DIABETES, V61, P1004, DOI 10.2337/db11-0874; Eriksson L., 2001, MULTI MEGAVARIATE DA; Farooqui AA, 1997, NEUROCHEM RES, V22, P523, DOI 10.1023/A:1027380331807; FLEISHER AS, 2012, LANCET NEUROLOGY; Fonteh AN, 2007, AMINO ACIDS, V32, P213, DOI 10.1007/s00726-006-0409-8; Friedman JI, 1999, BIOL PSYCHIAT, V46, P1243, DOI 10.1016/S0006-3223(99)00232-2; Funk K. E., 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/752894; Gamba P, 2012, ANN NY ACAD SCI, V1259, P54, DOI 10.1111/j.1749-6632.2012.06513.x; Gomez-Villafuertes R, 2004, J PHARMACOL EXP THER, V308, P1148, DOI 10.1124/jpet.103.061564; Han XL, 2010, BBA-MOL CELL BIOL L, V1801, P774, DOI 10.1016/j.bbalip.2010.01.010; Hendricksen M, 2004, AM J PSYCHIAT, V161, P1096, DOI 10.1176/appi.ajp.161.6.1096; HOLTZMAN DM, 2011, SCI TRANSLATIONAL ME, V3; Ibach B, 2006, NEUROBIOL AGING, V27, P1202, DOI 10.1016/j.neurobiolaging.2005.06.005; IBANEZ C, 2012, ANAL CHEM; IKEDA M, 1965, J BIOL CHEM, V240, P1395; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138; Jovanovic A, 1998, FEBS LETT, V423, P314, DOI 10.1016/S0014-5793(98)00114-8; Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010; Kaddurah-Daouk R, 2011, ALZHEIMERS DEMENT, V7, P309, DOI 10.1016/j.jalz.2010.06.001; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Lembcke J, 2005, J LIPID RES, V46, P21, DOI 10.1194/jlr.C400004-JLR200; McDonald JG, 2007, METHOD ENZYMOL, V432, P145, DOI 10.1016/S0076-6879(07)32006-5; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Miras-Portugal MT, 1998, FEBS LETT, V430, P78, DOI 10.1016/S0014-5793(98)00560-2; MORRISON LD, 1995, NEUROSCI LETT, V197, P5, DOI 10.1016/0304-3940(95)11881-V; Oresic M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.55; Ostrowitzki S, 2012, ARCH NEUROL-CHICAGO, V69, P198, DOI 10.1001/archneurol.2011.1538; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Roberts RO, 2008, NEUROEPIDEMIOLOGY, V30, P58, DOI 10.1159/000115751; Rosales-Corral S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/843649; Rosales-Corral Sergio A, 2012, Int J Alzheimers Dis, V2012, P459806, DOI 10.1155/2012/459806; Ruan BF, 2001, J LIPID RES, V42, P799; Sana TR, 2010, METABOLOMICS, V6, P451, DOI 10.1007/s11306-010-0218-7; Sato Y, 2012, J LIPID RES, V53, P567, DOI 10.1194/jlr.M022376; SCHAECHTER JD, 1990, BRAIN RES, V532, P203, DOI 10.1016/0006-8993(90)91761-5; Schmitt K, 2012, ANTIOXID REDOX SIGN, V16, P1456, DOI 10.1089/ars.2011.4400; Schuierer S, 2010, BIOINFORMATICS, V26, P1922, DOI 10.1093/bioinformatics/btq307; SELFRIDGE JE, 2012, NEUROBIOLOGY DIS; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaw LM, 2007, NAT REV DRUG DISCOV, V6, P295, DOI 10.1038/nrd2176; Song F, 2009, BRAIN RES REV, V61, P69, DOI 10.1016/j.brainresrev.2009.05.003; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019477; Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737; Valla J, 2010, J ALZHEIMERS DIS, V22, P307, DOI 10.3233/JAD-2010-100129; Wurtman R. J., 1969, Recent Progress in Hormone Research, V25, P493; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005; ZAMECNIK PC, 1966, BIOCHEM BIOPH RES CO, V24, P91, DOI 10.1016/0006-291X(66)90415-3; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1	71	280	290	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63644	10.1371/journal.pone.0063644	http://dx.doi.org/10.1371/journal.pone.0063644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700429	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400026
J	Evseenko, D; Latour, B; Richardson, W; Corselli, M; Sahaghian, A; Cardinal, S; Zhu, YH; Chan, R; Dunn, B; Crooks, GM				Evseenko, Denis; Latour, Brooke; Richardson, Wade; Corselli, Mirko; Sahaghian, Arineh; Cardinal, Sofie; Zhu, Yuhua; Chan, Rebecca; Dunn, Bruce; Crooks, Gay M.			Lysophosphatidic Acid Mediates Myeloid Differentiation within the Human Bone Marrow Microenvironment	PLOS ONE			English	Article							STEM-CELLS; B-CELLS; PROGENITOR; SPHINGOSINE-1-PHOSPHATE; IDENTIFICATION; TRAFFICKING; GENERATION; RECEPTORS; HISTOLOGY; MICE	Lysophosphatidic acid (LPA) is a pleiotropic phospholipid present in the blood and certain tissues at high concentrations; its diverse effects are mediated through differential, tissue specific expression of LPA receptors. Our goal was to determine if LPA exerts lineage-specific effects during normal human hematopoiesis. In vitro stimulation of CD34+ human hematopoietic progenitors by LPA induced myeloid differentiation but had no effect on lymphoid differentiation. LPA receptors were expressed at significantly higher levels on Common Myeloid Progenitors (CMP) than either multipotent Hematopoietic Stem/Progenitor Cells (HSPC) or Common Lymphoid Progenitors (CLP) suggesting that LPA acts on committed myeloid progenitors. Functional studies demonstrated that LPA enhanced migration, induced cell proliferation and reduced apoptosis of isolated CMP, but had no effect on either HSPC or CLP. Analysis of adult and fetal human bone marrow sections showed that PPAP2A, (the enzyme which degrades LPA) was highly expressed in the osteoblastic niche but not in the perivascular regions, whereas Autotaxin (the enzyme that synthesizes LPA) was expressed in perivascular regions of the marrow. We propose that a gradient of LPA with the highest levels in peri-sinusoidal regions and lowest near the endosteal zone, regulates the localization, proliferation and differentiation of myeloid progenitors within the bone marrow marrow.	[Evseenko, Denis; Corselli, Mirko; Sahaghian, Arineh; Zhu, Yuhua; Chan, Rebecca] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Evseenko, Denis; Dunn, Bruce; Crooks, Gay M.] Eli & Edythe Broad Inst Regenerat Med & Stem Cell, Los Angeles, CA USA; [Latour, Brooke; Crooks, Gay M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Richardson, Wade; Dunn, Bruce] Univ Calif Los Angeles, Dept Engn, Los Angeles, CA USA; [Cardinal, Sofie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Evseenko, D (corresponding author), Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90095 USA.	devseenko@mednet.ucla.edu	Latour, Brooke/AAW-9199-2021		National Institutes of Health (NIH) [K01AR061415]; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI [UL1TR000124]; California Institute of Regenerative Medicine [RB3-05217]; Broad Stem Cell Research Center (BSCRC) at UCLA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR061415] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Broad Stem Cell Research Center (BSCRC) at UCLA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health (NIH) K01AR061415 and by NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant Number UL1TR000124 (DE), the California Institute of Regenerative Medicine RB3-05217 (GMC), and from the Broad Stem Cell Research Center (BSCRC) at UCLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allende ML, 2010, J EXP MED, V207, P1113, DOI 10.1084/jem.20092210; Blackburn J, 2012, BONE, V50, P756, DOI 10.1016/j.bone.2011.12.002; Chiang CL, 2011, STEM CELLS, V29, P1763, DOI 10.1002/stem.733; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Hao QL, 1998, BLOOD, V91, P4145, DOI 10.1182/blood.V91.11.4145.411a10_4145_4151; ITOH K, 1989, EXP HEMATOL, V17, P145; Juarez JG, 2012, BLOOD, V119, P707, DOI 10.1182/blood-2011-04-348904; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Lee MJ, 1998, J BIOL CHEM, V273, P22105, DOI 10.1074/jbc.273.34.22105; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; OSMOND DG, 1992, BLOOD, V79, P1695; Sano T, 2002, J BIOL CHEM, V277, P21197, DOI 10.1074/jbc.M201289200; Seitz G, 2005, ANN NY ACAD SCI, V1044, P84, DOI 10.1196/annals.1349.011; TIGYI G, 1992, J BIOL CHEM, V267, P21360; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; WILKINS BS, 1992, J CLIN PATHOL, V45, P645, DOI 10.1136/jcp.45.8.645; Yanai N, 2000, BLOOD, V96, P139, DOI 10.1182/blood.V96.1.139.013k15_139_144	20	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63718	10.1371/journal.pone.0063718	http://dx.doi.org/10.1371/journal.pone.0063718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696850	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900056
J	Tasdelen, I; Berger, R; Kalkhoven, E				Tasdelen, Ismayil; Berger, Ruud; Kalkhoven, Eric			PPAR gamma Regulates Expression of Carbohydrate Sulfotransferase 11 (CHST11/C4ST1), a Regulator of LPL Cell Surface Binding	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; HEPARAN-SULFATE PROTEOGLYCANS; LIPOPROTEIN-LIPASE; IDENTIFICATION; DIFFERENTIATION; ADIPOCYTES; TARGETS; GENE; CHONDROITIN-4-SULFOTRANSFERASE-1; ADIPOGENESIS	The transcription factor PPAR gamma is the key regulator of adipocyte differentiation, function and maintenance, and the cellular target of the insulin-sensitizing thiazolidinediones. Identification and functional characterization of genes regulated by PPAR gamma will therefore lead to a better understanding of adipocyte biology and may also contribute to the development of new anti-diabetic drugs. Here, we report carbohydrate sulfotransferase 11 (Chst11/C4st1) as a novel PPAR gamma target gene. Chst11 can sulphate chondroitin, a major glycosaminoglycan involved in development and disease. The Chst11 gene contains two functional intronic PPAR gamma binding sites, and is up-regulated at the mRNA and protein level during 3T3-L1 adipogenesis. Chst11 knockdown reduced intracellular lipid accumulation in mature adipocytes, which is due to a lowered activity of lipoprotein lipase, which may associate with the adipocyte cell surface through Chst11-mediated sulfation of chondroitin, rather than impaired adipogenesis. Besides directly inducing Lpl expression, PPAR gamma may therefore control lipid accumulation by elevating the levels of Chst11-mediated proteoglycan sulfation and thereby increasing the binding capacity for Lpl on the adipocyte cell surface.	[Kalkhoven, Eric] Univ Med Ctr Utrecht, Dept Metab Dis, Utrecht, Netherlands; Univ Med Ctr Utrecht, Netherlands Metabol Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Kalkhoven, E (corresponding author), Univ Med Ctr Utrecht, Dept Metab Dis, Utrecht, Netherlands.	e.kalkhoven@umcutrecht.nl			Wilhelmina Children's Hospital Research Fund; The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/The Netherlands Organization for Scientific Research (NWO)	Wilhelmina Children's Hospital Research Fund; The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Wilhelmina Children's Hospital Research Fund and by the research programme of The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/The Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bugge A, 2010, J BIOL CHEM, V285, P17310, DOI 10.1074/jbc.M110.120584; CALVO JC, 1991, J BIOL CHEM, V266, P11237; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; EDWARDS IJ, 1995, ARTERIOSCL THROM VAS, V15, P400, DOI 10.1161/01.ATV.15.3.400; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gonzales AM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-22; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hegele RA, 2005, INT J OBESITY, V29, pS31, DOI 10.1038/sj.ijo.0802911; HENNIG B, 1984, ARTERIOSCLEROSIS, V4, P489, DOI 10.1161/01.ATV.4.5.489; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Jeninga EH, 2007, MOL ENDOCRINOL, V21, P1049, DOI 10.1210/me.2006-0485; Jeninga EH, 2009, J BIOL CHEM, V284, P26385, DOI 10.1074/jbc.M109.040741; Kalkhoven E, 2002, MOL CELL BIOL, V22, P1961, DOI 10.1128/MCB.22.7.1961-1970.2002; Kluppel M, 2010, PROG MOL BIOL TRANSL, V93, P113, DOI 10.1016/S1877-1173(10)93006-8; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Koppen A, 2009, MOL CELL PROTEOMICS, V8, P2212, DOI 10.1074/mcp.M900209-MCP200; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; MISRA KB, 1994, J BIOL CHEM, V269, P23838; Nadra K, 2010, ENDOCRINOLOGY, V151, P4969, DOI 10.1210/en.2010-0131; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Obunike JC, 2001, J BIOL CHEM, V276, P8934, DOI 10.1074/jbc.M008813200; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rutledge JC, 1997, CIRC RES, V80, P819; SAXENA U, 1991, J BIOL CHEM, V266, P17516; SAXENA U, 1991, P NATL ACAD SCI USA, V88, P2254, DOI 10.1073/pnas.88.6.2254; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Weinstein MM, 2008, J BIOL CHEM, V283, P34511, DOI 10.1074/jbc.M806067200; Willis CM, 2009, GENET MOL RES, V8, P1331, DOI 10.4238/vol8-4gmr673; Wilsie Larissa C, 2005, Lipids Health Dis, V4, P2, DOI 10.1186/1476-511X-4-2; Yamauchi S, 1999, J BIOL CHEM, V274, P2456, DOI 10.1074/jbc.274.4.2456; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	50	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64284	10.1371/journal.pone.0064284	http://dx.doi.org/10.1371/journal.pone.0064284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696875	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900078
J	Rocca, S; Schiavoni, G; Sali, M; Anfossi, AG; Abalsamo, L; Palucci, I; Mattei, F; Sanchez, M; Giagu, A; Antuofermo, E; Fadda, G; Belardelli, F; Delogu, G; Gabriele, L				Rocca, Stefano; Schiavoni, Giovanna; Sali, Michela; Anfossi, Antonio Giovanni; Abalsamo, Laura; Palucci, Ivana; Mattei, Fabrizio; Sanchez, Massimo; Giagu, Anna; Antuofermo, Elisabetta; Fadda, Giovanni; Belardelli, Filippo; Delogu, Giovanni; Gabriele, Lucia			Interferon Regulatory Factor 8-Deficiency Determines Massive Neutrophil Recruitment but T Cell Defect in Fast Growing Granulomas during Tuberculosis	PLOS ONE			English	Article							LEUKEMIA-LIKE SYNDROME; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; DENDRITIC CELLS; MICE; PATHOLOGY; LUNGS; GENE; IMMUNODEFICIENCY; ACTIVATION	Following Mycobacterium tuberculosis (Mtb) infection, immune cell recruitment in lungs is pivotal in establishing protective immunity through granuloma formation and neogenesis of lymphoid structures (LS). Interferon regulatory factor-8 (IRF-8) plays an important role in host defense against Mtb, although the mechanisms driving anti-mycobacterial immunity remain unclear. In this study, IRF-8 deficient mice (IRF-8(-/-)) were aerogenously infected with a low-dose Mtb Erdman virulent strain and the course of infection was compared with that induced in wild-type (WT-B6) counterparts. Tuberculosis (TB) progression was examined in both groups using pathological, microbiological and immunological parameters. Following Mtb exposure, the bacterial load in lungs and spleens progressed comparably in the two groups for two weeks, after which IRF-8(-/-) mice developed a fatal acute TB whereas in WT-B6 the disease reached a chronic stage. In lungs of IRF-8(-/-), uncontrolled growth of pulmonary granulomas and impaired development of LS were observed, associated with unbalanced homeostatic chemokines, progressive loss of infiltrating T lymphocytes and massive prevalence of neutrophils at late infection stages. Our data define IRF-8 as an essential factor for the maintenance of proper immune cell recruitment in granulomas and LS required to restrain Mtb infection. Moreover, IRF-8(-/-) mice, relying on a common human and mouse genetic mutation linked to susceptibility/severity of mycobacterial diseases, represent a valuable model of acute TB for comparative studies with chronically-infected congenic WT-B6 for dissecting protective and pathological immune reactions.	[Rocca, Stefano; Anfossi, Antonio Giovanni; Giagu, Anna; Antuofermo, Elisabetta] Univ Sassari, Dept Vet Med, I-07100 Sassari, Italy; [Schiavoni, Giovanna; Abalsamo, Laura; Mattei, Fabrizio; Sanchez, Massimo; Belardelli, Filippo; Gabriele, Lucia] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Sali, Michela; Palucci, Ivana; Fadda, Giovanni; Delogu, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, I-00168 Rome, Italy	University of Sassari; Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Gabriele, L (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	lucia.gabriele@iss.it	Sanchez, Massimo/AAD-1746-2021; Schiavoni, Giovanna/T-4418-2017; Mattei, Fabrizio/J-6585-2016; Schiavoni, Giovanna/K-2448-2019; Gabriele, Lucia/J-8335-2016; palucci, ivana/J-8542-2018	Sanchez, Massimo/0000-0003-3696-7582; Schiavoni, Giovanna/0000-0001-9135-0556; Mattei, Fabrizio/0000-0002-5357-7773; Schiavoni, Giovanna/0000-0001-9135-0556; Gabriele, Lucia/0000-0002-1483-866X; palucci, ivana/0000-0003-2106-1761; Delogu, Giovanni/0000-0003-0182-8267; Belardelli, Filippo/0000-0002-3082-3169; SALI, Michela/0000-0003-3609-2990; GIAGU, ANNA/0000-0002-1424-073X; ANTUOFERMO, Elisabetta/0000-0002-1193-7777; ROCCA, Stefano/0000-0001-8897-5707	European Community Seventh Framework Programme (HOMITB) [200732]	European Community Seventh Framework Programme (HOMITB)	This work was funded by the European Community Seventh Framework Programme (Project acronym: HOMITB, Title: "Host and microbial molecular dissection of pathogenesis and immunity in tuberculosis''; Grant agreement no.: 200732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Behr M, 2010, CELL, V140, P615, DOI 10.1016/j.cell.2010.02.030; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Carragher DM, 2008, SEMIN IMMUNOL, V20, P26, DOI 10.1016/j.smim.2007.12.004; Chen CY, 2012, J IMMUNOL, V188, P4278, DOI 10.4049/jimmunol.1101291; Corsiero E, 2012, IMMUNOL LETT, V145, P62, DOI 10.1016/j.imlet.2012.04.013; Day TA, 2010, EUR J IMMUNOL, V40, P1663, DOI 10.1002/eji.201040299; Delogu G, 2006, INFECT IMMUN, V74, P3006, DOI 10.1128/IAI.74.5.3006-3011.2006; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; El Shikh MEM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00292; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Gabriele L, 2007, CYTOKINE GROWTH F R, V18, P503, DOI 10.1016/j.cytogfr.2007.06.008; Gideon HP, 2011, IMMUNOL RES, V50, P202, DOI 10.1007/s12026-011-8229-7; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Guglani L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050052; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hunter RL, 2011, TUBERCULOSIS, V91, P497, DOI 10.1016/j.tube.2011.03.007; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Kahnert A, 2007, J INFECT DIS, V195, P46, DOI 10.1086/508894; Kashino SS, 2010, AM J PATHOL, V176, P198, DOI 10.2353/ajpath.2010.090446; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marquis JF, 2009, J IMMUNOL, V182, P3008, DOI 10.4049/jimmunol.0800680; Mattei F, 2006, BLOOD, V108, P609, DOI 10.1182/blood-2005-11-4490; Munder M, 2006, BLOOD, V108, P1627, DOI 10.1182/blood-2006-11-010389; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Randall TD, 2010, ADV IMMUNOL, V107, P187, DOI [10.1016/S0065-2776(10)07002-1, 10.1016/B978-0-12-381300-8.00007-1]; Sali M, 2008, MICROBES INFECT, V10, P605, DOI 10.1016/j.micinf.2008.02.012; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Slight SR, 2012, CYTOKINE GROWTH 1115, DOI [10.1016/j.cytogfr.2012.10.002, DOI 10.1016/J.CYT0GFR.2012.10.002.[]; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; Turcotte K, 2007, J IMMUNOL, V179, P2467, DOI 10.4049/jimmunol.179.4.2467; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; Urdahl KB, 2011, MUCOSAL IMMUNOL, V4, P288, DOI 10.1038/mi.2011.10; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Yoshikai Y, 2006, CRIT REV IMMUNOL, V26, P515, DOI 10.1615/CritRevImmunol.v26.i6.40; Zhou XH, 2012, FRONT BIOSCI-LANDMRK, V17, P2278, DOI 10.2741/4051	46	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e62751	10.1371/journal.pone.0062751	http://dx.doi.org/10.1371/journal.pone.0062751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717393	Green Submitted, gold, Green Published			2022-12-27	WOS:000319385300041
J	Johnson, L; Supuk, E; Buckley, JG; Elliott, DB				Johnson, Louise; Supuk, Elvira; Buckley, John G.; Elliott, David B.			Effects of Induced Astigmatism on Foot Placement Strategies when Stepping onto a Raised Surface	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ADAPTIVE GAIT CHANGES; EYE CATARACT-SURGERY; OLDER-PEOPLE; VISUAL IMPAIRMENT; HEALTH-STATUS; HIP FRACTURE; FALLS; VISION; MAGNIFICATION	Purpose: Large changes in spectacle prescription can increase falls risk in older people. We investigated the effect of induced astigmatism (a common cause of distorted or blurred vision in older people) on locomotor stepping patterns to determine whether the orientation of astigmatic changes could have differential effects on gait safety when negotiating steps and stairs. Methods: 10 older adults (mean age 76.0 +/- 6.4 years) walked up to and stepped onto a raised block whilst wearing their spectacle prescription and when blurred with +/- 3.00D cylinders at axes 45 degrees, 90 degrees, 135 degrees and 180 degrees. Gait measurements included foot placement before the block, toe clearance over the block edge and foot placement on the block. Results: Induced astigmatism with axes at 90 degrees, providing magnification in the horizontal meridian only, caused no change in stepping pattern. Induced astigmatism with axes at 180 degrees caused foot placement changes in the anterior or posterior direction according to whether magnification was positive or negative in the vertical meridian (block perceived higher or lower respectively). Induced astigmatism with axes oblique at 45 degrees and 135 degrees (causing the block to be perceived as a parallelogram sloping downwards either to the right or left) caused gait changes in the anterior and posterior, vertical and lateral directions. Changes in lateral foot placement appeared to be an attempt to maintain constant foot clearance levels over the block edge by stepping over the perceived 'lower' side of the 'sloping' block. Conclusions: Astigmatic changes with oblique axes had the greatest effect on gait. Clinicians, including optometrists, physiotherapists, occupational therapists and nurses should counsel older patients about the effects of astigmatism on gait safety. Furthermore, partial prescribing of astigmatic corrections should be considered to reduce the risk of falling.	[Johnson, Louise] Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England; [Supuk, Elvira; Elliott, David B.] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Buckley, John G.] Univ Bradford, Sch Engn Design & Technol, Bradford BD7 1DP, W Yorkshire, England	University of Bradford; University of Bradford; University of Bradford	Elliott, DB (corresponding author), Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England.	d.elliott1@bradford.ac.uk	Elliott, David/B-1806-2009	Elliott, David/0000-0001-9959-6841; Buckley, John/0000-0002-4085-4743	Federation of Ophthalmic and Dispensing Opticians	Federation of Ophthalmic and Dispensing Opticians	Elvira Supuk was supported from a grant from the Federation of Ophthalmic and Dispensing Opticians. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhafiz AH, 2003, AGE AGEING, V32, P26, DOI 10.1093/ageing/32.1.26; Adams WJ, 2001, NAT NEUROSCI, V4, P1063, DOI 10.1038/nn729; Brannan S, 2003, BRIT J OPHTHALMOL, V87, P560, DOI 10.1136/bjo.87.5.560; Buckhurst PJ, 2010, CLIN EXP OPTOM, V93, P409, DOI 10.1111/j.1444-0938.2010.00515.x; Buckley JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019079; Campbell AJ, 2005, BMJ-BRIT MED J, V331, P817, DOI 10.1136/bmj.38601.447731.55; Chapman GJ, 2011, OPHTHAL PHYSL OPT, V31, P311, DOI 10.1111/j.1475-1313.2010.00807.x; Chapman GJ, 2010, OPHTHAL PHYSL OPT, V30, P281, DOI 10.1111/j.1475-1313.2010.00725.x; Cox A, 2005, OPHTHAL PHYSL OPT, V25, P357, DOI 10.1111/j.1475-1313.2005.00307.x; Crane BT, 2000, J NEUROPHYSIOL, V83, P38, DOI 10.1152/jn.2000.83.1.38; Cumming RG, 2007, J AM GERIATR SOC, V55, P175, DOI 10.1111/j.1532-5415.2007.01046.x; Day L, 2002, BRIT MED J, V325, P128, DOI 10.1136/bmj.325.7356.128; Elliott DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004577; Elliott DB, 2010, INVEST OPHTH VIS SCI, V51, P718, DOI 10.1167/iovs.09-4250; Evans BJW, 2004, OPHTHAL PHYSL OPT, V24, P161, DOI 10.1111/j.1475-1313.2004.00197.x; Foss AJE, 2006, AGE AGEING, V35, P66, DOI 10.1093/ageing/afj005; Fylan F, 2005, PATIENT EDUC COUNS, V56, P291, DOI 10.1016/j.pec.2004.03.003; Hamel KA, 2005, GAIT POSTURE, V21, P135, DOI 10.1016/j.gaitpost.2004.01.006; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; Howell-Duffy C, 2011, OPHTHAL PHYSL OPT, V31, P155, DOI 10.1111/j.1475-1313.2010.00803.x; JACK CIA, 1995, GERONTOLOGY, V41, P280; Johnson L, 2008, J AM GERIATR SOC, V56, P178, DOI 10.1111/j.1532-5415.2007.01485.x; Johnson L, 2007, INVEST OPHTH VIS SCI, V48, P1466, DOI 10.1167/iovs.06-0586; McGwin G, 2006, J AM GERIATR SOC, V54, P1089, DOI 10.1111/j.1532-5415.2006.00770.x; Patla AE, 2003, EXP BRAIN RES, V148, P133, DOI 10.1007/s00221-002-1246-y; Pesudovs K, 2003, BRIT J OPHTHALMOL, V87, P964, DOI 10.1136/bjo.87.8.964; Read SA, 2007, CLIN EXP OPTOM, V90, P5, DOI 10.1111/J.1444-0938.2007.00112.x; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Schwartz S, 2005, INVEST OPHTH VIS SCI, V46, P920, DOI 10.1167/iovs.04-0543; Startzell JK, 2000, J AM GERIATR SOC, V48, P567, DOI 10.1111/j.1532-5415.2000.tb05006.x; Werner J., 2002, GENDER HOUSEHOLD STA	31	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63351	10.1371/journal.pone.0063351	http://dx.doi.org/10.1371/journal.pone.0063351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717414	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700016
J	Lee, JE; Lee, S; Lee, H; Song, YM; Lee, K; Han, MJ; Sung, J; Ko, G				Lee, Jung Eun; Lee, Sunghee; Lee, Heetae; Song, Yun-Mi; Lee, Kayoung; Han, Min Ji; Sung, Joohon; Ko, GwangPyo			Association of the Vaginal Microbiota with Human Papillomavirus Infection in a Korean Twin Cohort	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; PCR DETECTION; HEALTHY TWIN; WOMEN; RISK; DIVERSITY; HPV; HIV; INFLAMMATION; LACTOBACILLI	Human papillomavirus (HPV) is the most important causative agent of cervical cancers worldwide. However, our understanding of how the vaginal microbiota might be associated with HPV infection is limited. In addition, the influence of human genetic and physiological factors on the vaginal microbiota is unclear. Studies on twins and their families provide the ideal settings to investigate the complicated nature of human microbiota. This study investigated the vaginal microbiota of 68 HPV-infected or uninfected female twins and their families using 454-pyrosequencing analysis targeting the variable region (V2-V3) of the bacterial 16S rRNA gene. Analysis of the vaginal microbiota from both premenopausal women and HPV-discordant twins indicated that HPV-positive women had significantly higher microbial diversity with a lower proportion of Lactobacillus spp. than HPV-negative women. Fusobacteria, including Sneathia spp., were identified as a possible microbiological marker associated with HPV infection. The vaginal microbiotas of twin pairs were significantly more similar to each other than to those from unrelated individuals. In addition, there were marked significant differences from those of their mother, possibly due to differences in menopausal status. Postmenopausal women had a lower proportion of Lactobacillus spp. and a significantly higher microbiota diversity. This study indicated that HPV infection was associated with the composition of the vaginal microbiota, which is influenced by multiple host factors such as genetics and menopause. The potential biological markers identified in this study could provide insight into HPV pathogenesis and may represent biological targets for diagnostics.	[Lee, Jung Eun; Lee, Sunghee; Lee, Heetae; Ko, GwangPyo] Seoul Natl Univ, Sch Publ Hlth, Dept Environm Hlth, Seoul, South Korea; [Lee, Jung Eun; Lee, Sunghee; Lee, Heetae; Ko, GwangPyo] Seoul Natl Univ, Sch Publ Hlth, Inst Hlth & Environm, Seoul, South Korea; [Song, Yun-Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Family Med, Seoul, South Korea; [Lee, Kayoung] Inje Univ, Coll Med, Busan Paik Hosp, Dept Family Med, Busan, South Korea; [Han, Min Ji; Sung, Joohon] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Inje University; Seoul National University (SNU)	Ko, G (corresponding author), Seoul Natl Univ, Sch Publ Hlth, Dept Environm Hlth, Seoul, South Korea.	gko@snu.ac.kr	LEE, Sunghee/HCH-4510-2022; Lee, Kayoung/AAV-1254-2020; lee, kayoung/AAU-8352-2020	lee, kayoung/0000-0002-2816-554X	National Research Foundation of Korea (NRF) [2012-0008692]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work was supported by a grant from the National Research Foundation of Korea (NRF; No. 2012-0008692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2008, SEX TRANSM DIS, V35, P791, DOI 10.1097/OLQ.0b013e3181788301; [Anonymous], 2010, GLOBOCAN 2008 CANC I; Bachrach G, 2005, FEMS MICROBIOL LETT, V248, P235, DOI 10.1016/j.femsle.2005.05.055; BENNETT KW, 1993, J MED MICROBIOL, V39, P246, DOI 10.1099/00222615-39-4-246; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castro Therezita M Peixoto Patury Galvao, 2009, Braz J Otorhinolaryngol, V75, P167; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davis-Devine S, 2005, AM J CLIN PATHOL, V124, P24, DOI [10.1309/BFVVU29HCC5RCKY5, 10.1309/BFWU29HCC5RCKY5]; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; DOLS JAM, 2012, ISRN OBESTET GYNECOL, V2012, P5; Dols JAM, 2012, DIAGN CYTOPATHOL, V40, P472, DOI 10.1002/dc.21786; FREEDMAN M, 2008, MENOPAUSE MANAG, V17, P9; Garcea G, 2005, PANCREATOLOGY, V5, P514, DOI 10.1159/000087493; Gillet E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-10; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; Haakensen M, 2008, INT J FOOD MICROBIOL, V125, P236, DOI 10.1016/j.ijfoodmicro.2008.04.002; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Hillier SL, 1997, CLIN INFECT DIS, V25, pS123, DOI 10.1086/516221; Hummelen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026602; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Keller MJ, 2012, JAMA-J AM MED ASSOC, V308, P362, DOI 10.1001/jama.2012.5664; KOSTIC AD, 2011, GENOME, DOI DOI 10.1101/GR.126573.126111; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Lippman SA, 2010, INT J STD AIDS, V21, P105, DOI 10.1258/ijsa.2009.008436; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Marks MA, 2012, J CLIN MICROBIOL, V50, P300, DOI 10.1128/JCM.05979-11; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Pabich WL, 2003, J INFECT DIS, V188, P1054, DOI 10.1086/378203; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ralph SG, 1999, BRIT MED J, V319, P220, DOI 10.1136/bmj.319.7204.220; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scott M, 1999, CLIN DIAGN LAB IMMUN, V6, P751, DOI 10.1128/CDLI.6.5.751-755.1999; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Song YM, 2010, TWIN RES HUM GENET, V13, P223, DOI 10.1375/twin.13.3.223; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; STRAIGHT SW, 1995, J VIROL, V69, P3185, DOI 10.1128/JVI.69.5.3185-3192.1995; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Sung J, 2006, TWIN RES HUM GENET, V9, P844, DOI 10.1375/183242706779462822; TACHEZY R, 1994, BIOCHEM BIOPH RES CO, V204, P820, DOI 10.1006/bbrc.1994.2533; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uitto VJ, 2005, INFECT IMMUN, V73, P1171, DOI 10.1128/IAI.73.2.1171-1179.2005; Veldhuijzen NJ, 2010, LANCET INFECT DIS, V10, P862, DOI 10.1016/S1473-3099(10)70190-0; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Watts DH, 2005, J INFECT DIS, V191, P1129, DOI 10.1086/427777; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; WILSON M, 2008, BACTERIOLOGY HUMANS, P171; Woodworth CD, 2002, FRONT BIOSCI-LANDMRK, V7, pD2058, DOI 10.2741/woodworth; Yamamoto T, 2009, J PEDIATR ADOL GYNEC, V22, P11, DOI 10.1016/j.jpag.2008.01.073; Ye YZ, 2010, IEEE INT C BIOINFORM, P153, DOI 10.1109/BIBM.2010.5706555	61	158	191	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63514	10.1371/journal.pone.0063514	http://dx.doi.org/10.1371/journal.pone.0063514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717441	Green Published, gold			2022-12-27	WOS:000320362700031
J	Zheng, YM; Cao, P; Fu, BJ; Hughes, JM; He, JZ				Zheng, Yuan-Ming; Cao, Peng; Fu, Bojie; Hughes, Jane M.; He, Ji-Zheng			Ecological Drivers of Biogeographic Patterns of Soil Archaeal Community	PLOS ONE			English	Article							BETA-DIVERSITY; NEUTRAL THEORY; RIBOSOMAL-RNA; BACTERIAL; ABUNDANCE; FOREST; MACROORGANISMS; MICROORGANISMS; DISPERSAL; CRENARCHAEOTA	Knowledge about the biogeography of organisms has long been a focus in ecological research, including the mechanisms that generate and maintain diversity. In this study, we targeted a microbial group relatively underrepresented in the microbial biogeographic literature, the soil Archaea. We surveyed the archaeal abundance and community composition using real-time quantitative PCR and T-RFLP approaches for 105 soil samples from 2 habitat types to identify the archaeal distribution patterns and factors driving these patterns. Results showed that the soil archaeal community was affected by spatial and environmental variables, and 79% and 51% of the community variation was explained in the non-flooded soil (NS) and flooded soil (FS) habitat, respectively, showing its possible biogeographic distribution. The diversity patterns of soil Archaea across the landscape were influenced by a combination of stochastic and deterministic processes. The contribution from neutral processes was higher than that from deterministic processes associated with environmental variables. The variables pH, sample depth and longitude played key roles in determining the archaeal distribution in the NS habitat, while sampling depth, longitude and NH4+-N were most important in the FS habitat. Overall, there might be similar ecological drivers in the soil archaeal community as in macroorganism communities.	[Zheng, Yuan-Ming; Cao, Peng; Fu, Bojie; He, Ji-Zheng] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Hughes, Jane M.; He, Ji-Zheng] Griffith Univ, Griffith Sch Environm, Environm Futures Ctr, Nathan, Qld 4111, Australia	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Griffith University	He, JZ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	jzhe@rcees.ac.cn	He, Ji-Zheng/A-4488-2009; hughes, jane m/C-5321-2008; Fu, Bojie/B-1493-2009; Zheng, Yuan-Ming/A-4491-2009	He, Ji-Zheng/0000-0002-9169-8058; 	Natural Science Foundation of China [41230857, 41025004]; CAS/SAFEA International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services''	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services''(Chinese Academy of Sciences)	This work was supported by the Natural Science Foundation of China (41230857 and 41025004) and the CAS/SAFEA International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel R, 2010, ISME J, V4, P553, DOI 10.1038/ismej.2009.136; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brown J. H., 1998, BIOGEOGRAPHY; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cao P, 2012, FEMS MICROBIOL ECOL, V80, P146, DOI 10.1111/j.1574-6941.2011.01280.x; Caruso T, 2011, ISME J, V5, P1406, DOI 10.1038/ismej.2011.21; Chase JM, 2003, ECOLOGICAL NICHE; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chesson PL, 1986, COMMUNITY ECOLOGY, P229; Chytry M, 2012, J BIOGEOGR, V39, P1101, DOI 10.1111/j.1365-2699.2011.02664.x; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dumas J. B. A, 1831, ANN CHIM PHYS, V2, P198; Dumbrell AJ, 2010, ISME J, V4, P1078, DOI 10.1038/ismej.2010.48; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2011, ECOLOGY, V92, P797, DOI 10.1890/10-1170.1; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Ge Y, 2008, ISME J, V2, P254, DOI 10.1038/ismej.2008.2; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Hershberger KL, 1996, NATURE, V384, P420, DOI 10.1038/384420a0; Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell Stephen P., 2001, V32, pi; Kemnitz D, 2005, ENVIRON MICROBIOL, V7, P553, DOI 10.1111/j.1462-2920.2005.00723.x; Kemnitz D, 2007, FEMS MICROBIOL ECOL, V60, P442, DOI 10.1111/j.1574-6941.2007.00310.x; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Lauber CL, 2012, APPL ENVIRON MICROB, V75, P5111; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2008, ECOLOGY, V89, P3238, DOI 10.1890/07-0272.1; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Locey KJ, 2010, J BIOGEOGR, V37, P1835, DOI 10.1111/j.1365-2699.2010.02357.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mazaris AD, 2010, J BIOGEOGR, V37, P1341, DOI 10.1111/j.1365-2699.2010.02294.x; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Samuels CL, 1997, TRENDS ECOL EVOL, V12, P427, DOI 10.1016/S0169-5347(97)01182-8; Sparks DL, 1996, METHODS SOIL ANAL 3, V37, P1085; Tian HQ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002464; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Wang JJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P743, DOI 10.1111/j.1466-8238.2011.00718.x; WILSON JB, 1991, J VEG SCI, V2, P35, DOI 10.2307/3235896	62	15	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63375	10.1371/journal.pone.0063375	http://dx.doi.org/10.1371/journal.pone.0063375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717418	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700017
J	Gao, LN; Schwartzman, J; Gibbs, A; Lisac, R; Kleinschmidt, R; Wilmot, B; Bottomly, D; Coleman, I; Nelson, P; McWeeney, S; Alumkal, J				Gao, Lina; Schwartzman, Jacob; Gibbs, Angela; Lisac, Robert; Kleinschmidt, Richard; Wilmot, Beth; Bottomly, Daniel; Coleman, Ilsa; Nelson, Peter; McWeeney, Shannon; Alumkal, Joshi			Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; GROWTH-INHIBITION; CELL-GROWTH; GENE; AMPLIFICATION; OVEREXPRESSION; ANTIANDROGEN; MAINTENANCE; ABIRATERONE; EXPRESSION	The androgen receptor (AR) is the principal therapeutic target in prostate cancer. For the past 70 years, androgen deprivation therapy (ADT) has been the major therapeutic focus. However, some patients do not benefit, and those tumors that do initially respond to ADT eventually progress. One recently described mechanism of such an effect is growth and survival-promoting effects of the AR that are exerted independently of the AR ligands, testosterone and dihydrotestosterone. However, specific ligand-independent AR target genes that account for this effect were not well characterized. We show here that c-Myc, which is a key mediator of ligand-independent prostate cancer growth, is a key ligand-independent AR target gene. Using microarray analysis, we found that c-Myc and AR expression levels strongly correlated with each other in tumors from patients with castration-resistant prostate cancer (CRPC) progressing despite ADT. We confirmed that AR directly regulates c-Myc transcription in a ligand-independent manner, that AR and c-Myc suppression reduces ligand-independent prostate cancer cell growth, and that ectopic expression of c-Myc attenuates the anti-growth effects of AR suppression. Importantly, treatment with the bromodomain inhibitor JQ1 suppressed c-Myc function and suppressed ligand-independent prostate cancer cell survival. Our results define a new link between two critical proteins in prostate cancer - AR and c-Myc - and demonstrate the potential of AR and c-Myc-directed therapies to improve prostate cancer control.	[Gao, Lina; Schwartzman, Jacob; Gibbs, Angela; Lisac, Robert; Kleinschmidt, Richard; Alumkal, Joshi] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Oncol, Portland, OR 97201 USA; [Wilmot, Beth; Bottomly, Daniel; McWeeney, Shannon] Oregon Clin & Translat Res Inst, Portland, OR USA; [Wilmot, Beth; Bottomly, Daniel; McWeeney, Shannon] Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Coleman, Ilsa; Nelson, Peter] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA	Oregon Health & Science University; Oregon Health & Science University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Alumkal, J (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Oncol, Portland, OR 97201 USA.	alumkalj@ohsu.edu		Schwartzman, Jacob/0000-0002-2640-8181; McWeeney, Shannon/0000-0001-8333-6607; Lisac, Robert/0000-0001-8164-8113	Oregon Clinical and Translational Research Institute; National Center for Research Resources [KL2 RR024141]; National Center for Advancing Translational Sciences of the National Institutes of Health; Pacific Northwest Prostate Cancer SPORE/National Cancer Institute [P50CA097186]; Department of Defense [PC093509]; Flight Attendant Medical Research Institute Young Clinical Scientist Award; Wayne D. Kuni & Joan E. Kuni Foundation Kuni Scholar Award; Prostate Cancer Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE [P30CA069533, P50CA097186] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024141] Funding Source: NIH RePORTER	Oregon Clinical and Translational Research Institute; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Pacific Northwest Prostate Cancer SPORE/National Cancer Institute; Department of Defense(United States Department of Defense); Flight Attendant Medical Research Institute Young Clinical Scientist Award; Wayne D. Kuni & Joan E. Kuni Foundation Kuni Scholar Award; Prostate Cancer Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication was made possible with support from the Oregon Clinical and Translational Research Institute, grant number KL2 RR024141 from the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health (JA). This work was also supported by the Pacific Northwest Prostate Cancer SPORE/National Cancer Institute (P50CA097186) (JA, PN, IC), the Department of Defense (PC093509) (PSN), a Flight Attendant Medical Research Institute Young Clinical Scientist Award (JA), a Wayne D. Kuni & Joan E. Kuni Foundation Kuni Scholar Award (JA), and a Prostate Cancer Foundation Young Investigator Award (JA). With special thanks to Platt Electric, Bruce Burns, and The Burns Family Fund of the Oregon Community Foundation for their philanthropic support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard D, 2003, J CLIN INVEST, V112, P1724; Bradbury RH, 2011, BIOORG MED CHEM LETT, V21, P5442, DOI 10.1016/j.bmcl.2011.06.122; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; Efstathiou E, 2012, J CLIN ONCOL, V30, P637, DOI 10.1200/JCO.2010.33.7675; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gibbs A, 2009, P NATL ACAD SCI USA, V106, P16663, DOI 10.1073/pnas.0908908106; Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Jenkins RB, 1997, CANCER RES, V57, P524; Karlou M, 2011, J CLIN ONCOL, V29; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Linja MJ, 2001, CANCER RES, V61, P3550; Loddick SA, 2012, CANC RES, V72; Mecham BH, 2010, BIOINFORMATICS, V26, P1308, DOI 10.1093/bioinformatics/btq118; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Morrissey C, 2008, CLIN EXP METASTAS, V25, P377, DOI 10.1007/s10585-007-9116-4; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Page ST, 2011, J CLIN ENDOCR METAB, V96, P430, DOI 10.1210/jc.2010-1865; Scher HI, 2012, N ENGL J MED; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Zhang YX, 2011, MOL CANCER THER, V10, P2309, DOI 10.1158/1535-7163.MCT-11-0329	45	107	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63563	10.1371/journal.pone.0063563	http://dx.doi.org/10.1371/journal.pone.0063563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704919	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200050
J	Hackett, CA; McLean, K; Bryan, GJ				Hackett, Christine A.; McLean, Karen; Bryan, Glenn J.			Linkage Analysis and QTL Mapping Using SNP Dosage Data in a Tetraploid Potato Mapping Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RESISTANCE; MAP; MARKERS; CONSTRUCTION; TUBEROSUM; SEGREGATION; DISSECTION; AFLP	New sequencing and genotyping technologies have enabled researchers to generate high density SNP genotype data for mapping populations. In polyploid species, SNP data usually contain a new type of information, the allele dosage, which is not used by current methodologies for linkage analysis and QTL mapping. Here we extend existing methodology to use dosage data on SNPs in an autotetraploid mapping population. The SNP dosages are inferred from allele intensity ratios using normal mixture models. The steps of the linkage analysis (testing for distorted segregation, clustering SNPs, calculation of recombination fractions and LOD scores, ordering of SNPs and inference of parental phase) are extended to use the dosage information. For QTL analysis, the probability of each possible offspring genotype is inferred at a grid of locations along the chromosome from the ordered parental genotypes and phases and the offspring dosages. A normal mixture model is then used to relate trait values to the offspring genotypes and to identify the most likely locations for QTLs. These methods are applied to analyse a tetraploid potato mapping population of parents and 190 offspring, genotyped using an Infinium 8300 Potato SNP Array. Linkage maps for each of the 12 chromosomes are constructed. The allele intensity ratios are mapped as quantitative traits to check that their position and phase agrees with that of the corresponding SNP. This analysis confirms most SNP positions, and eliminates some problem SNPs to give high-density maps for each chromosome, with between 74 and 152 SNPs mapped and between 100 and 300 further SNPs allocated to approximate bins. Low numbers of double reduction products were detected. Overall 3839 of the 5378 polymorphic SNPs can be assigned putative genetic locations. This methodology can be applied to construct high-density linkage maps in any autotetraploid species, and could also be extended to higher autopolyploids.	[Hackett, Christine A.] Biomath & Stat Scotland, Dundee, Scotland; [McLean, Karen; Bryan, Glenn J.] James Hutton Inst, Dundee, Scotland	James Hutton Institute; James Hutton Institute	Hackett, CA (corresponding author), Biomath & Stat Scotland, Dundee, Scotland.	Christine@bioss.ac.uk		Bryan, Glenn/0000-0002-7752-5740	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	The authors would like to acknowledge the financial support of the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], P IEEE; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bradshaw JE, 1998, THEOR APPL GENET, V97, P202, DOI 10.1007/s001220050886; Bradshaw JE, 2004, EUPHYTICA, V137, P13, DOI 10.1023/B:EUPH.0000040499.19190.fb; Bradshaw JE, 2004, GENETICS, V168, P983, DOI 10.1534/genetics.104.030056; Bradshaw JE, 2008, THEOR APPL GENET, V116, P193, DOI 10.1007/s00122-007-0659-1; Bryan GJ, 2004, MOL BREEDING, V14, P105, DOI 10.1023/B:MOLB.0000037999.13581.9c; Bryan GJ, 2002, THEOR APPL GENET, V105, P68, DOI 10.1007/s00122-002-0873-9; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; de Boor C., 2001, APPL MATH SCI, V27; Dunning MJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-85; Durbin R., 1998, BIOL SEQUENCE ANAL P; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Gar O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020463; Hackett CA, 1998, GENET RES, V71, P143, DOI 10.1017/S0016672398003188; Hackett CA, 2001, GENETICS, V159, P1819; Han YH, 2012, MOL BREEDING, V29, P489, DOI 10.1007/s11032-011-9566-x; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; JANSEN RC, 1992, THEOR APPL GENET, V85, P252, DOI 10.1007/BF00222867; Kempthorne O, 1957, INTRO GENETIC STAT; Luo ZW, 2001, GENETICS, V157, P1369; Mather K, 1935, J GENET, V30, P53, DOI 10.1007/BF02982205; Mather K, 1936, J GENET, V32, P287, DOI 10.1007/BF02982683; McCord PH, 2011, THEOR APPL GENET, V122, P129, DOI 10.1007/s00122-010-1429-z; Meyer RC, 1998, MOL GEN GENET, V259, P150, DOI 10.1007/s004380050800; Ritchie ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002276; Robins JG, 2007, CROP SCI, V47, P1, DOI 10.2135/cropsci2005.11.0401; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Serang O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030906; Sledge MK, 2005, THEOR APPL GENET, V111, P980, DOI 10.1007/s00122-005-0038-8; Song YH, 2011, GRASSL SCI, V57, P158, DOI 10.1111/j.1744-697X.2011.00223.x; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stein J, 2007, MOL BREEDING, V20, P153, DOI 10.1007/s11032-007-9083-0; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; vanderVoort JNAMR, 1997, MOL GEN GENET, V255, P438, DOI 10.1007/s004380050516; Voorrips RE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-172; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; YU KF, 1993, GENOME, V36, P844, DOI 10.1139/g93-112	41	91	91	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63939	10.1371/journal.pone.0063939	http://dx.doi.org/10.1371/journal.pone.0063939			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704960	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200091
J	Majeed, H; Lampert, A; Ghazaryan, L; Gillor, O				Majeed, Hadeel; Lampert, Adam; Ghazaryan, Lusine; Gillor, Osnat			The Weak Shall Inherit: Bacteriocin-Mediated Interactions in Bacterial Populations	PLOS ONE			English	Article							ESCHERICHIA-COLI; FREQUENCY; SPITE; DIVERSITY; EVOLUTION; DYNAMICS; DEATH; GAME	Background: Evolutionary arms race plays a major role in shaping biological diversity. In microbial systems, competition often involves chemical warfare and the production of bacteriocins, narrow-spectrum toxins aimed at killing closely related strains by forming pores in their target's membrane or by degrading the target's RNA or DNA. Although many empirical and theoretical studies describe competitive exclusion of bacteriocin-sensitive strains by producers of bacteriocins, the dynamics among producers are largely unknown. Methodology/Principal findings: We used a reporter-gene assay to show that the bacterial response to bacteriocins' treatment mirrors the inflicted damage Potent bacteriocins are lethal to competing strains, but at sublethal doses can serve as strong inducing agents, enhancing their antagonists' bacteriocin production. In contrast, weaker bacteriocins are less toxic to their competitors and trigger mild bacteriocin expression. We used empirical and numerical models to explore the role of cross-induction in the arms race between bacteriocin-producing strains. We found that in well-mixed, unstructured environments where interactions are global, producers of weak bacteriocins are selectively advantageous and outcompete producers of potent bacteriocins. However, in spatially structured environments, where interactions are local, each producer occupies its own territory, and competition takes place only in "no man's lands'' between territories, resulting in much slower dynamics. Conclusion/Significance: The models we present imply that producers of potent bacteriocins that trigger a strong response in neighboring bacteriocinogenic strains are doomed, while producers of weak bacteriocins that trigger a mild response in bacteriocinogenic strains flourish. This counter-intuitive outcome might explain the preponderance of weak bacteriocin producers in nature. However, the described scenario is prolonged in spatially structured environments thus promoting coexistence, allowing migration and evolution, and maintaining bacterial diversity.	[Majeed, Hadeel; Ghazaryan, Lusine; Gillor, Osnat] Ben Gurion Univ Negev, J Blaustein Inst Desert Res, Zuckerberg Inst Water Res, Midreshet Ben Gurion, Israel; [Lampert, Adam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Ben Gurion University; Weizmann Institute of Science	Gillor, O (corresponding author), Ben Gurion Univ Negev, J Blaustein Inst Desert Res, Zuckerberg Inst Water Res, Sede Boqer Campus, Midreshet Ben Gurion, Israel.	gilloro@bgu.ac.il		Gillor, Osnat/0000-0003-0849-2241	National Institutes of Health [R01A1064588-01A2]; Israel Council of Higher Education; Israeli Ministry for Science and Technology for Women in Science [3-6485]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Council of Higher Education; Israeli Ministry for Science and Technology for Women in Science	This work was supported by the National Institutes of Health grant R01A1064588-01A2 (http://www.nih.gov/). HM is a recipient of a Ph.D. grant from the Israel Council of Higher Education and of a scholarship from the Israeli Ministry for Science and Technology for Women in Science Grant 3-6485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1979, GENETICS, V91, P627; Barnes B, 2007, MICROBIOL-SGM, V153, P2823, DOI 10.1099/mic.0.2007/007120-0; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Durrett R, 1997, J THEOR BIOL, V185, P165, DOI 10.1006/jtbi.1996.0292; FRANK SA, 1994, EVOL ECOL, V8, P369, DOI 10.1007/BF01238189; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Gillor O, 2008, MICROBIOL-SGM, V154, P1783, DOI 10.1099/mic.0.2007/016139-0; Gordon DM, 2006, MICROBIOL-SGM, V152, P3239, DOI 10.1099/mic.0.28690-0; Gordon DM, 1999, MICROBIOL-SGM, V145, P655, DOI 10.1099/13500872-145-3-655; Graille M, 2004, EMBO J, V23, P1474, DOI 10.1038/sj.emboj.7600162; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Inglis RF, 2009, P NATL ACAD SCI USA, V106, P5703, DOI 10.1073/pnas.0810850106; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; KLAENHAMMER TR, 1988, BIOCHIMIE, V70, P337, DOI 10.1016/0300-9084(88)90206-4; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lenski RE, 2002, P NATL ACAD SCI USA, V99, P556, DOI 10.1073/pnas.022641999; Majeed H, 2011, ISME J, V5, P71, DOI 10.1038/ismej.2010.90; Mulec J, 2003, J BACTERIOL, V185, P654, DOI 10.1128/JB.185.2.654-659.2003; PUGSLEY AP, 1985, J GEN MICROBIOL, V131, P369; Riley M.A., 2007, BACT EC EV; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; RILEY MA, 1992, J GEN MICROBIOL, V138, P1345, DOI 10.1099/00221287-138-7-1345; Siepielski AM, 2010, ECOLOGY, V91, P3153, DOI 10.1890/10-0154.1; SUIT JL, 1983, P NATL ACAD SCI-BIOL, V80, P579, DOI 10.1073/pnas.80.2.579; Van Dyk TK, 1998, METH MOL B, V102, P85; Van Dyk TK, 2001, J BACTERIOL, V183, P5496, DOI 10.1128/JB.183.19.5496-5505.2001; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Walker D, 2004, J BACTERIOL, V186, P866, DOI 10.1128/JB.186.3.866-869.2004; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; West SA, 2010, SCIENCE, V327, P1341, DOI 10.1126/science.1178332; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	37	32	33	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63837	10.1371/journal.pone.0063837	http://dx.doi.org/10.1371/journal.pone.0063837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704942	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200073
J	Panighini, A; Duranti, E; Santini, F; Maffei, M; Pizzorusso, T; Funel, N; Taddei, S; Bernardini, N; Ippolito, C; Virdis, A; Costa, M				Panighini, Anna; Duranti, Emiliano; Santini, Ferruccio; Maffei, Margherita; Pizzorusso, Tommaso; Funel, Niccola; Taddei, Stefano; Bernardini, Nunzia; Ippolito, Chiara; Virdis, Agostino; Costa, Mario			Vascular Dysfunction in a Mouse Model of Rett Syndrome and Effects of Curcumin Treatment	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; SYNAPTIC PLASTICITY; MECP2 DEFICIENCY; SMALL ARTERIES; MICE; EXPRESSION; NEURONS	Mutations in the coding sequence of the X-linked gene MeCP2 (Methyl CpG-binding protein) are present in around 80% of patients with Rett Syndrome, a common cause of intellectual disability in female and to date without any effective pharmacological treatment. A relevant, and so far unexplored feature of RTT patients, is a marked reduction in peripheral circulation. To investigate the relationship between loss of MeCP2 and this clinical aspect, we used the MeCP2 null mouse model B6.129SF1-MeCP2tm1Jae for functional and pharmacological studies. Functional experiments were performed on isolated resistance mesenteric vessels, mounted on a pressurized myograph. Vessels from female MeCP2(+/-) mice show a reduced endothelium-dependent relaxation, due to a reduced Nitric Oxide (NO) availability secondary to an increased Reactive Oxygen Species (ROS) generation. Such functional aspects are associated with an intravascular increase in superoxide anion production, and a decreased vascular eNOS expression. These alterations are reversed by curcumin administration (5% (w/w) dietary curcumin for 21 days), which restores endothelial NO availability, decreases intravascular ROS production and normalizes vascular eNOS gene expression. In conclusion our findings highlight alterations in the vascular/endothelial system in the absence of a correct function of MeCP2, and uncover related cellular/molecular mechanisms that are rescued by an anti-oxidant treatment.	[Panighini, Anna; Pizzorusso, Tommaso; Costa, Mario] Italian Natl Res Council CNR, Inst Neurosci, Pisa, Italy; [Costa, Mario] Scuola Normale Super Pisa, Pisa, Italy; [Santini, Ferruccio; Maffei, Margherita] Univ Hosp Pisa, Dept Endocrinol & Kidney, Pisa, Italy; [Maffei, Margherita] Dulbecco Telethon Inst, Rome, Italy; [Maffei, Margherita] CNR, Inst Food Sci, Avellino, Italy; [Duranti, Emiliano; Taddei, Stefano; Bernardini, Nunzia; Ippolito, Chiara; Virdis, Agostino] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Funel, Niccola] Univ Pisa, Dept Surg, Pisa, Italy; [Pizzorusso, Tommaso] Univ Florence, Inst Psychol, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Pisa; University of Pisa; University of Florence	Virdis, A (corresponding author), Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.	agostino.virdis@med.unipi.it; costa@in.cnr.it	Santini, Ferruccio/J-9272-2018; Maffei, Margherita/I-2454-2018; Costa, Mario/AAC-2362-2022; Virdis, Agostino/K-5315-2016; Taddei, Stefano/AAB-2828-2019; Bernardini, Nunzia/AAC-4602-2021; Pizzorusso, Tommaso/D-1399-2013	Santini, Ferruccio/0000-0002-1706-0822; Maffei, Margherita/0000-0002-8534-2450; Pizzorusso, Tommaso/0000-0001-5614-0668; BERNARDINI, NUNZIA/0000-0001-9061-9402; Funel, Niccola/0000-0002-5028-2363; Ippolito, Chiara/0000-0001-8671-313X	MIUR (PRIN); PNR-CNR Aging Program; Epigenomics MIUR-CNR Flagship Project EPIGEN; Telethon Project [GGP09196]	MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); PNR-CNR Aging Program; Epigenomics MIUR-CNR Flagship Project EPIGEN; Telethon Project(Fondazione Telethon)	This work was supported by MIUR (PRIN 2008) and PNR-CNR Aging Program 2012-2014, Epigenomics MIUR-CNR Flagship Project EPIGEN, Telethon Project GGP09196. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ataie A, 2010, PHARMACOL BIOCHEM BE, V96, P378, DOI 10.1016/j.pbb.2010.06.009; Atmaca M, 2004, EUR ARCH PSY CLIN N, V254, P231, DOI 10.1007/s00406-004-0484-3; Bissonnette JM, 2007, AUTON NEUROSCI-BASIC, V136, P82, DOI 10.1016/j.autneu.2007.04.007; Bjure J, 1997, EUR CHILD ADOLES PSY, V6, P64; Boggio Elena M, 2010, Front Synaptic Neurosci, V2, P28, DOI 10.3389/fnsyn.2010.00028; Bora-Tatar G, 2009, BIOORGAN MED CHEM, V17, P5219, DOI 10.1016/j.bmc.2009.05.042; Bumin G, 2003, J REHABIL MED, V35, P44, DOI 10.1080/16501970306107; Caballero IM, 2005, HUM MOL GENET, V14, pR19, DOI 10.1093/hmg/ddi102; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen Y, 2007, BASIC CLIN PHARMACOL, V101, P427, DOI 10.1111/j.1742-7843.2007.00142.x; Coban D, 2012, MOL NUTR FOOD RES, V56, P1270, DOI 10.1002/mnfr.201100818; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; De Felice C, 2009, FREE RADICAL BIO MED, V47, P440, DOI 10.1016/j.freeradbiomed.2009.05.016; Fish JE, 2005, J BIOL CHEM, V280, P24824, DOI 10.1074/jbc.M502115200; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; FLAVAHAN NA, 1991, J PHARMACOL EXP THER, V256, P50; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Glaze DG, 2004, MENT RETARD DEV D R, V10, P154, DOI 10.1002/mrdd.20030; Gonzales ML, 2010, CURR PSYCHIAT REP, V12, P127, DOI 10.1007/s11920-010-0097-7; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kim DSHL, 2001, NEUROSCI LETT, V303, P57, DOI 10.1016/S0304-3940(01)01677-9; Lappalainen R, 1997, ACTA NEUROL SCAND, V95, P44, DOI 10.1111/j.1600-0404.1997.tb00067.x; LaSalle JM, 2009, EPIGENOMICS-UK, V1, P119, DOI [10.2217/epi.09.13, 10.2217/EPI.09.13]; Lee JC, 2010, RADIAT RES, V173, P590, DOI 10.1667/RR1522.1; Li J, 2009, BIOMED CHROMATOGR, V23, P1201, DOI 10.1002/bmc.1244; Lonetti G, 2010, BIOL PSYCHIAT, V67, P657, DOI 10.1016/j.biopsych.2009.12.022; Luscher TF, 1997, CLIN CARDIOL, V20, P3; Majithiya JB, 2005, J CARDIOVASC PHARM, V46, P697, DOI 10.1097/01.fjc.0000183720.85014.24; McCauley MD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002982; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; O'Connor RD, 2009, BONE, V45, P346, DOI 10.1016/j.bone.2009.04.251; Pearson BL, 2012, BEHAV GENET, V42, P299, DOI 10.1007/s10519-011-9501-2; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Percy AK, 2011, ARCH NEUROL-CHICAGO, V68, P985, DOI 10.1001/archneurol.2011.149; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Servi M, 2013, CLIN HEMORHEOL MICRO; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2001, CURR OPIN NEUROL, V14, P171, DOI 10.1097/00019052-200104000-00006; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Sierra C, 2001, BRAIN DEV-JPN, V23, pS236, DOI 10.1016/S0387-7604(01)00369-2; Smeets EEJ, 2011, MOL SYNDROMOL, V2, P113, DOI 10.1159/000337637; Sompamit K, 2009, EUR J PHARMACOL, V616, P192, DOI 10.1016/j.ejphar.2009.06.014; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Vanhoutte PM, 1996, PROG CARDIOVASC DIS, V39, P229, DOI 10.1016/S0033-0620(96)80003-X; Virdis A, 2003, ARTERIOSCL THROM VAS, V23, P1352, DOI 10.1161/01.ATV.0000083297.47245.DA; Virdis A, 2007, HYPERTENSION, V49, P679, DOI 10.1161/01.HYP.0000253085.56217.11; Virdis A, 2011, J AM COLL CARDIOL, V58, P238, DOI 10.1016/j.jacc.2011.01.050; Wang R, 2008, BRAIN RES, V1210, P84, DOI 10.1016/j.brainres.2008.01.104; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004	57	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64863	10.1371/journal.pone.0064863	http://dx.doi.org/10.1371/journal.pone.0064863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705018	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200172
J	Starostova, Z; Konarzewski, M; Kozlowski, J; Kratochvil, L				Starostova, Zuzana; Konarzewski, Marek; Kozlowski, Jan; Kratochvil, Lukas			Ontogeny of Metabolic Rate and Red Blood Cell Size in Eyelid Geckos: Species Follow Different Paths	PLOS ONE			English	Article							GENOME SIZE; BODY-MASS; ERYTHROCYTE SIZE; PASSERINE BIRDS; GENERAL-MODEL; C-VALUE; EVOLUTION; FISH; MORPHOLOGY; SELECTION	While metabolism is a fundamental feature of all organisms, the causes of its scaling with body mass are not yet fully explained. Nevertheless, observations of negative correlations between red blood cell (RBC) size and the rate of metabolism suggest that size variation of these cells responsible for oxygen supply may play a crucial role in determining metabolic rate scaling in vertebrates. Based on a prediction derived from the Cell Metabolism Hypothesis, metabolic rate should increase linearly with body mass in species with RBC size invariance, and slower than linearly when RBC size increases with body mass. We found support for that prediction in five species of eyelid geckos (family Eublepharidae) with different patterns of RBC size variation during ontogenetic growth. During ontogeny, metabolic rate increases nearly linearly with body mass in those species of eyelid geckos where there is no correlation between RBC size and body mass, whereas non-linearity of metabolic rate scaling is evident in those species with ontogenetic increase of RBC size. Our findings provide evidence that ontogenetic variability in RBC size, possibly correlating with sizes of other cell types, could have important physiological consequences and can contribute to qualitatively different shape of the intraspecific relationship between metabolic rate and body mass.	[Starostova, Zuzana] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Konarzewski, Marek] Univ Bialystok, Dept Anim Ecol, Bialystok, Poland; [Konarzewski, Marek] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Kozlowski, Jan] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Kratochvil, Lukas] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic	Charles University Prague; University of Bialystok; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Jagiellonian University; Charles University Prague	Starostova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	zuzana.starostova@natur.cuni.cz	Starostová, Zuzana/F-3853-2010; Kratochvil, Lukas/M-2134-2019; Kozlowski, Jan/K-5549-2012; Kratochvíl, Lukáš/A-1997-2008; Konarzewski, Marek/AAR-9952-2020	Starostová, Zuzana/0000-0002-5251-1617; Kozlowski, Jan/0000-0002-7084-2030; Kratochvíl, Lukáš/0000-0002-3515-729X; Konarzewski, Marek/0000-0001-7428-6521	Czech Science Foundation [P505/10/P174, 206/09/0895]; Polish Ministry of Science and Higher Education [NN304172036, NN304 3902 33]; Polish National Science Center [2011/02/A/NZ8/00064]	Czech Science Foundation(Grant Agency of the Czech Republic); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Science Center	The research was supported by the Czech Science Foundation projects P505/10/P174 (to ZS) and 206/09/0895 (to LK), by Polish Ministry of Science and Higher Education grants NN304172036 (to JK), NN304 3902 33 (to MK) and Polish National Science Center grant 2011/02/A/NZ8/00064 to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banavar JR, 2010, P NATL ACAD SCI USA, V107, P15816, DOI 10.1073/pnas.1009974107; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brzek P, 2007, PHYSIOL BIOCHEM ZOOL, V80, P491, DOI 10.1086/520617; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calboli FCF, 2003, EVOLUTION, V57, P566, DOI 10.1111/j.0014-3820.2003.tb01548.x; Callier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045455; Chown SL, 2007, FUNCT ECOL, V21, P282, DOI 10.1111/j.1365-2435.2007.01245.x; Czarnoleski M, 2008, J EXP BIOL, V211, P391, DOI 10.1242/jeb.013169; Davies R, 2007, J EXP BIOL, V210, P3798, DOI 10.1242/jeb.003897; DAVISON J, 1955, BIOL BULL, V109, P407, DOI 10.2307/1539173; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; ELSE PL, 1985, J COMP PHYSIOL B, V156, P3, DOI 10.1007/BF00692920; Glazier DS, 2009, COMP BIOCHEM PHYS A, V153, P403, DOI 10.1016/j.cbpa.2009.03.020; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Goodman RM, 2010, INTEGR ZOOL, V5, P208, DOI 10.1111/j.1749-4877.2010.00206.x; Gregory TR, 2000, GENOME, V43, P895, DOI 10.1139/gen-43-5-895; Gregory TR, 2002, EVOLUTION, V56, P121; Gregory TR, 2001, BLOOD CELL MOL DIS, V27, P830, DOI 10.1006/bcmd.2001.0457; GREGORY TR, 2005, CELL SIZE DATABASE; Grenat PR, 2009, AMPHIBIA-REPTILIA, V30, P141, DOI 10.1163/156853809787392667; HULBERT AJ, 1991, AM J PHYSIOL, V261, pR561, DOI 10.1152/ajpregu.1991.261.3.R561; Kearney MR, 2012, AM NAT, V180, P546, DOI 10.1086/667860; Killen SS, 2007, MAR BIOL, V152, P1249, DOI 10.1007/s00227-007-0772-3; Killen SS, 2007, P ROY SOC B-BIOL SCI, V274, P431, DOI 10.1098/rspb.2006.3741; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Konarzewski M, 1995, EVOLUTION, V49, P1239, DOI 10.2307/2410448; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; Kozlowski J, 2010, BIOL LETTERS, V6, P792, DOI 10.1098/rsbl.2010.0288; Kratochvil L, 2003, FOLIA ZOOL, V52, P317; Lay PA, 1999, FISH PHYSIOL BIOCHEM, V20, P31, DOI 10.1023/A:1007785202280; Maciak S, 2011, FUNCT ECOL, V25, P1072, DOI 10.1111/j.1365-2435.2011.01870.x; Makarieva AM, 2008, P NATL ACAD SCI USA, V105, P16994, DOI 10.1073/pnas.0802148105; Maxwell LK, 2003, COMP BIOCHEM PHYS A, V136, P301, DOI 10.1016/S1095-6433(03)00145-4; Moran D, 2007, COMP BIOCHEM PHYS A, V148, P611, DOI 10.1016/j.cbpa.2007.08.006; Pis T, 2008, COMP BIOCHEM PHYS A, V151, P211, DOI 10.1016/j.cbpa.2008.06.026; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Post JR, 1996, CAN J FISH AQUAT SCI, V53, P910, DOI 10.1139/cjfas-53-4-910; Ricklefs Robert E., 1998, Oxford Ornithology Series, V8, P266; Snyder GK, 1999, AM ZOOL, V39, P189; Starostova Z, 2005, FUNCT ECOL, V19, P744, DOI 10.1111/j.1365-2435.2005.01020.x; Starostova Z, 2008, ZOOLOGY, V111, P377, DOI 10.1016/j.zool.2007.10.005; Starostova Z, 2009, AM NAT, V174, pE100, DOI 10.1086/603610; Streicher JW, 2012, J EXP BIOL, V215, P1137, DOI 10.1242/jeb.061143; Ugurtas IH, 2003, ZOOL STUD, V42, P173; vanVoorhies WA, 1996, EVOLUTION, V50, P1259, DOI 10.2307/2410666; Vijendravarma RK, 2011, J EVOLUTION BIOL, V24, P897, DOI 10.1111/j.1420-9101.2010.02225.x; Vinogradov AE, 1995, EVOLUTION, V49, P1249, DOI 10.1111/j.1558-5646.1995.tb04451.x; Vinogradov AE, 1997, EVOLUTION, V51, P220, DOI 10.1111/j.1558-5646.1997.tb02403.x; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; Yagi M, 2010, P ROY SOC B-BIOL SCI, V277, P2793, DOI 10.1098/rspb.2010.0583	54	39	41	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64715	10.1371/journal.pone.0064715	http://dx.doi.org/10.1371/journal.pone.0064715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705003	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200157
J	Wadia, PR; Cabaton, NJ; Borrero, MD; Rubin, BS; Sonnenschein, C; Shioda, T; Soto, AM				Wadia, Perinaaz R.; Cabaton, Nicolas J.; Borrero, Michael D.; Rubin, Beverly S.; Sonnenschein, Carlos; Shioda, Toshi; Soto, Ana M.			Low-Dose BPA Exposure Alters the Mesenchymal and Epithelial Transcriptomes of the Mouse Fetal Mammary Gland	PLOS ONE			English	Article							XENOESTROGEN BISPHENOL-A; ESTROGEN-RECEPTORS ALPHA; ENVIRONMENTAL ESTROGENS; PERINATAL EXPOSURE; FOCAL ADHESIONS; IN-VITRO; EXPRESSION; CANCER; BETA; MORPHOGENESIS	Exposure of rodent fetuses to low doses of the endocrine disruptor bisphenol A (BPA) causes subtle morphological changes in the prenatal mammary gland and results in pre-cancerous and cancerous lesions during adulthood. To examine whether the BPA-induced morphological alterations of the fetal mouse mammary glands are a) associated with changes in mRNA expression reflecting estrogenic actions and/or b) dependent on the estrogen receptor alpha (ER alpha), we compared the transcriptomal effects of BPA and the steroidal estrogen ethinylestradiol (EE2) on fetal mammary tissues of wild type and ER alpha knock-out mice. Mammary glands from fetuses of dams exposed to vehicle, 250 ng BPA/kg BW/d or 10 ng EE2/kg BW/d from embryonic day (E) 8 were harvested at E19. Transcriptomal analyses on the ductal epithelium and periductal stroma revealed altered expression of genes involved in the focal adhesion and adipogenesis pathways in the BPA-exposed stroma while genes regulating the apoptosis pathway changed their expression in the BPA-exposed epithelium. These changes in gene expression correlated with previously reported histological changes in matrix organization, adipogenesis, and lumen formation resulting in enhanced maturation of the fat-pad and delayed lumen formation in the epithelium of BPA-exposed fetal mammary glands. Overall similarities in the transcriptomal effects of BPA and EE2 were more pronounced in the epithelium, than in the stroma. In addition, the effects of BPA and EE2 on the expression of various genes involved in mammary stromal-epithelial interactions were suppressed in the absence of ER alpha. These observations support a model whereby BPA and EE2 act directly on the stroma, which expresses ER alpha, ER beta and GPR30 in fetal mammary glands, and that the stroma, in turn, affects gene expression in the epithelium, where ER alpha and ER beta are below the level of detection at this stage of development.	[Wadia, Perinaaz R.; Cabaton, Nicolas J.; Borrero, Michael D.; Rubin, Beverly S.; Sonnenschein, Carlos; Soto, Ana M.] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA; [Shioda, Toshi] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA	Tufts University; Harvard University; Massachusetts General Hospital	Soto, AM (corresponding author), Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA.	ana.soto@tufts.edu			National Institute of Environmental Health Sciences [ES08314];  [FAS0703860];  [KG090515]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008314] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences grant ES08314 and its Supplement to Dr. Ana M. Soto and by the Susan G. Komen for the Cure grants FAS0703860 and KG090515 to Dr. Toshi Shioda. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ayyanan A, 2011, MOL ENDOCRINOL, V25, P1915, DOI 10.1210/me.2011-1129; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; BERN HA, 1992, ADV MOD ENV, V21, P9; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P1085, DOI 10.1016/j.biocel.2004.01.007; Chung CY, 1996, MOL BIOL CELL, V7, P883, DOI 10.1091/mbc.7.6.883; DODDS E. C, 1936, NATURE [LONDON], V137, P996, DOI 10.1038/137996a0; Dupont S, 2000, DEVELOPMENT, V127, P4277; Durando M, 2007, ENVIRON HEALTH PERSP, V115, P80, DOI 10.1289/ehp.9282; Fenton SE, 2006, ENDOCRINOLOGY, V147, pS18, DOI 10.1210/en.2005-1131; Garcia Y, 2008, BIOMATERIALS, V29, P857, DOI 10.1016/j.biomaterials.2007.10.053; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; KIMATA K, 1985, J EMBRYOL EXP MORPH, V89, P243; Lamartiniere CA, 2011, HORM MOL BIOL CLIN I, V5, P45, DOI 10.1515/HMBCI.2010.075; Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150; Lemmen JG, 1999, MECH DEVELOP, V81, P163, DOI 10.1016/S0925-4773(98)00223-8; Liu J, 2012, AM J PATHOL, V180, P839, DOI 10.1016/j.ajpath.2011.10.020; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Mangala LS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-33; Markey CM, 2005, BIOL REPROD, V72, P1344, DOI 10.1095/biolreprod.104.036301; Markey CM, 2001, BIOL REPROD, V65, P1215, DOI 10.1093/biolreprod/65.4.1215; MARKEY CM, 2003, EVOL DEV, V5, P1, DOI DOI 10.1016/S0960-0760(02)00272-8; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Munoz-de-Toro M, 2005, ENDOCRINOLOGY, V146, P4138, DOI 10.1210/en.2005-0340; Murray TJ, 2007, REPROD TOXICOL, V23, P383, DOI 10.1016/j.reprotox.2006.10.002; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Prasanth GK, 2010, J APPL TOXICOL, V30, P769, DOI 10.1002/jat.1570; Quintas G, 2012, METABOLOMICS, V8, P86, DOI 10.1007/s11306-011-0292-5; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Rubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189; Ryo A, 2009, TRENDS BIOCHEM SCI, V34, P162, DOI 10.1016/j.tibs.2008.12.004; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Schlomm T, 2005, INT J ONCOL, V27, P713; Simian M, 2001, DEVELOPMENT, V128, P3117; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Soriano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031109; SOTO AM, 1992, ADV MOD ENV, V21, P295; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Vandenberg LN, 2007, ENDOCRINOLOGY, V148, P116, DOI 10.1210/en.2006-0561; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vandenberg LN, 2008, REPROD TOXICOL, V26, P210, DOI 10.1016/j.reprotox.2008.09.015; Veltmaat JM, 2003, DIFFERENTIATION, V71, P1, DOI 10.1046/j.1432-0436.2003.700601.x; Wadia PR, 2007, ENVIRON HEALTH PERSP, V115, P592, DOI 10.1289/ehp.9640; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Zoeller RT, 2005, ENDOCRINOLOGY, V146, P607, DOI 10.1210/en.2004-1018	50	57	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63902	10.1371/journal.pone.0063902	http://dx.doi.org/10.1371/journal.pone.0063902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704952	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200083
J	Schmidt-Kassow, M; Deusser, M; Thiel, C; Otterbein, S; Montag, C; Reuter, M; Banzer, W; Kaiser, J				Schmidt-Kassow, Maren; Deusser, Marie; Thiel, Christian; Otterbein, Sascha; Montag, Christian; Reuter, Martin; Banzer, Winfried; Kaiser, Jochen			Physical Exercise during Encoding Improves Vocabulary Learning in Young Female Adults: A Neuroendocrinological Study	PLOS ONE			English	Article							ACTIVITY-DEPENDENT SECRETION; CHOICE-REACTION-TIME; NEUROTROPHIC FACTOR; VAL66MET POLYMORPHISM; WORKING-MEMORY; BDNF VAL66MET; RESISTANCE EXERCISE; INTENSITY EXERCISE; MUSICAL EXPERTISE; AEROBIC EXERCISE	Acute physical activity has been repeatedly shown to improve various cognitive functions. However, there have been no investigations comparing the effects of exercise during verbal encoding versus exercise prior to encoding on long-term memory performance. In this current psychoneuroendocrinological study we aim to test whether light to moderate ergometric bicycling during vocabulary encoding enhances subsequent recall compared to encoding during physical rest and encoding after being physically active. Furthermore, we examined the kinetics of brain-derived neurotrophic factor (BDNF) in serum which has been previously shown to correlate with learning performance. We also controlled for the BDNF val66met polymorphism. We found better vocabulary test performance for subjects that were physically active during the encoding phase compared to sedentary subjects. Post-hoc tests revealed that this effect was particularly present in initially low performers. BDNF in serum and BDNF genotype failed to account for the current result. Our data indicates that light to moderate simultaneous physical activity during encoding, but not prior to encoding, is beneficial for subsequent recall of new items.	[Schmidt-Kassow, Maren; Deusser, Marie; Otterbein, Sascha; Kaiser, Jochen] Goethe Univ Frankfurt, Inst Med Psychol, D-60054 Frankfurt, Germany; [Thiel, Christian; Banzer, Winfried] Goethe Univ Frankfurt, Inst Sports Sci, Dept Sports Med, D-60054 Frankfurt, Germany; [Montag, Christian; Reuter, Martin] Univ Bonn, Inst Personal & Biol Psychol, Bonn, Germany; [Reuter, Martin] Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany	Goethe University Frankfurt; Goethe University Frankfurt; University of Bonn; University of Bonn	Schmidt-Kassow, M (corresponding author), Goethe Univ Frankfurt, Inst Med Psychol, D-60054 Frankfurt, Germany.	schmidt-kassow@med.uni-frankfurt.de	Thiel, Christian/AAB-4695-2022; Meijer, Anna/K-5118-2016; Montag, Christian/H-6536-2019; Kaiser, Jochen/T-9184-2017	Thiel, Christian/0000-0003-4507-8787; Montag, Christian/0000-0001-8112-0837; Kaiser, Jochen/0000-0001-6740-5000	German Research Foundation [DFG SCHM 2693/1-1]; Goethe University Frankfurt/Main	German Research Foundation(German Research Foundation (DFG)); Goethe University Frankfurt/Main	The first author (MSK) was supported by a grant from the German Research Foundation (DFG SCHM 2693/1-1) and received intramural funding for the current project within the program "Funding for outstanding junior scientists'' by the Goethe University Frankfurt/Main. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almela M, 2011, STRESS, V14, P117, DOI 10.3109/10253890.2010.514671; Audiffren M, 2009, ACUTE EXERCISE PSYCH, P3; Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Besson M, 2007, RESTOR NEUROL NEUROS, V25, P399; Breitenstein C, 2005, NEUROIMAGE, V25, P958, DOI 10.1016/j.neuroimage.2004.12.019; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chang YK, 2009, J SPORT EXERCISE PSY, V31, P640, DOI 10.1123/jsep.31.5.640; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chobert J, 2011, J COGNITIVE NEUROSCI, V23, P3874, DOI 10.1162/jocn_a_00088; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Coles K, 2008, J SPORT SCI, V26, P333, DOI 10.1080/02640410701591417; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Correa A, 2008, J NEUROPHYSIOL, V100, P1649, DOI 10.1152/jn.90656.2008; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Deeny SP, 2008, BIOL PSYCHOL, V78, P179, DOI 10.1016/j.biopsycho.2008.02.007; Dennis NA, 2011, HIPPOCAMPUS, V21, P980, DOI 10.1002/hipo.20809; DUNBAR CC, 1992, MED SCI SPORT EXER, V24, P94; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eston R G, 1988, Br J Sports Med, V22, P153; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Farazdaghi GR, 2001, CLIN PHYSIOL, V21, P682, DOI 10.1046/j.1365-2281.2001.00373.x; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Francois C, 2011, CEREB CORTEX, V21, P2357, DOI 10.1093/cercor/bhr022; Frey I, 1999, SOZ PRAVENTIV MED, V44, P55, DOI 10.1007/BF01667127; Gatti R, 2011, SCAND J MED SCI SPOR, V21, P157, DOI 10.1111/j.1600-0838.2010.01252.x; Gold SM, 2003, J NEUROIMMUNOL, V138, P99, DOI 10.1016/S0165-5728(03)00121-8; Grant S, 1999, CHEST, V116, P1208, DOI 10.1378/chest.116.5.1208; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Gustafsson G, 2009, PSYCHIAT RES, V169, P244, DOI 10.1016/j.psychres.2008.06.030; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; HODGETTS V, 1991, J APPL PHYSIOL, V71, P445, DOI 10.1152/jappl.1991.71.2.445; Hopkins ME, 2012, NEUROSCIENCE, V215, P59, DOI 10.1016/j.neuroscience.2012.04.056; Janker P., 1996, ELEMENTS GEN PHONETI, V7, P94; Joyce J, 2009, BRAIN COGNITION, V71, P14, DOI 10.1016/j.bandc.2009.03.004; Kahneman D., 1973, ATTENTION EFFORT; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2000, Prog Brain Res, V127, P35; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Labban JD, 2011, RES Q EXERCISE SPORT, V82, P712, DOI 10.1080/02701367.2011.10599808; Laing KR, 2012, AGE, V34, P1011, DOI 10.1007/s11357-011-9275-8; Lange K, 2010, INT J PSYCHOPHYSIOL, V78, P231, DOI 10.1016/j.ijpsycho.2010.08.003; LEVITT S, 1971, RES QUART, V42, P405, DOI 10.1080/10671188.1971.10615088; Macedonia M, 2011, HUM BRAIN MAPP, V32, P982, DOI 10.1002/hbm.21084; Mandelman SD, 2012, GENES BRAIN BEHAV, V11, P127, DOI 10.1111/j.1601-183X.2011.00738.x; McMorris T, 2008, PHARMACOL BIOCHEM BE, V89, P106, DOI 10.1016/j.pbb.2007.11.007; McMorris T., 2009, EXERCISE COGNITIVE F, DOI [10.1002/9780470740668.ch2, DOI 10.1002/9780470740668.CH2]; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Montag C, 2009, PSYCHOL MED, V39, P1831, DOI 10.1017/S0033291709005509; Netz Y, 2007, INT J SPORTS MED, V28, P82, DOI 10.1055/s-2006-924027; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otterbein S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051419; Ozan E, 2010, BRAIN RES BULL, V81, P61, DOI 10.1016/j.brainresbull.2009.06.022; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Pletzer B, 2010, BRAIN RES, V1348, P55, DOI 10.1016/j.brainres.2010.06.019; Pluchino N, 2009, HUM REPROD, V24, P2303, DOI 10.1093/humrep/dep119; Pontifex MB, 2009, MED SCI SPORT EXER, V41, P927, DOI 10.1249/MSS.0b013e3181907d69; Protopopescu X, 2008, HIPPOCAMPUS, V18, P985, DOI 10.1002/hipo.20468; Ruschemeyer SA, 2007, J COGNITIVE NEUROSCI, V19, P855, DOI 10.1162/jocn.2007.19.5.855; Salas CR, 2011, J COGN PSYCHOL, V23, P507, DOI 10.1080/20445911.2011.532207; Schmidt-Kassow M, 2012, NEUROREPORT, V23, P889, DOI 10.1097/WNR.0b013e32835946ca; Schmidt-Kassow M, 2010, NEUROSCI LETT, V482, P40, DOI 10.1016/j.neulet.2010.06.089; Schmidt-Kassow M, 2009, NEUROREPORT, V20, P31, DOI 10.1097/WNR.0b013e32831b4287; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Seifert T, 2010, AM J PHYSIOL-REG I, V298, pR372, DOI 10.1152/ajpregu.00525.2009; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Sibley BA, 2007, J SPORT EXERCISE PSY, V29, P783, DOI 10.1123/jsep.29.6.783; Tang SW, 2008, NEUROSCI LETT, V431, P62, DOI 10.1016/j.neulet.2007.11.019; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Uda M, 2006, BRAIN RES, V1104, P64, DOI 10.1016/j.brainres.2006.05.066; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	79	35	35	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64172	10.1371/journal.pone.0064172	http://dx.doi.org/10.1371/journal.pone.0064172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700461	gold, Green Published, Green Submitted			2022-12-27	WOS:000319966400048
J	Wang, VB; Chua, SL; Cao, B; Seviour, T; Nesatyy, VJ; Marsili, E; Kjelleberg, S; Givskov, M; Tolker-Nielsen, T; Song, H; Say, J; Loo, C; Yang, L				Wang, Victor Bochuan; Chua, Song-Lin; Cao, Bin; Seviour, Thomas; Nesatyy, Victor J.; Marsili, Enrico; Kjelleberg, Staffan; Givskov, Michael; Tolker-Nielsen, Tim; Song, Hao; Say, Joachim; Loo, Chye; Yang, Liang			Engineering PQS Biosynthesis Pathway for Enhancement of Bioelectricity Production in Pseudomonas aeruginosa Microbial Fuel Cells	PLOS ONE			English	Article							ELECTRICITY-GENERATION; QUINOLONE SIGNAL; BIOFILM DEVELOPMENT; ELECTRON-TRANSFER; DNA RELEASE; METABOLITES; SYSTEM; ANODES; MR-1; PA14	The biosynthesis of the redox shuttle, phenazines, in Pseudomonas aeruginosa, an ubiquitous microorganism in wastewater microflora, is regulated by the 2-heptyl-3,4-dihydroxyquinoline (PQS) quorum-sensing system. However, PQS inhibits anaerobic growth of P. aeruginosa. We constructed a P. aeruginosa strain that produces higher concentrations of phenazines under anaerobic conditions by over-expressing the PqsE effector in a PQS negative Delta pqsC mutant. The engineered strain exhibited an improved electrical performance in microbial fuel cells (MFCs) and potentiostat-controlled electrochemical cells with an approximate five-fold increase of maximum current density relative to the parent strain. Electrochemical analysis showed that the current increase correlates with an over-synthesis of phenazines. These results therefore demonstrate that targeting microbial cell-to-cell communication by genetic engineering is a suitable technique to improve power output of bioelectrochemical systems.	[Wang, Victor Bochuan; Chua, Song-Lin; Cao, Bin; Seviour, Thomas; Marsili, Enrico; Kjelleberg, Staffan; Givskov, Michael; Loo, Chye; Yang, Liang] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn SCELSE, Singapore 639798, Singapore; [Chua, Song-Lin; Nesatyy, Victor J.] Natl Univ Singapore, Singapore Ctr Environm Life Sci Engn SCELSE, Singapore 117548, Singapore; [Yang, Liang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Cao, Bin] Nanyang Technol Univ, Sch Civil & Environm Engn, Singapore 639798, Singapore; [Wang, Victor Bochuan; Loo, Chye] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Song, Hao] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore; [Kjelleberg, Staffan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Givskov, Michael; Tolker-Nielsen, Tim] Univ Copenhagen, Panum Inst, Dept Int Hlth Immunol & Microbiol, DK-2200 Copenhagen, Denmark	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of New South Wales Sydney; University of Copenhagen	Yang, L (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn SCELSE, Singapore 639798, Singapore.	yangliang@ntu.edu.sg	Yang, Liang/C-8487-2011; Cao, Bin/H-2639-2012; Kjelleberg, Staffan/C-9229-2015; Marsili, Enrico/A-8652-2008; Kjelleberg, Staffan/AAB-4641-2020; Cao, Bin/AAA-3829-2021; Song, Hao/G-6207-2010; Loo, Say Chye Joachim/A-2234-2011; Lin, Chua Song/AAQ-4765-2021	Yang, Liang/0000-0002-2362-0128; Cao, Bin/0000-0002-9462-496X; Kjelleberg, Staffan/0000-0003-4271-6413; Marsili, Enrico/0000-0003-3150-1564; Kjelleberg, Staffan/0000-0003-4271-6413; Song, Hao/0000-0001-5553-2539; Loo, Say Chye Joachim/0000-0001-5300-1275; Chua, Song Lin/0000-0001-7047-7451; Tolker-Nielsen, Tim/0000-0002-9751-474X; Givskov, Michael/0000-0001-5004-8609	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Programme; Nanyang Technological University, Singapore [M4320002.C70, M4080847.030]	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Programme(Ministry of Education, Singapore); Nanyang Technological University, Singapore(Nanyang Technological University)	This research is supported by the National Research Foundation and Ministry of Education Singapore under its Research Centre of Excellence Programme and the Start-up Grants (M4320002.C70) and (M4080847.030) from Nanyang Technological University, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Benincasa M, 2004, ANTON LEEUW INT J G, V85, P1, DOI 10.1023/B:ANTO.0000020148.45523.41; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; Fan YZ, 2007, J POWER SOURCES, V171, P348, DOI 10.1016/j.jpowsour.2007.06.220; Fan YZ, 2011, BIOSENS BIOELECTRON, V26, P1908, DOI 10.1016/j.bios.2010.05.006; Farrow JM, 2008, J BACTERIOL, V190, P7043, DOI 10.1128/JB.00753-08; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; HOLLOWAY BW, 1986, ANNU REV MICROBIOL, V40, P79, DOI 10.1146/annurev.mi.40.100186.000455; Hou HJ, 2011, BIOSENS BIOELECTRON, V26, P2680, DOI 10.1016/j.bios.2010.06.037; Hou HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006570; Huang LP, 2008, APPL MICROBIOL BIOT, V80, P349, DOI 10.1007/s00253-008-1546-7; Kargi F, 2007, J CHEM TECHNOL BIOT, V82, P658, DOI 10.1002/jctb.1723; Kouzuma A, 2010, APPL ENVIRON MICROB, V76, P4151, DOI 10.1128/AEM.00117-10; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Liu Y, 2010, BIOSENS BIOELECTRON, V25, P2167, DOI 10.1016/j.bios.2010.01.016; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lovley DR, 2006, CURR OPIN BIOTECH, V17, P327, DOI 10.1016/j.copbio.2006.04.006; Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5; Marsili E, 2008, APPL ENVIRON MICROB, V74, P7329, DOI 10.1128/AEM.00177-08; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Park DH, 2003, BIOTECHNOL BIOENG, V81, P348, DOI 10.1002/bit.10501; Park DH, 2000, APPL ENVIRON MICROB, V66, P1292, DOI 10.1128/AEM.66.4.1292-1297.2000; Pham TH, 2008, APPL MICROBIOL BIOT, V80, P985, DOI 10.1007/s00253-008-1619-7; Qiao Y, 2008, CHEM COMMUN, P1290, DOI 10.1039/b719955d; Qiao Y, 2008, ACS NANO, V2, P113, DOI 10.1021/nn700102s; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; Rabaey K, 2005, TRENDS BIOTECHNOL, V23, P291, DOI 10.1016/j.tibtech.2005.04.008; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Rampioni G, 2010, ENVIRON MICROBIOL, V12, P1659, DOI 10.1111/j.1462-2920.2010.02214.x; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Reguera G, 2006, APPL ENVIRON MICROB, V72, P7345, DOI 10.1128/AEM.01444-06; Ren ZY, 2007, ENVIRON SCI TECHNOL, V41, P4781, DOI 10.1021/es070577h; Richter H, 2008, LANGMUIR, V24, P4376, DOI 10.1021/la703469y; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Schertzer JW, 2010, MOL MICROBIOL, V77, P1527, DOI 10.1111/j.1365-2958.2010.07303.x; Sund CJ, 2007, APPL MICROBIOL BIOT, V76, P561, DOI 10.1007/s00253-007-1038-1; Sund CJ, 2009, BIOSENS BIOELECTRON, V24, P3144, DOI 10.1016/j.bios.2009.03.019; Toyofuku M, 2010, MICROBES ENVIRON, V25, P1, DOI 10.1264/jsme2.ME09156; Toyofuku M, 2008, J BACTERIOL, V190, P7947, DOI 10.1128/JB.00968-08; Venkataraman A, 2010, ELECTROCHEM COMMUN, V12, P459, DOI 10.1016/j.elecom.2010.01.019; WRATTEN SJ, 1977, ANTIMICROB AGENTS CH, V11, P411, DOI 10.1128/AAC.11.3.411; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Yong YC, 2011, BIOSENS BIOELECTRON, V30, P87, DOI 10.1016/j.bios.2011.08.032; Zhang T, 2006, CHEM COMMUN, P2257, DOI 10.1039/b600876c	49	56	59	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63129	10.1371/journal.pone.0063129	http://dx.doi.org/10.1371/journal.pone.0063129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700414	Green Published, gold			2022-12-27	WOS:000319966400012
J	Xu, W; Xu, J; Wang, Y; Tang, HD; Deng, YL; Ren, RJ; Wang, G; Niu, WQ; Ma, JF; Wu, YW; Zheng, JL; Chen, SD; Ding, JQ				Xu, Wei; Xu, Jun; Wang, Ying; Tang, Huidong; Deng, Yulei; Ren, Rujing; Wang, Gang; Niu, Wenquan; Ma, Jianfang; Wu, Yiwen; Zheng, Jialin; Chen, Shengdi; Ding, Jianqing			The Genetic Variation of SORCS1 Is Associated with Late-Onset Alzheimer's Disease in Chinese Han Population	PLOS ONE			English	Article							CANDIDATE GENES; LINKAGE PHASE; RECEPTOR; PROTEIN; MEMBER; TESTS; RISK	The variations of SORCS1 gene may play potential key roles in late-onset Alzheimer's disease (LOAD). To evaluate the relationship between the polymorphism of SORCS1 gene and LOAD in the ethnic Han Chinese, we conducted a case-control study to investigate the association between the single-nucleotide polymorphisms (SNPs) in intron 1 of SORCS1 and LOAD in Chinese Han population. Six reported SNPs in intron 1 of SORCS1 were analyzed by Snapshot, genotyping and haplotyping in 236 Chinese LOAD cases and 233 matched controls. The significant differences in frequencies of two SNPs (rs10884402, rs950809) were found between the two groups. In addition, haplotype analyses revealed that, in the LOAD group, the frequency of haplotypes C-C-G-T-C (alleles in order of rs17277986, rs6584777, rs10884402, rs7078098, rs950809 polymorphisms) were significantly higher (Psim<0.0001) while haplotype C-C-A-T-C, C-C-A-C-C, T-T-A-C-C were significantly lower (Psim<0.0001). Our data suggested that the genetic variation of the rs10884402 and rs950809 in intron 1 of SORCS1 was associated with the late-onset AD in the Chinese Han population.	[Xu, Wei; Wang, Ying; Tang, Huidong; Deng, Yulei; Ren, Rujing; Wang, Gang; Ma, Jianfang; Wu, Yiwen; Chen, Shengdi; Ding, Jianqing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China; [Xu, Wei; Wang, Ying; Tang, Huidong; Deng, Yulei; Ren, Rujing; Wang, Gang; Ma, Jianfang; Wu, Yiwen; Chen, Shengdi; Ding, Jianqing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Inst Neurol, Shanghai 200030, Peoples R China; [Xu, Jun] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Zheng, Jialin] Univ Nebraska Med Ctr, Omaha, NE USA; [Chen, Shengdi; Ding, Jianqing] Chinese Acad Sci, Lab Neurodegenerat Dis, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Chen, Shengdi; Ding, Jianqing] Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanjing Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Nebraska System; University of Nebraska Medical Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, SD (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China.	chen_sd@medmail.com.cn; jqding18@yahoo.com	Ren, Rujing/AAW-4982-2021; Wang, Gang/W-5850-2019; XU, JUN/U-7975-2017	Wang, Gang/0000-0001-6500-5863; XU, JUN/0000-0001-7432-6781	National "Twelfth Five-Year" Plan for Science Technology [2012BAI10B03]; National Natural Science Foundation of China [81171200, 81028007]; Shanghai Key Project of Basic Science Research [09DZ1950400]; Key Project of Shanghai data collection and analysis, decision; Municipal Education Commission [12ZZ115]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	National "Twelfth Five-Year" Plan for Science Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Project of Basic Science Research; Key Project of Shanghai data collection and analysis, decision; Municipal Education Commission; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National "Twelfth Five-Year" Plan for Science & Technology Support (No. 2012BAI10B03), National Natural Science Foundation of China (No. 81171200; No. 81028007, Shanghai Key Project of Basic Science Research (No. 09DZ1950400) and the Key Project of Shanghai data collection and analysis, decision to publish, or preparation of Municipal Education Commission (No. 12ZZ115). The funders had no role in study design, the manuscript.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Ashford JW, 2002, J ALZHEIMERS DIS, V4, P169, DOI 10.3233/JAD-2002-4307; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Carrasquillo MM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-54; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deng YL, 2012, HUM GENET; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gauthier S, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-13; Goedert M, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P195; Hermey G, 2004, J NEUROCHEM, V88, P1470, DOI 10.1046/j.1471-4159.2004.02286.x; Hermey G, 2001, NEUROSCI LETT, V313, P83, DOI 10.1016/S0304-3940(01)02252-2; Hermey G, 1999, BIOCHEM BIOPH RES CO, V266, P347, DOI 10.1006/bbrc.1999.1822; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jellinger KA, 2006, J NEURAL TRANSM, V113, P1603, DOI 10.1007/s00702-006-0578-3; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lane RF, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-62; Laumet G, 2010, J ALZHEIMERS DIS, V20, P1181, DOI 10.3233/JAD-2010-100126; Liang XY, 2009, HUM MUTAT, V30, P463, DOI 10.1002/humu.20953; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Reitz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024588; Reitz C, 2011, ANN NEUROL, V69, P47, DOI 10.1002/ana.22308; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Wang HF, 2012, BRAIN RES, V1448, P111, DOI 10.1016/j.brainres.2012.01.067; Xie ZC, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-8	30	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63621	10.1371/journal.pone.0063621	http://dx.doi.org/10.1371/journal.pone.0063621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700427	Green Submitted, gold, Green Published			2022-12-27	WOS:000319966400023
J	Higgins, HM; Green, LE; Green, MJ; Kaler, J				Higgins, Helen M.; Green, Laura E.; Green, Martin J.; Kaler, Jasmeet			How Does Reviewing the Evidence Change Veterinary Surgeons' Beliefs Regarding the Treatment of Ovine Footrot? A Quantitative and Qualitative Study	PLOS ONE			English	Article							VIRULENT FOOTROT; CLINICAL-TRIAL; PENICILLIN-STREPTOMYCIN; SHEEP LAME; OXYTETRACYCLINE; ERYTHROMYCIN; RECOVERY; MEDICINE; TIME	Footrot is a widespread, infectious cause of lameness in sheep, with major economic and welfare costs. The aims of this research were: (i) to quantify how veterinary surgeons' beliefs regarding the efficacy of two treatments for footrot changed following a review of the evidence (ii) to obtain a consensus opinion following group discussions (iii) to capture complementary qualitative data to place their beliefs within a broader clinical context. Grounded in a Bayesian statistical framework, probabilistic elicitation (roulette method) was used to quantify the beliefs of eleven veterinary surgeons during two one-day workshops. There was considerable heterogeneity in veterinary surgeons' beliefs before they listened to a review of the evidence. After hearing the evidence, seven participants quantifiably changed their beliefs. In particular, two participants who initially believed that foot trimming with topical oxytetracycline was the better treatment, changed to entirely favour systemic and topical oxytetracycline instead. The results suggest that a substantial amount of the variation in beliefs related to differences in veterinary surgeons' knowledge of the evidence. Although considerable differences in opinion still remained after the evidence review, with several participants having non-overlapping 95% credible intervals, both groups did achieve a consensus opinion. Two key findings from the qualitative data were: (i) veterinary surgeons believed that farmers are unlikely to actively seek advice on lameness, suggesting a proactive veterinary approach is required (ii) more attention could be given to improving the way in which veterinary advice is delivered to farmers. In summary this study has: (i) demonstrated a practical method for probabilistically quantifying how veterinary surgeons' beliefs change (ii) revealed that the evidence that currently exists is capable of changing veterinary opinion (iii) suggested that improved transfer of research knowledge into veterinary practice is needed (iv) identified some potential obstacles to the implementation of veterinary advice by farmers.	[Higgins, Helen M.; Green, Martin J.; Kaler, Jasmeet] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England; [Green, Laura E.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Nottingham; University of Warwick	Higgins, HM (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England.	helen.higgins@nottingham.ac.uk	Green, Laura/G-8345-2011; Green, Martin/F-7066-2011	Green, Laura/0000-0003-2957-8773; Green, Martin/0000-0002-6408-6443; Kaler, Jasmeet/0000-0002-3332-7064	Wellcome Trust [087797/Z/08/Z]; School of Veterinary Medicine and Science, University of Nottingham, United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); School of Veterinary Medicine and Science, University of Nottingham, United Kingdom	HMH is funded by a Wellcome Trust clinical research training fellowship [087797/Z/08/Z] (http://www.wellcome.ac.uk). The School of Veterinary Medicine and Science, University of Nottingham, United Kingdom provided additional funding (http://www.nottingham.ac.uk/vet/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGLEY CV, 1987, J AM VET MED ASSOC, V191, P541; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; BULGIN MS, 1986, J AM VET MED ASSOC, V189, P194; CASEY RH, 1988, AUST VET J, V65, P258, DOI 10.1111/j.1751-0813.1988.tb14315.x; Duncan JS, 2012, VET REC, V170, P462, DOI 10.1136/vr.100363; EGERTON JR, 1968, AUST VET J, V44, P275, DOI 10.1111/j.1751-0813.1968.tb04982.x; Farm Animal Welfare Council, 2011, REP GOV OP LAM SHEEP; Garthwaite PH, 2005, J AM STAT ASSOC, V100, P680, DOI 10.1198/016214505000000105; Green LE, 2012, ANIM WELFARE, V21, P65, DOI 10.7120/096272812X13345905673728; GROGONOTHOMAS R, 1994, BRIT VET J, V150, P561, DOI 10.1016/S0007-1935(94)80041-3; GROGONOTHOMAS R, 1997, STUDY OVINE LAMENESS; Hardin LE, 2006, J VET MED EDUC, V33, P474, DOI 10.3138/jvme.33.3.474; Jansen J, 2010, J DAIRY SCI, V93, P1296, DOI 10.3168/jds.2009-2794; Johnson SR, 2010, J CLIN EPIDEMIOL, V63, P355, DOI 10.1016/j.jclinepi.2009.06.003; Johnson SR, 2010, J CLIN EPIDEMIOL, V63, P370, DOI 10.1016/j.jclinepi.2009.08.005; Jordan D, 1996, AUST VET J, V73, P211, DOI 10.1111/j.1751-0813.1996.tb10037.x; Kaler J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-12; Kaler J, 2010, J VET INTERN MED, V24, P420, DOI 10.1111/j.1939-1676.2009.0450.x; Kaler J, 2009, PREV VET MED, V92, P52, DOI 10.1016/j.prevetmed.2009.08.001; Kaler J, 2009, VET J, V180, P189, DOI 10.1016/j.tvjl.2007.12.028; MALECKI JC, 1987, AUST VET J, V64, P301, DOI 10.1111/j.1751-0813.1987.tb07331.x; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nieuwhof GJ, 2005, ANIM SCI, V81, P23, DOI 10.1079/ASC41010023; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS; Proctor A, 2011, VET REC, V169, P408, DOI 10.1136/vr.d5387; R Development Core Team, 2009, R LANG ENV STAT COMP; Rendell DK, 1997, AUST VET J, V75, P354, DOI 10.1111/j.1751-0813.1997.tb15712.x; Sagliyan A, 2008, J ANIM VET ADV, V7, P986; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Toews L, 2011, J VET MED EDUC, V38, P123, DOI 10.3138/jvme.38.2.123; VENNING CM, 1990, AUST VET J, V67, P258, DOI 10.1111/j.1751-0813.1990.tb07781.x; WARE JKW, 1994, AUST VET J, V71, P88, DOI 10.1111/j.1751-0813.1994.tb03336.x; Wassink GJ, 2010, PREV VET MED, V96, P93, DOI 10.1016/j.prevetmed.2010.05.006; Whay H. R., 2009, IMPROVING ANIMAL WEL	34	6	6	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64175	10.1371/journal.pone.0064175	http://dx.doi.org/10.1371/journal.pone.0064175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696869	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900072
J	Lyskov, S; Chou, FC; Conchuir, SO; Der, BS; Drew, K; Kuroda, D; Xu, JQ; Weitzner, BD; Renfrew, PD; Sripakdeevong, P; Borgo, B; Havranek, JJ; Kuhlman, B; Kortemme, T; Bonneau, R; Gray, JJ; Das, R				Lyskov, Sergey; Chou, Fang-Chieh; Conchuir, Shane O.; Der, Bryan S.; Drew, Kevin; Kuroda, Daisuke; Xu, Jianqing; Weitzner, Brian D.; Renfrew, P. Douglas; Sripakdeevong, Parin; Borgo, Benjamin; Havranek, James J.; Kuhlman, Brian; Kortemme, Tanja; Bonneau, Richard; Gray, Jeffrey J.; Das, Rhiju			Serverification of Molecular Modeling Applications: The Rosetta Online Server That Includes Everyone (ROSIE)	PLOS ONE			English	Article							BETA-PEPTIDE BUNDLE; STRUCTURE PREDICTION; PROTEIN DESIGN; CHEMICAL-SHIFTS; ATOMIC-ACCURACY; IN-VITRO; REFINEMENT; DOCKING; NMR; AGGREGATION	The Rosetta molecular modeling software package provides experimentally tested and rapidly evolving tools for the 3D structure prediction and high-resolution design of proteins, nucleic acids, and a growing number of non-natural polymers. Despite its free availability to academic users and improving documentation, use of Rosetta has largely remained confined to developers and their immediate collaborators due to the code's difficulty of use, the requirement for large computational resources, and the unavailability of servers for most of the Rosetta applications. Here, we present a unified web framework for Rosetta applications called ROSIE (Rosetta Online Server that Includes Everyone). ROSIE provides (a) a common user interface for Rosetta protocols, (b) a stable application programming interface for developers to add additional protocols, (c) a flexible back-end to allow leveraging of computer cluster resources shared by RosettaCommons member institutions, and (d) centralized administration by the RosettaCommons to ensure continuous maintenance. This paper describes the ROSIE server infrastructure, a step-by-step 'serverification' protocol for use by Rosetta developers, and the deployment of the first nine ROSIE applications by six separate developer teams: Docking, RNA de novo, ERRASER, Antibody, Sequence Tolerance, Supercharge, Beta peptide design, NCBB design, and VIP redesign. As illustrated by the number and diversity of these applications, ROSIE offers a general and speedy paradigm for serverification of Rosetta applications that incurs negligible cost to developers and lowers barriers to Rosetta use for the broader biological community. ROSIE is available at http://rosie.rosettacommons.org.	[Lyskov, Sergey; Kuroda, Daisuke; Xu, Jianqing; Weitzner, Brian D.; Gray, Jeffrey J.] Johns Hopkins Univ, Dept Chem & Biochem Engn, Baltimore, MD 21218 USA; [Chou, Fang-Chieh; Das, Rhiju] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Sripakdeevong, Parin] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Der, Bryan S.; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Conchuir, Shane O.; Kortemme, Tanja] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; [Conchuir, Shane O.; Kortemme, Tanja] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Drew, Kevin; Renfrew, P. Douglas; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA; [Gray, Jeffrey J.] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Borgo, Benjamin; Havranek, James J.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Kortemme, Tanja] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA	Johns Hopkins University; Stanford University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; University of California System; University of California San Francisco; New York University; New York University; Johns Hopkins University; Stanford University; Washington University (WUSTL); University of California System; University of California San Francisco	Gray, JJ (corresponding author), Johns Hopkins Univ, Dept Chem & Biochem Engn, Baltimore, MD 21218 USA.	jgray@jhu.edu; rhiju@stanford.edu	Gray, Jeffrey J./B-5682-2008; Kortemme, Tanja/AAN-3180-2021; Bonneau, Richard/GZL-2900-2022; Bonneau, Richard/ABD-6737-2021; Kuroda, Daisuke/AAZ-5672-2020	Gray, Jeffrey J./0000-0001-6380-2324; Kuroda, Daisuke/0000-0003-2390-4785; Weitzner, Brian/0000-0002-1909-0961; Das, Rhiju/0000-0001-7497-0972; Drew, Kevin/0000-0002-1260-4413; Kortemme, Tanja/0000-0002-8494-680X	United States National Institutes of Health [R01-GM073151, R01-GM078221, R21-GM102716, R00-RR024107, U54CA143907-01, PN2 EY016586-06, T32 GM 88118-2]; Burroughs-Wellcome Career Award at Scientific Interface; Governmental Scholarship for Study Abroad of Taiwan and Howard Hughes Medical and Institute International Student Research Fellowship; DARPA Antibody Technology Program [HR-0011-10-1-0052]; National Science Foundation [MCB-CAREER 0744541, EF-0849400, EEC-0540879]; UC Lab Research Program; United States National Science Foundation [CHE-1151554, NSF IOS-1126971]; NATIONAL CANCER INSTITUTE [U54CA143907] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R00RR024107] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073151, R01GM101602, R21GM102716, R01GM073960, T32GM088118, R01GM078221] Funding Source: NIH RePORTER; Division Of Chemistry [1151554] Funding Source: National Science Foundation	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Career Award at Scientific Interface(Burroughs Wellcome Fund); Governmental Scholarship for Study Abroad of Taiwan and Howard Hughes Medical and Institute International Student Research Fellowship; DARPA Antibody Technology Program; National Science Foundation(National Science Foundation (NSF)); UC Lab Research Program; United States National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors acknowledge financial support from the United States National Institutes of Health (R01-GM073151 to B.K., J.J.G. and S.L.; R01-GM078221 to J.J.G., R21-GM102716 to R.D., R00-RR024107 to J.J.H., U54CA143907-01 and PN2 EY016586-06 to R.B. and P.D.R. and K.D., T32 GM 88118-2 to K.D.), a Burroughs-Wellcome Career Award at Scientific Interface (R.D.), Governmental Scholarship for Study Abroad of Taiwan and Howard Hughes Medical and Institute International Student Research Fellowship (F.-C.C.), and the DARPA Antibody Technology Program (HR-0011-10-1-0052) for J.X. and D.K. S.O.C and T.K. were supported by grants from the National Science Foundation (MCB-CAREER 0744541, EF-0849400, EEC-0540879) and the UC Lab Research Program. R.B., P.D.R. and K.D. were supported by United States National Science Foundation (CHE-1151554 and NSF IOS-1126971 to R.B. and P.D.R. and K.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro JC, 2011, PROTEINS, V79, P3050, DOI 10.1002/prot.23130; Baugh EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021931; Bautista AD, 2007, CURR OPIN CHEM BIOL, V11, P685, DOI 10.1016/j.cbpa.2007.09.009; Borgo B, 2012, P NATL ACAD SCI USA, V109, P1494, DOI 10.1073/pnas.1115172109; Bullock BN, 2011, J AM CHEM SOC, V133, P14220, DOI 10.1021/ja206074j; Butterfoss GL, 2009, J AM CHEM SOC, V131, P16798, DOI 10.1021/ja905267k; Chaudhury S, 2008, J MOL BIOL, V381, P1068, DOI 10.1016/j.jmb.2008.05.042; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/NMETH.2262, 10.1038/nmeth.2262]; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Craig CJ, 2011, CHEMBIOCHEM, V12, P1035, DOI 10.1002/cbic.201000753; Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daniels DS, 2007, J AM CHEM SOC, V129, P1532, DOI 10.1021/ja068678n; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; Davis IW, 2006, STRUCTURE, V14, P265, DOI 10.1016/j.str.2005.10.007; Der BS, 2013, PLOS ONE ROSET UNPUB; Drew K, 2013, PLOS ONE ROSET UNPUB; Eiben CB, 2012, NAT BIOTECHNOL, V30, P190, DOI 10.1038/nbt.2109; FIELDS GB, 1992, J PHYS CHEM-US, V96, P3974, DOI 10.1021/j100189a013; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Friedland GD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000393; Goodman JL, 2007, J AM CHEM SOC, V129, P14746, DOI 10.1021/ja0754002; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Henchey LK, 2010, J AM CHEM SOC, V132, P941, DOI 10.1021/ja9082864; Humphris EL, 2008, STRUCTURE, V16, P1777, DOI 10.1016/j.str.2008.09.012; Humphris-Narayanan E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002639; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Jared Adolf-Bryfogle RD, 2013, PLOSONE ROSETTACON20; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kilambi KP, 2012, BIOPHYS J, V103, P587, DOI 10.1016/j.bpj.2012.06.044; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kuhlman B, 2012, ALTERNATIVE CO UNPUB; Kuroda D, 2008, PROTEINS, V73, P608, DOI 10.1002/prot.22087; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; KUSZEWSKI J, 1995, J MAGN RESON SER B, V107, P293, DOI 10.1006/jmrb.1995.1093; Lange OF, 2012, PROTEINS, V80, P884, DOI 10.1002/prot.23245; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; London N, 2008, STRUCTURE, V16, P269, DOI 10.1016/j.str.2007.11.013; London N, 2007, PROTEINS, V69, P809, DOI 10.1002/prot.21736; Lund U, 2003, AM J PHYSIOL-RENAL, V284, pF1226, DOI 10.1152/ajprenal.00316.2002; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Miklos AE, 2012, CHEM BIOL, V19, P449, DOI 10.1016/j.chembiol.2012.01.018; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; Molski MA, 2013, CHEM SCI, V4, P319, DOI 10.1039/c2sc21117c; Molski MA, 2010, J AM CHEM SOC, V132, P3658, DOI 10.1021/ja910903c; Patgiri A, 2008, ACCOUNTS CHEM RES, V41, P1289, DOI 10.1021/ar700264k; Petersson EJ, 2008, J AM CHEM SOC, V130, P821, DOI 10.1021/ja077245x; Pokala N, 2001, J STRUCT BIOL, V134, P269, DOI 10.1006/jsbi.2001.4349; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Schueler-Furman O, 2011, NUCL ACIDS RES; Shandler SJ, 2010, J AM CHEM SOC, V132, P7312, DOI 10.1021/ja906700x; Sheffler W, 2009, PROTEIN SCI, V18, P229, DOI 10.1002/pro.8; Sircar A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000644; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Smith CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020451; Smith CA, 2010, J MOL BIOL, V402, P460, DOI 10.1016/j.jmb.2010.07.032; Sripakdeevong P CM, 2012, CONSISTENT STR UNPUB; Sripakdeevong P, 2011, P NATL ACAD SCI USA, V108, P20573, DOI 10.1073/pnas.1106516108; SZILAGYI L, 1995, PROG NUCL MAG RES SP, V27, P325, DOI 10.1016/0079-6565(95)01011-2; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Tosovska P, 2010, ORG LETT, V12, P1588, DOI 10.1021/ol1003143; Treynor TP, 2007, P NATL ACAD SCI USA, V104, P48, DOI 10.1073/pnas.0609647103; Vila JA, 2008, P NATL ACAD SCI USA, V105, P14389, DOI 10.1073/pnas.0807105105; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Zuckermann RN, 2009, CURR OPIN MOL THER, V11, P299	78	218	222	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63906	10.1371/journal.pone.0063906	http://dx.doi.org/10.1371/journal.pone.0063906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717507	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700078
J	Maree, FF; Blignaut, B; de Beer, TAP; Rieder, E				Maree, Francois F.; Blignaut, Belinda; de Beer, Tjaart A. P.; Rieder, Elizabeth			Analysis of SAT Type Foot-And-Mouth Disease Virus Capsid Proteins and the Identification of Putative Amino Acid Residues Affecting Virus Stability	PLOS ONE			English	Article							SPECIFICITY; RECEPTOR; ALPHA(V)BETA(3); NEUTRALIZATION; ADHESION; STRAINS; QUALITY; LOOP	Foot-and-mouth disease virus (FMDV) initiates infection by adhering to integrin receptors on target cells, followed by cell entry and disassembly of the virion through acidification within endosomes. Mild heating of the virions also leads to irreversible dissociation into pentamers, a characteristic linked to reduced vaccine efficacy. In this study, the structural stability of intra-and inter-serotype chimeric SAT2 and SAT3 virus particles to various conditions including low pH, mild temperatures or high ionic strength, was compared. Our results demonstrated that while both the SAT2 and SAT3 infectious capsids displayed different sensitivities in a series of low pH buffers, their stability profiles were comparable at high temperatures or high ionic strength conditions. Recombinant vSAT2 and intra-serotype chimeric viruses were used to map the amino acid differences in the capsid proteins of viruses with disparate low pH stabilities. Four His residues at the inter-pentamer interface were identified that change protonation states at pH 6.0. Of these, the H145 of VP3 appears to be involved in interactions with A141 in VP3 and K63 in VP2, and may be involved in orientating H142 of VP3 for interaction at the inter-pentamer interfaces.	[Maree, Francois F.; Blignaut, Belinda] Agr Res Council, Onderstepoort Vet Inst, Transboundary Anim Dis Programme, Pretoria, South Africa; [Maree, Francois F.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa; [Blignaut, Belinda] Univ Pretoria, Dept Microbiol & Plant Pathol, Fac Agr & Nat Sci, ZA-0002 Pretoria, South Africa; [de Beer, Tjaart A. P.] Univ Pretoria, Bioinformat & Computat Biol Unit, ZA-0002 Pretoria, South Africa; [de Beer, Tjaart A. P.] European Bioinformat Inst, Cambridge, England; [Rieder, Elizabeth] ARS, Foreign Anim Dis Res Unit, USDA, Plum Isl Anim Dis Ctr, Greenport, NY USA	Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria; University of Pretoria; University of Pretoria; European Molecular Biology Laboratory (EMBL); United States Department of Agriculture (USDA)	Maree, FF (corresponding author), Agr Res Council, Onderstepoort Vet Inst, Transboundary Anim Dis Programme, Pretoria, South Africa.	mareef@arc.agric.za	Maree, Francois/AAR-7418-2020	de Beer, Tjaart/0000-0001-5966-6091; Maree, Francois Frederick/0000-0002-8777-250X	Agricultural Research Council; Onderstepoort Veterinary Institute of South Africa; United States Department of Agriculture, Agricultural Research Service; Red meat Research and Development trust of SA; MSD Animal Health;  [58-3K95-M-894]	Agricultural Research Council; Onderstepoort Veterinary Institute of South Africa; United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Red meat Research and Development trust of SA; MSD Animal Health(Merck & CompanyIntervet International B.V.); 	Research findings documented in this manuscript are in part the result of a cooperative research and development agreement between the Agricultural Research Council, Onderstepoort Veterinary Institute of South Africa and the United States Department of Agriculture, Agricultural Research Service, entitled, "Genetic engineering of antigenically stable strains of foot-and-mouth disease virus for vaccine production'', agreement number 58-3K95-M-894. Additional financial support was received from the Red meat Research and Development trust of SA and MSD Animal Health (previously Intervet/Schering Plough), The Netherlands. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The funders were consulted in regards to the publication of the results and approved the manuscript for publication.	ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0; AMADORI M, 1994, VACCINE, V12, P159, DOI 10.1016/0264-410X(94)90055-8; BACHRACH HL, 1968, ANNU REV MICROBIOL, V22, P201, DOI 10.1146/annurev.mi.22.100168.001221; Barnett PV, 2002, VACCINE, V20, P1505, DOI 10.1016/S0264-410X(01)00503-5; Bastos ADS, 2003, J GEN VIROL, V84, P1595, DOI 10.1099/vir.0.18859-0; Bastos ADS, 2001, ARCH VIROL, V146, P1537, DOI 10.1007/s007050170077; Boettiger D, 2001, J BIOL CHEM, V276, P31684, DOI 10.1074/jbc.M103997200; BROWN F, 1963, NATURE, V199, P1168, DOI 10.1038/1991168a0; Burman A, 2006, J VIROL, V80, P9798, DOI 10.1128/JVI.00577-06; BURROUGHS JN, 1971, J GEN VIROL, V13, P73, DOI 10.1099/0022-1317-13-1-73; CARRILLO EC, 1984, VIROLOGY, V135, P542, DOI 10.1016/0042-6822(84)90208-3; Curry S, 1996, STRUCTURE, V4, P135, DOI 10.1016/S0969-2126(96)00017-2; Curry S, 1997, J VIROL, V71, P9743, DOI 10.1128/JVI.71.12.9743-9752.1997; CURRY S, 1995, J VIROL, V69, P430, DOI 10.1128/JVI.69.1.430-438.1995; DOEL TR, 1985, J BIOL STAND, V13, P335, DOI 10.1016/S0092-1157(85)80048-2; DOEL TR, 1981, ARCH VIROL, V70, P21, DOI 10.1007/BF01320790; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Domingo E, 2002, COMP IMMUNOL MICROB, V25, P297, DOI 10.1016/S0147-9571(02)00027-9; Duque H, 2004, J VIROL, V78, P9773, DOI 10.1128/JVI.78.18.9773-9781.2004; Duque H, 2003, J VIROL, V77, P2500, DOI 10.1128/JVI.77.4.2500-2511.2003; Ellard FM, 1999, J GEN VIROL, V80, P1911, DOI 10.1099/0022-1317-80-8-1911; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Jackson T, 2004, J VIROL, V78, P4533, DOI 10.1128/JVI.78.9.4533-4540.2004; Jackson T, 2002, J VIROL, V76, P935, DOI 10.1128/JVI.76.3.935-941.2002; Knipe T, 1997, J VIROL, V71, P2851, DOI 10.1128/JVI.71.4.2851-2856.1997; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; LEA S, 1994, STRUCTURE, V2, P123, DOI 10.1016/S0969-2126(00)00014-9; LEA S, 1995, STRUCTURE, V3, P571, DOI 10.1016/S0969-2126(01)00191-5; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; LILJAS L, 1986, PROG BIOPHYS MOL BIO, V48, P1, DOI 10.1016/0079-6107(86)90008-8; LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0; Maree FF, 2010, VIRUS RES, V153, P82, DOI 10.1016/j.virusres.2010.07.010; Mateo R, 2003, J BIOL CHEM, V278, P41019, DOI 10.1074/jbc.M304990200; Mateo R, 2007, J GEN VIROL, V88, P859, DOI 10.1099/vir.0.82521-0; Mateo R, 2007, J VIROL, V81, P1879, DOI 10.1128/JVI.01899-06; Mateo R, 2008, J VIROL, V82, P12232, DOI 10.1128/JVI.01553-08; MATEU MG, 1995, VIRUS RES, V38, P1, DOI 10.1016/0168-1702(95)00048-U; Mateu MG, 1996, J BIOL CHEM, V271, P12814, DOI 10.1074/jbc.271.22.12814; Neff S, 2000, J VIROL, V74, P7298, DOI 10.1128/JVI.74.16.7298-7306.2000; *OFF INT EP, 2009, MAN DIAGN TESTS VACC; PAY TWF, 1978, 15 C OFF INT DES EP, P1; PEREIRA HG, 1978, BR VET J, V35, P167; PRESTON KJ, 1982, J BIOL STAND, V10, P35, DOI 10.1016/S0092-1157(82)80046-2; R Core Team, 2020, R LANG ENV STAT COMP; Reguera J, 2005, J BIOL CHEM, V280, P17969, DOI 10.1074/jbc.M500867200; Reguera J, 2004, P NATL ACAD SCI USA, V101, P2724, DOI 10.1073/pnas.0307748101; RIEDER E, 1993, J VIROL, V67, P5139, DOI 10.1128/JVI.67.9.5139-5145.1993; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; ROSSMANN MG, 1997, STRUCTURAL BIOL VIRU, P105; RWEYEMAMU MM, 1984, J BIOL STAND, V12, P295, DOI 10.1016/S0092-1157(84)80009-8; Samuel AR, 2001, TRENDS GENET, V17, P421, DOI 10.1016/S0168-9525(01)02374-5; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TWOMEY T, 1995, VIROLOGY, V206, P69, DOI 10.1016/S0042-6822(95)80020-4; van Rensburg HG, 2004, J GEN VIROL, V85, P61, DOI 10.1099/vir.0.19509-0; Van Rensburg HG, 1999, VIRUS GENES, V19, P229, DOI 10.1023/A:1008140815045; van Vlijmen HWT, 1998, J MOL BIOL, V275, P295, DOI 10.1006/jmbi.1997.1418; VOSLOO W, 1995, EPIDEMIOL INFECT, V114, P203, DOI 10.1017/S0950268800052055	58	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e61612	10.1371/journal.pone.0061612	http://dx.doi.org/10.1371/journal.pone.0061612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717387	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700002
J	Tamminga, SJ; Verbeek, JHAM; Bos, MMEM; Fons, G; Kitzen, JJEM; Plaisier, PW; Frings-Dresen, MHW; de Boer, AGEM				Tamminga, Sietske J.; Verbeek, Jos H. A. M.; Bos, Monique M. E. M.; Fons, Guus; Kitzen, Jos J. E. M.; Plaisier, Peter W.; Frings-Dresen, Monique H. W.; de Boer, Angela G. E. M.			Effectiveness of a Hospital-Based Work Support Intervention for Female Cancer Patients - A Multi-Centre Randomised Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; RETURN-TO-WORK; BREAST-CANCER; SURVIVORS; FATIGUE; ABILITY; ABSENCE	Objective: One key aspect of cancer survivorship is return-to-work. Unfortunately, many cancer survivors face problems upon their return-to-work. For that reason, we developed a hospital-based work support intervention aimed at enhancing return-to-work. We studied effectiveness of the intervention compared to usual care for female cancer patients in a multi-centre randomised controlled trial. Methods: Breast and gynaecological cancer patients who were treated with curative intent and had paid work were randomised to the intervention group (n = 65) or control group (n = 68). The intervention involved patient education and support at the hospital and improvement of communication between treating and occupational physicians. In addition, we asked patient's occupational physician to organise a meeting with the patient and the supervisor to make a concrete gradual return-to-work plan. Outcomes at 12 months of follow-up included rate and time until return-to-work (full or partial), quality of life, work ability, work functioning, and lost productivity costs. Time until return-to-work was analyzed with Kaplan-Meier survival analysis. Results: Return-to-work rates were 86% and 83% (p = 0.6) for the intervention group and control group when excluding 8 patients who died or with a life expectancy of months at follow-up. Median time from initial sick leave to partial return-to-work was 194 days (range 14-435) versus 192 days (range 82-465) (p = 0.90) with a hazard ratio of 1.03 (95% CI 0.64-1.6). Quality of life and work ability improved statistically over time but did not differ statistically between groups. Work functioning and costs did not differ statistically between groups. Conclusion: The intervention was easily implemented into usual psycho-oncological care and showed high return-to-work rates. We failed to show any differences between groups on return-to-work outcomes and quality of life scores. Further research is needed to study which aspects of the intervention are useful and which elements need improvement.	[Tamminga, Sietske J.; Verbeek, Jos H. A. M.; Frings-Dresen, Monique H. W.; de Boer, Angela G. E. M.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, NL-1105 AZ Amsterdam, Netherlands; [Verbeek, Jos H. A. M.] Finnish Inst Occupat Hlth, Kuopio, Finland; [Bos, Monique M. E. M.] Reinier de Graaf Groep, Dept Internal Med, Delft, Netherlands; [Fons, Guus] Univ Amsterdam, Acad Med Ctr, Dept Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [Kitzen, Jos J. E. M.] Albert Schweitzer Hosp, Dept Internal Med, Dordrecht, Netherlands; [Plaisier, Peter W.] Albert Schweitzer Hosp, Dept Surg, Dordrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Finnish Institute of Occupational Health; Reinier de Graaf Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Albert Schweitzer Ziekenhuis; Albert Schweitzer Ziekenhuis	Tamminga, SJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	S.J.Tamminga@amc.uva.nl	Verbeek, Jos H.A.M./F-8382-2013	Verbeek, Jos H.A.M./0000-0002-6537-6100; de Boer, Angela/0000-0003-1942-6848; Tamminga, Sietske/0000-0002-2228-1187	Stichting Insituut Gak	Stichting Insituut Gak	The study was granted by the Stichting Insituut Gak and is part of the research program "Pathways to work'' (www.verbeteronderzoek.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Anema JR, 2009, J OCCUP REHABIL, V19, P419, DOI 10.1007/s10926-009-9202-3; Bennett JA, 2009, SUPPORT CARE CANCER, V17, P1057, DOI 10.1007/s00520-008-0540-z; BOSSCHER RJ, 1997, NEDERLANDS TIJDSCHRI, V0052; Bouwmans C, 2010, MANUAL COST STUDIES; de Boer AGEM, 2008, BRIT J CANCER, V98, P1342, DOI 10.1038/sj.bjc.6604302; de Boer AGEM, 2009, JAMA-J AM MED ASSOC, V301, P753, DOI 10.1001/jama.2009.187; Drolet M, 2005, CAN MED ASSOC J, V173, P765, DOI 10.1503/cmaj.050178; Dupont W. D., 2009, PS POWER SAMPLE SIZE; Feuerstein M, 2011, COCHRANE DATABASE SY, V2; Feuerstein M, 2007, J OCCUP ENVIRON MED, V49, P803, DOI 10.1097/JOM.0b013e318095a458; Fleer J, 2006, SUPPORT CARE CANCER, V14, P251, DOI 10.1007/s00520-005-0879-3; Hansen JA, 2008, J OCCUP ENVIRON MED, V50, P777, DOI 10.1097/JOM.0b013e318165159e; ILMARINEN J, 1992, SCAND J WORK ENV HEA, V18, P8; Koopmans PC, 2008, OCCUP ENVIRON MED, V65, P494, DOI 10.1136/oem.2007.034322; Lerner D, 2001, MED CARE, V39, P72, DOI 10.1097/00005650-200101000-00009; Maunsell E, 1999, PSYCHO-ONCOLOGY, V8, P467, DOI 10.1002/(SICI)1099-1611(199911/12)8:6<467::AID-PON400>3.3.CO;2-G; Mols F, 2005, EUR J CANCER, V41, P2613, DOI 10.1016/j.ejca.2005.05.017; Mols F, 2009, PSYCHO-ONCOLOGY, V18, P1252, DOI 10.1002/pon.1522; Nieuwenhuijsen K, 2006, J OCCUP REHABIL, V16, P647, DOI 10.1007/s10926-006-9057-9; Oeffinger KC, 2006, J CLIN ONCOL, V24, P5117, DOI 10.1200/JCO.2006.07.0474; Peteet JR, 2000, GEN HOSP PSYCHIAT, V22, P200, DOI 10.1016/S0163-8343(00)00076-1; Petrie KJ, 1996, BRIT MED J, V312, P1191; Pryce J, 2007, J OCCUP REHABIL, V17, P83, DOI 10.1007/s10926-006-9040-5; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Schellings R, 2009, J CLIN EPIDEMIOL, V62, P393, DOI 10.1016/j.jclinepi.2008.07.010; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Spelten ER, 2003, EUR J CANCER, V39, P1562, DOI 10.1016/S0959-8049(03)00364-2; Spelten ER, 2002, PSYCHO-ONCOL, V11, P124, DOI 10.1002/pon.585; Tamminga SJ, 2012, J OCCUP REHABIL, V22, P565, DOI 10.1007/s10926-012-9372-2; Tamminga SJ, 2010, OCCUP ENVIRON MED, V67, P639, DOI 10.1136/oem.2009.050070; Tamminga SJ, 2012, SCAND J WORK ENV HEA, V38, P144, DOI 10.5271/sjweh.3199; Tamminga SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-345; Taskila T, 2006, SUPPORT CARE CANCER, V14, P427, DOI 10.1007/s00520-005-0005-6; van Veldhoven M, 2002, MANUAL QEUSTIONNAIRE; Verbeek J., 2007, HDB CANC SURVIVORSHI, P381, DOI DOI 10.1007/978-0-387-34562-8_21	39	50	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63271	10.1371/journal.pone.0063271	http://dx.doi.org/10.1371/journal.pone.0063271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UP	23717406	gold, Green Submitted, Green Published			2022-12-27	WOS:000320362700013
J	Yoseph, BP; Breed, E; Overgaard, CE; Ward, CJ; Liang, Z; Wagener, ME; Lexcen, DR; Lusczek, ER; Beilman, GJ; Burd, EM; Farris, AB; Guidot, DM; Koval, M; Ford, ML; Coopersmith, CM				Yoseph, Benyam P.; Breed, Elise; Overgaard, Christian E.; Ward, Christina J.; Liang, Zhe; Wagener, Maylene E.; Lexcen, Daniel R.; Lusczek, Elizabeth R.; Beilman, Greg J.; Burd, Eileen M.; Farris, Alton B.; Guidot, David M.; Koval, Michael; Ford, Mandy L.; Coopersmith, Craig M.			Chronic Alcohol Ingestion Increases Mortality and Organ Injury in a Murine Model of Septic Peritonitis	PLOS ONE			English	Article							ACUTE LUNG INJURY; CHRONIC ETHANOL INGESTION; INCREASED INTESTINAL PERMEABILITY; PSEUDOMONAS-AERUGINOSA PNEUMONIA; RESPIRATORY-DISTRESS-SYNDROME; EPITHELIAL APOPTOSIS; BARRIER DYSFUNCTION; CRITICALLY-ILL; CECAL LIGATION; INTENSIVE-CARE	Background: Patients admitted to the intensive care unit with alcohol use disorders have increased morbidity and mortality. The purpose of this study was to determine how chronic alcohol ingestion alters the host response to sepsis in mice. Methods: Mice were randomized to receive either alcohol or water for 12 weeks and then subjected to cecal ligation and puncture. Mice were sacrificed 24 hours post-operatively or followed seven days for survival. Results: Septic alcohol-fed mice had a significantly higher mortality than septic water-fed mice (74% vs. 41%, p = 0.01). This was associated with worsened gut integrity in alcohol-fed mice with elevated intestinal epithelial apoptosis, decreased crypt proliferation and shortened villus length. Further, alcohol-fed mice had higher intestinal permeability with decreased ZO-1 and occludin protein expression in the intestinal tight junction. The frequency of splenic and bone marrow CD4+ T cells was similar between groups; however, splenic CD4+ T cells in septic alcohol-fed mice had a marked increase in both TNF and IFN-gamma production following ex vivo stimulation. Neither the frequency nor function of CD8+ T cells differed between alcohol-fed and water-fed septic mice. NK cells were decreased in both the spleen and bone marrow of alcohol-fed septic mice. Pulmonary myeloperoxidase levels and BAL levels of G-CSF and TFG-beta were higher in alcohol-fed mice. Pancreatic metabolomics demonstrated increased acetate, adenosine, xanthine, acetoacetate, 3-hydroxybutyrate and betaine in alcohol-fed mice and decreased cytidine, uracil, fumarate, creatine phosphate, creatine, and choline. Serum and peritoneal cytokines were generally similar between alcohol-fed and water-fed mice, and there were no differences in bacteremia, lung wet to dry weight, or pulmonary, liver or splenic histology. Conclusions: When subjected to the same septic insult, mice with chronic alcohol ingestion have increased mortality. Alterations in intestinal integrity, the host immune response, and pancreatic metabolomics may help explain this differential response.	[Yoseph, Benyam P.; Breed, Elise; Liang, Zhe; Coopersmith, Craig M.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Yoseph, Benyam P.; Breed, Elise; Liang, Zhe; Coopersmith, Craig M.] Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA 30322 USA; [Overgaard, Christian E.; Ward, Christina J.; Guidot, David M.; Koval, Michael] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [Overgaard, Christian E.; Ward, Christina J.; Guidot, David M.; Koval, Michael] Emory Univ, Sch Med, Emory Alcohol & Lung Biol Ctr, Atlanta, GA 30322 USA; [Wagener, Maylene E.; Ford, Mandy L.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Wagener, Maylene E.; Ford, Mandy L.] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Lexcen, Daniel R.; Lusczek, Elizabeth R.; Beilman, Greg J.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Burd, Eileen M.; Farris, Alton B.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; University of Minnesota System; University of Minnesota Twin Cities; Emory University	Coopersmith, CM (corresponding author), Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA.	cmcoop3@emory.edu	Koval, Michael/C-6366-2015; Farris, Alton Brad/S-6041-2017; Breed, Elise/G-2547-2017	Koval, Michael/0000-0002-5422-5614; Farris, Alton Brad/0000-0001-5534-7763; Breed, Elise/0000-0001-6468-8463; Lusczek, Elizabeth/0000-0003-4680-965X; Beilman, Gregory/0000-0001-5036-3027	United States National Institutes of Health [T32GM095442, R01GM072808, P50AA013757, R01AI073707, R01AA017627, R01HL083120, T32AA013528]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM095442, R01GM072808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013528, R01AA017627, P50AA013757] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the United States National Institutes of Health: T32GM095442, R01GM072808, P50AA013757, R01AI073707, R01AA017627, R01HL083120, T32AA013528. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amin PB, 2009, J SURG RES, V157, P187, DOI 10.1016/j.jss.2008.10.028; [Anonymous], 2013, WHO MAN SUBST AB FAC; Asai K, 2003, SCAND J GASTROENTERO, V38, P1154, DOI 10.1080/00365520310006252; BAKER CC, 1983, SURGERY, V94, P331; Ballas ZK, 2012, ALCOHOL CLIN EXP RES, V36, P826, DOI 10.1111/j.1530-0277.2011.01678.x; Barros FR, 2012, ALCOHOL ALCOHOLISM, V47, P677, DOI 10.1093/alcalc/ags081; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Best AM, 2007, BMC ANESTHESIOL, V7, P3, DOI [10.1186/1471-2253-7-3, DOI 10.1186/1471-2253-7-3]; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Bromberg Z, 2008, CRIT CARE MED, V36, P246, DOI 10.1097/01.CCM.0000295473.56522.EF; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Choudhry Mashkoor A, 2008, J Emerg Trauma Shock, V1, P81, DOI 10.4103/0974-2700.43187; Clark JA, 2008, SHOCK, V30, P36, DOI 10.1097/SHK.0b013e31815D0820; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Clark JA, 2009, AM J PHYSIOL-GASTR L, V297, pG471, DOI 10.1152/ajpgi.00012.2009; Cook RT, 2007, ALCOHOL CLIN EXP RES, V31, P1746, DOI 10.1111/j.1530-0277.2007.00478.x; Coopersmith CM, 2003, CRIT CARE MED, V31, P1630, DOI 10.1097/01.CCM.0000055385.29232.11; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; de RA, 2006, CHEST, V129, P1219, DOI [10.1378/chest.129.5.1219, DOI 10.1378/CHEST.129.5.1219]; de Wit M, 2010, CHEST, V138, P994, DOI 10.1378/chest.09-1425; Delgado-Rodriguez M, 2003, BRIT J SURG, V90, P1287, DOI 10.1002/bjs.4186; Delgado-Rodriguez M, 2003, ADDICTION, V98, P611, DOI 10.1046/j.1360-0443.2003.00353.x; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Dominguez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049159; Dominguez JA, 2011, SHOCK, V36, P381, DOI 10.1097/SHK.0b013e31822793c4; Dominguez JA, 2010, CRIT CARE CLIN, V26, P549, DOI 10.1016/j.ccc.2010.04.005; DSouza NB, 1996, ALCOHOL CLIN EXP RES, V20, P156, DOI 10.1111/j.1530-0277.1996.tb01059.x; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; FERNANDEZSOLA J, 1995, ARCH INTERN MED, V155, P1649, DOI 10.1001/archinte.155.15.1649; Fink Mitchell P, 2003, Curr Opin Crit Care, V9, P143, DOI 10.1097/00075198-200304000-00011; Fink MP, 2005, CRIT CARE CLIN, V21, P177, DOI 10.1016/j.ccc.2005.01.005; Fox AC, 2012, SHOCK, V38, P508, DOI 10.1097/SHK.0b013e31826e47e8; Fox AC, 2010, CRIT CARE MED, V38, P886, DOI 10.1097/CCM.0b013e3181c8fdb1; Gatt M, 2007, ALIMENT PHARM THER, V25, P741, DOI 10.1111/j.1365-2036.2006.03174.x; Gerke P, 1997, ALCOHOL ALCOHOLISM, V32, P179; Gika HG, 2012, J CHROMATOGR A, V1259, P128, DOI 10.1016/j.chroma.2012.02.053; GOLDBLUM SE, 1985, J APPL PHYSIOL, V59, P1978, DOI 10.1152/jappl.1985.59.6.1978; Guidot DM, 2005, J INVEST MED, V53, P235, DOI 10.2310/6650.2005.53506; Guidot DM, 2000, AM J PHYSIOL-LUNG C, V279, pL127, DOI 10.1152/ajplung.2000.279.1.L127; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Herzig DS, 2012, AM J RESP CRIT CARE, V185, P291, DOI 10.1164/rccm.201108-1560OC; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Holguin F, 1998, J CLIN INVEST, V101, P761, DOI 10.1172/JCI1396; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Husain KD, 2005, CRIT CARE MED, V33, P2350, DOI 10.1097/01.CCM.0000182797.89252.A3; Iskander KN, 2013, CRIT CARE MED, V41, P159, DOI 10.1097/CCM.0b013e3182676322; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Izquierdo-Garcia JL, 2011, INTENS CARE MED, V37, P2023, DOI 10.1007/s00134-011-2359-1; Joshi PC, 2005, J IMMUNOL, V175, P6837, DOI 10.4049/jimmunol.175.10.6837; Joshi PC, 2006, AM J PHYSIOL-LUNG C, V291, pL1150, DOI 10.1152/ajplung.00150.2006; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Lau K, 2008, ALCOHOL ALCOHOLISM, V43, P34, DOI [10.1093/alcalc/afm154, 10.1093/alcalc/agm154]; Li XL, 2011, J BURN CARE RES, V32, P489, DOI 10.1097/BCR.0b013e3182223c9e; Lin ZY, 2009, NMR BIOMED, V22, P601, DOI 10.1002/nbm.1373; Mason CM, 2000, ALCOHOL CLIN EXP RES, V24, P553, DOI 10.1111/j.1530-0277.2000.tb02024.x; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Maxson PM, 1999, MAYO CLIN PROC, V74, P448; Molina PE, 2004, ALCOHOL, V33, P217, DOI 10.1016/j.alcohol.2004.07.002; Moss M, 2005, CLIN INFECT DIS, V41, pS490, DOI 10.1086/432003; Moss M, 2003, CRIT CARE MED, V31, P869, DOI 10.1097/01.CCM.0000055389.64497.11; Moss M, 2000, AM J RESP CRIT CARE, V161, P414, DOI 10.1164/ajrccm.161.2.9905002; Moss M, 2006, LANCET, V368, P2231, DOI 10.1016/S0140-6736(06)69490-7; Pannequin J, 2007, MOL CANCER RES, V5, P1147, DOI 10.1158/1541-7786.MCR-07-0198; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Peres WAF, 2004, ALCOHOL, V33, P83, DOI 10.1016/j.alcohol.2004.05.001; Potoka DA, 2003, AM J PHYSIOL-GASTR L, V285, pG861, DOI 10.1152/ajpgi.00412.2002; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; R Core Team, 2012, R LANG ENV STAT COMP; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Santolaria F, 2011, EUR CYTOKINE NETW, V22, P1, DOI [10.1684/ecn.2011.0272, 10.1684/ecn.2011.0272_1]; Seitz HK, 1998, Z GASTROENTEROL, V36, P645; Smothers BA, 2004, ARCH INTERN MED, V164, P749, DOI 10.1001/archinte.164.7.749; Spies C, 2001, ALCOHOL CLIN EXP RES, V25, p164S, DOI 10.1111/j.1530-0277.2001.tb02392.x; Spies CD, 1996, ACTA ANAESTH SCAND, V40, P649, DOI 10.1111/j.1399-6576.1996.tb04505.x; Standiford TJ, 1997, ALCOHOL CLIN EXP RES, V21, P1212, DOI 10.1111/j.1530-0277.1997.tb04440.x; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Unsinger J, 2009, J LEUKOCYTE BIOL, V86, P219, DOI 10.1189/jlb.1008615; Unsinger J, 2009, J LEUKOCYTE BIOL, V85, P382, DOI 10.1189/jlb.0808491; Velasquez A, 2002, ALCOHOL CLIN EXP RES, V26, P1245, DOI 10.1097/01.ALC.0000024269.05402.97; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Wagner MC, 2012, ALCOHOL CLIN EXP RES, V36, P197, DOI 10.1111/j.1530-0277.2011.01599.x; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; WILMORE DW, 1988, SURGERY, V104, P917; Wu RQ, 2010, ALCOHOL CLIN EXP RES, V34, P1625, DOI 10.1111/j.1530-0277.2010.01248.x; Zhang H, 2009, ALCOHOL CLIN EXP RES, V33, P419, DOI 10.1111/j.1530-0277.2008.00852.x; Zhong W, 2010, AM J PHYSIOL-GASTR L, V299, pG643, DOI 10.1152/ajpgi.00515.2009; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, pG625, DOI 10.1152/ajpgi.00350.2009; Zivkovic AM, 2009, ALCOHOL CLIN EXP RES, V33, P751, DOI 10.1111/j.1530-0277.2008.00892.x	91	38	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e62792	10.1371/journal.pone.0062792	http://dx.doi.org/10.1371/journal.pone.0062792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717394	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700006
J	Ji, WT; Lee, CI; Chen, JYF; Cheng, YP; Yang, SR; Chen, JH; Chen, HR				Ji, Wen-Tsai; Lee, Cheng-I; Chen, Jeff Yi-Fu; Cheng, Ya-Ping; Yang, Sheng-Ru; Chen, Jung-Hua; Chen, Hau-Ren			Areca Nut Extract Induces Pyknotic Necrosis in Serum-Starved Oral Cells via Increasing Reactive Oxygen Species and Inhibiting GSK3 beta: An Implication for Cytopathic Effects in Betel Quid Chewers	PLOS ONE			English	Article							CANCER CELLS; CYCLE ARREST; AUTOPHAGY; CARCINOMA; APOPTOSIS; EXPRESSION; STRESS; TAIWAN; DEATH; DNA	Areca nut has been proven to be correlated with various pathologic alterations in oral cavity. However, the mechanisms for such cytopathic effects are still elusive due mostly to the limitations of cell culture systems. Here we discovered that areca nut extract (ANE) induced production of autophagosome vacuoles in cells cultured with rich medium but induced pyknosis and ballooning, two morphological alterations frequently observed in betel quid chewers, in cells under a serum-free culture condition. Permeability of the serum-starved cells to propidium iodide (PI) confirmed ANE induced novel necrosis with pyknosis (pyknotic necrosis), providing a possible explanation for inflammatory infiltration in chewers' mucosa. In these serum-starved cells, ANE strongly induced reactive oxygen species (ROS), which acted as a key switch for the initiation of pyknotic necrosis. Calcium flux was also involved in the morphological alterations. Besides, inhibition of GSK3 beta by SB216763 significantly exacerbated the pyknotic necrosis either induced by ANE or H2O2 in serum-starved cells, suggesting that GSK3 beta is a critical regulator for ANE/ROS-mediated pyknotic necrosis. Interestingly, LC3-II transition and PARP cleavage were still detected in the serum-starved cells after ANE treatment, suggesting concurrent activation of apoptotic and autophagic pathways. Finally, insulin could counteract the effect of ANE-induced pyknotic necrosis. Taken together, these data provide a platform for studying ANE-induced cytopathogenesis and the first clinical implication for several pathological alterations, such as ballooning and inflammatory infiltration, in betel quid chewers.	[Ji, Wen-Tsai; Lee, Cheng-I; Cheng, Ya-Ping; Yang, Sheng-Ru; Chen, Jung-Hua; Chen, Hau-Ren] Natl Chung Cheng Univ, Coll Sci, Inst Mol Biol, Dept Life Sci, Chiayi, Taiwan; [Ji, Wen-Tsai; Lee, Cheng-I; Cheng, Ya-Ping; Yang, Sheng-Ru; Chen, Jung-Hua; Chen, Hau-Ren] Natl Chung Cheng Univ, Coll Sci, Inst Biomed Sci, Chiayi, Taiwan; [Chen, Jeff Yi-Fu] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan	National Chung Cheng University; National Chung Cheng University; Kaohsiung Medical University	Chen, HR (corresponding author), Natl Chung Cheng Univ, Coll Sci, Inst Mol Biol, Dept Life Sci, Chiayi, Taiwan.	biohrc@ccu.edu.tw			National Science Council [97-2311-B-194-001-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was partially supported by National Science Council (97-2311-B-194-001-MY3). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang MC, 2001, CARCINOGENESIS, V22, P1527, DOI 10.1093/carcin/22.9.1527; Chen JYF, 2008, NEOPLASIA, V10, P1393, DOI 10.1593/neo.08854; Chen SH, 2011, HEALTH POLICY PLANN, V26, P266, DOI 10.1093/heapol/czq041; Cheng HL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-126; Cheng YP, 2012, J BIOMEDICAL SCI, P19; Chiu CT, 2008, J DENT SCI, V3, P75; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fimia GM, 1996, J BIOL CHEM, V271, P15575, DOI 10.1074/jbc.271.26.15575; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Huang LW, 2012, TOXICOL APPL PHARM, V258, P199, DOI 10.1016/j.taap.2011.11.001; Huang TT, 2010, J FORMOS MED ASSOC, V109, P326, DOI 10.1016/S0929-6646(10)60060-5; Ji WT, 2012, CANCER SCI, V103, P1221, DOI 10.1111/j.1349-7006.2012.02294.x; Lin MH, 2010, ORAL ONCOL, V46, P822, DOI 10.1016/j.oraloncology.2010.08.002; Liu TY, 1996, MUTAT RES-GENET TOX, V367, P25, DOI 10.1016/S0165-1218(96)90018-X; Lu HH, 2010, AUTOPHAGY, V6, P725, DOI 10.4161/auto.6.6.12423; Lu SY, 2006, CARCINOGENESIS, V27, P1273, DOI 10.1093/carcin/bgi357; Reichart PA, 1998, J ORAL PATHOL MED, V27, P239, DOI 10.1111/j.1600-0714.1998.tb01949.x; Richard V, 2010, BBA-REV CANCER, V1806, P146, DOI 10.1016/j.bbcan.2010.06.004; Rusten TE, 2010, NAT CELL BIOL, V12, P207, DOI 10.1038/ncb0310-207; Soderlund G, 2004, NEOPLASMA, V51, P1; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Trivedy CR, 2002, ADDICT BIOL, V7, P115, DOI 10.1080/13556210120091482; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Wang CC, 2009, TOXICOL IN VITRO, V23, P1234, DOI 10.1016/j.tiv.2009.07.033; Yang J, 2010, J CELL SCI, V123, P861, DOI 10.1242/jcs.060475; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	26	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63295	10.1371/journal.pone.0063295	http://dx.doi.org/10.1371/journal.pone.0063295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704899	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200028
J	Reis, AL; McCauley, JW				Reis, Ana Luisa; McCauley, John W.			The Influenza Virus Protein PB1-F2 Interacts with IKK beta and Modulates NF-kappa B Signalling	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; MITOCHONDRIAL-MEMBRANE; I INTERFERON; A VIRUSES; PATHOGENESIS; BINDING; PHOSPHORYLATION; EXPRESSION; SUBUNIT; P65	PB1-F2, a protein encoded by a second open reading frame of the influenza virus RNA segment 2, has emerged as a modulator of lung inflammatory responses but the molecular mechanisms underlying this are only poorly understood. Here we show that PB1-F2 inhibits the activation of NF-kappa B dependent signalling pathways in luciferase reporter assays. PB1-F2 proteins from four different viruses interact with IKK beta in yeast two-hybrid assays and by co-immunoprecipitation. PB1-F2 expression did not inhibit IKK beta kinase activity or NF-kappa B translocation into the nucleus, but NF-kappa B binding to DNA was severely impaired in PB1-F2 transfected cells as assessed by Electrophoretic Mobility Shift Assay. Neither the N-terminal 57 amino acid truncated forms nor the C-terminus of PB1-F2 were able to inhibit NF-kB dependent signalling, indicating that the full length protein is necessary for the inhibition.	[Reis, Ana Luisa; McCauley, John W.] MRC Natl Inst Med Res, Div Virol, London, England	MRC National Institute for Medical Research	McCauley, JW (corresponding author), MRC Natl Inst Med Res, Div Virol, London, England.	john.mccauley@nimr.mrc.ac.uk	Reis, Ana/AFR-1263-2022	Reis, Ana/0000-0003-1332-7822	Medical Research Council [U117585868]; Medical Research Council [MC_U117585868] Funding Source: researchfish; MRC [MC_U117585868] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council through programme U117585868. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dudek SE, 2011, BIOL CHEM, V392, P1135, DOI [10.1515/BC-2011-174, 10.1515/BC.2011.174]; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Gao SJ, 2012, CELL MICROBIOL, V14, P1849, DOI 10.1111/cmi.12005; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Gloire G, 2007, J BIOL CHEM, V282, P21308, DOI 10.1074/jbc.M610728200; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Henkel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011112; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; May MJ, 2004, J BIOL CHEM, V279, P45528, DOI 10.1074/jbc.M408579200; Mazur I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/j.1462-5822.2008.01116.x; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Meunier I, 2012, J VIROL, V86, P4271, DOI 10.1128/JVI.07243-11; Mitzner D, 2009, CELL MICROBIOL, V11, P1502, DOI 10.1111/j.1462-5822.2009.01343.x; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schmolke M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002186; Schwabe RF, 2005, FASEB J, V19, P1758, DOI 10.1096/fj.05-3736fje; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Tauber S, 2012, J GEN VIROL, V93, P840, DOI 10.1099/vir.0.039966-0; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; Weeks-Gorospe JN, 2012, J VIROL, V86, P9035, DOI 10.1128/JVI.00369-12; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	54	27	29	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63852	10.1371/journal.pone.0063852	http://dx.doi.org/10.1371/journal.pone.0063852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704945	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200076
J	Reis, VM; Oliveira, LS; Passos, RMF; Viana, NB; Mermelstein, C; Sant'Anna, C; Pereira, RC; Paradas, WC; Thompson, FL; Amado, GM; Salgado, LT				Reis, Vanessa M.; Oliveira, Louisi S.; Passos, Raoni M. F.; Viana, Nathan B.; Mermelstein, Claudia; Sant'Anna, Celso; Pereira, Renato C.; Paradas, Wladimir C.; Thompson, Fabiano L.; Amado-Filho, Gilberto M.; Salgado, Leonardo T.			Traffic of Secondary Metabolites to Cell Surface in the Red Alga Laurencia dendroidea Depends on a Two-Step Transport by the Cytoskeleton	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; GRACILARIA-CHANGII GRACILARIALES; PHENOLIC-COMPOUNDS; VESICLE TRANSPORT; CHEMICAL ECOLOGY; RHODOPHYTA; ACTIN; LOCALIZATION; PHAEOPHYTA; CYTOPLASM	In Laurencia dendroidea, halogenated secondary metabolites are primarily located in the vacuole named the corps en cerise (CC). For chemical defence at the surface level, these metabolites are intracellularly mobilised through vesicle transport from the CC to the cell periphery for posterior exocytosis of these chemicals. The cell structures involved in this specific vesicle traffic as well as the cellular structures related to the positioning and anchoring of the CC within the cell are not well known. Here, we aimed to investigate the role of cytoskeletal elements in both processes. Cellular and molecular assays were conducted to i) determine the ultrastructural apparatus involved in the vesicle traffic, ii) localise cytoskeletal filaments, iii) evaluate the role of different cytoskeletal filaments in the vesicle transport, iv) identify the cytoskeletal filaments responsible for the positioning and anchoring of the CC, and v) identify the transcripts related to cytoskeletal activity and vesicle transport. Our results show that microfilaments are found within the connections linking the CC to the cell periphery, playing an essential role in the vesicle traffic at these connections, which means a first step of the secondary metabolites transport to the cell surface. After that, the microtubules work in the positioning of the vesicles along the cell periphery towards specific regions where exocytosis takes place, which corresponds to the second step of the secondary metabolites transport to the cell surface. In addition, microtubules are involved in anchoring and positioning the CC to the cell periphery. Transcriptomic analysis revealed the expression of genes coding for actin filaments, microtubules, motor proteins and cytoskeletal accessory proteins. Genes related to vesicle traffic, exocytosis and membrane recycling were also identified. Our findings show, for the first time, that actin microfilaments and microtubules play an underlying cellular role in the chemical defence of red algae.	[Reis, Vanessa M.; Passos, Raoni M. F.; Amado-Filho, Gilberto M.; Salgado, Leonardo T.] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Oliveira, Louisi S.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil; [Viana, Nathan B.] Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, RJ, Brazil; [Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil; [Sant'Anna, Celso] Inst Nacl Metrol Qualidade & Tecnol Inmetro, Programas Dipro, Duque De Caxias, RJ, Brazil; [Pereira, Renato C.; Paradas, Wladimir C.] Univ Fed Fluminense, Dept Biol Marinha, Niteroi, RJ, Brazil	Jardim Botanico do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal Fluminense	Salgado, LT (corresponding author), Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil.	lsalgado@jbrj.gov.br	Salgado, Leonardo T/F-1123-2013; Viana, Nathan/AAH-5868-2021; FILHO, GILBERTO M AMADO/I-1324-2012; Pereira, Renato Crespo/AAA-7832-2020; mermelstein, Claudia/C-1464-2010	Viana, Nathan/0000-0002-2528-0876; Thompson, Fabiano/0000-0002-7562-1683; mermelstein, Claudia/0000-0002-8897-8526	CNPq; FAPERJ; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support for Leonardo T. Salgado, G. M. Amado Filho, Fabiano L. Thompson and Renato C. Pereira was received from CNPq (www.cnpq.br) and FAPERJ (www.faperj.br). A scholarship was granted to Vanessa M. Reis from CAPES (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Ackland JC, 2007, J PHYCOL, V43, P129, DOI 10.1111/j.1529-8817.2006.00311.x; Amsler C.D., 2008, ALGAL CHEM ECOLOGY; Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Bayoudh S, 2001, J MICROSC-OXFORD, V203, P214, DOI 10.1046/j.1365-2818.2001.00843.x; Bianco EM, 2010, BRAZ J OCEANOGR, V58, P213, DOI 10.1590/S1679-87592010000300004; Blunt JW, 2012, NAT PROD REP, V29, P144, DOI 10.1039/c2np00090c; BRAWLEY SH, 1976, J CELL SCI, V20, P255; Cassano V, 2012, EUR J PHYCOL, V47, P67, DOI 10.1080/09670262.2011.647334; Collen PN, 2012, J APPL PHYCOL, V24, P641, DOI 10.1007/s10811-011-9681-4; Da Gama BAP, 2002, BIOFOULING, V18, P13, DOI 10.1080/08927010290017680; da Gama BAP, 2008, BOT MAR, V51, P191, DOI 10.1515/BOT.2008.027; Day B, 2011, ANNU REV PHYTOPATHOL, V49, P483, DOI 10.1146/annurev-phyto-072910-095426; Dittami SM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r66; Dworjanyn SA, 1999, MAR BIOL, V133, P727, DOI 10.1007/s002270050514; Erickson K.L., 1983, MARINE NATURAL PRODU, V5, P131; Falcao VDR, 2008, J APPL PHYCOL, V20, P9, DOI 10.1007/s10811-007-9174-7; Fan XL, 2007, J PHYCOL, V43, P1287, DOI 10.1111/j.1529-8817.2007.00415.x; GRABSKI S, 1994, J CELL BIOL, V126, P713, DOI 10.1083/jcb.126.3.713; Hawes C, 2010, CURR OPIN PLANT BIOL, V13, P731, DOI 10.1016/j.pbi.2010.10.004; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Ho CL, 2009, MAR BIOTECHNOL, V11, P513, DOI 10.1007/s10126-008-9166-x; Hou GC, 2004, PLANT J, V39, P113, DOI 10.1111/j.1365-313X.2004.02114.x; KAUR I, 1992, AQUAT BOT, V42, P375, DOI 10.1016/0304-3770(92)90056-O; Kim GH, 1999, J PHYCOL, V35, P806, DOI 10.1046/j.1529-8817.1999.3540806.x; Kostamo K, 2011, J EXP MAR BIOL ECOL, V404, P21, DOI 10.1016/j.jembe.2011.05.006; Lane AL, 2009, P NATL ACAD SCI USA, V106, P7314, DOI 10.1073/pnas.0812020106; Lee H, 2007, J MICROBIOL, V45, P541; Lewin J., 1966, PHYCOLOGIA, V6, P1, DOI [10.2216/i0031-8884-6-1-1.1, DOI 10.2216/I0031-8884-6-1-1.1]; Li L, 2008, J EXP BOT, V59, P3575, DOI 10.1093/jxb/ern207; Luder UH, 2004, PLANTA, V218, P928, DOI 10.1007/s00425-003-1176-3; Manning SR, 2010, MAR DRUGS, V8, P678, DOI 10.3390/md8030678; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nylund GM, 2007, MAR ECOL PROG SER, V329, P73, DOI 10.3354/meps329073; Paradas WC, 2010, BIOFOULING, V26, P277, DOI 10.1080/08927010903515122; Paul NA, 2006, J PHYCOL, V42, P637, DOI 10.1111/j.1529-8817.2006.00226.x; Paul VJ, 2011, MAR ECOL PROG SER, V426, P161, DOI 10.3354/meps09032; Paul VJ, 2011, NAT PROD REP, V28, P345, DOI 10.1039/c0np00040j; PELLEGRINI L, 1980, J CELL SCI, V41, P209; Pelletreau K. N., 2008, P121, DOI 10.1007/978-3-540-74181-7_6; Pereira R. C., 2008, P25, DOI 10.1007/978-3-540-74181-7_2; Pereira R. C., 2003, Braz. J. Biol., V63, P665, DOI 10.1590/S1519-69842003000400013; Petrasek J, 2009, CURR OPIN PLANT BIOL, V12, P728, DOI 10.1016/j.pbi.2009.09.010; Plastino EM, 1995, MANUAL METODOS FICOL, P430; Pontes B, 2011, BIOPHYS J, V101, P43, DOI 10.1016/j.bpj.2011.05.044; RAGAN MA, 1976, BOT MAR, V19, P145, DOI 10.1515/botm.1976.19.3.145; Russell Catherine A., 1996, Phycological Research, V44, P57, DOI 10.1111/j.1440-1835.1996.tb00038.x; Salgado LT, 2008, J STRUCT BIOL, V162, P345, DOI 10.1016/j.jsb.2008.01.015; Salgado LT, 2005, PROTOPLASMA, V225, P123, DOI 10.1007/s00709-004-0066-2; Schmidt SM, 2007, PHYSIOL MOL PLANT P, V71, P135, DOI 10.1016/j.pmpp.2008.01.001; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schoenwaelder MEA, 2000, PLANT BIOLOGY, V2, P24, DOI 10.1055/s-2000-9178; Schoenwaelder MEA, 1999, EUR J PHYCOL, V34, P223, DOI 10.1017/S0967026299002140; Steinberg PD, 2002, J PHYCOL, V38, P621, DOI 10.1046/j.1529-8817.2002.02042.x; Sudatti DB, 2008, J PHYCOL, V44, P584, DOI 10.1111/j.1529-8817.2008.00507.x; Teo SS, 2007, EUR J PHYCOL, V42, P41, DOI 10.1080/09670260601012461; von Stosch H., 1964, P INT SEAWEED S, V4, P142; Wilson SM, 2006, PHYCOL RES, V54, P15, DOI 10.1111/j.1440-1835.2006.00404.x; Wong PF, 2006, J PHYCOL, V42, P113, DOI 10.1111/j.1529-8817.2006.00182.x; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Yotsukura N, 2010, J APPL PHYCOL, V22, P443, DOI 10.1007/s10811-009-9477-y; YOUNG DN, 1980, J PHYCOL, V16, P182; Zarsky V, 2009, NEW PHYTOL, V183, P255, DOI 10.1111/j.1469-8137.2009.02880.x	64	12	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63929	10.1371/journal.pone.0063929	http://dx.doi.org/10.1371/journal.pone.0063929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704959	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200090
J	Zalesak, M; Francis, K; Gedeon, A; Gillis, J; Hvidsten, K; Kidder, P; Li, H; Martyn, D; Orne, L; Smith, A; Kwong, A				Zalesak, Martin; Francis, Kevin; Gedeon, Alex; Gillis, John; Hvidsten, Kyle; Kidder, Phyllis; Li, Hong; Martyn, Derek; Orne, Leslie; Smith, Amanda; Kwong, Ann			Current and Future Disease Progression of the Chronic HCV Population in the United States	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SUSTAINED VIROLOGICAL RESPONSE; ALL-CAUSE MORTALITY; COST-EFFECTIVENESS; LIVER-TRANSPLANTATION; INFECTED POPULATION; RISK; PREVALENCE; BURDEN; COHORT	Chronic hepatitis C virus (HCV) infection can lead to advanced liver disease (AdvLD), including cirrhosis, decompensated cirrhosis, and liver cancer. The aim of this study was to determine recent historical rates of HCV patient progression to AdvLD and to project AdvLD prevalence through 2015. We first determined total 2008 US chronic HCV prevalence from the National Health and Nutrition Evaluation Surveys. Next, we examined disease progression and associated non-pharmacological costs of diagnosed chronic HCV-infected patients between 2007-2009 in the IMS LifeLink and CMS Medicare claims databases. A projection model was developed to estimate AdvLD population growth through 2015 in patients diagnosed and undiagnosed as of 2008, using the 2007-2009 progression rates to generate a "worst case'' projection of the HCV-related AdvLD population (i.e., scenario where HCV treatment is the same in the forecasted period as it was before 2009). We found that the total diagnosed chronic HCV population grew from 983,000 to 1.19 million in 20072009, with patients born from 1945-1964 accounting for 75.0% of all patients, 83.7% of AdvLD patients, and 79.2% of costs in 2009, indicating that HCV is primarily a disease of the `` baby boomer'' population. Non-pharmacological costs grew from $7.22 billion to $8.63 billion, with the majority of growth derived from the 60,000 new patients that developed AdvLD in 2007-2009, 91.5% of whom were born between 1945 and 1964. The projection model estimated the total AdvLD population would grow from 195,000 in 2008 to 601,000 in 2015, with 73.5% of new AdvLD cases from patients undiagnosed as of 2008. AdvLD prevalence in patients diagnosed as of 2008 was projected to grow 6.5% annually to 303,000 patients in 2015. These findings suggest that strategies to diagnose and treat HCV-infected patients are urgently needed to increase the likelihood that progression is interrupted, particularly for patients born from 1945-1964.	[Zalesak, Martin; Francis, Kevin; Gedeon, Alex; Gillis, John; Li, Hong; Martyn, Derek; Orne, Leslie; Smith, Amanda] Trinity Partners LLC, Waltham, MA USA; [Hvidsten, Kyle; Kidder, Phyllis; Kwong, Ann] Vertex Pharmaceut Inc, Cambridge, MA USA	Vertex Pharmaceuticals	Zalesak, M (corresponding author), Trinity Partners LLC, Waltham, MA USA.	zalesakm@trinitypartners.com		Li, Hong/0000-0002-0458-0714	Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts	Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts(Vertex Pharmaceuticals)	This project was funded by Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts. While the study was funded by Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1997, HEPATOLOGY, V26, pS62, DOI 10.1002/hep.510260711; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bochud PY, 2009, J HEPATOL, V51, P655, DOI 10.1016/j.jhep.2009.05.016; CDC, 2012, MORBIDITY MORTALITY; CDC (Centers for Disease Control and Prevention), 2009, VIR HEP STAT SURV; Centers for Disease Control and Prevention, HEP C FAQS HLTH PROF; Centers for Medicare and Medicaid Services, 2012, NAT HLTH EXP DAT HIS; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Department of Health and Human Services, 2001, WHO IS EL MED; Deuffic-Burban S, 2007, J VIRAL HEPATITIS, V14, P107, DOI 10.1111/j.1365-2893.2006.00785.x; Dorfman JD, 2007, WORLD J GASTROENTERO, V13, P781, DOI 10.3748/wjg.v13.i5.781; Drumright LN, 2011, J HEPATOL, V55, P45, DOI 10.1016/j.jhep.2010.10.028; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jacobson IM, 2010, CLIN GASTROENTEROL H, V8, P924, DOI 10.1016/j.cgh.2010.06.032; Kershenobich D, 2011, LIVER INT, V31, P4, DOI 10.1111/j.1478-3231.2011.02535.x; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Kucirka LM, 2011, AM J TRANSPLANT, V11, P1188, DOI 10.1111/j.1600-6143.2011.03460.x; Lai JC, 2011, HEPATOLOGY, V54, P418, DOI 10.1002/hep.24390; Leigh JP, 2001, ARCH INTERN MED, V161, P2231, DOI 10.1001/archinte.161.18.2231; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Louie KS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-86; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Maharshak N, 2011, WORLD J GASTROENTERO, V17, P5007, DOI 10.3748/wjg.v17.i45.5007; McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510; McHutchison JG, 2005, AM J MANAG CARE, V11, pS286; McHutchison JG, 2007, AM J MANAG CARE, V13, pS327; Muehlberger N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-34; Nasta Paola, 2011, Acta Biomed, V82, P115; National Center for Health Statistics, 2018, NAT HLTH NUTR EX SUR; Neal KR, 2007, GUT, V56, P1098, DOI 10.1136/gut.2006.113217; Pradat P, 2007, LIVER INT, V27, P335, DOI 10.1111/j.1478-3231.2006.01430.x; Reiberger T, 2010, J VIRAL HEPATITIS, V17, P400, DOI 10.1111/j.1365-2893.2009.01197.x; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Shepherd J, 2005, INT J TECHNOL ASSESS, V21, P47, DOI 10.1017/S0266462305050063; Sullivan SD, 2004, AM J GASTROENTEROL, V99, P1490, DOI 10.1111/j.1572-0241.2004.30286.x; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Tomaszewski KJ, 2012, AM J PUBLIC HEALTH, DOI [10.2105/AJPH.2011.300488, DOI 10.2105/AJPH.2011.300488.ACCESSED]; U.S. Census Bureau, 2012, 2012 STAT ABSTR NAT; US Census Bureau, 2011, POP EST NAT INT EST; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; WILLIAMS I, 1999, AM J MED S, V107, P2, DOI DOI 10.1016/S0002-9343(99)00373-3; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562	50	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63959	10.1371/journal.pone.0063959	http://dx.doi.org/10.1371/journal.pone.0063959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704962	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200093
J	de Sousa, E; Walter, LT; Higa, GSV; Augusto, O; Casado, N; Kihara, AH				de Sousa, Erica; Walter, Lais Takata; Vilar Higa, Guilherme Shigueto; Augusto, Otavio; Casado, Nocera; Kihara, Alexandre Hiroaki			Developmental and Functional Expression of miRNA-Stability Related Genes in the Nervous System	PLOS ONE			English	Article							GAP-JUNCTIONS; RETINA; MICRORNAS; TURNOVER; CELLS; HISTOGENESIS; NETWORKS; MEMORY; RANGE; MOUSE	In the nervous system, control of gene expression by microRNAs (miRNAs) has been investigated in fundamental processes, such as development and adaptation to ambient demands. The action of these short nucleotide sequences on specific genes depends on intracellular concentration, which in turn reflects the balance of biosynthesis and degradation. Whereas mechanisms underlying miRNA biogenesis has been investigated in recent studies, little is known about miRNA-stability related proteins. We first detected two genes in the retina that have been associated to miRNA stability, XRN2 and PAPD4. These genes are highly expressed during retinal development, however with distinct subcellular localization. We investigated whether these proteins are regulated during specific phases of the cell cycle. Combined analyses of nuclei position in neuroblastic layer and labeling using anti-cyclin D1 revealed that both proteins do not accumulate in S or M phases of the cell cycle, being poorly expressed in progenitor cells. Indeed, XRN2 and PAPD4 were observed mainly after neuronal differentiation, since low expression was also observed in astrocytes, endothelial and microglial cells. XRN2 and PAPD4 are expressed in a wide variety of neurons, including horizontal, amacrine and ganglion cells. To evaluate the functional role of both genes, we carried out experiments addressed to the retinal adaptation in response to different ambient light conditions. PAPD4 is upregulated after 3 and 24 hours of dark-adaptation, revealing that accumulation of this protein is governed by ambient light levels. Indeed, the fast and functional regulation of PAPD4 was not related to changes in gene expression, disclosing that control of protein levels occurs by post-transcriptional mechanisms. Furthermore, we were able to quantify changes in PAPD4 in specific amacrine cells after dark -adaptation, suggesting for circuitry-related roles in visual perception. In summary, in this study we first described the ontogenesis and functional expression of these two miRNA-stability related proteins in the retina.	[de Sousa, Erica; Walter, Lais Takata; Vilar Higa, Guilherme Shigueto; Augusto, Otavio; Casado, Nocera; Kihara, Alexandre Hiroaki] Univ Fed ABC, Ctr Matemat Comp & Cogn, Nucl Cognicao & Sistemas Complexos, St Andre, SP, Brazil; [Vilar Higa, Guilherme Shigueto; Kihara, Alexandre Hiroaki] Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol & Biofis, BR-05508 Sao Paulo, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Kihara, AH (corresponding author), Univ Fed ABC, Ctr Matemat Comp & Cogn, Nucl Cognicao & Sistemas Complexos, St Andre, SP, Brazil.	alexandrekihara@gmail.com	Kihara, Alexandre H/C-2458-2012; KIHARA, ALEXANDRE HIROAKI/T-9590-2019; Augusto, Ohara/D-3839-2012; Higa, Guilherme S. V./G-4282-2016; de Sousa, Erica/HGD-9751-2022	Kihara, Alexandre H/0000-0002-4027-7261; KIHARA, ALEXANDRE HIROAKI/0000-0002-4027-7261; Augusto, Ohara/0000-0002-7220-4286; Higa, Guilherme S. V./0000-0001-7006-9263; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Universidade Federal do ABC (UFABC)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do ABC (UFABC)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Universidade Federal do ABC (UFABC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros Victor, 2004, Methods Mol Biol, V265, P131; Andersson T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013453; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Belmonte MA, 2006, INVEST OPHTH VIS SCI, V47, P1193, DOI 10.1167/iovs.05-0446; Bredy TW, 2011, NEUROBIOL LEARN MEM, V96, P89, DOI 10.1016/j.nlm.2011.04.004; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Endeman D, 2010, J PHYSIOL-LONDON, V588, P435, DOI 10.1113/jphysiol.2009.179036; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Goldie BJ, 2012, MOL NEUROBIOL, V45, P99, DOI 10.1007/s12035-011-8222-0; Haverkamp S, 2000, J COMP NEUROL, V424, P1; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kihara AH, 2008, DEV NEUROBIOL, V68, P1287, DOI 10.1002/dneu.20652; Kihara AH, 2008, NEUROSCIENCE, V151, P995, DOI 10.1016/j.neuroscience.2007.09.088; Kihara AH, 2009, J COMP NEUROL, V512, P651, DOI 10.1002/cne.21920; Kihara AH, 2006, NEUROSCI LETT, V393, P36, DOI 10.1016/j.neulet.2005.09.033; Kihara AH, 2005, J NEUROSCI METH, V148, P103, DOI 10.1016/j.jneumeth.2005.04.019; Kihara AH, 2010, INT J DEV NEUROSCI, V28, P39, DOI 10.1016/j.ijdevneu.2009.09.006; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Konopka W, 2011, NEUROSCIENTIST, V17, P468, DOI 10.1177/1073858411411721; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Li QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026000; Masland RH, 2012, VISUAL NEUROSCI, V29, P3, DOI 10.1017/S0952523811000344; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Paschon V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045449; Pearson RA, 2005, J NEUROSCI, V25, P10803, DOI 10.1523/JNEUROSCI.2312-05.2005; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; Publio R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006970; Ragan C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001090; Reiner O, 2012, J MOL NEUROSCI, V46, P516, DOI 10.1007/s12031-011-9633-0; Reuter T, 2011, VISION RES, V51, P2243, DOI 10.1016/j.visres.2011.08.021; Ruegger S, 2012, TRENDS BIOCHEM SCI, V37, P436, DOI 10.1016/j.tibs.2012.07.002; Santos-Bredariol AS, 2006, J COMP NEUROL, V494, P976, DOI 10.1002/cne.20861; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Vreugdenhil E, 2010, FRONT NEUROENDOCRIN, V31, P128, DOI 10.1016/j.yfrne.2009.08.001; Zhang C, 2003, J NEUROSCI RES, V73, P840, DOI 10.1002/jnr.10713; Zheng K, 2010, J NEUROSCI, V30, P8245, DOI 10.1523/JNEUROSCI.1169-10.2010	43	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e56908	10.1371/journal.pone.0056908	http://dx.doi.org/10.1371/journal.pone.0056908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700402	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400001
J	Losey, RJ; Garvie-Lok, S; Leonard, JA; Katzenberg, MA; Germonpre, M; Nomokonova, T; Sablin, MV; Goriunova, OI; Berdnikova, NE; Savel'ev, NA				Losey, Robert J.; Garvie-Lok, Sandra; Leonard, Jennifer A.; Katzenberg, M. Anne; Germonpre, Mietje; Nomokonova, Tatiana; Sablin, Mikhail V.; Goriunova, Olga I.; Berdnikova, Natalia E.; Savel'ev, Nikolai A.			Burying Dogs in Ancient Cis-Baikal, Siberia: Temporal Trends and Relationships with Human Diet and Subsistence Practices	PLOS ONE			English	Article							LAKE BAIKAL; MIDDLE HOLOCENE; MITOCHONDRIAL-DNA; BRONZE-AGE; WOLF; DOMESTICATION; REGION; RECONSTRUCTION; AFFINITIES; EVOLUTION	The first objective of this study is to examine temporal patterns in ancient dog burials in the Lake Baikal region of Eastern Siberia. The second objective is to determine if the practice of dog burial here can be correlated with patterns in human subsistence practices, in particular a reliance on terrestrial mammals. Direct radiocarbon dating of a suite of the region's dog remains indicates that these animals were given burial only during periods in which human burials were common. Dog burials of any kind were most common during the Early Neolithic (similar to 7-8000 B.P.), and rare during all other time periods. Further, only foraging groups seem to have buried canids in this region, as pastoralist habitation sites and cemeteries generally lack dog interments, with the exception of sacrificed animals. Stable carbon and nitrogen isotope data indicate that dogs were only buried where and when human diets were relatively rich in aquatic foods, which here most likely included river and lake fish and Baikal seal (Phoca sibirica). Generally, human and dog diets appear to have been similar across the study subregions, and this is important for interpreting their radiocarbon dates, and comparing them to those obtained on the region's human remains, both of which likely carry a freshwater old carbon bias. Slight offsets were observed in the isotope values of dogs and humans in our samples, particularly where both have diets rich in aquatic fauna. This may result from dietary differences between people and their dogs, perhaps due to consuming fish of different sizes, or even different tissues from the same aquatic fauna. This paper also provides a first glimpse of the DNA of ancient canids in Northeast Asia.	[Losey, Robert J.; Garvie-Lok, Sandra] Univ Alberta, Dept Anthropol, Edmonton, AB, Canada; [Leonard, Jennifer A.] CSIC, Estn Biol Donana, Conservat & Evolutionary Genet Grp, E-41080 Seville, Spain; [Katzenberg, M. Anne] Univ Calgary, Dept Archaeol, Calgary, AB, Canada; [Germonpre, Mietje] Inst Royal Sci Nat Belgique, Dept Palaeontol, B-1040 Brussels, Belgium; [Nomokonova, Tatiana] Univ British Columbia, Dept Anthropol, Vancouver, BC V5Z 1M9, Canada; [Sablin, Mikhail V.] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Goriunova, Olga I.; Berdnikova, Natalia E.; Savel'ev, Nikolai A.] Irkutsk State Univ, Dept Archaeol & Ethnog, Irkutsk 664003, Russia	University of Alberta; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Calgary; University of British Columbia; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Irkutsk State University	Losey, RJ (corresponding author), Univ Alberta, Dept Anthropol, Edmonton, AB, Canada.	robert.losey@ualberta.ca	Goriunova, Olga/L-1252-2017; Saveliev, Nicolai/ABB-3849-2021; Mikhail, Sablin/K-7835-2013; Natalia, Berdnikova/AAH-8926-2019; Germonpré, Mietje/O-5952-2014; Berdnikova, Natalya/O-2584-2014; , Anne/GZG-5313-2022; Leonard, Jennifer/A-7894-2010	Saveliev, Nicolai/0000-0003-4373-9473; Mikhail, Sablin/0000-0002-2773-7454; Germonpré, Mietje/0000-0001-8865-0937; Berdnikova, Natalya/0000-0001-6663-4397; Garvie-Lok, Sandra/0000-0003-3360-6044; Gorunova, Ol'ga/0000-0002-5159-0894; Leonard, Jennifer/0000-0003-0291-7819	Standard Research Grant through the Social Sciences and Humanities Research Council of Canada [410-2008-0402]; MCRI grant [412-2011-1001]; EFF-SAS grant from the Faculty of Arts, University of Alberta	Standard Research Grant through the Social Sciences and Humanities Research Council of Canada; MCRI grant; EFF-SAS grant from the Faculty of Arts, University of Alberta	Funding for the data newly reported here was provided by a Standard Research Grant through the Social Sciences and Humanities Research Council of Canada (410-2008-0402) and through a MCRI grant (412-2011-1001) from this same granting agency (http://www.sshrc-crsh.gc.ca). Additional funding for this work was provided by an EFF-SAS grant from the Faculty of Arts, University of Alberta (http://www.foa.ualberta.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; Bazaliiskiy VI, 2003, ANTIQUITY, V77, P20, DOI 10.1017/S0003598X00061317; Benecke N., 1994, ARCHAOZOOLOGISCHE ST, P451; Berdnikova NE, 2001, KAMENNYI VEK IUZHNOG, V2, P113; Boudadi-Magali M, 2010, THESIS U BORDEAUX 1; Boyko AR, 2009, P NATL ACAD SCI USA, V106, P13903, DOI 10.1073/pnas.0902129106; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Brown SK, 2013, J ARCHAEOL SCI, V40, P1279, DOI 10.1016/j.jas.2012.09.010; Castroviejo-Fisher S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-73; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DEGERBOL M, 1961, P PREHIST SOC, V27, P35, DOI 10.1017/S0079497X0001598X; Detry C, 2010, J ARCHAEOL SCI, V37, P2762, DOI 10.1016/j.jas.2010.06.011; Drummond A. J., 2011, GENEIOUS; Druzhkova AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057754; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Germonpre M, 2013, J ARCHAEOL SCI, V40, P786, DOI 10.1016/j.jas.2012.06.016; Germonpre M, 2012, J ARCHAEOL SCI, V39, P184, DOI 10.1016/j.jas.2011.09.022; Goriunova OI, 2004, DREVNIE POGREBENIIA, P86; Goriunova OI, 2007, SEVERNAIA EVRAZIIA A, V1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HARCOURT RA, 1974, J ARCHAEOL SCI, V1, P151, DOI 10.1016/0305-4403(74)90040-5; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; Ingold T., 2000, PERCEPTION ENV ESSAY, P465; Katzenberg MA, 2012, J ARCHAEOL SCI, V39, P2612, DOI 10.1016/j.jas.2011.08.010; Katzenberg MA, 2010, PREHISTORIC HUNTER-GATHERERS OF THE BAIKAL REGION, SIBERIA, P175; Katzenberg MA, 2009, J ARCHAEOL SCI, V36, P663, DOI 10.1016/j.jas.2008.10.012; Katzenberg MA, 1999, J ARCHAEOL SCI, V26, P651, DOI 10.1006/jasc.1998.0382; Kharinskii AV, 2001, PREDBAIKALE KON TYS, P199; Khozov MM, 1950, PRESNYE VODY VOSTOCH, P368; Klementev A.M., 2005, KHISHCHNIKI CARNIVOR, P26; Konopatskii AK, 1982, DREVNIE KULTURY BAIK, P175; Kozhova OM, 1998, LAKE BAIKAL EVOLUTIO, P418; Krizhevskaia LIA, 1978, DREVNIE KULTURY PRIA, P69; Kuhnle GGC, 2013, EUR J NUTR, V52, P389, DOI 10.1007/s00394-012-0328-2; Larichev V.E., 1958, SCI ARCH I ARCHAEOLO; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; LAWRENCE BARBARA, 1967, Z SAUGETIERKUNDE, V32, P44; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Losey RJ, 2013, RELATIONAL ARCHAEOLO; Losey RJ, 2008, J ARCHAEOL SCI, V35, P577, DOI 10.1016/j.jas.2007.05.005; Losey RJ, 2011, J ANTHROPOL ARCHAEOL, V30, P174, DOI 10.1016/j.jaa.2011.01.001; Meachen JA, 2012, P NATL ACAD SCI USA, V109, P4191, DOI 10.1073/pnas.1113788109; MEDVEDEV GI, 1969, ARCTIC ANTHROPOL, V6, P61; Mooder KP, 2006, AM J PHYS ANTHROPOL, V129, P349, DOI 10.1002/ajpa.20247; Mooder KP, 2005, J ARCHAEOL SCI, V32, P619, DOI 10.1016/j.jas.2004.12.002; Morey D, 2010, DOGS DOMESTICATION D, P356; MOREY DF, 1992, J ARCHAEOL SCI, V19, P181, DOI 10.1016/0305-4403(92)90049-9; Nomokonova T, 2011, ARCHAEOL ETHNOL ANTH, V39, P30, DOI 10.1016/j.aeae.2011.08.003; Nomokonova T, 2013, QUATERN INT, V290, P110, DOI 10.1016/j.quaint.2012.06.007; Nomokonova Tatiana, 2011, Asian Perspectives, V49, P157; Okladnikov AP, 1955, MAT ISSLEDOVANIIA AR, V43, P208; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Pavlutskaia VV, 1990, THESIS LGU LENINGRAD, P16; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Richards MP, 1999, J ARCHAEOL SCI, V26, P717, DOI 10.1006/jasc.1998.0387; Rick TC, 2011, J ARCHAEOL SCI, V38, P1385, DOI 10.1016/j.jas.2011.02.008; Savelev N.A., 2001, SOVREMENNYE PROBLEMY, P338; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; SHOLTODOUGLAS AD, 1991, MAR ECOL PROG SER, V78, P23, DOI 10.3354/meps078023; Tito RY, 2011, AM J PHYS ANTHROPOL, V145, P653, DOI 10.1002/ajpa.21526; Verginelli F, 2005, MOL BIOL EVOL, V22, P2541, DOI 10.1093/molbev/msi248; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Von den Driesch A, 1976, GUID MEASUREMENT ANI, P149; WEBER A, 1995, J WORLD PREHIST, V9, P99, DOI 10.1007/BF02221004; Weber AW, 2011, J ANTHROPOL ARCHAEOL, V30, P523, DOI 10.1016/j.jaa.2011.06.006; Weber AW, 2010, J ANTHROPOL ARCHAEOL, V29, P491, DOI 10.1016/j.jaa.2010.08.002; Weber AW, 2002, J ANTHROPOL ARCHAEOL, V21, P230, DOI 10.1006/jaar.2001.0395; Weber AW, 2010, PREHISTORIC HUNTER-GATHERERS OF THE BAIKAL REGION, SIBERIA, P1; [No title captured]; [No title captured]	73	40	41	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63740	10.1371/journal.pone.0063740	http://dx.doi.org/10.1371/journal.pone.0063740			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696851	Green Published, gold			2022-12-27	WOS:000319107900056
J	Hofhuis, A; Herremans, T; Notermans, DW; Sprong, H; Fonville, M; van der Giessen, JWB; van Pelt, W				Hofhuis, Agnetha; Herremans, Tineke; Notermans, Daan W.; Sprong, Hein; Fonville, Manoj; van der Giessen, Joke W. B.; van Pelt, Wilfrid			A Prospective Study among Patients Presenting at the General Practitioner with a Tick Bite or Erythema Migrans in the Netherlands	PLOS ONE			English	Article							BURGDORFERI SENSU-STRICTO; IXODES-RICINUS TICKS; BORRELIA-BURGDORFERI; LYME BORRELIOSIS; RISK; SERODIAGNOSIS; DISEASE; TRANSMISSION; INFECTION; RECOMBINANT	Background: We performed a nationwide prospective study on the transmission risk for Borrelia to humans, investigating symptoms and serology at enrolment and three months after tick bites, and after standard treatment for erythema migrans (EM). Aiming to quantify the infection risk at point of care by physicians, we explored risk factors such as tick testing for Borrelia and assessment of the duration of the tick's blood meal. Methods and Findings: Questionnaires, blood samples and ticks from patients who consulted one of 307 general practitioners for tick bites (n = 327) or EM (n = 283) in 2007 and 2008, were collected at enrolment and three months later at follow-up. Borrelia burgdorferi sensu lato DNA was detected in 29.3% of 314 ticks, using PCR/reverse line blot and real-time PCR on the OspA gene. Seroconversion in C6 ELISA, IgM or IgG immunoblots for Borrelia-specific antibodies was observed in 3.2% of tick bite cases. Fourteen tick bite cases had evidence of early Borrelia infection, of which EM developed among seven cases. The risk of developing EM after tick bites was 2.6% (95% CI: 1.1%-5.0%), and the risk of either EM or seroconversion was 5.1% (95% CI: 2.9%-8.2%). Participants with Borrelia-positive ticks had a significantly higher risk of either EM or seroconversion (odds ratio 4.8, 95% CI: 1.1-20.4), and of seroconversion alone (odds ratio 11.1, 95% CI: 1.1-108.9). A third (34%) of the cases enrolled with EM did not recall preceding tick bites. Three EM cases (1%) reported persisting symptoms, three months after standard antibiotic treatment for EM. Conclusions: One out of forty participants developed EM within three months after tick bites. The infection risk can be assessed by tick testing for Borrelia at point of care by physicians. However, further refining is needed considering sensitivity and specificity of tick tests, accuracy of tick attachment time and engorgement.	[Hofhuis, Agnetha; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Epidemiol & Surveillance Unit, NL-3720 BA Bilthoven, Netherlands; [Herremans, Tineke; Notermans, Daan W.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Lab Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands; [Sprong, Hein; Fonville, Manoj; van der Giessen, Joke W. B.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Lab Zoonoses & Environm Microbiol, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Hofhuis, A (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Epidemiol & Surveillance Unit, NL-3720 BA Bilthoven, Netherlands.	Agnetha.Hofhuis@rivm.nl		Sprong, Hein/0000-0002-0218-4320; Hofhuis, Agnetha/0000-0002-9579-2148	ministry of Health, Welfare and Sport of the Netherlands	ministry of Health, Welfare and Sport of the Netherlands	This study was financed by, and conducted on behalf of, the ministry of Health, Welfare and Sport of the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; Crippa M, 2002, VECTOR-BORNE ZOONOT, V2, P3, DOI 10.1089/153036602760260724; deMik EL, 1997, INT J EPIDEMIOL, V26, P451, DOI 10.1093/ije/26.2.451; des Vignes F, 2001, J INFECT DIS, V183, P773, DOI 10.1086/318818; Estrada-Pena A., 2004, TICKS DOMESTIC ANIMA; Feder HM, 2006, CLIN DERMATOL, V24, P509, DOI 10.1016/j.clindermatol.2006.07.012; Fryland L, 2011, INT J INFECT DIS, V15, pE174, DOI 10.1016/j.ijid.2010.10.006; Goettner G, 2005, J CLIN MICROBIOL, V43, P3602, DOI 10.1128/JCM.43.8.3602-3609.2005; Gooskens J, 2006, CLIN MICROBIOL INFEC, V12, P894, DOI 10.1111/j.1469-0691.2006.01509.x; Heikkila T, 2003, J INFECT DIS, V187, P1888, DOI 10.1086/375371; Hofhuis A, 2010, INFECTIEZIEKTEN B, V3, P84; Huegli D, 2011, TICKS TICK-BORNE DIS, V2, P129, DOI 10.1016/j.ttbdis.2011.05.002; Huppertz HI, 1999, EUR J CLIN MICROBIOL, V18, P697, DOI 10.1007/s100960050381; Jacobs J J W M, 2008, Ned Tijdschr Geneeskd, V152, P2022; Jahfari S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-74; Kahl O, 1998, ZBL BAKT-INT J MED M, V287, P41; Letrilliart L, 2005, EPIDEMIOL INFECT, V133, P935, DOI 10.1017/S0950268805004413; Liang FT, 1999, J CLIN MICROBIOL, V37, P3990, DOI 10.1128/JCM.37.12.3990-3996.1999; Mather TN, 1996, AM J EPIDEMIOL, V144, P1066, DOI 10.1093/oxfordjournals.aje.a008879; Mogilyansky E, 2004, CLIN DIAGN LAB IMMUN, V11, P924, DOI 10.1128/CDLI.11.5.924-929.2004; Nahimana I, 2004, EUR J CLIN MICROBIOL, V23, P603, DOI 10.1007/s10096-004-1162-0; Orloski KA, 1998, AM J EPIDEMIOL, V147, P391; Philipp MT, 2003, J CLIN MICROBIOL, V41, P4955, DOI 10.1128/JCM.41.11.4955-4960.2003; PIESMAN J, 1993, J INFECT DIS, V167, P1082, DOI 10.1093/infdis/167.5.1082; Robertson J, 2000, J CLIN MICROBIOL, V38, P2097; Smismans A, 2006, CLIN MICROBIOL INFEC, V12, P648, DOI 10.1111/j.1469-0691.2006.01448.x; Speelman P, 2004, Ned Tijdschr Geneeskd, V148, P659; Sprong H, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-41; Stafford KC, 1998, J CLIN MICROBIOL, V36, P1240, DOI 10.1128/JCM.36.5.1240-1244.1998; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Strle F, 2002, WIEN KLIN WOCHENSCHR, V114, P493; Strle F, 1996, CLIN INFECT DIS, V23, P61, DOI 10.1093/clinids/23.1.61; Strle F, 1999, ANN INTERN MED, V130, P32, DOI 10.7326/0003-4819-130-1-199901050-00006; Stupica D, 2011, VECTOR-BORNE ZOONOT, V11, P883, DOI 10.1089/vbz.2010.0018; Tijsse-Klasen E, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-42; Tjernberg I, 2007, EUR J CLIN MICROBIOL, V26, P37, DOI 10.1007/s10096-006-0239-3; Warshafsky S, 2010, J ANTIMICROB CHEMOTH, V65, P1137, DOI 10.1093/jac/dkq097; Wielinga PR, 2006, APPL ENVIRON MICROB, V72, P7594, DOI 10.1128/AEM.01851-06; Wielinga PR, 2009, VECTOR-BORNE ZOONOT, V9, P119, DOI 10.1089/vbz.2008.0047; Wilske B, 2007, FEMS IMMUNOL MED MIC, V49, P13, DOI 10.1111/j.1574-695X.2006.00139.x; [No title captured], DOI DOI 10.2807/ESW.11.25.02978-EN	41	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64361	10.1371/journal.pone.0064361	http://dx.doi.org/10.1371/journal.pone.0064361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696884	Green Submitted, Green Published, gold			2022-12-27	WOS:000319081900087
J	Cacao, EE; Nasrullah, A; Sherlock, T; Kemper, S; Kourentzi, K; Ruchhoeft, P; Stein, GE; Willson, RC				Cacao, Eliedonna E.; Nasrullah, Azeem; Sherlock, Tim; Kemper, Steven; Kourentzi, Katerina; Ruchhoeft, Paul; Stein, Gila E.; Willson, Richard C.			High-Resolution, High-Throughput, Positive-Tone Patterning of Poly(ethylene glycol) by Helium Beam Exposure through Stencil Masks	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; SELF-ASSEMBLED MONOLAYERS; CHEMICAL NANOLITHOGRAPHY; MOLECULAR-CONFORMATION; PROTEIN ADSORPTION; LABELED DNA; ELECTRON; GOLD; PEO; LITHOGRAPHY	In this work, a collimated helium beam was used to activate a thiol-poly(ethylene glycol) (SH-PEG) monolayer on gold to selectively capture proteins in the exposed regions. Protein patterns were formed at high throughput by exposing a stencil mask placed in proximity to the PEG-coated surface to a broad beam of helium particles, followed by incubation in a protein solution. Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopy (ATR-FTIR) spectra showed that SH-PEG molecules remain attached to gold after exposure to beam doses of 1.5-60 mu C/cm(2) and incubation in PBS buffer for one hour, as evidenced by the presence of characteristic ether and methoxy peaks at 1120 cm(-1) and 2870 cm(-1), respectively. X-ray Photoelectron Spectroscopy (XPS) spectra showed that increasing beam doses destroy ether (C-O) bonds in PEG molecules as evidenced by the decrease in carbon C1s peak at 286.6 eV and increased alkyl (C-C) signal at 284.6 eV. XPS spectra also demonstrated protein capture on beam-exposed PEG regions through the appearance of a nitrogen N1s peak at 400 eV and carbon C1s peak at 288 eV binding energies, while the unexposed PEG areas remained protein-free. The characteristic activities of avidin and horseradish peroxidase were preserved after attachment on beam-exposed regions. Protein patterns created using a 35 mu m mesh mask were visualized by localized formation of insoluble diformazan precipitates by alkaline phosphatase conversion of its substrate bromochloroindoyl phosphate-nitroblue tetrazolium (BCIP-NBT) and by avidin binding of biotinylated antibodies conjugated on 100 nm gold nanoparticles (AuNP). Patterns created using a mask with smaller 300 nm openings were detected by specific binding of 40 nm AuNP probes and by localized HRP-mediated deposition of silver nanoparticles. Corresponding BSA-passivated negative controls showed very few bound AuNP probes and little to no enzymatic formation of diformazan precipitates or silver nanoparticles.	[Cacao, Eliedonna E.; Kemper, Steven; Kourentzi, Katerina; Stein, Gila E.; Willson, Richard C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX USA; [Nasrullah, Azeem; Sherlock, Tim; Ruchhoeft, Paul] Univ Houston, Dept Elect & Comp Engn, Houston, TX 77204 USA; [Ruchhoeft, Paul] Univ Houston, Dept Biomed Engn, Houston, TX USA; [Willson, Richard C.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Willson, Richard C.] Methodist Hosp, Res Inst, Houston, TX 77030 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Ruchhoeft, P (corresponding author), Univ Houston, Dept Elect & Comp Engn, Houston, TX 77204 USA.	PRuchhoeft@uh.edu; willson@uh.edu	Stein, Gila E/P-1927-2016; Willson, richard/AAD-4832-2019	Stein, Gila E/0000-0002-3973-4496; 	National Institute of Allergy and Infectious Diseases/National Institutes of Health [U54 AI057156]; National Science Foundation [CMMI-0900743, CBET-1133965, CBET-0932971]; Alliance for Nanohealth Competitive Research Program [W81XWH-09-2-0139]; Welch Foundation [E-1264]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); Alliance for Nanohealth Competitive Research Program; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant No. U54 AI057156 from the National Institute of Allergy and Infectious Diseases/National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the RCE Programs Office, NIAID, or NIH. Support was also provided by the National Science Foundation, Grant No. CMMI-0900743, CBET-1133965 and CBET-0932971, the Alliance for Nanohealth Competitive Research Program, Grant No. W81XWH-09-2-0139, and the Welch Foundation, Grant No. E-1264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besseling NAM, 1997, LANGMUIR, V13, P2113, DOI 10.1021/la960672w; Braden BC, 1998, IMMUNOL REV, V163, P45, DOI 10.1111/j.1600-065X.1998.tb01187.x; Bretagnol F, 2007, SENSOR ACTUAT B-CHEM, V123, P283, DOI 10.1016/j.snb.2006.08.040; Castle JE, 2001, J VAC SCI TECHNOL A, V19, P1170, DOI 10.1116/1.1378074; Christman KL, 2006, SOFT MATTER, V2, P928, DOI 10.1039/b611000b; Christman KL, 2009, J AM CHEM SOC, V131, P521, DOI 10.1021/ja804767j; Coates J., 2006, ENCY ANAL CHEM APPL, DOI [10.1002/9780470027318.a5606, DOI 10.1002/9780470027318.A5606]; Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o; Feulner P, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.178302; Francis GD, 2009, DIAGN MOL PATHOL, V18, P88, DOI 10.1097/PDM.0b013e31816f6374; FRANKS J, 1974, VACUUM, V24, P489, DOI 10.1016/0042-207X(74)90015-3; Geyer W, 2001, J VAC SCI TECHNOL B, V19, P2732, DOI 10.1116/1.1421560; Golzhauser A, 2001, ADV MATER, V13, P806, DOI 10.1002/1521-4095(200106)13:11%3C803::AID-ADMA806%3E3.0.CO;2-W; GREEN NM, 1965, BIOCHEM J, V94, pC23, DOI 10.1042/bj0940023C; Hainfeld JF, 2010, METHOD DETECTING TAR; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; Harnett CK, 2000, APPL PHYS LETT, V76, P2466, DOI 10.1063/1.126378; Harnett CK, 2001, LANGMUIR, V17, P178, DOI 10.1021/la0009543; Hering KK, 2008, CHEMPHYSCHEM, V9, P867, DOI 10.1002/cphc.200700591; Heuberger M, 2004, LANGMUIR, V20, P9445, DOI 10.1021/la048384k; HOGG AM, 1983, INT J MASS SPECTROM, V49, P25, DOI 10.1016/0020-7381(83)85073-6; Hong Y, 2004, LANGMUIR, V20, P11123, DOI 10.1021/la048651m; Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601; Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0; Krsko P., 2005, NANOFABRICATION TECH, V6002, P600201; LEARY JJ, 1983, P NATL ACAD SCI-BIOL, V80, P4045, DOI 10.1073/pnas.80.13.4045; Lee SW, 2010, J NANOSCI NANOTECHNO, V10, P3246, DOI 10.1166/jnn.2010.2266; Lu HB, 2000, LANGMUIR, V16, P1711, DOI 10.1021/la990221m; Lyon LA, 1998, ANAL CHEM, V70, P5177, DOI 10.1021/ac9809940; Silvan MM, 2007, CHEM VAPOR DEPOS, V13, P211, DOI 10.1002/cvde.200606580; Manso-Silvan M, 2004, SURF INTERFACE ANAL, V36, P733, DOI 10.1002/sia.1750; Moller R, 2005, NANO LETT, V5, P1475, DOI 10.1021/nl050824k; Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869; Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415; Nam JM, 2007, NAT PROTOC, V2, P1438, DOI 10.1038/nprot.2007.201; Nasrullah A, 2009, J VAC SCI TECHNOL B, V27, P2674, DOI 10.1116/1.3265462; Reynolds RA, 2000, J AM CHEM SOC, V122, P3795, DOI 10.1021/ja000133k; Riemenschneider L, 2005, NANO LETT, V5, P1643, DOI 10.1021/nl0484550; Rundqvist J, 2006, LANGMUIR, V22, P5100, DOI 10.1021/la052306v; Smith KH, 2011, CHEM SOC REV, V40, P4563, DOI 10.1039/c1cs15064b; Sofia SJ, 1998, J BIOMED MATER RES, V40, P153, DOI 10.1002/(SICI)1097-4636(199804)40:1<153::AID-JBM18>3.0.CO;2-P; Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3; Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952; Yoshimoto K, 2009, LANGMUIR, V25, P12243, DOI 10.1021/la901143h; Yun YH, 2009, SENSORS-BASEL, V9, P9275, DOI 10.3390/s91109275; Zharnikov M, 2002, J VAC SCI TECHNOL B, V20, P1793, DOI 10.1116/1.1514665	46	5	5	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e56835	10.1371/journal.pone.0056835	http://dx.doi.org/10.1371/journal.pone.0056835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717382	Green Published, gold, Green Submitted			2022-12-27	WOS:000319385300044
J	Dzayee, DAM; Ivert, T; Beiki, O; Alfredsson, L; Ljung, R; Moradi, T				Dzayee, Dashti Ali M.; Ivert, Torbjorn; Beiki, Omid; Alfredsson, Lars; Ljung, Rickard; Moradi, Tahereh			Short and Long Term Mortality after Coronary Artery Bypass Grafting (CABG) Is Influenced by Socioeconomic Position but Not by Migration Status in Sweden, 1995-2007	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; RISK-FACTORS EXPLAIN; HEART-DISEASE; INTERVENTIONAL CARDIOLOGY; CARDIOVASCULAR-DISEASE; INDEPENDENT PREDICTOR; 15-YEAR SURVIVAL; UNITED-STATES; FEMALE SEX; SURGERY	Background: There are no nationwide studies on mortality after coronary artery bypass grafting (CABG) among foreign-born populations that include detailed information about country of birth and information about socioeconomic position. The objective was to investigate the risk of mortality after CABG considering socioeconomic position, sex and country of birth. Material and Methods: We included all 72 333 patients undergoing a first isolated CABG in Sweden, during 1995 - 2007 of whom 12.7% were foreign-born. The patients were classified according to educational level, sex, and country of birth and were followed up to December 2007. We estimated the risk of short and long term mortality after CABG in a multivariable model adjusted for age, calendar year of surgery, diabetes, educational level, and waiting time for surgery. Hazard ratios (HR) with 95% confidence intervals (CI) were calculated based on the Cox proportional hazard model. Findings: There were 15,284 deaths during the follow-up, 10.4% of whom were foreign-born. The foreign-born patients were 3 to 4 years younger than Sweden-born patients at the time of CABG surgery. There were no significant differences in overall early or late mortality between foreign-born and Sweden-born men and women after CABG. All-cause mortality differed in between regions and was highest in foreign-born men from Eastern Africa (HR 3.80, 95% CI 1.58-9.17), China (HR 3.61, 95% CI 1.50-8.69), and in Chile (HR 2.12, 95% CI 1.01-4.47). Patients with low level of education had worse survival compared to those with longer than 12 years of education irrespective of sex and country of birth. This difference was more pronounced among foreign-born women (HR 1.50, 95% CI 1.00-2.33). Conclusion: This national study showed higher CABG mortality in patients from lower socioeconomic position. Early and late mortality did not differ after isolated CABG in foreign-born and Sweden-born patients.	[Dzayee, Dashti Ali M.; Alfredsson, Lars; Moradi, Tahereh] Karolinska Inst, Inst Environm Med, Div Epidemiol, S-10401 Stockholm, Sweden; [Ivert, Torbjorn] Karolinska Univ Hosp & Mol Med & Surg, Karolinska Inst, Dept Cardiothorac Surg & Anesthesiol, Stockholm, Sweden; [Beiki, Omid] Kermanshah Univ Med Sci, Kermanshah, Iran; [Beiki, Omid] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden; [Alfredsson, Lars] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Ljung, Rickard] Karolinska Inst, Unit Upper Gastrointestinal Res, Dept Mol Med & Surg, Stockholm, Sweden; [Ljung, Rickard] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Moradi, Tahereh] Ctr Epidemiol & Social, Stockholm, Stockholm Count, Sweden	Karolinska Institutet; Karolinska Institutet; Kermanshah University of Medical Sciences; Karolinska Institutet; Stockholm County Council; Karolinska Institutet; Karolinska Institutet	Dzayee, DAM (corresponding author), Karolinska Inst, Inst Environm Med, Div Epidemiol, S-10401 Stockholm, Sweden.	Dashti.dzayee@ki.se	Ljung, Rickard/E-6752-2011; Beiki, Omid/R-9499-2017; Beiki, Omid/B-6111-2009; Alfredsson, Lars/AAC-9007-2019	Beiki, Omid/0000-0002-3632-2365; Alfredsson, Lars/0000-0003-1688-6697; Ljung, Rickard/0000-0002-0654-4530	Kurdistan Regional Government/Iraq; Nanakali Group and Institute of Environmental Medicine	Kurdistan Regional Government/Iraq; Nanakali Group and Institute of Environmental Medicine	Dashti Ali. M. Dzayee's doctoral studies are partially financed by a fellowship from the Kurdistan Regional Government/Iraq and the Nanakali Group and Institute of Environmental Medicine (URL: http://ki.se/ki/jsp/polopoly.jsp?d = 1666&l = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov D, 2000, ANN THORAC SURG, V70, P800, DOI 10.1016/S0003-4975(00)01563-0; Agabiti N, 2008, J EPIDEMIOL COMMUN H, V62, P882, DOI 10.1136/jech.2007.067470; Ahmed WA, 2011, ANN THORAC SURG, V92, P59, DOI 10.1016/j.athoracsur.2011.02.033; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Arnold M, 2011, MIGRATION SENSITIVE, P106; BARBIR M, 1994, BRIT HEART J, V71, P408; Blackledge HM, 2009, HEART, V95, P304, DOI 10.1136/hrt.2007.127928; Boscarino JA, 1999, MED CARE, V37, P210, DOI 10.1097/00005650-199902000-00011; BrandrupWognsen G, 1996, EUR HEART J, V17, P1426; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; DAVIES MJ, 1985, BRIT HEART J, V53, P363; DAVIS KB, 1995, J AM COLL CARDIOL, V25, P1000, DOI 10.1016/0735-1097(94)00518-U; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Feder G, 2002, BRIT MED J, V324, P511, DOI 10.1136/bmj.324.7336.511; Fox AA, 2004, J CARDIOTHOR VASC AN, V18, P344, DOI 10.1053/j.jvca.2004.03.018; Gadd M, 2005, EUR J CARDIOV PREV R, V12, P535, DOI 10.1097/00149831-200512000-00004; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Hallqvist J, 1998, INT J EPIDEMIOL, V27, P410, DOI 10.1093/ije/27.3.410; HAM C, 1994, BRIT MED J, V308, P219, DOI 10.1136/bmj.308.6923.219; Hammar N, 1997, J AM COLL CARDIOL, V29, P659, DOI 10.1016/S0735-1097(96)00531-1; Hartz RS, 2001, ANN THORAC SURG, V71, P512, DOI 10.1016/S0003-4975(00)02030-0; Hollander AC, 2012, INT J EPIDEMIOL, V41, P1153, DOI 10.1093/ije/dys072; Hollander AC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-180; Jacobs AK, 1998, CIRCULATION, V98, P1279, DOI 10.1161/01.CIR.98.13.1279; Johannesson I, 2002, TOTAL POPULATION REG; JOHNSON WD, 1989, ANN THORAC SURG, V48, P19, DOI 10.1016/0003-4975(89)90170-7; Kim C, 2007, AM HEART J, V154, P385, DOI 10.1016/j.ahj.2007.04.052; Konstantinov IE, 1997, ANN THORAC SURG, V64, P1522, DOI 10.1016/S0003-4975(97)00928-4; Kressin NR, 2001, ANN INTERN MED, V135, P352, DOI 10.7326/0003-4819-135-5-200109040-00012; LOOP FD, 1983, J AM COLL CARDIOL, V1, P383, DOI 10.1016/S0735-1097(83)80064-3; LUEPKER RV, 1993, CIRCULATION, V88, P2172, DOI 10.1161/01.CIR.88.5.2172; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Meyer BJ, 1996, EUR HEART J, V17, P1318; Muennig P, 2007, PREV MED, V45, P35, DOI 10.1016/j.ypmed.2007.04.005; Official Statistics of Sweden, 1975, CENS POP HOUS 197 13; Panagiotakos DB, 2005, EUR J CARDIOV PREV R, V12, P68, DOI 10.1097/00149831-200502000-00011; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Sheifer SE, 2000, AM HEART J, V139, P848, DOI 10.1016/S0002-8703(00)90017-6; Socialstyrelsen, 2009, CAUS DEATH 2009; SWEDEHEART, 2011, ANN REP SWEDEHEART 2; Tomson Ylva, 1994, Scandinavian Journal of Primary Health Care, V12, P147, DOI 10.3109/02813439409003691; Vaccarino V, 2003, J THORAC CARDIOV SUR, V126, P1707, DOI 10.1016/j.jtcvs.2003.10.007; VAGERO D, 1989, LANCET, V2, P35, DOI 10.1016/S0140-6736(89)90266-3; van Domburg RT, 2009, EUR HEART J, V30, P453, DOI 10.1093/eurheartj/ehn530; Vargas A, 2001, AM HEART J, V142, P1080, DOI 10.1067/mhj.2001.118114; Vartiainen E, 1998, J EPIDEMIOL COMMUN H, V52, P416, DOI 10.1136/jech.52.7.416; Windecker S, 1998, EUR HEART J, V19, P40, DOI 10.1053/euhj.1997.0798; Wong KKL, 2012, COMPUT MED IMAG GRAP, V36, P527, DOI 10.1016/j.compmedimag.2012.04.003; Wong KKL, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-7; Wong KKL, 2009, J MECH MED BIOL, V9, P1, DOI 10.1142/S0219519409002894; Woods SE, 2003, J AM COLL SURGEONS, V196, P428, DOI 10.1016/S1072-7515(02)01756-8; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	55	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63877	10.1371/journal.pone.0063877	http://dx.doi.org/10.1371/journal.pone.0063877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717501	gold, Green Submitted, Green Published			2022-12-27	WOS:000320362700073
J	Bolhuis, H; Fillinger, L; Stal, LJ				Bolhuis, Henk; Fillinger, Lucas; Stal, Lucas J.			Coastal Microbial Mat Diversity along a Natural Salinity Gradient	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; GEL-ELECTROPHORESIS; COMMUNITY STRUCTURE; NITROGEN-FIXATION; PHOTOSYNTHESIS; OXYGEN; GENES; MANIPULATION; MIGRATION; SEDIMENT	The North Sea coast of the Dutch barrier island of Schiermonnikoog is covered by microbial mats that initiate a succession of plant communities that eventually results in the development of a densely vegetated salt marsh. The North Sea beach has a natural elevation running from the low water mark to the dunes resulting in gradients of environmental factors perpendicular to the beach. These gradients are due to the input of seawater at the low water mark and of freshwater from upwelling groundwater at the dunes and rainfall. The result is a natural and dynamic salinity gradient depending on the tide, rainfall and wind. We studied the microbial community composition in thirty three samples taken every ten meters along this natural salinity gradient by using denaturing gradient gel electrophoresis (DGGE) of rRNA gene fragments. We looked at representatives from each Domain of life (Bacteria, Archaea and Eukarya) and with a particular emphasis on Cyanobacteria. Analysis of the DGGE fingerprints together with pigment composition revealed three distinct microbial mat communities, a marine community dominated by diatoms as primary producers, an intermediate brackish community dominated by Cyanobacteria as primary producers and a freshwater community with Cyanobacteria and freshwater green algae.	[Bolhuis, Henk; Fillinger, Lucas; Stal, Lucas J.] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Microbiol, Yerseke, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Bolhuis, H (corresponding author), Royal Netherlands Inst Sea Res NIOZ, Dept Marine Microbiol, Yerseke, Netherlands.	henk.bolhuis@nioz.nl	Bolhuis, Henk/M-6677-2019; Bolhuis, Henk/S-2986-2019; Bolhuis, Henk/H-8535-2014	Bolhuis, Henk/0000-0002-4772-1898; Bolhuis, Henk/0000-0002-4772-1898; Fillinger, Lucas/0000-0001-5341-8097				Abed RMM, 2007, ENVIRON MICROBIOL, V9, P1384, DOI 10.1111/j.1462-2920.2007.01254.x; Bebout BM, 2002, ASTROBIOLOGY, V2, P383, DOI 10.1089/153110702762470491; BIANCHI TS, 1988, J EXP MAR BIOL ECOL, V122, P243, DOI 10.1016/0022-0981(88)90126-8; Bidigare R.R., 2005, ALGAL CULTURING TECH, P327; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Bolhuis H, 2011, ISME J, V5, P1701, DOI [10.1038/Ismej.2011.52, 10.1038/ismej.2011.52]; Brons JK, 2008, APPL ENVIRON MICROB, V74, P2717, DOI 10.1128/AEM.02195-07; BYERLY GR, 1986, NATURE, V319, P489, DOI 10.1038/319489a0; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; Clements F.E., 1916, PLANT SUCCESSION ANA; Coelho H, 2011, EUR J PHYCOL, V46, P271, DOI 10.1080/09670262.2011.598242; Consalvey M, 2004, DIATOM RES, V19, P181; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; DEBOER PL, 1981, SEDIMENTOLOGY, V28, P129; Dechesne Arnaud, 2007, P87; DEWIT R, 1989, NETH J SEA RES, V23, P271, DOI 10.1016/0077-7579(89)90048-3; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Dijkman NA, 2010, J SEA RES, V63, P62, DOI 10.1016/j.seares.2009.10.002; Dillon JG, 2009, FEMS MICROBIOL ECOL, V68, P46, DOI 10.1111/j.1574-6941.2009.00647.x; Gleason HA, 1926, INDIVIDUALISTIC CONC; Green SJ, 2008, ISME J, V2, P457, DOI 10.1038/ismej.2008.6; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Janse I, 2004, J MICROBIOL METH, V57, P279, DOI 10.1016/j.mimet.2003.12.006; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN, P37; Jonkers HM, 1998, MICROBIAL ECOL, V36, P93, DOI 10.1007/s002489900096; JORGENSEN BB, 1986, APPL ENVIRON MICROB, V51, P408; Krekeler D, 1997, ARCH MICROBIOL, V167, P369, DOI 10.1007/s002030050457; Looijen Rick C., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P210, DOI 10.1078/1433-8319-00071; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Minz D, 1999, APPL ENVIRON MICROB, V65, P4659; MURRAY RE, 1986, APPL ENVIRON MICROB, V52, P1177, DOI 10.1128/AEM.52.5.1177-1182.1986; Muyzer G, 1999, CURR OPIN MICROBIOL, V2, P317, DOI 10.1016/S1369-5274(99)80055-1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nicol GW, 2003, ENVIRON MICROBIOL, V5, P152, DOI 10.1046/j.1462-2920.2003.00399.x; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Piquet AMT, 2008, FEMS MICROBIOL ECOL, V66, P352, DOI 10.1111/j.1574-6941.2008.00588.x; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P1062, DOI 10.4319/lo.1983.28.6.1062; Rothrock MJ, 2005, ENVIRON MICROBIOL, V7, P593, DOI 10.1111/j.1462-2920.2005.00728.x; Schulz E., 1936, KIELER MEERESFORSCH, V1, P359; Severin I, 2008, ISME J, V2, P1077, DOI 10.1038/ismej.2008.63; Severin I, 2010, FEMS MICROBIOL ECOL, V73, P514, DOI 10.1111/j.1574-6941.2010.00925.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Siegesmund MA, 2008, J PHYCOL, V44, P1572, DOI 10.1111/j.1529-8817.2008.00604.x; Smith JM, 2008, ENVIRON MICROBIOL, V10, P386, DOI 10.1111/j.1462-2920.2007.01459.x; STAL LJ, 1985, FEMS MICROBIOL ECOL, V31, P111, DOI 10.1111/j.1574-6968.1985.tb01138.x; Stal LJ, 2010, ADV EXP MED BIOL, V675, P31, DOI 10.1007/978-1-4419-1528-3_3; TERBRAAK CJF, 1989, HYDROBIOLOGIA, V184, P169, DOI 10.1007/BF02392953; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569; vandenEnde FP, 1997, FEMS MICROBIOL ECOL, V23, P65, DOI 10.1016/S0168-6496(97)00014-7; VANDERMAAREL E, 1990, J VEG SCI, V1, P135, DOI 10.2307/3236065; VANGEMERDEN H, 1993, MAR GEOL, V113, P3, DOI 10.1016/0025-3227(93)90146-M; Youssef NH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012414	53	46	47	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63166	10.1371/journal.pone.0063166	http://dx.doi.org/10.1371/journal.pone.0063166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704895	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200024
J	Plumb, J; Robinson, L; Lea, S; Banyard, A; Blaikley, J; Ray, D; Bizzi, A; Volpi, G; Facchinetti, F; Singh, D				Plumb, Jonathan; Robinson, Laura; Lea, Simon; Banyard, Antonia; Blaikley, John; Ray, David; Bizzi, Andrea; Volpi, Giorgina; Facchinetti, Fabrizio; Singh, Dave			Evaluation of Glucocorticoid Receptor Function in COPD Lung Macrophages Using Beclomethasone-17-Monopropionate	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HISTONE DEACETYLASE ACTIVITY; AIRWAY INFLAMMATION; FK506-BINDING PROTEIN-51; NUCLEAR TRANSLOCATION; ALVEOLAR MACROPHAGES; CYTOKINE RELEASE; GENE-EXPRESSION; P38 MAPK; PHOSPHORYLATION	Previous studies of glucocorticoid receptor (GR) function in COPD lung macrophages have used dexamethasone to evaluate inhibition of cytokine production. We have now used the clinically relevant corticosteroid beclomethasone-17-monopropionate (17-BMP) to assess GR function in COPD lung macrophages, and investigated the transactivation of glucocorticoid sensitive genes and GR phosphorylation in addition to cytokine production. Lung macrophages were purified from surgically acquired lung tissue, from patients with COPD, smokers, and non-smokers. The transactivation of glucocorticoid sensitive genes (FKBP51 and GILZ) by 17-BMP were analysed by polymerase chain reaction. 17-BMP suppression of LPS-induced TNF alpha, IL-6 and CXCL8 was measured by ELISA and GR phosphorylation was measured by immunohistochemistry and Western blot. 17-BMP reduced cytokine release in a concentration dependent manner, with >70% inhibition of all cytokines, and no difference between COPD patients and controls. Similarly, the transactivation of FKBP51 and GILZ, and GR phosphorylation was similar between COPD patients and controls. In this context, GR function in COPD lung macrophages is unaltered. 17-BMP effectively suppresses cytokine production in COPD lung macrophages.	[Plumb, Jonathan; Robinson, Laura; Lea, Simon; Banyard, Antonia; Singh, Dave] Univ Manchester, Univ Hosp South Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res,Translat Res Facil, Manchester, Lancs, England; [Blaikley, John; Ray, David] Univ Manchester, Sch Med, Manchester, Lancs, England; [Bizzi, Andrea; Volpi, Giorgina; Facchinetti, Fabrizio] Chiesi Pharmaceut, Parma, Italy	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; University of Manchester; Chiesi Pharmaceuticals Inc	Plumb, J (corresponding author), Univ Manchester, Univ Hosp South Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res,Translat Res Facil, Manchester, Lancs, England.	jonathan.plumb@manchester.ac.uk	Lea, Simon/U-3590-2019; Singh, Dave/AAH-4342-2020	Singh, Dave/0000-0001-8918-7075; Ray, David/0000-0002-4739-6773; Blaikley, John/0000-0001-7651-5682; Plumb, Jonathan/0000-0002-7877-8053	AstraZeneca; Boehringer Ingelheim; Chiesi; GlaxoSmithKline; Almirall; Forest; Pfizer; UCB; Novartis; Cipla; Chiesi Pharmaceuticals; EPSRC [EP/I037253/1] Funding Source: UKRI; MRC [G0601556] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I037253/1] Funding Source: researchfish; Medical Research Council [G0601556] Funding Source: researchfish	AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Chiesi(Chiesi Pharmaceuticals Inc); GlaxoSmithKline(GlaxoSmithKline); Almirall(Almirall); Forest; Pfizer(Pfizer); UCB(UCB Pharma SA); Novartis(Novartis); Cipla; Chiesi Pharmaceuticals(Chiesi Pharmaceuticals Inc); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We have the following interests. Dr. Singh has received sponsorship to attend international meetings, honoraria for lecturing or attending advisory boards, and research grants from various pharmaceutical companies including AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Almirall, Forest, Pfizer, UCB, Novartis, and Cipla. Chiesi Pharmaceuticals funded this study and is the employer of Dr. Bizzi, Dr. Volpi and Dr. Facchinetti. Chiesi pharmaceutical provided a years salary for Dr Plumb. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed on-line in the guide for authors.	Acerbi D, 2007, PULM PHARMACOL THER, V20, P290, DOI 10.1016/j.pupt.2006.05.005; Adcock Ian M, 2005, Proc Am Thorac Soc, V2, P313, DOI 10.1513/pats.200504-035SR; Armstrong J, 2011, J PHARMACOL EXP THER, V338, P732, DOI 10.1124/jpet.111.180737; Armstrong J, 2009, CLIN EXP IMMUNOL, V158, P74, DOI 10.1111/j.1365-2249.2009.03986.x; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barnes Neil C, 2007, Prim Care Respir J, V16, P149, DOI 10.3132/pcrj.2007.00038; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Blind RD, 2008, J STEROID BIOCHEM, V109, P150, DOI 10.1016/j.jsbmb.2008.01.002; Bourbeau J, 2007, THORAX, V62, P938, DOI 10.1136/thx.2006.071068; Brand P, 2005, J AEROSOL MED, V18, P45, DOI 10.1089/jam.2005.18.45; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; Culpitt SV, 2003, AM J RESP CRIT CARE, V167, P24, DOI 10.1164/rccm.200204-298OC; Daley-Yates PT, 2001, BRIT J CLIN PHARMACO, V51, P400, DOI 10.1046/j.0306-5251.2001.01374.x; DiStefano A, 1996, AM J RESP CRIT CARE, V153, P629, DOI 10.1164/ajrccm.153.2.8564109; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; Fung P, 2006, ASSAY DRUG DEV TECHN, V4, P263, DOI 10.1089/adt.2006.4.263; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; GOLD, GLOB IN CHRON OBSTR; Hattotuwa KL, 2002, AM J RESP CRIT CARE, V165, P1592, DOI 10.1164/rccm.2105025; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Kent L, 2008, CYTOKINE, V42, P205, DOI 10.1016/j.cyto.2008.02.001; Kent LM, 2009, J PHARMACOL EXP THER, V328, P458, DOI 10.1124/jpet.108.142950; Koch A, 2004, EUR RESPIR J, V23, P805, DOI 10.1183/09031936.04.00104304; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; McMaster A, 2007, EXP PHYSIOL, V92, P299, DOI 10.1113/expphysiol.2006.036194; Miller AL, 2005, MOL ENDOCRINOL, V19, P1569, DOI 10.1210/me.2004-0528; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ratajczak T, 2003, CURR TOP MED CHEM, V3, P1348, DOI 10.2174/1568026033451934; Renda T, 2008, EUR RESPIR J, V31, P62, DOI 10.1183/09031936.00036707; SCHMIDT J, 1994, EUR J PHARMACOL, V260, P247, DOI 10.1016/0014-2999(94)90345-X; Smith SJ, 2006, BRIT J PHARMACOL, V149, P393, DOI 10.1038/sj.bjp.0706885; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P1037, DOI 10.1167/iovs.07-1279	47	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64257	10.1371/journal.pone.0064257	http://dx.doi.org/10.1371/journal.pone.0064257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704983	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200127
J	Rubin, D; Fekete, T; Mujica-Parodi, LR				Rubin, Denis; Fekete, Tomer; Mujica-Parodi, Lilianne R.			Optimizing Complexity Measures for fMRI Data: Algorithm, Artifact, and Sensitivity	PLOS ONE			English	Article							SCALE-INVARIANCE; BRAIN DYNAMICS; OSCILLATIONS; SPECTRUM; NOISE; MRI; EEG; AGE	Introduction: Complexity in the brain has been well-documented at both neuronal and hemodynamic scales, with increasing evidence supporting its use in sensitively differentiating between mental states and disorders. However, application of complexity measures to fMRI time-series, which are short, sparse, and have low signal/noise, requires careful modality-specific optimization. Methods: Here we use both simulated and real data to address two fundamental issues: choice of algorithm and degree/type of signal processing. Methods were evaluated with regard to resilience to acquisition artifacts common to fMRI as well as detection sensitivity. Detection sensitivity was quantified in terms of grey-white matter contrast and overlap with activation. We additionally investigated the variation of complexity with activation and emotional content, optimal task length, and the degree to which results scaled with scanner using the same paradigm with two 3T magnets made by different manufacturers. Methods for evaluating complexity were: power spectrum, structure function, wavelet decomposition, second derivative, rescaled range, Higuchi's estimate of fractal dimension, aggregated variance, and detrended fluctuation analysis. To permit direct comparison across methods, all results were normalized to Hurst exponents. Results: Power-spectrum, Higuchi's fractal dimension, and generalized Hurst exponent based estimates were most successful by all criteria; the poorest-performing measures were wavelet, detrended fluctuation analysis, aggregated variance, and rescaled range. Conclusions: Functional MRI data have artifacts that interact with complexity calculations in nontrivially distinct ways compared to other physiological data (such as EKG, EEG) for which these measures are typically used. Our results clearly demonstrate that decisions regarding choice of algorithm, signal processing, time-series length, and scanner have a significant impact on the reliability and sensitivity of complexity estimates.	[Rubin, Denis] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Rubin, Denis; Fekete, Tomer; Mujica-Parodi, Lilianne R.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mujica-Parodi, LR (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	Lilianne.Strey@stonybrook.edu		Fekete, Tomer/0000-0003-3164-125X; Rubin, Denis/0000-0002-0483-9458; Mujica-Parodi, Lilianne Rivka/0000-0002-3752-5519	Office of Naval Research [N000140410051]; National Science Foundation [0954643]; Directorate For Engineering [0954643, 1141995] Funding Source: National Science Foundation	Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the Office of Naval Research, Grant# N000140410051 (LRMP) and the National Science Foundation, Grant# 0954643 (LRMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandettini PA, 2008, HUM BRAIN MAPP, V29, P737, DOI 10.1002/hbm.20607; Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; Barth M, 2002, CONDMAT0208415; Bedard C, 2009, BIOPHYS J, V96, P2589, DOI 10.1016/j.bpj.2008.12.3951; Blok H J, 2000, ARXIVCONDMAT0010211; Breakspear M, 2011, PLOS COMPUT BIOL, V7; Bullmore ET, 2009, NEUROIMAGE, V47, P1125, DOI 10.1016/j.neuroimage.2009.05.032; Carlson JM, 2011, SOC COGN AFFECT NEUR, V6, P74, DOI 10.1093/scan/nsq017; Dacorogna MM, 2005, LONG TERM MEMORIES D; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Daneshyari M, 2010, ADV EXP MED BIOL, V680, P677, DOI 10.1007/978-1-4419-5913-3_75; Di Matteo T, 2007, QUANT FINANC, V7, P21, DOI 10.1080/14697680600969727; Di Matteo T, 2003, PHYSICA A, V324, P183, DOI 10.1016/S0378-4371(02)01996-9; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Ekman P., 1976, PICTURES FACIAL AFFE; FLANDRIN P, 1989, IEEE T INFORM THEORY, V35, P197, DOI 10.1109/18.42195; FLANDRIN P, 1992, IEEE T INFORM THEORY, V38, P910, DOI 10.1109/18.119751; Freyer F, 2009, J NEUROSCI, V29, P8512, DOI 10.1523/JNEUROSCI.0754-09.2009; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; Hu XS, 2011, NEUROSCI LETT, V504, P115, DOI 10.1016/j.neulet.2011.09.011; Istas J, 1997, ANN I H POINCARE-PR, V33, P407, DOI 10.1016/S0246-0203(97)80099-4; Lai MC, 2010, BIOL PSYCHIAT, V68, P1092, DOI 10.1016/j.biopsych.2010.06.027; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Lundqvist D., 1998, KAROLINSKA DIRECTED; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Mujica-Parodi LR, 2011, HUM BRAIN MAPP; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Perkiomaki JS, 2005, CLIN EXP HYPERTENS, V27, P149, DOI 10.1081/CEH-200048742; Polychronaki GE, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046007; Preis T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093024; Shimizu Y, 2004, NEUROIMAGE, V22, P1195, DOI 10.1016/j.neuroimage.2004.03.007; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Suckling J, 2008, J NEUROSCI METH, V174, P292, DOI 10.1016/j.jneumeth.2008.06.037; Taqqu MS, 1995, FRACTALS, V3, P785, DOI 10.1142/S0218348X95000692; Tolkunov D, 2010, NEUROIMAGE, V50, P72, DOI 10.1016/j.neuroimage.2009.12.021; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049; Wink AM, 2006, NEUROBIOL AGING, V27, P1395, DOI 10.1016/j.neurobiolaging.2005.08.011	44	29	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63448	10.1371/journal.pone.0063448	http://dx.doi.org/10.1371/journal.pone.0063448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700424	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200040
J	Stein, A; Kortemme, T				Stein, Amelie; Kortemme, Tanja			Improvements to Robotics-Inspired Conformational Sampling in Rosetta	PLOS ONE			English	Article							CYCLIC COORDINATE DESCENT; PROTEIN-PROTEIN DOCKING; STRUCTURE PREDICTION; OPTIMIZATION; DESIGN; SPACE; POLYPEPTIDES; REFINEMENT; PROGRESS; CLOSURE	To accurately predict protein conformations in atomic detail, a computational method must be capable of sampling models sufficiently close to the native structure. All-atom sampling is difficult because of the vast number of possible conformations and extremely rugged energy landscapes. Here, we test three sampling strategies to address these difficulties: conformational diversification, intensification of torsion and omega-angle sampling and parameter annealing. We evaluate these strategies in the context of the robotics-based kinematic closure (KIC) method for local conformational sampling in Rosetta on an established benchmark set of 45 12-residue protein segments without regular secondary structure. We quantify performance as the fraction of sub-Angstrom models generated. While improvements with individual strategies are only modest, the combination of intensification and annealing strategies into a new "next-generation KIC" method yields a four-fold increase over standard KIC in the median percentage of sub-Angstrom models across the dataset. Such improvements enable progress on more difficult problems, as demonstrated on longer segments, several of which could not be accurately remodeled with previous methods. Given its improved sampling capability, next-generation KIC should allow advances in other applications such as local conformational remodeling of multiple segments simultaneously, flexible backbone sequence design, and development of more accurate energy functions.	[Stein, Amelie] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stein, A (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA.	amelie.stein@ucsf.edu; kortemme@cgl.ucsf.edu	Kortemme, Tanja/AAN-3180-2021; Stein, Amelie/K-1417-2019	Stein, Amelie/0000-0002-5862-1681; Kortemme, Tanja/0000-0002-8494-680X	EMBO long-term fellowship [ALTF 698-2011]; National Institutes of Health [GM098101]; National Science Foundation [DBI-1262182]; University of California Lab Research Program [UCOP 118766]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098101] Funding Source: NIH RePORTER	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of California Lab Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AS was supported by an EMBO long-term fellowship (ALTF 698-2011). This work was supported by grants to TK from the National Institutes of Health (GM098101), the National Science Foundation (DBI-1262182) and the University of California Lab Research Program (UCOP 118766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Berkholz DS, 2012, P NATL ACAD SCI USA, V109, P449, DOI 10.1073/pnas.1107115108; Boomsma W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-159; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; BRUCCOLERI RE, 1985, MACROMOLECULES, V18, P2767, DOI 10.1021/ma00154a069; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Das R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020044; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Felts AK, 2008, J CHEM THEORY COMPUT, V4, P855, DOI 10.1021/ct800051k; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; Hu XZ, 2007, P NATL ACAD SCI USA, V104, P17668, DOI 10.1073/pnas.0707977104; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Kapp GT, 2012, P NATL ACAD SCI USA, V109, P5277, DOI 10.1073/pnas.1114487109; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Lange OF, 2012, PROTEINS, V80, P884, DOI 10.1002/prot.23245; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee J, 1997, J COMPUT CHEM, V18, P1222, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1222::AID-JCC10>3.0.CO;2-7; Lee J, 2010, PROTEINS, V78, P3428, DOI 10.1002/prot.22849; Liwo A, 1999, P NATL ACAD SCI USA, V96, P5482, DOI 10.1073/pnas.96.10.5482; Liwo A, 2008, CURR OPIN STRUC BIOL, V18, P134, DOI 10.1016/j.sbi.2007.12.001; Mandell DJ, 2009, CURR OPIN BIOTECH, V20, P420, DOI 10.1016/j.copbio.2009.07.006; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Misura KMS, 2005, PROTEINS, V59, P15, DOI 10.1002/prot.20376; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Richter F, 2012, J AM CHEM SOC, V134, P16197, DOI 10.1021/ja3037367; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Schrodinger L., 2020, PYMOL; Sellers BD, 2008, PROTEINS, V72, P959, DOI 10.1002/prot.21990; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Ting D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000763; Tyka MD, 2012, J COMPUT CHEM, V33, P2483, DOI 10.1002/jcc.23069; Ulmschneider JP, 2003, J CHEM PHYS, V118, P4261, DOI 10.1063/1.1542611; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Zhao SW, 2011, PROTEINS, V79, P2920, DOI 10.1002/prot.23129	49	118	120	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63090	10.1371/journal.pone.0063090	http://dx.doi.org/10.1371/journal.pone.0063090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704889	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200018
J	Matthews, K; Chung, NPY; Klasse, PJ; Moutaftsi, M; Carter, D; Salazar, AM; Reed, SG; Sanders, RW; Moore, JP				Matthews, Katie; Chung, Nancy P. Y.; Klasse, Per Johan; Moutaftsi, Magda; Carter, Darrick; Salazar, Andre M.; Reed, Steven G.; Sanders, Rogier W.; Moore, John P.			Clinical Adjuvant Combinations Stimulate Potent B-Cell Responses In Vitro by Activating Dermal Dendritic Cells	PLOS ONE			English	Article							ANTIBODY-RESPONSES; IMMUNE-RESPONSES; LANGERHANS CELLS; VACCINE; SUBSETS; GP120; SUPPRESSION; ALPHA; TLR4; SKIN	CD14(+) dermal DCs (CD14(+) DDCs) have a natural capacity to activate naive B-cells. Targeting CD14(+) DDCs is therefore a rational approach for vaccination strategies aimed at improving humoral responses towards poorly immunogenic antigens, for example, HIV-1 envelope glycoproteins (Env). Here, we show that two clinically relevant TLR ligand combinations, Hiltonol plus Resiquimod and Glucopyranosyl lipid A plus Resiquimod, potently activate CD14(+) DDCs, as shown by enhanced expression of multiple cytokines (IL-6, IL-10, IL-12p40 and TNF-alpha). Furthermore, the responses of CD14(+) DDCs to these TLR ligands were not compromised by the presence of HIV-1 gp120, which can drive immunosuppressive effects in vitro and in vivo. The above TLR ligand pairs were better than the individual agents at boosting the inherent capacity of CD14(+) DDCs to induce naive B-cells to proliferate and differentiate into CD27(+) CD38(+) B-cells that secrete high levels of immunoglobulins. CD14(+) DDCs stimulated by these TLR ligand combinations also promoted the differentiation of Th1 (IFN-gamma-secreting), but not Th17, CD4(+) T-cells. These observations may help to identify adjuvant strategies aimed at inducing better antibody responses to vaccine antigens, including, but not limited to HIV-1 Env.	[Matthews, Katie; Chung, Nancy P. Y.; Klasse, Per Johan; Sanders, Rogier W.; Moore, John P.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Moutaftsi, Magda] Bill & Melinda Gates Fdn, HIV Vaccine Initiat, Seattle, WA USA; [Carter, Darrick; Reed, Steven G.] Infect Dis Res Inst IDRI, Seattle, WA USA; [Salazar, Andre M.] Oncovir Inc, Washington, DC USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands	Cornell University; Bill & Melinda Gates Foundation; University of Amsterdam; Academic Medical Center Amsterdam	Moore, JP (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA.	jpm2003@med.cornell.edu	Klasse, P.J./AEX-0142-2022; Carter, Darrick/N-3304-2016	Klasse, P.J./0000-0001-8222-278X; Carter, Darrick/0000-0001-5901-3402	NIH [AI36082]; Bill and Melinda Gates Foundation [42387]; Vidi grant from the Netherlands Organization for Scientific Research (NWO); Starting Investigator Grant from the European Research Council [ERC-StG-2011-280829-SHEV]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036082, R37AI036082] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Vidi grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Starting Investigator Grant from the European Research Council(European Research Council (ERC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH grant AI36082 to JPM and by funding from the Bill and Melinda Gates Foundation, under grant #42387 to SGR and DR. RWS is a recipient of a Vidi grant from the Netherlands Organization for Scientific Research (NWO) and a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829-SHEV). The funders had no role in the study design, data collection and analysis, decision to publish, or publication of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BANCHEREAU J, 2012, BLOOD; Banerjee K, 2012, AIDS RES HUM RETROV, V28, P206, DOI 10.1089/aid.2011.0101; Banerjee K, 2009, VIROLOGY, V389, P108, DOI 10.1016/j.virol.2009.04.001; Bogunovic D, 2011, CANCER RES, V71, P5467, DOI 10.1158/0008-5472.CAN-10-3988; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Caux C, 1997, BLOOD, V90, P1458, DOI 10.1182/blood.V90.4.1458.1458_1458_1470; CHUNG NP, 2012, J IMMUNOL; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Combadiere B, 2011, HUM VACCINES, V7, P811, DOI 10.4161/hv.7.8.16274; Hovav AH, 2009, J VIROL, V83, P10941, DOI 10.1128/JVI.00394-09; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Klasse PJ, 2012, AIDS RES HUM RETROV, V28, P1, DOI [10.1089/aid.2011.0053, 10.1089/AID.2011.0053]; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Klechevsky E, 2009, HUM IMMUNOL, V70, P281, DOI 10.1016/j.humimm.2009.02.004; Liard C, 2011, VACCINE, V29, P6379, DOI 10.1016/j.vaccine.2011.04.080; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; MATTHEWS K, 2012, J IMMUNOL; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Teunissen MBM, 2012, CURR TOP MICROBIOL, V351, P25, DOI 10.1007/82_2011_169; Toapanta FR, 2007, CURR HIV RES, V5, P199, DOI 10.2174/157016207780077057; Ueno H, 2010, IMMUNOL CELL BIOL, V88, P376, DOI 10.1038/icb.2010.28; van der Aar AMG, 2007, J IMMUNOL, V178, P1986, DOI 10.4049/jimmunol.178.4.1986; van Montfort T, 2012, EXPERT REV VACCINES, V11, P1175, DOI [10.1586/ERV.12.102, 10.1586/erv.12.102]	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63785	10.1371/journal.pone.0063785	http://dx.doi.org/10.1371/journal.pone.0063785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700434	gold, Green Published, Green Submitted			2022-12-27	WOS:000319966400031
J	Datu, AK; Bag, J				Datu, Andrea-Kaye; Bag, Jnanankur			Enhanced Translation of mRNAs Encoding Proteins Involved in mRNA Translation during Recovery from Heat Shock	PLOS ONE			English	Article							POLY(A)-BINDING PROTEINS; POSTTRANSCRIPTIONAL CONTROL; BINDING-PROTEIN; REGION; EXPRESSION; DISTINCT; EEF1A2	The mRNAs encoding poly (A) binding protein (PABP1), eukaryotic elongation factor 1A (eEF1A) and ribosomal protein S6 (RPS6) belong to the family of terminal oligo pyrimidine tract (TOP) containing mRNAs. Translation of the TOP mRNAs is regulated by growth signals and usually codes for proteins involved in mRNA translation. Previous studies from our laboratory showed that translation of PABP1 mRNA was preferentially enhanced during recovery of HeLa cells from heat shock. Presence of the 5' TOP cis element was required for the observed increase of PABP1 mRNA translation. In the studies reported here we showed that translation of two additional TOP mRNAs such as, eEF1A and RPS6 was similarly enhanced during recovery. In addition, we showed by in vivo cross-linking experiments that the cellular nucleic acid binding protein ZNF9 binds to all three TOP mRNAs examined in these studies as well as to the beta-actin mRNA that lacks a TOP cis element. Binding of ZNF9 to mRNAs was observed in both heat-shocked and non heat-shocked cells. However, depletion of ZNF9 by siRNA prevented the preferred stimulation of PABP1, eEF1A and RPS6 expression during recovery from heat shock. There was no detectable effect of ZNF9 depletion on the basal level of expression of either beta-actin or PABP1, eEF1A and RPS6 in HeLa cells following recovery from heat shock. Conclusion: Although the presence of ZNF9 was required for the translational stimulation of PABP1, eEF1A and RPS6 mRNAs, the mechanistic details of this process are still unclear. Since ZNF9 was shown to bind both TOP and non-TOP mRNAs, it is uncertain whether ZNF9 exerts its stimulatory effect on TOP mRNA translation following recovery from heat shock through the TOP cis-element. Perhaps additional factors or post-translational modification(s) of ZNF9 following heat shock are necessary for the preferred increase of TOP mRNA translation.	[Datu, Andrea-Kaye; Bag, Jnanankur] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Bag, J (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jbag@uoguelph.ca			Natural Sciences & Engineering Research Council of Canada [3542-2011]	Natural Sciences & Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a discovery grant from the Natural Sciences & Engineering Research Council of Canada (grant number 3542-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Bag J, 2010, RNA BIOL, V7, P5, DOI 10.4161/rna.7.1.10256; Brook M, 2012, BIOCHEM J, V441, P803, DOI 10.1042/BJ20111474; Burgess HM, 2011, J CELL SCI, V124, P3344, DOI 10.1242/jcs.087692; Chekanova JA, 2003, RNA, V9, P1476, DOI 10.1261/rna.5128903; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; DUNCAN RF, 1989, J CELL BIOL, V109, P1467, DOI 10.1083/jcb.109.4.1467; FALLON AM, 1979, P NATL ACAD SCI USA, V76, P3411, DOI 10.1073/pnas.76.7.3411; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gerbasi VR, 2007, MOL CELL PROTEOMICS, V6, P1049, DOI 10.1074/mcp.M600384-MCP200; Gorgoni Barbara, 2004, Briefings in Functional Genomics & Proteomics, V3, P125, DOI 10.1093/bfgp/3.2.125; Gorgoni B, 2011, P NATL ACAD SCI USA, V108, P7844, DOI 10.1073/pnas.1017664108; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; Huichalaf C, 2009, J NEUROSCI, V29, P9042, DOI 10.1523/JNEUROSCI.1983-09.2009; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; LORENI F, 1993, NUCLEIC ACIDS RES, V21, P4721, DOI 10.1093/nar/21.20.4721; Lund A, 1996, GENOMICS, V36, P359, DOI 10.1006/geno.1996.0475; Ma SH, 2009, FEBS J, V276, P552, DOI 10.1111/j.1742-4658.2008.06803.x; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Patel GP, 2005, NUCLEIC ACIDS RES, V33, P7074, DOI 10.1093/nar/gki1014; PATINO MM, 1992, J BIOL CHEM, V267, P19011; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Soares DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006315; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Verlaet M, 2001, BIOCHEM BIOPH RES CO, V283, P12, DOI 10.1006/bbrc.2001.4731; Wu J, 1998, J BIOL CHEM, V273, P34535, DOI 10.1074/jbc.273.51.34535; Zhu JF, 2001, BBA-GENE STRUCT EXPR, V1521, P19, DOI 10.1016/S0167-4781(01)00277-9	30	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64171	10.1371/journal.pone.0064171	http://dx.doi.org/10.1371/journal.pone.0064171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696868	gold, Green Published, Green Submitted			2022-12-27	WOS:000319081900071
J	Garcia, CC; Weston-Davies, W; Russo, RC; Tavares, LP; Rachid, MA; Alves, JC; Machado, AV; Ryffel, B; Nunn, MA; Teixeira, MM				Garcia, Cristiana C.; Weston-Davies, Wynne; Russo, Remo C.; Tavares, Luciana P.; Rachid, Milene A.; Alves-Filho, Jose C.; Machado, Alexandre V.; Ryffel, Bernhard; Nunn, Miles A.; Teixeira, Mauro M.			Complement C5 Activation during Influenza A Infection in Mice Contributes to Neutrophil Recruitment and Lung Injury	PLOS ONE			English	Article							TICK ORNITHODOROS-MOUBATA; T-CELL RESPONSES; VIRUS-INFECTION; EXTRACELLULAR TRAPS; FACTOR RECEPTOR; INHIBITOR; PATHWAY; IMMUNOPATHOLOGY; PNEUMONITIS; GENERATION	Influenza virus A (IAV) causes annual epidemics and intermittent pandemics that affect millions of people worldwide. Potent inflammatory responses are commonly associated with severe cases of IAV infection. The complement system, an important mechanism of innate and humoral immune responses to infections, is activated during primary IAV infection and mediates, in association with natural IgM, viral neutralization by virion aggregation and coating of viral hemmagglutinin. Increased levels of the anaphylatoxin C5a were found in patients fatally infected with the most recent H1N1 pandemic virus. In this study, our aim was to evaluate whether targeting C5 activation alters inflammatory lung injury and viral load in a murine model of IAV infection. To address this question C57Bl/6j mice were infected intranasally with 10(4) PFU of the mouse adapted Influenza A virus A/WSN/33 (H1N1) or inoculated with PBS (Mock). We demonstrated that C5a is increased in bronchoalveolar lavage fluid (BALF) upon experimental IAV infection. To evaluate the role of C5, we used OmCI, a potent arthropod-derived inhibitor of C5 activation that binds to C5 and prevents release of C5a by complement. OmCI was given daily by intraperitoneal injection from the day of IAV infection until day 5. Treatment with OmCI only partially reduced C5a levels in BALF. However, there was significant inhibition of neutrophil and macrophage infiltration in the airways, Neutrophil Extracellular Traps (NETs) formation, death of leukocytes, lung epithelial injury and overall lung damage induced by the infection. There was no effect on viral load. Taken together, these data suggest that targeting C5 activation with OmCI during IAV infection could be a promising approach to reduce excessive inflammatory reactions associated with the severe forms of IAV infections.	[Garcia, Cristiana C.; Russo, Remo C.; Tavares, Luciana P.; Rachid, Milene A.; Teixeira, Mauro M.] Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Lab Imunofarmacol, Belo Horizonte, MG, Brazil; [Weston-Davies, Wynne] Varleigh Ltd, London, England; [Russo, Remo C.] Univ Fed Minas Gerais, ICB, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil; [Rachid, Milene A.] Univ Fed Minas Gerais, ICB, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Alves-Filho, Jose C.] Univ Sao Paulo, Dept Farmacol, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Machado, Alexandre V.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Ryffel, Bernhard] CNRS, UMR7355, F-75700 Paris, France; [Ryffel, Bernhard] Univ Orleans, F-45067 Orleans, France; [Ryffel, Bernhard] Univ Cape Town, IIDMM, ZA-7925 Cape Town, South Africa; [Nunn, Miles A.] Ctr Ecol & Hydrol, Wallingford, Oxon, England	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; University of Cape Town; UK Centre for Ecology & Hydrology (UKCEH)	Teixeira, MM (corresponding author), Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Lab Imunofarmacol, Belo Horizonte, MG, Brazil.	mmtex@icb.ufmg.br	Rachid, Milene Alvarenga/C-3530-2017; Russo, Remo Castro/O-8980-2019; Machado, Alexandre M Vieira/G-2468-2012; Garcia, Cristiana Couto/AAE-4290-2022; Russo, Remo Castro/F-9048-2010; Garcia, Cristiana C/G-9509-2013; Alves-Filho, Jose Carlos/B-5814-2008; Teixeira, Mauro M/A-4587-2008	Rachid, Milene Alvarenga/0000-0002-3142-6552; Russo, Remo Castro/0000-0002-1715-3834; Machado, Alexandre M Vieira/0000-0003-1506-4093; Garcia, Cristiana Couto/0000-0002-4400-9141; Russo, Remo Castro/0000-0002-1715-3834; Garcia, Cristiana C/0000-0002-4400-9141; Alves-Filho, Jose Carlos/0000-0002-9918-8714; Teixeira, Mauro M/0000-0002-6944-3008; Padua Tavares, Luciana/0000-0002-5319-0210	National Institute of Science and Technology in Dengue (INCT Dengue); National Institute of Science and Technology in Vaccines (INCTV) from CNPq/Fapemig; Natural Environment Research Council [CEH010021] Funding Source: researchfish	National Institute of Science and Technology in Dengue (INCT Dengue); National Institute of Science and Technology in Vaccines (INCTV) from CNPq/Fapemig; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors were funded by the National Institute of Science and Technology in Dengue (INCT Dengue) and the National Institute of Science and Technology in Vaccines (INCTV) from CNPq/Fapemig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt-Due A, 2011, J IMMUNOL, V187, P4913, DOI 10.4049/jimmunol.1101000; BJORNSON AB, 1991, AM REV RESPIR DIS, V143, P1062, DOI 10.1164/ajrccm/143.5_Pt_1.1062; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; Garcia CC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001171; Garcia CC, 2010, DISCOV MED, V10, P479; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Halstead SK, 2008, J PERIPHER NERV SYST, V13, P228, DOI 10.1111/j.1529-8027.2008.00181.x; Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Kanmura S, 2010, J GASTROENTEROL, V45, P459, DOI 10.1007/s00535-009-0160-5; Kim AHJ, 2004, J IMMUNOL, V173, P2524, DOI 10.4049/jimmunol.173.4.2524; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Kwan WH, 2013, J EXP MED, V210, P257, DOI 10.1084/jem.20121525; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lacerda-Queiroz N, 2012, AM J PATHOL, V180, P246, DOI 10.1016/j.ajpath.2011.09.038; Law S.K.A., 1995, COMPLEMENT; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052666; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Longhi MP, 2007, EUR J IMMUNOL, V37, P1266, DOI 10.1002/eji.200636755; Martin EL, 2010, AM J RESP CRIT CARE, V182, P762, DOI 10.1164/rccm.201001-0088OC; Monsalvo AC, 2010, NAT MED; Narasaraju T, 2010, AM J RESP CELL MOL, V42, P732, DOI 10.1165/rcmb.2008-0423OC; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782; Nataf S, 1999, J IMMUNOL, V162, P4018; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; O'Brien KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017377; Ohta R, MICROBIOL IMMUNOL; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Pisetsky DS, 2012, CLIN IMMUNOL, V144, P32, DOI 10.1016/j.clim.2012.04.006; Roversi P, 2013, IMMUNE COMP IN PRESS; Russo RC, 2009, AM J RESP CELL MOL, V40, P410, DOI 10.1165/rcmb.2007-0364OC; Sanderson SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040303; Soltys J, 2009, ANN NEUROL, V65, P67, DOI 10.1002/ana.21536; Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106; Stoermer KA, 2011, VIROLOGY; Tran AT, 2013, J VIROL, V87, P1049, DOI 10.1128/JVI.02017-12; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Zhang JJ, 2009, J GEN VIROL, V90, P2751, DOI 10.1099/vir.0.014316-0; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	52	64	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64443	10.1371/journal.pone.0064443	http://dx.doi.org/10.1371/journal.pone.0064443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696894	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000319081900097
J	Jiang, JL; Barnwell, JW; Meyer, EVS; Galinski, MR				Jiang, Jianlin; Barnwell, John W.; Meyer, Esmeralda V. S.; Galinski, Mary R.			Plasmodium vivax Merozoite Surface Protein-3 (PvMSP3): Expression of an 11 Member Multigene Family in Blood-Stage Parasites	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; NATURALLY ACQUIRED ANTIBODIES; BINDING-LIKE PROTEINS; ERYTHROCYTE INVASION; GENETIC DIVERSITY; FALCIPARUM MEROZOITES; VACCINE; IDENTIFICATION; KNOWLESI; AMAZON	Background: Three members of the Plasmodium vivax merozoite surface protein-3 (PvMSP3) family (PvMSP3-alpha, PvMSP3-beta and PvMSP3-gamma) were initially characterized and later shown to be part of a larger highly diverse family, encoded by a cluster of genes arranged head-to-tail in chromosome 10. PvMSP3-alpha and PvMSP3-beta have become genetic markers in epidemiological studies, and are being evaluated as vaccine candidates. This research investigates the gene and protein expression of the entire family and pertinent implications. Methodology/Principal Findings: A 60 kb multigene locus from chromosome 10 in P. vivax (Salvador 1 strain) was studied to classify the number of pvmsp3 genes present, and compare their transcription, translation and protein localization patterns during blood-stage development. Eleven pvmsp3 paralogs encode an N-terminal NLRNG signature motif, a central domain containing repeated variable heptad sequences, and conserved hydrophilic C-terminal features. One additional ORF in the locus lacks these features and was excluded as a member of the family. Transcripts representing all eleven pvmsp3 genes were detected in trophozoite- and schizont-stage RNA. Quantitative immunoblots using schizont-stage extracts and antibodies specific for each PvMSP3 protein demonstrated that all but PvMSP3.11 could be detected. Homologs were also detected by immunoblot in the closely related simian species, P. cynomolgi and P. knowlesi. Immunofluorescence assays confirmed that eight of the PvMSP3s are present in mature schizonts. Uniquely, PvMSP3.7 was expressed exclusively at the apical end of merozoites. Conclusion/Significance: Specific proteins were detected representing the expression of 10 out of 11 genes confirmed as members of the pvmsp3 family. Eight PvMSP3s were visualized surrounding merozoites. In contrast, PvMSP3.7 was detected at the apical end of the merozoites. Pvmsp3.11 transcripts were present, though no corresponding protein was detected. PvMSP3 functions remain unknown. The ten expressed PvMSP3s are predicted to have unique and complementary functions in merozoite biology.	[Jiang, Jianlin; Meyer, Esmeralda V. S.; Galinski, Mary R.] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Barnwell, John W.] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Atlanta, GA USA; [Galinski, Mary R.] Emory Univ, Dept Med, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA	Emory University; Centers for Disease Control & Prevention - USA; Emory University	Galinski, MR (corresponding author), Emory Univ, Dept Med, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA.	mary.galinski@emory.edu			National Institutes of Health, National Institute for Allergy and Infectious Diseases [1R01AI24710, R21AI094449]; National Center for Research Resources [P51RR000165]; Office of Research Infrastructure Programs/OD [P51OD011132]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094449, R01AI024710] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institutes of Health, National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the National Institutes of Health, National Institute for Allergy and Infectious Diseases to MRG (1R01AI24710 and R21AI094449). The Yerkes National Primate Research Center received support from the National Center for Research Resources P51RR000165, and it is currently supported by the Office of Research Infrastructure Programs/OD P51OD011132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyi S, 2012, MOL MICROBIOL, V84, P816, DOI 10.1111/j.1365-2958.2012.08060.x; Balu B, 2009, EXP PARASITOL, V121, P110, DOI 10.1016/j.exppara.2008.10.003; Bang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028165; Bannister LH, 2009, PARASITOLOGY, V136, P1435, DOI 10.1017/S0031182009990734; Barnwell JW, 1999, EXP PARASITOL, V91, P238, DOI 10.1006/expr.1998.4372; BARNWELL JW, 1989, J EXP MED, V169, P1795, DOI 10.1084/jem.169.5.1795; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bruce MC, 1999, POLYMORPHISM MEROZOI, P518; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; CAMPBELL CC, 1983, J PARASITOL, V69, P598, DOI 10.2307/3281376; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Cui LW, 2003, AM J TROP MED HYG, V68, P613, DOI 10.4269/ajtmh.2003.68.613; DAVID PH, 1985, J IMMUNOL, V134, P4146; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Galinski MR, 1999, MOL BIOCHEM PARASIT, V101, P131, DOI 10.1016/S0166-6851(99)00063-8; Galinski MR, 2005, MOLECULAR APPROACHES TO MALARIA, P113; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; Galinski MR, 2001, MOL BIOCHEM PARASIT, V115, P41, DOI 10.1016/S0166-6851(01)00267-5; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaur D, 2011, CURR OPIN MICROBIOL, V14, P422, DOI 10.1016/j.mib.2011.07.018; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Gunalan K, 2012, CELLULAR MICROBIOLOG; Harvey KL, 2012, INT J PARASITOL, V42, P567, DOI 10.1016/j.ijpara.2012.02.011; Ji YE, 1996, MOL BIOCHEM PARASIT, V81, P211, DOI 10.1016/0166-6851(96)02712-0; Jimenez MCS, 2008, BBA-GEN SUBJECTS, V1780, P983, DOI 10.1016/j.bbagen.2008.03.016; Kosek M, 2012, AM J TROP MED HYG, V86, P580, DOI 10.4269/ajtmh.2012.11-0627; Li J, 2012, BIOCHEM BIOPH RES CO, V426, P1, DOI 10.1016/j.bbrc.2012.08.055; Lima JC, 2011, VACCINE, V29, P1801, DOI 10.1016/j.vaccine.2010.12.099; Lima JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Manamperi A, 2008, TROP BIOMED, V25, P100; McColl DJ, 1997, MOL BIOCHEM PARASIT, V90, P21, DOI 10.1016/S0166-6851(97)00130-8; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; Mills KE, 2002, MOL MICROBIOL, V43, P1401, DOI 10.1046/j.1365-2958.2002.02834.x; Mourao LC, 2012, MICROBES INFECT, V14, P730, DOI 10.1016/j.micinf.2012.02.011; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; MULHERN TD, 1995, BIOCHEMISTRY-US, V34, P3479, DOI 10.1021/bi00011a001; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OEUVRAY C, 1994, BLOOD, V84, P1594; Ord R, 2005, MOL BIOCHEM PARASIT, V144, P86, DOI 10.1016/j.molbiopara.2005.08.005; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Pearce JA, 2005, MOL BIOCHEM PARASIT, V139, P141, DOI 10.1016/j.molbiopara.2004.09.012; Pfahler JM, 2006, MOL BIOCHEM PARASIT, V149, P99, DOI 10.1016/j.molbiopara.2006.03.018; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Prajapati SK, 2010, J VECTOR DIS, V47, P85; Rayner JC, 2002, PARASITOLOGY, V125, P393, DOI 10.1017/S0031182002002317; Rayner JC, 2004, INFECT GENET EVOL, V4, P309, DOI 10.1016/j.meegid.2004.03.003; Ribeiro RS, 2011, MEM I OSWALDO CRUZ, V106, P27, DOI 10.1590/S0074-02762011000900004; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SAUL A, 1990, MOL BIOCHEM PARASIT, V42, P55, DOI 10.1016/0166-6851(90)90112-Y; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Veron V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-40; WATERS AP, 1993, MOL BIOL EVOL, V10, P914; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; Zakeri S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-53	65	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63888	10.1371/journal.pone.0063888	http://dx.doi.org/10.1371/journal.pone.0063888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717506	gold, Green Published, Green Submitted			2022-12-27	WOS:000319435600035
J	Bryant, EK; Dressen, AS; Bunker, CH; Hokanson, JE; Hamman, RF; Kamboh, MI; Demirci, FY				Bryant, Emily K.; Dressen, Amy S.; Bunker, Clareann H.; Hokanson, John E.; Hamman, Richard F.; Kamboh, M. Ilyas; Demirci, F. Yesim			A Multiethnic Replication Study of Plasma Lipoprotein Levels-Associated SNPs Identified in Recent GWAS	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-LIPIDS; GENETIC-LOCI; POPULATION; CHOLESTEROL; VARIANTS; TRIGLYCERIDES; DISEASE; TRAITS; RISK	Genome-wide association studies (GWAS) have identified a number of loci/SNPs associated with plasma total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG) levels. The purpose of this study was to replicate 40 recent GWAS-identified HDL-C-related new loci in 3 epidemiological samples comprising U.S. non-Hispanic Whites (NHWs), U.S. Hispanics, and African Blacks. In each sample, the association analyses were performed with all 4 major lipid traits regardless of previously reported specific associations with selected SNPs. A total of 22 SNPs showed nominally significant association (p<0.05) with at least one lipid trait in at least one ethnic group, although not always with the same lipid traits reported as genome-wide significant in the original GWAS. The total number of significant loci was 10 for TC, 12 for LDL-C, 10 for HDL-C, and 6 for TG levels. Ten SNPs were significantly associated with more than one lipid trait in at least one ethnic group. Six SNPs were significantly associated with at least one lipid trait in more than one ethnic group, although not always with the same trait across various ethnic groups. For 25 SNPs, the associations were replicated with the same genome-wide significant lipid traits in the same direction in at least one ethnic group; at nominal significance for 13 SNPs and with a trend for association for 12 SNPs. However, the associations were not consistently present in all ethnic groups. This observation was consistent with mixed results obtained in other studies that also examined various ethnic groups.	[Bryant, Emily K.; Dressen, Amy S.; Bunker, Clareann H.; Kamboh, M. Ilyas; Demirci, F. Yesim] Univ Pittsburgh, GSPH, Pittsburgh, PA 15213 USA; [Hokanson, John E.; Hamman, Richard F.] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Kamboh, MI (corresponding author), Univ Pittsburgh, GSPH, Pittsburgh, PA 15213 USA.	kamboh@pitt.edu; fyd1@pitt.edu		Kamboh, M. Ilyas/0000-0002-3453-1438; Demirci, F. Yesim/0000-0001-6907-9843	National Heart, Lung and Blood Institute (NHLBI) [HL084613]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084613] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Heart, Lung and Blood Institute (NHLBI) grant, HL084613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; BUNKER CH, 1995, HYPERTENSION, V26, P616, DOI 10.1161/01.HYP.26.4.616; Bunker CH, 1996, ATHEROSCLEROSIS, V123, P215, DOI 10.1016/0021-9150(96)05810-8; Chang MH, 2011, CIRC-CARDIOVASC GENE, V4, P523, DOI 10.1161/CIRCGENETICS.111.959577; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Demirci FY, 2010, ANN NUTR METAB, V56, P59, DOI 10.1159/000268019; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; HAMMAN RF, 1989, AM J EPIDEMIOL, V129, P295, DOI 10.1093/oxfordjournals.aje.a115134; Harris MR, 1998, ATHEROSCLEROSIS, V137, P187, DOI 10.1016/S0021-9150(97)00230-X; Heid IM, 2008, CIRC-CARDIOVASC GENE, V1, P10, DOI 10.1161/CIRCGENETICS.108.776708; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Keebler ME, 2009, CIRC-CARDIOVASC GENE, V2, P238, DOI 10.1161/CIRCGENETICS.108.829473; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Lanktree MB, 2009, J LIPID RES, V50, P1487, DOI 10.1194/jlr.P900008-JLR200; Musunuru K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036473; Plenge RM, 2011, ARTHRITIS RHEUM-US, V63, P2839, DOI 10.1002/art.30509; Rewers Marian, 1993, Ethnicity and Disease, V3, P44; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76	23	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63469	10.1371/journal.pone.0063469	http://dx.doi.org/10.1371/journal.pone.0063469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717430	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700025
J	Eisinger, BE; Zhao, CJ; Driessen, TM; Saul, MC; Gammie, SC				Eisinger, Brian E.; Zhao, Changjiu; Driessen, Terri M.; Saul, Michael C.; Gammie, Stephen C.			Large Scale Expression Changes of Genes Related to Neuronal Signaling and Developmental Processes Found in Lateral Septum of Postpartum Outbred Mice	PLOS ONE			English	Article							MESSENGER-RNA; BEHAVIORAL-RESPONSES; MATERNAL AGGRESSION; KNOCKOUT MICE; BRAIN; ACTIVATION; INHIBITION; PLASTICITY; RECEPTORS; CHANNELS	Coordinated gene expression changes across the CNS are required to produce the mammalian maternal phenotype. Lateral septum (LS) is a brain region critically involved with aspects of maternal care, and we recently examined gene expression of whole septum (LS and medial septum) in selectively bred maternal mice. Here, we expand on the prior study by 1) conducting microarray analysis solely on LS in virgin and postpartum mice, 2) using outbred mice, and 3) evaluating the role of sensory input on gene expression changes. Large scale changes in genes related to neuronal signaling were identified, including four GABA(A) receptor subunits. Subunits alpha 4 and delta were downregulated in maternal LS, likely reflecting a reduction in the extrasynaptic, neurosteroid-sensitive alpha 4/delta containing receptor subtype. Conversely, subunits epsilon and theta were increased in maternal LS. Fifteen K+ channel related genes showed altered expression, as did dopamine receptors Drd1a and Drd2 (both downregulated), hypocretin receptor 1 (Hcrtr1), kappa opioid receptor 1 (Oprk1), and transient receptor potential channel 4 (Trpc4). Expression of a large number of genes linked to developmental processes or cell differentiation were also altered in postpartum LS, including chemokine (C-X-C) motif ligand 12 (Cxcl12), fatty acid binding protein 7 (Fabp7), plasma membrane proteolipid (Pllp), and suppressor of cytokine signaling 2 (Socs2). Additional genes that are linked to anxiety, such as glutathione reductase (Gsr), exhibited altered expression. Pathway analysis also identified changes in genes related to cyclic nucleotide metabolism, chromatin structure, and the Ras gene family. The sensory presence of pups was found to contribute to the altered expression of a subset of genes across all categories. This study suggests that both large changes in neuronal signaling and the possible terminal differentiation of neuronal and/or glial cells play important roles in producing the maternal state.	[Eisinger, Brian E.; Zhao, Changjiu; Driessen, Terri M.; Saul, Michael C.; Gammie, Stephen C.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Gammie, Stephen C.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Eisinger, BE (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	beeisinger@wisc.edu	Zhao, Changjiu/M-8263-2014; Saul, Michael C./N-9303-2019	Saul, Michael C./0000-0002-4916-8619	United States National Institutes of Health [R01 MH 085642]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085642] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by United States National Institutes of Health Grant R01 MH 085642 to S.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; Arosh JA, 2002, BIOL REPROD, V67, P161, DOI 10.1095/biolreprod67.1.161; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Banisadr G, 2003, EUR J NEUROSCI, V18, P1593, DOI 10.1046/j.1460-9568.2003.02893.x; Bradley J, 1997, J NEUROSCI, V17, P1993; Broad KD, 2006, PHILOS T R SOC B, V361, P2199, DOI 10.1098/rstb.2006.1940; Bruchas MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008528; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Childs E, 2008, NEUROPSYCHOPHARMACOL, V33, P2791, DOI 10.1038/npp.2008.17; COCHARY EF, 1990, J NEUROCHEM, V55, P602, DOI 10.1111/j.1471-4159.1990.tb04176.x; D'Anna KL, 2006, J NEUROENDOCRINOL, V18, P553, DOI 10.1111/j.1365-2826.2006.01448.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espana RA, 2004, PEPTIDES, V25, P1927, DOI 10.1016/j.peptides.2004.06.006; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; FISCHER I, 1991, J NEUROSCI RES, V28, P81, DOI 10.1002/jnr.490280108; Gammie SC, 2005, MOL BRAIN RES, V139, P201, DOI 10.1016/j.molbrainres.2005.05.011; Gerstner JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001631; Gordon N, 1997, BRAIN DEV-JPN, V19, P165, DOI 10.1016/S0387-7604(96)00560-8; GRAVES RA, 1987, CELL, V48, P615, DOI 10.1016/0092-8674(87)90240-6; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kuroda KO, 2011, PROG NEURO-PSYCHOPH, V35, P1205, DOI 10.1016/j.pnpbp.2011.02.008; Lambert Jeremy J, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS48, DOI 10.1016/j.psyneuen.2009.08.009; Lee G, 2009, BEHAV NEUROSCI, V123, P1169, DOI 10.1037/a0017535; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; Levy F, 2011, J NEUROENDOCRINOL, V23, P984, DOI 10.1111/j.1365-2826.2011.02203.x; Li MZ, 2009, SEMIN CANCER BIOL, V19, P111, DOI 10.1016/j.semcancer.2008.11.001; LISK RD, 1971, ANIM BEHAV, V19, P606, DOI 10.1016/S0003-3472(71)80118-5; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; MAKINO S, 1994, BRAIN RES, V657, P141, DOI 10.1016/0006-8993(94)90961-X; MANN PE, 1992, BRAIN RES, V580, P241, DOI 10.1016/0006-8993(92)90950-E; MANN PE, 1989, PHARMACOL BIOCHEM BE, V34, P83, DOI 10.1016/0091-3057(89)90357-2; McLaughlin JP, 2006, NEUROPSYCHOPHARMACOL, V31, P1241, DOI 10.1038/sj.npp.1300872; MONTAGNESE CM, 1987, J ENDOCRINOL, V115, P97, DOI 10.1677/joe.0.1150097; Nephew BC, 2009, BEHAV NEUROSCI, V123, P949, DOI 10.1037/a0016734; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Phelan KD, 2012, MOL PHARMACOL, V81, P384, DOI 10.1124/mol.111.075341; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; Ransome MI, 2004, EUR J NEUROSCI, V19, P2069, DOI 10.1111/j.0953-816X.2004.03308.x; RASMUS K, 2011, NATURE PRECEDINGS; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Risold PY, 1997, BRAIN RES REV, V24, P91, DOI 10.1016/S0165-0173(97)00008-8; ROMANO GJ, 1988, MOL ENDOCRINOL, V2, P1320, DOI 10.1210/mend-2-12-1320; Sakurai T, 1998, Cell, V92, P696; SAPIRSTEIN VS, 1988, J NEUROCHEM, V51, P925, DOI 10.1111/j.1471-4159.1988.tb01829.x; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Sergeeva OA, 2003, J NEUROCHEM, V85, P1547, DOI 10.1046/j.1471-4159.2003.01806.x; SHEA TB, 1986, J NEUROCHEM, V47, P697; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Simmons ML, 1996, MOL PHARMACOL, V50, P80; Sinkkonen ST, 2004, EUR J NEUROSCI, V20, P2168, DOI 10.1111/j.1460-9568.2004.03684.x; SITTMAN DB, 1983, P NATL ACAD SCI-BIOL, V80, P1849, DOI 10.1073/pnas.80.7.1849; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; SLOTNICK BM, 1975, J COMP PHYSIOL PSYCH, V88, P118, DOI 10.1037/h0076200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Turnley AM, 2005, TRENDS ENDOCRIN MET, V16, P53, DOI 10.1016/j.tem.2005.01.006; Vandamme J, 2012, CELL SIGNAL, V24, P1610, DOI 10.1016/j.cellsig.2012.04.001; VANDERSCHUREN LJMJ, 1995, EUR J PHARMACOL, V276, P257, DOI 10.1016/0014-2999(95)00040-R; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; Wang JP, 2002, J NEUROSCI RES, V67, P423, DOI 10.1002/jnr.10145; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; Wisden W, 2002, NEUROPHARMACOLOGY, V43, P530, DOI 10.1016/S0028-3908(02)00151-X; Zhao CJ, 2012, BRAIN RES, V1470, P35, DOI 10.1016/j.brainres.2012.06.002; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038602; Zufall F, 1997, CURR OPIN NEUROBIOL, V7, P404, DOI 10.1016/S0959-4388(97)80070-0	74	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63824	10.1371/journal.pone.0063824	http://dx.doi.org/10.1371/journal.pone.0063824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717492	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700067
J	Huoviala, P; Rantala, MJ				Huoviala, Paavo; Rantala, Markus J.			A Putative Human Pheromone, Androstadienone, Increases Cooperation between Men	PLOS ONE			English	Article							IBERIAN ROCK LIZARDS; ULTIMATUM GAME; BRAIN RESPONSE; SEX-PHEROMONE; FEMALE MICE; MALE ODOR; SIGNALS; ATTRACTIVENESS; TESTOSTERONE; WOMEN	Androstadienone, a component of male sweat, has been suggested to function as a human pheromone, an airborne chemical signal causing specific responses in conspecifics. In earlier studies androstadienone has been reported to increase attraction, affect subjects' mood, cortisol levels and activate brain areas linked to social cognition, among other effects. However, the existing psychological evidence is still relatively scarce, especially regarding androstadienone's effects on male behaviour. The purpose of this study was to look for possible behavioural effects in male subjects by combining two previously distinct branches of research: human pheromone research and behavioural game theory of experimental economics. Forty male subjects participated in a mixed-model, double-blind, placebo-controlled experiment. The participants were exposed to either androstadienone or a control stimulus, and participated in ultimatum and dictator games, decision making tasks commonly used to measure cooperation and generosity quantitatively. Furthermore, we measured participants' salivary cortisol and testosterone levels during the experiment. Salivary testosterone levels were found to positively correlate with cooperative behaviour. After controlling for the effects of participants' baseline testosterone levels, androstadienone was found to increase cooperative behaviour in the decision making tasks. To our knowledge, this is the first study to show that androstadienone directly affects behaviour in human males.	[Huoviala, Paavo; Rantala, Markus J.] Univ Turku, Dept Behav Sci & Philosophy, Turku, Finland; [Rantala, Markus J.] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland	University of Turku; University of Turku	Rantala, MJ (corresponding author), Univ Turku, Dept Behav Sci & Philosophy, Turku, Finland.	markus.rantala@utu.fi		Huoviala, Paavo/0000-0002-6072-7979	Academy of Finland [2608001]	Academy of Finland(Academy of Finland)	The study was financially supported by the Academy of Finland (grant number 2608001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensafi A, 2004, BEHAV BRAIN RES, V152, P11, DOI 10.1016/j.bbr.2003.09.009; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; CAMERER C, 1995, J ECON PERSPECT, V9, P209, DOI 10.1257/jep.9.2.209; Camerer C, 2003, BEHAV GAME THEORY; Cornwell RE, 2004, P ROY SOC B-BIOL SCI, V271, P635, DOI 10.1098/rspb.2003.2649; Eisenegger C, 2010, NATURE, V463, P356, DOI 10.1038/nature08711; Farrelly Daniel, 2007, EVOLUTIONARY PSYCHOL, V5, P313, DOI DOI 10.1177/147470490700500205; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; Grosser BI, 2000, PSYCHONEUROENDOCRINO, V25, P289, DOI 10.1016/S0306-4530(99)00056-6; Gulyas B, 2004, NEUROCHEM INT, V44, P595, DOI 10.1016/j.neuint.2003.10.003; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; Havlicek J, 2010, VITAM HORM, V83, P47, DOI 10.1016/S0083-6729(10)83003-1; Hummer TA, 2009, HORM BEHAV, V55, P548, DOI 10.1016/j.yhbeh.2009.01.002; Jacob S, 2000, HORM BEHAV, V37, P57, DOI 10.1006/hbeh.1999.1559; KAVALIERS M, 1995, P ROY SOC B-BIOL SCI, V261, P31, DOI 10.1098/rspb.1995.0113; Martin J, 2006, FUNCT ECOL, V20, P1087, DOI 10.1111/j.1365-2435.2006.01183.x; Martin J, 2007, FUNCT ECOL, V21, P568, DOI 10.1111/j.1365-2435.2007.01262.x; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Millet K, 2009, BRIT J PSYCHOL, V100, P151, DOI 10.1348/000712608X324359; Moore PJ, 1997, NATURE, V389, P25, DOI 10.1038/37888; NOVOTNY M, 1990, EXPERIENTIA, V46, P109, DOI 10.1007/BF01955433; Penn D, 1998, ETHOLOGY, V104, P685, DOI 10.1111/j.1439-0310.1998.tb00102.x; Piferi RL, 2000, INT J PSYCHOPHYSIOL, V37, P207, DOI 10.1016/S0167-8760(00)00102-1; Rantala MJ, 2002, P ROY SOC B-BIOL SCI, V269, P1681, DOI 10.1098/rspb.2002.2056; Ruther J, 2009, P ROY SOC B-BIOL SCI, V276, P3303, DOI 10.1098/rspb.2009.0738; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Saxton TK, 2008, HORM BEHAV, V54, P597, DOI 10.1016/j.yhbeh.2008.06.001; Solnick SJ, 1999, ORGAN BEHAV HUM DEC, V79, P199, DOI 10.1006/obhd.1999.2843; STYLIANOU M, 1961, J BIOL CHEM, V236, P692; Thornhill R, 1999, EVOL HUM BEHAV, V20, P175, DOI 10.1016/S1090-5138(99)00005-7; Van den Bergh B, 2006, P R SOC B, V273, P2091, DOI 10.1098/rspb.2006.3550; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; Zaatari D, 2007, EVOL HUM BEHAV, V28, P223, DOI 10.1016/j.evolhumbehav.2007.02.002; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128; Zak PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008330	39	30	30	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e62499	10.1371/journal.pone.0062499	http://dx.doi.org/10.1371/journal.pone.0062499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717389	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700003
J	Moyle, PB; Kiernan, JD; Crain, PK; Quinones, RM				Moyle, Peter B.; Kiernan, Joseph D.; Crain, Patrick K.; Quinones, Rebecca M.			Climate Change Vulnerability of Native and Alien Freshwater Fishes of California: A Systematic Assessment Approach	PLOS ONE			English	Article							SAN-FRANCISCO ESTUARY; BIODIVERSITY; IMPACTS; DECLINE; THREATS	Freshwater fishes are highly vulnerable to human-caused climate change. Because quantitative data on status and trends are unavailable for most fish species, a systematic assessment approach that incorporates expert knowledge was developed to determine status and future vulnerability to climate change of freshwater fishes in California, USA. The method uses expert knowledge, supported by literature reviews of status and biology of the fishes, to score ten metrics for both (1) current status of each species (baseline vulnerability to extinction) and (2) likely future impacts of climate change (vulnerability to extinction). Baseline and climate change vulnerability scores were derived for 121 native and 43 alien fish species. The two scores were highly correlated and were concordant among different scorers. Native species had both greater baseline and greater climate change vulnerability than did alien species. Fifty percent of California's native fish fauna was assessed as having critical or high baseline vulnerability to extinction whereas all alien species were classified as being less or least vulnerable. For vulnerability to climate change, 82% of native species were classified as highly vulnerable, compared with only 19% for aliens. Predicted climate change effects on freshwater environments will dramatically change the fish fauna of California. Most native fishes will suffer population declines and become more restricted in their distributions; some will likely be driven to extinction. Fishes requiring cold water (<22 degrees C) are particularly likely to go extinct. In contrast, most alien fishes will thrive, with some species increasing in abundance and range. However, a few alien species will likewise be negatively affected through loss of aquatic habitats during severe droughts and physiologically stressful conditions present in most waterways during summer. Our method has high utility for predicting vulnerability to climate change of diverse fish species. It should be useful for setting conservation priorities in many different regions.	[Moyle, Peter B.; Kiernan, Joseph D.; Crain, Patrick K.; Quinones, Rebecca M.] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA; [Moyle, Peter B.; Kiernan, Joseph D.; Crain, Patrick K.; Quinones, Rebecca M.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Kiernan, Joseph D.] NOAA, Fisheries Ecol Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Santa Cruz, CA USA; [Crain, Patrick K.] ICF Int, Sacramento, CA USA; [Quinones, Rebecca M.] Tech Univ Munich, Lehrstuhl Aquat Systembiol, Freising Weihenstephan, Germany	University of California System; University of California Davis; University of California System; University of California Davis; National Oceanic Atmospheric Admin (NOAA) - USA; Technical University of Munich	Moyle, PB (corresponding author), Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA.	pbmoyle@ucdavis.edu	Kiernan, Joseph/S-3613-2019		California Energy Commission	California Energy Commission	Funding for this work was provided by the California Energy Commission. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. An earlier version of the manuscript is available as a report (CEC-500-2012-028) at http://www.energy.ca.gov/publications.	[Anonymous], CONSERVATION BIOL TH; Aparicio E, 2000, ENVIRON BIOL FISH, V59, P11, DOI 10.1023/A:1007618517557; Aparicio E, 2011, AQUAT CONSERV, V21, P324, DOI 10.1002/aqc.1197; Arthington A.H, 2012, ENV FLOWS SAVING RIV; Carlisle DM, 2011, FRONT ECOL ENVIRON, V9, P264, DOI 10.1890/100053; Donley EE, 2012, GLOBAL CHANGE BIOL, V18, P3071, DOI 10.1111/j.1365-2486.2012.02773.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Galbraith H, 2009, EPA600R09011 NAT CTR; Galbraith H, 2011, SCANNING CONSERVATIO, P90; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Geist J, 2011, ECOL INDIC, V11, P1507, DOI 10.1016/j.ecolind.2011.04.002; Hanak E., 2011, MANAGING CALIFORNIAS; Helfman G. S., 2007, FISH CONSERVATION; Katz JVE, 2012, ENV BIOL FISHES; Kaushal SS, 2010, FRONT ECOL ENVIRON, V8, P461, DOI 10.1890/090037; Kiernan JD, 2012, ECOL APPL, V22, P1472; Kiernan JD, 2012, ECOL APPL, V22, P1146, DOI 10.1890/11-1047.1; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; Leidy RA, 2011, AQUAT CONSERV, V21, P472, DOI 10.1002/aqc.1208; Miller NL, 2003, J AM WATER RESOUR AS, V39, P771, DOI 10.1111/j.1752-1688.2003.tb04404.x; Moyle P, 2008, SALMON STEELHEAD TRO; Moyle P.B., 2002, INLAND FISHES CALIFO; Moyle P.B., 1995, FISH SPECIES SPECIAL; Moyle PB, 2012, CALIFORNIA ENERGY CO, VCEC-500-2012-028; Moyle PB, 2013, FISH SPECIE IN PRESS; Moyle PB, 2011, BIOL CONSERV, V144, P2414, DOI 10.1016/j.biocon.2011.06.002; Null S, 2012, CLIMATIC CHANGE, P1; Quinones RM, 2013, LINKING SCI MANAGEME; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wenger SJ, 2011, P NATL ACAD SCI	30	100	102	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63883	10.1371/journal.pone.0063883	http://dx.doi.org/10.1371/journal.pone.0063883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717503	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700075
J	Tamir, S; Zuris, JA; Agranat, L; Lipper, CH; Conlan, AR; Michaeli, D; Harir, Y; Paddock, ML; Mittler, R; Cabantchik, ZI; Jennings, PA; Nechushtai, R				Tamir, Sagi; Zuris, John A.; Agranat, Lily; Lipper, Colin H.; Conlan, Andrea R.; Michaeli, Dorit; Harir, Yael; Paddock, Mark L.; Mittler, Ron; Cabantchik, Zvi Ioav; Jennings, Patricia A.; Nechushtai, Rachel			Nutrient-Deprivation Autophagy Factor-1 (NAF-1): Biochemical Properties of a Novel Cellular Target for Anti-Diabetic Drugs	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PROTEIN; CRYSTAL-STRUCTURE; HUMAN MITONEET; IRON; THIAZOLIDINEDIONE; CELLS; GLUTATHIONE; LIGANDS; STRESS; MICE	Nutrient-deprivation autophagy factor-1 (NAF-1) (synonyms: Cisd2, Eris, Miner1, and Noxp70) is a [2Fe-2S] cluster protein immune-detected both in endoplasmic reticulum (ER) and mitochondrial outer membrane. It was implicated in human pathology (Wolfram Syndrome 2) and in BCL-2 mediated antagonization of Beclin 1-dependent autophagy and depression of ER calcium stores. To gain insights about NAF-1 functions, we investigated the biochemical properties of its 2Fe-2S cluster and sensitivity of those properties to small molecules. The structure of the soluble domain of NAF-1 shows that it forms a homodimer with each protomer containing a [2Fe-2S] cluster bound by 3 Cys and one His. NAF-1 has shown the unusual abilities to transfer its 2Fe-2S cluster to an apo-acceptor protein (followed in vitro by spectrophotometry and by native PAGE electrophoresis) and to transfer iron to intact mitochondria in cell models (monitored by fluorescence imaging with iron fluorescent sensors targeted to mitochondria). Importantly, the drug pioglitazone abrogates NAF-1's ability to transfer the cluster to acceptor proteins and iron to mitochondria. Similar effects were found for the anti-diabetes and longevity-promoting antioxidant resveratrol. These results reveal NAF-1 as a previously unidentified cell target of anti-diabetes thiazolidinedione drugs like pioglitazone and of the natural product resveratrol, both of which interact with the protein and stabilize its labile [2Fe-2S] cluster.	[Tamir, Sagi; Agranat, Lily; Michaeli, Dorit; Harir, Yael; Cabantchik, Zvi Ioav; Nechushtai, Rachel] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Jerusalem, Israel; [Zuris, John A.; Lipper, Colin H.; Conlan, Andrea R.; Paddock, Mark L.; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Zuris, John A.; Lipper, Colin H.; Conlan, Andrea R.; Paddock, Mark L.; Jennings, Patricia A.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Mittler, Ron] Univ N Texas, Dept Biol, Denton, TX 76203 USA	Hebrew University of Jerusalem; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Texas System; University of North Texas Denton	Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pajennings@ucsd.edu; rachel@vms.huji.ac.il	Mittler, Ron/ABE-6496-2020		Israel Science Foundation (ISF) [ISF 863/09, ISF 141/06]; Canadian Friends of the Hebrew University [ISF 214/08]; European Union; Cell and Molecular Genetics Training (CMG) [2T32GM007240-29]; National Institutes of Health (NIH) [GM54038]; NIH [GM101467]; Heme and Blood Proteins Training [5T32DK007233-34]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054038, R01GM101467, R01GM054038, T32GM007240] Funding Source: NIH RePORTER	Israel Science Foundation (ISF)(Israel Science Foundation); Canadian Friends of the Hebrew University; European Union(European Commission); Cell and Molecular Genetics Training (CMG); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heme and Blood Proteins Training; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following: the Israel Science Foundation (ISF) grant ISF 863/09 awarded to RN; ISF 141/06 and a grant from the Canadian Friends of the Hebrew University awarded to ZIC; ISF 214/08 and the European Union Grant FP7-Marie Curie 447 awarded to RM; the Cell and Molecular Genetics Training (CMG) grant 2T32GM007240-29 awarded to ARC; National Institutes of Health (NIH) GM54038 and NIH GM101467 to PAJ; and the Heme and Blood Proteins Training grant 5T32DK007233-34 to JAZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Bieganski RM, 2011, J MOL GRAPH MODEL, V29, P965, DOI 10.1016/j.jmgm.2011.04.001; Boucquey M, 2006, J NEUROCHEM, V99, P657, DOI 10.1111/j.1471-4159.2006.04093.x; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chang NC, 2012, HUM MOL GENET, V21, P2277, DOI 10.1093/hmg/dds048; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chen YF, 2010, ANN NY ACAD SCI, V1201, P58, DOI 10.1111/j.1749-6632.2010.05619.x; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Conlan AR, 2009, J MOL BIOL, V392, P143, DOI 10.1016/j.jmb.2009.06.079; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Fish A, 2005, J MOL BIOL, V350, P599, DOI 10.1016/j.jmb.2005.04.071; Gardner OS, 2005, J BIOL CHEM, V280, P10109, DOI 10.1074/jbc.M410445200; Geldenhuys WJ, 2011, BIOORG MED CHEM LETT, V21, P5498, DOI 10.1016/j.bmcl.2011.06.111; Glickstein H, 2005, BLOOD, V106, P3242, DOI 10.1182/blood-2005-02-0460; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Hu YS, 2011, J ENDOCRINOL, V208, pR1, DOI 10.1677/JOE-10-0393; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Petrat F, 2002, BIOCHEM J, V362, P137, DOI 10.1042/0264-6021:3620137; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Shvartsman M, 2007, AM J PHYSIOL-CELL PH, V293, pC1383, DOI 10.1152/ajpcell.00054.2007; Sohn YS, 2008, BLOOD, V111, P1690, DOI 10.1182/blood-2007-07-102335; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wu G, 2002, BIOCHEMISTRY-US, V41, P5024, DOI 10.1021/bi016073s; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	27	41	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e61202	10.1371/journal.pone.0061202	http://dx.doi.org/10.1371/journal.pone.0061202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717386	gold, Green Published			2022-12-27	WOS:000320362700001
J	Cifola, I; Pietrelli, A; Consolandi, C; Severgnini, M; Mangano, E; Russo, V; De Bellis, G; Battaglia, C				Cifola, Ingrid; Pietrelli, Alessandro; Consolandi, Clarissa; Severgnini, Marco; Mangano, Eleonora; Russo, Vincenzo; De Bellis, Gianluca; Battaglia, Cristina			Comprehensive Genomic Characterization of Cutaneous Malignant Melanoma Cell Lines Derived from Metastatic Lesions by Whole-Exome Sequencing and SNP Array Profiling	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; PROTEIN-COUPLED RECEPTORS; METABOTROPIC GLUTAMATE-RECEPTOR-1; KINASE PATHWAY; MUTATIONS; EXPRESSION; GALANIN; BRAF; METALLOPROTEINASE; IDENTIFICATION	Cutaneous malignant melanoma is the most fatal skin cancer and although improved comprehension of its pathogenic pathways allowed to realize some effective molecular targeted therapies, novel targets and drugs are still needed. Aiming to add genetic information potentially useful for novel targets discovery, we performed an extensive genomic characterization by whole-exome sequencing and SNP array profiling of six cutaneous melanoma cell lines derived from metastatic patients. We obtained a total of 3,325 novel coding single nucleotide variants, including 2,172 non-synonymous variants. We catalogued the coding mutations according to Sanger COSMIC database and to a manually curated list including genes involved in melanoma pathways identified by mining recent literature. Besides confirming the presence of known melanoma driver mutations (BRAF(V600E), NRAS(Q61R)), we identified novel mutated genes involved in signalling pathways crucial for melanoma pathogenesis and already addressed by current targeted therapies (such as MAPK and glutamate pathways). We also identified mutations in four genes (MUC19, PAICS, RBMXL1, KIF23) never reported in melanoma, which might deserve further investigations. All data are available to the entire research community in our Melanoma Exome Database (at https://155.253.6.64/MExDB/). In summary, these cell lines are valuable biological tools to improve the genetic comprehension of this complex cancer disease and to study functional relevance of individual mutational events, and these findings could provide insights potentially useful for identification of novel therapeutic targets for cutaneous malignant melanoma.	[Cifola, Ingrid; Pietrelli, Alessandro; Consolandi, Clarissa; Severgnini, Marco; Mangano, Eleonora; De Bellis, Gianluca; Battaglia, Cristina] CNR, Inst Biomed Technol, Milan, Italy; [Russo, Vincenzo] Ist Sci San Raffaele, Canc Gene Therapy Unit, I-20132 Milan, Italy; [Battaglia, Cristina] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan	Cifola, I (corresponding author), CNR, Inst Biomed Technol, Milan, Italy.	ingrid.cifola@itb.cnr.it	Pietrelli, Alessandro/J-4389-2016; Mangano, Eleonora/P-7028-2018; Russo, Vincenzo/K-5650-2016; Battaglia, Cristina/E-5166-2017; Severgnini, Marco/F-5832-2013; De Bellis, Gianluca/H-9725-2013	Pietrelli, Alessandro/0000-0003-0241-8542; Mangano, Eleonora/0000-0002-4040-4654; Russo, Vincenzo/0000-0003-1592-5041; Battaglia, Cristina/0000-0003-3025-9657; Severgnini, Marco/0000-0001-8655-1206; De Bellis, Gianluca/0000-0002-1622-4477; CIFOLA, INGRID/0000-0003-2819-1171	Cariplo Foundation grant (Genomic, epigenetic and transcriptional analysis of cancer by next-generation sequencing) [2006.0771]; PhD School of Molecular Medicine of University of Milan	Cariplo Foundation grant (Genomic, epigenetic and transcriptional analysis of cancer by next-generation sequencing); PhD School of Molecular Medicine of University of Milan	This work was supported by Cariplo Foundation grant (Genomic, epigenetic and transcriptional analysis of cancer by next-generation sequencing, Rif. 2006.0771) and by PhD School of Molecular Medicine of University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Atefi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028973; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bozic M, 2011, J AM SOC NEPHROL, V22, P1099, DOI 10.1681/ASN.2010070701; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Choi JS, 2009, INT J CANCER, V124, P1258, DOI 10.1002/ijc.24023; D'Abaco GM, 2006, NEUROSURGERY, V58, P179, DOI 10.1227/01.NEU.0000192363.84287.8B; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies MA, 2010, ONCOGENE, V29, P5545, DOI 10.1038/onc.2010.323; Dutton-Regester K, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00975.x; El Hour M, 2010, ONCOGENE, V29, P3025, DOI 10.1038/onc.2010.49; Flaherty K, 2012, ONCOGENE; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoeflich KP, 2006, INT J ONCOL, V29, P839; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; Jia M, 2010, PROTEOM CLIN APPL, V4, P816, DOI 10.1002/prca.201000006; Kanazawa T, 2007, ONCOGENE, V26, P5762, DOI 10.1038/sj.onc.1210384; Kim YS, 2011, BIOCHEM BIOPH RES CO, V404, P96, DOI 10.1016/j.bbrc.2010.11.071; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lambros MBK, 2005, J PATHOL, V205, P29, DOI 10.1002/path.1681; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lee HJ, 2011, CLIN CANCER RES, V17, P7080, DOI 10.1158/1078-0432.CCR-11-0098; Llamazares M, 2007, J CELL SCI, V120, P3544, DOI 10.1242/jcs.005751; Lo PHY, 2007, ONCOGENE, V26, P148, DOI 10.1038/sj.onc.1209767; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Marin YE, 2005, NEUROPHARMACOLOGY, V49, P70, DOI 10.1016/j.neuropharm.2005.05.018; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mitsukawa K, 2008, CELL MOL LIFE SCI, V65, P1796, DOI 10.1007/s00018-008-8153-8; Moncada-Pazos A, 2009, J CELL SCI, V122, P2906, DOI 10.1242/jcs.050468; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Oka D, 2009, CANCER-AM CANCER SOC, V115, P3412, DOI 10.1002/cncr.24394; Orgaz JL, 2012, PIGMENT CELL MELANOM; Park SY, 2011, VIRCHOWS ARCH, V458, P73, DOI 10.1007/s00428-010-1013-6; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Samuels Y, 2011, CURR TOP MICROBIOL, V347, P21, DOI 10.1007/82_2010_68; Scrima M, 2012, AM J PATHOL, V180, P1202, DOI 10.1016/j.ajpath.2011.11.038; Shin SS, 2008, PIGM CELL MELANOMA R, V21, P368, DOI 10.1111/j.1755-148X.2008.00452.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Stepulak A, 2005, P NATL ACAD SCI USA, V102, P15605, DOI 10.1073/pnas.0507679102; Takada H, 2005, ONCOGENE, V24, P8051, DOI 10.1038/sj.onc.1208952; Tamura H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-220; Villablanca EJ, 2010, NAT MED, V16, P98, DOI 10.1038/nm.2074; Walia V, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00976.x; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wei XM, 2010, MOL CANCER RES, V8, P1513, DOI 10.1158/1541-7786.MCR-10-0262; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wittau N, 2000, ONCOGENE, V19, P4199, DOI 10.1038/sj.onc.1203777	60	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63597	10.1371/journal.pone.0063597	http://dx.doi.org/10.1371/journal.pone.0063597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704925	Green Submitted, gold, Green Published			2022-12-27	WOS:000319330200056
J	Tanikawa, C; Matsuo, K; Kubo, M; Takahashi, A; Ito, H; Tanaka, H; Yatabe, Y; Yamao, K; Kamatani, N; Tajima, K; Nakamura, Y; Matsuda, K				Tanikawa, Chizu; Matsuo, Keitaro; Kubo, Michiaki; Takahashi, Atsushi; Ito, Hidemi; Tanaka, Hideo; Yatabe, Yasushi; Yamao, Kenji; Kamatani, Naoyuki; Tajima, Kazuo; Nakamura, Yusuke; Matsuda, Koichi			Impact of PSCA Variation on Gastric Ulcer Susceptibility	PLOS ONE			English	Article							STEM-CELL ANTIGEN; HELICOBACTER-PYLORI INFECTION; GENOME-WIDE ASSOCIATION; DUODENAL-ULCER; PEPTIC-ULCER; GENETIC POLYMORPHISMS; BLADDER-CANCER; ERADICATION; POPULATION; EXPRESSION	Peptic ulcer is one of the most common gastrointestinal disorders with complex etiology. Recently we conducted the genome wide association study for duodenal ulcer and identified disease susceptibility variations at two genetic loci corresponding to the Prostate stem cell antigen (PSCA) gene and the ABO blood group (ABO) gene. Here we investigated the association of these variations with gastric ulcer in two Japanese case-control sample sets, a total of 4,291 gastric ulcer cases and 22,665 controls. As a result, a C-allele of rs2294008 at PSCA increased the risk of gastric ulcer with odds ratio (OR) of 1.13 (P value of 5.85x10(-7)) in an additive model. On the other hand, SNP rs505922 on ABO exhibited inconsistent result between two cohorts. Our finding implies presence of the common genetic variant in the pathogenesis of gastric and duodenal ulcers.	[Tanikawa, Chizu; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Matsuo, Keitaro; Ito, Hidemi; Tanaka, Hideo; Tajima, Kazuo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Aichi, Japan; [Yatabe, Yasushi] Aichi Canc Ctr, Res Inst, Dept Pathol & Mol Diagnost, Aichi, Japan; [Yamao, Kenji] Aichi Canc Ctr, Res Inst, Dept Gastroenterol, Aichi, Japan; [Kamatani, Naoyuki] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Kanagawa, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Ctr Personalized Therapeut, Chicago, IL 60637 USA	University of Tokyo; Aichi Cancer Center; Aichi Cancer Center; Aichi Cancer Center; RIKEN; University of Chicago; University of Chicago; University of Chicago	Matsuda, K (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.	koichima@ims.u-tokyo.ac.jp	Matsuo, Keitaro/H-6758-2019; Kubo, Michiaki/N-7947-2015; Tanaka, Hideo/A-8145-2016; YATABE, Yasushi/J-6461-2014; Matsuda, Koichi/D-4597-2011	Matsuo, Keitaro/0000-0003-1761-6314; YATABE, Yasushi/0000-0003-1788-559X; Matsuda, Koichi/0000-0001-7292-2686	Ministry of Education, Culture, Sports, Science and Technology of Japan [Priority Areas of Cancer] [17015018]; Ministry of Education, Culture, Sports, Science and Technology of Japan [Innovative Areas] [221S0001]; Ministry of Health, Welfare and Labours of Japan [H24-3-G002, H23-Application(cancer)-G002]	Ministry of Education, Culture, Sports, Science and Technology of Japan [Priority Areas of Cancer]; Ministry of Education, Culture, Sports, Science and Technology of Japan [Innovative Areas]; Ministry of Health, Welfare and Labours of Japan	The Aichi part of the study was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan [Priority Areas of Cancer (No. 17015018) and Innovative Areas (No. 221S0001)] and from Ministry of Health, Welfare and Labours of Japan [H24-3-G002 and H23-Application(cancer)-G002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; ARAKI S, 1985, J EPIDEMIOL COMMUN H, V39, P82, DOI 10.1136/jech.39.1.82; Argent RH, 2007, CLIN INFECT DIS, V45, P1204, DOI 10.1086/522177; Arisawa T, 2007, INT J MOL MED, V20, P373; Bahrenberg G, 2000, BIOCHEM BIOPH RES CO, V275, P783, DOI 10.1006/bbrc.2000.3393; Brenner H, 2000, GASTROENTEROLOGY, V118, P31, DOI 10.1016/S0016-5085(00)70411-2; Brenner H, 1998, BRIT MED J, V316, P665, DOI 10.1136/bmj.316.7132.665; Breslow N E, 1987, IARC Sci Publ, P1; Chen TS, 2005, J CLIN GASTROENTEROL, V39, P699, DOI 10.1097/01.mcg.0000173854.55172.ee; Dalen AGD, 2003, INT J CANCER, V103, P768, DOI 10.1002/ijc.10903; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Furuta T, 2001, CLIN PHARMACOL THER, V69, P158, DOI 10.1067/mcp.2001.113959; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Gu ZN, 2005, CANCER RES, V65, P9495, DOI 10.1158/0008-5472.CAN-05-2086; Hatakeyama M, 2009, J GASTROENTEROL, V44, P239, DOI 10.1007/s00535-009-0014-1; Hopkins RJ, 1996, GASTROENTEROLOGY, V110, P1244, DOI 10.1053/gast.1996.v110.pm8613015; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kawaguchi T, 2010, JPN J CLIN ONCOL, V40, P319, DOI 10.1093/jjco/hyp181; Kohaar I, 2013, J NATL CANCER I, V105, P69, DOI 10.1093/jnci/djs458; Lanas A, 2001, GENES IMMUN, V2, P415, DOI 10.1038/sj.gene.6363798; Leung WK, 2006, SCAND J GASTROENTERO, V41, P274, DOI 10.1080/00365520510024269; Lu H, 2005, GASTROENTEROLOGY, V128, P833, DOI 10.1053/j.gastro.2005.01.009; Marra E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-129; MARSHALL BJ, 1994, AM J GASTROENTEROL, V89, pS116; MARSHALL BJ, 1988, LANCET, V2, P1437; Michel M, 2004, BLOOD, V103, P890, DOI 10.1182/blood-2003-03-0900; Montalban C, 2001, GUT, V49, P584, DOI 10.1136/gut.49.4.584; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Ohara T, 2003, HEPATO-GASTROENTEROL, V50, P1774; Ono H, 2012, GENE CHROMOSOME CANC, V51, P30, DOI 10.1002/gcc.20928; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raff AB, 2009, CANCER LETT, V277, P126, DOI 10.1016/j.canlet.2008.08.034; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Rokkas T, 2007, HELICOBACTER, V12, P32, DOI 10.1111/j.1523-5378.2007.00563.x; Saeki N, 2010, CLIN CANCER RES, V16, P3533, DOI 10.1158/1078-0432.CCR-09-3169; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; SCHLEMPER RJ, 1993, SCAND J GASTROENTERO, V28, P33, DOI 10.3109/00365529309101573; Schlesinger P K, 1992, J Assoc Acad Minor Phys, V3, P70; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154	42	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63698	10.1371/journal.pone.0063698	http://dx.doi.org/10.1371/journal.pone.0063698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704932	Green Submitted, gold, Green Published			2022-12-27	WOS:000319330200063
J	Yang, JG; Lu, CL; Yan, L; Tang, XR; Li, W; Yang, YJ; Hu, DY				Yang, Jingang; Lu, Changlin; Yan, Li; Tang, Xinran; Li, Wei; Yang, Yuejin; Hu, Dayi			The Association between Atherosclerotic Renal Artery Stenosis and Acute Kidney Injury in Patients Undergoing Cardiac Surgery	PLOS ONE			English	Article							OFF-PUMP; ASCENDING AORTA; BYPASS SURGERY; CARDIOPULMONARY BYPASS; RISK-FACTORS; FAILURE; DISEASE; REVASCULARIZATION; DYSFUNCTION; SCORE	Background: Atherosclerotic renal artery stenosis (ARAS) and coronary artery disease (CAD) commonly co-exist. Some patients with unidentified ARAS may undergo cardiac surgery. While acute kidney injury (AKI) is a frequent and serious complication of cardiac surgery, we aim to evaluate the influence of ARAS on the occurrence of postoperative AKI in patients with normal or near-normal baseline renal function following cardiac surgery. Methods: A total of 212 consecutive patients undergoing aortography after coronary angiography and cardiac surgery were retrospectively studied for their preoperative and intraoperative conditions. AKI was defined as an absolute increase in serum creatinine of more than or equal to 0.3 mg/dl (>= 26.4 mu mol/l) or a percentage increase in creatinine of more than or equal to 50% (1.5-fold from baseline) after cardiac surgery. A propensity score-adjusted logistic regression models was used in estimating the effect of ARAS on the risk of postoperative AKI. Results: ARAS (>= 50%) was observed in 50 (23.6%) patients, and 83 (39.2%) developed AKI after cardiac surgery. A correlation existed between renal artery patency and preoperative-to-postoperative %Delta Cr in patients with ARAS (r = 0.297, P<0.0001). The propensity score-adjusted regression model showed the occurrence of postoperative AKI in patients with ARAS was significantly higher than those without ARAS (OR 2.858, 95% CI 1.260-6.480, P = 0.011). Conclusion: ARAS is associated with postoperative AKI in patients with normal or near-normal baseline renal function after cardiac surgery.	[Yang, Jingang; Tang, Xinran; Li, Wei; Yang, Yuejin] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Yang, Jingang; Tang, Xinran; Li, Wei; Yang, Yuejin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lu, Changlin] Capital Med Univ, Beijing Tongren Hosp, Ctr Cardiovasc, Beijing, Peoples R China; [Yan, Li] Hebei Gen Hosp, Dept Cardiol, Shijiazhuang, Hebei Province, Peoples R China; [Hu, Dayi] Peking Univ, Peoples Hosp, Ctr Heart, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Peking University	Yang, JG (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	jingangyang@126.com			Beijing Nova Program [2006B52]	Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This study was supported by Beijing Nova Program (2006B52). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Ahmadi H, 2009, MED PRIN PRACT, V18, P300, DOI 10.1159/000215728; Ascione R, 2001, ANN THORAC SURG, V72, P2020, DOI 10.1016/S0003-4975(01)03250-7; Banbury MK, 2003, ANN THORAC SURG, V76, P508, DOI 10.1016/S0003-4975(03)00530-7; Barbash IM, 2012, AM HEART J, V163, P1031, DOI 10.1016/j.ahj.2012.01.009; BLAUTH CI, 1992, J THORAC CARDIOV SUR, V103, P1104; Bloor GK, 1996, J CARDIOTHOR VASC AN, V10, P899, DOI 10.1016/S1053-0770(96)80053-X; BORIONI R, 1994, ANN THORAC SURG, V58, P1788, DOI 10.1016/0003-4975(94)91701-9; BRANDRUPWOGNSEN G, 1995, THORAC CARDIOV SURG, V43, P77, DOI 10.1055/s-2007-1013775; Brown JR, 2007, CIRCULATION, V116, pI139, DOI 10.1161/CIRCULATIONAHA.106.677070; Chertow GM, 1997, CIRCULATION, V95, P878; Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158; Conlon PJ, 2005, RENAL FAILURE, V27, P81, DOI 10.1081/JDI-200042779; Davila-Roman VG, 1999, J THORAC CARDIOV SUR, V117, P111, DOI 10.1016/S0022-5223(99)70475-7; DONOFRIO A, 2011, CONGESTIVE HEART S1, V16, pS32; Elmistekawy E, 2012, J THORAC CARDIOV SUR, V143, P85, DOI 10.1016/j.jtcvs.2011.09.035; Erentug V, 2005, J CARDIAC SURG, V20, P345, DOI 10.1111/j.1540-8191.2005.200444.x; Halkos ME, 2009, ANN THORAC SURG, V88, P746, DOI 10.1016/j.athoracsur.2009.05.078; HARDING MB, 1992, J AM SOC NEPHROL, V2, P1608; HOSODA Y, 1991, J CARDIOVASC SURG, V32, P301; Huen SC, 2012, ANN THORAC SURG, V93, P337, DOI 10.1016/j.athoracsur.2011.09.010; Kim KB, 2002, ANN THORAC SURG, V74, pS1377; Koivuviita N, 2012, NEPHROL DIAL TRANSPL, V27, P3843, DOI 10.1093/ndt/gfs301; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Martin-Ucar AE, 2002, J ENDOVASC THER, V9, P218, DOI 10.1583/1545-1550(2002)009<0218:PSPFRA>2.0.CO;2; Massoudy P, 2008, NEPHROL DIAL TRANSPL, V23, P2853, DOI 10.1093/ndt/gfn153; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Murphy TP, 2002, J VASC INTERV RADIOL, V13, P1187, DOI 10.1016/S1051-0443(07)61964-2; Rahmanian PB, 2011, EUR J CARDIO-THORAC, V40, P701, DOI 10.1016/j.ejcts.2010.12.051; Rodrigues AJ, 2009, REV BRAS CIR CARDIOV, V24, P441, DOI 10.1590/S0102-76382009000500003; Rokkas C K, 1998, Semin Thorac Cardiovasc Surg, V10, P240; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Seabra VF, 2010, CLIN J AM SOC NEPHRO, V5, P1734, DOI 10.2215/CJN.02800310; Shaw A, 2008, NEPHRON PHYSIOL, V109, pP55, DOI 10.1159/000142937; Shumway SJ, 2003, ANN THORAC SURG, V76, P515; Shurrab AE, 2001, BRIT J RADIOL, V74, P213, DOI 10.1259/bjr.74.879.740213; SIGMON DH, 1993, HYPERTENSION, V22, P237, DOI 10.1161/01.HYP.22.2.237; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; van Straten AHM, 2010, EUR J CARDIO-THORAC, V37, P106, DOI 10.1016/j.ejcts.2009.06.048; WAREING TH, 1992, J THORAC CARDIOV SUR, V103, P453; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368; Yang JG, 2004, HYPERTENS RES, V27, P339, DOI 10.1291/hypres.27.339; Yang JG, 2010, J ATHEROSCLER THROMB, V17, P395, DOI 10.5551/jat.3061; Yang Jingang, 2002, Zhonghua Nei Ke Za Zhi, V41, P24; Zheng B, 2011, CHINESE MED J-PEKING, V124, P1453, DOI 10.3760/cma.j.issn.0366-6999.2011.10.003	47	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64104	10.1371/journal.pone.0064104	http://dx.doi.org/10.1371/journal.pone.0064104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700459	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200116
J	Yu, ZH; Gao, WM; Jiang, EZ; Lu, F; Zhang, L; Shi, ZR; Wang, XX; Chen, LB; Lv, TF				Yu, Zhenghong; Gao, Weimin; Jiang, Enze; Lu, Fang; Zhang, Luo; Shi, Zhaorong; Wang, Xinxing; Chen, Longbang; Lv, Tangfeng			Interaction between IGF-IR and ER Induced by E2 and IGF-I	PLOS ONE			English	Article							GROWTH-FACTOR-I; ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; PROLIFERATION; PHOSPHORYLATION; MODULATION; ACTIVATION; ESTRADIOL; APOPTOSIS; CELLS	Estrogen receptor (ER) is a nuclear receptor and the insulin-like growth factor-I (IGF-I) receptor (IGF-IR) is a transmembrane tyrosine kinase receptor. Estrogen and IGF-I are known to have synergistic effects on the growth of breast cancer cells. Recently, non-nuclear effects of ER have been under investigation. To study the mechanism involved in this process, we have used MCF-7 breast cancer cell lines transfected with IGF-IR anti-sense cDNA (SX13, MCF-7(SX13)) that resulted in 50% reduction of IGF-IR. In MCF-7 cells, estradiol (E2) and IGF-I induced the rapid association of ER to IGF-IR, however, the interaction was abrogated in MCF-7(SX13) cells. In addition, NWTB3 cells (NIH3T3 cells overexpressing IGF-IR) were transiently transfected with ER alpha, the ER-IGF-IR interaction was induced by both E2 and IGF-I. Moreover, ER alpha regulated the IGF-I signaling pathways through phosphorylation of ERK1/2 and Akt and the interaction of ER-IGF-IR potentiated the cell growth. Finally, E2 and IGF-I stimulated translocation of ER from the nucleus to the cytoplasm. Taken together, these findings reveal that the interaction of the ER and IGF-IR is important for the non-genomic effects of ER.	[Yu, Zhenghong; Zhang, Luo; Wang, Xinxing; Chen, Longbang] Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Gao, Weimin; Lv, Tangfeng] Texas Tech Univ, Inst Environm & Human Hlth, Dept Environm Toxicol, Lubbock, TX 79409 USA; [Jiang, Enze] Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Lu, Fang] Nanjing Foreign Language Sch, Nanjing, Jiangsu, Peoples R China; [Shi, Zhaorong] Jinling Hosp, Hosp Off, Nanjing, Jiangsu, Peoples R China; [Lv, Tangfeng] Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China	Texas Tech University System; Texas Tech University; Nanjing University	Yu, ZH (corresponding author), Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China.	m_fish@189.cn; lvtangfeng_1114@yahoo.com.cn	Wang, Xinxing/AAU-6356-2021					Ahmad S, 1999, BIOCHEM PHARMACOL, V58, P425, DOI 10.1016/S0006-2952(99)00125-2; Arnal JF, 2001, CLIN EXP PHARMACOL P, V28, P1032, DOI 10.1046/j.1440-1681.2001.03589.x; Baker SE, 2002, GENETICS, V162, P285; Bartella V, 2012, CELL SIGNAL, V24, P1515, DOI 10.1016/j.cellsig.2012.03.012; Cardona-Gomez GP, 2001, BRAIN RES REV, V37, P320, DOI 10.1016/S0165-0173(01)00137-0; Casa AJ, 2012, BREAST CANCER RES TR, V132, P61, DOI 10.1007/s10549-011-1540-0; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Clark VP, 2001, HUM BRAIN MAPP, V14, P116, DOI 10.1002/hbm.1046; Contois LW, 2012, J BIOL CHEM, V287, P1779, DOI 10.1074/jbc.M111.267732; Dufourny B, 1997, J BIOL CHEM, V272, P31163, DOI 10.1074/jbc.272.49.31163; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Feng WJ, 2001, MOL ENDOCRINOL, V15, P32, DOI 10.1210/me.15.1.32; Fox EM, 2011, CANCER RES, V71, P6773, DOI 10.1158/0008-5472.CAN-11-1295; Garcia-Segura LM, 2010, PROG BRAIN RES, V181, P251, DOI 10.1016/S0079-6123(08)81014-X; Hall JM, 2000, MOL ENDOCRINOL, V14, P2010, DOI 10.1210/me.14.12.2010; Hartog H, 2011, BREAST CANCER RES TR, V129, P725, DOI 10.1007/s10549-010-1256-6; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kawabe Y, 2002, GENE, V285, P291, DOI 10.1016/S0378-1119(01)00887-3; KLEINMAN D, 1995, ENDOCRINOLOGY, V136, P2531, DOI 10.1210/en.136.6.2531; LeRoith D, 2000, ENDOCRINOLOGY, V141, P1287, DOI 10.1210/en.141.4.1287; Lisztwan J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2113; Madhala-Levy D, 2012, J CELL PHYSIOL, V227, P1455, DOI 10.1002/jcp.22861; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Stenoien DL, 2000, MOL ENDOCRINOL, V14, P518, DOI 10.1210/me.14.4.518; Stoll BA, 2002, ANN ONCOL, V13, P191, DOI 10.1093/annonc/mdf059; Zhu L, 2007, P NATL ACAD SCI USA, V104, P15847, DOI 10.1073/pnas.0705749104	28	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62642	10.1371/journal.pone.0062642	http://dx.doi.org/10.1371/journal.pone.0062642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704881	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200010
J	Barnett, C; Salter, M; Chevallier, C; Robertson, N; Berard, O; Burns, KC				Barnett, Craig; Salter, Matt; Chevallier, Clement; Robertson, Nicola; Berard, Otis; Burns, Kevin C.			The Ability of North Island Robins to Discriminate between Humans Is Related to Their Behavioural Type	PLOS ONE			English	Article							INDIVIDUAL RECOGNITION; SEX-DIFFERENCES; GREAT TITS; REPEATABILITY; PERSONALITY; BOLDNESS; BIRDS; HERITABILITY; TEMPERAMENT; RESPONSES	Animals are able to learn to identify persistent threats to themselves and their offspring. For example, birds are able to quickly learn to discriminate between humans that have previously threatened their nests from humans with whom they have had no prior experience. However, no study has yet examined whether a bird's ability to discriminate between humans is related to the bird's underlying behavioural type. In this study, we examined whether there were differences among North Island (NI) robins (Petroica longipes), based on their underlying behavioural type, in their abilities to discriminate between familiar and novel human observers. Using a simple feeding experiment, we timed how long it took birds to attack a food item placed next to an observer on each of 7 days. On the eighth day, a different observer timed the birds. We found that birds could be split into two behaviour types based on their attack behaviour: fast attackers (latencies <20 sec) and slow attackers (latencies >20 secs). Interestingly, the fast birds did not increase their attack latency in response to the novel observer whereas the slow attackers did. This result, for the first time, demonstrates that a bird's ability to discriminate between humans can vary among birds based on their behavioural type.	[Barnett, Craig; Salter, Matt; Robertson, Nicola; Berard, Otis; Burns, Kevin C.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Barnett, Craig] Rikkyo Univ, Dept Life Sci, Toshima Ku, Tokyo 171, Japan; [Chevallier, Clement] Univ Quebec, Ctr Etud Nord, Rimouski, PQ G5L 3A1, Canada	Victoria University Wellington; Rikkyo University; University of Quebec	Barnett, C (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	optimalforager@hotmail.com	Robertson, Nicola/GWR-2021-2022	Chevallier, Clement/0000-0002-0956-5978; Burns, K.C./0000-0002-4938-2877; Barnett, Craig/0000-0001-5941-8370	School of Biological Sciences at Victoria University of Wellington	School of Biological Sciences at Victoria University of Wellington	This research was partially funded by the School of Biological Sciences at Victoria University of Wellington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2010, R LANG ENV STAT COMP; Barnett CA, 2012, ETHOLOGY, V118, P984, DOI 10.1111/j.1439-0310.2012.02092.x; Barnett CA, 2011, ETHOLOGY, V117, P28, DOI 10.1111/j.1439-0310.2010.01844.x; Belguermi A, 2011, ANIM COGN, V14, P909, DOI 10.1007/s10071-011-0420-7; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; BENUS RF, 1990, BEHAVIOUR, V112, P176, DOI 10.1163/156853990X00185; BOYSEN ST, 1986, J COMP PSYCHOL, V100, P321, DOI 10.1037/0735-7036.100.3.321; BUITRON D, 1983, BEHAVIOUR, V87, P209, DOI 10.1163/156853983X00435; Carere C, 2004, PHYSIOL BEHAV, V82, P905, DOI 10.1016/j.physbeh.2004.07.009; Carere C, 2011, CURR ZOOL, V57, P491, DOI 10.1093/czoolo/57.4.491; Caro T., 2005, ANTIPREDATOR DEFENCE; Chervet Noemie, 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/321729; Cockrem JF, 2002, GEN COMP ENDOCR, V125, P248, DOI 10.1006/gcen.2001.7749; Coleman K, 2005, AM J PRIMATOL, V65, P63, DOI 10.1002/ajp.20097; Cornell HN, 2012, P ROY SOC B-BIOL SCI, V279, P499, DOI 10.1098/rspb.2011.0957; David M, 2012, ETHOLOGY, V118, P932, DOI 10.1111/j.1439-0310.2012.02085.x; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; EAST M, 1981, IBIS, V123, P223, DOI 10.1111/j.1474-919X.1981.tb00930.x; Ellenberg U, 2009, ANIM BEHAV, V77, P289, DOI 10.1016/j.anbehav.2008.09.021; Emery NJ, 2006, P ROY SOC LOND B BIO, V275, P1811; Fernandez-Juricic E, 2004, TRENDS ECOL EVOL, V19, P25, DOI 10.1016/j.tree.2003.10.003; Ferrari MCO, 2008, P ROY SOC B-BIOL SCI, V275, P1811, DOI 10.1098/rspb.2008.0305; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; GRUBB TC, 1977, CONDOR, V79, P271, DOI 10.2307/1367175; Hedrick AV, 2012, BEHAV ECOL SOCIOBIOL, V66, P407, DOI 10.1007/s00265-011-1286-z; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; Jones KA, 2010, P ROY SOC B-BIOL SCI, V277, P625, DOI 10.1098/rspb.2009.1607; KNIGHT RL, 1986, ANIM BEHAV, V34, P561, DOI 10.1016/S0003-3472(86)80125-7; Lee WY, 2011, ANIM COGN, V14, P817, DOI 10.1007/s10071-011-0415-4; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Levey DJ, 2009, P NATL ACAD SCI USA, V106, P8959, DOI 10.1073/pnas.0811422106; Marzluff JM, 2010, ANIM BEHAV, V79, P699, DOI 10.1016/j.anbehav.2009.12.022; Matzel LD, 2003, J NEUROSCI, V23, P6423; MCLEAN IG, 1991, CURR ORNITHOL, V8, P173; Mercado, 2011, INT J COMP PSYCHOL, V24, P4, DOI DOI 10.1016/J.JEBDP.2005.01.011; MERRITT PG, 1984, J FIELD ORNITHOL, V55, P252; Range F, 2006, BEHAV PROCESS, V73, P100, DOI 10.1016/j.beproc.2006.04.002; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Remes V, 2012, BIOL CONSERV, V148, P54, DOI 10.1016/j.biocon.2012.01.063; Shettleworth S. J., 2009, COGNITION EVOLUTION; Sih Andrew, 2010, P516; Silverin B, 1998, POULT AVIAN BIOL REV, V9, P153; Sinn DL, 2010, BEHAV ECOL SOCIOBIOL, V64, P693, DOI 10.1007/s00265-009-0887-2; SLOBODCHIKOFF CN, 1991, ANIM BEHAV, V42, P713, DOI 10.1016/S0003-3472(05)80117-4; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Starling-Windhof A, 2011, BIOL INVASIONS, V13, P1021, DOI 10.1007/s10530-010-9886-5; Steiger S, 2008, TRENDS ECOL EVOL, V23, P355, DOI 10.1016/j.tree.2008.01.014; Taylor AA, 1998, APPL ANIM BEHAV SCI, V58, P13, DOI 10.1016/S0168-1591(97)00061-0; Thaker M, 2010, AM NAT, V175, P50, DOI 10.1086/648558; Tibbetts EA, 2008, TRENDS ECOL EVOL, V23, P356, DOI 10.1016/j.tree.2008.03.007; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Titulaer M, 2012, ANIM BEHAV, V83, P723, DOI 10.1016/j.anbehav.2011.12.020; Van Horik J, 2007, ANIM BEHAV, V73, P1043, DOI 10.1016/j.anbehav.2006.07.014; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; WALTERS JR, 1990, WILSON BULL, V102, P49; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018	58	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64487	10.1371/journal.pone.0064487	http://dx.doi.org/10.1371/journal.pone.0064487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700482	Green Published, gold			2022-12-27	WOS:000319966400058
J	Ling, N; Zhang, WW; Wang, DS; Mao, JG; Huang, QW; Guo, SW; Shen, QR				Ling, Ning; Zhang, Wenwen; Wang, Dongsheng; Mao, Jiugeng; Huang, Qiwei; Guo, Shiwei; Shen, Qirong			Root Exudates from Grafted-Root Watermelon Showed a Certain Contribution in Inhibiting Fusarium oxysporum f. sp niveum	PLOS ONE			English	Article							BIOORGANIC FERTILIZER; VERTICILLIUM-DAHLIAE; PHENOLIC-ACIDS; CINNAMIC ACID; ROOTSTOCK; GROWTH; WILT; RESISTANCE; CUCUMBER; IDENTIFICATION	Grafting watermelon onto bottle gourd rootstock is commonly used method to generate resistance to Fusarium oxysporum f. sp. niveum (FON), but knowledge of the effect of the root exudates of grafted watermelon on this soil-borne pathogen in rhizosphere remains limited. To investigate the root exudate profiles of the own-root bottle gourd, grafted-root watermelon and own-root watermelon, recirculating hydroponic culture system was developed to continuously trap these root exudates. Both conidial germination and growth of FON were significantly decreased in the presence of root exudates from the grafted-root watermelon compared with the own-root watermelon. HPLC analysis revealed that the composition of the root exudates released by the grafted-root watermelon differed not only from the own-root watermelon but also from the bottle gourd rootstock plants. We identified salicylic acid in all 3 root exudates, chlorogenic acid and caffeic acid in root exudates from own-root bottle gourd and grafted-root watermelon but not own-root watermelon, and abundant cinnamic acid only in own-root watermelon root exudates. The chlorogenic and caffeic acid were candidates for potentiating the enhanced resistance of the grafted watermelon to FON, therefore we tested the effects of the two compounds on the conidial germination and growth of FON. Both phenolic acids inhibited FON conidial germination and growth in a dose-dependent manner, and FON was much more susceptible to chlorogenic acid than to caffeic acid. In conclusion, the key factor in attaining the resistance to Fusarium wilt is grafting on the non-host root stock, however, the root exudates profile also showed some contribution in inhibiting FON. These results will help to better clarify the disease resistance mechanisms of grafted-root watermelon based on plant-microbe communication and will guide the improvement of strategies against Fusarium-mediated wilt of watermelon plants.	[Ling, Ning; Zhang, Wenwen; Huang, Qiwei; Guo, Shiwei; Shen, Qirong] Nanjing Agr Univ, Jiangsu Key Lab, Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China; [Ling, Ning; Zhang, Wenwen; Huang, Qiwei; Guo, Shiwei; Shen, Qirong] Nanjing Agr Univ, Engn Ctr Solid Organ Waste Utilizat, Nanjing, Jiangsu, Peoples R China; [Wang, Dongsheng; Mao, Jiugeng] Nanjing Inst Vegetable Sci, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Nanjing Agricultural University	Shen, QR (corresponding author), Nanjing Agr Univ, Jiangsu Key Lab, Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China.	shenqirong@njau.edu.cn	Shen, Qirong/AAB-6531-2020; Ling, Ning/AAF-3633-2019	Ling, Ning/0000-0003-1250-4073	Nature Science Foundation of China [31272255]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the Nature Science Foundation of China (31272255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; BANWART WL, 1985, J CHEM ECOL, V11, P383, DOI 10.1007/BF01411424; Beekrum S, 2003, FOOD ADDIT CONTAM, V20, P490, DOI 10.1080/0265203031000098678; Blum U, 1996, J NEMATOL, V28, P259; Cao Y, 2011, BIOL FERT SOILS, V47, P495, DOI 10.1007/s00374-011-0556-2; Martinez-Ballesta MC, 2010, SCI HORTIC-AMSTERDAM, V127, P112, DOI 10.1016/j.scienta.2010.08.002; Colla G, 2010, ENVIRON EXP BOT, V68, P283, DOI 10.1016/j.envexpbot.2009.12.005; D'Mello JPF, 1999, ANIM FEED SCI TECH, V80, P183, DOI 10.1016/S0377-8401(99)00059-0; Davis AR, 2008, CRIT REV PLANT SCI, V27, P50, DOI 10.1080/07352680802053940; De-La-Pena C, 2008, J BIOL CHEM, V283, P25247, DOI 10.1074/jbc.M801967200; Hao WY, 2010, PLANT SOIL, V336, P485, DOI 10.1007/s11104-010-0505-0; Hao ZP, 2007, SCI HORTIC-AMSTERDAM, V112, P315, DOI 10.1016/j.scienta.2006.12.030; Lanoue A, 2010, NEW PHYTOL, V185, P577, DOI 10.1111/j.1469-8137.2009.03066.x; Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131; Ling N, 2012, APPL SOIL ECOL, V59, P13, DOI 10.1016/j.apsoil.2012.05.001; Ling N, 2011, EUR J SOIL BIOL, V47, P374, DOI 10.1016/j.ejsobi.2011.08.009; Ling N, 2011, PLANT SOIL, V341, P485, DOI 10.1007/s11104-010-0660-3; Ling N, 2010, BIOCONTROL, V55, P673, DOI 10.1007/s10526-010-9290-1; Liu Na, 2012, African Journal of Agricultural Research, V7, P2791, DOI 10.5897/AJAR11.2113; Liu N, 2009, HORTSCIENCE, V44, P2058, DOI 10.21273/HORTSCI.44.7.2058; Luo J, 2010, SOIL SCI SOC AM J, V74, P2039, DOI 10.2136/sssaj2009.0437; Mandal SM, 2010, PLANT SIGNAL BEHAV, V5, P359, DOI 10.4161/psb.5.4.10871; Ponts N, 2011, PHYTOPATHOLOGY, V101, P929, DOI 10.1094/PHYTO-09-10-0230; Rouphael Y, 2010, SCI HORTIC-AMSTERDAM, V127, P172, DOI 10.1016/j.scienta.2010.09.001; Samapundo S, 2007, FOOD MICROBIOL, V24, P465, DOI 10.1016/j.fm.2006.10.003; Si Y, 2010, J EXP BOT, V61, P1635, DOI 10.1093/jxb/erq031; STAMP NE, 1992, ENTOMOL EXP APPL, V64, P135, DOI 10.1111/j.1570-7458.1992.tb01603.x; Thies JA, 2010, PLANT DIS, V94, P1195, DOI 10.1094/PDIS-09-09-0640; Turhan A, 2012, HORTIC ENVIRON BIOTE, V53, P336, DOI 10.1007/s13580-012-0034-2; Wu FZ, 2010, ALLELOPATHY J, V25, P403; Wu HS, 2009, SOIL SCI SOC AM J, V73, P1150, DOI 10.2136/sssaj2008.0266; Wu HS, 2008, CHEMOSPHERE, V74, P45, DOI 10.1016/j.chemosphere.2008.09.027; Yang YJ, 2012, PLANT PHYSIOL BIOCH, V58, P54, DOI 10.1016/j.plaphy.2012.05.026; Ye SF, 2004, PLANT SOIL, V263, P143, DOI 10.1023/B:PLSO.0000047721.78555.dc; Ye SF, 2006, ENVIRON EXP BOT, V56, P255, DOI 10.1016/j.envexpbot.2005.02.010; Yetisir H, 2003, PHYTOPARASITICA, V31, P163, DOI 10.1007/BF02980786; YU JQ, 1994, J CHEM ECOL, V20, P21, DOI 10.1007/BF02065988; Yu JQ, 2000, PLANT SOIL, V223, P149, DOI 10.1023/A:1004829512147; Zhao QY, 2011, APPL SOIL ECOL, V47, P67, DOI 10.1016/j.apsoil.2010.09.010; Zhou BL, 2010, ALLELOPATHY J, V25, P393	40	68	77	5	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63383	10.1371/journal.pone.0063383	http://dx.doi.org/10.1371/journal.pone.0063383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700421	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400019
J	Luck, GW; Carter, A; Smallbone, L				Luck, Gary W.; Carter, Andrew; Smallbone, Lisa			Changes in Bird Functional Diversity across Multiple Land Uses: Interpretations of Functional Redundancy Depend on Functional Group Identity	PLOS ONE			English	Article							USE INTENSIFICATION; SPECIES RICHNESS; ECOSYSTEM; BIODIVERSITY; TRAIT; FRAMEWORK; CONSEQUENCES; IMPACTS; INDEXES; LEVEL	Examinations of the impact of land-use change on functional diversity link changes in ecological community structure driven by land modification with the consequences for ecosystem function. Yet, most studies have been small-scale, experimental analyses and primarily focussed on plants. There is a lack of research on fauna communities and at large-scales across multiple land uses. We assessed changes in the functional diversity of bird communities across 24 land uses aligned along an intensification gradient. We tested the hypothesis that functional diversity is higher in less intensively used landscapes, documented changes in diversity using four diversity metrics, and examined how functional diversity varied with species richness to identify levels of functional redundancy. Functional diversity, measured using a dendogram-based metric, increased from high to low intensity land uses, but observed values did not differ significantly from randomlygenerated expected values. Values for functional evenness and functional divergence did not vary consistently with landuse intensification, although higher than expected values were mostly recorded in high intensity land uses. A total of 16 land uses had lower than expected values for functional dispersion and these were mostly low intensity native vegetation sites. Relations between functional diversity and bird species richness yielded strikingly different patterns for the entire bird community vs. particular functional groups. For all birds and insectivores, functional evenness, divergence and dispersion showed a linear decline with increasing species richness suggesting substantial functional redundancy across communities. However, for nectarivores, frugivores and carnivores, there was a significant hump-shaped or non-significant positive linear relationship between these functional measures and species richness indicating less redundancy. Hump-shaped relationships signify that the most functionally diverse communities occur at intermediate levels of species richness. Interpretations of redundancy thus vary for different functional groups and related ecosystem functions (e.g. pollination), and can be substantially different to relationships involving entire ecological communities.	[Luck, Gary W.; Carter, Andrew; Smallbone, Lisa] Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia	Charles Sturt University	Luck, GW (corresponding author), Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia.	galuck@csu.edu.au	Carter, Andrew/AAB-1807-2019	Carter, Andrew/0000-0001-5496-6706; Luck, Gary/0000-0002-7266-5568	Australia Research Council Discovery [DP0986566]; Future Fellowship [FT0990436]	Australia Research Council Discovery(Australian Research Council); Future Fellowship(Australian Research Council)	Funding support for this project was provided by an Australia Research Council Discovery Grant (DP0986566) and Future Fellowship (FT0990436) to Gary Luck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaum N, 2011, BIODIVERS CONSERV, V20, P2333, DOI 10.1007/s10531-011-9995-1; BROWN JH, 1978, AM ZOOL, V18, P687; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gerisch M, 2012, OIKOS, V121, P508, DOI 10.1111/j.1600-0706.2011.19749.x; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Luck GW, 2008, FOREST ECOL MANAG, V255, P2688, DOI 10.1016/j.foreco.2008.01.029; Luck GW, 2013, AUSTRAL ECOL, V38, P111, DOI 10.1111/j.1442-9993.2012.02383.x; Luck GW, 2012, J ANIM ECOL, V81, P1065, DOI 10.1111/j.1365-2656.2012.01974.x; Luck GW, 2010, GLOBAL ECOL BIOGEOGR, V19, P673, DOI 10.1111/j.1466-8238.2010.00545.x; MANLY BFJ, 1995, ECOLOGY, V76, P1109, DOI 10.2307/1940919; Mason NWH, 2008, J ANIM ECOL, V77, P285, DOI 10.1111/j.1365-2656.2007.01350.x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; Mayfield MM, 2006, J ECOL, V94, P522, DOI 10.1111/j.1365-2745.2006.01108.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Naeem S, 2002, ECOLOGY, V83, P2925; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Pakeman RJ, 2011, J ECOL, V99, P1143, DOI 10.1111/j.1365-2745.2011.01853.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; WALKER B, 1995, CONSERV BIOL, V9, P747, DOI 10.1046/j.1523-1739.1995.09040747.x	45	119	121	8	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63671	10.1371/journal.pone.0063671	http://dx.doi.org/10.1371/journal.pone.0063671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696844	gold, Green Published			2022-12-27	WOS:000319107900053
J	Bohr, S; Patel, SJ; Vasko, R; Shen, KY; Huang, GF; Yarmush, ML; Berthiaume, F				Bohr, Stefan; Patel, Suraj J.; Vasko, Radovan; Shen, Keyue; Huang, Guofeng; Yarmush, Martin L.; Berthiaume, Francois			Highly Upregulated Lhx2 in the Foxn1(-/-) Nude Mouse Phenotype Reflects a Dysregulated and Expanded Epidermal Stem Cell Niche	PLOS ONE			English	Article							HAIR FOLLICLE DEVELOPMENT; SKIN EPITHELIAL-CELLS; IMMUNOHISTOCHEMICAL EXPRESSION; PROMOTES DIFFERENTIATION; BETA-CATENIN; IN-VITRO; KERATINOCYTES; CD34; SHH; CD200	Hair cycling is a prime example of stem cell dependent tissue regeneration and replenishment, and its regulatory mechanisms remain poorly understood. In the present study, we evaluated the effect of a blockage in terminal keratinocytic lineage differentiation in the Foxn1(-/-) nude phenotype on the epithelial progeny. Most notably we found a constitutive upregulation of LIM homeobox protein 2 (Lhx2), a marker gene of epithelial stem cellness indispensible for hair cycle progression. However, histological evidence along with an erratic, acyclic rise of otherwise suppressed CyclinD1 levels along with several key markers of keratinocyte lineage differentiation indicate a frustrated expansion of epithelial stem cell niches in skin. In addition, CD49f/CD34/CD200-based profiling demonstrated highly significant shifts in subpopulations of epithelial progeny. Intriguingly this appeared to include the expansion of Oct4+ stem cells in dermal fractions of skin isolates in the Foxn1 knock-out opposed to wild type. Overall our findings indicate that the Foxn1(-/-) phenotype has a strong impact on epithelial progeny and thus offers a promising model to study maintenance and regulation of stem cell niches within skin not feasible in other in vitro or in vivo models.	[Bohr, Stefan; Patel, Suraj J.; Shen, Keyue; Huang, Guofeng; Yarmush, Martin L.] Harvard Univ, Shriners Hosp Children, Sch Med, Ctr Engn Med, Boston, MA 02115 USA; [Bohr, Stefan; Patel, Suraj J.; Shen, Keyue; Huang, Guofeng; Yarmush, Martin L.] Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Vasko, Radovan] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Yarmush, Martin L.; Berthiaume, Francois] Rutgers State Univ, Dept Biomed Engn, New Brunswick, NJ 08903 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; New York Medical College; Rutgers State University New Brunswick	Bohr, S (corresponding author), Harvard Univ, Shriners Hosp Children, Sch Med, Ctr Engn Med, Boston, MA 02115 USA.	bohrs@partners.org	Berthiaume, Francois/ABD-2139-2020	Yarmush, Martin/0000-0003-4986-8444	Shriners Hospitals for Children; Deutsche Forschungs Gemeinschaft (DFG, Germany) [GZ:BO3468/2-1]	Shriners Hospitals for Children; Deutsche Forschungs Gemeinschaft (DFG, Germany)(German Research Foundation (DFG))	This work was funded by the Shriners Hospitals for Children. S. Bohr is a recipient of a Deutsche Forschungs Gemeinschaft (DFG, Germany) postdoctoral fellowship award (GZ:BO3468/2-1). S. J. Patel was supported by a Shriners Hospital for Children postdoctoral fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SY, 2012, ANN DERMATOL, V24, P26, DOI 10.5021/ad.2012.24.1.26; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Chodankar R, 2003, J INVEST DERMATOL, V120, P20, DOI 10.1046/j.1523-1747.2003.12008.x; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Cui CY, 2011, CELL CYCLE, V10, P3379, DOI 10.4161/cc.10.19.17669; Fan CX, 2011, SKIN RES TECHNOL, V17, P387, DOI 10.1111/j.1600-0846.2011.00508.x; Gallego MI, 2002, DEV BIOL, V249, P131, DOI 10.1006/dbio.2002.0761; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Goldstein J, 2012, CELL MOL LIFE SCI; Gorczynski R, 2004, J IMMUNOL, V172, P7744, DOI 10.4049/jimmunol.172.12.7744; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Hakkinen Lari, 2001, Methods in Cell Science, V23, P189, DOI 10.1023/A:1016385109922; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hu B, 2010, GENE DEV, V24, P1519, DOI 10.1101/gad.1886910; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Janes SM, 2004, J CELL SCI, V117, P4157, DOI 10.1242/jcs.01302; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; Michno K, 2003, DEV BIOL, V264, P153, DOI 10.1016/S0012-1606(03)00401-9; Mill P, 2005, DEV CELL, V9, P293, DOI 10.1016/j.devcel.2005.05.009; Mill P, 2003, GENES DEV, V17, P282; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Mukhopadhyay A, 2012, DEV BIOL; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Olszewski Waldemar L, 2004, Ann Transplant, V9, P34; Ouji Y, 2006, BIOCHEM BIOPH RES CO, V345, P581, DOI 10.1016/j.bbrc.2006.04.142; Ouji Y, 2006, BIOCHEM BIOPH RES CO, V342, P1063, DOI 10.1016/j.bbrc.2006.02.028; Ouji Y, 2006, BIOCHEM BIOPH RES CO, V342, P28, DOI 10.1016/j.bbrc.2006.01.104; Panteleyev AA, 2001, J CELL SCI, V114, P3419; Pascucci L, 2006, VET DERMATOL, V17, P244, DOI 10.1111/j.1365-3164.2006.00527.x; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Plikus MV, 2012, SEMIN CELL DEV BIOL; Poblet E, 2008, BRIT J DERMATOL, V159, P646, DOI 10.1111/j.1365-2133.2008.08741.x; Poblet E, 2006, CLIN EXP DERMATOL, V31, P807, DOI 10.1111/j.1365-2230.2006.02255.x; Poblet E, 2003, J INVEST DERMATOL, V121, P1220, DOI 10.1046/j.1523-1747.2003.12550_2.x; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rodius S, 2007, J CELL PHYSIOL, V212, P439, DOI 10.1002/jcp.21040; Rosenblum MD, 2006, J DERMATOL SCI, V41, P165, DOI 10.1016/j.jdermsci.2005.11.003; Rosenblum MD, 2005, J INVEST DERMATOL, V125, P1130, DOI 10.1111/j.0022-202X.2005.23948.x; Rosenblum MD, 2004, J INVEST DERMATOL, V123, P880, DOI 10.1111/j.0022-202X.2004.23461.x; Samuelov L, 2012, J INVEST DERMATOL; Schlake T, 2000, DEV DYNAM, V217, P368, DOI 10.1002/(SICI)1097-0177(200004)217:4<368::AID-DVDY4>3.0.CO;2-Z; Streckfuss-Bomeke K, 2012, EUR HEART J, DOI 10.1093/eurheartj/ehs203; Suzuki K, 2009, DEVELOPMENT, V136, P367, DOI 10.1242/dev.021295; Teillet MA, 1998, P NATL ACAD SCI USA, V95, P11733, DOI 10.1073/pnas.95.20.11733; Terunuma A, 2008, J INVEST DERMATOL, V128, P1332, DOI 10.1038/sj.jid.5701154; Terunuma A, 2007, STEM CELLS, V25, P664; Tiede S, 2006, BIOESSAYS, V28, P1157, DOI 10.1002/bies.20506; Tornqvist G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000904; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Widelitz Randall B, 2008, Organogenesis, V4, P123; Xing YZ, 2011, ACTA HISTOCHEM, V113, P608, DOI 10.1016/j.acthis.2010.06.006; Xu XW, 2003, AM J PATHOL, V163, P969, DOI 10.1016/S0002-9440(10)63456-6; Zhou SY, 2010, CURR EYE RES, V35, P978, DOI 10.3109/02713683.2010.516465	61	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64223	10.1371/journal.pone.0064223	http://dx.doi.org/10.1371/journal.pone.0064223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696871	Green Submitted, Green Published, gold			2022-12-27	WOS:000319081900074
J	Isozumi, Y; Arai, R; Fujimoto, K; Koyama, T				Isozumi, Yu; Arai, Reina; Fujimoto, Kazumi; Koyama, Takatoshi			Activation of Coagulation by Lenalidomide-Based Regimens for the Treatment of Multiple Myeloma	PLOS ONE			English	Article							TISSUE FACTOR; DEXAMETHASONE; THALIDOMIDE; BORTEZOMIB; THROMBOSIS; EXPRESSION; BILAYERS; BINDING; ALPHA; CELLS	We investigated the procoagulant effects of lenalidomide (Len)-based regimens in vitro focusing on tissue factor (TF) and phosphatidylserine (PS). We examined the effects of a pharmacological concentration of Len with or without the corticosteroid dexamethasone (Dex) and the proteasome inhibitor bortezomib (Bor) using the human vascular endothelial cell line EAhy926 and the monocytic cell lines THP-1 and U937. Cell-surface procoagulant activity (PCA) was induced by Dexcontaining regimens in all lines. Expression of TF antigen on the cell surface and of TF mRNA was markedly increased by Dex-containing regimens. PS exposure was increased modestly by a Len-based regimen. PS exposure was increased modestly in EAhy926 cells, and markedly increased in THP-1 and U937 cells by Bor-containing treatment. An anti-TF monoclonal antibody almost completely blocked the induced PCA. When Len is given in combination with Dex, PCA may be induced on endothelial cells and monocytes through TF expression and PS exposure.	[Isozumi, Yu; Arai, Reina; Fujimoto, Kazumi; Koyama, Takatoshi] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Koyama, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Tokyo, Japan.	koyama.lmg@tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [22590519] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a research grant for TK from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Aue G, 2011, AM J HEMATOL, V86, P835, DOI 10.1002/ajh.22114; Bach RR, 2006, ARTERIOSCL THROM VAS, V26, P456, DOI 10.1161/01.ATV.0000202656.53964.04; Barosi G, 2012, ANN HEMATOL, V91, P875, DOI 10.1007/s00277-012-1445-y; Cesarman-Maus G, 2012, LEUKEMIA, V26, P1671, DOI 10.1038/leu.2012.43; CHARLES B, 1993, DEV PHARMACOL THERAP, V20, P205, DOI 10.1159/000457564; Coppola A, 2011, SEMIN THROMB HEMOST, V37, P928, DOI 10.1055/s-0031-1297372; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Gandhi AK, 2010, CURR CANCER DRUG TAR, V10, P155; Hiroi T, 2009, ARTERIOSCL THROM VAS, V29, P1587, DOI 10.1161/ATVBAHA.109.191957; Hoshi A, 2011, BLOOD COAGUL FIBRIN, V22, P532, DOI 10.1097/MBC.0b013e328348629d; Iida S, 2010, INT J HEMATOL, V92, P118, DOI 10.1007/s12185-010-0624-7; Klein U, 2009, ANN HEMATOL, V88, P67, DOI 10.1007/s00277-008-0561-1; Kumar S, 2012, BLOOD, V119, P4375, DOI 10.1182/blood-2011-11-395749; Larocca A, 2012, BLOOD, V119, P933, DOI 10.1182/blood-2011-03-344333; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Morrissey JH, 2009, J THROMB HAEMOST, V7, P169, DOI 10.1111/j.1538-7836.2009.03390.x; Ohsawa M, 2000, CIRCULATION, V102, P2867; Palumbo A, 2008, LEUKEMIA, V22, P414, DOI 10.1038/sj.leu.2405062; Quach H, 2012, AM J HEMATOL, V87, P1089, DOI 10.1002/ajh.23234; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; TAIT JF, 1989, J BIOL CHEM, V264, P7944; Valsami S, 2011, THROMB RES, V127, P264, DOI 10.1016/j.thromres.2010.11.018	24	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64369	10.1371/journal.pone.0064369	http://dx.doi.org/10.1371/journal.pone.0064369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696885	gold, Green Published, Green Submitted			2022-12-27	WOS:000319081900088
J	Wobke, TK; von Knethen, A; Steinhilber, D; Sorg, BL				Woebke, Thea K.; von Knethen, Andreas; Steinhilber, Dieter; Sorg, Bernd L.			CD69 Is a TGF-beta/1 alpha,25-dihydroxyvitamin D-3 Target Gene in Monocytes	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACTIVATION ANTIGEN CD69; NECROSIS-FACTOR-ALPHA; VITAMIN-D-RECEPTOR; T-CELL ACTIVATION; C-TYPE LECTIN; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; 5-LIPOXYGENASE EXPRESSION; MESSENGER-RNA	CD69 is a transmembrane lectin that can be expressed on most hematopoietic cells. In monocytes, it has been functionally linked to the 5-lipoxygenase pathway in which the leukotrienes, a class of highly potent inflammatory mediators, are produced. However, regarding CD69 gene expression and its regulatory mechanisms in monocytes, only scarce data are available. Here, we report that CD69 mRNA expression, analogous to that of 5-lipoxygenase, is induced by the physiologic stimuli transforming growth factor-beta (TGF-beta) and 1 alpha,25-dihydroxyvitamin D-3 (1 alpha,25(OH)(2)D-3) in monocytic cells. Comparison with T-and B-cell lines showed that the effect was specific for monocytes. CD69 expression levels were increased in a concentration-dependent manner, and kinetic analysis revealed a rapid onset of mRNA expression, indicating that CD69 is a primary TGF-beta/1 alpha,25(OH)(2)D-3 target gene. PCR analysis of different regions of the CD69 mRNA revealed that de novo transcription was initiated and proximal and distal parts were induced concomitantly. In common with 5-lipoxygenase, no activation of 0.7 kb or similar to 2.3 kb promoter fragments by TGF-beta and 1 alpha,25(OH)(2)D-3 could be observed in transient reporter assays for CD69. Analysis of mRNA stability using a transcription inhibitor and a 3'UTR reporter construct showed that TGF-beta and 1 alpha,25(OH)(2)D-3 do not influence CD69 mRNA stability. Functional knockdown of Smad3 clearly demonstrated that upregulation of CD69 mRNA, in contrast to 5-LO, depends on Smad3. Comparative studies with different inhibitors for mitogen activated protein kinases (MAPKs) revealed that MAPK signalling is involved in CD69 gene regulation, whereas 5-lipoxygenase gene expression was only partly affected. Mechanistically, we found evidence that CD69 gene upregulation depends on TAK1-mediated p38 activation. In summary, our data indicate that CD69 gene expression, conforming with 5-lipoxygenase, is regulated monocyte-specifically by the physiologic stimuli TGF-beta and 1 alpha,25(OH)(2)D-3 on mRNA level, although different mechanisms account for the upregulation of each gene.	[Woebke, Thea K.; Steinhilber, Dieter; Sorg, Bernd L.] Goethe Univ Frankfurt, Inst Pharmaceut Chem, ZAFES, D-60054 Frankfurt, Germany; [von Knethen, Andreas] Goethe Univ Frankfurt, Fac Med, Inst Biochem Pathobiochem 1, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Sorg, BL (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Chem, ZAFES, D-60054 Frankfurt, Germany.	b.sorg@pharmchem.uni-frankfurt.de	Sánchez-Margalet, Victor/AAB-9986-2021; Steinhilber, Dieter/J-3221-2012	Sánchez-Margalet, Victor/0000-0001-8638-8680; 	Goethe University, Frankfurt am Main, Germany	Goethe University, Frankfurt am Main, Germany	The study has been funded by the Goethe University, Frankfurt am Main, Germany. (www.uni-frankfurt.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUNGS M, 1994, BIOCHEM BIOPH RES CO, V205, P1572, DOI 10.1006/bbrc.1994.2846; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; Bury Y, 2001, J INVEST DERMATOL, V116, P785, DOI 10.1046/j.1523-1747.2001.01332.x; CANONNEHERGAUX F, 1995, J VIROL, V69, P6634, DOI 10.1128/JVI.69.11.6634-6642.1995; Carlberg C, 2007, DERMATOL CLIN, V25, P515, DOI 10.1016/j.det.2007.06.004; Castellanos MD, 2002, EUR J IMMUNOL, V32, P3108; Castellanos MD, 1997, J IMMUNOL, V159, P5463; CEBRIAN M, 1989, EUR J IMMUNOL, V19, P809, DOI 10.1002/eji.1830190505; DEMARIA R, 1994, J EXP MED, V180, P1999, DOI 10.1084/jem.180.5.1999; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Diaz A, 1998, EXP CELL RES, V241, P222, DOI 10.1006/excr.1998.4050; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Heberden C, 1998, GEN PHARMACOL-VASC S, V30, P145, DOI 10.1016/S0306-3623(97)00271-1; Herdick M, 2000, CHEM BIOL, V7, P885, DOI 10.1016/S1074-5521(00)00036-3; JAKOBSSON PJ, 1992, P NATL ACAD SCI USA, V89, P3521, DOI 10.1073/pnas.89.8.3521; Kanies CL, 2008, MOL CANCER RES, V6, P1124, DOI 10.1158/1541-7786.MCR-07-2095; Karimi K, 1999, J LEUKOCYTE BIOL, V65, P854, DOI 10.1002/jlb.65.6.854; Klan N, 2003, BIOTECHNIQUES, V34, P142, DOI 10.2144/03341rr05; LOPEZCABRERA M, 1995, J BIOL CHEM, V270, P21545, DOI 10.1074/jbc.270.37.21545; MORIKAWA M, 1990, IN VITRO CELL DEV B, V26, P682; Mu Y, 2011, CELL TISSUE RES; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; Pan Z, 1999, J BIOL CHEM, V274, P23242, DOI 10.1074/jbc.274.33.23242; Pike JW, 2010, ENDOCRIN METAB CLIN, V39, P255, DOI 10.1016/j.ecl.2010.02.007; Provost P, 2001, J BIOL CHEM, V276, P16520, DOI 10.1074/jbc.M011205200; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Ramirez R, 1996, CELL IMMUNOL, V172, P192, DOI 10.1006/cimm.1996.0232; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; SANTIS AG, 1995, EUR J IMMUNOL, V25, P2142, DOI 10.1002/eji.1830250804; Santos-Alvarez J, 1999, CELL IMMUNOL, V194, P6, DOI 10.1006/cimm.1999.1490; Seuter S, 2006, BIOCHEM BIOPH RES CO, V348, P1403, DOI 10.1016/j.bbrc.2006.08.011; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sorg BL, 2006, BBA-MOL CELL BIOL L, V1761, P686, DOI 10.1016/j.bbalip.2006.04.005; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; STEINHILBER D, 1993, P NATL ACAD SCI USA, V90, P5984, DOI 10.1073/pnas.90.13.5984; TESTA U, 1993, J IMMUNOL, V150, P2418; Werz O, 1996, PHARMAZIE, V51, P893; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yim D, 2002, IMMUNOGENETICS, V54, P276, DOI 10.1007/s00251-002-0464-6; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; ZHANG DE, 1994, J IMMUNOL, V153, P3276; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	51	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64635	10.1371/journal.pone.0064635	http://dx.doi.org/10.1371/journal.pone.0064635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696902	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900104
J	Costa, JA; Nguyen, DA; Leal-Pinto, E; Gordon, RE; Hanss, B				Costa, Justin A.; Nguyen, Dac A.; Leal-Pinto, Edgar; Gordon, Ronald E.; Hanss, Basil			Wicking: A Rapid Method for Manually Inserting Ion Channels into Planar Lipid Bilayers	PLOS ONE			English	Article							ALPHA-HEMOLYSIN; MEMBRANE INTERACTION; MICROFLUIDIC DEVICE; DNA-MOLECULES; PROTEIN; CLIC1; RECONSTITUTION; MANIPULATION; NCC27; FORM	The planar lipid bilayer technique has a distinguished history in electrophysiology but is arguably the most technically difficult and time-consuming method in the field. Behind this is a lack of experimental consistency between laboratories, the challenges associated with painting unilamellar bilayers, and the reconstitution of ion channels into them. While there has be a trend towards automation of this technique, there remain many instances where manual bilayer formation and subsequent membrane protein insertion is both required and advantageous. We have developed a comprehensive method, which we have termed "wicking", that greatly simplifies many experimental aspects of the lipid bilayer system. Wicking allows one to manually insert ion channels into planar lipid bilayers in a matter of seconds, without the use of a magnetic stir bar or the addition of other chemicals to monitor or promote the fusion of proteoliposomes. We used the wicking method in conjunction with a standard membrane capacitance test and a simple method of proteoliposome preparation that generates a heterogeneous mixture of vesicle sizes. To determine the robustness of this technique, we selected two ion channels that have been well characterized in the literature: CLIC1 and alpha-hemolysin. When reconstituted using the wicking technique, CLIC1 showed biophysical characteristics congruent with published reports from other groups; and alpha-hemolysin demonstrated Type A and B events when threading single stranded DNA through the pore. We conclude that the wicking method gives the investigator a high degree of control over many aspects of the lipid bilayer system, while greatly reducing the time required for channel reconstitution.	[Costa, Justin A.; Nguyen, Dac A.; Hanss, Basil] Icahn Sch Med Mt Sinai, Div Nephrol, Dept Med, New York, NY USA; [Costa, Justin A.; Nguyen, Dac A.; Hanss, Basil] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY USA; [Leal-Pinto, Edgar] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA; [Gordon, Ronald E.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY USA; [Nguyen, Dac A.] Mt Sinai Sch Med, NIH Med Scientist Training Program, New York, NY USA; [Nguyen, Dac A.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Dept Syst Biol Dis & Therapeut, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Icahn School of Medicine at Mount Sinai	Hanss, B (corresponding author), Icahn Sch Med Mt Sinai, Div Nephrol, Dept Med, New York, NY USA.	basil.hanss@mssm.edu		Costa, Justin/0000-0003-0687-9549	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/National Institutes of Health (NIH) [DK065838]; National Institute of General Medical Sciences [T32GM062754]; NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/National Institutes of Health (NIH) to BH (DK065838). JC is a trainee in the Integrated Pharmacological Sciences Training Program supported by grant T32GM062754 from the National Institute of General Medical Sciences. DN is supported by the NIH Medical Scientist Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONOV VF, 1980, NATURE, V283, P585, DOI 10.1038/283585a0; Bakas L, 1996, BIOPHYS J, V71, P1869, DOI 10.1016/S0006-3495(96)79386-4; BEAN RC, 1969, J GEN PHYSIOL, V53, P741, DOI 10.1085/jgp.53.6.741; Feigin AM, 1996, J MEMBRANE BIOL, V149, P41, DOI 10.1007/s002329900005; Fujii G, 1997, BIOCHEMISTRY-US, V36, P4959, DOI 10.1021/bi962894z; Funakoshi K, 2006, ANAL CHEM, V78, P8169, DOI 10.1021/ac0613479; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Goodchild SC, 2010, BIOCHEMISTRY-US, V49, P5278, DOI 10.1021/bi100111c; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Hasan N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014238; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HLADKY SB, 1970, NATURE, V225, P451, DOI 10.1038/225451a0; Le Pioufle B, 2008, ANAL CHEM, V80, P328, DOI 10.1021/ac7016635; Mach T, 2008, ANAL BIOANAL CHEM, V390, P841, DOI 10.1007/s00216-007-1647-7; Maglia G, 2008, P NATL ACAD SCI USA, V105, P19720, DOI 10.1073/pnas.0808296105; Malmstadt N, 2006, NANO LETT, V6, P1961, DOI 10.1021/nl0611034; Mathe J, 2005, P NATL ACAD SCI USA, V102, P12377, DOI 10.1073/pnas.0502947102; McGillivray DJ, 2009, BIOPHYS J, V96, P1547, DOI 10.1016/j.bpj.2008.11.020; McNally B, 2008, NANO LETT, V8, P3418, DOI 10.1021/nl802218f; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Oukhaled G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158101; Pastoriza-Gallego M, 2007, FEBS LETT, V581, P3371, DOI 10.1016/j.febslet.2007.06.036; Poulos JL, 2009, BIOSENS BIOELECTRON, V24, P1806, DOI 10.1016/j.bios.2008.08.041; Prevost G, 2001, CURR TOP MICROBIOL, V257, P53; Roskamp RF, 2008, CHEMPHYSCHEM, V9, P1920, DOI 10.1002/cphc.200800248; Simonsson L, 2011, J AM CHEM SOC, V133, P14027, DOI 10.1021/ja204589a; Suzuki H, 2007, BIOSENS BIOELECTRON, V22, P1111, DOI 10.1016/j.bios.2006.04.013; Szoszkiewicz R, 2008, LANGMUIR, V24, P1356, DOI 10.1021/la702368b; TIEN HT, 2000, MEMBRANE BIOPHYSICS; Toyama S, 1991, BIOPHYS J, V59, P934; Tulk BM, 2000, J BIOL CHEM, V275, P26986; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; Vockenroth IK, 2008, LANGMUIR, V24, P496, DOI 10.1021/la7030279; Warton K, 2002, J BIOL CHEM, V277, P26003, DOI 10.1074/jbc.M203666200; WHITE SH, 1981, BIOPHYS J, V36, P449, DOI 10.1016/S0006-3495(81)84744-3; WOODBURY DJ, 1990, BIOPHYS J, V58, P833, DOI 10.1016/S0006-3495(90)82429-2	36	10	10	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e60836	10.1371/journal.pone.0060836	http://dx.doi.org/10.1371/journal.pone.0060836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717384	Green Submitted, gold, Green Published			2022-12-27	WOS:000319435600001
J	Liu, G; Zhou, LZ; Zhang, LL; Luo, ZJ; Xu, WB				Liu, Gang; Zhou, Lizhi; Zhang, Lili; Luo, Zijun; Xu, Wenbin			The Complete Mitochondrial Genome of Bean Goose (Anser fabalis) and Implications for Anseriformes Taxonomy	PLOS ONE			English	Article							DABBLING DUCKS TRIBE; CONTROL REGION; GENE ORGANIZATION; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; COMPLETE SEQUENCE; CYTOCHROME-B; EVOLUTION; DNA; MORPHOLOGY	Mitochondrial DNA plays an important role in living organisms, and has been used as a powerful molecular marker in a variety of evolutionary studies. In this study, we determined the complete mtDNA of Bean goose (Anser fabalis), which is 16,688 bp long and contains 13 protein-coding genes, 2 rRNAs, 22 tRNAs and a control region. The arrangement is similar to that of typical Anseriform species. All protein-coding genes, except for Cyt b, ND5, COI, and COII, start with an ATG codon. The ATG start codon is also generally observed in the 12 other Anseriform species, including 2 Anser species, with sequenced mitochondrial genomes. TAA is the most frequent stop codon, one of three-TAA, TAG, and T- -commonly observed in Anseriformes. All tRNAs could be folded into canonical cloverleaf secondary structures except for tRNA(Ser) (AGY) and tRNA(Leu) (CUN), which are missing the dihydrouridine (DHU) arm. The control region of Bean goose mtDNA, with some conserved sequence boxes, such as F, E, D, and C, identified in its central domain. Phylogenetic analysis of complete mtDNA data for 13 Anseriform species supports the classification of them into four major branches: Anatinae, Anserinae, Dendrocygninae and Anseranatidae. Phylogenetic analyses were also conducted on 36 Anseriform birds using combined Cyt b, ND2, and COI sequences. The results clearly support the genus Somateria as an independent lineage classified in its own tribe, the Somaterini. Recovered topologies from both complete mtDNA and combined DNA sequences strongly indicate that Dendrocygninae is an independent subfamily within the family Anatidae and Anseranatidae represents an independent family. Based on the results of this study, we conclude that combining ND2, Cyt b, and COI sequence data is a workable solution at present for resolving phylogenetic relationships among Anseriform species in the absence of sufficient complete mtDNA data.	[Liu, Gang; Zhou, Lizhi; Zhang, Lili; Luo, Zijun] Anhui Univ, Sch Resources & Environm Engn, Hefei 230039, Peoples R China; [Liu, Gang; Zhou, Lizhi; Zhang, Lili; Luo, Zijun] Anhui Univ, Anhui Biodivers Informat Ctr, Hefei 230039, Peoples R China; [Xu, Wenbin] Shengjin Lake Natl Nat Reserve Anhui Prov, Dongzhi, Peoples R China	Anhui University; Anhui University	Zhou, LZ (corresponding author), Anhui Univ, Sch Resources & Environm Engn, Hefei 230039, Peoples R China.	zhoulz@ahu.edu.cn	Zhou, Lizhi/AAF-4535-2021	Zhou, Lizhi/0000-0002-5702-4658	National Natural Science Foundation of China [31172117]; Graduate Student Innovation Research Projects of Anhui University [YQH100111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Innovation Research Projects of Anhui University	This research was supported by the National Natural Science Foundation of China (grant number 31172117) and the Graduate Student Innovation Research Projects of Anhui University (YQH100111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-67; Bucheli SR, 2005, MOL PHYLOGENET EVOL, V35, P380, DOI 10.1016/j.ympev.2005.02.003; Cao SY, 2006, MITOCHONDRION, V6, P186, DOI 10.1016/j.mito.2006.07.003; Castro J A, 1998, Int Microbiol, V1, P327; Cramp S, 1977, HDB BIRDS EUROPE MID, P1; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Del Hoyo J, 1992, HDB BIRDS WORLD, V2; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Dickinsom EC, 2003, HAWARD MOORE COMPLET; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; Eberhard JR, 2001, MOL BIOL EVOL, V18, P1330, DOI 10.1093/oxfordjournals.molbev.a003917; Gonzalez J, 2009, J ZOOL, V279, P310, DOI 10.1111/j.1469-7998.2009.00622.x; Guan X, 2009, ANIM GENET, V40, P134, DOI 10.1111/j.1365-2052.2008.01810.x; Haring E, 2001, MOL BIOL EVOL, V18, P1892, DOI 10.1093/oxfordjournals.molbev.a003730; Harrison GL, 2004, MOL BIOL EVOL, V21, P974, DOI 10.1093/molbev/msh065; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; IUCN, 2012, IUCN RED LIST THREAT; Johnson KP, 1999, P ROY SOC B-BIOL SCI, V266, P759, DOI 10.1098/rspb.1999.0702; Johnson KP, 1998, MOL PHYLOGENET EVOL, V10, P82, DOI 10.1006/mpev.1997.0481; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Ke Yang, 2010, Yichuan, V32, P951, DOI 10.3724/SP.J.1005.2010.00951; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kumazawa Y, 2004, DNA RES, V11, P115, DOI 10.1093/dnares/11.2.115; Liu G, 2012, MOL BIOL REP, V39, P2139, DOI 10.1007/s11033-011-0961-5; LIVEZEY BC, 1991, AUK, V108, P471, DOI 10.2307/4088089; LIVEZEY BC, 1995, CONDOR, V97, P233, DOI 10.2307/1368999; Marshall HD, 1997, MOL BIOL EVOL, V14, P173, DOI 10.1093/oxfordjournals.molbev.a025750; Near TJ, 2003, MOL PHYLOGENET EVOL, V28, P87, DOI 10.1016/S1055-7903(03)00029-0; Olson S.L., 1980, Smithsonian Contributions to Zoology, P1; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; QUINN TW, 1993, J MOL EVOL, V37, P417; Randi E, 1998, J MOL EVOL, V47, P449, DOI 10.1007/PL00006402; Ruokonen M, 2000, J EVOLUTION BIOL, V13, P532, DOI 10.1046/j.1420-9101.2000.00184.x; SACCONE C, 1987, J MOL EVOL, V26, P205, DOI 10.1007/BF02099853; SACCONE C, 1991, J MOL EVOL, V33, P83, DOI 10.1007/BF02100199; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Slack KE, 2003, GENE, V302, P43, DOI 10.1016/S0378111902010533; Slack KE, 2007, MOL PHYLOGENET EVOL, V42, P1, DOI 10.1016/j.ympev.2006.06.002; Sorenson MD, 2003, MOL BIOL EVOL, V20, P1484, DOI 10.1093/molbev/msg157; SOUTHERN SO, 1988, J MOL EVOL, V28, P32, DOI 10.1007/BF02143495; Tong Xiao-Mei, 2006, Yichuan, V28, P769; [涂剑锋 TU Jian-feng], 2010, [西南大学学报. 自然科学版, Journal of Southwest University. Natural Science Edition], V32, P38; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang R, 2010, MOL BIOL REP, V37, P3517, DOI 10.1007/s11033-009-9945-0	47	25	27	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63334	10.1371/journal.pone.0063334	http://dx.doi.org/10.1371/journal.pone.0063334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717412	Green Submitted, Green Published, gold			2022-12-27	WOS:000319435600011
J	Vilar-Sanz, A; Puig, S; Garcia-Lledo, A; Trias, R; Balaguer, MD; Colprim, J; Baneras, L				Vilar-Sanz, Ariadna; Puig, Sebastia; Garcia-Lledo, Arantzazu; Trias, Rosalia; Dolors Balaguer, M.; Colprim, Jesus; Baneras, Lluis			Denitrifying Bacterial Communities Affect Current Production and Nitrous Oxide Accumulation in a Microbial Fuel Cell	PLOS ONE			English	Article							NOSZ GENES; BIOLOGICAL DENITRIFICATION; GENOME SEQUENCES; REDUCTASE GENES; N2O EMISSIONS; NITRATE; CARBON; REMOVAL; NARG; NIRS	The biocathodic reduction of nitrate in Microbial Fuel Cells (MFCs) is an alternative to remove nitrogen in low carbon to nitrogen wastewater and relies entirely on microbial activity. In this paper the community composition of denitrifiers in the cathode of a MFC is analysed in relation to added electron acceptors (nitrate and nitrite) and organic matter in the cathode. Nitrate reducers and nitrite reducers were highly affected by the operational conditions and displayed high diversity. The number of retrieved species-level Operational Taxonomic Units (OTUs) for narG, napA, nirS and nirK genes was 11, 10, 31 and 22, respectively. In contrast, nitrous oxide reducers remained virtually unchanged at all conditions. About 90% of the retrieved nosZ sequences grouped in a single OTU with a high similarity with Oligotropha carboxidovorans nosZ gene. nirS-containing denitrifiers were dominant at all conditions and accounted for a significant amount of the total bacterial density. Current production decreased from 15.0 A.m(-3) NCC (Net Cathodic Compartment), when nitrate was used as an electron acceptor, to 14.1 A.m(-3) NCC in the case of nitrite. Contrarily, nitrous oxide (N2O) accumulation in the MFC was higher when nitrite was used as the main electron acceptor and accounted for 70% of gaseous nitrogen. Relative abundance of nitrite to nitrous oxide reducers, calculated as (qnirS+qnirK)/qnosZ, correlated positively with N2O emissions. Collectively, data indicate that bacteria catalysing the initial denitrification steps in a MFC are highly influenced by main electron acceptors and have a major influence on current production and N2O accumulation.	[Vilar-Sanz, Ariadna; Garcia-Lledo, Arantzazu; Trias, Rosalia; Baneras, Lluis] Univ Girona, Mol Microbial Ecol Grp, Inst Aquat Ecol, Girona, Spain; [Puig, Sebastia; Dolors Balaguer, M.; Colprim, Jesus] Univ Girona, Inst Environm, LEQUIA, Girona, Spain	Universitat de Girona; Universitat de Girona	Baneras, L (corresponding author), Univ Girona, Mol Microbial Ecol Grp, Inst Aquat Ecol, Girona, Spain.	lluis.banyeras@udg.edu	Colprim, Jesús/L-3087-2014; Balaguer Condom, M. Dolors/L-3025-2014; Bañeras, Lluis/K-6736-2017; Balaguer, M. Dolors/AAC-6114-2019; Trias, Rosalia/F-2243-2010; Puig, Sebastià/L-8562-2014	Colprim, Jesús/0000-0002-6000-069X; Balaguer Condom, M. Dolors/0000-0001-6231-2163; Bañeras, Lluis/0000-0001-6908-3658; Balaguer, M. Dolors/0000-0001-6231-2163; Trias, Rosalia/0000-0002-2849-495X; Puig, Sebastià/0000-0003-2995-1443	Universitat de Girona; Ministerio de Ciencia y Educacion; Spanish Government [CGL2009-08338, CSD2007-00055, CTQ2011-23632]	Universitat de Girona; Ministerio de Ciencia y Educacion(Spanish Government); Spanish Government(Spanish GovernmentEuropean Commission)	A. V-S. and A. G-L. are recipients of pre-doctoral grants from the Universitat de Girona and the Ministerio de Ciencia y Educacion, respectively. This research was funded through grants from the Spanish Government (CGL2009-08338, CSD2007-00055 and CTQ2011-23632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell GCJ, 2010, ISME J, V4, P286, DOI 10.1038/ismej.2009.105; Chen GW, 2008, APPL MICROBIOL BIOT, V79, P379, DOI 10.1007/s00253-008-1451-0; CLAUS G, 1985, APPL MICROBIOL BIOT, V22, P283; Clauwaert P, 2007, ENVIRON SCI TECHNOL, V41, P3354, DOI 10.1021/es062580r; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Eaton A. D., 2005, STANDARD METHODS EXA; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Enwall K, 2010, APPL ENVIRON MICROB, V76, P2243, DOI 10.1128/AEM.02197-09; Etchebehere C, 2005, APPL ENVIRON MICROB, V71, P5642, DOI 10.1128/AEM.71.9.5642-5645.2005; Garcia-Lledo A, 2011, WATER RES, V45, P5621, DOI 10.1016/j.watres.2011.08.025; Green SJ, 2012, APPL ENVIRON MICROB, V78, P1039, DOI 10.1128/AEM.06435-11; Gregory KB, 2004, ENVIRON MICROBIOL, V6, P596, DOI 10.1111/j.1462-2920.2004.00593.x; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; He Z, 2009, ENVIRON SCI TECHNOL, V43, P3391, DOI 10.1021/es803492c; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Heylen K, 2006, APPL ENVIRON MICROB, V72, P2637, DOI 10.1128/AEM.72.4.2637-2643.2006; Horn MA, 2006, APPL ENVIRON MICROB, V72, P1019, DOI 10.1128/AEM.72.2.1019-1026.2006; Hu Z, 2013, ENVIRON SCI POLLUT R, V20, P1059, DOI 10.1007/s11356-012-1018-6; Huang LP, 2011, BIORESOURCE TECHNOL, V102, P316, DOI 10.1016/j.biortech.2010.06.096; Jones CM, 2008, MOL BIOL EVOL, V25, P1955, DOI 10.1093/molbev/msn146; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Jourand P, 2004, INT J SYST EVOL MICR, V54, P2269, DOI 10.1099/ijs.0.02902-0; Kampschreur MJ, 2009, WATER RES, V43, P4093, DOI 10.1016/j.watres.2009.03.001; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; Kostka JE, 2012, J BACTERIOL, V194, P4461, DOI 10.1128/JB.00871-12; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DY, 2002, APPL ENVIRON MICROB, V68, P2140, DOI 10.1128/AEM.68.5.2140-2147.2002; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Maltais-Landry G, 2009, ENVIRON POLLUT, V157, P748, DOI 10.1016/j.envpol.2008.11.019; Morales SE, 2010, ISME J, V4, P799, DOI 10.1038/ismej.2010.8; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Nagashima S, 2012, J BACTERIOL, V194, P3541, DOI 10.1128/JB.00511-12; Palmer K, 2012, APPL ENVIRON MICROB, V78, P5584, DOI 10.1128/AEM.00810-12; Palmer K, 2012, ISME J, V6, P1058, DOI 10.1038/ismej.2011.172; Palmer K, 2009, APPL ENVIRON MICROB, V75, P5170, DOI 10.1128/AEM.00254-09; Park HI, 2006, ENZYME MICROB TECH, V39, P453, DOI 10.1016/j.enzmictec.2005.11.028; Philippot L, 2002, BBA-GENE STRUCT EXPR, V1577, P355, DOI 10.1016/S0167-4781(02)00420-7; Philippot L, 2011, GLOBAL CHANGE BIOL, V17, P1497, DOI 10.1111/j.1365-2486.2010.02334.x; Pous N, 2013, J CHEM TECHNOL BIOT, V88, P1690, DOI 10.1002/jctb.4020; Puig S, 2008, WATER RES, V42, P557, DOI 10.1016/j.watres.2007.07.050; Puig S, 2011, BIORESOURCE TECHNOL, V102, P4462, DOI 10.1016/j.biortech.2010.12.100; Puig S, 2010, BIORESOURCE TECHNOL, V101, P9594, DOI 10.1016/j.biortech.2010.07.082; Randall C.W., 1992, WATER QUALITY MANAGE, V5; Reyes-Avila JS, 2004, WATER RES, V38, P3313, DOI 10.1016/j.watres.2004.04.035; Rosenbaum M, 2011, BIORESOURCE TECHNOL, V102, P324, DOI 10.1016/j.biortech.2010.07.008; Ruiz-Rueda O, 2009, FEMS MICROBIOL ECOL, V67, P308, DOI 10.1111/j.1574-6941.2008.00615.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt I, 2003, FEMS MICROBIOL REV, V27, P481, DOI 10.1016/S0168-6445(03)00039-1; SMITH RL, 1994, APPL ENVIRON MICROB, V60, P1949, DOI 10.1128/AEM.60.6.1949-1955.1994; Sovik AK, 2007, SCI TOTAL ENVIRON, V380, P28, DOI 10.1016/j.scitotenv.2006.10.007; Strycharz SM, 2011, BIOELECTROCHEMISTRY, V80, P142, DOI 10.1016/j.bioelechem.2010.07.005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Torres CI, 2008, BIOTECHNOL BIOENG, V100, P872, DOI 10.1002/bit.21821; van Cleemput O, 1998, NUTR CYCL AGROECOSYS, V52, P187, DOI 10.1023/A:1009728125678; Virdis B, 2008, WATER RES, V42, P3013, DOI 10.1016/j.watres.2008.03.017; Virdis B, 2009, ENVIRON SCI TECHNOL, V43, P5144, DOI 10.1021/es8036302; Volland S, 2011, J BACTERIOL, V193, P5043, DOI 10.1128/JB.05619-11; Wrighton KC, 2010, ISME J, V4, P1443, DOI 10.1038/ismej.2010.66; Wunderlin P, 2012, WATER RES, V46, P1027, DOI 10.1016/j.watres.2011.11.080; Yagi JM, 2009, ENVIRON MICROBIOL, V11, P2253, DOI 10.1111/j.1462-2920.2009.01947.x; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	63	67	70	1	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63460	10.1371/journal.pone.0063460	http://dx.doi.org/10.1371/journal.pone.0063460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717427	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600017
J	Duffy, K; Galukande, M; Wooding, N; Dea, M; Coutinho, A				Duffy, Kevin; Galukande, Moses; Wooding, Nick; Dea, Monica; Coutinho, Alex			Reach and Cost-Effectiveness of the PrePex Device for Safe Male Circumcision in Uganda	PLOS ONE			English	Article							HIV PREVENTION; MEN	Introduction: Modelling, supported by the USAID Health Policy Initiative and UNAIDS, performed in 2011, indicated that Uganda would need to perform 4.2 million medical male circumcisions (MMCs) to reach 80% prevalence. Since 2010 Uganda has completed 380,000 circumcisions, and has set a national target of 1 million for 2013. Objective: To evaluate the relative reach and cost-effectiveness of PrePex compared to the current surgical SMC method and to determine the effect that this might have in helping to achieve the Uganda national SMC targets. Methods: A cross-sectional descriptive cost-analysis study conducted at International Hospital Kampala over ten weeks from August to October 2012. Data collected during the performance of 625 circumcisions using PrePex was compared to data previously collected from 10,000 circumcisions using a surgical circumcision method at the same site. Ethical approval was obtained. Results: The moderate adverse events (AE) ratio when using the PrePex device was 2% and no severe adverse events were encountered, which is comparable to the surgical method, thus the AE rate has no effect on the reach or cost-effectiveness of PrePex. The unit cost to perform one circumcision using PrePex is $30.55, 35% ($7.90) higher than the current surgical method, but the PrePex method improves operator efficiency by 60%, meaning that a team can perform 24 completed circumcisions compared to 15 by the surgical method. The cost-effectiveness of PrePex, comparing the cost of performing circumcisions to the future cost savings of potentially averted HIV infections, is just 2% less than the current surgical method, at a device cost price of $20. Conclusion: PrePex is a viable SMC tool for scale-up with unrivalled potential for superior reach, however national targets can only be met with effective demand creation and availability of trained human resource.	[Duffy, Kevin] Int Med Grp, Kampala, Uganda; [Galukande, Moses] Mulago Hosp, Int Hosp Kampala, Kampala, Uganda; [Galukande, Moses] Mulago Hosp, Dept Surg, Kampala, Uganda; [Wooding, Nick] Int Hlth Sci Univ, Kampala, Uganda; [Dea, Monica] Ctr Dis Control, Kampala, Uganda; [Coutinho, Alex] Makerere Univ, Infect Dis Inst, Kampala, Uganda	Mulago National Referral Hospital; Mulago National Referral Hospital; Makerere University	Galukande, M (corresponding author), Mulago Hosp, Int Hosp Kampala, Kampala, Uganda.	mosesg@img.co.ug	Wooding, Nicholas/L-7934-2019					Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bbaale Sekavuga D, 2013, ADVERSE EVE IN PRESS; Binagwaho A, 2011, PROSPECTIVE RANDOMIZ; Bitega JP, 2011, JAIDS-J ACQ IMM DEF, V58, pE127, DOI 10.1097/QAI.0b013e3182354e65; DeCormier Plosky W, 2009, 1 FUT GROUP HLTH POL; Galukande Moses, 2012, Pan Afr Med J, V13, P88; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kuznik A, 2012, TROP DOCT, V42, P5, DOI 10.1258/td.2011.110297; Mutabazi V, 2011, ONE ARM OPEN LABEL P; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Okiria C, 2010, PROVIDING CD4 CELL C; Shepard DS., 2000, ANAL HOSP COSTS MANU; Thomas AG, 2012, J ACQ IMMUN DEF SYND, V60, P88; Uganda AIDS Commission, 2011, NAT PRIOR ACT PLAN; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; WHO, 2012, US DEV AD MAL CIRC P; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization (WHO), 2010, CONS IMPL MOD OPT VO	20	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63134	10.1371/journal.pone.0063134	http://dx.doi.org/10.1371/journal.pone.0063134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717402	gold, Green Submitted, Green Published			2022-12-27	WOS:000320362700010
J	Iismaa, SE; Aplin, M; Holman, S; Yiu, TW; Jackson, K; Burchfield, JG; Mitchell, CJ; O'Reilly, L; Davenport, A; Cantley, J; Schmitz-Peiffer, C; Biden, TJ; Cooney, GJ; Graham, RM				Iismaa, Siiri E.; Aplin, Mark; Holman, Sara; Yiu, Ting W.; Jackson, Kristy; Burchfield, James G.; Mitchell, Christopher J.; O'Reilly, Liam; Davenport, Aimee; Cantley, James; Schmitz-Peiffer, Carsten; Biden, Trevor J.; Cooney, Gregory J.; Graham, Robert M.			Glucose Homeostasis in Mice Is Transglutaminase 2 Independent	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; RAT PANCREATIC-ISLETS; GTP-BINDING PROTEIN; FUNCTIONAL-CHARACTERIZATION; TISSUE TRANSGLUTAMINASE; YOUNG MODY; RECEPTOR; G(H); INHIBITION; DISORDERS	Transglutaminase type 2 (TG2) has been reported to be a candidate gene for maturity onset diabetes of the young (MODY) because three different mutations that impair TG2 transamidase activity have been found in 3 families with MODY. TG2 null (TG2(-/-)) mice have been reported to be glucose intolerant and have impaired glucose-stimulated insulin secretion (GSIS). Here we rigorously evaluated the role of TG2 in glucose metabolism using independently generated murine models of genetic TG2 disruption, which show no compensatory enhanced expression of other TGs in pancreatic islets or other tissues. First, we subjected chow- or fat-fed congenic SV129 or C57BL/6 wild type (WT) and TG2(-/-) littermates, to oral glucose gavage. Blood glucose and serum insulin levels were similar for both genotypes. Pancreatic islets isolated from these animals and analysed in vitro for GSIS and cholinergic potentiation of GSIS, showed no significant difference between genotypes. Results from intraperitoneal glucose tolerance tests (GTTs) and insulin tolerance tests (ITTs) were similar for both genotypes. Second, we directly investigated the role of TG2 transamidase activity in insulin secretion using a coisogenic model that expresses a mutant form of TG2 (TG2(R579A)), which is constitutively active for transamidase activity. Intraperitoneal GTTs and ITTs revealed no significant differences between WT and TG2(R579A/R579A) mice. Given that neither deletion nor constitutive activation of TG2 transamidase activity altered basal responses, or responses to a glucose or insulin challenge, our data indicate that glucose homeostasis in mice is TG2 independent, and question a link between TG2 and diabetes.	[Iismaa, Siiri E.; Aplin, Mark; Holman, Sara; Yiu, Ting W.; Jackson, Kristy; Graham, Robert M.] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Sydney, NSW, Australia; [Burchfield, James G.; Mitchell, Christopher J.; O'Reilly, Liam; Davenport, Aimee; Cantley, James; Schmitz-Peiffer, Carsten; Biden, Trevor J.; Cooney, Gregory J.] Garvan Inst Med Res, Diabet & Obes Div, Sydney, NSW, Australia; [Iismaa, Siiri E.; Yiu, Ting W.; Graham, Robert M.] Univ New S Wales, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; Garvan Institute of Medical Research; University of New South Wales Sydney	Iismaa, SE (corresponding author), Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Sydney, NSW, Australia.	s.iismaa@victorchang.edu.au; b.graham@victorchang.edu.au	Biden, Trevor/AAW-2829-2021; Burchfield, James/C-1779-2019; Iismaa, Siiri/C-9300-2013	Burchfield, James/0000-0002-6609-6151; Cantley, James/0000-0003-2509-1271; Schmitz-Peiffer, Carsten/0000-0001-7330-7255; Jackson, Kristy/0000-0002-4707-4096; Iismaa, Siiri/0000-0003-2409-7356; Biden, Trevor/0000-0001-5211-0234	National Health and Medical Research Council of Australia [142000, 459406]; Victor Chang Cardiac Research Institute's	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victor Chang Cardiac Research Institute's	This study was supported by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/grants) grants 142000 (SEI, RMG), 459406 (RMG, SEI) and the Victor Chang Cardiac Research Institute's (http://www.victorchang.org.au/home/study-careers/research/prince-christian-fellowship/) Prince Christian Fellowship (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Bernassola F, 2002, FASEB J, V16, P1371, DOI 10.1096/fj.01-0689com; Brennan K, 2011, ADV PROTOCOLS ANIMAL, P535; BUNGAY PJ, 1984, BIOCHEM J, V219, P819, DOI 10.1042/bj2190819; Calkins MJ, 2010, EXP NEUROL, V224, P307, DOI 10.1016/j.expneurol.2010.04.008; Cantley J, 2011, DIABETOLOGIA, V54, P380, DOI 10.1007/s00125-010-1962-y; Carpenter L, 2004, DIABETES, V53, P53, DOI 10.2337/diabetes.53.1.53; Chen SH, 1996, J BIOL CHEM, V271, P32385, DOI 10.1074/jbc.271.50.32385; DAVIES PJA, 1984, DIABETES CARE, V7, P35; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Dupuis M, 2004, J BIOL CHEM, V279, P19257, DOI 10.1074/jbc.M314299200; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; GOMIS R, 1983, BIOCHIM BIOPHYS ACTA, V760, P384, DOI 10.1016/0304-4165(83)90378-1; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Iismaa SE, 2000, J BIOL CHEM, V275, P18259, DOI 10.1074/jbc.M000583200; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Iismaa TP, 2000, DIABETES, V49, P392, DOI 10.2337/diabetes.49.3.392; IM MJ, 1990, J BIOL CHEM, V265, P18952; LEDERMANN HM, 1995, DIABETOLOGIA, V38, P1482, DOI 10.1007/BF00400611; LEE SK, 1995, PANCREAS, V11, P206, DOI 10.1097/00006676-199508000-00016; Leiter EH, 2002, DIABETOLOGIA, V45, P296, DOI 10.1007/s00125-001-0743-z; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Park ES, 1998, BIOCHEM J, V331, P283, DOI 10.1042/bj3310283; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Porzio O, 2007, Hum Mutat, V28, P1150, DOI 10.1002/humu.9511; Ruan QM, 2007, FRONT BIOSCI-LANDMRK, V12, P891, DOI 10.2741/2111; Salter NW, 2012, J MOL ENDOCRINOL, V48, P203, DOI 10.1530/JME-11-0064; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Vezza R, 1999, J BIOL CHEM, V274, P12774, DOI 10.1074/jbc.274.18.12774; Wong GT, 2002, NEUROPEPTIDES, V36, P230, DOI 10.1054/npep.2002.0905; Zhang ZB, 2003, CIRC RES, V92, P1153, DOI 10.1161/01.RES.0000071749.22027.45	39	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63346	10.1371/journal.pone.0063346	http://dx.doi.org/10.1371/journal.pone.0063346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717413	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700015
J	Merz, WM; Kubler, K; Fimmers, R; Willruth, A; Stoffel-Wagner, B; Gembruch, U				Merz, Waltraut M.; Kuebler, Kirsten; Fimmers, Rolf; Willruth, Arne; Stoffel-Wagner, Birgit; Gembruch, Ulrich			Cardiorenal Syndrome is Present in Human Fetuses with Severe, Isolated Urinary Tract Malformations	PLOS ONE			English	Article							NATRIURETIC PEPTIDE CONCENTRATIONS; CHRONIC HEART-FAILURE; CARDIOVASCULAR-DISEASE; FETAL ANEMIA; CORD BLOOD; DIAGNOSIS; BETA(2)-MICROGLOBULIN; CIRCULATION; UPDATE; CKD	Objective: We analyzed the association between renal and cardiovascular parameters in fetuses with isolated severe urinary tract malformations. Methods: 39 fetuses at a mean gestational age of 23.6 weeks with nephropathies or urinary tract malformations and markedly impaired or absent renal function were prospectively examined. Fetal echocardiography was performed, and thicknesses of the interventricular septum, and left and right ventricular wall were measured. Blood flow velocity waveforms of the umbilical artery, middle cerebral artery, and ductus venosus were obtained by color Doppler ultrasound. Concentrations of circulating n-terminal pro-B-type natriuretic peptide (nt-proBNP), cystatin C, beta(2)-microglobulin, and hemoglobin were determined from fetal blood samples. Results: Malformations included 21 cases of obstructive uropathy, 10 fetuses with bilateral nephropathy, and 8 cases of bilateral renal agenesis. Marked biventricular myocardial hypertrophy was present in all cases. The ratio between measured and gestational age-adjusted normal values was 2.01 (interventricular septum), 1.85, and 1.78 (right and left ventricular wall, respectively). Compared to controls, levels of circulating nt-proBNP were significantly increased (median (IQR) 5035 ng/L (5936 ng/L) vs. 1874 ng/L (1092 ng/L); p<0.001). Cystatin C and beta(2)-microglobulin concentrations were elevated as follows (mean +/- SD) 1.85 +/- 0.391 mg/L and 8.44 +/- 2.423 mg/L, respectively (normal range 1.66 +/- 0.202 mg/L and 4.25 +/- 0.734 mg/L, respectively). No correlation was detected between cardiovascular parameters and urinary tract morphology and function. Despite increased levels of nt-proBNP cardiovascular function was preserved, with normal fetal Doppler indices in 90.2% of cases. Conclusion: Urinary tract malformations resulting in severe renal impairment are associated with biventricular myocardial hypertrophy and elevated concentrations of circulating nt-proBNP during fetal life. Cardiovascular findings do not correlate with kidney function or morphology.	[Merz, Waltraut M.; Kuebler, Kirsten; Willruth, Arne; Gembruch, Ulrich] Univ Bonn, Sch Med, Dept Obstet & Prenatal Med, Bonn, Germany; [Fimmers, Rolf] Univ Bonn, Sch Med, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Stoffel-Wagner, Birgit] Univ Bonn, Sch Med, Inst Clin Chem & Pharmacol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Merz, WM (corresponding author), Univ Bonn, Sch Med, Dept Obstet & Prenatal Med, Bonn, Germany.	waltraut.merz@ukb.uni-bonn.de	Gembruch, Ulrich/Q-8228-2017	Gembruch, Ulrich/0000-0001-8284-4669; Kubler, Kirsten/0000-0002-0342-5579				BERRY SM, 1995, LANCET, V345, P1277, DOI 10.1016/S0140-6736(95)90928-1; Bock JS, 2010, CIRCULATION, V121, P2592, DOI 10.1161/CIRCULATIONAHA.109.886473; Bokenkamp A, 2001, AM J OBSTET GYNECOL, V185, P468, DOI 10.1067/mob.2001.115283; Cameron VA, 2003, ENDOCRINOLOGY, V144, P2191, DOI 10.1210/en.2003-0127; Copelovitch L, 2011, CLIN J AM SOC NEPHRO, V6, P2047, DOI 10.2215/CJN.10751210; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; deFilippi CR, 2009, CLIN CHEM, V55, P1271, DOI 10.1373/clinchem.2009.128157; DeVore GR, 2005, ULTRASOUND OBST GYN, V26, P596, DOI 10.1002/uog.2605; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Firpo C, 2001, AM J CARDIOL, V87, P594, DOI 10.1016/S0002-9149(00)01437-5; Gibson KJ, 1999, CLIN EXP PHARMACOL P, V26, P765, DOI 10.1046/j.1440-1681.1999.03127.x; Girsen A, 2007, ULTRASOUND OBST GYN, V29, P296, DOI 10.1002/uog.3934; Hammerer-Lercher A, 2005, CLIN CHEM, V51, P913, DOI 10.1373/clinchem.2004.046557; Hunt SA, 2005, CIRCULATION, V112, P1825, DOI 10.1016/j.jacc.2005.08.023; Kocylowski RD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.009; Lechner E, 2009, PEDIATR RES, V66, P466, DOI 10.1203/PDR.0b013e3181b3aee4; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; McGrath MF, 2005, PEPTIDES, V26, P933, DOI 10.1016/j.peptides.2004.12.022; Merz WM, 2012, PEDIATR RES, V72, P174, DOI 10.1038/pr.2012.53; Merz WM, 2012, CLIN RES CARDIOL, V101, P73, DOI 10.1007/s00392-011-0366-4; Merz WM, 2010, CLIN BIOCHEM, V43, P519, DOI 10.1016/j.clinbiochem.2009.11.012; Nybo M, 2007, CLIN CHEM, V53, P1921, DOI 10.1373/clinchem.2007.089391; Ordonez-Llanos J, 2008, AM J CARDIOL, V101, p9A, DOI 10.1016/j.amjcard.2007.11.013; Patel HP, 2010, RENAL FAILURE, V32, P1, DOI 10.3109/08860220903288534; Pedra SRFF, 2002, CIRCULATION, V106, P585, DOI 10.1161/01.CIR.0000023900.58293.FE; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Rinat C, 2012, PEDIATR NEPHROL, V27, P617, DOI 10.1007/s00467-011-2025-4; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Rychik J, 2010, ULTRASOUND OBST GYN, V36, P682, DOI 10.1002/uog.7664; Saito Y, 2010, J CARDIOL, V56, P262, DOI 10.1016/j.jjcc.2010.08.001; Sanjuan R, 2011, CARDIORENAL MED, V1, P147, DOI 10.1159/000329337; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Sivasankaran S, 2005, CARDIOL YOUNG, V15, P409, DOI 10.1017/S1047951105000855; Veniant M, 1996, J CLIN INVEST, V98, P1966, DOI 10.1172/JCI119000; Wilson AC, 2009, AM J KIDNEY DIS, V54, P345, DOI 10.1053/j.ajkd.2009.04.027; Yamashita T, 2010, J CARDIOL, V55, P377, DOI 10.1016/j.jjcc.2010.01.008	36	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63664	10.1371/journal.pone.0063664	http://dx.doi.org/10.1371/journal.pone.0063664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717461	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700046
J	Volkow, ND; Tomasi, D; Wang, GJ; Telang, F; Fowler, JS; Goldstein, RZ; Klein, N; Wong, C; Swanson, JM; Shumay, E				Volkow, Nora D.; Tomasi, Dardo; Wang, Gene-Jack; Telang, Frank; Fowler, Joanna S.; Goldstein, Rita Z.; Klein, Nelly; Wong, Christopher; Swanson, James M.; Shumay, Elena			Association between Dopamine D4 Receptor Polymorphism and Age Related Changes in Brain Glucose Metabolism	PLOS ONE			English	Article							E TYPE-4 ALLELE; DEFICIT/HYPERACTIVITY DISORDER; DIFFERENTIAL SUSCEPTIBILITY; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; GENETIC-VARIATION; HEALTHY-SUBJECTS; DRD4 GENE; D4 GENE; PERSONALITY	Aging is associated with reductions in brain glucose metabolism in some cortical and subcortical regions, but the rate of decrease varies significantly between individuals, likely reflecting genetic and environmental factors and their interactions. Here we test the hypothesis that the variant of the dopamine receptor D4 (DRD4) gene (VNTR in exon 3), which has been associated with novelty seeking and sensitivity to environmental stimuli (negative and positive) including the beneficial effects of physical activity on longevity, influence the effects of aging on the human brain. We used positron emission tomography (PET) and [F-18]fluoro-D-glucose ((18)FDG) to measure brain glucose metabolism (marker of brain function) under baseline conditions (no stimulation) in 82 healthy individuals (age range 22-55 years). We determined their DRD4 genotype and found an interaction with age: individuals who did not carry the 7-repeat allele (7R-, n = 53) had a significant (p<0.0001) negative association between age and relative glucose metabolism (normalized to whole brain glucose metabolism) in frontal (r = -0.52), temporal (r = -0.51) and striatal regions (r = -0.47, p<0.001); such that older individuals had lower metabolism than younger ones. In contrast, for carriers of the 7R allele (7R+ n = 29), these correlations with age were not significant and they only showed a positive association with cerebellar glucose metabolism (r = +0.55; p = 0.002). Regression slopes of regional brain glucose metabolism with age differed significantly between the 7R+ and 7R- groups in cerebellum, inferior temporal cortex and striatum. These results provide evidence that the DRD4 genotype might modulate the associations between regional brain glucose metabolism and age and that the carriers of the 7R allele appear to be less sensitive to the effects of age on brain glucose metabolism.	[Volkow, Nora D.; Tomasi, Dardo] NIDA, NIH, Bethesda, MD 20892 USA; [Volkow, Nora D.; Telang, Frank; Wong, Christopher] NIAAA, NIH, Bethesda, MD USA; [Wang, Gene-Jack; Fowler, Joanna S.; Goldstein, Rita Z.; Klein, Nelly; Shumay, Elena] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; [Swanson, James M.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory; University of California System; University of California Irvine	Volkow, ND (corresponding author), NIDA, NIH, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov	Alia-Klein, Nelly/C-3154-2013; Tomasi, Dardo/J-2127-2015		National Institutes of Health (Intramural Research Program of the National Institute on Alcoholism and Alcohol Abuse); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	National Institutes of Health (Intramural Research Program of the National Institute on Alcoholism and Alcohol Abuse); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the National Institutes of Health (Intramural Research Program of the National Institute on Alcoholism and Alcohol Abuse). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GE, 2002, AM J PSYCHIAT, V159, P738, DOI 10.1176/appi.ajp.159.5.738; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bak LK, 2009, J NEUROCHEM, V109, P87, DOI 10.1111/j.1471-4159.2009.05943.x; Bakermans-Kranenburg MJ, 2007, J CHILD PSYCHOL PSYC, V48, P1160, DOI 10.1111/j.1469-7610.2007.01801.x; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Bittner Carla X, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00026; Boals A, 2011, PSYCHOL HEALTH, V26, P1049, DOI 10.1080/08870446.2010.529139; Borroto-Escuela DO, 2011, BIOCHEM BIOPH RES CO, V404, P928, DOI 10.1016/j.bbrc.2010.12.083; Bouchard TJ, 2001, BEHAV GENET, V31, P243; Buchman AS, 2008, AM J GERIAT PSYCHIAT, V16, P697, DOI 10.1097/JGP.0b013e31817945f6; BUCHMAN AS, 2012, AM J GERIATR PSYCHIA; Capitanio JP, 2008, BRAIN BEHAV IMMUN, V22, P647, DOI 10.1016/j.bbi.2008.02.002; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Das D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020177; DESANTI S, 1995, PSYCHIAT QUART, V66, P357, DOI 10.1007/BF02238755; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Eyler LT, 2011, BIOL PSYCHIAT, V70, P115, DOI 10.1016/j.biopsych.2010.12.032; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gillespie NA, 2003, PERS INDIV DIFFER, V35, P1931, DOI 10.1016/S0191-8869(03)00042-4; Glantz S.A., 2002, PRIMER BIOSTATISTICS; GONZALEZ S, 2011, MOL PSYCHIAT; Grady DL, 2013, J NEUROSCI, V33, P286, DOI 10.1523/JNEUROSCI.3515-12.2013; Helms CM, 2008, PHARMACOL BIOCHEM BE, V90, P387, DOI 10.1016/j.pbb.2008.03.013; James BD, 2011, J INT NEUROPSYCH SOC, V17, P998, DOI 10.1017/S1355617711000531; Kieling R., 2011, CURR TOP BEHAV NEURO, V9, P1, DOI [10.1007/7854_2010_115, DOI 10.1007/7854_2010_115]; Kim IJ, 2009, ACTA RADIOL, V50, P1169, DOI 10.3109/02841850903258058; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Knafo A, 2011, DEV PSYCHOPATHOL, V23, P53, DOI 10.1017/S0954579410000647; Kramer UM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-150; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lo RY, 2011, ARCH NEUROL-CHICAGO, V68, P1257, DOI 10.1001/archneurol.2011.123; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Michaelides M, 2010, EUR J NEUROSCI, V32, P668, DOI 10.1111/j.1460-9568.2010.07319.x; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Pardo JV, 2007, NEUROIMAGE, V35, P1231, DOI 10.1016/j.neuroimage.2006.12.044; Park A, 2011, J ABNORM PSYCHOL, V120, P585, DOI 10.1037/a0022648; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 2010, NEUROIMAGE, V49, P169, DOI 10.1016/j.neuroimage.2009.07.025; Rimajova M, 2008, J ALZHEIMERS DIS, V13, P137; Rosenbloom MH, 2011, NEUROLOGY, V76, P1789, DOI 10.1212/WNL.0b013e31821cccad; Sheese BE, 2007, DEV PSYCHOPATHOL, V19, P1039, DOI 10.1017/S0954579407000521; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; Swanson J, 2000, P NATL ACAD SCI USA, V97, P4754, DOI 10.1073/pnas.080070897; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Talairach J., 1988, COPLANAR STEREOTAXIC; Volkow ND, 2011, MOL PSYCHIATR, V16, P818, DOI 10.1038/mp.2011.30; VOLKOW ND, 1986, J CEREBR BLOOD F MET, V6, P441, DOI 10.1038/jcbfm.1986.77; Volkow ND, 2000, AM J PSYCHIAT, V157, P75, DOI 10.1176/ajp.157.1.75; Volkow ND, 2006, ARCH GEN PSYCHIAT, V63, P999, DOI 10.1001/archpsyc.63.9.999; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; WANG GJ, 1993, RADIOLOGY, V186, P59, DOI 10.1148/radiology.186.1.8416587; Wang HX, 2009, NEUROLOGY, V72, P253, DOI 10.1212/01.wnl.0000339485.39246.87; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zahr NM, 2008, CEREB CORTEX, V18, P2241, DOI 10.1093/cercor/bhm250	61	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63492	10.1371/journal.pone.0063492	http://dx.doi.org/10.1371/journal.pone.0063492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717434	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700027
J	Boyd, PW; Rynearson, TA; Armstrong, EA; Fu, FX; Hayashi, K; Hu, ZX; Hutchins, DA; Kudela, RM; Litchman, E; Mulholland, MR; Passow, U; Strzepek, RF; Whittaker, KA; Yu, E; Thomas, MK				Boyd, Philip W.; Rynearson, Tatiana A.; Armstrong, Evelyn A.; Fu, Feixue; Hayashi, Kendra; Hu, Zhangxi; Hutchins, David A.; Kudela, Raphael M.; Litchman, Elena; Mulholland, Margaret R.; Passow, Uta; Strzepek, Robert F.; Whittaker, Kerry A.; Yu, Elizabeth; Thomas, Mridul K.			Marine Phytoplankton Temperature versus Growth Responses from Polar to Tropical Waters - Outcome of a Scientific Community-Wide Study	PLOS ONE			English	Article							DINOFLAGELLATE AKASHIWO-SANGUINEA; DIATOM THALASSIOSIRA-ROTULA; HARMFUL ALGAL BLOOMS; SOUTHERN-OCEAN; LATITUDINAL GRADIENT; EMILIANIA-HUXLEYI; NORTH-ATLANTIC; IRON; LIGHT; CYANOBACTERIA	"It takes a village to finish (marine) science these days" Paraphrased from Curtis Huttenhower (the Human Microbiome project) The rapidity and complexity of climate change and its potential effects on ocean biota are challenging how ocean scientists conduct research. One way in which we can begin to better tackle these challenges is to conduct community-wide scientific studies. This study provides physiological datasets fundamental to understanding functional responses of phytoplankton growth rates to temperature. While physiological experiments are not new, our experiments were conducted in many laboratories using agreed upon protocols and 25 strains of eukaryotic and prokaryotic phytoplankton isolated across a wide range of marine environments from polar to tropical, and from nearshore waters to the open ocean. This community-wide approach provides both comprehensive and internally consistent datasets produced over considerably shorter time scales than conventional individual and often uncoordinated lab efforts. Such datasets can be used to parameterise global ocean model projections of environmental change and to provide initial insights into the magnitude of regional biogeographic change in ocean biota in the coming decades. Here, we compare our datasets with a compilation of literature data on phytoplankton growth responses to temperature. A comparison with prior published data suggests that the optimal temperatures of individual species and, to a lesser degree, thermal niches were similar across studies. However, a comparison of the maximum growth rate across studies revealed significant departures between this and previously collected datasets, which may be due to differences in the cultured isolates, temporal changes in the clonal isolates in cultures, and/or differences in culture conditions. Such methodological differences mean that using particular trait measurements from the prior literature might introduce unknown errors and bias into modelling projections. Using our community-wide approach we can reduce such protocol-driven variability in culture studies, and can begin to address more complex issues such as the effect of multiple environmental drivers on ocean biota.	[Boyd, Philip W.; Armstrong, Evelyn A.] Univ Otago, Dept Chem, NIWA Ctr Chem & Phys Oceanog, Dunedin, New Zealand; [Boyd, Philip W.] Natl Inst Water & Atmosphere, Wellington, New Zealand; [Rynearson, Tatiana A.; Whittaker, Kerry A.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Fu, Feixue; Hutchins, David A.; Yu, Elizabeth] Univ So Calif, Dept Biol, Los Angeles, CA USA; [Hayashi, Kendra; Kudela, Raphael M.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Hu, Zhangxi; Mulholland, Margaret R.] Old Dominion Univ, Dept Ocean Earth & Atmospher Sci, Norfolk, VA USA; [Litchman, Elena; Thomas, Mridul K.] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Passow, Uta] Univ Calif Santa Barbara, Dept Life Sci, Santa Barbara, CA 93106 USA; [Strzepek, Robert F.] Univ Otago, Dept Chem, Dunedin, New Zealand	University of Otago; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Rhode Island; University of Southern California; University of California System; University of California Santa Cruz; Old Dominion University; Michigan State University; University of California System; University of California Santa Barbara; University of Otago	Boyd, PW (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	pboyd@chemistry.otago.ac.nz	Hutchins, David A/D-3301-2013; Boyd, Philip W/J-7624-2014; Strzepek, Robert Francis/A-1216-2011; Strzepek, Robert/GQH-8703-2022	Hutchins, David A/0000-0002-6637-756X; Boyd, Philip W/0000-0001-7850-1911; Strzepek, Robert Francis/0000-0002-6442-7121; Litchman, Elena/0000-0001-7736-6332; Thomas, Mridul/0000-0002-5089-5610	National Science Foundation (NSF) [DEB-0845932, OCE-0928819.]; NSF [OCE-0727227, OCE-0926711, OCE-1041038, OCE-0238347, OCE-0942379, OCE-0962309, OCE-117030687, OCE-0722395]; New Zealand Royal Society Marsden Fund; Ministry of Science and Innovation; National Oceanic and Atmospheric Administration (NOAA) Monitoring and Event Response for Harmful Algal Blooms (MERHAB) [NA04NOS4780239]; NOAA The Ecology and Oceanography of Harmful Algal Blooms (ECOHAB) [NA06NO54780246]; Division Of Ocean Sciences [1041038] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Oceanic and Atmospheric Administration (NOAA) Monitoring and Event Response for Harmful Algal Blooms (MERHAB); NOAA The Ecology and Oceanography of Harmful Algal Blooms (ECOHAB); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	EL and MKT were in part supported by the National Science Foundation (NSF) grants DEB-0845932 and OCE-0928819. TAR and KAW were supported by NSF grant OCE-0727227. UP was supported by NSF grants OCE-0926711 and OCE-1041038. PWB and RS were supported by the New Zealand Royal Society Marsden Fund and the Ministry of Science and Innovation. RMK and KH were in part supported by National Oceanic and Atmospheric Administration (NOAA) Monitoring and Event Response for Harmful Algal Blooms (MERHAB) grant NA04NOS4780239 and NSF grant OCE-0238347. DAH and FX-F were supported by NSF grants OCE-0942379, OCE-0962309, and OCE-117030687. MRM was partially supported by NSF grant OCE-0722395 and a NOAA The Ecology and Oceanography of Harmful Algal Blooms (ECOHAB) grant NA06NO54780246. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the NSF-funded ECCO (Evolution and Climate Change in the Ocean http://hofmannlab.msi.ucsb.edu/ecco/workshop-products-1/ECCO%20full%20report%20final.pdf;) and Dave Garrison (NSF) for bringing this community together. We thank Eric Webb USC for providing diazotroph cultures.	ANDERSEN RA, 1992, BIODIVERS CONSERV, V1, P267, DOI 10.1007/BF00693765; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; BANSE K, 1991, LIMNOL OCEANOGR, V36, P1886, DOI 10.4319/lo.1991.36.8.1886; Behrenfeld MJ, 2006, NATURE, V442, P1025, DOI 10.1038/nature05083; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1479, DOI 10.4319/lo.1997.42.7.1479; Berman-Frank I, 2009, AQUAT MICROB ECOL, V56, P109, DOI 10.3354/ame01362; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Boyd PW, 2008, BIOGEOSCIENCES, V5, P847, DOI 10.5194/bg-5-847-2008; Boyd PW, 2012, MAR ECOL PROG SER, V470, P125, DOI 10.3354/meps10121; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; Boyd PW, 2003, GLOB CHANGE IGBP SER, P157; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; BRAND L E, 1981, Journal of Plankton Research, V3, P193, DOI 10.1093/plankt/3.2.193; Breitbarth E, 2007, BIOGEOSCIENCES, V4, P53, DOI 10.5194/bg-4-53-2007; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Cho SY, 2009, MOL ECOL RESOUR, V9, P915, DOI 10.1111/j.1755-0998.2008.02474.x; Cloern JE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023321; Collins S, 2011, P ROY SOC B-BIOL SCI, V278, P247, DOI 10.1098/rspb.2010.1173; COSTAS E, 1990, GENETICA, V82, P99, DOI 10.1007/BF00124638; Craig BA, 2010, BOOTSTRAP METHODS PE; Cubillos JC, 2007, MAR ECOL PROG SER, V348, P47, DOI 10.3354/meps07058; Domingos P, 1998, HYDROBIOLOGIA, V370, P297, DOI 10.1023/A:1017097826410; Doney SC, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002150; Du XN, 2011, HARMFUL ALGAE, V10, P784, DOI 10.1016/j.hal.2011.06.011; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Feng YY, 2009, MAR ECOL PROG SER, V388, P13, DOI 10.3354/meps08133; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Gomez F, 2004, HYDROBIOLOGIA, V517, P43, DOI 10.1023/B:HYDR.0000027336.05452.07; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; Hood RR, 2006, DEEP-SEA RES PT II, V53, P459, DOI 10.1016/j.dsr2.2006.01.025; Hoppe HG, 2002, NATURE, V416, P168, DOI 10.1038/416168a; Horner RA, 1997, LIMNOL OCEANOGR, V42, P1076, DOI 10.4319/lo.1997.42.5_part_2.1076; Huertas I Emma, 2011, Proc Biol Sci, V278, P3534, DOI 10.1098/rspb.2011.0160; Hurd CL, 2009, J PHYCOL, V45, P1236, DOI 10.1111/j.1529-8817.2009.00768.x; Hutchins DA, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1627, DOI 10.1016/B978-0-12-372522-6.00038-4; Hutchins DA, 2009, OCEANOGRAPHY, V22, P128, DOI 10.5670/oceanog.2009.103; Jessup DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004550; Khatib F, 2011, NAT STRUCT MOL BIOL, V18, P1175, DOI 10.1038/nsmb.2119; Kitajima S, 2009, LIMNOL OCEANOGR, V54, P537, DOI 10.4319/lo.2009.54.2.0537; KRAWIEC RW, 1982, MAR BIOL, V69, P79, DOI 10.1007/BF00396964; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Lee Changkyu, 2005, [JOURNAL OF THE KOREAN SOCIETY OF OCEANOGRAPHY, 바다], V10, P79; Levitus S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037155; LI WKW, 1985, DEEP-SEA RES, V32, P1381, DOI 10.1016/0198-0149(85)90054-8; Litchman E, 2012, MAR ECOL PROG SER, V470, P235, DOI 10.3354/meps09912; Locarnini R. A., 2010, WORLD OCEAN ATLAS 20, V1; Longhurst AR, 1998, ECOLOGICAL GEOGRAPHY; Lu SH, 2004, HYDROBIOLOGIA, V512, P231, DOI 10.1023/B:HYDR.0000020331.75003.18; Lurling M, 2003, J PLANKTON RES, V25, P979, DOI 10.1093/plankt/25.8.979; Matsubara T, 2007, J EXP MAR BIOL ECOL, V342, P226, DOI 10.1016/j.jembe.2006.09.013; Mehnert G, 2010, J PLANKTON RES, V32, P1009, DOI 10.1093/plankt/fbq033; Moisan JR, 2002, ECOL MODEL, V153, P197, DOI 10.1016/S0304-3800(02)00008-X; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Mulholland MR, 2007, BIOGEOSCIENCES, V4, P37, DOI 10.5194/bg-4-37-2007; Mulholland MR, HARMFUL ALG IN PRESS; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; Needoba JA, 2007, LIMNOL OCEANOGR, V52, P1317, DOI 10.4319/lo.2007.52.4.1317; Nogues-Bravo D, 2011, SCIENCE, V334, P1070, DOI 10.1126/science.1214833; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; Phillips Elizabeth M., 2011, Northwestern Naturalist, V92, P120; PRATT DM, 1959, LIMNOL OCEANOGR, V4, P425, DOI 10.4319/lo.1959.4.4.0425; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; Reay DS, 1999, APPL ENVIRON MICROB, V65, P2577; Reid PC, 2007, GLOBAL CHANGE BIOL, V13, P1910, DOI 10.1111/j.1365-2486.2007.01413.x; Reusch TBH, 2013, EVOLUTION, V67, P1849, DOI 10.1111/evo.12035; Riebesell U., 2011, GUIDE BEST PRACTICES, DOI DOI 10.2777/58454; Rose JM, 2009, BIOGEOSCIENCES, V6, P3131, DOI 10.5194/bg-6-3131-2009; Rynearson TA, 2000, LIMNOL OCEANOGR, V45, P1329, DOI 10.4319/lo.2000.45.6.1329; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; SAKSHAUG E, 1987, MAR ECOL PROG SER, V41, P275, DOI 10.3354/meps041275; Sarmento H, 2010, PHILOS T R SOC B, V365, P2137, DOI 10.1098/rstb.2010.0045; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; SMAYDA THEODORE J., 1958, OIKOS, V9, P158, DOI 10.2307/3564763; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Strzepek RF, 2012, LIMNOL OCEANOGR, V57, P1182, DOI 10.4319/lo.2012.57.4.1182; Strzepek RF, 2011, LIMNOL OCEANOGR, V56, P1983, DOI 10.4319/lo.2011.56.6.1983; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Taucher J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045934; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; Taylor F.J.R., 1987, Botanical Monographs (Oxford), V21, P398; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; THOMAS WH, 1973, FISH B-NOAA, V71, P599; Timmermans KR, 2005, J SEA RES, V53, P109, DOI 10.1016/j.seares.2004.05.003; Tortell PD, 2008, LIMNOL OCEANOGR, V53, P1266, DOI 10.4319/lo.2008.53.4.1266; Trainer VL, 2010, PROG OCEANOGR, V85, P33, DOI 10.1016/j.pocean.2010.02.003; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Tuck C, 2012, GLOBAL CHANGE BIOL, V18, P1597, DOI 10.1111/j.1365-2486.2012.02652.x; Whittaker KA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-209; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063; Zimmerman R, 1988, CHARACTERISTICS CAUS, V143, P19	105	203	206	5	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63091	10.1371/journal.pone.0063091	http://dx.doi.org/10.1371/journal.pone.0063091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704890	Green Published, gold			2022-12-27	WOS:000319330200019
J	Cusumano, A; Peri, E; Amodeo, V; McNeil, JN; Colazza, S				Cusumano, Antonino; Peri, Ezio; Amodeo, Valentina; McNeil, Jeremy N.; Colazza, Stefano			Intraguild Interactions between Egg Parasitoids: Window of Opportunity and Fitness Costs for a Facultative Hyperparasitoid	PLOS ONE			English	Article							VIRIDULA L HETEROPTERA; NEZARA-VIRIDULA; TRISSOLCUS-BASALIS; INTRINSIC COMPETITION; INTERSPECIFIC INTERACTIONS; GUILD PREDATION; HYMENOPTERA; PENTATOMIDAE; MECHANISMS; SECONDARY	We investigated intraguild interactions between two egg parasitoids of Nezara viridula (L.) (Heteroptera: Pentatomidae), Ooencyrtus telenomicida (Vassiliev) (Hymenoptera: Encyrtidae) and Trissolcus basalis (Wollaston) (Hymenoptera: Platygastridae), as the former has the potential to be a facultative hyperparasitoid of the latter. We assessed the suitability of N. viridula eggs for the development of O. telenomicida as a function of egg age when they were unparasitized, or had been attacked by T. basalis at different times prior to exposure to O. telenomicida females. Ooencyrtus telenomicida can exploit healthy N. viridula host eggs up to 5 days of age, just prior to the emergence of N. viridula. This window of opportunity can be extended for an additional 6-7 days through interspecific competition or facultative hyperparasitism. While there are minor fitness costs for O. telenomicida as the result of interspecific larval competition, those costs are greater with facultative hyperparasitism. In choice assays O. telenomicida females discriminated between different quality N. viridula eggs, avoiding those where their progeny would have to develop as facultative hyperparasitoids of T. basalis. Results are discussed with respect to the possible effects that the costs of intraguild parasitism might have on biological control programmes.	[Cusumano, Antonino; Peri, Ezio; Amodeo, Valentina; Colazza, Stefano] Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy; [McNeil, Jeremy N.] Univ Western Ontario, Dept Biol, London, ON, Canada	University of Palermo; Western University (University of Western Ontario)	Peri, E (corresponding author), Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy.	ezio.peri@unipa.it	Cusumano, Antonino/L-7375-2015	Cusumano, Antonino/0000-0001-9663-9164; colazza, stefano/0000-0001-8023-7814; PERI, Ezio/0000-0002-1095-7258	Italian Ministry of Education, University and Research (MIUR)	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was partially supported by the project of the Italian Ministry of Education, University and Research (MIUR) 2007. The authors now declare that no additional external funding was received for this study. "Enhancing foraging behavior of insect egg parasitoids: the role of the volatile organic compounds and the epicuticular layers of the plants.''	Amarasekare P, 2000, J ANIM ECOL, V69, P201, DOI 10.1046/j.1365-2656.2000.00378.x; Arim M, 2004, ECOL LETT, V7, P557, DOI 10.1111/j.1461-0248.2004.00613.x; BIN F, 1993, PHYSIOL ENTOMOL, V18, P7, DOI 10.1111/j.1365-3032.1993.tb00443.x; Boivin G, 2006, PROG BIOL CONTROL, V3, P123; Borer ET, 2007, ECOLOGY, V88, P2681, DOI 10.1890/06-1707.1; Brodeur J, 2000, PARASITOID POPULATION BIOLOGY, P163; Burgio G, 2002, BIOL CONTROL, V24, P110, DOI 10.1016/S1049-9644(02)00023-3; BUSCHMAN LL, 1980, FLA ENTOMOL, V63, P154, DOI 10.2307/3494669; Colazza S, 2004, J EXP BIOL, V207, P47, DOI 10.1242/jeb.00732; Colazza S, 1999, BIOL CONTROL, V16, P310, DOI 10.1006/bcon.1999.0763; Colazza S, 2009, NATURWISSENSCHAFTEN, V96, P975, DOI 10.1007/s00114-009-0548-3; Conti Eric, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/651015; Correa-Ferreira SB, 1986, AN SOC ENTOMOL BRAS, V5, P189; CORREAFERREIRA BS, 1995, BIOL CONTROL, V5, P196, DOI 10.1006/bcon.1995.1024; CRAIG TP, 1990, ECOLOGY, V71, P1471, DOI 10.2307/1938284; Cusumano A, 2012, BIOCONTROL, V57, P719, DOI 10.1007/s10526-012-9451-5; Cusumano A, 2012, ENTOMOL EXP APPL, V143, P155, DOI 10.1111/j.1570-7458.2012.01236.x; Cusumano A, 2011, BIOCONTROL, V56, P173, DOI 10.1007/s10526-010-9320-z; De Moraes CM, 1999, ECOL ENTOMOL, V24, P402, DOI 10.1046/j.1365-2311.1999.00212.x; Denno RF, 2004, ECOL ENTOMOL, V29, P566, DOI 10.1111/j.0307-6946.2004.00628.x; Ehler LE, 2002, BIOCONTROL, V47, P309, DOI 10.1023/A:1014895028451; Finke DL, 2002, ECOLOGY, V83, P643, DOI 10.1890/0012-9658(2002)083[0643:IPDICS]2.0.CO;2; Gariepy TD, 2012, BIOL CONTROL, V60, P26, DOI 10.1016/j.biocontrol.2011.06.011; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Grandgirard J, 2002, ENTOMOL EXP APPL, V103, P239, DOI 10.1023/A:1021193329749; Harvey JA, 2013, ANNU REV ENTOMOL, V58, P333, DOI 10.1146/annurev-ento-120811-153622; Harvey JA, 2011, OIKOS, V120, P226, DOI 10.1111/j.1600-0706.2010.18744.x; Harvey JA, 2009, J ANIM ECOL, V78, P686, DOI 10.1111/j.1365-2656.2008.01516.x; Harvey JA, 2009, ENTOMOL EXP APPL, V130, P238, DOI 10.1111/j.1570-7458.2008.00816.x; HAWKINS CP, 1989, ANNU REV ENTOMOL, V34, P423, DOI 10.1146/annurev.en.34.010189.002231; Hayward A, 2005, BASIC APPL ECOL, V6, P435, DOI 10.1016/j.baae.2005.07.003; Hoffmann M. P., 1991, California Agriculture, V45, P20; Hokyo N., 1965, NANKI SEIBUTSU, V7, P1; KFIR R, 1981, Journal of the Entomological Society of Southern Africa, V44, P151; Lo Giudice D, 2011, J CHEM ECOL, V37, P622, DOI 10.1007/s10886-011-9957-9; Lucas E, 1998, ECOLOGY, V79, P1084, DOI 10.1890/0012-9658(1998)079[1084:IPAAPC]2.0.CO;2; Nakashima Y, 2006, J CHEM ECOL, V32, P1989, DOI 10.1007/s10886-006-9123-y; Nicol CMY, 1999, ENTOMOL EXP APPL, V90, P83, DOI 10.1023/A:1003546731081; Perez-Lachaud G, 2004, BIOL CONTROL, V30, P149, DOI 10.1016/j.biocontrol.2004.03.003; Peri E, 2006, J EXP BIOL, V209, P3629, DOI 10.1242/jeb.02416; Peri E, 2011, BIOCONTROL, V56, P163, DOI 10.1007/s10526-010-9323-9; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Raak-van Den Berg CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040681; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; ROSENHEIM JA, 1993, OECOLOGIA, V96, P439, DOI 10.1007/BF00317517; Rosenheim JA, 2006, PROG BIOL CONTROL, V3, P1; Shaw Mark R., 1994, P111; SHEPARD BM, 1994, J AGR ENTOMOL, V11, P375; StatSoft, 2001, STAT PER WIND US MAN; TAKASU K, 1993, ANN ENTOMOL SOC AM, V86, P117, DOI 10.1093/aesa/86.1.117; Ueno T, 1999, RES POPUL ECOL, V41, P47, DOI 10.1007/PL00011982; VANALPHEN JJM, 1983, NETH J ZOOL, V33, P497, DOI 10.1163/002829683X00228; VOLKOFF N, 1992, INT J INSECT MORPHOL, V21, P323, DOI 10.1016/0020-7322(92)90027-K; Wajnberg E, 2004, J ANIM ECOL, V73, P1179, DOI 10.1111/j.0021-8790.2004.00892.x; Wang XG, 2004, ENVIRON ENTOMOL, V33, P1313, DOI 10.1603/0046-225X-33.5.1313; Wang XG, 2004, BIOL CONTROL, V31, P227, DOI 10.1016/j.biocontrol.2004.04.019; ZWOLFER H, 1971, P405	57	19	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64768	10.1371/journal.pone.0064768	http://dx.doi.org/10.1371/journal.pone.0064768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705009	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200163
J	de la Morena-Barrio, ME; Buil, A; Anton, AI; Martinez-Martinez, I; Minano, A; Gutierrez-Gallego, R; Navarro-Fernandez, J; Aguila, S; Souto, JC; Vicente, V; Soria, JM; Corral, J				Eugenia de la Morena-Barrio, Maria; Buil, Alfonso; Isabel Anton, Ana; Martinez-Martinez, Irene; Minano, Antonia; Gutierrez-Gallego, Ricardo; Navarro-Fernandez, Jose; Aguila, Sonia; Carlos Souto, Juan; Vicente, Vicente; Manuel Soria, Jose; Corral, Javier			Identification of Antithrombin-Modulating Genes. Role of LARGE, a Gene Encoding a Bifunctional Glycosyltransferase, in the Secretion of Proteins?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GLYCOSYLATION; THROMBOSIS; SUSCEPTIBILITY; DYSTROGLYCAN; DEFICIENCY; EXPRESSION; MUTATIONS; PATHWAY	The haemostatic relevance of antithrombin together with the low genetic variability of SERPINC1, and the high heritability of plasma levels encourage the search for modulating genes. We used a hypothesis-free approach to identify these genes, evaluating associations between plasma antithrombin and 307,984 polymorphisms in the GAIT study (352 individuals from 21 Spanish families). Despite no SNP reaching the genome wide significance threshold, we verified milder positive associations in 307 blood donors from a different cohort. This validation study suggested LARGE, a gene encoding a protein with xylosyltransferase and glucuronyltransferase activities that forms heparin-like linear polysaccharides, as a potential modulator of antithrombin based on the significant association of one SNPs, rs762057, with anti-FXa activity, particularly after adjustment for age, sex and SERPINC1 rs2227589 genotype, all factors influencing antithrombin levels (p = 0.02). Additional results sustained this association. LARGE silencing inHepG2 and HEK-EBNA cells did not affect SERPINC1 mRNA levels but significantly reduced the secretion of antithrombin with moderate intracellular retention. Milder effects were observed on alpha 1-antitrypsin, prothrombin and transferrin. Our study suggests LARGE as the first known modifier of plasma antithrombin, and proposes a new role for LARGE in modulating extracellular secretion of certain glycoproteins.	[Eugenia de la Morena-Barrio, Maria; Isabel Anton, Ana; Martinez-Martinez, Irene; Minano, Antonia; Navarro-Fernandez, Jose; Aguila, Sonia; Vicente, Vicente; Corral, Javier] Univ Murcia, Reg Campus Int Excellence Campus MareNostrum, HU Morales Meseguer, Serv Hematol & Oncol Med,Ctr Reg Hemodonac, Murcia, Spain; [Isabel Anton, Ana; Manuel Soria, Jose] Inst Invest St Pau IIB St, Unitat Genom Malalties Complexes, Barcelona, Spain; [Gutierrez-Gallego, Ricardo] PRBB, IMIM Parc Salut Mar, Neurosci Res Program, Bioanal Grp, Barcelona, Spain; [Gutierrez-Gallego, Ricardo] Pompeu Fabra Univ, PRBB, Dept Expt & Hlth Sci, Barcelona, Spain; [Carlos Souto, Juan] Inst Invest St Pau IIB St, Unitat Hemostasia & Trombosis, Barcelona, Spain	University of Murcia; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; Pompeu Fabra University	Corral, J (corresponding author), Univ Murcia, Reg Campus Int Excellence Campus MareNostrum, HU Morales Meseguer, Serv Hematol & Oncol Med,Ctr Reg Hemodonac, Murcia, Spain.	javier.corral@carm.es	de la Morena-Barrio, ME/AAG-5103-2021; Vicente, Vicente/L-6185-2019; Martínez-Martínez, Irene/AAM-8862-2020; Aguila, Sonia/Q-2822-2019; Soria Fernández, José Manuel/AAD-6761-2019; Anton, Ana I. I/M-2962-2018	de la Morena-Barrio, ME/0000-0001-7426-4947; Vicente, Vicente/0000-0002-4278-3264; Martínez-Martínez, Irene/0000-0002-1067-6464; Aguila, Sonia/0000-0001-5794-5177; Soria Fernández, José Manuel/0000-0002-6226-4293; Anton, Ana I. I/0000-0003-1527-6096; Corral, Javier/0000-0003-0288-1107; Gutierrez Gallego, Ricardo/0000-0001-9639-2181; Buil, Alfonso/0000-0002-3097-1014	Fundacion Seneca de la Region de Murcia [04515/GERM/06]; Spanish Ministerio de Ciencia y Tecnologia [SAF2009-08993]; Fondo Europeo de Desarrollo Regional de la Union Europea FEDER [SAF2008/01859, RECAVA RD06/0014/0039, RD06/0014/0016]; Spanish Instituto de Salud Carlos III [PI-08/0756, PI-11/0184, FI09/00190]; Centre National du Genotypage (Evry, France); "Programa d' Estabilitzacio d'Investigadors de la Direccio d'Estrategia i Coordinacio del Departament de Salut" (Generalitat de Catalunya)	Fundacion Seneca de la Region de Murcia(Fundacion Seneca); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo Europeo de Desarrollo Regional de la Union Europea FEDER; Spanish Instituto de Salud Carlos III(Instituto de Salud Carlos III); Centre National du Genotypage (Evry, France); "Programa d' Estabilitzacio d'Investigadors de la Direccio d'Estrategia i Coordinacio del Departament de Salut" (Generalitat de Catalunya)(Generalitat de Catalunya)	This study was supported partially by 04515/GERM/06 (Fundacion Seneca de la Region de Murcia), SAF2009-08993 and SAF2008/01859 (Spanish Ministerio de Ciencia y Tecnologia & Fondo Europeo de Desarrollo Regional de la Union Europea FEDER), PI-08/0756, PI-11/0184 and RECAVA RD06/0014/0039 & RD06/0014/0016 (Spanish Instituto de Salud Carlos III & Fondo Europeo de Desarrollo Regional de la Union Europea FEDER), and Centre National du Genotypage (Evry, France). MEMB is a holder of a predoctoral research grant from Spanish Instituto de Salud Carlos III (FI09/00190). IMM is a researcher from Fundacion para la Formacion e Investigacion Sanitarias. JNF is a postdoctoral researcher of the University of Murcia. JM Soria was supported by "Programa d' Estabilitzacio d'Investigadors de la Direccio d'Estrategia i Coordinacio del Departament de Salut" (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Anton AI, 2009, HAEMATOL-HEMATOL J, V94, P589, DOI 10.3324/haematol.2008.000604; Baker M, 2008, NATURE, V451, P516, DOI 10.1038/451516a; Bayston TA, 1997, THROMB HAEMOSTASIS, V78, P339; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; BROZE GJ, 1993, BLOOD, V82, P1679; Buil A, 2010, BLOOD, V115, P4644, DOI 10.1182/blood-2010-01-263038; CONLON MG, 1994, THROMB HAEMOSTASIS, V72, P551; Corral J, 2004, J THROMB HAEMOST, V2, P931, DOI 10.1111/j.1538-7836.2004.00749.x; de la Morena-Barrio ME, 2012, THROMB HAEMOSTASIS, V107, P430, DOI 10.1160/TH11-10-0701; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; Guerrero JA, 2011, HAEMATOL-HEMATOL J, V96, P1335, DOI 10.3324/haematol.2011.042077; Hernandez-Espinosa D, 2006, AM J PATHOL, V169, P142, DOI 10.2353/ajpath.2006.051238; Hu YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016866; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Llop E, 2007, PROTEOMICS, V7, P4278, DOI 10.1002/pmic.200700572; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Martinez-Martinez I, 2012, BLOOD, V120, P900, DOI 10.1182/blood-2012-01-406207; Martinez-Martinez I, 2010, HAEMATOL-HEMATOL J, V95, P1358, DOI 10.3324/haematol.2009.015487; McCoy AJ, 2003, J MOL BIOL, V326, P823, DOI 10.1016/S0022-2836(02)01382-7; Morange PE, 2011, J THROMB HAEMOST, V9, P258, DOI 10.1111/j.1538-7836.2011.04311.x; Mushunje A, 2003, BLOOD, V102, P4028, DOI 10.1182/blood-2003-05-1560; Oudot-Mellakh T, 2012, BRIT J HAEMATOL, V157, P230, DOI 10.1111/j.1365-2141.2011.09025.x; SMITH JW, 1987, J BIOL CHEM, V262, P11964; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; TAIT RC, 1993, BRIT J HAEMATOL, V84, P476, DOI 10.1111/j.1365-2141.1993.tb03104.x; Westrick RJ, 2009, J THROMB HAEMOST, V7, P132, DOI 10.1111/j.1538-7836.2009.03362.x; Zhang P, 2012, GLYCOBIOLOGY, V22, P235, DOI 10.1093/glycob/cwr131	33	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64998	10.1371/journal.pone.0064998	http://dx.doi.org/10.1371/journal.pone.0064998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705025	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200179
J	Jain, V; Baitharu, I; Prasad, D; Ilavazhagan, G				Jain, Vishal; Baitharu, Iswar; Prasad, Dipti; Ilavazhagan, Govindasamy			Enriched Environment Prevents Hypobaric Hypoxia Induced Memory Impairment and Neurodegeneration: Role of BDNF/PI3K/GSK3 beta Pathway Coupled with CREB Activation	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; NEUROTROPHIC FACTOR; HIGH-ALTITUDE; PHOSPHATIDYLINOSITOL 3-KINASE; COMPLEX ENVIRONMENT; SYNAPTIC PLASTICITY; NEURONAL APOPTOSIS; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; ISCHEMIC-INJURY	Adverse environmental conditions such as hypobaric hypoxia (HH) cause memory impairment by affecting cellular machinery leading to neurodegeneration. Providing enriched environment (EE) is found to be beneficial for curing several neurodegenerative disorders. The protective role of EE in preventing HH induced neuronal death has been reported previously but the involved mechanism is still not clearly understood. The present study is an attempt to verify the impact of EE on spatial memory during HH and also to explore the possible role of neurotrophin in EE mediated neuroprotection. Signaling mechanism involved in neuroprotection was also explored. Male Sprague Dawley rats were simulated to HH condition in an Animal Decompression Chamber at an altitude of 25000 feet in standard and enriched cages for 7 days. Spatial memory was assessed through Morris Water Maze. Role of different neurotrophins was explored by gene silencing and inhibitors for their respective receptors. Further, using different blockers signaling pathway was also explored. Finding of the present study suggested that EE prevents HH mediated memory impairment and neurodegeneration. Also brain-derived neurotrophic factor (BDNF) plays a major role in EE mediated neuroprotection and it effectively prevented neurodegeneration by activating PI3K/AKT pathway resulting in GSK3 beta inactivation which further inhibits apoptosis. Moreover GSK3 beta phosphorylation and hence its inactivation upregulates CREB phosphorylation which may also accounts for activation of survival machinery in cells and provides neuroprotection. From these observations it can be postulated that EE has a therapeutic potential in amelioration of HH induced memory impairment and neurodegeneration. Hence it may be used as a non invasive and non pharmacological intervention against various neurological disorders.	[Jain, Vishal; Baitharu, Iswar; Prasad, Dipti] Def Inst Physiol & Allied Sci, Dept Neurobiol, Delhi, India; [Ilavazhagan, Govindasamy] Hindustan Univ, Dept Res, Madras, Tamil Nadu, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Hindustan Institute of Technology & Science	Ilavazhagan, G (corresponding author), Hindustan Univ, Dept Res, Madras, Tamil Nadu, India.	ilavazhagang@hotmail.com	Baitharu, Iswar/AAM-3530-2021	Baitharu, Iswar/0000-0002-3046-2076	Defence Research and Development Organization (DRDO), Ministry of Defence India	Defence Research and Development Organization (DRDO), Ministry of Defence India	Financial support was received from the Defence Research and Development Organization (DRDO), Ministry of Defence India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock KH, 2002, DEV NEUROSCI-BASEL, V24, P382, DOI 10.1159/000069043; Aggleton JP, 2005, Q J EXP PSYCHOL-B, V58, P218, DOI 10.1080/02724990444000131; Almli LM, 2001, DEV BRAIN RES, V132, P121, DOI 10.1016/S0165-3806(01)00302-9; Banderet LF, 1998, INT J AVIAT PSYCHOL, V8, P319; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; CONNOR JR, 1982, EXP NEUROL, V78, P466, DOI 10.1016/0014-4886(82)90064-4; Countryman RA, 2005, NEUROBIOL LEARN MEM, V84, P175, DOI 10.1016/j.nlm.2005.07.005; Dosek A, 2007, RESP PHYSIOL NEUROBI, V158, P128, DOI 10.1016/j.resp.2007.03.013; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hetman M, 2000, J NEUROSCI, V20, P2567; Hota SK, 2008, EXP NEUROL, V212, P5, DOI 10.1016/j.expneurol.2008.01.030; Hota SK, 2008, J NEUROSCI RES, V86, P1142, DOI 10.1002/jnr.21554; Hota SK, 2007, NEUROCHEM INT, V51, P384, DOI 10.1016/j.neuint.2007.04.003; Hu YS, 2010, FASEB J, V24, P1667, DOI 10.1096/fj.09-136945; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; ISAACS KR, 1992, J CEREBR BLOOD F MET, V12, P110, DOI 10.1038/jcbfm.1992.14; Jain V, 2012, CELL MOL NEUROBIOL, V32, P599, DOI 10.1007/s10571-012-9807-5; KRAMER AF, 1993, HUM FACTORS, V35, P329, DOI 10.1177/001872089303500208; Lee EHY, 2003, EUR J NEUROSCI, V18, P2842, DOI 10.1111/j.1460-9568.2003.03032.x; Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049; Maiti P, 2007, BRAIN RES, V1175, P1, DOI 10.1016/j.brainres.2007.06.106; Maiti P, 2008, J CHEM NEUROANAT, V36, P227, DOI 10.1016/j.jchemneu.2008.07.003; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser MB, 1997, J COMP NEUROL, V380, P373, DOI 10.1002/(SICI)1096-9861(19970414)380:3<373::AID-CNE6>3.0.CO;2-#; Muthuraju S, 2009, BEHAV BRAIN RES, V203, P1, DOI 10.1016/j.bbr.2009.03.026; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Nitta A, 1999, J NEUROSCI RES, V57, P227, DOI 10.1002/(SICI)1097-4547(19990715)57:2<227::AID-JNR8>3.3.CO;2-5; Ortega F, 2010, CELL MOL LIFE SCI, V67, P1723, DOI 10.1007/s00018-010-0278-x; Park SY, 2002, MOL BRAIN RES, V107, P9, DOI 10.1016/S0169-328X(02)00421-7; Pereira LO, 2009, BRAIN RES, V1247, P188, DOI 10.1016/j.brainres.2008.10.017; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sifonios L, 2009, NEUROSCIENCE, V164, P929, DOI 10.1016/j.neuroscience.2009.08.059; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tauber SC, 2009, J NEUROSCI RES, V87, P1877, DOI 10.1002/jnr.22010; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; Waters NS, 1997, J NEUROSCI, V17, P7967; Wright RL, 2008, BEHAV BRAIN RES, V187, P41, DOI 10.1016/j.bbr.2007.08.025; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369	47	67	70	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62235	10.1371/journal.pone.0062235	http://dx.doi.org/10.1371/journal.pone.0062235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704876	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200005
J	Mosconi, MW; Luna, B; Kay-Stacey, M; Nowinski, CV; Rubin, LH; Scudder, C; Minshew, N; Sweeney, JA				Mosconi, Matthew W.; Luna, Beatriz; Kay-Stacey, Margaret; Nowinski, Caralynn V.; Rubin, Leah H.; Scudder, Charles; Minshew, Nancy; Sweeney, John A.			Saccade Adaptation Abnormalities Implicate Dysfunction of Cerebellar-Dependent Learning Mechanisms in Autism Spectrum Disorders (ASD)	PLOS ONE			English	Article							PURKINJE-CELLS; SUPERIOR COLLICULUS; OCULOMOTOR VERMIS; INFANTILE-AUTISM; EYE-MOVEMENTS; COMMUNICATION DEFICITS; ADAPTIVE MODIFICATION; POSTERIOR-FOSSA; MOTOR; CHILDREN	The cerebellar vermis (lobules VI-VII) has been implicated in both postmortem and neuroimaging studies of autism spectrum disorders (ASD). This region maintains the consistent accuracy of saccadic eye movements and plays an especially important role in correcting systematic errors in saccade amplitudes such as those induced by adaptation paradigms. Saccade adaptation paradigms have not yet been used to study ASD. Fifty-six individuals with ASD and 53 age-matched healthy controls performed an intrasaccadic target displacement task known to elicit saccadic adaptation reflected in an amplitude reduction. The rate of amplitude reduction and the variability of saccade amplitude across 180 adaptation trials were examined. Individuals with ASD adapted slower than healthy controls, and demonstrated more variability of their saccade amplitudes across trials prior to, during and after adaptation. Thirty percent of individuals with ASD did not significantly adapt, whereas only 6% of healthy controls failed to adapt. Adaptation rate and amplitude variability impairments were related to performance on a traditional neuropsychological test of manual motor control. The profile of impaired adaptation and reduced consistency of saccade accuracy indicates reduced neural plasticity within learning circuits of the oculomotor vermis that impedes the fine-tuning of motor behavior in ASD. These data provide functional evidence of abnormality in the cerebellar vermis that converges with previous reports of cellular and gross anatomic dysmorphology of this brain region in ASD.	[Mosconi, Matthew W.; Sweeney, John A.] Univ Texas Southwestern, Dept Psychiat, Dallas, TX USA; [Mosconi, Matthew W.; Sweeney, John A.] Univ Texas Southwestern, Dept Pediat, Dallas, TX USA; [Luna, Beatriz] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Luna, Beatriz] Univ Pittsburgh, Sch Med, Dept Psychol, Pittsburgh, PA USA; [Kay-Stacey, Margaret] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL USA; [Nowinski, Caralynn V.] Univ Illinois, Off Vice President Res, Urbana, IL 61801 USA; [Rubin, Leah H.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Scudder, Charles] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Scudder, Charles] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Minshew, Nancy] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Minshew, Nancy] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mosconi, MW (corresponding author), Univ Texas Southwestern, Dept Psychiat, Dallas, TX USA.	Matt.Mosconi@UTSouthwestern.edu	Mosconi, Matt/L-1885-2018	Mosconi, Matt/0000-0002-1981-6777; Sweeney, John/0000-0003-1752-2828	NIMH [MH092696]; NICHD Collaborative Program of Excellence in Autism [HD35469]; Autism Center of Excellence [HD055751, HD055748]; Autism Speaks and the National Alliance for Autism Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751, P50HD055748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092696] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD Collaborative Program of Excellence in Autism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Autism Center of Excellence; Autism Speaks and the National Alliance for Autism Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by NIMH MH092696, the NICHD Collaborative Program of Excellence in Autism HD35469, Autism Center of Excellence awards HD055751 and HD055748, Autism Speaks and the National Alliance for Autism Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2010, ARCH NEUROL-CHICAGO, V67, P395, DOI 10.1001/archneurol.2010.47; Aizawa H, 1998, J NEUROPHYSIOL, V79, P2082, DOI 10.1152/jn.1998.79.4.2082; Akshoomoff N, 2004, J AM ACAD CHILD PSY, V43, P349, DOI 10.1097/00004583-200403000-00018; Alahyane N, 2005, ANN NY ACAD SCI, V1039, P558, DOI 10.1196/annals.1325.067; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Allen G, 2003, AM J PSYCHIAT, V160, P262, DOI 10.1176/appi.ajp.160.2.262; Amaral GD, 2011, AUTISM SPECTRUM DISO; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ARIN D M, 1991, Neurology, V41, P307; Asperger H., 1991, AUTISM ASPERGER SYND, P37, DOI [10.1017/CBO9780511526770.002, DOI 10.1017/CBO9780511526770.002]; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; BAUMAN M, 1985, NEUROLOGY, V35, P866, DOI 10.1212/WNL.35.6.866; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bhat AN, 2012, INFANT BEHAV DEV, V35, P838, DOI 10.1016/j.infbeh.2012.07.019; Bhat AN, 2011, PHYS THER, V91, P1116, DOI 10.2522/ptj.20100294; Bryson SE, 2007, J AUTISM DEV DISORD, V37, P12, DOI 10.1007/s10803-006-0328-2; COURCHESNE E, 1994, AM J ROENTGENOL, V162, P123, DOI 10.2214/ajr.162.1.8273650; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Desmurget M, 2000, EXP BRAIN RES, V132, P243, DOI 10.1007/s002210000342; Desmurget M, 1998, NAT NEUROSCI, V1, P524, DOI 10.1038/2241; DEUBEL H, 1995, VISION RES, V35, P3529, DOI 10.1016/0042-6989(95)00058-M; Developmental Disabilities Monitoring Network, 2012, MMWR SURVEILL SUMM, V61, P1; Dewey D, 2007, J INT NEUROPSYCH SOC, V13, P246, DOI 10.1017/S1355617707070270; Diedrichsen J, 2005, J NEUROPHYSIOL, V93, P801, DOI 10.1152/jn.00662.2004; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P171, DOI 10.1023/A:1019861721160; Gaymard B, 2001, EUR J NEUROSCI, V14, P554, DOI 10.1046/j.0953-816x.2001.01669.x; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Golla H, 2008, EUR J NEUROSCI, V27, P132, DOI 10.1111/j.1460-9568.2007.05996.x; Greco CM, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-2; Green D, 2002, J CHILD PSYCHOL PSYC, V43, P655, DOI 10.1111/1469-7610.00054; Haas RH, 1996, J CHILD NEUROL, V11, P84, DOI 10.1177/088307389601100204; Hardan AY, 2001, J AM ACAD CHILD PSY, V40, P666, DOI 10.1097/00004583-200106000-00011; Havermann K, 2010, J NEUROPHYSIOL, V103, P3302, DOI 10.1152/jn.00970.2009; HOLTTUM JR, 1992, BIOL PSYCHIAT, V32, P1091, DOI 10.1016/0006-3223(92)90189-7; Ignashchenkova A, 2009, J NEUROPHYSIOL, V102, P3156, DOI 10.1152/jn.00659.2009; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; ITO M, 1989, NEUROSCI RES, V7, P168, DOI 10.1016/0168-0102(89)90058-8; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Izawa J, 2012, AUTISM RES, V5, P124, DOI 10.1002/aur.1222; Izawa J, 2012, J NEUROSCI, V32, P4230, DOI 10.1523/JNEUROSCI.6353-11.2012; Kanner L, 1943, NERV CHILD, V2, P217; Kaufmann WE, 2003, J CHILD NEUROL, V18, P463, DOI 10.1177/08830738030180070501; Kojima Y, 2011, BRAIN RES, V1401, P30, DOI 10.1016/j.brainres.2011.05.027; Larson JCG, 2008, BRAIN, V131, P2894, DOI 10.1093/brain/awn226; Lee M, 2002, BRAIN, V125, P1483, DOI 10.1093/brain/awf160; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Luna B, 2007, BIOL PSYCHIAT, V61, P474, DOI 10.1016/j.biopsych.2006.02.030; MacAskill MR, 2002, BRAIN, V125, P1570, DOI 10.1093/brain/awf168; MacNeil LK, 2012, NEUROPSYCHOLOGY, V26, P165, DOI 10.1037/a0026955; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; Minshew NJ, 1999, NEUROLOGY, V52, P917, DOI 10.1212/WNL.52.5.917; Mitchell SR, 2009, AM J PSYCHIAT, V166, P917, DOI 10.1176/appi.ajp.2009.08101538; Mosconi MW, 2010, ARCH GEN PSYCHIAT, V67, P830, DOI 10.1001/archgenpsychiatry.2010.87; Mostofsky SH, 2004, NEUROCASE, V10, P60, DOI 10.1080/13554790490960503; Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088; Muller RA, 2003, AM J PSYCHIAT, V160, P1847, DOI 10.1176/appi.ajp.160.10.1847; Nowinski CV, 2005, PSYCHIAT RES, V137, P11, DOI 10.1016/j.psychres.2005.07.005; OHTSUKA K, 1995, J NEUROPHYSIOL, V74, P1828, DOI 10.1152/jn.1995.74.5.1828; Ozonoff S, 2008, J AUTISM DEV DISORD, V38, P644, DOI 10.1007/s10803-007-0430-0; Piven J, 1997, NEUROLOGY, V49, P546, DOI 10.1212/WNL.49.2.546; Provost Beth, 2007, Phys Occup Ther Pediatr, V27, P21, DOI 10.1300/J006v27n03_03; Quessy S, 2010, J NEUROSCI, V30, P14235, DOI 10.1523/JNEUROSCI.3111-10.2010; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; RITVO ER, 1986, AM J PSYCHIAT, V143, P862; ROSENHALL U, 1988, J LARYNGOL OTOL, V102, P435, DOI 10.1017/S0022215100105286; Salman MS, 2006, J CHILD NEUROL, V21, P1025, DOI 10.1177/7010.2006.00238; Scott JA, 2009, AUTISM RES, V2, P246, DOI 10.1002/aur.97; Scudder CA, 2003, J NEUROPHYSIOL, V90, P1011, DOI 10.1152/jn.00193.2002; Scudder CA, 1998, J NEUROPHYSIOL, V79, P704, DOI 10.1152/jn.1998.79.2.704; Soetedjo R, 2009, J NEUROSCI, V29, P15213, DOI 10.1523/JNEUROSCI.4296-09.2009; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Straube A, 2001, NEUROLOGY, V57, P2105, DOI 10.1212/WNL.57.11.2105; Sutera S, 2007, J AUTISM DEV DISORD, V37, P98, DOI 10.1007/s10803-006-0340-6; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; Takarae Y, 2004, BRAIN, V127, P2584, DOI 10.1093/brain/awh307; Takarae Y, 2004, J NEUROL NEUROSUR PS, V75, P1359, DOI 10.1136/jnnp.2003.022491; Takarae Y, 2007, PSYCHIAT RES-NEUROIM, V156, P117, DOI 10.1016/j.pscychresns.2007.03.008; Thier P, 2000, NATURE, V405, P72, DOI 10.1038/35011062; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Webb SJ, 2009, PSYCHIAT RES-NEUROIM, V172, P61, DOI 10.1016/j.pscychresns.2008.06.001; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Whitney ER, 2008, CEREBELLUM, V7, P406, DOI 10.1007/s12311-008-0043-y; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; Yip J, 2008, J NEUROSCI RES, V86, P525, DOI 10.1002/jnr.21520; Yip J, 2007, ACTA NEUROPATHOL, V113, P559, DOI 10.1007/s00401-006-0176-3	91	54	54	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63709	10.1371/journal.pone.0063709	http://dx.doi.org/10.1371/journal.pone.0063709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704934	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200065
J	Liu, DL; Chang, CH; Rossi, EA; Cardillo, TM; Goldenberg, DM				Liu, Donglin; Chang, Chien-Hsing; Rossi, Edmund A.; Cardillo, Thomas M.; Goldenberg, David M.			Interferon-lambda 1 Linked to a Stabilized Dimer of Fab Potently Enhances both Antitumor and Antiviral Activities in Targeted Cells	PLOS ONE			English	Article							IFN-LAMBDA; MULTIFUNCTIONAL STRUCTURES; SIGNAL-TRANSDUCTION; DEFINED COMPOSITION; GENETIC-VARIATION; LOCK METHOD; ALPHA; CANCER; IL28B; EXPRESSION	The type III interferons (IFNs), comprising IFN-lambda 1, IFN-lambda 2, and IFN-lambda 3, behave similarly to IFN-alpha in eliciting antiviral, antitumor, and immune-modulating activities. Due to their more restricted cellular targets, IFN-lambda s are attractive as potential alternatives to existing therapeutic regimens based on IFN-alpha s. We have applied the DOCK-AND-LOCK (TM) method to improve the anti-proliferative potency of IFN-lambda 1 up to 1,000-fold in targeted cancer cell lines by tethering stabilized Fab dimers, derived from hRS7 (humanized anti-Trop-2), hMN-15 (humanized anti-CEACAM6), hL243 (humanized anti-HLA-DR), and c225 (chimeric anti-EGFR), to IFN-lambda 1 site-specifically, resulting in novel immunocytokines designated (E1)-lambda 1, (15)-lambda 1, (C2)-lambda 1, and (c225)-lambda 1, respectively. Targeted delivery of IFN-lambda 1 via (15)-lambda 1 or (c225)-lambda 1 to respective antigen-expressing cells also significantly increased antiviral activity when compared with non-targeting (C2)-lambda 1, as demonstrated in human lung adenocarcinoma cell line A549 by (15)-lambda 1 against encephalomyocarditis virus (EC50 = 22.2 pM versus 223 pM), and in human hepatocarcinoma cell line Huh-7 by (c225)-lambda 1 against hepatitis C virus (EC50 = 0.56 pM versus 91.2 pM). These promising results, which are attributed to better localization and stronger binding of IFN-lambda 1 to antibody-targeted cells, together with the favorable pharmacokinetic profile of (E1)-lambda 1 in mice (T-1/2 = 8.6 h), support further investigation of selective prototypes as potential antiviral and antitumor therapeutic agents.	[Liu, Donglin; Chang, Chien-Hsing; Rossi, Edmund A.; Goldenberg, David M.] IBC Pharmaceut Inc, Morris Plains, NJ USA; [Chang, Chien-Hsing; Cardillo, Thomas M.; Goldenberg, David M.] Immunomedics Inc, Morris Plains, NJ USA; [Goldenberg, David M.] Ctr Mol Med & Immunol, Garden State Canc Ctr, Morris Plains, NJ USA	Immunomedics Inc	Goldenberg, DM (corresponding author), IBC Pharmaceut Inc, Morris Plains, NJ USA.	dmg.gscancer@att.net						Abushahba W, 2010, CANCER IMMUNOL IMMUN, V59, P1059, DOI 10.1007/s00262-010-0831-3; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Blight K.J., 2006, HEPATITIS C VIRUSES, P311; Byrnes-Blake KA, 2012, J INTERF CYTOK RES, V32, P198, DOI 10.1089/jir.2011.0075; Chang CH, 2007, CLIN CANCER RES, V13, p5586S, DOI 10.1158/1078-0432.CCR-07-1217; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Ferrantini M, 2007, BIOCHIMIE, V89, P884, DOI 10.1016/j.biochi.2007.04.006; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Grace MJ, 2005, J BIOL CHEM, V280, P6327, DOI 10.1074/jbc.M412134200; Guenterberg KD, 2010, MOL CANCER THER, V9, P510, DOI 10.1158/1535-7163.MCT-09-0461; Hsu CS, 2011, P NATL ACAD SCI USA, V108, P3719, DOI 10.1073/pnas.1100349108; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; La QH, 2010, EUR J CANCER, V46, P180, DOI 10.1016/j.ejca.2009.10.002; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Maher SG, 2008, CANCER BIOL THER, V7, P1109, DOI 10.4161/cbt.7.7.6192; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Miller DM, 2009, ANN NY ACAD SCI, V1182, P80, DOI 10.1111/j.1749-6632.2009.05241.x; Miyamoto M, 2005, INTERVIROLOGY, V49, P37, DOI 10.1159/000087261; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Pagliaccetti NE, 2008, J BIOL CHEM, V283, P30079, DOI 10.1074/jbc.M804296200; Pardoll D, 2012, J EXP MED, V209, P201, DOI 10.1084/jem.20112275; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Ramos EL, 2010, J INTERF CYTOK RES, V30, P591, DOI 10.1089/jir.2010.0066; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Rossi DL, 2011, BIOTECHNOL PROGR, V27, P766, DOI 10.1002/btpr.584; Rossi EA, 2006, P NATL ACAD SCI USA, V103, P6841, DOI 10.1073/pnas.0600982103; Rossi EA, 2011, BLOOD, V118, P1877, DOI 10.1182/blood-2011-03-343145; Rossi EA, 2009, BLOOD, V114, P3864, DOI 10.1182/blood-2009-06-228890; Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Witte K, 2009, GENES IMMUN, V10, P702, DOI 10.1038/gene.2009.72; Witte K, 2010, CYTOKINE GROWTH F R, V21, P237, DOI 10.1016/j.cytogfr.2010.04.002; Wolk K, 2005, GENES IMMUN, V6, P8, DOI 10.1038/sj.gene.6364144; Zeuzem S, 2011, J HEPATOL, V54, pS538, DOI 10.1016/S0168-8278(11)61362-7; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06; Zitzmann K, 2006, BIOCHEM BIOPH RES CO, V344, P1334, DOI 10.1016/j.bbrc.2006.04.043	49	6	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63940	10.1371/journal.pone.0063940	http://dx.doi.org/10.1371/journal.pone.0063940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696859	gold, Green Published, Green Submitted			2022-12-27	WOS:000319081900063
J	Arrighi, JF; Cartieaux, F; Chaintreuil, C; Brown, S; Boursot, M; Giraud, E				Arrighi, Jean-Francois; Cartieaux, Fabienne; Chaintreuil, Clemence; Brown, Spencer; Boursot, Marc; Giraud, Eric			Genotype Delimitation in the Nod-Independent Model Legume Aeschynomene evenia	PLOS ONE			English	Article							STEM NODULATION; DIVERSITY; INFECTION; SYMBIOSIS; GENETICS; PLANT	Research on the nitrogen-fixing symbiosis has been so far focused on two model legumes, Medicago truncatula and Lotus japonicus, which use a sophisticated infection process involving infection thread formation. However, in 25% of the legumes, the bacterial entry occurs more simply in an intercellular fashion. Among them, some semi-aquatic Aeschynomene species present the distinctive feature to form nitrogen-fixing nodules on both roots and stems following elicitation by photosynthetic bradyrhizobia that do not produce Nod factors. This interaction is believed to represent a living testimony of the ancestral state of the rhizobium-legume symbiosis. To decipher the molecular mechanisms of this unique Nod-independent nitrogen-fixing symbiosis, we previously identified A. evenia C. Wright as an appropriate model legume, because it displays all the requisites for molecular and genetic approaches. To advance the use of this new model legume species, here we characterized the intraspecific diversity found in A. evenia. For this, the accessions available in germplasm banks were collected and subjected to morphological investigations, genotyping with RAPD and SSR markers, molecular phylogenies using ITS and single nuclear gene sequences, and cross-compatibility tests. These combined analyses revealed an important intraspecific differentiation that led us to propose a new taxonomic classification for A. evenia comprising two subspecies and four varieties. The A. evenia ssp. evenia contains var. evenia and var. pauciciliata whereas A. evenia ssp. serrulata comprises var. serrulata and var. major. This study provides information to exploit efficiently the diversity encountered in A. evenia and proposes subsp. evenia as the most appropriate subspecies for future projects aimed at identifying plant determinants of the Nod-independent symbiotic process.	[Arrighi, Jean-Francois; Cartieaux, Fabienne; Chaintreuil, Clemence; Boursot, Marc; Giraud, Eric] UMR IRD SupAgro INRA UM2 CIRAD, Lab Symbioses Trop & Mediterraneennes, IRD, Montpellier, France; [Brown, Spencer] CNRS, IBiSA Imagerie Gif & Imagif BioCell, Inst Sci Vegetal, UPR 2355, Gif Sur Yvette, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Arrighi, JF (corresponding author), UMR IRD SupAgro INRA UM2 CIRAD, Lab Symbioses Trop & Mediterraneennes, IRD, Campus Int Baillarguet, Montpellier, France.	jean-francois.arrighi@ird.fr	ARRIGHI, Jean-Francois JF/B-1130-2012; BROWN, Spencer/B-6878-2014; Cartieaux, Fabienne/GNH-3617-2022	ARRIGHI, Jean-Francois/0000-0001-6184-2066; Cartieaux, Fabienne/0000-0002-8992-0131	French National Research Agency [ANR-SESAM-2010-BLAN-170801, ANR-10-LABX-0001-01, 1202-009]; Agropolis Fondation [ANR-10-LABX-0001-01, 1202-009]	French National Research Agency(French National Research Agency (ANR)); Agropolis Fondation	This work was supported by grants from the French National Research Agency (ANR-SESAM-2010-BLAN-170801) and conjointly from the Agropolis Fondation and the French National Research Agency (program "Investissements d'avenir" ANR-10-LABX-0001-01, Project "Aeschynomene mapping" id: 1202-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAZARD D, 1987, PLANT SOIL, V101, P141, DOI 10.1007/BF02371043; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Arrighi JF, 2012, MOL PLANT MICROBE IN, V25, P851, DOI 10.1094/MPMI-02-12-0045-TA; Beatty PH, 2011, SCIENCE, V333, P416, DOI 10.1126/science.1209467; Bishop H. G., 1997, P 18 INT GRASSL C; BLONDON F, 1994, GENOME, V37, P264, DOI 10.1139/g94-037; Boivin C, 1997, CRIT REV PLANT SCI, V16, P1, DOI 10.1080/713608143; Bonaldi K, 2011, MOL PLANT MICROBE IN, V24, P1359, DOI 10.1094/MPMI-04-11-0093; CHANDLER MR, 1982, J EXP BOT, V33, P47, DOI 10.1093/jxb/33.1.47; CHANDLER MR, 1978, J EXP BOT, V29, P749, DOI 10.1093/jxb/29.3.749; Charpentier M, 2010, CURR OPIN PLANT BIOL, V13, P556, DOI 10.1016/j.pbi.2010.08.003; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ellwood SR, 2006, THEOR APPL GENET, V112, P977, DOI 10.1007/s00122-005-0202-1; EVANS WR, 1990, APPL ENVIRON MICROB, V56, P3445, DOI 10.1128/AEM.56.11.3445-3449.1990; Ferguson ME, 2004, CROP SCI, V44, P1847, DOI 10.2135/cropsci2004.1847; Giraud E, 2004, PHOTOSYNTH RES, V82, P115, DOI 10.1007/s11120-004-1768-1; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Hribova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017863; KRETSCHMER AE, 1994, SOIL CROP SCI SOC FL, V53, P52; Kretschmer AE, 1997, CROP SCI, P37; Macedo Selma E, 2012, BMC Res Notes, V5, P86, DOI 10.1186/1756-0500-5-86; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Nicholas KB., 1997, GENEDOC TOOL EDITING; RUDD VELVA E., 1955, CONTR U S NATL HERBARIUM, V32, P1; Sprent JI, 2008, NEW PHYTOL, V179, P3, DOI 10.1111/j.1469-8137.2008.02494.x; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vendramini J, 2010, FLORIDA FORAGE HDB; Xu P, 2010, MOL BREEDING, V25, P675, DOI 10.1007/s11032-009-9364-x	32	9	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63836	10.1371/journal.pone.0063836	http://dx.doi.org/10.1371/journal.pone.0063836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717496	gold, Green Published, Green Submitted			2022-12-27	WOS:000319435600034
J	Njuguna, C; Orrell, C; Kaplan, R; Bekker, LG; Wood, R; Lawn, SD				Njuguna, Christine; Orrell, Catherine; Kaplan, Richard; Bekker, Linda-Gail; Wood, Robin; Lawn, Stephen D.			Rates of Switching Antiretroviral Drugs in a Primary Care Service in South Africa before and after Introduction of Tenofovir	PLOS ONE			English	Article							PROGRAMMATIC OUTCOMES; THERAPY; SAFETY; ADULTS; COMBINATION; TOXICITY; EFFICACY; DF	Introduction: Antiretroviral changes (single drug substitutions and regimen switches) limit treatment options and introduce challenges such as increased cost, monitoring and adherence difficulties. Patterns of drug substitutions and regimen switches from stavudine (d4T) and zidovudine (AZT) regimens have been well described but data on tenofovir (TDF) are more limited. This study describes the patterns and risk factors for drug changes of these antiretroviral drugs in adults. Method: This retrospective cohort study included HIV positive, antiretroviral treatment (ART) naive adults aged >= 18 years who started ART with two nucleoside reverse transcriptase inhibitors (NRTIs) and a non-nucleoside reverse transcriptase inhibitor. Follow-up was censored at first drug change and analysis focused on NRTI changes only. Results: Between September 2002 and April 2011, 5095 adults initiated ART in Gugulethu. This comprised 948 subjects on TDF, 3438 on d4T and 709 subjects on AZT. Virological suppression rates at 1 year, regimen switching due to virological failure and overall losses to the programme were similar across the three groups. TDF had the lowest incidence rate of drug substitutions (2.6 per 100 P/Ys) compared to 17.9 for d4T and 8.5 per 100 P/Ys for AZT. Adverse drug reactions (ADRs) accounted for the majority of drug substitutions of d4T. Multivariate analysis showed that increasing age, female sex and d4T exposure were associated with increased hazard of drug substitution due to ADRs. Conversely, TDF exposure was associated with a substantially lower risk of substitution (adjusted hazards ratio 0.38; 95% CI 0.20-0.72). Conclusion: Regimen switches and virological suppression were similar for patients exposed to TDF, d4T and AZT, suggesting all regimens were equally effective. However, TDF was better tolerated with a substantially lower rate of drug substitutions due to ADRs.	[Njuguna, Christine; Orrell, Catherine; Kaplan, Richard; Bekker, Linda-Gail; Wood, Robin; Lawn, Stephen D.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Lawn, Stephen D.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1E 7HT, England	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Njuguna, C (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	christine_njuguna@yahoo.co.uk	Orrell, Catherine/AAF-3405-2019; Bekker, Linda-Gail/AAZ-8929-2020	Orrell, Catherine/0000-0003-1134-7475; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Kaplan, Richard/0000-0003-1565-4704	Fogarty International Grant [5D43TW007115-06]; Wellcome Trust; FOGARTY INTERNATIONAL CENTER [D43TW007115] Funding Source: NIH RePORTER	Fogarty International Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding was provided by Fogarty International Grant, grant number 5D43TW007115-06. Dr. Stephen D. Lawn is funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendavid E, 2011, AIDS, V25, P211, DOI 10.1097/QAD.0b013e328340fdf8; Boulle A, 2007, ANTIVIR THER, V12, P753; BOYLE A, 2012, 11 INT C DRUG THER H; BRENNAN A, 2013, CROI C ATL; BRENNAN A, 2012, IMPACT CHANGE STAVUD; Bygrave H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017609; Cassetti I, 2007, HIV CLIN TRIALS, V8, P164, DOI 10.1310/hct0803-164; Castelnuovo B, 2011, JAIDS-J ACQ IMM DEF, V56, P59, DOI 10.1097/QAI.0b013e3181f5bd03; Chi BH, 2010, JAIDS-J ACQ IMM DEF, V54, P63, DOI 10.1097/QAI.0b013e3181c6c65c; Davidson I, 2010, ANTIVIR RES, V86, P227, DOI 10.1016/j.antiviral.2010.03.001; *DESM TUT HIV FDN, 2011, ANN REV 2010 2011 DE; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Hawkins C, 2007, JAIDS-J ACQ IMM DEF, V45, P304; Landier J, 2011, AIDS CARE, V23, P75, DOI 10.1080/09540121.2010.498867; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; National Department of Health, 2004, NAT ANT TREATM GUID; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Orrell C, 2007, ANTIVIR THER, V12, P83; Prosperi MCF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-296; South African National Department of Health, 2010, S AFR ANT TREATM GUI; Statistics South Africa, 2010, MID POP EST; Subbaraman R, 2007, CLIN INFECT DIS, V45, P1093, DOI 10.1086/521150; TAKUVA S, 2012, J ANTIVIR ANTIRETROV, V4; WHO, 2010, ANT THER HIV INF AD	26	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63596	10.1371/journal.pone.0063596	http://dx.doi.org/10.1371/journal.pone.0063596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717451	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000320362700037
J	Bonander, N; Jamshad, M; Oberthur, D; Clare, M; Barwell, J; Hu, K; Farquhar, MJ; Stamataki, Z; Harris, HJ; Dierks, K; Dafforn, TR; Betzel, C; McKeating, JA; Bill, RM				Bonander, Nicklas; Jamshad, Mohammed; Oberthuer, Dominik; Clare, Michelle; Barwell, James; Hu, Ke; Farquhar, Michelle J.; Stamataki, Zania; Harris, Helen J.; Dierks, Karsten; Dafforn, Timothy R.; Betzel, Christian; McKeating, Jane A.; Bill, Roslyn M.			Production, Purification and Characterization of Recombinant, Full-Length Human Claudin-1	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; STRUCTURAL-CHARACTERIZATION; TRANSMEMBRANE PROTEIN; TETRASPANIN PROTEINS; MEMBRANE-PROTEINS; CD81; ENTRY; ASSOCIATION; INFECTION; RECEPTOR	The transmembrane domain proteins of the claudin superfamily are the major structural components of cellular tight junctions. One family member, claudin-1, also associates with tetraspanin CD81 as part of a receptor complex that is essential for hepatitis C virus (HCV) infection of the liver. To understand the molecular basis of claudin-1/CD81 association we previously produced and purified milligram quantities of functional, full-length CD81, which binds a soluble form of HCV E2 glycoprotein (sE2). Here we report the production, purification and characterization of claudin-1. Both yeast membrane-bound and detergent-extracted, purified claudin-1 were antigenic and recognized by specific antibodies. Analytical ultracentrifugation demonstrated that extraction with n-octyl-beta-D-glucopyranoside yielded monodispersed, dimeric pools of claudin-1 while extraction with profoldin-8 or n-decylphosphocholine yielded a dynamic mixture of claudin-1 oligomers. Neither form bound sE2 in line with literature expectations, while further functional analysis was hampered by the finding that incorporation of claudin-1 into proteoliposomes rendered them intractable to study. Dynamic light scattering demonstrated that claudin-1 oligomers associate with CD81 in vitro in a defined molar ratio of 1:2 and that complex formation was enhanced by the presence of cholesteryl hemisuccinate. Attempts to assay the complex biologically were limited by our finding that claudin-1 affects the properties of proteoliposomes. We conclude that recombinant, correctly-folded, full-length claudin-1 can be produced in yeast membranes, that it can be extracted in different oligomeric forms that do not bind sE2 and that a dynamic preparation can form a specific complex with CD81 in vitro in the absence of any other cellular components. These findings pave the way for the structural characterization of claudin-1 alone and in complex with CD81.	[Bonander, Nicklas; Jamshad, Mohammed; Clare, Michelle; Barwell, James; Bill, Roslyn M.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Bonander, Nicklas] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Oberthuer, Dominik; Dierks, Karsten; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, Hamburg, Germany; [Oberthuer, Dominik] Deutsch Elektronen Synchrotron DESY, Ctr Free Electron Laser Sci, Hamburg, Germany; [McKeating, Jane A.] Univ Birmingham, Inst Biomed Res, Birmingham, W Midlands, England; [McKeating, Jane A.] Univ Birmingham, NIHR Ctr Liver Dis, Birmingham, W Midlands, England; [Dafforn, Timothy R.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	Aston University; Chalmers University of Technology; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Birmingham; University of Birmingham; University of Birmingham	Bill, RM (corresponding author), Aston Univ, Sch Life & Hlth Sci, Aston Triangle, Birmingham B4 7ET, W Midlands, England.	r.m.bill@aston.ac.uk	Betzel, Christian/G-8105-2018; Bill, Roslyn M/D-4554-2012; Oberthuer, Dominik/AAG-5059-2021; Stamataki, Zania/P-4681-2019; Dafforn, Tim/A-9072-2015	Betzel, Christian/0000-0002-3879-5019; Bill, Roslyn M/0000-0003-1331-0852; Oberthuer, Dominik/0000-0002-0894-9590; Stamataki, Zania/0000-0003-3823-4497; Dafforn, Tim/0000-0003-2257-6679; McKeating, Jane/0000-0002-7229-5886	OptiCryst [LSHG-CT-2006-037793]; E-MeP [LSHG-CT-2004-504601]; Wellcome Trust [14101]; BBSRC; MRC; Royal Society Dorothy Hodgkin Fellowship; Wellcome Trust ISSF award; Rontgen-Angstrom-Cluster [05K12GU3]; German Federal Ministry of Education and Research (BMBF); Biotechnology and Biological Sciences Research Council, UK [BB/H016651/1]; Janssen; MRC [G0801976, G1100247] Funding Source: UKRI; Medical Research Council [G1100247, G0801976] Funding Source: researchfish	OptiCryst; E-MeP; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Dorothy Hodgkin Fellowship(Royal Society of London); Wellcome Trust ISSF award(Wellcome Trust); Rontgen-Angstrom-Cluster; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Commission (via contracts LSHG-CT-2006-037793 (OptiCryst) and LSHG-CT-2004-504601 (E-MeP)), the Wellcome Trust (Grant 14101) and BBSRC to RMB, and by Wellcome Trust and MRC grants to JAM. MC is supported by a BBSRC studentship with Janssen. ZS is supported by a Royal Society Dorothy Hodgkin Fellowship and a Wellcome Trust ISSF award. DO and CB are supported by the Rontgen-Angstrom-Cluster (Project 05K12GU3) and the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Michelle Clare is supported by grant BB/H016651/1 from the Biotechnology and Biological Sciences Research Council, UK, which is co-sponsored by Janssen. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bonander Nicklas, 2012, Methods Mol Biol, V866, P1, DOI 10.1007/978-1-61779-770-5_1; Bonander N, 2011, BIOCHEM SOC T, V39, P537, DOI 10.1042/BST0390537; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Davis C, 2012, CELLULAR MI IN PRESS; Dierks K, 2008, CRYST GROWTH DES, V8, P1628, DOI 10.1021/cg701067r; Drummer HE, 2005, BIOCHEM BIOPH RES CO, V328, P251, DOI 10.1016/j.bbrc.2004.12.160; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08; Farquhar MJ, 2012, J VIROL, V86, P4305, DOI 10.1128/JVI.06996-11; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Harris HJ, 2013, CELL MICROBIOL, V15, P430, DOI 10.1111/cmi.12047; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Jamshad M, 2008, PROTEIN EXPRES PURIF, V57, P206, DOI 10.1016/j.pep.2007.10.013; Jamshad M, 2011, BIOCHEM SOC T, V39, P813, DOI 10.1042/BST0390813; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kovalenko OV, 2007, MOL CELL PROTEOMICS, V6, P1855, DOI 10.1074/mcp.M700183-MCP200; Kovalenko OV, 2004, BIOCHEM J, V377, P407, DOI 10.1042/BJ20031037; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LORBER B, 1990, BIOCHIM BIOPHYS ACTA, V1023, P254, DOI 10.1016/0005-2736(90)90421-J; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Ma JC, 2008, J APPL CRYSTALLOGR, V41, P1150, DOI 10.1107/S0021889808033797; McKeating JA, 2004, J VIROL, V78, P8496, DOI 10.1128/JVI.78.16.8496-8505.2004; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; Meredith LW, 2012, REV MED VIROL, V22, P182, DOI 10.1002/rmv.723; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; Oberthuer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033545; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; RENSHAW PF, 1983, J LIPID RES, V24, P47; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schmitz K. S., 1990, INTRO DYNAMIC LIGHT; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Simons K, 2011, P NATL ACAD SCI; Singh Shweta, 2012, Methods Mol Biol, V866, P197, DOI 10.1007/978-1-61779-770-5_17; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Werkmeister E, 2013, CELL MICROBIOL; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zhu YZ, 2012, VIROLOGY, V429, P112, DOI 10.1016/j.virol.2012.03.002	54	8	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64517	10.1371/journal.pone.0064517	http://dx.doi.org/10.1371/journal.pone.0064517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704991	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000319330200145
J	della Vergiliana, JFV; Lansley, SM; Porcel, JM; Bielsa, S; Brown, JS; Creaney, J; Temple, SEL; Waterer, GW; Lee, YCG				della Vergiliana, Julius F. Varano; Lansley, Sally M.; Porcel, Jose M.; Bielsa, Silvia; Brown, Jeremy S.; Creaney, Jenette; Temple, Suzanna E. L.; Waterer, Grant W.; Lee, Y. C. Gary			Bacterial Infection Elicits Heat Shock Protein 72 Release from Pleural Mesothelial Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HEAT-SHOCK-PROTEIN-70 HSP70; PARAPNEUMONIC EFFUSIONS; INFLAMMATORY RESPONSE; CYTOKINE PRODUCTION; MURINE MACROPHAGES; EXPRESSION; EMPYEMA; PATHWAY; CONTAMINATION	Heat shock protein 70 (HSP70) has been implicated in infection-related processes and has been found in body fluids during infection. This study aimed to determine whether pleural mesothelial cells release HSP70 in response to bacterial infection in vitro and in mouse models of serosal infection. In addition, the in vitro cytokine effects of the HSP70 isoform, Hsp72, on mesothelial cells were examined. Further, Hsp72 was measured in human pleural effusions and levels compared between non-infectious and infectious patients to determine the diagnostic accuracy of pleural fluid Hsp72 compared to traditional pleural fluid parameters. We showed that mesothelial release of Hsp72 was significantly raised when cells were treated with live and heat-killed Streptococcus pneumoniae. In mice, intraperitoneal injection of S. pneumoniae stimulated a 2-fold increase in Hsp72 levels in peritoneal lavage (p < 0.01). Extracellular Hsp72 did not induce or inhibit mediator release from cultured mesothelial cells. Hsp72 levels were significantly higher in effusions of infectious origin compared to non-infectious effusions (p < 0.05). The data establish that pleural mesothelial cells can release Hsp72 in response to bacterial infection and levels are raised in infectious pleural effusions. The biological role of HSP70 in pleural infection warrants exploration.	[della Vergiliana, Julius F. Varano; Lansley, Sally M.; Lee, Y. C. Gary] Univ Western Australia, Lung Inst Western Australia, Sch Med & Pharmacol, Pleural Dis Unit,Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia; [Porcel, Jose M.; Bielsa, Silvia] Arnau de Vilanova Univ Hosp, Biomed Res Inst Lleida, Dept Internal Med, Pleural Dis Unit, Lleida, Spain; [Brown, Jeremy S.] Ctr Resp Res, London, England; [Brown, Jeremy S.] UCL, London, England; [Creaney, Jenette] Univ Western Australia, Natl Ctr Asbestos Related Dis, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Temple, Suzanna E. L.; Waterer, Grant W.] Royal Perth Hosp, Resp Dept, Perth, WA, Australia; [Lee, Y. C. Gary] Sir Charles Gairdner Hosp, Resp Dept, Perth, WA, Australia	University of Western Australia; University of London; University College London; University of London; University College London; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Lee, YCG (corresponding author), Univ Western Australia, Lung Inst Western Australia, Sch Med & Pharmacol, Pleural Dis Unit,Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia.	gary.lee@uwa.edu.au	Lee, Y C Gary/H-5264-2014; Waterer, Grant/AAG-2385-2021	Bielsa, Silvia/0000-0001-6888-4162; Brown, Jeremy/0000-0002-5650-5361; Lee, Yun Chor Gary/0000-0002-0036-511X	Royal Perth Hospital Medical Research Foundation; Cancer Council Western Australia; Westcare; Sir Charles Gairdner Research Advisory Committee; New South Wales Dust Disease Board; University of Western Australia; UCLH/UCL Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centre	Royal Perth Hospital Medical Research Foundation; Cancer Council Western Australia(Cancer Council Western Australia); Westcare; Sir Charles Gairdner Research Advisory Committee; New South Wales Dust Disease Board; University of Western Australia; UCLH/UCL Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	This project was supported, in part, by a Royal Perth Hospital Medical Research Foundation grant. Y.C. Gary Lee receives research funding from project grants from Cancer Council Western Australia, Westcare, Sir Charles Gairdner Research Advisory Committee, and the New South Wales Dust Disease Board. Sally M. Lansley receives a research grant from the University of Western Australia. Jeremy S. Brown is supported by the UCLH/UCL Biomedical Research Centre, which receives a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asea A, 2000, CELL STRESS CHAPERON, V5, P425, DOI 10.1379/1466-1268(2000)005<0425:HPBAPN>2.0.CO;2; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Brims FJH, 2010, EUR RESPIR REV, V19, P220, DOI 10.1183/09059180.00005610; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Cailhier JFO, 2006, AM J RESP CRIT CARE, V173, P540, DOI 10.1164/rccm.200504-538OC; Chase MA, 2007, J IMMUNOL, V179, P6318, DOI 10.4049/jimmunol.179.9.6318; Creaney J, 2008, J THORAC ONCOL, V3, P851, DOI 10.1097/JTO.0b013e318180477b; Davies HE, 2009, AM J RESP CRIT CARE, V180, P437, DOI 10.1164/rccm.200811-1729OC; Elstrand MB, 2009, INT J GYNECOL PATHOL, V28, P211, DOI 10.1097/PGP.0b013e31818b0f5e; Ferguson AD, 1996, QJM-MON J ASSOC PHYS, V89, P285; Gao BC, 2004, BIOCHEM BIOPH RES CO, V317, P1149, DOI 10.1016/j.bbrc.2004.03.160; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Giraldo E, 2010, BRAIN BEHAV IMMUN, V24, P672, DOI 10.1016/j.bbi.2010.02.003; Guo H, 2010, PROSTATE CANC PROSTA; Guzhova I, 2001, BRAIN RES, V914, P66, DOI 10.1016/S0006-8993(01)02774-3; Hecker JG, 2008, CELL STRESS CHAPERON, V13, P435, DOI 10.1007/s12192-008-0039-z; Ianaro A, 2001, FEBS LETT, V508, P61, DOI 10.1016/S0014-5793(01)03035-6; Ianaro A, 2001, FEBS LETT, V499, P239, DOI 10.1016/S0014-5793(01)02569-8; Kang Rui, 2007, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V19, P346; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Koegelenberg CFN, 2008, RESPIRATION, V75, P241, DOI 10.1159/000117172; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lansley SM, 2010, J CELL MOL MED, V15, P2095; Lee YCG, 2005, AM J PHYSIOL-LUNG C, V288, pL734, DOI 10.1152/ajplung.00173.2004; Light Richard W, 2006, Proc Am Thorac Soc, V3, P75, DOI 10.1513/pats.200510-113JH; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Lisboa T, 2011, RESPIROLOGY, V16, P598, DOI 10.1111/j.1440-1843.2011.01964.x; Luo XJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2399; Luo XJ, 2008, CELL STRESS CHAPERON, V13, P365, DOI 10.1007/s12192-008-0036-2; Madden J, 2010, CELL BIOL TOXICOL, V26, P215, DOI 10.1007/s10565-009-9134-x; MISTRY Y, 1992, INFECT IMMUN, V60, P3105, DOI 10.1128/IAI.60.8.3105-3110.1992; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Pockley AG, 1998, IMMUNOL INVEST, V27, P367, DOI 10.3109/08820139809022710; Riesenhuber A, 2011, PERITON DIALYSIS INT, V31, P332, DOI 10.3747/pdi.2009.00206; Sahn SA, 2007, CLIN INFECT DIS, V45, P1480, DOI 10.1086/522996; SCHWAN WR, 1994, P NATL ACAD SCI USA, V91, P6428, DOI 10.1073/pnas.91.14.6428; Singleton KD, 2006, AM J PHYSIOL-LUNG C, V290, pL956, DOI 10.1152/ajplung.00466.2005; Suzuki T, 2000, INT J ORAL MAX SURG, V29, P301, DOI 10.1034/j.1399-0020.2000.290414.x; Svensson PA, 2006, ATHEROSCLEROSIS, V185, P32, DOI 10.1016/j.atherosclerosis.2005.05.007; Tobin CL, 2012, CURR OPIN PULM MED, V18, P321, DOI 10.1097/MCP.0b013e328352c673; Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2; Van Molle W, 2007, CANCER RES, V67, P7301, DOI 10.1158/0008-5472.CAN-06-4010; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang RB, 2006, J SURG RES, V136, P58, DOI 10.1016/j.jss.2006.06.003; Wheeler Derek S, 2005, Pediatr Crit Care Med, V6, P308, DOI 10.1097/01.PCC.0000161075.97355.2E; Wood KL, 2010, J HEART LUNG TRANSPL, V29, P786, DOI 10.1016/j.healun.2010.03.004; Ye ZY, 2007, J BIOL CHEM, V282, P4479, DOI 10.1074/jbc.M606802200; Zou N, 2008, AM J PHYSIOL-HEART C, V294, pH2805, DOI 10.1152/ajpheart.00299.2008	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63873	10.1371/journal.pone.0063873	http://dx.doi.org/10.1371/journal.pone.0063873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704948	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200079
J	Hall, H; Jewett, M; Landeck, N; Nilsson, N; Schagerlof, U; Leanza, G; Kirik, D				Hall, Helene; Jewett, Michael; Landeck, Natalie; Nilsson, Nathalie; Schagerlof, Ulrika; Leanza, Giampiero; Kirik, Deniz			Characterization of Cognitive Deficits in Rats Overexpressing Human Alpha-Synuclein in the Ventral Tegmental Area and Medial Septum Using Recombinant Adeno-Associated Viral Vectors	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOPAMINE NEURONS; LEWY BODIES; ALZHEIMERS-DISEASE; MOUSE MODEL; MICE; IMPAIRMENT; DEGENERATION; PATHOLOGY; MIDBRAIN	Intraneuronal inclusions containing alpha-synuclein (a-syn) constitute one of the pathological hallmarks of Parkinson's disease (PD) and are accompanied by severe neurodegeneration of A9 dopaminergic neurons located in the substantia nigra. Although to a lesser extent, A10 dopaminergic neurons are also affected. Neurodegeneration of other neuronal populations, such as the cholinergic, serotonergic and noradrenergic cell groups, has also been documented in PD patients. Studies in human post-mortem PD brains and in rodent models suggest that deficits in cholinergic and dopaminergic systems may be associated with the cognitive impairment seen in this disease. Here, we investigated the consequences of targeted overexpression of a-syn in the mesocorticolimbic dopaminergic and septohippocampal cholinergic pathways. Rats were injected with recombinant adeno-associated viral vectors encoding for either human wild-type a-syn or green fluorescent protein (GFP) in the ventral tegmental area and the medial septum/vertical limb of the diagonal band of Broca, two regions rich in dopaminergic and cholinergic neurons, respectively. Histopathological analysis showed widespread insoluble a-syn positive inclusions in all major projections areas of the targeted nuclei, including the hippocampus, neocortex, nucleus accumbens and anteromedial striatum. In addition, the rats overexpressing human a-syn displayed an abnormal locomotor response to apomorphine injection and exhibited spatial learning and memory deficits in the Morris water maze task, in the absence of obvious spontaneous locomotor impairment. As losses in dopaminergic and cholinergic immunoreactivity in both the GFP and a-syn expressing animals were mild-to-moderate and did not differ from each other, the behavioral impairments seen in the a-syn overexpressing animals appear to be determined by the long term persisting neuropathology in the surviving neurons rather than by neurodegeneration.	[Hall, Helene; Jewett, Michael; Landeck, Natalie; Nilsson, Nathalie; Schagerlof, Ulrika; Kirik, Deniz] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Jewett, Michael; Leanza, Giampiero] Univ Trieste, Ctr Neurosci, Dept Life Sci Basic Res & Integrat Neurosci, Trieste, Italy	Lund University; University of Trieste	Hall, H (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	helene.hall@med.lu.se	Landeck, Natalie/AAR-8915-2020	Landeck, Natalie/0000-0002-8399-4009; LEANZA, Giampiero/0000-0002-8609-2561; Nilsson, Nathalie/0000-0002-5236-3263	European Research Council [TreatPD 242932]; Swedish Research Council [2008-3092, 2009-2318]; Swedish Foundation for Strategic Research (Parkinson's models for translational research)	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research (Parkinson's models for translational research)	This study was supported by grants from the European Research Council (TreatPD 242932), the Swedish Research Council (2008-3092, 2009-2318) and the Swedish Foundation for Strategic Research (Parkinson's models for translational research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 1999, J NEUROL NEUROSUR PS, V67, P492, DOI 10.1136/jnnp.67.4.492; Aarsland D, 2010, J NEUROL SCI, V289, P18, DOI 10.1016/j.jns.2009.08.034; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bosboom JLW, 2004, J NEURAL TRANSM, V111, P1303, DOI 10.1007/s00702-004-0168-1; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2006, J NEUROL SCI, V248, P255, DOI 10.1016/j.jns.2006.05.011; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Decressac M, 2012, NEUROBIOL DIS, V45, P939, DOI 10.1016/j.nbd.2011.12.013; DUBOIS B, 1983, BRAIN RES, V288, P213; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; FAHN S, 1971, J NEUROL SCI, V14, P427, DOI 10.1016/0022-510X(71)90178-X; GAGE FH, 1986, NEUROSCIENCE, V19, P241, DOI 10.1016/0306-4522(86)90018-7; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Koprich JB, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-43; Lam HA, 2011, J NEUROSCI RES, V89, P1091, DOI 10.1002/jnr.22611; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lim Y, 2011, J NEUROSCI, V31, P10076, DOI 10.1523/JNEUROSCI.0618-11.2011; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Lundblad M, 2012, P NATL ACAD SCI USA, V109, P3213, DOI 10.1073/pnas.1200575109; Magen I, 2012, EUR J NEUROSCI, V35, P870, DOI 10.1111/j.1460-9568.2012.08012.x; Maingay M, 2006, NEUROBIOL DIS, V23, P522, DOI 10.1016/j.nbd.2006.04.007; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Mattila PM, 2001, ACTA NEUROPATHOL, V102, P160; Mattila PM, 2000, ACTA NEUROPATHOL, V100, P285, DOI 10.1007/s004019900168; McRitchie DA, 1997, EXP NEUROL, V144, P202, DOI 10.1006/exnr.1997.6418; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; NAKANO I, 1984, ANN NEUROL, V15, P415, DOI 10.1002/ana.410150503; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nuber S, 2008, J NEUROSCI, V28, P2471, DOI 10.1523/JNEUROSCI.3040-07.2008; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PERRY EK, 1985, J NEUROL NEUROSUR PS, V48, P413, DOI 10.1136/jnnp.48.5.413; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Szego EM, 2013, NEUROBIOL AGING, V34, P589, DOI 10.1016/j.neurobiolaging.2012.04.012; Szego EM, 2011, J NEUROL SCI, V310, P90, DOI 10.1016/j.jns.2011.06.048; Tanji K, 2010, ACTA NEUROPATHOL, V120, P145, DOI 10.1007/s00401-010-0676-z; Ulusoy A, 2010, P NATL ACAD SCI USA, V107, P13159, DOI 10.1073/pnas.1003432107; Ulusoy A, 2009, MOL THER, V17, P1574, DOI 10.1038/mt.2009.142; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wisman LAB, 2008, J NEUROSCI, V28, P7797, DOI 10.1523/JNEUROSCI.1885-08.2008; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x	47	34	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64844	10.1371/journal.pone.0064844	http://dx.doi.org/10.1371/journal.pone.0064844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705016	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200170
J	Li, LH; Yen, MY; Ho, CC; Wu, P; Wang, CC; Maurya, PK; Chen, PS; Chen, W; Hsieh, WY; Chen, HW				Li, Lan-Hui; Yen, Muh-Yong; Ho, Chao-Chi; Wu, Ping; Wang, Chien-Chun; Maurya, Pawan Kumar; Chen, Pai-Shan; Chen, Wei; Hsieh, Wan-Yu; Chen, Huei-Wen			Non-Cytotoxic Nanomaterials Enhance Antimicrobial Activities of Cefmetazole against Multidrug-Resistant Neisseria gonorrhoeae	PLOS ONE			English	Article							SILVER NANOPARTICLES; ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; PARTICLE-SIZE; MECHANISM; CELLS; STRATEGIES; NANOSILVER; IONS	The emergence and spread of antibiotic-resistant Neisseria gonorrhoeae has led to difficulties in treating patients, and novel strategies to prevent and treat this infection are urgently needed. Here, we examined 21 different nanomaterials for their potential activity against N. gonorrhoeae (ATCC 49226). Silver nanoparticles (Ag NPs, 120 nm) showed the greatest potency for reducing N. gonorrhoeae colony formation (MIC: 12.5 mu g/ml) and possessed the dominant influence on the antibacterial activity with their properties of the nanoparticles within a concentration range that did not induce cytotoxicity in human fibroblasts or epithelial cells. Electron microscopy revealed that the Ag NPs significantly reduced bacterial cell membrane integrity. Furthermore, the use of clinical isolates of multidrug-resistant N. gonorrhoeae showed that combined treatment with 120 nm Ag NPs and cefmetazole produced additive effects. This is the first report to screen the effectiveness of nanomaterials against N. gonorrhoeae, and our results indicate that 120 nm Ag NPs deliver low levels of toxicity to human epithelial cells and could be used as an adjuvant with antibiotic therapy, either for topical use or as a coating for biomaterials, to prevent or treat multidrug-resistant N. gonorrhoeae.	[Li, Lan-Hui; Wu, Ping; Hsieh, Wan-Yu] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei, Taiwan; [Li, Lan-Hui; Yen, Muh-Yong; Wang, Chien-Chun] Taipei City Hosp, Kunming Branch, Taipei, Taiwan; [Yen, Muh-Yong] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan; [Ho, Chao-Chi] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Ho, Chao-Chi] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Wu, Ping] Natl Yang Ming Univ, Sch Med, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Maurya, Pawan Kumar] Amity Univ, Amity Inst Biotechnol, Lucknow, Uttar Pradesh, India; [Chen, Pai-Shan] Natl Taiwan Univ, Coll Med, Dept & Grad Inst Forens Med, Taipei, Taiwan; [Chen, Wei] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan	National Taiwan University; Taipei City Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University	Chen, HW (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei, Taiwan.	shwchen@ntu.edu.tw	Chen, Wei/M-4793-2019	Chen, Wei/0000-0002-2909-3023; Chen, Pai-Shan/0000-0002-2047-4276; HO, CHAO-CHI/0000-0002-8156-2413; CHEN, HUEI-WEN/0000-0001-5051-9896	National Science Council [NSC101-2325-B-002-047]; National Taiwan University Cutting-Edge Steering Research Project [NTU CESRP-10R71602C2, 100R705057]; Research and Diagnostic Center, Centers for Disease Control (CDC), Taiwan; Microarray Core Facility of National Taiwan University-Center of Genomic Medicine (NTUCGM); Clinical Laboratory of Taipei City Hospital Kunming Branch	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Cutting-Edge Steering Research Project; Research and Diagnostic Center, Centers for Disease Control (CDC), Taiwan; Microarray Core Facility of National Taiwan University-Center of Genomic Medicine (NTUCGM); Clinical Laboratory of Taipei City Hospital Kunming Branch	This study was supported by the National Science Council (NSC101-2325-B-002-047), National Taiwan University Cutting-Edge Steering Research Project (NTU CESRP-10R71602C2 and 100R705057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We greatly appreciate the technical supports on SEM and TEM by the Joint Center for Instruments and Researches, College of Bioresources and Agriculture at National Taiwan University; ICP-MS by Instrumentation Center at National Tsing-Hua University. The authors also thank the supporting from the Research and Diagnostic Center, Centers for Disease Control (CDC), Taiwan, the Microarray Core Facility of National Taiwan University-Center of Genomic Medicine (NTUCGM) and Clinical Laboratory of Taipei City Hospital Kunming Branch.	Abdel-Mohsen AM, 2012, INT J BIOL MACROMOL, V50, P1245, DOI 10.1016/j.ijbiomac.2012.03.018; Blecher K, 2011, VIRULENCE, V2, P395, DOI 10.4161/viru.2.5.17035; Centers for Disease Control and Prevention (CDC), 2010, MMWR-MORBID MORTAL W, V59, P49; Chen MW, 2011, INT J NANOMED, V6, P2873, DOI 10.2147/IJN.S23945; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Cortivo R, 2010, NANOMEDICINE-UK, V5, P641, DOI 10.2217/NNM.10.32; Danilczuk M, 2006, SPECTROCHIM ACTA A, V63, P189, DOI 10.1016/j.saa.2005.05.002; dos Santos CA, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-43; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; Engel LS, 2009, EMERGEN MED, V41, P18; Fayaz AM, 2012, INT J NANOMED, V7, P5007, DOI 10.2147/IJN.S34973; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015; Hyun JS, 2008, TOXICOL LETT, V179, P130; Jain J, 2009, MOL PHARMACEUT, V6, P1388, DOI 10.1021/mp900056g; Kim ES, 2009, J MICROBIOL BIOTECHN, V19, P1576, DOI 10.4014/jmb.0903.03015; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kong H, 2008, BIOMACROMOLECULES, V9, P2677, DOI 10.1021/bm800574x; Kurek A, 2011, POL J MICROBIOL, V60, P3, DOI 10.33073/pjm-2011-001; Lara HH, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-30; Lara Humberto H., 2010, Journal of Nanobiotechnology, V8, P1, DOI [10.1186/1477-3155-8-1, 10.1186/1477-3155-8-15]; Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; Makepeace BL, 2001, INFECT IMMUN, V69, P1909, DOI 10.1128/IAI.69.3.1909-1913.2001; Miura N, 2009, BIOCHEM BIOPH RES CO, V390, P733, DOI 10.1016/j.bbrc.2009.10.039; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; National Committee for Clinical Laboratory Standards, 2004, METH ANT SUSC TEST A; Ohnishi M, 2011, EMERG INFECT DIS, V17, P148, DOI 10.3201/eid1701.100397; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001; Powers CM, 2011, ENVIRON HEALTH PERSP, V119, P37, DOI 10.1289/ehp.1002337; Ruden S, 2009, ANTIMICROB AGENTS CH, V53, P3538, DOI 10.1128/AAC.01106-08; Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sotiriou GA, 2013, SMALL; Sotiriou GA, 2010, ENVIRON SCI TECHNOL, V44, P5649, DOI 10.1021/es101072s; Tian J, 2007, CHEMMEDCHEM, V2, P129, DOI 10.1002/cmdc.200600171; Trop M, 2006, J TRAUMA, V60, P648, DOI 10.1097/01.ta.0000208126.22089.b6; U.S. Centers for Disease Control and Prevention, 2006, MMWR RECOMM REP, V55, P42; Vlachou E, 2007, BURNS, V33, P979, DOI 10.1016/j.burns.2007.07.014; Wang CC, 1999, MED CLIN N AM, V83, P975; Workowski KA, 2008, ANN INTERN MED, V148, P606, DOI 10.7326/0003-4819-148-8-200804150-00005; World Health Organization Department of Reproductive Health and Research, 2011, WHORHR1114 DEP REPR; YANG CY, 1994, J DENT RES, V73, P1407, DOI 10.1177/00220345940730080301	45	29	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64794	10.1371/journal.pone.0064794	http://dx.doi.org/10.1371/journal.pone.0064794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705013	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200167
J	Povlsen, JA; Lofgren, B; Dalgas, C; Birkler, RID; Johannsen, M; Stottrup, NB; Botker, HE				Povlsen, Jonas Agerlund; Lofgren, Bo; Dalgas, Christian; Birkler, Rune Isak Dupont; Johannsen, Mogens; Stottrup, Nicolaj Brejnholt; Botker, Hans Erik			Protection against Myocardial Ischemia-Reperfusion Injury at Onset of Type 2 Diabetes in Zucker Diabetic Fatty Rats Is Associated with Altered Glucose Oxidation	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; TRICARBOXYLATE CYCLE; ELECTRON-TRANSPORT; METABOLIC-FATE; HEART; GLYCOLYSIS; CARDIOPROTECTION; SHUTTLE; ACTIVATION; INFARCTION	Background: Inhibition of glucose oxidation during initial reperfusion confers protection against ischemia-reperfusion (IR) injury in the heart. Mitochondrial metabolism is altered with progression of type 2 diabetes (T2DM). We hypothesized that the metabolic alterations present at onset of T2DM induce cardioprotection by metabolic shutdown during IR, and that chronic alterations seen in late T2DM cause increased IR injury. Methods: Isolated perfused hearts from 6 (prediabetic), 12 (onset of T2DM) and 24 (late T2DM) weeks old male Zucker diabetic fatty rats (ZDF) and their age-matched heterozygote controls were subjected to 40 min ischemia/120 min reperfusion. IR injury was assessed by TTC-staining. Myocardial glucose metabolism was evaluated by glucose tracer kinetics (glucose uptake-, glycolysis-and glucose oxidation rates), myocardial microdialysis (metabolomics) and tissue glycogen measurements. Results: T2DM altered the development in sensitivity towards IR injury compared to controls. At late diabetes ZDF hearts suffered increased damage, while injury was decreased at onset of T2DM. Coincident with cardioprotection, oxidation of exogenous glucose was decreased during the initial and normalized after 5 minutes of reperfusion. Metabolomic analysis of citric acid cycle intermediates demonstrated that cardioprotection was associated with a reversible shutdown of mitochondrial glucose metabolism during ischemia and early reperfusion at onset of but not at late type 2 diabetes. Conclusions: The metabolic alterations of type 2 diabetes are associated with protection against IR injury at onset but detrimental effects in late diabetes mellitus consistent with progressive dysfunction of glucose oxidation. These findings may explain the variable efficacy of cardioprotective interventions in individuals with type 2 diabetes.	[Povlsen, Jonas Agerlund; Lofgren, Bo; Dalgas, Christian; Stottrup, Nicolaj Brejnholt; Botker, Hans Erik] Aarhus Univ Hosp, Dept Cardiol, Aarhus N, Denmark; [Povlsen, Jonas Agerlund; Lofgren, Bo; Dalgas, Christian; Stottrup, Nicolaj Brejnholt; Botker, Hans Erik] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Birkler, Rune Isak Dupont; Johannsen, Mogens] Aarhus Univ, Dept Forens Med, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Povlsen, JA (corresponding author), Aarhus Univ Hosp, Dept Cardiol, Aarhus N, Denmark.	jonas.povlsen@ki.au.dk	Johannsen, Mogens/O-7964-2019; Johannsen, Mogens/E-5374-2011	Johannsen, Mogens/0000-0002-2548-7025; Johannsen, Mogens/0000-0002-2548-7025; Botker, Hans Erik/0000-0001-6358-8962	Fondation Leducq [06CVD]; The Danish Heart Foundation; Danish Research Council [11-108354]; The Danish Strategic Research Council [11-1115818]; The A.P. Moller and Chastine Mc-Kinney Moller Foundation; The Foundation in Memory of Asta Florida Bolding Renee Andersen; Novo Nordisk Foundation; Institute of Clinical Medicine, Aarhus University; Novo Nordisk Fonden [NNF13OC0007447] Funding Source: researchfish	Fondation Leducq(Leducq Foundation); The Danish Heart Foundation; Danish Research Council(Det Frie Forskningsrad (DFF)); The Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); The A.P. Moller and Chastine Mc-Kinney Moller Foundation; The Foundation in Memory of Asta Florida Bolding Renee Andersen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Institute of Clinical Medicine, Aarhus University; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported financially by Fondation Leducq (Grant no. 06CVD, www.fondationleducq.org), The Danish Heart Foundation (http://www.hjerteforeningen.dk), the Danish Research Council (11-108354, http://en.fi.dk), The Danish Strategic Research Council (11-1115818, http://en.fi.dk), The A.P. Moller and Chastine Mc-Kinney Moller Foundation (www.apmollerfonde.dk), The Foundation in Memory of Asta Florida Bolding Renee Andersen, Novo Nordisk Foundation (www.novonordiskfonden.dk/en), and Institute of Clinical Medicine, Aarhus University (http://clin.au.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Balakumar P, 2012, CELL SIGNAL, V24, P53, DOI 10.1016/j.cellsig.2011.09.007; Baynes J, 2009, OXID MED CELL LONGEV, V2, P328, DOI 10.4161/oxim.2.5.9831; Birkler RID, 2010, J PHARMACEUT BIOMED, V53, P983, DOI 10.1016/j.jpba.2010.06.005; Bolukoglu H, 1996, AM J PHYSIOL-HEART C, V270, pH817, DOI 10.1152/ajpheart.1996.270.3.H817; Bonen A, 2009, AM J PHYSIOL-REG I, V297, pR1202, DOI 10.1152/ajpregu.90820.2008; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; BOTKER HE, 1995, J MOL CELL CARDIOL, V27, P1325, DOI 10.1016/S0022-2828(05)82395-8; Bradamante S, 2000, BBA-MOL BASIS DIS, V1502, P363, DOI 10.1016/S0925-4439(00)00060-0; Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026; Byrne CJ, 2012, CIRCULATION, V125, P1256, DOI 10.1161/CIRCULATIONAHA.111.055392; Chatham JC, 2010, BBA-GEN SUBJECTS, V1800, P57, DOI 10.1016/j.bbagen.2009.07.004; Chen H, 2006, CLIN EXP PHARMACOL P, V33, P910, DOI 10.1111/j.1440-1681.2006.04463.x; Chen Q, 2006, J PHARMACOL EXP THER, V316, P200, DOI 10.1124/jpet.105.091702; Contreras L, 2007, J BIOL CHEM, V282, P7098, DOI 10.1074/jbc.M610491200; Dalgas C, 2012, CLIN EXP PHARMACOL P, V39, P878, DOI 10.1111/j.1440-1681.2012.05749.x; Doenst T, 2000, J NUCL MED, V41, P488; Ebrahim Z, 2007, PHARMACOL RES, V55, P42, DOI 10.1016/j.phrs.2006.10.004; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; FINEGAN BA, 1995, AM J PHYSIOL-HEART C, V269, pH1767, DOI 10.1152/ajpheart.1995.269.5.H1767; Fredersdorf S, 2004, CARDIOVASC PATHOL, V13, P11, DOI 10.1016/S1054-8807(03)00109-1; Gaster M, 2009, BIOCHEM BIOPH RES CO, V387, P651, DOI 10.1016/j.bbrc.2009.07.064; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Jensen RV, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0285-1; KATZ J, 1967, BIOCHEMISTRY-US, V6, P1, DOI 10.1021/bi00853a001; Kocsis GF, 2012, AM J PHYSIOL-HEART C, V303, pH1229, DOI 10.1152/ajpheart.00379.2012; Kupai K, 2009, AM J PHYSIOL-HEART C, V297, pH1729, DOI 10.1152/ajpheart.00484.2009; Leonard BL, 2005, ACTA DIABETOL, V42, P162, DOI 10.1007/s00592-005-0197-8; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lofgren B, 2010, EXP PHYSIOL, V95, P140, DOI 10.1113/expphysiol.2009.049452; LOPASCHUK GD, 1993, J PHARMACOL EXP THER, V264, P135; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; Naito Z, 2003, EXP MOL PATHOL, V74, P23, DOI 10.1016/S0014-4800(03)80005-9; NEELY JR, 1972, BIOCHEM J, V128, P147, DOI 10.1042/bj1280147; Nielsen TT, 2011, CARDIOVASC RES, V91, P382, DOI 10.1093/cvr/cvr051; Oliveira PJ, 2005, CURR DIABETES REV, V1, P11, DOI 10.2174/1573399052952578; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PISARENKO O, 1988, BIOCHIM BIOPHYS ACTA, V934, P55, DOI 10.1016/0005-2728(88)90119-3; Povlsen JA, 2009, CLIN EXP PHARMACOL P, V36, P892, DOI 10.1111/j.1440-1681.2009.05166.x; Ralphe JC, 2005, AM J PHYSIOL-HEART C, V288, pH2521, DOI 10.1152/ajpheart.00991.2004; RANDLE PJ, 1970, BIOCHEM J, V117, P677, DOI 10.1042/bj1170677; Ravingerova TA, 2003, MOL CELL BIOCHEM, V249, P167, DOI 10.1023/A:1024751109196; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; Sarkozy M, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-16; Schroeder MA, 2009, FASEB J, V23, P2529, DOI 10.1096/fj.09-129171; SPEECHLYDICK ME, 1994, CARDIOVASC RES, V28, P1025, DOI 10.1093/cvr/28.7.1025; Stottrup NB, 2010, CARDIOVASC RES, V88, P257, DOI 10.1093/cvr/cvq205; TAEGTMEYER H, 1978, CIRC RES, V43, P808, DOI 10.1161/01.RES.43.5.808; Tosaki A, 1996, CARDIOVASC RES, V31, P526; Ungi I, 2005, CHEST, V128, P1623, DOI 10.1378/chest.128.3.1623; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; Vogt AM, 2002, J BIOL CHEM, V277, P24411, DOI 10.1074/jbc.M201138200; Wang PP, 2004, AM J PHYSIOL-ENDOC M, V286, pE725, DOI 10.1152/ajpendo.00295.2003; Xu G, 2004, EXP MOL PATHOL, V76, P57, DOI 10.1016/j.yexmp.2003.08.003; Yakubu-Madus FE, 1999, DIABETES, V48, P1093, DOI 10.2337/diabetes.48.5.1093; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	60	34	36	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64093	10.1371/journal.pone.0064093	http://dx.doi.org/10.1371/journal.pone.0064093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704975	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200114
J	Samaranayake, YH; Cheung, BPK; Yau, JYY; Yeung, SKW; Samaranayake, LP				Samaranayake, Yuthika Hemamala; Cheung, Becky P. K.; Yau, Joyce Y. Y.; Yeung, Shadow K. W.; Samaranayake, Lakshman P.			Human Serum Promotes Candida albicans Biofilm Growth and Virulence Gene Expression on Silicone Biomaterial	PLOS ONE			English	Article							SECRETED ASPARTYL PROTEINASES; IN-VITRO; TISSUE-DAMAGE; WILD-TYPE; MODEL; ADHERENCE; ADHESIN; FAMILY; EFG1; MORPHOGENESIS	Objectives: Systemic candidal infections are a common problem in hospitalized patients due to central venous catheters fabricated using silicone biomaterial (SB). We therefore evaluated the effect of human serum on C. albicans biofilm morphology, growth, and the expression of virulence-related genes on SB in vitro. Methods: We cultivated C. albicans SC5314 (wild-type strain, WT) and its derivative HLC54 (hyphal mutant, HM) for 48 h in various conditions, including the presence or absence of SB discs, and human serum. The growth of planktonic and biofilm cells of both strains was monitored at three time points by a tetrazolium salt reduction assay and by scanning electron microscopy. We also analyzed by RT-PCR its expression of the virulence-related genes ALS3, HWP1, EAP1, ECE1, SAP1 - SAP10, PLB1, PLB2, PLC and PLD. Results: At each time point, planktonic cells of WT strain cultured in yeast nitrogen base displayed a much higher expression of EAP1 and HWP1, and a moderately higher ALS3 expression, than HM cells. In planktonic cells, expression of the ten SAP genes was higher in the WT strain initially, but were highly expressed in the HM strain by 48 h. Biofilm growth of both strains on SB was promoted in the presence of human serum than in its absence. Significant upregulation of ALS3, HWP1, EAP1, ECE1, SAP1, SAP4, SAP6 - SAP10, PLB1, PLB2 and PLC was observed for WT biofilms grown on serum-treated SB discs for at least one time point, compared with biofilms on serum-free SB discs. Conclusions: Human serum stimulates C. albicans biofilm growth on SB discs and upregulates the expression of virulence genes, particularly adhesion genes ALS3 and HWP1, and hydrolase-encoding genes SAP, PLB1 and PLB2. This response is likely to promote the colonization of this versatile pathogen within the human host.	[Samaranayake, Yuthika Hemamala; Cheung, Becky P. K.; Yau, Joyce Y. Y.; Yeung, Shadow K. W.; Samaranayake, Lakshman P.] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Samaranayake, LP (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	lakshman@hkucc.hku.hk	/K-4947-2018	/0000-0002-9122-336X	Research Grants Council of the University of Hong Kong (HKU) [201109176041]	Research Grants Council of the University of Hong Kong (HKU)	This study was funded by the Research Grants Council of the University of Hong Kong (HKU, Project code: 201109176041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004; Aoki W, 2011, J BIOCHEM, V150, P431, DOI 10.1093/jb/mvr073; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Borg-von Zepelin M, 1999, J INVEST DERMATOL, V113, P747, DOI 10.1046/j.1523-1747.1999.00747.x; Cao YY, 2005, ANTIMICROB AGENTS CH, V49, P584, DOI 10.1128/AAC.49.2.584-589.2005; Cauda R, 2009, DRUGS, V69, P33, DOI 10.2165/11315520-000000000-00000; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Chen YC, 2002, MICROBIOL-SGM, V148, P3743, DOI 10.1099/00221287-148-11-3743; Coleman DA, 2009, J MICROBIOL METH, V78, P71, DOI 10.1016/j.mimet.2009.05.002; Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493; Dolan JW, 2004, MED MYCOL, V42, P439, DOI 10.1080/13693780410001657162; Felk A, 2002, INFECT IMMUN, V70, P3689, DOI 10.1128/IAI.70.7.3689-3700.2002; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Francois P, 1998, ANN VASC SURG, V12, P34, DOI 10.1007/s100169900112; Fu Y, 2002, MOL MICROBIOL, V44, P61, DOI 10.1046/j.1365-2958.2002.02873.x; Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Green CB, 2005, MICROBIOL-SGM, V151, P1051, DOI 10.1099/mic.0.27696-0; Hilmioglu S, 2007, MYCOSES, V50, P282, DOI 10.1111/j.1439-0507.2007.01359.x; Hoyer LL, 1998, CURR GENET, V33, P451, DOI 10.1007/s002940050359; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; HUBE B, 1994, MOL MICROBIOL, V14, P87, DOI 10.1111/j.1365-2958.1994.tb01269.x; Hube B, 2001, MICROBIOL-SGM, V147, P1997, DOI 10.1099/00221287-147-8-1997; Ibrahim AS, 1998, INFECT IMMUN, V66, P3003, DOI 10.1128/IAI.66.6.3003-3005.1998; Jayatilake JAMS, 2006, J ORAL PATHOL MED, V35, P484, DOI 10.1111/j.1600-0714.2006.00435.x; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Kunze D, 2005, MICROBIOL-SGM, V151, P3381, DOI 10.1099/mic.0.28353-0; Kvaal C, 1999, INFECT IMMUN, V67, P6652; Lachke SA, 2000, INFECT IMMUN, V68, P884, DOI 10.1128/IAI.68.2.884-895.2000; Li F, 2003, EUKARYOT CELL, V2, P1266, DOI 10.1128/EC.2.6.1266-1273.2003; Li F, 2007, EUKARYOT CELL, V6, P931, DOI 10.1128/EC.00049-07; Liu HP, 2002, INT J MED MICROBIOL, V292, P299, DOI 10.1078/1438-4221-00215; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Marchais V, 2005, FEMS MICROBIOL LETT, V245, P25, DOI 10.1016/j.femsle.2005.02.014; Mendes A, 2007, BIOL PHARM BULL, V30, P1813, DOI 10.1248/bpb.30.1813; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nailis H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-114; Nett JE, 2009, J INFECT DIS, V200, P307, DOI 10.1086/599838; Nikawa H, 2000, MYCOSES, V43, P139, DOI 10.1046/j.1439-0507.2000.00564.x; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; O'Connor L, 2005, MOL CELL PROBE, V19, P153, DOI 10.1016/j.mcp.2004.10.007; Odds F. C., 1994, ASM News (Washington), V60, P313; RADD I, 1993, J INFECT DIS, V168, P400, DOI 10.1093/infdis/168.2.400; Ramage G, 2001, Am Clin Lab, V20, P42; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; SAMARANAYAKE LP, 1980, ARCH ORAL BIOL, V25, P611, DOI 10.1016/0003-9969(80)90076-X; Samaranayake YH, 2006, APMIS, V114, P857, DOI 10.1111/j.1600-0463.2006.apm_479.x; Samaranayake YH, 2005, J MED MICROBIOL, V54, P583, DOI 10.1099/jmm.0.45762-0; Schaller M, 2005, MYCOSES, V48, P365, DOI 10.1111/j.1439-0507.2005.01165.x; Schaller M, 1999, MOL MICROBIOL, V34, P169, DOI 10.1046/j.1365-2958.1999.01590.x; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Sharkey LL, 1999, J BACTERIOL, V181, P5273, DOI 10.1128/JB.181.17.5273-5279.1999; SHEPHERD MG, 1980, CAN J MICROBIOL, V26, P21, DOI 10.1139/m80-004; Snide JL, 2006, 8 ASM C CAND CAND DE; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Taniguchi L, 2009, J MICROBIOL METH, V78, P171, DOI 10.1016/j.mimet.2009.05.012; Taylor BN, 2005, INFECT IMMUN, V73, P7061, DOI 10.1128/IAI.73.10.7061-7063.2005; Thein ZM, 2007, ARCH ORAL BIOL, V52, P1200, DOI 10.1016/j.archoralbio.2007.06.007; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; WHITE TC, 1995, J BACTERIOL, V177, P5215, DOI 10.1128/jb.177.18.5215-5221.1995; Yeater KM, 2007, MICROBIOL-SGM, V153, P2373, DOI 10.1099/mic.0.2007/006163-0; Zhang L, 2008, J BACTERIOL, V190, P4447, DOI 10.1128/JB.01655-07; Zhao X, 2005, MICROBIOL-SGM, V151, P1619, DOI 10.1099/mic.0.27763-0; Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0	72	42	49	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62902	10.1371/journal.pone.0062902	http://dx.doi.org/10.1371/journal.pone.0062902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704884	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200013
J	Tseng, WY; Huang, YS; Chiang, NY; Chou, YP; Wu, YJJ; Luo, SF; Kuo, CF; Lin, KM; Lin, HH				Tseng, Wen-Yi; Huang, Yi-Shu; Chiang, Nien-Yi; Chou, Yeh-Pin; Wu, Yeong-Jian Jan; Luo, Shue-Fen; Kuo, Chang-Fu; Lin, Ko-Ming; Lin, Hsi-Hsien			Increased Soluble CD4 in Serum of Rheumatoid Arthritis Patients Is Generated by Matrix Metalloproteinase (MMP)-Like Proteinases	PLOS ONE			English	Article							CYTOKINE RECEPTOR GENERATION; ACTIVATION ANTIGEN CD69; CELL-SURFACE; INFLAMMATORY RESPONSES; VIRUS-INFECTION; KINASE P56LCK; L-SELECTIN; MOLECULES; MECHANISMS; EXPRESSION	Higher soluble CD4 (sCD4) levels in serum have been detected in patients of infectious and chronic inflammatory diseases. However, how and why sCD4 is produced remains poorly understood. We establish sensitive ELISA and WB assays for sCD4 detection in conditioned medium of in vitro cell culture system and serum of chronic inflammatory patients. Serum samples from patients with systemic lupus erythematosus (SLE) (n = 79), rheumatoid arthritis (RA) (n = 59), ankylosing spondylitis (AS) (n = 25), gout (n = 31), and normal controls (n = 99) were analyzed using ELISA for sCD4 detection. Results from each assay were analyzed by the Kruskal-Wallis test. Dunn's multiple comparison post-test was then applied between groups. We confirm that cells expressing exogenous CD4 produce sCD4 in a constitutive and PMA-induced manner. Importantly, sCD4 production in a heterologous expression system is inhibited by GM6001 and TAPI-0, suggesting receptor shedding by matrix metalloproteinase (MMP)-like proteinases. Moreover, similar findings are recapitulated in human primary CD4(+) T cells. Finally, we show that serum sCD4 levels are increased in patients of chronic inflammatory diseases including RA and SLE, but not in those with gout. Intriguingly, sCD4 levels in RA patients are correlated positively with the disease activities and higher sCD4 levels seem to associate with poor prognosis. Taken together, we conclude that CD4 is shed from cell surface by a MMP-like sheddase and sCD4 level is closely related with the inflammatory condition in certain chronic diseases. Hence, sCD4 might be considered an important parameter for RA disease progression with potential diagnostic importance.	[Tseng, Wen-Yi; Wu, Yeong-Jian Jan] Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol, Keelung, Taiwan; [Tseng, Wen-Yi] Chang Gung Mem Hosp Keelung, Grad Inst Clin Med, Tao Yuan, Taiwan; [Huang, Yi-Shu; Chiang, Nien-Yi; Lin, Hsi-Hsien] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Chou, Yeh-Pin; Wu, Yeong-Jian Jan; Luo, Shue-Fen] Chang Gung Univ, Coll Med, Dept Med, Tao Yuan, Taiwan; [Chou, Yeh-Pin] Chang Gung Mem Hosp Kaohsiung, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Luo, Shue-Fen; Kuo, Chang-Fu] Chang Gung Mem Hosp Linkou, Div Rheumatol Allergy & Immunol, Linkou, Taiwan; [Lin, Ko-Ming] Chang Gung Mem Hosp Chiayi, Div Rheumatol Allergy & Immunol, Chiayi, Taiwan; [Lin, Hsi-Hsien] Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lin, HH (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	hhlin@mail.cgu.edu.tw	Kuo, Chang-Fu/Q-1714-2016; LIN, Hsi-Hsien/N-1488-2015; Huang, I-Shu/S-9341-2017	Kuo, Chang-Fu/0000-0002-9770-5730; Huang, I-Shu/0000-0001-8770-9298; Jan Wu, Yeong-Jian/0000-0002-5444-4729	National Science Council, Taiwan [NSC98-2320-B-182-028-MY3, NSC101-2320-B-182-029-MY3]; Chang Gung Memorial Hospital [CMRPG670381, CMRPG280431, CMRPG891331, CMRPD190553]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from National Science Council, Taiwan (NSC98-2320-B-182-028-MY3 and NSC101-2320-B-182-029-MY3 to H.-H. Lin), and Chang Gung Memorial Hospital (CMRPG670381 and CMRPG280431 to W.-Y. Tseng, CMRPG891331 to Y.-P. Chou, and CMRPD190553 to H.-H. Lin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong PB, 2001, TRENDS IMMUNOL, V22, P47, DOI 10.1016/S1471-4906(00)01803-2; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Davies JQ, 2007, J BIOL CHEM, V282, P27343, DOI 10.1074/jbc.M704096200; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; FISHER RA, 1988, NATURE, V331, P76, DOI 10.1038/331076a0; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Giusca SE, ROM J MORPHOL EMBRYO, V51, P215; Goto H, 1996, SCAND J IMMUNOL, V43, P690, DOI 10.1046/j.1365-3083.1996.d01-264.x; HAMANN J, 1993, J IMMUNOL, V150, P4920; Hepburn TW, 2003, RHEUMATOLOGY, V42, P54, DOI 10.1093/rheumatology/keg030; HEY AS, 1994, J IMMUNOL, V152, P4542; Isaacs JD, 2008, RHEUMATOLOGY, V47, P1461, DOI 10.1093/rheumatology/ken163; KAHN J, 1994, J CELL BIOL, V125, P461, DOI 10.1083/jcb.125.2.461; Lai HY, CHANG GUNG MED J, V34, P468; Levine SJ, 2004, J IMMUNOL, V173, P5343, DOI 10.4049/jimmunol.173.9.5343; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; Marcante R, 1991, Allergol Immunopathol (Madr), V19, P99; Matsumoto Y, 1998, NEPHRON, V78, P490, DOI 10.1159/000044981; Miller MC, 2009, ARTHRITIS RHEUM-US, V60, P686, DOI 10.1002/art.24331; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Nadali G, 1997, LEUKEMIA LYMPHOMA, V26, P99, DOI 10.3109/10428199709058606; NORTH ME, 1991, CLIN EXP IMMUNOL, V86, P252; Ohkubo T, 2001, J INT MED RES, V29, P488, DOI 10.1177/147323000102900604; PEAKMAN M, 1992, J INFECT DIS, V165, P799, DOI 10.1093/infdis/165.5.799; Ridgeway W, 1996, IMMUNOLOGIST, V4, P203; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Sato S, 1996, ARCH DERMATOL RES, V288, P358, DOI 10.1007/s004030050063; SAWADA S, 1993, J CLIN LAB ANAL, V7, P141, DOI 10.1002/jcla.1860070303; SAWADA S, 1992, AM J MED, V92, P134, DOI 10.1016/0002-9343(92)90103-I; Strand V, 2007, NAT REV DRUG DISCOV, V6, P75, DOI 10.1038/nrd2196; SYMONS JA, 1991, CLIN IMMUNOL IMMUNOP, V60, P72, DOI 10.1016/0090-1229(91)90113-O; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; YONEYAMA A, 1995, BRIT J HAEMATOL, V89, P47, DOI 10.1111/j.1365-2141.1995.tb08912.x; Yoon SO, 2003, J BIOCHEM MOL BIOL, V36, P128; Zhao LC, 2001, J BIOL CHEM, V276, P30631, DOI 10.1074/jbc.M103748200; ZIEGLER SF, 1993, EUR J IMMUNOL, V23, P1643, DOI 10.1002/eji.1830230737	41	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63963	10.1371/journal.pone.0063963	http://dx.doi.org/10.1371/journal.pone.0063963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700441	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200094
J	Zhai, G; Grubbs, CJ; Stockard, CR; Umphrey, HR; Beasley, TM; Kim, H				Zhai, Guihua; Grubbs, Clinton J.; Stockard, Cecil R.; Umphrey, Heidi R.; Beasley, T. Mark; Kim, Hyunki			Diffusion Weighted Imaging Evaluated the Early Therapy Effect of Tamoxifen in an MNU-Induced Mammary Cancer Rat Model	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; BREAST-CANCER; NEOADJUVANT CHEMOTHERAPY; EXPRESSION; APOPTOSIS; SEQUENCE; TUMORS; CELLS; BCL-2; ER	Purpose: To assess the optimal time point of diffusion-weighted imaging (DWI) for early prognosis of breast cancer following tamoxifen therapy using a methylnitrosourea (MNU)-induced ER-positive breast-cancer model. Methods: Two groups of Sprague-Dawley rats (n = 15 for group 1; n = 10 for group 2) were used. All animals (50 days old) were intravenously injected with MNU (50 mg/kg body weight) to induce ER-positive mammary tumors. When tumors were approximately 2 cm in diameter, DWI was performed on days 0, 3, and 7, and intratumoral apparent diffusion coefficient (ADC) values were measured. Therapy started on day 0 with tamoxifen (10 mg/kg diet) and continued for 4 weeks for group 1, but only 1 week for group 2, while tumor volume was measured by caliper twice weekly. All animals of group 2 were euthanized on day 7 after imaging, and Ki-67, TUNEL, ER alpha, and ER beta staining were performed on tumor tissue. Results: DW images of MNU-induced mammary tumors were successfully obtained with minimal motion artifact. For group 1, ADC change for 3 days after therapy initiation (ADC(3D)) was significantly correlated with tumor-volume change until day 11, but the significant correlation between ADC change for 7 days (ADC(7D)) and the tumor-volume change was observed until day 18. Similarly, for group 2, either ADC(7D) or ADC(3D) was significantly correlated with the tumor-volume change, but the higher significance was observed for ADC(7D). Furthermore, ADC(7D) was significantly correlated with apoptotic (TUNEL stained), proliferative (Ki-67 stained), and ERb-positive cell densities, but ADC(3D) was not significantly correlated with any of those. Conclusions: ADC(7D) might be a more reliable surrogate imaging biomarker than ADC(3D) to assess effectiveness of tamoxifen therapy for ER-positive breast cancer, which may enable personalized treatment. The significant correlation between ADC(7D) and ER beta-positive cell density suggests that ER beta may play an important role as a therapeutic indicator of tamoxifen.	[Zhai, Guihua; Umphrey, Heidi R.; Kim, Hyunki] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA; [Grubbs, Clinton J.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Beasley, T. Mark] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Stockard, Cecil R.; Kim, Hyunki] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kim, H (corresponding author), Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA.	Hyunki@uab.edu			National Cancer Institute UAB Comprehensive Cancer Center Junior Faculty Development Grant Program [CA13148-35]; National Institutes of Health [2P30CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER	National Cancer Institute UAB Comprehensive Cancer Center Junior Faculty Development Grant Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by The National Cancer Institute CA13148-35 UAB Comprehensive Cancer Center Junior Faculty Development Grant Program and the National Institutes of Health grant 2P30CA013148. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briest Susanne, 2009, Clin Adv Hematol Oncol, V7, P185; Brown JM, 1998, CANCER RES, V58, P1408; Buzdar AU, 2008, DRUG TODAY, V44, P679, DOI [10.1358/dot.2008.44.9.1269854, 10.1358/dot.2008.44.9.1256862]; Chhieng DC, 2002, CANCER CYTOPATHOL, V96, P232, DOI 10.1002/cncr.10714; Christov K, 2003, BREAST CANCER RES TR, V77, P253, DOI 10.1023/A:1021804121171; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Grubbs CJ, 2003, CANCER LETT, V201, P17, DOI 10.1016/S0304-3835(03)00461-0; Gruvberger-Saal SK, 2007, CLIN CANCER RES, V13, P1987, DOI 10.1158/1078-0432.CCR-06-1823; Henriksen K, 2009, ACTA ONCOL, V48, P522, DOI 10.1080/02841860802676383; HERTZOG C, 1985, CHILD DEV, V56, P787, DOI 10.1111/j.1467-8624.1985.tb00153.x; Hompland T, 2012, CANCER RES, V72, P4899, DOI 10.1158/0008-5472.CAN-12-0903; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; Kim H, 2008, RADIOLOGY, V248, P844, DOI 10.1148/radiol.2483071740; Kim H, 2012, MOL CANCER THER, V11, P405, DOI 10.1158/1535-7163.MCT-11-0581; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuo WH, 2008, ULTRASOUND MED BIOL, V34, P857, DOI 10.1016/j.ultrasmedbio.2007.11.011; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Miller WR, 2006, BRIT J CANCER, V94, P1333, DOI 10.1038/sj.bjc.6603082; Murata Y, 2010, ONCOL LETT, V1, P293, DOI 10.3892/ol_00000052; Neter J., 1996, APPL LINEAR STAT MOD; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Park SH, 2012, EUR RADIOL, V22, P18, DOI 10.1007/s00330-011-2236-x; Pritchard KI, 2003, CLIN CANCER RES, V9, p460S; Razandi M., 2012, ONCOGENE; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; ROSE DP, 1992, CANCER RES, V52, P5386; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Thomassin-Naggara I, 2012, EUROPEAN J RADIOLOGY; Wang Xiao-hong, 2010, Zhonghua Zhong Liu Za Zhi, V32, P539; Zhang GJ, 1999, CLIN CANCER RES, V5, P2971; Zheng AP, 2007, ENDOCRINOLOGY, V148, P2764, DOI 10.1210/en.2006-1269	33	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64445	10.1371/journal.pone.0064445	http://dx.doi.org/10.1371/journal.pone.0064445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700476	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200135
J	Felix, R; Crottes, D; Delalande, A; Fauconnier, J; Lebranchu, Y; Le Guennec, JY; Velge-Roussel, F				Felix, Romain; Crottes, David; Delalande, Anthony; Fauconnier, Jeremy; Lebranchu, Yvon; Le Guennec, Jean-Yves; Velge-Roussel, Florence			The Orai-1 and STIM-1 Complex Controls Human Dendritic Cell Maturation (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							TYPE-1 RYANODINE RECEPTORS; INTERLEUKIN-12 PRODUCTION; MOLECULAR-BASIS; CA2+ ENTRY; CHANNEL; ACTIVATION; CRAC; IDENTIFICATION; DEFICIENCY; EXPRESSION	Ca2+ signaling plays an important role in the function of dendritic cells (DC), the professional antigen presenting cells. Here, we described the role of Calcium released activated (CRAC) channels in the maturation and cytokine secretion of human DC. Recent works identified STIM1 and Orai1 in human T lymphocytes as essential for CRAC channel activation. We investigated Ca2+ signaling in human DC maturation by imaging intracellular calcium signaling and pharmalogical inhibitors. The DC response to inflammatory mediators or PAMPs (Pathogen-associated molecular patterns) is due to a depletion of intracellular Ca2+ stores that results in a store-operated Ca2+ entry (SOCE). This Ca2+ influx was inhibited by 2-APB and exhibited a Ca2+ permeability similar to the CRAC (Calcium-Released Activated Calcium), found in T lymphocytes. Depending on the PAMPs used, SOCE profiles and amplitudes appeared different, suggesting the involvement of different CRAC channels. Using siRNAi, we identified the STIM1 and Orai1 protein complex as one of the main pathways for Ca2+ entry for LPS- and TNF-alpha-induced maturation in DC. Cytokine secretions also seemed to be SOCE-dependent with profile differences depending on the maturating agents since IL-12 and IL10 secretions appeared highly sensitive to 2-APB whereas IFN-gamma was less affected. Altogether, these results clearly demonstrate that human DC maturation and cytokine secretions depend on SOCE signaling involving STIM1 and Orai1 proteins.	[Felix, Romain; Crottes, David; Lebranchu, Yvon; Velge-Roussel, Florence] Univ Tours, EA Cellules Dendrit Immunomodulat & Greffes 4245, IFR Agents Transmissibles & Infectiol 136, UFR Med, Tours, France; [Delalande, Anthony] CNRS, Ctr Biophys Mol, UPR 4301, F-45071 Orleans, France; [Delalande, Anthony] Inst Natl Sante & Rech Med, Tours, France; [Fauconnier, Jeremy; Le Guennec, Jean-Yves] Inst Natl Sante & Rech Med U637, Montpellier, France; [Lebranchu, Yvon] CHRU Tours, Serv Nephrol & Immunol Clin, Tours, France; [Velge-Roussel, Florence] UFR Sci Pharmaceut, Tours, France	Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours	Velge-Roussel, F (corresponding author), Univ Tours, EA Cellules Dendrit Immunomodulat & Greffes 4245, IFR Agents Transmissibles & Infectiol 136, UFR Med, Tours, France.	florence.velge-roussel@univ-tours.fr	LE GUENNEC, Jean-Yves/P-1067-2016; Crottès, David/AAC-2180-2022; FELIX, Romain/N-7727-2016; Jeremy, Jeremy/N-6233-2018	Crottès, David/0000-0002-4038-6345; Jeremy, Jeremy/0000-0003-2748-0983; Delalande, Anthony/0000-0001-8280-4616	French Ministere de la recherche	French Ministere de la recherche(Ministry of Research, France)	This work was supported by a doctoral fellowship from French Ministere de la recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antigny F, 2011, CELL CALCIUM, V49, P115, DOI 10.1016/j.ceca.2010.12.001; Baba Y, 2009, IMMUNOL REV, V231, P174, DOI 10.1111/j.1600-065X.2009.00813.x; Bagley KC, 2004, CLIN DIAGN LAB IMMUN, V11, P77, DOI 10.1128/CDLI.11.1.77-82.2004; BAIXERAS E, 1993, IMMUNOL REV, V132, P5, DOI 10.1111/j.1600-065X.1993.tb00836.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bandyopadhyay BC, 2011, J LEUKOCYTE BIOL, V89, P57, DOI 10.1189/jlb.0610381; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Bell D, 1999, ADV IMMUNOL, V72, P255, DOI 10.1016/S0065-2776(08)60023-1; Braun MC, 2001, MICROBES INFECT, V3, P99, DOI 10.1016/S1286-4579(00)01357-5; Cabral MD, 2010, AM J RESP CRIT CARE, V181, P1310, DOI [10.1164/rccm.200907-1166oc, 10.1164/rccm.200907-1166OC]; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Cai XJ, 2007, J MOL BIOL, V368, P1284, DOI 10.1016/j.jmb.2007.03.022; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; Faries MB, 2001, BLOOD, V98, P2489, DOI 10.1182/blood.V98.8.2489; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Herrmann TL, 2007, J LEUKOCYTE BIOL, V82, P686, DOI 10.1189/jlb.0107045; Herrmann TL, 2005, J LEUKOCYTE BIOL, V78, P1397, DOI 10.1189/jlb.0205105; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; Ito T, 2005, INT J HEMATOL, V81, P188, DOI 10.1532/IJH97.05012; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Lagaraine C, 2005, INT IMMUNOL, V17, P351, DOI 10.1093/intimm/dxh215; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; O'Connell PJ, 2002, FEBS LETT, V512, P67, DOI 10.1016/S0014-5793(01)03321-X; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Pigozzi D, 2006, CELL CALCIUM, V39, P401, DOI 10.1016/j.ceca.2006.01.003; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rossi M, 2005, J IMMUNOL, V175, P1373, DOI 10.4049/jimmunol.175.3.1373; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Uemura Y, 2007, BIOCHEM BIOPH RES CO, V362, P510, DOI 10.1016/j.bbrc.2007.08.024; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727	41	35	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e61595	10.1371/journal.pone.0061595	http://dx.doi.org/10.1371/journal.pone.0061595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700407	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400006
J	Nygardas, M; Paavilainen, H; Muther, N; Nagel, CH; Roytta, M; Sodeik, B; Hukkanen, V				Nygardas, Michaela; Paavilainen, Henrik; Muether, Nadine; Nagel, Claus-Henning; Roytta, Matias; Sodeik, Beate; Hukkanen, Veijo			A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; CENTRAL-NERVOUS-SYSTEM; RELAPSING MULTIPLE-SCLEROSIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; REGULATORY T-CELLS; BACTERIAL ARTIFICIAL CHROMOSOMES; IL-6 SIGNAL TRANSDUCER; SPINAL-CORD-INJURY; OLIGODENDROCYTE SURVIVAL; MEDIATED DEMYELINATION	Herpes simplex virus type 1 (HSV-1) has properties that can be exploited for the development of gene therapy vectors. The neurotropism of HSV enables delivery of therapeutic genes to the nervous system. Using a bacterial artificial chromosome (BAC), we constructed an HSV-1(17(+))-based replicative vector deleted of the neurovirulence gene gamma(1)34.5, and expressing leukemia inhibitory factor (LIF) as a transgene for treatment of experimental autoimmune encephalomyelitis (EAE). EAE is an inducible T-cell mediated autoimmune disease of the central nervous system (CNS) and is used as an animal model for multiple sclerosis. Demyelination and inflammation are hallmarks of both diseases. LIF is a cytokine that has the potential to limit demyelination and oligodendrocyte loss in CNS autoimmune diseases and to affect the T-cell mediated autoimmune response. In this study SJL/J mice, induced for EAE, were treated with a HSV-LIF vector intracranially and the subsequent changes in disease parameters and immune responses during the acute disease were investigated. Replicating HSV-LIF and its DNA were detected in the CNS during the acute infection, and the vector spread to the spinal cord but was non-virulent. The HSV-LIF significantly ameliorated the EAE and contributed to a higher number of oligodendrocytes in the brains when compared to untreated mice. The HSV-LIF therapy also induced favorable changes in the expression of immunoregulatory cytokines and T-cell population markers in the CNS during the acute disease. These data suggest that BAC-derived HSV vectors are suitable for gene therapy of CNS disease and can be used to test the therapeutic potential of immunomodulatory factors for treatment of EAE.	[Nygardas, Michaela; Paavilainen, Henrik; Hukkanen, Veijo] Univ Turku, Dept Virol, Turku, Finland; [Roytta, Matias] Univ Turku, Dept Pathol, Turku, Finland; [Muether, Nadine; Nagel, Claus-Henning; Sodeik, Beate] Hannover Med Sch, Inst Virol, Hannover, Germany	University of Turku; University of Turku; Hannover Medical School	Nygardas, M (corresponding author), Univ Turku, Dept Virol, Turku, Finland.	michaela.nygardas@utu.fi; veijo.hukkanen@utu.fi	Sodeik, Beate/C-9732-2010	Sodeik, Beate/0000-0003-4650-3036	Academy of Finland [118366, 128915]; German Research Foundation; EU 6th Framework Program (EU-NEST AXON SUPPORT) [12702]; Turku Doctoral Programme of Biomedical Sciences; Turku University Foundation; Medicinska Understodsforeningen Liv och Halsa; Finnish MS foundation; Maud Kuistila Memorial Foundation; German Academic Exchange Service (DAAD); Alfred Kordelin Foundation; FinPharma Doctoral program - Drug Discovery section	Academy of Finland(Academy of Finland); German Research Foundation(German Research Foundation (DFG)); EU 6th Framework Program (EU-NEST AXON SUPPORT); Turku Doctoral Programme of Biomedical Sciences; Turku University Foundation; Medicinska Understodsforeningen Liv och Halsa; Finnish MS foundation; Maud Kuistila Memorial Foundation; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Alfred Kordelin Foundation; FinPharma Doctoral program - Drug Discovery section	This study was supported by the Academy of Finland (grant number 118366 and 128915 to VH, www.aka.fi) and the German Research Foundation (DFG Excellence Cluster EXC 62, REBIRTH -From Regenerative Biology to Reconstructive Therapy to BS, www.dfg.de) and the EU 6th Framework Program (EU-NEST AXON SUPPORT, contract number 12702 to BS, ec.europa.eu/research/fp6/index_en.cfm). MN has been funded by Turku Doctoral Programme of Biomedical Sciences (www.tubs.utu.fi), Turku University Foundation (www.turunyliopistosaatio.fi), Medicinska Understodsforeningen Liv och Halsa (www.livochhalsa.fi), The Finnish MS foundation (http://www.ms-saatio.fi), the Maud Kuistila Memorial Foundation (www.maudkuistilanmuistosaatio.fi) and the German Academic Exchange Service (DAAD, www.daad.de). HP has been funded by the Alfred Kordelin Foundation (www.kordelin.fi) and FinPharma Doctoral program - Drug Discovery section (http://fpdp.fi). The funders had no role in study design, data collection and analysis, design to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adler H, 2003, REV MED VIROL, V13, P111, DOI 10.1002/rmv.380; Andreansky S, 1998, GENE THER, V5, P121, DOI 10.1038/sj.gt.3300550; Azari MF, 2006, J NEUROPATH EXP NEUR, V65, P914, DOI 10.1097/01.jnen.0000235855.77716.25; Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Banner LR, 1997, EXP NEUROL, V147, P1, DOI 10.1006/exnr.1997.6536; Berges BK, 2007, MOL THER, V15, P20, DOI 10.1038/sj.mt.6300018; Broberg E, 2001, GENE THER, V8, P769, DOI 10.1038/sj.gt.3301465; Broberg EK, 2002, J INTERF CYTOK RES, V22, P641, DOI 10.1089/10799900260100123; BROWN MA, 1994, CYTOKINE, V6, P300, DOI 10.1016/1043-4666(94)90027-2; Butzkueven H, 2006, GLIA, V53, P696, DOI 10.1002/glia.20321; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Campadelli-Fiume G, 2011, REV MED VIROL, V21, P213, DOI 10.1002/rmv.691; CANTIN EM, 1995, J VIROL, V69, P4898, DOI 10.1128/JVI.69.8.4898-4905.1995; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; CHOU J, 1992, P NATL ACAD SCI USA, V89, P3266, DOI 10.1073/pnas.89.8.3266; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64; CUA DJ, 1995, J IMMUNOL, V155, P4052; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Frampton AR, 2005, GENE THER, V12, P891, DOI 10.1038/sj.gt.3302545; Furlan R, 1998, HUM GENE THER, V9, P2605, DOI 10.1089/hum.1998.9.17-2605; Gao W, 2009, CELL CYCLE, V8, P1444, DOI 10.4161/cc.8.9.8348; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Gierasch WW, 2006, J VIROL METHODS, V135, P197, DOI 10.1016/j.jviromet.2006.03.014; Gresle MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047379; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Hukkanen V, 2000, J CLIN MICROBIOL, V38, P3214, DOI 10.1128/JCM.38.9.3214-3218.2000; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6; KENNEDY MK, 1992, J IMMUNOL, V149, P2496; Kerr BJ, 2005, GLIA, V51, P73, DOI 10.1002/glia.20177; Kesari S, 1998, J GEN VIROL, V79, P525, DOI 10.1099/0022-1317-79-3-525; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Mahic M, 2008, SCAND J IMMUNOL, V68, P391, DOI 10.1111/j.1365-3083.2008.02148.x; Manservigi Roberto, 2010, Open Virol J, V4, P123, DOI 10.2174/1874357901004030123; Markovitz NS, 1997, J VIROL, V71, P5560, DOI 10.1128/JVI.71.7.5560-5569.1997; Martino G, 2001, TRENDS IMMUNOL, V22, P483, DOI 10.1016/S1471-4906(01)01990-1; Martuza RL, 2000, J CLIN INVEST, V105, P841, DOI 10.1172/JCI9744; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Nagel CH, 2008, J VIROL, V82, P3109, DOI 10.1128/JVI.02124-07; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Nygardas M, 2011, GENE THER, V18, P646, DOI 10.1038/gt.2011.4; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sandbaumhuter M, 2013, CELL MICROBIOL, V15, P248, DOI 10.1111/cmi.12075; Slaets H, 2008, PROTEOMICS, V8, P1237, DOI 10.1002/pmic.200700641; Slaets H, 2010, MOL THER, V18, P684, DOI 10.1038/mt.2009.311; Sugiura S, 2000, EUR J NEUROSCI, V12, P457, DOI 10.1046/j.1460-9568.2000.00922.x; Vanderlocht J, 2006, J NEUROSCI RES, V83, P763, DOI 10.1002/jnr.20781; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; WHITLEY RJ, 1993, J CLIN INVEST, V91, P2837, DOI 10.1172/JCI116527; YOSHIDA T, 1993, DEV BRAIN RES, V76, P147, DOI 10.1016/0165-3806(93)90132-T; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051	59	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64200	10.1371/journal.pone.0064200	http://dx.doi.org/10.1371/journal.pone.0064200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700462	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400049
J	Pak, J; Lee, JH; Lee, SH				Pak, Jaewoo; Lee, Jung Hun; Lee, Sang Hee			A Novel Biological Approach to Treat Chondromalacia Patellae	PLOS ONE			English	Article							STEM-CELL THERAPY; ADIPOSE-TISSUE; STROMAL CELLS; CARTILAGE	Mesenchymal stem cells from several sources (bone marrow, synovial tissue, cord blood, and adipose tissue) can differentiate into variable parts (bones, cartilage, muscle, and adipose tissue), representing a promising new therapy in regenerative medicine. In animal models, mesenchymal stem cells have been used successfully to regenerate cartilage and bones. However, there have been no follow-up studies on humans treated with adipose-tissue-derived stem cells (ADSCs) for the chondromalacia patellae. To obtain ADSCs, lipoaspirates were obtained from lower abdominal subcutaneous adipose tissue. The stromal vascular fraction was separated from the lipoaspirates by centrifugation after treatment with collagenase. The stem-cell-containing stromal vascular fraction was mixed with calcium chloride-activated platelet rich plasma and hyaluronic acid, and this ADSCs mixture was then injected under ultrasonic guidance into the retro-patellar joints of all three patients. Patients were subjected to pre-and post-treatment magnetic resonance imaging (MRI) scans. Pre-and post-treatment subjective pain scores and physical therapy assessments measured clinical changes. One month after the injection of autologous ADSCs, each patient's pain improved 50-70%. Three months after the treatment, the patients' pain improved 80-90%. The pain improvement persisted over 1 year, confirmed by telephone follow ups. Also, all three patients did not report any serious side effects. The repeated magnetic resonance imaging scans at three months showed improvement of the damaged tissues (softened cartilages) on the patellae-femoral joints. In patients with chondromalacia patellae who have continuous anterior knee pain, percutaneous injection of autologous ADSCs may play an important role in the restoration of the damaged tissues (softened cartilages). Thus, ADSCs treatment presents a glimpse of a new promising, effective, safe, and non-surgical method of treatment for chondromalacia patellae.	[Pak, Jaewoo; Lee, Jung Hun] Stems Med Clin, Seoul, South Korea; [Lee, Jung Hun; Lee, Sang Hee] Myongji Univ, Dept Biol Sci, Natl Leading Res Lab, Yongin, Gyeonggido, South Korea	Myongji University	Lee, SH (corresponding author), Myongji Univ, Dept Biol Sci, Natl Leading Res Lab, Yongin, Gyeonggido, South Korea.	sangheelee@mju.ac.kr	Lee, Jung Hun/GYU-7134-2022; Lee, Sang Hee/A-3200-2012	Lee, Sang Hee/0000-0002-5660-7122; pak, jaewoo/0000-0001-6589-7849	National-Research-Foundation-MEST [2012-0008737]; Marine-Extreme-Genome-Research-Center-MLTM; Next-Generation-BioGreen21-RDA [SA00005735]	National-Research-Foundation-MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Marine-Extreme-Genome-Research-Center-MLTM; Next-Generation-BioGreen21-RDA	This work was supported by grants from the National-Research-Foundation-MEST (2012-0008737), Marine-Extreme-Genome-Research-Center-MLTM, and Next-Generation-BioGreen21-RDA (SA00005735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; Brody LT, 1998, J ORTHOP SPORT PHYS, V28, P336, DOI 10.2519/jospt.1998.28.5.336; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343; Johnstone B, 1999, CLIN ORTHOP RELAT R, pS156, DOI 10.1097/00003086-199910001-00017; Luyten FP, 2004, CURR OPIN RHEUMATOL, V16, P599, DOI 10.1097/01.bor.0000130284.64686.63; Magne D, 2005, TRENDS MOL MED, V11, P519, DOI 10.1016/j.molmed.2005.09.002; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Nevo Z, 1998, CELL TRANSPLANT, V7, P63, DOI 10.1016/S0963-6897(97)00066-3; Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000; Pak J, 2012, PAIN PHYSICIAN, V15, P75; Pak Jaewoo, 2011, J Med Case Rep, V5, P296, DOI 10.1186/1752-1947-5-296; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Richardson DW, 2003, INFLAMM RES, V52, P39, DOI 10.1007/s000110300012; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Walsh CJ, 1999, TISSUE ENG, V5, P327, DOI 10.1089/ten.1999.5.327; Wittstein JR, 2009, SKELETAL RADIOL, V38, P895, DOI 10.1007/s00256-009-0698-6; Wu W, 2007, J ORAL MAXIL SURG, V65, P1951, DOI 10.1016/j.joms.2006.11.044; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	21	39	39	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64569	10.1371/journal.pone.0064569	http://dx.doi.org/10.1371/journal.pone.0064569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700485	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400061
J	Russ, AE; Peters, JS; McNabb, WC; Barnett, MPG; Anderson, RC; Park, Z; Zhu, ST; Maclean, P; Young, W; Reynolds, GW; Roy, NC				Russ, Anna E.; Peters, Jason S.; McNabb, Warren C.; Barnett, Matthew P. G.; Anderson, Rachel C.; Park, Zaneta; Zhu, Shuotun; Maclean, Paul; Young, Wayne; Reynolds, Gordon W.; Roy, Nicole C.			Gene Expression Changes in the Colon Epithelium Are Similar to Those of Intact Colon during Late Inflammation in Interleukin-10 Gene Deficient Mice	PLOS ONE			English	Article							DELTA INTRAEPITHELIAL LYMPHOCYTES; BOWEL-DISEASE; MATRIX METALLOPROTEINASES; EXPERIMENTAL COLITIS; OLEIC-ACID; MICRODISSECTION; GENOME; MUCOSA; RNA; PLASMALOGENS	In addition to their role in absorption and secretion, epithelial cells play an important role in the protection of the colon mucosa from the resident microbiota and are important for the maintenance of homeostasis. Microarray analysis of intact colon samples is widely used to gain an overview of the cellular pathways and processes that are active in the colon during inflammation. Laser microdissection of colon epithelial cells allows a more targeted analysis of molecular pathways in the mucosa, preceding and during inflammation, with potentially increased sensitivity to changes in specific cell populations. The aim of this study was to investigate the molecular changes that occur in early and late inflammation stages in colon epithelium of a mouse model of inflammatory bowel diseases. Microarray analysis of intact colon samples and microdissected colon epithelial cell samples from interleukin-10 gene deficient and control mice at 6 and 12 weeks of age was undertaken. Results of gene set enrichment analysis showed that more immune-related pathways were identified between interleukin-10 gene deficient and control mice at 6 weeks of age in epithelial cells than intact colon. This suggests that targeting epithelial cells could increase sensitivity for detecting immune changes that occur early in the inflammatory process. However, in the later stages of inflammation, microarray analyses of intact colon and epithelium both provide a similar overview of gene expression changes in the colon mucosa at the pathway level.	[Russ, Anna E.; Peters, Jason S.; Barnett, Matthew P. G.; Anderson, Rachel C.; Young, Wayne; Roy, Nicole C.] AgRes Grasslands, Food & Biobased Prod Grp, Food Nutr & Hlth Team, Palmerston North, New Zealand; [Russ, Anna E.; Reynolds, Gordon W.] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [McNabb, Warren C.; Roy, Nicole C.] Massey Univ, Riddet Inst, Palmerston North, New Zealand; [McNabb, Warren C.] AgRes Grasslands, Palmerston North, New Zealand; [Park, Zaneta; Maclean, Paul] AgResearch, Bioinformat & Stat, Hamilton, New Zealand; [Zhu, Shuotun] Univ Auckland, Fac Med & Hlth Sci, Discipline Nutr, Auckland 1, New Zealand; [Zhu, Shuotun] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand	AgResearch - New Zealand; Massey University; Massey University; AgResearch - New Zealand; AgResearch - New Zealand; University of Auckland; University of Auckland	Roy, NC (corresponding author), AgRes Grasslands, Food & Biobased Prod Grp, Food Nutr & Hlth Team, Palmerston North, New Zealand.	nicole.roy@agresearch.co.nz	Barnett, Matthew PG/E-8539-2011; Roy, Nicole C/AAP-5016-2020	Barnett, Matthew PG/0000-0002-5186-5579; Young, Wayne/0000-0003-0464-2062; McNabb, Warren/0000-0003-2514-6551; roy, nicole clemence/0000-0002-6744-9705; Maclean, Paul/0000-0001-8898-8276; Anderson, Rachel/0000-0003-2191-0655	MSI [C11X1009]; Massey University Doctoral Scholarship	MSI; Massey University Doctoral Scholarship	The work described in this paper is part of Nutrigenomics New Zealand (http://www.nutrigenomics.org.nz), a collaboration between AgResearch Limited, Plant & Food Research and The University of Auckland, which is largely funded by The New Zealand Ministry of Business, Innovation, and Employment (http://www.mbie.govt.nz/),and its predecessors the New Zealand Ministry for Science & Innovation (MSI) and the New Zealand Foundation for Research, Science & Technology (FRST). This work was primarily supported by funding from the MSI contract C11X1009. Anna Russ was supported by a Massey University Doctoral Scholarship during the course of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Barnett MPG, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-39; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brosche T, 1998, EXP GERONTOL, V33, P363, DOI 10.1016/S0531-5565(98)00014-X; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Clement-Ziza M, 2008, RNA, V14, P2698, DOI 10.1261/rna.1261708; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; DIECKGRAEFE BK, 2001, PHYSIOL GENOMICS, V2001, P1; Dommels YEM, 2007, GENES NUTR, V2, P209, DOI 10.1007/s12263-007-0051-4; Dooley TP, 2004, INFLAMM BOWEL DIS, V10, P1, DOI 10.1097/00054725-200401000-00001; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edmunds SJ, 2012, BRIT J NUTR, V108, P113, DOI 10.1017/S0007114511005241; Engelmann B, 2004, BIOCHEM SOC T, V32, P147, DOI 10.1042/BST0320147; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Flanagan K, 2008, J IMMUNOL, V180, P3874, DOI 10.4049/jimmunol.180.6.3874; Funke B, 2011, INFLAMM BOWEL DIS, V17, P1943, DOI 10.1002/ibd.21572; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gill HS, 2001, MED MICROBIOL IMMUN, V190, P97, DOI 10.1007/s004300100095; Hansen JJ, 2009, INFLAMM BOWEL DIS, V15, P890, DOI 10.1002/ibd.20850; Hooper LV, 2004, CURR OPIN MICROBIOL, V7, P290, DOI 10.1016/j.mib.2004.04.004; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Kennedy RJ, 2000, BRIT J SURG, V87, P1346, DOI 10.1046/j.1365-2168.2000.01615.x; Knoch B, 2010, BIOTECHNOL J, V5, P1226, DOI 10.1002/biot.201000066; Knoch B, 2010, PPAR RES, V2010, DOI 10.1155/2010/621069; Knoch B, 2010, MOL NUTR FOOD RES, V54, pS62, DOI 10.1002/mnfr.200900543; Knoch B, 2009, J NUTRIGENET NUTRIGE, V2, P9, DOI 10.1159/000134292; Kruschewski M, 2001, DIGEST DIS SCI, V46, P2336, DOI 10.1023/A:1012334727509; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Liu ZJ, 2011, J LEUKOCYTE BIOL, V89, P597, DOI 10.1189/jlb.0810456; Mannick EE, 2004, CLIN IMMUNOL, V112, P247, DOI 10.1016/j.clim.2004.03.014; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mesko B, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-15; Moens E, 2012, IMMUNOLOGY, V135, P1, DOI 10.1111/j.1365-2567.2011.03506.x; Morgan AR, 2011, HUM IMMUNOL, V72, P1117, DOI 10.1016/j.humimm.2011.08.011; Mueller A, 2003, P NATL ACAD SCI USA, V100, P1292, DOI 10.1073/pnas.242741699; Murdoch C, 2000, BLOOD, V95, P3032; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nygaard V, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-147; O'Neil D, 2003, ADV EXP MED BIOL, V520, P252; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Park EI, 1997, J NUTR, V127, P566, DOI 10.1093/jn/127.4.566; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; REEVES PG, 1989, J NUTR, V119, P1081, DOI 10.1093/jn/119.8.1081; Reeves PG, 1997, J NUTR, V127, pS838; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Velde AAT, 2007, INFLAMM BOWEL DIS, V13, P325, DOI 10.1002/ibd.20079; von Lampe B, 2000, GUT, V47, P63, DOI 10.1136/gut.47.1.63; Walch A, 2001, HISTOCHEM CELL BIOL, V115, P269; Wang YD, 2006, WORLD J GASTROENTERO, V12, P6050, DOI 10.3748/wjg.v12.i37.6050; Yang SK, 1997, GASTROENTEROLOGY, V113, P1214, DOI 10.1053/gast.1997.v113.pm9322516	59	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63251	10.1371/journal.pone.0063251	http://dx.doi.org/10.1371/journal.pone.0063251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700416	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400014
J	Serra-Cobo, J; Lopez-Roig, M; Segui, M; Sanchez, LP; Nadal, J; Borras, M; Lavenir, R; Bourhy, H				Serra-Cobo, Jordi; Lopez-Roig, Marc; Segui, Magdalena; Pilar Sanchez, Luisa; Nadal, Jacint; Borras, Miquel; Lavenir, Rachel; Bourhy, Herve			Ecological Factors Associated with European Bat Lyssavirus Seroprevalence in Spanish Bats	PLOS ONE			English	Article							RABIES; HOST; VIRUS; INFECTION; TRANSMISSION; PHYLOGENY; EVOLUTION; DYNAMICS; COLONIES; EXPOSURE	Bats have been proposed as major reservoirs for diverse emerging infectious viral diseases, with rabies being the best known in Europe. However, studies exploring the ecological interaction between lyssaviruses and their natural hosts are scarce. This study completes our active surveillance work on Spanish bat colonies that began in 1992. Herein, we analyzed ecological factors that might affect the infection dynamics observed in those colonies. Between 2001 and 2011, we collected and tested 2,393 blood samples and 45 dead bats from 25 localities and 20 bat species. The results for dead confirmed the presence of EBLV-1 RNA in six species analyzed (for the first time in Myotis capaccinii). Samples positive for European bat lyssavirus-1 (EBLV-1)-neutralizing antibodies were detected in 68% of the localities sampled and in 13 bat species, seven of which were found for the first time (even in Myotis daubentonii, a species to date always linked to EBLV-2). EBLV-1 seroprevalence (20.7%) ranged between 11.1 and 40.2% among bat species and seasonal variation was observed, with significantly higher antibody prevalence in summer (July). EBLV-1 seroprevalence was significantly associated with colony size and species richness. Higher seroprevalence percentages were found in large multispecific colonies, suggesting that intra-and interspecific contacts are major risk factors for EBLV-1 transmission in bat colonies. Although bat-roosting behavior strongly determines EBLV-1 variability, we also found some evidence that bat phylogeny might be involved in bat-species seroprevalence. The results of this study highlight the importance of life history and roost ecology in understanding EBLV-1-prevalence patterns in bat colonies and also provide useful information for public health officials.	[Serra-Cobo, Jordi; Lopez-Roig, Marc; Segui, Magdalena] Govern Illes Balears, Ctr Recerca Infecc Viriques, Illes Balears CRIVIB, Fundacio Invest Sanitaria Illes Balears,Conseller, Palma De Mallorca, Spain; [Serra-Cobo, Jordi; Lopez-Roig, Marc; Nadal, Jacint] Univ Barcelona, Fac Biol, IRBIO, Barcelona, Spain; [Serra-Cobo, Jordi; Lopez-Roig, Marc; Nadal, Jacint] Univ Barcelona, Fac Biol, Dept Biol Anim, Barcelona, Spain; [Pilar Sanchez, Luisa] CIBERESP, Ctr Nacl Epidemiol, Inst Salud Carlos III, Madrid, Spain; [Borras, Miquel] Unitat Toxicol Expt & Ecotoxicol, Barcelona, Spain; [Lavenir, Rachel; Bourhy, Herve] Inst Pasteur, Unite Dynam Lyssavirus & Adaptat Hote, Paris, France	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Serra-Cobo, J (corresponding author), Govern Illes Balears, Ctr Recerca Infecc Viriques, Illes Balears CRIVIB, Fundacio Invest Sanitaria Illes Balears,Conseller, Palma De Mallorca, Spain.	serracobo@areambiental.com	Serra-Cobo, Jordi/G-4673-2016		Conselleria de Salut, FamA-lia i Benestar Social, Govern de les Illes Balears [PI 32/2009]; Researchers Stabilization Program and Technical Support Research; Intensification of Research Activity in the National Health System of the Ministry of Health (Instituto de Salud Carlos III), Instituto de Salud Carlos III [EMER 07/051]; RABMEDCONTROL UE project [517727]; PREDEMICS UE project [278433]	Conselleria de Salut, FamA-lia i Benestar Social, Govern de les Illes Balears; Researchers Stabilization Program and Technical Support Research; Intensification of Research Activity in the National Health System of the Ministry of Health (Instituto de Salud Carlos III), Instituto de Salud Carlos III; RABMEDCONTROL UE project; PREDEMICS UE project	This work was financed by the Conselleria de Salut, FamA-lia i Benestar Social, Govern de les Illes Balears (PI 32/2009), the Researchers Stabilization Program and Technical Support Research, and Intensification of Research Activity in the National Health System of the Ministry of Health (Instituto de Salud Carlos III), Instituto de Salud Carlos III (EMER 07/051), RABMEDCONTROL UE project No. 517727, and PREDEMICS UE project No. 278433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LC, 2009, J COMP PHYSIOL B, V179, P315, DOI 10.1007/s00360-008-0315-3; Amengual B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000566; Arneberg P, 2002, ECOGRAPHY, V25, P88, DOI 10.1034/j.1600-0587.2002.250110.x; Badrane H, 2001, J VIROL, V75, P8096, DOI 10.1128/JVI.75.17.8096-8104.2001; Begon M, 2003, J ANIM ECOL, V72, P343, DOI 10.1046/j.1365-2656.2003.00705.x; Botvinkin AD, 2003, EMERG INFECT DIS, V9, P1623, DOI 10.3201/eid0912.030374; BOURHY H, 1990, METHODES LAB DIAGNOS; BROSSET A, 1990, MAMMALIA, V54, P207; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Christe P, 2000, ECOL LETT, V3, P207; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; Dacheux L, 2009, EMERG INFECT DIS, V15, P280, DOI 10.3201/eid1502.080637; Davis PL, 2005, J VIROL, V79, P10487, DOI 10.1128/JVI.79.16.10487-10497.2005; Delmas O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002057; Dietz C, 2004, ILLUSTRATED IDENTIFI; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Echevarria JE, 2001, J CLIN MICROBIOL, V39, P3678, DOI 10.1128/JCM.39.10.3678-3683.2001; Fox J., 2019, CAR COMPANION APPL R; Freuling CM, 2011, EMERG INFECT DIS, V17, P1519, DOI 10.3201/eid1708.110201; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; Gouilh MA, 2011, INFECT GENET EVOL, V11, P1690, DOI 10.1016/j.meegid.2011.06.021; Harris SL, 2006, BIOL CONSERV, V131, P193, DOI 10.1016/j.biocon.2006.04.006; Hutterer R., 2005, BAT MIGRATIONS EUROP; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Kuzmin IV, 2010, VIRUS RES, V149, P197, DOI 10.1016/j.virusres.2010.01.018; Lumlertdacha B, 2005, EMERG INFECT DIS, V11, P232, DOI 10.3201/eid1102.040691; Marston DA, 2012, EMERG INFECT DIS, V18, P664, DOI 10.3201/eid1804.111553; Megali A, 2010, ARCH VIROL, V155, P1655, DOI 10.1007/s00705-010-0750-9; MOHR W, 1957, Med Klin, V52, P1057; Muller T, 2007, ARCH VIROL, V152, P273, DOI 10.1007/s00705-006-0853-5; NIKOLIC M, 1956, WHO B, V14, P801; Nokireki T., 2011, Rabies Bulletin Europe, V35, P8; Picard-Meyer E, 2011, VET MICROBIOL, V151, P390, DOI 10.1016/j.vetmic.2011.03.034; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2008, R LANG ENV STAT COMP; RACEY PA, 1974, J ZOOL, V173, P264, DOI 10.1111/j.1469-7998.1974.tb03136.x; RACEY PA, 2009, ECOLOGICAL BEHAV MET; Sanchez Serrano L. P., 1999, Boletin Epidemiologico Semanal, V7, P149; SANCHEZSERRANO LP, 2003, EURO SURVEILL, V7; Serra-Cobo J, 1998, ACTA THERIOL, V43, P271, DOI 10.4098/AT.arch.98-22; Serra-Cobo J, 2002, EMERG INFECT DIS, V8, P413, DOI 10.3201/eid0804.010263; Serra-Cobo J., 2008, Boletin Epidemiologico Semanal, V16, P169; SERRACOBO J, 2008, SCIVEE TV; SERRACOBO J, 2009, BATS SCI MYTH; Smreczak M, 2009, B VET I PULAWY, V53, P589; Streicker DG, 2012, P ROY SOC B-BIOL SCI, V279, P3384, DOI 10.1098/rspb.2012.0538; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Turmelle AS, 2010, J GEN VIROL, V91, P2360, DOI 10.1099/vir.0.020073-0; Turmelle AS, 2010, VECTOR-BORNE ZOONOT, V10, P165, DOI 10.1089/vbz.2008.0163; Van der Poel WHM, 2005, EMERG INFECT DIS, V11, P1854, DOI 10.3201/eid1112.041200; Vazquez-Moron S, 2008, EMERG INFECT DIS, V14, P1263, DOI [10.3201/eid1408.080068, 10.3201/1408.080068]; Vazquez-Moron S, 2011, EMERG INFECT DIS, V17, P520, DOI 10.3201/eid1703.100894; Willis CKR, 2007, BEHAV ECOL SOCIOBIOL, V62, P97, DOI 10.1007/s00265-007-0442-y; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520	56	30	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64467	10.1371/journal.pone.0064467	http://dx.doi.org/10.1371/journal.pone.0064467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700480	Green Submitted, Green Published, gold			2022-12-27	WOS:000319966400056
J	Sonawani, A; Niazi, S; Idicula-Thomas, S				Sonawani, Archana; Niazi, Sarfaraj; Idicula-Thomas, Susan			In Silico Study on Binding Specificity of Gonadotropins and Their Receptors: Design of a Novel and Selective Peptidomimetic for Human Follicle Stimulating Hormone Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; LEUCINE-RICH REPEATS; BETA-STRANDS; FORCE-FIELD; LIGANDS; PEPTIDE; FOLLITROPIN; VALIDATION; INHIBITORS; EXODOMAIN	Gonadotropins bind to specific receptors in spite of sharing a high level of sequence and structural similarity. This specific binding is crucial for maintaining the reproductive health of an organism. In this study, residues that dictate the receptor binding specificity of the gonadotropins (FSH and LH) have been identified using combination of in silico methods. Docking studies (ZDOCK), based on the systematic replacement of these residues, confirmed its importance in receptor binding. An interesting observation is that the relative positioning of the residues conferring binding specificity varied for the gonadotropin-receptor complexes. This spatial difference of the key residues could be exploited for design of specific modulators. Based on the identified residues, we have rationally designed a peptidomimetic (FSHP) that displays good binding affinity and specificity for hFSHR. FSHP was developed by screening 3.9 million compounds using pharmacophore-shape similarity followed by fragment-based approach. It was observed that FSHP and hFSHa can share the same receptor binding site thereby mimicking the native hFSHR-FSH interactions. FSHP also displayed higher binding affinity to hFSHR as compared to two reported hFSHR antagonists. MD simulation studies on hFSHR-FSHP complex revealed that FSHP is conformationally rigid and the intermolecular interactions are maintained during the course of simulation.	[Sonawani, Archana; Niazi, Sarfaraj; Idicula-Thomas, Susan] Natl Inst Res Reprod Hlth, Indian Council Med Res, Biomed Informat Ctr, Mumbai, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Idicula-Thomas, S (corresponding author), Natl Inst Res Reprod Hlth, Indian Council Med Res, Biomed Informat Ctr, Mumbai, Maharashtra, India.	thomass@nirrh.res.in	Niazi, Sarfaraj/L-7222-2015	Niazi, Sarfaraj/0000-0002-0136-3108	Department of Biotechnology; Government of India [NIRRH/M/77/12, BT/PR12904/BID/07/301/2009]	Department of Biotechnology; Government of India(Department of Biotechnology (DBT) India)	This work (NIRRH/M/77/12) has been supported by grant from Department of Biotechnology; Government of India (BT/PR12904/BID/07/301/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen J, 2012, MOL CELL ENDOCRINOL, V364, P89, DOI 10.1016/j.mce.2012.08.013; [Anonymous], 2011, GLID VERS 5 7; [Anonymous], 2011, LIGPREP VERS 2 5; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Ballet S, 2006, J MED CHEM, V49, P3990, DOI 10.1021/jm0603264; Becker OM, 2004, P NATL ACAD SCI USA, V101, P11304, DOI 10.1073/pnas.0401862101; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bhagwanth S, 2013, BEILSTEIN J ORG CHEM, V9, P204, DOI 10.3762/bjoc.9.24; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; Bruns C, 2002, EUR J ENDOCRINOL, V146, P707, DOI 10.1530/eje.0.1460707; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CAMPBELL RK, 1991, P NATL ACAD SCI USA, V88, P760, DOI 10.1073/pnas.88.3.760; *CHEMOFF, 2004, CHEMOFFICE 2004; Chopineau M, 1997, J ENDOCRINOL, V152, P371, DOI 10.1677/joe.0.1520371; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DIAS JA, 1994, J BIOL CHEM, V269, P25289; Engel JB, 2012, ANTICANCER RES, V32, P2063; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Floris M, 2012, MOL INFORM, V31, P12, DOI 10.1002/minf.201100093; Floris M, 2011, NUCLEIC ACIDS RES, V39, pW261, DOI 10.1093/nar/gkr287; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; *GOLD, 2010, GOLD VERS 5 0 US GUI; Gonzalez-Ruiz D, 2006, CURR MED CHEM, V13, P2607, DOI 10.2174/092986706778201530; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess S, 2008, J MED CHEM, V51, P1026, DOI 10.1021/jm701093y; Hruby VJ, 2013, ANNU REV PHARMACOL, V53, P557, DOI 10.1146/annurev-pharmtox-010510-100456; Hruby VJ, 2000, CURR MED CHEM, V7, P945, DOI 10.2174/0929867003374499; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kumar TR, 2005, REPRODUCTION, V130, P293, DOI 10.1530/rep.1.00660; *LLC, 2011, MAESTR VERS 9 2; Loving K, 2009, J COMPUT AID MOL DES, V23, P541, DOI 10.1007/s10822-009-9268-1; Masciocchi J, 2009, NUCLEIC ACIDS RES, V37, pD284, DOI 10.1093/nar/gkn727; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; Moyle WR, 2005, ENDOCRINE, V26, P189, DOI 10.1385/ENDO:26:3:189; Moyle WR, 2004, J BIOL CHEM, V279, P44442, DOI 10.1074/jbc.M406948200; Nambi P, 2003, ASSAY DRUG DEV TECHN, V1, P305, DOI 10.1089/15406580360545116; NOCE T, 1989, J MOL ENDOCRINOL, V3, P129, DOI 10.1677/jme.0.0030129; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Pierce AC, 2004, J MED CHEM, V47, P2768, DOI 10.1021/jm030543u; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Shacham S, 2001, MED RES REV, V21, P472, DOI 10.1002/med.1019; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Van Durme J, 2006, MOL ENDOCRINOL, V20, P2247, DOI 10.1210/me.2006-0020; van Straten N, 2009, ANNU REP MED CHEM, V44, P171, DOI 10.1016/S0065-7743(09)04408-X; Vischer HF, 2006, MOL ENDOCRINOL, V20, P1880, DOI 10.1210/me.2005-0202; Vischer HF, 2003, MOL ENDOCRINOL, V17, P1972, DOI 10.1210/me.2003-0172; Vischer HF, 2003, J BIOL CHEM, V278, P15505, DOI 10.1074/jbc.M300634200; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Wrobel J, 2002, BIOORGAN MED CHEM, V10, P639, DOI 10.1016/S0968-0896(01)00324-8; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	62	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64475	10.1371/journal.pone.0064475	http://dx.doi.org/10.1371/journal.pone.0064475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700481	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400057
J	Zhu, Y; Li, H; Li, KH; Zhao, XF; An, T; Hu, XM; Park, J; Huang, H; Bin, Y; Qiang, BQ; Yuan, JG; Peng, XZ; Qiu, MS				Zhu, Ying; Li, Hong; Li, Kehan; Zhao, Xiaofeng; An, Tai; Hu, Xuemei; Park, Jinsil; Huang, Hao; Bin, Yin; Qiang, Boqin; Yuan, Jiangang; Peng, Xiaozhong; Qiu, Mengsheng			Necl-4/SynCAM-4 Is Expressed in Myelinating Oligodendrocytes but Not Required for Axonal Myelination	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CELL-ADHESION; PROTEIN; CNS; MEMBRANE; ASSOCIATION; TSLC1	The timing and progression of axonal myelination are precisely controlled by intercellular interactions between neurons and glia in development. Previous in vitro studies demonstrated that Nectin like 4 (Necl-4, also known as cell adhesion molecule Cadm-4 or SynCAM-4) plays an essential role in axonal myelination by Schwann cells in the peripheral nervous system (PNS). However, the role of Necl-4 protein in axonal myelination in the developing central nervous system (CNS) has remained unknown. In this study, we discovered upregulation of Necl-4 expression in mature oligodendrocytes at perinatal stages when axons undergo active myelination. We generated Necl4 gene knockout mice, but found that disruption of Necl-4 gene did not affect oligodendrocyte differentiation and myelin formation in the CNS. Surprisingly, disruption of Necl-4 had no significant effect on axonal myelination in the PNS either. Therefore, our results demonstrated that Necl-4 is dispensable for axonal myelination in the developing nervous system.	[Zhu, Ying; Li, Hong; Zhao, Xiaofeng; Hu, Xuemei; Park, Jinsil; Qiu, Mengsheng] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Li, Kehan; An, Tai; Bin, Yin; Qiang, Boqin; Yuan, Jiangang; Peng, Xiaozhong] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Li, Kehan; An, Tai; Bin, Yin; Qiang, Boqin; Yuan, Jiangang; Peng, Xiaozhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhao, Xiaofeng; Huang, Hao; Qiu, Mengsheng] Hangzhou Normal Univ, Inst Dev & Regenerat Biol, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	University of Louisville; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Hangzhou Normal University	Peng, XZ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	pengxiaozhong@pumc.edu.cn; m0qiu001@yahoo.com	Huang, Hao/M-6127-2019; Huang, Hao/O-8809-2017	Huang, Hao/0000-0001-7346-7056; Huang, Hao/0000-0001-7346-7056	National Multiple Sclerosis Society [RG 3275]; National Institutes of Health [R01 NS037717]; National Natural Sciences Foundation of China [30828004, 31071879, 31000488]; Zhejiang Provincial Natural Science Foundation of China [Z2100730]; Major Project of Science and Technology Department of Zhejiang Province [Y2111122]; Program for New Century Excellent Talents in University [NCET-070505]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037717] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Major Project of Science and Technology Department of Zhejiang Province; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Multiple Sclerosis Society (RG 3275) and National Institutes of Health (R01 NS037717), the National Natural Sciences Foundation of China (grants 30828004, 31071879, 31000488); Zhejiang Provincial Natural Science Foundation of China (Z2100730), Major Project of Science and Technology Department of Zhejiang Province (Y2111122) and the Program for New Century Excellent Talents in University (NCET-070505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Benninger Y, 2006, J NEUROSCI, V26, P7665, DOI 10.1523/JNEUROSCI.0444-06.2006; Bhat RV, 1996, GLIA, V17, P169; Boiko T, 2006, J CELL BIOL, V172, P799, DOI 10.1083/jcb.200602101; Buttery PC, 1999, MOL CELL NEUROSCI, V14, P199, DOI 10.1006/mcne.1999.0781; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; McKee KK, 2012, J CELL SCI; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Park J, 2008, J NEUROSCI, V28, P12815, DOI 10.1523/JNEUROSCI.2665-08.2008; Qi YC, 2001, DEVELOPMENT, V128, P2723; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Simons M, 2006, J CELL SCI, V119, P4381, DOI 10.1242/jcs.03242; Southwood C, 2004, J NEUROSCI, V24, P11215, DOI 10.1523/JNEUROSCI.3479-04.2004; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Yageta M, 2002, CANCER RES, V62, P5129; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766; Zhou Y, 2005, BBA-BIOMEMBRANES, V1669, P142, DOI 10.1016/j.bbamem.2005.01.013	25	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64264	10.1371/journal.pone.0064264	http://dx.doi.org/10.1371/journal.pone.0064264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700466	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400051
J	Kriz, Z; Klusak, J; Kristofikova, Z; Koca, J				Kriz, Zdenek; Klusak, Jiri; Kristofikova, Zdena; Koca, Jaroslav			How Ionic Strength Affects the Conformational Behavior of Human and Rat Beta Amyloids - A Computational Study	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ALZHEIMERS-DISEASE; FIBRIL FORMATION; PROTEIN; PEPTIDE; RECOGNITION; MICROSCOPY; PATTERN; MODELS	Progressive cerebral deposition of amyloid beta occurs in Alzheimers disease and during the aging of certain mammals (human, monkey, dog, bear, cow, cat) but not others (rat, mouse). It is possibly due to different amino acid sequences at positions 5, 10 and 13. To address this issue, we performed series of 100 ns long trajectories (each trajectory was run twice with different initial velocity distribution) on amyloid beta (1-42) with the human and rat amino acid sequence in three different environments: water with only counter ions, water with NaCl at a concentration of 0.15 M as a model of intracellular Na+ concentration at steady state, and water with NaCl at a concentration of 0.30 M as a model of intracellular Na+ concentration under stimulated conditions. We analyzed secondary structure stability, internal hydrogen bonds, and residual fluctuation. It was observed that the change in ionic strength affects the stability of internal hydrogen bonds. Increasing the ionic strength increases atomic fluctuation in the hydrophobic core of the human amyloid, and decreases the atomic fluctuation in the case of rat amyloid. The secondary structure analyses show a stable a-helix part between residues 10 and 20. However, C-terminus of investigated amyloids is much more flexible showing no stable secondary structure elements. Increasing ionic strength of the solvent leads to decreasing stability of the secondary structural elements. The difference in conformational behavior of the three amino acids at position 5, 10 and 13 for human and rat amyloids significantly changes the conformational behavior of the whole peptide.	[Kriz, Zdenek; Koca, Jaroslav] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic; [Kriz, Zdenek; Klusak, Jiri; Koca, Jaroslav] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CS-61137 Brno, Czech Republic; [Kristofikova, Zdena] Prague Psychiat Ctr, Alzheimer Dis Ctr, Prague, Czech Republic	Masaryk University Brno; Masaryk University Brno	Koca, J (corresponding author), Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic.	jkoca@chemi.muni.cz	Koca, Jaroslav/E-4460-2012	Koca, Jaroslav/0000-0002-2780-4901	Grant Agency of the Czech Republic [305/09/0457]; Ministry of Education, Youth, and Sports of the Czech Republic [LM2010005]; Czech Science Foundation [GD301/09/H004]; European Community from the European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; "Capacities" specific programme [286154]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); European Community from the European Regional Development Fund; "Capacities" specific programme	This work was financially supported by the Grant Agency of the Czech Republic grant number 305/09/0457. The access to the MetaCentrum computing facilities provided under the programme "Projects of Large Infrastructure for Research, Development, and Innovations" LM2010005 funded by the Ministry of Education, Youth, and Sports of the Czech Republic is gratefully acknowledged. The work was also financially supported by the Czech Science Foundation (GD301/09/H004), by the European Community's Seventh Framework Programme (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund and from the "Capacities" specific programme (Contract No. 286154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRAAK H, 1994, NEUROBIOL AGING, V15, P355, DOI 10.1016/0197-4580(94)90032-9; Case DA, 2011, AMBER; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Curtain CC, 2001, J BIOL CHEM, V276, P20466, DOI 10.1074/jbc.M100175200; Dominy BN, 2002, J MOL BIOL, V319, P541, DOI 10.1016/S0022-2836(02)00259-0; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Florova P, 2010, J CHEM THEORY COMPUT, V6, P3569, DOI 10.1021/ct1003687; Grubmuller H., 1996, SOLVATE PROGRAM CREA; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lepsik M, 2004, PROTEINS, V57, P279, DOI 10.1002/prot.20192; Losic D, 2006, J STRUCT BIOL, V155, P104, DOI 10.1016/j.jsb.2006.02.013; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; Milton NGN, 1999, BIOCHEM J, V344, P293, DOI 10.1042/0264-6021:3440293; Milton NGN, 2001, NEUROREPORT, V12, P2561, DOI 10.1097/00001756-200108080-00054; Otyepka M, 2006, J BIOL CHEM, V281, P7271, DOI 10.1074/jbc.M509699200; Otzen DE, 2002, BIOPHYS J, V83, P2219, DOI 10.1016/S0006-3495(02)73982-9; Pawlik M, 1999, NEUROBIOL AGING, V20, P47, DOI 10.1016/S0197-4580(99)00017-2; PODLISNY MB, 1991, AM J PATHOL, V138, P1423; Prokop M, 2008, BIOINFORMATICS, V24, P1955, DOI 10.1093/bioinformatics/btn344; Rauk A, 2008, DALTON T, P1273, DOI 10.1039/b718601k; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schladitz C, 1999, BIOPHYS J, V77, P3305, DOI 10.1016/S0006-3495(99)77161-4; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Shafrir Y, 2010, PROTEINS, V78, P3458, DOI 10.1002/prot.22832; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Sklenovsky P, 2008, J MOL MODEL, V14, P747, DOI 10.1007/s00894-008-0300-5; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1997, J BIOL CHEM, V272, P12601, DOI 10.1074/jbc.272.19.12601; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Wang H, 2000, ADV IND CON; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Yao ZX, 2002, FASEB J, V16, P1677, DOI 10.1096/fj.02-0285fje; Zidar J, 2011, J PHYS CHEM B, V115, P2075, DOI 10.1021/jp109025b	43	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e62914	10.1371/journal.pone.0062914	http://dx.doi.org/10.1371/journal.pone.0062914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717395	Green Published, Green Submitted, gold			2022-12-27	WOS:000319435600004
J	Ding, JR; An, DM; Liao, W; Li, JM; Wu, GR; Xu, Q; Long, ZL; Gong, QY; Zhou, D; Sporns, O; Chen, HF				Ding, Ju-Rong; An, Dongmei; Liao, Wei; Li, Jinmei; Wu, Guo-Rong; Xu, Qiang; Long, Zhiliang; Gong, Qiyong; Zhou, Dong; Sporns, Olaf; Chen, Huafu			Altered Functional and Structural Connectivity Networks in Psychogenic Non-Epileptic Seizures	PLOS ONE			English	Article							SMALL-WORLD; BRAIN NETWORKS; ORGANIZATION	Psychogenic non-epileptic seizures (PNES) are paroxysmal behaviors that resemble epileptic seizures but lack abnormal electrical activity. Recent studies suggest aberrant functional connectivity involving specific brain regions in PNES. Little is known, however, about alterations of topological organization of whole-brain functional and structural connectivity networks in PNES. We constructed functional connectivity networks from resting-state functional MRI signal correlations and structural connectivity networks from diffusion tensor imaging tractography in 17 PNES patients and 20 healthy controls. Graph theoretical analysis was employed to compute network properties. Moreover, we investigated the relationship between functional and structural connectivity networks. We found that PNES patients exhibited altered small-worldness in both functional and structural networks and shifted towards a more regular (lattice-like) organization, which could serve as a potential imaging biomarker for PNES. In addition, many regional characteristics were altered in structural connectivity network, involving attention, sensorimotor, subcortical and default-mode networks. These regions with altered nodal characteristics likely reflect disease-specific pathophysiology in PNES. Importantly, the coupling strength of functional-structural connectivity was decreased and exhibited high sensitivity and specificity to differentiate PNES patients from healthy controls, suggesting that the decoupling strength of functional-structural connectivity might be an important characteristic reflecting the mechanisms of PNES. This is the first study to explore the altered topological organization in PNES combining functional and structural connectivity networks, providing a new way to understand the pathophysiological mechanisms of PNES.	[Ding, Ju-Rong; Wu, Guo-Rong; Xu, Qiang; Long, Zhiliang; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab Neuroinformat Minist Educ, Chengdu 610054, Peoples R China; [Ding, Ju-Rong; Sporns, Olaf] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Ding, Ju-Rong; Sporns, Olaf] Indiana Univ, Program Cognit Sci, Bloomington, IN USA; [Ding, Ju-Rong] Third Mil Med Univ, Dept Med Informat & Med Image, Coll Biomed Engn & Med Imaging, Chongqing, Peoples R China; [An, Dongmei; Li, Jinmei; Zhou, Dong] West China Hosp Sichuan Univ, Dept Neurol, Chengdu, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Wu, Guo-Rong] Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, B-9000 Ghent, Belgium; [Gong, Qiyong] West China Hosp Sichuan Univ, Dept Radiol, Chengdu, Peoples R China	University of Electronic Science & Technology of China; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Army Medical University; Sichuan University; Hangzhou Normal University; Hangzhou Normal University; Ghent University; Sichuan University	Zhou, D (corresponding author), West China Hosp Sichuan Univ, Dept Neurol, Chengdu, Peoples R China.	zhoudong66@yahoo.de; chenhf@uestc.edu.cn	Sporns, Olaf/A-1667-2010; Gong, Qiyong/W-3052-2019	Sporns, Olaf/0000-0001-7265-4036; Gong, Qiyong/0000-0002-5912-4871; Xu, Qiang/0000-0002-7739-7515	973 Project [2012CB517901]; Natural Science Foundation of China [61035006, 61125304]; Academic new artist Ministry of Education doctoral post graduate [A03003023901004]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120185110028]	973 Project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic new artist Ministry of Education doctoral post graduate; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the 973 Project [2012CB517901]; the Natural Science Foundation of China [61035006, 61125304]; the Academic new artist Ministry of Education doctoral post graduate [A03003023901004]; and the Specialized Research Fund for the Doctoral Program of Higher Education of China [20120185110028]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Baslet G, 2011, SEIZURE-EUR J EPILEP, V20, P1, DOI 10.1016/j.seizure.2010.10.032; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Benbadis SR, 2000, SEIZURE-EUR J EPILEP, V9, P280, DOI 10.1053/seiz.2000.0409; Benbadis SR, 2004, NEUROLOGY, V63, P1728, DOI 10.1212/01.WNL.0000143273.18099.50; Brown RJ, 2011, EPILEPSY BEHAV, V22, P85, DOI 10.1016/j.yebeh.2011.02.016; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Devinsky O, 2011, NAT REV NEUROL, V7, P210, DOI 10.1038/nrneurol.2011.24; Ding JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026596; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Feil D, 1999, Curr Psychiatry Rep, V1, P69, DOI 10.1007/s11920-999-0012-2; Gleichgerrcht E, 2010, NAT REV NEUROL, V6, P611, DOI 10.1038/nrneurol.2010.148; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Knyazeva MG, 2011, J NEUROL NEUROSUR PS, V82, P505, DOI 10.1136/jnnp.2010.224873; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Kramer MA, 2012, NEUROSCIENTIST, V18, P360, DOI 10.1177/1073858411422754; Labate A, 2012, EPILEPSIA, V53, P377, DOI 10.1111/j.1528-1167.2011.03347.x; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; LEIS AA, 1992, NEUROLOGY, V42, P95, DOI 10.1212/WNL.42.1.95; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Reuber M, 2004, NEUROLOGY, V62, P834, DOI 10.1212/01.WNL.0000113755.11398.90; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van der Kruijs SJM, 2012, J NEUROL NEUROSUR PS, V83, P239, DOI 10.1136/jnnp-2011-300776; Vlooswijk MCG, 2011, NEUROLOGY, V77, P938, DOI 10.1212/WNL.0b013e31822cfc2f; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	42	135	139	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63850	10.1371/journal.pone.0063850	http://dx.doi.org/10.1371/journal.pone.0063850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717498	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700071
J	Du, Y; Liu, H; He, YQ; Liu, YW; Yang, CX; Zhou, MQ; Wang, WJ; Cui, L; Hu, JJ; Gao, F				Du, Yan; Liu, Hua; He, Yiqing; Liu, Yiwen; Yang, Cuixia; Zhou, Muqing; Wang, Wenjuan; Cui, Lian; Hu, Jiajie; Gao, Feng			The Interaction between LYVE-1 with Hyaluronan on the Cell Surface May Play a Role in the Diversity of Adhesion to Cancer Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PERICELLULAR MATRIX; TUMOR-CELLS; EXPRESSION; CD44; LYMPHANGIOGENESIS; MECHANISM; ACID; INVASIVENESS; METASTASIS	Hyaluronan (HA), a simple disaccharide unit, can polymerize and is considered a primary component of the extracellular matrix, which has a wide range of biological functions. In recent years, HA was found on the surface of tumor cells. According to previous reports, differing HA content on the cell surface of tumor cells is closely related to lymph node metastases, but the mechanisms mediating this process remained unclear. This research intended to study the surface content of HA on tumor cells and analyze cell adhesive changes caused by the interaction between HA and its lymphatic endothelial receptor (LYVE-1). We screened and observed high HA content on HS-578T breast cells and low HA content on MCF-7 breast cells through particle exclusion, immunofluorescence and flow cytometry experiments. The expression of LYVE-1, the lymph-vessel specific HA receptor, was consistent with our previous report and enhanced the adhesion of HA(high)-HS-578T cells to COS-7(LYVE-1(+)) through HA in cell static adhesion and dynamic parallel plate flow chamber experiments. MCF-7 breast cells contain little HA on the surface; however, our results showed little adhesion difference between MCF-7 cells and COS-7(LYVE-1(+)) and COS-7(LYVE-1(-)) cells. Similar results were observed concerning the adhesion of HS-578T cells or MCF-7 cells to SVEC4-10 cells. Furthermore, we observed for the first time that the cell surface HA content of high transfer tumor cells was rich, and we visualized the cross-linking of HA cable structures, which may activate LYVE-1 on lymphatic endothelial cells, promoting tumor adhesion. In summary, high-low cell surface HA content of tumor cells through the interaction with LYVE-1 leads to adhesion differences.	[Du, Yan; He, Yiqing; Liu, Yiwen; Yang, Cuixia; Wang, Wenjuan; Cui, Lian; Hu, Jiajie; Gao, Feng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Mol Biol Lab, Shanghai 200030, Peoples R China; [Liu, Hua; Zhou, Muqing; Gao, Feng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Clin Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Mol Biol Lab, Shanghai 200030, Peoples R China.	gao3507@126.com	liu, yi/GXE-9662-2022		shanghai Committee of Science and Technology [10411950500]; National Natural Science Foundation of China [81071814, 81172027, 81272479]; Program of Shanghai Subject Chief Scientist [11XD1404000]	shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist	This research was supported by the shanghai Committee of Science and Technology (No. 10411950500), the National Natural Science Foundation of China (81071814, 81172027, 81272479) and the Program of Shanghai Subject Chief Scientist (11XD1404000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO J, 1995, ANN NY ACAD SCI, V748, P148; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 2009, J BIOL CHEM; Cai B, 2012, J APPL PHYSIOL, V113, P1141, DOI 10.1152/japplphysiol.00479.2012; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Du Y, 2011, CLIN INVEST MED, V34, pE45; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Gal I, 2003, J BIOL CHEM, V278, P11150, DOI 10.1074/jbc.M210661200; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Hou WH, 2012, FEBS LETT, V586, P1480, DOI 10.1016/j.febslet.2012.04.001; Itano N, 1999, CANCER RES, V59, P2499; Jacobs AL, 1997, CANCER RES, V57, P5148; Jojovic M, 2002, CANCER LETT, V188, P181, DOI 10.1016/S0304-3835(02)00037-X; KIMATA K, 1983, CANCER RES, V43, P1347; Lanisnik Rizner T, 2011, CHEM BIOL INTERACT; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Li LZ, 2011, ADV EXP MED BIOL, V701, P137, DOI 10.1007/978-1-4419-7756-4_19; LUSCINSKAS FW, 1994, J CELL BIOL, V125, P1417, DOI 10.1083/jcb.125.6.1417; Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; PINTAR JE, 1978, DEV BIOL, V67, P444, DOI 10.1016/0012-1606(78)90211-7; SCHOR SL, 1989, IN VITRO CELL DEV B, V25, P737; Shpyleva SI, 2011, BREAST CANCER RES TR, V126, P63, DOI 10.1007/s10549-010-0849-4; Simpson MA, 2002, J BIOL CHEM, V277, P10050, DOI 10.1074/jbc.M110069200; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stasinopoulos I, 2007, MOL CANCER RES, V5, P435, DOI 10.1158/1541-7786.MCR-07-0010; TOOLE BP, 1971, DEV BIOL, V26, P28, DOI 10.1016/0012-1606(71)90104-7; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; UNDERHILL CB, 1989, CIBA FDN S, V143, P87; Wang Fang, 2011, Chinese Journal of Pathology, V40, P99, DOI 10.3760/cma.j.jssn.0529-5807.2011.02.007; Williams CSM, 2003, J PATHOL, V200, P195, DOI 10.1002/path.1343; Zeng GF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-113; ZHANG LR, 1995, CANCER RES, V55, P428; Zheng FJ, 2012, ASIAN PAC J CANCER P, V13, P3751, DOI 10.7314/APJCP.2012.13.8.3751; Zia MK, 2007, INT J MOL MED, V20, P605	40	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63463	10.1371/journal.pone.0063463	http://dx.doi.org/10.1371/journal.pone.0063463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717428	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700023
J	Teuber, J; Mueller, B; Fukabori, R; Lang, D; Albrecht, A; Stork, O				Teuber, Jan; Mueller, Bettina; Fukabori, Ryoji; Lang, Daniel; Albrecht, Anne; Stork, Oliver			The Ubiquitin Ligase Praja1 Reduces NRAGE Expression and Inhibits Neuronal Differentiation of PC12 Cells	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; EXONIC SPLICING ENHANCERS; NEURITE OUTGROWTH; INTERACTING PROTEIN; FAMILY PROTEIN; RING-H2 MOTIF; TGF-BETA; GENE; IDENTIFICATION; ACTIVATION	Evidence suggests that regulated ubiquitination of proteins plays a critical role in the development and plasticity of the central nervous system. We have previously identified the ubiquitin ligase Praja1 as a gene product induced during fear memory consolidation. However, the neuronal function of this enzyme still needs to be clarified. Here, we investigate its involvement in the nerve growth factor (NGF)-induced differentiation of rat pheochromocytoma (PC12) cells. Praja1 colocalizes with cytoskeleton components and the neurotrophin receptor interacting MAGE homologue (NRAGE). We observed an enhanced expression of Praja1 after 3 days of NGF treatment and a suppression of neurite formation upon Praja1 overexpression in stably transfected PC12 cell lines, which was associated with a proteasome-dependent reduction of NRAGE levels. Our data suggest that Praja1, through ubiquitination and degradation of NRAGE, inhibits neuronal differentiation. The two murine isoforms, Praja1.1 and Praja1.2, appear to be functionally homologous in this respect.	[Teuber, Jan; Mueller, Bettina; Fukabori, Ryoji; Lang, Daniel; Albrecht, Anne; Stork, Oliver] Univ Magdeburg, Inst Biol, Dept Genet & Mol Neurobiol, D-39106 Magdeburg, Germany; [Stork, Oliver] Ctr Behav Brain Sci, Magdeburg, Germany	Otto von Guericke University	Stork, O (corresponding author), Univ Magdeburg, Inst Biol, Dept Genet & Mol Neurobiol, D-39106 Magdeburg, Germany.	oliver.stork@ovgu.de	Albrecht, Anne/GNP-7475-2022	Albrecht, Anne/0000-0001-8613-2968; Fukabori, Ryoji/0000-0001-7534-8237; Stork, Oliver/0000-0003-4285-7507	federal state of Sachsonia-Anhalt (Center for Behavioral Brain Sciences); German Research Foundation [SFB854 TP10]; Studienstiftung des deutschen Volkes	federal state of Sachsonia-Anhalt (Center for Behavioral Brain Sciences); German Research Foundation(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	This work was supported by grants from the federal state of Sachsonia-Anhalt (Center for Behavioral Brain Sciences) and the German Research Foundation (SFB854 TP10 to OS). JT was supported through a scholarship of the Studienstiftung des deutschen Volkes, and DL was a graduate student of the graduate school GRK1167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; Althini S, 2003, BIOCHEM BIOPH RES CO, V307, P632, DOI 10.1016/S0006-291X(03)01236-1; Barrett GL, 2005, NEUROSCIENCE, V133, P381, DOI 10.1016/j.neuroscience.2005.01.067; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Bui NT, 2002, J NEUROCHEM, V81, P594, DOI 10.1046/j.1471-4159.2002.00841.x; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Feng ZH, 2010, J NEUROSCI RES, V88, P1822, DOI 10.1002/jnr.22340; Giasson BI, 2001, NEURON, V31, P885, DOI 10.1016/S0896-6273(01)00439-1; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Ito H, 2002, J NEUROSCI RES, V69, P653, DOI 10.1002/jnr.10359; Iwasaki S, 1999, J BIOL CHEM, V274, P26503, DOI 10.1074/jbc.274.37.26503; Johnston JA, 2004, PROG NEUROBIOL, V73, P227, DOI 10.1016/j.pneurobio.2004.05.004; Jordan BWM, 2001, J BIOL CHEM, V276, P39985, DOI 10.1074/jbc.C100171200; Kendall SE, 2005, MOL CELL BIOL, V25, P7711, DOI 10.1128/MCB.25.17.7711-7724.2005; Kishino T, 1997, NAT GENET, V15, P411, DOI 10.1038/ng0497-411d; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Laser H, 2003, J NEUROSCI RES, V74, P906, DOI 10.1002/jnr.10806; Loch CM, 2011, CELL BIOCHEM BIOPHYS, V60, P127, DOI 10.1007/s12013-011-9180-x; Lonn P, 2005, NEUROCHEM RES, V30, P753, DOI 10.1007/s11064-005-6868-6; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; Masuda Y, 2001, J BIOL CHEM, V276, P5331, DOI 10.1074/jbc.M008590200; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mishra L, 2005, CANCER BIOL THER, V4, P694, DOI 10.4161/cbt.4.7.2015; Mishra L, 1997, ONCOGENE, V15, P2361, DOI 10.1038/sj.onc.1201405; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NAKAYAMA M, 1995, J NEUROSCI, V15, P5238; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Obin M, 1999, J BIOL CHEM, V274, P11789, DOI 10.1074/jbc.274.17.11789; Reddy EM, 2010, EXP CELL RES, V316, P2220, DOI 10.1016/j.yexcr.2010.05.030; Saha T, 2006, ONCOGENE, V25, P693, DOI 10.1038/sj.onc.1209123; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stork O, 2004, J BIOL CHEM, V279, P45773, DOI 10.1074/jbc.M403552200; Stork O, 2001, LEARN MEMORY, V8, P209, DOI 10.1101/lm.39401; Tcherpakov M, 2002, J BIOL CHEM, V277, P49101, DOI 10.1074/jbc.C200533200; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; Wieland I, 2007, CLIN GENET, V72, P506, DOI 10.1111/j.1399-0004.2007.00905.x; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Williams ME, 2003, J BIOL CHEM, V278, P17483, DOI 10.1074/jbc.M300415200; Xue B, 2005, BIOCHEM BIOPH RES CO, V336, P247, DOI 10.1016/j.bbrc.2005.08.069; Zoabi M, 2011, BIOCHEM BIOPH RES CO, V408, P393, DOI 10.1016/j.bbrc.2011.04.025	48	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63067	10.1371/journal.pone.0063067	http://dx.doi.org/10.1371/journal.pone.0063067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717400	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700009
J	Chapa, J; Bourgo, RJ; Greene, GL; Kulkarni, S; An, G				Chapa, Joaquin; Bourgo, Ryan J.; Greene, Geoffrey L.; Kulkarni, Swati; An, Gary			Examining the Pathogenesis of Breast Cancer Using a Novel Agent-Based Model of Mammary Ductal Epithelium Dynamics	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; STEROID-HORMONE LEVELS; ATHYMIC NUDE-MICE; IN-SITU DCIS; E-CADHERIN; GLAND DEVELOPMENT; PROGESTERONE-RECEPTOR; CELL-PROLIFERATION; KNOWLEDGE REPRESENTATION; TUMOR-SUPPRESSOR	The study of the pathogenesis of breast cancer is challenged by the long time-course of the disease process and the multifactorial nature of generating oncogenic insults. The characterization of the longitudinal pathogenesis of malignant transformation from baseline normal breast duct epithelial dynamics may provide vital insight into the cascading systems failure that leads to breast cancer. To this end, extensive information on the baseline behavior of normal mammary epithelium and breast cancer oncogenesis was integrated into a computational model termed the Ductal Epithelium Agent-Based Model (DEABM). The DEABM is composed of computational agents that behave according to rules established from published cellular and molecular mechanisms concerning breast duct epithelial dynamics and oncogenesis. The DEABM implements DNA damage and repair, cell division, genetic inheritance and simulates the local tissue environment with hormone excretion and receptor signaling. Unrepaired DNA damage impacts the integrity of the genome within individual cells, including a set of eight representative oncogenes and tumor suppressors previously implicated in breast cancer, with subsequent consequences on successive generations of cells. The DEABM reproduced cellular population dynamics seen during the menstrual cycle and pregnancy, and demonstrated the oncogenic effect of known genetic factors associated with breast cancer, namely TP53 and Myc, in simulations spanning similar to 40 years of simulated time. Simulations comparing normal to BRCA1-mutant breast tissue demonstrated rates of invasive cancer development similar to published epidemiologic data with respect to both cumulative incidence over time and estrogen-receptor status. Investigation of the modeling of ER alpha-positive (ER+) tumorigenesis led to a novel hypothesis implicating the transcription factor and tumor suppressor RUNX3. These data suggest that the DEABM can serve as a potentially valuable framework to augment the traditional investigatory workflow for future hypothesis generation and testing of the mechanisms of breast cancer oncogenesis.	[Chapa, Joaquin] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Bourgo, Ryan J.; Greene, Geoffrey L.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Kulkarni, Swati; An, Gary] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Kulkarni, S (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	skulkarni@surgery.bsd.uchicago.edu; docgca@aol.com		An, Gary/0000-0003-4549-9004				Akhtar N, 2009, DEVELOPMENT, V136, P1019, DOI 10.1242/dev.028423; Altekruse SF, 2010, SEER CANC STAT REV 1; An G, 2001, SHOCK, V16, P266, DOI 10.1097/00024382-200116040-00006; An G., 2009, AGENT BASED MODELS T; An G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000390; An G, 2009, MATH BIOSCI, V217, P43, DOI 10.1016/j.mbs.2008.10.001; An G, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-11; An GC, 2009, MATH BIOSCI, V217, P53, DOI 10.1016/j.mbs.2008.08.013; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Angeloni SV, 2004, J ENDOCRINOL, V180, P497, DOI 10.1677/joe.0.1800497; Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Balci O, 1998, HANDBOOK OF SIMULATION, P335; Balci O., 2001, ACM T MODEL COMPUT S, V11, P352, DOI DOI 10.1145/508366.508369; Bankes SC, 2002, P NATL ACAD SCI USA, V99, P7199, DOI 10.1073/pnas.072081299; Bankhead A, 2007, J THEOR BIOL, V246, P491, DOI 10.1016/j.jtbi.2007.01.011; BERG J, 1995, CANCER S, V75, P139; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; CALEFFI M, 1994, CANCER, V73, P2147, DOI 10.1002/1097-0142(19940415)73:8<2147::AID-CNCR2820730820>3.0.CO;2-5; CATTORETTI G, 1988, INT J CANCER, V41, P178, DOI 10.1002/ijc.2910410204; Chen LF, 2012, J CELL BIOCHEM, V113, P1470, DOI 10.1002/jcb.24074; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; CHIMGE NO, 2012, ONCOGENE; Clarke RB, 1997, CANCER RES, V57, P4987; Clarke RB, 1997, BREAST CANCER RES TR, V45, P121, DOI 10.1023/A:1005805831460; Colleoni M, 2012, ANN ONCOL, V23, P1428, DOI 10.1093/annonc/mdr461; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; EASTON DF, 1995, AM J HUM GENET, V56, P265; Engelberg JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002030; Engelberg JA, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-110; Feuerhake F, 2000, CELL TISSUE RES, V299, P47, DOI 10.1007/s004410050005; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; Foulkes WD, 2004, CLIN CANCER RES, V10, P2029, DOI 10.1158/1078-0432.CCR-03-1061; GAUTSCHI JR, 1971, J CELL BIOL, V51, P653, DOI 10.1083/jcb.51.3.653; Geyer FC, 2009, INT J SURG PATHOL, V17, P285, DOI 10.1177/1066896908328577; GOING JJ, 1988, AM J PATHOL, V130, P193; Gorski JJ, 2009, CLIN CANCER RES, V15, P1514, DOI 10.1158/1078-0432.CCR-08-0640; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Hankinson SE, 1998, JNCI-J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; Haslam SZ, 2008, ENDOCRINOLOGY, V149, P2098, DOI 10.1210/en.2007-1398; Hinck L, 2005, BREAST CANCER RES, V7, P245, DOI 10.1186/bcr1331; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Huang B, 2012, ONCOGENE, V31, P527, DOI 10.1038/onc.2011.252; Hynes NE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2406; Kaiser MI, 2011, HIST PHIL LIFE SCI, V33, P453; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; KENNEDY RC, 2006, VERIFICATION VALIDAT; Khan SA, 2002, INT J CANCER, V102, P334, DOI 10.1002/ijc.10737; Kim C, 2010, NAT REV CLIN ONCOL, V7, P340, DOI 10.1038/nrclinonc.2010.61; Kim M, 2012, SURG INFECT, V13, P18, DOI 10.1089/sur.2011.057; Kim SHJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-122; Kohrmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-188; LAIDLAW IJ, 1995, ENDOCRINOLOGY, V136, P164, DOI 10.1210/en.136.1.164; LARSSON O, 1993, CELL BIOL INT, V17, P565, DOI 10.1006/cbir.1993.1100; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee E, 2011, J CLIN ONCOL, V29, P4373, DOI 10.1200/JCO.2010.33.6446; LESTER SC, 2005, ROBBINS COTRAN PATHO, P1065; Liu YL, 2002, BREAST CANCER RES, V4, P9, DOI 10.1186/bcr417; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Macklin P, 2012, J THEOR BIOL, V301, P122, DOI 10.1016/j.jtbi.2012.02.002; Masciari S, 2012, BREAST CANCER RES TR, V133, P1125, DOI 10.1007/s10549-012-1993-9; McCave EJ, 2010, J MAMMARY GLAND BIOL, V15, P291, DOI 10.1007/s10911-010-9190-0; MEYER JS, 1982, CANCER, V50, P746, DOI 10.1002/1097-0142(19820815)50:4<746::AID-CNCR2820500420>3.0.CO;2-A; Nakopoulou L, 2000, HISTOPATHOLOGY, V36, P313; Nass SJ, 2000, CANCER RES, V60, P4346; Navarrete MAH, 2005, BREAST CANCER RES, V7, pR306, DOI 10.1186/bcr994; Norton KA, 2010, J THEOR BIOL, V263, P393, DOI 10.1016/j.jtbi.2009.11.024; OLEARY P, 1991, CLIN CHEM, V37, P667; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Palmieri C, 2004, J MOL ENDOCRINOL, V33, P35, DOI 10.1677/jme.0.0330035; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Rucker EB, 2011, GENESIS, V49, P24, DOI 10.1002/dvg.20691; Seal JB, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-33; Sharma P, 2006, BREAST CANCER RES TR, V100, P71, DOI 10.1007/s10549-006-9234-8; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Shoker BS, 1999, AM J PATHOL, V155, P1811, DOI 10.1016/S0002-9440(10)65498-3; SODERQVIST G, 1993, AM J OBSTET GYNECOL, V168, P874; Soldin OP, 2005, FERTIL STERIL, V84, P701, DOI 10.1016/j.fertnstert.2005.02.045; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stern JR, 2012, WOUND REPAIR REGEN, V20, P862, DOI 10.1111/j.1524-475X.2012.00852.x; STERN JR, 2013, J SURG RES; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Stoelzle T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-63; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Subramaniam MM, 2009, BREAST CANCER RES TR, V113, P113, DOI 10.1007/s10549-008-9917-4; Taylor D, 2009, BREAST CANCER RES TR, V118, P161, DOI 10.1007/s10549-009-0322-4; Tung N, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2478; Umekita Y, 2007, IN VIVO, V21, P535; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Wilensky U., 2009, INTRO AGENT BASED MO; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Young P, 2002, MOL CELL NEUROSCI, V21, P341, DOI 10.1006/mcne.2002.1177	108	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64091	10.1371/journal.pone.0064091	http://dx.doi.org/10.1371/journal.pone.0064091			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704974	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200113
J	Kawahara, E; Maenaka, S; Shimada, E; Nishimura, Y; Sakurai, H				Kawahara, Ei; Maenaka, Shiori; Shimada, Eri; Nishimura, Yoshihiro; Sakurai, Hiroshi			Dynamic Regulation of Extracellular Signal-Regulated Kinase (ERK) by Protein Phosphatase 2A Regulatory Subunit B56 gamma 1 in Nuclei Induces Cell Migration	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; MAP KINASE; CARCINOMA-CELL; TYROSINE PHOSPHORYLATION; SUSTAINED ACTIVATION; TRUNCATED ISOFORM; B56 SUBUNIT; GENE IEX-1; CYCLIN D1; B-BETA	Extracellular signal-regulated kinase (ERK) signalling plays a central role in various biological processes, including cell migration, but it remains unknown what factors directly regulate the strength and duration of ERK activation. We found that, among the B56 family of protein phosphatase 2A (PP2A) regulatory subunits, B56 gamma 1 suppressed EGF-induced cell migration on collagen, bound to phosphorylated-ERK, and dephosphorylated ERK, whereas B56 alpha 1 and B56 beta 1 did not. B56 gamma 1 was immunolocalized in nuclei. The IER3 protein was immediately highly expressed in response to costimulation of cells with EGF and collagen. Knockdown of IER3 inhibited cell migration and enhanced dephosphorylation of ERK. Analysis of the time course of PP2A-B56 gamma 1 activity following the costimulation showed an immediate loss of phosphatase activity, followed by a rapid increase in activity, and this activity then remained at a stable level that was lower than the original level. Our results indicate that the strength and duration of the nuclear ERK activation signal that is initially induced by ERK kinase (MEK) are determined at least in part by modulation of the phosphatase activity of PP2A-B56 gamma 1 through two independent pathways.	[Kawahara, Ei; Maenaka, Shiori; Shimada, Eri; Nishimura, Yoshihiro; Sakurai, Hiroshi] Kanazawa Univ, Dept Clin Lab Sci, Kanazawa, Ishikawa, Japan	Kanazawa University	Kawahara, E (corresponding author), Kanazawa Univ, Dept Clin Lab Sci, Kanazawa, Ishikawa, Japan.	kawahara@staff.kanazawa-u.ac.jp	Kawahara, Ei/C-3233-2015; SAKURAI, Hiroshi/L-3693-2015; Kawahara, Ei/AAD-5189-2020	Kawahara, Ei/0000-0002-8571-5448; Sakurai, Hiroshi/0000-0002-0336-2301	Kanazawa University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055748, P50HD055751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092696] Funding Source: NIH RePORTER	Kanazawa University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this project was provided by Kanazawa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Bae D, 2009, BIOCHEM BIOPH RES CO, V385, P523, DOI 10.1016/j.bbrc.2009.05.082; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Chajry N, 1996, EUR J BIOCHEM, V235, P97, DOI 10.1111/j.1432-1033.1996.00097.x; CHARLES CH, 1993, ONCOGENE, V8, P797; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Dozier C, 2004, BIOL CELL, V96, P509, DOI 10.1016/j.biolcel.2004.04.010; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Garcia J, 2002, EMBO J, V21, P5151, DOI 10.1093/emboj/cdf488; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Gronda M, 2001, MOL CELL BIOL, V21, P6851, DOI 10.1128/MCB.21.20.6851-6858.2001; Hashigasako A, 2004, J BIOL CHEM, V279, P26445, DOI 10.1074/jbc.M314254200; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Isoda M, 2011, DEV CELL, V21, P506, DOI 10.1016/j.devcel.2011.06.029; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Ito A, 2003, AM J PATHOL, V162, P479, DOI 10.1016/S0002-9440(10)63842-4; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Joslin EJ, 2007, J CELL SCI, V120, P3688, DOI 10.1242/jcs.010488; KAHAN C, 1992, J BIOL CHEM, V267, P13369; Kawahara E, 2005, CELL BIOL INT, V29, P521, DOI 10.1016/j.cellbi.2005.02.006; Kawahara E, 2002, EXP CELL RES, V272, P84, DOI 10.1006/excr.2001.5399; KAWAHARA E, 1993, JPN J CANCER RES, V84, P409, DOI 10.1111/j.1349-7006.1993.tb00151.x; Kawahara E, 1999, CELL BIOL INT, V23, P163, DOI 10.1006/cbir.1998.0331; Koma YI, 2004, HISTOL HISTOPATHOL, V19, P391, DOI 10.14670/HH-19.391; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Ma J, 2007, ONCOGENE, V26, P5145, DOI 10.1038/sj.onc.1210323; MAIER GD, 1995, INT J CANCER, V61, P54, DOI 10.1002/ijc.2910610110; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; MORINO N, 1995, J BIOL CHEM, V270, P269, DOI 10.1074/jbc.270.1.269; Mukhopadhyay NK, 2004, ANN THORAC SURG, V78, P450, DOI 10.1016/j.athoracsur.2004.01.042; Muneer S, 2002, GENOMICS, V79, P344, DOI 10.1006/geno.2002.6721; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nakada N, 2005, CELL PHYSIOL BIOCHEM, V15, P19, DOI 10.1159/000083635; Noordman Yvet E, 2006, J Mol Signal, V1, P4, DOI 10.1186/1750-2187-1-4; Ortega-Lazaro JC, 2003, CYTOGENET GENOME RES, V103, P345, DOI 10.1159/000076823; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Pitman MR, 2011, INT J BIOCHEM CELL B, V43, P342, DOI 10.1016/j.biocel.2010.11.001; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Sacks DB, 2006, BIOCHEM SOC T, V34, P833, DOI 10.1042/BST0340833; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tian YC, 2007, EXP CELL RES, V313, P2367, DOI 10.1016/j.yexcr.2007.03.022; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; Van Kanegan MJ, 2009, MOL CELL BIOL, V29, P662, DOI 10.1128/MCB.01242-08; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; YEBRA M, 1995, MOL BIOL CELL, V6, P841, DOI 10.1091/mbc.6.7.841; YOUNG MRI, 1993, INT J CANCER, V54, P1036, DOI 10.1002/ijc.2910540629; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	74	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63729	10.1371/journal.pone.0063729	http://dx.doi.org/10.1371/journal.pone.0063729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704935	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200066
J	Wang, HY; Wen, CF; Chiu, YH; Lee, IN; Kao, HY; Lee, IC; Ho, WH				Wang, Hue-Yu; Wen, Ching-Feng; Chiu, Yu-Hsien; Lee, I-Nong; Kao, Hao-Yun; Lee, I-Chen; Ho, Wen-Hsien			Leuconostoc Mesenteroides Growth in Food Products: Prediction and Sensitivity Analysis by Adaptive-Network-Based Fuzzy Inference Systems	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; ESCHERICHIA-COLI O157-H7; MODELING TECHNIQUE; BACTERIAL-GROWTH; WATER ACTIVITY; TEMPERATURE; PERFORMANCE; PARAMETERS; ANFIS	Background: An adaptive-network-based fuzzy inference system (ANFIS) was compared with an artificial neural network (ANN) in terms of accuracy in predicting the combined effects of temperature (10.5 to 24.5 degrees C), pH level (5.5 to 7.5), sodium chloride level (0.25% to 6.25%) and sodium nitrite level (0 to 200 ppm) on the growth rate of Leuconostoc mesenteroides under aerobic and anaerobic conditions. Methods: The ANFIS and ANN models were compared in terms of six statistical indices calculated by comparing their prediction results with actual data: mean absolute percentage error (MAPE), root mean square error (RMSE), standard error of prediction percentage (SEP), bias factor (B-f), accuracy factor (A(f)), and absolute fraction of variance (R-2). Graphical plots were also used for model comparison. Conclusions: The learning-based systems obtained encouraging prediction results. Sensitivity analyses of the four environmental factors showed that temperature and, to a lesser extent, NaCl had the most influence on accuracy in predicting the growth rate of Leuconostoc mesenteroides under aerobic and anaerobic conditions. The observed effectiveness of ANFIS for modeling microbial kinetic parameters confirms its potential use as a supplemental tool in predictive mycology. Comparisons between growth rates predicted by ANFIS and actual experimental data also confirmed the high accuracy of the Gaussian membership function in ANFIS. Comparisons of the six statistical indices under both aerobic and anaerobic conditions also showed that the ANFIS model was better than all ANN models in predicting the four kinetic parameters. Therefore, the ANFIS model is a valuable tool for quickly predicting the growth rate of Leuconostoc mesenteroides under aerobic and anaerobic conditions.	[Wang, Hue-Yu] Chi Mei Med Ctr, Dept Pharm, Tainan, Taiwan; [Wen, Ching-Feng] Kaohsiung Med Univ, Ctr Fundamental Sci, Kaohsiung, Taiwan; [Chiu, Yu-Hsien; Lee, I-Nong; Kao, Hao-Yun; Lee, I-Chen; Ho, Wen-Hsien] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan	Chi Mei Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Ho, WH (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.	whho@kmu.edu.tw	Wen, Ching-Feng/AAD-6334-2020; Kao, Hao-Yun/AAZ-5597-2021; Hao-Yun, Kao/AGD-6394-2022	Wen, Ching-Feng/0000-0001-8900-761X; Kao, Hao-Yun/0000-0002-9390-9314; 	Chi-Mei Medical Center [101CM-KMU-09]; Kaohsiung University Research Foundation; National Science Council, Taiwan, Republic of China [NSC 101-2320-B-037-022]	Chi-Mei Medical Center; Kaohsiung University Research Foundation; National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grant 101CM-KMU-09 from the Chi-Mei Medical Center and Kaohsiung University Research Foundation and by grant NSC 101-2320-B-037-022 from the National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins Ralitsa B, 2005, BMC Med Res Methodol, V5, P37, DOI 10.1186/1471-2288-5-37; AlaKorpela M, 1995, NMR BIOMED, V8, P235, DOI 10.1002/nbm.1940080603; BUCHANAN RL, 1994, INT J FOOD MICROBIOL, V23, P317, DOI 10.1016/0168-1605(94)90160-0; Dantigny P, 2005, INT J FOOD MICROBIOL, V100, P187, DOI 10.1016/j.ijfoodmicro.2004.10.013; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ertunc HM, 2008, INT J REFRIG, V31, P1426, DOI 10.1016/j.ijrefrig.2008.03.007; Garcia-Gimeno RM, 2005, INT J FOOD MICROBIOL, V105, P317, DOI 10.1016/j.ijfoodmicro.2005.04.013; Garcia-Gimeno RM, 2003, J FOOD SCI, V68, P639, DOI 10.1111/j.1365-2621.2003.tb05723.x; Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5; Gibson AM, 1997, TRENDS FOOD SCI TECH, V8, P353, DOI 10.1016/S0924-2244(97)01065-0; Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5; Ho WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029179; Ho WH, 2011, EXPERT SYST APPL, V38, P13050, DOI 10.1016/j.eswa.2011.04.109; Ho WH, 2011, EXPERT SYST APPL, V38, P6319, DOI 10.1016/j.eswa.2010.11.110; Ho WH, 2010, NONLINEAR DYNAM, V61, P29, DOI 10.1007/s11071-009-9629-2; Ho WH, 2010, IEEE T AUTOM SCI ENG, V7, P143, DOI 10.1109/TASE.2009.2023673; intVeld JHJH, 1996, INT J FOOD MICROBIOL, V33, P1, DOI 10.1016/0168-1605(96)01139-7; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9; Lo SP, 2003, J MATER PROCESS TECH, V142, P665, DOI 10.1016/S0924-0136(03)00687-3; Lou W, 2001, J AGR FOOD CHEM, V49, P1799, DOI 10.1021/jf000650m; Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6; MATLAB Documentation, 2002, FUZZ TOOLB US GUID M; Murphy PA, 2006, J FOOD SCI, V71, pR51, DOI 10.1111/j.1750-3841.2006.00052.x; Panagou EZ, 2009, EXPERT SYST APPL, V36, P121, DOI 10.1016/j.eswa.2007.09.022; Parra R, 2004, J APPL MICROBIOL, V97, P429, DOI 10.1111/j.1365-2672.2004.02320.x; Patriarca A, 2001, INT J FOOD MICROBIOL, V68, P61, DOI 10.1016/S0168-1605(01)00470-6; Piscaglia F, 2006, EUR J GASTROEN HEPAT, V18, P1255, DOI 10.1097/01.meg.0000243885.55562.7e; Ratkowsky D.A, 1990, HDB NONLINEAR REGRES; Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x; ROSS T, 1994, INT J FOOD MICROBIOL, V23, P241, DOI 10.1016/0168-1605(94)90155-4; Shi HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035781; Tsai JT, 2006, IEEE T NEURAL NETWOR, V17, P69, DOI 10.1109/TNN.2005.860885; Zurera-Cosano G, 2006, FOOD CONTROL, V17, P429, DOI 10.1016/j.foodcont.2005.02.003	34	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64995	10.1371/journal.pone.0064995	http://dx.doi.org/10.1371/journal.pone.0064995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705023	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200177
J	Zhang, DH; Cui, Y; Shen, HT; Xing, LX; Cui, JF; Wang, J; Zhang, XH				Zhang, Donghui; Cui, Yu; Shen, Haitao; Xing, Lingxiao; Cui, Jinfeng; Wang, Juan; Zhang, Xianghong			Sterigmatocystin-Induced DNA Damage Triggers G(2) Arrest via an ATM/p53-Related Pathway in Human Gastric Epithelium GES-1 Cells In Vitro	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; CYCLE ARREST; ATM ACTIVATION; APOPTOSIS; P53; CHECKPOINT; INDUCTION; DEOXYNIVALENOL; PROGRESSION; ZEARALENONE	Sterigmatocystin (ST), which is commonly detected in food and feed commodities, is a mutagenic and carcinogenic mycotoxin that has been recognized as a possible human carcinogen. Our previous study showed that ST can induce G(2) phase arrest in GES-1 cells in vitro and that the MAPK and PI3K signaling pathways are involved in the ST-induced G(2) arrest. It is now widely accepted that DNA damage plays a critical role in the regulation of cell cycle arrest and apoptosis. In response to DNA damage, a complex signaling network is activated in eukaryotic cells to trigger cell cycle arrest and facilitate DNA repair. To further explore the molecular mechanism through which ST induces G(2) arrest, the current study was designed to precisely dissect the role of DNA damage and the DNA damage sensor ataxia telangiectasia-mutated (ATM)/p53-dependent pathway in the ST-induced G(2) arrest in GES-1 cells. Using the comet assay, we determined that ST induces DNA damage, as evidenced by the formation of DNA comet tails, in GES-1 cells. We also found that ST induces the activation of ATM and its downstream molecules, Chk2 and p53, in GES-1 cells. The ATM pharmacological inhibitor caffeine was found to effectively inhibit the activation of the ATM-dependent pathways and to rescue the ST-induced G(2) arrest in GES-1 cells, which indicating its ATM-dependent characteristic. Moreover, the silencing of the p53 expression with siRNA effectively attenuated the ST-induced G(2) arrest in GES-1 cells. We also found that ST induces apoptosis in GES-1 cells. Thus, our results show that the ST-induced DNA damage activates the ATM/53-dependent signaling pathway, which contributes to the induction of G(2) arrest in GES-1 cells.	[Zhang, Donghui; Cui, Yu; Shen, Haitao; Xing, Lingxiao; Wang, Juan; Zhang, Xianghong] Hebei Med Univ, Pathol Lab, Shijiazhuang, Peoples R China; [Zhang, Donghui; Cui, Jinfeng; Zhang, Xianghong] Hebei Med Univ, Hosp 2, Dept Pathol, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei Medical University	Zhang, XH (corresponding author), Hebei Med Univ, Pathol Lab, Shijiazhuang, Peoples R China.	zhangxianghong2008@163.com	cui, yu/CAF-5802-2022	cui, yu/0000-0003-4577-5080	Special funds of National Natural Science Foundation of China [81041072]; General Program of National Natural Science Foundation of China [81171889]; Natural Science Foundation of Hebei Province of China [C2010000479, C2009001108]	Special funds of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province)	This work was supported by Special funds of National Natural Science Foundation of China (Grant No. 81041072), General Program of National Natural Science Foundation of China (Grant No. 81171889) and Natural Science Foundation of Hebei Province of China (Grant No. C2010000479 and C2009001108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid-Essefi S, 2003, TOXICOLOGY, V192, P237, DOI 10.1016/S0300-483X(03)00329-9; Ahuja YR, 1999, PROTOC J CYTOL GENET, V34, P57; Ayed-Boussema I, 2008, TOXICOL IN VITRO, V22, P1671, DOI 10.1016/j.tiv.2008.06.016; Aylon Y, 2011, MOL ONCOL, V5, P315, DOI 10.1016/j.molonc.2011.07.007; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Chen CY, 2008, FOOD CHEM TOXICOL, V46, P2476, DOI 10.1016/j.fct.2008.04.016; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Cui JF, 2010, TOXICOL LETT, V193, P152, DOI 10.1016/j.toxlet.2009.12.019; CURRY PT, 1984, MUTAT RES, V137, P111, DOI 10.1016/0165-1218(84)90099-5; Davis AJ, 2010, CELL CYCLE, V9, P2529, DOI 10.4161/cc.9.13.12148; Dujka ME, 2010, ONCOGENE, V29, P957, DOI 10.1038/onc.2009.394; FUJII K, 1976, CANCER RES, V36, P1615; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; GOPALAKRISHNAN S, 1992, BIOCHEMISTRY-US, V31, P10790, DOI 10.1021/bi00159a021; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Huang Xiang-hua, 2004, Zhonghua Zhongliu Zazhi, V26, P705; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Karagiannis TC, 2004, CELL MOL LIFE SCI, V61, P2137, DOI 10.1007/s00018-004-4174-0; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kosakowska-Cholody T, 2005, MOL CANCER THER, V4, P1617, DOI 10.1158/1535-7163.MCT-05-0170; Kusunoki Masahiro, 2011, Environmental Health and Preventive Medicine, V16, P224, DOI 10.1007/s12199-010-0190-x; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lavin MF, 2005, MUTAT RES-FUND MOL M, V569, P123, DOI 10.1016/j.mrfmmm.2004.04.020; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Leonce S, 2006, CANCER RES, V66, P7203, DOI 10.1158/0008-5472.CAN-05-3946; Ma F, 2003, SCAND J GASTROENTERO, V38, P360, DOI 10.1080/0036552031001699; Madan E, 2011, ONCOTARGET, V2, P948; Minervini F, 2004, TOXICOL IN VITRO, V18, P21, DOI 10.1016/S0887-2333(03)00130-9; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Nam C, 2010, HISTOL HISTOPATHOL, V25, P485, DOI 10.14670/HH-25.485; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Orren DK, 1997, MOL BIOL CELL, V8, P1129, DOI 10.1091/mbc.8.6.1129; PURCHASE IF, 1973, TOXICOL APPL PHARM, V26, P274, DOI 10.1016/0041-008X(73)90262-7; RABIE CJ, 1977, APPL ENVIRON MICROB, V33, P1023, DOI 10.1128/AEM.33.5.1023-1025.1977; Ravindran J, 2011, APOPTOSIS, V16, P145, DOI 10.1007/s10495-010-0554-0; Reijula K, 2003, FRONT BIOSCI-LANDMRK, V8, pS232, DOI 10.2741/978; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Robertson JD, 2000, CRIT REV TOXICOL, V30, P609, DOI 10.1080/10408440008951122; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Skladanowski A, 2002, APOPTOSIS, V7, P347, DOI 10.1023/A:1016127513947; SPEIT G, 2004, METH MOL B, V291, P85; Stewart ZA, 2001, CHEM RES TOXICOL, V14, P243, DOI 10.1021/tx000199t; Sttina R, 1986, FOLIA BIOL PRAHA, V32, P406; Versilovskis A, 2010, MOL NUTR FOOD RES, V54, P136, DOI 10.1002/mnfr.200900345; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Weinert T, 1997, SCIENCE, V277, P1450, DOI 10.1126/science.277.5331.1450; Xie TX, 2000, INT J ONCOL, V17, P737; Xing X, 2011, MOL NUTR FOOD RES, V55, P749, DOI 10.1002/mnfr.201000344; Yang H, 2008, TOXICOLOGY, V243, P145, DOI 10.1016/j.tox.2007.10.002; Zhu H, 2009, NEOPLASIA, V11, P1226, DOI 10.1593/neo.09986	57	14	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65044	10.1371/journal.pone.0065044	http://dx.doi.org/10.1371/journal.pone.0065044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705030	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200184
J	Funk, JL; Glenwinkel, LA; Sack, L				Funk, Jennifer L.; Glenwinkel, Lori A.; Sack, Lawren			Differential Allocation to Photosynthetic and Non-Photosynthetic Nitrogen Fractions among Native and Invasive Species	PLOS ONE			English	Article							RELATIVE GROWTH-RATE; USE EFFICIENCY; AMINO-ACIDS; CELL-WALLS; CAPILLARY-ELECTROPHORESIS; PHOSPHORUS FRACTIONS; C-3 PLANTS; LEAF-LEVEL; LEAVES; ACCLIMATION	Invasive species are expected to cluster on the "high-return'' end of the leaf economic spectrum, displaying leaf traits consistent with higher carbon assimilation relative to native species. Intra-leaf nitrogen (N) allocation should support these physiological differences; however, N biochemistry has not been examined in more than a few invasive species. We measured 34 leaf traits including seven leaf N pools for five native and five invasive species from Hawaii under low irradiance to mimic the forest understory environment. We found several trait differences between native and invasive species. In particular, invasive species showed preferential N allocation to metabolism (amino acids) rather than photosynthetic light reactions (membrane-bound protein) by comparison with native species. The soluble protein concentration did not vary between groups. Under these low irradiance conditions, native species had higher light-saturated photosynthetic rates, possibly as a consequence of a greater investment in membrane-bound protein. Invasive species may succeed by employing a wide range of N allocation mechanisms, including higher amino acid production for fast growth under high irradiance or storage of N in leaves as soluble protein or amino acids.	[Funk, Jennifer L.] Chapman Univ, Sch Earth & Environm Sci, Orange, CA 92866 USA; [Glenwinkel, Lori A.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Sack, Lawren] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Chapman University System; Chapman University; Columbia University; University of California System; University of California Los Angeles	Funk, JL (corresponding author), Chapman Univ, Sch Earth & Environm Sci, Orange, CA 92866 USA.	jlfunk@chapman.edu	Funk, Jennifer/AAX-9325-2021; Funk, Jennifer/B-6328-2009; Funk, Jennifer/AAL-6185-2021; Sack, Lawren/A-5492-2008	Funk, Jennifer/0000-0002-1916-5513; Sack, Lawren/0000-0002-7009-7202	USDA Biology of Weedy and Invasive Species In Agroecosystems Program [2008-35320-18721]	USDA Biology of Weedy and Invasive Species In Agroecosystems Program	This research was supported by a grant from the USDA Biology of Weedy and Invasive Species In Agroecosystems Program (2008-35320-18721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIX H, 1981, CAN J FOREST RES, V11, P775, DOI 10.1139/x81-111; Bronk DA, 2000, MAR CHEM, V69, P163, DOI 10.1016/S0304-4203(99)00103-6; Cavaleri MA, 2010, ECOLOGY, V91, P2705, DOI 10.1890/09-0582.1; CHAPIN FS, 1986, J ECOL, V74, P167; CHAPIN FS, 1983, ECOLOGY, V64, P376, DOI 10.2307/1937083; Coleman MD, 1998, PHYSIOL PLANTARUM, V103, P513, DOI 10.1034/j.1399-3054.1998.1030410.x; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Evans JR, 1996, PHOTOSYNTHESIS ENV, P281; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Field C. H., 1986, EC FORM FUNCTION, P25; Frak E, 2001, PLANT CELL ENVIRON, V24, P1279, DOI 10.1046/j.0016-8025.2001.00784.x; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Funk JL, 2007, TREE PHYSIOL, V27, P1731, DOI 10.1093/treephys/27.12.1731; Grotkopp E, 2010, J APPL ECOL, V47, P1320, DOI 10.1111/j.1365-2664.2010.01878.x; Harrison MT, 2009, PLANT CELL ENVIRON, V32, P259, DOI 10.1111/j.1365-3040.2008.01918.x; HIKOSAKA K, 1995, PLANT CELL ENVIRON, V18, P605, DOI 10.1111/j.1365-3040.1995.tb00562.x; Hikosaka K, 2009, OECOLOGIA, V160, P443, DOI 10.1007/s00442-009-1315-z; Husted S, 2000, PHYSIOL PLANTARUM, V109, P167, DOI 10.1034/j.1399-3054.2000.100209.x; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Leishman MR, 2010, J ECOL, V98, P28, DOI 10.1111/j.1365-2745.2009.01608.x; Leleu O, 2004, J EXP BOT, V55, P815, DOI 10.1093/jxb/erh088; Lichtenthaler H K, 2001, CURRENT PROTOCOLS FO, P18; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; LOOMIS WD, 1966, PHYTOCHEMISTRY, V5, P423, DOI 10.1016/S0031-9422(00)82157-3; Mao QZ, 2012, PHOTOSYNTHETICA, V50, P422, DOI 10.1007/s11099-012-0049-z; MCGRATH R, 1972, ANAL BIOCHEM, V49, P95, DOI 10.1016/0003-2697(72)90245-X; Menge DNL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012056; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; NASHOLM T, 1994, NEW PHYTOL, V126, P137, DOI 10.1111/j.1469-8137.1994.tb07539.x; Niinemets U, 2003, PLANT CELL ENVIRON, V26, P941, DOI 10.1046/j.1365-3040.2003.01027.x; Noctor G, 2007, METABOLOMICS, V3, P161, DOI 10.1007/s11306-007-0057-3; Onoda Y, 2004, FUNCT ECOL, V18, P419, DOI 10.1111/j.0269-8463.2004.00847.x; Ordonez A, 2010, FUNCT ECOL, V24, P1353, DOI 10.1111/j.1365-2435.2010.01739.x; Penuelas J, 2010, GLOBAL CHANGE BIOL, V16, P2171, DOI 10.1111/j.1365-2486.2009.02054.x; Pons TL, 2004, PHYSIOL PLANTARUM, V122, P68, DOI 10.1111/j.1399-3054.2004.00380.x; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Purcell LC, 1996, AGRON J, V88, P111, DOI 10.2134/agronj1996.00021962008800010023x; Reich PB, 2007, ECOL APPL, V17, P1982, DOI 10.1890/06-1803.1; Reiter WD, 1998, TRENDS PLANT SCI, V3, P27; Shipley B, 2002, FUNCT ECOL, V16, P682, DOI 10.1046/j.1365-2435.2002.00672.x; Sun SW, 2006, J FOOD COMPOS ANAL, V19, P112, DOI 10.1016/j.jfca.2005.04.006; Takashima T, 2004, PLANT CELL ENVIRON, V27, P1047, DOI 10.1111/j.1365-3040.2004.01209.x; TERASHIMA I, 1988, PLANT CELL PHYSIOL, V29, P143; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; VITOUSEK PM, 1993, BIOGEOCHEMISTRY, V23, P197, DOI 10.1007/BF00023752; Wagner WL, 1999, MANUAL FLOWERING PLA, V1; WALTERS MB, 1989, TREE PHYSIOL, V5, P159, DOI 10.1093/treephys/5.2.159; Warren CR, 2000, PHYSIOL PLANTARUM, V110, P52, DOI 10.1034/j.1399-3054.2000.110107.x; Warren CR, 2004, TRENDS PLANT SCI, V9, P270, DOI 10.1016/j.tplants.2004.04.004; Warren CR, 2000, AUST J PLANT PHYSIOL, V27, P407, DOI 10.1071/PP98162; Warren CR, 2000, J EXP BOT, V51, P1147, DOI 10.1093/jexbot/51.347.1147; Warren CR, 2001, PLANT CELL ENVIRON, V24, P597, DOI 10.1046/j.1365-3040.2001.00711.x; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Wendler R, 1996, TREE PHYSIOL, V16, P153; Wright IJ, 2000, FUNCT ECOL, V14, P97, DOI 10.1046/j.1365-2435.2000.00393.x; WULLSCHLEGER SD, 1993, J EXP BOT, V44, P907, DOI 10.1093/jxb/44.5.907	61	54	61	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64502	10.1371/journal.pone.0064502	http://dx.doi.org/10.1371/journal.pone.0064502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700483	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400059
J	Muhlenbruch, K; Jeppesen, C; Joost, HG; Boeing, H; Schulze, MB				Muehlenbruch, Kristin; Jeppesen, Charlotte; Joost, Hans-Georg; Boeing, Heiner; Schulze, Matthias B.			The Value of Genetic Information for Diabetes Risk Prediction - Differences According to Sex, Age, Family History and Obesity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TYPE-2; RECLASSIFICATION; SCORE; IMPROVEMENT; ADULTHOOD; VARIANTS; DIETARY; LOCI; AREA	Background: Genome-wide association studies have identified numerous single nucleotide polymorphisms associated with type 2 diabetes through the past years. In previous studies, the usefulness of these genetic markers for prediction of diabetes was found to be limited. However, differences may exist between substrata of the population according to the presence of major diabetes risk factors. This study aimed to investigate the added predictive value of genetic information (42 single nucleotide polymorphisms) in subgroups of sex, age, family history of diabetes, and obesity. Methods: A case-cohort study (random subcohort N = 1,968; incident cases: N = 578) within the European Prospective Investigation into Cancer and Nutrition Potsdam study was used. Prediction models without and with genetic information were evaluated in terms of the area under the receiver operating characteristic curve and the integrated discrimination improvement. Stratified analyses included subgroups of sex, age (<50 or >= 50 years), family history (positive if either father or mother or a sibling has/had diabetes), and obesity (BMI< or >= 30 kg/m(2)). Results: A genetic risk score did not improve prediction above classic and metabolic markers, but - compared to a non-invasive prediction model - genetic information slightly improved the area under the receiver operating characteristic curve (difference [95%-CI]: 0.007 [0.002-0.011]). Stratified analyses showed stronger improvement in the older age group (0.010 [0.002-0.018]), the group with a positive family history (0.012 [0.000-0.023]) and among obese participants (0.015 [-0.005-0.034]) compared to the younger participants (0.005 [-0.004-0.014]), participants with a negative family history (0.003 [-0.001-0.008]) and non-obese (0.007 [0.000-0.014]), respectively. No difference was found between men and women. Conclusion: There was no incremental value of genetic information compared to standard non-invasive and metabolic markers. Our study suggests that inclusion of genetic variants in diabetes risk prediction might be useful for subgroups with already manifest risk factors such as older age, a positive family history and obesity.	[Muehlenbruch, Kristin; Jeppesen, Charlotte; Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Joost, Hans-Georg] German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Nuthetal, Germany; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Muehlenbruch, Kristin; Jeppesen, Charlotte; Joost, Hans-Georg; Schulze, Matthias B.] German Ctr Diabet Res, Neuherberg, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Schulze, MB (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany.	mschulze@dife.de	Joost, Hans-Georg/J-4462-2013; Schulze, Matthias B/AAH-6906-2021	Joost, Hans-Georg/0000-0002-5860-606X; Schulze, Matthias B/0000-0002-0830-5277; Muhlenbruch, Kristin/0000-0001-6188-2017	German Federal Ministry of Education and Research (BMBF); Federal Ministry of Science, Germany [01 EA 9401]; European Union [SOC 95201408 05F02]; German Cancer Aid [70-2488-Ha I]; European Community [SOC 98200769 05F02]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Science, Germany; European Union(European Commission); German Cancer Aid(Deutsche Krebshilfe); European Community(European Commission)	This work was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (01 EA 9401) and the European Union (SOC 95201408 05F02). The follow-up of the EPIC-Potsdam Study was supported by German Cancer Aid (70-2488-Ha I) and the European Community (SOC 98200769 05F02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; de Miguel-Yanes JM, 2011, DIABETES CARE, V34, P121, DOI 10.2337/dc10-1265; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Franks PW, 2012, DIABETOLOGIA, V55, P2555, DOI 10.1007/s00125-012-2683-1; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Kroke A, 1999, AM J CLIN NUTR, V70, P439; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Mihaescu R, 2010, AM J EPIDEMIOL, V172, P353, DOI 10.1093/aje/kwq122; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Muhlenbruch K, 2013, EUR J EPIDEMIOL, V28, P25, DOI 10.1007/s10654-012-9744-0; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Schulze MB, 2009, DIABETES CARE, V32, P2116, DOI 10.2337/dc09-0197; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; THOMAS SB, 1997, INT J EPIDEMIOL S1, pS59; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Vassy JL, 2012, DIABETOLOGIA, V55, P2604, DOI 10.1007/s00125-012-2637-7; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Willems SM, 2011, CURR DIABETES REP, V11, P511, DOI 10.1007/s11892-011-0235-6; 1997, INT J EPIDEMIOL S1, V26, pS71	29	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64307	10.1371/journal.pone.0064307	http://dx.doi.org/10.1371/journal.pone.0064307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700469	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400052
J	Sun, XQ; Zhang, MX; Yu, JY; Jin, Y; Ling, B; Du, JP; Li, GH; Qin, QM; Cai, QN				Sun, Xiao-Qin; Zhang, Mao-Xin; Yu, Jing-Ya; Jin, Yu; Ling, Bing; Du, Jin-Ping; Li, Gui-Hua; Qin, Qing-Ming; Cai, Qing-Nian			Glutathione S-Transferase of Brown Planthoppers (Nilaparvata lugens) Is Essential for Their Adaptation to Gramine-Containing Host Plants	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; INDOLE ALKALOIDS; RNA INTERFERENCE; DETOXIFICATION ENZYMES; SECONDARY METABOLITES; PHYTOPHAGOUS INSECTS; ACYRTHOSIPHON-PISUM; MOLECULAR-CLONING; PEA APHID; GENE	Plants have evolved complex processes to ward off attacks by insects. In parallel, insects have evolved mechanisms to thwart these plant defenses. To gain insight into mechanisms that mediate this arms race between plants and herbivorous insects, we investigated the interactions between gramine, a toxin synthesized by plants of the family Gramineae, and glutathione S transferase (GST), an enzyme found in insects that is known to detoxify xenobiotics. Here, we demonstrate that rice (Oryza sativa), a hydrophytic plant, also produces gramine and that rice resistance to brown planthoppers (Nilaparvata lugens, BPHs) is highly associated with in planta gramine content. We also show that gramine is a toxicant that causes BPH mortality in vivo and that knockdown of BPH GST gene nlgst1-1 results in increased sensitivity to diets containing gramine. These results suggest that the knockdown of key detoxification genes in sap-sucking insects may provide an avenue for increasing their sensitivity to natural plant-associated defense mechanisms.	[Sun, Xiao-Qin; Yu, Jing-Ya; Jin, Yu; Cai, Qing-Nian] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Zhang, Mao-Xin; Ling, Bing] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Du, Jin-Ping] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Li, Gui-Hua; Qin, Qing-Ming] Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China; [Qin, Qing-Ming] Jilin Univ, Key Lab Zoonosis Res, Minist Educ, Inst Zoonosis, Changchun 130023, Peoples R China	China Agricultural University; South China Agricultural University; Huazhong Agricultural University; Jilin University; Jilin University	Qin, QM (corresponding author), Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China.	qmqin@jlu.edu.cn; caiqn@cau.edu.cn	gh, Li/AES-0505-2022; Cai, Qing-Nian/A-1015-2016	Jin, Yu/0000-0003-2557-8565	China Agricultural University [KYCX2011010]; Agricultural Division, Jilin University [4305050102QW, 4305050102QX]	China Agricultural University; Agricultural Division, Jilin University	This work was supported by Innovation Fund for Graduate Student (grant no. KYCX2011010) from China Agricultural University and partly supported by the start-up funding (4305050102QW and 4305050102QX) from Agricultural Division, Jilin University to QMQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi K, 2003, PHYSIOL ENTOMOL, V28, P232, DOI 10.1046/j.1365-3032.2003.00329.x; Bao YY, 2012, GENOMICS, V99, P256, DOI 10.1016/j.ygeno.2012.02.002; Bass C, 2012, INSECT SCI, V19, P1, DOI 10.1111/j.1744-7917.2011.01440.x; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; BECK SD, 1965, ANNU REV ENTOMOL, V10, P207, DOI 10.1146/annurev.en.10.010165.001231; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bullangpoti V, 2006, Commun Agric Appl Biol Sci, V71, P475; Cai QN, 2009, J CHEM ECOL, V35, P320, DOI 10.1007/s10886-009-9603-y; Cai QN, 2004, J APPL ENTOMOL, V128, P517, DOI 10.1111/j.1439-0418.2004.00770.x; Castaneda LE, 2010, J EVOLUTION BIOL, V23, P2474, DOI 10.1111/j.1420-9101.2010.02112.x; CLARK AG, 1984, PESTIC BIOCHEM PHYS, V22, P249, DOI 10.1016/0048-3575(84)90018-X; CORCUERA LJ, 1993, PHYTOCHEMISTRY, V33, P741, DOI 10.1016/0031-9422(93)85267-U; CORCUERA LJ, 1984, PHYTOCHEMISTRY, V23, P539, DOI 10.1016/S0031-9422(00)80376-3; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Figueroa CC, 1999, J CHEM ECOL, V25, P2465, DOI 10.1023/A:1020870023736; FRANCIOSA H, 1995, INSECT BIOCHEM MOLEC, V25, P311, DOI 10.1016/0965-1748(94)00053-K; Francis F, 2005, ARCH INSECT BIOCHEM, V58, P166, DOI 10.1002/arch.20049; Ghaffar MBAB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022137; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Heinrichs E., 1985, GENETIC EVALUATION I; HEMINGWAY J, 1991, PESTIC BIOCHEM PHYS, V39, P49, DOI 10.1016/0048-3575(91)90213-6; Horgan F., 2009, PLANTHOPPERS NEW THR, P281; HOULT AHC, 1993, J CHEM ECOL, V19, P2245, DOI 10.1007/BF00979661; Ishikawa Y, 2000, APPL ENTOMOL ZOOL, V35, P251, DOI 10.1303/aez.2000.251; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Jena KK, 2010, RICE, V3, P161, DOI 10.1007/s12284-010-9050-y; KANEHISA K, 1990, APPL ENTOMOL ZOOL, V25, P251, DOI 10.1303/aez.25.251; Kim CS, 2008, Z NATURFORSCH C, V63, P755; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; KOYAMA K, 1980, JPN J APPL ENTOMOL Z, V24, P117, DOI 10.1303/jjaez.24.117; LEE KW, 1991, INSECT BIOCHEM, V21, P353, DOI 10.1016/0020-1790(91)90001-U; LESZCZYNSKI B, 1989, ENTOMOL EXP APPL, V52, P135, DOI 10.1007/BF00163247; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Liu SH, 2008, J INSECT PHYSIOL, V54, P1495, DOI 10.1016/j.jinsphys.2008.08.010; Liu ZW, 2006, PEST MANAG SCI, V62, P279, DOI 10.1002/ps.1169; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mewis I, 2005, PLANT PHYSIOL, V138, P1149, DOI 10.1104/pp.104.053389; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Nagadhara D, 2003, PLANT BIOTECHNOL J, V1, P231, DOI 10.1046/j.1467-7652.2003.00022.x; Nathan SS, 2007, CHEMOSPHERE, V67, P80, DOI 10.1016/j.chemosphere.2006.09.045; NODA H, 1991, J GEN VIROL, V72, P2425, DOI 10.1099/0022-1317-72-10-2425; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; POWELL KS, 1993, ENTOMOL EXP APPL, V66, P119, DOI 10.1007/BF02382280; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Small GJ, 2000, INSECT MOL BIOL, V9, P647, DOI 10.1046/j.1365-2583.2000.00229.x; Su C.C., 2002, CHIN J GENET, V29, P332; Sudakin Daniel L., 2003, Toxicological Reviews, V22, P83, DOI 10.2165/00139709-200322020-00003; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; VANDERHEIJDEN R, 1987, J CHROMATOGR, V396, P287, DOI 10.1016/S0021-9673(01)94066-X; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Vontas JG, 2002, BIOCHEM J, V362, P329, DOI 10.1042/bj3620329; Wang T, 1999, ANAL BIOCHEM, V269, P198, DOI 10.1006/abio.1999.4022; Wang Y, 2006, EUR J ENTOMOL, V103, P255, DOI 10.14411/eje.2006.030; Xu XF, 2002, THEOR APPL GENET, V104, P248, DOI 10.1007/s00122-001-0777-0; Yang ZF, 2006, B ENTOMOL RES, V96, P53, DOI 10.1079/BER2005400; Yang ZF, 2005, ARCH INSECT BIOCHEM, V59, P59, DOI 10.1002/arch.20055; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; YU SJ, 1993, ARCH INSECT BIOCHEM, V24, P21, DOI 10.1002/arch.940240103; Yuan JS, 2008, PLANT J, V55, P491, DOI 10.1111/j.1365-313X.2008.03524.x; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhao Ying, 2004, Yingyong Shengtai Xuebao, V15, P2161; Zhou Yi-hong, 2003, Nanjing Nongye Daxue Xuebao, V26, P24; Zhu-Salzman Keyan, 2005, Insect Science, V12, P3, DOI 10.1111/j.1672-9609.2005.00002.x; ZUNIGA GE, 1986, ENTOMOL EXP APPL, V40, P259, DOI 10.1007/BF00293708	70	31	33	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64026	10.1371/journal.pone.0064026	http://dx.doi.org/10.1371/journal.pone.0064026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700450	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400042
J	Amorim, CEG; Bisso-Machado, R; Ramallo, V; Bortolini, MC; Bonatto, SL; Salzano, FM; Hunemeier, T				Guerra Amorim, Carlos Eduardo; Bisso-Machado, Rafael; Ramallo, Virginia; Bortolini, Maria Catira; Bonatto, Sandro Luis; Salzano, Francisco Mauro; Huenemeier, Tabita			A Bayesian Approach to Genome/Linguistic Relationships in Native South Americans	PLOS ONE			English	Article							POPULATION-GENETICS; COEVOLUTION; LANGUAGES; MODELS; DIVERSITY; EVOLUTION; PATTERNS; GENOMICS; PROGRAMS; HISTORY	The relationship between the evolution of genes and languages has been studied for over three decades. These studies rely on the assumption that languages, as many other cultural traits, evolve in a gene-like manner, accumulating heritable diversity through time and being subjected to evolutionary mechanisms of change. In the present work we used genetic data to evaluate South American linguistic classifications. We compared discordant models of language classifications to the current Native American genome-wide variation using realistic demographic models analyzed under an Approximate Bayesian Computation (ABC) framework. Data on 381 STRs spread along the autosomes were gathered from the literature for populations representing the five main South Amerindian linguistic groups: Andean, Arawakan, Chibchan-Paezan, Macro-Je, and Tupi. The results indicated a higher posterior probability for the classification proposed by J.H. Greenberg in 1987, although L. Campbell's 1997 classification cannot be ruled out. Based on Greenberg's classification, it was possible to date the time of Tupi-Arawakan divergence (2.8 kya), and the time of emergence of the structure between present day major language groups in South America (3.1 kya).	[Guerra Amorim, Carlos Eduardo; Bisso-Machado, Rafael; Ramallo, Virginia; Bortolini, Maria Catira; Salzano, Francisco Mauro; Huenemeier, Tabita] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Bonatto, Sandro Luis] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Salzano, FM (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	francisco.salzano@ufrgs.br	Hünemeier, Tábita/F-4181-2011; Bisso-Machado, Rafael/F-4184-2011; Bonatto, Sandro L/A-1240-2010; Salzano, Francisco M/L-7916-2015	Bisso-Machado, Rafael/0000-0003-1384-8054; Bonatto, Sandro L/0000-0002-0064-467X; Hunemeier, Tabita/0000-0002-3156-2079	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS, PRONEX), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS, PRONEX), Brazil	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS, PRONEX), Brazil. These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELAAR WFH, 1989, LINGUA, V78, P249; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Beaumont MA, 2002, GENETICS, V162, P2025; Bolnick DA, 2004, AM J HUM GENET, V75, P519; Brown CH, 2010, P NATL ACAD SCI USA, V107, pE34, DOI 10.1073/pnas.0914859107; Callegari-Jacques SM, 2011, AM J PHYS ANTHROPOL, V145, P371, DOI 10.1002/ajpa.21505; Campbell Lyle, 1997, AM INDIAN LANGUAGES; CAVALLISFORZA LL, 1992, P NATL ACAD SCI USA, V89, P5620, DOI 10.1073/pnas.89.12.5620; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Durr M, 1995, STUDIES HONOR HEINZ, P102; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2002, AM J PHYS ANTHROPOL, V117, P68, DOI 10.1002/ajpa.10015; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; Greenberg J.H., 2007, AMERIND ETYMOLOGICAL; Greenberg JosephH., 1987, LANGUAGES AM; Hornborg A, 2005, CURR ANTHROPOL, V46, P589, DOI 10.1086/431530; Hunley K, 2005, P NATL ACAD SCI USA, V102, P1312, DOI 10.1073/pnas.0409301102; Hunley KL, 2007, AM J PHYS ANTHROPOL, V132, P622, DOI 10.1002/ajpa.20542; Hunley K, 2012, P ROY SOC B-BIOL SCI, V279, P2281, DOI 10.1098/rspb.2011.2296; Janda R.D., 2008, HDB HIST LINGUISTICS, P262; Jay F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016227; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Long JC, 2003, HUM BIOL, V75, P449, DOI 10.1353/hub.2003.0058; Loukotka ., 1968, CLASSIFICATION S AM; MATISOFF JA, 1990, LANGUAGE, V66, P106, DOI 10.2307/415281; Neuenschwander S, 2008, MOL ECOL, V17, P757, DOI 10.1111/j.1365-294X.2007.03621.x; Noelli FS, 1998, ANTIQUITY, V72, P648, DOI 10.1017/S0003598X00087068; OROURKE DH, 1986, ANN HUM BIOL, V13, P13, DOI 10.1080/03014468600008171; Perreault C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045150; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; R_Development_Core_Team, 2011, R LANG ENV STAT COMP; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Reali F, 2010, P ROY SOC B-BIOL SCI, V277, P429, DOI 10.1098/rspb.2009.1513; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Richerson PJ, 2010, P NATL ACAD SCI USA, V107, P8985, DOI 10.1073/pnas.0914631107; Rodrigues, 1986, LINGUAS BRASILEIRAS; Salzano FM, 2005, CURR ANTHROPOL, V46, pS121, DOI 10.1086/497667; Sharma G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032546; Trask RL, 1999, NOSTRATIC EXAMINING, P157; Urban G., 1998, HIST INDIOS BRASIL, P87; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wegmann D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-116; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120; [No title captured]	49	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64099	10.1371/journal.pone.0064099	http://dx.doi.org/10.1371/journal.pone.0064099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	146HW	23696865	Green Submitted, Green Published, gold			2022-12-27	WOS:000319081900069
J	Hu, D; Hu, GH; Zhu, J; Shen, Y; Kang, HY; Hong, SL				Hu, Di; Hu, Guohua; Zhu, Jing; Shen, Yang; Kang, Houyong; Hong, Suling			Association between Polymorphisms of the IL-23R Gene and Allergic Rhinitis in a Chinese Han Population	PLOS ONE			English	Article							INTERLEUKIN-23 RECEPTOR GENE; GENOME-WIDE ASSOCIATION; T-CELLS; ASTHMA; DISEASE; IL23R; SUSCEPTIBILITY; PATHOGENESIS; METAANALYSIS; PSORIASIS	Objective: Polymorphism of the interleukin-23 receptor gene corresponds with susceptibility to several immune-related diseases. For the terminal differentiation of IL-17-producing effector T-helper cells in vivo, the interleukin-23 receptor gene is of vital importance. As shown recently, Th17 cells probably have a great influence on the pathogenesis of allergic airway diseases. Our intention was to establish an association between polymorphisms in the IL-23R gene and allergic rhinitis (AR) in the Chinese Han population. Methods: We included 358 AR patients and 407 control Chinese subjects in a case-control comparison. The study involved obtaining blood samples for DNA extraction genotyping and determination of 4 selected single-nucleotide polymorphisms in IL-23R by performing PCR restriction fragment length polymorphism analysis (PCR-RFLP). Results: A substantially growing prevalence of the homozygous rs7517847 GG genotype and G allele appeared in the AR patients unlike that observed in the control individuals (P<0.001). In addition, substantially high frequencies of the GGCA and GGCG haplotypes were observed in the AR patients, unlike that observed in the control individuals (P<0.05). The results suggest that the AGTG haplotype may provide protection against AR (P<0.001). Conclusions: To the best of our knowledge, this is the first study to demonstrate an important association between polymorphisms in IL-23R and AR in the Chinese Han population. A strong association between rs7517847 in a SNP of IL-23R, and AR was identified.	[Hu, Di; Hu, Guohua; Zhu, Jing; Shen, Yang; Kang, Houyong; Hong, Suling] Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing, Peoples R China	Chongqing Medical University	Hong, SL (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing, Peoples R China.	icehudi@sina.com			Nature Science Foundation of China [81271061]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Nature Science Foundation of China (81271061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andiappan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019719; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2009, ALLERGY, V64, P969, DOI 10.1111/j.1398-9995.2009.02059.x; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Ciprandi G, 2009, ALLERGY, V64, P1375, DOI 10.1111/j.1398-9995.2009.02010.x; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Gaddam SL, 2012, GENET TEST MOL BIOMA, V16, P632, DOI 10.1089/gtmb.2011.0255; Genuneit J, 2009, CLIN EXP ALLERGY, V39, P1875, DOI 10.1111/j.1365-2222.2009.03364.x; GLAS J, 2010, PLOS ONE, V5; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Hi G, 2012, AM J RHINOL ALLERGY; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; Juyal G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016565; Karaderi T, 2009, RHEUMATOLOGY, V48, P386, DOI 10.1093/rheumatology/ken501; McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Michel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013894; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Safrany E, 2009, CURR MED CHEM, V16, P3766, DOI 10.2174/092986709789104975; Shen J, 2011, J HUAZHONG U SCI-MED, V31, P433, DOI 10.1007/s11596-011-0469-1; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang M, 2012, HUM IMMUNOL, V73, P647, DOI 10.1016/j.humimm.2012.03.010; Zhang XY, 2006, IMMUNOGENETICS, V57, P934, DOI 10.1007/s00251-005-0067-0; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021769; Zhu KJ, 2012, INFLAMM RES, V61, P1149, DOI 10.1007/s00011-012-0509-8	29	21	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63858	10.1371/journal.pone.0063858	http://dx.doi.org/10.1371/journal.pone.0063858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696856	gold, Green Submitted, Green Published			2022-12-27	WOS:000319081900060
J	Ng, YP; Chen, YW; Hu, YQ; Ip, FCF; Ip, NY				Ng, Yu Pong; Chen, Yuewen; Hu, Yueqing; Ip, Fanny C. F.; Ip, Nancy Y.			Olean-12-Eno[2,3-c] [1,2,5]Oxadiazol-28-Oic Acid (OEOA) Induces G(1) Cell Cycle Arrest and Differentiation in Human Leukemia Cell Lines	PLOS ONE			English	Article							MATRIX-ASSOCIATED PROTEIN; SUPPRESSES TUMOR-GROWTH; ERYTHROID-DIFFERENTIATION; OLEANOLIC ACID; REGULATED NUCLEAR; BCR-ABL; URSOLIC ACID; DERIVATIVES; MECHANISMS; RESISTANCE	Oleanolic acid (3 beta-hydroxy-olea-12-en-28-oic acid) is a natural pentacyclic triterpenoic acid found in many fruits, herbs and medicinal plants. In the past decade, increasing evidence has suggested that oleanolic acid exhibits inhibitory activities against different types of cancer including skin cancer and colon cancer, but not leukemia. We report here that a derivative of oleanolic acid, olean-12-eno[2,3-c] [1,2,5]oxadiazol-28-oic acid (designated OEOA) effectively blocks the proliferation of human leukemia cells. OEOA significantly reduces cell proliferation without inducing cell death in three types of leukemia cell lines, including K562, HEL and Jurket. Moreover, exposure of K562 cells to OEOA results in G(1) cell cycle arrest, with a concomitant induction of cyclin-dependent kinase inhibitor p27 and downregulation of cyclins and Cdks that are essential for cell cycle progression. Interestingly, OEOA also enhances erythroid differentiation in K562 cells through suppressing the expression of Bcr-Abl and phosphorylation of Erk1/2. These findings identify a novel chemical entity for further development as therapeutics against leukemia.	[Ng, Yu Pong; Chen, Yuewen; Hu, Yueqing; Ip, Fanny C. F.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Ng, Yu Pong; Hu, Yueqing; Ip, Fanny C. F.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China; [Chen, Yuewen; Ip, Fanny C. F.; Ip, Nancy Y.] Ji Nan Univ, JNU HKUST Joint Lab, Guangzhou, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Jinan University	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	boip@ust.hk		Ip, Nancy Yuk-Yu/0000-0002-2763-8907	National Basic Research Program of China (973 Program); Shenzhen Peacock Plan; Hong Kong Research Grants Council Theme-based Research Scheme [T13-607/12R]; Innovation and Technology Fund [State Key Laboratory] [(ITCPT/17-9)]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shenzhen Peacock Plan; Hong Kong Research Grants Council Theme-based Research Scheme(Hong Kong Research Grants Council); Innovation and Technology Fund [State Key Laboratory]	This study is supported in part by the National Basic Research Program of China (973 Program), Shenzhen Peacock Plan, Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), and Innovation and Technology Fund [State Key Laboratory (ITCPT/17-9)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Baraniskin A, 2012, CARCINOGENESIS, V33, P732, DOI 10.1093/carcin/bgs020; Bishayee A, 2011, FRONT BIOSCI-LANDMRK, V16, P980, DOI 10.2741/3730; Bixby D, 2011, LEUKEMIA, V25, P7, DOI 10.1038/leu.2010.238; Brognara E, 2011, EUR J PHARMACOL, V672, P30, DOI 10.1016/j.ejphar.2011.09.024; Brozik A, 2006, ANN NY ACAD SCI, V1090, P344, DOI 10.1196/annals.1378.038; Bueno-da-Silva AEB, 2003, CELL DEATH DIFFER, V10, P592, DOI 10.1038/sj.cdd.4401210; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Cao T, 2005, MED HYPOTHESES, V65, P1202, DOI 10.1016/j.mehy.2005.06.011; Chen J, 2006, BIOORG MED CHEM LETT, V16, P2915, DOI 10.1016/j.bmcl.2006.03.009; Cheung WMW, 2001, J BIOL CHEM, V276, P17083, DOI 10.1074/jbc.M010802200; Crazzolara R, 2009, CURR CANCER DRUG TAR, V9, P19, DOI 10.2174/156800909787314057; CRISSMAN HA, 1982, CYTOMETRY, V3, P84, DOI 10.1002/cyto.990030204; Decker T, 2002, LEUKEMIA, V16, P327, DOI 10.1038/sj.leu.2402389; Fukuchi Y, 2006, ONCOL REP, V16, P1099; Furtado RA, 2008, TOXICOL PATHOL, V36, P576, DOI 10.1177/0192623308317423; Guilhot F, 2012, CURR OPIN HEMATOL, V19, P102, DOI 10.1097/MOH.0b013e32834ff610; Hsi ED, 2012, SEMIN ONCOL, V39, P74, DOI 10.1053/j.seminoncol.2011.11.007; Jabbour E, 2011, HEMATOL ONCOL CLIN N, V25, P981, DOI 10.1016/j.hoc.2011.09.004; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; Koschmieder S, 2007, BLOOD, V110, P3695, DOI 10.1182/blood-2006-11-058941; Kowalski R, 2007, J AGR FOOD CHEM, V55, P656, DOI 10.1021/jf0625858; Lampronti I, 2003, EUR J HAEMATOL, V71, P189, DOI 10.1034/j.1600-0609.2003.00113.x; Landi M, 2009, EUR J MED CHEM, V44, P745, DOI 10.1016/j.ejmech.2008.05.001; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Lee J, 2009, EXP MOL MED, V41, P765, DOI 10.3858/emm.2009.41.11.102; Li J, 2009, BRIT J CANCER, V101, P691, DOI 10.1038/sj.bjc.6605202; Li N, 2012, J CHROMATOGR SCI, V50, P885, DOI 10.1093/chromsci/bms086; Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024; Lu XM, 2007, J PHARM PHARMACOL, V59, P1087, DOI 10.1211/jpp.59.8.0005; Moosavi MA, 2007, INT J BIOCHEM CELL B, V39, P1685, DOI 10.1016/j.biocel.2007.04.016; Nagano K, 2006, ONCOGENE, V25, P493, DOI 10.1038/sj.onc.1208996; Naka K, 2010, CANCER SCI, V101, P1577, DOI 10.1111/j.1349-7006.2010.01584.x; National Cancer Institute, 2012, LEUKEMIA; Olsson I, 1996, EUR J HAEMATOL, V57, P1; Ovesna Z, 2004, NEOPLASMA, V51, P327; Pan HW, 2006, CELL CYCLE, V5, P2676, DOI 10.4161/cc.5.22.3500; Paternot S, 2010, CELL CYCLE, V9, P689, DOI 10.4161/cc.9.4.10611; Perrotti D, 2010, J CLIN INVEST, V120, P2254, DOI 10.1172/JCI41246; Pleyer L, 2009, NAT REV CLIN ONCOL, V6, P405, DOI 10.1038/nrclinonc.2009.72; Rangatia J, 2006, LEUKEMIA, V20, P68, DOI 10.1038/sj.leu.2403999; Ribera JM, 2011, CURR OPIN ONCOL, V23, P692, DOI 10.1097/CCO.0b013e32834bb854; Saunthararajah Y, 2012, SEMIN ONCOL, V39, P97, DOI 10.1053/j.seminoncol.2011.11.011; Sell S, 2005, STEM CELL REV, V1, P197, DOI 10.1385/SCR:1:3:197; Shaffer BC, 2012, DRUG RESIST UPDATE, V15, P62, DOI 10.1016/j.drup.2012.02.001; Sogno I, 2009, RECENT RESULTS CANC, V181, P209; Sultana N, 2008, J ENZYM INHIB MED CH, V23, P739, DOI [10.1080/14756360701633187, 10.1080/14756360701633187 ]; Suryadinata R, 2010, BIOSCIENCE REP, V30, P243, DOI 10.1042/BSR20090171; Tsao T, 2010, CANCER RES, V70, P4949, DOI 10.1158/0008-5472.CAN-09-1962; Ueki T, 2008, ONCOGENE, V27, P5672, DOI 10.1038/onc.2008.186	50	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63580	10.1371/journal.pone.0063580	http://dx.doi.org/10.1371/journal.pone.0063580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696836	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900044
J	Frings, V; van der Veldt, AAM; Boellaard, R; Herder, GJM; Giovannetti, E; Honeywell, R; Peters, GJ; Thunnissen, E; Hoekstra, OS; Smit, EF				Frings, Virginie; van der Veldt, Astrid A. M.; Boellaard, Ronald; Herder, Gerarda J. M.; Giovannetti, Elisa; Honeywell, Richard; Peters, Godefridus J.; Thunnissen, Erik; Hoekstra, Otto S.; Smit, Egbert F.			Pemetrexed Induced Thymidylate Synthase Inhibition in Non-Small Cell Lung Cancer Patients: A Pilot Study with 3 '-Deoxy-3 '-[F-18]fluorothymidine Positron Emission Tomography	PLOS ONE			English	Article							MULTITARGETED ANTIFOLATE; PHASE-II; 5-FLUOROURACIL; CHEMOTHERAPY; TUMORS; PET; PROLIFERATION; POLYMORPHISMS; PHARMACOLOGY; VALIDATION	Objectives: Pemetrexed is a thymidylate synthase (TS) inhibitor and is effective in non-small cell lung cancer (NSCLC). 3'-deoxy-3'-[F-18] fluorothymidine (F-18-FLT), a proliferation marker, could potentially identify tumor specific TS-inhibition. The aim of this study was to investigate the effect of pemetrexed-induced TS-inhibition on F-18-FLT uptake 4 hours after pemetrexed administration in metastatic NSCLC patients. Methods: Fourteen NSCLC patients underwent dynamic F-18-FLT positron emission tomography (PET) scans at baseline and 4 hours after the first dose of pemetrexed. Volumes of interest were defined with a 41%, 50% and 70% threshold of the maximum pixel. Kinetic analysis and simplified measures were performed. At one, two, four and six hours after pemetrexed, plasma deoxyuridine was measured as systemic indicator of TS-inhibition. Tumor response measured with response evaluation criteria in solid tumors (RECIST), time to progression (TTP) and overall survival (OS) were determined. Results: Eleven patients had evaluable F-18-FLT PET scans at baseline and 4 hours after pemetrexed. Two patients had increased F-18-FLT uptake of 35% and 31% after pemetrexed, whereas two other patients had decreased uptake of 31%. In the remaining seven patients F-18-FLT uptake did not change beyond test-retest borders. In all patients deoxyuridine levels raised after administration of pemetrexed, implicating pemetrexed-induced TS-inhibition. F-18-FLT uptake in bone marrow was significantly increased 4 hours after pemetrexed administration. Six weeks after the start of treatment 5 patients had partial response, 4 stable disease and 2 progressive disease. Median TTP was 4.2 months (range 3.0-7.4 months); median OS was 13.0 months (range 5.1-30.8 months). Changes in F-18-FLT uptake were not predictive for tumor response, TTP or OS. Conclusions: Measuring TS-inhibition in a clinical setting 4 hours after pemetrexed revealed a non-systematic change in F-18-FLT uptake within the tumor. No significant association with tumor response, TTP or OS was observed.	[Frings, Virginie; van der Veldt, Astrid A. M.; Boellaard, Ronald; Hoekstra, Otto S.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Herder, Gerarda J. M.] St Antonius Hosp, Dept Pulm Dis, Nieuwegein, Netherlands; [Giovannetti, Elisa; Honeywell, Richard; Peters, Godefridus J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Thunnissen, Erik] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Smit, Egbert F.] Vrije Univ Amsterdam, Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; St. Antonius Hospital Utrecht; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Frings, V (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands.	v.frings@vumc.nl	giovannetti, elisa/F-4261-2011; Peters, Godefridus J/C-7562-2013	giovannetti, elisa/0000-0002-7565-7504; Smit, Egbert/0000-0002-7329-6995; Thunnissen, Erik/0000-0001-5355-8508; Hoekstra, Otto S/0000-0003-0767-2734; Boellaard, Ronald/0000-0002-0313-5686; Peters, Godefridus J/0000-0002-5447-2877	Quantitative Imaging in Cancer: Connecting Cellular Processes with Therapy project (QuIC-ConCePT project) from the Innovative Medicines Initiative (IMI)	Quantitative Imaging in Cancer: Connecting Cellular Processes with Therapy project (QuIC-ConCePT project) from the Innovative Medicines Initiative (IMI)	The authors acknowledge the Quantitative Imaging in Cancer: Connecting Cellular Processes with Therapy project (QuIC-ConCePT project) from the Innovative Medicines Initiative (IMI) for partly funding the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bijnsdorp IV, 2011, INVEST NEW DRUG, V29, P248, DOI 10.1007/s10637-009-9353-2; Brix G, 1997, J NUCL MED, V38, P1614; Clarke SJ, 2002, ANN ONCOL, V13, P737, DOI 10.1093/annonc/mdf115; Contractor KB, 2011, CLIN CANCER RES, V17, P7664, DOI 10.1158/1078-0432.CCR-11-0783; de Langen AJ, 2009, EUR J NUCL MED MOL I, V36, P389, DOI 10.1007/s00259-008-0960-5; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ford HER, 2002, CLIN CANCER RES, V8, P103; Frings V, 2010, J NUCL MED, V51, P1870, DOI 10.2967/jnumed.110.077255; Galvani E, 2011, EXPERT OPIN INV DRUG, V20, P1343, DOI 10.1517/13543784.2011.617742; Giovannetti E, 2008, LEUKEMIA RES, V32, P19, DOI 10.1016/j.leukres.2007.02.011; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Hammad H, 2012, ONCOL REP, V27, P246, DOI 10.3892/or.2011.1469; Honeywell R, 2007, J CHROMATOGR B, V847, P142, DOI 10.1016/j.jchromb.2006.09.045; Janku F, 2011, J THORAC ONCOL, V6, P1601, DOI 10.1097/JTO.0b013e31822944b3; Joerger M, 2010, CURR DRUG TARGETS, V11, P37, DOI 10.2174/138945010790030974; Kenny LM, 2009, CLIN CANCER RES, V15, P6649, DOI 10.1158/1078-0432.CCR-09-1213; Muzi M, 2005, J NUCL MED, V46, P274; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Perumal M, 2006, CANCER RES, V66, P8558, DOI 10.1158/0008-5472.CAN-06-0898; Peters GJ, 2009, PTERIDINES, V20, P115; Peters GJ, 2002, BBA-MOL BASIS DIS, V1587, P194, DOI 10.1016/S0925-4439(02)00082-0; Pillai RG, 2008, CANCER RES, V68, P3827, DOI 10.1158/0008-5472.CAN-08-0135; Rollins KD, 2005, CLIN THER, V27, P1343, DOI 10.1016/j.clinthera.2005.09.010; Rusthoven JJ, 1999, J CLIN ONCOL, V17, P1194, DOI 10.1200/JCO.1999.17.4.1194; Soloviev D, 2012, EUR J CANCER, V48, P416, DOI 10.1016/j.ejca.2011.11.035; Takehara A, 2005, ANTICANCER RES, V25, P4455; Takezawa K, 2011, BRIT J CANCER, V104, P1594, DOI 10.1038/bjc.2011.129; van der Wilt CL, 1997, J CANCER RES CLIN, V123, P595, DOI 10.1007/s004320050111; Van TB, 2000, J HISTOCHEM CYTOCHEM, V48, P755; VANDERWILT CL, 1995, EUR J CANCER, V31A, P754, DOI 10.1016/0959-8049(94)00477-M; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Visvikis D, 2004, EUR J NUCL MED MOL I, V31, P169, DOI 10.1007/s00259-003-1339-2; Wells P, 2003, JNCI-J NATL CANCER I, V95, P675, DOI 10.1093/jnci/95.9.675	36	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63705	10.1371/journal.pone.0063705	http://dx.doi.org/10.1371/journal.pone.0063705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717468	Green Submitted, Green Published, gold			2022-12-27	WOS:000319385300035
J	Zanini, C; Ercole, E; Mandili, G; Salaroli, R; Poli, A; Renna, C; Papa, V; Cenacchi, G; Forni, M				Zanini, Cristina; Ercole, Elisabetta; Mandili, Giorgia; Salaroli, Roberta; Poli, Alice; Renna, Cristiano; Papa, Valentina; Cenacchi, Giovanna; Forni, Marco			Medullospheres from DAOY, UW228 and ONS-76 Cells: Increased Stem Cell Population and Proteomic Modifications	PLOS ONE			English	Article							CANCER CELLS; MEDULLOBLASTOMA; EXPRESSION; PROFILES; FEATURES; IDENTIFICATION; INVASIVENESS; CYTOSCAPE; NETWORKS; LINES	Background: Medulloblastoma (MB) is an aggressive pediatric tumor of the Central Nervous System (CNS) usually treated according to a refined risk stratification. The study of cancer stem cells (CSC) in MB is a promising approach aimed at finding new treatment strategies. Methodology/Principal Findings: The CSC compartment was studied in three characterized MB cell lines (DAOY, UW228 and ONS-76) grown in standard adhesion as well as being grown as spheres, which enables expansion of the CSC population. MB cell lines, grown in adherence and as spheres, were subjected to morphologic analysis at the light and electron microscopic level, as well as cytofluorimetric determinations. Medullospheres (MBS) were shown to express increasingly immature features, along with the stem cells markers: CD133, Nestin and beta-catenin. Proteomic analysis highlighted the differences between MB cell lines, demonstrating a unique protein profile for each cell line, and minor differences when grown as spheres. In MBS, MALDI-TOF also identified some proteins, that have been linked to tumor progression and resistance, such as Nucleophosmin (NPM). In addition, immunocytochemistry detected Sox-2 as a stemness marker of MBS, as well as confirming high NPM expression. Conclusions/Significance: Culture conditioning based on low attachment flasks and specialized medium may provide new data on the staminal compartment of CNS tumors, although a proteomic profile of CSC is still elusive for MB.	[Zanini, Cristina; Ercole, Elisabetta; Forni, Marco] Univ Turin, MBC, EuroClone SpA Res Lab, Turin, Italy; [Mandili, Giorgia] Univ Turin, Dept Expt Med & Oncol CERMS, Turin, Italy; [Salaroli, Roberta; Renna, Cristiano; Papa, Valentina; Cenacchi, Giovanna] Univ Bologna, Alma Mater Studiorum, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Poli, Alice] BioDigitalValley Srl, Pont St Martin, AO, Italy	University of Turin; University of Turin; University of Bologna	Zanini, C (corresponding author), Univ Turin, MBC, EuroClone SpA Res Lab, Turin, Italy.	c.zanini@euroclone.it		Zanini, Cristina/0000-0002-6554-2113; Papa, Valentina/0000-0002-0718-2965; CENACCHI, GIOVANNA/0000-0001-5824-3118	Ricerca Finanziata Regione Piemonte and Comitato Interministeriale per la programmazione Economica (CIPE); Piattaforma Piemontese per la Ricerca sulle Cellule staminali (PISTEM)	Ricerca Finanziata Regione Piemonte and Comitato Interministeriale per la programmazione Economica (CIPE); Piattaforma Piemontese per la Ricerca sulle Cellule staminali (PISTEM)	This work was supported by Ricerca Finanziata Regione Piemonte and Comitato Interministeriale per la programmazione Economica (CIPE); by Piattaforma Piemontese per la Ricerca sulle Cellule staminali (PISTEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; BURT AD, 1986, J CLIN PATHOL, V39, P114, DOI 10.1136/jcp.39.1.114-d; Castellino RC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-127; Deleyrolle LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015844; Giangaspero F, 2007, WHO CLASSIFICATION T, P132; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Huang A, 2005, CANCER RES, V65, P5607, DOI 10.1158/0008-5472.CAN-05-0500; Knights MJ, 2012, BRAIN PATHOL, V22, P592, DOI 10.1111/j.1750-3639.2012.00573.x; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Kuo MF, 2009, J NEUROSURG-PEDIATR, V4, P74, DOI 10.3171/2009.2.PEDS08287; Kyrgidis Athanassios, 2010, J Carcinog, V9, P3, DOI 10.4103/1477-3163.62141; Lee EK, 2011, BIOCHEM BIOPH RES CO, V412, P279, DOI 10.1016/j.bbrc.2011.07.083; Liu Y, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-53; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mandili G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018254; Manoranjan B, 2012, PEDIATR RES, V71, P516, DOI 10.1038/pr.2011.62; Natale M, 2010, BIOINFORMATICS, V26, P946, DOI 10.1093/bioinformatics/btq073; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pearson CG, 2009, J CELL BIOL, V187, P904, DOI 10.1083/jcb.200908019; Peyrl A, 2003, PROTEOMICS, V3, P1781, DOI 10.1002/pmic.200300460; Ranger A, 2010, J NEURO-ONCOL, V96, P181, DOI 10.1007/s11060-009-9962-9; Raso A, 2008, NEUROPATH APPL NEURO, V34, P306, DOI 10.1111/j.1365-2990.2007.00896.x; Rau R, 2009, HEMATOL ONCOL, V27, P171, DOI 10.1002/hon.904; Read TA, 2012, CANCER CELL, V21, P1, DOI 10.1016/j.ccr.2011.12.011; Redaelli S, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt138; Rodini CO, 2012, J NEURO-ONCOL, V106, P71, DOI 10.1007/s11060-011-0647-9; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun L, 2013, J RADIAT RES, V54, P61, DOI 10.1093/jrr/rrs078; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; von Bueren AO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-10; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Zanini C, 2010, J CANC THERAPY, V1, P97, DOI DOI 10.4236/JCT.2010.12017; Zanini C, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-59; Zanini C, 2011, CHILD NERV SYST, V27, P2077, DOI 10.1007/s00381-011-1515-9	37	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63748	10.1371/journal.pone.0063748	http://dx.doi.org/10.1371/journal.pone.0063748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717474	Green Published, gold, Green Submitted			2022-12-27	WOS:000319385300034
J	Lombardo, F; Maggini, M; Gruden, G; Bruno, G				Lombardo, Flavia; Maggini, Marina; Gruden, Gabriella; Bruno, Graziella			Temporal Trend in Hospitalizations for Acute Diabetic Complications: A Nationwide Study, Italy, 2001-2010	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; TIME TRENDS; KETOACIDOSIS; MORTALITY; CHILDREN; HYPOGLYCEMIA; RISK; ASSOCIATION; ONTARIO; ACCORD	Background: We investigated temporal trends and geographic variations in both hospitalizations and in-hospital mortality rates for acute diabetic complications (ADC) in the Italian universal health care system. Methods and Findings: A retrospective review of the medical records of patients with either primary or secondary discharge diagnosis of hyperglycaemic acute complications (ICD-9-CM codes 250.1, 250.2, 250.3) or hypoglycemic coma (ICD-9-CM code 251.0) was performed in period 2001-2010. Standardized rates by age and gender on 2001 Italian population and by diabetic population were calculated. We identified 7,601.883 diabetes-related hospital discharges. Out of them, 266,374 (3.5%) were due to ADC, either ketoacidosis/hyperosmolarity (94.4%) or hypoglycemic coma (5.6%). The rate of discharge for ADC decreased by 51.1% from 2001 to 2010 (14.4 vs. 7.1 discharge rate/1,000 diabetic people; 5.7% decrease per year, test for trend, p<0.001) with a similar trend for both hyperglycemic and hypoglycemic complications. Diabetic people in the younger age groups (<= 19 and 20-44 years old) had a significantly greater rate of discharge for ADC than people aged 65 years and over (<= 19 10-fold increase; 20-44: 2-fold increase). In-hospital mortality rate was 7.6%, with 211 preventable deaths in younger diabetic people (<= 44 years old). There was a large variability among Italian Regions and the ratio between the highest and the lowest regional discharge rate reached 300% in 2010. Conclusions: Decreasing temporal trend in hospitalizations for preventable ADC suggests improving outpatient care. In younger diabetic patients, however, both hospitalization rates and in-hospital mortality are still a matter of concern.	[Lombardo, Flavia; Maggini, Marina] Natl Inst Hlth, Rome, Italy; [Gruden, Gabriella; Bruno, Graziella] Univ Turin, Dept Med Sci, Turin, Italy	Istituto Superiore di Sanita (ISS); University of Turin	Bruno, G (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	graziella.bruno@unito.it	Oliveira, Claudia DL/G-8618-2011; Lombardo, Flavia/AAA-9723-2021	BRUNO, Graziella/0000-0002-3011-8304; Lombardo, Flavia Lucia/0000-0001-6183-0735	Piedmont Region, Diabetes Prevention	Piedmont Region, Diabetes Prevention	This work was supported by the Piedmont Region, Diabetes Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagdure D, 2013, PEDIATR DIABETES, V14, P18, DOI 10.1111/j.1399-5448.2012.00897.x; BILD D, 1988, J CLIN EPIDEMIOL, V41, P999, DOI 10.1016/0895-4356(88)90039-X; Booth GL, 2005, DIABETES CARE, V28, P1045, DOI 10.2337/diacare.28.5.1045; Brodovicz KG, 2013, CURR MED RES OPIN, V29, P101, DOI 10.1185/03007995.2012.754744; Bruno G, 2012, NUTR METAB CARDIOVAS, V22, P684, DOI 10.1016/j.numecd.2011.04.007; Bruno G, 2009, NUTR METAB CARDIOVAS, V19, P340, DOI 10.1016/j.numecd.2008.03.010; Bruno G, 2008, NUTR METAB CARDIOVAS, V18, P39, DOI 10.1016/j.numecd.2006.08.007; Chen HF, 2010, INTERNAL MED, V49, P729, DOI 10.2169/internalmedicine.49.2965; Curtis JR, 2002, DIABETES CARE, V25, P1591, DOI 10.2337/diacare.25.9.1591; Fadini GP, 2009, DIABETES RES CLIN PR, V84, P267, DOI 10.1016/j.diabres.2009.01.019; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Govan L, 2012, DIABETOLOGIA, V55, P2356, DOI 10.1007/s00125-012-2601-6; Harjutsalo V, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5364; Hirasing RA, 1996, DIABETES CARE, V19, P431, DOI 10.2337/diacare.19.5.431; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hsu PF, 2013, DIABETES CARE, V36, P894, DOI 10.2337/dc12-0916; Jiang HJ, 2003, DIABETES CARE, V26, P1421, DOI 10.2337/diacare.26.5.1421; Johnston SS, 2011, DIABETES CARE, V34, P1164, DOI 10.2337/dc10-1915; Liu CC, 2010, J FORMOS MED ASSOC, V109, P725, DOI 10.1016/S0929-6646(10)60117-9; Marchesini G, 2011, NUTR METAB CARDIOVAS, V21, P339, DOI 10.1016/j.numecd.2009.10.009; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Punthakee Z, 2012, DIABETES CARE, V35, P787, DOI 10.2337/dc11-1855; Randall L, 2011, DIABETES CARE, V34, P1891, DOI 10.2337/dc11-0701; Rosenbauer J, 2002, J PEDIATR ENDOCR MET, V15, P1137; Seaquist ER, 2012, DIABETES CARE, V35, P409, DOI 10.2337/dc11-0996; Wang J, 2009, DIABETES CARE, V32, P1213, DOI 10.2337/dc08-2211	26	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63675	10.1371/journal.pone.0063675	http://dx.doi.org/10.1371/journal.pone.0063675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717464	Green Submitted, Green Published, gold			2022-12-27	WOS:000319435600028
J	Chen, HT; Liu, YS				Chen, Hao-tai; Liu, Yong-sheng			Immunity of Foot-and-Mouth Disease Serotype Asia 1 by Sublingual Vaccination	PLOS ONE			English	Article							PANDEMIC STRAIN; VIRUS; OUTBREAK; EFFICACY; CATTLE; COSTS; PIGS; FMDV	Foot-and-mouth disease virus (FMDV) causes vesicular disease of cloven-hoofed animals, with severe agricultural and economic losses. Here we present study using a sublingual (SL) route with the killed serotype Asia 1 FMDV vaccine. Guinea pigs were vaccinated using a commercially available vaccine formulation at the manufacturer's recommended full, 1/4, and 1/16 antigen doses. Animals were challenged with homologous FMDV Asia1 strain at various times following vaccination. All control guinea pigs exhibited clinical disease, including fever, viremia, and lesions, specifically vesicle formation in feet. Animals vaccinated with the 1/16 and 1/4 doses were protected after challenge at days 7, 28, and 35 post vaccination. These data suggest that effective protection against foot-and-mouth disease can be achieved with 1/16 of the recommended vaccine dose using SL vaccination, indicating that the sublingual route is an attractive alternative for the administration of the FMDV vaccine.	[Chen, Hao-tai; Liu, Yong-sheng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab China, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Chen, HT (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab China, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	haotaichen@163.com; liuyongshengvip@sina.com.cn			National Natural Science Foundation of China [31172335, 31072143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 31172335 and No. 31072143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beignon AS, 2005, VET IMMUNOL IMMUNOP, V104, P273, DOI 10.1016/j.vetimm.2004.12.008; Boender GJ, 2010, EPIDEMICS-NETH, V2, P36, DOI 10.1016/j.epidem.2010.03.001; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005; Chen HT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-489; Dory D, 2009, ANTIVIR RES, V83, P45, DOI 10.1016/j.antiviral.2009.03.004; Dory D, 2009, ANTIVIR RES, V81, P217, DOI 10.1016/j.antiviral.2008.11.005; Dunn CS, 1997, VET REC, V141, P174, DOI 10.1136/vr.141.7.174; Eble PL, 2009, VACCINE, V27, P1272, DOI 10.1016/j.vaccine.2008.12.011; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Golde WT, 2005, VACCINE, V23, P5775, DOI 10.1016/j.vaccine.2005.07.043; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Joo YS, 2002, CAN J VET RES, V66, P122; Knowles NJ, 2005, EMERG INFECT DIS, V11, P1887; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Knowles NJ, 2001, VET REC, V148, P258; Niborski V, 2006, VACCINE, V24, P7204, DOI 10.1016/j.vaccine.2006.06.048; Nobiron I, 2005, VIRUS RES, V108, P225, DOI 10.1016/j.virusres.2004.08.023; Pacheco JM, 2010, J VET SCI, V11, P133, DOI 10.4142/jvs.2010.11.2.133; Parida S, 2005, VACCINE, V23, P5186, DOI 10.1016/j.vaccine.2005.06.012; Pasick John, 2004, Animal Health Research Reviews, V5, P257, DOI 10.1079/AHR200479; Remond M, 2009, VACCINE, V27, P93, DOI 10.1016/j.vaccine.2008.10.036; Sakamoto K, 2002, J VET MED SCI, V64, P91, DOI 10.1292/jvms.64.91; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Yang PC, 1999, VET REC, V145, P731, DOI 10.1136/vr.145.25.731; Yoon SH, 2011, ARCH VIROL, V156, P817, DOI 10.1007/s00705-011-0921-3	26	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63839	10.1371/journal.pone.0063839	http://dx.doi.org/10.1371/journal.pone.0063839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717497	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700070
J	Chaudhury, S; Abdulhameed, MDM; Singh, N; Tawa, GJ; D'haeseleer, PM; Zemla, AT; Navid, A; Zhou, CE; Franklin, MC; Cheung, J; Rudolph, MJ; Love, J; Graf, JF; Rozak, DA; Dankmeyer, JL; Amemiya, K; Daefler, S; Wallqvist, A				Chaudhury, Sidhartha; Abdulhameed, Mohamed Diwan M.; Singh, Narender; Tawa, Gregory J.; D'haeseleer, Patrik M.; Zemla, Adam T.; Navid, Ali; Zhou, Carol E.; Franklin, Matthew C.; Cheung, Jonah; Rudolph, Michael J.; Love, James; Graf, John F.; Rozak, David A.; Dankmeyer, Jennifer L.; Amemiya, Kei; Daefler, Simon; Wallqvist, Anders			Rapid Countermeasure Discovery against Francisella tularensis Based on a Metabolic Network Reconstruction	PLOS ONE			English	Article							FLUX BALANCE ANALYSIS; MYCOBACTERIUM-TUBERCULOSIS; ACCURATE DOCKING; SYSTEMS BIOLOGY; DRUG DISCOVERY; INHIBITORS; DATABASE; ENZYME; PREDICTION; TULAREMIA	In the future, we may be faced with the need to provide treatment for an emergent biological threat against which existing vaccines and drugs have limited efficacy or availability. To prepare for this eventuality, our objective was to use a metabolic network-based approach to rapidly identify potential drug targets and prospectively screen and validate novel small-molecule antimicrobials. Our target organism was the fully virulent Francisella tularensis subspecies tularensis Schu S4 strain, a highly infectious intracellular pathogen that is the causative agent of tularemia and is classified as a category A biological agent by the Centers for Disease Control and Prevention. We proceeded with a staggered computational and experimental workflow that used a strain-specific metabolic network model, homology modeling and X-ray crystallography of protein targets, and ligand- and structure-based drug design. Selected compounds were subsequently filtered based on physiological-based pharmacokinetic modeling, and we selected a final set of 40 compounds for experimental validation of antimicrobial activity. We began screening these compounds in whole bacterial cell-based assays in biosafety level 3 facilities in the 20th week of the study and completed the screens within 12 weeks. Six compounds showed significant growth inhibition of F. tularensis, and we determined their respective minimum inhibitory concentrations and mammalian cell cytotoxicities. The most promising compound had a low molecular weight, was non-toxic, and abolished bacterial growth at 13 mu M, with putative activity against pantetheine-phosphate adenylyltransferase, an enzyme involved in the biosynthesis of coenzyme A, encoded by gene coaD. The novel antimicrobial compounds identified in this study serve as starting points for lead optimization, animal testing, and drug development against tularemia. Our integrated in silico/in vitro approach had an overall 15% success rate in terms of active versus tested compounds over an elapsed time period of 32 weeks, from pathogen strain identification to selection and validation of novel antimicrobial compounds.	[Chaudhury, Sidhartha; Abdulhameed, Mohamed Diwan M.; Singh, Narender; Tawa, Gregory J.; Wallqvist, Anders] USA, Dept Def Biotechnol, High Performance Comp Software Applicat Inst, Telemed & Adv Technol Res Ctr,Med Res & Mat Comma, Ft Detrick, MD USA; [D'haeseleer, Patrik M.; Zemla, Adam T.; Navid, Ali; Zhou, Carol E.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Franklin, Matthew C.; Cheung, Jonah; Rudolph, Michael J.; Love, James] New York Struct Biol Ctr, New York, NY USA; [Graf, John F.] GE Co, GE Global Res, Diagnost & Biomed Technol, Computat Biol & Biostat Lab, Niskayuna, NY USA; [Rozak, David A.; Dankmeyer, Jennifer L.; Amemiya, Kei] USA, Bacteriol Div, Med Res Inst Infect Dis, Ft Detrick, MD USA; [Daefler, Simon] Mt Sinai Sch Med, New York, NY USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; General Electric; Icahn School of Medicine at Mount Sinai	Wallqvist, A (corresponding author), USA, Dept Def Biotechnol, High Performance Comp Software Applicat Inst, Telemed & Adv Technol Res Ctr,Med Res & Mat Comma, Ft Detrick, MD USA.	awallqvist@bhsai.org	wallqvist, anders/W-2584-2019; Navid, Ali/A-1336-2013; AbdulHameed, Mohamed Diwan M/O-3088-2015	wallqvist, anders/0000-0002-9775-7469; Navid, Ali/0000-0003-2560-6984; AbdulHameed, Mohamed Diwan M/0000-0003-1483-4084; Graf, John/0000-0002-0396-9867	Defense Threat Reduction Agency [TMTI0004.09.BH.T, HDTRA1-08-C-0052, TMTI10049.09.RD.T, W911SR-11-C-0014]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Defense Threat Reduction Agency through projects TMTI0004.09.BH.T, HDTRA1-08-C-0052, TMTI10049.09.RD.T, and W911SR-11-C-0014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bostrom J, 2001, J COMPUT AID MOL DES, V15, P1137, DOI 10.1023/A:1015930826903; Bostrom J, 2003, J MOL GRAPH MODEL, V21, P449, DOI 10.1016/S1093-3263(02)00204-8; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Chavali AK, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-27; Chavali AK, 2012, TRENDS MICROBIOL, V20, P113, DOI 10.1016/j.tim.2011.12.004; De Pascalis R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002494; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dias MVB, 2007, CURR DRUG TARGETS, V8, P437; Edwards JS, 2000, BMC BIOINFORMATICS, V1, DOI 10.1186/1471-2105-1-1; Fang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002688; Fang X, 2011, MOL BIOSYST, V7, P2622, DOI 10.1039/c1mb05106g; Fang X, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-160; Fang X, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-92; Fatumo S, 2011, INFECT GENET EVOL, V11, P708, DOI 10.1016/j.meegid.2011.04.013; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Geerlof A, 1999, J BIOL CHEM, V274, P27105, DOI 10.1074/jbc.274.38.27105; Graf JF, 2012, J PHARMACOKINET PHAR, V39, P37, DOI 10.1007/s10928-011-9229-x; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hassan M, 2006, MOL DIVERS, V10, P283, DOI 10.1007/s11030-006-9041-5; IMSANDE J, 1961, J BIOL CHEM, V236, P1494; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kell DB, 2006, DRUG DISCOV TODAY, V11, P1085, DOI 10.1016/j.drudis.2006.10.004; Kim HU, 2012, BIOTECHNOL J, V7, P330, DOI 10.1002/biot.201100159; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Miller JR, 2010, CHEM BIOL DRUG DES, V75, P444, DOI 10.1111/j.1747-0285.2010.00957.x; Moro WB, 2009, BIOORG MED CHEM LETT, V19, P2001, DOI 10.1016/j.bmcl.2009.02.034; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller JH, 1941, P SOC EXP BIOL MED, V48, P330, DOI 10.3181/00379727-48-13311; Nicholls A, 2005, J COMPUT AID MOL DES, V19, P661, DOI 10.1007/s10822-005-9019-x; Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Papin JA, 2012, DRUG DISCOV TODAY; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Perumal D, 2011, J DRUG TARGET, V19, P1, DOI 10.3109/10611861003649753; Raghunathan A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-118; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; Rockx-Brouwer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037752; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schmitt DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031172; Scholl D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033637; Sharma V, 1998, STRUCTURE, V6, P1587, DOI 10.1016/S0969-2126(98)00156-7; Shen Y, 2010, P NATL ACAD SCI USA, V107, P1082, DOI 10.1073/pnas.0909181107; Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285; Taylor PL, 2008, J BIOL CHEM, V283, P2835, DOI 10.1074/jbc.M706163200; Thomas MG, 2003, BIOORG MED CHEM LETT, V13, P423, DOI 10.1016/S0960-894X(02)00957-5; Umamaheswari Amineni, 2010, Genomics Proteomics & Bioinformatics, V8, P246, DOI 10.1016/S1672-0229(10)60026-5; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wishart DS, 2008, PHARMACOGENOMICS, V9, P1155, DOI 10.2217/14622416.9.8.1155; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	70	9	9	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63369	10.1371/journal.pone.0063369	http://dx.doi.org/10.1371/journal.pone.0063369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704901	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200030
J	Ladage, D; Yaniz-Galende, E; Rapti, K; Ishikawa, K; Tilemann, L; Shapiro, S; Takewa, Y; Muller-Ehmsen, J; Schwarz, M; Garcia, MJ; Sanz, J; Hajjar, RJ; Kawase, Y				Ladage, Dennis; Yaniz-Galende, Elisa; Rapti, Kleopatra; Ishikawa, Kiyotake; Tilemann, Lisa; Shapiro, Scott; Takewa, Yoshiaki; Muller-Ehmsen, Jochen; Schwarz, Martin; Garcia, Mario J.; Sanz, Javier; Hajjar, Roger J.; Kawase, Yoshiaki			Stimulating Myocardial Regeneration with Periostin Peptide in Large Mammals Improves Function Post-Myocardial Infarction but Increases Myocardial Fibrosis	PLOS ONE			English	Article							CARDIAC STEM-CELLS; MYOCYTE PROLIFERATION; PROGENITOR CELLS; HEART; CARDIOMYOCYTES; PROTEIN; REPAIR; EXPRESSION	Aims: Mammalian myocardium has a finite but limited capacity to regenerate. Experimentally stimulating proliferation of cardiomyocytes with extracellular regeneration factors like periostin enhances cardiac repair in rodents. The aim of this study was to develop a safe method for delivering regeneration factors to the heart and to test the functional and structural effects of periostin peptide treatment in a large animal model of myocardial infarction (MI). Methods and Results: We developed a controlled release system to deliver recombinant periostin peptide into the pericardial space. A single application of this method was performed two days after experimental MI in swine. Animals were randomly assigned to receive either saline or periostin peptide. Experimental groups were compared at baseline, day 2, 1 month and 3 months. Treatment with periostin peptide increased the EF from 31% to 41% and decreased by 22% the infarct size within 12 weeks. Periostin peptide-treated animals had newly formed myocardium strips within the infarct scar, leading to locally improved myocardial function. In addition the capillary density was increased in animals receiving periostin. However, periostin peptide treatment increased myocardial fibrosis in the remote region at one week and 12 weeks post-treatment. Conclusion: Our study shows that myocardial regeneration through targeted peptides is possible. However, in the case of periostin the effects on cardiac fibrosis may limit its clinical application as a viable therapeutic strategy.	[Ladage, Dennis; Yaniz-Galende, Elisa; Rapti, Kleopatra; Ishikawa, Kiyotake; Tilemann, Lisa; Shapiro, Scott; Takewa, Yoshiaki; Schwarz, Martin; Hajjar, Roger J.; Kawase, Yoshiaki] Mt Sinai Sch Med, Dept Cardiol, Cardiovasc Res Ctr, New York, NY 10029 USA; [Ladage, Dennis; Muller-Ehmsen, Jochen] Univ Hosp Cologne, Ctr Heart, Cologne, Germany; [Garcia, Mario J.; Sanz, Javier] Mt Sinai Sch Med, Cardiovasc Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; Icahn School of Medicine at Mount Sinai	Ladage, D (corresponding author), Mt Sinai Sch Med, Dept Cardiol, Cardiovasc Res Ctr, New York, NY 10029 USA.	dennis.ladage@mssm.edu	Sanz, Javier/J-7251-2016; Ishikawa, Kiyotake/I-6013-2015	Ladage, Dennis/0000-0002-4512-0917; ishikawa, kiyotake/0000-0002-8287-3483	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	DL was supported by a personal stipend from the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Borg TK, 2007, CIRC RES, V101, P230, DOI 10.1161/CIRCRESAHA.107.159103; Cheng RK, 2007, CIRC RES, V100, P1741, DOI 10.1161/CIRCRESAHA.107.153544; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dorn GW, 2007, NEW ENGL J MED, V357, P1552, DOI 10.1056/NEJMcibr074816; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Ibanez B, 2007, CIRCULATION, V115, P2909, DOI 10.1161/circulationaha.106.679639; ISHIMORI S, 1967, J NEUROSURG, V27, P315, DOI 10.3171/jns.1967.27.4.0315; Itzhaki-Alfia A, 2009, CIRCULATION, V120, P2559, DOI 10.1161/CIRCULATIONAHA.109.849588; Kajstura J, 2012, CIRC RES, V111, P894, DOI 10.1161/CIRCRESAHA.112.273649; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04; Lorts A, 2009, CIRC RES, V104, pE1, DOI 10.1161/CIRCRESAHA.108.188649; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Palumbo R, 2004, BIOCHEM PHARMACOL, V68, P1165, DOI 10.1016/j.bcp.2004.03.048; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Polizzotti BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036788; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Schachinger V, 2009, EUR J HEART FAIL, V11, P973, DOI 10.1093/eurjhf/hfp113; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028	41	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e59656	10.1371/journal.pone.0059656	http://dx.doi.org/10.1371/journal.pone.0059656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700403	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400002
J	Sturrock, HJW; Novotny, JM; Kunene, S; Dlamini, S; Zulu, Z; Cohen, JM; Hsiang, MS; Greenhouse, B; Gosling, RD				Sturrock, Hugh J. W.; Novotny, Joe M.; Kunene, Simon; Dlamini, Sabelo; Zulu, Zulisile; Cohen, Justin M.; Hsiang, Michelle S.; Greenhouse, Bryan; Gosling, Roly D.			Reactive Case Detection for Malaria Elimination: Real-Life Experience from an Ongoing Program in Swaziland	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TRANSMISSION; INFECTIONS; BRAZIL; RISK	As countries move towards malaria elimination, methods to identify infections among populations who do not seek treatment are required. Reactive case detection, whereby individuals living in close proximity to passively detected cases are screened and treated, is one approach being used by a number of countries including Swaziland. An outstanding issue is establishing the epidemiologically and operationally optimal screening radius around each passively detected index case. Using data collected between December 2009 and June 2012 from reactive case detection (RACD) activities in Swaziland, we evaluated the effect of screening radius and other risk factors on the probability of detecting cases by reactive case detection. Using satellite imagery, we also evaluated the household coverage achieved during reactive case detection. Over the study period, 250 cases triggered RACD, which identified a further 74 cases, showing the value of RACD over passive surveillance alone. Results suggest that the odds of detecting a case within the household of the index case were significantly higher than in neighbouring households (odds ratio (OR) 13, 95% CI 3.1-54.4). Furthermore, cases were more likely to be detected when RACD was conducted within a week of the index presenting at a health facility (OR 8.7, 95% CI 1.1-66.4) and if the index household had not been sprayed with insecticide (OR sprayed vs not sprayed 0.11, 95% CI 0.03-0.46). The large number of households missed during RACD indicates that a 1 km screening radius may be impractical in such resource limited settings such as Swaziland. Future RACD in Swaziland could be made more effective by achieving high coverage amongst individuals located near to index cases and in areas where spraying has not been conducted. As well as allowing the programme to implement RACD more rapidly, this would help to more precisely define the optimal screening radius.	[Sturrock, Hugh J. W.; Hsiang, Michelle S.; Gosling, Roly D.] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Novotny, Joe M.; Cohen, Justin M.] Clinton Hlth Access Initiat, Mbabane, Swaziland; [Kunene, Simon; Dlamini, Sabelo; Zulu, Zulisile] Swaziland Natl Malaria Control Programme, Manzini, Swaziland; [Hsiang, Michelle S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Greenhouse, Bryan] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sturrock, HJW (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	SturrockH@globalhealth.ucsf.edu	Dlamini, Sabelo Nick/AAC-2213-2020	Dlamini, Sabelo Nick/0000-0002-4165-580X; Sturrock, Hugh/0000-0002-0029-3101; Cohen, Justin/0000-0003-4481-6784; Greenhouse, Bryan/0000-0003-0287-9111	Bill & Melinda Gates Foundation; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [P0045532]; Burroughs Wellcome Fund-American Society of Tropical Medicine and Hygiene Fellowship [P0049395]; NIH/NIAID [AI076614]; Doris Duke Clinical Scientist Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI101012, K23AI076614] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund-American Society of Tropical Medicine and Hygiene Fellowship; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Bill & Melinda Gates Foundation. MH is supported by a National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) K23 Award [#P0045532] and a Burroughs Wellcome Fund-American Society of Tropical Medicine and Hygiene Fellowship [#P0049395]. BG is supported by a NIH/NIAID K23 Award [#AI076614] and is a recipient of a Doris Duke Clinical Scientist Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SAF EFF SINGL DOS PR; [Anonymous], 2010, R LANG ENV STAT COMP; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Cohen JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-61; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Enk MJ, 2008, AM J TROP MED HYG, V78, P140, DOI 10.4269/ajtmh.2008.78.140; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Gosling RD, 2011, CLIN MICROBIOL INFEC, V17, P1617, DOI 10.1111/j.1469-0691.2011.03660.x; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Kunene S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-313; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; *MALERA CONS GROUP, 2011, PLOS MED, V0008; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; MUIRHEADTHOMSON RC, 1954, BRIT MED J, V1, P68, DOI 10.1136/bmj.1.4853.68; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; StataCorp, 2011, STAT STAT SOFTW REL; Stresman GH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-265; WHO, 2012, DIS SURV MAL EL OP M; YEKUTIEL P, 1960, Bull World Health Organ, V22, P669	27	87	87	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63830	10.1371/journal.pone.0063830	http://dx.doi.org/10.1371/journal.pone.0063830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700437	gold, Green Published, Green Submitted			2022-12-27	WOS:000319966400034
J	Huang, HM; Hsiao, G; Fan, CK; Lin, CL; Leu, SJ; Chiang, BL; Lee, YL				Huang, Huei-Mei; Hsiao, George; Fan, Chia-Kwung; Lin, Chu-Lun; Leu, Sy-Jye; Chiang, Bor-Luen; Lee, Yueh-Lun			Notch Ligand Delta-Like 4-Pretreated Dendritic Cells Alleviate Allergic Airway Responses by Enhancing IL-10 Production	PLOS ONE			English	Article							T-CELL; IMMUNE-SYSTEM; DIFFERENTIATION; MATURATION; CYTOKINES; DISEASE; PATHOGENESIS; INDUCTION; TOLERANCE; MATURE	The Notch pathway plays a role in the processes of cell proliferation, differentiation, and apoptosis, which affect the development and function of various organs. Dendritic cells (DCs), as professional antigen-presenting cells (APCs), induce T cell activation and promote T cell differentiation by antigen stimulation. Research has shown that Notch ligand delta-like 4 (Dll4) in APCs is associated with stimulation of a Th1-type response. However, the regulatory roles of Dll4 in the activation and function of DCs have yet to be clearly elucidated. In this study, we demonstrated that activation of Dll4-pretreated bone marrow-derived DCs by performing ovalbumin (OVA) stimulation expressed a high level of interleukin (IL)-10 without diminishing IL-12 production. By contrast, the proinflammatory cytokines, IL-1 beta, IL-6, and tumor necrosis factor (TNF)-alpha, decreased in Dll4-pretreated DCs by performing either lipopolysaccharide (LPS) or OVA stimulation. Compared to fully mature DCs, lower levels of MHC class II CD40 and higher levels of CD80 and CD86 molecules were expressed in these semi-mature like DCs. Dll4 Notch signaling also enhanced Notch ligand mRNA expression of Dll1, Dll4, and Jagged1 in DCs. Dll4-modified DCs exhibited a reduced capacity to stimulate the proliferation of OVA-specific CD4(+) T cells, but actively promoted large amounts of IL-10 production in these activated T cells. Furthermore, immunomodulatory effects of Dll4-modified DCs were examined in an established asthmatic animal model. After adoptive transfer of OVA-pulsed plus Dll4-pretreated DCs in OVA-immunized mice, OVA challenge induced lower OVA-specific immunoglobulin E (IgE) and higher IgG(2a) antibody production, lower eotaxin, keratinocyte-derived chemokine (KC), IL-5, and IL-13 release in bronchial alveolar lavage fluid, attenuated airway hyper-responsiveness, and promoted higher IL-10 and interferon (IFN)-gamma production in the spleen. In summary, our findings elucidate the new role of Dll4 in the phenotype and function of DCs and provide a novel approach for manipulating T cell-driven deleterious immune diseases.	[Huang, Huei-Mei; Lin, Chu-Lun] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Hsiao, George] Taipei Med Univ, Dept Pharmacol, Coll Med, Taipei, Taiwan; [Fan, Chia-Kwung] Taipei Med Univ, Dept Parasitol, Coll Med, Taipei, Taiwan; [Leu, Sy-Jye; Lee, Yueh-Lun] Taipei Med Univ, Dept Microbiol & Immunol, Coll Med, Taipei, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; National Taiwan University	Lee, YL (corresponding author), Taipei Med Univ, Dept Microbiol & Immunol, Coll Med, Taipei, Taiwan.	yllee@tmu.edu.tw		Fan, Chia-Kwung/0000-0001-5579-8169; CHIANG, BOR-LUEN/0000-0002-6705-0286	National Science Council, Taiwan [NSC 99-2314-B-038-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Taiwan (NSC 99-2314-B-038-002-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2002, IMMUNOL REV, V187, P75, DOI 10.1034/j.1600-065X.2002.18707.x; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2009, NAT REV IMMUNOL, V9, P116, DOI 10.1038/nri2488; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bigas A, 2012, BLOOD, V119, P3226, DOI 10.1182/blood-2011-10-355826; Borowski C, 2002, CURR OPIN IMMUNOL, V14, P200, DOI 10.1016/S0952-7915(02)00322-9; Bugeon L, 2008, J IMMUNOL, V181, P8189, DOI 10.4049/jimmunol.181.12.8189; Cheng P, 2008, IMMUNOL RES, V41, P1, DOI 10.1007/s12026-007-8011-z; Cheng PY, 2007, BLOOD, V109, P507, DOI 10.1182/blood-2006-05-025601; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Dallman MJ, 2005, CURR OPIN IMMUNOL, V17, P259, DOI 10.1016/j.coi.2005.04.002; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Enk AH, 2005, IMMUNOL LETT, V99, P8, DOI 10.1016/j.imlet.2005.01.011; Fukushima A, 2008, IMMUNOL LETT, V121, P140, DOI 10.1016/j.imlet.2008.10.006; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Huang MT, 2009, J IMMUNOL, V183, P4745, DOI 10.4049/jimmunol.0804371; Imayoshi I, 2011, MOL NEUROBIOL, V44, P7, DOI 10.1007/s12035-011-8186-0; Ito T, 2012, J LEUKOCYTE BIOL, V92, P59, DOI 10.1189/jlb.1011529; Jang S, 2010, J IMMUNOL, V185, P5835, DOI 10.4049/jimmunol.1000175; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Ohishi K, 2001, BLOOD, V98, P1402, DOI 10.1182/blood.V98.5.1402; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Raymond Tracy, 2007, Proc Am Thorac Soc, V4, P635, DOI 10.1513/pats.200706-067TH; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Rutella S, 2004, IMMUNOL LETT, V94, P11, DOI 10.1016/j.imlet.2004.04.015; Sauma D, 2011, SCAND J IMMUNOL, V74, P62, DOI 10.1111/j.1365-3083.2011.02541.x; Schaller MA, 2007, J EXP MED, V204, P2925, DOI 10.1084/jem.20070661; Sirin Y, 2012, J PATHOL, V226, P394, DOI 10.1002/path.2967; Skokos D, 2007, J EXP MED, V204, P1525, DOI 10.1084/jem.20062305; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Suchting S, 2009, CELL, V137, P988, DOI 10.1016/j.cell.2009.05.024; Sultana DA, 2010, SEMIN IMMUNOL, V22, P254, DOI 10.1016/j.smim.2010.04.011; Sun J, 2008, J IMMUNOL, V180, P1655, DOI 10.4049/jimmunol.180.3.1655; Tsukumo S, 2004, J IMMUNOL, V173, P7109, DOI 10.4049/jimmunol.173.12.7109; Wakui M, 2007, BIOCHEM BIOPH RES CO, V358, P596, DOI 10.1016/j.bbrc.2007.04.175; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719	46	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63613	10.1371/journal.pone.0063613	http://dx.doi.org/10.1371/journal.pone.0063613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696838	gold, Green Published, Green Submitted			2022-12-27	WOS:000319081900046
J	Kraanen, FL; Vedel, E; Scholing, A; Emmelkamp, PMG				Kraanen, Fleur L.; Vedel, Ellen; Scholing, Agnes; Emmelkamp, Paul M. G.			Screening on Perpetration and Victimization of Intimate Partner Violence (IPV): Two Studies on the Validity of an IPV Screening Instrument in Patients in Substance Abuse Treatment	PLOS ONE			English	Article							CONFLICT-TACTICS-SCALES; DOMESTIC VIOLENCE; USE DISORDERS; HETEROSEXUAL PARTNERS; HEALTH CONSEQUENCES; DIAGNOSTIC-TESTS; SEX-DIFFERENCES; WOMEN; RELIABILITY; AGGRESSION	Background: About 50% of patients in substance abuse treatment with a partner perpetrated and/or experienced intimate partner violence in the past year. To date, there are no screeners to identify both perpetrators and victims of partner intimate violence in a substance abusing population. We developed a 4 item screening instrument for this purpose, the Jellinek Inventory for assessing Partner Violence (J-IPV). Important strengths of the J-IPV are that it takes only 2 minutes to administer and is easy to use and to score. Methods: To investigate the validity of the J-IPV, two independent studies were conducted including 98 and 99 participants, respectively. Aim of the second study was to cross-validate findings from the first study. Psychometric properties of the J-IPV were determined by calculating sensitivity, specificity, positive and negative predictive value, and positive and negative likelihood ratio's by comparing J-IPV outcomes to outcomes on the Revised Conflict Tactics Scales ('gold standard'). Also, receiver operator characteristics (ROC)-curves were determined to weight sensitivity and specificity as a result of different J-IPV cutoffs, and the area under the curve (AUC) was calculated. Results: Results of the first study demonstrated that the J-IPV possesses good psychometric properties to detect perpetrators and victims of any as well as severe intimate partner violence. Results from the second study replicated findings from the first study. Conclusions: We recommend administering the J-IPV to patients entering substance abuse treatment. If perpetrators and victims of partner violence are identified, action can be taken to stop IPV perpetration and arrange help for victims, for example by offering perpetrators treatment or by providing safety planning or advocacy interventions to victims.	[Kraanen, Fleur L.; Scholing, Agnes; Emmelkamp, Paul M. G.] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Kraanen, Fleur L.; Scholing, Agnes; Emmelkamp, Paul M. G.] Forens Outpatient Clin De Waag, Amsterdam, Netherlands; [Vedel, Ellen] Jellinek Subst Abuse Treatment Ctr, Amsterdam, Netherlands; [Emmelkamp, Paul M. G.] King Abdulaziz Univ, Dept Psychol, Jeddah 21413, Saudi Arabia	University of Amsterdam; King Abdulaziz University	Kraanen, FL (corresponding author), Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands.	F.L.Kraanen@uva.nl	, paulemmelkamp/G-3274-2011	, paulemmelkamp/0000-0001-6066-5512	Royal Netherlands Academy of Arts and Sciences (KNAW)	Royal Netherlands Academy of Arts and Sciences (KNAW)	The present study is supported by the Royal Netherlands Academy of Arts and Sciences (KNAW) by the Academy Professorship awarded to Paul Emmelkamp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasi A., 1997, PSYCHOL TESTING; Archer J, 1999, J INTERPERS VIOLENCE, V14, P1263, DOI 10.1177/088626099014012003; Archer J, 2000, PSYCHOL BULL, V126, P651, DOI [10.1037/0033-2909.126.5.651, 10.1037//0033-2909.126.5.651]; Archer J, 2002, AGGRESS VIOLENT BEH, V7, P313, DOI 10.1016/S1359-1789(01)00061-1; Attia J, 2003, AUST PRESCR, V26, P111, DOI 10.18773/austprescr.2003.082; Babcock JC, 2004, CLIN PSYCHOL REV, V23, P1023, DOI 10.1016/j.cpr.2002.07.001; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Biggerstaff BJ, 2000, STAT MED, V19, P649, DOI 10.1002/(SICI)1097-0258(20000315)19:5&lt;649::AID-SIM371&gt;3.0.CO;2-H; Bogaerts S., 2010, HUISELIJK GEWELD NED; Brown JB, 1996, FAM MED, V28, P122; Brown T G, 1999, Violence Vict, V14, P179; Brown TG, 1998, ADDICT BEHAV, V23, P573, DOI 10.1016/S0306-4603(98)00004-5; Butler SF, 2009, J ADDICT MED, V3, P66, DOI 10.1097/ADM.0b013e31818e41da; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Chermack ST, 2002, DRUG ALCOHOL DEPEN, V66, P29, DOI 10.1016/S0376-8716(01)00180-6; Chermack ST, 2000, DRUG ALCOHOL DEPEN, V58, P43, DOI 10.1016/S0376-8716(99)00067-8; Chermack ST, 2001, PSYCHOL ADDICT BEHAV, V15, P140, DOI 10.1037/0893-164X.15.2.140; Chermack ST, 2008, DRUG ALCOHOL DEPEN, V98, P35, DOI 10.1016/j.drugalcdep.2008.04.010; Chuang CH., 2002, JCOM WAYNE PA, V9, P565; Easton CJ, 2007, AM J ADDICTION, V16, P24, DOI 10.1080/10550490601077809; El-Bassel N, 2000, J FAM VIOLENCE, V15, P209, DOI 10.1023/A:1007532917759; El-Bassel N, 2004, PSYCHOL ADDICT BEHAV, V18, P180, DOI 10.1037/0893-164X.18.2.180; Emery CR, 2010, J FAM VIOLENCE, V25, P173, DOI 10.1007/s10896-009-9281-0; Emmelkamp P.M.G., 2006, EVIDENCE BASED TREAT; Feder L., 2005, J EXPT CRIMINOLOGY, V1, P239, DOI [10.1007/s11292-005-1179-0, https://doi.org/10.1007/s11292-005-1179-0, DOI 10.1007/S11292-005-1179-0]; Feldhaus KM, 1997, JAMA-J AM MED ASSOC, V277, P1357, DOI 10.1001/jama.277.17.1357; Flahault A, 2005, J CLIN EPIDEMIOL, V58, P859, DOI 10.1016/j.jclinepi.2004.12.009; Gilbert L, 2012, PSYCHOL ADDICT BEHAV, V26, P226, DOI 10.1037/a0025869; Heckert DA, 2000, J FAM VIOLENCE, V15, P181, DOI 10.1023/A:1007594928605; Hien D, 2009, INT J LAW PSYCHIAT, V32, P48, DOI 10.1016/j.ijlp.2008.11.003; Holt S, 2008, CHILD ABUSE NEGLECT, V32, P797, DOI 10.1016/j.chiabu.2008.02.004; Jones NT, 2002, J FAM ISSUES, V23, P441, DOI 10.1177/0192513X02023003006; KANTOR GK, 1989, AM J DRUG ALCOHOL AB, V15, P173, DOI 10.3109/00952998909092719; Kim J, 2008, AMBUL PEDIATR, V8, P255, DOI 10.1016/j.ambp.2008.03.033; Kitzmann K., 2008, J CONSULT CLIN PSYCH, V71, P339; Kraanen FL, 2012, INT J OFFENDER THER, V56, P1201, DOI 10.1177/0306624X11420252; Kraanen FL, 2010, INT J OFFENDER THER, V54, P430, DOI 10.1177/0306624X08330189; LAWRENCE E, 1995, BEHAV THER, V26, P671, DOI 10.1016/S0005-7894(05)80038-3; Leonard K. E, 2001, J SUBST USE, V6, P235, DOI [10.1080/146598901753325075, DOI 10.1080/146598901753325075]; Maiden R. P, 1997, ALCOHOLISM TREATMENT, V15, P31, DOI DOI 10.1300/J020V15N02_; Murphy C.M., 1994, J FAM PSYCHOL, V8, P321, DOI [DOI 10.1037/0893-3200.8.3.321, 10.1037/0893-3200.8.3.321]; Murphy CM, 2010, AGGRESS VIOLENT BEH, V15, P325, DOI 10.1016/j.avb.2010.01.006; Newton RR, 2001, EDUC PSYCHOL MEAS, V61, P317, DOI 10.1177/00131640121971130; Pico-Alfonso MA, 2006, J WOMENS HEALTH, V15, P599, DOI 10.1089/jwh.2006.15.599; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Rabin RF, 2009, AM J PREV MED, V36, P439, DOI 10.1016/j.amepre.2009.01.024; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Reddy Madhavi K, 2006, Violence Vict, V21, P499, DOI 10.1891/vivi.21.4.499; Rosenbaum Alan, 2006, Violence Vict, V21, P461, DOI 10.1891/vivi.21.4.461; Schafer J, 1998, AM J PUBLIC HEALTH, V88, P1702, DOI 10.2105/AJPH.88.11.1702; Schippers GM, 2007, MATE 2 0 HANDLEIDING; Sherin K M, 1998, Fam Med, V30, P508; Sprague S, 2012, WOMEN HEALTH, V52, P587, DOI 10.1080/03630242.2012.690840; Stith SM, 2004, AGGRESS VIOLENT BEH, V10, P65, DOI 10.1016/j.avb.2003.09.001; Stover CS, 2009, PROF PSYCHOL-RES PR, V40, P223, DOI 10.1037/a0012718; Straus M.A., 1990, PHYS VIOLENCE AM FAM, P49; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Straus MA, 2004, CROSS-CULT RES, V38, P407, DOI 10.1177/1069397104269543; Straus MA, 2007, ENCY DOMESTIC VIOLEN; Straus Murray A, 2004, Violence Vict, V19, P507; Stuart GL, 2005, J INTERPERS VIOLENCE, V20, P388, DOI 10.1177/0886260504267881; Stuart GL, 2003, ADDICT BEHAV, V28, P1603, DOI 10.1016/j.addbeh.2003.08.038; Stuart Gregory L, 2003, Subst Abus, V24, P107, DOI 10.1023/A:1023736732766; Stuart GL, 2009, SUBST USE MISUSE, V44, P1298, DOI 10.1080/10826080902961385; Sugarman DB, 1997, J INTERPERS VIOLENCE, V12, P275, DOI 10.1177/088626097012002008; Tiet QQ, 2008, CLIN PSYCHOL REV, V28, P578, DOI 10.1016/j.cpr.2007.08.002; Vega EM, 2007, J FAM VIOLENCE, V22, P703, DOI 10.1007/s10896-007-9118-7; Wood SL, J CHILD ADOLESC PSYC, V24, P223; Yoshihama M, 2009, AM J PUBLIC HEALTH, V99, P647, DOI 10.2105/AJPH.2007.118976	70	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63681	10.1371/journal.pone.0063681	http://dx.doi.org/10.1371/journal.pone.0063681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146HW	23696847	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900053
J	Meng, W; McElroy, JP; Volinia, S; Palatini, J; Warner, S; Ayers, LW; Palanichamy, K; Chakravarti, A; Lautenschlaeger, T				Meng, Wei; McElroy, Joseph P.; Volinia, Stefano; Palatini, Jeff; Warner, Sarah; Ayers, Leona W.; Palanichamy, Kamalakannan; Chakravarti, Arnab; Lautenschlaeger, Tim			Comparison of MicroRNA Deep Sequencing of Matched Formalin-Fixed Paraffin-Embedded and Fresh Frozen Cancer Tissues	PLOS ONE			English	Article							EXPRESSION; APOPTOSIS; SAMPLES; CELLS; PCR	MicroRNAs regulate several aspects of tumorigenesis and cancer progression. Most cancer tissues are archived formalin-fixed and paraffin-embedded (FFPE). While microRNAs are a more stable form of RNA thought to withstand FFPE-processing and degradation there is only limited evidence for the latter assumption. We examined whether microRNA profiling can be successfully conducted on FFPE cancer tissues using SOLiD ligation based sequencing. Tissue storage times (2-9 years) appeared to not affect the number of detected microRNAs in FFPE samples compared to matched frozen samples (paired t-test p>0.7). Correlations of microRNA expression values were very high across microRNAs in a given sample (Pearson's r = 0.71-0.95). Higher variance of expression values among samples was associated with higher correlation coefficients between FFPE and frozen tissues. One of the FFPE samples in this study was degraded for unknown reasons with a peak read length of 17 nucleotides compared to 21 in all other samples. The number of detected microRNAs in this sample was within the range of microRNAs detected in all other samples. Ligation-based microRNA deep sequencing on FFPE cancer tissues is feasible and RNA degradation to the degree observed in our study appears to not affect the number of microRNAs that can be quantified.	[Meng, Wei; Palanichamy, Kamalakannan; Chakravarti, Arnab; Lautenschlaeger, Tim] Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Meng, Wei; Palatini, Jeff; Warner, Sarah; Palanichamy, Kamalakannan; Chakravarti, Arnab; Lautenschlaeger, Tim] Ohio State Univ, Richard L Solove Res Inst, Columbus, OH 43210 USA; [McElroy, Joseph P.] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Volinia, Stefano] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Palatini, Jeff; Warner, Sarah] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Ayers, Leona W.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chakravarti, A (corresponding author), Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA.	Arnab.Chakravarti@osumc.edu; TL@osumc.edu	Palanichamy, Kamalakannan/Z-1376-2019; Volinia, Stefano/AAA-9264-2019; Meng, Wei/J-2753-2015; Volinia, Stefano/A-3029-2010; Palanichamy, Kamalakannan/E-3807-2011	Volinia, Stefano/0000-0003-0910-3893; Volinia, Stefano/0000-0003-0910-3893; Palatini, Jeffrey/0000-0001-9280-4417	Department of Radiation Oncology and the Comprehensive Cancer Center; The Ohio State University; National Center For Advancing Translational Sciences [8UL1TR000090-05]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER	Department of Radiation Oncology and the Comprehensive Cancer Center; The Ohio State University(Ohio State University); National Center For Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by funding from the Department of Radiation Oncology and the Comprehensive Cancer Center, and, by the Biostatistics Core and by Microarray shared resource at The Ohio State University. The work was supported by Award Number Grant 8UL1TR000090-05 from the National Center For Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Advancing Translational Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; de Biase D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035596; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Ferruelo A, 2011, INT J CLIN EXP PATHO, V4, P156; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Glud M, 2009, J INVEST DERMATOL, V129, P1219, DOI 10.1038/jid.2008.347; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00684; Lake SL, 2012, INVEST OPHTHALMOL VI; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Li S, 2012, BREAST CANCER RES TR, V136, P77, DOI 10.1007/s10549-012-2166-6; Lin J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.134; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma ZH, 2009, J MOL DIAGN, V11, P420, DOI 10.2353/jmoldx.2009.090041; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Norden-Krichmar TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022870; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Soares Ana Raquel, 2012, Methods Mol Biol, V822, P189, DOI 10.1007/978-1-61779-427-8_13; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Zhang W, 2012, CANCER; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077; Zinn PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041522	37	65	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64393	10.1371/journal.pone.0064393	http://dx.doi.org/10.1371/journal.pone.0064393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696889	Green Submitted, Green Published, gold			2022-12-27	WOS:000319081900092
J	Nakaima, Y; Watanabe, K; Koyama, T; Miura, O; Fukuda, T				Nakaima, Yukana; Watanabe, Ken; Koyama, Takatoshi; Miura, Osamu; Fukuda, Tetsuya			CD137 Is Induced by the CD40 Signal on Chronic Lymphocytic Leukemia B Cells and Transduces the Survival Signal via NF-kappa B Activation	PLOS ONE			English	Article							T-LYMPHOCYTES; SOLUBLE FORM; 4-1BB; LIGAND; PROLIFERATION; PROMOTES; RECEPTOR; BAFF; DIFFERENTIATION; NF-KAPPA-B2	CD137 is a member of the tumor necrosis factor receptor family that is expressed on activated T cells. This molecule provides a co-stimulatory signal that enhances the survival, and differentiation of cells, and has a crucial role in the development of CD8 cytotoxic T cells and anti-tumor immunity. Here we report that CD137 expression is also induced on normal or malignant human B cells by CD40 ligation by its ligand CD154. This CD137 induction was more prominent in chronic lymphocytic leukemia (CLL) cells than in other types of B cells. CD137 stimulation on B cells by its ligand induced the nuclear translocation of p52 (a non-canonical NF-kappa B factor). In agreement with this finding, expression of the survival factor BCL-XL was upregulated. Consequently, the CD137 signal augmented the survival of CD154-stimulated CLL B cells in vitro. This unexpected induction of CD137 on B cells by CD40 signal may influence the clinical course of CLL.	[Nakaima, Yukana; Watanabe, Ken; Miura, Osamu; Fukuda, Tetsuya] Tokyo Med & Dent Univ, Dept Hematol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Nakaima, Yukana; Koyama, Takatoshi] Tokyo Med & Dent Univ, Lab Mol Genet Hematol, Grad Sch Hlth Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Fukuda, T (corresponding author), Tokyo Med & Dent Univ, Dept Hematol, Grad Sch Med & Dent Sci, Tokyo, Japan.	fuku.hema@tmd.ac.jp		Miura, Osamu/0000-0002-0981-3054	Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture of Japan (O.M., T.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Buechele C, 2012, EUR J IMMUNOL, V42, P737, DOI 10.1002/eji.201141920; Caligaris-Cappio F, 2008, J CLIN ONCOL, V26, P4497, DOI 10.1200/JCO.2007.15.4393; Choi BK, 2009, J IMMUNOL, V182, P4107, DOI 10.4049/jimmunol.0800459; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; de Jong D, 2011, BEST PRACT RES CL HA, V24, P135, DOI 10.1016/j.beha.2011.02.007; Dicker F, 2005, BLOOD, V105, P3193, DOI 10.1182/blood-2003-10-3684; Dicker F, 2006, BLOOD, V108, P3450, DOI 10.1182/blood-2006-04-017749; Endo T, 2007, BLOOD, V109, P703, DOI 10.1182/blood-2006-06-027755; Fayad L, 2001, BLOOD, V97, P256, DOI 10.1182/blood.V97.1.256; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Furtner M, 2005, LEUKEMIA, V19, P883, DOI 10.1038/sj.leu.2403675; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Hallaert DYH, 2008, BLOOD, V112, P5141, DOI 10.1182/blood-2008-03-146704; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Houot R, 2009, BLOOD, V114, P3431, DOI 10.1182/blood-2009-05-223958; Jiang D, 2008, STEM CELLS, V26, P2372, DOI 10.1634/stemcells.2008-0158; Jiang DS, 2008, J IMMUNOL, V181, P3923, DOI 10.4049/jimmunol.181.6.3923; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Lee SW, 2008, NAT IMMUNOL, V9, P917, DOI 10.1038/ni.1632; Lin W, 2008, BLOOD, V112, P699, DOI 10.1182/blood-2007-11-122465; Lippert U, 2008, EUR J IMMUNOL, V38, P1024, DOI [10.1002/eji.200737800, 10.1002/eji.200890024]; LOTZ M, 1994, J EXP MED, V179, P999, DOI 10.1084/jem.179.3.999; Lynch DH, 2008, IMMUNOL REV, V222, P277, DOI 10.1111/j.1600-065X.2008.00621.x; Melero I, 2008, TRENDS PHARMACOL SCI, V29, P383, DOI 10.1016/j.tips.2008.05.005; Mellstedt H, 2006, CANCER IMMUNOL IMMUN, V55, P210, DOI 10.1007/s00262-005-0675-4; Michel J, 1998, EUR J IMMUNOL, V28, P290, DOI 10.1002/(SICI)1521-4141(199801)28:01<290::AID-IMMU290>3.0.CO;2-S; Olofsson PS, 2008, CIRCULATION, V117, P1292, DOI 10.1161/CIRCULATIONAHA.107.699173; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; Sabbagh L, 2008, J IMMUNOL, V180, P8093, DOI 10.4049/jimmunol.180.12.8093; Scielzo C, 2011, LEUKEMIA, V25, P1760, DOI 10.1038/leu.2011.149; SETAREH M, 1995, GENE, V164, P311, DOI 10.1016/0378-1119(95)00349-B; Smit LA, 2007, BLOOD, V109, P1660, DOI 10.1182/blood-2006-05-021683; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wilcox RA, 2004, BLOOD, V103, P177, DOI 10.1182/blood-2003-06-2184; Zhang XY, 2010, J IMMUNOL, V184, P787, DOI 10.4049/jimmunol.0901619	38	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64425	10.1371/journal.pone.0064425	http://dx.doi.org/10.1371/journal.pone.0064425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696891	Green Submitted, gold, Green Published			2022-12-27	WOS:000319081900094
J	Rabinovich, M; Tristan, I; Varona, P				Rabinovich, Mikhail; Tristan, Irma; Varona, Pablo			Neural Dynamics of Attentional Cross-Modality Control	PLOS ONE			English	Article							WORKING-MEMORY; TRANSIENT DYNAMICS; CELL ASSEMBLIES; NETWORKS; NEUROSCIENCE; INHIBITION; MECHANISMS; SEQUENCES; SYSTEMS; MODELS	Attentional networks that integrate many cortical and subcortical elements dynamically control mental processes to focus on specific events and make a decision. The resources of attentional processing are finite. Nevertheless, we often face situations in which it is necessary to simultaneously process several modalities, for example, to switch attention between players in a soccer field. Here we use a global brain mode description to build a model of attentional control dynamics. This model is based on sequential information processing stability conditions that are realized through nonsymmetric inhibition in cortical circuits. In particular, we analyze the dynamics of attentional switching and focus in the case of parallel processing of three interacting mental modalities. Using an excitatory-inhibitory network, we investigate how the bifurcations between different attentional control strategies depend on the stimuli and analyze the relationship between the time of attention focus and the strength of the stimuli. We discuss the interplay between attention and decision-making: in this context, a decision-making process is a controllable bifurcation of the attention strategy. We also suggest the dynamical evaluation of attentional resources in neural sequence processing.	[Rabinovich, Mikhail; Tristan, Irma] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Varona, Pablo] Univ Autonoma Madrid, Grp Neurocomputac Biol, Dpto Ingn Informat, Escuela Politecn Super, Madrid, Spain	University of California System; University of California San Diego; Autonomous University of Madrid	Varona, P (corresponding author), Univ Autonoma Madrid, Grp Neurocomputac Biol, Dpto Ingn Informat, Escuela Politecn Super, Madrid, Spain.	pablo.varona@uam.es	Varona, Pablo/B-5583-2012	Varona, Pablo/0000-0002-1754-8991; Rabinovich, Mikhail I./0000-0003-4499-5348	ONR [N00014-07-1-074]; UC-MEXUS-CONACYT; MINECO [TIN2012-30883]	ONR(Office of Naval Research); UC-MEXUS-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); MINECO(Spanish Government)	MIR acknowledges support from ONR grant N00014-07-1-074. IT acknowledges support from the UC-MEXUS-CONACYT Fellowship. PV was supported by MINECO TIN2012-30883. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraimovich VS, 2012, COMPUT NEUROSCI-MIT, P313; Afraimovich VS, 2004, INT J BIFURCAT CHAOS, V14, P1195, DOI 10.1142/S0218127404009806; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Baldauf D, 2010, J VISION, V9, P255, DOI [10.1167/9.8.255, DOI 10.1167/9.8.255]; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Bick C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.218101; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Bystritsky A, 2012, J PSYCHIATR RES, V46, P428, DOI 10.1016/j.jpsychires.2011.10.013; Calvert G., 2004, HDB MULTISENSORY PRO; Chen YC, 2010, COGNITION, V114, P389, DOI 10.1016/j.cognition.2009.10.012; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Deco G, 2005, PROG NEUROBIOL, V76, P236, DOI 10.1016/j.pneurobio.2005.08.004; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dieter KC, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00155; Dodds CM, 2011, CEREB CORTEX, V21, P1155, DOI 10.1093/cercor/bhq187; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Duncan J, 1998, PHILOS T ROY SOC B, V353, P1307, DOI 10.1098/rstb.1998.0285; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Fingelkurts AA, 2010, PHYS LIFE REV, V7, P195, DOI 10.1016/j.plrev.2010.04.001; Francis AL, 2002, J EXP PSYCHOL HUMAN, V28, P349, DOI 10.1037//0096-1523.28.2.349; Friston KJ, 1997, NEUROIMAGE, V5, P164, DOI 10.1006/nimg.1997.0259; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gottlieb J, 2010, TRENDS COGN SCI, V14, P240, DOI 10.1016/j.tics.2010.03.001; Grent-'T-Jong T, 2007, PLOS BIOL, V5, P114, DOI 10.1371/journal.pbio.0050012; Hernandez-Bermejo B, 1998, J PHYS A-MATH GEN, V31, P2415, DOI 10.1088/0305-4470/31/10/016; Huerta R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238104; Humphries MD, 2010, PLOS COMPUTATIONAL B, V6, P16; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; Jones LM, 2007, P NATL ACAD SCI USA, V104, P18772, DOI 10.1073/pnas.0705546104; Kahnt T, 2011, NEURON, V70, P549, DOI 10.1016/j.neuron.2011.02.054; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kiyonaga A, 2013, PSYCHON B REV, V20, P228, DOI 10.3758/s13423-012-0359-y; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Kraus N, 2012, ANN NY ACAD SCI, V1252, P100, DOI 10.1111/j.1749-6632.2012.06463.x; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Lee K, 2008, J COMPUT SCI TECH-CH, V23, P874, DOI 10.1007/s11390-008-9171-6; Lewis MD, 2005, BEHAV BRAIN SCI, V28, P169, DOI 10.1017/S0140525X0500004X; Li L, 2009, BRAIN RES, V1282, P84, DOI 10.1016/j.brainres.2009.05.078; Liu JK, 2009, J NEUROSCI, V29, P13172, DOI 10.1523/JNEUROSCI.2358-09.2009; Lustig C, 2005, MEMORY, V13, P441, DOI 10.1080/09658210344000404; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Meehan TP, 2012, NEUROSCI BIOBEHAV R, V36, P2232, DOI 10.1016/j.neubiorev.2012.08.002; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Mirman D, 2008, COGNITIVE SCI, V32, P398, DOI 10.1080/03640210701864063; Muller J, 2005, J ANXIETY DISORD, V19, P1, DOI 10.1016/j.janxdis.2003.12.001; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Nee DE, 2009, NEUROIMAGE, V45, P963, DOI 10.1016/j.neuroimage.2009.01.005; Nowotny T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128106; O'Reilly RC, 2010, CURR OPIN NEUROBIOL, V20, P257, DOI 10.1016/j.conb.2010.01.008; Olivers CNL, 2011, TRENDS COGN SCI, V15, P327, DOI 10.1016/j.tics.2011.05.004; Ponzi A, 2010, J NEUROSCI, V30, P5894, DOI 10.1523/JNEUROSCI.5540-09.2010; Posner MI, 2006, NEURAL NETWORKS, V19, P1422, DOI 10.1016/j.neunet.2006.08.004; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Rabinovich MI, 2012, COMPUT NEUROSCI-MIT, P1; Rabinovich MI, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000072; Rabinovich MI, 2006, BIOL CYBERN, V95, P519, DOI 10.1007/s00422-006-0121-5; Rabinovich MI, 2012, PHYS LIFE REV, V9, P51, DOI 10.1016/j.plrev.2011.11.002; Rabinovich MI, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00024; Rabinovich MI, 2010, DYNAM SYST, V25, P433, DOI 10.1080/14689367.2010.515396; Reeves A, 2005, VISION RES, V45, P3343, DOI 10.1016/j.visres.2005.07.041; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Scimeca JM, 2012, NEURON, V75, P380, DOI 10.1016/j.neuron.2012.07.014; Seminowicz DA, 2007, J NEUROPHYSIOL, V97, P3651, DOI 10.1152/jn.01210.2006; Senkowski D, 2008, NEUROIMAGE, V43, P379, DOI 10.1016/j.neuroimage.2008.06.046; Sridharan D, 2007, NEURON, V55, P521, DOI 10.1016/j.neuron.2007.07.003; Stormer VS, 2009, P NATL ACAD SCI USA, V106, P22456, DOI 10.1073/pnas.0907573106; STONE E, 1990, SIAM J APPL MATH, V50, P726, DOI 10.1137/0150043; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Strigo IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015093; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Wiener M, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00031; Xiao DM, 2000, J DIFFER EQUATIONS, V164, P1, DOI 10.1006/jdeq.1999.3729; Zeeman EC, 2003, T AM MATH SOC, V355, P713, DOI 10.1090/S0002-9947-02-03103-3; Zeeman M.L., 1993, DYNAM STABIL SYST, V8, P189	84	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64406	10.1371/journal.pone.0064406	http://dx.doi.org/10.1371/journal.pone.0064406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696890	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900093
J	Shi, JJ; Hu, J; Zhou, Q; Du, YH; Jiang, CZ				Shi, Jiejun; Hu, Jian; Zhou, Qing; Du, Yanhua; Jiang, Cizhong			PEpiD: A Prostate Epigenetic Database in Mammals	PLOS ONE			English	Article							DNA METHYLATION; CPG-ISLAND; EXPRESSION; ANDROGEN	Epigenetic mechanisms play key roles in initiation and progression of prostate cancer by changing gene expression. The Prostate Epigenetic Database (PEpiD: http://wukong.tongji.edu.cn/pepid) archives the three extensively characterized epigenetic mechanisms DNA methylation, histone modification, and microRNA implicated in prostate cancer of human, mouse, and rat. PEpiD uses a distinct color scheme to present the three types of epigenetic data and provides a user-friendly interface for flexible query. The retrieved information includes Refseq ID, gene symbol, gene alias, genomic loci of epigenetic changes, tissue source, experimental method, and supportive references. The change of histone modification (hyper or hypo) and the corresponding gene expression change (up or down) are also indicated. A graphic view of DNA methylation with exon-intron structure and predicted CpG islands is provided as well. Moreover, the prostate-related ENCODE tracks (DNA methylation, histone modifications, chromatin remodelers), and other key transcription factors with reported roles in prostate are displayed in the browser as well. The reversibility of epigenetic aberrations has made them potential markers for diagnosis and prognosis, and targets for treatment of cancers. This curated information will improve our understanding of epigenetic mechanisms of gene regulation in prostate cancer, and serve as an important resource for epigenetic research in prostate cancer.	[Shi, Jiejun; Hu, Jian; Zhou, Qing; Du, Yanhua; Jiang, Cizhong] Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Shanghai Peoples Hosp 10, Dept Bioinformat,Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University	Jiang, CZ (corresponding author), Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Shanghai Peoples Hosp 10, Dept Bioinformat,Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	czjiang@tongji.edu.cn	Shi, Jiejun/P-3329-2019	Shi, Jiejun/0000-0001-9777-1183	Ministry of Science and Technology of China [2010CB944901, 2011CB965104, 2012AA020405]; National Natural Science Foundation of China [91019017, 31271373]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China [2010CB944901, 2011CB965104, 2012AA020405 to CJ]; and the National Natural Science Foundation of China [91019017, 31271373 to CJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoreira C, 2003, NUCLEIC ACIDS RES, V31, P75, DOI 10.1093/nar/gkg093; BAYLIN SB, 1991, CANCER CELL-MON REV, V3, P383; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Jarrard DF, 1998, CANCER RES, V58, P5310; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Kawamoto K, 2007, CLIN CANCER RES, V13, P2541, DOI 10.1158/1078-0432.CCR-06-2225; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li LC, 2003, NUCLEIC ACIDS RES, V31, P291, DOI 10.1093/nar/gkg008; Maqungo M, 2011, NUCLEIC ACIDS RES, V39, pD980, DOI 10.1093/nar/gkq849; Nelson PS, 2002, NUCLEIC ACIDS RES, V30, P218, DOI 10.1093/nar/30.1.218; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Sahu B, 2013, CANCER RES, V73, P1570, DOI 10.1158/0008-5472.CAN-12-2350; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Zhang CP, 2011, CANCER RES, V71, P6738, DOI 10.1158/0008-5472.CAN-11-1882; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, pD149, DOI 10.1093/nar/gkp968	18	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64289	10.1371/journal.pone.0064289	http://dx.doi.org/10.1371/journal.pone.0064289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696878	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900081
J	Vasilyeva, I; Biscontri, RG; Enns, MW; Metge, CJ; Alessi-Severini, S				Vasilyeva, Irina; Biscontri, Robert G.; Enns, Murray W.; Metge, Colleen J.; Alessi-Severini, Silvia			Movement Disorders in Elderly Users of Risperidone and First Generation Antipsychotic Agents: A Canadian Population-Based Study	PLOS ONE			English	Article							DRUG-INDUCED PARKINSONISM; ATYPICAL ANTIPSYCHOTICS; OLDER-ADULTS; ADVERSE EVENTS; RISK; MORTALITY; DEMENTIA; MEDICATIONS; COHORT; TRENDS	Background: Despite concerns over the potential for severe adverse events, antipsychotic medications remain the mainstay of treatment of behaviour disorders and psychosis in elderly patients. Second-generation antipsychotic agents (SGAs; e.g., risperidone, olanzapine, quetiapine) have generally shown a better safety profile compared to the first-generation agents (FGAs; e.g., haloperidol and phenothiazines), particularly in terms of a lower potential for involuntary movement disorders. Risperidone, the only SGA with an official indication for the management of inappropriate behaviour in dementia, has emerged as the antipsychotic most commonly prescribed to older patients. Most clinical trials evaluating the risk of movement disorders in elderly patients receiving antipsychotic therapy have been of limited sample size and/or of relatively short duration. A few observational studies have produced inconsistent results. Methods: A population-based retrospective cohort study of all residents of the Canadian province of Manitoba aged 65 and over, who were dispensed antipsychotic medications for the first time during the time period from April 1, 2000 to March 31, 2007, was conducted using Manitoba's Department of Health's administrative databases. Cox proportional hazards models were used to determine the risk of extrapyramidal symptoms (EPS) in new users of risperidone compared to new users of FGAs. Results: After controlling for potential confounders (demographics, comorbidity and medication use), risperidone use was associated with a lower risk of EPS compared to FGAs at 30, 60, 90 and 180 days (adjusted hazard ratios [HR] 0.38, 95% CI: 0.22-0.67; 0.45, 95% CI: 0.28-0.73; 0.50, 95% CI: 0.33-0.77; 0.65, 95% CI: 0.45-0.94, respectively). At 360 days, the strength of the association weakened with an adjusted HR of 0.75, 95% CI: 0.54-1.05. Conclusions: In a large population of elderly patients the use of risperidone was associated with a lower risk of EPS compared to FGAs.	[Vasilyeva, Irina; Metge, Colleen J.; Alessi-Severini, Silvia] Univ Manitoba, Fac Pharm, Winnipeg, MB R3T 2N2, Canada; [Biscontri, Robert G.] Univ Manitoba, Asper Sch Business, Dept Accounting & Finance, Winnipeg, MB, Canada; [Enns, Murray W.] Univ Manitoba, Dept Psychiat, Fac Med, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba; University of Manitoba	Alessi-Severini, S (corresponding author), Univ Manitoba, Fac Pharm, Winnipeg, MB R3T 2N2, Canada.	alessise@cc.umanitoba.ca	Metge, Colleen/G-7727-2016	Metge, Colleen/0000-0001-9170-3294; Alessi-Severini, Silvia/0000-0002-6543-7719; Enns, Murray/0000-0002-8375-0151	Manitoba Medical Service Foundation; Manitoba Health Research Council Graduate Studentship Award	Manitoba Medical Service Foundation; Manitoba Health Research Council Graduate Studentship Award	This work was funded in part by a grant from the Manitoba Medical Service Foundation. Irina Vasilyeva was supported by the Manitoba Health Research Council Graduate Studentship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi-Severini S, 2008, PSYCHIAT SERV, V59, P547, DOI 10.1176/ps.2008.59.5.547; AVORN J, 1995, AM J MED, V99, P48, DOI 10.1016/S0002-9343(99)80104-1; Ballard C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003476.pub2; Ballard C, 2011, EXPERT OPIN DRUG SAF, V10, P35, DOI 10.1517/14740338.2010.506711; Barnett MJ, 2006, J CLIN PSYCHOPHARM, V26, P182, DOI 10.1097/01.jcp.0000203598.43314.34; Canadian Institute for Health Information, 2009, ANT US SEN AN FOC DR; Chan WC, 2011, CURR OPIN PSYCHIATR, V24, P455, DOI 10.1097/YCO.0b013e32834a3f47; Drug safety update, ANT US ELD PEOPL DEM; Esper CD, 2008, MOVEMENT DISORD, V23, P401, DOI 10.1002/mds.21854; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Gurevich A, 2012, J NUTR HEALTH AGING, V16, P557, DOI 10.1007/s12603-012-0057-5; HE H, 1995, INT CLIN PSYCHOPHARM, V10, P19, DOI 10.1097/00004850-199503000-00003; Health Canada, ZYPREXA OL CER ADV E; Health Canada, IMP DRUG SAF INF RIS; Health Canada, INCR MORT ASS US AT; Kales HC, 2007, AM J PSYCHIAT, V164, P1568, DOI 10.1176/appi.ajp.2007.06101710; Kales HC, 2011, ARCH GEN PSYCHIAT, V68, P190, DOI 10.1001/archgenpsychiatry.2010.200; Kleijer BC, 2009, J PSYCHOPHARMACOL, V23, P909, DOI 10.1177/0269881108093583; Lee PE, 2005, J AM GERIATR SOC, V53, P1374, DOI 10.1111/j.1532-5415.2005.53418.x; Leslie DL, 2012, AM J MANAG CARE, V18, pE109; Liperoti R, 2009, J CLIN PSYCHIAT, V70, P1340, DOI 10.4088/JCP.08m04597yel; Martinez C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002080; McDonagh M., 2010, DRUG CLASS REV ATYPI; Mehta S, 2010, J CLIN PSYCHIAT, V71, P689, DOI 10.4088/JCP.09m05817yel; Milton JC, 2008, BMJ-BRIT MED J, V336, P606, DOI 10.1136/bmj.39503.424653.80; Peluso MJ, 2012, BRIT J PSYCHIAT, V200, P387, DOI 10.1192/bjp.bp.111.101485; Pratt N, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-72; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Reid R., 1999, MEASURING MORBIDITY; Rochon PA, 2005, ARCH INTERN MED, V165, P1882, DOI 10.1001/archinte.165.16.1882; Rochon PA, 2008, ARCH INTERN MED, V168, P1090, DOI 10.1001/archinte.168.10.1090; Sacchetti E, 2010, DRUG SAFETY, V33, P273, DOI 10.2165/11319120-000000000-00000; Schneeweiss S, 2007, CAN MED ASSOC J, V176, P627, DOI 10.1503/cmaj.061250; Schulze J, 2013, EUR NEUROPSYCHOPHARM, V23, P1034, DOI 10.1016/j.euroneuro.2013.02.001; Seeman P, 2002, CAN J PSYCHIAT, V47, P27, DOI 10.1177/070674370204700106; Setoguchi S, 2008, J AM GERIATR SOC, V56, P1644, DOI 10.1111/j.1532-5415.2008.01839.x; Sitar DS, 2008, GERIATRIC CLIN PHARM; Stahl S., 2003, PRIM CARE COMPANION, V5, P9; STARFIELD B, 1991, HEALTH SERV RES, V26, P53; Thanvi B, 2009, POSTGRAD MED J, V85, P322, DOI 10.1136/pgmj.2008.073312; The Manitoba Centre for Health Policy, CONC ADJ CLIN GROUP; Trifiro G, 2007, PHARMACOEPIDEM DR S, V16, P538, DOI 10.1002/pds.1334; U.S, FOOD DRUG ADM FDA RE; Valiyeva E, 2008, CAN MED ASSOC J, V179, P438, DOI 10.1503/cmaj.071540; Vasilyeva I, 2013, J CLIN PSYCHOPHARM, V33, P24, DOI 10.1097/JCP.0b013e31827934a4; Verdoux H, 2010, ACTA PSYCHIAT SCAND, V121, P4, DOI 10.1111/j.1600-0447.2009.01425.x; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; WEINER JP, 1991, MED CARE, V29, P452, DOI 10.1097/00005650-199105000-00006; Zulman DM, 2011, J GEN INTERN MED, V26, P783, DOI 10.1007/s11606-010-1629-x	49	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64217	10.1371/journal.pone.0064217	http://dx.doi.org/10.1371/journal.pone.0064217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696870	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900073
J	Alekseeva, L; Rault, L; Almeida, S; Legembre, P; Edmond, V; Azevedo, V; Miyoshi, A; Even, S; Taieb, F; Arlot-Bonnemains, Y; Le Loir, Y; Berkova, N				Alekseeva, Ludmila; Rault, Lucie; Almeida, Sintia; Legembre, Patrick; Edmond, Valerie; Azevedo, Vasco; Miyoshi, Anderson; Even, Sergine; Taieb, Frederic; Arlot-Bonnemains, Yannick; Le Loir, Yves; Berkova, Nadia			Staphylococcus aureus-Induced G2/M Phase Transition Delay in Host Epithelial Cells Increases Bacterial Infective Efficiency	PLOS ONE			English	Article							DNA-DAMAGE; CYCLE ARREST; MAC-T; TOXIN; APOPTOSIS; PROTEIN; GROWTH; DIFFERENTIATION; ACTIVATION; VIRULENCE	Staphylococcus aureus is a highly versatile, opportunistic pathogen and the etiological agent of a wide range of infections in humans and warm-blooded animals. The epithelial surface is its principal site of colonization and infection. In this work, we investigated the cytopathic effect of S. aureus strains from human and animal origins and their ability to affect the host cell cycle in human HeLa and bovine MAC-T epithelial cell lines. S. aureus invasion slowed down cell proliferation and induced a cytopathic effect, resulting in the enlargement of host cells. A dramatic decrease in the number of mitotic cells was observed in the infected cultures. Flow cytometry analysis revealed an S. aureus-induced delay in the G2/M phase transition in synchronous HeLa cells. This delay required the presence of live S. aureus since the addition of the heat-killed bacteria did not alter the cell cycle. The results of Western blot experiments showed that the G2/M transition delay was associated with the accumulation of inactive cyclin-dependent kinase Cdk1, a key inducer of mitosis entry, and with the accumulation of unphosphorylated histone H3, which was correlated with a reduction of the mitotic cell number. Analysis of S. aureus proliferation in asynchronous, G1- and G2-phase-enriched HeLa cells showed that the G2 phase was preferential for bacterial infective efficiency, suggesting that the G2 phase delay may be used by S. aureus for propagation within the host. Taken together, our results divulge the potential of S. aureus in the subversion of key cellular processes such as cell cycle progression, and shed light on the biological significance of S. aureus-induced host cell cycle alteration.	[Alekseeva, Ludmila] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Alekseeva, Ludmila; Rault, Lucie; Almeida, Sintia; Even, Sergine; Le Loir, Yves; Berkova, Nadia] INRA, Unite Mixte Rech 1253, Rennes, France; [Alekseeva, Ludmila; Rault, Lucie; Almeida, Sintia; Even, Sergine; Le Loir, Yves; Berkova, Nadia] AGROCAMPUS OUEST, Unite Mixte Rech 1253, Rennes, France; [Almeida, Sintia; Azevedo, Vasco; Miyoshi, Anderson] Univ Fed Minas Gerais, Dept Biol Geral, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Legembre, Patrick; Edmond, Valerie] Univ Rennes 1, Inst Rech Sante, Inst Rech Sante Environm & Travail, U1085, Rennes, France; [Taieb, Frederic] INRA, Inst Natl Sante & Rech Med, USC U1043, Toulouse, France; [Arlot-Bonnemains, Yannick] Univ Rennes 1, CNRS, Unite Mixte Rech 6290, Rennes, France	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; INRAE; Institut Agro; Agrocampus Ouest; Universidade Federal de Minas Gerais; Universite de Rennes; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Berkova, N (corresponding author), INRA, Unite Mixte Rech 1253, Rennes, France.	nadia.berkova@rennes.inra.fr	Legembre, Patrick/U-1882-2019; Almeida, Sintia/K-1217-2012; Azevedo, Vasco/B-1556-2019; Azevedo, Vasco A.C/F-4315-2011; legembre, patrick/L-3475-2016; LE LOIR, Yves/AAD-1879-2021	Legembre, Patrick/0000-0001-6649-8049; Almeida, Sintia/0000-0003-0270-9059; Azevedo, Vasco/0000-0002-4775-2280; Azevedo, Vasco A.C/0000-0002-4775-2280; legembre, patrick/0000-0001-6649-8049; taieb, frederic/0000-0001-9612-2069; Le Loir, Yves/0000-0002-0355-1065; Berkova, Nadia/0000-0001-6246-5549	Animal Health Department of INRA; MRI INRA; CAPES-COFECUB [720/11]	Animal Health Department of INRA; MRI INRA; CAPES-COFECUB(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding provided by a grant from the Animal Health Department of INRA. LA is the recipient of a fellowship from MRI INRA. SA is the recipient of a CAPES-COFECUB grant (Project 720/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseeva L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-33; Barratt RA, 1998, CANCER RES, V58, P2639; Ben Zakour NL, 2008, J BACTERIOL, V190, P6302, DOI 10.1128/JB.01984-07; Berkova N, 2006, INT IMMUNOL, V18, P139, DOI 10.1093/intimm/dxh356; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; Brunet J, 2008, CELL MICROBIOL, V10, P908, DOI 10.1111/j.1462-5822.2007.01093.x; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castro J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-9; Chen XP, 2011, ORGAN BEHAV HUM DEC, V114, P1, DOI 10.1016/j.obhdp.2010.11.001; Cimini D, 2003, MOL BIOL CELL, V14, P3821, DOI 10.1091/mbc.E03-01-0860; Comayras C, 1997, INFECT IMMUN, V65, P5088, DOI 10.1128/IAI.65.12.5088-5095.1997; Dego OK, 2002, VET QUART, V24, P181, DOI 10.1080/01652176.2002.9695135; Ding SZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009875; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; Fitzgerald JR, 2012, TRENDS MICROBIOL, V20, P192, DOI 10.1016/j.tim.2012.01.006; Gray MC, 2011, CELL MICROBIOL, V13, P123, DOI 10.1111/j.1462-5822.2010.01525.x; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Heimer SR, 2010, VIRULENCE, V1, P223, DOI 10.4161/viru.1.4.11466; Hess BJ, 2003, J SURG RES, V114, P42, DOI 10.1016/S0022-4804(03)00314-7; Huang J, 2008, NATURE, V456, P112, DOI 10.1038/nature07355; HUYNH HT, 1991, EXP CELL RES, V197, P191, DOI 10.1016/0014-4827(91)90422-Q; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; JELINEK DF, 1985, J IMMUNOL, V134, P1690; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P103, DOI 10.1016/0882-4010(88)90052-6; Kahl BC, 2000, INFECT IMMUN, V68, P5385, DOI 10.1128/IAI.68.9.5385-5392.2000; Kintarak S, 2004, INFECT IMMUN, V72, P5668, DOI 10.1128/IAI.72.10.5668-5675.2004; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Marechal C, 2009, J MICROBIOL METH, V79, P131, DOI 10.1016/j.mimet.2009.08.017; Le Marechal C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027354; Lutzow YCS, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-18; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; Martinez-Pulgarin S, 2009, MICROBIOL-SGM, V155, P1505, DOI 10.1099/mic.0.025544-0; MATTHEWS KR, 1994, J DAIRY SCI, V77, P2959, DOI 10.3168/jds.S0022-0302(94)77237-4; McKillip JL, 1998, APPL ENVIRON MICROB, V64, P4264; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Mou XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026544; Nikitas G, 2011, J EXP MED, V208, P2263, DOI 10.1084/jem.20110560; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Orosz L, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-47; OWEN TA, 1989, J CELL PHYSIOL, V139, P424, DOI 10.1002/jcp.1041390227; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Sayed M, 2001, ONCOGENE, V20, P6994, DOI 10.1038/sj.onc.1204894; Steeneveld W, 2011, J DAIRY SCI, V94, P174, DOI 10.3168/jds.2010-3367; SUGAI M, 1992, J BIOL CHEM, V267, P2600; Taieb F, 2006, CELL MICROBIOL, V8, P1910, DOI 10.1111/j.1462-5822.2006.00757.x; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vautor E, 2003, VET MICROBIOL, V96, P69, DOI 10.1016/S0378-1135(03)00207-4; Vautor E, 2009, VET MICROBIOL, V133, P105, DOI 10.1016/j.vetmic.2008.06.006; Wu WN, 2011, J VIROL, V85, P10300, DOI 10.1128/JVI.05164-11; ZAVIZION B, 1995, J DAIRY SCI, V78, P277, DOI 10.3168/jds.S0022-0302(95)76635-8	57	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63279	10.1371/journal.pone.0063279	http://dx.doi.org/10.1371/journal.pone.0063279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717407	Green Submitted, Green Published, gold			2022-12-27	WOS:000319435600007
J	Shinzawa, N; Ishino, T; Tachibana, M; Tsuboi, T; Torii, M				Shinzawa, Naoaki; Ishino, Tomoko; Tachibana, Mayumi; Tsuboi, Takafumi; Torii, Motomi			Phenotypic Dissection of a Plasmodium-Refractory Strain of Malaria Vector Anopheles stephensi: The Reduced Susceptibility to P. berghei and P. yoelii	PLOS ONE			English	Article							OOKINETE DESTRUCTION; XANTHURENIC ACID; GENETIC-ANALYSIS; MOSQUITO; GAMBIAE; FALCIPARUM; MIDGUT; INFECTION; RESISTANCE; PROTEINS	Anopheline mosquitoes are the major vectors of human malaria. Parasite-mosquito interactions are a critical aspect of disease transmission and a potential target for malaria control. Current investigations into parasite-mosquito interactions frequently assume that genetically resistant and susceptible mosquitoes exist in nature. Therefore, comparisons between the Plasmodium susceptibility profiles of different mosquito species may contribute to a better understanding of vectorial capacity. Anopheles stephensi is an important malaria vector in central and southern Asia and is widely used as a laboratory model of parasite transmission due to its high susceptibility to Plasmodium infection. In the present study, we identified a rodent malaria-refractory strain of A. stephensi mysorensis (Ehime) by comparative study of infection susceptibility. A very low number of oocysts develop in Ehime mosquitoes infected with P. berghei and P. yoelii, as determined by evaluation of developed oocysts on the basal lamina. A stage-specific study revealed that this reduced susceptibility was due to the impaired formation of ookinetes of both Plasmodium species in the midgut lumen and incomplete crossing of the midgut epithelium. There were no apparent abnormalities in the exflagellation of male parasites in the ingested blood or the maturation of oocysts after the rounding up of the ookinetes. Overall, these results suggest that invasive-stage parasites are eliminated in both the midgut lumen and epithelium in Ehime mosquitoes by strain-specific factors that remain unknown. The refractory strain newly identified in this report would be an excellent study system for investigations into novel parasite-mosquito interactions in the mosquito midgut.	[Shinzawa, Naoaki; Ishino, Tomoko; Tachibana, Mayumi; Torii, Motomi] Ehime Univ, Grad Sch Med, Dept Mol Parasitol, Toon, Ehime, Japan; [Tsuboi, Takafumi] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan	Ehime University; Ehime University	Shinzawa, N (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Parasitol, Toon, Ehime, Japan.	shinzawa@m.ehime-u.ac.jp	Tsuboi, Takafumi/AAK-6145-2021	Tsuboi, Takafumi/0000-0002-7415-1325; Ishino, Tomoko/0000-0003-2466-711X	Japan Society for the Promotion of Science KAKENHI [22890128]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 22890128. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak T, 2005, J PARASITOL, V91, P79, DOI 10.1645/GE-3514; Arai M, 2001, MOL BIOCHEM PARASIT, V116, P17, DOI 10.1016/S0166-6851(01)00299-7; Baton LA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-15; Baton LA, 2012, INT J PARASITOL, V42, P249, DOI 10.1016/j.ijpara.2011.12.005; Billingsley PF, 1997, PARASITOL TODAY, V13, P297, DOI 10.1016/S0169-4758(97)01094-6; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Collins FH, 1996, INSECT MOL BIOL, V5, P1, DOI 10.1111/j.1365-2583.1996.tb00034.x; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5; Djadid ND, 2006, ACTA TROP, V97, P65, DOI 10.1016/j.actatropica.2005.08.003; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; FELDMANN AM, 1990, PARASITOLOGY, V101, P193, DOI 10.1017/S003118200006323X; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; Feldmann AM, 1998, MED VET ENTOMOL, V12, P302, DOI 10.1046/j.1365-2915.1998.00122.x; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Frischknecht F, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-23; Gonzalez-Ceron L, 2001, EXP PARASITOL, V98, P152, DOI 10.1006/expr.2001.4626; Gorman MJ, 1997, GENETICS, V146, P965; Grieco JP, 2005, J AM MOSQUITO CONTR, V21, P279, DOI 10.2987/8756-971X(2005)21[279:CSOTSO]2.0.CO;2; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Hume JCC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-139; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jacobs-Lorena VY, 2010, MOL BIOCHEM PARASIT, V171, P40, DOI 10.1016/j.molbiopara.2009.12.009; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Paskewitz SM, 2005, INSECT BIOCHEM MOLEC, V35, P815, DOI 10.1016/j.ibmb.2005.03.002; PORTER CH, 1991, AM J TROP MED HYG, V45, P271, DOI 10.4269/ajtmh.1991.45.271; Prevot GI, 1998, INSECT MOL BIOL, V7, P375, DOI 10.1046/j.1365-2583.1998.740375.x; Ramakrishnan C, 2011, INT J PARASITOL, V41, P1029, DOI 10.1016/j.ijpara.2011.05.007; RAWLINGS DJ, 1992, MOL BIOCHEM PARASIT, V56, P239, DOI 10.1016/0166-6851(92)90173-H; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; SUBBARAO SK, 1987, MED VET ENTOMOL, V1, P265, DOI 10.1111/j.1365-2915.1987.tb00353.x; Tikar SN, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.8501; Tsuboi T, 1997, INFECT IMMUN, V65, P2260, DOI 10.1128/IAI.65.6.2260-2264.1997; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Vatandoost H, 2006, ACTA TROP, V97, P196, DOI 10.1016/j.actatropica.2005.11.002; Vlachou D, 2005, CURR OPIN MICROBIOL, V8, P415, DOI 10.1016/j.mib.2005.06.013; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	48	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63753	10.1371/journal.pone.0063753	http://dx.doi.org/10.1371/journal.pone.0063753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717475	Green Published, Green Submitted, gold			2022-12-27	WOS:000319435600031
J	Rusine, J; Ondoa, P; Asiimwe-Kateera, B; Boer, KR; Uwimana, JM; Mukabayire, O; Zaaijer, H; Mugabekazi, J; Reiss, P; van de Wijgert, JH				Rusine, John; Ondoa, Pascale; Asiimwe-Kateera, Brenda; Boer, Kimberly R.; Uwimana, Jean Marie; Mukabayire, Odette; Zaaijer, Hans; Mugabekazi, Julie; Reiss, Peter; van de Wijgert, Janneke H.			High Seroprevalence of HBV and HCV Infection in HIV-Infected Adults in Kigali, Rwanda	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SUB-SAHARAN AFRICA; COINFECTION; EPIDEMIOLOGY; ANTIBODY; COHORT	Background: Data on prevalence and incidence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in Rwanda are scarce. Methods: HBV status was assessed at baseline and Month 12, and anti-HCV antibodies at baseline, in a prospective cohort study of HIV-infected patients in Kigali, Rwanda: 104 men and 114 women initiating antiretroviral therapy (ART) at baseline, and 200 women not yet eligible for ART. Results: Baseline prevalence of active HBV infection (HBsAg positive), past or occult HBV infection (anti-HBc positive and HBsAg negative) and anti-HCV was 5.2%, 42.9%, and 5.7%, respectively. The active HBV incidence rate was 4.2/1,000 person years (PY). In a multivariable logistic regression model using baseline data, participants with WHO stage 3 or 4 HIV disease were 4.19 times (95% CI 1.21-14.47) more likely to have active HBV infection, and older patients were more likely to have evidence of past exposure to HBV (aRR 1.03 per year; 95% CI 1.01-1.06). Older age was also positively associated with having anti-HCV antibodies (aOR 1.09; 95% CI 1.04-1.14) while having a higher baseline HIV viral load was negatively associated with HCV (aOR 0.60; 95% CI 0.40-0.98). The median CD4 increase during the first 12 months of ART was lower for those with active HBV infection or anti-HCV at baseline. Almost all participants (88%) with active HBV infection who were on ART were receiving lamivudine monotherapy for HBV. Conclusion: HBV and HCV are common in HIV-infected patients in Rwanda. Regular HBsAg screening is needed to ensure that HIV-HBV co-infected patients receive an HBV-active ART regimen, and the prevalence of occult HBV infection should be determined. Improved access to HBV vaccination is recommended. Active HCV prevalence and incidence should be investigated further to determine whether HCV RNA PCR testing should be introduced in Rwanda.	[Rusine, John; Ondoa, Pascale; Boer, Kimberly R.; Reiss, Peter; van de Wijgert, Janneke H.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Rusine, John; Ondoa, Pascale; Boer, Kimberly R.; Reiss, Peter; van de Wijgert, Janneke H.] AIGHD, Amsterdam, Netherlands; [Rusine, John; Asiimwe-Kateera, Brenda; Boer, Kimberly R.] INTERACT Program, Kigali, Rwanda; [Rusine, John; Uwimana, Jean Marie; Mukabayire, Odette] Natl Reference Lab, Kigali, Rwanda; [Boer, Kimberly R.] Royal Trop Inst, NL-1105 AZ Amsterdam, Netherlands; [Mugabekazi, Julie] KUTH, Kigali, Rwanda; [Zaaijer, Hans] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke H.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool	van de Wijgert, JH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.vandewijgert@liv.ac.uk	Asiimwe-Kateera, Brenda/H-3378-2019	van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Asiimwe Kateera, Brenda/0000-0001-6134-1042	Netherlands-African Partnership for Capacity Development; Clinical Interventions against Poverty-related Diseases (NACCAP) of the Netherlands Organisation for Scientific Research - The Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO); European and Developing Countries Clinical Trials Partnership (EDCTP)	Netherlands-African Partnership for Capacity Development; Clinical Interventions against Poverty-related Diseases (NACCAP) of the Netherlands Organisation for Scientific Research - The Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO); European and Developing Countries Clinical Trials Partnership (EDCTP)	This work was part of the INTERACT Program funded by the Netherlands-African Partnership for Capacity Development and Clinical Interventions against Poverty-related Diseases (NACCAP) of the Netherlands Organisation for Scientific Research - The Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO; URL: http://www.nwo.nl/nwohome.nsf/pages/NWOP_5VWBMM_Eng). Funding was also received from the European and Developing Countries Clinical Trials Partnership (EDCTP) as part of a project entitled: 'Preparing for Phase III vaginal microbicide trials in Rwanda and Kenya: Preparedness studies, capacity building, and strengthening of medical referral systems' (CT_ct_05_33070_001; URL: http://www.edctp.org/). The views expressed in this paper are those of the authors and do not necessarily represent the official position of NWO-WOTRO or EDCTP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2003, J HEPATOL, V39, pS64, DOI 10.1016/S0168-8278(03)00141-7; Arshad M, 2011, J VIRAL HEPATITIS, V18, P229, DOI 10.1111/j.1365-2893.2010.01413.x; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Burnett RJ, 2005, LIVER INT, V25, P201, DOI 10.1111/j.1478-3231.2005.01054.x; Chadwick D, 2012, J ANTIMICROB CHEMOTH, V67, P2939, DOI 10.1093/jac/dks333; Chadwick D, 2013, AIDS, V27, P139, DOI 10.1097/QAD.0b013e3283589879; Di Bisceglie AM, 2010, ANTIVIR THER, V15, P499, DOI 10.3851/IMP1494; Diop-Ndiaye H, 2008, J MED VIROL, V80, P1332, DOI 10.1002/jmv.21236; Edmunds WJ, 1996, EPIDEMIOL INFECT, V117, P313, DOI 10.1017/S0950268800001497; Firnhaber C, 2009, INT J INFECT DIS, V13, P488, DOI 10.1016/j.ijid.2008.08.018; Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09; Harania RS, 2008, AIDS, V22, P1221, DOI 10.1097/QAD.0b013e32830162a8; HOFFMAN CJ, 2009, CLIN INFECT DIS, V49, P1268; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Idoko J, 2009, CLIN INFECT DIS, V49, P1268, DOI 10.1086/605675; Ladep N G, 2007, Niger J Med, V16, P231; Laurent C, 2010, HIV MED, V11, P85, DOI 10.1111/j.1468-1293.2009.00742.x; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/j.gastro.2003.09.033; Nakwagala F N, 2002, East Afr Med J, V79, P68; Nebbia G, 2007, J MED VIROL, V79, P1464, DOI 10.1002/jmv.20954; Nunez M, 2006, AIDS RES HUM RETROV, V22, P842, DOI 10.1089/aid.2006.22.842; Omland LH, 2008, HIV MED, V9, P300, DOI 10.1111/j.1468-1293.2008.00564.x; Otegbayo JA, 2008, ANN HEPATOL, V7, P152, DOI 10.1016/S1665-2681(19)31872-1; Pirillo MF, 2007, J MED VIROL, V79, P1797, DOI 10.1002/jmv.21007; Rao HY, 2012, J GASTROEN HEPATOL, V27, P526, DOI 10.1111/j.1440-1746.2011.06880.x; *RWAND MIN HLTH, 2011, NAT HIV CAR TREATM G; Seremba E, 2010, J MED VIROL, V82, P1371, DOI 10.1002/jmv.21817; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shire NJ, 2004, JAIDS-J ACQ IMM DEF, V36, P869, DOI 10.1097/00126334-200407010-00015; Taylor LE, 2012, CLIN INFECT DIS, V55, pS33, DOI 10.1093/cid/cis367; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; van Bommel F, 2006, HEPATOLOGY, V44, P318, DOI 10.1002/hep.21253; Vardas E, 1999, J MED VIROL, V58, P111, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;111::AID-JMV2&gt;3.0.CO;2-B	34	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63303	10.1371/journal.pone.0063303	http://dx.doi.org/10.1371/journal.pone.0063303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717409	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700014
J	Buckley, AM; Spencer, J; Maclellan, LM; Candlish, D; Irvine, JJ; Douce, GR				Buckley, Anthony M.; Spencer, Janice; Maclellan, Lindsay M.; Candlish, Denise; Irvine, June J.; Douce, Gillian R.			Susceptibility of Hamsters to Clostridium difficile Isolates of Differing Toxinotype	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; STRAINS; INFECTION; DIVERSITY; SPORES; PREVALENCE; VIRULENCE; REVEALS; DISEASE	Clostridium difficile is the most commonly associated cause of antibiotic associated disease (AAD), which caused similar to 21,000 cases of AAD in 2011 in the U.K. alone. The golden Syrian hamster model of CDI is an acute model displaying many of the clinical features of C. difficile disease. Using this model we characterised three clinical strains of C. difficile, all differing in toxinotype; CD1342 (PaLoc negative), M68 (toxinotype VIII) & BI-7 (toxinotype III). The naturally occurring non-toxic strain colonised all hamsters within 1-day post challenge (d.p.c.) with high-levels of spores being shed in the faeces of animals that appeared well throughout the entire experiment. However, some changes including increased neutrophil influx and unclotted red blood cells were observed at early time points despite the fact that the known C. difficile toxins (TcdA, TcdB and CDT) are absent from the genome. In contrast, hamsters challenged with strain M68 resulted in a 45% mortality rate, with those that survived challenge remaining highly colonised. It is currently unclear why some hamsters survive infection, as bacterial & toxin levels and histology scores were similar to those culled at a similar time-point. Hamsters challenged with strain BI-7 resulted in a rapid fatal infection in 100% of the hamsters approximately 26 hr post challenge. Severe caecal pathology, including transmural neutrophil infiltrates and extensive submucosal damage correlated with high levels of toxin measured in gut filtrates ex vivo. These data describes the infection kinetics and disease outcomes of 3 clinical C. difficile isolates differing in toxin carriage and provides additional insights to the role of each toxin in disease progression.	[Buckley, Anthony M.; Spencer, Janice; Maclellan, Lindsay M.; Candlish, Denise; Irvine, June J.; Douce, Gillian R.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland	University of Glasgow	Douce, GR (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland.	Gillian.Douce@Glasgow.ac.uk		Buckley, Anthony/0000-0002-2790-0717; Douce, Gillian/0000-0002-6654-7346	Wellcome Trust [086418]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors gratefully acknowledge the support of the Wellcome Trust (grant number 086418 awarded to Dr G. Douce & Prof. B. Wren). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS JM, 2001, J ANTIMICROB CHEMOTH, V48, pS15; Arvand M, 2009, EUROSURVEILLANCE, V14, P27; BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; Belloni V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012940; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; Brouwer MSM, 2012, J BACTERIOL, V194, P2125, DOI 10.1128/JB.00122-12; Buckley AM, 2011, J MED MICROBIOL, V60, P1174, DOI 10.1099/jmm.0.028514-0; Cartman ST, 2010, INT J MED MICROBIOL, V300, P387, DOI 10.1016/j.ijmm.2010.04.008; Casas V, 2011, FUTURE MICROBIOL, V6, P1461, DOI [10.2217/fmb.11.124, 10.2217/FMB.11.124]; Drudy D, 2007, CLIN MICROBIOL INFEC, V13, P298, DOI 10.1111/j.1469-0691.2006.01634.x; Duerden BI, 2011, ANAEROBE, V17, P175, DOI 10.1016/j.anaerobe.2010.12.004; Elliott B, 2011, J MED MICROBIOL, V60, P1108, DOI 10.1099/jmm.0.031062-0; Goulding D, 2009, INFECT IMMUN, V77, P5478, DOI 10.1128/IAI.00551-09; Guerrero DM, 2012, AM J INFECT CONTROL, V40, P556, DOI 10.1016/j.ajic.2011.08.002; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Huang H, 2009, CLIN MICROBIOL INFEC, V15, P1170, DOI 10.1111/j.1469-0691.2009.02992.x; KAMIYA S, 1989, J MED MICROBIOL, V28, P217, DOI 10.1099/00222615-28-3-217; Kim H, 2008, J CLIN MICROBIOL, V46, P1116, DOI 10.1128/JCM.01188-07; Kim H, 2010, KOREAN J LAB MED, V30, P491, DOI 10.3343/kjlm.2010.30.5.491; Kim J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-109; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Marsh JW, 2006, J CLIN MICROBIOL, V44, P2558, DOI 10.1128/JCM.02364-05; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Miyajima F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022804; NERANDZIC MM, 2012, INFECT IMMUN, V80, P2704; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Ogura Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r138; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; PETRELLA LA, 2012, DECREASED CURE INCRE; Razaq N, 2007, J INFECT DIS, V196, P1813, DOI 10.1086/523106; Rousseau C, 2011, J MED MICROBIOL, V60, P1112, DOI 10.1099/jmm.0.029736-0; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Sambol SP, 2002, J INFECT DIS, V186, P1781, DOI 10.1086/345676; Sambol SP, 2001, J INFECT DIS, V183, P1760, DOI 10.1086/320736; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2008, J MED MICROBIOL, V57, P771, DOI 10.1099/jmm.0.47743-0; Steiner TS, 1997, CLIN DIAGN LAB IMMUN, V4, P719, DOI 10.1128/CDLI.4.6.719-722.1997; Stoesser N, 2011, J CLIN MICROBIOL, V49, P3994, DOI 10.1128/JCM.05349-11; Vesteinsdottir I, 2012, EUR J CLIN MICROBIOL, V31, P2601, DOI 10.1007/s10096-012-1603-0; Villano SA, 2012, ANTIMICROB AGENTS CH, V56, P5224, DOI 10.1128/AAC.00913-12; Vohra P, 2011, MICROBIOL-SGM, V157, P1343, DOI 10.1099/mic.0.046243-0; Wang JP, 1997, NEUROIMMUNOMODULAT, V4, P230, DOI 10.1159/000097341; Wilcox MH, 2000, LANCET, V356, P1324, DOI 10.1016/S0140-6736(00)02819-1; Wilcox MH, 1996, J HOSP INFECT, V34, P23, DOI 10.1016/S0195-6701(96)90122-X	47	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64121	10.1371/journal.pone.0064121	http://dx.doi.org/10.1371/journal.pone.0064121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704976	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000319330200118
J	Doerr, C; Blenn, N; Van Mieghem, P				Doerr, Christian; Blenn, Norbert; Van Mieghem, Piet			Lognormal Infection Times of Online Information Spread	PLOS ONE			English	Article								The infection times of individuals in online information spread such as the inter-arrival time of Twitter messages or the propagation time of news stories on a social media site can be explained through a convolution of lognormally distributed observation and reaction times of the individual participants. Experimental measurements support the lognormal shape of the individual contributing processes, and have resemblance to previously reported lognormal distributions of human behavior and contagious processes.	[Doerr, Christian; Blenn, Norbert; Van Mieghem, Piet] Delft Univ Technol, Delft, Netherlands	Delft University of Technology	Doerr, C (corresponding author), Delft Univ Technol, Delft, Netherlands.	C.Doerr@tudelft.nl			EU Network of Excellence in Internet Science EINS [288021]; Trans-sector Research Academy for complex Networks and Services (TRANS)	EU Network of Excellence in Internet Science EINS; Trans-sector Research Academy for complex Networks and Services (TRANS)	This research has been supported by the EU Network of Excellence in Internet Science EINS (project no. 288021) and the Trans-sector Research Academy for complex Networks and Services (TRANS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2005, ARXIVPHYSICS0510216; Amarala LAN, 2008, PNAS, V105; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barcelo F, 1998, ELECT LETT, V34; Bollobas B, 2001, RANDOM STRUCT ALGOR, V18, P279, DOI 10.1002/rsa.1009; Crow E. L., 1988, LOGNORMAL DISTRIBUTI; Fortunato S, 2008, PNAS, V105; Gibrat R., 1931, INEGALITES EC; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Huberman BA, 2012, ARTIFICIAL INATION R; Jordan J, 2000, IEEE T VEHICULAR TEC; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Lawrence RJ, 1984, J ROYAL STAT SOC A, V147; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Iribarren JL, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038702; MARLOW NA, 1967, AT&T TECH J, V46, P2081, DOI 10.1002/j.1538-7305.1967.tb04244.x; Newman M.E.J., 2005, CONT PHYS; Nishiura H, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-2; SARTWELL PE, 1950, AM J HYG, V51, P310, DOI 10.1093/oxfordjournals.aje.a119397; Shockley W, 1957, P IRE; Vajna S, 2012, ARXIV12111175; van der Linden WJ, 2006, J ED BEHAV STAT, V31; Van Mieghem P, 2011, EUR PHYS J B, V83, P251, DOI 10.1140/epjb/e2011-20124-0; Van Mieghem P, 2012, COMPUTER COMMUNICATI, V35; van Mieghem P., 2006, PERFORMANCE ANAL COM; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990	27	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64349	10.1371/journal.pone.0064349	http://dx.doi.org/10.1371/journal.pone.0064349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700473	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200131
J	Jeong, YH; Park, CH; Jang, GH; Jeong, YI; Hwang, IS; Jeong, YW; Kim, YK; Shin, T; Kim, NH; Hyun, SH; Jeung, EB; Hwang, WS				Jeong, Young-Hee; Park, Chi-Hun; Jang, Gun-Hyuk; Jeong, Yeun-Ik; Hwang, In-Sung; Jeong, Yeon-woo; Kim, Yu-Kyung; Shin, Taeyoung; Kim, Nam-Hyung; Hyun, Sang-Hwan; Jeung, Eui-Bae; Hwang, Woo-Suk			Production of Multiple Transgenic Yucatan Miniature Pigs Expressing Human Complement Regulatory Factors, Human CD55, CD59, and H-Transferase Genes	PLOS ONE			English	Article							EX-VIVO MODEL; HUMAN ALPHA-1,2-FUCOSYL-TRANSFERASE; HUMAN DAF; XENOTRANSPLANTATION; KNOCKOUT; COMBINATION; GENERATION; PROTEINS; SURVIVAL; VECTORS	The present study was conducted to generate transgenic pigs coexpressing human CD55, CD59, and H-transferase (HT) using an IRES-mediated polycistronic vector. The study focused on hyperacute rejection (HAR) when considering clinical xenotransplantation as an alternative source for human organ transplants. In total, 35 transgenic cloned piglets were produced by somatic cell nuclear transfer (SCNT) and were confirmed for genomic integration of the transgenes from umbilical cord samples by PCR analysis. Eighteen swine umbilical vein endothelial cells (SUVEC) were isolated from umbilical cord veins freshly obtained from the piglets. We observed a higher expression of transgenes in the transgenic SUVEC (Tg SUVEC) compared with the human umbilical vein endothelial cells (HUVEC). Among these genes, HT and hCD59 were expressed at a higher level in the tested Tg organs compared with non-Tg control organs, but there was no difference in hCD55 expression between them. The transgenes in various organs of the Tg clones revealed organ-specific and spatial expression patterns. Using from 0 to 50% human serum solutions, we performed human complement-mediated cytolysis assays. The results showed that, overall, the Tg SUVEC tested had greater survival rates than did the non-Tg SUVEC, and the Tg SUVEC with higher HT expression levels tended to have more down-regulated alpha-Gal epitope expression, resulting in greater protection against cytotoxicity. By contrast, several Tg SUVEC with low CD55 expression exhibited a decreased resistance response to cytolysis. These results indicated that the levels of HT expression were inversely correlated with the levels of alpha-Gal epitope expression and that the combined expression of hCD55, hCD59, and HT proteins in SUVECs markedly enhances a protective response to human serum-mediated cytolysis. Taken together, these results suggest that combining a polycistronic vector system with SCNT methods provides a fast and efficient alternative for the generation of transgenic large animals with multiple genetic modifications.	[Jeong, Young-Hee; Park, Chi-Hun; Jang, Gun-Hyuk; Jeong, Yeun-Ik; Hwang, In-Sung; Jeong, Yeon-woo; Kim, Yu-Kyung; Shin, Taeyoung; Hwang, Woo-Suk] Sooam Biotech Res Fdn, Seoul, South Korea; [Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Hyun, Sang-Hwan; Jeung, Eui-Bae] Chungbuk Natl Univ, Coll Vet Med, Cheongju, South Korea	Chungbuk National University; Chungbuk National University	Hwang, WS (corresponding author), Sooam Biotech Res Fdn, Seoul, South Korea.	hwangws@sooam.org	Park, Chi-Hun/J-1258-2019	Park, Chi-Hun/0000-0002-7618-9028	Next-Generation BioGreen 21 Program Rural Development Administration, Republic of Korea [PJ00832303]	Next-Generation BioGreen 21 Program Rural Development Administration, Republic of Korea	This work was supported by a grant of Next-Generation BioGreen 21 Program (No. PJ00832303) Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Bouabe H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1119; BRENNER P, 2000, TRANSPL INT S1, V1, pS508; Bucher P, 2005, TRANSPL INT, V18, P894, DOI 10.1111/j.1432-2277.2005.00124.x; Byrne G, 1997, TRANSPLANTATION, V63, P149, DOI 10.1097/00007890-199701150-00027; Candotti F, 2000, CANCER GENE THER, V7, P574, DOI 10.1038/sj.cgt.7700153; CARRINGTON CA, 1995, TRANSPLANT P, V27, P321; Chan HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028885; Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536; Chen CG, 1998, TRANSPLANTATION, V65, P832, DOI 10.1097/00007890-199803270-00011; CHENG L, 1993, P NATL ACAD SCI USA, V90, P4455, DOI 10.1073/pnas.90.10.4455; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; Costa C, 2002, XENOTRANSPLANTATION, V9, P45, DOI 10.1034/j.1399-3089.2002.0o142.x; Cowan PJ, 1998, TRANSPLANTATION, V65, P826, DOI 10.1097/00007890-199803270-00010; Cowan PJ, 2000, TRANSPLANTATION, V69, P2504, DOI 10.1097/00007890-200006270-00008; COZZI E, 1995, NAT MED, V1, P964, DOI 10.1038/nm0995-964; Deng W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019986; Diamond LE, 2001, TRANSPLANTATION, V71, P132, DOI 10.1097/00007890-200101150-00021; Diamond LE, 1996, TRANSPLANTATION, V61, P1241, DOI 10.1097/00007890-199604270-00021; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Ekser B, 2009, TRANSPL IMMUNOL, V21, P87, DOI 10.1016/j.trim.2008.10.005; FODOR WL, 1994, P NATL ACAD SCI USA, V91, P11153, DOI 10.1073/pnas.91.23.11153; Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; Knosalla C, 2009, AM J TRANSPLANT, V9, P1006, DOI 10.1111/j.1600-6143.2009.02602.x; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; LANGFORD GA, 1994, TRANSPLANT P, V26, P1400; Lee JH, 2006, TRANSPL P, V38, P1618, DOI 10.1016/j.transproceed.2006.02.129; Li SZ, 2009, XENOTRANSPLANTATION, V16, P27, DOI 10.1111/j.1399-3089.2009.00509.x; Liu BQ, 2008, SCI CHINA SER C, V51, P199, DOI 10.1007/s11427-008-0019-7; Menoret S, 2004, TRANSPLANTATION, V77, P1468, DOI 10.1097/01.TP.0000111758.35048.EA; Niemann H, 2000, ANIM REPROD SCI, V60, P277, DOI 10.1016/S0378-4320(00)00091-9; Park CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051398; Petersen B, 2009, COMP IMMUNOL MICROB, V32, P91, DOI 10.1016/j.cimid.2007.11.014; Pizzato M, 1998, GENE THER, V5, P1003, DOI 10.1038/sj.gt.3300670; Prather RS, 2008, BIOTECHNOL GENET ENG, V25, P245; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Ramirez P, 2000, TRANSPLANTATION, V70, P989, DOI 10.1097/00007890-200010150-00001; SANDRIN MS, 1995, NAT MED, V1, P1261, DOI 10.1038/nm1295-1261; Sprangers B, 2008, KIDNEY INT, V74, P14, DOI 10.1038/ki.2008.135; Tseng YL, 2005, TRANSPLANTATION, V80, P1493, DOI 10.1097/01.tp.0000181397.41143.fa; Zhou CY, 2005, XENOTRANSPLANTATION, V12, P142, DOI 10.1111/j.1399-3089.2005.00209.x	45	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63241	10.1371/journal.pone.0063241	http://dx.doi.org/10.1371/journal.pone.0063241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704897	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200026
J	Kenyon, C; Buyze, J; Colebunders, R				Kenyon, Chris; Buyze, Jozefien; Colebunders, Robert			HIV Prevalence by Race Co-Varies Closely with Concurrency and Number of Sex Partners in South Africa	PLOS ONE			English	Article							CAPE-TOWN; HEALTH; RISK; DIFFERENTIALS; POPULATION; BEHAVIORS; EPIDEMICS; TALE; MEN	Background: HIV prevalence differs by more than an order of magnitude between South Africa's racial groups. Comparing the sexual behaviors and other risk factors for HIV transmission between the different races may shed light on the determinants of South Africa's generalized HIV epidemic. Methods: Five nationally representative and one city-representative population-based surveys of sexual behavior were used to assess the extent to which various risk factors co-varied with HIV prevalence by race in South Africa. Results: In 2004, the prevalence of HIV was 0.5%, 1%, 3.2% and 19.9% in 15-49 year old whites, Indians, coloureds and blacks respectively. The risk factors which co-varied with HIV prevalence by race in the six surveys were age of sexual debut (in five out of five surveys for men and three out of six surveys for women), age gap (zero surveys in men and three in women), mean number of sex partners in the previous year (five surveys in men and three in women) and concurrent partnerships (five surveys in men and one in women). Condom usage and circumcision were both more prevalent in the high HIV prevalence groups. The reported prevalence of concurrency was 6 to 17 times higher in the black as opposed to the white men in the five surveys. Conclusions: The differences in sexual behavior in general, and the prevalence of concurrency and the number of sexual partners in particular, offer a plausible and parsimonious cause to explain a part of the differing prevalences of HIV between South Africa's racial groups.	[Kenyon, Chris] Inst Trop Med, HIV STD Unit, B-2000 Antwerp, Belgium; [Kenyon, Chris] Univ Cape Town, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Buyze, Jozefien] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert] Inst Trop Med, Clin HIV STI Unit, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Cape Town; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Kenyon, C (corresponding author), Inst Trop Med, HIV STD Unit, B-2000 Antwerp, Belgium.	chriskenyon0@gmail.com	Buyze, Jozefien/B-8550-2014	Buyze, Jozefien/0000-0001-6780-380X; Kenyon, Chris/0000-0002-2557-8998				[Anonymous], 2009, CONS CONC SEX PARTN; Badri M, 2010, S AFRICAN J HIV MED, V10, P29; BIGGAR RJ, 1992, AM J PUBLIC HEALTH, V82, P1506, DOI 10.2105/AJPH.82.11.1506; Buve A, 2012, AIDS, V26, P1203, DOI 10.1097/QAD.0b013e328353bc36; Colvin M, 2007, KWAZULU NATAL HIV IM; Delate R, 2010, 2 NAT HIV COMM SURV; Department of Health, 1999, S AFR DEM HLTH SURV; Department of Health Medical Research Council OrcMacro, 2007, S AFR DEM HLTH SURV; Epstein H, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-13; Fraser-Hurt N., 2011, HIV EPIDEMIC S AFRIC, DOI [10/3589/7038.pdf?sequence=1&isAllowed=y, DOI 10/3589/7038.PDF?SEQUENCE=1&ISALLOWED=Y]; Glynn JR, 2012, AIDS, V26, P977, DOI 10.1097/QAD.0b013e328350fc1f; Gourvenec D, 2009, 5 IAS C CAP TOWN; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; HEAIDS, 2010, HIV PREV REL FACT HI; Helleringer S, 2011, AIDS, V25, P503, DOI 10.1097/QAD.0b013e3283434485; Johnson LF, 2009, AIDS, V23, P1583, DOI 10.1097/QAD.0b013e32832d407e; Kenyon C, 2013, INT J INFECT DIS, V17, pE286, DOI 10.1016/j.ijid.2012.12.020; Kenyon C, 2012, INT J INFECT DIS, V16, pE826, DOI 10.1016/j.ijid.2012.05.008; Kenyon C, 2012, J ADOLESCENT HEALTH, V50, P208, DOI 10.1016/j.jadohealth.2011.09.016; Kenyon C, 2010, S AFR J HIV MED, P22; Kenyon C, 2009, AJAR-AFR J AIDS RES, V8, P243, DOI 10.2989/AJAR.2009.8.3.1.922; Kirby D, 2008, SEX TRANSM INFECT, V84, pII35, DOI 10.1136/sti.2008.029892; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Lam D, 2006, CAPE AREA PANEL STUD; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Leclerc-Madlala S, 2009, SEX HEALTH, V6, P103, DOI 10.1071/SH08032; Mah TL, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-33; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Maughan-Brown B, 2013, SEXUAL HLTH IN PRESS; Maughan-Brown B, 2012, SEX TRANSM DIS, V39, P537, DOI 10.1097/OLQ.0b013e31824cc0c1; Maughan-Brown B, 2011, JAIDS-J ACQ IMM DEF, V58, P499, DOI 10.1097/QAI.0b013e31823584c1; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014092; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Pettifor AE, 2011, J ADOLESCENT HEALTH, V49, P237, DOI 10.1016/j.jadohealth.2010.10.002; Sawers L, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-34; Shisana O, 2002, S AFRICAN NATL HIV P; SHISANA O, 2005, S AFRICAN NATL HIV P; Shisana O, 2009, S AFRICAN NATL HIV P; Smith M. K., 2002, Gender and Development, V10, P63, DOI 10.1080/13552070215914; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8	46	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64080	10.1371/journal.pone.0064080	http://dx.doi.org/10.1371/journal.pone.0064080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23704973	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200112
J	Kim, J; Buckett, PD; Wessling-Resnick, M				Kim, Jonghan; Buckett, Peter D.; Wessling-Resnick, Marianne			Absorption of Manganese and Iron in a Mouse Model of Hemochromatosis	PLOS ONE			English	Article							HFE-DEFICIENT MICE; HEREDITARY HEMOCHROMATOSIS; OLFACTORY TRANSPORT; METAL-TRANSPORTER; DIETARY IRON; RAT-BRAIN; EXPRESSION; MUTATION; LIVER; FERROPORTIN	Hereditary hemochromatosis, an iron overload disease associated with excessive intestinal iron absorption, is commonly caused by loss of HFE gene function. Both iron and manganese absorption are regulated by iron status, but the relationships between the transport pathways of these metals and how they are affected by HFE-associated hemochromatosis remain poorly understood. Loss of HFE function is known to alter the intestinal expression of DMT1 (divalent metal transporter-1) and Fpn (ferroportin), transporters that have been implicated in absorption of both iron and manganese. Although the influence of HFE deficiency on dietary iron absorption has been characterized, potential effects on manganese metabolism have yet to be explored. To investigate the role of HFE in manganese absorption, we characterized the uptake and distribution of the metal in Hfe(-/-) knockout mice after intravenous, intragastric, and intranasal administration of Mn-54. These values were compared to intravenous and intragastric administration of Fe-59. Intestinal absorption of Fe-59 was increased and clearance of injected Fe-59 was also increased in Hfe(-/-) mice compared to controls. Hfe(-/-) mice displayed greater intestinal absorption of Mn-54 compared to wild-type Hfe(+/+) control mice. After intravenous injection, the distribution of Fe-59 to heart and liver was greater in Hfe(-/-) mice but no remarkable differences were observed for Mn-54. Although olfactory absorption of Mn-54 into blood was unchanged in Hfe(-/-) mice, higher levels of intranasally-instilled Mn-54 were associated with Hfe(-/-) brain compared to controls. These results show that manganese transport and metabolism can be modified by HFE deficiency.	[Kim, Jonghan] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Kim, Jonghan; Buckett, Peter D.; Wessling-Resnick, Marianne] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Northeastern University; Harvard University; Harvard T.H. Chan School of Public Health	Kim, J (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA.	j.kim@neu.edu; wessling@hsph.harvard.edu			NIH [R03 DA027030, K99/R00 ES017781, P30 ES000002]; Yerby Fellowship from the Harvard School of Public Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES017781, R01ES014638, P30ES000002, R00ES017781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027030] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yerby Fellowship from the Harvard School of Public Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by grants R03 DA027030 (MWR) and K99/R00 ES017781 and P30 ES000002 (JK) from the NIH and the Yerby Fellowship from the Harvard School of Public Health (JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Ajioka RS, 2002, BLOOD, V100, P1465, DOI 10.1182/blood-2001-11-0037; Andersen ME, 1999, NEUROTOXICOLOGY, V20, P161; Bacon Bruce R., 1999, Gastroenterology, V116, P193, DOI 10.1016/S0016-5085(99)70244-1; Bahram S, 1999, P NATL ACAD SCI USA, V96, P13312, DOI 10.1073/pnas.96.23.13312; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; BERTINCHAMPS AJ, 1966, AM J PHYSIOL, V211, P217, DOI 10.1152/ajplegacy.1966.211.1.217; BONILLA E, 1984, EXP NEUROL, V84, P696, DOI 10.1016/0014-4886(84)90216-4; Bradley LA, 1998, J MED SCREEN, V5, P34, DOI 10.1136/jms.5.1.34; Brenneman KA, 2000, TOXICOL APPL PHARM, V169, P238, DOI 10.1006/taap.2000.9073; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Chaudhury C, 2006, J NUTR, V136, P2993, DOI 10.1093/jn/136.12.2993; Chua ACG, 1996, BIOL TRACE ELEM RES, V55, P39, DOI 10.1007/BF02784167; COTZIAS GC, 1958, PHYSIOL REV, V38, P503, DOI 10.1152/physrev.1958.38.3.503; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; DONALDSON J, 1987, NEUROTOXICOLOGY, V8, P451; Dorman DC, 2002, J TOXICOL ENV HEAL A, V65, P1493, DOI 10.1080/00984100290071630; Dupic F, 2002, GUT, V51, P648, DOI 10.1136/gut.51.5.648; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Griffiths WJH, 2001, GASTROENTEROLOGY, V120, P1420, DOI 10.1053/gast.2001.24050; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haynes EN, 2010, NEUROTOXICOLOGY, V31, P468, DOI 10.1016/j.neuro.2009.10.011; Henn BC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-97; Herrmann T, 2004, J MOL MED, V82, P39, DOI 10.1007/s00109-003-0508-x; Hojyo S, 2013, HAEMATOLOGICA; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033533; Kim J, 2011, AM J PHYSIOL-LUNG C, V300, pL659, DOI 10.1152/ajplung.00343.2010; Kumara VMR, 2012, AM J PHYSIOL-LUNG C, V302, pL1280, DOI 10.1152/ajplung.00004.2012; Lee PL, 1998, BLOOD CELL MOL DIS, V24, P199, DOI 10.1006/bcmd.1998.0186; Levy JE, 1999, BLOOD, V94, P9, DOI 10.1182/blood.V94.1.9.413a43_9_11; Li L, 2011, BIOL TRACE ELEM RES, V143, P1581, DOI 10.1007/s12011-011-8967-3; Lucchini R, 1997, ENVIRON RES, V73, P175, DOI 10.1006/enrs.1997.3702; Madejczyk MS, 2012, BBA-BIOMEMBRANES, V1818, P651, DOI 10.1016/j.bbamem.2011.12.002; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Merryweather-Clarke AT, 2000, GENET TEST, V4, P183, DOI 10.1089/10906570050114902; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nong A, 2008, J TOXICOL ENV HEAL A, V71, P413, DOI 10.1080/15287390701838697; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Rodrigues P, 2006, INT J EXP PATHOL, V87, P317, DOI 10.1111/j.1365-2613.2006.00491.x; Roels HA, 2012, NEUROTOXICOLOGY, V33, P872, DOI 10.1016/j.neuro.2012.03.009; Rolfs A, 2002, AM J PHYSIOL-GASTR L, V282, pG598, DOI 10.1152/ajpgi.00371.2001; Roth JA, 2003, BIOCHEM PHARMACOL, V66, P1, DOI 10.1016/S0006-2952(03)00145-X; Simpson RJ, 2003, GUT, V52, P510, DOI 10.1136/gut.52.4.510; Thompson K, 2006, TOXICOL APPL PHARM, V210, P17, DOI 10.1016/j.taap.2005.05.014; Thompson K, 2007, FASEB J, V21, P223, DOI 10.1096/fj.06-6710com; Tjalve H, 1996, PHARMACOL TOXICOL, V79, P347; Tran TT, 2002, NEUROTOXICOLOGY, V23, P645, DOI 10.1016/S0161-813X(02)00068-2; Trinder D, 2002, P NATL ACAD SCI USA, V99, P5622, DOI 10.1073/pnas.082112299; Turoczi T, 2003, CIRC RES, V92, P1240, DOI 10.1161/01.RES.0000076890.59807.23; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; YAMADA M, 1986, ACTA NEUROPATHOL, V70, P273, DOI 10.1007/BF00686083; Yin ZB, 2010, J NEUROCHEM, V112, P1190, DOI 10.1111/j.1471-4159.2009.06534.x; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492; Zoller H, 1999, LANCET, V353, P2120, DOI 10.1016/S0140-6736(98)11179-0; Zoller H, 2001, GASTROENTEROLOGY, V120, P1412, DOI 10.1053/gast.2001.24033	63	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64944	10.1371/journal.pone.0064944	http://dx.doi.org/10.1371/journal.pone.0064944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705020	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200174
J	Knight, HE; Self, A; Kennedy, SH				Knight, Hannah E.; Self, Alice; Kennedy, Stephen H.			Why Are Women Dying When They Reach Hospital on Time? A Systematic Review of the 'Third Delay'	PLOS ONE			English	Review							EMERGENCY OBSTETRIC CARE; UN PROCESS INDICATORS; MATERNAL MORTALITY; HEALTH-CARE; MAGNESIUM-SULFATE; DEVELOPING-COUNTRIES; ASSESS NEEDS; PROGRAM NOTE; SERVICES; AVAILABILITY	Background: The 'three delays model' attempts to explain delays in women accessing emergency obstetric care as the result of: 1) decision-making, 2) accessing services and 3) receipt of appropriate care once a health facility is reached. The third delay, although under-researched, is likely to be a source of considerable inequity in access to emergency obstetric care in developing countries. The aim of this systematic review was to identify and categorise specific facility-level barriers to the provision of evidence-based maternal health care in developing countries. Methods and Findings: Five electronic databases were systematically searched using a 4-way strategy that combined search terms related to: 1) maternal health care; 2) maternity units; 3) barriers, and 4) developing countries. Forty-three original research articles were eligible to be included in the review. Thirty-two barriers to the receipt of timely and appropriate obstetric care at the facility level were identified and categorised into six emerging themes (Drugs and equipment; Policy and guidelines; Human resources; Facility infrastructure; Patient-related and Referral-related). Two investigators independently recorded the frequency with which barriers relating to the third delay were reported in the literature. The most commonly cited barriers were inadequate training/skills mix (86%); drug procurement/logistics problems (65%); staff shortages (60%); lack of equipment (51%) and low staff motivation (44%). Conclusions: This review highlights how a focus on patient-side delays in the decision to seek care can conceal the fact that many health facilities in the developing world are still chronically under-resourced and unable to cope effectively with serious obstetric complications. We stress the importance of addressing supply-side barriers alongside demand-side factors if further reductions in maternal mortality are to be achieved.	[Knight, Hannah E.; Self, Alice; Kennedy, Stephen H.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Knight, Hannah E.; Self, Alice; Kennedy, Stephen H.] Univ Oxford, Oxford Maternal & Perinatal Hlth Inst, Oxford, England; [Self, Alice] Sandwell Gen Hosp, Lyndon, West Bromwich, England	University of Oxford; University of Oxford	Knight, HE (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	hknight@rcog.org.uk		Self, Alice/0000-0002-8846-9916				Aaserud M, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-68; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; AMDD Working Group on Indicators, 2004, Int J Gynaecol Obstet, V86, P110, DOI 10.1016/j.ijgo.2004.04.034; [Anonymous], 2010, KEY COMP WELL FUNCT; Ansong-Tornui Janet, 2007, Ghana Med J, V41, P125; Aslam A, 2002, INT J GYNECOL OBSTET, V78, P275, DOI 10.1016/S0020-7292(02)00190-X; Bailey P, 2005, INT J GYNECOL OBSTET, V89, P221, DOI 10.1016/j.ijgo.2004.12.045; Bailey PE, 2003, INT J GYNECOL OBSTET, V80, P222, DOI 10.1016/S0020-7292(02)00390-9; Bailey PE, 2002, INT J GYNECOL OBSTET, V77, P277; Bankana B, 2003, INT J GYNECOL OBSTET, V83, P112, DOI 10.1016/S0020-7292(03)00187-5; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Belizan M, 2007, HEALTH EDUC RES, V22, P839, DOI 10.1093/her/cym012; Bertrand J, 2002, MEASURE EVALUATION M, V1; Borchert M, 2010, INT J GYNECOL OBSTET, V110, P97, DOI 10.1016/j.ijgo.2010.02.021; Bos E, 2007, OBSTET CARE POOR SET; Buchan James, 2006, Policy Polit Nurs Pract, V7, p16S, DOI 10.1177/1527154406291520; Campbell O, 1990, MEASURING MATERNAL M; Cham Mamady, 2005, Reprod Health, V2, P3, DOI 10.1186/1742-4755-2-3; Cham Mamady, 2009, Reprod Health, V6, P5, DOI 10.1186/1742-4755-6-5; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Choo S, 2010, TROP MED INT HEALTH, V15, P1109, DOI 10.1111/j.1365-3156.2010.02589.x; Conde-Agudelo A, 2008, BJOG-INT J OBSTET GY, V115, P1547, DOI 10.1111/j.1471-0528.2008.01930.x; D'Ambruoso L, 2010, J BIOSOC SCI, V42, P213, DOI 10.1017/S0021932009990496; DEMUYLDER X, 1990, ARCH GYNECOL OBSTET, V247, P131, DOI 10.1007/BF02390861; Fauveau V, 2007, INT J GYNECOL OBSTET, V96, P233, DOI 10.1016/j.ijgo.2006.12.004; Fikree Fariyal F., 2006, JPMA Journal of the Pakistan Medical Association, V56, P156; Fortney JA, 2004, INT J GYNECOL OBSTET, V86, P109, DOI 10.1016/j.ijgo.2004.04.013; Fortney JA, 2001, INT J GYNECOL OBSTET, V74, P95; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gill Z, 2005, INT J GYNECOL OBSTET, V89, P191, DOI 10.1016/j.ijgo.2004.12.043; Gohou V, 2004, TROP MED INT HEALTH, V9, P406, DOI 10.1111/j.1365-3156.2004.01204.x; Hailu S, 2009, ETHIOP J HEALTH DEV, V23, P115; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Haynes B, 1998, BMJ-BRIT MED J, V317, P273, DOI 10.1136/bmj.317.7153.273; Hodgins S, 2011, GLOBAL HLTH; Hoestermann CFL, 1996, TROP MED INT HEALTH, V1, P710; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Ijadunola KT, 2007, J HEALTH POPUL NUTR, V25, P94; Kawuwa M B, 2006, J Obstet Gynaecol, V26, P544, DOI 10.1080/01443610600811334; Khalil K, 2005, BIRTH-ISS PERINAT C, V32, P283, DOI 10.1111/j.0730-7659.2005.00385.x; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kongnyuy EJ, 2009, MATERN CHILD HLTH J, V13, P687, DOI 10.1007/s10995-008-0380-y; Kongnyuy EJ, 2009, WOMEN HEALTH ISS, V19, P14, DOI 10.1016/j.whi.2008.09.008; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Lindmark G, 2009, AFR J REPROD HEALTH, V12, P113; Maine D, 1999, AM J PUBLIC HEALTH, V89, P480, DOI 10.2105/AJPH.89.4.480; Maine Deborah, 1997, DESIGN EVALUATION MA; Mavalankar DV, 2005, AM J PUBLIC HEALTH, V95, P200, DOI 10.2105/AJPH.2003.036715; McNamee Paul, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P41, DOI 10.1586/14737167.9.1.41; Mfinanga Godfrey S, 2009, Health Res Policy Syst, V7, P6, DOI 10.1186/1478-4505-7-6; Morestin F, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-20; Nyamtema Angelo S, 2008, East Afr J Public Health, V5, P17; Nyango Dalyop D, 2010, Afr J Reprod Health, V14, P129; OKONOFUA FE, 1992, STUD FAMILY PLANN, V23, P319, DOI 10.2307/1966529; Olukoya AA, 1997, INT J GYNECOL OBSTET, V59, pS67, DOI 10.1016/S0020-7292(97)00149-5; Orji E O, 2006, J Obstet Gynaecol, V26, P643, DOI 10.1080/01443610600903628; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Pearson L, 2005, INT J GYNECOL OBSTET, V88, P208, DOI 10.1016/j.ijgo.2004.09.027; Pitchforth E, 2006, QUAL SAF HEALTH CARE, V15, P214, DOI 10.1136/qshc.2005.017285; Pitchforth E, 2010, SOC SCI MED, V71, P1739, DOI 10.1016/j.socscimed.2010.08.001; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Ridge AL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-340; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Sevene E, 2005, BMJ-BRIT MED J, V331, P765, DOI 10.1136/bmj.331.7519.765; Shah N, 2007, RAWAL MED J, V32, P163; Supratikto G, 2002, B WORLD HEALTH ORGAN, V80, P228; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tita ATN, 2005, B WORLD HEALTH ORGAN, V83, P895; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; United Nations, 2008, MILL DEV GOALS REP; Urassa E, 1997, HEALTH POLICY PLANN, V12, P50, DOI 10.1093/heapol/12.1.50; Villar J, 2013, BARRIERS EFFEC UNPUB; Wells GA, 2011, NEWCASTLE OTTAWA SCA; WHO, 2009, WHO PEPFAR PLANN M S; WHO, 1994, MOTH BAB PACK IMPL S; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization DoMPS, 2009, TOOL ASS PERF HLTH S; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	79	140	142	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63846	10.1371/journal.pone.0063846	http://dx.doi.org/10.1371/journal.pone.0063846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23704943	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000319330200074
J	Koritzer, J; Boxhammer, V; Schafer, A; Shimizu, T; Klampfl, TG; Li, YF; Welz, C; Schwenk-Zieger, S; Morfill, GE; Zimmermann, JL; Schlegel, J				Koeritzer, Julia; Boxhammer, Veronika; Schaefer, Andrea; Shimizu, Tetsuji; Klaempfl, Tobias G.; Li, Yang-Fang; Welz, Christian; Schwenk-Zieger, Sabina; Morfill, Gregor E.; Zimmermann, Julia L.; Schlegel, Juergen			Restoration of Sensitivity in Chemo - Resistant Glioma Cells by Cold Atmospheric Plasma	PLOS ONE			English	Article							NONTHERMAL PLASMA; ADJUVANT TEMOZOLOMIDE; PROMOTER METHYLATION; MELANOMA-CELLS; METHYLTRANSFERASE; GLIOBLASTOMA; MGMT; DECONTAMINATION; CHEMORESISTANCE; INACTIVATION	Glioblastoma (GBM) is the most common and aggressive brain tumor in adults. Despite multimodal treatments including surgery, chemotherapy and radiotherapy the prognosis remains poor and relapse occurs regularly. The alkylating agent temozolomide (TMZ) has been shown to improve the overall survival in patients with malignant gliomas, especially in tumors with methylated promoter of the O6-methylguanine-DNA-methyltransferase (MGMT) gene. However, intrinsic and acquired resistance towards TMZ makes it crucial to find new therapeutic strategies aimed at improving the prognosis of patients suffering from malignant gliomas. Cold atmospheric plasma is a new auspicious candidate in cancer treatment. In the present study we demonstrate the anti-cancer properties of different dosages of cold atmospheric plasma (CAP) both in TMZ-sensitive and TMZ-resistant cells by proliferation assay, immunoblotting, cell cycle analysis, and clonogenicity assay. Importantly, CAP treatment restored the responsiveness of resistant glioma cells towards TMZ therapy. Concomitant treatment with CAP and TMZ led to inhibition of cell growth and cell cycle arrest, thus CAP might be a promising candidate for combination therapy especially for patients suffering from GBMs showing an unfavorable MGMT status and TMZ resistance.	[Koeritzer, Julia; Boxhammer, Veronika; Shimizu, Tetsuji; Klaempfl, Tobias G.; Li, Yang-Fang; Morfill, Gregor E.; Zimmermann, Julia L.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Schaefer, Andrea; Schlegel, Juergen] Tech Univ Munich, Dept Neuropathol, D-80290 Munich, Germany; [Welz, Christian; Schwenk-Zieger, Sabina] Univ Munich, Dept Head & Neck Canc, Munich, Germany	Max Planck Society; Technical University of Munich; University of Munich	Koritzer, J (corresponding author), Max Planck Inst Extraterr Phys, D-85748 Garching, Germany.	koeritzer@mpe.mpg.de	Shimizu, Tetsuji/L-1478-2018	Shimizu, Tetsuji/0000-0001-9432-1152; Schlegel, Jurgen/0000-0002-5544-2717; Li, Yangfang/0000-0002-5346-3741	Max Planck Institute for Extraterrestrial Physics, Garching, Germany [M.TT.A.EXT00002]	Max Planck Institute for Extraterrestrial Physics, Garching, Germany	The work was supported by the grant (M.TT.A.EXT00002) of the Max Planck Institute for Extraterrestrial Physics, Garching, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Baxter HC, 2005, J GEN VIROL, V86, P2393, DOI 10.1099/vir.0.81016-0; Baxter HC, 2006, IEEE T PLASMA SCI, V34, P1337, DOI 10.1109/TPS.2006.878387; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Bobola MS, 1996, CLIN CANCER RES, V2, P735; Carlson BL, 2009, INT J RADIAT ONCOL, V75, P212, DOI 10.1016/j.ijrobp.2009.04.026; Carmo A, 2011, ONCOL LETT, V2, P1165, DOI 10.3892/ol.2011.406; Danson S J, 2001, Expert Rev Anticancer Ther, V1, P13, DOI 10.1586/14737140.1.1.13; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Felsberg J, 2011, INT J CANCER, V129, P659, DOI 10.1002/ijc.26083; Gerson SL, 2002, J CLIN ONCOL, V20, P2388, DOI 10.1200/JCO.2002.06.110; Hahnel M, 2010, PLASMA PROCESS POLYM, V7, P244, DOI 10.1002/ppap.200900076; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x; Isbary G, 2012, BR J DERMATOL; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Kim CH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3449575; Kim JY, 2011, BIOSENS BIOELECTRON, V28, P333, DOI 10.1016/j.bios.2011.07.039; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Lademann O, 2011, SKIN PHARMACOL PHYS, V24, P284, DOI 10.1159/000329913; Lee JJ, 2011, CELL DEATH DIFFER, V18, P666, DOI 10.1038/cdd.2010.139; Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610; Maisch T, 2012, APPL ENVIRON MICROB, V78, P4242, DOI 10.1128/AEM.07235-11; Morfill GE, 2009, NEW J PHYS, V11; Ostermann S, 2004, CLIN CANCER RES, V10, P3728, DOI 10.1158/1078-0432.CCR-03-0807; Paz MF, 2004, CLIN CANCER RES, V10, P4933, DOI 10.1158/1078-0432.CCR-04-0392; Portnow J, 2009, CLIN CANCER RES, V15, P7092, DOI 10.1158/1078-0432.CCR-09-1349; Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Shimizu T, 2012, APPL ENV MICROBIOL; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Vandamme M, 2011, INT J CANC; Villano JL, 2009, CANCER CHEMOTH PHARM, V64, P647, DOI 10.1007/s00280-009-1050-5; Weiler M, 2010, INT J RADIAT ONCOL, V77, P670, DOI 10.1016/j.ijrobp.2009.05.031; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Whittaker AG, 2004, J HOSP INFECT, V56, P37, DOI 10.1016/j.jhin.2003.09.019; Zhang JH, 2010, ONCOLOGY-BASEL, V78, P103, DOI 10.1159/000306139; Zimmermann JL, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/50/505201; Zucker SN, 2012, CANCER BIOL THER, V13, P1299, DOI 10.4161/cbt.21787	41	152	156	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64498	10.1371/journal.pone.0064498	http://dx.doi.org/10.1371/journal.pone.0064498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704990	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200144
J	Lloyd, MW; Campbell, L; Neel, MC				Lloyd, Michael W.; Campbell, Lesley; Neel, Maile C.			The Power to Detect Recent Fragmentation Events Using Genetic Differentiation Methods	PLOS ONE			English	Article							ENDEMIC ASTRAGALUS-BIBULLATUS; HABITAT FRAGMENTATION; POPULATION-STRUCTURE; SEED BANK; FOREST FRAGMENTATION; PATCH SIZE; F-ST; LANDSCAPE CONNECTIVITY; DIVERSITY; PLANT	Habitat loss and fragmentation are imminent threats to biological diversity worldwide and thus are fundamental issues in conservation biology. Increased isolation alone has been implicated as a driver of negative impacts in populations associated with fragmented landscapes. Genetic monitoring and the use of measures of genetic divergence have been proposed as means to detect changes in landscape connectivity. Our goal was to evaluate the sensitivity of Wright's F-st, Hedrick' G'(st), Sherwin's MI, and Jost's D to recent fragmentation events across a range of population sizes and sampling regimes. We constructed an individual-based model, which used a factorial design to compare effects of varying population size, presence or absence of overlapping generations, and presence or absence of population sub-structuring. Increases in population size, overlapping generations, and population sub-structuring each reduced F-st, G'(st), MI, and D. The signal of fragmentation was detected within two generations for all metrics. However, the magnitude of the change in each was small in all cases, and when Ne was >100 individuals it was extremely small. Multi-generational sampling and population estimates are required to differentiate the signal of background divergence from changes in F-st, G'(st), MI, and D associated with fragmentation. Finally, the window during which rapid change in F-st, G'(st), MI, and D between generations occurs can be small, and if missed would lead to inconclusive results. For these reasons, use of F-st, G'(st), MI, or D for detecting and monitoring changes in connectivity is likely to prove difficult in real-world scenarios. We advocate use of genetic monitoring only in conjunction with estimates of actual movement among patches such that one could compare current movement with the genetic signature of past movement to determine there has been a change.	[Lloyd, Michael W.] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Lloyd, MW (corresponding author), Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.	mlloyd13@umd.edu	Campbell, Lesley G/G-5866-2012; Lloyd, Michael/C-8430-2017	Campbell, Lesley G/0000-0002-6263-5170; Lloyd, Michael/0000-0003-1021-8129				ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2006, CONNECTIVITY CONSERV, DOI DOI 10.1017/CBO9780511754821.001; Avise J, 2004, MOL MARKERS NATURAL; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Barrett LG, 2005, MOL ECOL, V14, P4169, DOI 10.1111/j.1365-294X.2005.02726.x; Baskauf CJ, 1998, ANN MO BOT GARD, V85, P90, DOI 10.2307/2991999; Bazinet AL, 2007, FUTURE GENER COMP SY, V23, P517, DOI 10.1016/j.future.2006.07.009; Belisle M, 2002, CONSERV ECOL, V5; Bender DJ, 2003, LANDSCAPE ECOL, V18, P17, DOI 10.1023/A:1022937226820; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; Bowers MA, 1999, LANDSCAPE ECOL, V14, P381, DOI 10.1023/A:1008014426117; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Bruna EM, 2005, ECOLOGY, V86, P1816, DOI 10.1890/04-1716; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Bullock JM, 2003, ECOGRAPHY, V26, P692, DOI 10.1034/j.1600-0587.2003.03525.x; Bullock JM, 2004, ACTA OECOL, V25, P35, DOI 10.1016/j.actao.2003.10.005; Burkey Tormod V., 2006, Songklanakarin Journal of Science and Technology, V28, P9; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Cale PG, 2003, BIOL CONSERV, V109, P237, DOI 10.1016/S0006-3207(02)00152-0; Chao A, 2008, BIOMETRICS, V64, P1178, DOI 10.1111/j.1541-0420.2008.01010.x; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Coates DJ, 2001, BIOL CONSERV, V97, P251, DOI 10.1016/S0006-3207(00)00123-3; Collingham YC, 2000, ECOL APPL, V10, P131, DOI 10.1890/1051-0761(2000)010[0131:IOHFAP]2.0.CO;2; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; Diniz JAF, 2002, CONSERV BIOL, V16, P924, DOI 10.1046/j.1523-1739.2002.00295.x; Dooley JL, 1998, ECOLOGY, V79, P969, DOI 10.1890/0012-9658(1998)079[0969:DRTHFE]2.0.CO;2; ELLSTRAND NC, 1992, OIKOS, V63, P77, DOI 10.2307/3545517; England PR, 2010, CONSERV GENET, V11, P2425, DOI 10.1007/s10592-010-0112-x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 1998, ECOSYSTEMS, V1, P197, DOI 10.1007/s100219900015; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAHRIG L, 1985, ECOLOGY, V66, P1762, DOI 10.2307/2937372; Fox LR, 2006, PLANT ECOL, V183, P157, DOI 10.1007/s11258-005-9014-2; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; GUSTAFSON EJ, 1994, LANDSCAPE URBAN PLAN, V29, P117, DOI 10.1016/0169-2046(94)90022-1; Hall P, 1996, CONSERV BIOL, V10, P757, DOI 10.1046/j.1523-1739.1996.10030757.x; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hanfling B, 2004, CONSERV GENET, V5, P247, DOI 10.1023/B:COGE.0000030008.20492.2c; Hargis CD, 1998, LANDSCAPE ECOL, V13, P167, DOI 10.1023/A:1007965018633; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Hoffman EA, 2004, MOL ECOL, V13, P271, DOI 10.1046/j.1365-294X.2003.02057.x; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; Hovel KA, 2001, ECOLOGY, V82, P1814; Ims RA, 1999, J ANIM ECOL, V68, P839, DOI 10.1046/j.1365-2656.1999.00336.x; Jaeger JAG, 2000, LANDSCAPE ECOL, V15, P115, DOI 10.1023/A:1008129329289; Jaquiery J, 2011, MOL ECOL, V20, P692, DOI 10.1111/j.1365-294X.2010.04966.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Jules ES, 1998, ECOLOGY, V79, P1645, DOI 10.1890/0012-9658(1998)079[1645:HFADCF]2.0.CO;2; Kahmen S, 2008, ANN BOT-LONDON, V101, P541, DOI 10.1093/aob/mcm311; Kalamees R, 1997, FOLIA GEOBOT PHYTOTX, V32, P1, DOI 10.1007/BF02803879; KELLY D, 1989, J ECOL, V77, P785, DOI 10.2307/2260985; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kennedy CM, 2010, ECOL MONOGR, V80, P651, DOI 10.1890/09-0904.1; KIMURA M, 1963, EVOLUTION, V17, P279, DOI 10.2307/2406157; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Krauss J, 2004, MOL ECOL, V13, P311, DOI 10.1046/j.1365-294X.2003.02072.x; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Lawler JJ, 2002, ECOL APPL, V12, P663, DOI 10.2307/3060975; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Li WX, 2008, J PARASITOL, V94, P643, DOI 10.1645/GE-1034.1; Matern A, 2009, CONSERV GENET, V10, P391, DOI 10.1007/s10592-008-9606-1; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; McGarigal K., 2002, FRAGSTATS SPATIAL PA; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Meldgaard T, 2003, CONSERV GENET, V4, P735, DOI 10.1023/B:COGE.0000006115.14106.de; Meyer CFJ, 2009, BIOTROPICA, V41, P95, DOI 10.1111/j.1744-7429.2008.00443.x; Morris AB, 2002, AM J BOT, V89, P29, DOI 10.3732/ajb.89.1.29; Myers DS, 2008, GRID COMPUTING FOR BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P71; Myers DS, 2003, J PARALLEL DISTR COM, V63, P578, DOI 10.1016/S0743-7315(03)00004-2; Neel MC, 2004, LANDSCAPE ECOL, V19, P435, DOI 10.1023/B:LAND.0000030521.19856.cb; NEI M, 1978, GENETICS, V89, P583; Neigel JE, 2002, CONSERV GENET, V3, P167, DOI 10.1023/A:1015213626922; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Nunney L, 2002, AM NAT, V160, P195, DOI 10.1086/341017; Nussey DH, 2005, MOL ECOL, V14, P3395, DOI 10.1111/j.1365-294X.2005.02692.x; Parker M, 2002, BIOL CONSERV, V105, P217, DOI 10.1016/S0006-3207(01)00184-7; Pascual-Hortal L, 2006, LANDSCAPE ECOL, V21, P959, DOI 10.1007/s10980-006-0013-z; Patten MA, 2005, EVOL ECOL RES, V7, P235; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Procaccini G, 2007, J EXP MAR BIOL ECOL, V350, P234, DOI 10.1016/j.jembe.2007.05.035; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Robledo-Arnuncio JJ, 2006, GENETICS, V173, P1033, DOI 10.1534/genetics.105.052035; Rouget M, 2003, BIOL CONSERV, V112, P63, DOI 10.1016/S0006-3207(02)00395-6; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Saura S, 2001, PHOTOGRAMM ENG REM S, V67, P1027; Schiller JR, 2000, WETLANDS, V20, P386, DOI 10.1672/0277-5212(2000)020[0386:TEODDI]2.0.CO;2; Schumaker NH, 1996, ECOLOGY, V77, P1210, DOI 10.2307/2265590; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Sherwin WB, 2010, ENTROPY-SWITZ, V12, P1765, DOI 10.3390/e12071765; SILANDER JA, 1985, OECOLOGIA, V66, P256, DOI 10.1007/BF00379863; SLATKIN M, 1991, GENET RES, V58, P167, DOI 10.1017/S0016672300029827; Sork VL, 1999, TRENDS ECOL EVOL, V14, P219, DOI 10.1016/S0169-5347(98)01585-7; Tallmon DA, 2010, MOL ECOL RESOUR, V10, P684, DOI 10.1111/j.1755-0998.2010.02831.x; Taylor PD, 2006, CONNECTIVITY CONSERV, P29, DOI DOI 10.1017/CBO9780511754821.003; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Tischendorf L, 2000, LANDSCAPE ECOL, V15, P633, DOI 10.1023/A:1008177324187; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Urban DL, 2005, ECOLOGY, V86, P1996, DOI 10.1890/04-0918; Vitalis R, 2004, AM NAT, V163, P295, DOI 10.1086/381041; Wallace L.E., 2002, PLANT SPEC BIOL, V17, P37; Walters CJ, 1986, ADAPTIVE MANAGEMENT, Vx; Waples RS, 2002, GENETICS, V161, P783; Weber MHW, 2008, DISTRIBUTED GRID COM, P71; Weekley CW, 2007, CAN J BOT, V85, P621, DOI 10.1139/B07-061; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; WHITLOCK MC, 1992, EVOLUTION, V46, P608, DOI [10.2307/2409631, 10.1111/j.1558-5646.1992.tb02069.x]; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Whittaker JC, 2003, GENETICS, V164, P781; Wiegand T, 1999, AM NAT, V154, P605, DOI 10.1086/303272; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; With KA, 2004, RISK ANAL, V24, P803, DOI 10.1111/j.0272-4332.2004.00480.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wunsch M, 1998, MAR ECOL PROG SER, V169, P277, DOI 10.3354/meps169277; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Young AG, 1999, CONSERV BIOL, V13, P256, DOI 10.1046/j.1523-1739.1999.013002256.x; YOUNG AG, 1994, HEREDITY, V72, P201, DOI 10.1038/hdy.1994.27; ZAMMIT C, 1990, OECOLOGIA, V84, P24, DOI 10.1007/BF00665590	141	18	18	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63981	10.1371/journal.pone.0063981	http://dx.doi.org/10.1371/journal.pone.0063981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704965	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200097
J	Ma, XF; Liu, P; Yan, H; Sun, H; Liu, XY; Zhou, F; Li, L; Chen, Y; Muthana, MM; Chen, X; Wang, PG; Zhang, LW				Ma, Xiaofeng; Liu, Pi; Yan, Hui; Sun, Hong; Liu, Xiaoyan; Zhou, Feng; Li, Lei; Chen, Yi; Muthana, Musleh M.; Chen, Xi; Wang, Peng G.; Zhang, Lianwen			Substrate Specificity Provides Insights into the Sugar Donor Recognition Mechanism of O-GlcNAc Transferase (OGT)	PLOS ONE			English	Article							LINKED N-ACETYLGLUCOSAMINE; MODIFIED PROTEINS; REPEAT DOMAIN; CROSS-TALK; NUCLEAR; GLYCOSYLATION; GLCNACYLATION; EXPRESSION; ROLES	O-Linked beta-N-acetylglucosaminyl transferase (OGT) plays an important role in the glycosylation of proteins, which is involved in various cellular events. In human, three isoforms of OGT (short OGT [sOGT]; mitochondrial OGT [mOGT]; and nucleocytoplasmic OGT [ncOGT]) share the same catalytic domain, implying that they might adopt a similar catalytic mechanism, including sugar donor recognition. In this work, the sugar-nucleotide tolerance of sOGT was investigated. Among a series of uridine 5'-diphosphate-N-acetylglucosamine (UDP-GlcNAc) analogs tested using the casein kinase II (CKII) peptide as the sugar acceptor, four compounds could be used by sOGT, including UDP-6-deoxy-GlcNAc, UDP-GlcNPr, UDP-6-deoxy-GalNAc and UDP-4-deoxy-GlcNAc. Determined values of Km showed that the substitution of the N-acyl group, deoxy modification of C6/C4-OH or epimerization of C4-OH of the GlcNAc in UDP-GlcNAc decreased its affinity to sOGT. A molecular docking study combined with site-directed mutagenesis indicated that the backbone carbonyl oxygen of Leu653 and the hydroxyl group of Thr560 in sOGT contributed to the recognition of the sugar moiety via hydrogen bonds. The close vicinity between Met501 and the N-acyl group of GlcNPr, as well as the hydrophobic environment near Met501, were responsible for the selective binding of UDP-GlcNPr. These findings illustrate the interaction of OGT and sugar nucleotide donor, providing insights into the OGT catalytic mechanism.	[Ma, Xiaofeng; Liu, Pi; Yan, Hui; Sun, Hong; Liu, Xiaoyan; Zhou, Feng; Li, Lei; Wang, Peng G.; Zhang, Lianwen] Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Ma, Xiaofeng; Liu, Pi; Yan, Hui; Sun, Hong; Liu, Xiaoyan; Zhou, Feng; Li, Lei; Wang, Peng G.; Zhang, Lianwen] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China; [Chen, Yi; Muthana, Musleh M.; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	Nankai University; Nankai University; University of California System; University of California Davis	Wang, PG (corresponding author), Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	pwang@nankai.edu.cn; lianwen@nankai.edu.cn	WANG, Peng/GSN-5263-2022; Chen, Xi/H-1811-2018	Chen, Xi/0000-0002-3160-614X	National Basic Research Program of China (973 Program) [2012CB910300]; National Natural Science Foundation of China [30970644]; National Institutes of Health (NIH) [R01HD065122]; National Science Foundation (NSF) [CHE-1012511]; Division Of Chemistry [1012511] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065122] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Basic Research Program of China (973 Program, grant No. 2012CB910300) (to Peng George Wang), National Natural Science Foundation of China (30970644) (to Lianwen Zhang), National Institutes of Health (NIH) grant R01HD065122 and National Science Foundation (NSF) grant CHE-1012511 (to Xi Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto Y, 2007, GLYCOBIOLOGY, V17, P127, DOI 10.1093/glycob/cwl067; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cai L, 2009, CHEM COMMUN, P2944, DOI 10.1039/b904853g; Chen Y, 2011, CHEM COMMUN, V47, P10815, DOI 10.1039/c1cc14034e; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Delano W. L., 2004, PYMOL USERS GUIDE; GRIFFITH LS, 1995, BIOCHEM BIOPH RES CO, V213, P424, DOI 10.1006/bbrc.1995.2149; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Gurcel C, 2008, ANAL BIOANAL CHEM, V390, P2089, DOI 10.1007/s00216-008-1950-y; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kanno T, 2010, NEUROCHEM RES, V35, P782, DOI 10.1007/s11064-010-0135-1; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Lazarus BD, 2005, J BIOL CHEM, V280, P35537, DOI 10.1074/jbc.M504948200; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; LUBAS WA, 1995, BIOCHEMISTRY-US, V34, P1686, DOI 10.1021/bi00005a025; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mayer A, 2011, BIOORG MED CHEM LETT, V21, P1199, DOI 10.1016/j.bmcl.2010.12.090; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Morris G., 2012, USER GUIDE AUTODOCK; Muthana MM, 2012, CHEM COMMUN, V48, P2728, DOI 10.1039/c2cc17577k; Oliveira FG, 2006, BIOORGAN MED CHEM, V14, P6001, DOI 10.1016/j.bmc.2006.05.017; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007	43	18	19	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63452	10.1371/journal.pone.0063452	http://dx.doi.org/10.1371/journal.pone.0063452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700425	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200041
J	Pena, MJR; Bennett, JVC; Soler, OM; Mayorga, LS; Michaut, MA				Rodriguez Pena, Marcelo J.; Castillo Bennett, Jimena V.; Soler, Osvaldo M.; Mayorga, Luis S.; Michaut, Marcela A.			MARCKS Protein Is Phosphorylated and Regulates Calcium Mobilization during Human Acrosomal Exocytosis	PLOS ONE			English	Article							C-KINASE-SUBSTRATE; CORTICAL F-ACTIN; RAB3A TRIGGERS; RELEASE; DEGRANULATION; PROGESTERONE; SPERMATOZOA; ACTIVATION; SECRETION; INTERPLAY	Acrosomal exocytosis is a calcium-regulated exocytosis that can be triggered by PKC activators. The involvement of PKC in acrosomal exocytosis has not been fully elucidated, and it is unknown if MARCKS, the major substrate for PKC, participates in this exocytosis. Here, we report that MARCKS is expressed in human spermatozoa and localizes to the sperm head and the tail. Calcium-and phorbol ester-triggered acrosomal exocytosis in permeabilized sperm was abrogated by different anti-MARCKS antibodies raised against two different domains, indicating that the protein participates in acrosomal exocytosis. Interestingly, an anti-phosphorylated MARCKS antibody was not able to inhibit secretion. Similar results were obtained using recombinant proteins and phospho-mutants of MARCKS effector domain (ED), indicating that phosphorylation regulates MARCKS function in acrosomal exocytosis. It is known that unphosphorylated MARCKS sequesters PIP2. This phospholipid is the precursor for IP3, which in turn triggers release of calcium from the acrosome during acrosomal exocytosis. We found that PIP2 and adenophostin, a potent IP3-receptor agonist, rescued MARCKS inhibition in permeabilized sperm, suggesting that MARCKS inhibits acrosomal exocytosis by sequestering PIP2 and, indirectly, MARCKS regulates the intracellular calcium mobilization. In non-permeabilized sperm, a permeable peptide of MARCKS ED also inhibited acrosomal exocytosis when stimulated by a natural agonist such as progesterone, and pharmacological inducers such as calcium ionophore and phorbol ester. The preincubation of human sperm with the permeable MARCKS ED abolished the increase in calcium levels caused by progesterone, demonstrating that MARCKS regulates calcium mobilization. In addition, the phosphorylation of MARCKS increased during acrosomal exocytosis stimulated by the same activators. Altogether, these results show that MARCKS is a negative modulator of the acrosomal exocytosis, probably by sequestering PIP2, and that it is phosphorylated during acrosomal exocytosis.	[Rodriguez Pena, Marcelo J.; Soler, Osvaldo M.; Michaut, Marcela A.] Univ Nacl Cuyo, Reprod Biol Lab, RA-5500 Mendoza, Argentina; [Rodriguez Pena, Marcelo J.; Castillo Bennett, Jimena V.; Soler, Osvaldo M.; Mayorga, Luis S.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol, Lab Biol Celular & Mol, RA-5500 Mendoza, Argentina; [Michaut, Marcela A.] Univ Nacl Cuyo, Inst Ciencias Basicas, RA-5500 Mendoza, Argentina	University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza	Michaut, MA (corresponding author), Univ Nacl Cuyo, Reprod Biol Lab, RA-5500 Mendoza, Argentina.	mmichaut@gmail.com	Michaut, Marcela Alejandra/D-3725-2015	Michaut, Marcela Alejandra/0000-0002-0528-6605; Mayorga, Luis S/0000-0002-5995-0671; Castillo Bennett, Jimena/0000-0001-8651-7083	National Institutes of Health Research [R01 TW007571]; Fogarty International Center; Universidad Nacional de Cuyo; Consejo Nacional de Investigaciones Cientificas Y Tecnicas; Fondo para la Investigacion Cientifica y Tecnologica-Agencia Nacional de Promocion Cientifica y Technologica, Argentina; CONICET, Argentina; Facultad de Ciencias Medicas, Universidad Nacional de Cuyo, Argentina; NIH/Fogarty Training Grant [5-D43TW00671]; FOGARTY INTERNATIONAL CENTER [R01TW007571, D43TW000671] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Universidad Nacional de Cuyo; Consejo Nacional de Investigaciones Cientificas Y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo para la Investigacion Cientifica y Tecnologica-Agencia Nacional de Promocion Cientifica y Technologica, Argentina; CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Facultad de Ciencias Medicas, Universidad Nacional de Cuyo, Argentina; NIH/Fogarty Training Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by National Institutes of Health Research Grant # R01 TW007571, funded by the Fogarty International Center, and Universidad Nacional de Cuyo grant to MAM, and grants from Consejo Nacional de Investigaciones Cientificas Y Tecnicas and Fondo para la Investigacion Cientifica y Tecnologica-Agencia Nacional de Promocion Cientifica y Technologica, Argentina, to LSM and MAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank A. Medero and M. Furlan for technical assistance; Dr. Claudia N. Tomes for critical reading of the manuscript, and Dr. Jae-Won Soh for MARCKS plasmid. M. R. P. and J. C. B. are thankful to CONICET, Argentina for fellowships. O. S. is thankful to Facultad de Ciencias Medicas, Universidad Nacional de Cuyo, Argentina for fellowship. M.A.M. is thankful to Dr. Karen Schindler, Dr. Carmen Williams, Dr. Richard Shultz, and NIH/Fogarty Training Grant 5-D43TW00671 for support in preparing MARCKS mutants at University of Pennsylvania, USA.	Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Bello OD, 2012, EXP CELL RES, V318, P478, DOI 10.1016/j.yexcr.2012.01.002; Belmonte SA, 2005, DEV BIOL, V285, P393, DOI 10.1016/j.ydbio.2005.07.001; BLACKMORE PF, 1990, J BIOL CHEM, V265, P1376; Breitbart H, 2002, MOL CELL ENDOCRINOL, V187, P139, DOI 10.1016/S0303-7207(01)00704-3; Bennett JC, 2010, J BIOL CHEM, V285, P26269, DOI 10.1074/jbc.M109.095752; Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; DEJONGE CJ, 1991, J ANDROL, V12, P62; Doreian BW, 2009, MOL BIOL CELL, V20, P3142, DOI 10.1091/mbc.E09-03-0197; Elzagallaai A, 2001, BRIT J HAEMATOL, V112, P593, DOI 10.1046/j.1365-2141.2001.02642.x; Gadi D, 2011, MOL BIOL CELL, V22, P4908, DOI 10.1091/mbc.E11-07-0614; Garnier-Lhomme M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004255; Garrett AM, 2012, NEURON, V74, P269, DOI 10.1016/j.neuron.2012.01.028; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li YH, 2001, J BIOL CHEM, V276, P40982, DOI 10.1074/jbc.M105614200; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Lopez CI, 2012, BBA-MOL CELL BIOL L, V1821, P1186, DOI 10.1016/j.bbalip.2012.05.001; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; Mosevitsky M, 2011, ACTA HISTOCHEM, V113, P13, DOI 10.1016/j.acthis.2009.07.002; Mosevitsky MI, 2012, ACTA HISTOCHEM, V114, P237, DOI 10.1016/j.acthis.2011.06.009; O'Toole CMB, 1996, MOL HUM REPROD, V2, P921, DOI 10.1093/molehr/2.12.921; OSMAN RA, 1989, BIOCHEM BIOPH RES CO, V160, P828, DOI 10.1016/0006-291X(89)92508-4; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; ROLDAN ERS, 1994, BIOCHEM J, V297, P225, DOI 10.1042/bj2970225; Rose SD, 2001, J BIOL CHEM, V276, P36757, DOI 10.1074/jbc.M006518200; Salli U, 2003, BIOL REPROD, V69, P2053, DOI 10.1095/biolreprod.103.017640; Salli U, 2000, BIOL REPROD, V63, P12, DOI 10.1095/biolreprod63.1.12; Singer M, 2004, NAT MED, V10, P193, DOI 10.1038/nm983; SISTINA Y, 1993, J REPROD FERTIL, V99, P335; Suhaiman L, 2010, J BIOL CHEM, V285, P16302, DOI 10.1074/jbc.M109.072439; Sundaram M, 2004, BIOCHEM CELL BIOL, V82, P191, DOI 10.1139/o03-087; SWIERCZYNSKI SL, 1995, J BIOL CHEM, V270, P13436, DOI 10.1074/jbc.270.22.13436; Takashi S, 2006, AM J RESP CELL MOL, V34, P647, DOI 10.1165/rcmb.2006-0030RC; THOMAS P, 1989, BIOCHEM J, V264, P539, DOI 10.1042/bj2640539; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Trifaro JM, 2000, BIOCHIMIE, V82, P339, DOI 10.1016/S0300-9084(00)00193-0; Vazquez JM, 1997, MOL REPROD DEV, V48, P95, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;95::AID-MRD12&gt;3.0.CO;2-V; Wiederkehr A, 1997, EXP CELL RES, V236, P103, DOI 10.1006/excr.1997.3709; Yanagimachi R., 1994, P189; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166	48	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64551	10.1371/journal.pone.0064551	http://dx.doi.org/10.1371/journal.pone.0064551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704996	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200150
J	Slagter, HA; Georgopoulou, K				Slagter, Heleen A.; Georgopoulou, Katerina			Distractor Inhibition Predicts Individual Differences in Recovery from the Attentional Blink	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; DOPAMINE; INFORMATION; IRRELEVANT; TASK; DISTINCTIVENESS; SUPPRESSION; SELECTION; MONKEYS; MODEL	Background: The attentional blink (AB) refers to an impairment in detecting the second of two target stimuli presented in close succession in a rapid stream of distractors. Recent studies indicate that the AB results, in part, from distractor suppression mechanisms, that may be mediated by striatal dopamine. Yet, it is currently unclear how distractor suppression ability may contribute to the AB. Here, we examined whether distractor suppression ability is predictive of an individual's AB depth and/or recovery. In addition, we investigated the relationship between individual spontaneous eye blink rate (sEBR), a marker of striatal dopaminergic functioning, and AB performance. Methodology/Principal findings: Subjects were presented with rapid streams of letters containing white distractors, a red T1 and a green T2. T2 was presented either at Lag2, Lag4 or Lag10, and preceded by a distractor that shared the same identity as T2 (T2 primed) or not (T2 not primed). Replicating previous work [1], we found that slow AB recovery (poor T2 performance in Lag4 vs. Lag10) was associated with a failure to inhibit distractors, as indexed by greater positive priming. However, no relationship was observed between a subject's ability to suppress distractors and AB depth (Lag10 vs. Lag2). Moreover, no relationship between sEBR and AB performance was observed. Results/Significance: These results indicate that a failure to inhibit distracting information impairs AB recovery, possibly by interfering with target encoding in working memory - but does not affect AB magnitude. The absence of a relationship between individual sEBR and AB performance may be explained by task specifics.	[Slagter, Heleen A.; Georgopoulou, Katerina] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Slagter, Heleen A.] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Slagter, HA (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	h.a.slagter@uva.nl	Slagter, Heleen/ABF-1338-2020	Slagter, Heleen/0000-0002-4180-1483	VIDI grant from the Dutch Scientific Organisation (NWO); Marie Curie Reintegration grant	VIDI grant from the Dutch Scientific Organisation (NWO); Marie Curie Reintegration grant(European Commission)	This work was supported by a VIDI grant from the Dutch Scientific Organisation (NWO; http://www.nwo.nl/) to HAS and a Marie Curie Reintegration grant (http://cordis.europa.eu/fp7/home_en.html) to HAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnell KM, 2010, PSYCHOL RES-PSYCH FO, V74, P457, DOI 10.1007/s00426-009-0265-8; Barbato G, 2000, PSYCHIAT RES, V93, P145, DOI 10.1016/S0165-1781(00)00108-6; Braver T S, 1999, Prog Brain Res, V121, P327; Brisson B, 2011, ATTEN PERCEPT PSYCHO, V73, P42, DOI 10.3758/s13414-010-0003-8; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109, DOI DOI 10.1037/0096-1523.21.1.109; Colzato LS, 2008, NEUROPSYCHOLOGIA, V46, P3179, DOI 10.1016/j.neuropsychologia.2008.07.006; Colzato LS, 2011, J COGNITIVE NEUROSCI, V23, P3576, DOI 10.1162/jocn_a_00049; Colzato LS, 2009, PERS INDIV DIFFER, V46, P377, DOI 10.1016/j.paid.2008.10.017; Colzato LS, 2009, EXP BRAIN RES, V196, P467, DOI 10.1007/s00221-009-1862-x; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Dale G, 2013, ATTEN PERCEPT PSYCHO, V75, P456, DOI 10.3758/s13414-012-0415-8; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Dux PE, 2007, PSYCHON B REV, V14, P723, DOI 10.3758/BF03196828; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Dux PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003330; Dux PE, 2006, COGNITION, V99, P355, DOI 10.1016/j.cognition.2005.04.002; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Hommel B, 2006, PSYCHOL RES-PSYCH FO, V70, P425, DOI 10.1007/s00426-005-0009-3; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Kaminer J, 2011, J NEUROSCI, V31, P11256, DOI 10.1523/JNEUROSCI.6218-10.2011; KARSON CN, 1983, BRAIN, V106, P643, DOI 10.1093/brain/106.3.643; Kelly AJ, 2011, J EXP PSYCHOL HUMAN, V37, P1867, DOI 10.1037/a0025975; Kleven MS, 1996, J PHARMACOL EXP THER, V279, P1211; LAWRENCE MS, 1991, PHARMACOL BIOCHEM BE, V38, P869, DOI 10.1016/0091-3057(91)90255-Z; MAKI WS, 1994, PSYCHON B REV, V1, P499, DOI 10.3758/BF03210954; Maki WS, 1997, J EXP PSYCHOL HUMAN, V23, P1014, DOI 10.1037/0096-1523.23.4.1014; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013509; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Martens S, 2009, EXP PSYCHOL, V56, P18, DOI 10.1027/1618-3169.56.1.18; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P1083, DOI 10.1037/0096-1523.32.5.1083; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Slagter HA, 2012, J COGNITIVE NEUROSCI, V24, P1932, DOI 10.1162/jocn_a_00255; Slagter HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010556; Slagter HA, 2010, NEUROPSYCHOLOGIA, V48, P1265, DOI 10.1016/j.neuropsychologia.2009.12.027; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Visser TA, 2004, PERCEPT PSYCHOPHYS, V66, P1418, DOI 10.3758/BF03195008; Walter NT, 2012, EUR NEUROPSYCHOPHARM, DOI [10.1016/j.euroneuro.2012.09.010, DOI 10.1016/J.EUR0NEUR0.2012.09.010]; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902; Zhao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044786	43	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64681	10.1371/journal.pone.0064681	http://dx.doi.org/10.1371/journal.pone.0064681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23705002	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200156
J	Zhang, S; Li, F; Younes, M; Liu, H; Chen, CY; Yao, QZ				Zhang, Sheng; Li, Feng; Younes, Mamoun; Liu, Hao; Chen, Changyi; Yao, Qizhi			Reduced Selenium-Binding Protein 1 in Breast Cancer Correlates with Poor Survival and Resistance to the Anti-Proliferative Effects of Selenium	PLOS ONE			English	Article							CELL-PROLIFERATION; EXPRESSION; ESTROGEN; CARCINOMA; CARCINOGENESIS; ASSOCIATION	Supplemental dietary selenium is associated with reduced incidence of many cancers. The antitumor function of selenium is thought to be mediated through selenium-binding protein 1 (SELENBP1). However, the significance of SELENBP1 expression in breast cancer is still largely unknown. A total of 95 normal and tumor tissues assay and 12 breast cancer cell lines were used in this study. We found that SELENBP1 expression in breast cancer tissues is reduced compared to normal control. Low SELENBP1 expression in ER+ breast cancer patients was significantly associated with poor survival (p<0.01), and SELENBP1 levels progressively decreased with advancing clinical stages of breast cancer. 17-beta estradiol (E2) treatment of high SELENBP1-expressing ER+ cell lines led to a down-regulation of SELENBP1, a result that did not occur in ER- cell lines. However, after ectopic expression of ER in an originally ER- cell line, down-regulation of SELENBP1 upon E2 treatment was observed. In addition, selenium treatment resulted in reduced cell proliferation in endogenous SELENBP1 high cells; however, after knocking-down SELENBP1, we observed no significant reduction in cell proliferation. Similarly, selenium has no effect on inhibition of cell proliferation in low endogenous SELENBP1 cells, but the inhibitory effect is regained following ectopic SELENBP1 expression. Furthermore, E2 treatment of an ER silenced high endogenous SELENBP1 expressing cell line showed no abolishment of cell proliferation inhibition upon selenium treatment. These data indicate that SELENBP1 expression is regulated via estrogen and that the cell proliferation inhibition effect of selenium treatment is dependent on the high level of SELENBP1 expression. Therefore, the expression level of SELENBP1 could be an important marker for predicting survival and effectiveness of selenium supplementation in breast cancer. This is the first study to reveal the importance of monitoring SELENBP1 expression as a potential biomarker in contributing to breast cancer prevention and treatment.	[Zhang, Sheng; Li, Feng; Chen, Changyi; Yao, Qizhi] Baylor Coll Med, Mol Surgeon Res Ctr, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Yao, Qizhi] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Younes, Mamoun] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Liu, Hao] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Yao, QZ (corresponding author), Baylor Coll Med, Mol Surgeon Res Ctr, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	qizhiyao@bcm.edu		Younes, Mamoun/0000-0001-9618-3451				ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; BANSAL MP, 1990, CARCINOGENESIS, V11, P2071, DOI 10.1093/carcin/11.11.2071; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; Brown LM, 2006, MOL CARCINOGEN, V45, P613, DOI 10.1002/mc.20193; Chang PWG, 1997, J CELL BIOCHEM, V64, P217, DOI 10.1002/(SICI)1097-4644(199702)64:2<217::AID-JCB5>3.0.CO;2-#; Chen GA, 2004, J PATHOL, V202, P321, DOI 10.1002/path.1524; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Giometti CS, 2000, ELECTROPHORESIS, V21, P2162; Gruvberger S, 2001, CANCER RES, V61, P5979; He QY, 2004, PROTEOMICS, V4, P3276, DOI 10.1002/pmic.200300916; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Jemal A, 2011, CA CANC J CLIN; Kim H, 2006, PROTEOMICS, V6, P3466, DOI 10.1002/pmic.200500629; KYPRIANOU N, 1991, CANCER RES, V51, P162; Lai TC, 2010, J PROTEOME RES, V9, P1302, DOI 10.1021/pr900825t; LANFEAR J, 1993, CARCINOGENESIS, V14, P335, DOI 10.1093/carcin/14.3.335; Lee SO, 2005, CANCER RES, V65, P3487, DOI 10.1158/0008-5472.CAN-04-3267; Li LS, 2004, PROTEOMICS, V4, P3394, DOI 10.1002/pmic.200400901; Li M, 2008, MOL CANCER THER, V7, P286, DOI 10.1158/1535-7163.MCT-07-0483; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; Li ZS, 2009, BREAST CANCER RES TR, V118, P33, DOI 10.1007/s10549-008-0216-x; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pohl NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007774; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Raucci R, 2011, BBA-PROTEINS PROTEOM, V1814, P513, DOI 10.1016/j.bbapap.2011.02.006; SHAMBERGER RJ, 1969, CAN MED ASSOC J, V100, P682; Surai PF, 2006, SELENIUM NUTR HLTH; Sutherland RL, 1998, J MAMMARY GLAND BIOL, V3, P63, DOI 10.1023/A:1018774302092; Suzuki T, 2006, ENDOCR-RELAT CANCER, V13, P233, DOI 10.1677/erc.1.01075; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; WANG TTY, 1995, CANCER RES, V55, P2487; Wulfkuhle JD, 2002, CANCER RES, V62, P6740; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yang MH, 1998, CANCER RES, V58, P3150; Yoshida N, 2004, CANCER SCI, V95, P496, DOI 10.1111/j.1349-7006.2004.tb03239.x; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005; Zhang J, 2011, MED ONCOL, V28, P481, DOI 10.1007/s12032-010-9482-7; Zhang P, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-80	38	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63702	10.1371/journal.pone.0063702	http://dx.doi.org/10.1371/journal.pone.0063702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704933	gold, Green Submitted, Green Published			2022-12-27	WOS:000319330200064
J	Bushman, JD; Zhou, Q; Shyng, SL				Bushman, Jeremy D.; Zhou, Qing; Shyng, Show-Ling			A Kir6.2 Pore Mutation Causes Inactivation of ATP-Sensitive Potassium Channels by Disrupting PIP2-Dependent Gating	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE PIP2; RECTIFIER K+ CHANNELS; SULFONYLUREA RECEPTOR; CONGENITAL HYPERINSULINISM; G-PROTEINS; MECHANISM; ACTIVATION; SUBUNIT; MODULATION; INHIBITION	In the absence of intracellular nucleotides, ATP-sensitive potassium (K-ATP) channels exhibit spontaneous activity via a phosphatidylinositol-4,5-bisphosphate (PIP2)-dependent gating process. Previous studies show that stability of this activity requires subunit-subunit interactions in the cytoplasmic domain of Kir6.2; selective mutagenesis and disease mutations at the subunit interface result in time-dependent channel inactivation. Here, we report that mutation of the central glycine in the pore-lining second transmembrane segment (TM2) to proline in Kir6.2 causes K-ATP channel inactivation. Unlike C-type inactivation, a consequence of selectivity filter closure, in many K+ channels, the rate of inactivation in G156P channels was insensitive to changes in extracellular ion concentrations or ion species fluxing through the pore. Instead, the rate of G156P inactivation decreased with exogenous application of PIP2 and increased when PIP2-channel interaction was inhibited with neomycin or poly-L-lysine. These findings indicate the G156P mutation reduces the ability of PIP2 to stabilize the open state of K-ATP channels, similar to mutations in the cytoplasmic domain that produce inactivation. Consistent with this notion, when PIP2-dependent open state stability was substantially increased by addition of a second gain-of-function mutation, G156P inactivation was abolished. Importantly, bath application and removal of Mg2+-free ATP or a nonhydrolyzable analog of ATP, which binds to the cytoplasmic domain of Kir6.2 and causes channel closure, recover G156P channel from inactivation, indicating crosstalk between cytoplasmic and transmembrane domains. The G156P mutation provides mechanistic insight into the structural and functional interactions between the pore and cytoplasmic domains of Kir6.2 during gating.	[Bushman, Jeremy D.; Zhou, Qing; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.	shyngs@ohsu.edu			NIH [1F31NS065688, R01DK066485]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS065688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Fellowship 1F31NS065688 to JDB and R01DK066485 to SLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderemane-Ali F, 2013, J BIOL CHEM, V288, P10951, DOI 10.1074/jbc.A112.382085; Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; An HL, 2012, J BIOL CHEM, V287, P42278, DOI 10.1074/jbc.M112.418640; ASHCROFT FM, 1989, J PHYSIOL-LONDON, V408, P413, DOI 10.1113/jphysiol.1989.sp017467; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Bavro VN, 2012, NAT STRUCT MOL BIOL, V19, P158, DOI 10.1038/nsmb.2208; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Bushman JD, 2010, J BIOL CHEM, V285, P6012, DOI 10.1074/jbc.M109.085860; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; Loechner KJ, 2011, DIABETES, V60, P209, DOI 10.2337/db10-0731; Loussouarn G, 2001, J BIOL CHEM, V276, P29098, DOI 10.1074/jbc.M102365200; MacGregor GG, 2002, P NATL ACAD SCI USA, V99, P2726, DOI 10.1073/pnas.042688899; Meng XY, 2012, BIOPHYS J, V102, P2049, DOI 10.1016/j.bpj.2012.03.050; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Phillips LR, 2003, J GEN PHYSIOL, V122, P795, DOI 10.1085/jgp.200308953; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Pratt EB, 2011, J GEN PHYSIOL, V137, P299, DOI 10.1085/jgp.201010557; Proks P, 2005, EMBO REP, V6, P470, DOI 10.1038/sj.embor.7400393; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rosenhouse-Dantsker A, 2007, CHANNELS, V1, P189, DOI 10.4161/chan.4475; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Schulze D, 2003, J PHYSIOL-LONDON, V552, P357, DOI 10.1113/jphysiol.2003.047035; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; SPRUCE AE, 1987, J PHYSIOL-LONDON, V382, P213, DOI 10.1113/jphysiol.1987.sp016364; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Taschenberger G, 2002, J BIOL CHEM, V277, P17139, DOI 10.1074/jbc.M200363200; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Venkatachalan SP, 2007, PFLUG ARCH EUR J PHY, V454, P155, DOI 10.1007/s00424-006-0183-1; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Xie LH, 2008, J PHYSIOL-LONDON, V586, P1833, DOI 10.1113/jphysiol.2007.147868; Xie LH, 2007, PROG BIOPHYS MOL BIO, V94, P320, DOI 10.1016/j.pbiomolbio.2006.04.001; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	60	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63733	10.1371/journal.pone.0063733	http://dx.doi.org/10.1371/journal.pone.0063733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700433	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400030
J	Zhou, M; Zhang, GQ; Ren, GP; Gnanadurai, CW; Li, ZG; Chai, QQ; Yang, Y; Leyson, CM; Wu, WX; Cui, M; Fu, ZF				Zhou, Ming; Zhang, Guoqing; Ren, Guiping; Gnanadurai, Clement W.; Li, Zhenguang; Chai, Qingqing; Yang, Yang; Leyson, Christina M.; Wu, Wenxue; Cui, Min; Fu, Zhen F.			Recombinant Rabies Viruses Expressing GM-CSF or Flagellin Are Effective Vaccines for Both Intramuscular and Oral Immunizations	PLOS ONE			English	Article							CONFERS PROTECTIVE IMMUNITY; MUCOSAL ADJUVANT ACTIVITY; DENDRITIC CELLS; BACTERIAL FLAGELLIN; RESPIRATORY CHALLENGE; SINGLE IMMUNIZATION; HUMAN ADENOVIRUS; PROTEIN VACCINE; FUSION PROTEIN; PUBLIC-HEALTH	Our previous studies indicated that recombinant rabies viruses (rRABV) expressing chemokines or cytokines (including GMCSF) could enhance the immunogenicity by recruiting and/or activating dendritic cells (DC). In this study, bacterial flagellin was cloned into the RABV genome and recombinant virus LBNSE-Flagellin was rescued. To compare the immunogenicity of LBNSE-Flagellin with recombinant virus expressing GMCSF (LBNSE-GMCSF), mice were immunized with each of these rRABVs by intramuscular (i.m.) or oral route. The parent virus (LBNSE) without expression of any foreign molecules was included for comparison. The i.m.-immunized mice were bled at three weeks after the immunization for the measurement of virus neutralizing antibody (VNA) and then challenged with 50 LD50 challenge virus standard (CVS-24). Orally immunized mice were boosted after three weeks and then bled and challenged one week after the booster immunization. It was found that both LBNSE-GMCSF and LBNSE-Flagellin recruited/activated more DCs and B cells in the periphery, stimulated higher levels of adaptive immune responses (VNA), and protected more mice against challenge infection than the parent virus LBNSE in both the i.m. and the orally immunized groups. Together, these studies suggest that recombinant RABV expressing GM-CSF or flagellin are more immunogenic than the parent virus in both i.m. and oral immunizations.	[Zhou, Ming; Cui, Min; Fu, Zhen F.] Huazhong Agr Univ, Coll Anim Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Zhou, Ming; Zhang, Guoqing; Ren, Guiping; Gnanadurai, Clement W.; Li, Zhenguang; Chai, Qingqing; Yang, Yang; Leyson, Christina M.; Fu, Zhen F.] Univ Georgia, Dept Pathol, Athens, GA 30602 USA; [Zhou, Ming; Wu, Wenxue] China Agr Univ, Minist Agr, Key Lab Zoonosis, Coll Vet Med, Beijing 100094, Peoples R China	Huazhong Agricultural University; University System of Georgia; University of Georgia; China Agricultural University; Ministry of Agriculture & Rural Affairs	Fu, ZF (corresponding author), Huazhong Agr Univ, Coll Anim Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	zhenfu@uga.edu	Zhou, Ming/K-7968-2017; cui, min/HGD-8340-2022; zhang, guoqing/GXG-4800-2022	Zhou, Ming/0000-0001-7012-017X	USA Public Health Service grant from the National Institute of Allergy and Infectious Diseases [AI-051560]; China Department of Sciences and Technology (863 program) [2011AA10A212]; China Department of Agriculture (special fund for Agro-scientific research in the Public Interest) [201303042]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051560] Funding Source: NIH RePORTER	USA Public Health Service grant from the National Institute of Allergy and Infectious Diseases; China Department of Sciences and Technology (863 program); China Department of Agriculture (special fund for Agro-scientific research in the Public Interest); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported partially by USA Public Health Service grant AI-051560 from the National Institute of Allergy and Infectious Diseases, China Department of Sciences and Technology (863 program, #2011AA10A212), and China Department of Agriculture (special fund for Agro-scientific research in the Public Interest, 201303042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHOMO HO, 1990, VET RES COMMUN, V14, P415, DOI 10.1007/BF00343220; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Ahmed M, 2010, J VIROL, V84, P12093, DOI 10.1128/JVI.00406-10; AMANN R, 2012, J VIROL; BAER GM, 1975, AM J EPIDEMIOL, V101, P160, DOI 10.1093/oxfordjournals.aje.a112080; Bates JT, 2008, MECH AGEING DEV, V129, P271, DOI 10.1016/j.mad.2008.01.009; BLACK JG, 1973, CAN VET J, V14, P206; BROCHIER B, 1991, NATURE, V354, P520, DOI 10.1038/354520a0; CHARLTON KM, 1992, ARCH VIROL, V123, P169, DOI 10.1007/BF01317147; Clark KA, 1996, J AM VET MED ASSOC, V208, P1827; Cliquet F, 2004, DEV BIOLOGICALS, V119, P185; Cliquet F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001535; CONZELMANN KK, 1990, VIROLOGY, V175, P485, DOI 10.1016/0042-6822(90)90433-R; Dato V., 2009, Morbidity and Mortality Weekly Report, V58, P1204; Delaney KN, 2010, VIRAL IMMUNOL, V23, P201, DOI 10.1089/vim.2009.0107; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; ESH JB, 1982, J AM VET MED ASSOC, V180, P1336; Estrada R, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-23; Faber M, 2007, J VIROL, V81, P7041, DOI 10.1128/JVI.00357-07; Farley Susan, 2012, Morbidity and Mortality Weekly Report, V61, P777; Fearneyhough MG, 1998, J AM VET MED ASSOC, V212, P498; Flamand A, 1993, Trends Microbiol, V1, P317, DOI 10.1016/0966-842X(93)90010-O; Fu ZF, 1997, VACCINE, V15, pS20, DOI 10.1016/S0264-410X(96)00312-X; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Hanlon CA, 2002, J WILDLIFE DIS, V38, P420, DOI 10.7589/0090-3558-38.2.420; Hanlon CA, 1998, J WILDLIFE DIS, V34, P228, DOI 10.7589/0090-3558-34.2.228; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Inoue K, 2003, J VIROL METHODS, V107, P229, DOI 10.1016/S0166-0934(02)00249-5; KIENY MP, 1984, NATURE, V312, P163, DOI 10.1038/312163a0; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; LAFAY F, 1994, VACCINE, V12, P317, DOI 10.1016/0264-410X(94)90095-7; LEE F, 1985, P NATL ACAD SCI USA, V82, P4360, DOI 10.1073/pnas.82.13.4360; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Levi R, 1996, VACCINE, V14, P85, DOI 10.1016/0264-410X(95)00088-I; Li JW, 2006, VIROLOGY, V356, P147, DOI 10.1016/j.virol.2006.07.037; Liu G, 2012, VACCINE, V30, P6833, DOI 10.1016/j.vaccine.2012.09.013; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MacInnes CD, 2001, J WILDLIFE DIS, V37, P119, DOI 10.7589/0090-3558-37.1.119; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; MCEWEN J, 1992, VACCINE, V10, P405, DOI 10.1016/0264-410X(92)90071-Q; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Mempel M, 2003, J INVEST DERMATOL, V120, P356, DOI 10.1046/j.1523-1747.2003.12074.x; Meslin F X, 1994, Curr Top Microbiol Immunol, V187, P1; Mizel SB, 2009, CLIN VACCINE IMMUNOL, V16, P21, DOI 10.1128/CVI.00333-08; Monaco F, 2006, DEV BIOLOGICALS, V125, P233; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Nigg AJ, 2009, PHARMACOTHERAPY, V29, P1182, DOI 10.1592/phco.29.10.1182; Niin E, 2006, DEV BIOLOGICALS, V125, P145; Orciari LA, 2001, VACCINE, V19, P4511, DOI 10.1016/S0264-410X(01)00186-4; Pino O, 2005, INFECT IMMUN, V73, P6763, DOI 10.1128/IAI.73.10.6763-6770.2005; Rasalingam P, 2005, VIRUS RES, V111, P55, DOI 10.1016/j.virusres.2005.03.010; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robbins AH, 1998, J AM VET MED ASSOC, V213, P1407; Roscoe DE, 1998, J WILDLIFE DIS, V34, P752, DOI 10.7589/0090-3558-34.4.752; RUPPRECHT CE, 1988, REV INFECT DIS, V10, pS803; Rupprecht CE, 2001, NEW ENGL J MED, V345, P582, DOI 10.1056/NEJMoa010560; Rupprecht CE, 2005, VIRUS RES, V111, P101, DOI 10.1016/j.virusres.2005.03.017; RUPPRECHT CE, 1995, EMERG INFECT DIS, V1, P107, DOI 10.3201/eid0104.950401; SCHNEIDER LG, 1988, REV INFECT DIS, V10, pS654; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Stohr K, 1996, VET REC, V139, P32, DOI 10.1136/vr.139.2.32; Tsujimoto H, 2005, J LEUKOCYTE BIOL, V78, P888, DOI 10.1189/jlb.0105051; Vos A, 2001, J GEN VIROL, V82, P2191, DOI 10.1099/0022-1317-82-9-2191; WANDELER AI, 1988, REV INFECT DIS, V10, pS649; Wen YJ, 2011, J VIROL, V85, P1634, DOI 10.1128/JVI.01552-10; WINKLER WG, 1976, AM J EPIDEMIOL, V104, P294, DOI 10.1093/oxfordjournals.aje.a112302; Wu XF, 2011, EXPERT REV VACCINES, V10, P1597, DOI [10.1586/ERV.11.140, 10.1586/erv.11.140]; Yuan ZG, 2009, VACCINE, V27, P5247, DOI 10.1016/j.vaccine.2009.06.062; Yuan ZG, 2008, VACCINE, V26, P1314, DOI 10.1016/j.vaccine.2007.12.050; Zhao L, 2010, J VIROL, V84, P9642, DOI 10.1128/JVI.00326-10	71	39	43	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63384	10.1371/journal.pone.0063384	http://dx.doi.org/10.1371/journal.pone.0063384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700422	gold, Green Submitted, Green Published			2022-12-27	WOS:000319966400020
J	Kato, H; Katoh, R; Kitamura, M				Kato, Hironori; Katoh, Ryohei; Kitamura, Masanori			Dual Regulation of Cadmium-Induced Apoptosis by mTORC1 through Selective Induction of IRE1 Branches in Unfolded Protein Response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; FREE-RADICALS; CELL-DEATH; ACTIVATION; ER; PHOSPHORYLATION; ANTIOXIDANTS; GENERATION; TOXICITY	Cadmium (Cd) causes generation of reactive oxygen species (ROS) that trigger renal tubular injury. We found that rapamycin, an inhibitor of mTORC1, attenuated Cd-induced apoptosis in renal tubular cells. Knockdown of Raptor, a positive regulator of mTORC1, also had the similar effect. However, rapamycin did not alter generation of ROS, suggesting that mTORC1 is a target downstream of ROS. Indeed, ROS caused activation of mTORC1, which contributed to induction of a selective branch of the unfolded protein response (UPR); i.e., the IRE1 pathway. Although Cd triggered three major UPR pathways, activation of mTORC1 by Cd did not contribute to induction of the PERK-eIF2 alpha and ATF6 pathways. Consistently, knockdown of Raptor caused suppression of JNK without affecting the PERK-eIF2 alpha pathway in Cd-exposed cells. Knockdown of TSC2, a negative regulator of mTORC1, caused activation of mTORC1 and enhanced Cd induction of the IRE1-JNK pathway and apoptosis without affecting other UPR branches. Inhibition of IRE1 alpha kinase led to suppression of JNK activity and apoptosis in Cd-treated cells. Dominant-negative inhibition of JNK also suppressed Cd-induced apoptosis. In contrast, inhibition of IRE1 alpha endoribonuclease activity or downstream XBP1 modestly enhanced Cd-induced apoptosis. In vivo, administration with rapamycin suppressed activation of mTORC1 and JNK, but not eIF2 alpha, in the kidney of Cd-treated mice. It was correlated with attenuation of tubular injury and apoptotic cell death in the tubules. These results elucidate dual regulation of Cd-induced renal injury by mTORC1 through selective induction of IRE1 signaling.	[Kato, Hironori; Kitamura, Masanori] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Chuo, Yamanashi, Japan; [Katoh, Ryohei] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Pathol, Chuo, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Kitamura, M (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Chuo, Yamanashi, Japan.	masanori@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [19651024, 40610283]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 19651024 to M. Kitamura; No. 40610283 to H. Kato). (http://www.jsps.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard A, 2004, BIOMETALS, V17, P519, DOI 10.1023/B:BIOM.0000045731.75602.b9; Chen L, 2008, J NEUROCHEM, V105, P251, DOI 10.1111/j.1471-4159.2007.05133.x; Chen L, 2011, FREE RADICAL BIO MED, V50, P624, DOI 10.1016/j.freeradbiomed.2010.12.032; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Figueiredo-Pereira ME, 1998, J BIOL CHEM, V273, P12703, DOI 10.1074/jbc.273.21.12703; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Klee M, 2009, EMBO J, V28, P1757, DOI 10.1038/emboj.2009.90; Lam D, 2009, P NATL ACAD SCI USA, V106, P11978, DOI 10.1073/pnas.0900608106; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lind Y, 1997, FOOD CHEM TOXICOL, V35, P891, DOI 10.1016/S0278-6915(97)00068-9; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ognjanovic BI, 2010, REPROD TOXICOL, V29, P191, DOI 10.1016/j.reprotox.2009.11.009; Oh SH, 2006, TOXICOL APPL PHARM, V212, P212, DOI 10.1016/j.taap.2005.07.018; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; Pathak N, 2006, TOXICOLOGY, V220, P26, DOI 10.1016/j.tox.2005.11.027; Piao XH, 2009, BIOCHEM BIOPH RES CO, V389, P16, DOI 10.1016/j.bbrc.2009.08.070; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Sugawara M, 2002, EXP BIOL MED, V227, P141, DOI 10.1177/153537020222700209; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang Z, 2012, TOXICOL APPL PHARM, V259, P236, DOI 10.1016/j.taap.2012.01.001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamada T, 2012, FREE RADICAL BIO MED, V52, P1285, DOI 10.1016/j.freeradbiomed.2012.02.003; Yokouchi M, 2007, CELL DEATH DIFFER, V14, P1467, DOI 10.1038/sj.cdd.4402154; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106	43	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64344	10.1371/journal.pone.0064344	http://dx.doi.org/10.1371/journal.pone.0064344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696882	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900085
J	Naito, T; Nishio, SY; Iwasa, Y; Yano, T; Kumakawa, K; Abe, S; Ishikawa, K; Kojima, H; Namba, A; Oshikawa, C; Usami, S				Naito, Takehiko; Nishio, Shin-ya; Iwasa, Yoh-ichiro; Yano, Takuya; Kumakawa, Kozo; Abe, Satoko; Ishikawa, Kotaro; Kojima, Hiromi; Namba, Atsushi; Oshikawa, Chie; Usami, Shin-ichi			Comprehensive Genetic Screening of KCNQ4 in a Large Autosomal Dominant Nonsyndromic Hearing Loss Cohort: Genotype-Phenotype Correlations and a Founder Mutation	PLOS ONE			English	Article							EAST ASIANS; DEAFNESS; CONNEXIN-26; IMPAIRMENT	The present study of KCNQ4 mutations was carried out to 1) determine the prevalence by unbiased population-based genetic screening, 2) clarify the mutation spectrum and genotype/phenotype correlations, and 3) summarize clinical characteristics. In addition, a review of the reported mutations was performed for better understanding of this deafness gene. The screening using 287 probands from unbiased Japanese autosomal dominant nonsyndromic hearing loss (ADNSHL) families identified 19 families with 7 different disease causing mutations, indicating that the frequency is 6.62% (19/287). While the majority were private mutations, one particular recurrent mutation, c.211delC, was observed in 13 unrelated families. Haplotype analysis in the vicinity of c.211delC suggests existence of a common ancestor. The majority of the patients showed all frequency, but high-frequency predominant, sensorineural hearing loss. The present study adds a new typical audiogram configuration characterized by mid-frequency predominant hearing loss caused by the p.V230E mutation. A variant at the N-terminal site (c.211delC) showed typical ski-slope type audiogram configuration. Concerning clinical features, onset age was from 3 to 40 years old, and mostly in the teens, and hearing loss was gradually progressive. Progressive nature is a common feature of patients with KCNQ4 mutations regardless of the mutation type. In conclusion, KCNQ4 mutations are frequent among ADNSHL patients, and therefore screening of the gene and molecular confirmation of these mutations have become important in the diagnosis of these conditions.	[Naito, Takehiko; Nishio, Shin-ya; Iwasa, Yoh-ichiro; Yano, Takuya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan; [Kumakawa, Kozo; Abe, Satoko] Toranomon Gen Hosp, Dept Otolaryngol, Tokyo, Japan; [Ishikawa, Kotaro] Jichi Med Univ, Dept Otorhinolaryngol, Mibu, Tochigi, Japan; [Kojima, Hiromi] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Tokyo, Japan; [Namba, Atsushi] Hirosaki Univ, Sch Med, Dept Otorhinolaryngol, Hirosaki, Aomori 036, Japan; [Oshikawa, Chie] Kyushu Univ, Sch Med, Dept Otorhinolaryngol, Fukuoka 812, Japan	Shinshu University; Toranomon Hospital; Jichi Medical University; Jikei University; Hirosaki University; Kyushu University	Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Ministry of Health, Labour and Welfare of Japan; Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan; Japanese Ministry of Health, Labour and Welfare; Ministry of Education, Science and Culture of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan; Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/) (S. U.), by the Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/) (S. U.), by a Health and Labour Sciences Research Grant for Research on Specific Diseases (Vestibular Disorders) from the Japanese Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/) (S. U.), and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (S. U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita J, 2001, J HUM GENET, V46, P355, DOI 10.1007/s100380170053; Arnett J, 2011, ARCH OTOLARYNGOL, V137, P54, DOI 10.1001/archoto.2010.234; Baek JI, 2010, BIOCH BIOPHYSICA ACT, P536; Coucke PJ, 1999, HUM MOL GENET, V8, P1321, DOI 10.1093/hmg/8.7.1321; Dominguez LM, 2012, APPL CLIN GENET, V5, P97, DOI 10.2147/TACG.S35525; Hildebrand MS, 2008, GENET MED, V10, P297, DOI 10.1097/GIM.0b013e318187e106; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Kamada F, 2006, J HUM GENET, V51, P455, DOI 10.1007/s10038-006-0384-7; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Miyagawa M, 2012, PLOS ONE IN PRESS; Moteki H, 2012, J HUM GENET IN PRESS, V21; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Park HJ, 2010, J HUM GENET, V55, P59, DOI 10.1038/jhg.2009.114; Van Camp G, 2002, HUM MUTAT, V20, P15, DOI 10.1002/humu.10096; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; von Ilberg CA, 2011, AUDIOL NEURO-OTOL, V16, P1, DOI 10.1159/000327765; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1	18	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63231	10.1371/journal.pone.0063231	http://dx.doi.org/10.1371/journal.pone.0063231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717403	Green Published, Green Submitted, gold			2022-12-27	WOS:000319435600006
J	Scharmann, M; Thornham, DG; Grafe, TU; Federle, W				Scharmann, Mathias; Thornham, Daniel G.; Grafe, T. Ulmar; Federle, Walter			A Novel Type of Nutritional Ant-Plant Interaction: Ant Partners of Carnivorous Pitcher Plants Prevent Nutrient Export by Dipteran Pitcher Infauna	PLOS ONE			English	Article							ALTERNATIVE TRAPPING STRATEGIES; LEAF-LITTER UTILIZATION; NEPENTHES-BICALCARATA; NITROGEN; PREY; CAPTURE; EFFICIENCY; DIVERSITY; PREDATION; MUTUALISM	Many plants combat herbivore and pathogen attack indirectly by attracting predators of their herbivores. Here we describe a novel type of insect-plant interaction where a carnivorous plant uses such an indirect defence to prevent nutrient loss to kleptoparasites. The ant Camponotus schmitzi is an obligate inhabitant of the carnivorous pitcher plant Nepenthes bicalcarata in Borneo. It has recently been suggested that this ant-plant interaction is a nutritional mutualism, but the detailed mechanisms and the origin of the ant-derived nutrient supply have remained unexplained. We confirm that N. bicalcarata host plant leaves naturally have an elevated N-15/N-14 stable isotope abundance ratio (delta N-15) when colonised by C. schmitzi. This indicates that a higher proportion of the plants' nitrogen is insect-derived when C. schmitzi ants are present (ca. 100%, vs. 77% in uncolonised plants) and that more nitrogen is available to them. We demonstrated direct flux of nutrients from the ants to the host plant in a N-15 pulse-chase experiment. As C. schmitzi ants only feed on nectar and pitcher contents of their host, the elevated foliar delta N-15 cannot be explained by classic ant-feeding (myrmecotrophy) but must originate from a higher efficiency of the pitcher traps. We discovered that C. schmitzi ants not only increase the pitchers' capture efficiency by keeping the pitchers' trapping surfaces clean, but they also reduce nutrient loss from the pitchers by predating dipteran pitcher inhabitants (infauna). Consequently, nutrients the pitchers would have otherwise lost via emerging flies become available as ant colony waste. The plants' prey is therefore conserved by the ants. The interaction between C. schmitzi, N. bicalcarata and dipteran pitcher infauna represents a new type of mutualism where animals mitigate the damage by nutrient thieves to a plant.	[Scharmann, Mathias] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany; [Scharmann, Mathias; Thornham, Daniel G.; Federle, Walter] Univ Cambridge, Dept Zool, Cambridge, England; [Thornham, Daniel G.] Univ Glamorgan, Div Biol, Pontypridd CF37 1DL, M Glam, Wales; [Grafe, T. Ulmar] Univ Brunei Darussalam, Dept Biol, Gadong, Brunei	University of Wurzburg; University of Cambridge; University of South Wales; University Brunei Darussalam	Scharmann, M (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.	mathias.scharmann@env.ethz.ch	Federle, Walter/K-8263-2014	Federle, Walter/0000-0002-6375-3005	Leverhulme Trust [F/09 364/G]; German Academic Exchange Service; BBSRC [BB/I008667/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I008667/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a grant from the Leverhulme Trust (F/09 364/G; http://www.leverhulme.ac.uk/) to WF, and a scholarship from the German Academic Exchange Service (http://www.daad.de) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Jumaat H., 1997, Pertanika Journal of Tropical Agricultural Science, V20, P121; Adlassnig W, 2011, ANN BOT-LONDON, V107, P181, DOI 10.1093/aob/mcq238; Anderson B, 2002, OECOLOGIA, V132, P369, DOI 10.1007/s00442-002-0998-1; [Anonymous], 2001, FLORA MALESIANA 1; Bauer U, 2012, J EVOLUTION BIOL, V25, P90, DOI 10.1111/j.1420-9101.2011.02406.x; Bauer U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038951; Bauer U, 2011, J EXP BOT, V62, P3683, DOI 10.1093/jxb/err082; Bazile V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036179; BEATTIE A, 1989, TRENDS ECOL EVOL, V4, P172, DOI 10.1016/0169-5347(89)90122-5; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Beaver R.A., 1983, P129; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Bohn HF, 2012, J COMP PHYSIOL A, V198, P465, DOI 10.1007/s00359-012-0723-4; Bonhomme V, 2011, NEW PHYTOL, V191, P545, DOI 10.1111/j.1469-8137.2011.03696.x; Bonhomme V, 2011, J TROP ECOL, V27, P15, DOI 10.1017/S0266467410000532; BRADSHAW WE, 1984, AM MIDL NAT, V112, P294, DOI 10.2307/2425436; Burbidge FW, 1880, GARDENS SUN; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; Clarke C., 1997, NEPENTHES OF BORNEO; Clarke CM, 2009, BIOL LETTERS, V5, P632, DOI 10.1098/rsbl.2009.0311; CLARKE CM, 1993, ECOL ENTOMOL, V18, P7, DOI 10.1111/j.1365-2311.1993.tb01074.x; CLARKE CM, 1995, J TROP ECOL, V11, P589, DOI 10.1017/S0266467400009160; Clarke CM, 1992, THESIS U NEW ENGLAND; Cresswell JE, 2000, ECOL ENTOMOL, V25, P362, DOI 10.1046/j.1365-2311.2000.00267.x; Darwin C., 1875, INSECTIVOROUS PLANTS; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; GAY H, 1993, BIOL J LINN SOC, V50, P221, DOI 10.1111/j.1095-8312.1993.tb00928.x; Gibson TC, 2009, NEW PHYTOL, V183, P575, DOI 10.1111/j.1469-8137.2009.02935.x; Grafe TU, 2011, BIOL LETTERS, V7, P436, DOI 10.1098/rsbl.2010.1141; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Karagatzides JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006164; Kato M., 1993, Tropical Zoology, V6, P11; KITCHING R, 1986, NEW SCI, V109, P48; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Kolb KJ, 2002, NEW PHYTOL, V156, P57, DOI 10.1046/j.1469-8137.2002.00490.x; Lloyd F.E., 1942, CARNIVOROUS PLANTS; Merbach MA, 2002, NATURE, V415, P36, DOI 10.1038/415036a; Merbach MA, 2001, FLORA, V196, P153, DOI 10.1016/S0367-2530(17)30030-0; Merbach Marlis A., 2007, Ecotropica-Bonn, V13, P45; Merbach Marlis A., 1999, Ecotropica, V5, P45; MOGI M, 1992, OECOLOGIA, V90, P172, DOI 10.1007/BF00317174; Mogi M, 1996, RAFFLES B ZOOL, V44, P233; Moran JA, 2003, INT J PLANT SCI, V164, P635, DOI 10.1086/375422; Moran JA, 2001, ANN BOT-LONDON, V88, P307, DOI 10.1006/anbo.2001.1460; Moran JA, 1996, J ECOL, V84, P515, DOI 10.2307/2261474; Moran JA, 1998, INT J PLANT SCI, V159, P996; Moran JA, 2010, J EXP BOT, V61, P1365, DOI 10.1093/jxb/erq004; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; Oosterbroek P., 1998, FAMILIES DIPTERA MAL; Osunkoya OO, 2008, ANN BOT-LONDON, V102, P845, DOI 10.1093/aob/mcn162; Pavlovic A, 2010, PHOTOSYNTHETICA, V48, P227, DOI 10.1007/s11099-010-0028-1; Pavlovic A, 2011, PLANT CELL ENVIRON, V34, P1865, DOI 10.1111/j.1365-3040.2011.02382.x; Pavlovic A, 2009, ANN BOT-LONDON, V104, P307, DOI 10.1093/aob/mcp121; Poppinga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045735; Rotheray Graham E., 2012, Entomologist's Monthly Magazine, V148, P15; SCHULZE ED, 1991, OECOLOGIA, V87, P240, DOI 10.1007/BF00325262; Schulze W, 1997, OECOLOGIA, V112, P464, DOI 10.1007/s004420050333; Sota T, 1998, BIOTROPICA, V30, P82, DOI 10.1111/j.1744-7429.1998.tb00371.x; Starcke A., 1933, Natuurhistorisch Maandblad Maastricht, V22, P29; Starzomski BM, 2010, ECOL ENTOMOL, V35, P53, DOI 10.1111/j.1365-2311.2009.01155.x; Thornham DG, 2012, FUNCT ECOL, V26, P11, DOI 10.1111/j.1365-2435.2011.01937.x; Tofilski A, 2012, DRAWWING INSECTS IDE; TRESEDER KK, 1995, NATURE, V375, P137, DOI 10.1038/375137a0; Watkins JE, 2008, NEW PHYTOL, V180, P5, DOI 10.1111/j.1469-8137.2008.02606.x; ZAMORA R, 1990, OIKOS, V59, P368, DOI 10.2307/3545148; Zamora R, 1996, J ANIM ECOL, V65, P154, DOI 10.2307/5718	69	21	21	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63556	10.1371/journal.pone.0063556	http://dx.doi.org/10.1371/journal.pone.0063556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717446	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700034
J	Zhang, H; Zhang, Y; Zhao, HS; Zhang, YF; Chen, Q; Peng, HY; Lei, L; Qiao, JQ; Shi, JC; Cao, ZH; Duan, EK; Jin, YP				Zhang, He; Zhang, Ying; Zhao, Huashan; Zhang, Yunfang; Chen, Qi; Peng, Hongying; Lei, Li; Qiao, Jingqiao; Shi, Junchao; Cao, Zhonghong; Duan, Enkui; Jin, Yaping			Hormonal Regulation of Ovarian Bursa Fluid in Mice and Involvement of Aquaporins	PLOS ONE			English	Article							LYMPHATIC STOMATA; GOLDEN-HAMSTER; WATER CHANNELS; REPRODUCTIVE-SYSTEMS; 8-DEFICIENT MICE; OVULATION; RAT; ESTROGEN; FEMALE; IDENTIFICATION	In rodent species, the ovary and the end of oviduct are encapsulated by a thin membrane called ovarian bursa. The biological functions of ovarian bursa remain unexplored despite its structural arrangement in facilitating oocytes transport into oviduct. In the present study, we observed a rapid fluid accumulation and reabsorption within the ovarian bursa after ovarian stimulation (PMSG-primed hCG injection), suggesting that the ovarian bursa might play an active role in regulating local fluid homeostasis around the timing of ovulation. We hypothesized that the aquaporin proteins, which are specialized channels for water transport, might be involved in this process. By screening the expression of aquaporin family members (Aqp1-9) in the ovarian tissue and isolated ovarian bursa (0, 1, 2 and 5 h after hCG injection), we found that AQP2 and AQP5 mRNA showed dynamic changes after hCG treatment, showing upregulation at 1-2 h followed by gradually decrease at 5 h, which is closely related with the intra-bursa fluid dynamics. Further immunofluorescence examinations of AQP2 and AQP5 in the ovarian bursa revealed that AQP2 is specifically localized in the outer layer (peritoneal side) while AQP5 localized in the inner layer (ovarian side) of the bursa, such cell type specific and spatial-temporal expressions of AQP2 and 5 support our hypothesis that they might be involved in efficient water transport through ovarian bursa under ovulation related hormonal regulation. The physiological significance of aquaporin-mediated water transport in the context of ovarian bursa still awaits further clarification.	[Zhang, He; Jin, Yaping] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Zhang, Ying; Zhao, Huashan; Zhang, Yunfang; Chen, Qi; Peng, Hongying; Lei, Li; Qiao, Jingqiao; Shi, Junchao; Cao, Zhonghong; Duan, Enkui] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Zhao, Huashan; Lei, Li; Cao, Zhonghong] Univ Chinese Acad Sci, Beijing, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Duan, EK (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	duane@ioz.ac.cn; yapingjin@163.com	cao, zhonghong/AAQ-9968-2020; Shi, Junchao/J-4909-2019; Chen, Qi/K-4059-2019; Chen, Qi/W-1759-2019	Shi, Junchao/0000-0002-1548-5069; Chen, Qi/0000-0001-6353-9589; Zhang, Ying/0000-0003-4082-5026; Cao, Zhonghong/0000-0003-1138-0080	National Basic Research Program of China [2011CB944401, 2011CB710905]; National Natural Science Foundation of China [31200879]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (2011CB944401 and 2011CB710905) and National Natural Science Foundation of China (31200879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Q, 2011, J BIOL CHEM, V286, P4349, DOI 10.1074/jbc.M110.197202; Chen Q, 2011, CELL RES, V21, P922, DOI 10.1038/cr.2010.169; GUERRE EF, 1991, FERTIL STERIL, V56, P126; Hausman GJ, 2012, BIOCHIMIE, V94, P2075, DOI 10.1016/j.biochi.2012.02.022; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Huang HF, 2006, HUM REPROD UPDATE, V12, P785, DOI 10.1093/humupd/dml035; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kobayashi M, 2006, GENES CELLS, V11, P1133, DOI 10.1111/j.1365-2443.2006.01009.x; Li M, 2007, ANAT REC, V290, P1195, DOI 10.1002/ar.20583; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; McConnell NA, 2002, ENDOCRINOLOGY, V143, P2905, DOI 10.1210/en.143.8.2905; NAKATANI T, 1986, J ANAT, V148, P1; PARR EL, 1974, BIOL REPROD, V11, P504, DOI 10.1095/biolreprod11.5.504; PARR EL, 1974, BIOL REPROD, V11, P483, DOI 10.1095/biolreprod11.5.483; Rodgers RJ, 2010, BIOL REPROD, V82, P1021, DOI 10.1095/biolreprod.109.082941; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Rojek A, 2006, P NATL ACAD SCI USA, V103, P6037, DOI 10.1073/pnas.0511324103; Sasaki S, 2012, MOL ASPECTS MED, V33, P535, DOI 10.1016/j.mam.2012.03.004; Sha XY, 2011, ACTA PHARMACOL SIN, V32, P840, DOI 10.1038/aps.2011.45; SHINOHARA H, 1985, ANAT REC, V213, P44, DOI 10.1002/ar.1092130107; SHINOHARA H, 1987, AM J ANAT, V179, P385, DOI 10.1002/aja.1001790408; SHINOHARA H, 1986, J ANAT, V147, P45; Shkolnik K, 2011, P NATL ACAD SCI USA, V108, P1462, DOI 10.1073/pnas.1017213108; Song YL, 2001, J BIOL CHEM, V276, P41288, DOI 10.1074/jbc.M107257200; Su WH, 2010, IUBMB LIFE, V62, P852, DOI 10.1002/iub.398; Sui M H, 2001, Shi Yan Sheng Wu Xue Bao, V34, P291; Sun XL, 2009, FERTIL STERIL, V92, P1736, DOI 10.1016/j.fertnstert.2008.07.1785; Thoroddsen A, 2011, J CLIN ENDOCR METAB, V96, P1021, DOI 10.1210/jc.2010-2545; Van der Hoek KH, 2000, BIOL REPROD, V62, P1059, DOI 10.1095/biolreprod62.4.1059; VANDERHYDEN BC, 1986, J REPROD FERTIL, V77, P393, DOI 10.1530/jrf.0.0770393; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Wang ZB, 2010, ANAT REC, V293, P754, DOI 10.1002/ar.21101; Zhang D, 2012, MOL ASPECTS MED, V33, P676, DOI 10.1016/j.mam.2012.02.002; Zou LB, 2011, J CLIN ENDOCR METAB, V96, pE1399, DOI 10.1210/jc.2011-0426	34	14	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63823	10.1371/journal.pone.0063823	http://dx.doi.org/10.1371/journal.pone.0063823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717491	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700066
J	Hartel, T; von Wehrden, H				Hartel, Tibor; von Wehrden, Henrik			Farmed Areas Predict the Distribution of Amphibian Ponds in a Traditional Rural Landscape	PLOS ONE			English	Article							BOMBINA-VARIEGATA POPULATION; DISTRIBUTION MODELS; AVAILABILITY; BIODIVERSITY; RESTORATION; COMMUNITY; DYNAMICS; CATTLE; FISH; BUFO	Background: Traditional rural landscapes of Eastern Europe are undergoing major changes due to agricultural intensification, land abandonment, change in agricultural practices and infrastructural development. Small man-made ponds are important yet vulnerable components of rural landscapes. Despite their important role for biodiversity, these ponds tend to be excluded from conservation strategies. Methodology/Findings: Our study was conducted in a traditional rural landscape in Eastern Europe. The aim of this study is twofold: (i) to model the distribution of four major man-made pond types and (ii) to present the importance of man-made ponds for the endangered Yellow Bellied Toad (Bombina variegata) and the Common Toad (Bufo bufo). Six environmental variables were used to model pond distribution: Corine landcover, the heterogeneity of the landcover, slope, road distance, distance to closest village and the human population density. Land cover heterogeneity was the most important driver for the distribution of fishponds. Areas used for agriculture with significant areas of natural vegetation were the most important predictors for the distribution of temporary ponds. In addition, areas covered by transitional woodland and scrub were important for the open cattle ponds. Bombina variegata was found predominantly in the temporary ponds (e. g. ponds created by cattle and buffalo, dirt road ponds and concrete ponds created for livestock drinking) and Bufo bufo in fishponds. Conclusions/Significance: Our Maxent models revealed that the highest probability of occurrence for amphibian ponds was in areas used as farmland. The traditional farming practices combined with a low level of infrastructure development produces a large number of amphibian ponds. The challenge is to harmonize economic development and the maintenance of high densities of ponds in these traditional rural landscapes.	[Hartel, Tibor; von Wehrden, Henrik] Leuphana Univ Luneburg, Fac Sustainabil, Inst Ecol, Luneburg, Germany; [Hartel, Tibor] Sapientia Univ, Dept Environm Sci, Cluj Napoca, Romania; [Hartel, Tibor] Ovidius Univ Constanta, Fac Nat & Agr Sci, Constanta, Romania; [von Wehrden, Henrik] Leuphana Univ Luneburg, Ctr Methods, Luneburg, Germany; [von Wehrden, Henrik] Res Inst Wildlife Ecol, Vienna, Austria	Leuphana University Luneburg; Sapientia Hungarian University of Transylvania; Ovidius University; Leuphana University Luneburg	Hartel, T (corresponding author), Leuphana Univ Luneburg, Fac Sustainabil, Inst Ecol, Luneburg, Germany.	hartel.tibor@gmail.com	Tibor, Hartel/B-3440-2012		European Regional Development Fund (ERDF) through Sectorial Operational Plan - Environment (POS Mediu) under the project "For nature and local communities - the basis for a Natura integrated management in Hartibaciu -Tarnava Mare - Olt area''; Alexander von Humboldt Foundation via a Sofja Kovalevskaja Award; Alexander von Humboldt Foundation	European Regional Development Fund (ERDF) through Sectorial Operational Plan - Environment (POS Mediu) under the project "For nature and local communities - the basis for a Natura integrated management in Hartibaciu -Tarnava Mare - Olt area''; Alexander von Humboldt Foundation via a Sofja Kovalevskaja Award(Alexander von Humboldt Foundation); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Data collection was made with the support of European Regional Development Fund (ERDF) through Sectorial Operational Plan - Environment (POS Mediu) under the project "For nature and local communities - the basis for a Natura 2000 integrated management in Hartibaciu -Tarnava Mare - Olt area.'' The authors gratefully acknowledge support for the processing of spatial data. Data processing was conducted as part of a larger research project at Leuphana University Lueneburg, which was externally funded by the Alexander von Humboldt Foundation via a Sofja Kovalevskaja Award to Professor Joern Fischer. The research stay of TH in Germany and the publication of this manuscript were supported by Alexander von Humboldt Foundation. The publication of the collected data was approved by the World Wild Fund (WWF) - the leader of this project with the condition to mention the funding source in the Acknowledgments. The funders had no role in study design, data collection, analysis and the preparation.	Barandun J, 1998, COPEIA, P497, DOI 10.2307/1447450; Barandun Jonas, 1997, Amphibia-Reptilia, V18, P143, DOI 10.1163/156853897X00035; Barbaro L, 2001, BIODIVERS CONSERV, V10, P119, DOI 10.1023/A:1016629507196; Beebee TJC, 1997, BIOL CONSERV, V81, P215, DOI 10.1016/S0006-3207(97)00002-5; Benton T, 2011, NATURE, V480, P39, DOI 10.1038/480039d; Boix D, 2012, HYDROBIOLOGIA, V689, P1, DOI 10.1007/s10750-012-1015-2; Boll S, 2002, THESIS JULIUS MAXIMI; Boothby J, 1997, AQUAT CONSERV, V7, P127; Briggs J, 1994, BRIT WILDLIFE, V5, P273; Briggs Lars, 2001, Freshwater Forum, V17, P63; Crochet PA, 2004, BIOL CONSERV, V119, P297, DOI 10.1016/j.biocon.2003.12.004; Curado N, 2011, BIOL CONSERV, V144, P1610, DOI 10.1016/j.biocon.2011.02.011; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Demeter L, 2007, ANN LIMNOL-INT J LIM, V43, P101, DOI 10.1051/limn/2007016; Denoel M, 2007, ECOL APPL, V17, P302, DOI 10.1890/1051-0761(2007)017[0302:LTANC]2.0.CO;2; Dolman PM, 2008, CONSERV LETT, V5, P11; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Dorner B, 1910, AZ ERDELYI SZASZOK M; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Feder M. E., 1992, ENV PHYSL AMPHIBIANS; Ficetola GF, 2004, BIOL CONSERV, V119, P219, DOI 10.1016/j.biocon.2003.11.004; Fischer J, 2012, CONSERV LETT, V5, P167, DOI 10.1111/j.1755-263X.2012.00227.x; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gibson L, 2007, DIVERS DISTRIB, V13, P704, DOI 10.1111/j.1472-4642.2007.00365.x; Gollmann G, 1998, CURRENT STUDIES HERP, P139; Grootjans AP, 2002, HYDROBIOLOGIA, V478, P181, DOI 10.1023/A:1021086832201; Halley JM, 1996, J APPL ECOL, V33, P455, DOI 10.2307/2404977; Hartel T, 2008, NORTH-WEST J ZOOL, V4, P79; Hartel T, 2008, APPL HERPETOL, V5, P1, DOI 10.1163/157075408783489248; Hartel Tibor, 2007, Acta Zoologica Lituanica, V17, P56; Hartel T, 2007, HYDROBIOLOGIA, V583, P173, DOI 10.1007/s10750-006-0490-8; Hartel T, 2011, FRESHWATER BIOL, V56, P2288, DOI 10.1111/j.1365-2427.2011.02655.x; Hartel T, 2010, BIOL CONSERV, V143, P1118, DOI 10.1016/j.biocon.2010.02.006; Hull Andrew, 1997, P101; Jahn K, 1996, NATURSCHUTZREPORT, V11, P3246; Jeffries MJ, 2012, HYDROBIOLOGIA, V689, P11, DOI 10.1007/s10750-011-0678-4; Lofvenhaft K, 2004, LANDSCAPE URBAN PLAN, V68, P403, DOI 10.1016/S0169-2046(03)00154-3; Manteifel YB, 2002, ARCH HYDROBIOL, V153, P657; Mikulcak F, 2013, ENVIRON CONSERV, V40, P129, DOI 10.1017/S0376892912000392; Paracchini M.L., 2008, JRC SCI TECHNICAL RE, DOI DOI 10.2788/8891; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Plaiasu R, 2012, HERPETOL J, V22, P13; Putfarken D, 2008, APPL ANIM BEHAV SCI, V111, P54, DOI 10.1016/j.applanim.2007.05.012; Pyke CR, 2005, CONSERV BIOL, V19, P1619, DOI 10.1111/j.1523-1739.2005.00233.x; Scheffer M, 2006, OIKOS, V112, P227, DOI 10.1111/j.0030-1299.2006.14145.x; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; SINSCH U, 1995, AUST J ECOL, V20, P351, DOI 10.1111/j.1442-9993.1995.tb00550.x; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x	52	44	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63649	10.1371/journal.pone.0063649	http://dx.doi.org/10.1371/journal.pone.0063649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704928	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200059
J	Vanderhasselt, MA; De Raedt, R; Brunoni, AR; Campanha, C; Baeken, C; Remue, J; Boggio, PS				Vanderhasselt, Marie-Anne; De Raedt, Rudi; Brunoni, Andre R.; Campanha, Camila; Baeken, Chris; Remue, Jonathan; Boggio, Paulo S.			tDCS over the Left Prefrontal Cortex Enhances Cognitive Control for Positive Affective Stimuli	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; IMPROVING WORKING-MEMORY; MAJOR DEPRESSION; NEGATIVE AFFECT; CONFLICT; STROOP; VALIDATION; VOLUNTEERS; PANAS; MOOD	Transcranial Direct Current Stimulation (tDCS) is a neuromodulation technique with promising results for enhancing cognitive information processes. So far, however, research has mainly focused on the effects of tDCS on cognitive control operations for non-emotional material. Therefore, our aim was to investigate the effects on cognitive control considering negative versus positive material. For this sham-controlled, within-subjects study, we selected a homogeneous sample of twenty-five healthy participants. By using behavioral measures and event related potentials (ERP) as indexes, we aimed to investigate whether a single session of anodal tDCS of the left dorsolateral prefrontal cortex (DLPFC) would have specific effects in enhancing cognitive control for positive and negative valenced stimuli. After tDCS over the left DLPFC (and not sham control stimulation), we observed more negative N450 amplitudes along with faster reaction times when inhibiting a habitual response to happy compared to sad facial expressions. Gender did not influence the effects of tDCS on cognitive control for emotional information. In line with the Valence Theory of side-lateralized activity, this stimulation protocol might have led to a left dominant (relative to right) prefrontal cortical activity, resulting in augmented cognitive control specifically for positive relative to negative stimuli. To verify that tDCS induces effects that are in line with all aspects of the well known Valence Theory, future research should investigate the effects of tDCS over the left vs. right DLPFC on cognitive control for emotional information.	[Vanderhasselt, Marie-Anne; De Raedt, Rudi; Remue, Jonathan] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Brunoni, Andre R.] Univ Sao Paulo, Clin Res Ctr, Univ Hosp, Sao Paulo, Brazil; [Brunoni, Andre R.] Univ Sao Paulo, Inst Psychol, Dept Neurosci, Sao Paulo, Brazil; [Campanha, Camila; Boggio, Paulo S.] Univ Prebiteriana Mackenzie, Social & Cognit Neurosci Lab, Ctr Hlth & Biol Sci, Sao Paulo, Brazil; [Campanha, Camila; Boggio, Paulo S.] Univ Prebiteriana Mackenzie, Dev Disorders Program, Ctr Hlth & Biol Sci, Sao Paulo, Brazil; [Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, B-9000 Ghent, Belgium; [Baeken, Chris] Univ Brussels, Brussels, Belgium; [Baeken, Chris] Univ Hosp UZBrussel, Dept Psychiat, Brussels, Belgium	Ghent University; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Presbiteriana Mackenzie; Universidade Presbiteriana Mackenzie; Ghent University	Vanderhasselt, MA (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	MarieAnne.Vanderhasselt@UGent.be	De Raedt, Rudi/A-3269-2012; Baeken, Chris/D-6790-2013; Remue, Jonathan/A-8112-2013; Boggio, Paulo S/K-6272-2012; Brunoni, Andre R./H-8394-2012; Baeken, Chris/E-2074-2013	De Raedt, Rudi/0000-0001-6781-4808; Remue, Jonathan/0000-0001-7012-6221; Boggio, Paulo S/0000-0002-6109-0447; Brunoni, Andre R./0000-0002-6310-3571; Vanderhasselt, Marie-Anne/0000-0002-4045-1055	Research Foundation Flanders (FWO) [FWO08/PDO/168]; Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; CNPq [305718/2009-6]; FAPESP [2010/20063-9];  [BOF10/GOA/014]	Research Foundation Flanders (FWO)(FWO); Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); 	MAV (FWO08/PDO/168) is a postdoctoral research fellow of the Research Foundation Flanders (FWO). Preparation of this paper was also supported by Grant BOF10/GOA/014 for a Concerted Research Action of Ghent University (awarded to RDR). This work was also supported by the Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control" (CB). PSB is supported by a CNPq researcher grant (305718/2009-6). CC is supported by a PhD grant (FAPESP 2010/20063-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Baeken C, 2008, CLIN NEUROPHYSIOL, V119, P568, DOI 10.1016/j.clinph.2007.11.044; Boggio PS, 2007, J AFFECT DISORDERS, V101, P91, DOI 10.1016/j.jad.2006.10.026; Boggio PS, 2005, MOVEMENT DISORD, V20, P1178, DOI 10.1002/mds.20508; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brunoni AR, 2013, PSYCHONEURO IN PRESS; Campanella S, 2012, PSYCHIAT RES; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; De Raedt R, 2013, BIOL PSYCHO IN PRESS; Dutra S, 2012, J PSYCHIAT NEUROSCIE; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Holmes AJ, 2008, NEUROPSYCHOLOGIA, V46, P2904, DOI 10.1016/j.neuropsychologia.2008.05.028; Lundqvist D., 1998, KAROLINSKA DIRECTED; Miniussi C, 2010, CORTEX, V46, P128, DOI 10.1016/j.cortex.2009.03.004; Mosimann UP, 2000, PSYCHIAT RES, V94, P251, DOI 10.1016/S0165-1781(00)00146-3; Mulquiney PG, 2011, CLIN NEUROPHYSIOL, V122, P2384, DOI 10.1016/j.clinph.2011.05.009; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Vines BW, 2006, NEUROREPORT, V17, P671, DOI 10.1097/00001756-200604240-00023; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; West R, 2000, PSYCHOPHYSIOLOGY, V37, P179, DOI 10.1111/1469-8986.3720179; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; Wolkenstein L, 2013, BIOL PSYCHIAT, V73, P646, DOI 10.1016/j.biopsych.2012.10.010; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2	30	66	67	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62219	10.1371/journal.pone.0062219	http://dx.doi.org/10.1371/journal.pone.0062219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704874	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200003
J	Zhao, L; Zhang, Y; Ji, PF; Zhang, XF; Zhao, ZX; Hou, GY; Huo, LH; Liu, GM; Li, C; Xu, P; Sun, XW				Zhao, Lan; Zhang, Yan; Ji, Peifeng; Zhang, Xiaofeng; Zhao, Zixia; Hou, Guangyuan; Huo, Linhe; Liu, Guiming; Li, Chao; Xu, Peng; Sun, Xiaowen			A Dense Genetic Linkage Map for Common Carp and Its Integration with a BAC-Based Physical Map	PLOS ONE			English	Article							CATFISH ICTALURUS-PUNCTATUS; COMPARATIVE GENOME ANALYSIS; CYPRINUS-CARPIO; END SEQUENCES; ATLANTIC SALMON; MICROSATELLITES; L.; CONSTRUCTION; GENERATION; IMPACT	Background: Common carp (Cyprinus carpio) is one of the most important aquaculture species with an annual global production of 3.4 million metric tons. It is also an important ornamental species as well as an important model species for aquaculture research. To improve the economically important traits of this fish, a number of genomic resources and genetic tools have been developed, including several genetic maps and a bacterial artificial chromosome (BAC)-based physical map. However, integrated genetic and physical maps are not available to study quantitative trait loci (QTL) and assist with fine mapping, positional cloning and whole genome sequencing and assembly. The objective of this study was to integrate the currently available BAC-based physical and genetic maps. Results: The genetic map was updated with 592 novel markers, including 312 BAC-anchored microsatellites and 130 SNP markers, and contained 1,209 genetic markers on 50 linkage groups, spanning 3,565.9 cM in the common carp genome. An integrated genetic and physical map of the common carp genome was then constructed, which was composed of 463 physical map contigs and 88 single BACs. Combined lengths of the contigs and single BACs covered a physical length of 498.75 Mb, or around 30% of the common carp genome. Comparative analysis between common carp and zebrafish genomes was performed based on the integrated map, providing more insights into the common carp specific whole genome duplication and segmental rearrangements in the genome. Conclusion: We integrated a BAC-based physical map to a genetic linkage map of common carp by anchoring BAC-associated genetic markers. The density of the genetic linkage map was significantly increased. The integrated map provides a tool for both genetic and genomic studies of common carp, which will help us to understand the genomic architecture of common carp and facilitate fine mapping and positional cloning of economically important traits for genetic improvement and modification.	[Zhao, Lan; Zhang, Yan; Ji, Peifeng; Zhao, Zixia; Hou, Guangyuan; Xu, Peng; Sun, Xiaowen] Chinese Acad Fishery Sci, Ctr Appl Aquat Gen, Beijing, Peoples R China; [Zhang, Xiaofeng; Li, Chao; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang Fisheries Res Inst, Harbin, Peoples R China; [Zhao, Lan] Dalian Ocean Univ, Coll Life Sci & Technol, Dalian, Peoples R China; [Huo, Linhe; Liu, Guiming] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Dalian Ocean University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Xu, P (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Gen, Beijing, Peoples R China.	xupeng@cafs.ac.cn; sunxw2002@163.com	Sun, Xiaowen/F-1516-2014; Zhao, Zi-Xia/AAM-8065-2021; Xu, Peng/J-4018-2012	Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Peng/0000-0002-1531-5078; Zhao, Lan/0000-0003-2681-7695	National Department Public Benefit Research Foundation [200903045]; National High-tech Research & Development Program of China [2009AA10Z105, 2011AA100401]; China Ministry of Agriculture "948'' Program [2010-Z11, 2011-G12]; Research Foundation of Chinese Academy of Fishery Sciences [2009B002]	National Department Public Benefit Research Foundation; National High-tech Research & Development Program of China; China Ministry of Agriculture "948'' Program; Research Foundation of Chinese Academy of Fishery Sciences	This study was supported by the grants from National Department Public Benefit Research Foundation (No. 200903045), National High-tech Research & Development Program of China (No. 2009AA10Z105 and 2011AA100401), China Ministry of Agriculture "948'' Program (No. 2010-Z11 and 2011-G12) and Research Foundation of Chinese Academy of Fishery Sciences (No. 2009B002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Henkel CV, 2012, ZEBRAFISH, V9, P59, DOI 10.1089/zeb.2012.0773; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Katagiri T, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-89; Kongchum P, 2010, FISH SHELLFISH IMMUN, V29, P356, DOI 10.1016/j.fsi.2010.04.013; Kroupova H, 2010, ENVIRON TOXICOL CHEM, V29, P535, DOI 10.1002/etc.84; Kucuktas H, 2009, GENETICS, V181, P1649, DOI 10.1534/genetics.108.098855; Kulhanek SA, 2011, ECOL APPL, V21, P203, DOI 10.1890/09-1639.1; LARHAMMAR D, 1994, MOL PHYLOGENET EVOL, V3, P59, DOI 10.1006/mpev.1994.1007; Li Y, 2011, MAR BIOTECHNOL, V13, P706, DOI 10.1007/s10126-010-9332-9; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Liu D, 2010, MAR BIOTECHNOL, V12, P186, DOI 10.1007/s10126-009-9212-3; Liu H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-592; Lorenz S, 2010, ANIM GENET, V41, P48, DOI 10.1111/j.1365-2052.2009.01963.x; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Mao Rui-Xin, 2009, Yichuan, V31, P407, DOI 10.3724/SP.J.1005.2009.00407; Moens LN, 2007, J BIOCHEM MOL TOXIC, V21, P299, DOI 10.1002/jbt.20190; Neilan BA, 1997, NUCLEIC ACIDS RES, V25, P2938, DOI 10.1093/nar/25.14.2938; Ng SHS, 2005, GENOMICS, V86, P396, DOI 10.1016/j.ygeno.2005.06.001; Ninwichian P, 2012, G3-GENES GENOM GENET, V2, P1233, DOI 10.1534/g3.112.003962; Ohno S., 1970, EVOLUTION GENE DUPLI; Palti Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-180; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Somridhivej B, 2008, AQUACULTURE, V275, P76, DOI 10.1016/j.aquaculture.2008.01.013; Sonesson AK, 2007, GENET SEL EVOL, V39, P301, DOI 10.1051/gse:2007005; Sun X, 2004, AQUACULTURE, V238, P8; Van Campenhout K, 2009, ENVIRON TOXICOL CHEM, V28, P209, DOI 10.1897/08-136.1; Wan YM, 2012, MOL BIOL REP, V39, P2215, DOI 10.1007/s11033-011-0970-4; Wang D, 2007, AQUACULTURE, V271, P558, DOI 10.1016/j.aquaculture.2007.06.001; Wang SL, 2007, MAR BIOTECHNOL, V9, P701, DOI 10.1007/s10126-007-9021-5; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Xia JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011974; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Xu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021057; Xu P, 2006, ANIM GENET, V37, P321, DOI 10.1111/j.1365-2052.2006.01453.x; Xu P, 2007, GENOMICS, V90, P380, DOI 10.1016/j.ygeno.2007.05.008; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yue GH, 2004, AQUACULTURE, V234, P85, DOI 10.1016/j.aquaculture.2003.12.021; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9; Zhang XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027612; Zhang Y, 2008, J GENET GENOMICS, V35, P97, DOI 10.1016/S1673-8527(08)60015-6; Zhang Y, 2011, MAR BIOTECHNOL, V13, P376, DOI 10.1007/s10126-010-9307-x; Zhang YJ, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-169; Zheng XH, 2011, MOL GENET GENOMICS, V286, P261, DOI 10.1007/s00438-011-0644-x; Zhou Jianfeng, 2004, Genetika, V40, P1389	52	25	27	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63928	10.1371/journal.pone.0063928	http://dx.doi.org/10.1371/journal.pone.0063928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704958	gold, Green Submitted, Green Published			2022-12-27	WOS:000319330200089
J	Deschenes, SM; Gagnon, MP; Legare, F; Lapointe, A; Turcotte, S; Desroches, S				Deschenes, Sarah-Maude; Gagnon, Marie-Pierre; Legare, France; Lapointe, Annie; Turcotte, Stephane; Desroches, Sophie			Psychosocial Factors of Dietitians' Intentions to Adopt Shared Decision Making Behaviours: A Cross-Sectional Survey	PLOS ONE			English	Article							PLANNED BEHAVIOR; NURSES	Objectives: While shared decision making (SDM) promotes health-related decisions that are informed, value-based and adhered to, few studies report on theory-based approaches to SDM adoption by healthcare professionals. We aimed to identify the factors influencing dietitians' intentions to adopt two SDM behaviours: 1) present dietary treatment options to patients and 2) help patients clarify their values and preferences. Methods: We conducted a cross-sectional postal survey based on the Theory of Planned Behaviour among 428 randomly selected dietitians working in clinical practice across the Province of Quebec, Canada. We performed descriptive analyses and multiple regression analyses to determine the variables that explained the variance in intention to perform the behaviours. Results: A total of 203 dietitians completed the questionnaire. Their ages were from 23 to 66 and they had been practising dietetics for 15.4 +/- 11.1 years (mean +/- SD). On a scale from 1 to 7 (from strongly disagree to strongly agree), dietitians' intentions to present dietary treatment options and to clarify their patients' values and preferences were 5.00 +/- 1.14 and 5.68 +/- 0.74, respectively. Perceived behavioural control (beta = 0.56, p<0.0001), subjective norm (beta = 0.16, p<0.05), and moral norm (beta = 0.22, p<0.0001), were the factors significantly predicting the intention to present dietary treatment options, while perceived behavioural control (beta = 0.60, p<0.0001), attitude (beta = 0.20, p<0.05), and professional norm (beta = 0.22, p<0.001), significantly predicted the intention to help patients' clarify their values and preferences. Conclusion: Our results showed that dietitians intend to adopt the two SDM behaviours studied. Factors influencing intention were different for each behaviour, except for perceived behavioural control which was common to both behaviours. Thus, perceived behavioural control could be a key factor in interventions aiming to encourage implementation of SDM by dietitians.	[Deschenes, Sarah-Maude; Gagnon, Marie-Pierre; Legare, France; Lapointe, Annie; Turcotte, Stephane; Desroches, Sophie] Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada; [Deschenes, Sarah-Maude; Desroches, Sophie] Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ, Canada; [Gagnon, Marie-Pierre] Univ Laval, Fac Nursing, Quebec City, PQ, Canada; [Legare, France] Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Desroches, S (corresponding author), Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada.	sophie.desroches@fsaa.ulaval.ca	Gagnon, Marie-Pierre/I-3013-2019	Gagnon, Marie-Pierre/0000-0002-0782-5457; Desroches, Sophie/0000-0003-0797-605X; Legare, France/0000-0002-2296-6696; Lapointe, Annie/0000-0001-7081-4809	Canadian Institutes of Health Research [191614]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by an operating grant from the Canadian Institutes of Health Research (grant #191614)(http://www.cihr-irsc.gc.ca/f/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; [Anonymous], 1978, MAIL TELEPHONE SURVE; Byham-Gray LD, 2005, J AM DIET ASSOC, V105, P1574, DOI 10.1016/j.jada.2005.07.007; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; Chase K, 2003, J AM DIET ASSOC, V103, P1639, DOI 10.1016/j.jada.2003.09.026; Chewning B, 2012, PATIENT EDUC COUNS, V86, P9, DOI 10.1016/j.pec.2011.02.004; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Conner M, 1998, J APPL SOC PSYCHOL, V28, P1429, DOI 10.1111/j.1559-1816.1998.tb01685.x; Cote F, 2012, J ADV NURS, V68, P2289, DOI 10.1111/j.1365-2648.2011.05922.x; Daneault S, 2004, CAN J PUBLIC HEALTH, V95, P151, DOI 10.1007/BF03405785; Desroches Sophie, 2013, Cochrane Database Syst Rev, pCD008722, DOI 10.1002/14651858.CD008722.pub2; Desroches S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-57; *DIET CAN, 2004, ROL REG DIET PRIM HL; Elwyn G, 2003, QUAL SAF HEALTH CARE, V12, P93, DOI 10.1136/qhc.12.2.93; FERMANIAN J, 1984, REV EPIDEMIOL SANTE, V32, P408; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; Gagnon MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-8; Gagnon MP, 2003, INT J MED INFORM, V71, P103, DOI 10.1016/S1386-5056(03)00094-7; Gagnu C., 1999, THEORIES SOCIALES CO; Godin G, 2005, BRIT J SOC PSYCHOL, V44, P497, DOI 10.1348/014466604X17452; Godin G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-36; GODOLPHIN W, 2009, HEALTHC Q; Goss C, 2008, BRIT J PSYCHIAT, V193, P416, DOI 10.1192/bjp.bp.107.048728; HILLS FJ, 1978, AGR EXPT DESIGN ANAL; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Legare F, 2007, HEALTH EXPECT, V10, P364, DOI 10.1111/j.1369-7625.2007.00465.x; Legare F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006732.pub2; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; Maclellan DL, 2006, CAN J DIET PRACT RES, V67, P119, DOI 10.3148/67.3.2006.119; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; *OPDQ, NORM COMP DIET NUTR; Politi MC, 2010, PATIENT EDUC COUNS, V80, P155, DOI 10.1016/j.pec.2009.10.030; Rosner B., 2006, FUNDAMENTALS BIOSTAT; *SERV CAN, DIET NUTR STAT; Streiner DL, 2008, HLTH MEASUREMENT SCA, V4th; Towle A, 1999, BRIT MED J, V319, P766, DOI 10.1136/bmj.319.7212.766; Young HN, 2008, ARCH INTERN MED, V168, P1404, DOI 10.1001/archinte.168.13.1404	39	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64523	10.1371/journal.pone.0064523	http://dx.doi.org/10.1371/journal.pone.0064523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158JQ	23700484	gold, Green Published			2022-12-27	WOS:000319966400060
J	Perreault, M; Feng, G; Will, S; Gareski, T; Kubasiak, D; Marquette, K; Vugmeyster, Y; Unger, TJ; Jones, J; Qadri, A; Hahm, S; Sun, Y; Rohde, CM; Zwijnenberg, R; Paulsen, J; Gimeno, RE				Perreault, Mylene; Feng, Guo; Will, Sarah; Gareski, Tiffany; Kubasiak, David; Marquette, Kimberly; Vugmeyster, Yulia; Unger, Thaddeus J.; Jones, Juli; Qadri, Ariful; Hahm, Seung; Sun, Ying; Rohde, Cynthia M.; Zwijnenberg, Raphael; Paulsen, Janet; Gimeno, Ruth E.			Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; PARAVENTRICULAR NUCLEUS; NEUROPEPTIDE-Y; OBESITY; RECEPTORS; DELETION; AGONISTS; NEURONS; PROTEIN; POTENT	Strong genetic data link the Tyrosine kinase receptor B (TrkB) and its major endogenous ligand brain-derived neurotrophic factor (BDNF) to the regulation of energy homeostasis, with loss-of-function mutations in either gene causing severe obesity in both mice and humans. It has previously been reported that peripheral administration of the endogenous TrkB agonist ligand neurotrophin-4 (NT-4) profoundly decreases food intake and body weight in rodents, while paradoxically increasing these same parameters in monkeys. We generated a humanized TrkB agonist antibody, TAM-163, and characterized its therapeutic potential in several models of type 2 diabetes and obesity. In vitro, TAM-163 bound to human and rodent TrkB with high affinity, activated all aspects of the TrkB signaling cascade and induced TrkB internalization and degradation in a manner similar to BDNF. In vivo, peripheral administration of TAM-163 decreased food intake and/or body weight in mice, rats, hamsters, and dogs, but increased food intake and body weight in monkeys. The magnitude of weight change was similar in rodents and non-human primates, occurred at doses where there was no appreciable penetration into deep structures of the brain, and could not be explained by differences in exposures between species. Rather, peripherally administered TAM-163 localized to areas in the hypothalamus and the brain stem located outside the blood-brain barrier in a similar manner between rodents and non-human primates, suggesting differences in neuroanatomy across species. Our data demonstrate that a TrkB agonist antibody, administered peripherally, causes species-dependent effects on body weight similar to the endogenous TrkB ligand NT-4. The possible clinical utility of TrkB agonism in treating weight regulatory disorder, such as obesity or cachexia, will require evaluation in man.	[Perreault, Mylene; Feng, Guo; Will, Sarah; Gareski, Tiffany; Kubasiak, David; Unger, Thaddeus J.; Jones, Juli; Qadri, Ariful; Hahm, Seung; Gimeno, Ruth E.] Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Cambridge, MA USA; [Marquette, Kimberly; Sun, Ying; Paulsen, Janet] Pfizer Inc, GBT, Cambridge, MA USA; [Vugmeyster, Yulia] Pfizer Inc, PDM, Andover, MA USA; [Rohde, Cynthia M.] Pfizer Inc, DSRD, Andover, MA USA; [Zwijnenberg, Raphael] Pfizer Inc, Ft Dodge Anim Hlth, Princeton, NJ USA	Pfizer; Pfizer; Pfizer; Pfizer; Pfizer	Perreault, M (corresponding author), Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Cambridge, MA USA.	mylene.perreault@pfizer.com						Allen SJ, 2006, CLIN SCI, V110, P175, DOI 10.1042/CS20050161; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; Ganong WF, 2000, CLIN EXP PHARMACOL P, V27, P422, DOI 10.1046/j.1440-1681.2000.03259.x; Gray J, 2006, DANCING TIMES, V96, P55; Grove KL, 2003, MOL BRAIN RES, V113, P133, DOI 10.1016/S0169-328X(03)00093-7; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Lebrun B, 2006, AUTON NEUROSCI-BASIC, V126, P30, DOI 10.1016/j.autneu.2006.02.027; Lin JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001900; Menyhert J, 2007, ENDOCRINOLOGY, V148, P4276, DOI 10.1210/en.2007-0390; MURAGAKI Y, 1995, J COMP NEUROL, V356, P387, DOI 10.1002/cne.903560306; Nakagawa T, 2003, INT J OBESITY, V27, P557, DOI 10.1038/sj.ijo.0802265; Nakagawa T, 2002, DIABETES-METAB RES, V18, P185, DOI 10.1002/dmrr.290; Picha KM, 2008, DIABETES, V57, P1926, DOI 10.2337/db07-1775; Qian MD, 2006, J NEUROSCI, V26, P9394, DOI 10.1523/JNEUROSCI.1118-06.2006; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Shibayama E, 1996, AM J PATHOL, V148, P1807; Sun HJD, 2007, AM J PHYSIOL-ENDOC M, V292, pE964, DOI 10.1152/ajpendo.00089.2006; Tsao D, 2008, ENDOCRINOLOGY, V149, P1038, DOI 10.1210/en.2007-1166; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Vugmeyster Y, 2010, J PHARM SCI-US, V99, P1028, DOI 10.1002/jps.21855; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1003, DOI 10.1152/ajpregu.00011.2007; Wellmer A, 2001, J PERIPHER NERV SYST, V6, P204, DOI 10.1046/j.1529-8027.2001.01019.x; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Zhang J, 2006, NEUROSIGNALS, V15, P26, DOI 10.1159/000094385; Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200	28	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e62616	10.1371/journal.pone.0062616	http://dx.doi.org/10.1371/journal.pone.0062616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700410	Green Submitted, gold, Green Published			2022-12-27	WOS:000319966400008
J	Perrin, RJ; Payton, JE; Malone, JP; Gilmore, P; Davis, AE; Xiong, CJ; Fagan, AM; Townsend, RR; Holtzman, DM				Perrin, Richard J.; Payton, Jacqueline E.; Malone, James P.; Gilmore, Petra; Davis, Alan E.; Xiong, Chengjie; Fagan, Anne M.; Townsend, R. Reid; Holtzman, David M.			Quantitative Label-Free Proteomics for Discovery of Biomarkers in Cerebrospinal Fluid: Assessment of Technical and Inter-Individual Variation	PLOS ONE			English	Article							DIFFERENTIAL PROTEIN EXPRESSION; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; ENTORHINAL CORTEX; PREDICTION; DIAGNOSIS; DECLINE; MARKERS; MS/MS	Background: Biomarkers are required for pre-symptomatic diagnosis, treatment, and monitoring of neurodegenerative diseases such as Alzheimer's disease. Cerebrospinal fluid (CSF) is a favored source because its proteome reflects the composition of the brain. Ideal biomarkers have low technical and inter-individual variability (subject variance) among control subjects to minimize overlaps between clinical groups. This study evaluates a process of multi-affinity fractionation (MAF) and quantitative label-free liquid chromatography tandem mass spectrometry (LC-MS/MS) for CSF biomarker discovery by (1) identifying reparable sources of technical variability, (2) assessing subject variance and residual technical variability for numerous CSF proteins, and (3) testing its ability to segregate samples on the basis of desired biomarker characteristics. Methods/Results: Fourteen aliquots of pooled CSF and two aliquots from six cognitively normal individuals were randomized, enriched for low-abundance proteins by MAF, digested endoproteolytically, randomized again, and analyzed by nano-LC-MS. Nano-LC-MS data were time and m/z aligned across samples for relative peptide quantification. Among 11,433 aligned charge groups, 1360 relatively abundant ones were annotated by MS2, yielding 823 unique peptides. Analyses, including Pearson correlations of annotated LC-MS ion chromatograms, performed for all pairwise sample comparisons, identified several sources of technical variability: i) incomplete MAF and keratins; ii) globally- or segmentally-decreased ion current in isolated LC-MS analyses; and iii) oxidized methionine-containing peptides. Exclusion of these sources yielded 609 peptides representing 81 proteins. Most of these proteins showed very low coefficients of variation (CV<5%) whether they were quantified from the mean of all or only the 2 most-abundant peptides. Unsupervised clustering, using only 24 proteins selected for high subject variance, yielded perfect segregation of pooled and individual samples. Conclusions: Quantitative label-free LC-MS/MS can measure scores of CSF proteins with low technical variability and can segregate samples according to desired criteria. Thus, this technique shows potential for biomarker discovery for neurological diseases.	[Perrin, Richard J.] Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63130 USA; [Payton, Jacqueline E.] Washington Univ, Sch Med, Div Lab & Genom Med, St Louis, MO USA; [Perrin, Richard J.; Payton, Jacqueline E.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Malone, James P.; Gilmore, Petra; Davis, Alan E.; Townsend, R. Reid; Holtzman, David M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Townsend, R. Reid] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Xiong, Chengjie] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Fagan, Anne M.; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Perrin, Richard J.; Xiong, Chengjie; Fagan, Anne M.; Holtzman, David M.] Washington Univ, Sch Med, Knight Alzheimer Dis Res Ctr, St Louis, MO USA; [Perrin, Richard J.; Fagan, Anne M.; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Perrin, RJ (corresponding author), Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63130 USA.	rperrin@path.wustl.edu			National Institute of Aging of the National Institutes of Health (NIH) [1RC1AG035654, P01-AG026276, P01-AG03991, P50-AG05681]; National Institute of Neurological Disorders and Stroke of the NIH [1P30NS057105]; National Center for Research Resources of the NIH [P41RR000954, UL1 RR024992]; NIH Roadmap for Medical Research, NIH Neuroscience Blueprint Core Grant [P30 NS057105]; Silvio O.Conte Digestive Diseases Core Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri; Center Support Grant [P30 DK52574]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681, RC1AG035654, P01AG026276] Funding Source: NIH RePORTER	National Institute of Aging of the National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke of the NIH; National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research, NIH Neuroscience Blueprint Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Silvio O.Conte Digestive Diseases Core Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri; Center Support Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported with grants 1RC1AG035654, P01-AG026276, P01-AG03991, P50-AG05681 from the National Institute of Aging of the National Institutes of Health (NIH) and from the National Institute of Neurological Disorders and Stroke of the NIH (1P30NS057105). The Proteomics Core Laboratory is supported with grants P41RR000954 and UL1 RR024992 from the National Center for Research Resources of the NIH, and NIH Roadmap for Medical Research, NIH Neuroscience Blueprint Core Grant P30 NS057105 to Washington University, and the Silvio O.Conte Digestive Diseases Core Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, which is supported in part by Center Support Grant P30 DK52574. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Boja E, 2011, J PROTEOME RES, V10, P66, DOI 10.1021/pr100532g; Carlson NE, 2008, NEUROLOGY, V70, P828, DOI 10.1212/01.wnl.0000280577.43413.d9; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Choe LH, 2002, ELECTROPHORESIS, V23, P2247, DOI 10.1002/1522-2683(200207)23:14<2247::AID-ELPS2247>3.0.CO;2-M; Craig-Schapiro R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018850; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; Deutsch EW, 2008, PHYSIOL GENOMICS, V33, P18, DOI 10.1152/physiolgenomics.00298.2007; Elliott MH, 2009, J MASS SPECTROM, V44, P1637, DOI 10.1002/jms.1692; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2012, BIOMARK MED, V6, P455, DOI [10.2217/bmm.12.42, 10.2217/BMM.12.42]; Fagan AM, 2009, EMBO MOL MED, V1, P371, DOI 10.1002/emmm.200900048; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Finehout EJ, 2007, ANN NEUROL, V61, P120, DOI 10.1002/ana.21038; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Grimmer T, 2009, BIOL PSYCHIAT, V65, P927, DOI 10.1016/j.biopsych.2009.01.027; Hansson Sara Folkesson, 2004, Proteome Sci, V2, P7, DOI 10.1186/1477-5956-2-7; Holtzman DM, 2011, SCI TRANSL MED, V3; Hu WT, 2010, ACTA NEUROPATHOL, V119, P669, DOI 10.1007/s00401-010-0667-0; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Hu Y, 2007, PROTEOM CLIN APPL, V1, P1373, DOI 10.1002/prca.200600999; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Karpievitch Y, 2009, BIOINFORMATICS, V25, P2028, DOI 10.1093/bioinformatics/btp362; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Neubert H, 2008, J PROTEOME RES, V7, P2270, DOI 10.1021/pr700705u; Ogata Y, 2007, PROTEOMICS, V7, P3726, DOI 10.1002/pmic.200700455; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Ranganathan S, 2005, J NEUROCHEM, V95, P1461, DOI 10.1111/j.1471-4159.2005.03478.x; Roche SL, 2010, PEDIATR TRANSPLANT, V14, P159, DOI 10.1111/j.1399-3046.2009.01205.x; Schutzer SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017287; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Simonsen AH, 2007, DEMENT GERIATR COGN, V24, P434, DOI 10.1159/000110576; Simonsen AH, 2007, ARCH NEUROL-CHICAGO, V64, P366, DOI 10.1001/archneur.64.3.366; Stoop MP, 2008, PROTEOMICS, V8, P1576, DOI 10.1002/pmic.200700446; Storandt M, 2006, NEUROLOGY, V67, P467, DOI 10.1212/01.wnl.0000228231.26111.6e; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Tang KQ, 2004, J AM SOC MASS SPECTR, V15, P1416, DOI 10.1016/j.jasms.2004.04.034; Tarawneh R, 2012, NEUROLOGY, V78, P709, DOI 10.1212/WNL.0b013e318248e568; Tolboom N, 2009, J NUCL MED, V50, P1464, DOI 10.2967/jnumed.109.064360; Vafadar-Isfahani B, 2012, J ALZHEIMERS DIS, V28, P625, DOI 10.3233/JAD-2011-111505; Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g; Zhang J, 2005, J ALZHEIMERS DIS, V7, P125; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	61	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64314	10.1371/journal.pone.0064314	http://dx.doi.org/10.1371/journal.pone.0064314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700471	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400054
J	Rueff, F; Przybilla, B; Bilo, MB; Muller, U; Scheipl, F; Seitz, MJ; Aberer, W; Bodzenta-Lukaszyk, A; Bonifazi, F; Campi, P; Darsow, U; Haeberli, G; Hawranek, T; Kuchenhoff, H; Lang, R; Quercia, O; Reider, N; Schmid-Grendelmeier, P; Severino, M; Sturm, GJ; Treudler, R; Wuthrich, B				Rueff, Franziska; Przybilla, Bernhard; Bilo, Maria Beatrice; Mueller, Ulrich; Scheipl, Fabian; Seitz, Michael J.; Aberer, Werner; Bodzenta-Lukaszyk, Anna; Bonifazi, Floriano; Campi, Paolo; Darsow, Ulf; Haeberli, Gabrielle; Hawranek, Thomas; Kuechenhoff, Helmut; Lang, Roland; Quercia, Oliviero; Reider, Norbert; Schmid-Grendelmeier, Peter; Severino, Maurizio; Sturm, Gunter Johannes; Treudler, Regina; Wuethrich, Brunello			Clinical Effectiveness of Hymenoptera Venom Immunotherapy: A Prospective Observational Multicenter Study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity	PLOS ONE			English	Article							SERUM TRYPTASE; ALLERGIC REACTIONS; MASTOCYTOSIS; SEVERITY; ANAPHYLAXIS; DIAGNOSIS; EFFICACY; SAFETY; CELL	Background: Treatment failure during venom immunotherapy (VIT) may be associated with a variety of risk factors. Objective: Our aim was to evaluate the association of baseline serum tryptase concentration (BTC) and of other parameters with the frequency of VIT failure during the maintenance phase. Methods: In this observational prospective multicenter study, we followed 357 patients with established honey bee or vespid venom allergy after the maintenance dose of VIT had been reached. In all patients, VIT effectiveness was either verified by sting challenge (n = 154) or patient self-reporting of the outcome of a field sting (n = 203). Data were collected on BTC, age, gender, preventive use of anti-allergic drugs (oral antihistamines and/or corticosteroids) right after a field sting, venom dose, antihypertensive medication, type of venom, side effects during VIT, severity of index sting reaction preceding VIT, and duration of VIT. Relative rates were calculated with generalized additive models. Results: 22 patients (6.2%) developed generalized symptoms during sting challenge or after a field sting. A strong association between the frequency of VIT failure and BTC could be excluded. Due to wide confidence bands, however, weaker effects (odds ratios < 3) of BTC were still possible, and were also suggested by a selective analysis of patients who had a sting challenge. The most important factor associated with VIT failure was a honey bee venom allergy. Preventive use of anti-allergic drugs may be associated with a higher protection rate. Interpretation: It is unlikely that an elevated BTC has a strong negative effect on the rate of treatment failures. The magnitude of the latter, however, may depend on the method of effectiveness assessment. Failure rate is higher in patients suffering from bee venom allergy.	[Rueff, Franziska; Przybilla, Bernhard] Univ Munich, Dept Dermatol & Allergol, Munich, Germany; [Bilo, Maria Beatrice; Bonifazi, Floriano] Azienda Osped Univ, Osped Riuniti Ancona, Allergy Unit, Dept Internal Med Allergy Immunol & Resp Dis, Ancona, Italy; [Mueller, Ulrich; Haeberli, Gabrielle] Spitalnetz Bern, Allergiestat Med Klin, Spital Ziegler, Bern, Switzerland; [Scheipl, Fabian; Seitz, Michael J.; Kuechenhoff, Helmut] Univ Munich, Dept Stat, Stat Consulting Unit, Munich, Germany; [Aberer, Werner; Sturm, Gunter Johannes] Med Univ Graz, Dept Dermatol, Graz, Austria; [Bodzenta-Lukaszyk, Anna] Med Univ Bialystok, Dept Allergol & Internal Med, Bialystok, Poland; [Campi, Paolo; Severino, Maurizio] Nuovo Osped San Giovanni di Dio, Allergy Clin, Florence, Italy; [Darsow, Ulf] Tech Univ Munich, Dept Dermatol & Allergy Biederstein, D-80290 Munich, Germany; [Darsow, Ulf] ZAUM Ctr Allergy & Environm, Munich, Germany; [Hawranek, Thomas; Lang, Roland] Paracelsus Med Univ, Dept Dermatol, Salzburg, Austria; [Quercia, Oliviero] Osped Infermi, Dipartimento Med Interna, Faenza, Italy; [Reider, Norbert] Med Univ Innsbruck, Dept Dermatol, A-6020 Innsbruck, Austria; [Schmid-Grendelmeier, Peter; Wuethrich, Brunello] Univ Spital Zurich, Allergiestat Dermatol Klin & Poliklin, Zurich, Switzerland; [Treudler, Regina] Univ Klinikum Leipzig, Klin Dermatol Venerol & Allergol, Leipzig, Germany	University of Munich; University of Munich; Medical University of Graz; Medical University of Bialystok; Technical University of Munich; Paracelsus Private Medical University; Hospital of Rimini; Medical University of Innsbruck; University of Zurich; University Zurich Hospital; Leipzig University	Rueff, F (corresponding author), Univ Munich, Dept Dermatol & Allergol, Munich, Germany.	Franziska.Rueff@med.uni-muenchen.de	; Bodzenta - Lukaszyk, Anna/V-4795-2018	Kuchenhoff, Helmut/0000-0002-6372-2487; Bodzenta - Lukaszyk, Anna/0000-0001-7187-8660; Scheipl, Fabian/0000-0001-8172-3603	Phadia, Freiburg, Germany; ALK Abello, Wedel, Germany	Phadia, Freiburg, Germany; ALK Abello, Wedel, Germany	This study (collection of the data) was supported by grants from Phadia, Freiburg, Germany and ALK Abello, Wedel, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum S, 2011, ALLERGY, V66, P222, DOI 10.1111/j.1398-9995.2010.02470.x; Bonadonna P, 2010, CURR OPIN ALLERGY CL, V10, P347, DOI 10.1097/ACI.0b013e32833b280c; Bonifazi F, 2005, ALLERGY, V60, P1459, DOI 10.1111/j.1398-9995.2005.00960.x; Dugas-Breit Susanne, 2005, J Dtsch Dermatol Ges, V3, P343, DOI 10.1111/j.1610-0387.2005.05706.x; ELREMELI M, 2010, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD008838; Goldberg A, 2010, ALLERGY, V65, P391, DOI 10.1111/j.1398-9995.2009.02198.x; Golden DBK, 2011, J ALLERGY CLIN IMMUN, V127, P852, DOI 10.1016/j.jaci.2011.01.025; Golden DBK, 2006, J ALLERGY CLIN IMMUN, V117, P670, DOI 10.1016/j.jaci.2005.12.1313; Haeberli G, 2003, CLIN EXP ALLERGY, V33, P1216, DOI 10.1046/j.1365-2222.2003.01755.x; Hassan E., 2005, INTERNET J EPIDEMIOL, V3, P1, DOI [DOI 10.5580/2732, 10.5580/2732]; Hidvegi B, 2003, INT ARCH ALLERGY IMM, V132, P177, DOI 10.1159/000073719; Hockenhull J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16120; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Krishna MT, 2011, CLIN EXP ALLERGY, V41, P1201, DOI 10.1111/j.1365-2222.2011.03788.x; LOCKEY RF, 1988, J ALLERGY CLIN IMMUN, V82, P370, DOI 10.1016/0091-6749(88)90008-5; MULLER U, 1991, CLIN EXP ALLERGY, V21, P281, DOI 10.1111/j.1365-2222.1991.tb01659.x; Niedoszytko M, 2009, ALLERGY, V64, P1237, DOI 10.1111/j.1398-9995.2009.02118.x; Przybilla B, 2010, J DTSCH DERMATOL GES, V8, P114, DOI [10.1111/j.1610-0387.2009.07125.x, 10.1111/j.1610-0387.2009.07125_supp.x]; R Development Core Team, R LANG ENV STAT COMP; Redelmeier DA, 2011, J GEN INTERN MED, V26, P900, DOI 10.1007/s11606-011-1655-3; RING J, 1977, LANCET, V1, P466; Roca-Pardinas J, 2009, STAT MED, V28, P240, DOI 10.1002/sim.3472; Ross RN, 2000, CLIN THER, V22, P351, DOI 10.1016/S0149-2918(00)80039-9; Rueff F, 1996, ALLERGY, V51, P216, DOI 10.1111/j.1398-9995.1996.tb04596.x; Rueff F, 2010, J ALLERGY CLIN IMMUN, V126, P105, DOI 10.1016/j.jaci.2010.04.025; Rueff F, 2009, J ALLERGY CLIN IMMUN, V124, P1047, DOI 10.1016/j.jaci.2009.08.027; Sargur R, 2011, CLIN EXP IMMUNOL, V163, P339, DOI 10.1111/j.1365-2249.2010.04287.x; Solley GO, 2004, ANN ALLERG ASTHMA IM, V93, P532, DOI 10.1016/S1081-1206(10)61259-8; Valent P, 2012, INT ARCH ALLERGY IMM, V157, P215, DOI 10.1159/000328760; van Toorenenbergen AW, 2005, J ALLERGY CLIN IMMUN, V116, P1159, DOI 10.1016/j.jaci.2005.07.023; Watanabe AS, 2010, SAO PAULO MED J, V128, P30, DOI 10.1590/S1516-31802010000100007; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S. N., MGCV GAMS GCV AIC RE; Worm M, 2012, ALLERGY, V67, P691, DOI 10.1111/j.1398-9995.2012.02795.x; Worm M, 2012, BUNDESGESUNDHEITSBLA, V55, P380, DOI 10.1007/s00103-011-1436-5	35	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63233	10.1371/journal.pone.0063233	http://dx.doi.org/10.1371/journal.pone.0063233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700415	gold, Green Published, Green Accepted			2022-12-27	WOS:000319966400013
J	Thuring, A; Brannstrom, KJ; Ewerlof, M; Hernandez-Andrade, E; Ley, D; Lingman, G; Liuba, K; Marsal, K; Jansson, T				Thuring, Ann; Brannstrom, K. Jonas; Ewerlof, Maria; Hernandez-Andrade, Edgar; Ley, David; Lingman, Goran; Liuba, Karina; Marsal, Karel; Jansson, Tomas			Operator Auditory Perception and Spectral Quantification of Umbilical Artery Doppler Ultrasound Signals	PLOS ONE			English	Article							FLOW VELOCITY WAVEFORMS; BLOOD-FLOW; FETAL ANEMIA; RESISTANCE; MODEL	Objective: An experienced sonographer can by listening to the Doppler audio signals perceive various timbres that distinguish different types of umbilical artery flow despite an unchanged pulsatility index (PI). Our aim was to develop an objective measure of the Doppler audio signals recorded from fetoplacental circulation in a sheep model. Methods: Various degrees of pathological flow velocity waveforms in the umbilical artery, similar to those in human complicated pregnancies, were induced by microsphere embolization of the placental bed (embolization model, 7 lamb fetuses, 370 Doppler recordings) or by fetal hemodilution (anemia model, 4 lamb fetuses, 184 recordings). A subjective 11-step operator auditory scale (OAS) was related to conventional Doppler parameters, PI and time average mean velocity (TAM), and to sound frequency analysis of Doppler signals (sound frequency with the maximum energy content [MAX(peak)] and frequency band at maximum level minus 15 dB [MAX(peak-15dB)] over several heart cycles). Results: We found a negative correlation between the OAS and PI: median Rho -0.73 (range -0.35- -0.94) and -0.68 (range -0.57- -0.78) in the two lamb models, respectively. There was a positive correlation between OAS and TAM in both models: median Rho 0.80 (range 0.58-0.95) and 0.90 (range 0.78-0.95), respectively. A strong correlation was found between TAM and the results of sound spectrum analysis; in the embolization model the median r was 0.91 (range 0.88-0.97) for MAX(peak) and 0.91 (range 0.82-0.98) for MAX(peak-15 dB). In the anemia model, the corresponding values were 0.92 (range 0.78-0.96) and 0.96 (range 0.89-0.98), respectively. Conclusion: Audio-spectrum analysis reflects the subjective perception of Doppler sound signals in the umbilical artery and has a strong correlation to TAM-velocity. This information might be of importance for clinical management of complicated pregnancies as an addition to conventional Doppler parameters.	[Thuring, Ann; Lingman, Goran; Liuba, Karina; Marsal, Karel] Lund Univ, Dept Obstet & Gynecol, Clin Sci Lund, Lund, Sweden; [Brannstrom, K. Jonas] Lund Univ, Dept Logoped Phoniatr & Audiol, Lund, Sweden; [Ewerlof, Maria; Jansson, Tomas] Lund Univ, Dept Biomed Engn, Clin Sci Lund, Lund, Sweden; [Hernandez-Andrade, Edgar] Wayne State Univ, Perinatol Res Branch, NICHHD, NIH, Detroit, MI USA; [Ley, David] Lund Univ, Dept Pediat, Clin Sci Lund, Lund, Sweden	Lund University; Lund University; Lund University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Lund University	Thuring, A (corresponding author), Lund Univ, Dept Obstet & Gynecol, Clin Sci Lund, Lund, Sweden.	ann.thuring@med.lu.se	Ewerlöf, Maria/GYU-7608-2022	Ewerlöf, Maria/0000-0001-8128-871X	Swedish government; Swedish Research Council [14940]	Swedish government; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Ann Thuring, K. Jonas Brannstrom and David Ley were supported by the grants to researchers in the Public Health Service from the Swedish government. The study was supported by the Swedish Research Council (grant No. 14940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2005, ULTRASOUND OBST GYN, V25, P444, DOI 10.1002/uog.1880; Alcantara JI, 1996, J ACOUST SOC AM, V100, P2382, DOI 10.1121/1.417948; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; EIKNES SH, 1982, J BIOMED ENG, V4, P28, DOI 10.1016/0141-5425(82)90023-1; EIKNES SH, 1984, ULTRASOUND MED BIOL, V10, P329, DOI 10.1016/0301-5629(84)90167-4; Fastl H., 2007, PSYCHOACOUSTICS, Vthird; GOSLING RG, 1971, ANGIOLOGY, V22, P52, DOI 10.1177/000331977102200109; GUDMUNDSSON S, 1988, ACTA OBSTET GYN SCAN, V67, P347, DOI 10.3109/00016348809004234; Jensen JA., 1996, ESTIMATION BLOOD VEL; Madazli R, 2003, PLACENTA, V24, P510, DOI 10.1053/plac.2002.0945; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; Marsal K, 2009, BEST PRACT RES CL OB, V23, P857, DOI 10.1016/j.bpobgyn.2009.08.011; Moraes R., 1995, J VASCULAR INVEST, V1, P126; MORROW RJ, 1989, AM J OBSTET GYNECOL, V161, P1055, DOI 10.1016/0002-9378(89)90783-7; NICOLAIDES KH, 1990, AM J OBSTET GYNECOL, V162, P209, DOI 10.1016/0002-9378(90)90852-X; Reference manual: HDI 5000 ultrasound system, 2000, ATL ULTR, P15; THOMPSON RS, 1990, ULTRASOUND MED BIOL, V16, P449, DOI 10.1016/0301-5629(90)90167-B; Thompson RS, 1986, ULTRASOUND MED BIOL, V11, P845; TRUDINGER BJ, 1985, BRIT J OBSTET GYNAEC, V92, P23, DOI 10.1111/j.1471-0528.1985.tb01044.x; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901	20	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64033	10.1371/journal.pone.0064033	http://dx.doi.org/10.1371/journal.pone.0064033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700452	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400044
J	Ali, AH; Belachew, T; Yami, A; Ayen, WY				Ali, Alima Hassen; Belachew, Tefera; Yami, Alemeshet; Ayen, Wubeante Yenet			Anti-Tuberculosis Drug Induced Hepatotoxicity among TB/HIV Co-Infected Patients at Jimma University Hospital, Ethiopia: Nested Case-Control Study	PLOS ONE			English	Article							RISK-FACTORS; ANTIRETROVIRAL THERAPY; HIV; TUBERCULOSIS; TOXICITY; MANAGEMENT; RIFAMPICIN; HEPATITIS; SEVERITY; CARE	Background: This study was carried out to determine the incidence and predictors of anti-tuberculosis drug induced hepatotoxicity among TB/HIV co-infected patients at Jimma University Hospital, Ethiopia. Methods/Principal Findings: A nested case-control study was conducted by reviewing charts of all TB/HIV co-infected patients who commenced anti-TB treatment from January 2008 to December 2011 at Jimma University Hospital. Patients who had developed hepatotoxicity after at least 5 days of standard doses of anti-TB drug therapy were labeled as "cases" and those without hepatotoxicity were "controls". Each case with anti-TB drug induced hepatotoxicity was compared with 3 controls selected randomly from the cohort. From a cohort of 296 TB/HIV co-infected patients 8 were excluded from the study as the causality between anti-TB drugs and hepatotoxicity was not confirmed, 33 had developed hepatotoxicity. On bivariate logistic regression analysis, body mass index (BMI) <18.5 Kg/m(2) [P = 0.01; OR (95% CI): 3.6 (1.4-9.5)], disseminated pulmonary TB [P = 0.00; OR (95% CI): 5.6 (2.2-14.6)], CD4 count <= 50 [P = 0.016; OR (95% CI): 3.6(1.27-10.23)] and WHO stage 4 [P = 0.004, OR (95%CI): 3.8 (1.68-8.77)] were significantly associated with anti-TB drug induced hepatotoxicity. Predictor variables with p-value <0.05 by bivariate analysis were analyzed using multivariable logistic regression analysis and identified disseminated pulmonary TB [P = 0.001; AOR (95%CI) = 5.6 (2.1-15.0)] and BMI <18.5 [P = 0.014; AOR (95%CI) = 3.6 (1.3-10.1)] as independent predictors of anti-TB drug induced hepatotoxicity. Conclusions: The incidence of anti-TB drug induced hepatotoxicity was 11.5%. The results suggest that in the presence of disseminated pulmonary TB and/or BMI <18.5 Kg/m(2), TB/HIV co-infected patients should be closely followed for the occurrence of hepatotoxicity during the intensive phase of TB treatment to prevent morbidity and mortality.	[Ali, Alima Hassen; Ayen, Wubeante Yenet] Jimma Univ, Sch Pharm, Jimma, Ethiopia; [Belachew, Tefera] Jimma Univ, Dept Populat & Family Hlth, Jimma, Ethiopia; [Yami, Alemeshet] Jimma Univ, Dept Internal Med, Jimma, Ethiopia	Jimma University; Jimma University; Jimma University	Ayen, WY (corresponding author), Jimma Univ, Sch Pharm, Jimma, Ethiopia.	wubeante.yenet@ju.edu.et	Belachew, Tefera/AAO-5877-2020		Jimma University Student Research Program	Jimma University Student Research Program	This work was as partial fulfilment of the requirements for the degree of Master science in clinical pharmacy by Alima Hassen. The study was funded by Jimma University Student Research Program, and the program did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR; Burman WJ, 2005, CLIN CHEST MED, V26, P283, DOI 10.1016/j.ccm.2005.02.002; Burman WJ, 2001, AM J RESP CRIT CARE, V164, P1112, DOI 10.1164/ajrccm.164.7.2109052; Devarbhavi Harshad, 2011, Trop Gastroenterol, V32, P167; Durand F, 1996, DRUG SAFETY, V15, P394, DOI 10.2165/00002018-199615060-00004; Javadi MR, 2007, PHARMACOEPIDEM DR S, V16, P1104, DOI 10.1002/pds.1468; Kalsi SS, 2011, OPEN ACCESS EMERG M, V3, P87, DOI 10.2147/OAEM.S24963; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Khalili H, 2009, DARU, V17, P163; Khoharo HK, 2010, J LIAQUAT UNIV MED H, V9, P84; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Makhlouf HA, 2008, HEPATOL INT, V2, P353, DOI 10.1007/s12072-008-9085-y; Manosuthi W, 2006, AIDS, V20, P131, DOI 10.1097/01.aids.0000196181.18916.9b; Marks DJB, 2009, INT J STD AIDS, V20, P339, DOI 10.1258/ijsa.2008.008361; Marzuki OA, 2008, SINGAP MED J, V49, P688; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; NIN, 1989, BMI MORT RAT 10 YEAR; Pande JN, 1996, THORAX, V51, P132, DOI 10.1136/thx.51.2.132; PARTHASARATHY R, 1986, TUBERCLE, V67, P99, DOI 10.1016/0041-3879(86)90003-6; Pukenyte E, 2007, INT J TUBERC LUNG D, V11, P78; Senaratne W. V., 2006, CEYLON MEDICAL JOURNAL, V51, P9; Shakya R, 2004, ANN PHARMACOTHER, V38, P1074, DOI 10.1345/aph.1D525; Shang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021836; Sharifzadeh M, 2005, PHARMACOL RES, V51, P353, DOI 10.1016/j.phrs.2004.10.009; Sharma SK, 2002, AM J RESP CRIT CARE, V166, P916, DOI 10.1164/rccm.2108091; de Lima MDS, 2012, CAD SAUDE PUBLICA, V28, P698, DOI 10.1590/S0102-311X2012000400009; Tahaoglu K, 2001, INT J TUBERC LUNG D, V5, P65; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Varma JK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-42; Walker UA, 2007, CURR OPIN HIV AIDS, V2, P293, DOI 10.1097/COH.0b013e328122dbaa; Yimer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027810; Yimer G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001809	32	26	26	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64622	10.1371/journal.pone.0064622	http://dx.doi.org/10.1371/journal.pone.0064622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696901	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900103
J	Soda, K; Kano, Y; Chiba, F; Koizumi, K; Miyaki, Y				Soda, Kuniyasu; Kano, Yoshihiko; Chiba, Fumihiro; Koizumi, Kei; Miyaki, Yuichiro			Increased Polyamine Intake Inhibits Age-Associated Alteration in Global DNA Methylation and 1,2-Dimethylhydrazine-Induced Tumorigenesis	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE ODC; ADENOSYL-L-METHIONINE; SPERMINE SYNTHASE; SACCHAROMYCES-CEREVISIAE; NATURAL POLYAMINE; LFA-1 EXPRESSION; CELL-ADHESION; GROWTH; MOUSE; RAT	Polyamines (spermine and spermidine) play many important roles in cellular function and are supplied from the intestinal lumen. We have shown that continuous high polyamine intake inhibits age-associated pathologies in mice. The mechanism by which polyamines elicit these effects was examined. Twenty-four week old Jc1:ICR male mice were fed one of three experimental chows containing different polyamine concentrations. Lifetime intake of high polyamine chow, which had a polyamine content approximately three times higher than regular chow, elevated polyamine concentrations in whole blood, suppressed age-associated increases in pro-inflammatory status, decreased age-associated pathological changes, inhibited age-associated global alteration in DNA methylation status and reduced the mortality in aged mice. Exogenous spermine augmented DNA methyltransferase activity in Jurkat and HT-29 cells and inhibited polyamine deficiency-induced global alteration in DNA methylation status in vitro. In addition, increased polyamine intake was associated with a decreased incidence of colon tumors in BALB/c mice after 1,2-demethylhydrazine administration; 12 mice (60%) in the low polyamine group developed tumors, compared with only 5 mice (25%) in the high polyamine group (Fisher's exact probability = 0.027, p = 0.025). However, increased polyamine intake accelerated the growth of established tumors; maximal tumor diameter in the Low and High groups was 3.85 +/- 0.90 mm and 5.50 +/- 1.93 mm, respectively (Mann-Whitney test, p = 0.039). Spermine seems to play important roles in inhibiting age-associated and polyamine-deficient induced abnormal gene methylation as well as pathological changes including tumorigenesis.	[Soda, Kuniyasu] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Res Inst, Saitama, Japan; [Soda, Kuniyasu; Kano, Yoshihiko; Chiba, Fumihiro] Jichi Med Univ, Saitama Med Ctr, Dept Surg, Saitama, Japan; [Koizumi, Kei; Miyaki, Yuichiro] Hamamatsu Univ Sch Med, Dept Surg 1, Hamamatsu, Shizuoka 4313192, Japan	Jichi Medical University; Jichi Medical University; Hamamatsu University School of Medicine	Soda, K (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Res Inst, Saitama, Japan.	soda@jichi.ac.jp			JKA through its promotion funds from KEIRIN RACE	JKA through its promotion funds from KEIRIN RACE	This publication was subsidized by JKA through its promotion funds from KEIRIN RACE (http://www.keirin-autorace.or.jp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEYER HS, 1992, J LAB CLIN MED, V119, P38; BINH PNT, 2010, NUTR DIETARY SUPPLEM, V3, P1; Brodal BP, 1999, J NUTR BIOCHEM, V10, P700, DOI 10.1016/S0955-2863(99)00058-3; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P13869, DOI 10.1073/pnas.1835918100; CHIRICOLO M, 1995, GERONTOLOGY, V41, P227; CLIFFORD A, 1995, CANCER RES, V55, P1680; DANZIN C, 1982, BIOCHEM J, V202, P175, DOI 10.1042/bj2020175; DAS R, 1982, EXP GERONTOL, V17, P95, DOI 10.1016/0531-5565(82)90042-0; Ding ZM, 1999, J IMMUNOL, V163, P5029; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Frostesjo L, 1997, J BIOL CHEM, V272, P4359, DOI 10.1074/jbc.272.7.4359; Fujisawa S, 2005, ANTICANCER RES, V25, P965; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hamasaki-Katagiri N, 1998, GENE, V210, P195, DOI 10.1016/S0378-1119(98)00027-4; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; HIBSHOOSH H, 1991, ONCOGENE, V6, P739; Kano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056056; Lopatina N, 2002, J CELL BIOCHEM, V84, P324, DOI 10.1002/jcb.10015; Lorenz B, 1998, HUM MOL GENET, V7, P541, DOI 10.1093/hmg/7.3.541; Lu QJ, 2002, BLOOD, V99, P4503, DOI 10.1182/blood.V99.12.4503; LYON MF, 1986, P NATL ACAD SCI USA, V83, P4899, DOI 10.1073/pnas.83.13.4899; Mackintosh CA, 2000, BIOCHEM J, V351, P439, DOI 10.1042/0264-6021:3510439; MAMONT PS, 1981, BIOCHEM J, V196, P411, DOI 10.1042/bj1960411; Mamont PS, EUR J BIOCH, V123, P499; Newton GL, 1996, RADIAT RES, V145, P776, DOI 10.2307/3579370; OBrien TG, 1997, CANCER RES, V57, P2630; ONO T, 1993, AGE AGEING, V22, pS34, DOI 10.1093/ageing/22.suppl_1.S34; PAPAZAFIRI P, 1987, BIOCHEM J, V242, P479, DOI 10.1042/bj2420479; Phan Nguyen Thanh Binh, 2010, Health, V2, P1390, DOI 10.4236/health.2010.212206; PORTER CW, 1990, BIOCHEM J, V268, P207, DOI 10.1042/bj2680207; POWERS DC, 1992, CELL IMMUNOL, V141, P444, DOI 10.1016/0008-8749(92)90162-I; Romanenko EB, 1998, BIOCHEMISTRY-MOSCOW+, V63, P159; RUSSELL DH, 1983, CRC CR REV CL LAB SC, V18, P261; SHAIN SA, 1986, ENDOCRINOLOGY, V119, P1830, DOI 10.1210/endo-119-4-1830; Soda K, 2005, J IMMUNOL, V175, P237, DOI 10.4049/jimmunol.175.1.237; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; Soda K, 2009, J NUTR SCI VITAMINOL, V55, P361, DOI 10.3177/jnsv.55.361; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; Wacholtz MC, J EXP MED, V170, P431; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Werther WA, 1996, J IMMUNOL, V157, P4986; WHITE R, 1983, J BIOL CHEM, V258, P8943; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Yamamoto D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012554; Yamamoto F, 2004, MOL GENET GENOMICS, V271, P678, DOI 10.1007/s00438-004-1017-5; Zhang MH, 1997, J EXP MED, V185, P1759, DOI 10.1084/jem.185.10.1759; Zhang ZY, 2002, MECH AGEING DEV, V123, P1257, DOI 10.1016/S0047-6374(02)00014-3	48	64	68	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64357	10.1371/journal.pone.0064357	http://dx.doi.org/10.1371/journal.pone.0064357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696883	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900086
J	Gordon, DM; Dektar, KN; Pinter-Wollman, N				Gordon, Deborah M.; Dektar, Katherine N.; Pinter-Wollman, Noa			Harvester Ant Colony Variation in Foraging Activity and Response to Humidity	PLOS ONE			English	Article							FIRE ANT; ECOLOGY; SIZE; PERSONALITY; FOOD; AGGRESSION; PHEROMONE; CONFLICT; BEHAVIOR; SCALE	Collective behavior is produced by interactions among individuals. Differences among groups in individual response to interactions can lead to ecologically important variation among groups in collective behavior. Here we examine variation among colonies in the foraging behavior of the harvester ant, Pogonomyrmex barbatus. Previous work shows how colonies regulate foraging in response to food availability and desiccation costs: the rate at which outgoing foragers leave the nest depends on the rate at which foragers return with food. To examine how colonies vary in response to humidity and in foraging rate, we performed field experiments that manipulated forager return rate in 94 trials with 17 colonies over 3 years. We found that the effect of returning foragers on the rate of outgoing foragers increases with humidity. There are consistent differences among colonies in foraging activity that persist from year to year.	[Gordon, Deborah M.; Dektar, Katherine N.; Pinter-Wollman, Noa] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Gordon, DM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	dmgordon@stanford.edu			NSF [IOS-0718631]; Stanford University	NSF(National Science Foundation (NSF)); Stanford University(Stanford University)	The work was funded by NSF grant IOS-0718631 to DMG, and by a grant from the CleanSlate program at Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; [Anonymous], 2010, ANT ENCOUNTERS INTER, Vviii; Azcarate FM, 2007, J INSECT BEHAV, V20, P315, DOI 10.1007/s10905-007-9074-3; Beverly BD, 2009, BEHAV ECOL, V20, P633, DOI 10.1093/beheco/arp041; Bourke AFG, 1999, J EVOLUTION BIOL, V12, P245, DOI 10.1046/j.1420-9101.1999.00028.x; Brown MJF, 2000, BEHAV ECOL SOCIOBIOL, V47, P195, DOI 10.1007/s002650050011; Buhl J, 2005, BEHAV ECOL SOCIOBIOL, V58, P9, DOI 10.1007/s00265-004-0906-2; Burd M, 2010, ECOL ENTOMOL, V35, P464, DOI 10.1111/j.1365-2311.2010.01202.x; CASSILL DL, 1995, ANIM BEHAV, V50, P801, DOI 10.1016/0003-3472(95)80140-5; Cole BJ, 2010, BEHAV ECOL, V21, P337, DOI 10.1093/beheco/arp193; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; CRIST TO, 1994, OIKOS, V69, P37, DOI 10.2307/3545281; CROSLAND MWJ, 1990, J INSECT BEHAV, V3, P359, DOI 10.1007/BF01052114; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dupuy F, 2006, ANIM BEHAV, V72, P1081, DOI 10.1016/j.anbehav.2006.03.011; Foitzik S, 2004, BEHAV ECOL SOCIOBIOL, V55, P484, DOI 10.1007/s00265-003-0718-9; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; Gordon DM, 2011, BEHAV ECOL, V22, P429, DOI 10.1093/beheco/arq218; Gordon DM, 2011, BEHAV ECOL, V22, P225, DOI 10.1093/beheco/arq172; GORDON DM, 1992, BEHAV ECOL SOCIOBIOL, V31, P417, DOI 10.1007/BF00170609; Gordon DM, 1996, ECOLOGY, V77, P2393, DOI 10.2307/2265741; GORDON DM, 1991, AM NAT, V138, P379, DOI 10.1086/285223; Gordon DM, 2002, AM NAT, V159, P509, DOI 10.1086/339461; GORDON DM, 1993, OECOLOGIA, V95, P479, DOI 10.1007/BF00317431; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; Greene MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052219; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Ingram KK, 2013, J ANIMAL EC IN PRESS; LIGHTON JRB, 1988, P NATL ACAD SCI USA, V85, P4765, DOI 10.1073/pnas.85.13.4765; LIGHTON JRB, 1989, PHYSIOL ZOOL, V62, P1232, DOI 10.1086/physzool.62.6.30156211; Lott D., 1991, INTRASPECIFIC VARIAT; Mailleux AC, 2011, INSECT SOC, V58, P559, DOI 10.1007/s00040-011-0177-7; Modlmeier AP, 2011, BEHAV ECOL, V22, P1026, DOI 10.1093/beheco/arr086; MUNGER JC, 1984, ECOLOGY, V65, P1077, DOI 10.2307/1938315; Muscedere ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031618; Muscedere ML, 2012, J COMP PHYSIOL A, V198, P219, DOI 10.1007/s00359-011-0701-2; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Papoulis A., 2002, PROBABILITY RANDOM V; Pinter-Wollman N, 2012, BEHAV ECOL, V23, P1022, DOI 10.1093/beheco/ars066; Prabhakar B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002670; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Schafer RJ, 2006, ANIM BEHAV, V71, P815, DOI 10.1016/j.anbehav.2005.05.024; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Thomas ML, 2003, NATURWISSENSCHAFTEN, V90, P88, DOI 10.1007/s00114-002-0396-x; Torney C, 2009, P NATL ACAD SCI USA, V106, P22055, DOI 10.1073/pnas.0907929106; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wray MK, 2011, ANIM BEHAV, V81, P559, DOI 10.1016/j.anbehav.2010.11.027; Yamagata N, 2006, P ROY SOC B-BIOL SCI, V273, P2219, DOI 10.1098/rspb.2006.3565	52	37	38	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63363	10.1371/journal.pone.0063363	http://dx.doi.org/10.1371/journal.pone.0063363			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717415	Green Published, Green Submitted, gold			2022-12-27	WOS:000319435600012
J	Leeper, NJ; Bauer-Mehren, A; Iyer, SV; LePendu, P; Olson, C; Shah, NH				Leeper, Nicholas J.; Bauer-Mehren, Anna; Iyer, Srinivasan V.; LePendu, Paea; Olson, Cliff; Shah, Nigam H.			Practice-Based Evidence: Profiling the Safety of Cilostazol by Text-Mining of Clinical Notes	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; INTERMITTENT CLAUDICATION; TRIAL; RISK; ATHEROTHROMBOSIS; MORTALITY; AWARENESS; SURVIVAL; PLACEBO; WOMEN	Background: Peripheral arterial disease (PAD) is a growing problem with few available therapies. Cilostazol is the only FDA-approved medication with a class I indication for intermittent claudication, but carries a black box warning due to concerns for increased cardiovascular mortality. To assess the validity of this black box warning, we employed a novel text-analytics pipeline to quantify the adverse events associated with Cilostazol use in a clinical setting, including patients with congestive heart failure (CHF). Methods and Results: We analyzed the electronic medical records of 1.8 million subjects from the Stanford clinical data warehouse spanning 18 years using a novel text-mining/statistical analytics pipeline. We identified 232 PAD patients taking Cilostazol and created a control group of 1,160 PAD patients not taking this drug using 1: 5 propensity-score matching. Over a mean follow up of 4.2 years, we observed no association between Cilostazol use and any major adverse cardiovascular event including stroke (OR = 1.13, CI [0.82, 1.55]), myocardial infarction (OR = 1.00, CI [0.71, 1.39]), or death (OR = 0.86, CI [0.63, 1.18]). Cilostazol was not associated with an increase in any arrhythmic complication. We also identified a subset of CHF patients who were prescribed Cilostazol despite its black box warning, and found that it did not increase mortality in this high-risk group of patients. Conclusions: This proof of principle study shows the potential of text-analytics to mine clinical data warehouses to uncover 'natural experiments' such as the use of Cilostazol in CHF patients. We envision this method will have broad applications for examining difficult to test clinical hypotheses and to aid in post-marketing drug safety surveillance. Moreover, our observations argue for a prospective study to examine the validity of a drug safety warning that may be unnecessarily limiting the use of an efficacious therapy.	[Leeper, Nicholas J.] Stanford Univ, Div Vasc Surg, Stanford, CA 94305 USA; [Leeper, Nicholas J.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Bauer-Mehren, Anna; Iyer, Srinivasan V.; LePendu, Paea; Shah, Nigam H.] Stanford Univ, Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Olson, Cliff] Palo Alto Med Fdn, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; Palo Alto Medical Foundation Research Institute	Bauer-Mehren, A (corresponding author), Stanford Univ, Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA.	anna.bauermehren@stanford.edu; nigam@stanford.edu		LePendu, Paea/0000-0001-7358-931X	National Institutes of Health (NIH) [U54 HG004028]; Department of Medicine of the Stanford University; NIH [K12 HL087746]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087746] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine of the Stanford University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	ABM, PLP and NHS acknowledge support from the National Institutes of Health (NIH) grant U54 HG004028 for the National Center for Biomedical Ontology, and the Department of Medicine of the Stanford University. NJL acknowledges support from the NIH grant K12 HL087746. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fernandez Luis Javier, 2009, Med Clin (Barc), V132 Suppl 2, P25, DOI 10.1016/S0025-7753(09)71749-X; [Anonymous], 2007, WORKSH BIONLP 2007 B, P1; Beebe HG, 1999, ARCH INTERN MED, V159, P2041, DOI 10.1001/archinte.159.17.2041; Bodenreider O, 2003, J BIOMED INFORM, V36, P414, DOI 10.1016/j.jbi.2003.11.002; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; Chi YW, 2008, VASC HEALTH RISK MAN, V4, P1197, DOI 10.2147/VHRM.S3160; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Frankovich J, 2011, NEW ENGL J MED, V365, P1758, DOI 10.1056/NEJMp1108726; GAIL MH, 1981, BIOMETRIKA, V68, P703, DOI 10.1093/biomet/68.3.703; Hiatt WR, 2008, J VASC SURG, V47, P330, DOI 10.1016/j.jvs.2007.10.009; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; LePendu P, 2013, PHARMACOVIGILANCE US; Lependu Paea, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P63; Lependu Paea, 2012, J Biomed Semantics, V3 Suppl 1, pS5, DOI 10.1186/2041-1480-3-S1-S5; Liu Yi, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P47; Mahoney EM, 2008, CIRC-CARDIOVASC QUAL, V1, P38, DOI 10.1161/CIRCOUTCOMES.108.775247; Margolis Jay, 2005, J Manag Care Pharm, V11, P727; Marshall MS, 2012, J WEB SEMANT, V14, P2, DOI 10.1016/j.websem.2012.02.003; McDermott MM, 2003, J GEN INTERN MED, V18, P461, DOI 10.1046/j.1525-1497.2003.20527.x; Mechtouff L, 2010, J INTERN MED, V267, P621, DOI 10.1111/j.1365-2796.2009.02198.x; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Pande RL, 2010, VASC MED, V15, P181, DOI 10.1177/1358863X10361545; Parai Gautam K, 2010, AMIA Annu Symp Proc, V2010, P587; Pratt CM, 2001, AM J CARDIOL, V87, p28D; Regensteiner JG, 2008, VASC MED, V13, P15, DOI 10.1177/1358863X07084911; Reilly MP, 2001, ANN PHARMACOTHER, V35, P48; Robless P, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003748.pub3; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sekhon J, 2011, J STAT SOFTWARE, V42; Shah NH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S14; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Thernau T, 2012, PACKAGE SURVIVAL ANA; Thompson PD, 2002, AM J CARDIOL, V90, P1314, DOI 10.1016/S0002-9149(02)02869-2; Uzuner O, 2009, J AM MED INFORM ASSN, V16, P561, DOI 10.1197/jamia.M3115; Wilson AM, 2011, J VASC SURG, V54, P427, DOI 10.1016/j.jvs.2011.02.052; Wu ST, 2012, J AM MED INFORM ASS; Xu Rong, 2010, AMIA Annu Symp Proc, V2010, P907	38	49	50	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63499	10.1371/journal.pone.0063499	http://dx.doi.org/10.1371/journal.pone.0063499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717437	gold, Green Submitted, Green Published			2022-12-27	WOS:000319435600020
J	Yang, XL; Long, SY; Deng, JP; Deng, TX; Gong, ZH; Hao, P				Yang, Xingliang; Long, Shuyu; Deng, Jianping; Deng, Tianxing; Gong, Zhihua; Hao, Ping			Glutathione S-Transferase Polymorphisms (GSTM1, GSTT1 and GSTP1) and Their Susceptibility to Renal Cell Carcinoma: An Evidence-Based Meta-Analysis	PLOS ONE			English	Article							CANCER-RISK; GENE POLYMORPHISMS; OCCUPATIONAL-EXPOSURE; LUNG-CANCER; ASSOCIATION; M1; T1; TRICHLOROETHYLENE; IDENTIFICATION; MODIFIERS	Background: The association of the three Glutathione S-transferases (GSTs) polymorphisms (GSTM1, GSTT1 and GSTP1) genotypes with their individual susceptibilities to renal cell carcinoma (RCC) has not been well established. We performed a quantitative meta-analysis to assess the possible associations between the GSTM1, GSTT1 and GSTP1 genotypes and their individual susceptibilities to renal cell carcinoma. Methods: We systematically searched the PubMed, CNKI and Embase databases to identify the relevant studies. Finally, 11 eligible studies were selected. The pooled odds ratios (ORs) with their 95% confidence intervals (CIs) were used to assess the association between the GSTs polymorphisms and the risk of RCC. Multiple subgroup analyses and quality assessment of the included studies were performed based on the available information. Results: None of the GSTs polymorphisms had a significant association with the RCC risk. Similar results were found in the subgroup analyses, except for the GSTs polymorphisms in the situations described below. The GSTM1 and GSTT1 active genotypes in subjects exposed to pesticides (GSTM1: OR = 3.44; 95% CI, 2.04-5.80; GSTT1: OR = 2.84; 95% CI, 1.75-4.60), most of the GSTs genotypes in Asian populations (GSTT1: OR = 2.39, 95% CI = 1.63-3.51; GSTP1: Dominant model: OR = 1.50, 95% CI = 1.14-1.99; Additive model: OR = 1.39, 95% CI = 1.12-1.73; AG vs. AA: OR = 1.47, 95% CI = 1.10-1.97; GG vs. AA: OR = 1.82, 95% CI = 1.07-3.09) and the dual null genotype of GSTT1-GSTP1 (OR = 2.84, 95% CI = 1.75-4.60) showed positive associations with the RCC risk. Conclusion: Our present study provides evidence that the GSTM1, GSTT1 and GSTP1 polymorphisms are not associated with the development of RCC. However, more case-control studies are needed for further confirmation.	[Yang, Xingliang; Deng, Jianping; Deng, Tianxing] Third Mil Med Univ, Xinqiao Hosp, Dept Urol, Chongqing, Peoples R China; [Long, Shuyu] Sichuan Univ, West China Hosp 2, Dept Gynecol & Obstet, Chengdu 610064, Sichuan, Peoples R China; [Gong, Zhihua; Hao, Ping] Third Mil Med Univ, Xinqiao Hosp, Dept Oncol, Chongqing, Peoples R China	Army Medical University; Sichuan University; Army Medical University	Hao, P (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Oncol, Chongqing, Peoples R China.	haoping833@hotmail.com			National Natural Science Foundation of China [81071911]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81071911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2008, AM J EPIDEMIOL, V168, P268, DOI 10.1093/aje/kwn122; Ahmad ST, 2012, DNA CELL BIOL, V31, P636, DOI 10.1089/dna.2011.1392; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bruning T, 1997, ARCH TOXICOL, V71, P596, DOI 10.1007/s002040050432; Buzio L, 2003, OCCUP ENVIRON MED, V60, P789, DOI 10.1136/oem.60.10.789; Cheng HY, 2012, RENAL FAILURE, V34, P1052, DOI 10.3109/0886022X.2012.708380; Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Coric V, 2010, J MED BIOCHEM, V29, P204, DOI 10.2478/v10011-010-0025-8; CURADO MP, 2008, JAMA-J AM MED ASSOC, V282, P2119; De Martino M, 2010, J UROLOGY, V183, P878, DOI 10.1016/j.juro.2009.11.032; DEKANT W, 1986, CHEM-BIOL INTERACT, V60, P31, DOI 10.1016/0009-2797(86)90015-3; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FACCHINI F, 1994, DIABETES CARE, V17, P115, DOI 10.2337/diacare.17.2.115; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020157; GROVES CE, 1991, TOXICOL APPL PHARM, V107, P54, DOI 10.1016/0041-008X(91)90330-H; Harries LW, 1997, CARCINOGENESIS, V18, P641, DOI 10.1093/carcin/18.4.641; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu X, 1997, BIOCHEM BIOPH RES CO, V238, P397, DOI 10.1006/bbrc.1997.7311; Karami S, 2008, CARCINOGENESIS, V29, P1567, DOI 10.1093/carcin/bgn153; Katner HP, 1999, JAMA-J AM MED ASSOC, V282, P2119, DOI 10.1001/jama.282.22.2119; KETTERER B, 1988, MUTAT RES, V202, P343, DOI 10.1016/0027-5107(88)90197-2; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Liu R, 2012, ASIAN PAC J CANCER P, V13, P3109, DOI 10.7314/APJCP.2012.13.7.3109; Longuemaux S, 1999, CANCER RES, V59, P2903; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; Palli D, 2005, AM J GASTROENTEROL, V100, P1941, DOI 10.1111/j.1572-0241.2005.50084.x; PEARSON WR, 1993, AM J HUM GENET, V53, P220; Pekmezovic T, 2010, J MED BIOCHEM, V29, P131, DOI 10.2478/v10011-010-0021-z; Salinas-Sanchez AS, 2012, UROL ONCOL-SEMIN ORI, V30, P864, DOI 10.1016/j.urolonc.2010.10.001; SEIDEGARD J, 1986, CARCINOGENESIS, V7, P751, DOI 10.1093/carcin/7.5.751; Sergentanis TN, 2010, BREAST CANCER RES TR, V121, P195, DOI 10.1007/s10549-009-0520-0; Shi XQ, 2008, LUNG CANCER, V59, P155, DOI 10.1016/j.lungcan.2007.08.004; Simic T, 2009, NAT REV UROL, V6, P281, DOI 10.1038/nrurol.2009.49; Sui Y, 2011, EUR J OBSTET GYN R B, V159, P443, DOI 10.1016/j.ejogrb.2011.09.012; Sweeney C, 2000, CANCER EPIDEM BIOMAR, V9, P449; van Bladeren PJ, 2000, CHEM-BIOL INTERACT, V129, P61, DOI 10.1016/S0009-2797(00)00214-3; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Wang GP, 2012, CANCER EPIDEMIOL, V36, P177, DOI 10.1016/j.canep.2011.09.006; Webb G, 1996, GENOMICS, V33, P121, DOI 10.1006/geno.1996.0167; Wiesenhutter B, 2007, INT ARCH OCC ENV HEA, V81, P247, DOI 10.1007/s00420-007-0200-5; Ye Z, 2005, EUR J CANCER, V41, P980, DOI 10.1016/j.ejca.2005.01.014; Ye Z, 2006, PLOS MED, V3, P524, DOI 10.1371/journal.pmed.0030091; ZIMNIAK P, 2005, EUR J BIOCHEM, V224, P893; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	47	6	7	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63827	10.1371/journal.pone.0063827	http://dx.doi.org/10.1371/journal.pone.0063827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717494	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700069
J	Biela, I; Tidten-Luksch, N; Immekus, F; Glinca, S; Nguyen, TXP; Gerber, HD; Heine, A; Klebe, G; Reuter, K				Biela, Inna; Tidten-Luksch, Naomi; Immekus, Florian; Glinca, Serghei; Tran Xuan Phong Nguyen; Gerber, Hans-Dieter; Heine, Andreas; Klebe, Gerhard; Reuter, Klaus			Investigation of Specificity Determinants in Bacterial tRNA-Guanine Transglycosylase Reveals Queuine, the Substrate of Its Eucaryotic Counterpart, as Inhibitor	PLOS ONE			English	Article							X-RAY-DIFFRACTION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RIBOSYLTRANSFERASE-ISOMERASE; SHIGELLA-FLEXNERI; QUEUOSINE; SEQUENCE; RECOGNITION; MECHANISM; BINDING	Bacterial tRNA-guanine transglycosylase (Tgt) catalyses the exchange of the genetically encoded guanine at the wobble position of tRNAs(His,Tyr,Asp,Asn) by the premodified base preQ(1), which is further converted to queuine at the tRNA level. As eucaryotes are not able to synthesise queuine de novo but acquire it through their diet, eucaryotic Tgt directly inserts the hypermodified base into the wobble position of the tRNAs mentioned above. Bacterial Tgt is required for the efficient pathogenicity of Shigella sp, the causative agent of bacillary dysentery and, hence, it constitutes a putative target for the rational design of anti-Shigellosis compounds. Since mammalian Tgt is known to be indirectly essential to the conversion of phenylalanine to tyrosine, it is necessary to create substances which only inhibit bacterial but not eucaryotic Tgt. Therefore, it seems of utmost importance to study selectivity-determining features within both types of proteins. Homology models of Caenorhabditis elegans Tgt and human Tgt suggest that the replacement of Cys158 and Val233 in bacterial Tgt (Zymomonas mobilis Tgt numbering) by valine and accordingly glycine in eucaryotic Tgt largely accounts for the different substrate specificities. In the present study we have created mutated variants of Z. mobilis Tgt in order to investigate the impact of a Cys158Val and a Val233Gly exchange on catalytic activity and substrate specificity. Using enzyme kinetics and X-ray crystallography, we gained evidence that the Cys158Val mutation reduces the affinity to preQ1 while leaving the affinity to guanine unaffected. The Val233Gly exchange leads to an enlarged substrate binding pocket, that is necessary to accommodate queuine in a conformation compatible with the intermediately covalently bound tRNA molecule. Contrary to our expectations, we found that a priori queuine is recognised by the binding pocket of bacterial Tgt without, however, being used as a substrate.	[Biela, Inna; Tidten-Luksch, Naomi; Immekus, Florian; Glinca, Serghei; Tran Xuan Phong Nguyen; Gerber, Hans-Dieter; Heine, Andreas; Klebe, Gerhard; Reuter, Klaus] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany	Philipps University Marburg	Reuter, K (corresponding author), Univ Marburg, Inst Pharmazeut Chem, Marbacher Weg 6, D-35032 Marburg, Germany.	reuterk@staff.uni-marburg.de		Glinca, Serghei/0000-0002-0394-8468	Philipps-University of Marburg; German Research Foundation (Graduiertenkolleg "Protein Function at the Atomic Level'' and DFG) [KL1204/11-1]	Philipps-University of Marburg; German Research Foundation (Graduiertenkolleg "Protein Function at the Atomic Level'' and DFG)(German Research Foundation (DFG))	This work was supported by the Philipps-University of Marburg and the German Research Foundation (Graduiertenkolleg "Protein Function at the Atomic Level'' and DFG grant KL1204/11-1). The travel costs to the BESSY II synchrotron in Berlin were covered by the Helmhotz-Zentrum Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boland C, 2009, J BIOL CHEM, V284, P18218, DOI 10.1074/jbc.M109.002477; Brenk R, 2003, CHEMBIOCHEM, V4, P1066, DOI 10.1002/cbic.200300644; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YC, 2011, NUCLEIC ACIDS RES, V39, P2834, DOI 10.1093/nar/gkq1188; Chen YC, 2010, RNA, V16, P958, DOI 10.1261/rna.1997610; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chikwana VM, 2012, J BIOL CHEM, V287, P30560, DOI 10.1074/jbc.M112.388538; CURNOW AW, 1993, BIOCHEMISTRY-US, V32, P5239, DOI 10.1021/bi00070a036; CURNOW AW, 1995, J BIOL CHEM, V270, P17264, DOI 10.1074/jbc.270.29.17264; Deshpande KL, 2001, GENE, V265, P205, DOI 10.1016/S0378-1119(01)00368-7; Durand JMB, 2000, MOL MICROBIOL, V35, P924, DOI 10.1046/j.1365-2958.2000.01767.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESWAR N, 2000, CURRENT PROTOCOLS S, V15; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; FREY B, 1988, J BACTERIOL, V170, P2078, DOI 10.1128/jb.170.5.2078-2082.1988; Garcia GA, 2009, BIOCHEMISTRY-US, V48, P11243, DOI 10.1021/bi901501a; Gerber HD, 2012, ORG BIOMOL CHEM, V10, P8660, DOI 10.1039/c2ob26387d; Goodenough-Lashua DM, 2003, BIOORG CHEM, V31, P331, DOI 10.1016/S0045-2068(03)00069-5; Gradler U, 1999, FEBS LETT, V454, P142, DOI 10.1016/S0014-5793(99)00793-0; Gradler U, 2001, J MOL BIOL, V306, P455, DOI 10.1006/jmbi.2000.4256; Grimm C, 2006, BIOCHEM BIOPH RES CO, V351, P695, DOI 10.1016/j.bbrc.2006.10.096; Hurt JK, 2007, NUCLEIC ACIDS RES, V35, P4905, DOI 10.1093/nar/gkm473; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Kohler PC, 2009, CHEM-EUR J, V15, P10809, DOI 10.1002/chem.200901270; Kung FL, 1998, FEBS LETT, V431, P427, DOI 10.1016/S0014-5793(98)00801-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee BWK, 2007, BIOCHEMISTRY-US, V46, P12844, DOI 10.1021/bi701265r; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Mathews I, 2005, PROTEINS, V59, P869, DOI 10.1002/prot.20419; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P3847, DOI 10.1021/bi900400e; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P2301, DOI 10.1021/bi9001437; Meyer EA, 2006, HELV CHIM ACTA, V89, P573, DOI 10.1002/hlca.200690062; Miles ZD, 2011, P NATL ACAD SCI USA, V108, P7368, DOI 10.1073/pnas.1018636108; NAKANISHI S, 1994, J BIOL CHEM, V269, P32221; OKADA N, 1979, J BIOL CHEM, V254, P3061; Oliva R, 2007, RNA, V13, P1427, DOI 10.1261/rna.574407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Phillips G, 2008, J BACTERIOL, V190, P7876, DOI 10.1128/JB.00874-08; Rakovich T, 2011, J BIOL CHEM, V286, P19354, DOI 10.1074/jbc.M111.219576; Ritschel T, 2009, CHEMMEDCHEM, V4, P2012, DOI 10.1002/cmdc.200900343; Ritschel T, 2009, J MOL BIOL, V393, P833, DOI 10.1016/j.jmb.2009.07.040; Ritschel T, 2009, CHEMBIOCHEM, V10, P716, DOI 10.1002/cbic.200800782; Romier C, 1997, FEBS LETT, V416, P93, DOI 10.1016/S0014-5793(97)01175-7; Romier C, 1996, PROTEINS, V24, P516; Romier C, 1996, EMBO J, V15, P2850, DOI 10.1002/j.1460-2075.1996.tb00646.x; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Stengl B, 2005, CHEMBIOCHEM, V6, P1926, DOI 10.1002/cbic.200500063; Thomas CE, 2011, BIOCHEM BIOPH RES CO, V410, P34, DOI 10.1016/j.bbrc.2011.05.100; Tidten N, 2007, J MOL BIOL, V374, P764, DOI 10.1016/j.jmb.2007.09.062; Van Lanen SG, 2005, P NATL ACAD SCI USA, V102, P4264, DOI 10.1073/pnas.0408056102; Van Lanen SG, 2003, J BIOL CHEM, V278, P10491, DOI 10.1074/jbc.M207727200; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xie W, 2003, NAT STRUCT BIOL, V10, P781, DOI 10.1038/nsb976	60	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64240	10.1371/journal.pone.0064240	http://dx.doi.org/10.1371/journal.pone.0064240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704982	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200126
J	Dhar, MS; Gupta, V; Virdi, JS				Dhar, Mahesh Shanker; Gupta, Vatika; Virdi, Jugsharan Singh			Detection, Distribution and Characterization of Novel Superoxide Dismutases from Yersinia enterocolitica Biovar 1A	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; EXPRESSION; PURIFICATION; GROWTH; COPPER; GENE; SODA; IDENTIFICATION	Background: Superoxide dismutases (SODs) cause dismutation of superoxide radicals to hydrogen peroxide and oxygen. Besides protecting the cells against oxidative damage by endogenously generated oxygen radicals, SODs play an important role in intraphagocytic survival of pathogenic bacteria. The complete genome sequences of Yersinia enterocolitica strains show presence of three different sod genes. However, not much is known about the types of SODs present in Y. enterocolitica, their characteristics and role in virulence and intraphagocytic survival of this organism. Methodology/Principal Findings: This study reports detection and distribution of the three superoxide dismutase (sodA, sodB and sodC) genes in 59 strains of Y. enterocolitica and related species. The majority (94%) of the strains carried all three genes and constitutive expression of sodA and sodB was detected in 88% of the strains. Expression of sodC was not observed in any of the strains. The sodA, sodB and sodC genes of Y. enterocolitica were cloned in pET28a (+) vector. Recombinant SodA (82 kDa) and SodB (21 kDa) were expressed as homotetramer and monomer respectively, and showed activity over a broad range of pH (3.0-8.0) and temperature (4-70 degrees C). SodA and SodB showed optimal activity at 4 degrees C under acidic pH of 6.0 and 4.0 respectively. The secondary structures of recombinant SodA and SodB were studied using circular dichroism. Production of YeSodC was not observed even after cloning and expression in E. coli BL21(DE3) cells. A SodA(-) SodB(-) Escherichia coli strain which was unable to grow in medium supplemented with paraquat showed normal growth after complementation with Y. enterocolitica SodA or SodB. Conclusions/Significance: This is the first report on the distribution and characterization of superoxide dismutases from Y. enterocolitica. The low pH optima of both SodA and SodB encoded by Y. enterocolitica seem to implicate their role in acidic environments such as the intraphagocytic vesicles.	[Dhar, Mahesh Shanker; Gupta, Vatika; Virdi, Jugsharan Singh] Univ Delhi, Dept Microbiol, Microbial Pathogen Lab, New Delhi, India	University of Delhi	Virdi, JS (corresponding author), Univ Delhi, Dept Microbiol, Microbial Pathogen Lab, South Campus, New Delhi, India.	virdi_dusc@rediffmail.com	; Virdi, Jugsharan Singh/L-8241-2015	Dhar, Mahesh shanker/0000-0002-2006-3581; Virdi, Jugsharan Singh/0000-0002-6282-0018				Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Battistoni A, 1996, BIOCHEM J, V320, P713, DOI 10.1042/bj3200713; Battistoni A, 2003, BIOCHEM SOC T, V31, P1326; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BENOV LT, 1994, J BIOL CHEM, V269, P25310; BEYER WF, 1991, J BIOL CHEM, V266, P303; Bollag D.M., 1996, PROTEIN METHODS; Bond CJ, 2000, ACTA CRYSTALLOGR D, V56, P1359, DOI 10.1107/S0907444900009537; Bordo D, 1999, J MOL BIOL, V285, P283, DOI 10.1006/jmbi.1998.2267; BORDO D, 1994, J MOL BIOL, V238, P366, DOI 10.1006/jmbi.1994.1298; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castellano I, 2006, BIOCHIMIE, V88, P1377, DOI 10.1016/j.biochi.2006.04.005; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; DOHERTY A, 1995, FOOD MICROBIOL, V12, P251, DOI 10.1016/S0740-0020(95)80105-7; Edwards RA, 1998, J BIOL INORG CHEM, V3, P161, DOI 10.1007/s007750050217; Ekanayake PM, 2006, COMP BIOCHEM PHYS B, V145, P318, DOI 10.1016/j.cbpb.2006.08.004; Esposito L, 2008, BBA-PROTEINS PROTEOM, V1784, P1601, DOI 10.1016/j.bbapap.2008.04.024; FARR SB, 1986, P NATL ACAD SCI USA, V83, P8268, DOI 10.1073/pnas.83.21.8268; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Goverde RLJ, 1998, MOL MICROBIOL, V28, P555, DOI 10.1046/j.1365-2958.1998.00816.x; Grant T, 1999, INFECT IMMUN, V67, P4367, DOI 10.1128/IAI.67.9.4367-4375.1999; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; HANNA MO, 1977, J FOOD PROTECT, V40, P689, DOI 10.4315/0362-028X-40.10.689; HASSAN HM, 1979, J BIOL CHEM, V254, P846; HEIKKILA RE, 1976, J BIOL CHEM, V251, P2182; Holovska K, 2002, VET MED-CZECH, V47, P38, DOI 10.17221/5801-VETMED; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Kim CH, 1998, CLIN VACCINE IMMUNOL, V5, P6784; Kim KA, 2000, INFECT IMMUN, V68, P3861, DOI 10.1128/IAI.68.7.3861-3866.2000; LAH MS, 1995, BIOCHEMISTRY-US, V34, P1646, DOI 10.1021/bi00005a021; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Leclere V, 2001, MICROBIOL-SGM, V147, P3105, DOI 10.1099/00221287-147-11-3105; Lefebre MD, 2001, MICROBIOL-SGM, V147, P97, DOI 10.1099/00221287-147-1-97; Liu P, 2007, ACTA CRYSTALLOGR F, V63, P1003, DOI 10.1107/S1744309107054127; LUMSDEN J, 1976, BIOCHIM BIOPHYS ACTA, V438, P380, DOI 10.1016/0005-2744(76)90255-2; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; Merlino A, 2012, BIOCHIMIE, V94, P768, DOI 10.1016/j.biochi.2011.11.008; Mingde Z, 1993, FAGOPYRUM, V13, P31; MISRA HP, 1978, ARCH BIOCHEM BIOPHYS, V189, P317, DOI 10.1016/0003-9861(78)90218-7; Mori M, 2008, BIOCHEMISTRY-US, V47, P12954, DOI 10.1021/bi801252e; Na J, 2011, B KOREAN CHEM SOC, V32, P2405, DOI 10.5012/bkcs.2011.32.7.2405; PARKER MW, 1988, J MOL BIOL, V199, P649, DOI 10.1016/0022-2836(88)90308-7; Pedersen HL, 2009, ACTA CRYSTALLOGR F, V65, P84, DOI 10.1107/S1744309109001110; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; REVEILLAUD I, 1991, MOL CELL BIOL, V11, P632, DOI 10.1128/MCB.11.2.632; Revell PA, 2001, FEMS MICROBIOL LETT, V205, P159, DOI [10.1111/j.1574-6968.2001.tb10941.x, 10.1016/S0378-1097(01)00476-1]; RINGE D, 1983, P NATL ACAD SCI-BIOL, V80, P3879, DOI 10.1073/pnas.80.13.3879; Roggenkamp A, 1997, INFECT IMMUN, V65, P4705, DOI 10.1128/IAI.65.11.4705-4710.1997; Santos R, 2001, MOL PLANT MICROBE IN, V14, P758, DOI 10.1094/MPMI.2001.14.6.758; SCHININA ME, 1987, FEBS LETT, V221, P87, DOI 10.1016/0014-5793(87)80357-5; Singh I, 2003, CURR SCI INDIA, V84, P1353; SMITH MW, 1992, J MOL EVOL, V34, P175; Smith SG, 1996, MOL PLANT MICROBE IN, V9, P584, DOI 10.1094/MPMI-9-0584; STALLINGS WC, 1985, J BIOL CHEM, V260, P6424; STEINMAN HM, 1993, J BACTERIOL, V175, P1198, DOI 10.1128/JB.175.4.1198-1202.1993; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Tarhan L, 2000, TURK J CHEM, V24, P109; Teixeira-Gomes AP, 2000, INFECT IMMUN, V68, P2954, DOI 10.1128/IAI.68.5.2954-2961.2000; TOORA S, 1994, FOOD MICROBIOL, V11, P369, DOI 10.1006/fmic.1994.1042; VANLOON APGM, 1986, P NATL ACAD SCI USA, V83, P3820; Wang X, 2008, J IND MICROBIOL BIOT, V35, P133, DOI 10.1007/s10295-007-0274-9; Youn HD, 1996, BIOCHEM J, V318, P889, DOI 10.1042/bj3180889; Yun YS, 2004, EXTREMOPHILES, V8, P237, DOI 10.1007/s00792-004-0383-6; ZHU DH, 1995, FREE RADICAL BIO MED, V18, P179, DOI 10.1016/0891-5849(94)00113-X	68	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63919	10.1371/journal.pone.0063919	http://dx.doi.org/10.1371/journal.pone.0063919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704955	gold, Green Submitted, Green Published			2022-12-27	WOS:000319330200086
J	Fang, ZQ; Chen, FL; Wang, XW; Yi, SH; Chen, W; Ye, G				Fang, Zhenqiang; Chen, Fanglin; Wang, Xiangwei; Yi, Shanhong; Chen, Wei; Ye, Gang			XRCC1 Arg194Trp and Arg280His Polymorphisms Increase Bladder Cancer Risk in Asian Population: Evidence from a Meta-Analysis	PLOS ONE			English	Article							EXCISION-REPAIR PATHWAY; DNA-REPAIR; GENETIC-VARIANTS; EPIDEMIOLOGY; ASSOCIATION; CARCINOMA	Background: A lot of studies have investigated the correlation between x-ray cross complementing group 1 (XRCC1) polymorphisms and bladder cancer risk, but the results in Asian population were still inconclusive. We conducted a meta-analysis to ascertain the association of XRCC1 Arg194Trp, Arg280His and Arg399Gln polymorphisms with bladder cancer risk in Asian population. Methodology/Principal findings: The association strength was measured with odds ratios (ORs) and 95% confidence intervals (95% CIs). A total of 9 eligible studies, conducted in China, India and Japan, were identified. We observed a significant increased risk of bladder cancer in dominant model (OR = 1.199, 95% CI: 1.021,1.408, P-heterogeneity = 0.372), allele comparison (OR = 1.200, 95% CI: 1.057,1.362, P-heterogeneity = 0.107) of Arg194Trp, heterozygote comparison (OR = 1.869, 95% CI: 1.205,2.898, P-heterogeneity = 0.011) and dominant model (OR = 1.748, 95% CI: 1.054,2.900, P-heterogeneity = 0.01) of Arg280His. Pooled results estimated from adjusted ORs further validated these findings. No publication bias was detected. Subgroup analyses found that significant increased risk was only found among community-based studies not hospital-based studies. There was no evidence of publication bias. Conclusion: This is the first meta-analysis conducted in Asian investigating the correlation between XRCC1 polymorphisms and susceptibility to bladder cancer. Our meta-analysis shows that XRCC1 Arg194Trp and Arg280His polymorphisms are associated with a significantly increased risk of bladder cancer in Asian population.	[Fang, Zhenqiang; Wang, Xiangwei; Yi, Shanhong; Chen, Wei; Ye, Gang] Third Mil Med Univ, Affiliated Hosp 2, Ctr Nephrol, Dept Urol, Chongqing, Peoples R China; [Chen, Fanglin] Third Mil Med Univ, Affiliated Hosp 2, Canc Inst PLA, Chongqing, Peoples R China	Army Medical University; Army Medical University	Fang, ZQ (corresponding author), Third Mil Med Univ, Affiliated Hosp 2, Ctr Nephrol, Dept Urol, Chongqing, Peoples R China.	zqfangcn@126.com	Wu, Yuqi/AAL-9861-2020		National Natural Science Foundation of China [81200500]; Natural Science Foundation Project of CQ-CSTC [2009BB5154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ-CSTC(Natural Science Foundation Project of CQ CSTC)	This work was supported by National Natural Science Foundation of China (81200500)and Natural Science Foundation Project of CQ-CSTC ( No. 2009BB5154, CSTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizono K, 2008, JPN J CLIN ONCOL, V38, P186, DOI 10.1093/jjco/hym176; Bosetti C, 2005, CANCER CAUSE CONTROL, V16, P997, DOI 10.1007/s10552-005-3636-5; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Garcia-Closas M, 2006, HUM GENET, V119, P376, DOI 10.1007/s00439-006-0135-z; Hao B, 2006, ONCOGENE, V25, P3613, DOI 10.1038/sj.onc.1209355; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; Hsu LI, 2008, TOXICOL APPL PHARM, V228, P144, DOI 10.1016/j.taap.2007.12.003; Huang J, 2011, MOL BIOL REP, V38, P4565, DOI 10.1007/s11033-010-0588-y; Lao T, 2008, MUTAGENESIS, V23, P523, DOI 10.1093/mutage/gen046; Lei YC, 2002, MUTAT RES-GEN TOX EN, V519, P93, DOI 10.1016/S1383-5718(02)00127-4; Liu L, 2011, LUNG CANCER, V73, P110, DOI 10.1016/j.lungcan.2010.11.004; Liu L, 2011, BREAST CANCER RES TR, V125, P479, DOI 10.1007/s10549-010-0959-z; Manuguerra M, 2006, AM J EPIDEMIOL, V164, P297, DOI 10.1093/aje/kwj189; Miao XP, 2006, GASTROENTEROLOGY, V131, P420, DOI 10.1053/j.gastro.2006.05.050; Mittal RD, 2008, CANCER BIOL THER, V7, P645; Mittal RD, 2012, MECH AGEING DEV, V133, P127, DOI 10.1016/j.mad.2011.10.002; Murta-Nascimento C, 2007, WORLD J UROL, V25, P285, DOI 10.1007/s00345-007-0168-5; Qiu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050887; Sakano S, 2006, PATHOBIOLOGY, V73, P295, DOI 10.1159/000099124; SHIELDS PG, 1991, JAMA-J AM MED ASSOC, V266, P681, DOI 10.1001/jama.266.5.681; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Taylor RM, 2002, MOL CELL BIOL, V22, P2556, DOI 10.1128/MCB.22.8.2556-2563.2002; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Wang CY, 2008, UROLOGY, V72, P869, DOI 10.1016/j.urology.2007.12.059; Wang ML, 2010, DNA CELL BIOL, V29, P303, DOI 10.1089/dna.2009.0969; Wang SY, 2008, INT J UROL, V15, P534, DOI 10.1111/j.1442-2042.2008.02049.x; Wang YF, 2003, DNA REPAIR, V2, P901, DOI 10.1016/S1568-7864(03)00085-5; Wen H, 2009, INT UROL NEPHROL, V41, P855, DOI 10.1007/s11255-009-9560-y; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wu JJ, 2012, CLIN CANCER RES, V18, P3972, DOI 10.1158/1078-0432.CCR-11-1531; Wu W, 2005, STUDY RELATIONSHIP P; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813; YANG Q, 2009, ZHONG GUO WU ZHEN ZA, V9, P8383; Zhang W, 2006, ZHONG GUO ZHONG LIU, V10, P667; Zhi Y, 2012, INT J MED SCI, V9, P498, DOI 10.7150/ijms.4799	36	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64001	10.1371/journal.pone.0064001	http://dx.doi.org/10.1371/journal.pone.0064001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704969	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200102
J	Han, SW; Kim, HP; Shin, JY; Jeong, EG; Lee, WC; Lee, KH; Won, JK; Kim, TY; Oh, DY; Im, SA; Bang, YJ; Jeong, SY; Park, KJ; Park, JG; Kang, GH; Seo, JS; Kim, JI; Kim, TY				Han, Sae-Won; Kim, Hwang-Phill; Shin, Jong-Yeon; Jeong, Eun-Goo; Lee, Won-Chul; Lee, Kyung-Hun; Won, Jae-Kyung; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Seo, Jeong-Sun; Kim, Jong-Il; Kim, Tae-You			Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing	PLOS ONE			English	Article							HUMAN BREAST; INSTABILITY; MUTATIONS; VARIANTS; PLUS; KRAS	Recent advance in sequencing technology has enabled comprehensive profiling of genetic alterations in cancer. We have established a targeted sequencing platform using next-generation sequencing (NGS) technology for clinical use, which can provide mutation and copy number variation data. NGS was performed with paired-end library enriched with exons of 183 cancer-related genes. Normal and tumor tissue pairs of 60 colorectal adenocarcinomas were used to test feasibility. Somatic mutation and copy number alteration were analyzed. A total of 526 somatic non-synonymous sequence variations were found in 113 genes. Among these, 278 single nucleotide variations were 232 different somatic point mutations. 216 SNV were 79 known single nucleotide polymorphisms in the dbSNP. 32 indels were 28 different indel mutations. Median number of mutated gene per tumor was 4 (range 0-23). Copy number gain (>X2 fold) was found in 65 genes in 40 patients, whereas copy number loss (<X0.5 fold) was found in 103 genes in 39 patients. The most frequently altered genes (mutation and/or copy number alteration) were APC in 35 patients (58%), TP53 in 34 (57%), and KRAS in 24 (40%). Altered gene list revealed ErbB signaling pathway as the most commonly involved pathway (25 patients, 42%). Targeted sequencing platform using NGS technology is feasible for clinical use and provides comprehensive genetic alteration data.	[Han, Sae-Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Han, Sae-Won; Kim, Hwang-Phill; Jeong, Eun-Goo; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Shin, Jong-Yeon; Lee, Won-Chul; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul, South Korea; [Shin, Jong-Yeon; Kim, Jong-Il] Psoma Therapeut Inc, Seoul, South Korea; [Lee, Won-Chul; Seo, Jeong-Sun; Kim, Jong-Il; Kim, Tae-You] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Won, Jae-Kyung; Kang, Gyeong Hoon] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea; [Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea; [Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Coll Med, Dept Biochem, Seoul, South Korea; [Seo, Jeong-Sun] Macrogen Inc, Seoul, South Korea; [Kim, Tae-You] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Macrogen, Inc.; Seoul National University (SNU)	Kim, TY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	kimty@snu.ac.kr	KIM, JONG-IL/D-1019-2011; Lee, Won-Chul/D-5789-2012; Seo, Jeong-Sun/J-2763-2012; Kang, Gyeong Hoon/F-1051-2010; Bang, Yung Jue/J-2759-2012	KIM, JONG-IL/0000-0002-7240-3744; Lee, Won-Chul/0000-0001-8052-2420; Kang, Gyeong Hoon/0000-0003-2380-6675; Bang, Yung Jue/0000-0001-6000-4597; Won, Jae-Kyung/0000-0003-1459-8093	Korean Healthcare Technology RAMP;D project, Ministry for Health, Welfare AMP; Family Affairs, Republic of Korea [A091081]	Korean Healthcare Technology RAMP;D project, Ministry for Health, Welfare AMP; Family Affairs, Republic of Korea	This study was supported by a grant from the Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A091081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2010, LANCET, V376, P1302; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jimeno A, 2009, J CLIN ONCOL, V27, P1130, DOI 10.1200/JCO.2008.19.8168; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kim JH, 2009, VIRCHOWS ARCH, V455, P485, DOI 10.1007/s00428-009-0857-0; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tran B, 2012, J CLIN ONCOL, V30, P647, DOI 10.1200/JCO.2011.39.2316; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	27	58	95	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64271	10.1371/journal.pone.0064271	http://dx.doi.org/10.1371/journal.pone.0064271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700467	Green Submitted, gold, Green Published			2022-12-27	WOS:000319330200129
J	Heid, H; Rickelt, S; Zimbelmann, R; Winter, S; Schumacher, H; Dorflinger, Y				Heid, Hans; Rickelt, Steffen; Zimbelmann, Ralf; Winter, Stefanie; Schumacher, Heiderose; Doerflinger, Yvette			Lipid Droplets, Perilipins and Cytokeratins - Unravelled Liaisons in Epithelium-Derived Cells	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; INTERMEDIATE-FILAMENTS; PAT-FAMILY; ADIPOSE CONVERSION; TUMOR-CELLS; VIMENTIN; EXPRESSION; ADIPOPHILIN; CHOLESTEROL; MEMBRANE	Lipid droplets (LDs) are spherical accumulations of apolar lipids and other hydrophobic substances and are generally surrounded by a thin cortical layer of specific amphiphilic proteins (APs). These APs segregate the LDs from the mostly polar components of the cytoplasm. We have studied LDs in epithelium-derived cell cultures and in particular characterized proteins from the perilipin (PLIN) gene family - in mammals consisting of the proteins Perilipin, Adipophilin, TIP47, S3-12 and MLDP/OXPAT (PLIN 1-5). Using a large number of newly generated and highly specific mono- and polyclonal antibodies specific for individual APs, and using improved LD isolation methods, we have enriched and characterized APs in greater detail and purity. The majority of lipid-AP complexes could be obtained in the top layer fractions of density gradient centrifugation separations of cultured cells, but APs could also be detected in other fractions within such separations. The differently sized LD complexes were analyzed using various biochemical methods and mass spectrometry as well as immunofluorescence and electron- in particular immunoelectron-microscopy. Moreover, by immunoprecipitation, protein-protein binding assays and by immunoelectron microscopy we identified a direct linkage between LD-binding proteins and the intermediate-sized filaments (IF) cytokeratins 8 and 18 (also designated as keratins K8 and K18). Specifically, in gradient fractions of higher density supposedly containing small LDs, we received as co-precipitations cytidylyl-, palmitoyl- and cholesterol transferases and other specific enzymes involved in lipid metabolism. So far, common proteomic studies have used LDs from top layer fractions only and did not report on these transferases and other enzymes. In addition to findings of short alternating hydrophobic/hydrophilic segments within the PLIN protein family, we propose and discuss a model for the interaction of LD-coating APs with IF proteins.	[Heid, Hans; Rickelt, Steffen; Zimbelmann, Ralf; Winter, Stefanie; Schumacher, Heiderose; Doerflinger, Yvette] German Canc Res Ctr, Helmholtz Grp Cell Biol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Heid, H (corresponding author), German Canc Res Ctr, Helmholtz Grp Cell Biol, Heidelberg, Germany.	h.heid@dkfz.de		Rickelt, Steffen/0000-0002-5224-7764	Bundesministerium fur Bildung und Forschung in the framework "Zellbasierte, regenerative Medizin" START-MSC [01 GN 0942]	Bundesministerium fur Bildung und Forschung in the framework "Zellbasierte, regenerative Medizin" START-MSC(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung in the framework "Zellbasierte, regenerative Medizin" START-MSC (STAndardization for Regenerative Therapy - Mesenchymal Stem Cells; W. Franke and H. Heid, DKFZ) Grant 01 GN 0942. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTSTAETTER T, 1986, METHOD ENZYMOL, V134, P355; ALMAHBOBI G, 1993, J REPROD FERTIL, V98, P209; ALMAHBOBI G, 1995, CELL TISSUE RES, V281, P387, DOI 10.1007/s004410050436; ALMAHBOBI G, 1992, J CELL SCI, V101, P383; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bozza PT, 2010, PROSTAG LEUKOTR ESS, V82, P243, DOI 10.1016/j.plefa.2010.02.005; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Buers I, 2011, HISTOL HISTOPATHOL, V26, P631, DOI 10.14670/HH-26.631; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Evans RM, 1998, BIOESSAYS, V20, P79, DOI 10.1002/(SICI)1521-1878(199801)20:1<79::AID-BIES11>3.3.CO;2-I; Evans Robert M., 1994, Trends in Cell Biology, V4, P149, DOI 10.1016/0962-8924(94)90189-9; Franke WW, 2011, INT J CANCER, V129, P2588, DOI 10.1002/ijc.26227; FRANKE WW, 1987, CELL, V49, P131, DOI 10.1016/0092-8674(87)90763-X; FRANKE WW, 1969, HISTOCHEMISTRY, V19, P162, DOI 10.1007/BF00281096; FRANKE WW, 1981, EXP CELL RES, V134, P345, DOI 10.1016/0014-4827(81)90435-3; Fujimoto T., 2011, COLD SPRING HARB PER, V3; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; GEORGATOS SD, 1985, J CELL BIOL, V100, P1955, DOI 10.1083/jcb.100.6.1955; Graham JM, 1996, ATHEROSCLEROSIS, V124, P125, DOI 10.1016/0021-9150(96)05797-8; Hall PF, 1997, MICROSC RES TECHNIQ, V36, P463, DOI 10.1002/(SICI)1097-0029(19970315)36:6<463::AID-JEMT4>3.0.CO;2-J; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Holwell TA, 1999, J LIPID RES, V40, P1440; HSIEH K, 2012, J CELL SCI; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Klemm EJ, 2011, J BIOL CHEM, V286, P37602, DOI 10.1074/jbc.M111.284794; KNAPP AC, 1986, J CELL BIOL, V103, P657, DOI 10.1083/jcb.103.2.657; Larsson S, 2012, J PROTEOME RES, V11, P1264, DOI 10.1021/pr200957p; Lee TF, 2010, J CELL PHYSIOL, V223, P648, DOI 10.1002/jcp.22063; Leung CL, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-6; Lieber JG, 1996, J CELL SCI, V109, P3047; Mak KM, 2008, ALCOHOL CLIN EXP RES, V32, P683, DOI 10.1111/j.1530-0277.2008.00624.x; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; Rickelt S, 2009, INT J CANCER, V125, P2036, DOI 10.1002/ijc.24552; Robenek H, 2005, J BIOL CHEM, V280, P26330, DOI 10.1074/jbc.M413312200; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; SARRIA AJ, 1992, J BIOL CHEM, V267, P19455; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Sawle A, 2002, J LIPID RES, V43, P335; Scherer PE, 1998, NAT BIOTECHNOL, V16, P581, DOI 10.1038/nbt0698-581; Schmitt CJ, 2007, J INVEST DERMATOL, V127, P2191, DOI 10.1038/sj.jid.5700849; Schweitzer S C, 1998, Subcell Biochem, V31, P437; Smith CJ, 1999, TRENDS CELL BIOL, V9, P335, DOI 10.1016/S0962-8924(99)01631-1; Spandl J, 2011, J BIOL CHEM, V286, P5599, DOI 10.1074/jbc.M110.190785; Straub BK, 2010, MODERN PATHOL, V23, P480, DOI 10.1038/modpathol.2009.191; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; STRAUB BK, 2012, HISTOPATHOLOGY; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Tanaka S, 2012, INT J CLIN EXP PATHO, V5, P824; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Urahama Y, 2008, AM J PATHOL, V173, P1286, DOI 10.2353/ajpath.2008.080137; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Yao M, 2007, CLIN CANCER RES, V13, P152, DOI 10.1158/1078-0432.CCR-06-1877; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584	65	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63061	10.1371/journal.pone.0063061	http://dx.doi.org/10.1371/journal.pone.0063061			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704888	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200017
J	Kouse, AB; Righetti, F; Kortmann, J; Narberhaus, F; Murphy, ER				Kouse, Andrew B.; Righetti, Francesco; Kortmann, Jens; Narberhaus, Franz; Murphy, Erin R.			RNA-Mediated Thermoregulation of Iron-Acquisition Genes in Shigella dysenteriae and Pathogenic Escherichia coli	PLOS ONE			English	Article							HEME RECEPTOR; AEROBACTIN GENES; TRANSPORT-SYSTEM; BORDETELLA-AVIUM; EXPRESSION; VIRULENCE; IDENTIFICATION; GENETICS; FLEXNERI; PROTEIN	The initiation, progression and transmission of most bacterial infections is dependent upon the ability of the invading pathogen to acquire iron from each of the varied environments encountered during the course of a natural infection. In total, 95% of iron within the human body is complexed within heme, making heme a potentially rich source of host-associated nutrient iron for invading bacteria. As heme is encountered only within the host, pathogenic bacteria often regulate synthesis of heme utilization factors such that production is maximal under host-associated environmental conditions. This study examines the regulated production of ShuA, an outer-membrane receptor required for the utilization of heme as a source of nutrient iron by Shigella dysenteriae, a pathogenic bacterium that causes severe diarrheal diseases in humans. Specifically, the impact of the distinct environmental temperatures encountered during infection within a host (37 degrees C) and transmission between hosts (25 degrees C) on shuA expression is investigated. We show that shuA expression is subject to temperature-dependent post-transcriptional regulation resulting in increased ShuA production at 37 degrees C. The observed thermoregulation is mediated by nucleic acid sequences within the 59 untranslated region. In addition, we have identified similar nucleotide sequences within the 59 untranslated region of the orthologous chuA transcript of enteropathogenic E. coli and have demonstrated that it also functions to confer temperature-dependent post-transcriptional regulation. In both function and predicted structure, the regulatory element within the shuA and chuA 59 untranslated regions closely resembles a FourU RNA thermometer, a zipper-like RNA structure that occludes the Shine-Dalgarno sequence at low temperatures. Increased production of ShuA and ChuA in response to the host body temperature allows for maximal production of these heme acquisition factors within the environment where S. dysenteriae and pathogenic E. coli strains would encounter heme, a host-specific iron source.	[Kouse, Andrew B.] Ohio Univ, Dept Biol, Mol Cell Biol Program, Athens, OH 45701 USA; [Righetti, Francesco; Kortmann, Jens; Narberhaus, Franz] Ruhr Univ Bochum, Bochum, Germany; [Murphy, Erin R.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University; Ruhr University Bochum; University System of Ohio; Ohio University	Murphy, ER (corresponding author), Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.	murphy@oucom.ohiou.edu	Taylor, Graham/A-4027-2012	Narberhaus, Franz/0000-0002-8552-5310; Murphy, Erin/0000-0002-5716-4829; Righetti, Francesco/0000-0003-4903-2321	Ohio University Heritage College of Osteopathic Medicine; Department of Biomedical Sciences (ERM); German Research Foundation [SPP1258]	Ohio University Heritage College of Osteopathic Medicine; Department of Biomedical Sciences (ERM); German Research Foundation(German Research Foundation (DFG))	This work was supported by Ohio University Heritage College of Osteopathic Medicine and by the Department of Biomedical Sciences (ERM) and by the German Research Foundation (priority program SPP1258; FN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; Battisti JM, 2006, INFECT IMMUN, V74, P3251, DOI 10.1128/IAI.00245-06; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Burkhard KA, 2008, BIOCHEMISTRY-US, V47, P7977, DOI 10.1021/bi801005u; Burkhard KA, 2007, J BIOL CHEM, V282, P15126, DOI 10.1074/jbc.M611121200; CALIN A, 1979, WESTERN J MED, V131, P205; Chowdhury S, 2003, J BIOL CHEM, V278, P47915, DOI 10.1074/jbc.M306874200; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Headley V, 1997, INFECT IMMUN, V65, P818, DOI 10.1128/IAI.65.2.818-821.1997; HENDERSON DP, 1994, INFECT IMMUN, V62, P5120, DOI 10.1128/IAI.62.11.5120-5125.1994; Hoffmann H, 2001, INT J MED MICROBIOL, V291, P227, DOI 10.1078/1438-4221-00123; Jennison AV, 2004, FEMS MICROBIOL REV, V28, P43, DOI 10.1016/j.femsre.2003.07.002; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kirby AE, 2001, INFECT IMMUN, V69, P6951, DOI 10.1128/IAI.69.11.6951-6961.2001; Klinkert B, 2012, J BIOTECHNOL, V160, P55, DOI 10.1016/j.jbiotec.2012.01.007; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; LAWLOR KM, 1984, J BACTERIOL, V160, P266, DOI 10.1128/JB.160.1.266-272.1984; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mills M, 1997, INFECT IMMUN, V65, P5358, DOI 10.1128/IAI.65.12.5358-5363.1997; MILLS M, 1995, J BACTERIOL, V177, P3004, DOI 10.1128/jb.177.11.3004-3009.1995; Murphy ER, 2002, INFECT IMMUN, V70, P5390, DOI 10.1128/IAI.70.10.5390-5403.2002; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Narberhaus F, 2002, ARCH MICROBIOL, V178, P404, DOI 10.1007/s00203-002-0481-8; Niyogi SK, 2005, J MICROBIOL, V43, P133; Oh MH, 2009, INFECT IMMUN, V77, P1208, DOI 10.1128/IAI.01006-08; Okeke IN, 2004, J CLIN MICROBIOL, V42, P36, DOI 10.1128/JCM.42.1.36-44.2004; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Paulley JT, 2007, INFECT IMMUN, V75, P5248, DOI 10.1128/IAI.00460-07; Payne SM, 2006, BIOMETALS, V19, P173, DOI 10.1007/s10534-005-4577-x; PAYNE SM, 1980, J BACTERIOL, V143, P1420, DOI 10.1128/JB.143.3.1420-1424.1980; PAYNE SM, 1983, J BACTERIOL, V155, P949, DOI 10.1128/JB.155.3.949-955.1983; Rinnenthal J, 2011, NUCLEIC ACIDS RES, V39, P8258, DOI 10.1093/nar/gkr314; Rinnenthal J, 2010, NUCLEIC ACIDS RES, V38, P3834, DOI 10.1093/nar/gkq124; ROGERS HJ, 1973, INFECT IMMUN, V7, P445, DOI 10.1128/IAI.7.3.445-456.1973; Rossi MS, 2001, INFECT IMMUN, V69, P6707, DOI 10.1128/IAI.69.11.6707-6717.2001; Runyen-Janecky LJ, 2003, INFECT IMMUN, V71, P1919, DOI 10.1128/IAI.71.4.1919-1928.2003; SCHMITT MP, 1988, J BACTERIOL, V170, P5579, DOI 10.1128/jb.170.12.5579-5587.1988; SCHMITT MP, 1991, J BACTERIOL, V173, P816, DOI 10.1128/jb.173.2.816-825.1991; Seekircher S, 2012, PLOS PATHOG, V8, P1; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Smith AM, 2010, RNA BIOL, V7, P104, DOI 10.4161/rna.7.1.10757; STOEBNER JA, 1988, INFECT IMMUN, V56, P2891, DOI 10.1128/IAI.56.11.2891-2895.1988; Taylor CM, 2008, PEDIATR NEPHROL, V23, P1425, DOI 10.1007/s00467-008-0820-3; Torres AG, 1997, MOL MICROBIOL, V23, P825, DOI 10.1046/j.1365-2958.1997.2641628.x; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vokes SA, 1999, MOL MICROBIOL, V33, P63, DOI 10.1046/j.1365-2958.1999.01448.x; Waldminghaus T, 2005, BIOL CHEM, V386, P1279, DOI 10.1515/BC.2005.145; Waldminghaus T, 2007, MOL MICROBIOL, V65, P413, DOI 10.1111/j.1365-2958.2007.05794.x; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wyckoff EE, 1998, MOL MICROBIOL, V28, P1139, DOI 10.1046/j.1365-2958.1998.00873.x; Wyckoff EE, 2005, J BACTERIOL, V187, P5658, DOI 10.1128/JB.187.16.5658-5664.2005; Wyckoff E, 2009, BIOMETALS, V22, P43, DOI 10.1007/s10534-008-9188-x	59	51	51	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63781	10.1371/journal.pone.0063781	http://dx.doi.org/10.1371/journal.pone.0063781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704938	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200069
J	Mu, XX; Lin, S; Yang, JH; Chen, C; Chen, Y; Herzig, MC; Washburn, K; Halff, GA; Walter, CA; Sun, BC; Sun, LZ				Mu, Xiaoxin; Lin, Shu; Yang, Junhua; Chen, Chen; Chen, Yun; Herzig, Maryanne C.; Washburn, Kenneth; Halff, Glenn A.; Walter, Christi A.; Sun, Beicheng; Sun, Lu-Zhe			TGF-beta Signaling Is Often Attenuated during Hepatotumorigenesis, but Is Retained for the Malignancy of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PLASMA TRANSFORMING GROWTH-FACTOR-BETA-1; RECEPTOR-TYPE-II; TUMOR-SUPPRESSOR; EXPRESSION; LIVER; INHIBITOR; SURVIVAL; PROTEIN; SMAD4	The role of transforming growth factor-beta (TGF-beta) signaling in hepatocarcinogenesis remains controversial. We aimed to reveal TGF-beta signaling status in human and murine tissues of hepatocellular carcinoma (HCC) and the mechanisms that mediate TGF-beta's role in regulating HCC malignancy. Here, TGF-beta pathway component expression and activation in human and murine HCC tissues were measured with quantitative RT-PCR and Western blotting assays. The role of TGF-beta receptor and Smad signaling in the growth and survival of several HCC cell lines was determined with several in vitro and in vivo approaches. We found that TGF-beta receptor II (T beta RII) expression was downregulated in two different HCC patient cohorts. Consistently, Smad3 phosphorylation was also downregulated in HCC tissues in comparison to that in adjacent normal tissues. Interestingly, many HCC cell lines were sensitive to TGF-beta and growth-inhibited by exogenous TGF-beta. However, stable knockdown of T beta RII inhibited cell growth on plastic and in soft agar, and induced apoptosis resulting in suppressed subcutaneous tumor growth and metastatic potential in vivo. Furthermore, knockdown of Smad4 also led to a significant inhibition of growth on plastic and in soft agar with concomitant increase of apoptosis, PTEN expression, and reduced nuclear accumulation of linker region-phosphorylated Smad3. Taken together, TGF-beta signaling pathway plays a dichotomous role in hepatocellular carcinogenesis. It appears to suppress HCC development, but is retained for HCC cell survival and malignancy. Furthermore, Smad4 can mediate both growth inhibitory activity induced by exogenous TGF-beta and the survival activity induced by autocrine TGF-beta revealing a delicate selection of the two opposing activities of TGF-beta during HCC evolution.	[Mu, Xiaoxin; Chen, Chen; Chen, Yun; Sun, Beicheng] Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China; [Mu, Xiaoxin; Lin, Shu; Yang, Junhua; Herzig, Maryanne C.; Walter, Christi A.; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Washburn, Kenneth; Halff, Glenn A.] Univ Texas Hlth Sci Ctr San Antonio, Transplant Ctr, San Antonio, TX 78229 USA; [Walter, Christi A.; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Canc Ctr, San Antonio, TX 78229 USA; [Walter, Christi A.] Audie Murphy Hosp, South Texas Vet Hlth Care Syst, San Antonio, TX USA	Nanjing Medical University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Sun, BC (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China.	sunbc@njmu.edu.cn; sunl@uthscsa.edu	, LuZhe/AAW-4095-2021; Washburn, William/Q-5677-2016; Lin, Shu/C-3790-2013		NIH [R01CA75253, R01CA79683]; Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio (UTHSCSA) through the NCI Cancer Center Support Grant [2 P30 CA054174-17]; National Science Foundation for Distinguished Young Scholars of China Grant [81225017]; NATIONAL CANCER INSTITUTE [R01CA079683, P30CA054174, R01CA075253] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio (UTHSCSA) through the NCI Cancer Center Support Grant; National Science Foundation for Distinguished Young Scholars of China Grant(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH Grants R01CA75253 and R01CA79683, the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio (UTHSCSA) through the NCI Cancer Center Support Grant 2 P30 CA054174-17, and the National Science Foundation for Distinguished Young Scholars of China Grant No.81225017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDOSSA P, 1995, HEPATOLOGY, V21, P760, DOI 10.1016/0270-9139(95)90530-8; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; BISSELL DM, 1995, J CLIN INVEST, V96, P447, DOI 10.1172/JCI118055; Chen CG, 1997, J BIOL CHEM, V272, P12862, DOI 10.1074/jbc.272.19.12862; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; FRIDMAN R, 1990, P NATL ACAD SCI USA, V87, P6698, DOI 10.1073/pnas.87.17.6698; Furuta K, 1999, INT J CANCER, V81, P851, DOI 10.1002/(SICI)1097-0215(19990611)81:6<851::AID-IJC2>3.0.CO;2-D; Gourley C, 2005, INT J ONCOL, V26, P1681; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; INAGAKI M, 1993, P NATL ACAD SCI USA, V90, P5359, DOI 10.1073/pnas.90.11.5359; ITO N, 1995, CANCER LETT, V89, P45, DOI 10.1016/0304-3835(94)03651-X; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kawate S, 1999, INT J ONCOL, V14, P127; Kawate S, 2001, INT J MOL MED, V8, P49; Kiss A, 1997, CLIN CANCER RES, V3, P1059; Lei XF, 2002, ONCOGENE, V21, P7514, DOI 10.1038/sj.onc.1205966; Lei XF, 2007, EXP CELL RES, V313, P1687, DOI 10.1016/j.yexcr.2007.02.016; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Li DM, 1997, CANCER RES, V57, P2124; LI LM, 1989, JNCI-J NATL CANCER I, V81, P1406, DOI 10.1093/jnci/81.18.1406; Lin S, 2011, J BIOL CHEM, V286, P44023, DOI 10.1074/jbc.M111.265397; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuzaki K, 2000, CANCER RES, V60, P1394; Matsuzaki K, 2000, HEPATOLOGY, V32, P218, DOI 10.1053/jhep.2000.9145; Matsuzaki K, 2007, HEPATOLOGY, V46, P48, DOI 10.1002/hep.21672; Matsuzaki K, 2011, CARCINOGENESIS, V32, P1578, DOI 10.1093/carcin/bgr172; Mishra S, 2011, PROSTATE, V71, P1441, DOI 10.1002/pros.21361; Morris SM, 2012, HEPATOLOGY, V55, P121, DOI 10.1002/hep.24653; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Muraoka-Cook RS, 2006, ONCOGENE, V25, P3408, DOI 10.1038/sj.onc.1208964; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; SHIRAI Y, 1994, CANCER, V73, P2275, DOI 10.1002/1097-0142(19940501)73:9<2275::AID-CNCR2820730907>3.0.CO;2-T; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Singh J, 2003, BIOORG MED CHEM LETT, V13, P4355, DOI 10.1016/j.bmcl.2003.09.028; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yakicier MC, 1999, ONCOGENE, V18, P4879, DOI 10.1038/sj.onc.1202866; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhou ZQ, 2001, P NATL ACAD SCI USA, V98, P12566, DOI 10.1073/pnas.221232998	43	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63436	10.1371/journal.pone.0063436	http://dx.doi.org/10.1371/journal.pone.0063436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704908	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200038
J	Namouchi, A; Karboul, A; Fabre, M; Gutierrez, MC; Mardassi, H				Namouchi, Amine; Karboul, Anis; Fabre, Michel; Gutierrez, Maria Cristina; Mardassi, Helmi			Evolution of Smooth Tubercle Bacilli PE and PE_PGRS Genes: Evidence for a Prominent Role of Recombination and Imprint of Positive Selection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS COMPLEX; PHYLOGENETIC ANALYSIS; DNA-SEQUENCES; NUCLEOTIDE SUBSTITUTION; DETECTING RECOMBINATION; ADAPTIVE EVOLUTION; GENOMIC ANALYSIS; IMMUNE-RESPONSE; PE-PGRS33 GENE; PROTEINS	Background: PE and PE_PGRS are two mycobateria-restricted multigene families encoding membrane associated and secreted proteins that have expanded mainly in the pathogenic species, notably the Mycobacterium tuberculosis complex (MTBC). Several lines of evidence attribute to PE and PE_PGRS genes critical roles in mycobacterial pathogenicity. To get more insight into the nature of these genes, we sought to address their evolutionary trajectories in the group of smooth tubercle bacilli (STB), the putative ancestor of the clonal MTBC. Methodology/Principal Findings: By focussing on six polymorphic STB PE/PE_PGRS genes, we demonstrate significant incongruence among single gene genealogies and detect strong signals of recombination using various approaches. Coalescent-based estimation of population recombination and mutation rates (rho and theta, respectively) indicates that the two mechanisms are of roughly equal importance in generating diversity (rho/theta = 1.457), a finding in a marked contrast to house keeping genes (HKG) whose evolution is chiefly brought about by mutation (rho/theta = 0.012). In comparison to HKG, we found 15 times higher mean rate of nonsynonymous substitutions, with strong evidence of positive selection acting on PE_PGRS62 (dN/dS = 1.42), a gene that has previously been shown to be essential for mycobacterial survival in macrophages and granulomas. Imprint of positive selection operating on specific amino acid residues or along branches of PE_PGRS62 phylogenetic tree was further demonstrated using maximum likelihood- and covarion-based approaches, respectively. Strikingly, PE_PGR62 proved highly conserved in present-day MTBC strains. Conclusions/Significance: Overall the data indicate that, in STB, PE/PE_PGRS genes have undergone a strong diversification process that is speeded up by recombination, with evidence of positive selection. The finding that positive selection involved an essential PE_PGRS gene whose sequence appears to be driven to fixation in present-day MTBC strains lends further support to the critical role of PE/PE_PGRS genes in the evolution of mycobacterial pathogenicity.	[Namouchi, Amine; Karboul, Anis; Mardassi, Helmi] Inst Pasteur Tunis, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Unit Typing & Genet Mycobacteria, Tunis, Tunisia; [Fabre, Michel] HIA Percy, Lab Biol Clin, Clamart, France; [Gutierrez, Maria Cristina] Inst Pasteur, Dept Infect & Epidemiol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Mardassi, H (corresponding author), Inst Pasteur Tunis, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Unit Typing & Genet Mycobacteria, Tunis, Tunisia.	helmi.merdassi@pasteur.rns.tn	Gutierrez, Cristina/B-5597-2012	Gutierrez, Cristina/0000-0002-5567-5908	Tunisian Ministry of Higher Education and Scientific Research	Tunisian Ministry of Higher Education and Scientific Research	This work has received funding from the Tunisian Ministry of Higher Education and Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brisse S, 2006, PLOS PATHOG, V2, P812, DOI 10.1371/journal.ppat.0020095; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Campuzano J, 2007, VACCINE, V25, P3722, DOI 10.1016/j.vaccine.2006.12.042; CANETTI G, 1970, LILLE MED, V15, P280; Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251; Chen TA, 2010, MICROB PATHOGENESIS, V49, P311, DOI 10.1016/j.micpath.2010.07.004; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dong DD, 2012, INFECT IMMUN, V80, P43, DOI 10.1128/IAI.05249-11; Fabre M, 2004, J CLIN MICROBIOL, V42, P3248, DOI 10.1128/JCM.42.7.3248-3255.2004; Fabre M, 2010, INFECT GENET EVOL, V10, P1165, DOI 10.1016/j.meegid.2010.07.016; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gordon SV, 2001, TUBERCULOSIS, V81, P157, DOI 10.1054/tube.2000.0269; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hebert AM, 2007, INFECT IMMUN, V75, P5798, DOI 10.1128/IAI.00335-07; Huang Y, 2012, VET MICROBIOL, V160, P117, DOI 10.1016/j.vetmic.2012.05.011; HUDSON RR, 1985, GENETICS, V111, P147; Hughes AL, 2002, EMERG INFECT DIS, V8, P1342, DOI 10.3201/eid0811.020064; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Jha SS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-100; Karboul A, 2008, J BACTERIOL, V190, P7838, DOI 10.1128/JB.00827-08; Karboul A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-107; Koeck JL, 2011, CLIN MICROBIOL INFEC, V17, P1013, DOI 10.1111/j.1469-0691.2010.03347.x; Koh KW, 2009, INFECT IMMUN, V77, P3337, DOI 10.1128/IAI.01175-08; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Liberles DA, 2001, MOL BIOL EVOL, V18, P2040, DOI 10.1093/oxfordjournals.molbev.a003745; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Machowski EE, 2007, J BACTERIOL, V189, P2190, DOI 10.1128/JB.01647-06; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Mardassi H, 2005, EMERG INFECT DIS, V11, P957; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; McEvoy CRE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-237; McVean G, 2002, GENETICS, V160, P1231; Mehta PK, 2006, MICROB PATHOGENESIS, V40, P139, DOI 10.1016/j.micpath.2005.12.002; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Reed FA, 2006, GENETICS, V172, P2011, DOI 10.1534/genetics.105.052183; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Siltberg J, 2002, J EVOLUTION BIOL, V15, P588, DOI 10.1046/j.1420-9101.2002.00416.x; Singh KK, 2001, INFECT IMMUN, V69, P4185, DOI 10.1128/IAI.69.6.4185-4191.2001; Singh PP, 2008, MICROBIOL-SGM, V154, P3469, DOI 10.1099/mic.0.2008/019968-0; SMITH JM, 1992, J MOL EVOL, V34, P126; Smith NH, 2006, PLOS PATHOG, V2, P809, DOI 10.1371/journal.ppat.0020098; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Talarico S, 2005, J CLIN MICROBIOL, V43, P4954, DOI 10.1128/JCM.43.10.4954-4960.2005; Talarico S, 2008, TUBERCULOSIS, V88, P283, DOI 10.1016/j.tube.2008.01.001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; vanSoolingen D, 1997, INT J SYST BACTERIOL, V47, P1236, DOI 10.1099/00207713-47-4-1236; Wang J, 2011, TUBERCULOSIS, V91, P287, DOI 10.1016/j.tube.2011.05.001; WHO, 2011, GLOB TURB CONTR 2010; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	90	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64718	10.1371/journal.pone.0064718	http://dx.doi.org/10.1371/journal.pone.0064718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705005	Green Published, gold			2022-12-27	WOS:000319330200159
J	Zhang, M; Feng, Y; Wang, J; Zhao, JW; Li, T; He, M; Yang, DH; Nosjean, O; Boutin, J; Renard, P; Wang, MW				Zhang, Meng; Feng, Yang; Wang, Jia; Zhao, Jianwei; Li, Ting; He, Min; Yang, Dehua; Nosjean, Olivier; Boutin, Jean; Renard, Pierre; Wang, Ming-Wei			High-Throughput Screening for GPR119 Modulators Identifies a Novel Compound with Anti-Diabetic Efficacy in db/db Mice	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; GLYCEMIC CONTROL; RECEPTOR; AGONISTS; G-PROTEIN-COUPLED-RECEPTOR-119; PATHOGENESIS; SECRETION; DISCOVERY; RELEASE; NIDDM	G protein-coupled receptor 119 (GPR119) is highly expressed in pancreatic beta cells and enteroendocrine cells. It is involved in glucose-stimulated insulin secretion and glucagon-like peptide-1 (GLP-1) release, thereby representing a promising target for the treatment of type 2 diabetes. Although a number of GPR119 agonists were developed, no positive allosteric modulator (PAM) to this receptor has been reported. Here we describe a high-throughput assay for screening GPR119 PAMs and agonists simultaneously. Following screening of a small molecule compound library containing 312,000 synthetic and natural product-derived samples, one potent GPR119 agonist with novel chemical structure, MW1219, was identified. Exposure of MIN6 and GLUTag cells to MW1219 enhanced glucose-stimulated insulin secretion and GLP-1 release; once-daily oral dosing of MW1219 for 6 weeks in diabetic db/db mice reduced hemoglobin A1c (HbA1c) and improved plasma glucose, insulin and GLP-1 levels; it also increased glucose tolerance. The results demonstrate that MW1219 is capable of effectively controlling blood glucose level and may have the potential to be developed as a new class of anti-diabetic agents.	[Zhang, Meng; Feng, Yang; Li, Ting; Yang, Dehua; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Wang, Jia; Zhao, Jianwei; He, Min; Wang, Ming-Wei] Chinese Natl Cpd Lib, Shanghai, Peoples R China; [Nosjean, Olivier; Boutin, Jean; Renard, Pierre] Les Labs Servier, Neuilly Sur Seine, France	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Servier	Wang, MW (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	wangmw@mail.shcnc.ac.cn	Boutin, Jean Albert/W-9103-2019; Yang, Dehua/S-6156-2017; Yang, Dehua/M-5789-2019	Boutin, Jean Albert/0000-0003-0068-7204; 	Ministry of Health of China [2012ZX09304011, 2013ZX09507002]; Shanghai Science and Technology Development Fund [11DZ2292200]; Les Laboratories Servier (France)	Ministry of Health of China; Shanghai Science and Technology Development Fund; Les Laboratories Servier (France)	This work was supported in part by grants from the Ministry of Health of China (2012ZX09304011 and 2013ZX09507002), Shanghai Science and Technology Development Fund (11DZ2292200) and Les Laboratories Servier (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brubaker PL, 1998, ENDOCRINOLOGY, V139, P4108, DOI 10.1210/en.139.10.4108; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; Chu ZL, 2010, MOL ENDOCRINOL, V24, P161, DOI 10.1210/me.2009-0239; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Jones RM, 2009, EXPERT OPIN THER PAT, V19, P1339, DOI 10.1517/13543770903153878; Lan H, 2012, BRIT J PHARMACOL, V165, P2799, DOI 10.1111/j.1476-5381.2011.01754.x; Lauffer L, 2008, ENDOCRINOLOGY, V149, P2035, DOI 10.1210/en.2008-0182; May LT, 2004, CURR PHARM DESIGN, V10, P2003, DOI 10.2174/1381612043384303; Meier Juris J, 2004, Curr Opin Investig Drugs, V5, P402; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Sakamoto Y, 2006, BIOCHEM BIOPH RES CO, V351, P474, DOI 10.1016/j.bbrc.2006.10.076; Semple G, 2008, J MED CHEM, V51, P5172, DOI 10.1021/jm8006867; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; TAYLOR SI, 1994, DIABETES, V43, P735, DOI 10.2337/diab.43.6.735; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Williams C, 2004, NAT REV DRUG DISCOV, V3, P125, DOI 10.1038/nrd1306; Yoshida S, 2010, BIOCHEM BIOPH RES CO, V400, P745, DOI 10.1016/j.bbrc.2010.08.141; Young AA, 1996, METABOLISM, V45, P1, DOI 10.1016/S0026-0495(96)90192-4; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	23	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63861	10.1371/journal.pone.0063861	http://dx.doi.org/10.1371/journal.pone.0063861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704946	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200077
J	Hoffecker, BM; Raffield, LM; Kamen, DL; Nowling, TK				Hoffecker, Brett M.; Raffield, Laura M.; Kamen, Diane L.; Nowling, Tamara K.			Systemic Lupus Erythematosus and Vitamin D Deficiency Are Associated with Shorter Telomere Length among African Americans: A Case-Control Study	PLOS ONE			English	Article							REVISED CRITERIA; DISEASE-ACTIVITY; CELLS; CLASSIFICATION; PREVALENCE; ANTIBODIES; MORTALITY; INNATE; DAMAGE; INDEX	Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that disproportionately affects African American females. The causes of SLE are unknown but postulated to be a combination of genetic predisposition and environmental triggers. Vitamin D deficiency is one of the possible environmental triggers. In this study we evaluated relationships between vitamin D status, cellular aging (telomere length) and anti-telomere antibodies among African American Gullah women with SLE. The study population included African American female SLE patients and unaffected controls from the Sea Island region of South Carolina. Serum 25-hydroxyvitamin D levels were measured using a nonchromatographic radioimmunoassay. Telomere length was measured in genomic DNA of peripheral blood mononuclear cells (PBMCs) by monochrome multiplex quantitative PCR. Anti-telomere antibody levels were measured by enzyme-linked immunosorbent assay (ELISA). Patients with SLE had significantly shorter telomeres and higher anti-telomere antibody titers compared to age-and gender-matched unaffected controls. There was a positive correlation between anti-telomere antibody levels and disease activity among patients and a significant correlation of shorter telomeres with lower 25-hydroxyvitamin D levels in both patients and controls. In follow-up examination of a subset of the patients, the patients who remained vitamin D deficient tended to have shorter telomeres than those patients whose 25-hydroxyvitamin D levels were repleted. Increasing 25-hydroxyvitamin D levels in African American patients with SLE may be beneficial in maintaining telomere length and preventing cellular aging. Moreover, anti-telomere antibody levels may be a promising biomarker of SLE status and disease activity.	[Hoffecker, Brett M.; Raffield, Laura M.; Kamen, Diane L.; Nowling, Tamara K.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Nowling, Tamara K.] Ralph H Johnson Vet Affairs Med Ctr, Med Res Serv, Charleston, SC USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Kamen, DL (corresponding author), Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA.	kamend@musc.edu; nowling@musc.edu		Raffield, Laura/0000-0002-7892-193X	Medical Research Service, Veterans Affairs Medical Center [BX000115]; National Institutes of Health (NIH) [AR053376, K23 AR052364]; South Carolina Clinical & Translational Research (SCTR) Institute; Medical University of South Carolina, (NIH/NCRR) [UL1 RR029882]; NIAMS [P60 AR062755]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR052364, R03AR053376, P60AR062755] Funding Source: NIH RePORTER	Medical Research Service, Veterans Affairs Medical Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Clinical & Translational Research (SCTR) Institute; Medical University of South Carolina, (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by VA Merit Review grant BX000115 from the Medical Research Service, Veterans Affairs Medical Center and National Institutes of Health (NIH) grant AR053376 awarded to TKN, NIH grant K23 AR052364 awarded to DLK and by the South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina, (NIH/NCRR UL1 RR029882), and NIAMS grant P60 AR062755 (DLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Al Mheid I, 2011, J AM COLL CARDIOL, V58, P186, DOI 10.1016/j.jacc.2011.02.051; ALARCON GS, 1983, ARTHRITIS RHEUM, V26, P238, DOI 10.1002/art.1780260226; Alvarez-Rodriguez L, 2012, J LEUKOCYTE BIOL, V91, P829, DOI 10.1189/jlb.1011523; Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755; Beier F, 2007, LUPUS, V16, P955, DOI 10.1177/0961203307084299; Ben-Zvi I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009193; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Calvo-Alen J, 1995, J Clin Rheumatol, V1, P260, DOI 10.1097/00124743-199510000-00002; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chebel A, 2009, AGING CELL, V8, P52, DOI 10.1111/j.1474-9726.2008.00448.x; Gilkeson GS, 2011, LUPUS, V20, P1095, DOI 10.1177/0961203311404915; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Goronzy JJ, 2006, EXP GERONTOL, V41, P246, DOI 10.1016/j.exger.2005.12.002; Hathcock KS, 2005, IMMUNOL REV, V205, P104, DOI 10.1111/j.0105-2896.2005.00267.x; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hollis BW, 2000, CLIN CHEM, V46, P1657; Honda M, 2001, CLIN IMMUNOL, V99, P211, DOI 10.1006/clim.2001.5023; Kamen DL, 2008, ARTHRITIS RHEUM, V58, P1237, DOI 10.1002/art.23416; Kamen DL, 2010, J MOL MED, V88, P441, DOI 10.1007/s00109-010-0590-9; Kamen Diane L, 2008, Curr Rheumatol Rep, V10, P273, DOI 10.1007/s11926-008-0044-3; Kaszubowska L, 2008, J PHYSIOL PHARMACOL, V59, P169; Kurosaka D, 2003, LUPUS, V12, P591, DOI 10.1191/0961203303lu426oa; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Ouyang Q, 2007, ANN NY ACAD SCI, V1106, P240, DOI 10.1196/annals.1392.001; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richards JB, 2007, AM J CLIN NUTR, V86, P1420, DOI 10.1093/ajcn/86.5.1420; Ritterhouse LL, 2011, ANN RHEUM DIS, V70, P1569, DOI 10.1136/ard.2010.148494; Salonen EM, 2004, ANN RHEUM DIS, V63, P1250, DOI 10.1136/ard.2003.011890; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tew MB, 2001, ARTHRITIS RHEUM, V44, P981, DOI 10.1002/1529-0131(200104)44:4<981::AID-ANR158>3.3.CO;2-S; Vila LM, 2004, RHEUMATOLOGY, V43, P358, DOI 10.1093/rheumatology/keh048; Wallace DJ, 2000, LUPUS, V9, P328, DOI 10.1191/096120300678828343; Wu CH, 2007, LUPUS, V16, P265, DOI 10.1177/0961203307077155; Zhao GX, 2012, J HYPERTENS, V30, P284, DOI 10.1097/HJH.0b013e32834e1f0a; Zittermann A, 2012, AM J CLIN NUTR, V95, P91, DOI 10.3945/ajcn.111.014779	41	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63725	10.1371/journal.pone.0063725	http://dx.doi.org/10.1371/journal.pone.0063725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700431	gold, Green Published, Green Submitted			2022-12-27	WOS:000319966400028
J	Mikkola, TS; Gissler, M; Merikukka, M; Tuomikoski, P; Ylikorkala, O				Mikkola, Tomi S.; Gissler, Mika; Merikukka, Marko; Tuomikoski, Pauliina; Ylikorkala, Olavi			Sex Differences in Age-Related Cardiovascular Mortality	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; METABOLIC SYNDROME; NATURAL MENOPAUSE; RISK-FACTORS; FINLAND; TRENDS; VALIDITY; HORMONES; COHORT; DEATH	Introduction: Sex-related physiological differences result in different expressions of diseases for men and women. Data are contradicting regarding the increase in the female risk for cardiovascular disease (CVD) at mid-life. Thus, we studied possible sex differences in age-adjusted mortality for CVD and non-vascular diseases stratifying our findings by specific age groups. Methods: Over one million deaths (1 080 910) reported to the Finnish nationwide Causes of Death Register in 1986-2009 were analyzed. A total of 247 942 male deaths and 278 752 female deaths were of CVD origin, the remaining deaths were non-vascular. The annual mortality rates were calculated per 100 000 mid-year population, separately for men and women in 5-year age categories. Results: The age-standardized risk of death from CVD was 80% higher for men (442/100 000) than for women (246/100 000). After age 45-54 the male CVD mortality rate elevated parallel to the non-vascular mortality, whereas in women the CVD mortality elevated considerably more rapidly than the non-vascular mortality from age 60 years onwards. Conclusions: Heart disease mortality in men accelerates at a relatively young age, but in women the risk shows a steep increase at approximately 60 years of age. These data emphasize the need to identify and prevent risk factors for CVD, especially in women in their mid-life years.	[Mikkola, Tomi S.; Tuomikoski, Pauliina; Ylikorkala, Olavi] Helsinki Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Mikkola, Tomi S.] Folkhalsan Res Ctr, Helsinki, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Merikukka, Marko] Natl Inst Hlth & Welf, Oulu, Finland	University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Mikkola, TS (corresponding author), Helsinki Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland.	tomi.mikkola@hus.fi		Gissler, Mika/0000-0001-8254-7525; Mikkola, Tomi/0000-0003-2049-088X	Paivikki and Sakari Sohlberg Foundation; Emil Aaltonen Foundation; Finnish Medical Foundation; Finska Lakaresallskapet; Orion-Farmos Research Foundation; Paavo Nurmi Foundation; special governmental grant for health sciences research; Medical Research Council [MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1] Funding Source: UKRI	Paivikki and Sakari Sohlberg Foundation; Emil Aaltonen Foundation; Finnish Medical Foundation; Finska Lakaresallskapet; Orion-Farmos Research Foundation; Paavo Nurmi Foundation; special governmental grant for health sciences research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by unrestricted grants from the Paivikki and Sakari Sohlberg Foundation, the Emil Aaltonen Foundation, the Finnish Medical Foundation, Finska Lakaresallskapet, the Orion-Farmos Research Foundation, the Paavo Nurmi Foundation, and a special governmental grant for health sciences research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Charchar FJ, 2003, TRENDS ENDOCRIN MET, V14, P163, DOI 10.1016/S1043-2760(03)00032-8; Hu FB, 1999, ARCH INTERN MED, V159, P1061, DOI 10.1001/archinte.159.10.1061; Joakimsen O, 2000, J CLIN EPIDEMIOL, V53, P525, DOI 10.1016/S0895-4356(99)00197-3; KALIN MF, 1990, STEROIDS, V55, P330, DOI 10.1016/0039-128X(90)90058-J; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; Lahti RA, 1998, FORENSIC SCI INT, V91, P109, DOI 10.1016/S0379-0738(97)00180-1; Lehto Hanna-Riikka, 2007, BMC Cardiovasc Disord, V7, P35, DOI 10.1186/1471-2261-7-35; Lin JW, 2010, J CLIN ENDOCR METAB, V95, P4258, DOI 10.1210/jc.2010-0332; McCarthy JJ, 2007, NUTR METAB CARDIOVAS, V17, P153, DOI 10.1016/j.numecd.2006.01.005; Mondul AM, 2005, AM J EPIDEMIOL, V162, P1089, DOI 10.1093/aje/kwi324; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Rapola JM, 1997, EUR J EPIDEMIOL, V13, P133, DOI 10.1023/A:1007380408729; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; The Editorial Committee for Health Statistics in the Nordic Countries, HLTH STAT NORD COUNT; Tom SE, 2012, J WOMENS HEALTH, V21, P10, DOI 10.1089/jwh.2011.2745; Towfighi A, 2009, ARCH INTERN MED, V169, P1762, DOI 10.1001/archinternmed.2009.318; Tunstall-Pedoe H, 1998, LANCET, V351, P1425, DOI 10.1016/S0140-6736(97)11321-6; Vaartjes I, 2011, HEART, V97, P569, DOI 10.1136/hrt.2010.206565; Vaidya D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5170; vanderSchouw YT, 1996, LANCET, V347, P714, DOI 10.1016/S0140-6736(96)90075-6; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Witteman JC, 1988, LANCET, V352, P407	28	85	86	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63347	10.1371/journal.pone.0063347	http://dx.doi.org/10.1371/journal.pone.0063347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700418	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400016
J	Tseng, YT; Chang, CH; Wang, SM; Huang, KJ; Wang, CT				Tseng, Ying-Tzu; Chang, Chia-Hui; Wang, Shiu-Mei; Huang, Kuo-Jung; Wang, Chin-Tien			Identifying SARS-CoV Membrane Protein Amino Acid Residues Linked to Virus-Like Particle Assembly	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; CARBOXY-TERMINAL DOMAIN; MOUSE HEPATITIS-VIRUS; NUCLEOCAPSID PROTEIN; MOLECULAR-BIOLOGY; GOLGI-COMPLEX; AVIAN CORONAVIRUS; ENVELOPE PROTEIN; PI-STACKING; SURFACE	Severe acute respiratory syndrome coronavirus (SARS-CoV) membrane (M) proteins are capable of self-assembly and release in the form of membrane-enveloped vesicles, and of forming virus-like particles (VLPs) when coexpressed with SARS-CoV nucleocapsid (N) protein. According to previous deletion analyses, M self-assembly involves multiple M sequence regions. To identify important M amino acid residues for VLP assembly, we coexpressed N with multiple M mutants containing substitution mutations at the amino-terminal ectodomain, carboxyl-terminal endodomain, or transmembrane segments. Our results indicate that a dileucine motif in the endodomain tail (218LL219) is required for efficient N packaging into VLPs. Results from cross-linking VLP analyses suggest that the cysteine residues 63, 85 and 158 are not in close proximity to the M dimer interface. We noted a significant reduction in M secretion due to serine replacement for C158, but not for C63 or C85. Further analysis suggests that C158 is involved in M-N interaction. In addition to mutations of the highly conserved 107-SWWSFNPE-114 motif, substitutions at codons W19, W57, P58, W91, Y94 or F95 all resulted in significantly reduced VLP yields, largely due to defective M secretion. VLP production was not significantly affected by a tryptophan replacement of Y94 or F95 or a phenylalanine replacement of W19, W57 or W91. Combined, these results indicate the involvement of specific M amino acids during SARS-CoV virus assembly, and suggest that aromatic residue retention at specific positions is critical for M function in terms of directing virus assembly.	[Tseng, Ying-Tzu; Huang, Kuo-Jung; Wang, Chin-Tien] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chang, Chia-Hui] Natl Yang Ming Univ, Inst Publ Hlth, Sch Med, Taipei 112, Taiwan; [Wang, Shiu-Mei; Wang, Chin-Tien] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wang, CT (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan.	chintien@ym.edu.tw			Taipei Veterans General Hospital [V98C1-021, V99C1-013]; National Science Council, Taiwan [NSC 97-2320-B-010-002-MY3, 100-2320-B-010-015-MY3]; Ministry of Education, Aim for the Top University Plan	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was supported by Grants V98C1-021 and V99C1-013 from Taipei Veterans General Hospital, by Grant NSC 97-2320-B-010-002-MY3 and 100-2320-B-010-015-MY3 from the National Science Council, Taiwan, and by a grant from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai BK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002685; Baudoux P, 1998, J VIROL, V72, P8636, DOI 10.1128/JVI.72.11.8636-8643.1998; Bos ECW, 1996, VIROLOGY, V218, P52, DOI 10.1006/viro.1996.0165; Chang YF, 2007, J MOL BIOL, V370, P585, DOI 10.1016/j.jmb.2007.05.020; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; de Haan CAM, 1998, J VIROL, V72, P6838, DOI 10.1128/JVI.72.8.6838-6850.1998; de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7; de Haan CAM, 1998, ADV EXP MED BIOL, V440, P367; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Escors D, 2001, J VIROL, V75, P1312, DOI 10.1128/JVI.75.3.1312-1324.2001; Fang XN, 2005, J BIOCHEM MOL BIOL, V38, P381; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Godeke GJ, 2000, J VIROL, V74, P1566, DOI 10.1128/JVI.74.3.1566-1571.2000; Hatakeyama S, 2008, VIROLOGY, V380, P99, DOI 10.1016/j.virol.2008.07.012; Ho Y, 2004, BIOCHEM BIOPH RES CO, V318, P833, DOI 10.1016/j.bbrc.2004.04.111; Hsieh PK, 2005, J VIROL, V79, P13848, DOI 10.1128/JVI.79.22.13848-13855.2005; Hu Yongwu, 2003, Genomics Proteomics & Bioinformatics, V1, P118; Huang Y, 2004, J VIROL, V78, P12557, DOI 10.1128/JVI.78.22.12557-12565.2004; Hurst KR, 2005, J VIROL, V79, P13285, DOI 10.1128/JVI.79.21.13285-13297.2005; JACOBSEGEELS HEL, 1983, J GEN VIROL, V64, P1859, DOI 10.1099/0022-1317-64-9-1859; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; King AMQ., 2012, VIRUS TAXONOMY, P806, DOI 10.1016/ B978-0-12-384684-6.00068-9; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; KLUMPERMAN J, 1994, J VIROL, V68, P6523, DOI 10.1128/JVI.68.10.6523-6534.1994; KRIJNSELOCKER J, 1994, J CELL BIOL, V124, P55, DOI 10.1083/jcb.124.1.55; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuo L, 2002, J VIROL, V76, P4987, DOI 10.1128/JVI.76.10.4987-4999.2002; Lai M M, 1987, Adv Exp Med Biol, V218, P7; LAVIADA MD, 1990, VIRUS RES, V16, P247, DOI 10.1016/0168-1702(90)90051-C; Lim KP, 2001, J BIOL CHEM, V276, P17515, DOI 10.1074/jbc.M009731200; Luo HB, 2006, INT J BIOCHEM CELL B, V38, P589, DOI 10.1016/j.biocel.2005.10.022; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; MACHAMER CE, 1990, P NATL ACAD SCI USA, V87, P6944, DOI 10.1073/pnas.87.18.6944; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; McDermott J, 1996, J VIROL, V70, P5106, DOI 10.1128/JVI.70.8.5106-5114.1996; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Mortola E, 2004, FEBS LETT, V576, P174, DOI 10.1016/j.febslet.2004.09.009; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0; Narayanan K, 2000, J VIROL, V74, P8127, DOI 10.1128/JVI.74.17.8127-8134.2000; Neuman BW, 2011, J STRUCT BIOL, V174, P11, DOI 10.1016/j.jsb.2010.11.021; OPSTELTEN DJE, 1995, J CELL BIOL, V131, P339, DOI 10.1083/jcb.131.2.339; Risco C, 1996, J VIROL, V70, P4773, DOI 10.1128/JVI.70.7.4773-4777.1996; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; Sambrook J., 2001, MOL CLONING LAB MANU; Satija N, 2007, ANN NY ACAD SCI, V1102, P26, DOI 10.1196/annals.1408.002; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; STURMAN LS, 1980, J VIROL, V33, P449, DOI 10.1128/JVI.33.1.449-462.1980; Sun S, 1996, J PHYS CHEM-US, V100, P13348, DOI 10.1021/jp960739o; Surjit M, 2004, BIOCHEM BIOPH RES CO, V317, P1030, DOI 10.1016/j.bbrc.2004.03.154; TO LT, 1991, VET MICROBIOL, V29, P361, DOI 10.1016/0378-1135(91)90143-4; TOOZE J, 1984, EUR J CELL BIOL, V33, P281; TOOZE J, 1985, EUR J CELL BIOL, V37, P203; Tseng YT, 2010, J BIOL CHEM, V285, P12862, DOI 10.1074/jbc.M109.030270; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Voss D, 2006, FEBS LETT, V580, P968, DOI 10.1016/j.febslet.2006.01.026; Voss D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-79; Wang SM, 2008, J BIOMED SCI, V15, P719, DOI 10.1007/s11373-008-9265-8; World Health Organization, 2004, WORLD HLTH REP 2004; Yu IM, 2005, J BIOL CHEM, V280, P23280, DOI 10.1074/jbc.M501015200; Ziebuhr J, 2004, CURR OPIN MICROBIOL, V7, P412, DOI 10.1016/j.mib.2004.06.007	62	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64013	10.1371/journal.pone.0064013	http://dx.doi.org/10.1371/journal.pone.0064013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700447	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400040
J	Duhoux, A; Delye, C				Duhoux, Arnaud; Delye, Christophe			Reference Genes to Study Herbicide Stress Response in Lolium sp.: Up-Regulation of P450 Genes in Plants Resistant to Acetolactate-Synthase Inhibitors	PLOS ONE			English	Article							SITE-BASED RESISTANCE; QUANTITATIVE RT-PCR; HOUSEKEEPING GENES; ACETYL-COENZYME; EXPRESSION; VALIDATION; GENOME; CARBOXYLASE; GUIDELINES	Variation in the expression of numerous genes is at the basis of plant response to environmental stresses. Non-target-site-based resistance to herbicides (NTSR), the major threat to grass weed chemical control, is governed by a subset of the genes involved in herbicide stress response. Quantitative PCR assays allowing reliable comparison of gene expression are thus key to identify genes governing NTSR. This work aimed at identifying a set of reference genes with a stable expression to be used as an internal standard for the normalisation of quantitative PCR data in studies investigating NTSR to herbicides inhibiting acetolactate synthase (ALS) in the major grass weed Lolium sp. Gene expression stability was assessed in plants resistant or sensitive to two ALS inhibitors, subjected or not to herbicide stress. Using three complementary approaches implemented in the programs BestKeeper, NormFinder and geNorm, cap-binding protein, glyceraldehyde-3-phosphate-dehydrogenase and ubiquitin were identified as the most suitable reference genes. This reference gene set can probably be used to study herbicide response in other weed species. It was used to compare the expression of the genes encoding two herbicide target enzymes (ALS and acetyl-coenzyme A carboxylase) and five cytochromes P450 (CYP) with potential herbicide-degrading activity between plants resistant or sensitive to ALS inhibitors. Overall, herbicide application enhanced CYP gene expression. Constitutive up-regulation of all CYP genes observed in resistant plants compared to sensitive plants suggested enhanced secondary metabolism in the resistant plants. Comprehensive transcriptome studies associated to gene expression analyses using the reference gene set validated here are required to unravel NTSR genetic determinants.	[Duhoux, Arnaud; Delye, Christophe] INRA, Agroecol UMR1347, F-21034 Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Delye, C (corresponding author), INRA, Agroecol UMR1347, F-21034 Dijon, France.	delye@dijon.inra.fr			Arvalis - Institut du Vegetal	Arvalis - Institut du Vegetal	This work was supported by funding from Arvalis - Institut du Vegetal (http://www.arvalisinstitutduvegetal.fr) to AD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Busi R, 2011, HEREDITY, V106, P817, DOI 10.1038/hdy.2010.124; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cummins I, 2009, PLANT BIOTECHNOL J, V7, P807, DOI 10.1111/j.1467-7652.2009.00445.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Delye C, 2005, WEED SCI, V53, P728, DOI 10.1614/WS-04-203R.1; Delye C, 2009, WEED RES, V49, P326, DOI 10.1111/j.1365-3180.2009.00700.x; Delye C, 2013, PEST MANAG SCI, V69, P176, DOI 10.1002/ps.3318; Dombrowski JE, 2009, PLANT SCI, V176, P390, DOI 10.1016/j.plantsci.2008.12.005; Glombitza S, 2004, PLANT MOL BIOL, V54, P817, DOI 10.1007/s11103-004-0274-3; Heap I., 2013, INT SURVEY HERBICIDE; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Inui H, 2001, PESTIC BIOCHEM PHYS, V71, P156, DOI 10.1006/pest.2001.2574; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Lei Z, 2007, MOL BREEDING, V68, P19; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Ovesna J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041886; Petit Cecile, 2012, BMC Res Notes, V5, P18, DOI 10.1186/1756-0500-5-18; Petit C, 2010, PLANT SCI, V178, P501, DOI 10.1016/j.plantsci.2010.03.007; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeifer M, 2013, PLANT PHYSIOL, V161, P571, DOI 10.1104/pp.112.207282; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; SNUSTAD DP, 1992, PLANT CELL, V4, P549, DOI 10.1105/tpc.4.5.549; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tranel PJ, 2002, WEED SCI, V50, P700, DOI 10.1614/0043-1745(2002)050[0700:RROWTA]2.0.CO;2; Tsujii H, 2004, INT S CYT P450 BIOD, P69; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Werck-Reichhart D, 2000, TRENDS PLANT SCI, V5, P116, DOI 10.1016/S1360-1385(00)01567-3; Werk-Reichhart D., 2000, GENOME BIOL, V1	36	46	59	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63576	10.1371/journal.pone.0063576	http://dx.doi.org/10.1371/journal.pone.0063576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696834	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900042
J	Gaardbo, JC; Hartling, HJ; Ronit, A; Thorsteinsson, K; Madsen, HO; Springborg, K; Gjerdrum, LMR; Birch, C; Laye, M; Ullum, H; Andersen, AB; Nielsen, SD				Gaardbo, Julie Christine; Hartling, Hans J.; Ronit, Andreas; Thorsteinsson, Kristina; Madsen, Hans Ole; Springborg, Karoline; Gjerdrum, Lise Mette Rahbek; Birch, Carsten; Laye, Matthew; Ullum, Henrik; Andersen, Ase Bengaard; Nielsen, Susanne Dam			Different Immunological Phenotypes Associated with Preserved CD4+T Cell Counts in HIV-Infected Controllers and Viremic Long Term Non-Progressors	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; T-CELLS; IMMUNE ACTIVATION; PERIPHERAL-BLOOD; DISEASE PROGRESSION; THYMIC OUTPUT; RECEPTOR; INDIVIDUALS; EXPRESSION; RESPONSES	Background: HIV-infected controllers control viral replication and maintain normal CD4+ T cell counts. Long Term Non-Progressors (LTNP) also maintain normal CD4+ T cell counts, but have on-going viral replication. We hypothesized that different immunological mechanisms are responsible for preserved CD4+ T cell counts in controllers and LTNP. Methods: 25 HIV-infected controllers and 14 LTNP were included in this cross-sectional study. For comparison, 25 progressors and 34 healthy controls were included. Production and destruction of T cells were addressed by determination of T cell receptor excision circles (TREC), recent thymic emigrants, naive cells, immune activation, senescence and apoptosis. Furthermore, telomere length was determined, and the amount of lymphoid tissue in tonsil biopsies was quantified. Results: Controllers presented with partly preserved thymic output, preserved expression of the IL-7 receptor and IL-7 receptor density, and lower levels of destruction of cells than progressors resembling HIV-negative healthy controls. In contrast, LTNP appeared much like progressors, and different from controllers in immune activation, senescence, and apoptosis. Interestingly, CD8+ RTE, TREC and telomere length were partly preserved. Finally, both controllers and LTNP displayed decreased amounts of lymphoid tissue compared to healthy controls. Conclusions: Controllers presented with an immunological profile different from LTNP. While controllers resembled healthy controls, LTNP were similar to progressors, suggesting different immunological mechanisms to be responsible for preserved CD4+ T cell counts in LTNP and controllers. However, both controllers and LTNP presented with reduced amounts of lymphoid tissue despite preserved CD4+ T cell counts, indicating HIV to cause damage even in non-progressors.	[Gaardbo, Julie Christine; Hartling, Hans J.; Ronit, Andreas; Birch, Carsten; Nielsen, Susanne Dam] Univ Copenhagen Hosp, Rigshosp, Dept Infect Dis, Viroimmunol Res Grp, DK-2100 Copenhagen, Denmark; [Gaardbo, Julie Christine; Hartling, Hans J.; Ronit, Andreas; Madsen, Hans Ole; Birch, Carsten; Ullum, Henrik] Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Thorsteinsson, Kristina] Univ Copenhagen Hosp, Hvidovre Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Springborg, Karoline] Univ Copenhagen Hosp, Rigshosp, Dept Otorhinolaryngol, DK-2100 Copenhagen, Denmark; [Gjerdrum, Lise Mette Rahbek] Univ Copenhagen Hosp, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Laye, Matthew] Univ Copenhagen Hosp, Rigshosp, Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark; [Andersen, Ase Bengaard] Univ Southern Denmark, Odense Hosp, Dept Infect Dis, Odense, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Nielsen, SD (corresponding author), Univ Copenhagen Hosp, Rigshosp, Dept Infect Dis, Viroimmunol Res Grp, DK-2100 Copenhagen, Denmark.	sdn@dadlnet.dk	Madsen, Hans O/Q-2035-2015; Laye, Matthew J/AAQ-1897-2020	Madsen, Hans O/0000-0001-5551-4787; Laye, Matthew J/0000-0003-3214-3113; Hartling, Hans Jakob/0000-0002-4886-0419; Nielsen, Susanne Dam/0000-0001-6391-7455; Gjerdrum, Lise Mette Rahbek/0000-0003-4377-3209; Ullum, Henrik/0000-0001-7306-9058	University of Copenhagen; Novo Nordisk Foundation; Augustinus Foundation; Danish Medical Association; Novo Nordisk Fonden [NNF10OC1013203] Funding Source: researchfish	University of Copenhagen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Augustinus Foundation; Danish Medical Association; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by University of Copenhagen, Novo Nordisk Foundation, Augustinus Foundation and Danish Medical Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bello G, 2009, J MED VIROL, V81, P1681, DOI 10.1002/jmv.21565; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Broussard SR, 2001, J VIROL, V75, P2262, DOI 10.1128/JVI.75.5.2262-2275.2001; Carbone J, 2003, AIDS, V17, P133, DOI 10.1097/00002030-200301030-00021; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Fang RHT, 2005, AIDS, V19, P663, DOI 10.1097/01.aids.0000166089.93574.5a; Franceschi C, 1997, CELL DEATH DIFFER, V4, P815, DOI 10.1038/sj.cdd.4400305; Gaardbo JC, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/161584; Hatzakis A, 2000, LANCET, V355, P599, DOI 10.1016/S0140-6736(99)10311-8; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Kamya P, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-20; Kaur A, 1998, J VIROL, V72, P9597, DOI 10.1128/JVI.72.12.9597-9611.1998; Kitchen CR, 2013, C RETR OPP INF CROI; Laye MJ, 2012, J APPL PHYSIOL, V112, P773, DOI 10.1152/japplphysiol.00997.2011; Lefrere JJ, 1997, BLOOD, V90, P1133, DOI 10.1182/blood.V90.3.1133.1133_1133_1140; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Marchetti G, 2009, HIV MED, V10, P422, DOI 10.1111/j.1468-1293.2009.00710.x; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; Mozos A, 2007, JAIDS-J ACQ IMM DEF, V46, P529, DOI 10.1097/QAI.0b013e31815b69ae; Nielsen SD, 2001, BLOOD, V98, P398, DOI 10.1182/blood.V98.2.398; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Palmer BE, 2005, J IMMUNOL, V175, P8415, DOI 10.4049/jimmunol.175.12.8415; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PARK LS, 1990, J EXP MED, V171, P1073, DOI 10.1084/jem.171.4.1073; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Richardson MW, 2003, AIDS, V17, P915, DOI 10.1097/00002030-200304110-00018; Rodes B, 2004, AIDS, V18, P1109, DOI [10.1097/00002030-200405210-00004, 10.1097/01.aids.0000125962.16506.f9]; Ruiz-Mateos E, 2010, CURR HIV RES, V8, P471, DOI 10.2174/157016210793499268; Sanchez J, 2013, C RETR OPP INF CROI; Schweneker M, 2008, J IMMUNOL, V180, P6490, DOI 10.4049/jimmunol.180.10.6490; Sottini A, 2010, CLIN IMMUNOL, V136, P217, DOI 10.1016/j.clim.2010.04.005; Vieillard V, 2010, JAIDS-J ACQ IMM DEF, V53, P564, DOI 10.1097/QAI.0b013e3181d0c5b4; Westrop SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005474; Whittall T, 2011, CLIN EXP IMMUNOL, V166, P208, DOI 10.1111/j.1365-2249.2011.04463.x; Wolthers KC, 1996, SCIENCE, V274, P1543, DOI 10.1126/science.274.5292.1543; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Yang Y, 2012, AIDS, V26, P701, DOI 10.1097/QAD.0b013e3283519b22; Zanussi S, 1996, CLIN EXP IMMUNOL, V105, P220, DOI 10.1046/j.1365-2249.1996.d01-746.x	44	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63744	10.1371/journal.pone.0063744	http://dx.doi.org/10.1371/journal.pone.0063744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696852	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900057
J	O'Rourke, M; Traweger, A; Lusa, L; Stupica, D; Maraspin, V; Barrett, PN; Strle, F; Livey, I				O'Rourke, Maria; Traweger, Andreas; Lusa, Lara; Stupica, Dasa; Maraspin, Vera; Barrett, P. Noel; Strle, Franc; Livey, Ian			Quantitative Detection of Borrelia burgdorferi sensu lato in Erythema Migrans Skin Lesions Using Internally Controlled Duplex Real Time PCR	PLOS ONE			English	Article							EARLY LYME-DISEASE; CEREBROSPINAL-FLUID; SEQUENCE-ANALYSIS; ASSAY; DIAGNOSIS; STRAINS; PATIENT; SAMPLES; OSPA; DNA	B. burgdorferi sensu stricto, B. afzelii, B. garinii and B. bavariensis are the principal species which account for Lyme borreliosis (LB) globally. We have developed an internally controlled duplex quantitative real time PCR assay targeting the Borrelia 16S rRNA and the human RNAseP genes. This assay is well-suited for laboratory confirmation of suspected cases of LB and will be used to assess the efficacy of a vaccine against LB in clinical trials. The assay is highly specific, successfully detecting DNA extracted from 83 diverse B. burgdorferi sensu lato strains representing all major species causing LB, while 21 unrelated microbial species and human genomic DNA tested negative. The assay was highly reproducible and sensitive, with a lower limit of detection of 6 copies per PCR reaction. Together with culture, the assay was used to evaluate paired 3 mm skin biopsy samples taken from 121 patients presenting with solitary erythema migrans (EM) lesion. PCR testing identified more positive biopsy samples than culture (77.7% PCR positive versus 55.1% culture positive) and correctly identified all specimens scored as culture positive. OspA-based typing identified the majority of isolates as B. afzelii (96.8%) and the bacterial load was significantly higher in culture positive biopsies than in culture negative biopsies (P<0.001). The quantitative data also enabled relationships between Borrelia burden and patient symptoms to be evaluated. The bacterial load was significantly higher among patients with systemic symptoms than without (P = 0.02) and was significantly higher for biopsies retrieved from patients with EM lesions with central clearing (P<0.001). 16S copy numbers were moderately lower in samples from patients reporting a history of LB (P = 0.10). This is the first quantitative PCR study of human skin biopsies predominantly infected with B. afzelii and the first study to demonstrate a clear relationship between clinical symptoms in B. afzelii-infected patients and Borrelia burden.	[O'Rourke, Maria; Traweger, Andreas; Barrett, P. Noel; Livey, Ian] Baxter Biosci, Vaccine R&D, Orth, Austria; [Lusa, Lara] Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia; [Stupica, Dasa; Maraspin, Vera; Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia; [Traweger, Andreas] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Inst Tendon & Bone Regenerat, Salzburg, Austria	University of Ljubljana; University Medical Centre Ljubljana; Paracelsus Private Medical University	O'Rourke, M (corresponding author), Baxter Biosci, Vaccine R&D, Orth, Austria.	maria_o'rourke@baxter.com	Lusa, Lara/C-6692-2015; Traweger, Andreas/M-1460-2015	Lusa, Lara/0000-0002-8981-2421; Traweger, Andreas/0000-0002-0220-4766; Stupica, Dasa/0000-0001-8927-2683	Baxter; Slovenian Research Agency [P3-0296, J3-3636]	Baxter; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was funded by Baxter and supported in part by the Slovenian Research Agency (Grant Numbers P3-0296 and J3-3636). Baxter employees were involved in study design, data collection and analysis, the decision to publish, and preparation of the manuscript. The Slovenian Research Agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Brettschneider S, 1998, J CLIN MICROBIOL, V36, P2658, DOI 10.1128/JCM.36.9.2658-2665.1998; Casjens SR, 2011, J BACTERIOL, V193, P1489, DOI 10.1128/JB.01521-10; Chen CY, 2008, SEX TRANSM INFECT, V84, P273, DOI 10.1136/sti.2007.029058; Collares-Pereira M, 2004, J CLIN MICROBIOL, V42, P1316, DOI 10.1128/JCM.42.3.1316-1318.2004; Diza E, 2004, EMERG INFECT DIS, V10, P1692, DOI 10.3201/eid1009.030439; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Germer J, 1999, MOL DIAGN, V4, P185, DOI 10.1016/S1084-8592(99)80022-8; Gooskens J, 2006, CLIN MICROBIOL INFEC, V12, P894, DOI 10.1111/j.1469-0691.2006.01509.x; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Li X, 2011, ARTHRITIS RHEUM-US, V63, P2238, DOI 10.1002/art.30384; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Livey I, 2011, CLIN INFECT DIS, V52, pS266, DOI 10.1093/cid/ciq118; Lopes de Carvalho I, 2008, CLIN RHEUMATOL, V27, P1587, DOI 10.1007/s10067-008-1012-z; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; NADELMAN RB, 1993, AM J MED, V94, P583, DOI 10.1016/0002-9343(93)90208-7; Nadelman RB, 2007, CLIN INFECT DIS, V45, P1032, DOI 10.1086/521256; Nolan T, 2006, ANAL BIOCHEM, V351, P308, DOI 10.1016/j.ab.2006.01.051; Nowakowski J, 2001, CLIN INFECT DIS, V33, P2023, DOI 10.1086/324490; Pahl A, 1999, J CLIN MICROBIOL, V37, P1958, DOI 10.1128/JCM.37.6.1958-1963.1999; Pau CP, 2010, J VIROL METHODS, V164, P55, DOI 10.1016/j.jviromet.2009.11.027; PFISTER HW, 1986, LANCET, V2, P984; Picken MM, 1997, J CLIN PATHOL-MOL PA, V50, P186, DOI 10.1136/mp.50.4.186; R Core Team, 2020, R LANG ENV STAT COMP; Rijpkema Sjoerd G. T., 1997, Clin Microbiol Infect, V3, P109; Rudenko N, 2009, FEMS MICROBIOL LETT, V292, P274, DOI 10.1111/j.1574-6968.2009.01498.x; Rudenko N, 2008, J CLIN MICROBIOL, V46, P3540, DOI 10.1128/JCM.01032-08; Ruzic-Sabljic E, 2002, WIEN KLIN WOCHENSCHR, V114, P544; Ruzic-Sabljic E, 2001, J MED MICROBIOL, V50, P896, DOI 10.1099/0022-1317-50-10-896; Saidac DS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-43; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Straubinger RK, 2000, J CLIN MICROBIOL, V38, P2191; Strle F, 1999, ANN INTERN MED, V130, P32, DOI 10.7326/0003-4819-130-1-199901050-00006; Strle F, 2011, VECTOR-BORNE ZOONOT, V11, P1253, DOI 10.1089/vbz.2010.0230; Stupica D, 2012, CLIN INFECT DIS, V55, P343, DOI 10.1093/cid/cis402; Stupica D, 2011, VECTOR-BORNE ZOONOT, V11, P883, DOI 10.1089/vbz.2010.0018; Wang GQ, 1999, J CLIN MICROBIOL, V37, P3025, DOI 10.1128/JCM.37.9.3025-3028.1999; Wilhelmsson P, 2010, J CLIN MICROBIOL, V48, P4169, DOI 10.1128/JCM.01061-10; WILL G, 1995, MED MICROBIOL IMMUN, V184, P73, DOI 10.1007/BF00221390; Wormser GP, 2006, WIEN KLIN WOCHENSCHR, V118, P634, DOI 10.1007/s00508-006-0688-9; ZUMSTEIN G, 1992, MED MICROBIOL IMMUN, V181, P57, DOI 10.1007/BF00189424	43	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63968	10.1371/journal.pone.0063968	http://dx.doi.org/10.1371/journal.pone.0063968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696863	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900067
J	Prabhakar, S; Goto, J; Zuang, X; Sena-Esteves, M; Bronson, R; Brockmann, J; Gianni, D; Wojtkiewicz, GR; Chen, JW; Stemmer-Rachamimov, A; Kwiatkowski, DJ; Breakefield, XO				Prabhakar, Shilpa; Goto, June; Zuang, Xuan; Sena-Esteves, Miguel; Bronson, Roderick; Brockmann, Jillian; Gianni, Davide; Wojtkiewicz, Gregory R.; Chen, John W.; Stemmer-Rachamimov, Anat; Kwiatkowski, David J.; Breakefield, Xandra O.			Stochastic Model of Tsc1 Lesions in Mouse Brain	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; MTOR PATHWAY; GIANT-CELLS; RAPAMYCIN; ACTIVATION; MANAGEMENT; SURVIVAL; DEFICITS; MICE	Tuberous sclerosis complex (TSC) is an autosomal dominant disorder due to mutations in either TSC1 or TSC2 that affects many organs with hamartomas and tumors. TSC-associated brain lesions include subependymal nodules, subependymal giant cell astrocytomas and tubers. Neurologic manifestations in TSC comprise a high frequency of mental retardation and developmental disorders including autism, as well as epilepsy. Here, we describe a new mouse model of TSC brain lesions in which complete loss of Tsc1 is achieved in multiple brain cell types in a stochastic pattern. Injection of an adeno-associated virus vector encoding Cre recombinase into the cerebral ventricles of mice homozygous for a Tsc1 conditional allele on the day of birth led to reduced survival, and pathologic findings of enlarged neurons, cortical heterotopias, subependymal nodules, and hydrocephalus. The severity of clinical and pathologic findings as well as survival was shown to be dependent upon the dose and serotype of Cre virus injected. Although several other models of TSC brain disease exist, this model is unique in that the pathology reflects a variety of TSC-associated lesions involving different numbers and types of cells. This model provides a valuable and unique addition for therapeutic assessment.	[Prabhakar, Shilpa; Zuang, Xuan; Breakefield, Xandra O.] Massachusetts Gen Hosp, Dept Neurol, Mol Neurogenet Unit, Boston, MA 02114 USA; [Prabhakar, Shilpa; Zuang, Xuan; Breakefield, Xandra O.] Massachusetts Gen Hosp, Dept Radiol, Ctr Mol Imaging Res, Boston, MA 02114 USA; [Prabhakar, Shilpa; Zuang, Xuan; Breakefield, Xandra O.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Goto, June; Kwiatkowski, David J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA; [Sena-Esteves, Miguel; Gianni, Davide] Univ Massachusetts, Sch Med, Dept Neurol, Gene Therapy Ctr, Worcester, MA USA; [Bronson, Roderick] Harvard Univ, Sch Med, Rodent Histopathol Core Facil, Boston, MA USA; [Brockmann, Jillian; Stemmer-Rachamimov, Anat] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Wojtkiewicz, Gregory R.; Chen, John W.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Wojtkiewicz, Gregory R.; Chen, John W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Breakefield, XO (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Mol Neurogenet Unit, Boston, MA 02114 USA.	breakefield@hms.harvard.edu	; Wojtkiewicz, Gregory/L-3660-2018	Goto, June/0000-0002-4000-9750; Wojtkiewicz, Gregory/0000-0002-3148-8411	NIH/NINDS [NS24279-23, R01NS070835, R01NS072167]; DOD Army Grant [W81XWH-13-1-0076]; NATIONAL CANCER INSTITUTE [K08CA136983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070835, R01NS072167, P01NS024279] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD Army Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH/NINDS NS24279-23, R01NS070835, R01NS072167 and DOD Army Grant W81XWH-13-1-0076 for the Award Mechanism: Exploration - Hypothesis Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderl S, 2011, HUM MOL GENET, V20, P4597, DOI 10.1093/hmg/ddr393; Beaumont TL, 2012, CHILD NERV SYST, V28, P963, DOI 10.1007/s00381-012-1785-x; Berhouma M, 2010, WORLD J PEDIATR, V6, P103, DOI 10.1007/s12519-010-0025-2; Boer K, 2010, BRAIN PATHOL, V20, P704, DOI 10.1111/j.1750-3639.2009.00341.x; BORDARIER C, 1994, BRAIN DEV-JPN, V16, P467, DOI 10.1016/0387-7604(94)90010-8; Broekman MLD, 2006, NEUROSCIENCE, V138, P501, DOI 10.1016/j.neuroscience.2005.11.057; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Doherty C, 2005, J CHILD NEUROL, V20, P837, DOI 10.1177/08830738050200101301; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; European Chromosome 16 Tuberous Sclerosis C, 1993, CELL, V75; Feliciano DM, 2012, HUM MOL GENET, V21, P799, DOI 10.1093/hmg/ddr511; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Franz DN, 2012, LANCET, VS0140-6736, P61134; Goto J, 2011, PROCNATLACADSCI US; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Katz JS, 2012, J NEUROSURG-PEDIATR, V9, P406, DOI 10.3171/2011.12.PEDS11418; Krueger DA, N ENGL J MED, V363, P1801; Kwiatkowski D.J., 2010, TUBEROUS SCLEROSIS C; Liang MC, 2010, ONCOGENE, V29, P1588, DOI 10.1038/onc.2009.452; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Magri L, 2011, CELL STEM CELL, V9, P447, DOI 10.1016/j.stem.2011.09.008; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Ogita S, 2011, TARGET ONCOL, V6, P103, DOI 10.1007/s11523-011-0176-7; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Sahin M, 2012, CURR OPIN NEUROBIOL, V22, P895, DOI 10.1016/j.conb.2012.04.008; Tyburczy ME, 2010, AM J PATHOL, V176, P1878, DOI 10.2353/ajpath.2010.090950; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Way SW, 2009, HUM MOL GENET, V18, P1252, DOI 10.1093/hmg/ddp025; Winterkorn EB, 2007, NEUROLOGY, V68, P62, DOI 10.1212/01.wnl.0000250330.44291.54; Xu L, 2009, NEUROBIOL DIS, V34, P291, DOI 10.1016/j.nbd.2009.01.010; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yuan E, 2012, HUM MOL GENET, V21, P4286, DOI 10.1093/hmg/dds262; Zhou J, 2011, GENE DEV, V25, P1595, DOI 10.1101/gad.16750211	39	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64224	10.1371/journal.pone.0064224	http://dx.doi.org/10.1371/journal.pone.0064224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696872	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900075
J	Chen, ZG; He, X; Jia, MY; Liu, Y; Qu, DH; Wu, D; Wu, P; Ni, C; Zhang, ZG; Ye, J; Xu, JH; Huang, J				Chen, Zhigang; He, Xin; Jia, Minyue; Liu, Yang; Qu, Dihong; Wu, Dang; Wu, Pin; Ni, Chao; Zhang, Zhigang; Ye, Jun; Xu, Jinghong; Huang, Jian			beta-catenin Overexpression in the Nucleus Predicts Progress Disease and Unfavourable Survival in Colorectal Cancer: A Meta-Analysis	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; TISSUE MICROARRAY; PROGNOSTIC-SIGNIFICANCE; POOR-PROGNOSIS; WNT; METASTASIS; STATISTICS	Background: beta-catenin plays a key role in the progression of colorectal cancer (CRC). However, its prognostic significance for patients with CRC remains controversial. Methodology: Identical search strategies were used to search relevant literatures in the PubMed, Embase and Web of Science databases. The correlation between beta-catenin expression and clinicopathological features and prognosis was analyzed. Principal Findings: A total of 18 studies met the inclusion criteria, which comprised 3665 cases. Meta-analysis suggested that beta-catenin overexpression in the nucleus was significantly associated with disease free survival (DFS) (n = 541 in 3 studies; HR = 1.87, 95% CI: 1.28-2.71; Z = 3.26; P = 0.001) and overall survival (OS) for CRC patients (n = 2630 in 10 studies; HR = 1.55, 95% CI: 1.12-2.14; Z = 2.62; P = 0.009). However, there was no significant association between beta-catenin expression in the cytoplasm and OS (n = 1327 in 3 studies; HR = 1.04, 95% CI: 0.88-1.24, Z = 0.46, P = 0.643). The combined odds ratio (OR) of beta-catenin in the nucleus indicated that beta-catenin overexpression was associated with advanced stage CRC (n = 950 in 7 studies; OR = 0.71, 95% CI: 0.53-0.94; Z = 2.35; P = 0.019) and metastasis of CRC (n = 628 in 5 studies; OR = 0.49, 95% CI: 0.25-0.96, Z = 2.06, P = 0.039). beta-catenin overexpression in the nucleus had no correlation with the tumor site (colon or rectum), differentiation grade, lymph node status or depth of invasion. The pooled ORs were 1.09 (95% CI: 0.41-2.91, Z = 0.18, P = 0.856), 1.27(95% CI: 0.76-2.10, Z = 0.92, P = 0.357), 0.71(95% CI: 0.46-1.09, Z = 1.58, P = 0.115) and 0.82(95% CI: 0.4-1.68, Z = 0.53, P = 0.594). Conclusions: This study showed that beta-catenin overexpression in the nucleus, rather than in the cytoplasm, appeared to be associated with progress disease and a worse prognosis for CRC patients.	[Chen, Zhigang; Liu, Yang; Qu, Dihong; Wu, Dang; Wu, Pin; Ni, Chao; Zhang, Zhigang; Ye, Jun; Huang, Jian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhigang; Wu, Dang; Wu, Pin; Ni, Chao; Zhang, Zhigang; Ye, Jun; Huang, Jian] Zhejiang Univ, Sch Med, Key Lab Canc Prevent & Intervent, Canc Inst,Natl Minist Educ,Prov Key Lab Mol Biol, Hangzhou 310003, Zhejiang, Peoples R China; [He, Xin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Jia, Minyue] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Jinghong] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Huang, J (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	drhuangjian@126.com	yang, liu/GVU-8760-2022; xu, jing/GRR-8698-2022; wei, jiang/GRX-7907-2022	Huang, Jian/0000-0003-3340-5007	National Natural Scientific Foundation of China [91019005, 81272672]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents, Zhejiang Provincial key subject of traditional Chinese medicine and Zhejiang Provincial medicine and health care innovation subject	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents, Zhejiang Provincial key subject of traditional Chinese medicine and Zhejiang Provincial medicine and health care innovation subject	This work was supported by the National Natural Scientific Foundation of China (NO. 91019005 and 81272672). JH was sponsored by the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents, Zhejiang Provincial key subject of traditional Chinese medicine and Zhejiang Provincial medicine and health care innovation subject. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras C, 2012, HEPATO-GASTROENTEROL, V59, P1091, DOI 10.5754/hge12041; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bravou V, 2006, J PATHOL, V208, P91, DOI 10.1002/path.1860; Chen SQ, 2008, SCAND J GASTROENTERO, V43, P456, DOI 10.1080/00365520701785194; Chung GG, 2001, CLIN CANCER RES, V7, P4013; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Fernebro E, 2004, INT J CANCER, V111, P921, DOI 10.1002/ijc.20229; Filiz AI, 2010, COLORECTAL DIS, V12, P1223, DOI 10.1111/j.1463-1318.2009.01994.x; Fuchs SY, 2005, CELL CYCLE, V4, P1522; Gough NR, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002806; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Magnusson C, 2010, EUR J CANCER, V46, P826, DOI 10.1016/j.ejca.2009.12.022; MANTEL N, 1959, J NATL CANCER I, V22, P719; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Martensson A, 2007, ONCOL REP, V17, P447; Maruyama K, 2000, ONCOLOGY-BASEL, V59, P302, DOI 10.1159/000012187; Matsuoka T, 2011, J SURG ONCOL, V103, P674, DOI 10.1002/jso.21854; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ougolkov AV, 2002, GASTROENTEROLOGY, V122, P60, DOI 10.1053/gast.2002.30306; Ozguven BY, 2011, POL J PATHOL, V62, P19; Pancione M, 2010, HUM PATHOL, V41, P867, DOI 10.1016/j.humpath.2009.09.019; Pancione M, 2009, HUM PATHOL, V40, P714, DOI 10.1016/j.humpath.2008.08.019; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Ricci-Vitiani L, 2008, GUT, V57, P538, DOI 10.1136/gut.2007.127837; Rodriguez-Moranta F, 2006, J CLIN ONCOL, V24, P386, DOI 10.1200/JCO.2005.02.0826; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stanczak A, 2011, PATHOL ONCOL RES, V17, P955, DOI 10.1007/s12253-011-9409-4; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Suh EK, 2003, EXP CELL RES, V290, P447, DOI 10.1016/S0014-4827(03)00370-7; Sun LC, 2011, AM J PATHOL, V179, P380, DOI 10.1016/j.ajpath.2011.03.046; Togo N, 2008, WORLD J GASTROENTERO, V14, P4880, DOI 10.3748/wjg.14.4880; Toth L, 2012, PATHOL ONCOL RES, V18, P429, DOI 10.1007/s12253-011-9463-y; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048	40	60	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63854	10.1371/journal.pone.0063854	http://dx.doi.org/10.1371/journal.pone.0063854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717499	Green Published, gold, Green Submitted			2022-12-27	WOS:000319385300031
J	Mahmoud, MF; Hassan, NA; El Bassossy, HM; Fahmy, A				Mahmoud, Mona F.; Hassan, Noura A.; El Bassossy, Hany M.; Fahmy, Ahmed			Quercetin Protects against Diabetes-Induced Exaggerated Vasoconstriction in Rats: Effect on Low Grade Inflammation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; FACTOR-ALPHA; CARDIOVASCULAR COMPLICATIONS; PROINFLAMMATORY CYTOKINES; VASCULAR REACTIVITY; OXIDATIVE STRESS; HIGH GLUCOSE	Vascular complications are the leading cause of morbidity and mortality in patients with diabetes. Quercetin is an important flavonoid with antioxidant and anti-inflammatory activity. Here, the effect of quercetin on diabetes-induced exaggerated vasoconstriction in insulin deficient and insulin resistant rat models was investigated. Insulin deficiency was induced by streptozotocin while, insulin resistance by fructose. Rats were left 8 weeks or 12 weeks after STZ or fructose administration respectively. Quercetin was daily administered in the last 6 weeks. Then, tail blood pressure (BP) was recorded in conscious animals; concentration-response curves for phenylephrine (PE) and KCl were studied in thoracic aorta rings. Non-fasting blood glucose level, serum insulin level, insulin resistance index, serum tumour necrosis factor-alpha (TNF-alpha) and serum Creactive protein (CRP) were determined. Nuclear transcription factor-kappa B (NF-kappa B) was assessed by immunofluorescence technique. Histopathological examination was also performed. The results showed that quercetin protected against diabetes-induced exaggerated vasoconstriction and reduced the elevated blood pressure. In addition, quercetin inhibited diabetes associated adventitial leukocyte infiltration, endothelial pyknosis and increased collagen deposition. These effects were accompanied with reduction in serum level of both TNF-alpha and CRP and inhibition of aortic NF-kappa B by quercetin in both models of diabetes. On the other hand, quercetin did not affect glucose level in any of the used diabetic models. This suggests that the protective effect of quercetin is mediated by its anti-inflammatory effect rather than its metabolic effects. In summary, quercetin is potential candidate to prevent diabetic vascular complications in both insulin deficiency and resistance via its inhibitory effect on inflammatory pathways especially NF-kappa B signaling.	[Mahmoud, Mona F.; Hassan, Noura A.; El Bassossy, Hany M.; Fahmy, Ahmed] Zagazig Univ, Fac Pharm, Dept Pharmacol & Toxicol, Zagazig, Egypt; [El Bassossy, Hany M.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah 21413, Saudi Arabia	Egyptian Knowledge Bank (EKB); Zagazig University; King Abdulaziz University	Mahmoud, MF (corresponding author), Zagazig Univ, Fac Pharm, Dept Pharmacol & Toxicol, Zagazig, Egypt.	mona_pharmacology@yahoo.com	Hassan, Noura/GXN-4621-2022; Mahmoud, Mona/Q-8851-2019; El-Bassossy, Hany M/I-1576-2012; El-Bassossy, Hany/O-2242-2019	Hassan, Noura/0000-0001-8941-3781; El-Bassossy, Hany M/0000-0002-6838-6945; El-Bassossy, Hany/0000-0002-6838-6945; Mahmoud, Mona/0000-0002-5312-2066	Science and Technology Development Fund, Egypt [ID1024]	Science and Technology Development Fund, Egypt(Science and Technology Development Fund (STDF))	The publication fees and the additional measurements were funded by a research grant ID1024 provided by the Science and Technology Development Fund, Egypt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 2002, CYTOKINE, V18, P179, DOI 10.1006/cyto.2001.1007; Ajay M, 2006, DIABETES RES CLIN PR, V73, P1, DOI 10.1016/j.diabres.2005.11.004; Alvarez A, 1999, J ETHNOPHARMACOL, V67, P333, DOI 10.1016/S0378-8741(99)00092-6; Ansarullah, 2010, EUR J INTEGR MED, V2, P79, DOI 10.1016/j.eujim.2010.03.005; Bhaskar S, 2013, NUTRITION, V29, P219, DOI 10.1016/j.nut.2012.01.019; Carlstrom J, 2007, J NUTR, V137, P628, DOI 10.1093/jn/137.3.628; Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740; Cirico TL, 2006, FOOD CHEM TOXICOL, V44, P510, DOI 10.1016/j.fct.2005.08.025; Cohuet G, 2006, PHARMACOL THERAPEUT, V111, P81, DOI 10.1016/j.pharmthera.2005.09.002; DANIELSEN R, 1987, AM J CARDIOL, V60, P143, DOI 10.1016/0002-9149(87)91001-0; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Delbosc S, 2005, ATHEROSCLEROSIS, V179, P43, DOI 10.1016/j.atherosclerosis.2004.10.018; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; El-Bassossy HM, 2012, VASC PHARMACOL, V57, P194, DOI 10.1016/j.vph.2012.01.001; El-Bassossy HM, 2011, FOOD CHEM TOXICOL, V49, P3007, DOI 10.1016/j.fct.2011.07.060; El-Bassossy HM, 2011, N-S ARCH PHARMACOL, V384, P277, DOI 10.1007/s00210-011-0669-z; Ergul A, 2011, PHARMACOL RES, V63, P477, DOI 10.1016/j.phrs.2011.01.012; Fan X, 2003, ARCH BIOCHEM BIOPHYS, V409, P274, DOI 10.1016/S0003-9861(02)00599-4; Farhangkhoee H, 2006, PHARMACOL THERAPEUT, V111, P384, DOI 10.1016/j.pharmthera.2005.10.008; FONG Y, 1990, SURG GYNECOL OBSTET, V170, P363; Fukui M, 2003, DIABETES RES CLIN PR, V59, P153, DOI 10.1016/S0168-8227(02)00204-8; Garcia-Mediavilla V, 2007, EUR J PHARMACOL, V557, P221, DOI 10.1016/j.ejphar.2006.11.014; Ghanem FA, 2007, J AM SOC HYPERTENS, V1, P113, DOI 10.1016/j.jash.2007.01.004; Goldfine AB, 2011, CLIN CHEM, V57, P162, DOI 10.1373/clinchem.2010.148833; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hattori Y, 2003, CARDIOVASC RES, V58, P186, DOI 10.1016/S0008-6363(02)00855-6; Hertog MGL, 1996, CANCER EPIDEM BIOMAR, V5, P673; Hill BJF, 2001, ATHEROSCLEROSIS, V159, P117, DOI 10.1016/S0021-9150(01)00501-9; Huang BF, 2009, PATHOL RES PRACT, V205, P515, DOI 10.1016/j.prp.2009.01.007; Iwasaki Y, 2007, J DIABETES COMPLICAT, V21, P56, DOI 10.1016/j.jdiacomp.2006.02.001; Jain SK, 2007, FREE RADICAL BIO MED, V43, P1124, DOI 10.1016/j.freeradbiomed.2007.05.019; Kawakami Y, 2012, FOOD CHEM, V131, P1069, DOI 10.1016/j.foodchem.2011.10.011; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; Li Jian-Mei, 2008, Chinese Journal of Natural Medicines, V6, P466, DOI 10.3724/SP.J.1009.2008.00466; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu CM, 2010, ENVIRON TOXICOL PHAR, V30, P264, DOI 10.1016/j.etap.2010.07.002; Liu XL, 2012, FOOD CHEM, V131, P685, DOI 10.1016/j.foodchem.2011.09.063; Liu XP, 2010, EUR J PHARMACOL, V629, P153, DOI 10.1016/j.ejphar.2009.11.059; Mahmoud MF, 2012, ARCH PHARM RES, V35, P155, DOI 10.1007/s12272-012-0117-8; MANACH C, 1995, J NUTR, V125, P1911, DOI 10.1093/jn/125.7.1911; Mansour SM, 2011, PHYTOMEDICINE, V18, P641, DOI 10.1016/j.phymed.2011.01.014; MARIN J, 1995, MECH AGEING DEV, V79, P71, DOI 10.1016/0047-6374(94)01551-V; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; MING WJ, 1987, J IMMUNOL, V138, P1469; Mishima Y, 2001, DIABETES RES CLIN PR, V52, P119, DOI 10.1016/S0168-8227(00)00247-3; Mythili MD, 2004, MICROSC RES TECHNIQ, V63, P274, DOI 10.1002/jemt.20039; Nair MP, 2006, CLIN VACCINE IMMUNOL, V13, P319, DOI 10.1128/CVI.13.3.319-328.2006; Nakakuki T, 2005, ARTERIOSCL THROM VAS, V25, P2088, DOI 10.1161/01.ATV.0000183607.50230.9f; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Peyroux J, 2006, PATHOL BIOL, V54, P405, DOI 10.1016/j.patbio.2006.07.006; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Punithavathi VR, 2009, CHEM-BIOL INTERACT, V181, P322, DOI 10.1016/j.cbi.2009.07.002; Reddy GK, 2004, MICROVASC RES, V68, P132, DOI 10.1016/j.mvr.2004.04.002; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rial NS, 2012, MED HYPOTHESES, V78, P29, DOI 10.1016/j.mehy.2011.09.034; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Romero M, 2010, EUR J PHARMACOL, V627, P242, DOI 10.1016/j.ejphar.2009.11.006; Shahid M, 2008, AM J PHYSIOL-RENAL, V295, pF1836, DOI 10.1152/ajprenal.90297.2008; Shiomi T, 2003, J AM COLL CARDIOL, V42, P165, DOI 10.1016/S0735-1097(03)00509-6; Shoskes DA, 2011, UROL CLIN N AM, V38, P279, DOI 10.1016/j.ucl.2011.05.003; Southerland JH, 2012, ATHEROSCLEROSIS, V222, P196, DOI 10.1016/j.atherosclerosis.2012.01.026; Szocs K, 2002, ARTERIOSCL THROM VAS, V22, P21, DOI 10.1161/hq0102.102189; Tan K., 2004, INT C SER, V1262, P511, DOI [10.1016/j.ics.2003.11.028, DOI 10.1016/J.ICS.2003.11.028]; Tribolo S, 2008, ATHEROSCLEROSIS, V197, P50, DOI 10.1016/j.atherosclerosis.2007.07.040; Tsimogiannis DI, 2006, INNOV FOOD SCI EMERG, V7, P140, DOI 10.1016/j.ifset.2005.09.001; Vasdev S, 1998, MOL CELL BIOCHEM, V181, P1, DOI 10.1023/A:1006844222963; Wang HR, 2005, CLIN CHIM ACTA, V353, P53, DOI 10.1016/j.cccn.2004.10.007; Wang LJ, 2005, CIRC RES, V97, P891, DOI 10.1161/01.RES.0000187469.82595.15; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Wyllie AH, 1997, BRIT MED BULL, V53, P451	72	99	107	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63784	10.1371/journal.pone.0063784	http://dx.doi.org/10.1371/journal.pone.0063784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717483	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700060
J	Panyukov, VV; Ozoline, ON				Panyukov, Valeriy V.; Ozoline, Olga N.			Promoters of Escherichia coli versus Promoter Islands: Function and Structure Comparison	PLOS ONE			English	Article							RNA-POLYMERASE; H-NS; TRANSCRIPTIONAL REGULATION; BINDING SITES; GENE-TRANSFER; DNA-BINDING; RPOH GENE; GENOME; IDENTIFICATION; REGIONS	Expression of bacterial genes takes place under the control of RNA polymerase with exchangeable sigma-subunits and multiple transcription factors. A typical promoter region contains one or several overlapping promoters. In the latter case promoters have the same or different sigma-specificity and are often subjected to different regulatory stimuli. Genes, transcribed from multiple promoters, have on average higher expression levels. However, recently in the genome of Escherichia coli we found 78 regions with an extremely large number of potential transcription start points (promoter islands, PIs). It was shown that all PIs interact with RNA polymerase in vivo and are able to form transcriptionally competent open complexes both in vitro and in vivo but their transcriptional activity measured by oligonucleotide microarrays was very low, if any. Here we confirmed transcriptional defectiveness of PIs by analyzing the 5 ' -end specific RNA-seq data, but showed their ability to produce short oligos (9-14 bases). This combination of functional properties indicated a deliberate suppression of transcriptional activity within PIs. According to our data this suppression may be due to a specific conformation of the DNA double helix, which provides an ideal platform for interaction with both RNA polymerase and the histone-like nucleoid protein H-NS. The genomic DNA of E. coli contains therefore several dozen sites optimized by evolution for staying in a heterochromatin-like state. Since almost all promoter islands are associated with horizontally acquired genes, we offer them as specific components of bacterial evolution involved in acquisition of foreign genetic material by turning off the expression of toxic or useless aliens or by providing optimal promoter for beneficial genes. The putative molecular mechanism underlying the appearance of promoter islands within recipient genomes is discussed.	[Panyukov, Valeriy V.] Russian Acad Sci, Inst Math Problems Biol, Dept Bioinformat, Pushchino 142292, Moscow Region, Russia; [Ozoline, Olga N.] Russian Acad Sci, Inst Cell Biophys, Dept Funct Genom & Cellular Stress, Pushchino 142292, Moscow Region, Russia; [Ozoline, Olga N.] Pushchino State Inst Nat Sci, Dept Cell Biol, Pushchino, Moscow Region, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS	Ozoline, ON (corresponding author), Russian Acad Sci, Inst Cell Biophys, Dept Funct Genom & Cellular Stress, Pushchino 142292, Moscow Region, Russia.	ozoline@rambler.ru	Panyukov, Valery/O-1812-2013	Panyukov, Valery/0000-0003-1813-7403	Russian Foundation for Basic Research [10-04-01218, 12-07-00530, 13-04-00997]; Ministry of Education and Science of the Russian Federation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	The work has been supported by Russian Foundation for Basic Research (grants No. 10-04-01218, No. 12-07-00530, and 13-04-00997), and by the Ministry of Education and Science of the Russian Federation (project "Multiple promoters as indicators of overlapping transcription and alternative coding''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR HM, 1987, J BACTERIOL, V169, P3435, DOI 10.1128/jb.169.8.3435-3440.1987; Bolshoy A, 2000, GENOME RES, V10, P1185, DOI 10.1101/gr.10.8.1185; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Cho BK, 2008, GENOME RES, V18, P900, DOI 10.1101/gr.070276.107; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Dominguez-Cuevas P, 2005, J BIOL CHEM, V280, P41315, DOI 10.1074/jbc.M505415200; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Dornenburg JE, 2010, MBIO, V1, DOI 10.1128/mBio.00024-10; Friedel M, 2009, NUCLEIC ACIDS RES, V37, pD37, DOI 10.1093/nar/gkn597; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Goldman SR, 2011, MOL CELL, V42, P817, DOI 10.1016/j.molcel.2011.06.005; GOODRICH JA, 1991, TRENDS BIOCHEM SCI, V16, P394, DOI 10.1016/0968-0004(91)90162-O; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hertz GZ, 1996, METHOD ENZYMOL, V273, P30; Huang QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033759; Huerta AM, 2006, MOL BIOL EVOL, V23, P997, DOI 10.1093/molbev/msk004; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Huerta AM, 2006, PLOS GENET, V2, P1740, DOI 10.1371/journal.pgen.0020185; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Janaszak A, 2009, FEMS MICROBIOL LETT, V291, P65, DOI 10.1111/j.1574-6968.2008.01436.x; Janaszak A, 2007, MICROBIOL-SGM, V153, P111, DOI 10.1099/mic.0.2006/000463-0; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Kallipolitis BH, 1998, MOL MICROBIOL, V29, P1091, DOI 10.1046/j.1365-2958.1998.00999.x; Kenter AL, 2012, SEMIN IMMUNOL, V24, P281, DOI 10.1016/j.smim.2012.06.001; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lee HJ, 2012, FEMS MICROBIOL LETT, V326, P131, DOI 10.1111/j.1574-6968.2011.02441.x; Lee SJ, 2001, J BIOL CHEM, V276, P30064, DOI 10.1074/jbc.M102886200; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Maciag A, 2011, NUCLEIC ACIDS RES, V39, P5338, DOI 10.1093/nar/gkr129; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olson WK, 2001, J MOL BIOL, V313, P229, DOI 10.1006/jmbi.2001.4987; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Ozolin' O n, 2004, Mol Biol (Mosk), V38, P786; Ozoline ON, 1997, NUCLEIC ACIDS RES, V25, P4703, DOI 10.1093/nar/25.23.4703; Ozoline ON, 1999, NUCLEIC ACIDS RES, V27, P4768, DOI 10.1093/nar/27.24.4768; PANYUKOV V, 2011, MATH BIOL BIOINFORMA, V6, pT36; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Petit V, 2009, PHILOS T R SOC B, V364, P705, DOI 10.1098/rstb.2008.0272; Price MN, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r4; Prieto AI, 2012, NUCLEIC ACIDS RES, V40, P3524, DOI 10.1093/nar/gkr1236; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Rhodius VA, 2010, P NATL ACAD SCI USA, V107, P2854, DOI 10.1073/pnas.0915066107; Rivetti C, 1999, EMBO J, V18, P4464, DOI 10.1093/emboj/18.16.4464; Shavkunov KS, 2009, NUCLEIC ACIDS RES, V37, P4919, DOI 10.1093/nar/gkp490; SHAVKUNOV KS, 2011, J BIOMOL STRUCT DYN, V28, P1128; Sponer J, 1997, BIOPHYS J, V73, P76, DOI 10.1016/S0006-3495(97)78049-4; Tutukina MN, 2007, J BIOINF COMPUT BIOL, V5, P549, DOI 10.1142/S0219720007002801; Tututkina M N, 2010, Mol Biol (Mosk), V44, P497; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Wade JT, 2006, NAT STRUCT MOL BIOL, V13, P806, DOI 10.1038/nsmb1130; WANG QP, 1989, J BIOL CHEM, V264, P7338; Yus E, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.16; Zahrl D, 2006, J BACTERIOL, V188, P6611, DOI 10.1128/JB.00632-06	66	20	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e62601	10.1371/journal.pone.0062601	http://dx.doi.org/10.1371/journal.pone.0062601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717391	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700005
J	Takahashi, M; Shirayama, Y; Muneoka, K; Suzuki, M; Sato, K; Hashimoto, K				Takahashi, Michio; Shirayama, Yukihiko; Muneoka, Katsumasa; Suzuki, Masatoshi; Sato, Koichi; Hashimoto, Kenji			Personality Traits as Risk Factors for Treatment-Resistant Depression	PLOS ONE			English	Article							MAJOR DEPRESSION; CHARACTER INVENTORY; TEMPERAMENT; QUESTIONNAIRE; DISORDERS; SCORES; STATE; MODEL	Background: The clinical outcome of antidepressant treatment in patients with major depressive disorder (MDD) is thought to be associated with personality traits. A number of studies suggest that depressed patients show high harm avoidance, low self-directedness and cooperativeness, as measured on the Temperament and Character Inventory (TCI). However, the psychology of these patients is not well documented. Methods: Psychological evaluation using Cloninger's TCI, was performed on treatment-resistant MDD patients (n = 35), remission MDD patients (n = 31), and age-and gender-matched healthy controls (n = 174). Results: Treatment-resistant patients demonstrated high scores for harm avoidance, and low scores for reward dependence, self-directedness, and cooperativeness using the TCI, compared with healthy controls and remission patients. Interestingly, patients in remission continued to show significantly high scores for harm avoidance, but not other traits in the TCI compared with controls. Moreover, there was a significant negative correlation between reward dependence and harm avoidance in the treatment-resistant depression cohort, which was absent in the control and remitted depression groups. Conclusions: This study suggests that low reward dependence and to a lesser extent, low cooperativeness in the TCI may be risk factors for treatment-resistant depression.	[Takahashi, Michio; Shirayama, Yukihiko; Muneoka, Katsumasa; Suzuki, Masatoshi; Sato, Koichi] Teikyo Univ, Chiba Med Ctr, Dept Psychiat, Ichihara, Chiba, Japan; [Takahashi, Michio; Shirayama, Yukihiko; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan	Teikyo University; Chiba University	Shirayama, Y (corresponding author), Teikyo Univ, Chiba Med Ctr, Dept Psychiat, Ichihara, Chiba, Japan.	shirayama@rapid.ocn.ne.jp	Takahashi, Michio/R-2889-2019; Hashimoto, Kenji/I-5800-2015	Takahashi, Michio/0000-0002-7151-1364; Hashimoto, Kenji/0000-0002-8892-0439	Teikyo University Chiba Medical Center, Ichihara, Japan	Teikyo University Chiba Medical Center, Ichihara, Japan	Funding for this study was provided by Teikyo University Chiba Medical Center, Ichihara, Japan. The funder of this study had no role in the data collection, analysis, interpretation or reporting of this paper.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Black KJ, 1997, J AFFECT DISORDERS, V43, P11, DOI 10.1016/S0165-0327(96)00101-2; Celikel FC, 2009, COMPR PSYCHIAT, V50, P556, DOI 10.1016/j.comppsych.2008.11.012; Chien AJ, 1996, J PSYCHIAT RES, V30, P21, DOI 10.1016/0022-3956(95)00041-0; Cloninger CR, 2011, J AFFECT DISORDERS, V128, P24, DOI 10.1016/j.jad.2010.06.012; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Conrad R, 2009, PSYCHIAT RES, V165, P137, DOI 10.1016/j.psychres.2007.10.013; Corruble E, 2002, PSYCHIAT RES, V109, P17, DOI 10.1016/S0165-1781(01)00366-3; Farmer A, 2003, ARCH GEN PSYCHIAT, V60, P490, DOI 10.1001/archpsyc.60.5.490; Gorwood P, 2010, BRIT J PSYCHIAT, V196, P139, DOI 10.1192/bjp.bp.109.067058; Hansenne M, 1999, J PSYCHIATR RES, V33, P31, DOI 10.1016/S0022-3956(98)00036-3; Hirano S, 2002, J AFFECT DISORDERS, V69, P31, DOI 10.1016/S0165-0327(00)00329-3; JOFFE RT, 1993, AM J PSYCHIAT, V150, P959; JOYCE PR, 1994, J AFFECT DISORDERS, V30, P35, DOI 10.1016/0165-0327(94)90149-X; Kampman O, 2012, EUR PSYCHIAT, V27, P245, DOI 10.1016/j.eurpsy.2010.07.006; Kampman O, 2011, J AFFECT DISORDERS, V135, P20, DOI 10.1016/j.jad.2010.12.021; Marijnissen G, 2002, J AFFECT DISORDERS, V70, P219, DOI 10.1016/S0165-0327(01)00364-0; MULDER RT, 1994, PSYCHOL REP, V75, P1315, DOI 10.2466/pr0.1994.75.3.1315; Mulder RT, 2002, AM J PSYCHIAT, V159, P359, DOI 10.1176/appi.ajp.159.3.359; NELSEN MR, 1995, J PSYCHIAT RES, V29, P43, DOI 10.1016/0022-3956(94)00042-P; Richter J, 2000, EUR ARCH PSY CLIN N, V250, P40, DOI 10.1007/PL00007538; Sasayama D, 2011, J AFFECT DISORDERS, V132, P319, DOI 10.1016/j.jad.2011.03.009; Skodol AE, 2011, AM J PSYCHIAT, V168, P257, DOI 10.1176/appi.ajp.2010.10050695; Smith DJ, 2005, J AFFECT DISORDERS, V87, P83, DOI 10.1016/j.jad.2005.03.014; Spittlehouse JK, 2010, J AFFECT DISORDERS, V126, P140, DOI 10.1016/j.jad.2010.03.010; Suzuki N, 2005, PSYCHOL REP, V86, P1050; SVRAKIC DM, 1993, ARCH GEN PSYCHIAT, V50, P991; Takeuchi M, 2011, COMPR PSYCHIAT, V52, P109, DOI 10.1016/j.comppsych.2010.04.002; Thase Michael E., 1995, P1081; Tome MB, 1997, J AFFECT DISORDERS, V44, P101, DOI 10.1016/S0165-0327(97)00030-X	30	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63756	10.1371/journal.pone.0063756	http://dx.doi.org/10.1371/journal.pone.0063756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UP	23717477	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700055
J	Thompson, TW; Waskom, ML; Garel, KLA; Cardenas-Iniguez, C; Reynolds, GO; Winter, R; Chang, P; Pollard, K; Lala, N; Alvarez, GA; Gabrieli, JDE				Thompson, Todd W.; Waskom, Michael L.; Garel, Keri-Lee A.; Cardenas-Iniguez, Carlos; Reynolds, Gretchen O.; Winter, Rebecca; Chang, Patricia; Pollard, Kiersten; Lala, Nupur; Alvarez, George A.; Gabrieli, John D. E.			Failure of Working Memory Training to Enhance Cognition or Intelligence	PLOS ONE			English	Article							GENERAL FLUID INTELLIGENCE; SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; NEURAL MECHANISMS; PROCESSING SPEED; CAPACITY; CHILDREN; ABILITY; GRIT	Fluid intelligence is important for successful functioning in the modern world, but much evidence suggests that fluid intelligence is largely immutable after childhood. Recently, however, researchers have reported gains in fluid intelligence after multiple sessions of adaptive working memory training in adults. The current study attempted to replicate and expand those results by administering a broad assessment of cognitive abilities and personality traits to young adults who underwent 20 sessions of an adaptive dual n-back working memory training program and comparing their post-training performance on those tests to a matched set of young adults who underwent 20 sessions of an adaptive attentional tracking program. Pre- and post-training measurements of fluid intelligence, standardized intelligence tests, speed of processing, reading skills, and other tests of working memory were assessed. Both training groups exhibited substantial and specific improvements on the trained tasks that persisted for at least 6 months post-training, but no transfer of improvement was observed to any of the non-trained measurements when compared to a third untrained group serving as a passive control. These findings fail to support the idea that adaptive working memory training in healthy young adults enhances working memory capacity in non-trained tasks, fluid intelligence, or other measures of cognitive abilities.	[Thompson, Todd W.; Waskom, Michael L.; Garel, Keri-Lee A.; Cardenas-Iniguez, Carlos; Reynolds, Gretchen O.; Winter, Rebecca; Chang, Patricia; Pollard, Kiersten; Lala, Nupur; Gabrieli, John D. E.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Waskom, Michael L.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Waskom, Michael L.] Stanford Univ, Ctr Mind Brain & Computat, Stanford, CA 94305 USA; [Cardenas-Iniguez, Carlos] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Reynolds, Gretchen O.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Winter, Rebecca] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Lala, Nupur] Childrens Canc Hosp, MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX USA; [Alvarez, George A.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; University of Chicago; Boston University; Icahn School of Medicine at Mount Sinai; University of Texas System; UTMD Anderson Cancer Center; Harvard University	Thompson, TW (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	toddt@mit.edu	Gabrieli, John/AAJ-2869-2020	Garel, Keri-Lee/0000-0002-9198-6535; , Carlos Cardenas-Iniguez/0000-0002-6736-3020	Defense Advanced Research Projects Agency [NBCHC070105]; NIH Blueprint for Neuroscience Research [T90DA022759/R90DA023427]; Department of Defense (DoD) through the National Defense Science and Engineering Graduate Fellowship (NDSEG) program; Department of Defense (DoD) through the Sheldon Razin Fellowship at MIT; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022759, R90DA023427] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH Blueprint for Neuroscience Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DoD) through the National Defense Science and Engineering Graduate Fellowship (NDSEG) program; Department of Defense (DoD) through the Sheldon Razin Fellowship at MIT; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Defense Advanced Research Projects Agency (government contract no. NBCHC070105). The first author was supported by a training grant from the NIH Blueprint for Neuroscience Research (T90DA022759/R90DA023427), by the Department of Defense (DoD) through the National Defense Science and Engineering Graduate Fellowship (NDSEG) program, and through the Sheldon Razin (1959) Fellowship at MIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 2005, PSYCHOL BULL, V131, P30, DOI 10.1037/0033-2909.131.1.30; Alvarez GA, 2007, J VISION, V7, DOI 10.1167/7.13.14; Anguera JA, 2012, BEHAV BRAIN RES, V228, P107, DOI 10.1016/j.bbr.2011.11.040; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Blackwell LS, 2007, CHILD DEV, V78, P246, DOI 10.1111/j.1467-8624.2007.00995.x; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; Burgess GC, 2011, J EXP PSYCHOL GEN, V140, P674, DOI 10.1037/a0024695; Buschkuehl M, 2008, PSYCHOL AGING, V23, P743, DOI 10.1037/a0014342; Chein JM, 2010, PSYCHON B REV, V17, P193, DOI 10.3758/PBR.17.2.193; Chooi WT, 2012, INTELLIGENCE, V40, P531, DOI 10.1016/j.intell.2012.07.004; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Costa PT, 2007, REVISED NEO PERSONAL; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; Duckworth AL, 2009, J PERS ASSESS, V91, P166, DOI 10.1080/00223890802634290; Dweck C., 2000, SELF THEORIES THEIR; Dweck C. S., 2006, MINDSET NEW PSYCHOL; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Hanna G.S., 1993, NELSON DENNY READING; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jaeggi SM, 2011, P NATL ACAD SCI USA, V108, P10081, DOI 10.1073/pnas.1103228108; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; Jausovec N, 2012, BRAIN COGNITION, V79, P96, DOI 10.1016/j.bandc.2012.02.007; Jones E., 2001, SCIPY OPEN SOURCE SC; Kane MJ, 2005, PSYCHOL BULL, V131, P66, DOI 10.1037/0033-2909.131.1.66; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; Loosli Sandra V, 2012, Child Neuropsychol, V18, P62, DOI 10.1080/09297049.2011.575772; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; Novick JM, 2014, LANG COGN NEUROSCI, V29, P186, DOI 10.1080/01690965.2012.758297; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Ramsden S, 2011, NATURE, V479, P113, DOI 10.1038/nature10514; Raven J. C., 1998, RAVENS PROGR MATRICE; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Schunk DH, 2007, LEARNING THEORIES ED; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Sternberg RJ, 2008, P NATL ACAD SCI USA, V105, P6791, DOI 10.1073/pnas.0803396105; Studer-Luethi B, 2012, PERS INDIV DIFFER, V53, P44, DOI 10.1016/j.paid.2012.02.012; Takeuchi H, 2011, J NEUROSCI, V31, P12139, DOI 10.1523/JNEUROSCI.2948-11.2011; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2005, WECHSLER ADULT INTEL; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Wickens T.D., 2001, ELEMENTARY SIGNAL DE; Woodcock RW, 2001, WOODCOCK JOHNSON 3 B	61	137	141	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63614	10.1371/journal.pone.0063614	http://dx.doi.org/10.1371/journal.pone.0063614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UP	23717453	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700038
J	Berisha, SZ; Hsu, J; Robinet, P; Smith, JD				Berisha, Stela Z.; Hsu, Jeffrey; Robinet, Peggy; Smith, Jonathan D.			Transcriptome Analysis of Genes Regulated by Cholesterol Loading in Two Strains of Mouse Macrophages Associates Lysosome Pathway and ER Stress Response with Atherosclerosis Susceptibility	PLOS ONE			English	Article							LIVER X RECEPTOR; E-DEFICIENT MICE; FOAM CELLS; HEMATOPOIETIC STEM; PROGENITOR CELLS; TRANSPORT; APOPTOSIS; METABOLISM; EXPRESSION; EFFLUX	Cholesterol loaded macrophages in the arterial intima are the earliest histological evidence of atherosclerosis. Studies of mouse models of atherosclerosis have shown that the strain background can have a significant effect on lesion development. We have previously shown that DBA/2 ApoE(-/-) mice have aortic root lesions 10-fold larger than AKR ApoE(-/-) mice. The current study analyzes the response to cholesterol loading of macrophages from these two strains. Macrophages from the atherosclerosis susceptible DBA/2 strain had significantly higher levels of total and esterified cholesterol compared to atherosclerosis resistant AKR macrophages, while free cholesterol levels were higher in AKR cells. Gene expression profiles were obtained and data were analyzed for strain, cholesterol loading, and strain-cholesterol loading interaction effects by a fitted linear model. Pathway and transcriptional motif enrichment were identified by gene set enrichment analysis. In addition to observed strain differences in basal gene expression, we identified many transcripts whose expression was significantly altered in response to cholesterol loading, including P2ry13 and P2ry14, Trib3, Hyal1, Vegfa, Ccr5, Ly6a, and Ifit3. Eight pathways were significantly enriched in transcripts regulated by cholesterol loading, among which the lysosome and cytokine-cytokine receptor interaction pathways had the highest number of significantly regulated transcripts. Of the differentially regulated transcripts with a strain-cholesterol loading interaction effect, we identified three genes known to participate in the endoplasmic reticulum (ER) stress response, Ddit3, Trib3 and Atf4. These three transcripts were highly up-regulated by cholesterol in AKR and either down-regulated or unchanged in loaded DBA/2 macrophages, thus associating a robust ER stress response with atherosclerosis resistance. We identified significant transcripts with strain, loading, or strain-loading interaction effect that reside within previously described quantitative trait loci as atherosclerosis modifier candidate genes. In conclusion, we characterized several strain and cholesterol induced differences that may lead to new insights into cellular cholesterol metabolism and atherosclerosis.	[Berisha, Stela Z.; Hsu, Jeffrey; Robinet, Peggy; Smith, Jonathan D.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Hsu, Jeffrey; Smith, Jonathan D.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Smith, JD (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	smithj4@ccf.org	Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X	National Institutes of Health grant [HL098193]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088088] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant HL098193 to JDS (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwaili K, 2010, EXPERT REV CARDIOVAS, V8, P413, DOI [10.1586/erc.10.4, 10.1586/ERC.10.4]; Blom D, 2010, BBA-MOL CELL BIOL L, V1801, P1349, DOI 10.1016/j.bbalip.2010.08.013; Bolstad B, 2005, BIOINFORMATICS COMPU; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Curcio-Morelli C, 2010, NEUROBIOL DIS, V40, P370, DOI 10.1016/j.nbd.2010.06.010; DeBose-Boyd RA, 2011, COLD SPRING HARB PER, V3, P10; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Dorum G, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1418; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fabre AC, 2010, HEPATOLOGY, V52, P1477, DOI 10.1002/hep.23897; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Hsu J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005421; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Lee BC, 2003, GENE DEV, V17, P1592, DOI 10.1101/gad.1071503; Li CM, 2002, GENOMICS, V79, P218, DOI 10.1006/geno.2002.6686; Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; Marcel YL, 2008, CURR OPIN LIPIDOL, V19, P455, DOI 10.1097/MOL.0b013e32830f4a1d; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Moreno PR, 2009, J AM COLL CARDIOL, V53, P2315, DOI 10.1016/j.jacc.2009.02.057; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Pehkonen P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-50; Pennings M, 2006, FEBS LETT, V580, P5588, DOI 10.1016/j.febslet.2006.08.022; Prudente S, 2012, ENDOCR REV, V33, P526, DOI 10.1210/er.2011-1042; Robinet P, 2013, ARTERIOSCLE IN PRESS; Robinet P, 2010, J LIPID RES, V51, P3364, DOI 10.1194/jlr.D007336; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shang YY, 2010, CLIN EXP PHARMACOL P, V37, P51, DOI 10.1111/j.1440-1681.2009.05229.x; Shang YY, 2009, FEBS J, V276, P2752, DOI 10.1111/j.1742-4658.2009.06998.x; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; Smith JD, 2006, ARTERIOSCL THROM VAS, V26, P597, DOI 10.1161/01.ATV.0000201044.33220.5c; Smith JD, 2003, ARTERIOSCL THROM VAS, V23, P117, DOI 10.1161/01.ATV.0000047461.18902.80; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Strong A, 2012, J CLIN INVEST, V122, P2807, DOI 10.1172/JCI63563; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Thompson EG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-54; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tiwari RL, 2008, MED RES REV, V28, P483, DOI 10.1002/med.20118; Vainio S, 2003, ANN MED, V35, P146, DOI 10.1080/07853890310008198; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Wang ZH, 2012, DIABETES, V61, P463, DOI 10.2337/db11-0518; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	54	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65003	10.1371/journal.pone.0065003	http://dx.doi.org/10.1371/journal.pone.0065003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705026	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200180
J	Bonvallot, N; Tremblay-Franco, M; Chevrier, C; Canlet, C; Warembourg, C; Cravedi, JP; Cordier, S				Bonvallot, Nathalie; Tremblay-Franco, Marie; Chevrier, Cecile; Canlet, Cecile; Warembourg, Charline; Cravedi, Jean-Pierre; Cordier, Sylvaine			Metabolomics Tools for Describing Complex Pesticide Exposure in Pregnant Women in Brittany (France)	PLOS ONE			English	Article							PRENATAL EXPOSURE; URINE SAMPLES; AMINO-ACIDS; METABONOMICS; METABOLISM; BLOOD; ORGANOPHOSPHORUS; TECHNOLOGIES; MOTHERS; AGE	Background: The use of pesticides and the related environmental contaminations can lead to human exposure to various molecules. In early-life, such exposures could be responsible for adverse developmental effects. However, human health risks associated with exposure to complex mixtures are currently under-explored. Objective: This project aims at answering the following questions: What is the influence of exposures to multiple pesticides on the metabolome? What mechanistic pathways could be involved in the metabolic changes observed? Methods: Based on the PELAGIE cohort (Brittany, France), 83 pregnant women who provided a urine sample in early pregnancy, were classified in 3 groups according to the surface of land dedicated to agricultural cereal activities in their town of residence. Nuclear magnetic resonance-based metabolomics analyses were performed on urine samples. Partial Least Squares Regression-Discriminant Analysis (PLS-DA) and polytomous regressions were used to separate the urinary metabolic profiles from the 3 exposure groups after adjusting for potential confounders. Results: The 3 groups of exposure were correctly separated with a PLS-DA model after implementing an orthogonal signal correction with pareto standardizations (R2 = 90.7% and Q2 = 0.53). After adjusting for maternal age, parity, body mass index and smoking habits, the most statistically significant changes were observed for glycine, threonine, lactate and glycerophosphocholine (upward trend), and for citrate (downward trend). Conclusion: This work suggests that an exposure to complex pesticide mixtures induces modifications of metabolic fingerprints. It can be hypothesized from identified discriminating metabolites that the pesticide mixtures could increase oxidative stress and disturb energy metabolism.	[Bonvallot, Nathalie] Natl Inst Hlth & Med Res, INSERM, UMR 1085, IRSET,Res Inst Environm & Occupat Hlth, Rennes, France; [Bonvallot, Nathalie] EHESP Sch Publ Hlth Rennes, Paris, France; [Bonvallot, Nathalie; Tremblay-Franco, Marie; Canlet, Cecile; Cravedi, Jean-Pierre] Univ Toulouse, Natl Inst Agr Res INRA UMR Toxalim 1331, Res Ctr Food Toxicol, INP,ENVT,EIP,UPS,UMR1331, Toulouse, France; [Chevrier, Cecile; Warembourg, Charline; Cordier, Sylvaine] INSERM UMR 1085 IRSET, Rennes, France; [Chevrier, Cecile; Warembourg, Charline; Cordier, Sylvaine] Univ Rennes 1, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Bonvallot, N (corresponding author), Natl Inst Hlth & Med Res, INSERM, UMR 1085, IRSET,Res Inst Environm & Occupat Hlth, Rennes, France.	nathalie.bonvallot@ehesp.fr	Bonvallot, Nathalie/J-9378-2015; Warembourg, Charline/AAP-5498-2020; Cordier, Sylvaine/X-7440-2019; Cordier, Sylvaine/F-7919-2013; Chevrier, Cecile/J-9170-2015; Bonvallot, Nathalie/ABF-7860-2020	Bonvallot, Nathalie/0000-0002-8070-6008; Warembourg, Charline/0000-0003-2716-9167; Chevrier, Cecile/0000-0003-3101-8222; Bonvallot, Nathalie/0000-0002-8070-6008; Cordier, Sylvaine/0000-0002-2349-2277	EHESP-School of Public Health (Young researchers); French Ministry for Environment and sustainable development (Antiopes, INERIS)	EHESP-School of Public Health (Young researchers); French Ministry for Environment and sustainable development (Antiopes, INERIS)	This work was supported by grants from the EHESP-School of Public Health (Young researchers, www.ehesp.fr) and the French Ministry for Environment and sustainable development (Antiopes, INERIS, http://www.ineris.fr/dossiers-thematiques-ineris/509). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram HC, 2009, METABOLISM, V58, P1039, DOI 10.1016/j.metabol.2009.03.011; Boehm G, 1998, PEDIATR RES, V44, P900, DOI 10.1203/00006450-199812000-00013; Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P1189, DOI 10.1289/ehp.1003185; Bradman A, 2011, INT J ENV RES PUB HE, V8, P1061, DOI 10.3390/ijerph8041061; Bretagne Agreste, 2009, ENQ PRAT CULT 2006 P; Chevrier C, 2011, ENVIRON HEALTH PERSP, V119, P1034, DOI 10.1289/ehp.1002775; Clayton CA, 2003, J EXPO ANAL ENV EPID, V13, P100, DOI 10.1038/sj.jea.7500261; D'Adamo P, 2010, AMINO ACIDS, V38, P65, DOI 10.1007/s00726-008-0205-8; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Ellis JK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-61; Eriksson L., 2006, MULTI MEGAVARIATE 1; Eskenazi B, 2008, BASIC CLIN PHARMACOL, V102, P228, DOI 10.1111/j.1742-7843.2007.00171.x; FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032; Gu HW, 2009, NMR BIOMED, V22, P826, DOI 10.1002/nbm.1395; Gunier RB, 2011, ENVIRON HEALTH PERSP, V119, P970, DOI 10.1289/ehp.1002532; Kamel F, 2004, ENVIRON HEALTH PERSP, V112, P950, DOI 10.1289/ehp.7135; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Kochhar S, 2006, ANAL BIOCHEM, V352, P274, DOI 10.1016/j.ab.2006.02.033; Kuo CH, 2012, CHEM RES TOXICOL, V25, P676, DOI 10.1021/tx200465e; Lee JE, 2012, TOXICOL APPL PHARM, V263, P148, DOI 10.1016/j.taap.2012.06.005; Lenz EM, 2004, J PHARMACEUT BIOMED, V36, P841, DOI 10.1016/j.jpba.2004.08.002; Li HY, 2011, TOXICOL IND HEALTH, V27, P579, DOI 10.1177/0748233710393400; Lindon JC, 2004, BIOMARKERS, V9, P1, DOI 10.1080/13547500410001668379; London L, 2012, NEUROTOXICOLOGY, V33, P887, DOI 10.1016/j.neuro.2012.01.004; Maher AD, 2007, ANAL CHEM, V79, P5204, DOI 10.1021/ac070212f; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Petit C, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-71; Petrat F, 2012, BRIT J PHARMACOL, V165, P2059, DOI 10.1111/j.1476-5381.2011.01711.x; Rauch SA, 2012, ENVIRON HEALTH PERSP, V120, P1055, DOI 10.1289/ehp.1104615; Regnault TRH, 2005, PLACENTA, V26, pS52, DOI 10.1016/j.placenta.2005.01.003; Robertson DG, 2011, TOXICOL SCI, V120, pS146, DOI 10.1093/toxsci/kfq358; Schreinemachers DM, 2003, ENVIRON HEALTH PERSP, V111, P1259, DOI 10.1289/ehp.5830; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Tea I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029947; Munoz-Quezada MT, 2012, ENVIRON INT, V47, P28, DOI 10.1016/j.envint.2012.06.002; Verwaest KA, 2011, BBA-MOL BASIS DIS, V1812, P1371, DOI 10.1016/j.bbadis.2011.08.001; Vlaanderen J, 2010, OCCUP ENVIRON MED, V67, P136, DOI 10.1136/oem.2008.042788; Ward MH, 2006, ENVIRON HEALTH PERSP, V114, P893, DOI 10.1289/ehp.8770; Whyatt RM, 2003, ENVIRON HEALTH PERSP, V111, P749, DOI 10.1289/ehp.5768; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P175, DOI 10.1016/S0169-7439(98)00109-9; Wolff MS, 2007, PEDIATR RES, V61, P243, DOI 10.1203/pdr.0b013e31802d77f0; Xiang HY, 2000, ENVIRON RES, V82, P160, DOI 10.1006/enrs.1999.4009	42	42	45	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64433	10.1371/journal.pone.0064433	http://dx.doi.org/10.1371/journal.pone.0064433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704985	Green Published, gold			2022-12-27	WOS:000319330200134
J	Jiang, KZ; Zhang, H; Wang, JM; Li, F; Qian, MR				Jiang, Kezhi; Zhang, Hu; Wang, Jianmei; Li, Fei; Qian, Mingrong			Fragmentation of Deprotonated Diacylhydrazine Derivatives in Electrospray Ionization Tandem Mass Spectrometry: Generation of Acid Anions via Intramolecular Rearrangement	PLOS ONE			English	Article							COLLISION-INDUCED DISSOCIATION; LIQUID-CHROMATOGRAPHY; NEGATIVE-ION; METHOXYFENOZIDE RESIDUES; ECDYSONE AGONISTS; TEBUFENOZIDE; VEGETABLES; PESTICIDES; MECHANISM; PEPTIDES	The gas-phase fragmentation pathways of deprotonated diacylhydrazine derivatives (R-1(C=O)-N(t-Bu)NH(C=O)R-2, Compounds 1-6) were investigated by the combination of electrospray ionization tandem mass spectrometry (ESI-MS/MS) and theoretical calculations. Upon collisional activation, the deprotonated molecular ions [M - H](-) dissociate in two reaction channels, both of which involve intramolecular rearrangement. The main product ion is confirmed to be an anionic acid species, [R-1-CO2](-), generated through intramolecular rearrangement of [M - H](-) initiated by the nucleophilic attack of the amide O6 on the carbonyl C2 (Path-1). The minor fragment channel (Path-2) involves methylpropene elimination of the precursor ion, followed by a similar nucleophilic displacement reaction to produce another acid anion [ R-2-CO2](-). Density functional theory calculations at the B3LYP/6-31+G(d,p) level indicate that Path-1 is more favorable than Path-2 for dissociation of the deprotonated halofenozide.	[Jiang, Kezhi; Li, Fei] Hangzhou Normal Univ, Key Lab Organosilicon Chem & Mat Technol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Hu; Wang, Jianmei; Qian, Mingrong] Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, MOA Key Lab Pesticide Residue Detect, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Zhejiang Academy of Agricultural Sciences	Qian, MR (corresponding author), Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, MOA Key Lab Pesticide Residue Detect, Hangzhou, Zhejiang, Peoples R China.	qianmr@mail.zaas.ac.cn	Wang, Jianmei/HHZ-0585-2022		National Natural Science Foundation of China [21205025, 21207118]; National Science Foundation of Zhejiang Province [Y4100020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Zhejiang Province	This work received financial support from the National Natural Science Foundation of China (No. 21205025, No. 21207118) and the National Science Foundation of Zhejiang Province (No. Y4100020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami M, 2001, MASS SPECTROM REV, V20, P195, DOI 10.1002/mas.10005; Alex A, 2009, RAPID COMMUN MASS SP, V23, P2619, DOI 10.1002/rcm.4163; Araujo L, 2010, ANAL LETT, V43, P2340, DOI 10.1080/00032711003717372; Bandu ML, 2006, INT J MASS SPECTROM, V251, P40, DOI 10.1016/j.ijms.2006.01.004; Bonacci G, 2011, J AM SOC MASS SPECTR, V22, P1534, DOI 10.1007/s13361-011-0185-x; BUDZIKIEWICZ H, 1986, MASS SPECTROM REV, V5, P345, DOI 10.1002/mas.1280050402; Cataldi TRI, 2010, ANAL CHEM, V82, P5686, DOI 10.1021/ac100703w; Cazorla-Reyes R, 2011, TALANTA, V85, P183, DOI 10.1016/j.talanta.2011.03.048; Dai L, 2008, CHINESE J ANAL CHEM, V36, P87; Doohan RA, 2011, J AM SOC MASS SPECTR, V22, P1052, DOI 10.1007/s13361-011-0102-3; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; George M, 2011, INT J MASS SPECTROM, V306, P232, DOI 10.1016/j.ijms.2011.01.007; Hall GL, 2004, J AGR FOOD CHEM, V52, P672, DOI 10.1021/jf030591n; Hu N, 2008, RAPID COMMUN MASS SP, V22, P2715, DOI 10.1002/rcm.3672; Kanawati B, 2007, INT J MASS SPECTROM, V266, P97, DOI 10.1016/j.ijms.2007.07.014; Kanawati B, 2010, RAPID COMMUN MASS SP, V24, P1198, DOI 10.1002/rcm.4504; Kanawati B, 2009, INT J MASS SPECTROM, V288, P6, DOI 10.1016/j.ijms.2009.07.010; Lee JH, 2010, ANAL CHIM ACTA, V674, P64, DOI 10.1016/j.aca.2010.06.016; Liu XG, 2011, ANAL BIOANAL CHEM, V401, P1051, DOI 10.1007/s00216-011-5148-3; Nakagawa Y, 2005, VITAM HORM, V73, P131, DOI 10.1016/S0083-6729(05)73005-3; Qian L, 2008, PESTIC BIOCHEM PHYS, V91, P175, DOI 10.1016/j.pestbp.2008.03.011; Qian MR, 2012, ANAL BIOANAL CHEM, V402, P2451, DOI 10.1007/s00216-011-5699-3; Ramesh M, 2011, RAPID COMMUN MASS SP, V25, P1949, DOI 10.1002/rcm.5076; RETNAKARAN A, 1995, INSECT BIOCHEM MOLEC, V25, P109, DOI 10.1016/0965-1748(94)00037-I; Retnakaran A, 2003, ARCH INSECT BIOCHEM, V54, P187, DOI 10.1002/arch.10116; Rifai A, 2011, J MASS SPECTROM, V46, P1079, DOI 10.1002/jms.1991; Sannino A, 2004, J CHROMATOGR A, V1036, P161, DOI 10.1016/j.chroma.2004.02.078; Sundaram M, 2002, INSECT BIOCHEM MOLEC, V32, P225, DOI 10.1016/S0965-1748(01)00111-4; Timonen J, 2009, EUR J MASS SPECTROM, V15, P595, DOI 10.1255/ejms.1019; Volmer DA, 2010, RAPID COMMUN MASS SP, V24, P3499, DOI 10.1002/rcm.4802; Wang HY, 2006, J AM SOC MASS SPECTR, V17, P253, DOI 10.1016/j.jasms.2005.11.001; Wang TF, 2009, RAPID COMMUN MASS SP, V23, P1669, DOI 10.1002/rcm.4061; Williams BJ, 2011, J AM SOC MASS SPECTR, V22, P1622, DOI 10.1007/s13361-011-0165-1; Zhang JY, 2004, J MASS SPECTROM, V39, P295, DOI 10.1002/jms.582; Zhou YP, 2007, J AM SOC MASS SPECTR, V18, P1813, DOI 10.1016/j.jasms.2007.07.012	35	3	3	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63097	10.1371/journal.pone.0063097	http://dx.doi.org/10.1371/journal.pone.0063097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704891	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200020
J	Kim, Y; Suktitipat, B; Yanek, LR; Faraday, N; Wilson, AF; Becker, DM; Becker, LC; Mathias, RA				Kim, Yoonhee; Suktitipat, Bhoom; Yanek, Lisa R.; Faraday, Nauder; Wilson, Alexander F.; Becker, Diane M.; Becker, Lewis C.; Mathias, Rasika A.			Targeted Deep Resequencing Identifies Coding Variants in the PEAR1 Gene That Play a Role in Platelet Aggregation	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; RARE VARIANTS; HUMAN GENOME; HERITABILITY; ASPIRIN; AGGREGABILITY; ASSOCIATION; ACTIVATION; TESTS	Platelet aggregation is heritable, and genome-wide association studies have detected strong associations with a common intronic variant of the platelet endothelial aggregation receptor1 (PEAR1) gene both in African American and European American individuals. In this study, we used a sequencing approach to identify additional exonic variants in PEAR1 that may also determine variability in platelet aggregation in the GeneSTAR Study. A 0.3 Mb targeted region on chromosome 1q23.1 including the entire PEAR1 gene was Sanger sequenced in 104 subjects (45% male, 49% African American, age = 52 +/- 13) selected on the basis of hyper- and hypo- aggregation across three different agonists (collagen, epinephrine, and adenosine diphosphate). Single-variant and multi-variant burden tests for association were performed. Of the 235 variants identified through sequencing, 61 were novel, and three of these were missense variants. More rare variants (MAF<5%) were noted in African Americans compared to European Americans (108 vs. 45). The common intronic GWAS-identified variant (rs12041331) demonstrated the most significant association signal in African Americans (p = 4.020 x 10(-4)); no association was seen for additional exonic variants in this group. In contrast, multi-variant burden tests indicated that exonic variants play a more significant role in European Americans (p = 0.0099 for the collective coding variants compared to p = 0.0565 for intronic variant rs12041331). Imputation of the individual exonic variants in the rest of the GeneSTAR European American cohort (N = 1,965) supports the results noted in the sequenced discovery sample: p = 3.56 x 10(-4), 2.27 x 10(-7), 5.20 x 10(-5) for coding synonymous variant rs56260937 and collagen, epinephrine and adenosine diphosphate induced platelet aggregation, respectively. Sequencing approaches confirm that a common intronic variant has the strongest association with platelet aggregation in African Americans, and show that exonic variants play an additional role in platelet aggregation in European Americans.	[Kim, Yoonhee; Suktitipat, Bhoom; Wilson, Alexander F.] NHGRI, Genometr Sect, Inherited Dis Res Branch, NIH, Baltimore, MD USA; [Kim, Yoonhee; Suktitipat, Bhoom; Yanek, Lisa R.; Becker, Diane M.; Becker, Lewis C.; Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Dept Med, GeneSTAR Res Program, Baltimore, MD 21205 USA; [Faraday, Nauder] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University	Mathias, RA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, GeneSTAR Res Program, Baltimore, MD 21205 USA.	rmathias@jhmi.edu	Wilson, Alexander F./Q-6910-2019; Suktitipat, Bhoom/H-4239-2019	Suktitipat, Bhoom/0000-0001-8034-7757	National Heart, Lung, and Blood Institute [HL72518, HL087698]; National Center for Research Resources [M01-RR000052]; Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health; MOSAIC award from The Johns Hopkins University Provosts Office; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107446, U01HL072518, R01HL087698] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000200] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MOSAIC award from The Johns Hopkins University Provosts Office; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by grants from the National Heart, Lung, and Blood Institute, (HL72518 and HL087698), and the National Center for Research Resources (M01-RR000052) and by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. R.A. Mathias was supported in part by the MOSAIC award from The Johns Hopkins University Provosts Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2009, PLOS GENET, V2009, DOI [10.1101/pdb.ip71, DOI 10.1101/PDB.IP71]; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Becker DM, 2006, JAMA-J AM MED ASSOC, V295, P1420, DOI 10.1001/jama.295.12.1420; Bray PF, 2007, J THROMB HAEMOST, V5, P1617, DOI 10.1111/j.1538-7836.2007.02618.x; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Faraday N, 2007, CIRCULATION, V115, P2490, DOI 10.1161/CIRCULATIONAHA.106.667584; Faraday N, 2011, BLOOD, V118, P3367, DOI 10.1182/blood-2010-11-320788; FUSTER V, 1993, CIRCULATION, V87, P659, DOI 10.1161/01.CIR.87.2.659; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Herrera-Galeano JE, 2008, ARTERIOSCL THROM VAS, V28, P1484, DOI 10.1161/ATVBAHA.108.168971; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Shaw E, 2009, CURR ATHEROSCLER REP, V11, P289, DOI 10.1007/s11883-009-0044-4; Suktitipat B, 2012, HUM HERED, V74, P17, DOI 10.1159/000341636	21	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64179	10.1371/journal.pone.0064179	http://dx.doi.org/10.1371/journal.pone.0064179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704978	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200120
J	Kriticos, DJ; Morin, L; Leriche, A; Anderson, RC; Caley, P				Kriticos, Darren J.; Morin, Louise; Leriche, Agathe; Anderson, Robert C.; Caley, Peter			Combining a Climatic Niche Model of an Invasive Fungus with Its Host Species Distributions to Identify Risks to Natural Assets: Puccinia psidii Sensu Lato in Australia	PLOS ONE			English	Article							POTENTIAL GEOGRAPHIC RANGE; EUCALYPTUS RUST; PLANT; DISEASE; AREAS; TEMPERATURE; SYSTEM	Puccinia psidii sensu lato (s.l.) is an invasive rust fungus threatening a wide range of plant species in the family Myrtaceae. Originating from Central and South America, it has invaded mainland USA and Hawai'i, parts of Asia and Australia. We used CLIMEX to develop a semi-mechanistic global climatic niche model based on new data on the distribution and biology of P. psidii s.l. The model was validated using independent distribution data from recently invaded areas in Australia, China and Japan. We combined this model with distribution data of its potential Myrtaceae host plant species present in Australia to identify areas and ecosystems most at risk. Myrtaceaeous species richness, threatened Myrtaceae and eucalypt plantations within the climatically suitable envelope for P. psidii s.l in Australia were mapped. Globally the model identifies climatically suitable areas for P. psidii s.l. throughout the wet tropics and sub-tropics where moist conditions with moderate temperatures prevail, and also into some cool regions with a mild Mediterranean climate. In Australia, the map of species richness of Myrtaceae within the P. psidii s.l. climatic envelope shows areas where epidemics are hypothetically more likely to be frequent and severe. These hotspots for epidemics are along the eastern coast of New South Wales, including the Sydney Basin, in the Brisbane and Cairns areas in Queensland, and in the coastal region from the south of Bunbury to Esperance in Western Australia. This new climatic niche model for P. psidii s.l. indicates a higher degree of cold tolerance; and hence a potential range that extends into higher altitudes and latitudes than has been indicated previously. The methods demonstrated here provide some insight into the impacts an invasive species might have within its climatically suited range, and can help inform biosecurity policies regarding the management of its spread and protection of valued threatened assets.	[Kriticos, Darren J.; Morin, Louise; Leriche, Agathe; Caley, Peter] Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia; [Kriticos, Darren J.] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Anderson, Robert C.] Univ Hawaii, Coll Trop Agr & Human Resources, Honolulu, HI 96822 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Minnesota System; University of Minnesota Twin Cities; University of Hawaii System	Kriticos, DJ (corresponding author), Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia.	Darren.kriticos@csiro.au	Leriche, Agathe/C-3151-2008; Morin, Louise/B-4822-2009; Kriticos, Darren J/A-4170-2008; Caley, Peter/D-8638-2011	Leriche, Agathe/0000-0001-9646-5344; Kriticos, Darren J/0000-0003-2599-8105; Caley, Peter/0000-0002-8077-6460; Morin, Louise/0000-0002-9515-2255	Commonwealth Scientific and Industrial Research Organisation Biosecurity Flagship; Sustainable Agriculture Flagships; New Zealand's Foundation for Research, Science Technology [CO2X0501]; etter Border Biosecurity (B3) programme	Commonwealth Scientific and Industrial Research Organisation Biosecurity Flagship; Sustainable Agriculture Flagships; New Zealand's Foundation for Research, Science Technology(New Zealand Foundation for Research, Science and Technology); etter Border Biosecurity (B3) programme	This work was partially funded by the Commonwealth Scientific and Industrial Research Organisation Biosecurity Flagship and Sustainable Agriculture Flagships, and New Zealand's Foundation for Research, Science & Technology through contract CO2X0501, the Better Border Biosecurity (B3) programme (www.b3nz.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARES, 2010, LAND USE AUSTR VERS; Anderson R. C., 2012, BASELINE ANAL DISTRI; Baker R. H. A., 2012, Bulletin OEPP, V42, P65, DOI [10.1111/j.1365-2338.2012.02545.x, 10.1111/epp.2545]; BARBOUR MG, 1967, ECOLOGY, V48, P861, DOI 10.2307/1933746; Bonde MR, 2007, PHYTOPATHOLOGY, V97, P997, DOI 10.1094/PHYTO-97-8-0997; Booth TH, 2000, AGR ECOSYST ENVIRON, V82, P295, DOI 10.1016/S0167-8809(00)00233-4; Booth TH, 2012, AUSTRALAS PLANT PATH, V41, P425, DOI 10.1007/s13313-012-0130-x; Brasier C. M., 1994, Bulletin OEPP, V24, P221, DOI 10.1111/j.1365-2338.1994.tb01063.x; Brockerhoff EG, 2012, PLOS ONE, V8; CABI, 2005, DISTR MAPS PLANT DIS; Carnegie AJ, 2010, AUSTRALAS PLANT PATH, V39, P463, DOI 10.1071/AP10102; Carnegie AJ, 2011, AUSTRALAS PLANT PATH, V40, P346, DOI 10.1007/s13313-011-0066-6; Chiani R. G., 1959, Bol argent. for., V17, P10; Coelho Lisias, 2001, Summa Phytopathologica, V27, P295; Coutinho TA, 1998, PLANT DIS, V82, P819, DOI 10.1094/PDIS.1998.82.7.819; de Villiers M, 2013, B ENTOMOL RES, V103, P60, DOI 10.1017/S0007485312000454; Department of Sustainability Environment Water Population and Communities, 2009, EPBC ACT LIST THREAT; Elith J, 2013, AUSTRALAS PLANT PATH, V42, P43, DOI 10.1007/s13313-012-0178-7; Eyre D., 2012, Bulletin OEPP, V42, P48, DOI [10.1111/epp.2549, 10.1111/j.1365-2338.2012.02549.x]; FAO, 2006, INT STAND PHYT MEAS; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Ferreira F. A., 1983, Revista Arvore, V7, P91; Ferreira F.A., 1981, FITOPATOL BRAS, V6, P603; Gavran M., 2010, AUSTR PLANTATIONS 20; GIT Forestry Consulting, 2008, GLOB EUC MAP; Glen M, 2007, AUSTRALAS PLANT PATH, V36, P1, DOI 10.1071/AP06088; Gommes R, 2004, EUROPEAN SOC AGRONOM, V26; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hoddle MS, 2004, CROP PROT, V23, P691, DOI 10.1016/j.cropro.2003.11.017; Hutchinson M., 2009, ANUCLIM 6 0 USERS GU; HUTCHINSON MF, 1994, GEODERMA, V62, P45, DOI 10.1016/0016-7061(94)90027-2; HUTCHINSON MF, 1995, INT J GEOGR INF SYST, V9, P385, DOI 10.1080/02693799508902045; Kawanishi T, 2009, J GEN PLANT PATHOL, V75, P428, DOI 10.1007/s10327-009-0202-0; Keatley MR, 2002, INT J CLIMATOL, V22, P1769, DOI 10.1002/joc.822; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos DJ, 2007, J APPL ECOL, V44, P853, DOI 10.1111/j.1365-2664.2007.01331.x; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Kriticos DJ, 2008, 200928 MAF BIOS NZ S; Ladiges PY, 2003, J BIOGEOGR, V30, P989, DOI 10.1046/j.1365-2699.2003.00881.x; Lanoiselet V, 2002, AUSTRALAS PLANT PATH, V31, P1, DOI 10.1071/AP01070; MacLachlan JD, 1938, PHYTOPATHOLOGY, V28, P157; Magarey RD, 2007, PLANT DIS, V91, P336, DOI 10.1094/PDIS-91-4-0336; MARLATT RB, 1979, PLANT DIS REP, V63, P510; McCarthy HR, 2011, ECOL APPL, V21, P3115, DOI 10.1890/11-0048.1; Mellano V, 2006, HLTH GARD HLTH HOME, V1, P3; Morin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035434; Myerscough Peter J., 1998, Cunninghamia, V5, P787; NSW Department of Primary Industries, 2012, FIELD HOSTS MYRTL RU; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; Queensland Department of Agriculture Fisheries and Forestry, 2012, LIST HOST PLANTS AFF; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ricciardi A, 2007, BIOL INVASIONS, V9, P309, DOI 10.1007/s10530-006-9034-4; RUIZ R A R, 1989, Fitopatologia Brasileira, V14, P55; Schroeder TA, 1986, RAINFALL ATLAS HAWAI, pR76; Simpson JA, 2006, AUSTRALAS PLANT PATH, V35, P549, DOI 10.1071/AP06057; Sutherst R W, 2007, CLIMEX VERSION 3 USE; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Tessmann D. J., 2002, Fitopatologia Brasileira, V27, P538, DOI 10.1590/S0100-41582002000500017; Uchida J, 2006, PLANT DIS, V90, P524, DOI 10.1094/PD-90-0524C; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Watt MS, 2009, FOREST ECOL MANAG, V257, P1505, DOI 10.1016/j.foreco.2008.12.026; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodall GS, 1998, J EXP BOT, V49, P79, DOI 10.1093/jexbot/49.318.79; Xavier Aloisio, 2010, Agron. Costarricense, V34, P93; Yonow T, 2004, PHYTOPATHOLOGY, V94, P805, DOI 10.1094/PHYTO.2004.94.8.805; [Zhuang Jianyun 庄剑云], 2011, [菌物学报, Mygosystema], V30, P853	70	56	60	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64479	10.1371/journal.pone.0064479	http://dx.doi.org/10.1371/journal.pone.0064479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704988	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200141
J	Moussa, S; Jenabian, MA; Gody, JC; Leal, J; Gresenguet, G; Le Faou, A; Belec, L				Moussa, Sandrine; Jenabian, Mohammad-Ali; Gody, Jean Chrysostome; Leal, Josiane; Gresenguet, Gerard; Le Faou, Alain; Belec, Laurent			Adaptive HIV-Specific B Cell-Derived Humoral Immune Defenses of the Intestinal Mucosa in Children Exposed to HIV via Breast-Feeding	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE-CHAIN-REACTION; EPITHELIAL-CELLS; MONOCLONAL-ANTIBODIES; ANTIRETROVIRAL DRUGS; RESISTANCE MUTATIONS; HIV-1-INFECTED WOMEN; HIV-1-SPECIFIC IGG; VIRAL TRANSCYTOSIS; MILK TRANSMISSION	Background: We evaluated whether B cell-derived immune defenses of the gastro-intestinal tract are activated to produce HIV-specific antibodies in children continuously exposed to HIV via breast-feeding. Methods: Couples of HIV-1-infected mothers (n = 14) and their breastfed non HIV-infected (n = 8) and HIV-infected (n = 6) babies, and healthy HIV-negative mothers and breastfed babies (n = 10) as controls, were prospectively included at the Complexe Pediatrique of Bangui, Central African Republic. Immunoglobulins (IgA, IgG and IgM) and anti-gp160 antibodies from mother's milk and stools of breastfed children were quantified by ELISA. Immunoaffinity purified anti-gp160 antibodies were characterized functionally regarding their capacity to reduce attachment and/or infection of R5- and X4- tropic HIV-1 strains on human colorectal epithelial HT29 cells line or monocyte-derived-macrophages (MDM). Results: The levels of total IgA and IgG were increased in milk of HIV-infected mothers and stools of HIV-exposed children, indicating the activation of B cell-derived mucosal immunity. Breast milk samples as well as stool samples from HIV-negative and HIV-infected babies exposed to HIV by breast-feeding, contained high levels of HIV-specific antibodies, mainly IgG antibodies, less frequently IgA antibodies, and rarely IgM antibodies. Relative ratios of excretion by reference to lactoferrin calculated for HIV-specific IgA, IgG and IgM in stools of HIV-exposed children were largely superior to 1, indicating active production of HIV-specific antibodies by the intestinal mucosa. Antibodies to gp160 purified from pooled stools of HIV-exposed breastfed children inhibited the attachment of HIV-1NDK on HT29 cells by 63% and on MDM by 77%, and the attachment of HIV-1JRCSF on MDM by 40%; and the infection of MDM by HIV-1JRCSF by 93%. Conclusions: The intestinal mucosa of children exposed to HIV by breast-feeding produces HIV-specific antibodies harbouring in vitro major functional properties against HIV. These observations lay the conceptual basis for the design of a prophylactic vaccine against HIV in exposed children.	[Moussa, Sandrine; Leal, Josiane; Le Faou, Alain] Inst Pasteur, Lab Retrovirus VIH, Bangui, Cent Afr Republ; [Jenabian, Mohammad-Ali; Belec, Laurent] Hop Europe Georges Pompidou, AP HP, Virol Lab, Paris, France; [Gody, Jean Chrysostome] Complexe Pediat, Bangui, Cent Afr Republ; [Gresenguet, Gerard] Fac Sci Sante Bangui, Unite Rech & Intervent Malad Sexuellement Transmi, Dept Sante Publ, Bangui, Cent Afr Republ; [Belec, Laurent] Fac Med Paris Descartes, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Moussa, S (corresponding author), Inst Pasteur, Lab Retrovirus VIH, Bangui, Cent Afr Republ.	sandmoussa@hotmail.com		Le Faou, Alain/0000-0003-3243-7330	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	External funding sources were received for this study by a french research organism (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, J HUM LACT, V27, P171, DOI 10.1177/0890334410395761; Alexander R, 2007, CURR HIV RES, V5, P588, DOI 10.2174/157016207782418452; Artenstein AW, 1997, J INFECT DIS, V175, P265, DOI 10.1093/infdis/175.2.265; Ballan WM, 2007, J IMMUNOL, V179, P3362, DOI 10.4049/jimmunol.179.5.3362; Becquart P, 2000, J INFECT DIS, V181, P532, DOI 10.1086/315255; Becquart P, 1999, AIDS, V13, P1323, DOI 10.1097/00002030-199907300-00008; Becquart P, 2007, VIROLOGY, V363, P256, DOI 10.1016/j.virol.2007.02.003; BELEC L, 1989, J INFECT DIS, V160, P385, DOI 10.1093/infdis/160.3.385; BELEC L, 1995, J INFECT DIS, V172, P691, DOI 10.1093/infdis/172.3.691; BELEC L, 1990, PEDIATRICS, V85, P1022; Belec L, 2001, J INFECT DIS, V184, P1412, DOI 10.1086/324375; Belec L, 2012, ADV EXP MED BIOL, V743, P139, DOI 10.1007/978-1-4614-2251-8_10; Bertolli J, 1996, J INFECT DIS, V174, P722, DOI 10.1093/infdis/174.4.722; Bobat R, 1997, AIDS, V11, P1627, DOI 10.1097/00002030-199713000-00012; Bouhlal H, 2002, J IMMUNOL, V169, P3301, DOI 10.4049/jimmunol.169.6.3301; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; BROCK JH, 1980, ARCH DIS CHILD, V55, P417, DOI 10.1136/adc.55.6.417; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BULTERYS M, 1995, AIDS, V9, P93; Bunders M, 2010, AIDS RES HUM RETROV, V26, P967, DOI 10.1089/aid.2009.0241; Carthagena Laetitia, 2011, Open Virol J, V5, P27, DOI 10.2174/1874357901105010027; Charpentier C, 2012, AIDS RES HUM RETROV, V28, P87, DOI [10.1089/aid.2011.0035, 10.1089/AID.2011.0035]; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Chomont N, 2008, VIROLOGY, V370, P246, DOI 10.1016/j.virol.2007.09.006; Chong Y, 2004, AIDS RES HUM RETROV, V20, P621, DOI 10.1089/0889222041217455; Chong Y, 2004, AIDS RES HUM RETROV, V20, P219, DOI 10.1089/088922204773004941; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Creek TL, 2007, AM J OBSTET GYNECOL, V197, pS64, DOI 10.1016/j.ajog.2007.03.002; Cummins AG, 1997, IMMUNOL CELL BIOL, V75, P419, DOI 10.1038/icb.1997.67; D'Orsogna LJ, 2007, AIDS, V21, P1747, DOI 10.1097/QAD.0b013e32828642c7; DATTA P, 1994, J INFECT DIS, V170, P1134, DOI 10.1093/infdis/170.5.1134; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; DUPRAT C, 1994, PEDIATR INFECT DIS J, V13, P603, DOI 10.1097/00006454-199407000-00004; Ekpini ER, 1997, LANCET, V349, P1054, DOI 10.1016/S0140-6736(96)06444-6; Eslahpazir J, 2008, CLIN VACCINE IMMUNOL, V15, P872, DOI 10.1128/CVI.00463-07; FANTINI J, 1992, J VIROL, V66, P580, DOI 10.1128/JVI.66.1.580-585.1992; Farquhar C, 2008, CLIN EXP IMMUNOL, V153, P37, DOI 10.1111/j.1365-2249.2008.03664.x; Farquhar C, 2003, CLIN EXP IMMUNOL, V134, P367, DOI 10.1111/j.1365-2249.2003.02292.x; Filipp D, 2001, P NATL ACAD SCI USA, V98, P603, DOI 10.1073/pnas.98.2.603; Filteau S, 2009, TROP MED INT HEALTH, V14, P276, DOI 10.1111/j.1365-3156.2009.02220.x; Fouda GG, 2011, J VIROL, V85, P9555, DOI 10.1128/JVI.05174-11; Fowler MG, 2002, J ACQ IMMUN DEF SYND, V30, P230, DOI [10.1097/00042560-200206010-00012, 10.1097/01.QAI.0000018364.28828.14]; Gody JC, 2008, JAIDS-J ACQ IMM DEF, V49, P566, DOI 10.1097/QAI.0b013e318183acae; GOLDMAN AS, 1990, PEDIATR RES, V27, P252, DOI 10.1203/00006450-199003000-00009; GOLDMAN AS, 1993, PEDIATR INFECT DIS J, V12, P664, DOI 10.1097/00006454-199308000-00008; Haimovici F, 1997, J ACQ IMMUN DEF SYND, V15, P185, DOI 10.1097/00042560-199707010-00001; HANSON LA, 1984, ANN ALLERGY, V53, P576; Hasselrot K, 2009, CRIT REV IMMUNOL, V29, P369, DOI 10.1615/CritRevImmunol.v29.i5.10; Hirbod T, 2007, J INTERN MED, V262, P44, DOI 10.1111/j.1365-2796.2007.01822.x; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; HOCINI H, 1995, SCAND J IMMUNOL, V42, P269, DOI 10.1111/j.1365-3083.1995.tb03653.x; Hocini H, 2001, J VIROL, V75, P5370, DOI 10.1128/JVI.75.11.5370-5374.2001; ISRAEL ZR, 1995, J MED PRIMATOL, V24, P53, DOI 10.1111/j.1600-0684.1995.tb00146.x; John-Stewart G, 2004, JAIDS-J ACQ IMM DEF, V35, P196, DOI 10.1097/00126334-200402010-00015; John-Stewart GC, 2009, J INFECT DIS, V199, P889, DOI 10.1086/597120; JONARD PP, 1984, J CLIN INVEST, V74, P525, DOI 10.1172/JCI111450; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kourtis AP, 2003, LANCET INFECT DIS, V3, P786, DOI 10.1016/S1473-3099(03)00832-6; Kuhn L, 2006, J PEDIATR-US, V149, P611, DOI 10.1016/j.jpeds.2006.06.017; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Laibe S, 2003, CLIN CHEM LAB MED, V41, P134, DOI 10.1515/CCLM.2003.022; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Langhorst J, 2012, DRUG TODAY, V48, P149, DOI 10.1358/dot.2012.48.2.1732555; Lehman DA, 2007, REV MED VIROL, V17, P381, DOI 10.1002/rmv.543; Lepage P, 2012, ADV EXP MED BIOL, V743, P121, DOI 10.1007/978-1-4614-2251-8_9; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Lewis P, 1998, J INFECT DIS, V177, P34, DOI 10.1086/513816; Long KZ, 2011, J NUTR, V141, P957, DOI 10.3945/jn.110.132134; Lu FX, 2000, CLIN IMMUNOL, V97, P59, DOI 10.1006/clim.2000.4910; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; McGhee, 1994, MUCOSAL IMMUNOLOGY, P439; Mestecky J, 2004, AIDS RES HUM RETROV, V20, P972, DOI 10.1089/aid.2004.20.972; Mestecky J, 2011, AIDS RES HUM RETROV, V27, P469, DOI 10.1089/aid.2010.0169; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Moog C, 2008, AIDS, V22, P1461, DOI 10.1097/QAD.0b013e3282fdf625; Moussa S, 2010, AIDS RES HUM RETROV, V26, P1247, DOI 10.1089/aid.2010.0091; Neveu D, 2011, CLIN INFECT DIS, V52, P819, DOI 10.1093/cid/ciq203; OGRA PL, 1995, ANN NY ACAD SCI, V754, P97, DOI 10.1111/j.1749-6632.1995.tb44442.x; Permar SR, 2010, J VIROL, V84, P8209, DOI 10.1128/JVI.00656-10; Pfefferkorn MD, 2010, J PEDIATR GASTR NUTR, V51, P425, DOI 10.1097/MPG.0b013e3181d67e8f; Raux M, 1999, AIDS RES HUM RETROV, V15, P1365, DOI 10.1089/088922299310070; Richardson BA, 2003, J INFECT DIS, V187, P736, DOI 10.1086/374272; Rouet F, 2003, PEDIATRICS, V112, pE289, DOI 10.1542/peds.112.4.e289; Rouet F, 2007, JAIDS-J ACQ IMM DEF, V45, P380, DOI 10.1097/QAI.0b013e3180640cf5; Ruggeri FM, 1998, J VIROL, V72, P2708, DOI 10.1128/JVI.72.4.2708-2714.1998; Saidi H, 2007, J LEUKOCYTE BIOL, V81, P642, DOI 10.1189/jlb.0406278; Saidi H, 2006, J IMMUNOL, V177, P5540, DOI 10.4049/jimmunol.177.8.5540; Saidi Hela, 2008, AIDS Res Ther, V5, P10, DOI 10.1186/1742-6405-5-10; Saidi H, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-28; Salazar-Gonzalez JF, 2011, J VIROL, V85, P2751, DOI 10.1128/JVI.02316-10; Schafer F, 2002, GUT, V50, P608, DOI 10.1136/gut.50.5.608; Semba RD, 1999, NUTR REV, V57, P146; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shearer G, 2010, J INFECT DIS, V202, pS329, DOI 10.1086/655974; Sherman GG, 2005, PEDIATR INFECT DIS J, V24, P993, DOI 10.1097/01.inf.0000187036.73539.8d; Smith PD, 2003, J LEUKOCYTE BIOL, V74, P642, DOI 10.1189/jlb.0503219; SPIK G, 1982, ACTA PAEDIATR SCAND, V71, P979, DOI 10.1111/j.1651-2227.1982.tb09560.x; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Tiemessen CT, 2009, J IMMUNOL, V182, P5914, DOI 10.4049/jimmunol.0900419; Titanji K, 2005, AIDS, V19, P1947, DOI 10.1097/01.aids.0000191231.54170.89; Tugizov SM, 2012, J VIROL, V86, P2556, DOI 10.1128/JVI.06578-11; UNAIDS, 2011, GLOB HIV AIDS RESP E; Van de Perre P, 1999, AIDS, V13, P1133, DOI 10.1097/00002030-199906180-00018; Van de Perre P, 2000, ANN NY ACAD SCI, V918, P122; VANDEPERRE P, 1993, LANCET, V341, P914, DOI 10.1016/0140-6736(93)91210-D; VANDEPERRE P, 1988, J PEDIATR-US, V113, P1039, DOI 10.1016/S0022-3476(88)80578-X; WHO, 2010, REC ANT THER HIV INF; WHO, 2010, ANT THER HIV INF BAB; Wilson C, 2005, INFECT DIS FETUS NEW, P37; WOLFF H, 1992, J ACQ IMMUN DEF SYND, V5, P65; Wright PF, 2002, AIDS RES HUM RETROV, V18, P1291, DOI 10.1089/088922202320886334	112	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63408	10.1371/journal.pone.0063408	http://dx.doi.org/10.1371/journal.pone.0063408			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704905	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200035
J	Paalman, CH; Terwee, CB; Jansma, EP; Jansen, LMC				Paalman, Carmen H.; Terwee, Caroline B.; Jansma, Elise P.; Jansen, Lucres M. C.			Instruments Measuring Externalizing Mental Health Problems in Immigrant Ethnic Minority Youths: A Systematic Review of Measurement Properties	PLOS ONE			English	Review							CHILD-BEHAVIOR CHECKLIST; DIAGNOSTIC INTERVIEW SCHEDULE; UPDATED METHOD GUIDELINES; AFRICAN-AMERICAN; DIFFICULTIES QUESTIONNAIRE; SCREENING INSTRUMENT; JUVENILE-OFFENDERS; RACIAL-DIFFERENCES; TEACHER RATINGS; AGED 6-11	Background: Little is known about reliability and validity of instruments measuring externalizing mental health problems in immigrant ethnic minority youths. Aims: To provide an overview of studies on measurement properties of instruments measuring these problems in immigrant ethnic minority youths, their methodological quality and results. Methods: A systematic review of the literature in MEDLINE, EMbase, PsycINFO and Cochrane Library was performed. Evaluation of methodological quality of studies found was done by using the 'COSMIN-checklist'. Full text, original articles, published in English after 1990 were included. Articles had to concern the development or evaluation of the measurement properties of self-reported, parent-reported and/or teacher- or clinician-reported questionnaires assessing or screening externalizing mental health problems in immigrant ethnic minority youths. Specific results of analyses on (an) immigrant ethnic minority group had to be given. Results: Twenty-nine studies evaluating 18 instruments met our criteria. Most studies concerned instruments with known validity in Western populations, tested mainly in African Americans. Considering methodological quality, inequivalences between ethnicities were found, self-reports seemed to perform better, and administration of an instrument influenced reliability and validity. Conclusion: It seems that the majority of instruments for assessing externalizing problems in immigrant ethnic minority youths is currently not sufficiently validated. Further evaluating existing instruments is crucial to accurately assess and interpreted externalizing problems in immigrant ethnic minority youths.	[Paalman, Carmen H.; Jansen, Lucres M. C.] Vrije Univ Amsterdam, Med Ctr, Dept Child & Adolescent Psychiat, Amsterdam, Netherlands; [Terwee, Caroline B.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Jansma, Elise P.] Vrije Univ Amsterdam, Med Ctr, Med Lib, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Paalman, CH (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Child & Adolescent Psychiat, Amsterdam, Netherlands.	c.paalman@debascule.com	Jansma, Elise P/E-8358-2016; Nauta-Jansen, Lucres/D-7754-2015; Jansma, Elise/AAG-7983-2020; Jansen, Lucres/O-4166-2019	Jansma, Elise P/0000-0002-1516-2171; Jansen, Lucres/0000-0001-8475-4050; Terwee, Caroline/0000-0003-4570-2826				Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; Achenbach TM, 2006, CURR DIR PSYCHOL SCI, V15, P94, DOI 10.1111/j.0963-7214.2006.00414.x; ACHENBACH TM, 1995, J AM ACAD CHILD PSY, V34, P658, DOI 10.1097/00004583-199505000-00018; ACHENBACH TM, 1987, J CHILD PSYCHOL PSYC, V28, P437, DOI 10.1111/j.1469-7610.1987.tb01765.x; Alegria M, 2008, AM J PSYCHIAT, V165, P359, DOI 10.1176/appi.ajp.2007.07040704; Alonso J, 2010, BMC MED RES METH, V10; Anderson ER, 2010, CLIN PSYCHOL REV, V30, P338, DOI 10.1016/j.cpr.2009.12.008; Angold A, 2002, ARCH GEN PSYCHIAT, V59, P893, DOI 10.1001/archpsyc.59.10.893; [Anonymous], 2011, SDQ YOUTH MIND; Barkley R. A, 2014, ATTENTION DEFICIT HY; Berry JW, 2010, Z PADAGOGIK, P17; Berry JW, 2005, INT J INTERCULT REL, V29, P697, DOI 10.1016/j.ijintrel.2005.07.013; Bidaut-Russell M, 1998, CHILD PSYCHIAT HUM D, V28, P249, DOI 10.1023/A:1022636115485; Blumentritt TL, 2004, J PERS ASSESS, V83, P64, DOI 10.1207/s15327752jpa8301_06; Bongers IL, 2008, PSYCHOL MED, V38, P989, DOI 10.1017/S0033291707002309; Brandt JR, 1997, PSYCHOL ASSESSMENT, V9, P429, DOI 10.1037/1040-3590.9.4.429; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Bussing R, 2011, CIRCULATION, V124, P317; Byrne BM, 2009, TRAIN EDUC PROF PSYC, V3, P94, DOI 10.1037/a0014516; Cauffman E, 2006, EDUC PSYCHOL MEAS, V66, P502, DOI 10.1177/0013164405282460; Cervantes RC, 2006, J INTERPERS VIOLENCE, V21, P24, DOI 10.1177/0886260505281602; Cook, 1986, YOUTH SELF REPORT HO; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; CURTIS PA, 1993, CHILD WELFARE, V72, P453; de Vet HCW., 2018, MEASUREMENT MED, V10th; DuPaul GJ, 1997, PSYCHOL ASSESSMENT, V9, P436, DOI 10.1037/1040-3590.9.4.436; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; Engen RL, 2002, SOC PROBL, V49, P194, DOI 10.1525/sp.2002.49.2.194; Epstein JN, 1998, J ABNORM CHILD PSYCH, V26, P109, DOI 10.1023/A:1022617821422; Farrington DP, 2000, CHILD ADOL PSYCH CL, V9, P733; Forth A.E., 2003, HARE PSYCHOPATHY CHE; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Gilbody SM, 2000, PSYCHOL MED, V30, P253, DOI 10.1017/S0033291700001732; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Greig Ramona, 2003, Issues Ment Health Nurs, V24, P317, DOI 10.1080/01612840305278; Grisso T, 2001, J AM ACAD CHILD PSY, V40, P541, DOI 10.1097/00004583-200105000-00013; Guevara JP, 2006, HEALTH SERV RES, V41, P532, DOI 10.1111/j.1475-6773.2005.00484.x; Guttmannova K, 2008, EDUC PSYCHOL MEAS, V68, P676, DOI 10.1177/0013164407310127; Hare R. D., 2003, HARE PSYCHOPATHY CHE, V2nd; HARKNESS S, 2000, HDB DEV PSYCHOPATHOL, P197, DOI DOI 10.1007/978-1-4615-4163-9_11; Hillemeier MM, 2007, J DEV BEHAV PEDIATR, V28, P353, DOI 10.1097/DBP.0b013e31811ff8b8; Huemer J, 2013, CHILD PSYCHIAT HUM D, V44, P39, DOI 10.1007/s10578-012-0308-z; HUI CH, 1989, J CROSS CULT PSYCHOL, V20, P296, DOI 10.1177/0022022189203004; Ivanova MY, 2007, J CLIN CHILD ADOLESC, V36, P405, DOI 10.1080/15374410701444363; Javo C, 2009, EUR CHILD ADOLES PSY, V18, P154, DOI 10.1007/s00787-008-0714-8; JELLINEK MS, 1988, AM J DIS CHILD, V142, P1153, DOI 10.1001/archpedi.1988.02150110031013; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Jones S, 2006, PSYCHOL ASSESSMENT, V18, P33, DOI 10.1037/1040-3590.18.1.33; Jutte DP, 2003, ARCH PEDIAT ADOL MED, V157, P1169, DOI 10.1001/archpedi.157.12.1169; KNIGHT GP, 1994, AM J COMMUN PSYCHOL, V22, P767, DOI 10.1007/BF02521558; Komen M, 2006, CRIME LAW SOCIAL CH, V45, P55, DOI 10.1007/s10611-006-9023-7; Lambert MC, 2005, J BLACK PSYCHOL, V31, P321, DOI 10.1177/0095798405278409; Lambert MC., 2002, J CHILD FAMILY STUDI, V11, P271, DOI [10.1023/A:1016816005732, DOI 10.1023/A:1016816005732]; Lau AS, 2004, J EMOT BEHAV DISORD, V12, P145, DOI 10.1177/10634266040120030201; Leiner M, 2010, PSYCHOL ASSESSMENT, V22, P618, DOI 10.1037/a0019778; LOEBER R, 1983, PSYCHOL BULL, V94, P68, DOI 10.1037/0033-2909.94.1.68; Mano KEJ, 2009, J CHILD FAM STUD, V18, P606, DOI 10.1007/s10826-009-9263-0; MARIN G, 1992, J CROSS CULT PSYCHOL, V23, P498, DOI 10.1177/0022022192234006; Matsunaga M, 2010, J CROSS CULT PSYCHOL, V41, P410, DOI 10.1177/0022022109359689; MCDERMOTT PA, 1993, PSYCHOL ASSESSMENT, V5, P413, DOI DOI 10.1037/1040-3590.5.4.413; MEYERS K, 1995, J SUBST ABUSE TREAT, V12, P181, DOI 10.1016/0740-5472(95)00009-T; Meyers K, 2006, AM J DRUG ALCOHOL AB, V32, P287, DOI 10.1080/00952990500479464; Miller SM, 2000, HDB DEV PSYCHOPATHOL, P177, DOI DOI 10.1007/978-1-4615-4163-9_; MILLON T, 1993, J COUNS DEV, V71, P570, DOI 10.1002/j.1556-6676.1993.tb02244.x; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; MURPHY JM, 1992, J AM ACAD CHILD PSY, V31, P1105, DOI 10.1097/00004583-199211000-00019; PELHAM WE, 1989, J CLIN CHILD PSYCHOL, V18, P259, DOI 10.1207/s15374424jccp1803_9; PLUTCHIK R, 1990, COMPR PSYCHIAT, V31, P450, DOI 10.1016/0010-440X(90)90031-M; QUAY HC, 1977, J ABNORM CHILD PSYCH, V5, P277, DOI 10.1007/BF00913698; Reid R, 1998, J ABNORM CHILD PSYCH, V26, P187, DOI 10.1023/A:1022620217886; Reid R, 2001, J EMOT BEHAV DISORD, V9, P210, DOI 10.1177/106342660100900401; Reijneveld S, 2005, EUR CHILD ADOLES PSY, V14, P145, DOI 10.1007/s00787-005-0454-y; Richter J, 2011, J CHILD PSYCHOL PSYC, V52, P1002, DOI 10.1111/j.1469-7610.2011.02372.x; Roberts RE, 1996, J ABNORM CHILD PSYCH, V24, P349, DOI 10.1007/BF01441635; Rousseau C, 2013, CLIN CHILD PSYCHOL P, V18, P121, DOI 10.1177/1359104512444117; Ruchkin V, 2008, PSYCHOL ASSESSMENT, V20, P175, DOI 10.1037/1040-3590.20.2.175; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; SONUGABARKE EJS, 1993, BRIT J DEV PSYCHOL, V11, P187, DOI 10.1111/j.2044-835X.1993.tb00597.x; Spencer MS, 2005, J CROSS CULT PSYCHOL, V36, P573, DOI 10.1177/0022022105278543; Stevens GWJM, 2008, J CHILD PSYCHOL PSYC, V49, P276, DOI 10.1111/j.1469-7610.2007.01848.x; Stevens GWJM, 2003, SOC PSYCH PSYCH EPID, V38, P576, DOI 10.1007/s00127-003-0677-5; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Swanson J, 2008, J ATTEN DISORD, V12, P4, DOI 10.1177/1087054708319345; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Terwee CB, 2011, QUAL LIFE RES; Tonry M., 1997, ETHNICITY CRIME IMMI; Tyson EH, 2005, RES SOCIAL WORK PRAC, V15, P97, DOI 10.1177/1049731504270383; US Census Bureau, 2013, BLACK POP; VALLA JP, 1994, J ABNORM CHILD PSYCH, V22, P403, DOI 10.1007/BF02168082; van de Vijver FJR, 2004, APPL PSYCHOL-INT REV, V53, P215, DOI 10.1111/j.1464-0597.2004.00169.x; van de Vijver FJR, 2002, APPL PSYCHOL-INT REV, V51, P545, DOI 10.1111/1464-0597.00107; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; vandeVijver FJR, 1997, EUR J PSYCHOL ASSESS, V13, P29, DOI 10.1027/1015-5759.13.1.29; Vaughn MG, 2008, INT J OFFENDER THER, V52, P311, DOI 10.1177/0306624X07304095; VERHULST FC, 1988, J CHILD PSYCHOL PSYC, V29, P879, DOI 10.1111/j.1469-7610.1988.tb00760.x; Youngstrom E, 2000, J CONSULT CLIN PSYCH, V68, P1038, DOI 10.1037/0022-006X.68.6.1038; Zwirs B, 2011, J CROSS CULT PSYCHOL, V42, P466, DOI 10.1177/0022022110362752; Zwirs BWC, 2008, J AM ACAD CHILD PSY, V47, P309, DOI 10.1097/chi.0b013e318160c5c7; Zwirs BWC, 2006, EUR CHILD ADOLES PSY, V15, P418, DOI 10.1007/s00787-006-0550-7; Zwirs BWC, 2006, J AM ACAD CHILD PSY, V45, P476, DOI 10.1097/01.chi.0000192251.46023.5a	103	26	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63109	10.1371/journal.pone.0063109	http://dx.doi.org/10.1371/journal.pone.0063109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23704892	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200021
J	Schriner, SE; Lee, K; Truong, S; Salvadora, KT; Maler, S; Nam, A; Lee, T; Jafari, M				Schriner, Samuel E.; Lee, Kevin; Truong, Stephanie; Salvadora, Kathyrn T.; Maler, Steven; Nam, Alexander; Lee, Thomas; Jafari, Mahtab			Extension of Drosophila Lifespan by Rhodiola rosea through a Mechanism Independent from Dietary Restriction	PLOS ONE			English	Article							CALORIC RESTRICTION; STRESS RESISTANCE; OXIDATIVE STRESS; RHESUS-MONKEYS; FAT-BODY; MELANOGASTER; MICE; CELLS; OVEREXPRESSION; EXPRESSION	Rhodiola rosea has been extensively used to improve physical and mental performance and to protect against stress. We, and others, have reported that R. rosea can extend lifespan in flies, worms, and yeast. However, its molecular mechanism is currently unknown. Here, we tested whether R. rosea might act through a pathway related to dietary restriction (DR) that can extend lifespan in a range of model organisms. While the mechanism of DR itself is also unknown, three molecular pathways have been associated with it: the silent information regulator 2 (SIR2) proteins, insulin and insulin-like growth factor signaling (IIS), and the target of rapamycin (TOR). In flies, DR is implemented through a reduction in dietary yeast content. We found that R. rosea extract extended lifespan in both sexes independent of the yeast content in the diet. We also found that the extract extended lifespan when the SIR2, IIS, or TOR pathways were genetically perturbed. Upon examination of water and fat content, we found that R. rosea decreased water content and elevated fat content in both sexes, but did not sensitize flies to desiccation or protect them against starvation. There were some sex-specific differences in response to R. rosea. In female flies, the expression levels of glycolytic genes and dSir2 were down-regulated, and NADH levels were decreased. In males however, R. rosea provided no protection against heat stress and had no effect on the major heat shock protein HSP70 and actually down-regulated the mitochondrial HSP22. Our findings largely rule out an elevated general resistance to stress and DR-related pathways as mechanistic candidates. The latter conclusion is especially relevant given the limited potential for DR to improve human health and lifespan, and presents R. rosea as a potential viable candidate to treat aging and age-related diseases in humans.	[Schriner, Samuel E.; Lee, Kevin; Truong, Stephanie; Salvadora, Kathyrn T.; Maler, Steven; Nam, Alexander; Lee, Thomas; Jafari, Mahtab] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Jafari, M (corresponding author), Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92717 USA.	mjafari@uci.edu			National Institutes of Health [AT004987]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by an National Institutes of Health R21 grant, AT004987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abidov M, 2003, B EXP BIOL MED+, V136, P585, DOI 10.1023/B:BEBM.0000020211.24779.15; Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; Archer MA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P386, DOI 10.1086/518354; Bai H, 2012, AGING CELL, V11, P978, DOI 10.1111/acel.12000; Bayliak MM, 2011, PHYTOMEDICINE, V18, P1262, DOI 10.1016/j.phymed.2011.06.010; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Boon-Niermeijer EK, 2000, PHYTOMEDICINE, V7, P389, DOI 10.1016/S0944-7113(00)80060-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; Grandison RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004067; Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6; Humphrey DM, 2009, EXP GERONTOL, V44, P316, DOI 10.1016/j.exger.2009.02.001; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Ingram DK, 2011, EXP GERONTOL, V46, P148, DOI 10.1016/j.exger.2010.12.001; Jafari M, 2007, REJUV RES, V10, P587, DOI 10.1089/rej.2007.0560; Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kelly G S, 2001, Altern Med Rev, V6, P293; Kim SH, 2006, BIOFACTORS, V26, P209, DOI 10.1002/biof.5520260306; Lee KS, 2010, REJUV RES, V13, P561, DOI 10.1089/rej.2010.1031; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Magwere T, 2006, J GERONTOL A-BIOL, V61, P36, DOI 10.1093/gerona/61.1.36; MARTIN GM, 1989, GENOME, V31, P390, DOI 10.1139/g89-059; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Matsumura H., 1980, METHOD ENZYMOL, V69, P465, DOI DOI 10.1016/S0076-6879(80)69045-4; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Orr WC, 2003, EXP GERONTOL, V38, P227, DOI 10.1016/S0531-5565(02)00263-2; Panossian A, 2010, PHYTOMEDICINE, V17, P481, DOI 10.1016/j.phymed.2010.02.002; Perez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Schriner SE, 2012, BIOGERONTOLOGY, V13, P105, DOI 10.1007/s10522-011-9357-0; Schriner SE, 2009, FREE RADICAL RES, V43, P836, DOI 10.1080/10715760903089724; Schriner SE, 2009, FREE RADICAL BIO MED, V47, P577, DOI 10.1016/j.freeradbiomed.2009.05.025; Slack C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047699; Spindler SR, 2006, AGING CELL, V5, P39, DOI 10.1111/j.1474-9726.2006.00194.x; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; UDINTSEV SN, 1991, EUR J CANCER, V27, P1182, DOI 10.1016/0277-5379(91)90323-6; Wiegant FAC, 2009, BIOGERONTOLOGY, V10, P27, DOI 10.1007/s10522-008-9151-9	48	35	36	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63886	10.1371/journal.pone.0063886	http://dx.doi.org/10.1371/journal.pone.0063886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704949	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200080
J	Bjursell, M; Wedin, M; Admyre, T; Hermansson, M; Bottcher, G; Goransson, M; Linden, D; Bamberg, K; Oscarsson, J; Bohlooly-Y, M				Bjursell, Mikael; Wedin, Marianne; Admyre, Therese; Hermansson, Majlis; Bottcher, Gerhard; Goransson, Melker; Linden, Daniel; Bamberg, Krister; Oscarsson, Jan; Bohlooly-Y, Mohammad			Ageing Fxr Deficient Mice Develop Increased Energy Expenditure, Improved Glucose Control and Liver Damage Resembling NASH	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; FAMILIAL INTRAHEPATIC CHOLESTASIS; BILE-ACID-HOMEOSTASIS; HIGH-FAT DIET; NUCLEAR RECEPTOR; NONALCOHOLIC STEATOHEPATITIS; INSULIN SENSITIVITY; GENE-EXPRESSION; KNOCKOUT MICE; PPAR-ALPHA	Nuclear receptor subfamily 1, group H, member 4 (Nr1h4, FXR) is a bile acid activated nuclear receptor mainly expressed in the liver, intestine, kidney and adrenal glands. Upon activation, the primary function is to suppress cholesterol 7 alpha-hydroxylase (Cyp7a1), the rate-limiting enzyme in the classic or neutral bile acid synthesis pathway. In the present study, a novel Fxr deficient mouse line was created and studied with respect to metabolism and liver function in ageing mice fed chow diet. The Fxr deficient mice were similar to wild type mice in terms of body weight, body composition, energy intake and expenditure as well as behaviours at a young age. However, from 15 weeks of age and onwards, the Fxr deficient mice had almost no body weight increase up to 39 weeks of age mainly because of lower body fat mass. The lower body weight gain was associated with increased energy expenditure that was not compensated by increased food intake. Fasting levels of glucose and insulin were lower and glucose tolerance was improved in old and lean Fxr deficient mice. However, the Fxr deficient mice displayed significantly increased liver weight, steatosis, hepatocyte ballooning degeneration and lobular inflammation together with elevated plasma levels of ALT, bilirubin and bile acids, findings compatible with non-alcoholic steatohepatitis (NASH) and cholestasis. In conclusion, ageing Fxr deficient mice display late onset leanness associated with elevated energy expenditure and improved glucose control but develop severe NASH-like liver pathology.	[Bjursell, Mikael; Wedin, Marianne; Admyre, Therese; Hermansson, Majlis; Bottcher, Gerhard; Goransson, Melker; Linden, Daniel; Bamberg, Krister; Oscarsson, Jan; Bohlooly-Y, Mohammad] AstraZeneca R&D, Molndal, Sweden	AstraZeneca	Bjursell, M (corresponding author), AstraZeneca R&D, Molndal, Sweden.	mikael.bjursell@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	This study was funded by AstraZeneca, the employer of Mikael Bjursell, Marianne Wedin, Therese Admyre, Majlis Hermansson, Gerhard Bottcher, Melker Goransson, Daniel Linden, Krister Bamberg, Jan Oscarsson, Mohammad Bohlooly-Y. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Binczek E, 2007, BIOL CHEM, V388, P405, DOI 10.1515/BC.2007.046; Bjursell M, 2005, BIOCHEM BIOPH RES CO, V326, P759, DOI 10.1016/j.bbrc.2004.11.116; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Boufker HI, 2011, BONE, V49, P1219, DOI 10.1016/j.bone.2011.08.013; Cariou B, 2005, FEBS LETT, V579, P4076, DOI 10.1016/j.febslet.2005.06.033; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chen F, 2004, GASTROENTEROLOGY, V126, P756, DOI 10.1053/j.gastro.2003.12.013; Dufer M, 2012, DIABETES, V61, P1479, DOI 10.2337/db11-0815; Edvardsson U, 2006, J LIPID RES, V47, P329, DOI 10.1194/jlr.M500203-JLR200; Figge A, 2004, J BIOL CHEM, V279, P2790, DOI 10.1074/jbc.M307363200; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Hanley K, 1997, J CLIN INVEST, V100, P705, DOI 10.1172/JCI119583; Hashidume T, 2011, BIOSCI BIOTECH BIOCH, V75, P1702, DOI 10.1271/bbb.110224; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Inoue M, 2011, J CLIN BIOCHEM NUTR, V48, P161, DOI 10.3164/jcbn.09-122GFR; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lian F, 2011, BIOCHEM J, V438, P315, DOI 10.1042/BJ20102096; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Malaguarnera L, 2005, J HEPATOL, V42, P585, DOI 10.1016/j.jhep.2004.11.040; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Meng ZP, 2010, MOL ENDOCRINOL, V24, P886, DOI 10.1210/me.2009-0286; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srivastava RAK, 2006, MOL CELL BIOCHEM, V285, P35, DOI 10.1007/s11010-005-9053-y; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; van Dijk TH, 2009, J BIOL CHEM, V284, P10315, DOI 10.1074/jbc.M807317200; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Ye DW, 2012, GUT, V61, P1058, DOI 10.1136/gutjnl-2011-300269; Zhang YQ, 2006, ARTERIOSCL THROM VAS, V26, P2316, DOI 10.1161/01.ATV.0000235697.35431.05; Zhang YQ, 2012, MOL ENDOCRINOL, V26, P272, DOI 10.1210/me.2011-1157; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	49	45	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64721	10.1371/journal.pone.0064721	http://dx.doi.org/10.1371/journal.pone.0064721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700488	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400064
J	Lim, K; Kulakova, L; Galkin, A; Herzberg, O				Lim, Kap; Kulakova, Liudmila; Galkin, Andrey; Herzberg, Osnat			Crystal Structures of Carbamate Kinase from Giardia lamblia Bound with Citric Acid and AMP-PNP	PLOS ONE			English	Article							STATE ANALOG COMPLEX; ANGSTROM RESOLUTION; ARGININE; ENZYME; MECHANISMS; EXPRESSION; PHOSPHATE; ALIGNMENT; PROTEINS; PROGRAM	The parasite Giardia lamblia utilizes the L-arginine dihydrolase pathway to generate ATP from L-arginine. Carbamate kinase (CK) catalyzes the last step in this pathway, converting ADP and carbamoyl phosphate to ATP and ammonium carbamate. Because the L-arginine pathway is essential for G. lamblia survival and absent in high eukaryotes including humans, the enzyme is a potential target for drug development. We have determined two crystal structures of G. lamblia CK (glCK) with bound ligands. One structure, in complex with a nonhydrolyzable ATP analog, adenosine 5'-adenylyl-beta,gamma-imidodiphosphate (AMP-PNP), was determined at 2.6 angstrom resolution. The second structure, in complex with citric acid bound in the postulated carbamoyl phosphate binding site, was determined in two slightly different states at 2.1 and 2.4 angstrom resolution. These structures reveal conformational flexibility of an auxiliary domain (amino acid residues 123-170), which exhibits open or closed conformations or structural disorder, depending on the bound ligand. The structures also reveal a smaller conformational change in a region associated the AMP-PNP adenine binding site. The protein residues involved in binding, together with a model of the transition state, suggest that catalysis follows an in-line, predominantly dissociative, phosphotransfer reaction mechanism, and that closure of the flexible auxiliary domain is required to protect the transition state from bulk solvent.	[Lim, Kap; Kulakova, Liudmila; Galkin, Andrey; Herzberg, Osnat] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Herzberg, Osnat] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Herzberg, O (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.	osnat@umd.edu		Herzberg, Osnat/0000-0003-2823-7627	NIH [R56AI059733]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI059733] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R56AI059733. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Brown DM, 1998, INT J PARASITOL, V28, P149, DOI 10.1016/S0020-7519(97)00172-0; Chen Catherine Z, 2012, Curr Chem Genomics, V6, P93, DOI 10.2174/1875397301206010093; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galkin A, 2010, ACTA CRYSTALLOGR F, V66, P386, DOI 10.1107/S1744309110004665; Gallego P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047886; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P13861, DOI 10.1021/bi026655p; Li EQ, 2006, J IMMUNOL, V176, P516, DOI 10.4049/jimmunol.176.1.516; Lim K, 2010, BIOCHEMISTRY-US, V49, P2031, DOI 10.1021/bi9020988; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; Minotto L, 1999, MOL BIOCHEM PARASIT, V98, P43, DOI 10.1016/S0166-6851(98)00141-8; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Pauling L., 1960, NATURE CHEM BOND; Raijmann L, 1973, ENZYMES, P97; Ramon-Maique S, 2010, J MOL BIOL, V397, P1261, DOI 10.1016/j.jmb.2010.02.038; Ramon-Maiques S, 2000, J MOL BIOL, V299, P463, DOI 10.1006/jmbi.2000.3779; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Thoden JB, 1999, BIOCHEMISTRY, V38; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yousef MS, 2002, ACTA CRYSTALLOGR D, V58, P2009, DOI 10.1107/S0907444902014683	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64004	10.1371/journal.pone.0064004	http://dx.doi.org/10.1371/journal.pone.0064004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700444	gold, Green Submitted, Green Published			2022-12-27	WOS:000319966400039
J	Liu, YH; Xu, Y; Wen, YB; Guan, K; Ling, WH; He, LP; Su, YX; Chen, YM				Liu, Yan-hua; Xu, Ying; Wen, Ya-bin; Guan, Ke; Ling, Wen-hua; He, Li-ping; Su, Yi-xiang; Chen, Yu-ming			Association of Weight-Adjusted Body Fat and Fat Distribution with Bone Mineral Density in Middle-Aged Chinese Adults: A Cross-Sectional Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; ABDOMINAL VISCERAL FAT; OSTEOPOROTIC FRACTURES; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK-FACTORS; LEAN MASS; WOMEN; MEN; OBESITY	Background: Although it is well established that a higher body weight is protective against osteoporosis, the effects of body fat and fat distribution on bone mineral density (BMD) after adjustment for body weight remains uncertain. To examine the relationship between body fat and fat distribution and BMD beyond its weight-bearing effect in middle-aged Chinese adults. Method: The study had a community-based cross-sectional design and involved 1,767 women and 698 men aged 50-75 years. The BMD of the lumbar spine, total hip, and whole body, and the fat mass (FM) and percentage fat mass (% FM) of the total body and segments of the body were measured by dual-energy X-ray absorptiometry. General information on the participants was collected using structured questionnaire interviews. Result: After adjusting for potential confounders, an analysis of covariance showed the weight-adjusted (WA-) total FM (or % FM) to be negatively associated with BMD in all of the studied sites (P < 0.05) in both women and men. The unfavorable effects of WA-total FM were generally more substantial in men than in women, and the whole body was the most sensitive site related to FM, followed by the total hip and the lumbar spine, in both genders. The mean BMD of the lumbar spine, total hip, and whole body was 3.93%, 3.01%, and 3.65% (in women) and 5.02%, 5.57%, 6.03% (in men) lower in the highest quartile (vs. lowest quartile) according to the WA-total FM (all p < 0.05). Similar results were noted among the groups for WA-total FM%. In women, abdominal fat had the most unfavorable association with BMD, whereas in men it was limb fat. Conclusion: FM (or % FM) is inversely associated with BMD beyond its weight-bearing effect. Abdominal fat in women and limb fat in men seems to have the greatest effect on BMD.	[Liu, Yan-hua; Xu, Ying; Wen, Ya-bin; Guan, Ke; Ling, Wen-hua; He, Li-ping; Su, Yi-xiang; Chen, Yu-ming] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Su, YX (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China.	suyx@mail.sysu.edu.cn; chenyum@mail.sysu.edu.cn	Chen, Yu/Y-3292-2019; liu, yan/HCI-5542-2022; Chen, Yi/HIR-2608-2022	chen, Yu-ming/0000-0003-1658-5528	5010 Program for Clinical Researches of Sun Yat-sen University [2007032]; National Natural Science Foundation of China [81130052, 81072299]	5010 Program for Clinical Researches of Sun Yat-sen University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was jointly supported by the 5010 Program for Clinical Researches of Sun Yat-sen University (No. 2007032) and the National Natural Science Foundation of China (No. 81130052, 81072299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikan S, 2012, J CLIN DENSITOM, V15, P186, DOI 10.1016/j.jocd.2011.11.005; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Bhupathiraju SN, 2011, AM J CLIN NUTR, V94, P1063, DOI 10.3945/ajcn.111.016030; Biver E, 2011, J CLIN ENDOCR METAB, V96, P2703, DOI 10.1210/jc.2011-0047; Casanueva FF, 2010, CLIN ENDOCRINOL, V73, P35, DOI 10.1111/j.1365-2265.2009.03727.x; Chanprasertyothin Suwannee, 2005, Journal of the Medical Association of Thailand, V88, P655; Chen YM, 2010, OSTEOPOROSIS INT, V21, P939, DOI 10.1007/s00198-009-1029-4; Choi HS, 2010, CALCIFIED TISSUE INT, V87, P218, DOI 10.1007/s00223-010-9398-4; Cole ZA, 2012, BONE, V50, P562, DOI 10.1016/j.bone.2011.05.005; Cui LH, 2007, J BONE MINER METAB, V25, P165, DOI 10.1007/s00774-006-0747-3; Goh VHH, 2010, AGING MALE, V13, P265, DOI 10.3109/13685538.2010.489623; Gonnelli S, 2012, J CLIN DENSITOM, DOI [10.1016/j.jocd.2012.02.013, DOI 10.1016/J.J0CD.2012.02.013]; Guney E, 2003, OBES SURG, V13, P383, DOI 10.1381/096089203765887705; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Huang JS, 2001, AIDS, V15, P975, DOI 10.1097/00002030-200105250-00005; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Katzmarzyk PT, 2012, BONE, V50, P576, DOI 10.1016/j.bone.2011.04.012; Kim JH, 2012, OSTEOPOROSIS INT, V23, P2009, DOI 10.1007/s00198-011-1808-6; Kim KC, 2010, YONSEI MED J, V51, P857, DOI 10.3349/ymj.2010.51.6.857; Lee HR, 2011, KOREAN J FAM MED, V32, P219, DOI 10.4082/kjfm.2011.32.4.219; Lee J, 2012, J KOREAN MED SCI, V27, P184, DOI 10.3346/jkms.2012.27.2.184; Lekamwasam S, 2009, J BONE MINER METAB, V27, P83, DOI 10.1007/s00774-008-0006-x; Lord J, 2006, BJOG-INT J OBSTET GY, V113, P1203, DOI 10.1111/j.1471-0528.2006.00973.x; Melton LJ, 2003, J BONE MINER RES, V18, P1139, DOI 10.1359/jbmr.2003.18.6.1139; Miyawaki T, 2004, INTERNAL MED, V43, P1138, DOI 10.2169/internalmedicine.43.1138; Moseley KF, 2011, CLIN ENDOCRINOL, V74, P565, DOI 10.1111/j.1365-2265.2010.03965.x; Muraki S, 2004, OSTEOPOROSIS INT, V15, P724, DOI 10.1007/s00198-004-1600-y; Napoli N, 2010, BONE, V47, P1001, DOI 10.1016/j.bone.2010.08.010; Nedungadi TP, 2009, J CARDIOVASC TRANSL, V2, P321, DOI 10.1007/s12265-009-9101-1; Ohnishi H, 2008, HYPERTENS RES, V31, P1385, DOI 10.1291/hypres.31.1385; Pickhardt PJ, 2012, AM J ROENTGENOL, V198, P1100, DOI 10.2214/AJR.11.7361; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Sandeep S, 2010, INDIAN J MED RES, V131, P629; Savgan-Gurol E, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-86; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Sukumar D, 2011, OSTEOPOROSIS INT, V22, P635, DOI 10.1007/s00198-010-1305-3; Suzuki Takao, 2011, Clin Calcium, V21, P722, DOI CliCa1105722729; Thomas T, 2002, J BONE MINER RES, V17, P1563, DOI 10.1359/jbmr.2002.17.9.1563; van der Leeuw J, 2013, MENOPAUSE, V20, P409, DOI 10.1097/gme.0b013e31827212a5; Weiss LA, 2006, J BONE MINER RES, V21, P758, DOI 10.1359/JBMR.060206; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Yoo HJ, 2012, J BONE MINER METAB, V30, P47, DOI 10.1007/s00774-011-0283-7; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240; Zhao LJ, 2008, J BONE MINER RES, V23, P17, DOI 10.1359/JBMR.070813; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572; Zillikens MC, 2010, CALCIFIED TISSUE INT, V86, P116, DOI 10.1007/s00223-009-9319-6	48	37	38	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63339	10.1371/journal.pone.0063339	http://dx.doi.org/10.1371/journal.pone.0063339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700417	Green Submitted, Green Published, gold			2022-12-27	WOS:000319966400015
J	Magliano, DC; Bargut, TCL; de Carvalho, SN; Aguila, MB; Mandarim-de-Lacerda, CA; Souza-Mello, V				Magliano, D'Angelo Carlo; Lonzetti Bargut, Thereza Cristina; de Carvalho, Simone Nunes; Aguila, Marcia Barbosa; Mandarim-de-Lacerda, Carlos Alberto; Souza-Mello, Vanessa			Peroxisome Proliferator-Activated Receptors-Alpha and Gamma Are Targets to Treat Offspring from Maternal Diet-Induced Obesity in Mice	PLOS ONE			English	Article							BETA-CELL FUNCTION; ADIPOSE-TISSUE; INSULIN-RESISTANCE; PPAR-ALPHA; HEPATIC STEATOSIS; GENE-EXPRESSION; C57BL/6 MICE; X-RECEPTOR; BEZAFIBRATE; LIVER	Aim: The aim of the present study was to evaluate whether activation of peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma by Bezafibrate (BZ) could attenuate hepatic and white adipose tissue (WAT) abnormalities in male offspring from diet-induced obese dams. Materials and Methods: C57BL/6 female mice were fed a standard chow (SC; 10% lipids) diet or a high-fat (HF; 49% lipids) diet for 8 weeks before mating and during gestation and lactation periods. Male offspring received SC diet at weaning and were subdivided into four groups: SC, SC/BZ, HF and HF/BZ. Treatment with BZ (100 mg/Kg diet) started at 12 weeks of age and was maintained for three weeks. Results: The HF diet resulted in an overweight phenotype and an increase in oral glucose intolerance and fasting glucose of dams. The HF offspring showed increased body mass, higher levels of plasmatic and hepatic triglycerides, higher levels of pro-inflammatory and lower levels of anti-inflammatory adipokines, impairment of glucose metabolism, abnormal fat pad mass distribution, higher number of larger adipocytes, hepatic steatosis, higher expression of lipogenic proteins concomitant to decreased expression of PPARalpha and carnitine palmitoyltransferase I (CPT-1) in liver, and diminished expression of PPARgamma and adiponectin in WAT. Treatment with BZ ameliorated the hepatic and WAT abnormalities generated by diet-induced maternal obesity, with improvements observed in the structural, biochemical and molecular characteristics of the animals' livers and epididymal fat. Conclusion: Diet-induced maternal obesity lead to alterations in metabolism, hepatic lipotoxicity and adverse liver and WAT remodeling in the offspring. Targeting PPAR with Bezafibrate has beneficial effects reducing the alterations, mainly through reduction of WAT inflammatory state through PPARgamma activation and enhanced hepatic beta-oxidation due to increased PPARalpha/PPARgamma ratio in liver.	[Magliano, D'Angelo Carlo; Lonzetti Bargut, Thereza Cristina; de Carvalho, Simone Nunes; Aguila, Marcia Barbosa; Mandarim-de-Lacerda, Carlos Alberto; Souza-Mello, Vanessa] Univ Estado Rio De Janeiro, Lab Morphometry Metab & Cardiovasc Dis, Biomed Ctr, Inst Biol, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Mandarim-de-Lacerda, CA (corresponding author), Univ Estado Rio De Janeiro, Lab Morphometry Metab & Cardiovasc Dis, Biomed Ctr, Inst Biol, Rio De Janeiro, Brazil.	mandarim@uerj.br	Souza-Mello, Vanessa/E-3463-2014; Aguila, Marcia Barbosa/ABF-6505-2020; Magliano, D'Angelo Carlo/U-7364-2019; Mandarim-de-Lacerda, Carlos A/F-7125-2012; Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019; Aguila, Marcia/P-2349-2019; Souza-Mello, Vanessa/D-5092-2013; Bargut, Thereza/AAK-4649-2020	Souza-Mello, Vanessa/0000-0002-2510-9569; Aguila, Marcia Barbosa/0000-0003-3994-4589; Magliano, D'Angelo Carlo/0000-0002-0575-961X; Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978; Bargut, Thereza/0000-0001-9218-3104; Carvalho, Simone/0000-0003-3310-2970	CNPq (Brazilian Council of Science and Technology) [470727/2009-8, 472033/2011-5]; FAPERJ (Rio de Janeiro State Foundation for Scientific Research) [E-26/102.289/2010]	CNPq (Brazilian Council of Science and Technology)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Rio de Janeiro State Foundation for Scientific Research)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Financial support was provided by the agencies CNPq (Brazilian Council of Science and Technology, www.cnpq.br), grant number 470727/2009-8 for CAML and 472033/2011-5 for VSM; and FAPERJ (Rio de Janeiro State Foundation for Scientific Research, www.faperj.br), grant number E-26/102.289/2010 for VSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila M.B., 2010, INSULIN RESISTANCE S, P1; Barbosa-da-Silva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039837; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cabrero A, 2003, METABOLISM, V52, P652, DOI 10.1053/meta.2003.50100; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Catta-Preta M, 2012, NUTRITION, V28, P212, DOI 10.1016/j.nut.2011.05.011; Catta-Preta M, 2011, VIRCHOWS ARCH, V459, P477, DOI 10.1007/s00428-011-1147-1; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Christodoulides C, 2010, MOL CELL ENDOCRINOL, V318, P61, DOI 10.1016/j.mce.2009.09.014; De Souza CT, 2010, J PHYSIOL-LONDON, V588, P2239, DOI 10.1113/jphysiol.2009.183996; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fernandes-Santos C, 2009, NUTRITION, V25, P818, DOI 10.1016/j.nut.2008.12.010; Festi D, 2004, Obes Rev, V5, P27, DOI 10.1111/j.1467-789X.2004.00126.x; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Gregorio BM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.042; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Hays T, 2005, CARCINOGENESIS, V26, P219, DOI 10.1093/carcin/bgh285; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Kleemann R, 2003, BLOOD, V101, P545, DOI 10.1182/blood-2002-06-1762; Kudoh A, 2011, LIFE SCI, V88, P1055, DOI 10.1016/j.lfs.2011.04.001; Kwon EY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-450; Lee HJ, 2002, BIOCHEM BIOPH RES CO, V296, P293, DOI 10.1016/S0006-291X(02)00822-7; Lee JK, 2010, KOREAN J PHYSIOL PHA, V14, P185, DOI 10.4196/kjpp.2010.14.3.185; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nagasawa T, 2006, EUR J PHARMACOL, V536, P182, DOI 10.1016/j.ejphar.2006.02.028; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Peters JM, 2003, BBA-MOL CELL BIOL L, V1632, P80, DOI 10.1016/S1388-1981(03)00065-9; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; Pettinelli P, 2009, BBA-MOL BASIS DIS, V1792, P1080, DOI 10.1016/j.bbadis.2009.08.015; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Serviddio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024084; Souza-Mello V, 2007, BRIT J NUTR, V98, P1159, DOI 10.1017/S0007114507771878; Souza-Mello V, 2010, CLIN SCI, V119, P239, DOI 10.1042/CS20100061; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sullivan EL, 2011, NEUROENDOCRINOLOGY, V93, P1, DOI 10.1159/000322038; Takahashi S, 2006, PHARMACOL RES, V53, P501, DOI 10.1016/j.phrs.2006.03.019; Tenenbaum A, 2008, ADV CARDIOL, V45, P127, DOI 10.1159/000115192; Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14; Tenenbaum H, 2007, ATHEROSCLEROSIS, V194, P265, DOI 10.1016/j.atherosclerosis.2006.08.005; Teramoto T, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-29; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Vickers MH, 2001, J ENDOCRINOL, V170, P323, DOI 10.1677/joe.0.1700323; Vosper H, 2001, J BIOL CHEM, V276, P44258, DOI 10.1074/jbc.M108482200; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269	55	58	61	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64258	10.1371/journal.pone.0064258	http://dx.doi.org/10.1371/journal.pone.0064258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700465	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400050
J	O'Neill, T; Guaraldi, G; Orlando, G; Carli, F; Garlassi, E; Zona, S; Despres, JP; Ross, R				O'Neill, Trevor; Guaraldi, Giovanni; Orlando, Gabriella; Carli, Federica; Garlassi, Elisa; Zona, Stefano; Despres, Jean-Pierre; Ross, Robert			Combined Use of Waist and Hip Circumference to Identify Abdominally Obese HIV-Infected Patients at Increased Health Risk	PLOS ONE			English	Article							OPPOSITE ASSOCIATIONS; THIGH CIRCUMFERENCES; CARDIOVASCULAR RISK; FAT DISTRIBUTION; GLUCOSE-LEVELS; HEART-DISEASE; ALL-CAUSE; MORTALITY; MEN; LIPODYSTROPHY	Objectives: To determine whether for a given waist circumference (WC), a larger hip circumference (HC) was associated with a reduced risk of insulin resistance, type 2 diabetes (T2D), hypertension and cardiovascular disease (CVD) in HIV-infected patients. A second objective was to determine whether, for a given WC, the addition of HC improved upon estimates of abdominal adiposity, in particular visceral adipose tissue (VAT), compared to those obtained by WC alone. Methods: HIV-infected men (N = 1481) and women (N = 841) were recruited between 2005 and 2009. WC and HC were obtained using standard techniques and abdominal adiposity was measured using computed tomography. Results: After control for WC and covariates, HC was negatively associated with risk of insulin resistance (p < 0.05) and T2D [Men: OR = 0.91 (95% CI: 0.86-0.96); Women: OR = 0.91 (95% CI: 0.84-0.98)]. For a given WC, HC was also negatively associated with a lower risk of hypertension (p < 0.05) and CVD [OR = 0.94 (95% CI: 0.88-0.99)] in men, but not women. Although HC was negatively associated with VAT in men and women after control for WC (p < 0.05), the addition of HC did not substantially improve upon the prediction of VAT compared to WC alone. Conclusions: The identification of HIV-infected individuals at increased health risk by WC alone is substantially improved by the addition of HC. Estimates of visceral adipose tissue by WC are not substantially improved by the addition of HC and thus variation in visceral adiposity may not be the conduit by which HC identifies increased health risk.	[O'Neill, Trevor; Ross, Robert] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Guaraldi, Giovanni; Orlando, Gabriella; Carli, Federica; Garlassi, Elisa; Zona, Stefano] Univ Modena & Reggio Emilia, Dept Med, Metab Clin, Infect & Trop Dis Unit, Modena, Italy; [Despres, Jean-Pierre] Hop Laval, Res Ctr, Quebec Heart Inst, Quebec City, PQ, Canada	Queens University - Canada; Universita di Modena e Reggio Emilia; Laval University	Ross, R (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	rossr@queensu.ca	Guaraldi, Giovanni/J-9467-2018; Orlando, Gabriella/K-3954-2018	Orlando, Gabriella/0000-0002-4590-9045; Zona, Stefano/0000-0003-3451-2744; Guaraldi, Giovanni/0000-0002-5724-3914				American Diabetes Association, 1999, DIABETES CARE, V22, pS1; Andersen O, 2003, METABOLISM, V52, P1343, DOI 10.1016/S0026-0495(03)00201-4; Bacchetti P, 2005, JAIDS-J ACQ IMM DEF, V40, P121, DOI 10.1097/01.qai.0000182230.47819.aa; Bacchetti P, 2006, JAIDS-J ACQ IMM DEF, V42, P562; Bigaard J, 2004, INT J OBESITY, V28, P741, DOI 10.1038/sj.ijo.0802635; Cameron AJ, 2012, INT J EPIDEMIOL, V41, P484, DOI 10.1093/ije/dyr198; Canoy D, 2007, CIRCULATION, V116, P2933, DOI 10.1161/CIRCULATIONAHA.106.673756; Caron-Debarle M, 2010, TRENDS MOL MED, V16, P218, DOI 10.1016/j.molmed.2010.03.002; de Koning L, 2010, DIABETOLOGIA, V53, P1322, DOI 10.1007/s00125-010-1710-3; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Gabriella O, 2012, JAIDS-J ACQ IMM DEF, V59, P494, DOI 10.1097/QAI.0b013e31824c8397; Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541; Heitmann BL, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3292; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; Kuk JL, 2007, AM J CLIN NUTR, V85, P1540, DOI 10.1093/ajcn/85.6.1540; Lake JE, 2011, AIDS CARE, V23, P929, DOI 10.1080/09540121.2010.543885; Lissner L, 2001, OBES RES, V9, P644, DOI 10.1038/oby.2001.85; Mynarcik DC, 2000, J ACQ IMMUN DEF SYND, V25, P312, DOI 10.1097/00126334-200012010-00004; Parker ED, 2009, AM J EPIDEMIOL, V169, P837, DOI 10.1093/aje/kwn395; Sakai Y, 2005, J INTERN MED, V257, P194, DOI 10.1111/j.1365-2796.2004.01432.x; Seidell JC, 2001, AM J CLIN NUTR, V74, P315; Seidell JC, 1997, J INTERN MED, V242, P401, DOI 10.1046/j.1365-2796.1997.00235.x; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Snijder MB, 2003, OBES RES, V11, P104, DOI 10.1038/oby.2003.18; Tien PC, 2003, JAIDS-J ACQ IMM DEF, V34, P461, DOI 10.1097/00126334-200312150-00003; Villarroya F, 2010, BBA-MOL CELL BIOL L, V1801, P392, DOI 10.1016/j.bbalip.2009.09.018; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e62538	10.1371/journal.pone.0062538	http://dx.doi.org/10.1371/journal.pone.0062538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700409	Green Published, gold			2022-12-27	WOS:000319966400007
J	Dangi-Garimella, S; Sahai, V; Ebine, K; Kumar, K; Munshi, HG				Dangi-Garimella, Surabhi; Sahai, Vaibhav; Ebine, Kazumi; Kumar, Krishan; Munshi, Hidayatullah G.			Three-Dimensional Collagen I Promotes Gemcitabine Resistance In Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase Expression	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; HMGA PROTEINS; TUMOR GRADE; ACETYLATION; SITES; TRANSCRIPTION; INHIBITORS; GROWTH; REPAIR; P300	Pancreatic ductal adenocarcinoma (PDAC) is associated with a pronounced collagen-rich stromal reaction that has been shown to contribute to chemo-resistance. We have previously shown that PDAC cells are resistant to gemcitabine chemotherapy in the collagen microenvironment because of increased expression of the chromatin remodeling protein high mobility group A2 (HMGA2). We have now found that human PDAC tumors display higher levels of histone H3K9 and H3K27 acetylation in fibrotic regions. We show that relative to cells grown on tissue culture plastic, PDAC cells grown in three-dimensional collagen gels demonstrate increased histone H3K9 and H3K27 acetylation, along with increased expression of p300, PCAF and GCN5 histone acetyltransferases (HATs). Knocking down HMGA2 attenuates the effect of collagen on histone H3K9 and H3K27 acetylation and on collagen-induced p300, PCAF and GCN5 expression. We also show that human PDAC tumors with HMGA2 demonstrate increased histone H3K9 and H3K27 acetylation. Additionally, we show that cells in three-dimensional collagen gels demonstrate increased protection against gemcitabine. Significantly, downregulation of HMGA2 or p300, PCAF and GCN5 HATs sensitizes the cells to gemcitabine in three-dimensional collagen. Overall, our results increase our understanding of how the collagen microenvironment contributes to chemo-resistance in vitro and identify HATs as potential therapeutic targets against this deadly cancer.	[Dangi-Garimella, Surabhi; Sahai, Vaibhav; Ebine, Kazumi; Kumar, Krishan; Munshi, Hidayatullah G.] Northwestern Univ, Dept Med, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Munshi, Hidayatullah G.] Northwestern Univ, Jesse Brown VA Med Ctr, Chicago, IL 60611 USA; [Munshi, Hidayatullah G.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Dangi-Garimella, S (corresponding author), Northwestern Univ, Dept Med, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA.	surabhiyd@gmail.com; h-munshi@northwestern.edu			National Cancer Institute [R01CA126888]; Department of Veterans Affairs Merit Grant [I01BX001363]; NATIONAL CANCER INSTITUTE [R01CA126888] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs Merit Grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute Grant # R01CA126888 Department of Veterans Affairs Merit Grant # I01BX001363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer TK, 2008, EXPERT OPIN THER TAR, V12, P1457, DOI [10.1517/14728222.12.10.1301 , 10.1517/14728220802384047, 10.1517/14728222.12.11.1457 , 10.1517/14728220802384013]; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Dangi-Garimella S, 2011, ONCOGENE, V30, P1002, DOI 10.1038/onc.2010.485; Dangi-Garimella S, 2011, CANCER RES, V71, P1019, DOI 10.1158/0008-5472.CAN-10-1855; Dangi-Garimella S, 2010, J BIOL CHEM, V285, P28363, DOI 10.1074/jbc.M110.146019; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Eliseeva ED, 2007, MOL CANCER THER, V6, P2391, DOI 10.1158/1535-7163.MCT-07-0159; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Guo RF, 2011, NUCLEIC ACIDS RES, V39, P1390, DOI 10.1093/nar/gkq983; HARRIS CC, 1974, CANCER RES, V34, P3461; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hristov AC, 2009, MODERN PATHOL, V22, P43, DOI 10.1038/modpathol.2008.140; Jacobetz MA, 2012, GUT; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Li AYJ, 2011, MOL CELL BIOL, V31, P2605, DOI 10.1128/MCB.05447-11; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Ouaissi M, 2008, ANN SURG ONCOL, V15, P2318, DOI 10.1245/s10434-008-9940-z; Ouaissi M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/315939; Palmieri D, 2011, ONCOGENE, V30, P3024, DOI 10.1038/onc.2011.21; Pfannkuche K, 2009, STEM CELL REV REP, V5, P224, DOI 10.1007/s12015-009-9078-9; Piscuoglio S, 2012, HISTOPATHOLOGY, V60, P397, DOI 10.1111/j.1365-2559.2011.04121.x; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Richards DA, 2006, ANN ONCOL, V17, P1096, DOI 10.1093/annonc/mdl081; Santer FR, 2011, MOL CANCER THER, V10, P1644, DOI 10.1158/1535-7163.MCT-11-0182; Schneider Gunter, 2011, J Gastrointest Cancer, V42, P85, DOI 10.1007/s12029-011-9257-1; Shields MA, 2012, J BIOL CHEM, V287, P6218, DOI 10.1074/jbc.M111.308940; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Shields MA, 2011, J BIOL CHEM, V286, P10495, DOI 10.1074/jbc.M110.195628; Storch K, 2010, CANCER RES, V70, P3925, DOI 10.1158/0008-5472.CAN-09-3848; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wang G, PLOS ONE, V7; Wei YK, 2008, MOL CARCINOGEN, V47, P701, DOI 10.1002/mc.20413; Yu KR, 2013, STEM CELL RES, V10, P156, DOI 10.1016/j.scr.2012.11.002; Zha L, 2012, MOL CELL BIOCHEM, V364, P243, DOI 10.1007/s11010-012-1224-z	50	45	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64566	10.1371/journal.pone.0064566	http://dx.doi.org/10.1371/journal.pone.0064566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696899	gold, Green Published, Green Submitted			2022-12-27	WOS:000319081900102
J	Liu, SK; Li, Q; Liu, ZJ				Liu, Shikai; Li, Qi; Liu, Zhanjiang			Genome-Wide Identification, Characterization and Phylogenetic Analysis of 50 Catfish ATP-Binding Cassette (ABC) Transporter Genes	PLOS ONE			English	Article							RNA-SEQ ANALYSIS; SULFONYLUREA RECEPTORS; FAMILY; RESISTANCE; EVOLUTION; EFFLUX; TRANSCRIPTOME; TRANSLATION; DUPLICATION; MODULATION	Background: Although a large set of full-length transcripts was recently assembled in catfish, annotation of large gene families, especially those with duplications, is still a great challenge. Most often, complexities in annotation cause mis-identification and thereby much confusion in the scientific literature. As such, detailed phylogenetic analysis and/or orthology analysis are required for annotation of genes involved in gene families. The ATP-binding cassette (ABC) transporter gene superfamily is a large gene family that encodes membrane proteins that transport a diverse set of substrates across membranes, playing important roles in protecting organisms from diverse environment. Methodology/Principal Findings: In this work, we identified a set of 50 ABC transporters in catfish genome. Phylogenetic analysis allowed their identification and annotation into seven subfamilies, including 9 ABCA genes, 12 ABCB genes, 12 ABCC genes, 5 ABCD genes, 2 ABCE genes, 4 ABCF genes and 6 ABCG genes. Most ABC transporters are conserved among vertebrates, though cases of recent gene duplications and gene losses do exist. Gene duplications in catfish were found for ABCA1, ABCB3, ABCB6, ABCC5, ABCD3, ABCE1, ABCF2 and ABCG2. Conclusion/Significance: The whole set of catfish ABC transporters provide the essential genomic resources for future biochemical, toxicological and physiological studies of ABC drug efflux transporters. The establishment of orthologies should allow functional inferences with the information from model species, though the function of lineage-specific genes can be distinct because of specific living environment with different selection pressure.	[Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Program Cell & Mol Biosci, Auburn, AL 36849 USA; [Liu, Shikai; Li, Qi] Ocean Univ China, Coll Fisheries, Shellfish Genet & Breeding Lab, Qingdao, Peoples R China	Auburn University System; Auburn University; Auburn University System; Auburn University; Ocean University of China	Liu, ZJ (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA.	liuzhan@auburn.edu	Liu, Zhanjiang/R-9633-2019; Liu, Shikai/AAO-2247-2021; Liu, Shikai/D-4664-2013	Liu, Shikai/0000-0001-5777-489X; Liu, Shikai/0000-0001-5777-489X	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA) [2009-35205-05101, 2010-65205-20356, 2012-67015-19410]; China Scholarship Council	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA); China Scholarship Council(China Scholarship Council)	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2009-35205-05101 and 2010-65205-20356 and 2012-67015-19410 from the USDA National Institute of Food and Agriculture (NIFA). Shikai Liu was supported by a scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Abele R, 2006, FEBS LETT, V580, P1156, DOI 10.1016/j.febslet.2005.11.048; Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Annilo T, 2003, MAMM GENOME, V14, P7, DOI 10.1007/s00335-002-2229-9; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Bryan J, 1999, BBA-BIOMEMBRANES, V1461, P285, DOI 10.1016/S0005-2736(99)00164-9; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; Hinz A, 2012, BIOCHEMISTRY-US, V51, P4981, DOI 10.1021/bi300128f; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x; Kerr ID, 2004, BIOCHEM BIOPH RES CO, V315, P166, DOI 10.1016/j.bbrc.2004.01.044; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kusuhara H, 2007, PFLUG ARCH EUR J PHY, V453, P735, DOI 10.1007/s00424-006-0134-x; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; Leprohon P, 2006, EUKARYOT CELL, V5, P1713, DOI 10.1128/EC.00152-06; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li G, 2007, GENOMICS, V89, P385, DOI 10.1016/j.ygeno.2006.07.015; Li P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-177; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Liu SM, 2011, BMC GENOMICS, P12; Moitra K, 2011, PLOS ONE, P6; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Oram JF, 2001, J LIPID RES, V42, P1173; Robinson-Rechavi M, 2001, GENOME RES, V11, P781, DOI 10.1101/gr.165601; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Shani N, 1998, METHOD ENZYMOL, V292, P753; Sheps JA, 2004, GENOME BIOL, P5; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stover BC, 2010, BMC BIOINFORMATICS, P11; Sturm A, 2009, BMC GENOMICS, P10; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Sun H, 2000, NAT GENET, V26, P242, DOI 10.1038/79994; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tsybovsky Y, 2010, ADV EXP MED BIOL, V703, P105, DOI 10.1007/978-1-4419-5635-4_8; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; Ulrich DL, 2012, J BIOL CHEM, V287, P12679, DOI 10.1074/jbc.M111.336180; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Vasiliou Vasilis, 2008, Hum Genomics, V3, P1; Vlaming MLH, 2009, ADV DRUG DELIVER REV, V61, P14, DOI 10.1016/j.addr.2008.08.007; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; Woodward OM, 2011, FEBS J, V278, P3215, DOI 10.1111/j.1742-4658.2011.08171.x; Xie XD, 2012, MOL BIOL REP, V39, P7281, DOI 10.1007/s11033-012-1558-3; Xiong J, 2010, BMC EVOLUTIONARY BIO, P10; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhao ZY, 2007, GENETICS, V175, P1407, DOI 10.1534/genetics.106.066720; Zhao ZY, 2004, BIOCHEM BIOPH RES CO, V323, P104, DOI 10.1016/j.bbrc.2004.08.068	75	38	39	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63895	10.1371/journal.pone.0063895	http://dx.doi.org/10.1371/journal.pone.0063895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696857	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900061
J	Politzer-Ahles, S; Fiorentino, R				Politzer-Ahles, Stephen; Fiorentino, Robert			The Realization of Scalar Inferences: Context Sensitivity without Processing Cost	PLOS ONE			English	Article							TIME-COURSE; IMPLICATURES	Scalar inference is the phenomenon whereby the use of a less informative term (e.g., some of) is inferred to mean the negation of a more informative term (e.g., to mean not all of). Default processing accounts assume that the interpretation of some of as meaning not all of is realized easily and automatically (regardless of context), whereas context-driven processing accounts assume that it is realized effortfully and only in certain contexts. In the present study, participants' self-paced reading times were recorded as they read vignettes in which the context did or did not bias the participants to make a scalar inference (to interpret some of as meaning not all of). The reading times suggested that the realization of the inference was influenced by the context, but did not provide evidence for processing cost at the time the inference is realized, contrary to the predictions of context-driven processing accounts. The results raise the question of why inferencing occurs only in certain contexts if it does not involve extra processing effort.	[Politzer-Ahles, Stephen; Fiorentino, Robert] Univ Kansas, Dept Linguist, Lawrence, KS 66045 USA	University of Kansas	Politzer-Ahles, S (corresponding author), Univ Kansas, Dept Linguist, Lawrence, KS 66045 USA.	sjpa@ku.edu	Politzer-Ahles, Stephen/N-4421-2014	Politzer-Ahles, Stephen/0000-0002-5474-7930; Fiorentino, Robert/0000-0002-2864-1200	National Institutes of Health (NIH) [5T32DC000052-15]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005803, T32DC000052] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	SPA was supported by a National Institutes of Health (NIH) institutional training grant (5T32DC000052-15, "Training researchers in language impairment'') to the University of Kansas (PI: Mabel Rice). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen H., 2008, ANAL LINGUISTIC DATA; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bergen L, 2012, J EXP PSYCHOL LEARN, V38, P1450, DOI 10.1037/a0027850; Bott L, 2004, J MEM LANG, V51, P437, DOI 10.1016/j.jml.2004.05.006; Bott L, 2012, J MEM LANG, V66, P123, DOI 10.1016/j.jml.2011.09.005; Breheny R, 2006, COGNITION, V100, P434, DOI 10.1016/j.cognition.2005.07.003; Breheny R, 2013, COGNITION, V126, P423, DOI 10.1016/j.cognition.2012.11.012; Chierchia G., 2004, STRUCTURES, P39; De Neys W, 2007, EXP PSYCHOL, V54, P128, DOI 10.1027/1618-3169.54.2.128; Dieussaert K, 2011, Q J EXP PSYCHOL, V64, P2352, DOI 10.1080/17470218.2011.588799; Doran R, 2012, LANGUAGE, V88, P124, DOI 10.1353/lan.2012.0008; Feeney A, 2004, CAN J EXP PSYCHOL, V58, P121, DOI 10.1037/h0085792; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Grodner DJ, 2010, COGNITION, V116, P42, DOI 10.1016/j.cognition.2010.03.014; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Huang YT, 2009, COGNITIVE PSYCHOL, V58, P376, DOI 10.1016/j.cogpsych.2008.09.001; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Katsos N, 2010, LANG LINGUIST COMPAS, V4, P282, DOI 10.1111/j.1749-818x.2010.00203.x; Lenth RV, 2001, AM STAT, V55, P187, DOI 10.1198/000313001317098149; Levinson S, 2000, PRESUMPTIVE MEANINGS, P480; Nieuwland MS, 2010, J MEM LANG, V63, P324, DOI 10.1016/j.jml.2010.06.005; Noveck I., 2007, ADV PRAGMATICS, DOI DOI 10.1017/CBO9781139028370.018; Noveck IA, 2003, BRAIN LANG, V85, P203, DOI 10.1016/S0093-934X(03)00053-1; Politzer-Ahles S, 2013, BRAIN RES, V1490, P134, DOI 10.1016/j.brainres.2012.10.042; Tanenhaus K., 2011, P 33 ANN C COGN SCI, V33, P3299	25	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63943	10.1371/journal.pone.0063943	http://dx.doi.org/10.1371/journal.pone.0063943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	146HW	23696860	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900064
J	Zhang, Z; Zhao, ZW; Liu, YF; Wang, W; Wu, Y; Ding, JP				Zhang, Zheng; Zhao, Zhiwen; Liu, Yongfeng; Wang, Wei; Wu, Ying; Ding, Jiuping			Kinetic Model of Nav1.5 Channel Provides a Subtle Insight into Slow Inactivation Associated Excitability in Cardiac Cells	PLOS ONE			English	Article							MUSCLE SODIUM-CHANNEL; SCN5A MUTATIONS; NA+ CHANNELS; VENTRICULAR MYOCYTES; GIANT-AXONS; CHANNELOPATHIES; SKELETAL; CURRENTS; ACTIVATION; EXPRESSION	Voltage-gated sodium channel Nav1.5 has been linked to the cardiac cell excitability and a variety of arrhythmic syndromes including long QT, Brugada, and conduction abnormalities. Nav1.5 exhibits a slow inactivation, corresponding to a duration-dependent bi-exponential recovery, which is often associated with various arrhythmia syndromes. However, the gating mechanism of Nav1.5 and the physiological role of slow inactivation in cardiac cells remain elusive. Here a 12-state two-step inactivation Markov model was successfully developed to depict the gating kinetics of Nav1.5. This model can simulate the Nav1.5 channel in not only steady state processes, but also various transient processes. Compared with the simpler 8-state model, this 12-state model is well-behaved in simulating and explaining the processes of slow inactivation and slow recovery. This model provides a good framework for further studying the gating mechanism and physiological role of sodium channel in excitable cells.	[Zhang, Zheng; Zhao, Zhiwen; Liu, Yongfeng; Wang, Wei; Wu, Ying; Ding, Jiuping] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Wu, Y (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China.	wuying2010@mail.hust.edu.cn; jpding@mail.hust.edu.cn	Liu, Yongfeng/ABG-1361-2020	Liu, Yongfeng/0000-0002-8649-7892	Chinese National Natural Science Foundation [30971179, 31170814, 31028006]; Ministry of Science and Technology [2010CB529804]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work is supported by Chinese National Natural Science Foundation (30971179, 31170814, 31028006), the Ministry of Science and Technology (2010CB529804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; Armstrong CM, 2006, P NATL ACAD SCI USA, V103, P17991, DOI 10.1073/pnas.0607603103; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Clancy CE, 2004, BIOPHYS J, V86, P2606, DOI 10.1016/S0006-3495(04)74315-5; Cummins TR, 1996, BIOPHYS J, V71, P227, DOI 10.1016/S0006-3495(96)79219-6; DOERR T, 1990, PFLUG ARCH EUR J PHY, V416, P230, DOI 10.1007/BF00392058; GOLDMAN L, 1972, J GEN PHYSIOL, V59, P659, DOI 10.1085/jgp.59.6.659; He BJ, 2010, NEUROSCI LETT, V469, P268, DOI 10.1016/j.neulet.2009.12.012; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Jarecki BW, 2010, J CLIN INVEST, V120, P369, DOI 10.1172/JCI40801; Kambouris NG, 1998, J PHYSIOL-LONDON, V512, P693, DOI 10.1111/j.1469-7793.1998.693bd.x; KIYOSUE T, 1989, CIRC RES, V64, P389, DOI 10.1161/01.RES.64.2.389; KUO CC, 1994, NEURON, V12, P819, DOI 10.1016/0896-6273(94)90335-2; LIU YM, 1992, BIOPHYS J, V63, P654, DOI 10.1016/S0006-3495(92)81635-1; Magyar J, 2004, CARDIOVASC RES, V64, P477, DOI 10.1016/j.cardiores.2004.07.014; Milescu LS, 2008, BIOPHYS J, V95, P66, DOI 10.1529/biophysj.107.118190; Milescu LS, 2010, J NEUROSCI, V30, P12113, DOI 10.1523/JNEUROSCI.0445-10.2010; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; Moran O, 2000, FEBS LETT, V473, P132, DOI 10.1016/S0014-5793(00)01518-0; PATLAK J, 1991, PHYSIOL REV, V71, P1047, DOI 10.1152/physrev.1991.71.4.1047; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Remme CA, 2008, TRENDS CARDIOVAS MED, V18, P78, DOI 10.1016/j.tcm.2008.01.002; Rook MB, 2012, CARDIOVASC RES, V93, P12, DOI 10.1093/cvr/cvr252; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; RUDY B, 1978, J PHYSIOL-LONDON, V283, P1; Sheets MF, 1999, J PHYSIOL-LONDON, V514, P425, DOI 10.1111/j.1469-7793.1999.425ae.x; Sun L, 2009, BIOPHYS J, V97, P1832, DOI 10.1016/j.bpj.2009.06.042; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Viswanathan PC, 2004, TRENDS CARDIOVAS MED, V14, P28, DOI 10.1016/j.tcm.2003.10.001; Wang DW, 2000, CIRC RES, V87, pE37, DOI 10.1161/01.RES.87.8.e37; Wang DW, 2002, CIRCULATION, V105, P341, DOI 10.1161/hc0302.102592; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035208; Watanabe H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P268, DOI 10.1161/CIRCEP.108.779181; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D; ZILBERTER YI, 1994, BIOPHYS J, V67, P153, DOI 10.1016/S0006-3495(94)80464-3	42	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64286	10.1371/journal.pone.0064286	http://dx.doi.org/10.1371/journal.pone.0064286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696876	gold, Green Submitted, Green Published			2022-12-27	WOS:000319081900079
J	Gottenberg, JE; Seror, R; Miceli-Richard, C; Benessiano, J; Devauchelle-Pensec, V; Dieude, P; Dubost, JJ; Fauchais, AL; Goeb, V; Hachulla, E; Hatron, PY; Larroche, C; Le Guern, V; Morel, J; Perdriger, A; Puechal, X; Rist, S; Saraux, A; Sene, D; Sibilia, J; Vittecoq, O; Nocturne, G; Ravaud, P; Mariette, X				Gottenberg, Jacques-Eric; Seror, Raphaele; Miceli-Richard, Corinne; Benessiano, Joelle; Devauchelle-Pensec, Valerie; Dieude, Philippe; Dubost, Jean-Jacques; Fauchais, Anne-Laure; Goeb, Vincent; Hachulla, Eric; Hatron, Pierre Yves; Larroche, Claire; Le Guern, Veronique; Morel, Jacques; Perdriger, Aleth; Puechal, Xavier; Rist, Stephanie; Saraux, Alain; Sene, Damien; Sibilia, Jean; Vittecoq, Olivier; Nocturne, Gaetane; Ravaud, Philippe; Mariette, Xavier			Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjogren's Syndrome. Data at Enrollment in the Prospective ASSESS Cohort	PLOS ONE			English	Article							CELL-ACTIVATING FACTOR; B-LYMPHOCYTE STIMULATOR; RHEUMATOID-ARTHRITIS; RITUXIMAB TREATMENT; CIRCULATING LEVELS; INCREASED RISK; FACTOR GENE; BAFF; EXPRESSION; MICROGLOBULIN	Objectives: To analyze the clinical and immunological characteristics at enrollment in a large prospective cohort of patients with primary Sjogren's syndrome (pSS) and to investigate the association between serum BAFF, beta2-microglobulin and free light chains of immunoglobulins and systemic disease activity at enrollment. Methods: Three hundred and ninety five patients with pSS according to American-European Consensus Criteria were included from fifteen centers of Rheumatology and Internal Medicine in the "Assessment of Systemic Signs and Evolution of Sjogren's Syndrome'' (ASSESS) 5-year prospective cohort. At enrollment, serum markers were assessed as well as activity of the disease measured with the EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI). Results: Patient median age was 58 (25th-75th : 51-67) and median disease duration was 5 (2-9) years. Median ESSDAI at enrollment was 2 (0-7) with 30.9% of patients having features of systemic involvement. Patients with elevated BAFF, beta2-microglobulin and kappa, lambda FLCS had higher ESSDAI scores at enrollment (4 [2-11] vs 2 [0-7], P = 0.03; 4 [1-11] vs 2 [0-7], P< 0.0001); 4 [2-10] vs 2 [0-6.6], P< 0.0001 and 4 [2-8.2] vs 2 [0-7.0], P = 0.02, respectively). In multivariate analysis, increased beta2-microglobulin, kappa and lambda FLCs were associated with a higher ESSDAI score. Median BAFF and beta2-microglobulin were higher in the 16 patients with history of lymphoma (1173.3(873.1-3665.5) vs 898.9 (715.9-1187.2) pg/ml, P = 0.01 and 2.6 (2.2-2.9) vs 2.1 (1.8-2.6) mg/l, P = 0.04, respectively). Conclusion: In pSS, higher levels of beta2-microglobulin and free light chains of immunoglobulins are associated with increased systemic disease activity.	[Gottenberg, Jacques-Eric; Sibilia, Jean] Univ Strasbourg, Rheumatol Ctr Natl Reference Malad Autoimmunes Ra, INSERM, UMRS Federat Med Translat Strasbourg 1109,Strasbo, Strasbourg, France; [Seror, Raphaele; Miceli-Richard, Corinne; Nocturne, Gaetane; Mariette, Xavier] Univ Paris 11, Hop Bicetre, Assistance Publ Hop Paris, INSERM,U1012, Paris, France; [Benessiano, Joelle] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Ctr Ressources Biol, F-75877 Paris, France; [Devauchelle-Pensec, Valerie; Saraux, Alain] Brest Univ Hosp, Brest, France; [Dieude, Philippe] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, F-75877 Paris, France; [Dubost, Jean-Jacques] Clermont Ferrand Hosp, Clermont Ferrand, France; [Fauchais, Anne-Laure] Limoges Hosp, Limoges, France; [Goeb, Vincent] Amiens Univ Hosp, Amiens, France; [Hachulla, Eric; Hatron, Pierre Yves] Lille Univ Hosp, Lille, France; [Larroche, Claire] Hop Avicenne, Assistance Publ Hop Paris, F-93009 Bobigny, France; [Le Guern, Veronique; Puechal, Xavier] Hop Cochin, Assistance Publ Hop Paris, F-75674 Paris, France; [Morel, Jacques] Montpellier Univ Hosp, Montpellier, France; [Perdriger, Aleth] Rennes Univ Hosp, Rennes, France; [Rist, Stephanie] Orleans Hosp, Orleans, France; [Sene, Damien] Hop Lariboisiere, Assistance Publ Hop Paris, F-75475 Paris, France; [Vittecoq, Olivier] Rouen Univ Hosp, Rouen, France; [Ravaud, Philippe] Univ Paris 05, Hotel Dieu Hosp, Assistance Publ Hop Paris, INSERM,U378,Ctr Clin Epidemiol,Fac Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU Brest; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU Limoges; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; CHU Rennes; Universite de Rennes; Centre Hospitalier Regional d'Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Gottenberg, JE (corresponding author), Univ Strasbourg, Rheumatol Ctr Natl Reference Malad Autoimmunes Ra, INSERM, UMRS Federat Med Translat Strasbourg 1109,Strasbo, Strasbourg, France.	jacques-eric.gottenberg@chru-strasbourg.fr; xavier.mariette@bct.aphp.fr	Puéchal, Xavier/P-1555-2017; SEROR, Raphaele/E-2283-2017; ravaud, philippe/C-1694-2009; sene, damien/R-3970-2017; HACHULLA, ERIC/R-8488-2018	Puéchal, Xavier/0000-0003-3573-9203; SEROR, Raphaele/0000-0002-5523-1856; sene, damien/0000-0001-8640-4580; HACHULLA, ERIC/0000-0001-7432-847X; Ravaud, Philippe/0000-0001-8264-9206; Nocturne, Gaetane/0000-0001-6809-0733; Dieude, Philippe/0000-0002-4814-0307; Fauchais, Anne Laure/0000-0002-0489-8570; Goeb, Vincent/0000-0002-3807-545X; Sibilia, Jean/0000-0002-1601-4795	French Society of Rheumatology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060804] Funding Source: NIH RePORTER	French Society of Rheumatology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The French Society of Rheumatology provided a grant to the cohort. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P723, DOI 10.1002/art.21650; Candon S, 2009, ANN RHEUM DIS, V68, P1208, DOI 10.1136/ard.2008.095257; Emmerich F, 2007, BRIT J HAEMATOL, V136, P309, DOI 10.1111/j.1365-2141.2006.06431.x; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gottenberg JE, 2007, ANN RHEUM DIS, V66, P23, DOI 10.1136/ard.2006.052159; Gottenberg JE, 2012, CURR PHARM BIOTECHNO, V13, P2022, DOI 10.2174/138920112802273128; Gottenberg JE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1884; Gottenberg JE, 2005, ANN RHEUM DIS, V64, P1050, DOI 10.1136/ard.2004.030643; Gottenberg JE, 2003, ARTHRITIS RHEUM, V48, P2240, DOI 10.1002/art.11103; Gragnani L, 2011, ARTHRITIS RHEUM-US, V63, P1446, DOI 10.1002/art.30274; Ioannidis JPA, 2002, ARTHRITIS RHEUM, V46, P741, DOI 10.1002/art.10221; Jonsson MV, 2005, J CLIN IMMUNOL, V25, P189, DOI 10.1007/s10875-005-4091-5; KASSAN SS, 1978, ANN INTERN MED, V89, P888, DOI 10.7326/0003-4819-89-6-888; Lavie F, 2008, SCAND J IMMUNOL, V67, P185, DOI 10.1111/j.1365-3083.2007.02049.x; Lavie F, 2007, ANN RHEUM DIS, V66, P700, DOI 10.1136/ard.2006.060772; Mackaya F, 2007, CURR OPIN RHEUMATOL, V19, P406, DOI 10.1097/BOR.0b013e328277ef4c; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; Mariette X, 2010, CURR OPIN RHEUMATOL, V22, P471, DOI 10.1097/BOR.0b013e32833c36c5; MICHALSKI JP, 1975, NEW ENGL J MED, V293, P1228, DOI 10.1056/NEJM197512112932404; MOUTSOPOULOS HM, 1983, J IMMUNOL, V130, P2663; Nossent JC, 2008, RHEUMATOLOGY, V47, P1311, DOI 10.1093/rheumatology/ken246; Novak AJ, 2006, J CLIN ONCOL, V24, P983, DOI 10.1200/JCO.2005.02.7938; Novak AJ, 2004, BLOOD, V104, P2247, DOI 10.1182/blood-2004-02-0762; Novak AJ, 2009, CANCER RES, V69, P4217, DOI 10.1158/0008-5472.CAN-08-4915; Pers JO, 2007, ARTHRITIS RHEUM, V56, P1464, DOI 10.1002/art.22603; Pertovaara M, 2011, ANN RHEUM DIS, V70, P2236, DOI 10.1136/ard.2011.153098; Quartuccio L, 2012, RHEUMATOLOGY     AUG; Sellam J, 2007, ANN RHEUM DIS, V66, P790, DOI 10.1136/ard.2006.065656; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Seror R, 2011, ANN RHEUM DIS, V70, P880, DOI 10.1136/2009.110619corr1; SMITH DK, 1993, NEW ENGL J MED, V328, P373, DOI 10.1056/NEJM199302113280601; Theander E, 2006, ANN RHEUM DIS, V65, P796, DOI 10.1136/ard.2005.041186; Tzioufas AG, 1996, ARTHRITIS RHEUM, V39, P767, DOI 10.1002/art.1780390508; Voulgarelis M, 2008, RHEUM DIS CLIN N AM, V34, P921, DOI 10.1016/j.rdc.2008.08.006	34	126	129	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e59868	10.1371/journal.pone.0059868	http://dx.doi.org/10.1371/journal.pone.0059868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717383	gold, Green Submitted, Green Published			2022-12-27	WOS:000319385300043
J	Patil, DN; Datta, M; Dev, A; Dhindwal, S; Singh, N; Dasauni, P; Kundu, S; Sharma, AK; Tomar, S; Kumar, P				Patil, Dipak N.; Datta, Manali; Dev, Aditya; Dhindwal, Sonali; Singh, Nirpendra; Dasauni, Pushpanjali; Kundu, Suman; Sharma, Ashwani K.; Tomar, Shailly; Kumar, Pravindra			Structural Investigation of a Novel N-Acetyl Glucosamine Binding Chi-Lectin Which Reveals Evolutionary Relationship with Class III Chitinases	PLOS ONE			English	Article							CRYSTAL-STRUCTURE DETERMINATION; CARBOHYDRATE-BINDING; PLANT-LECTINS; MAXIMUM-LIKELIHOOD; 4 COMPLEXES; XIP-I; PROTEIN; FAMILY; GLYCOPROTEIN; IDENTIFICATION	The glycosyl hydrolase 18 (GH18) family consists of active chitinases as well as chitinase like lectins/proteins (CLPs). The CLPs share significant sequence and structural similarities with active chitinases, however, do not display chitinase activity. Some of these proteins are reported to have specific functions and carbohydrate binding property. In the present study, we report a novel chitinase like lectin (TCLL) from Tamarindus indica. The crystal structures of native TCLL and its complex with N-acetyl glucosamine were determined. Similar to the other CLPs of the GH18 members, TCLL lacks chitinase activity due to mutations of key active site residues. Comparison of TCLL with chitinases and other chitin binding CLPs shows that TCLL has substitution of some chitin binding site residues and more open binding cleft due to major differences in the loop region. Interestingly, the biochemical studies suggest that TCLL is an N-acetyl glucosamine specific chi-lectin, which is further confirmed by the complex structure of TCLL with N-acetyl glucosamine complex. TCLL has two distinct N-acetyl glucosamine binding sites S1 and S2 that contain similar polar residues, although interaction pattern with N-acetyl glucosamine varies extensively among them. Moreover, TCLL structure depicts that how plants utilize existing structural scaffolds ingenuously to attain new functions. To date, this is the first structural investigation of a chi-lectin from plants that explore novel carbohydrate binding sites other than chitin binding groove observed in GH18 family members. Consequently, TCLL structure confers evidence for evolutionary link of lectins with chitinases.	[Patil, Dipak N.; Datta, Manali; Dev, Aditya; Dhindwal, Sonali; Sharma, Ashwani K.; Tomar, Shailly; Kumar, Pravindra] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttar Pradesh, India; [Singh, Nirpendra; Dasauni, Pushpanjali; Kundu, Suman] Univ Delhi, Dept Biochem, New Delhi, India; [Dasauni, Pushpanjali] Univ Delhi, Cent Instrumentat Facil, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; University of Delhi; University of Delhi	Kumar, P (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttar Pradesh, India.	pravshai@gmail.com	KUMAR, PRAVINDRA/AAF-2859-2020; Patil, Dipak N./X-9567-2019	KUMAR, PRAVINDRA/0000-0003-2128-7736; Patil, Dipak N./0000-0003-1112-5557; Dasauni, Pushpanjali/0000-0002-7556-7330; Datta, Manali/0000-0002-5335-3446	Department of Science and Technology (DST), New Delhi, India [SERB/F/5551/2012-13]; University of Delhi (RD Grant); UGC (SAP programme); DBT; MHRD; AICTE, Government of India	Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India)); University of Delhi (RD Grant); UGC (SAP programme); DBT(Department of Biotechnology (DBT) India); MHRD; AICTE, Government of India(All India Council for Technical Education (AICTE))	Financial support has been provided for this work by Department of Science and Technology (DST ref no. SERB/F/5551/2012-13 dated 22/01/2012), New Delhi, India. DNP and MD thank MHRD and AICTE, Government of India for financial support, respectively. Financial support to SK from University of Delhi (R&D Grant), UGC (SAP programme) and DBT are duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bokma E, 2002, EUR J BIOCHEM, V269, P893, DOI 10.1046/j.0014-2956.2001.02721.x; Bovi M, 2011, GLYCOBIOLOGY, V21, P1000, DOI 10.1093/glycob/cwr012; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Carrizo ME, 2005, J BIOL CHEM, V280, P10614, DOI 10.1074/jbc.M411989200; Cavada BS, 2006, FEBS J, V273, P3962, DOI 10.1111/j.1742-4658.2006.05400.x; Chandra NR, 2006, GLYCOBIOLOGY, V16, P938, DOI 10.1093/glycob/cwl012; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; COULSON AFW, 1994, FEBS LETT, V354, P41, DOI 10.1016/0014-5793(94)01084-6; De Hoff PL, 2009, MOL GENET GENOMICS, V282, P1, DOI 10.1007/s00438-009-0460-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Edge ASB, 2003, BIOCHEM J, V376, P339, DOI 10.1042/BJ20030673; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARBER GK, 1993, CURR OPIN STRUC BIOL, V3, P409, DOI 10.1016/S0959-440X(05)80114-9; Fu LL, 2011, INT J BIOCHEM CELL B, V43, P1442, DOI 10.1016/j.biocel.2011.07.004; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harata K, 2000, J MOL BIOL, V297, P673, DOI 10.1006/jmbi.2000.3594; Hayashida M, 2003, J MOL BIOL, V334, P551, DOI 10.1016/j.jmb.2003.09.076; HENNIG M, 1992, FEBS LETT, V306, P80, DOI 10.1016/0014-5793(92)80842-5; HENNIG M, 1995, ACTA CRYSTALLOGR D, V51, P177, DOI 10.1107/S0907444994009807; HENNIG M, 1995, J MOL BIOL, V254, P237, DOI 10.1006/jmbi.1995.0614; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Houston DR, 2003, J BIOL CHEM, V278, P30206, DOI 10.1074/jbc.M303371200; Hurtado-Guerrero R, 2007, CHEM BIOL, V14, P589, DOI 10.1016/j.chembiol.2007.03.015; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Itoh Y, 2006, APPL MICROBIOL BIOT, V72, P1176, DOI 10.1007/s00253-006-0405-7; Kaur N, 2006, PROTEIN PEPTIDE LETT, V13, P895; Kawamura K, 1999, DEVELOPMENT, V126, P211; Kumar J, 2007, ACTA CRYSTALLOGR D, V63, P437, DOI 10.1107/S0907444907001631; Kumar J, 2006, ACTA CRYSTALLOGR D, V62, P953, DOI 10.1107/S0907444906020427; Kumar S, 2010, FEBS J, V277, P2868, DOI 10.1111/j.1742-4658.2010.07703.x; Kuo CJ, 2008, J AGR FOOD CHEM, V56, P11507, DOI 10.1021/jf8017589; Lee BS, 2005, RAPID COMMUN MASS SP, V19, P2629, DOI 10.1002/rcm.2096; Leonidas DD, 2007, J MOL BIOL, V368, P1145, DOI 10.1016/j.jmb.2007.02.092; Lienemann M, 2009, GLYCOBIOLOGY, V19, P1116, DOI 10.1093/glycob/cwp102; Loris R, 2000, J MOL BIOL, V301, P987, DOI 10.1006/jmbi.2000.4016; Manali Datta, 2010, International Journal of Life Sciences and Technology (IJLST), V3, P16; Meng G, 2010, J BIOL CHEM, V285, P39898, DOI 10.1074/jbc.M110.130781; Mohanty AK, 2003, J BIOL CHEM, V278, P14451, DOI 10.1074/jbc.M208967200; Moller M, 2002, BIOCHEM MOL BIOL EDU, V30, P175, DOI 10.1002/bmb.2002.494030030035; MORRISON BW, 1994, ONCOGENE, V9, P3417; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; Patil DN, 2009, ACTA CRYSTALLOGR F, V65, P343, DOI 10.1107/S1744309109006472; Payan F, 2004, J BIOL CHEM, V279, P36029, DOI 10.1074/jbc.M404225200; Payan F, 2003, BIOCHEM J, V372, P399, DOI 10.1042/BJ20021802; Rao DH, 2008, J AGR FOOD CHEM, V56, P2175, DOI 10.1021/jf073183i; Rudiger H, 2001, GLYCOCONJUGATE J, V18, P589, DOI 10.1023/A:1020687518999; Schimpl M, 2012, BIOCHEM J, V446, P149, DOI 10.1042/BJ20120377; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwefel D, 2010, J AM CHEM SOC, V132, P8704, DOI 10.1021/ja101646k; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Sinha S, 2007, CURR OPIN STRUC BIOL, V17, P498, DOI 10.1016/j.sbi.2007.06.007; Somashekar D, 1997, CARBOHYD POLYM, V34, P343, DOI 10.1016/S0144-8617(97)00052-0; Srivastava DB, 2007, J STRUCT BIOL, V158, P255, DOI 10.1016/j.jsb.2006.11.002; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Damme EJM, 1998, CRIT REV PLANT SCI, V17, P575, DOI 10.1016/S0735-2689(98)00365-7; Van Damme EJM, 2007, PLANT PHYSIOL, V144, P662, DOI 10.1104/pp.106.087981; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; vanScheltinga ACT, 1996, J MOL BIOL, V262, P243, DOI 10.1006/jmbi.1996.0510; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Varela PF, 2002, J BIOL CHEM, V277, P13229, DOI 10.1074/jbc.M110502200; WATANABE T, 1993, J BIOL CHEM, V268, P18567; Watanabe T, 2001, FEBS LETT, V494, P74, DOI 10.1016/S0014-5793(01)02317-1; Ye XY, 2001, J PROTEIN CHEM, V20, P367, DOI 10.1023/A:1012276619686; Zhang JZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019899; Zhu KY, 1996, PLANT PHYSIOL, V110, P195, DOI 10.1104/pp.110.1.195; Zhu QS, 2008, INSECT BIOCHEM MOLEC, V38, P452, DOI 10.1016/j.ibmb.2007.06.010; Zhu QS, 2004, BIOINFORMATICS, V20, P161, DOI 10.1093/bioinformatics/bth020	78	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63779	10.1371/journal.pone.0063779	http://dx.doi.org/10.1371/journal.pone.0063779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717482	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600032
J	Kari, V; Karpiuk, O; Tieg, B; Kriegs, M; Dikomey, E; Krebber, H; Begus-Nahrmann, Y; Johnsen, SA				Kari, Vijayalakshmi; Karpiuk, Oleksandra; Tieg, Bettina; Kriegs, Malte; Dikomey, Ekkehard; Krebber, Heike; Begus-Nahrmann, Yvonne; Johnsen, Steven A.			A Subset of Histone H2B Genes Produces Polyadenylated mRNAs under a Variety of Cellular Conditions	PLOS ONE			English	Article							STEM-LOOP; EXPRESSION; MONOUBIQUITINATION; IDENTIFICATION; PATTERNS; PATHWAY; CDK9; LIFE; END; P53	Unlike other metazoan mRNAs, replication-dependent histone gene transcripts are not polyadenylated but instead have a conserved stem-loop structure at their 39 end. Our previous work has shown that under certain conditions replication-dependent histone genes can produce alternative transcripts that are polyadenylated at the 39 end and, in some cases, spliced. A number of microarray studies examining the expression of polyadenylated mRNAs identified changes in the levels of histone transcripts e. g. during differentiation and tumorigenesis. However, it remains unknown which histone genes produce polyadenylated transcripts and which conditions regulate this process. In the present study we examined the expression and polyadenylation of the human histone H2B gene complement in various cell lines. We demonstrate that H2B genes display a distinct expression pattern that is varies between different cell lines. Further we show that the fraction of polyadenylated HIST1H2BD and HIST1H2AC transcripts is increased during differentiation of human mesenchymal stem cells (hMSCs) and human fetal osteoblast (hFOB 1.19). Furthermore, we observed an increased fraction of polyadenylated transcripts produced from the histone genes in cells following ionizing radiation. Finally, we show that polyadenylated transcripts are transported to the cytoplasm and found on polyribosomes. Thus, we propose that the production of polyadenylated histone mRNAs from replication-dependent histone genes is a regulated process induced under specific cellular circumstances.	[Kari, Vijayalakshmi; Johnsen, Steven A.] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany; [Kari, Vijayalakshmi; Karpiuk, Oleksandra; Begus-Nahrmann, Yvonne; Johnsen, Steven A.] Univ Med Ctr Gottingen, Gottingen Ctr Mol Biosci, Dept Mol Oncol, Gottingen, Germany; [Tieg, Bettina; Krebber, Heike] Univ Med Ctr Gottingen, Inst Microbiol & Genet, Dept Mol Genet, Gottingen, Germany; [Kriegs, Malte; Dikomey, Ekkehard] Univ Med Ctr Hamburg Eppendorf, Dept Radiat Oncol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Johnsen, SA (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany.	sjohnsen@alumni.mayo.edu	Johnsen, Steven/AAX-2322-2020	Johnsen, Steven/0000-0003-1198-5805	Dorothea-Schlozer Program at the University of Gottingen; Deutsche Forschungsgemeinschaft [JO 815/1, GRK1034]; State of Lower Saxony, Hannover, Germany [VWZN2562]	Dorothea-Schlozer Program at the University of Gottingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); State of Lower Saxony, Hannover, Germany	This work was supported by a doctoral fellowship from the Dorothea-Schlozer Program at the University of Gottingen to O.K. and grants from the Deutsche Forschungsgemeinschaft (JO 815/1 and GRK1034) and the State of Lower Saxony, Hannover, Germany (VWZN2562) to S.A.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; COLLART D, 1991, BIOCHEMISTRY-US, V30, P1610, DOI 10.1021/bi00220a024; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Kari V, 2011, CELL CYCLE, V10, P3495, DOI 10.4161/cc.10.20.17769; Karpiuk O, 2012, MOL CELL, V46, P705, DOI 10.1016/j.molcel.2012.05.022; KIRSH AL, 1989, GENE DEV, V3, P2172, DOI 10.1101/gad.3.12b.2172; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Martinez I, 2007, EUR J CANCER, V43, P415, DOI 10.1016/j.ejca.2006.09.001; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Masek T, 2011, METHODS MOL BIOL, V703, P293, DOI 10.1007/978-1-59745-248-9_20; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; PANDEY NB, 1990, NUCLEIC ACIDS RES, V18, P3161, DOI 10.1093/nar/18.11.3161; PANDEY NB, 1994, MOL CELL BIOL, V14, P1709, DOI 10.1128/MCB.14.3.1709; Pirngruber J, 2010, ONCOGENE, V29, P2853, DOI 10.1038/onc.2010.42; Pirngruber J, 2009, CELL CYCLE, V8, P3636, DOI 10.4161/cc.8.22.9890; Pirngruber J, 2009, EMBO REP, V10, P894, DOI 10.1038/embor.2009.108; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tan DZ, 2013, SCIENCE, V339, P318, DOI 10.1126/science.1228705; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; WU RS, 1981, CELL, V27, P321, DOI 10.1016/0092-8674(81)90415-3; Yan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r78; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	29	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63745	10.1371/journal.pone.0063745	http://dx.doi.org/10.1371/journal.pone.0063745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717473	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700053
J	Escaramis, G; Tornador, C; Bassaganyas, L; Rabionet, R; Tubio, JMC; Martinez-Fundichely, A; Caceres, M; Gut, M; Ossowski, S; Estivill, X				Escaramis, Georgia; Tornador, Cristian; Bassaganyas, Laia; Rabionet, Raquel; Tubio, Jose M. C.; Martinez-Fundichely, Alexander; Caceres, Mario; Gut, Marta; Ossowski, Stephan; Estivill, Xavier			PeSV-Fisher: Identification of Somatic and Non-Somatic Structural Variants Using Next Generation Sequencing Data	PLOS ONE			English	Article							COPY NUMBER VARIATION; COMBINATORIAL ALGORITHMS; READ ALIGNMENT; GENOME; CHROMOTHRIPSIS; REARRANGEMENTS; INSERTIONS	Next-generation sequencing technologies expedited research to develop efficient computational tools for the identification of structural variants (SVs) and their use to study human diseases. As deeper data is obtained, the existence of higher complexity SVs in some genomes becomes more evident, but the detection and definition of most of these complex rearrangements is still in its infancy. The full characterization of SVs is a key aspect for discovering their biological implications. Here we present a pipeline (PeSV-Fisher) for the detection of deletions, gains, intra- and inter-chromosomal translocations, and inversions, at very reasonable computational costs. We further provide comprehensive information on co-localization of SVs in the genome, a crucial aspect for studying their biological consequences. The algorithm uses a combination of methods based on paired-reads and read-depth strategies. PeSV-Fisher has been designed with the aim to facilitate identification of somatic variation, and, as such, it is capable of analysing two or more samples simultaneously, producing a list of non-shared variants between samples. We tested PeSV-Fisher on available sequencing data, and compared its behaviour to that of frequently deployed tools (BreakDancer and VariationHunter). We have also tested this algorithm on our own sequencing data, obtained from a tumour and a normal blood sample of a patient with chronic lymphocytic leukaemia, on which we have also validated the results by targeted re-sequencing of different kinds of predictions. This allowed us to determine confidence parameters that influence the reliability of breakpoint predictions.	[Escaramis, Georgia; Tornador, Cristian; Bassaganyas, Laia; Rabionet, Raquel; Tubio, Jose M. C.; Martinez-Fundichely, Alexander; Caceres, Mario; Estivill, Xavier] Ctr Genom Regulat CRG, Genet Causes Dis Grp, Barcelona, Spain; [Escaramis, Georgia; Tornador, Cristian; Bassaganyas, Laia; Rabionet, Raquel; Tubio, Jose M. C.; Martinez-Fundichely, Alexander; Caceres, Mario; Ossowski, Stephan; Estivill, Xavier] UPF, Barcelona, Spain; [Escaramis, Georgia; Tornador, Cristian; Bassaganyas, Laia; Rabionet, Raquel; Tubio, Jose M. C.; Martinez-Fundichely, Alexander; Caceres, Mario; Estivill, Xavier] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain; [Escaramis, Georgia; Tornador, Cristian; Bassaganyas, Laia; Rabionet, Raquel; Tubio, Jose M. C.; Martinez-Fundichely, Alexander; Caceres, Mario; Ossowski, Stephan; Estivill, Xavier] Hosp Mar Med Res Inst IMIM, Barcelona, Spain; [Martinez-Fundichely, Alexander] CHUS, Galician Fdn Genom Med SERGAS, Santiago De Compostela, Spain; [Martinez-Fundichely, Alexander; Caceres, Mario] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain; [Caceres, Mario] ICREA, Barcelona, Spain; [Gut, Marta] Natl Ctr Genom Anal CNAG CRG, Barcelona, Spain; [Ossowski, Stephan] CRG, Genom & Epigen Variat Dis Grp, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Complexo Hospitalario Universitario de Santiago de Compostela; Autonomous University of Barcelona; ICREA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Estivill, X (corresponding author), Ctr Genom Regulat CRG, Genet Causes Dis Grp, Barcelona, Spain.	xavier.estivill@crg.eu	Tubio, Jose M.C./H-5076-2015; Estivill, Xavier/A-3125-2013; rabionet, raquel/A-7407-2009; Tornador, Cristian/S-2197-2018; Ossowski, Stephan/E-2139-2011; Escaramis, Georgia/B-2997-2015; Rabionet, Raquel/C-8379-2009; Cáceres, Mario/A-6379-2009; Escaramis, Georgia/AAR-5586-2020; Martinez-Fundichely, Alexander/AAR-7309-2020	Tubio, Jose M.C./0000-0003-3540-2459; Estivill, Xavier/0000-0002-0723-2256; rabionet, raquel/0000-0001-5006-8140; Tornador, Cristian/0000-0002-6437-9270; Ossowski, Stephan/0000-0002-7416-9568; Escaramis, Georgia/0000-0002-5416-3177; Rabionet, Raquel/0000-0001-5006-8140; Cáceres, Mario/0000-0002-7736-3251; Martinez-Fundichely, Alexander/0000-0002-7660-5511; BASSAGANYAS, LAIA/0000-0002-4575-0214	AGAUR (Generalitat de Catalunya) [2009 SGR 1502]; CIBERESP (Instituto de Salud Carlos III); ESGI (European Commission) [262055_ESGI]; ENGAGE (European Commission) [ENGAGE_201413]; TECHGENE (European Commission) [TECHGENE_223143]; GEUVADIS (European Commission) [261123_GEUVADIS]; NOVADIS (Ministerio de Ciencia y Technologia) [SAF2008-00357]; Galicia Government Xunta de Galicia (Spain) [10PXIB918057]; MAEC-AEC1 Predoctoral Fellowship (Ministerio de Asuntos Exteriores y Cooperacion, Spain); Ramon y Cajal (Ministerio de Educacion y Ciencia) [BFU2007-60930]; ICREA Funding Source: Custom	AGAUR (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); CIBERESP (Instituto de Salud Carlos III); ESGI (European Commission); ENGAGE (European Commission); TECHGENE (European Commission); GEUVADIS (European Commission); NOVADIS (Ministerio de Ciencia y Technologia); Galicia Government Xunta de Galicia (Spain); MAEC-AEC1 Predoctoral Fellowship (Ministerio de Asuntos Exteriores y Cooperacion, Spain); Ramon y Cajal (Ministerio de Educacion y Ciencia)(Spanish Government); ICREA(ICREA)	This work was supported by AGAUR (Generalitat de Catalunya, 2009 SGR 1502) (X.E.); CIBERESP (Instituto de Salud Carlos III) (G.E.); ESGI (European Commission, 262055_ESGI) (R.R., X.E.), ENGAGE (European Commission, ENGAGE_201413), TECHGENE (European Commission, TECHGENE_223143), and GEUVADIS (European Commission, 261123_GEUVADIS) (X.E.); NOVADIS (Ministerio de Ciencia y Technologia, SAF2008-00357) (X.E.); Galicia Government Xunta de Galicia (Spain) through the project number 10PXIB918057 (J.M.C.T.); MAEC-AEC1 Predoctoral Fellowship (Ministerio de Asuntos Exteriores y Cooperacion, Spain) (A.M.F.); and Ramon y Cajal position and grant BFU2007-60930 (Ministerio de Educacion y Ciencia) (M.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Hajirasouliha I, 2010, BIOINFORMATICS, V26, P1277, DOI 10.1093/bioinformatics/btq152; Hormozdiari F, 2010, BIOINFORMATICS, V26, pi350, DOI 10.1093/bioinformatics/btq216; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; MARCOSOLA S, 2012, NAT METHODS; Medvedev P, 2010, GENOME RES, V20, P1613, DOI 10.1101/gr.106344.110; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Qi J, 2011, NUCLEIC ACIDS RES, V39, pW567, DOI 10.1093/nar/gkr506; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Sindi SS, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r22; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Wong K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r128; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	44	12	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63377	10.1371/journal.pone.0063377	http://dx.doi.org/10.1371/journal.pone.0063377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704902	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200031
J	Hruschka, DJ; Henrich, J				Hruschka, Daniel J.; Henrich, Joseph			Institutions, Parasites and the Persistence of In-group Preferences	PLOS ONE			English	Article							INTERGROUP BIAS; ORIGINS; CULTURE; SELF; COLLECTIVISM; UNCERTAINTY; PREVALENCE; CORRUPTION; EVOLUTION; EXCHANGE	Much research has established reliable cross-population differences in motivations to invest in one's in-group. We compare two current historical-evolutionary hypotheses for this variation based on (1) effective large-scale institutions and (2) pathogen threats by analyzing cross-national differences (N = 122) in in-group preferences measured in three ways. We find that the effectiveness of government institutions correlates with favoring in-group members, even when controlling for pathogen stress and world region, assessing reverse causality, and providing a check on endogeneity with an instrumental variable analysis. Conversely, pathogen stress shows inconsistent associations with in-group favoritism when controlling for government effectiveness. Moreover, pathogen stress shows little to no association with in-group favoritism within major world regions whereas government effectiveness does. These results suggest that variation in in-group preferences across contemporary nation-states is more consistent with a generalized response to institutions that meet basic needs rather than an evolved response dedicated to pathogens.	[Hruschka, Daniel J.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Henrich, Joseph] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Henrich, Joseph] Univ British Columbia, Dept Econ, Vancouver, BC V6T 1W5, Canada	Arizona State University; Arizona State University-Tempe; University of British Columbia; University of British Columbia	Hruschka, DJ (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	dhruschk@asu.edu			National Science Foundation [BCS-1150813]; Program in Cultural Anthropology; Program in Social Psychology Program; Program in Decision, Risk, and Management Sciences; University of Chicago; Templeton Foundation New Science of Virtues Grant; Canadian Institute For Advanced Research (CIFAR)	National Science Foundation(National Science Foundation (NSF)); Program in Cultural Anthropology; Program in Social Psychology Program; Program in Decision, Risk, and Management Sciences; University of Chicago(University of Chicago); Templeton Foundation New Science of Virtues Grant; Canadian Institute For Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR))	DJH acknowledges support from the National Science Foundation grant BCS-1150813, jointly funded by the Programs in Cultural Anthropology, Social Psychology Program and Decision, Risk, and Management Sciences, as well as support from the University of Chicago and Templeton Foundation New Science of Virtues Grant. JH acknowledges support from the Canadian Institute For Advanced Research (CIFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2001, AM ECON REV, V91, P1369, DOI 10.1257/aer.91.5.1369; Alesina A., 2004, FIGHTING POVERTY US; Alesina A, 2010, J ECON GROWTH, V15, P93, DOI 10.1007/s10887-010-9052-z; Algan Y, 2010, AM ECON REV, V100, P2060, DOI 10.1257/aer.100.5.2060; Antonakis J, 2010, LEADERSHIP QUART, V21, P1086, DOI 10.1016/j.leaqua.2010.10.010; Atran Scott, 2010, Biology Theory, V5, P18, DOI 10.1162/BIOT_a_00018; Currie TE, 2012, BEHAV BRAIN SCI, V35, P83, DOI 10.1017/S0140525X11000963; de Barra M, 2012, BEHAV BRAIN SCI, V35, P85, DOI 10.1017/S0140525X11000975; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P1279, DOI 10.1098/rspb.2008.0094; Fincher CL, 2012, BEHAV BRAIN SCI, V35, P99, DOI 10.1017/S0140525X11001774; Fisman R, 2007, J POLIT ECON, V115, P1020, DOI 10.1086/527495; Fukuyama F., 1995, TRUST SOCIAL VIRTUES; GEERTZ C, 1978, AM ECON REV, V68, P28; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Gelman A., 2007, DATA ANAL USING REGR; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Guiso L, 2006, J ECON PERSPECT, V20, P23, DOI 10.1257/jep.20.2.23; Hackman J, 2013, EVOLUTION HUMAN BEHA; HAMPDENTURNER CM, 2000, BUILDING CROSS CULTU; Heine S.J., 2008, CULTURAL PSYCHOL; Heine SJ, 2006, PERS SOC PSYCHOL REV, V10, P88, DOI 10.1207/s15327957pspr1002_1; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Hofstede G., 2001, CULTURES CONSEQUENCE; Hohman ZP, 2011, EUR J SOC PSYCHOL, V41, P751, DOI 10.1002/ejsp.818; House Robert., 2004, CULTURE LEADERSHIP; Hruschka D. J., 2010, FRIENDSHIP DEV ECOLO; Inglehart R., 2004, HUMAN BELIEFS VALUES; Johnson S, 2011, HITHER THOU SHALT CO; Kaplan H.S., 2005, MORAL SENTIMENTS MAT, P75; Kaplan HS, 2012, P ROYAL SOC B; KOLLOCK P, 1994, AM J SOCIOL, V100, P313, DOI 10.1086/230539; Kranton RE, 1996, AM ECON REV, V86, P830; LIPSET S, 2000, CULTURE MATTERS VALU; Lomnitz L. A., 2014, NETWORKS MARGINALITY; Lopez-Claros A, 2005, GLOBAL COMPETITIVENE; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Mathew S, 2011, P NATL ACAD SCI USA, V108, P11375, DOI 10.1073/pnas.1105604108; McNeill William H., 1977, PLAGUES PEOPLES; Mikulincer M, 2001, J PERS SOC PSYCHOL, V81, P97, DOI 10.1037//0022-3514.81.1.97; MILLER JG, 1992, J PERS SOC PSYCHOL, V62, P541, DOI 10.1037/0022-3514.62.4.541; Murray DR, 2010, J CROSS CULT PSYCHOL, V41, P99, DOI 10.1177/0022022109349510; Navarrete CD, 2004, GROUP PROCESS INTERG, V7, P370, DOI 10.1177/1368430204046144; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Norris Pippa, 2004, SACRED SECULAR RELIG; Proulx T, 2010, SOC PERSONAL PSYCHOL, V4, P889, DOI 10.1111/j.1751-9004.2010.00304.x; Realo A, 2008, J CROSS CULT PSYCHOL, V39, P447, DOI 10.1177/0022022108318096; Sachs J.D., 2003, I DONT RULE DIRECT E; Schaller M, 2010, EVOLUTION, CULTURE, AND THE HUMAN MIND, P1; Schaller M, 2011, PHILOS T R SOC B, V366, P3418, DOI 10.1098/rstb.2011.0029; Schwartz S. H., 2009, QUOD ERAT DEMONSTRAN, P1; Sugiyama LS, 2004, AM J PHYS ANTHROPOL, V123, P371, DOI 10.1002/ajpa.10325; Thornhill R, 2009, BIOL REV, V84, P113, DOI 10.1111/j.1469-185X.2008.00062.x; Treisman D, 2000, J PUBLIC ECON, V76, P399, DOI 10.1016/S0047-2727(99)00092-4; Triandis H. C., 1995, INDIVIDUALISM COLLEC, DOI 10.4324/9780429499845; TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323; Trompenaars F., 1998, RIDING WAVES; Van de Vliert E, 2012, BEHAV BRAIN SCI, V35, P94, DOI 10.1017/S0140525X11001075; Van de Vliert E, 2011, J CROSS CULT PSYCHOL, V42, P494, DOI 10.1177/0022022110381120; Weber Max., 1951, RELIG CHINA CONFUCIA; World Bank, 2011, WORLD BANK IND; World Bank, 2011, WORLD BANK GOV IND	62	63	64	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63642	10.1371/journal.pone.0063642	http://dx.doi.org/10.1371/journal.pone.0063642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23704926	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200057
J	Lamoureux, L; Simon, SLR; Plews, M; Ruddat, V; Brunet, S; Graham, C; Czub, S; Knox, JD				Lamoureux, Lise; Simon, Sharon L. R.; Plews, Margot; Ruddat, Viola; Brunet, Simone; Graham, Catherine; Czub, Stefanie; Knox, J. David			Urine Proteins Identified by Two-Dimensional Differential Gel Electrophoresis Facilitate the Differential Diagnoses of Scrapie	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; QUAKING-INDUCED CONVERSION; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; PRION PROTEIN; TRANSTHYRETIN AMYLOIDOSIS; PLASMINOGEN-ACTIVATOR; EXPERIMENTAL-DESIGN; EXPRESSION; MICE	The difficulty in developing a diagnostic assay for Creutzfeldt - Jakob disease (CJD) and other transmissible spongiform encephalopathies (TSEs) stems in part from the fact that the infectious agent is an aberrantly folded form of an endogenous cellular protein. This precludes the use of the powerful gene based technologies currently applied to the direct detection of other infectious agents. To circumvent this problem our research objective has been to identify a set of proteins exhibiting characteristic differential abundance in response to TSE infection. The objective of the present study was to assess the disease specificity of differentially abundant urine proteins able to identify scrapie infected mice. Two-dimensional differential gel electrophoresis was used to analyze longitudinal collections of urine samples from both prion-infected mice and a transgenic mouse model of Alzheimer's disease. The introduction of fluorescent dyes, that allow multiple samples to be co-resolved and visualized on one two dimensional gel, have increased the accuracy of this methodology for the discovery of robust protein biomarkers for disease. The accuracy of a small panel of differentially abundant proteins to correctly classify an independent naive sample set was determined. The results demonstrated that at the time of clinical presentation the differential abundance of urine proteins were capable of identifying the prion infected mice with 87% sensitivity and 93% specificity. The identity of the diagnostic differentially abundant proteins was investigated by mass spectrometry.	[Lamoureux, Lise; Simon, Sharon L. R.; Plews, Margot; Brunet, Simone; Knox, J. David] Publ Hlth Agcy Canada, Prion Lab Serv Sect, Winnipeg, MB, Canada; [Graham, Catherine; Czub, Stefanie] Canadian Food Inspect Agcy, Natl Anim Dis Ctr, Lethbridge, AB, Canada; [Ruddat, Viola] GE Healthcare, San Francisco, CA USA; [Knox, J. David] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	Public Health Agency of Canada; Canadian Food Inspection Agency; General Electric; University of Manitoba	Knox, JD (corresponding author), Publ Hlth Agcy Canada, Prion Lab Serv Sect, Winnipeg, MB, Canada.	david.knox@phac-aspc.gc.ca			Public Health Agency of Canada; Alberta Prion Research Institute	Public Health Agency of Canada; Alberta Prion Research Institute	The work was supported by the Public Health Agency of Canada and the Alberta Prion Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Basora N, 2010, EXP CELL RES, V316, P1454, DOI 10.1016/j.yexcr.2010.02.033; Brechlin P, 2008, PROTEOMICS, V8, P4357, DOI 10.1002/pmic.200800375; Carriero MV, 2009, FRONT BIOSCI-LANDMRK, V14, P3782, DOI [10.2735/3488, 10.2741/3488]; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Cavaggioni A, 2000, BBA-PROTEIN STRUCT M, V1482, P218, DOI 10.1016/S0167-4838(00)00149-7; Cepek L, 2007, DEMENT GERIATR COGN, V23, P22, DOI 10.1159/000096589; Cunningham O, 2009, GLIA, V57, P1802, DOI 10.1002/glia.20892; de Bruin A, 2007, EXP DERMATOL, V16, P468, DOI 10.1111/j.1600-0625.2007.00557.x; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Ferone G, 2013, HUM MOL GENET, V22, P531, DOI 10.1093/hmg/dds464; Friedman David B, 2007, Methods Mol Biol, V367, P219; Gmitterova K, 2009, NEURODEGENER DIS, V6, P263, DOI 10.1159/000237221; Gmitterova K, 2009, NEUROBIOL AGING, V30, P1842, DOI 10.1016/j.neurobiolaging.2008.01.007; Han SH, 2011, J ALZHEIMERS DIS, V25, P77, DOI 10.3233/JAD-2011-102145; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; Li XY, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-79; Li XY, 2011, J NEUROSCI, V31, P12483, DOI 10.1523/JNEUROSCI.2417-11.2011; Lobato L, 2012, CLIN J AM SOC NEPHRO, V7, P1337, DOI 10.2215/CJN.08720811; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Love S, 2011, J CELL MOL MED; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; Mori K, 2002, ARCH HISTOL CYTOL, V65, P359, DOI 10.1679/aohc.65.359; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Olivry T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032072; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Peden AH, 2012, J GEN VIROL, V93, P438, DOI 10.1099/vir.0.033365-0; Plews M, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-6; Plews M, 2010, FREE RADICAL BIO MED, V49, P1417, DOI 10.1016/j.freeradbiomed.2010.07.025; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Robertson DHL, 1996, BIOCHEM J, V316, P265, DOI 10.1042/bj3160265; Rocha A, 2011, TRANSPL P, V43, P189, DOI 10.1016/j.transproceed.2010.11.014; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sanchez D, 2002, MECH DEVELOP, V117, P293, DOI 10.1016/S0925-4773(02)00202-2; Schauer-Vukasinovic V, 2001, Biochim Biophys Acta, V1524, P51; Sheehan JJ, 2007, J NEUROSCI, V27, P1738, DOI 10.1523/JNEUROSCI.4987-06.2007; Simon SLR, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-23; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016804; Skrzypiec AE, 2009, BIOL PSYCHIAT, V66, P785, DOI 10.1016/j.biopsych.2009.05.021; Steinacker P, 2010, J ALZHEIMERS DIS, V22, P119, DOI 10.3233/JAD-2010-100030; Suzuki M, 2002, J BIOL CHEM, V277, P8022, DOI 10.1074/jbc.M108545200; Thornton E, 2010, MOLECULES, V15, P6598, DOI 10.3390/molecules15096598; Velayudhan L, 2012, J ALZHEIMERS DIS, V28, P369, DOI 10.3233/JAD-2011-110611; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217	49	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64044	10.1371/journal.pone.0064044	http://dx.doi.org/10.1371/journal.pone.0064044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704971	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200109
J	Yasukawa, A; Hosoki, K; Toda, M; Miyake, Y; Matsushima, Y; Matsumoto, T; Boveda-Ruiz, D; Gil-Bernabe, P; Nagao, M; Sugimoto, M; Hiraguchi, Y; Tokuda, R; Naito, M; Takagi, T; D'Alessandro-Gabazza, CN; Suga, S; Kobayashi, T; Fujisawa, T; Taguchi, O; Gabazza, EC				Yasukawa, Atsushi; Hosoki, Koa; Toda, Masaaki; Miyake, Yasushi; Matsushima, Yuki; Matsumoto, Takahiro; Boveda-Ruiz, Daniel; Gil-Bernabe, Paloma; Nagao, Mizuho; Sugimoto, Mayumi; Hiraguchi, Yukiko; Tokuda, Reiko; Naito, Masahiro; Takagi, Takehiro; D'Alessandro-Gabazza, Corina N.; Suga, Shigeru; Kobayashi, Tetsu; Fujisawa, Takao; Taguchi, Osamu; Gabazza, Esteban C.			Eosinophils Promote Epithelial to Mesenchymal Transition of Bronchial Epithelial Cells	PLOS ONE			English	Article							TGF-BETA; SUBEPITHELIAL FIBROSIS; PULMONARY-FIBROSIS; ASTHMA; MECHANISMS; EXPRESSION; DISEASE; PROTEIN; MOUSE; MICE	Eosinophilic inflammation and remodeling of the airways including subepithelial fibrosis and myofibroblast hyperplasia are characteristic pathological findings of bronchial asthma. Epithelial to mesenchymal transition (EMT) plays a critical role in airway remodelling. In this study, we hypothesized that infiltrating eosinophils promote airway remodelling in bronchial asthma. To demonstrate this hypothesis we evaluated the effect of eosinophils on EMT by in vitro and in vivo studies. EMT was assessed in mice that received intra-tracheal instillation of mouse bone marrow derived eosinophils and in human bronchial epithelial cells co-cultured with eosinophils freshly purified from healthy individuals or with eosinophilic leukemia cell lines. Intra-tracheal instillation of eosinophils was associated with enhanced bronchial inflammation and fibrosis and increased lung concentration of growth factors. Mice instilled with eosinophils pre-treated with transforming growth factor(TGF)-beta 1 siRNA had decreased bronchial wall fibrosis compared to controls. EMT was induced in bronchial epithelial cells co-cultured with human eosinophils and it was associated with increased expression of TGF-beta 1 and Smad3 phosphorylation in the bronchial epithelial cells. Treatment with anti-TGF-beta 1 antibody blocked EMT in bronchial epithelial cells. Eosinophils induced EMT in bronchial epithelial cells, suggesting their contribution to the pathogenesis of airway remodelling.	[Yasukawa, Atsushi; Hosoki, Koa; Toda, Masaaki; Miyake, Yasushi; Matsushima, Yuki; Matsumoto, Takahiro; Boveda-Ruiz, Daniel; Gil-Bernabe, Paloma; D'Alessandro-Gabazza, Corina N.; Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan; [Naito, Masahiro; Takagi, Takehiro; Kobayashi, Tetsu; Taguchi, Osamu] Mie Univ, Grad Sch Med, Dept Pulm & Crit Care Med, Tsu, Mie 514, Japan; [Hosoki, Koa; Nagao, Mizuho; Sugimoto, Mayumi; Hiraguchi, Yukiko; Tokuda, Reiko; Suga, Shigeru; Fujisawa, Takao] Mie Natl Hosp, Inst Clin Res, Tsu, Mie, Japan	Mie University; Mie University	Gabazza, EC (corresponding author), Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan.	gabazza@clin.medic.mie-u.ac.jp	Suga, Shigeru/GPK-7811-2022	Gabazza, Esteban/0000-0001-5748-1499; Hosoki, Koa/0000-0003-4228-2176	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; Burt AD, LIVER TRANSPL, V16, P567; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cho JY, KOREAN J INTERN MED, V26, P367; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Fujisawa T, 2000, J ALLERGY CLIN IMMUN, V106, P507; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Hamasaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042655; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Johnson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016175; Kariyawasam HH, 2007, CURR OPIN IMMUNOL, V19, P681, DOI 10.1016/j.coi.2007.07.021; Koller DY, 1997, J ALLERGY CLIN IMMUN, V99, P752, DOI 10.1016/S0091-6749(97)80007-3; Lan HY, INT J BIOL SCI, V7, P1056; Lange-Sperandio B, 2007, AM J PATHOL, V171, P861, DOI 10.2353/ajpath.2007.061199; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Ma KL, J CELL BIOCH, V112, P1585; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Payne DNR, 2003, AM J RESP CRIT CARE, V167, P78, DOI 10.1164/rccm.200205-414OC; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; Robertson H, 2004, J AM SOC NEPHROL, V15, P390, DOI 10.1097/01.ASN.0000108521.39082.E1; ROCHE WR, 1989, LANCET, V1, P520; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Royce SG, 2012, MOL CELL ENDOCRINOL, V351, P167, DOI 10.1016/j.mce.2012.01.007; Sagara H, 2002, J ALLERGY CLIN IMMUN, V110, P249, DOI 10.1067/mai.2002.126078; Shi HZ, 2000, J CLIN INVEST, V105, P945, DOI 10.1172/JCI8945; Takagi T, AM J RESP CELL MOL B, V46, P397; Takagi T, 2011, AM J RESP CRIT CARE, V183, P31, DOI 10.1164/rccm.201001-0107OC; Venge P, 2010, CLIN RESPIR J, V4, P15, DOI 10.1111/j.1752-699X.2010.00192.x; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yasui H, 2001, AM J RESP CRIT CARE, V163, P1660, DOI 10.1164/ajrccm.163.7.9911068; Yokote K, 2006, TRENDS CARDIOVAS MED, V16, P240, DOI 10.1016/j.tcm.2006.04.005	38	40	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64281	10.1371/journal.pone.0064281	http://dx.doi.org/10.1371/journal.pone.0064281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700468	Green Published, Green Submitted			2022-12-27	WOS:000319330200130
J	Zhao, HM; Karman, J; Jiang, JL; Zhang, JH; Gumlaw, N; Lydon, J; Zhou, Q; Qiu, HW; Jiang, CW; Cheng, SH; Zhu, YX				Zhao, Hongmei; Karman, Jozsef; Jiang, Ji-Lei; Zhang, Jinhua; Gumlaw, Nathan; Lydon, John; Zhou, Qun; Qiu, Huawei; Jiang, Canwen; Cheng, Seng H.; Zhu, Yunxiang			A Bispecific Protein Capable of Engaging CTLA-4 and MHCII Protects Non-Obese Diabetic Mice from Autoimmune Diabetes	PLOS ONE			English	Article							REGULATORY T-CELLS; VERSUS-HOST-DISEASE; TRANSCRIPTION FACTOR FOXP3; GROWTH-FACTOR-BETA; NOD MOUSE; TGF-BETA; DENDRITIC CELLS; NEGATIVE REGULATOR; POTENTIAL ROLE; CUTTING EDGE	Crosslinking ligand-engaged cytotoxic T lymphocyte antigen-4 (CTLA-4) to the T cell receptor (TCR) with a bispecific fusion protein (BsB) comprised of a mutant mouse CD80 and lymphocyte activation antigen-3 (LAG-3) has been shown to attenuate TCR signaling and to direct T-cell differentiation toward Foxp(3+) regulatory T cells (Tregs) in an allogenic mixed lymphocyte reaction (MLR). Here, we show that antigen-specific Tregs can also be induced in an antigen-specific setting in vitro. Treatment of non-obese diabetic (NOD) female mice between 9-12 weeks of age with a short course of BsB elicited a transient increase of Tregs in the blood and moderately delayed the onset of autoimmune type 1 diabetes (T1D). However, a longer course of treatment (10 weeks) of 4-13 weeks-old female NOD animals with BsB significantly delayed the onset of disease or protected animals from developing diabetes, with only 13% of treated animals developing diabetes by 35 weeks of age compared to 80% of the animals in the control group. Histopathological analysis of the pancreata of the BsB-treated mice that remained non-diabetic revealed the preservation of insulin-producing beta-cells despite the presence of different degrees of insulitis. Thus, a bifunctional protein capable of engaging CTLA-4 and MHCII and indirectly co-ligating CTLA-4 to the TCR protected NOD mice from developing T1D.	[Zhao, Hongmei; Karman, Jozsef; Jiang, Ji-Lei; Zhang, Jinhua; Gumlaw, Nathan; Lydon, John; Zhou, Qun; Qiu, Huawei; Jiang, Canwen; Cheng, Seng H.; Zhu, Yunxiang] Genzyme Corp, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation	Zhu, YX (corresponding author), Genzyme Corp, Framingham, MA 01701 USA.	yunxiang.zhu@genzyme.com	zhou, qun/AAU-7592-2020; Cheng, Seng H/AAC-6564-2022	zhou, qun/0000-0001-6271-3143; 	Genzyme Corporation, a Sanofi Company	Genzyme Corporation, a Sanofi Company	The work is entirely funded by Genzyme Corporation, a Sanofi Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BE, 2004, BLOOD, V104, P1565, DOI 10.1182/blood-2004-01-0328; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Andre-Schmutz I, 1999, EUR J IMMUNOL, V29, P245, DOI 10.1002/(SICI)1521-4141(199901)29:01<245::AID-IMMU245>3.3.CO;2-F; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Baroja ML, 2002, J IMMUNOL, V168, P5070, DOI 10.4049/jimmunol.168.10.5070; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Blair PJ, 1998, J IMMUNOL, V160, P12; Caretto D, 2010, J IMMUNOL, V184, P30, DOI 10.4049/jimmunol.0903412; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Daniel C, 2011, J EXP MED, V208, P1501, DOI 10.1084/jem.20110574; Fife BT, 2006, J CLIN INVEST, V116, P2252, DOI 10.1172/JCI27856; Gonzalez-Rey E, 2006, ARTHRITIS RHEUM-US, V54, P864, DOI 10.1002/art.21652; Griffin MD, 2000, J IMMUNOL, V164, P4433, DOI 10.4049/jimmunol.164.9.4433; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Guntermann C, 2002, J IMMUNOL, V168, P4420, DOI 10.4049/jimmunol.168.9.4420; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Jain N, 2010, P NATL ACAD SCI USA, V107, P1524, DOI 10.1073/pnas.0910341107; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Karman J, 2012, J BIOL CHEM, V287, P11098, DOI 10.1074/jbc.M111.283705; Kastner L, 2010, J IMMUNOL, V185, P5778, DOI 10.4049/jimmunol.0901948; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Lee MH, 2010, J IMMUNOL, V185, P2493, DOI 10.4049/jimmunol.1001036; Leiter Edward H, 2001, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1509s24; Linsley PS, 1996, CURR BIOL, V6, P398, DOI 10.1016/S0960-9822(02)00506-7; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; McDevitt H, 1996, HORM METAB RES, V28, P287, DOI 10.1055/s-2007-979794; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nishio J, 2010, J EXP MED, V207, P1879, DOI 10.1084/jem.20100205; Ohata J, 2007, ARTHRITIS RHEUM, V56, P2947, DOI 10.1002/art.22846; Onodera T, 2009, J IMMUNOL, V183, P5608, DOI 10.4049/jimmunol.0804116; Paterson AM, 2010, NAT IMMUNOL, V11, P109, DOI 10.1038/ni0210-109; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; PONTOW SE, 1992, INT REV CYTOL, V137B, P221; Qu HQ, 2009, GENES IMMUN, V10, pS27, DOI 10.1038/gene.2009.88; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sarween N, 2004, J IMMUNOL, V173, P2942, DOI 10.4049/jimmunol.173.5.2942; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Simon G, 2008, DIABETES, V57, P405, DOI 10.2337/db06-1384; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; WAHL SM, 1990, ANN NY ACAD SCI, V593, P188, DOI 10.1111/j.1749-6632.1990.tb16111.x; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Walunas TL, 1998, J IMMUNOL, V160, P3855; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEIGEL PH, 1994, BIOESSAYS, V16, P519, DOI 10.1002/bies.950160713; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Zhao DC, 2008, BLOOD, V112, P2129, DOI 10.1182/blood-2008-02-140277; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zhou Q, 2011, BIOCONJUGATE CHEM, V22, P741, DOI 10.1021/bc1005416	66	3	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63530	10.1371/journal.pone.0063530	http://dx.doi.org/10.1371/journal.pone.0063530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704916	Green Submitted, gold, Green Published			2022-12-27	WOS:000319330200047
J	McKuen, MJ; Dahl, G; Fields, KA				McKuen, Mary J.; Dahl, Gerhard; Fields, Kenneth A.			Assessing a Potential Role of Host Pannexin 1 during Chlamydia trachomatis Infection	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; INFLAMMASOME; INCLUSION; MEMBRANE; ATP; ACTIVATION; CHANNELS; CELLS; INHIBITION; EXPRESSION	Pannexin 1 (Panx1) is a plasma membrane channel glycoprotein that plays a role in innate immune response through association with the inflammasome complex. Probenecid, a classic pharmacological agent for gout, has also been used historically in combination therapy with antibiotics to prevent cellular drug efflux and has been reported to inhibit Panx1. As the inflammasome has been implicated in the progression of Chlamydia infections, and with chlamydial infections at record levels in the US, we therefore investigated whether probenecid would have a direct effect on Chlamydia trachomatis development through inhibition of Panx1. We found chlamydial development to be inhibited in a dose-dependent, yet reversible manner in the presence of probenecid. Drug treatment induced an aberrant chlamydial morphology consistent with persistent bodies. Although Panx1 was shown to localize to the chlamydial inclusion, no difference was seen in chlamydial development during infection of cells derived from wild-type and Panx1 knockout mice. Therefore, probenecid may inhibit C. trachomatis growth by an as yet unresolved mechanism.	[McKuen, Mary J.; Fields, Kenneth A.] Univ Miami, Miller Sch Med, Dept Microbiol, Miami, FL 33136 USA; [McKuen, Mary J.; Fields, Kenneth A.] Univ Miami, Miller Sch Med, Dept Immunol, Miami, FL 33136 USA; [Dahl, Gerhard] Univ Miami, Miller Sch Med, Dept Physiol, Miami, FL 33136 USA; [Dahl, Gerhard] Univ Miami, Miller Sch Med, Dept Biophys, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Fields, KA (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol, Miami, FL 33136 USA.	Kfields@med.miami.edu			National Institutes of Health, NIAID [AI065530]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065530] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KAF and MJM are supported by funding (AI065530) from the National Institutes of Health, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Abdul-Sater AA, 2010, MICROBES INFECT, V12, P652, DOI 10.1016/j.micinf.2010.04.008; Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Balakrishnan A, 2009, MICROBIOL RES, V164, P338, DOI 10.1016/j.micres.2007.05.002; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bao XF, 2011, MICROBIOL-SGM, V157, P2569, DOI 10.1099/mic.0.049668-0; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Baroja-Mazo A, 2013, BBA-BIOMEMBRANES, V1828, P79, DOI 10.1016/j.bbamem.2012.01.002; Batteiger BE, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P1, DOI 10.1128/9781555817329.ch1; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Bevan CD, 2003, J INT MED RES, V31, P45, DOI 10.1177/147323000303100108; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Cox JV, 2012, CELL MICROBIOL, V14, P1497, DOI 10.1111/j.1462-5822.2012.01823.x; Dahl G, 2012, BRAIN RES, V1487, P150, DOI 10.1016/j.brainres.2012.04.058; Di Virgilio F., 1989, METHOD CELL BIOL, P453; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; FURNESS G, 1960, J GEN MICROBIOL, V23, P613, DOI 10.1099/00221287-23-3-613; Gollapudi S, 1997, CANCER CHEMOTH PHARM, V40, P150, DOI 10.1007/s002800050640; GRIESHABER S, 2002, CELL MICROBIOL; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Haggerty CL, 2007, CLIN INFECT DIS, V44, P953, DOI 10.1086/512191; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Heinzen RA, 1997, INFECT IMMUN, V65, P1088, DOI 10.1128/IAI.65.3.1088-1094.1997; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; KEELING DJ, 1991, BIOCHIM BIOPHYS ACTA, V1115, P42, DOI 10.1016/0304-4165(91)90009-6; Kokes M, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P170, DOI 10.1128/9781555817329.ch8; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Nagarajan UM, 2012, J IMMUNOL, V188, P2866, DOI 10.4049/jimmunol.1103461; ORIEL JD, 1976, J INFECT DIS, V133, P568, DOI 10.1093/infdis/133.5.568; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Qiu F, 2011, FEBS LETT, V585, P3430, DOI 10.1016/j.febslet.2011.09.033; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Scidmore-Carlson MA, 1999, MOL MICROBIOL, V33, P753, DOI 10.1046/j.1365-2958.1999.01523.x; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Shimada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021477; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; STAMM WE, 1984, NEW ENGL J MED, V310, P545, DOI 10.1056/NEJM198403013100901; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Sweet DH, 2005, TOXICOL APPL PHARM, V204, P198, DOI 10.1016/j.taap.2004.10.016; Thacker JD, 2012, ANTIMICROB AGENTS CH, V56, P1921, DOI 10.1128/AAC.06372-11; TOOMEY KE, 1990, REV INFECT DIS, V12, pS645; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63732	10.1371/journal.pone.0063732	http://dx.doi.org/10.1371/journal.pone.0063732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700432	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400029
J	Lin, TT; Chen, Y; Ding, ZY; Luo, GM; Liu, JQ; Shen, JC				Lin, Tingting; Chen, Yong; Ding, Zhiying; Luo, Guimin; Liu, Junqiu; Shen, Jiacong			Novel Insights into the Synergistic Interaction of a Thioredoxin Reductase Inhibitor and TRAIL: The Activation of the ASK1-ERK-Sp1 Pathway	PLOS ONE			English	Article							INDUCED APOPTOSIS; ORGANOTELLURIUM COMPOUNDS; OVARIAN-CANCER; MAPK PATHWAY; CELL-DEATH; TRANSCRIPTION; RESISTANCE; GROWTH; CYCLODEXTRIN; APO2L/TRAIL	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces cell death in various types of cancer cells but has little or no effects on normal cells. Unfortunately, not all cancer cells respond to TRAIL; therefore, TRAIL sensitizing agents are currently being explored. Here, we reported that 6-(4-N,N-Dimethylaminophenyltelluro)-6-deoxy-beta-cyclodextrin (DTCD), a cyclodextrin-derived diorganyl telluride which has been identified as an excellent inhibitor of thioredoxin reductase (TrxR), could sensitize TRAIL resistant human ovarian cancer cells to undergo apoptosis. In vitro, DTCD enhanced TRAIL-induced cytotoxicity in human ovarian cancer cells through up-regulation of DR5. Luciferase analysis and CHIP assays showed that DTCD increased DR5 promoter activity via Sp1 activation. Additionally, DTCD stimulated extracellular signal-regulated kinase (ERK) activation, while the ERK inhibitor PD98059 blocked DTCD-induced DR5 expression and suppressed binding of Sp1 to the DR5 promoter. We further demonstrated that DTCD could induce the release of ASK1 from its complex with Trx-1, and recovered its kinase activity. Meanwhile, suppression of ASK1 by RNA interference led to decreased ERK phosphorylation induced by DTCD. The underlying mechanisms reveal that Trx-1 is heavily oxidized in response to DTCD treatment, in accordance with the fact that DTCD could inhibit the activity of TrxR that reduces oxidized Trx-1. Moreover, using an A2780 xenograft model, DTCD plus TRAIL significantly inhibited the growth of tumor in vivo. Our results suggest that Trx/TrxR system inhibition may play a critical role in apoptosis by combined treatment with DTCD and TRAIL, and raise the possibility that their combination may be a promising strategy for ovarian carcinoma treatment.	[Lin, Tingting] Jilin Univ, Coll Instrumentat & Elect Engn, Changchun 130023, Peoples R China; [Chen, Yong; Luo, Guimin] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Ding, Zhiying] Jilin Univ, Sch Pharmaceut Sci, Changchun 130023, Peoples R China; [Liu, Junqiu; Shen, Jiacong] Jilin Univ, State Key Lab Supramol Struct & Mat, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University	Lin, TT (corresponding author), Jilin Univ, Coll Instrumentat & Elect Engn, Changchun 130023, Peoples R China.	ttlin@jlu.edu.cn			Young Scientists Fund of the National Natural Science Foundation of China [21101071]; China Postdoctoral Science Foundation [2012T50306, 20110491303]; Outstanding Youth Foundation of Jilin Province, China [3D511B190537]; Fundamental Research Funds for Jilin University [450060441140, 450060445216]	Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Outstanding Youth Foundation of Jilin Province, China; Fundamental Research Funds for Jilin University	This work was supported by the Young Scientists Fund of the National Natural Science Foundation of China (Grant No. 21101071); Project supported by the China Postdoctoral Science Foundation (Grant No. 2012T50306; 20110491303); Outstanding Youth Foundation of Jilin Province, China (Grant No. 3D511B190537); Fundamental Research Funds for Jilin University (Grant No. 450060441140, 450060445216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Bevis KS, 2010, GYNECOL ONCOL, V119, P157, DOI 10.1016/j.ygyno.2010.05.034; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Engman L, 2003, BIOORGAN MED CHEM, V11, P5091, DOI 10.1016/j.bmc.2003.08.021; Engman L, 2000, ANTI-CANCER DRUG DES, V15, P323; Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062; Goncharenko-Khaider N, 2010, ONCOGENE, V29, P5523, DOI 10.1038/onc.2010.288; Herzog TJ, 2004, CLIN CANCER RES, V10, P7439, DOI 10.1158/1078-0432.CCR-04-0683; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Huang X, 2011, CHEM SOC REV, V40, P1171, DOI 10.1039/c0cs00046a; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kendrick JE, 2007, GYNECOL ONCOL, V106, P614, DOI 10.1016/j.ygyno.2007.05.035; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Lane D, 2006, MOL CANCER THER, V5, P509, DOI 10.1158/1535-7163.MCT-05-0362; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liao MJ, 2008, MOL ENDOCRINOL, V22, P1449, DOI 10.1210/me.2008-0035; Lin TT, 2011, CARCINOGENESIS, V32, P154, DOI 10.1093/carcin/bgq234; Mao HL, 2007, PHARMACOL RES, V56, P483, DOI 10.1016/j.phrs.2007.09.010; McNaughton M, 2004, J MED CHEM, V47, P233, DOI 10.1021/jm030916r; Nogueira CW, 2004, CHEM REV, V104, P6255, DOI 10.1021/cr0406559; Pan MR, 2002, J BIOL CHEM, V277, P32775, DOI 10.1074/jbc.M202334200; Park BG, 2005, TOXICOLOGY, V215, P115, DOI 10.1016/j.tox.2005.07.003; Pennington JD, 2007, CURR PHARM DESIGN, V13, P3368, DOI 10.2174/138161207782360528; Saggioro D, 2007, CHEM BIOL, V14, P1128, DOI 10.1016/j.chembiol.2007.08.016; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang K, 2009, BIOCHEM BIOPH RES CO, V409, P675; Woods DC, 2011, TLR4 ACTIVATES NF KB; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Yamagishi S, 2005, BRAIN RES, V1038, P223, DOI 10.1016/j.brainres.2005.01.041; Yoshida T, 2001, FEBS LETT, V507, P381, DOI 10.1016/S0014-5793(01)02947-7; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	39	21	22	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63966	10.1371/journal.pone.0063966	http://dx.doi.org/10.1371/journal.pone.0063966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696862	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900066
J	Liu, XL; Wu, HF; Ji, CL; Wei, L; Zhao, JM; Yu, JB				Liu, Xiaoli; Wu, Huifeng; Ji, Chenglong; Wei, Lei; Zhao, Jianmin; Yu, Junbao			An Integrated Proteomic and Metabolomic Study on the Chronic Effects of Mercury in Suaeda salsa under an Environmentally Relevant Salinity	PLOS ONE			English	Article							LASER-DESORPTION/IONIZATION-TIME; PROTEIN DISULFIDE-ISOMERASE; OXIDATIVE STRESS; ASPARTATE-AMINOTRANSFERASE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; ARABIDOPSIS; TOLERANCE; RESPONSES; IDENTIFICATION	As an environmental contaminant, mercury is of great concern due to its high risk to environmental and human health. The halophyte Suaeda salsa is the dominant plant in the intertidal zones of the Yellow River Delta (YRD) where has been contaminated by mercury in some places. This study aimed at evaluating the chronic effects of mercury (Hg2+, 20 mu g L-1) and the influence of an environmentally relevant salinity (NaCl, 500 mM) on mercury-induced effects in S. salsa. A total of 43 protein spots with significant changes were identified in response to Hg2+, salinity and combined Hg2+ and salinity. These proteins can be categorized into diverse functional classes, related to metabolic processes, photosynthesis, stress response, protein fate, energy metabolism, signaling pathways and immunosuppression. Metabolic responses demonstrated that Hg2+ could disturb protein and energy metabolisms in S. salsa co-exposed with or without salinity. In addition, both antagonistic and synergistic effects between Hg2+ and salinity were confirmed by differential levels of proteins (magnesium-chelatase and ribulose-l,5-bisphosphate carboxylase/oxygenase) and metabolites (valine, malonate, asparagine, glycine, fructose and glucose) in S. salsa. These findings suggest that a combination of proteomics and metabolomics can provide insightful information of environmental contaminant-induced effects in plants at molecular levels.	[Liu, Xiaoli; Wu, Huifeng; Ji, Chenglong; Wei, Lei; Zhao, Jianmin; Yu, Junbao] Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Zone Environm Proc, Yantai, Shandong, Peoples R China; [Liu, Xiaoli; Wu, Huifeng; Ji, Chenglong; Wei, Lei; Zhao, Jianmin; Yu, Junbao] YICCAS, Shandong Prov Key Lab Coastal Zone Environm Proc, Yantai, Shandong, Peoples R China; [Liu, Xiaoli; Ji, Chenglong; Wei, Lei] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, HF (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Zone Environm Proc, Yantai, Shandong, Peoples R China.	hfwu@yic.ac.cn	Liu, Xiaoli/HGE-7614-2022; Wu, Huifeng/E-4886-2016	Wu, Huifeng/0000-0002-4042-8103; Yu, Junbao/0000-0002-3433-3538	National Science & Technology Pillar Program in "12th Five Year'' Period [2011BAC02B01]; 100 Talents Program of the Chinese Academy of Sciences	National Science & Technology Pillar Program in "12th Five Year'' Period; 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Project of National Science & Technology Pillar Program in "12th Five Year'' Period (2011BAC02B01) and The 100 Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ado K, 2006, BBA-PROTEINS PROTEOM, V1764, P586, DOI 10.1016/j.bbapap.2006.01.015; Ahsan N, 2009, PROTEOMICS, V9, P2602, DOI 10.1002/pmic.200800935; Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Baginsky S, 2009, MOL PLANT, V2, P1141, DOI 10.1093/mp/ssp058; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Chen JG, 2001, PLANT J, V28, P607, DOI 10.1046/j.1365-313x.2001.01152.x; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; Daviss B, 2005, SCIENTIST, V19, P25; Elbaz A, 2010, ECOTOXICOLOGY, V19, P1285, DOI 10.1007/s10646-010-0514-z; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Fernandez-Garcia N, 2011, PLANT CELL ENVIRON, V34, P821, DOI 10.1111/j.1365-3040.2011.02285.x; Fukayama H, 2010, PLANT PHYSIOL BIOCH, V48, P808, DOI 10.1016/j.plaphy.2010.08.002; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Ghosh S, 2001, PLANT SCI, V160, P1171, DOI 10.1016/S0168-9452(01)00361-2; Gonzalez LMG, 2012, PLANT CELL ENVIRON, V35, P682, DOI 10.1111/j.1365-3040.2011.02444.x; Graiia X, 1992, J BIOL CHEM, V267, P12797; GREENWAY H, 1972, PLANT PHYSIOL, V49, P256, DOI 10.1104/pp.49.2.256; Hajheidari M, 2005, PROTEOMICS, V5, P950, DOI 10.1002/pmic.200401101; Horling F, 2003, PLANT PHYSIOL, V131, P317, DOI 10.1104/pp.010017; Hoshida H, 2000, PLANT MOL BIOL, V43, P103, DOI 10.1023/A:1006408712416; Huang DJ, 2005, PLANT SCI, V169, P776, DOI 10.1016/j.plantsci.2005.05.034; Ikegami A, 2007, J BIOL CHEM, V282, P19282, DOI 10.1074/jbc.M703324200; Katayama H, 2001, RAPID COMMUN MASS SP, V15, P1416, DOI 10.1002/rcm.379; Lalle M, 2012, J PROTEOME RES, V11, P2666, DOI 10.1021/pr3000199; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; Li MJ, 2009, J BIOSCIENCES, V34, P227, DOI 10.1007/s12038-009-0027-1; Li R., 2001, ACTA SEDIMENTOLOGICA, V19, P622; Li X, 2007, JIANGSU ENV SCI TECH, V20, P53; Lindon JC, 1999, ANNU REP NMR SPECTRO, V38, P1, DOI 10.1016/S0066-4103(08)60035-6; Liu XL, 2011, CLEAN-SOIL AIR WATER, V39, P720, DOI 10.1002/clen.201000515; Liu XL, 2011, ECOTOXICOLOGY, V20, P1422, DOI 10.1007/s10646-011-0699-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACDONALD RC, 1993, PLANT PHYSIOL, V102, P173, DOI 10.1104/pp.102.1.173; Marquez V, 2011, J MOL BIOL, V405, P1215, DOI 10.1016/j.jmb.2010.11.055; Matsushika A, 2012, ENZYME MICROB TECH, V51, P16, DOI 10.1016/j.enzmictec.2012.03.008; McDonagh B, 2007, PROTEOMICS, V7, P3395, DOI 10.1002/pmic.200700241; Moghaieb REA, 2004, PLANT SCI, V166, P1345, DOI 10.1016/j.plantsci.2004.01.016; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Nagaoka S, 2003, J EXP BOT, V54, P2231, DOI 10.1093/jxb/erg241; Nazarbeygi E., 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V10, P70; Pang QY, 2010, J PROTEOME RES, V9, P2584, DOI 10.1021/pr100034f; Patra M, 2004, ENVIRON EXP BOT, V52, P199, DOI 10.1016/j.envexpbot.2004.02.009; Pedras MSC, 2010, PHYTOCHEMISTRY, V71, P581, DOI 10.1016/j.phytochem.2009.12.008; Peel GJ, 2010, PHYTOCHEMISTRY, V71, P404, DOI 10.1016/j.phytochem.2009.11.002; Poynton HC, 2011, ENVIRON SCI TECHNOL, V45, P3710, DOI 10.1021/es1037222; Przybyla-Zawislak B, 1998, EUR J BIOCHEM, V258, P736, DOI 10.1046/j.1432-1327.1998.2580736.x; Purohit PV, 2004, OMICS, V8, P118, DOI 10.1089/1536231041388348; Qin AG, 2011, MOL BIOL REP, V38, P1557, DOI 10.1007/s11033-010-0264-2; Raman SB, 2004, PLANT SCI, V167, P961, DOI 10.1016/j.plantsci.2004.06.019; Romano PGN, 2004, PLANT PHYSIOL, V134, P1268, DOI 10.1104/pp.103.022160; Santos EM, 2010, ENVIRON SCI TECHNOL, V44, P820, DOI 10.1021/es902558k; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Sauer M, 2006, PROTEOMICS, V6, P2530, DOI 10.1002/pmic.200500564; Schultz CJ, 1998, GENETICS, V149, P491; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Tilton GB, 2006, PLANT MOL BIOL, V61, P629, DOI 10.1007/s11103-006-0037-4; Tullius MV, 2002, INFECT IMMUN, V70, P2853, DOI 10.1128/IAI.70.6.2853-2861.2002; Urano J, 2000, FEBS LETT, V466, P107, DOI 10.1016/S0014-5793(99)01768-8; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; WADSWORTH GJ, 1993, PLANT MOL BIOL, V21, P993, DOI 10.1007/BF00023598; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wei D, 2011, FISH SHELLFISH IMMUN, V30, P720, DOI 10.1016/j.fsi.2010.12.028; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wu HF, 2005, ANAL BIOCHEM, V340, P99, DOI 10.1016/j.ab.2005.01.057; Wu HF, 2010, AQUAT TOXICOL, V100, P339, DOI 10.1016/j.aquatox.2010.08.005; Xu CY, 2007, J SAF ENV, V1, P37; Yadav SK, 2007, PROTEIN EXPRES PURIF, V51, P126, DOI 10.1016/j.pep.2006.07.007; Zhang HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020862; Zhang JT, 2011, J PROTEOME RES, V10, P1904, DOI 10.1021/pr101140n; Zhang W, 2012, ENVIRON INT, V42, P20, DOI 10.1016/j.envint.2011.03.002; Zhang XL., 2001, HEILONGJIANG ENV J, V25, P87; Zhao H.L., 2010, J ANHUI AGRICUL SCI, V38, P14350	75	37	41	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64041	10.1371/journal.pone.0064041	http://dx.doi.org/10.1371/journal.pone.0064041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696864	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900068
J	Zgaga, L; Agakov, F; Theodoratou, E; Farrington, SM; Tenesa, A; Dunlop, MG; McKeigue, P; Campbell, H				Zgaga, Lina; Agakov, Felix; Theodoratou, Evropi; Farrington, Susan M.; Tenesa, Albert; Dunlop, Malcolm G.; McKeigue, Paul; Campbell, Harry			Model Selection Approach Suggests Causal Association between 25-Hydroxyvitamin D and Colorectal Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SOLAR ULTRAVIOLET-B; VITAMIN-D REDUCE; MENDELIAN RANDOMIZATION; INSTRUMENTAL VARIABLES; SUSCEPTIBILITY LOCI; BREAST-CANCER; RISK; INFERENCE; METAANALYSIS	Introduction: Vitamin D deficiency has been associated with increased risk of colorectal cancer (CRC), but causal relationship has not yet been confirmed. We investigate the direction of causation between vitamin D and CRC by extending the conventional approaches to allow pleiotropic relationships and by explicitly modelling unmeasured confounders. Methods: Plasma 25-hydroxyvitamin D (25-OHD), genetic variants associated with 25-OHD and CRC, and other relevant information was available for 2645 individuals (1057 CRC cases and 1588 controls) and included in the model. We investigate whether 25-OHD is likely to be causally associated with CRC, or vice versa, by selecting the best modelling hypothesis according to Bayesian predictive scores. We examine consistency for a range of prior assumptions. Results: Model comparison showed preference for the causal association between low 25-OHD and CRC over the reverse causal hypothesis. This was confirmed for posterior mean deviances obtained for both models (11.5 natural log units in favour of the causal model), and also for deviance information criteria (DIC) computed for a range of prior distributions. Overall, models ignoring hidden confounding or pleiotropy had significantly poorer DIC scores. Conclusion: Results suggest causal association between 25-OHD and colorectal cancer, and support the need for randomised clinical trials for further confirmations.	[Zgaga, Lina; Agakov, Felix; Theodoratou, Evropi; McKeigue, Paul; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Zgaga, Lina; Farrington, Susan M.; Tenesa, Albert; Dunlop, Malcolm G.; Campbell, Harry] Univ Edinburgh, Western Gen Hosp, Colon Canc Genet Grp & Acad Coloproctol, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia; [Agakov, Felix] Pharmat Ltd, Edinburgh, Midlothian, Scotland; [Tenesa, Albert] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Zagreb; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Zgaga, L (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	lina.zgaga@ed.ac.uk; harry.campbell@ed.ac.uk	Campbell, Harry/E-2959-2010; Dunlop, Malcolm G/F-1973-2011; Theodoratou, Evropi/C-3430-2014; Farrington, Susan M/C-7319-2013; Farrington, Susan M/Q-2710-2019; Zgaga, Lina/Q-9415-2018	Campbell, Harry/0000-0002-6169-6262; Dunlop, Malcolm G/0000-0002-3033-5851; Theodoratou, Evropi/0000-0001-5887-9132; Farrington, Susan M/0000-0001-5955-7389; Zgaga, Lina/0000-0003-4089-9703; Agakov, Felix/0000-0003-4280-9062; Tenesa, Albert/0000-0003-4884-4475	Cancer Research UK [C348/A12076]; Scottish Government Chief Scientist Office [CZH/4/529]; Cancer Research UK Fellowship [C31250/A10107]; MRC [MC_PC_U127527198, G0800604, MR/K018647/1, MC_U127527198] Funding Source: UKRI; Cancer Research UK [12076] Funding Source: researchfish; Medical Research Council [MC_U127527198, MC_PC_U127527198, G0800604] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4, CZH/4/529] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Scottish Government Chief Scientist Office; Cancer Research UK Fellowship(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This work was supported by Programme Grants funding from Cancer Research UK (C348/A12076) and Scottish Government Chief Scientist Office (CZH/4/529). ET is funded by Cancer Research UK Fellowship (C31250/A10107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agakov F, 2011, J EPIDEMIOL COMMUN H, V65, pA10, DOI 10.1136/jech.2011.142976a.20; Agakov F., 2011, JSCI, V9, P1; Agakov FV, 2010, ADV NEURAL INFORM PR, V23, P28; Bochud M, 2010, INT J ENV RES PUB HE, V7, P711, DOI 10.3390/ijerph7030711; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; Gelman A., 2004, BAYESIAN DATA ANAL; Grant WB, 2006, ANTICANCER RES, V26, P2687; Grant WB, 2009, DERM-ENDOCRINOL, V1, P17, DOI 10.4161/derm.1.1.7388; Hernan MA, 2006, EPIDEMIOLOGY, V17, P360, DOI 10.1097/01.ede.0000222409.00878.37; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; Knox S, 2009, ANN CLIN BIOCHEM, V46, P226, DOI 10.1258/acb.2009.008206; Lagunova Z, 2010, MOL NUTR FOOD RES, V54, P1127, DOI 10.1002/mnfr.200900512; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; Lamprecht SA, 2001, ANN NY ACAD SCI, V952, P73, DOI 10.1111/j.1749-6632.2001.tb02729.x; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lawson A.B, 2013, BAYESIAN DIS MAPPING, Vsecond; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; MacKay D. J. C., 2003, INFORM THEORY INFERE; Martens EP, 2006, EPIDEMIOLOGY, V17, P260, DOI 10.1097/01.ede.0000215160.88317.cb; McKeigue PM, 2010, INT J EPIDEMIOL, V39, P907, DOI 10.1093/ije/dyp397; McLean R, 1991, AM STAT, V45; Mohr SB, 2012, DERM-ENDOCRINOL, V4, P152, DOI 10.4161/derm.20449; Neal RM, 2001, STAT COMPUT, V11, P125, DOI 10.1023/A:1008923215028; Neuhouser ML, 2012, AM J EPIDEMIOL, V175, P673, DOI 10.1093/aje/kwr350; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Palmer TM, 2012, STAT METHODS MED RES, V21, P223, DOI 10.1177/0962280210394459; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pearl J, 2009, STAT SURV, V3, P96, DOI 10.1214/09-SS057; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Seeger MW, 2008, J MACH LEARN RES, V9, P759; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Sleiman PMA, 2010, CLIN CHEM, V56, P723, DOI 10.1373/clinchem.2009.141564; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stock JH, 2001, INT ENCY SOCIAL BEHA; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Theodoratou E, 2012, PLOS ONE; Theodoratou E, 2007, CANCER EPIDEM BIOMAR, V16, P684, DOI 10.1158/1055-9965.EPI-06-0785; Thomas DC, 2004, INT J EPIDEMIOL, V33, P21, DOI 10.1093/ije/dyh048; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Trostel P, 2002, LABOUR ECON, V9, P1, DOI 10.1016/S0927-5371(01)00052-5; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Whittaker J., 1990, GRAPHICAL MODELS APP; Winn J, 2012, CAUSALITY GATES, P1314; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zgaga L, 2011, J NUTR, V141, P1535, DOI 10.3945/jn.111.140012	64	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63475	10.1371/journal.pone.0063475	http://dx.doi.org/10.1371/journal.pone.0063475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717431	Green Published, Green Submitted, gold			2022-12-27	WOS:000319385300037
J	Muths, D; Le Couls, S; Evano, H; Grewe, P; Bourjea, J				Muths, Delphine; Le Couls, Sarah; Evano, Hugues; Grewe, Peter; Bourjea, Jerome			Multi-Genetic Marker Approach and Spatio-Temporal Analysis Suggest There Is a Single Panmictic Population of Swordfish Xiphias gladius in the Indian Ocean	PLOS ONE			English	Article							SOUTH ATLANTIC POPULATIONS; TUNA THUNNUS-OBESUS; BIGEYE TUNA; STOCK STRUCTURE; INDO-PACIFIC; MIGRATION; PATTERNS; DIFFERENTIATION; PHYLOGEOGRAPHY; POLYMORPHISM	Genetic population structure of swordfish Xiphias gladius was examined based on 2231 individual samples, collected mainly between 2009 and 2010, among three major sampling areas within the Indian Ocean (IO; twelve distinct sites), Atlantic (two sites) and Pacific (one site) Oceans using analysis of nineteen microsatellite loci (n = 2146) and mitochondrial ND2 sequences (n = 2001) data. Sample collection was stratified in time and space in order to investigate the stability of the genetic structure observed with a special focus on the South West Indian Ocean. Significant AMOVA variance was observed for both markers indicating genetic population subdivision was present between oceans. Overall value of F-statistics for ND2 sequences confirmed that Atlantic and Indian Oceans swordfish represent two distinct genetic stocks. Indo-Pacific differentiation was also significant but lower than that observed between Atlantic and Indian Oceans. However, microsatellite F-statistics failed to reveal structure even at the inter-oceanic scale, indicating that resolving power of our microsatellite loci was insufficient for detecting population subdivision. At the scale of the Indian Ocean, results obtained from both markers are consistent with swordfish belonging to a single unique panmictic population. Analyses partitioned by sampling area, season, or sex also failed to identify any clear structure within this ocean. Such large spatial and temporal homogeneity of genetic structure, observed for such a large highly mobile pelagic species, suggests as satisfactory to consider swordfish as a single panmictic population in the Indian Ocean.	[Muths, Delphine; Le Couls, Sarah; Evano, Hugues; Bourjea, Jerome] IFREMER, Delegat Ocean Indien, Le Port, France; [Grewe, Peter] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia	Ifremer; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Muths, D (corresponding author), IFREMER, Delegat Ocean Indien, Le Port, France.	muthsdelphine@yahoo.fr	Grewe, Peter/AAJ-5227-2021; Grewe, Peter/P-1515-2015; Muths, Delphine/G-1693-2010	Grewe, Peter/0000-0001-7111-4150; Grewe, Peter/0000-0001-7111-4150; Muths, Delphine/0000-0002-5366-4834; Bourjea, Jerome/0000-0001-7149-3648	European Union: The FEP (DMSOI La Reunion) [31122/DRAM/2009]; European Union: French State (DMSOI La Reunion) [31122/DRAM/2009]; La Reunion Council (Region Reunion) [DAE4/20090164]; EU 7th Funding Program: Capacities, Research Potential (project RUNSeaSciences); Ifremer	European Union: The FEP (DMSOI La Reunion); European Union: French State (DMSOI La Reunion); La Reunion Council (Region Reunion); EU 7th Funding Program: Capacities, Research Potential (project RUNSeaSciences); Ifremer	This work was funded by the European Union: The FEP and the French State (DMSOI La Reunion; No31122/DRAM/2009), La Reunion Council (Region Reunion; NoDAE4/20090164), the EU 7th Funding Program: Capacities, Research Potential (project RUNSeaSciences) and Ifremer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, IOTCWPB10; Appleton B, 2010, CONSERV GENET, V3, P263; Bakun Andrew, 1998, P103; Beal LM, 2011, NATURE, V472, P429, DOI 10.1038/nature09983; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; Bourjea J, 2007, MOL ECOL, V16, P175, DOI 10.1111/j.1365-294X.2006.03122.x; Bradman H, 2011, FISH RES, V109, P95, DOI 10.1016/j.fishres.2011.01.022; Bremer JRA, 2005, J EXP MAR BIOL ECOL, V327, P167, DOI 10.1016/j.jembe.2005.06.022; Buonaccorsi VP, 2001, MOL ECOL, V10, P1179, DOI 10.1046/j.1365-294X.2001.01270.x; CAREY FG, 1981, FISH B-NOAA, V79, P277; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Cherel Y, 2012, DEEP SEA RES 2; Chow S, 2007, MAR BIOL, V152, P87, DOI 10.1007/s00227-007-0662-8; Chow S, 2000, MOL ECOL, V9, P221, DOI 10.1046/j.1365-294x.2000.00851.x; Chow S, 2000, J FISH BIOL, V56, P1087, DOI 10.1006/jfbi.2000.1229; Codispoti LA, 1991, US JGOFS ARABIAN SEA; Conway N, 2011, E AFRICA BILLFISH CO; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Durand JD, 2005, MAR BIOL, V147, P313, DOI 10.1007/s00227-005-1564-2; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; Fu YX, 1997, GENETICS, V147, P915; Garcia A, 2011, ICES J MAR SCI, V68, P175, DOI 10.1093/icesjms/fsq147; Garcia-Cortes B., 2003, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V55, P1476; Gonzalez EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-252; Graves JE, 2003, MAR FRESHWATER RES, V54, P287, DOI 10.1071/MF01290; Graves JE, 2006, B MAR SCI, V79, P469; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heileman S., 2009, UNEP LARGE MARINE EC; International Hydrographic Organization, 1953, LIM OC SEAS, V3rd; IOTC, 2011, IOTCSC14; IOTC, 2011, 9 SESS ITC WORK PART; Jean C, 2006, B MAR SCI, V79, P521; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KOTOULAS G, 1995, MOL ECOL, V4, P473, DOI 10.1111/j.1365-294X.1995.tb00241.x; Levy M, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004090; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Lu CP, 2006, ZOOL STUD, V45, P269; Lukas R, 1996, J GEOPHYS RES-OCEANS, V101, P12209, DOI 10.1029/96JC01204; Luschi P, 2006, S AFR J SCI, V102, P51; Lutjeharms JRE, 2007, OCEAN SCI, V3, P129, DOI 10.5194/os-3-129-2007; Lutjeharms JRE, 2006, AGULHAS CURRENT; MCCARTHY C., 1997, CHROMAS VERSION 1 41; Mejuto J., 2006, OVERVIEW RES ACTIVIT; Menard F, 2006, MAR ECOL PROG SER, V323, P223, DOI 10.3354/meps323223; Muths D, 2009, FISH RES, V97, P263, DOI 10.1016/j.fishres.2009.03.004; Nakamura I., 1985, FAO SPECIES CATALOGU, V5, P65; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nei M., 1987, MOL EVOLUTIONARY GEN; Neilson JD, 2009, REV-METHODS TECHNOL, V9, P145, DOI 10.1007/978-1-4020-9640-2_9; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Nishikawa Y, 1985, S SERIES FAR SEAS FI, V12, P99; Palko B, 1981, 441 NOAA NMFS, V441, P2; Poisson F, 2009, AQUAT LIVING RESOUR, V22, P45, DOI 10.1051/alr/2009007; Potier M, 2007, FISH RES, V83, P60, DOI 10.1016/j.fishres.2006.08.020; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Reeb CA, 2003, MOL ECOL NOTES, V3, P147, DOI 10.1046/j.1471-8286.2003.00385.x; Reeb CA, 2000, MAR BIOL, V136, P1123, DOI 10.1007/s002270000291; Richardson PL, 2003, DEEP-SEA RES PT II, V50, P1, DOI 10.1016/S0967-0645(02)00376-4; Rousset F, 1997, TRENDS ECOL EVOL, V12, P313, DOI 10.1016/S0169-5347(97)01104-X; Russello MA, 2012, EVOL APPL, V5, P39, DOI 10.1111/j.1752-4571.2011.00206.x; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Sedberry GR, 2001, MAR BIOL, V139, P355; Stanley C, 2006, DETERMINING NATURE E; Takahashi M, 2003, MAR FRESHWATER RES, V54, P527, DOI 10.1071/MF01245; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theisen TC, 2008, MOL ECOL, V17, P4233, DOI 10.1111/j.1365-294X.2008.03913.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Watanabe H, 1959, REP NANKAI REG FISH, V10, P107; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright F, 1969, THEORY GENE FREQUENC, V2; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	80	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63558	10.1371/journal.pone.0063558	http://dx.doi.org/10.1371/journal.pone.0063558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717447	Green Published, gold			2022-12-27	WOS:000320362700035
J	Sommerfeld, J; Kato, A; Ropert-Coudert, Y; Garthe, S; Hindell, MA				Sommerfeld, Julia; Kato, Akiko; Ropert-Coudert, Yan; Garthe, Stefan; Hindell, Mark A.			Foraging Parameters Influencing the Detection and Interpretation of Area-Restricted Search Behaviour in Marine Predators: A Case Study with the Masked Booby	PLOS ONE			English	Article							FINE-SCALE; 1ST-PASSAGE TIME; GPS TRACKING; FUR SEALS; MOVEMENT; BUOYANCY; ANIMALS; HABITAT; SUCCESS; DIVE	Identification of Area-restricted search (ARS) behaviour is used to better understand foraging movements and strategies of marine predators. Track-based descriptive analyses are commonly used to detect ARS behaviour, but they may be biased by factors such as foraging trip duration or non-foraging behaviours (i.e. resting on the water). Using first-passage time analysis we tested if (I) daylight resting at the sea surface positions falsely increase the detection of ARS behaviour and (II) short foraging trips are less likely to include ARS behaviour in Masked Boobies Sula dactylatra. We further analysed whether ARS behaviour may be used as a proxy to identify important feeding areas. Depth-acceleration and GPS-loggers were simultaneously deployed on chick-rearing adults to obtain (1) location data every 4 minutes and (2) detailed foraging activity such as diving rates, time spent sitting on the water surface and in flight. In 82% of 50 foraging trips, birds adopted ARS behaviour. In 19.3% of 57 detected ARS zones, birds spent more than 70% of total ARS duration resting on the water, suggesting that these ARS zones were falsely detected. Based on generalized linear mixed models, the probability of detecting false ARS zones was 80%. False ARS zones mostly occurred during short trips in close proximity to the colony, with low or no diving activity. This demonstrates the need to account for resting on the water surface positions in marine animals when determining ARS behaviour based on foraging locations. Dive rates were positively correlated with trip duration and the probability of ARS behaviour increased with increasing number of dives, suggesting that the adoption of ARS behaviour in Masked Boobies is linked to enhanced foraging activity. We conclude that ARS behaviour may be used as a proxy to identify important feeding areas in this species.	[Sommerfeld, Julia; Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Sommerfeld, Julia; Garthe, Stefan] Univ Kiel, Res & Technol Ctr, Busum, Germany; [Kato, Akiko; Ropert-Coudert, Yan] Univ Strasbourg, IPHC, Strasbourg, France; [Kato, Akiko; Ropert-Coudert, Yan] CNRS, UMR7178, Strasbourg, France	University of Tasmania; University of Kiel; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sommerfeld, J (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Julia.Sommerfeld@utas.edu.au	Hindell, Mark A/K-1131-2013; Kato, Akiko/W-2447-2019	Hindell, Mark/0000-0002-7823-7185; Kato, Akiko/0000-0002-8947-3634	ANZ Trustees Foundation - Holsworth Wildlife Research Endowment, Birds Australia and the Australian Geographic Society	ANZ Trustees Foundation - Holsworth Wildlife Research Endowment, Birds Australia and the Australian Geographic Society	This research was funded by the ANZ Trustees Foundation - Holsworth Wildlife Research Endowment, Birds Australia and the Australian Geographic Society. URL of funders' websites: http://www.anz.com/personal/, http://www.birdlife.org.au/, http://www.australiangeographic.com.au/society/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSONSPRECHER R, 1991, J AM STAT ASSOC, V86, P596, DOI 10.2307/2290387; Ashmole N.P, 1971, AVIAN BIOL, VI, P223; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Bartumeus F, 2008, J THEOR BIOL, V252, P43, DOI 10.1016/j.jtbi.2008.01.009; Bell WJ, 1991, SEARCHING BEHAV BEHA, DOI DOI 10.1371/journal.pone.0086271; BENHAMOU S, 1989, ANIM BEHAV, V38, P375, DOI 10.1016/S0003-3472(89)80030-2; Biuw M, 2003, J EXP BIOL, V206, P3405, DOI 10.1242/jeb.00583; Bolker B, 2011, PACKAGE LME4 R SOFTW; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Calenge C., 2012, PACKAGE ADEHABITATLT; Capuska GEM, 2011, MAR ECOL PROG SER, V442, P255, DOI 10.3354/meps09458; Costa DP, 2012, ANNU REV ECOL EVOL S, V43, P73, DOI 10.1146/annurev-ecolsys-102710-145045; Crawley M.J., 2007, R BOOK; Dorward DF, 1962, IBIS, V103, P221; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Dutson G, 2010, ACTION PLAN AUSTR BI; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fauchald P, 1999, AM NAT, V153, P603, DOI 10.1086/303203; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Furlani D, 2006, ASSESSMENT CONSERVAT; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Harkonen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002006; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695; Lavielle M, 1999, STOCH PROC APPL, V83, P79, DOI 10.1016/S0304-4149(99)00023-X; Lavielle M, 2005, 5339 I NAT RECH INF; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; MARSH LM, 1988, J THEOR BIOL, V133, P113, DOI 10.1016/S0022-5193(88)80028-6; McCafferty DJ, 1998, MAR ECOL PROG SER, V166, P285, DOI 10.3354/meps166285; Nams VO, 1996, LANDSCAPE ECOL, V11, P289, DOI 10.1007/BF02059856; NELSON J.B., 1978, SULIDAE GANNETS BOOB; Paiva VH, 2010, OIKOS, V119, P1423, DOI 10.1111/j.1600-0706.2010.18294.x; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinaud D, 2005, J ANIM ECOL, V74, P852, DOI 10.1111/j.1365-2656.2005.00984.x; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Pittau MG, 2012, PACKAGE ARM R SOFTWA; Priddel David, 2010, Notornis, V57, P113; QUENOUILLE MH, 1949, J ROY STAT SOC B, V11, P68; R Development Core Team, 2012, R LANG ENV STAT COMP; Ripley B, 2011, PACKAGE TREE R SOFTW; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Ropert-Coudert Y, 2004, IBIS, V146, P281, DOI 10.1111/j.1474-919x.2003.00250.x; Ropert-Coudert Y, 2009, J AVIAN BIOL, V40, P380, DOI 10.1111/j.1600-048X.2008.04592.x; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Sibert JR, 2003, FISH OCEANOGR, V12, P141, DOI 10.1046/j.1365-2419.2003.00228.x; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Tanaka H, 2001, J EXP BIOL, V204, P3895; Thums M, 2011, ECOLOGY, V92, P1258, DOI 10.1890/09-1299.1; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; TRILLMICH F, 1990, BEHAVIOUR, V114, P3, DOI 10.1163/156853990X00022; Vandenabeele SP, 2012, MAR BIOL, V159, P1, DOI 10.1007/s00227-011-1784-6; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Watanuki Y, 2003, P ROY SOC B-BIOL SCI, V270, P483, DOI 10.1098/rspb.2002.2252; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; Wilson RP, 1997, WILDLIFE SOC B, V25, P101	59	28	28	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63742	10.1371/journal.pone.0063742	http://dx.doi.org/10.1371/journal.pone.0063742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717471	Green Published, gold			2022-12-27	WOS:000320362700052
J	Villar, SR; Ronco, MT; Bussy, RF; Roggero, E; Lepletier, A; Manarin, R; Savino, W; Perez, AR; Bottasso, O				Villar, Silvina R.; Ronco, M. Teresa; Fernandez Bussy, Rodrigo; Roggero, Eduardo; Lepletier, Ailin; Manarin, Romina; Savino, Wilson; Rosa Perez, Ana; Bottasso, Oscar			Tumor Necrosis Factor-alpha Regulates Glucocorticoid Synthesis in the Adrenal Glands of Trypanosoma cruzi Acutely-Infected Mice. The Role of TNF-R1	PLOS ONE			English	Article							GENE-EXPRESSION; THYMUS ATROPHY; CYTOKINES; AXIS; STEROIDOGENESIS; RECEPTORS	Adrenal steroidogenesis is under a complex regulation involving extrinsic and intrinsic adrenal factors. TNF-alpha is an inflammatory cytokine produced in response to tissue injury and several other stimuli. We have previously demonstrated that TNF-R1 knockout (TNF-R1(-/-)) mice have a dysregulated synthesis of glucocorticoids (GCs) during Trypanosoma cruzi acute infection. Since TNF-alpha may influence GCs production, not only through the hypothalamus-pituitary axis, but also at the adrenal level, we now investigated the role of this cytokine on the adrenal GCs production. Wild type (WT) and TNF-R1(-/-) mice undergoing acute infection (Tc-WT and Tc-TNF-R1(-/-) groups), displayed adrenal hyperplasia together with increased GCs levels. Notably, systemic ACTH remained unchanged in Tc-WT and Tc-TNF-R1(-/-) compared with uninfected mice, suggesting some degree of ACTH-independence of GCs synthesis. TNF-alpha expression was increased within the adrenal gland from both infected mouse groups, with Tc-WT mice showing an augmented TNF-R1 expression. Tc-WT mice showed increased levels of P-p38 and P-ERK compared to uninfected WT animals, whereas Tc-TNF-R1(-/-) mice had increased p38 and JNK phosphorylation respect to Tc-WT mice. Strikingly, adrenal NF-kappa B and AP-1 activation during infection was blunted in Tc-TNF-R1(-/-) mice. The accumulation of mRNAs for steroidogenic acute regulatory protein and cytochrome P450 were significantly increased in both Tc-WT and Tc-TNF-R1(-/-) mice; being much more augmented in the latter group, which also had remarkably increased GCs levels. TNF-alpha emerges as a potent modulator of steroidogenesis in adrenocortical cells during T. cruzi infection in which MAPK pathways, NF-kappa B and AP-1 seem to play a role in the adrenal synthesis of pro-inflammatory cytokines and enzymes regulating GCs synthesis. These results suggest the existence of an intrinsic immune-adrenal interaction involved in the dysregulated synthesis of GCs during murine Chagas disease.	[Villar, Silvina R.; Fernandez Bussy, Rodrigo; Roggero, Eduardo; Manarin, Romina; Rosa Perez, Ana; Bottasso, Oscar] Univ Nacl Rosario, Fac Ciencias Med, Inst Inmunol, RA-2000 Rosario, Argentina; [Ronco, M. Teresa] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Fisiol Expt IFISE CONICET, RA-2000 Rosario, Argentina; [Roggero, Eduardo] UAI, Fac Med, Dept Fisiol, Rosario, Argentina; [Lepletier, Ailin; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil	National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Fundacao Oswaldo Cruz	Villar, SR (corresponding author), Univ Nacl Rosario, Fac Ciencias Med, Inst Inmunol, RA-2000 Rosario, Argentina.	svillar@conicet.gov.ar		Ronco, Maria Teresa/0000-0003-0559-2095; Lepletier, Ailin/0000-0002-1371-7313	SCYT-UNR [1MED 372]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2008-0980]; AmSud-Pasteur Network; CNPq; Faperj (Brazil)	SCYT-UNR; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); AmSud-Pasteur Network; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj (Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	S.R.V., A.R.P., M.T.R. and O.A.B. are members of National Council Research (CONICET). Support for this study was provided by SCYT-UNR (1MED 372) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, PICT 2008-0980), AmSud-Pasteur Network, as well as CNPq and Faperj (Brazil). The funders had no role in study design, data collection and analysis, decision to publish or preparation the manuscript.	Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; Barney M, 2000, ENDOCRINE, V13, P369, DOI 10.1385/ENDO:13:3:369; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; Bornstein SR, 2004, MOL CELL ENDOCRINOL, V215, P135, DOI 10.1016/j.mce.2003.11.022; Bornstein SR, 1999, J CLIN ENDOCR METAB, V84, P1729; Bornstein SR, 1998, HORM METAB RES, V30, P292, DOI 10.1055/s-2007-978887; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Correa-De-Santana E, 2006, J NEUROIMMUNOL, V173, P12, DOI 10.1016/j.jneuroim.2005.08.015; Correa-De-Santana E, 2006, ANN NY ACAD SCI, V1088, P274, DOI 10.1196/annals.1366.005; DARLING G, 1989, SURGERY, V106, P1155; Davies E, 2003, CLIN EXP PHARMACOL P, V30, P437, DOI 10.1046/j.1440-1681.2003.03867.x; Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101; Foster RH, 2004, J MOL ENDOCRINOL, V32, P893, DOI 10.1677/jme.0.0320893; JAATTELA M, 1991, ENDOCRINOLOGY, V128, P623; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Judd AM, 2000, ANN NY ACAD SCI, V917, P628; Kanczkowski W, 2010, NEUROIMMUNOMODULAT, V17, P180, DOI 10.1159/000258718; Karin M, 2001, J ENDOCRINOL, V169, P447, DOI 10.1677/joe.0.1690447; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marx C, 1998, HORM METAB RES, V30, P416, DOI 10.1055/s-2007-978907; MILKHAYLOVA IV, 2001, ENDOCRINOLOGY, V148, P386; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Otis M, 2007, MOL CELL ENDOCRINOL, V265, P126, DOI 10.1016/j.mce.2006.12.008; Perez AR, 2007, BRAIN BEHAV IMMUN, V21, P890, DOI 10.1016/j.bbi.2007.02.004; Roggero E, 2002, CLIN EXP IMMUNOL, V128, P421, DOI 10.1046/j.1365-2249.2002.01874.x; Roggero E, 2006, J ENDOCRINOL, V190, P495, DOI 10.1677/joe.1.06642; Roggero E, 2009, ANN NY ACAD SCI, V1153, P264, DOI 10.1111/j.1749-6632.2008.03982.x; Perez AR, 2011, NEUROIMMUNOMODULAT, V18, P328, DOI 10.1159/000329494; Savino W, 2007, CYTOKINE GROWTH F R, V18, P107, DOI 10.1016/j.cytogfr.2007.01.010; Seckl JR, 2004, CURR OPIN PHARMACOL, V4, P597, DOI 10.1016/j.coph.2004.09.001; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1	34	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63814	10.1371/journal.pone.0063814	http://dx.doi.org/10.1371/journal.pone.0063814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717489	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700064
J	Zhang, SS; Xu, LL; Zhao, XW; Chen, X; Fan, YL; Wan, ZP; Xu, YS; Liu, WL				Zhang, Shaosen; Xu, Liling; Zhao, Xingwang; Chen, Xin; Fan, Yilin; Wan, Zhengpeng; Xu, Yinsheng; Liu, Wanli			A New and Robust Method of Tethering IgG Surrogate Antigens on Lipid Bilayer Membranes to Facilitate the TIRFM Based Live Cell and Single Molecule Imaging Experiments	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; PROTEIN-A; STAPHYLOCOCCUS-AUREUS; IMMUNOLOGICAL-SYNAPSE; T-CELLS; IMMUNE-SYNAPSE; ACTIVATION; RECEPTOR; BINDING; STIMULATION	Our understanding of cell-cell interactions has been significantly improved in the past years with the help of Total Internal Reflection Fluorescence Microscope (TIRFM) in combination with an antigen presenting system supported by planar lipid bilayer (PLB) membranes, which are used to mimic the extensive receptor and ligand interactions within cell-cell contact interface. In TIRFM experiments, it is a challenge to uniformly present ligand molecules in monomeric format on the surface of PLB membranes. Here, we introduce a new and robust method of tethering IgG surrogate antigen ligands on the surface of Ni2+-containing PLB membranes. In this method, we use a modified D domain from staphylococcal protein A molecule that is fused with an N-terminus polyhistidine tag (H12-D-domain) to tether IgG surrogate antigens on Ni2+-containing PLB membranes. We systematically assessed the specificity and capability of H12-D-domain construct to capture IgG molecules from different species through live cell and single molecule TIRFM imaging. We find that these IgG surrogate antigens tethered by H12-D-domain show better lateral mobility and are more uniformly distributed on PLB membranes than the ones tethered by streptavidin. Neither IgM molecules, nor Fab or F(ab')(2) fragments of IgG molecules can be tethered on PLB membranes by H12-D-domain construct. These tethered IgG surrogate antigens strongly induce the formation and accumulation of signaling active antigen receptor microclusters within the immunological synapse in B or T lymphocyte cells. Thus our method provides a new and robust method to tether IgG surrogate antigens or other molecules fused with IgG Fc portion on PLB membranes for TIRFM based molecule imaging experiments.	[Zhang, Shaosen; Xu, Liling; Zhao, Xingwang; Fan, Yilin; Wan, Zhengpeng; Xu, Yinsheng; Liu, Wanli] Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Liu, Wanli] Collaborat Innovat Ctr Infect Dis, Beijing, Peoples R China; [Chen, Xin] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Liu, WL (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.	liuwanli@biomed.tsinghua.edu.cn	Chen, Xin/GNH-1799-2022; Wan, Zhengpeng/AAZ-9783-2021; liu, wanli/H-5690-2011	Chen, Xin/0000-0001-6212-2335; Wan, Zhengpeng/0000-0001-5626-7722; liu, wanli/0000-0003-2624-6802; Liu, Wanli/0000-0003-0395-2800; Zhang, Shaosen/0000-0003-0010-1445; Fan, Yilin/0000-0001-7713-4152	National Science Foundation China [31270913]; Beijing Natural Science Foundation [5132016]; Ph.D. Programs Foundation of Ministry of Education of China [20120002120007]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-12-0299]; Tsinghua University-Gates Foundation	National Science Foundation China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Tsinghua University-Gates Foundation	This work is supported by funds from National Science Foundation China (31270913), Beijing Natural Science Foundation (5132016), The Ph.D. Programs Foundation of Ministry of Education of China (20120002120007), Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-12-0299) and Tsinghua University-Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Arva E, 1999, SCAND J IMMUNOL, V49, P237; Bajenoff M, 2007, EUR J IMMUNOL, V37, pS18, DOI 10.1002/eji.200737663; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; BJORCK L, 1984, J IMMUNOL, V133, P969; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Coombes JL, 2010, NAT REV IMMUNOL, V10, P353, DOI 10.1038/nri2746; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; De Meyer SF, 2009, BLOOD, V113, P5049, DOI 10.1182/blood-2008-10-165621; Dehmelt L, 2010, NAT REV MOL CELL BIO, V11, P440, DOI 10.1038/nrm2903; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Douglass AD, 2008, METHOD CELL BIOL, V85, P113, DOI 10.1016/S0091-679X(08)85006-6; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Dustin ML, 2009, J STRUCT BIOL, V168, P152, DOI 10.1016/j.jsb.2009.05.007; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Fooksman DR, 2009, ANN REV IMMUNOL; FORSGREN A, 1966, J IMMUNOL, V97, P822; Gouda H, 1998, BIOCHEMISTRY-US, V37, P129, DOI 10.1021/bi970923f; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Groves JT, 2008, ANNU REV BIOMED ENG, V10, P311, DOI 10.1146/annurev.bioeng.10.061807.160431; HAFEMAN DG, 1981, P NATL ACAD SCI-BIOL, V78, P4552, DOI 10.1073/pnas.78.7.4552; Hartleib J, 2000, BLOOD, V96, P2149; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; HEATH DG, 1989, P NATL ACAD SCI USA, V86, P4741, DOI 10.1073/pnas.86.12.4741; JENDEBERG L, 1995, J MOL RECOGNIT, V8, P270, DOI 10.1002/jmr.300080405; Kim HK, 2010, J EXP MED, V207, P1863, DOI 10.1084/jem.20092514; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Liu WL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002820; Liu WL, 2010, IMMUNITY, V32, P778, DOI 10.1016/j.immuni.2010.06.006; Liu WL, 2010, J EXP MED, V207, P1095, DOI 10.1084/jem.20092123; Liu WL, 2010, J IMMUNOL, V184, P1977, DOI 10.4049/jimmunol.0902334; Lund LN, 2011, J MOL RECOGNIT, V24, P945, DOI 10.1002/jmr.1140; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Pierce SK, 2010, NAT REV IMMUNOL, V10, P767, DOI 10.1038/nri2853; REIS KJ, 1984, J IMMUNOL, V132, P3091; Saha K, 2003, ANAL CHEM, V75, P835, DOI 10.1021/ac0204911; SJODAHL J, 1977, EUR J BIOCHEM, V73, P343, DOI 10.1111/j.1432-1033.1977.tb11324.x; TESTI R, 1990, J EXP MED, V172, P701, DOI 10.1084/jem.172.3.701; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Waldemarson S, 2012, J EXP MED; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; WATTS TH, 1986, P NATL ACAD SCI USA, V83, P9660, DOI 10.1073/pnas.83.24.9660; WEIS RM, 1982, J BIOL CHEM, V257, P6440	54	3	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63735	10.1371/journal.pone.0063735	http://dx.doi.org/10.1371/journal.pone.0063735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717469	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700051
J	Massom, R; Reid, P; Stammerjohn, S; Raymond, B; Fraser, A; Ushio, S				Massom, Robert; Reid, Philip; Stammerjohn, Sharon; Raymond, Ben; Fraser, Alexander; Ushio, Shuki			Change and Variability in East Antarctic Sea Ice Seasonality, 1979/80-2009/10	PLOS ONE			English	Article							MERTZ GLACIER POLYNYA; SOUTHERN-OCEAN; CLIMATE-CHANGE; INTERANNUAL VARIABILITY; CONTINENTAL-SLOPE; PENINSULA REGION; INDIAN-OCEAN; WATER MASSES; ADELIE LAND; CIRCULATION	Recent analyses have shown that significant changes have occurred in patterns of sea ice seasonality in West Antarctica since 1979, with wide-ranging climatic, biological and biogeochemical consequences. Here, we provide the first detailed report on long-term change and variability in annual timings of sea ice advance, retreat and resultant ice season duration in East Antarctica. These were calculated from satellite-derived ice concentration data for the period 1979/80 to 2009/10. The pattern of change in sea ice seasonality off East Antarctica comprises mixed signals on regional to local scales, with pockets of strongly positive and negative trends occurring in near juxtaposition in certain regions e.g., Prydz Bay. This pattern strongly reflects change and variability in different elements of the marine "icescape'', including fast ice, polynyas and the marginal ice zone. A trend towards shorter sea-ice duration (of 1 to 3 days per annum) occurs in fairly isolated pockets in the outer pack from similar to 95-110 degrees E, and in various near-coastal areas that include an area of particularly strong and persistent change near Australia's Davis Station and between the Amery and West Ice Shelves. These areas are largely associated with coastal polynyas that are important as sites of enhanced sea ice production/melt. Areas of positive trend in ice season duration are more extensive, and include an extensive zone from 160-170 degrees E (i.e., the western Ross Sea sector) and the near-coastal zone between 40-100 degrees E. The East Antarctic pattern is considerably more complex than the well-documented trends in West Antarctica e.g., in the Antarctic Peninsula-Bellingshausen Sea and western Ross Sea sectors.	[Massom, Robert; Raymond, Ben] Australian Antarctic Div, Dept Sustainabil Environm Water Populat & Communi, Kingston, Tas, Australia; [Massom, Robert; Raymond, Ben; Fraser, Alexander] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Sandy Bay, Tas, Australia; [Reid, Philip] Ctr Australian Weather & Climate Res, Australian Bur Meteorol, Hobart, Tas, Australia; [Stammerjohn, Sharon] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Ushio, Shuki] Natl Inst Polar Res, Tachikawa, Tokyo, Japan	Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Bureau of Meteorology - Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Colorado System; University of Colorado Boulder; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Massom, R (corresponding author), Australian Antarctic Div, Dept Sustainabil Environm Water Populat & Communi, Kingston, Tas, Australia.	R.Massom@utas.edu.au	Fraser, Alexander/AFO-7186-2022	Fraser, Alexander/0000-0003-1924-0015; Massom, Robert/0000-0003-1533-5084; STAMMERJOHN, SHARON/0000-0002-1697-8244	Australian Government's Cooperative Research Centre programme through the ACE CRC; AAS [3024, 4116]; AAD CPC [18]; Grants-in-Aid for Scientific Research [24651016] Funding Source: KAKEN; Directorate For Geosciences [1440435] Funding Source: National Science Foundation	Australian Government's Cooperative Research Centre programme through the ACE CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); AAS; AAD CPC; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The work was supported by the Australian Government's Cooperative Research Centre programme through the ACE CRC, and contributes to AAS Projects 3024 and 4116 and AAD CPC Project 18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper is dedicated to our dear friend and colleague Neil Adams. This analysis forms a contribution to the joint Japanese-Australian (JST-DIISR) project "Establishing a Benchmark to Assess Climate Change Impact in the Eastern Antarctic Marine System'', and we are grateful to the project leaders Dr Mitsuo Fukuchi (NIPR, Japan) and Dr So Kawaguchi (AAD, Australia) for their support. We are grateful to an anonymous reviewer, the editor Dr Peter Strutton and Dr Tania Raymond for their highly constructive comments which greatly improved the paper. MODIS data were obtained from the NASA Level 1 Atmosphere Archive and Distribution System (LAADS) (http://ladsweb.nascom.nasa.gov/). Satellite sea ice concentration data were obtained from the NASA Earth Observing System Distributed Active Archive Center (DAAC) at the U.S. National Snow and Ice Data Center, University of Colorado, Boulder (http://www.nsidc.org). This work was supported by the Australian Government's Cooperative Research Centre programme through the ACE CRC, and contributes to AAS Project 4116.	Allison I, 1997, AUST J PHYS, V50, P759, DOI 10.1071/P96113; Amante C., 2009, NGDC24 NOAA NESDIS; Arbetter TE, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001837; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035624; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001739; Barber DG, 2007, ELSEV OCEANOGR SERIE, V74, P1, DOI 10.1016/S0422-9894(06)74001-6; Bindoff N.L., 2000, PAPERS P ROYAL SOC T, V133, P51; Bindoff NL, 2000, DEEP-SEA RES PT II, V47, P2299, DOI 10.1016/S0967-0645(00)00038-2; Comiso JC, 1996, J GEOPHYS RES-OCEANS, V101, P18297, DOI 10.1029/96JC01500; Comiso JC, 2010, SEA ICE, P205, DOI DOI 10.1002/9781444317145.CH6; Comiso JC, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006391; Delille B, 2007, LIMNOL OCEANOGR, V52, P1367, DOI 10.4319/lo.2007.52.4.1367; Dieckmann GS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033540; Dinniman MS, 2012, J CLIMATE, V25, P4799, DOI 10.1175/JCLI-D-11-00307.1; Ducklow Hugh, 2012, P121; Fraser AD, 2012, J CLIMATE, V25, P1137, DOI 10.1175/JCLI-D-10-05032.1; Galton-Fenzi B, 2009, THESIS U TASMANIA HO; Giles AB, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004139; Gloersen P, 1992, NASA SPECIAL PUBLICA, V511; GORDON AL, 1981, J GEOPHYS RES-OCEANS, V86, P4193, DOI 10.1029/JC086iC05p04193; Heil P, 1999, J GEOPHYS RES-OCEANS, V104, P15789, DOI 10.1029/1999JC900076; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Kern S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038062; Kimura N, 2004, J METEOROL SOC JPN, V82, P1223, DOI 10.2151/jmsj.2004.1223; Kimura N, 2007, J OCEANOGR, V63, P685, DOI 10.1007/s10872-007-0060-3; Kimura N, 2011, TELLUS A, V63, P828, DOI 10.1111/j.1600-0870.2011.00526.x; LUBIN D., 2006, POLAR REMOTE SENSING, V1; Maksym T, 2012, OCEANOGRAPHY, V25, P140, DOI 10.5670/oceanog.2012.88; Martinson DG, 2008, DEEP-SEA RES PT II, V55, P1964, DOI 10.1016/j.dsr2.2008.04.038; Martinson DG, 2012, PALAEOGEOGR PALAEOCL, V335, P71, DOI 10.1016/j.palaeo.2011.04.007; Massom RA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001354; Massom RA, 2001, ANN GLACIOL, V33, P391, DOI 10.3189/172756401781818518; Massom RA, 1999, REMOTE SENS ENVIRON, V68, P61, DOI 10.1016/S0034-4257(98)00100-X; Massom RA, 1998, ANN GLACIOL, V27, P420; Massom RA, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004239; Massom RA, 2006, J CLIMATE, V19, P3544, DOI 10.1175/JCLI3805.1; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; Massom RA, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006083; Massom RA, 2009, MAR ECOL PROG SER, V374, P243, DOI 10.3354/meps07734; McCartney MS, 2007, PROG OCEANOGR, V75, P675, DOI 10.1016/j.pocean.2007.02.008; McClintock J, 2008, AM SCI, V96, P302; Meijers AJS, 2010, DEEP-SEA RES PT II, V57, P723, DOI 10.1016/j.dsr2.2009.04.019; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Nicol S, 2000, DEEP-SEA RES PT II, V47, P2281, DOI 10.1016/S0967-0645(00)00026-6; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; Nihashi S, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2003JC002235; Nihashi S, 2001, J GEOPHYS RES-OCEANS, V106, P16767, DOI 10.1029/2000JC000399; Ohshima KI, 2013, NAT GEOSCI, V6, P235, DOI 10.1038/NGEO1738; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Parkinson CL, 2002, ANN GLACIOL, V34, P435, DOI 10.3189/172756402781817482; PARKINSON CL, 1998, ANTAR RES S, V74, P173; Perovich DK, 2011, OCEANOGRAPHY, V24, P162, DOI 10.5670/oceanog.2011.68; Perovich DK, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034007; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Raymond B, 2012, ANTARCTIC ECOSYSTEMS, DOI [10.1002/9781444347241.ch8, DOI 10.1002/9781444347241.CH8]; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Rintoul Sr, 1998, ANTARCT RES SER, V75, P151; Rintoul SR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004541; Smith MB, 2011, POLAR SCI, V5, P104, DOI 10.1016/j.polar.2011.04.007; Speer K, 2012, SO OCEAN OBSERVING S; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Stammerjohn S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050874; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Tamura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1820; Tamura T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032903; Tchernia P., 1984, POLAR REC, V22, P263, DOI [DOI 10.1017/, 10.1017/S0032247400005386, DOI 10.1017/S0032247400005386]; Thomas D.N., 2010, SEA ICE, V2nd; Ushio S, 2006, ANN GLACIOL, V44, P177, DOI 10.3189/172756406781811835; Wadhams P., 2000, ICE OCEAN, DOI [10.1201/9781482283082, DOI 10.1201/9781482283082]; Watkins AB, 1999, GEOPHYS RES LETT, V26, P1481, DOI 10.1029/1999GL900292; Williams GD, 2010, DEEP-SEA RES PT II, V57, P738, DOI 10.1016/j.dsr2.2009.04.020; Williams GD, 2010, DEEP SEA RES 2, V57, P9; Young NW, 1997, ESA SP PUBL, V414, P1007	75	72	72	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64756	10.1371/journal.pone.0064756	http://dx.doi.org/10.1371/journal.pone.0064756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705008	Green Submitted, gold, Green Published			2022-12-27	WOS:000319330200162
J	Navarro, A; Munoz, C; Gaya, A; Diaz-Beya, M; Gel, B; Tejero, R; Diaz, T; Martinez, A; Monzo, M				Navarro, Alfons; Munoz, Carmen; Gaya, Anna; Diaz-Beya, Marina; Gel, Bernat; Tejero, Rut; Diaz, Tania; Martinez, Antonio; Monzo, Mariano			MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients	PLOS ONE			English	Article							BINDING-SITE POLYMORPHISM; HUMAN CANCER; PROGNOSTIC-FACTORS; GENETIC-VARIATION; MICRORNA; DISEASE; DICER; CELL; PHARMACOGENOMICS; EXPRESSION	Background: In recent years, microRNA (miRNA) pathways have emerged as a crucial system for the regulation of tumorogenesis. miR-SNPs are a novel class of single nucleotide polymorphisms that can affect miRNA pathways. Design and Methods: We analyzed eight miR-SNPs by allelic discrimination in 141 patients with Hodgkin lymphoma and correlated the results with treatment-related toxicity, response, disease-free survival (DFS) and overall survival (OS). Results: The KRT81 (rs3660) GG genotype was associated with an increased risk of neurological toxicity (P = 0.016), while patients with XPO5 (rs11077) AA or CC genotypes had a higher rate of bleomycin-associated pulmonary toxicity (P = 0.048). Both miR-SNPs emerged as independent factors in the multivariate analysis. The XPO5 AA and CC genotypes were also associated with a lower response rate (P = 0.036). XPO5 (P = 0.039) and TRBP (rs784567) (P = 0.022) genotypes emerged as prognostic markers for DFS, and XPO5 was also associated with OS (P = 0.033). In the multivariate analysis, only XPO5 emerged as an independent prognostic factor for DFS (HR: 2.622; 95% CI 1.039-6.620; P = 0.041). Given the influence of XPO5 and TRBP as individual markers, we then investigated the combined effect of these miR-SNPs. Patients with both the XPO5 AA/CC and TRBP TT/TC genotypes had the shortest DFS (P = 0.008) and OS (P = 0.008). Conclusion: miR-SNPs can add useful prognostic information on treatment-related toxicity and clinical outcome in Hodgkin lymphoma and can be used to identify patients likely to be chemoresistant or to relapse.	[Navarro, Alfons; Munoz, Carmen; Tejero, Rut; Diaz, Tania; Monzo, Mariano] Univ Barcelona, Sch Med, IDIBAPS, Human Anat Unit,Mol Oncol & Embryol Lab, Barcelona, Spain; [Gaya, Anna; Diaz-Beya, Marina] Hosp Clin Barcelona, IDIBAPS, Dept Hematol, Barcelona, Spain; [Diaz-Beya, Marina] Josep Carreras Leukaemia Res Inst, Barcelona, Spain; [Gel, Bernat] Inst Predict & Personalized Med Canc IMPPC, Hereditary Canc Program, Badalona, Spain; [Martinez, Antonio] Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); University of Barcelona; Hospital Clinic de Barcelona	Navarro, A (corresponding author), Univ Barcelona, Sch Med, IDIBAPS, Human Anat Unit,Mol Oncol & Embryol Lab, Barcelona, Spain.	anavarroponz@ub.edu	Gel Moreno, Bernat/B-8806-2016; Martinez, Antonio/D-8188-2012; Navarro, Alfons/C-2453-2015; MARTINEZ, ANTONIO/AAB-2633-2020	Gel Moreno, Bernat/0000-0001-8878-349X; Martinez, Antonio/0000-0003-0790-9017; Navarro, Alfons/0000-0001-6071-0926; MARTINEZ, ANTONIO/0000-0003-0790-9017; Tejero-Villalba, Rut/0000-0001-5134-4813; MONZO, MARIANO/0000-0003-2322-4851; Diaz-Beya, Marina/0000-0001-9624-2597	Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III [FIS-PI0900547]; Sociedad Espanola de Hematologia y Hemoterapia (SEHH)	Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III(Instituto de Salud Carlos III); Sociedad Espanola de Hematologia y Hemoterapia (SEHH)	This work was supported by a grant from Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III (FIS-PI0900547). Rut Tejero is an APIF fellow of the University of Barcelona. Marina Diaz-Beya is supported by Sociedad Espanola de Hematologia y Hemoterapia (SEHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani R, 2011, HEMATOL-AM SOC HEMAT, P310, DOI 10.1182/asheducation-2011.1.310; Armitage JO, 2010, NEW ENGL J MED, V363, P653, DOI 10.1056/NEJMra1003733; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bennasser Y, 2011, NAT STRUCT MOL BIOL, V18, P323, DOI 10.1038/nsmb.1987; Bertino JR, 2007, PHARMACOGENOMICS, V8, P1625, DOI 10.2217/14622416.8.12.1625; Blum KA, 2010, ANN ONCOL, V21, P2246, DOI 10.1093/annonc/mdq211; Boni V, 2011, PHARMACOGENOMICS J, V11, P429, DOI 10.1038/tpj.2010.58; Campayo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022509; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Cordano P, 2005, BRIT J HAEMATOL, V128, P493, DOI 10.1111/j.1365-2141.2004.05353.x; COX DR, 1972, J R STAT SOC B, V34, P187; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Draube A, 2006, CLIN LYMPHOMA MYELOM, V6, P458, DOI 10.3816/CLM.2006.n.026; Duggan DB, 2003, J CLIN ONCOL, V21, P607, DOI 10.1200/JCO.2003.12.086; Engert A, 2010, NEW ENGL J MED, V363, P640, DOI 10.1056/NEJMoa1000067; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Feng S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-12; de Larrea CF, 2012, CLIN CANCER RES, V18, P3697, DOI 10.1158/1078-0432.CCR-12-0191; Fung HC, 2002, HEMATOL ONCOL, V20, P1, DOI 10.1002/hon.683; Gibcus JH, 2009, NEOPLASIA, V11, P167, DOI 10.1593/neo.08980; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Hsi ED, 2008, LEUKEMIA LYMPHOMA, V49, P1668, DOI 10.1080/10428190802163339; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Josting A, 2000, CURR OPIN ONCOL, V12, P403, DOI 10.1097/00001622-200009000-00004; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; LONGO DL, 1986, J CLIN ONCOL, V4, P1295, DOI 10.1200/JCO.1986.4.9.1295; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Monroy CM, 2011, MOL CARCINOGEN, V50, P825, DOI 10.1002/mc.20747; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; Navarro A, 2009, BLOOD, V114, P2945, DOI 10.1182/blood-2009-02-204842; Nie K, 2008, AM J PATHOL, V173, P242, DOI 10.2353/ajpath.2008.080009; Ribrag V, 2009, BLOOD, V113, P3307, DOI 10.1182/blood-2008-03-148874; Roberts R, 2008, J CARDIOVASC TRANSL, V1, P11, DOI 10.1007/s12265-007-9001-1; Rueda A, 2006, CLIN LYMPHOMA MYELOM, V6, P389, DOI 10.3816/CLM.2006.n.015; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sleijfer S, 2001, CHEST, V120, P617, DOI 10.1378/chest.120.2.617; Sul JK, 2006, SEMIN ONCOL, V33, P324, DOI 10.1053/j.seminoncol.2006.03.006; Van Vlierberghe P, 2009, BRIT J HAEMATOL, V147, P686, DOI 10.1111/j.1365-2141.2009.07909.x; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yazbeck Victor, 2006, Future Oncol, V2, P533, DOI 10.2217/14796694.2.4.533; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480	58	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64716	10.1371/journal.pone.0064716	http://dx.doi.org/10.1371/journal.pone.0064716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705004	gold, Green Submitted, Green Published			2022-12-27	WOS:000319330200158
J	Niibori-Nambu, A; Midorikawa, U; Mizuguchi, S; Hide, T; Nagai, M; Komohara, Y; Nagayama, M; Hirayama, M; Kobayashi, D; Tsubota, N; Takezaki, T; Makino, K; Nakamura, H; Takeya, M; Kuratsu, J; Araki, N				Niibori-Nambu, Akiko; Midorikawa, Uichi; Mizuguchi, Souhei; Hide, Takuichiro; Nagai, Minako; Komohara, Yoshihiro; Nagayama, Megumi; Hirayama, Mio; Kobayashi, Daiki; Tsubota, Nobuyuki; Takezaki, Tatsuya; Makino, Keishi; Nakamura, Hideo; Takeya, Motohiro; Kuratsu, Junichi; Araki, Norie			Glioma Initiating Cells Form a Differentiation Niche Via the Induction of Extracellular Matrices and Integrin alpha V	PLOS ONE			English	Article							STEM; GLIOBLASTOMA; FIBRONECTIN; MIGRATION	Glioma initiating cells (GICs) are considered responsible for the therapeutic resistance and recurrence of malignant glioma. To clarify the molecular mechanism of GIC maintenance/differentiation, we established GIC clones having the potential to differentiate into malignant gliomas, and subjected to DNA microarray/iTRAQ based integrated proteomics. 21,857 mRNAs and 8,471 proteins were identified and integrated into a gene/protein expression analysis chart. Gene Ontology analysis revealed that the expression of cell adhesion molecules, including integrin subfamilies, such as alpha 2 and alpha, and extracellular matrices (ECMs), such as collagen IV (COL4), laminin alpha 2 (LAMA2), and fibronectin 1 (FN), was significantly upregulated during serum-induced GIC differentiation. This differentiation process, accompanied by the upregulation of MAPK as well as glioma specific proteins in GICs, was dramatically accelerated in these ECM (especially FN)-coated dishes. Integrin alpha V blocking antibody and RGD peptide significantly suppressed early events in GIC differentiation, suggesting that the coupling of ECMs to integrin alpha V is necessary for GIC differentiation. In addition, the expression of integrin alpha V and its strong ligand FN was prominently increased in glioblastomas developed from mouse intracranial GIC xenografts. Interestingly, during the initial phase of GIC differentiation, the RGD treatment significantly inhibited GIC proliferation and raised their sensitivity against anti-cancer drug temozolomide (TMZ). We also found that combination treatments of TMZ and RGD inhibit glioma progression and lead the longer survival of mouse intracranial GIC xenograft model. These results indicate that GICs induce/secrete ECMs to develop microenvironments with serum factors, namely differentiation niches that further stimulate GIC differentiation and proliferation via the integrin recognition motif RGD. A combination of RGD treatment with TMZ could have the higher inhibitory potential against the glioma recurrence that may be regulated by the GICs in the differentiation niche. This study provides a new perspective for developing therapeutic strategies against the early onset of GIC-associated glioma.	[Niibori-Nambu, Akiko; Midorikawa, Uichi; Mizuguchi, Souhei; Nagai, Minako; Nagayama, Megumi; Hirayama, Mio; Kobayashi, Daiki; Tsubota, Nobuyuki; Araki, Norie] Kumamoto Univ, Grad Sch Med Sci, Dept Tumor Genet & Biol, Kumamoto, Japan; [Midorikawa, Uichi] Sharp Co Ltd, Healthcare Syst Labs, Chiba, Japan; [Hide, Takuichiro; Tsubota, Nobuyuki; Takezaki, Tatsuya; Makino, Keishi; Nakamura, Hideo; Kuratsu, Junichi] Kumamoto Univ, Dept Neurosurg, Grad Sch Med Sci, Kumamoto, Japan; [Komohara, Yoshihiro; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto, Japan	Kumamoto University; Hisense; Sharp Corporation; Kumamoto University; Kumamoto University	Araki, N (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Tumor Genet & Biol, Kumamoto, Japan.	nori@gpo.kumamoto-u.ac.jp		Kobayashi, Daiki/0000-0003-4131-5220	Ministry of Health, Labor and Welfare of Japan; Houga Research [23659693]; Exploratory Research for Young Scientists from Ministry of Education, Science, Sports, and Culture of Japan [22700905]; COE project B of Kumamoto University; Grants-in-Aid for Scientific Research [25293312, 24700981] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Houga Research; Exploratory Research for Young Scientists from Ministry of Education, Science, Sports, and Culture of Japan; COE project B of Kumamoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Health, Labor and Welfare of Japan (NA), Houga Research (NA) (grant number 23659693), Exploratory Research for Young Scientists (B) (A.NN) (grant number 22700905) from the Ministry of Education, Science, Sports, and Culture of Japan; and from the COE project B of Kumamoto University for proteomic research and education (NA) (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Chang HC, 2010, CELL TRANSPLANTATION; Cosset EC, 2011, INT J CANC; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Fukushima Y, 2007, J NEUROSURG, V107, P578, DOI 10.3171/JNS-07/09/0578; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gilbert MR, 2012, J NEURO-ONCOL, V106, P147, DOI 10.1007/s11060-011-0650-1; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Hirayama M, 2013, MOL CELLULAR PROTEOM; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kobayashi D, 2009, MOL CELL PROTEOMICS, V8, P2350, DOI 10.1074/mcp.M900179-MCP200; Ohka F, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/878425; Ohnishi T, 1998, CLIN EXP METASTAS, V16, P729, DOI 10.1023/A:1006532812408; Oka N, 2007, BIOCHEM BIOPH RES CO, V360, P553, DOI 10.1016/j.bbrc.2007.06.094; Pimton P, 2011, CELL ADHES MIGR, V5, P73, DOI 10.4161/cam.5.1.13704; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Reardon David A, 2011, Genes Cancer, V2, P1159, DOI 10.1177/1947601912450586; Rich JN, 2007, CELL STEM CELL, V1, P353, DOI 10.1016/j.stem.2007.09.011; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, ANN ONCOL, V16, P64, DOI 10.1093/annonc/mdi834; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Wick W, 2011, NEURO-ONCOLOGY, V13, P566, DOI 10.1093/neuonc/nor039	26	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e59558	10.1371/journal.pone.0059558	http://dx.doi.org/10.1371/journal.pone.0059558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704872	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200001
J	Sporbert, A; Cseresnyes, Z; Heidbreder, M; Domaing, P; Hauser, S; Kaltschmidt, B; Kaltschmidt, C; Heilemann, M; Widera, D				Sporbert, Anje; Cseresnyes, Zoltan; Heidbreder, Meike; Domaing, Petra; Hauser, Stefan; Kaltschmidt, Barbara; Kaltschmidt, Christian; Heilemann, Mike; Widera, Darius			Simple Method for Sub-Diffraction Resolution Imaging of Cellular Structures on Standard Confocal Microscopes by Three-Photon Absorption of Quantum Dots	PLOS ONE			English	Article							STEM-CELLS; HIV	This study describes a simple technique that improves a recently developed 3D sub-diffraction imaging method based on three-photon absorption of commercially available quantum dots. The method combines imaging of biological samples via tri-exciton generation in quantum dots with deconvolution and spectral multiplexing, resulting in a novel approach for multi-color imaging of even thick biological samples at a 1.4 to 1.9-fold better spatial resolution. This approach is realized on a conventional confocal microscope equipped with standard continuous-wave lasers. We demonstrate the potential of multi-color tri-exciton imaging of quantum dots combined with deconvolution on viral vesicles in lentivirally transduced cells as well as intermediate filaments in three-dimensional clusters of mouse-derived neural stem cells (neurospheres) and dense microtubuli arrays in myotubes formed by stacks of differentiated C2C12 myoblasts.	[Sporbert, Anje; Cseresnyes, Zoltan; Domaing, Petra] Max Delbruck Ctr Mol Med, Confocal & Photon Microscopy Core Facil 2, Berlin, Germany; [Heidbreder, Meike] Univ Wurzburg, Dept Biotechnol & Biophys, D-97070 Wurzburg, Germany; [Hauser, Stefan; Kaltschmidt, Barbara; Widera, Darius] Univ Bielefeld, D-33615 Bielefeld, Germany; [Kaltschmidt, Barbara; Kaltschmidt, Christian; Widera, Darius] Univ Bielefeld, LiMiTec, D-33615 Bielefeld, Germany; [Heilemann, Mike] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; University of Bielefeld; University of Bielefeld; Goethe University Frankfurt	Sporbert, A (corresponding author), Max Delbruck Ctr Mol Med, Confocal & Photon Microscopy Core Facil 2, Berlin, Germany.	asporb@mdc-berlin.de; darius.widera@uni-bielefeld.de	Cseresnyes, Zoltan/AAG-4266-2020; Widera, Darius/J-4237-2012	Widera, Darius/0000-0003-1686-130X; Cseresnyes, Zoltan/0000-0002-6574-2588; Heilemann, Mike/0000-0002-9821-3578; Hauser, Stefan/0000-0002-1022-7482	DFG Grant [NI 1167/3-1]; BMBF (FORSYS) [0315262, 01GN1006A]; DFG, The German Research Foundation; FiF grant of the University of Bielefeld; Deutsche Forschungsgemeinschaft (DFG); Open Access Publication Funds of Bielefeld University Library	DFG Grant(German Research Foundation (DFG)); BMBF (FORSYS)(Federal Ministry of Education & Research (BMBF)); DFG, The German Research Foundation(German Research Foundation (DFG)); FiF grant of the University of Bielefeld; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University Library	AS and ZC are supported by a DFG Grant for Core Facilities (NI 1167/3-1). MiHeidbreder and MHeilemann are grateful for funding by the BMBF (FORSYS, grant nr. 0315262). SH and BK are supported by the BMBF (grant nr. BMBF, grant: 01GN1006A.). CK is grateful for funding by the DFG, The German Research Foundation. DW was supported by a FiF grant of the University of Bielefeld. The authors acknowledge the support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Fisher B, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.087403; Franceschetti A, 2007, J PHYS CHEM C, V111, P6154, DOI 10.1021/jp070223c; Gunzenhauser J, 2012, NANO LETT, V12, P4705, DOI 10.1021/nl3021076; Hauser S, 2012, STEM CELLS DEV, V21, P742, DOI 10.1089/scd.2011.0419; Heidbreder M, 2010, BBA-MOL CELL RES, V1803, P1224, DOI 10.1016/j.bbamcr.2010.06.004; Heilemann M, 2010, J BIOTECHNOL, V149, P243, DOI 10.1016/j.jbiotec.2010.03.012; Hennig S, 2009, NANO LETT, V9, P2466, DOI 10.1021/nl9012387; Huang B, 2010, CURR OPIN CHEM BIOL, V14, P10, DOI 10.1016/j.cbpa.2009.10.013; Kaltschmidt C, 2012, STEM CELL REV; Kontrogianni-Konstantopoulos A, 2006, AM J PHYSIOL-CELL PH, V290, pC626, DOI 10.1152/ajpcell.00442.2005; Lehmann M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002456; Martin I, 2012, STEM CELL REV; Muranyi W, 2012, HISTOCHEM CELL BIOL; Musa H, 2003, J MUSCLE RES CELL M, V24, P301; Nowak SJ, 2009, J CELL SCI, V122, P3282, DOI 10.1242/jcs.047597; Pereira CF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-84; Prins KC, 2012, JOVE-J VIS EXP, DOI 10.3791/3757; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Sibarita JB, 2005, ADV BIOCHEM ENG BIOT, V95, P201, DOI 10.1007/b102215; vanKempen GMP, 1996, IEEE ENG MED BIOL, V15, P76, DOI 10.1109/51.482846; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64	24	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64023	10.1371/journal.pone.0064023	http://dx.doi.org/10.1371/journal.pone.0064023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700448	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200106
J	Su, RJ; Baylink, DJ; Neises, A; Kiroyan, JB; Meng, XM; Payne, KJ; Tschudy-Seney, B; Duan, YY; Appleby, N; Kearns-Jonker, M; Gridley, DS; Wang, J; Lau, KHW; Zhang, XB				Su, Rui-Jun; Baylink, David J.; Neises, Amanda; Kiroyan, Jason B.; Meng, Xianmei; Payne, Kimberly J.; Tschudy-Seney, Benjamin; Duan, Yuyou; Appleby, Nancy; Kearns-Jonker, Mary; Gridley, Daila S.; Wang, Jun; Lau, K. -H. William; Zhang, Xiao-Bing			Efficient Generation of Integration-Free iPS Cells from Human Adult Peripheral Blood Using BCL-XL Together with Yamanaka Factors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; HUMAN FIBROBLASTS; CORD BLOOD; LENTIVIRAL VECTOR; GENE-EXPRESSION; HIV VECTORS; T-CELLS; DIFFERENTIATION; PLASMID	The ability to efficiently generate integration-free induced pluripotent stem cells (iPSCs) from the most readily available source-peripheral blood-has the potential to expedite the advances of iPSC-based therapies. We have successfully generated integration-free iPSCs from cord blood (CB) CD34(+) cells with improved oriP/EBNA1-based episomal vectors (EV) using a strong spleen focus forming virus ( SFFV) long terminal repeat (LTR) promoter. Here we show that Yamanaka factors (OCT4, SOX2, MYC, and KLF4)-expressing EV can also reprogram adult peripheral blood mononuclear cells (PBMNCs) into pluripotency, yet at a very low efficiency. We found that inclusion of BCL-XL increases the reprogramming efficiency by approximately 10-fold. Furthermore, culture of CD3(-)/CD19(-) cells or T/B cell-depleted MNCs for 4-6 days led to the generation of 20-30 iPSC colonies from 1 ml PB, an efficiency that is substantially higher than previously reported. PB iPSCs express pluripotency markers, form teratomas, and can be induced to differentiate in vitro into mesenchymal stem cells, cardiomyocytes, and hepatocytes. Used together, our optimized factor combination and reprogramming strategy lead to efficient generation of integration-free iPSCs from adult PB. This discovery has potential applications in iPSC banking, disease modeling and regenerative medicine.	[Su, Rui-Jun; Baylink, David J.; Neises, Amanda; Kiroyan, Jason B.; Meng, Xianmei; Zhang, Xiao-Bing] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA; [Su, Rui-Jun; Payne, Kimberly J.; Appleby, Nancy; Kearns-Jonker, Mary] Loma Linda Univ, Div Anat, Loma Linda, CA 92350 USA; [Su, Rui-Jun; Payne, Kimberly J.] Loma Linda Univ, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Tschudy-Seney, Benjamin; Duan, Yuyou] Univ Calif Davis, Med Ctr, Inst Regenerat Cures, Dept Internal Med, Sacramento, CA 95817 USA; [Gridley, Daila S.] Loma Linda Univ, Dept Radiat Med, Loma Linda, CA 92350 USA; [Wang, Jun] Loma Linda Univ, Dept Pathol, Loma Linda, CA 92350 USA; [Lau, K. -H. William] Jerry L Pettis Mem VA Med Ctr, Loma Linda, CA USA	Loma Linda University; Loma Linda University; Loma Linda University; University of California System; University of California Davis; Loma Linda University; Loma Linda University	Zhang, XB (corresponding author), Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA.	xzhang@llu.edu	Payne, Kimberly/AAS-6814-2020; Duan, Yuyou/L-2301-2015; Gridley, Daila S/P-7711-2015	Payne, Kimberly/0000-0002-7025-5821; Duan, Yuyou/0000-0002-1402-7402; Kearns-Jonker, Mary/0000-0002-8989-3698; Lau, Kin-Hing/0000-0003-1109-5052; Zhang, Xiao-Bing/0000-0003-4319-6181	NSF Grant [MRI-DBI 0923559]; Loma Linda University (LLU) School of Medicine; Loma Linda University; GRASP Award; Department of Defense (DOD) Concept Award [W81XWH-11-1-0607]; United States Army Medical Research Acquisition Activity (USAMRAA) Grant [W81XWH-12-1-0023]; Division of Anatomy; Department of Basic Sciences; Center for Health Disparities and Molecular Medicine at LLU; Radiation Research Laboratories in the Department of Radiation Medicine at LLU	NSF Grant(National Science Foundation (NSF)); Loma Linda University (LLU) School of Medicine; Loma Linda University; GRASP Award; Department of Defense (DOD) Concept Award; United States Army Medical Research Acquisition Activity (USAMRAA) Grant; Division of Anatomy; Department of Basic Sciences; Center for Health Disparities and Molecular Medicine at LLU; Radiation Research Laboratories in the Department of Radiation Medicine at LLU	Imaging was performed in the LLUSM Advanced Imaging and Microscopy Core that is supported by NSF Grant No. MRI-DBI 0923559 (Sean M Wilson) and the Loma Linda University (LLU) School of Medicine. The authors thank Monica Rubalcava for technical support in confocal imaging.; This work was supported by Loma Linda University (LLU) GRASP Award (XBZ), and Department of Defense (DOD) Concept Award W81XWH-11-1-0607 (XBZ), United States Army Medical Research Acquisition Activity (USAMRAA) Grant W81XWH-12-1-0023 (DJB), and the Division of Anatomy, the Department of Basic Sciences, the Center for Health Disparities and Molecular Medicine at LLU (KJP and RJS) and Radiation Research Laboratories in the Department of Radiation Medicine at LLU (DSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bai H, 2012, STEM CELL RES, V8, P26, DOI 10.1016/j.scr.2011.08.002; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Daley GQ, 2012, CELL, V151, P1151, DOI 10.1016/j.cell.2012.11.016; De Palma M, 2005, BLOOD, V105, P2307, DOI 10.1182/blood-2004-03-0798; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Dowey SN, 2012, NAT PROTOC, V7, P2013, DOI 10.1038/nprot.2012.121; Duan YY, 2010, STEM CELLS, V28, P674, DOI 10.1002/stem.315; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Hiratsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025961; Hu KJ, 2011, BLOOD, V117, pE109, DOI 10.1182/blood-2010-07-298331; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Jaenisch R, 2012, CELL STEM CELL, V11, P744, DOI 10.1016/j.stem.2012.11.005; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Jin ZB, 2012, STEM CELL TRANSL MED, V1, P503, DOI 10.5966/sctm.2012-0005; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Mack AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027956; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705; Meng XM, 2013, CELL RES, V23, P658, DOI 10.1038/cr.2013.40; Meng XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037569; Meng XM, 2012, MOL THER, V20, P408, DOI 10.1038/mt.2011.258; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Narsinh KH, 2011, NAT PROTOC, V6, P78, DOI 10.1038/nprot.2010.173; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042855; Papapetrou EP, 2011, NAT PROTOC, V6, P1251, DOI 10.1038/nprot.2011.374; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rajesh D, 2011, BLOOD, V118, P1797, DOI 10.1182/blood-2011-01-332064; Seki T, 2012, NAT PROTOC, V7, P718, DOI 10.1038/nprot.2012.015; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Su RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059908; Surani MA, 2012, CELL STEM CELL, V11, P748, DOI 10.1016/j.stem.2012.11.014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Williams DA, 1999, ANN NY ACAD SCI, V872, P109, DOI 10.1111/j.1749-6632.1999.tb08457.x; Williams DA, 1999, ANN NY ACAD SCI, V872, P113; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017557; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang XB, 2006, PLOS MED, V3, P687, DOI 10.1371/journal.pmed.0030173; Zhang XB, 2007, STEM CELLS, V25, P2074, DOI 10.1634/stemcells.2006-0742; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	85	59	71	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64496	10.1371/journal.pone.0064496	http://dx.doi.org/10.1371/journal.pone.0064496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704989	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200143
J	You, W; Tang, QY; Zhang, CY; Wu, JD; Gu, CR; Wu, ZS; Li, XC				You, Wei; Tang, Qiyun; Zhang, Chuanyong; Wu, Jindao; Gu, Chunrong; Wu, Zhengshan; Li, Xiangcheng			IL-26 Promotes the Proliferation and Survival of Human Gastric Cancer Cells by Regulating the Balance of STAT1 and STAT3 Activation	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; T-CELLS; IL-10; INTERLEUKIN-10; INFLAMMATION; RECEPTOR-1	Interleukin-26 (IL-26) is one of the cytokines secreted by Th17 cells whose role in human tumors remains unknown. Here, we investigated the expression and potential role of IL-26 in human gastric cancer (GC). The expression of IL-26 and related molecules such as IL-20R1, STAT1 and STAT3 was examined by real-time PCR and immunohistochemisty. The effects of IL-26 on cell proliferation and cisplatin-induced apoptosis were analyzed by BrdU cooperation assay and PI-Annexin V co-staining, respectively. Lentiviral mediated siRNA was used to explore its mechanism of action, and IL-26 related signaling was analyzed by western blotting. Human GC tissues showed increased levels of IL-26 and its related molecules and activation of STAT3 signaling, whereas STAT1 activation did not differ significantly between GC and normal gastric tissues. Moreover, IL-26 was primarily produced by Th17 and NK cells. IL-26 promoted the proliferation and survival of MKN45 and SGC-7901 gastric cancer cells in a dose-dependent manner. Furthermore, IL-20R2 and IL-10R1, which are two essential receptors for IL-26 signaling, were expressed in both cell lines. IL-26 activated STAT1 and STAT3 signaling; however, the upregulation of the expression of Bcl-2, Bcl-xl and c-myc indicated that the effect of IL-26 is mediated by STAT3 activation. Knockdown of STAT1 and STAT3 expression suggested that the proliferative and anti-apoptotic effects of IL-26 are mediated by the modulation of STAT1/STAT3 activation. In summary, elevated levels of IL-26 in human GC promote proliferation and survival by modulating STAT1/STAT3 signaling.	[You, Wei; Zhang, Chuanyong; Wu, Jindao; Gu, Chunrong; Wu, Zhengshan; Li, Xiangcheng] Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China; [You, Wei; Zhang, Chuanyong; Wu, Jindao; Gu, Chunrong; Wu, Zhengshan; Li, Xiangcheng] Minist Hlth, Key Lab Living Donor Liver Transplantat, Nanjing, Jiangsu, Peoples R China; [Tang, Qiyun] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wu, ZS (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China.	Wuzs@163.com.cn; Lixc2012ac@yahoo.cn	li, xiang/GWM-6319-2022		National Natural Science Foundation [81170415]; Jiangsu Province's Key Provincial Talents Program [RC2011079, RC2007056]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Key Provincial Talents Program	This work was supported by grants from the National Natural Science Foundation (81170415 for XC) and Jiangsu Province's Key Provincial Talents Program (RC2011079 for QT and RC2007056 for XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam JP, 2011, ALLERGY, V66, P532, DOI 10.1111/j.1398-9995.2010.02510.x; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Asaoka Y, 2011, EXPERT OPIN INV DRUG, V20, P595, DOI 10.1517/13543784.2011.566863; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Backert S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-28; Caruso R, 2007, WORLD J GASTROENTERO, V13, P5547, DOI 10.3748/wjg.v13.i42.5547; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Conti P, 2003, IMMUNOL LETT, V88, P171, DOI 10.1016/S0165-2478(03)00087-7; Donnelly RP, 2010, CYTOKINE GROWTH F R, V21, P393, DOI 10.1016/j.cytogfr.2010.09.001; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fickenscher H, 2004, INT IMMUNOPHARMACOL, V4, P609, DOI 10.1016/j.intimp.2004.01.004; Fitzpatrick LR, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/389404; Ghoreschi K, 2011, TRENDS IMMUNOL, V32, P395, DOI 10.1016/j.it.2011.06.007; Hahn JN, 2011, J CLIN INVEST, V121, P4030, DOI 10.1172/JCI45114; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hor S, 2004, J BIOL CHEM, V279, P33343, DOI 10.1074/jbc.M405000200; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Ishigami S, 2000, CANCER, V88, P577, DOI 10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.3.CO;2-M; Jiang RQ, 2010, INT J CANCER, V126, P1263, DOI 10.1002/ijc.24854; Knappe A, 2000, J VIROL, V74, P3881, DOI 10.1128/JVI.74.8.3881-3887.2000; Kohanbash G, 2012, SEMIN CANCER BIOL, V22, P70, DOI 10.1016/j.semcancer.2011.12.010; Oshima H, 2012, J GASTROENTEROL, V47, P97, DOI 10.1007/s00535-011-0523-6; Ott K, 2011, LANGENBECK ARCH SURG, V396, P743, DOI 10.1007/s00423-010-0738-7; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; Sheikh F, 2004, J IMMUNOL, V172, P2006, DOI 10.4049/jimmunol.172.4.2006; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Takeuchi H, 2001, AM J GASTROENTEROL, V96, P574; Weyand CM, 2011, CURR OPIN RHEUMATOL, V23, P43, DOI 10.1097/BOR.0b013e32833ee946; Yoshida T, 2012, INT J CANC; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060	32	49	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63588	10.1371/journal.pone.0063588	http://dx.doi.org/10.1371/journal.pone.0063588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704922	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200053
J	Giampa, C; Montagna, E; Dato, C; Melone, MAB; Bernardi, G; Fusco, FR				Giampa, Carmela; Montagna, Elena; Dato, Clemente; Melone, Mariarosa A. B.; Bernardi, Giorgio; Fusco, Francesca Romana			Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; WILD-TYPE HUNTINGTIN; BLOOD-BRAIN; CELLULAR-LOCALIZATION; CORTICAL-NEURONS; BINDING-PROTEIN; RAT; TRANSCRIPTION; CREB; NEUROINFLAMMATION	Loss of huntingtin-mediated BDNF gene transcription has been shown to occur in HD and thus contribute to the degeneration of the striatum. Several studies have indicated that an increase in BDNF levels is associated with neuroprotection and amelioration of neurological signs in animal models of HD. In a recent study, an increase in BDNF mRNA and protein levels was recorded in mice administered recombinant BDNF peripherally. Chronic, indwelling osmotic mini-pumps containing either recombinant BDNF or saline were surgically placed in R6/2 or wild-type mice from 4 weeks of age until euthanasia. Neurological evaluation (paw clasping, rotarod performance, locomotor activity in an open field) was performed. After transcardial perfusion, histological and immunohistochemical studies were performed. We found that BDNF-treated R6/2 mice survived longer and displayed less severe signs of neurological dysfunction than the vehicle treated ones. Primary outcome measures such as brain volume, striatal atrophy, size and morphology of striatal neurons, neuronal intranuclear inclusions and microglial reaction confirmed a neuroprotective effect of the compound. BDNF was effective in increasing significantly the levels of activated CREB and of BDNF the striatal spiny neurons. Moreover, systemically administered BDNF increased the synthesis of BDNF as demonstrated by RT-PCR, and this might account for the beneficial effects observed in this model.	[Giampa, Carmela; Montagna, Elena; Dato, Clemente; Bernardi, Giorgio; Fusco, Francesca Romana] European Ctr Brain Res, Lab Neuroanat, Santa Lucia Fdn IRCCS Hosp, Rome, Italy; [Bernardi, Giorgio] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Melone, Mariarosa A. B.] Univ Naples 2, Div Neurol, Dept Clin & Expt Med & Surg, Naples, Italy; [Melone, Mariarosa A. B.] CNR, Inst Prot Biochem, I-80125 Naples, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Fusco, FR (corresponding author), European Ctr Brain Res, Lab Neuroanat, Santa Lucia Fdn IRCCS Hosp, Rome, Italy.	f.fusco@hsantalucia.it	Melone, Mariarosa Anna Beatrice/N-6788-2015; Fusco, Francesca R/K-1080-2018; terracciano, chiara/C-2955-2018	Melone, Mariarosa Anna Beatrice/0000-0002-7213-9277; Fusco, Francesca R/0000-0003-2226-523X; terracciano, chiara/0000-0002-1853-5578; , Giampa/0000-0002-1763-5665	Italian Department of Health [RC12C]	Italian Department of Health	The work has been supported by grant RC12C of the Italian Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; BECK T, 1994, J CEREBR BLOOD F MET, V14, P689, DOI 10.1038/jcbfm.1994.86; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Ciammola A, 2007, AM J MED GENET B, V144B, P574, DOI 10.1002/ajmg.b.30501; Conner JM, 1997, J NEUROSCI, V17, P2295; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; DeMarch Z, 2007, NEUROBIOL DIS, V25, P266, DOI 10.1016/j.nbd.2006.09.006; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; FigueredoCardenas G, 1997, EXP NEUROL, V146, P444, DOI 10.1006/exnr.1997.6549; Fusco FR, 1999, J NEUROSCI, V19, P1189; Fusco FR, 2003, EUR J NEUROSCI, V18, P1093, DOI 10.1046/j.1460-9568.2003.02844.x; Fusco FR, 2012, NEUROBIOL DIS, V46, P225, DOI 10.1016/j.nbd.2012.01.011; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Giampa C, 2006, EUR J NEUROSCI, V23, P11, DOI 10.1111/j.1460-9568.2005.04545.x; Giampa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013417; Giampa C, 2009, EUR J NEUROSCI, V29, P902, DOI 10.1111/j.1460-9568.2009.06649.x; Giralt A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-71; Givalois L, 2006, J ENDOCRINOL, V188, P425, DOI 10.1677/joe.1.06578; Harry GJ, 2008, EXPERT OPIN DRUG MET, V4, P1265, DOI [10.1517/17425255.4.10.1265, 10.1517/17425255.4.10.1265 ]; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Kishino A, 2001, NEUROREPORT, V12, P1067, DOI 10.1097/00001756-200104170-00040; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Meade CA, 2002, J COMP NEUROL, V449, P241, DOI 10.1002/cne.10295; Moller T, 2006, SEMIN THROMB HEMOST, V32, P69, DOI 10.1055/s-2006-939556; Moller T, 2010, J NEURAL TRANSM, V117, P1001, DOI 10.1007/s00702-010-0430-7; Nakao N, 1995, DEV BRAIN RES, V90, P92, DOI 10.1016/0165-3806(96)83489-4; Pan WH, 1999, ADV DRUG DELIVER REV, V36, P291, DOI 10.1016/S0169-409X(98)00086-6; PARDRIDGE WM, 1994, PHARMACEUT RES, V11, P738, DOI 10.1023/A:1018940732550; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Perez-Navarro E, 2000, J NEUROCHEM, V75, P2190, DOI 10.1046/j.1471-4159.2000.0752190.x; Petersen A, 2001, BRAIN RES BULL, V56, P331, DOI 10.1016/S0361-9230(01)00580-9; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Sakane T, 1997, PHARMACEUT RES, V14, P1085, DOI 10.1023/A:1012117815460; SALIN T, 1995, NEUROSCI LETT, V194, P181, DOI 10.1016/0304-3940(95)11772-O; Schmidt HD, 2010, NEUROPSYCHOPHARMACOL, V35, P2378, DOI 10.1038/npp.2010.114; Schmidt Heath D, 2008, Drug Discov Today Ther Strateg, V5, P151, DOI 10.1016/j.ddstr.2008.10.003; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Song XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001707; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; WILSON RS, 1987, J CLIN EXP NEUROPSYC, V9, P147, DOI 10.1080/01688638708405354; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1992, J NEUROSCI, V12, P4793; Zhang YU, 2003, J NEUROCHEM, V87, P101, DOI 10.1046/j.1471-4159.2003.01980.x; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	56	65	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64037	10.1371/journal.pone.0064037	http://dx.doi.org/10.1371/journal.pone.0064037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700454	Green Submitted, Green Published, gold			2022-12-27	WOS:000319966400045
J	Zhang, AH; Sun, H; Han, Y; Yan, GL; Wang, XJ				Zhang, Aihua; Sun, Hui; Han, Ying; Yan, Guangli; Wang, Xijun			Urinary Metabolic Biomarker and Pathway Study of Hepatitis B Virus Infected Patients Based on UPLC-MS System	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; LIVER; DRUG; DISCOVERY	Hepatitis B virus (HBV) is the fatal consequence of chronic hepatitis, and lack of biomarkers has been a long standing bottleneck in the clinical diagnosis. Metabolomics concerns with comprehensive analysis of small molecules and provides a powerful approach to discover biomarkers in biological systems. Here, we present metabolomics analysis applying ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. (UPLC-Q-TOF-HDMS) to determine metabolite alterations in HBV patients. Most important permutations are elaborated using multivariate statistical analysis and network analysis that was used to select the metabolites for the noninvasive diagnosis of HBV. In this study, the total 11 urinary differential metabolites were identified and contributed to HBV progress involving several key metabolic pathways by using pathway analysis with MetPA, which are promising biomarker candidates for diagnostic research. More importantly, of 11 altered metabolites, 4 metabolite markers were effective for the diagnosis of human HBV, achieved a satisfactory accuracy, sensitivity and specificity, respectively. It demonstrates that metabolomics has the potential as a non-invasive tool to evaluate the potential of these metabolites in the early diagnosis of HBV patients. These findings may be promising to yield a valuable insight into the pathophysiology of HBV and to advance the approaches of diagnosis, treatment, and prevention.	[Wang, Xijun] Heilongjiang Univ Chinese Med, Natl TCM Key Lab Serum Pharmacochem, Key Lab Chinmed, Harbin, Peoples R China; Key Pharmacometabol Platform Chinese Med, Harbin, Peoples R China	Heilongjiang University of Chinese Medicine	Wang, XJ (corresponding author), Heilongjiang Univ Chinese Med, Natl TCM Key Lab Serum Pharmacochem, Key Lab Chinmed, Harbin, Peoples R China.	xijunwangls@126.com	Wang, Xijun/C-4477-2014	Wang, Xijun/0000-0002-0949-3492	Key Program of Natural Science Foundation of State [90709019]; National Specific Program on the Subject of Public Welfare [200807014]; National Key Subject of Drug Innovation [2009ZX09502-005]; National Program on Key Basic Research Project of China [2005CB523406]	Key Program of Natural Science Foundation of State(National Natural Science Foundation of China (NSFC)); National Specific Program on the Subject of Public Welfare; National Key Subject of Drug Innovation; National Program on Key Basic Research Project of China(National Basic Research Program of China)	This work was supported by grants from the Key Program of Natural Science Foundation of State (Grant No. 90709019), the National Specific Program on the Subject of Public Welfare (Grant No. 200807014), National Key Subject of Drug Innovation (Grant No. 2009ZX09502-005), and National Program on Key Basic Research Project of China (Grant No. 2005CB523406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantonico A, 2010, ANAL BIOANAL CHEM, V398, P2493, DOI 10.1007/s00216-010-3850-1; Chen JH, 2012, MOL BIOSYST, V8, P871, DOI 10.1039/c2mb05454j; Dove ADM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049379; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Hall JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049510; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Meissen JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046770; van Wietmarschen HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044331; Walsh BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050520; Wang XJ, 2013, MOL CELL PROTEOMICS, V12, P1226, DOI 10.1074/mcp.M112.021683; Wang XJ, 2013, HEPATOLOGY, V57, P2072, DOI 10.1002/hep.26130; Wang XJ, 2013, J PHARMACEUT BIOMED, V74, P22, DOI 10.1016/j.jpba.2012.10.009; Wang XJ, 2012, MOL CELL PROTEOMICS, V11, P370, DOI 10.1074/mcp.M111.016006; Wang XJ, 2012, OMICS, V16, P414, DOI 10.1089/omi.2011.0138; Wang XJ, 2012, J PROTEOMICS, V75, P1411, DOI 10.1016/j.jprot.2011.11.011; Wedemeyer H, 2011, NEW ENGL J MED, V364, P322, DOI 10.1056/NEJMoa0912696; Wong VWS, 2012, J HEPATOL, V56, P533, DOI 10.1016/j.jhep.2011.09.013; Zhang A, 2013, OBES REV, V14, P344, DOI 10.1111/obr.12011; Zhang AH, 2013, CLIN CHIM ACTA, V418, P86, DOI 10.1016/j.cca.2012.12.024; Zhang AH, 2013, ANALYST, V138, P353, DOI 10.1039/c2an36382h; Zhang AH, 2012, CLIN CHIM ACTA, V414, P65, DOI 10.1016/j.cca.2012.08.016; Zhang AH, 2012, APPL BIOCHEM BIOTECH, V168, P1718, DOI 10.1007/s12010-012-9891-5; Zhang AH, 2012, ANALYST, V137, P4200, DOI 10.1039/c2an35780a; Zhang AH, 2012, J PROTEOMICS, V75, P1079, DOI 10.1016/j.jprot.2011.10.027; Zheng DH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048451, 10.1371/journal.pone.0049495]	26	60	62	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64381	10.1371/journal.pone.0064381	http://dx.doi.org/10.1371/journal.pone.0064381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696887	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900090
J	Sieri, S; Brighenti, F; Agnoli, C; Grioni, S; Masala, G; Bendinelli, B; Sacerdote, C; Ricceri, F; Tumino, R; Giurdanella, MC; Pala, V; Berrino, F; Mattiello, A; Chiodini, P; Panico, S; Krogh, V				Sieri, Sabina; Brighenti, Furio; Agnoli, Claudia; Grioni, Sara; Masala, Giovanna; Bendinelli, Benedetta; Sacerdote, Carlotta; Ricceri, Fulvio; Tumino, Rosario; Giurdanella, Maria Concetta; Pala, Valeria; Berrino, Franco; Mattiello, Amalia; Chiodini, Paolo; Panico, Salvatore; Krogh, Vittorio			Dietary Glycemic Load and Glycemic Index and Risk of Cerebrovascular Disease in the EPICOR Cohort	PLOS ONE			English	Article							OBESE YOUNG-ADULTS; CARDIOVASCULAR-DISEASE; HEART-DISEASE; CARBOHYDRATE INTAKE; SWEDISH MEN; WEIGHT-LOSS; STROKE; WOMEN; REPRODUCIBILITY; QUESTIONNAIRE	Background: Studies on the association of stroke risk to dietary glycemic index (GI) and glycemic load (GL) have produced contrasting results. Objective: To investigate the relation of dietary GI and GL to stroke risk in the large EPIC-Italy cohort (EPICOR) recruited from widely dispersed geographic areas of Italy. Design: We studied 44099 participants (13,646 men and 30,453 women) who completed a dietary questionnaire. Multivariable Cox modeling estimated adjusted hazard ratios (HRs) of stroke with 95% confidence intervals (95% CI). Over 11 years of follow-up, 355 stroke cases (195 ischemic and 83 hemorrhagic) were identified. Results: Increasing carbohydrate intake was associated with increasing stroke risk (HR = 2.01, 95% CI = 1.04-3.86 highest vs. lowest quintile; p for trend 0.025). Increasing carbohydrate intake from high-GI foods was also significantly associated with increasing stroke risk (HR 1.87, 95% CI = 1.16-3.02 highest vs. lowest, p trend 0.008), while increasing carbohydrate intake from low-GI foods was not. Increasing GL was associated with significantly increasing stroke risk (HR 2.21, 95% CI = 1.16-4.20, highest vs. lowest; p trend 0.015). Dietary carbohydrate from high GI foods was associated with increased both ischemic stroke risk (highest vs. lowest HR 1.92, 95% CI = 1.01-3.66) and hemorrhagic stroke risk (highest vs. lowest HR 3.14, 95% CI = 1.09-9.04). GL was associated with increased both ischemic and hemorrhagic stroke risk (HR 1.44, 95% CI = 1.09-1.92 and HR 1.56, 95% CI = 1.01-2.41 respectively, continuous variable). Conclusions: In this Italian cohort, high dietary GL and carbohydrate from high GI foods consumption increase overall risk of stroke.	[Sieri, Sabina; Agnoli, Claudia; Grioni, Sara; Pala, Valeria; Berrino, Franco; Krogh, Vittorio] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Brighenti, Furio] Univ Parma, Dept Publ Hlth, I-43100 Parma, Italy; [Masala, Giovanna; Bendinelli, Benedetta] ISPO Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Sacerdote, Carlotta] Ctr Canc Prevent CPO Piemonte, Turin, Italy; [Sacerdote, Carlotta; Ricceri, Fulvio] Human Genet Fdn HuGeF, Turin, Italy; [Tumino, Rosario; Giurdanella, Maria Concetta] Osped Civile MP Arezzo, Dept Oncol, Canc Registry, Ragusa, Italy; [Tumino, Rosario] Osped Civile MP Arezzo, Dept Oncol, Histopathol Unit, Ragusa, Italy; [Mattiello, Amalia; Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Chiodini, Paolo] Univ Naples 2, Dept Publ Hlth & Prevent Med, Naples, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Parma; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; University of Naples Federico II; Universita della Campania Vanvitelli	Sieri, S (corresponding author), Fdn IRCCS Ist Nazl Tumori, Milan, Italy.	sabina.sieri@istitutotumori.mi.it	Krogh, Vittorio/AAA-9171-2019; Ricceri, Fulvio/I-9910-2018; Krogh, Vittorio/K-2628-2016; Grioni, Sara/K-5320-2016; Pala, Valeria/K-4738-2016; brighenti, furio/T-4444-2019; Berrino, Franco/AAC-2364-2020; Mattiello, Amalia AM/K-5112-2016; Chiodini, Paolo/E-7290-2014; Sieri, Sabina/K-4667-2016; Agnoli, Claudia/K-5916-2016; brighenti, furio/E-4174-2010; Masala, Giovanna/AAC-5474-2022	Krogh, Vittorio/0000-0003-0122-8624; Ricceri, Fulvio/0000-0001-8749-9737; Krogh, Vittorio/0000-0003-0122-8624; Grioni, Sara/0000-0002-5891-8426; Pala, Valeria/0000-0001-5438-970X; brighenti, furio/0000-0001-8441-4611; Berrino, Franco/0000-0002-4858-1866; Mattiello, Amalia AM/0000-0003-3676-7353; Chiodini, Paolo/0000-0003-0139-2264; Sieri, Sabina/0000-0001-5201-172X; Agnoli, Claudia/0000-0003-4472-1179; brighenti, furio/0000-0001-8441-4611; Masala, Giovanna/0000-0002-5758-9069; Bendinelli, Benedetta/0000-0002-4796-1517; tumino, rosario/0000-0003-2666-414X; Sacerdote, Carlotta/0000-0002-8008-5096; Panico, Salvatore/0000-0002-5498-8312	Compagnia di San Paolo; Associazione Italiana per la Ricerca sul Cancro (AIRC)	Compagnia di San Paolo(Compagnia di San Paolo); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	EPICOR is supported by Compagnia di San Paolo. The Italian EPIC collaboration is supported by Associazione Italiana per la Ricerca sul Cancro (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryangat AV, 2010, VASC HEALTH RISK MAN, V6, P145; ASPLUND K, 1988, ACTA MED SCAND, P26; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Bao JS, 2011, AM J CLIN NUTR, V93, P984, DOI 10.3945/ajcn.110.005033; Beulens JWJ, 2007, J AM COLL CARDIOL, V50, P14, DOI 10.1016/j.jacc.2007.02.068; Brand-Miller J, 2012, CURR OPIN LIPIDOL, V23, P62, DOI 10.1097/MOL.0b013e32834ec705; Burger KNJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025955; Ebbeling CB, 2005, AM J CLIN NUTR, V81, P976; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Jenkins DJA, 2008, JAMA-J AM MED ASSOC, V300, P2742, DOI 10.1001/jama.2008.808; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Kaushik S, 2009, STROKE, V40, P206, DOI 10.1161/STROKEAHA.108.513812; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Levitan EB, 2008, METABOLISM, V57, P437, DOI 10.1016/j.metabol.2007.11.002; Levitan EB, 2007, AM J CLIN NUTR, V85, P1521, DOI 10.1093/ajcn/85.6.1521; Levitan EB, 2007, AM J CLIN NUTR, V85, P548, DOI 10.1093/ajcn/85.2.548; Liu SM, 2001, AM J CLIN NUTR, V73, P560; McMillan-Price J, 2006, ARCH INTERN MED, V166, P1466, DOI 10.1001/archinte.166.14.1466; Oba S, 2010, METABOLISM, V59, P1574, DOI 10.1016/j.metabol.2010.02.004; Oh K, 2005, AM J EPIDEMIOL, V161, P161, DOI 10.1093/aje/kwi026; Pala V, 2003, TUMORI J, V89, P594, DOI 10.1177/030089160308900603; Palli D, 2003, TUMORI, V89, P586, DOI 10.1177/030089160308900602; Pereira MA, 2004, JAMA-J AM MED ASSOC, V292, P2482, DOI 10.1001/jama.292.20.2482; Pisani P, 1997, INT J EPIDEMIOL, V26, pS152, DOI 10.1093/ije/26.suppl_1.S152; Roberts Christian K, 2009, J Diabetes Sci Technol, V3, P697; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Salvini S., 1998, BANCA DATI COMPOSIZI; Sieri S, 2010, ARCH INTERN MED, V170, P640, DOI 10.1001/archinternmed.2010.15; Sloth B, 2004, AM J CLIN NUTR, V80, P337, DOI 10.1093/ajcn/80.2.337; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wolever TMS, 2006, AM J CLIN NUTR, V83, P1306, DOI 10.1093/ajcn/83.6.1306	32	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e62625	10.1371/journal.pone.0062625	http://dx.doi.org/10.1371/journal.pone.0062625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717392	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600003
J	Yara, S; Lavoie, JC; Beaulieu, JF; Delvin, E; Amre, D; Marcil, V; Seidman, E; Levy, E				Yara, Sabrina; Lavoie, Jean-Claude; Beaulieu, Jean-Francois; Delvin, Edgard; Amre, Devendra; Marcil, Valerie; Seidman, Ernest; Levy, Emile			Iron-Ascorbate-Mediated Lipid Peroxidation Causes Epigenetic Changes in the Antioxidant Defense in Intestinal Epithelial Cells: Impact on Inflammation (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							INDUCED OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; IN-VITRO; HYDROGEN-PEROXIDE; GENE-EXPRESSION; OXYGEN RADICALS; CACO-2 CELLS; PROMOTER HYPERMETHYLATION; GLUTATHIONE-PEROXIDASE; ULCERATIVE-COLITIS	Introduction: The gastrointestinal tract is frequently exposed to noxious stimuli that may cause oxidative stress, inflammation and injury. Intraluminal pro-oxidants from ingested nutrients especially iron salts and ascorbic acid frequently consumed together, can lead to catalytic formation of oxygen-derived free radicals that ultimately overwhelm the cellular antioxidant defense and lead to cell damage. Hypothesis: Since the mechanisms remain sketchy, efforts have been exerted to evaluate the role of epigenetics in modulating components of endogenous enzymatic antioxidants in the intestine. To this end, Caco-2/15 cells were exposed to the iron-ascorbate oxygen radical-generating system. Results: Fe/Asc induced a significant increase in lipid peroxidation as reflected by the elevated formation of malondialdehyde along with the alteration of antioxidant defense as evidenced by raised superoxide dismutase 2 (SOD2) and diminished glutathione peroxidase (GPx) activities and genes. Consequently, there was an up-regulation of inflammatory processes illustrated by the activation of NF-kappa B transcription factor, the higher production of interleukin-6 and cycloxygenase-2 as well as the decrease of l kappa B. Assessment of promoter's methylation revealed decreased levels for SOD2 and increased degree for GPx2. On the other hand, pre-incubation of Caco-2/15 cells with 5-Aza-2 '-deoxycytidine, a demethylating agent, or Trolox antioxidant normalized the activities of SOD2 and GPx, reduced lipid peroxidation and prevented inflammation. Conclusion: Redox and inflammatory modifications in response to Fe/Asc -mediated lipid peroxidation may implicate epigenetic methylation.	[Yara, Sabrina; Levy, Emile] Univ Montreal, Dept Nutr, CHU St Justine, Res Ctr, Montreal, PQ H3C 3J7, Canada; [Lavoie, Jean-Claude; Amre, Devendra] Univ Montreal, Dept Pediat, CHU St Justine, Res Ctr, Montreal, PQ H3C 3J7, Canada; [Beaulieu, Jean-Francois; Seidman, Ernest; Levy, Emile] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Anat & Cellular Biol, Canadian Inst Hlth Res Team Digest Epithelium, Sherbrooke, PQ J1K 2R1, Canada; [Delvin, Edgard] Univ Montreal, Dept Biochem, CHU St Justine, Res Ctr, Montreal, PQ H3C 3J7, Canada; [Marcil, Valerie; Seidman, Ernest] McGill Univ, Res Inst, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Sherbrooke; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University	Levy, E (corresponding author), Univ Montreal, Dept Nutr, CHU St Justine, Res Ctr, Montreal, PQ H3C 3J7, Canada.	emile.levy@recherche-ste-justine.qc.ca	AMRE, DEVENDRA K/D-4988-2015; Lavoie, Jean-claude/K-2701-2016	Lavoie, Jean-claude/0000-0002-5910-0300	J. A. DeSeve Research Chair in Nutrition	J. A. DeSeve Research Chair in Nutrition	This study was supported by the J. A. DeSeve Research Chair in Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia N, 2010, J NUTR, V140, P812, DOI 10.3945/jn.109.110353; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; BABBS CF, 1992, FREE RADICAL BIO MED, V13, P169, DOI 10.1016/0891-5849(92)90079-V; Beaulieu JF, 1997, PROG HISTOCHEM CYTOC, V31, P1; Bernotti S, 2003, AM J PHYSIOL-GASTR L, V285, pG898, DOI 10.1152/ajpgi.00042.2003; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Brunet S, 2000, FREE RADICAL BIO MED, V28, P46, DOI 10.1016/S0891-5849(99)00197-5; Cartron PF, 2012, EUR J CANCER, V48, P2431, DOI 10.1016/j.ejca.2012.01.002; Chen BS, 2011, CANCER LETT, V309, P37, DOI 10.1016/j.canlet.2011.05.013; Choudhuri S, 2010, TOXICOL APPL PHARM, V245, P378, DOI 10.1016/j.taap.2010.03.022; Circu ML, 2011, FREE RADICAL RES, V45, P1245, DOI 10.3109/10715762.2011.611509; Courtois F, 2002, J NUTR, V132, P1289, DOI 10.1093/jn/132.6.1289; Courtois F, 2000, AM J PHYSIOL-GASTR L, V279, pG12, DOI 10.1152/ajpgi.2000.279.1.G12; Couto MR, 2012, CELL BIOL TOXICOL, V28, P369, DOI 10.1007/s10565-012-9228-8; CYR A, 2012, ANTIOXID REDOX SIGNA; Da Costa LA, 2012, PROG MOL BIOL TRANSL, V108, P179, DOI 10.1016/B978-0-12-398397-8.00008-3; Delie F, 1997, CRIT REV THER DRUG, V14, P221; Denis MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053725; Fatima N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041533; Fearn RA, 2006, ENVIRON TOXICOL PHAR, V21, P168, DOI 10.1016/j.etap.2005.06.002; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Gillespie MN, 2009, ANN NY ACAD SCI, V1177, P140, DOI 10.1111/j.1749-6632.2009.05036.x; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Grenier E, 2007, AM J PHYSIOL-GASTR L, V293, pG1178, DOI 10.1152/ajpgi.00295.2007; GRISHAM MB, 1988, DIGEST DIS SCI, V33, pS6, DOI 10.1007/BF01538126; Hanada N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-66; Hansen RD, 2009, MUTAT RES-FUND MOL M, V664, P13, DOI 10.1016/j.mrfmmm.2009.01.009; Hitchiler MJ, 2008, FREE RADICAL BIO MED, V45, P1573, DOI 10.1016/j.freeradbiomed.2008.09.005; Hodge DR, 2005, CANCER BIOL THER, V4, P585, DOI 10.4161/cbt.4.5.1704; Intarasunanont P, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-31; Jiang MH, 2012, AGING CELL, V11, P29, DOI 10.1111/j.1474-9726.2011.00757.x; Kankuri E, 2001, INFLAMMATION, V25, P301, DOI 10.1023/A:1012860509440; Karatug A, 2012, PEPTIDES, V33, P101, DOI 10.1016/j.peptides.2011.11.003; KINLEN LJ, 1983, BMJ-BRIT MED J, V286, P1081, DOI 10.1136/bmj.286.6371.1081; Korkmaz Ahmet, 2009, Interdiscip Toxicol, V2, P219, DOI 10.2478/v10102-009-0020-4; KretzRemy C, 1996, J CELL BIOL, V133, P1083, DOI 10.1083/jcb.133.5.1083; Kruidenier L, 2003, J PATHOL, V201, P28, DOI 10.1002/path.1409; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Levy E, 2007, AM J PHYSIOL-GASTR L, V293, pG1252, DOI 10.1152/ajpgi.00369.2007; Levy E, 2011, ARTERIOSCL THROM VAS, V31, P2692, DOI 10.1161/ATVBAHA.111.233908; Li RG, 2009, B ENVIRON CONTAM TOX, V82, P419, DOI 10.1007/s00128-008-9599-y; Li Y, 2012, CARCINOGENESIS, V33, P1889, DOI 10.1093/carcin/bgs214; Linley E, 2012, J ANTIMICROB CHEMOTH, V67, P1589, DOI 10.1093/jac/dks129; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; Marcil V, 2010, J BIOL CHEM, V285, P40448, DOI 10.1074/jbc.M110.155358; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Nadif R, 2005, FREE RADICAL RES, V39, P1345, DOI 10.1080/10715760500306711; Nishiyama R, 2005, MOL CANCER RES, V3, P617, DOI 10.1158/1541-7786.MCR-05-0146; Ntimbane Thierry, 2009, Clin Biochem Rev, V30, P153; O'Sullivan AM, 2012, FOOD CHEM, V134, P1137, DOI 10.1016/j.foodchem.2012.02.205; Okayasu I, 2012, PATHOL INT, V62, P368, DOI 10.1111/j.1440-1827.2012.02807.x; Ozkaya D, 2011, CELL BIOCHEM FUNCT, V29, P287, DOI 10.1002/cbf.1749; PARKS DA, 1989, GUT, V30, P293, DOI 10.1136/gut.30.3.293; PARKS DA, 1988, AM J PHYSIOL, V254, pG768, DOI 10.1152/ajpgi.1988.254.5.G768; PARKS DA, 1983, SURGERY, V94, P415; Patel K, 2010, NUCLEIC ACIDS RES, V38, P4313, DOI 10.1093/nar/gkq187; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Precourt LP, 2012, AM J PHYSIOL-GASTR L, V303, pG623, DOI 10.1152/ajpgi.00039.2012; Precourt LP, 2009, INT J BIOCHEM CELL B, V41, P1628, DOI 10.1016/j.biocel.2009.02.013; Rosenblum JS, 1996, P NATL ACAD SCI USA, V93, P4471, DOI 10.1073/pnas.93.9.4471; Rubas W, 1996, J PHARM SCI, V85, P165, DOI 10.1021/js950267+; Ryan Julie L, 2010, Infect Agent Cancer, V5, P27, DOI 10.1186/1750-9378-5-27; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; Schneider-Stock R, 2005, J PHARMACOL EXP THER, V312, P525, DOI 10.1124/jpet.104.074195; Sefi M, 2011, J ETHNOPHARMACOL, V135, P243, DOI 10.1016/j.jep.2011.02.029; Simon-Assman P, 2007, CELL BIOL TOXICOL, V23, P241, DOI 10.1007/s10565-006-0175-0; Singh KP, 2012, CANCER LETT, V316, P62, DOI 10.1016/j.canlet.2011.10.022; STEVENS RG, 1994, INT J CANCER, V56, P364, DOI 10.1002/ijc.2910560312; Taha R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011817; Thaler R, 2009, BRIT J NUTR, V101, P743, DOI 10.1017/S0007114508047685; Trudel K, 2005, J CELL BIOCHEM, V96, P404, DOI 10.1002/jcb.20542; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vaziri ND, 2012, CURR OPIN NEPHROL HY, V21, P587, DOI 10.1097/MNH.0b013e328358c8d5; Wallace JL, 2001, GASTROENTEROL CLIN N, V30, P971, DOI 10.1016/S0889-8553(05)70223-5; Welch KD, 2002, FREE RADICAL BIO MED, V32, P577, DOI 10.1016/S0891-5849(02)00760-8; Williams MV, 2006, J BIOL CHEM, V281, P10127, DOI 10.1074/jbc.M600178200; Yanagisawa Y, 2002, BBA-GENE STRUCT EXPR, V1577, P457, DOI 10.1016/S0167-4781(02)00482-7; Zhai XH, 2013, MOL NUTR FOOD RES, V57, P249, DOI 10.1002/mnfr.201200536; Zhang JF, 2013, EXP THER MED, V5, P735, DOI 10.3892/etm.2013.901; Zhang WJ, 2010, EXP BIOL MED, V235, P633, DOI 10.1258/ebm.2009.009229; Zhao XM, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.014; Zhu H, 2012, EXP BIOL MED, V237, P474, DOI 10.1258/ebm.2011.011358; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	87	29	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63456	10.1371/journal.pone.0063456	http://dx.doi.org/10.1371/journal.pone.0063456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717425	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700022
J	Bosque, PJ; Boyer, PJ; Mishra, P				Bosque, Patrick J.; Boyer, Philip J.; Mishra, Priya			A 43-kDa TDP-43 Species Is Present in Aggregates Associated with Frontotemporal Lobar Degeneration	PLOS ONE			English	Article							DNA-BINDING PROTEIN-43; C-TERMINAL FRAGMENTS; TARDBP MUTATIONS; PRION; DISEASE; INCLUSIONS; PHOSPHORYLATION; NEUROPATHOLOGY; CLEAVAGE; BRAIN	The transactive response DNA-binding protein (TDP-43) is a major component of the abnormal intracellular inclusions that occur in two common neurodegenerative diseases of humans: (1) a subtype of frontotemporal lobar degeneration and (2) amyotrophic lateral sclerosis. Genetics, experiments in cultured cells and animals, and analogy with other neurodegenerative diseases indicate that the process of TDP-43 aggregation is fundamental to the pathogenesis of these 2 diseases, but the process by which this aggregation occurs is not understood. Biochemical fractionation has revealed truncated, phosphorylated and ubiquitinated forms of TDP-43 in a detergent-insoluble fraction from diseased CNS tissue, while these forms are absent from controls. However, a large amount of the normally predominant 43-kDa form of TDP-43 is present in the detergent-insoluble fraction even from control brains, so it has not been possible to determine if this form of TDP-43 is part of pathological aggregates in frontotemporal lobe degeneration. We used semi-denaturing detergent-agarose gel electrophoresis to isolate high molecular weight aggregates containing TDP-43 that are present in the cerebral cortex of individuals with frontotemporal lobar degeneration but not that of controls. These aggregates include the same covalently modified forms of TDP-43 seen in detergent-insoluble extracts. In addition, aggregates include a 43-kDa TDP-43 species. This aggregated 43-kDa form of TDP-43 is absent or present only at low levels in controls. The presence of 43-kDa TDP-43 in aggregates raises the possibility that covalent modification is not a primary step in the pathogenic aggregation of TDP-43 associated with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.	[Bosque, Patrick J.; Mishra, Priya] Denver Hlth Med Ctr, Div Neurol, Denver, CO USA; [Bosque, Patrick J.; Mishra, Priya] Univ Denver, Eleanor Roosevelt Inst, Denver, CO USA; [Bosque, Patrick J.; Boyer, Philip J.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Boyer, Philip J.] Univ Colorado, Sch Med, Dept Neuropathol, Aurora, CO USA	Denver Health Medical Center; University of Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Bosque, PJ (corresponding author), Denver Hlth Med Ctr, Div Neurol, Denver, CO USA.	patrick.bosque@dhha.org			National Institutes of Health grant [R21 NS054754-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054754] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were funded by National Institutes of Health grant R21 NS054754-01A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MATHEMATICA; Bagriantsev S, 2004, J BIOL CHEM, V279, P51042, DOI 10.1074/jbc.M410611200; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hoffman MD, 2008, ANAL CHIM ACTA, V627, P50, DOI 10.1016/j.aca.2008.03.032; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kim YS, 2001, J BIOL CHEM, V276, P1626, DOI 10.1074/jbc.M007766200; Knopman DS, 2011, J MOL NEUROSCI; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lipton AM, 2004, ACTA NEUROPATHOL, V108, P379, DOI 10.1007/s00401-004-0900-9; Liu T, 2008, J PROTEOME RES, V7, P4256, DOI 10.1021/pr800182b; Mackenzie IRA, 2006, ACTA NEUROPATHOL, V112, P551, DOI 10.1007/s00401-006-0123-3; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Ritchie DL, 2004, NEUROPATH APPL NEURO, V30, P360, DOI 10.1111/j.1365-2990.2003.00544.x; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; Seelaar H, 2010, J NEUROL, V257, P747, DOI 10.1007/s00415-009-5404-z; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Taniguchi S, 2004, NEUROPATH APPL NEURO, V30, P1, DOI 10.1046/j.0305-1846.2003.00481.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33	39	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62301	10.1371/journal.pone.0062301	http://dx.doi.org/10.1371/journal.pone.0062301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704877	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200006
J	Gaquerel, E; Kotkar, H; Onkokesung, N; Galis, I; Baldwin, IT				Gaquerel, Emmanuel; Kotkar, Hemlata; Onkokesung, Nawaporn; Galis, Ivan; Baldwin, Ian T.			Silencing an N-Acyltransferase-Like Involved in Lignin Biosynthesis in Nicotiana attenuata Dramatically Alters Herbivory-Induced Phenolamide Metabolism	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MEDIATED DEFENSES; DOWN-REGULATION; PATHWAY; ACCUMULATION; EVOLUTION; SHIKIMATE; GENES	In a transcriptomic screen of Manduca sexta-induced N-acyltransferases in leaves of Nicotiana attenuata, we identified an N-acyltransferase gene sharing a high similarity with the tobacco lignin-biosynthetic hydroxycinnamoyl-CoA: shikimate/quinate hydroxycinnamoyl transferase (HCT) gene whose expression is controlled by MYB8, a transcription factor that regulates the production of phenylpropanoid polyamine conjugates (phenolamides, PAs). To evaluate the involvement of this HCT-like gene in lignin production as well as the resulting crosstalk with PA metabolism during insect herbivory, we transiently silenced (by VIGs) the expression of this gene and performed non-targeted (UHPLC-ESI/TOF-MS) metabolomics analyses. In agreement with a conserved function of N. attenuata HCT-like in lignin biogenesis, HCT-silenced plants developed weak, soft stems with greatly reduced lignin contents. Metabolic profiling demonstrated large shifts (up to 12% deregulation in total extracted ions in insect-attacked leaves) due to a large diversion of activated coumaric acid units into the production of developmentally and herbivory-induced coumaroyl-containing PAs (N', N ''-dicoumaroylspermidine, N', N ''-coumaroylputrescine, etc) and to minor increases in the most abundant free phenolics (chlorogenic and cryptochlorogenic acids), all without altering the production of well characterized herbivory-responsive caffeoyl-and feruloyl-based putrescine and spermidine PAs. These data are consistent with a strong metabolic tension, exacerbated during herbivory, over the allocation of coumaroyl-CoA units among lignin and unusual coumaroyl-containing PAs, and rule out a role for HCT-LIKE in tuning the herbivory-induced accumulation of other PAs. Additionally, these results are consistent with a role for lignification as an induced anti-herbivore defense.	[Gaquerel, Emmanuel; Kotkar, Hemlata; Onkokesung, Nawaporn; Galis, Ivan; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany; [Kotkar, Hemlata] Natl Chem Lab, CSIR, Div Biochem Sci, Plant Mol Biol Unit, Pune, Maharashtra, India; [Galis, Ivan] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan	Max Planck Society; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Okayama University	Gaquerel, E (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	egaquerel@ice.mpg.de; baldwin@ice.mpg.de	Galis, Ivan/F-5734-2011; Baldwin, Ian T/K-1809-2013; Gaquerel, Emmanuel/I-2503-2014; Gaquerel, Emmanuel/ABE-6313-2020	Gaquerel, Emmanuel/0000-0003-0796-6417; Gaquerel, Emmanuel/0000-0003-0796-6417; Galis, Ivan/0000-0001-9840-8845; Onkokesung, Nawaporn/0000-0002-5094-5788; Baldwin, Ian/0000-0001-5371-2974	Max Planck Society; European Research Council [293926]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission)	This research was supported by the Max Planck Society. The Max Planck Society also provided a Max Planck-India Visiting Fellowship for H. Kotkar to conduct experiments at MPI-CE in Jena. The work of Emmanuel Gaquerel is funded by Advanced Grant No 293926 of the European Research Council to Ian T. Baldwin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2002, PLANT PHYSIOL, V128, P844, DOI 10.1104/pp.010698; Bassard JE, 2010, PHYTOCHEMISTRY, V71, P1808, DOI 10.1016/j.phytochem.2010.08.003; Berenbaum MR, 2008, PLANT PHYSIOL, V146, P804, DOI 10.1104/pp.107.113472; Besseau S, 2007, PLANT CELL, V19, P148, DOI 10.1105/tpc.106.044495; BLECHERT S, 1995, P NATL ACAD SCI USA, V92, P4099, DOI 10.1073/pnas.92.10.4099; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Diezel C, 2011, PLANT PHYSIOL, V155, P1936, DOI 10.1104/pp.110.170936; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; Galis I, 2006, PLANT J, V46, P573, DOI 10.1111/j.1365-313X.2006.02719.x; Gaquerel E, 2010, J AGR FOOD CHEM, V58, P9418, DOI 10.1021/jf1017737; Goujon T, 2003, PLANT MOL BIOL, V51, P973, DOI 10.1023/A:1023022825098; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Keinanen M, 2001, J AGR FOOD CHEM, V49, P3553, DOI 10.1021/jf010200+; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; Mitra S, 2008, PLANT PHYSIOL, V148, P1128, DOI 10.1104/pp.108.124354; MUELLER MJ, 1993, P NATL ACAD SCI USA, V90, P7490, DOI 10.1073/pnas.90.16.7490; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; Onkokesung N, 2012, PLANT PHYSIOL, V158, P389, DOI 10.1104/pp.111.187229; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Sansone SA, 2007, NAT BIOTECHNOL, V25, P844, DOI 10.1038/nbt0807-846b; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Shadle G, 2007, PHYTOCHEMISTRY, V68, P1521, DOI 10.1016/j.phytochem.2007.03.022; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Steppuhn A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-171; Sundin L, 2012, PLANT CELL; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319	32	17	17	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62336	10.1371/journal.pone.0062336	http://dx.doi.org/10.1371/journal.pone.0062336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704878	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200007
J	Maurin, H; Seymour, CM; Lechat, B; Borghgraef, P; Devijver, H; Jaworski, T; Schmidt, MV; Kuegler, S; Van Leuven, F				Maurin, Herve; Seymour, Claire Marie; Lechat, Benoit; Borghgraef, Peter; Devijver, Herman; Jaworski, Tomasz; Schmidt, Mathias V.; Kuegler, Sebastian; Van Leuven, Fred			Tauopathy Differentially Affects Cell Adhesion Molecules in Mouse Brain: Early Down-Regulation of Nectin-3 in Stratum Lacunosum Moleculare	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; UP-REGULATION; MEMORY; TAU; NCAM; CA1; HIPPOCAMPUS	Cell adhesion molecules are important structural substrates, required for synaptic plasticity and synaptogenesis. CAMs differ widely in their expression throughout different brain regions and their specific structural and functional roles in the brain remain to be elucidated. Here, we investigated selected cell adhesion molecules for alterations in expression levels and neuronal localization in validated mouse models for Alzheimer's disease that mimic the age-related progression of amyloid accumulation and tauopathy. Among the cell adhesion molecules analyzed, Nectin-3 expression was affected most and specifically in all mouse models with tauopathy. In particular was Nectin-3 depleted from the specific region of the hippocampus, known as the stratum lacunosum and moleculare, in mice that express wild-type or mutant human protein Tau, either chronically or sub-acutely. Tauopathy progresses from the entorhinal cortex to the hippocampus by unknown mechanisms that could involve transport by the myelinated axons of the temporoammonic and perforant pathways. The decreased expression of Nectin-3 in the stratum lacunosum moleculare is an early marker of impaired transport, and eventual synaptic problems, caused by beginning tauopathy.	[Maurin, Herve; Seymour, Claire Marie; Lechat, Benoit; Borghgraef, Peter; Devijver, Herman; Jaworski, Tomasz; Van Leuven, Fred] KULeuven, Dept Human Genet, Expt Genet Grp LEGTEGG, Louvain, Belgium; [Schmidt, Mathias V.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Kuegler, Sebastian] Mol Physiol Brain CMPB, Gottingen, Germany	KU Leuven; Max Planck Society	Van Leuven, F (corresponding author), KULeuven, Dept Human Genet, Expt Genet Grp LEGTEGG, Louvain, Belgium.	fred.vanleuven@med.kuleuven.be	Seymour, Claire M/B-6758-2008	Schmidt, Mathias/0000-0002-3788-2268; Jaworski, Tomasz/0000-0002-6387-9249	Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen); Instituut Wetenschap Techniek (IWT); EEC 6th & 7th Framework Program (MEMStick); EEC 6th & 7th Framework Program (neuroGSK3); EEC 6th & 7th Framework Program (EURON); EEC 6th & 7th Framework Program (NEURAD); de Rooms-fund; KULeuven-Research Fund; KULeuven-ResearchDevelopment; Marie Curie fellowship [MEST CT 2005/020013 NEURAD]	Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen)(FWO); Instituut Wetenschap Techniek (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); EEC 6th & 7th Framework Program (MEMStick); EEC 6th & 7th Framework Program (neuroGSK3); EEC 6th & 7th Framework Program (EURON); EEC 6th & 7th Framework Program (NEURAD); de Rooms-fund; KULeuven-Research Fund(KU Leuven); KULeuven-ResearchDevelopment; Marie Curie fellowship(European Commission)	The authors thank many collaborators and fellow scientists for technical assistance, advice, materials, and scientific and moral support. These investigations were funded and supported by Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen); Instituut Wetenschap & Techniek (IWT); EEC 6th & 7th Framework Programs (MEMStick, neuroGSK3, EURON, NEURAD); de Rooms-fund; KULeuven-Research Fund; KULeuven-Research&Development. HM acknowledges Marie Curie fellowship MEST CT 2005/020013 NEURAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Braak E, 1997, ACTA NEUROPATHOL, V93, P323, DOI 10.1007/s004010050622; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Chung SH, 2009, BMB REP, V42, P467, DOI 10.5483/BMBRep.2009.42.8.467; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Florian C, 2006, LEARN MEMORY, V13, P335, DOI 10.1101/lm.187506; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Foley AG, 2000, J NEUROCHEM, V74, P2607, DOI 10.1046/j.1471-4159.2000.0742607.x; FOX GB, 1995, J NEUROCHEM, V65, P2796; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; Ito HT, 2012, HIPPOCAMPUS, V22, P372, DOI 10.1002/hipo.20909; Jaworski T, 2010, INT J ALZHEIMERS DIS, V2010; Jaworski T, 2011, NATURE, V480, pE4, DOI 10.1038/nature10615; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Jaworski T, 2010, BBA-MOL BASIS DIS, V1802, P808, DOI 10.1016/j.bbadis.2010.03.005; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; Kajiwara R, 2008, HIPPOCAMPUS, V18, P266, DOI 10.1002/hipo.20385; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kerchner GA, 2012, NEUROIMAGE, V63, P194, DOI 10.1016/j.neuroimage.2012.06.048; Kim J, 2010, J BIOL CHEM, V285, P22917, DOI 10.1074/jbc.M110.126649; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Kremer A, 2011, J NEUROSCI, V31, P18036, DOI 10.1523/JNEUROSCI.4859-11.2011; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Kunzi V, 2002, J NEUROSCI, V22, P7471; Lace G, 2009, BRAIN, V132, P1324, DOI 10.1093/brain/awp059; Lim ST, 2008, J COMP NEUROL, V507, P1228, DOI 10.1002/cne.21608; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; MACKIE K, 1989, J NEUROSCI, V9, P1883; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; MIZUTANI T, 1995, NEUROSCI LETT, V184, P141, DOI 10.1016/0304-3940(94)11190-T; Moechars D, 1999, NEUROSCIENCE, V91, P819, DOI 10.1016/S0306-4522(98)00599-5; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Muyllaert D, 2006, REV NEUROL-FRANCE, V162, P903, DOI 10.1016/S0035-3787(06)75098-6; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; REYES AA, 1991, MOL CELL BIOL, V11, P1654, DOI 10.1128/MCB.11.3.1654; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Ronn LCB, 2000, INT J DEV NEUROSCI, V18, P193, DOI 10.1016/S0736-5748(99)00088-X; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; Schmued L, 2008, BRAIN RES, V1229, P210, DOI 10.1016/j.brainres.2008.06.129; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Seymour CM, 2008, NEUROSCIENCE, V157, P813, DOI 10.1016/j.neuroscience.2008.09.041; SPACEK J, 1974, J ANAT, V117, P487; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Spittaels K, 2002, NEUROSCIENCE, V113, P797, DOI 10.1016/S0306-4522(02)00236-1; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Takashima Akihiko, 2012, Front Mol Neurosci, V5, P47, DOI 10.3389/fnmol.2012.00047; Tanghe A, 2010, INT J ALZHEIMERS DIS, V2010; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Van Dorpe J, 2000, AM J PATHOL, V157, P1283, DOI 10.1016/S0002-9440(10)64644-5; Venero C, 2006, EUR J NEUROSCI, V23, P1585, DOI 10.1111/j.1460-9568.2006.04663.x; Wang XD, 2011, NEUROBIOL DIS, V42, P300, DOI 10.1016/j.nbd.2011.01.020; WITTER MP, 1988, NEUROSCI LETT, V85, P193, DOI 10.1016/0304-3940(88)90350-3; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zelano J, 2006, EXP NEUROL, V201, P461, DOI 10.1016/j.expneurol.2006.04.026	72	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63589	10.1371/journal.pone.0063589	http://dx.doi.org/10.1371/journal.pone.0063589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704923	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200054
J	Stegger, M; Aziz, M; Chroboczek, T; Price, LB; Ronco, T; Kiil, K; Skov, RL; Laurent, F; Andersen, PS				Stegger, Marc; Aziz, Maliha; Chroboczek, Tomasz; Price, Lance B.; Ronco, Troels; Kiil, Kristoffer; Skov, Robert L.; Laurent, Frederic; Andersen, Paal S.			Genome Analysis of Staphylococcus aureus ST291, a Double Locus Variant of ST398, Reveals a Distinct Genetic Lineage	PLOS ONE			English	Article							COMMUNITY; SEQUENCE; INFECTIONS; SPREAD; HOST	Staphylococcus aureus ST291 has been reported as a homologue recombinant double locus variant of the livestock associated S. aureus ST398. However, whole genome sequencing show that ST291 is a unique genetic lineage with highly variable content within its accessory genome compared to both human and livestock associated genome sequenced CC398s.	[Stegger, Marc; Ronco, Troels; Kiil, Kristoffer; Skov, Robert L.; Andersen, Paal S.] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Stegger, Marc; Aziz, Maliha; Price, Lance B.; Andersen, Paal S.] Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ USA; [Price, Lance B.] George Washington Univ, Dept Environm & Occupat Hlth, Washington, DC USA; [Chroboczek, Tomasz; Laurent, Frederic] Hop Croix Rousse, Inserm U851, Natl Reference Ctr Staphylococci, Bacteriol Lab, F-69317 Lyon, France	Statens Serum Institut; Translational Genomics Research Institute; George Washington University; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Stegger, M (corresponding author), Statens Serum Inst, DK-2300 Copenhagen, Denmark.	mtg@ssi.dk	Andersen, Paal S/H-2087-2015; Skov, Robert/ABB-3105-2020; Chroboczek, Jadwiga/M-6554-2014; Laurent, Frederic/M-4719-2014; LAURENT, Frederic/AGM-0706-2022	Andersen, Paal S/0000-0001-5656-0427; Skov, Robert/0000-0002-6079-5381; Stegger, Marc/0000-0003-0321-1180; laurent, frederic/0000-0003-0609-9091				Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Cafiso V, 2010, EUR J CLIN MICROBIOL, V29, P1277, DOI 10.1007/s10096-010-1000-5; Green SM, 2010, J MED MICROBIOL, V59, P1084, DOI 10.1099/jmm.0.018986-0; Hallin PF, 2009, STAND GENOMIC SCI, V1, P204, DOI 10.4056/sigs.28177; Havaei SA, 2011, J CLIN MICROBIOL, V49, P3990, DOI 10.1128/JCM.05445-11; Kechrid A, 2011, CLIN MICROBIOL INFEC, V17, P1020, DOI 10.1111/j.1469-0691.2010.03367.x; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; McCarthy AJ, 2011, GENOME BIOL EVOL, V3, P1164, DOI 10.1093/gbe/evr092; Mediavilla JR, 2012, EMERG INFECT DIS, V18, P700, DOI 10.3201/eid1804.111419; Moon SY, 2010, MICROB DRUG RESIST, V16, P217, DOI 10.1089/mdr.2010.0010; Munro P, 2010, INFECT IMMUN, V78, P3404, DOI 10.1128/IAI.00319-10; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rasigade JP, 2010, J INFECT DIS, V201, P1589, DOI 10.1086/652008; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Sakwinska O, 2009, APPL ENVIRON MICROB, V75, P175, DOI 10.1128/AEM.01860-08; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Shambat S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-64; Stegger M, 2012, J BACTERIOL, V194, P1625, DOI 10.1128/JB.06653-11; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tokajian S, 2011, ISRN MICROBIOLOGY, V2011; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x	26	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63008	10.1371/journal.pone.0063008	http://dx.doi.org/10.1371/journal.pone.0063008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704886	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200015
J	Tram, E; Savas, S; Ozcelik, H				Tram, Eric; Savas, Sevtap; Ozcelik, Hilmi			Missense Variants of Uncertain Significance (VUS) Altering the Phosphorylation Patterns of BRCA1 and BRCA2	PLOS ONE			English	Article							OVARIAN-CANCER; DEPENDENT PHOSPHORYLATION; FUNCTIONAL-ANALYSIS; SEQUENCE VARIANTS; IN-VIVO; BREAST; KINASE; ATM; MUTATIONS; GENE	Mutations in BRCA1 and BRCA2 are responsible for a large proportion of breast-ovarian cancer families. Protein-truncating mutations have been effectively used in the clinical management of familial breast cancer due to their deleterious impact on protein function. However, the majority of missense variants identified throughout the genes continue to pose an obstacle for predictive informative testing due to low frequency and lack of information on how they affect BRCA1/2 function. Phosphorylation of BRCA1 and BRCA2 play an important role in their function as regulators of DNA repair, transcription and cell cycle in response to DNA damage but whether missense variants of uncertain significance (VUS) are able to disrupt this important process is not known. Here we employed a novel approach using NetworKIN which predicts in vivo kinase-substrate relationship, and evolutionary conservation algorithms SIFT, PolyPhen and Align-GVGD. We evaluated whether 191 BRCA1 and 43 BRCA2 VUS from the Breast Cancer Information Core (BIC) database can functionally alter the consensus phosphorylation motifs and abolish kinase recognition and binding to sites known to be phosphorylated in vivo. Our results show that 13.09% (25/191) BRCA1 and 13.95% (6/43) BRCA2 VUS altered the phosphorylation of BRCA1 and BRCA2. We highlight six BRCA1 (K309T, S632N, S1143F, Q1144H, Q1281P, S1542C) and three BRCA2 (S196I, T207A, P3292L) VUS as potentially clinically significant. These occurred rarely (n<2 in BIC), mutated evolutionarily conserved residues and abolished kinase binding to motifs established in the literature involved in DNA repair, cell cycle regulation, transcription or response to DNA damage. Additionally in vivo phosphorylation sites identified via through-put methods are also affected by VUS and are attractive targets for studying their biological and functional significance. We propose that rare VUS affecting phosphorylation may be a novel and important mechanism for which BRCA1 and BRCA2 functions are disrupted in breast cancer.	[Tram, Eric; Savas, Sevtap; Ozcelik, Hilmi] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Ozcelik, Hilmi] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Tram, Eric; Savas, Sevtap; Ozcelik, Hilmi] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Ozcelik, H (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	ozcelik@lunenfeld.ca		Savas, Sevtap/0000-0002-7324-938X	Canadian Breast Cancer Foundation (CBCF), Toronto, Canada; Canadian Institutes of Health Research (CIHR), Toronto, Canada	Canadian Breast Cancer Foundation (CBCF), Toronto, Canada; Canadian Institutes of Health Research (CIHR), Toronto, Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Breast Cancer Foundation (CBCF) (HO) and Canadian Institutes of Health Research (CIHR) (HO), Toronto, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaroe J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2472; Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Au WWY, 2007, CELL SIGNAL, V19, P1879, DOI 10.1016/j.cellsig.2007.04.010; Bennetzen MV, 2010, MOL CELL PROTEOMICS, V9, P1314, DOI 10.1074/mcp.M900616-MCP200; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Carvalho MA, 2007, INT J BIOCHEM CELL B, V39, P298, DOI 10.1016/j.biocel.2006.08.002; Chen L, 2010, J PROTEOME RES, V9, P174, DOI 10.1021/pr900338q; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Fleming MA, 2003, P NATL ACAD SCI USA, V100, P1151, DOI 10.1073/pnas.0237285100; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; Gatei M, 2000, CANCER RES, V60, P3299; Gatei M, 2001, J BIOL CHEM, V276, P17276, DOI 10.1074/jbc.M011681200; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hayes F, 2000, CANCER RES, V60, P2411; Hinton CV, 2007, EXP CELL RES, V313, P1735, DOI 10.1016/j.yexcr.2007.03.008; Hjerrild M, 2004, J PROTEOME RES, V3, P426, DOI 10.1021/pr0341033; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Humphrey JS, 1997, P NATL ACAD SCI USA, V94, P5820, DOI 10.1073/pnas.94.11.5820; Johnson LN, 1996, CURR OPIN STRUC BIOL, V6, P762, DOI 10.1016/S0959-440X(96)80005-4; Kehn K, 2007, ONCOGENE, V26, P5060, DOI 10.1038/sj.onc.1210319; Kreegipuu A, 1998, FEBS LETT, V430, P45, DOI 10.1016/S0014-5793(98)00503-1; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lin HR, 2003, J BIOL CHEM, V278, P35979, DOI 10.1074/jbc.M210659200; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Marx J, 2001, SCIENCE, V292, P426, DOI 10.1126/science.292.5516.426; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Mirkovic N, 2004, CANCER RES, V64, P3790, DOI 10.1158/0008-5472.CAN-03-3009; Monteiro ANA, 2006, CANCER RES, V66, P1897, DOI 10.1158/0008-5472.CAN-05-3034; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; O'Brien KA, 1999, BIOCHEM BIOPH RES CO, V260, P658, DOI 10.1006/bbrc.1999.0892; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; PEPPERKOK R, 1994, J BIOL CHEM, V269, P6986; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ramus SJ, 2009, MOL ONCOL, V3, P138, DOI 10.1016/j.molonc.2009.02.001; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Ruffner H, 1999, MOL CELL BIOL, V19, P4843; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sankaran S, 2007, CANCER RES, V67, P11186, DOI 10.1158/0008-5472.CAN-07-2578; Savas S, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-107; Savas S, 2007, PHYSIOL GENOMICS, V29, P109, DOI 10.1152/physiolgenomics.00226.2006; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xu B, 2002, CANCER RES, V62, P4588; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	74	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62468	10.1371/journal.pone.0062468	http://dx.doi.org/10.1371/journal.pone.0062468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704879	Green Published, gold, Green Accepted			2022-12-27	WOS:000319330200008
J	Yang, M; Virassamy, B; Vijayaraj, SL; Lim, Y; Saadipour, K; Wang, YJ; Han, YC; Zhong, JH; Morales, CR; Zhou, XF				Yang, Miao; Virassamy, Balaji; Vijayaraj, Swarna Lekha; Lim, Yoon; Saadipour, Khalil; Wang, Yan-Jiang; Han, Yan-Chuang; Zhong, Jin-Hua; Morales, Carlos R.; Zhou, Xin-Fu			The Intracellular Domain of Sortilin Interacts with Amyloid Precursor Protein and Regulates Its Lysosomal and Lipid Raft Trafficking	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; BETA-SECRETASE; GOLGI; APP; PHOSPHORYLATION; SORLA/LR11; RECEPTORS; NEURONS; BINDING	The processing of Amyloid precursor protein (APP) is multifaceted, comprising of protein transport, internalization and sequential proteolysis. However, the exact mechanism of APP intracellular trafficking and distribution remains unclear. To determine the interaction between sortilin and APP and the effect of sortilin on APP trafficking and processing, we studied the binding site and its function by mapping experiments, colocalization, coimmunoprecipitation and sucrose gradient fractionation. We identified for the first time that sortilin interacts with APP at both N- and C-terminal regions. The sortilin-FLVHRY (residues 787-792) and APP-NPTYKFFE (residues 759-766) motifs are crucial for the C-terminal interaction. We also found that lack of the FLVHRY motif reduces APP lysosomal targeting and increases APP distribution in lipid rafts in co-transfected HEK293 cells. These results are consistent with our in vivo data where sortilin knockout mice showed a decrease of APP lysosomal distribution and an increase of APP in lipid rafts. We further confirmed that overexpression of sortilin-FLVHRY mutants failed to rescue the lysosomal degradation of APP. Thus, our data suggests that sortilin is implicated in APP lysosomal and lipid raft targeting via its carboxyl-terminal F/YXXXXF/Y motif. Our study provides new molecular insights into APP trafficking and processing.	[Yang, Miao; Lim, Yoon; Han, Yan-Chuang; Zhong, Jin-Hua; Zhou, Xin-Fu] Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Yang, Miao; Virassamy, Balaji; Vijayaraj, Swarna Lekha; Saadipour, Khalil; Zhou, Xin-Fu] Flinders Univ South Australia, Dept Human Physiol, Adelaide, SA, Australia; [Wang, Yan-Jiang] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing, Peoples R China; [Morales, Carlos R.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	University of South Australia; Flinders University South Australia; Army Medical University; McGill University	Yang, M (corresponding author), Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	miao.yang@unisa.edu.au	Wang, Yanjiang/F-3703-2012; Zhou, Xiaofang/C-6169-2013; zhou, xin-fu/F-4119-2013	Wang, Yanjiang/0000-0002-6227-6112; Zhou, Xiaofang/0000-0001-6343-1455; zhou, xin-fu/0000-0002-8687-0175; Lim, Yoon/0000-0003-1110-1969	NHMRC [595937, 488022]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by NHMRC grants (595937, 488022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; COLE GM, 1992, ANN NY ACAD SCI, V674, P103; De Strooper B, 2000, J CELL SCI, V113, P1857; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Finan GM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.170217; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Hampe W, 2001, HUM GENET, V108, P529, DOI 10.1007/s004390100504; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Hung YH, 2009, J BIOL CHEM, V284, P21899, DOI 10.1074/jbc.M109.019521; Kaether C, 2004, J CELL BIOL, V167, P809, DOI 10.1083/jcb.200410090; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kwon S, 2011, J BIOL CHEM, V286, P21876, DOI 10.1074/jbc.M111.228262; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Lorenzen A, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-11; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mazella J, 2001, CELL SIGNAL, V13, P1, DOI 10.1016/S0898-6568(00)00130-3; Ni XY, 2006, TRAFFIC, V7, P889, DOI 10.1111/j.1600-0854.2006.00429.x; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Ono Y, 1997, J BIOCHEM-TOKYO, V121, P585; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yang M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.195347	46	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63049	10.1371/journal.pone.0063049	http://dx.doi.org/10.1371/journal.pone.0063049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704887	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000319330200016
J	Agrawal, V; Smart, K; Jilling, T; Hirsch, E				Agrawal, Varkha; Smart, Keith; Jilling, Tamas; Hirsch, Emmet			Surfactant Protein (SP)-A Suppresses Preterm Delivery and Inflammation via TLR2	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE PRODUCTION; TOLL-LIKE RECEPTORS; CELLULAR-RESPONSE; MURINE MODEL; LABOR; INFECTION; FETAL; MACROPHAGES; ACTIVATION	Toll like receptors (TLRs) are pattern-recognition molecules that initiate the innate immune response to pathogens. Pulmonary surfactant protein (SP)-A is an endogenously produced ligand for TLR2 and TLR4. SP-A has been proposed as a fetally produced signal for the onset of parturition in the mouse. We examined the effect of interactions between SP-A and the pathogenic TLR agonists lipopolysaccharide (LPS), peptidoglycan (PGN) and polyinosinic:cytidylic acid (poly(I:C)) (ligands for TLR4, TLR2 and TLR3, respectively) on the expression of inflammatory mediators and preterm delivery. Three types of mouse macrophages (the cell line RAW 264.7, and fresh amniotic fluid and peritoneal macrophages, including macrophages from TLR4 and TLR2 knockout mice) were treated for up to 7 hours with pathogenic TLR agonists with or without SP-A. SP-A alone had no effect upon inflammatory mediators in mouse macrophages and did not independently induce preterm labor. SP-A significantly suppressed TLR ligand-induced expression of inflammatory mediators (interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha and the chemokine CCL5) via a TLR2 dependent mechanism. In a mouse inflammation-induced preterm delivery model, intrauterine administration of SP-A significantly inhibited preterm delivery, suppressed the expression of proinflammatory mediators and enhanced the expression of the CXCL1 and anti-inflammatory mediator IL-10. We conclude that SP-A acts via TLR2 to suppress TLR ligand-induced preterm delivery and inflammatory responses.	[Agrawal, Varkha; Smart, Keith; Hirsch, Emmet] NorthShore Univ HealthSyst, Dept Obstet & Gynecol, Evanston, IL USA; [Hirsch, Emmet] Univ Chicago, Pritzker Sch Med, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Jilling, Tamas] NorthShore Univ HealthSyst, Dept Pediat, Evanston, IL USA	NorthShore University Health System; University of Chicago; NorthShore University Health System	Agrawal, V (corresponding author), NorthShore Univ HealthSyst, Dept Obstet & Gynecol, Evanston, IL USA.	varkhaagrawal@gmail.com		Jilling, Tamas/0000-0002-6200-3851	NIH [1R01 HD056118, 3R01HD056118-03S1]; March of Dimes Birth Defects Foundation [21-FY10-202]; Satter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056118] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Birth Defects Foundation(March of Dimes); Satter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded in part by NIH (#1R01 HD056118 and 3R01HD056118-03S1), the March of Dimes Birth Defects Foundation (#21-FY10-202) and the Satter Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; BLAU H, 1994, AM J PHYSIOL, V266, pL148, DOI 10.1152/ajplung.1994.266.2.L148; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; DING AH, 1987, J IMMUNOL, V139, P1971; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Filipovich Y, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.038; Garcia-Verdugo I, 2008, BIOL REPROD, V79, P348, DOI 10.1095/biolreprod.108.068338; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gibson A T, 1997, Br J Hosp Med, V58, P381; Goldmann T, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-8; Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Hirsch E, 1999, AM J OBSTET GYNECOL, V180, P429, DOI 10.1016/S0002-9378(99)70227-9; HIRSCH E, 1995, AM J OBSTET GYNECOL, V172, P1598, DOI 10.1016/0002-9378(95)90503-0; Hussain S, 2003, AM J RESP CELL MOL, V28, P520, DOI 10.1165/rcmb.2002-0072OC; Ilievski V, 2007, REPROD SCI, V14, P315, DOI 10.1177/1933719107302959; Ilievski V, 2010, BIOL REPROD, V83, P767, DOI 10.1095/biolreprod.110.085464; Kankavi O, 2007, ANIM REPROD SCI, V98, P259, DOI 10.1016/j.anireprosci.2006.03.009; Kim CJ, 2006, AM J OBSTET GYNECOL, V195, P829, DOI 10.1016/j.ajog.2006.06.052; Koga K, 2009, J OBSTET GYNAECOL RE, V35, P191, DOI 10.1111/j.1447-0756.2008.00963.x; Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x; KREMLEV SG, 1994, AM J PHYSIOL-LUNG C, V267, pL712, DOI 10.1152/ajplung.1994.267.6.L712; Lamont RF, 2003, BJOG-INT J OBSTET GY, V110, P71, DOI 10.1016/S1470-0328(03)00034-X; Lee DC, 2010, J IMMUNOL, V184, P6479, DOI 10.4049/jimmunol.0903867; Leong ASY, 2008, REPROD SCI, V15, P59, DOI 10.1177/1933719107309646; Li LP, 2010, MOL HUM REPROD, V16, P267, DOI 10.1093/molehr/gap106; MacNeill C, 2004, IMMUNOLOGY, V111, P91, DOI 10.1111/j.1365-2567.2004.01782.x; Madsen J, 2003, AM J RESP CELL MOL, V29, P591, DOI 10.1165/rcmb.2002-0274OC; MIYAMURA K, 1994, BBA-LIPID LIPID MET, V1210, P303, DOI 10.1016/0005-2760(94)90233-X; Murakami S, 2002, J BIOL CHEM, V277, P6830, DOI 10.1074/jbc.M106671200; Mussalli GM, 1999, J SOC GYNECOL INVEST, V6, P188, DOI 10.1016/S1071-5576(99)00013-1; Salminen A, 2011, CYTOKINE, V56, P442, DOI 10.1016/j.cyto.2011.07.025; Sano H, 1999, J IMMUNOL, V163, P387; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Thaxton J. E., 2010, INFECT DIS OBSTET GY, V2010; Wang H, 2003, BIOL REPROD, V69, P1957, DOI 10.1095/biolreprod.103.019620; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Zhao TZ, 2009, NEUROL SCI, V30, P379, DOI 10.1007/s10072-009-0123-x	41	47	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63990	10.1371/journal.pone.0063990	http://dx.doi.org/10.1371/journal.pone.0063990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700442	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400038
J	Munizza, C; Argentero, P; Coppo, A; Tibaldi, G; Di Giannantonio, M; Picci, RL; Rucci, P				Munizza, Carmine; Argentero, Piergiorgio; Coppo, Alessandro; Tibaldi, Giuseppe; Di Giannantonio, Massimo; Picci, Rocco Luigi; Rucci, Paola			Public Beliefs and Attitudes towards Depression in Italy: A National Survey	PLOS ONE			English	Article							MENTAL-DISORDERS; HELP-SEEKING; HEALTH-CARE; STIGMA; EPIDEMIOLOGY; PREVALENCE; DANGEROUSNESS; LIFETIME; REASONS; NEED	Background: Previous studies have shown that attitudes towards depression may be influenced by country-specific social and cultural factors. A survey was carried out to collect beliefs on and attitudes toward depression in Italy, which has an established community-based mental health system. Methods: A telephone survey was carried out in a probabilistic sample aged >= 15 years. A 20-item questionnaire was administered to explore knowledge of depression, stigma, causal beliefs, treatment preference, and help-seeking attitudes. Results: Of the 1001 participants, 98% were aware of depression, and 62% had experienced it, either directly or indirectly. A widespread belief (75%) was that people suffering from depression should avoid talking about their problem. A minority of the sample viewed depression as a condition that should be managed without recourse to external help or a "socially dangerous'' illness. Among perceived causes of depression, most respondents mentioned life stressors or physical strains. Psychologists were often indicated as an adequate source of professional help. Half of the sample believed that depression should be pharmacologically treated, but drugs were often seen as addictive. Referring to a primary care physician (PCP) was considered embarrassing; furthermore, many people thought that PCPs are too busy to treat patients suffering from depression. Conclusions: Our findings indicate that depression is seen as a reaction to significant life events that should be overcome with the support of significant others or the help of health professionals (mainly psychologists). However, there are still barriers to the disclosure of depressive symptoms to PCPs, and concerns about the addictive effect of antidepressants. In the presence of a gap between people's beliefs and what health professionals consider appropriate for the treatment of depression, a "shared decision making'' approach to treatment selection should be adopted taking into account the patients' preference for psychological interventions to ensure active compliance with effective treatments.	[Munizza, Carmine; Coppo, Alessandro; Tibaldi, Giuseppe] Ctr Studi & Ric Psichiatria, Turin, Italy; [Argentero, Piergiorgio] Univ Pavia, Dipartimento Psicol, I-27100 Pavia, Italy; [Di Giannantonio, Massimo] Univ G dAnnunzio, Fac Psicol, Chieti, Italy; [Picci, Rocco Luigi] Univ Turin, Fac Med & Chirurg, Turin, Italy; [Rucci, Paola] Alma Mater Studiorum Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy	University of Pavia; G d'Annunzio University of Chieti-Pescara; University of Turin; University of Bologna	Munizza, C (corresponding author), Ctr Studi & Ric Psichiatria, Turin, Italy.	cmunizza@tin.it		Rucci, Paola/0000-0002-7704-0831; Tibaldi, Giuseppe/0000-0001-8410-2810	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This survey has been funded by the Italian Ministry of Health, under the 2006 Strategic Programme. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Alonso J, 2007, BRIT J PSYCHIAT, V190, P299, DOI 10.1192/bjp.bp.106.022004; Alonso J, 2007, J CLIN PSYCHIAT, V68, P3; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angermeyer MC, 1996, ACTA PSYCHIAT SCAND, V94, P326, DOI 10.1111/j.1600-0447.1996.tb09868.x; Angermeyer MC, 2005, SOC PSYCH PSYCH EPID, V40, P855, DOI 10.1007/s00127-005-0958-x; Barney LJ, 2006, AUST NZ J PSYCHIAT, V40, P51, DOI 10.1080/j.1440-1614.2006.01741.x; Bell RA, 2011, ANN FAM MED, V9, P439, DOI 10.1370/afm.1277; Cape J, 1999, BRIT J GEN PRACT, V49, P875; Comas A, 2004, ACTAS ESP PSIQUIATRI, V32, P371; de Girolamo G, 2006, SOC PSYCH PSYCH EPID, V41, P853, DOI 10.1007/s00127-006-0097-4; Griffiths KM, 2011, J AFFECT DISORDERS, V132, P413, DOI 10.1016/j.jad.2011.03.012; Hansson M, 2010, J AFFECT DISORDERS, V124, P54, DOI 10.1016/j.jad.2009.10.032; Highet NJ, 2006, AUST NZ J PSYCHIAT, V40, P55, DOI 10.1111/j.1440-1614.2006.01742.x; Holzinger A, 2011, EPIDEMIOL PSYCH SCI, V20, P163, DOI 10.1017/S2045796011000266; Jorm AF, 1997, SOC PSYCH PSYCH EPID, V32, P468; Jorm AF, 2006, J AFFECT DISORDERS, V96, P59, DOI 10.1016/j.jad.2006.05.018; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; Lasalvia A, 2013, LANCET, V381, P55, DOI 10.1016/S0140-6736(12)61379-8; Link BG, 1999, AM J PUBLIC HEALTH, V89, P1328, DOI 10.2105/AJPH.89.9.1328; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Nakane Y, 2005, BMC PSYCHIATRY, V21, P5; *NICE, 2009, NICE CLIN GUID; Ozmen E, 2005, SOC PSYCH PSYCH EPID, V40, P869, DOI 10.1007/s00127-005-0985-x; Pescosolido BA, 1999, AM J PUBLIC HEALTH, V89, P1339, DOI 10.2105/AJPH.89.9.1339; Peluso EDP, 2009, J AFFECT DISORDERS, V115, P201, DOI 10.1016/j.jad.2008.08.013; Priest RG, 1996, BRIT MED J, V313, P858; Robins LN, 1991, PSYCHIAT DISORDERS A, P328; Schomerus G, 2006, PSYCHIAT RES, V144, P233, DOI 10.1016/j.psychres.2006.05.002; Sirey JA, 2001, AM J PSYCHIAT, V158, P479, DOI 10.1176/appi.ajp.158.3.479; Wang J, 2008, J AFFECT DISORDERS, V110, P191, DOI 10.1016/j.jad.2008.01.005; WEISSMAN MM, 1995, SCIENCE, V269, P799, DOI 10.1126/science.7638596; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Yap MBH, 2013, J AFFECT DISORDERS, V148, P299, DOI 10.1016/j.jad.2012.12.015	36	31	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63806	10.1371/journal.pone.0063806	http://dx.doi.org/10.1371/journal.pone.0063806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158JQ	23700435	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400032
J	Virkkala, R; Heikkinen, RK; Fronzek, S; Leikola, N				Virkkala, Raimo; Heikkinen, Risto K.; Fronzek, Stefan; Leikola, Niko			Climate Change, Northern Birds of Conservation Concern and Matching the Hotspots of Habitat Suitability with the Reserve Network	PLOS ONE			English	Article							PROTECTED AREAS; POTENTIAL IMPACTS; SPECIES DISTRIBUTIONS; LAND-USE; PROJECTED IMPACTS; ENVELOPE MODELS; BIODIVERSITY; MANAGEMENT; DIVERSITY; PATTERNS	National reserve networks are one of the most important means of species conservation, but their efficiency may be diminished due to the projected climatic changes. Using bioclimatic envelope models and spatial data on habitats and conservation areas, we studied how efficient the reserve network will be in preserving 100 forest, mire, marshland, and alpine bird species of conservation concern in Finland in 2051-2080 under three different climate scenarios. The occurrences of the studied bird species were related to the amount of habitat preferred by each species in the different boreal zones. We employed a novel integrated habitat suitability index that takes into account both the species' probability of occurrence from the bioclimatic models and the availability of suitable habitat. Using this suitability index, the distribution of the topmost 5% suitability squares ("hotspots'') in the four bird species groups in the period 1971-2000 and under the three scenarios were compared with the location of reserves with the highest amounts of the four habitats to study the efficiency of the network. In species of mires, marshlands, and Arctic mountains, a high proportion of protected habitat was included in the 5% hotspots in the scenarios in 2051-2080, showing that protected areas cover a high proportion of occurrences of bird species. In contrast, in forests in the southern and middle boreal zones, only a small proportion of the protected habitat was included in the 5% hotspots, indicating that the efficiency of the protected area network will be insufficient for forest birds in the future. In the northern boreal zone, the efficiency of the reserve network in forests was highly dependent on the strength of climate change varying between the scenarios. Overall, there is no single solution to preserving biodiversity in a changing climate, but several future pathways should be considered.	[Virkkala, Raimo; Heikkinen, Risto K.] Finnish Environm Inst, Nat Environm Ctr, Ecosyst Change Unit, Helsinki, Finland; [Fronzek, Stefan] Finnish Environm Inst, Climate Change Programme, Helsinki, Finland; [Leikola, Niko] Finnish Environm Inst, Nat Environm Ctr, Biodivers Unit, Helsinki, Finland	Finnish Environment Institute; Finnish Environment Institute; Finnish Environment Institute	Virkkala, R (corresponding author), Finnish Environm Inst, Nat Environm Ctr, Ecosyst Change Unit, Helsinki, Finland.	raimo.virkkala@ymparisto.fi	Heikkinen, Risto K./AAN-6257-2020; Virkkala, Raimo/AAN-6178-2020; Fronzek, Stefan/W-5724-2019	Heikkinen, Risto K./0000-0003-4190-5108; Fronzek, Stefan/0000-0003-2478-8050	Academy of Finland in the Research Programme on Climate Change (FICCA) in the project A-LA-CARTE	Academy of Finland in the Research Programme on Climate Change (FICCA) in the project A-LA-CARTE	The work was partly funded by the Academy of Finland in the Research Programme on Climate Change (FICCA) in the project A-LA-CARTE led by Tim Carter. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aapala K, 2008, WIS US FUT PEATL P 1, P1; Alagador D, 2011, BIOL CONSERV, V144, P811, DOI 10.1016/j.biocon.2010.11.011; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2004, BIRDS EUR UN STAT AS; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2004, BIOL CONSERV, V118, P533, DOI 10.1016/j.biocon.2003.10.006; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Austin MP, 2006, ECOL MODEL, V199, P197, DOI 10.1016/j.ecolmodel.2006.05.023; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; BirdLife International, 2004, BIRDL CONSERV SER, V12; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Brommer JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043648; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Carvalho SB, 2010, GLOBAL CHANGE BIOL, V16, P3257, DOI 10.1111/j.1365-2486.2010.02212.x; Carvalho SB, 2010, BIOL CONSERV, V143, P426, DOI 10.1016/j.biocon.2009.11.010; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; D'Amen M, 2011, BIOL CONSERV, V144, P989, DOI 10.1016/j.biocon.2010.11.004; Denoel M, 2008, AQUAT CONSERV, V18, P714, DOI 10.1002/aqc.853; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ervin Jamison, 2011, BIODIVERSITY-OTTAWA, V12, P2, DOI 10.1080/14888386.2011.564850; Faleiro FV, 2013, BIOL CONSERV, V158, P248, DOI 10.1016/j.biocon.2012.09.020; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Forsman JT, 2003, J BIOGEOGR, V30, P55, DOI 10.1046/j.1365-2699.2003.00812.x; Gould W, 2000, ECOL APPL, V10, P1861, DOI 10.1890/1051-0761(2000)010[1861:RSOVPS]2.0.CO;2; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Heath MF, 2000, IMPORTANT BIRD AREAS, V8; Heikkinen RK, 2006, DIVERS DISTRIB, V12, P502, DOI 10.1111/j.1366-9516.2006.00284.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hof AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052574; Hole DG, 2011, CONSERV BIOL, V25, P305, DOI 10.1111/j.1523-1739.2010.01633.x; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Huntley B., 2007, CLIMATIC ATLAS EUROP; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Huntley B, 2012, DIVERS DISTRIB, V18, P769, DOI 10.1111/j.1472-4642.2012.00890.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jylha K, 2004, BOREAL ENVIRON RES, V9, P127; Kharouba HM, 2010, BIOL CONSERV, V143, P1094, DOI 10.1016/j.biocon.2010.02.002; Kuhlmann M, 2012, DIVERS DISTRIB, V18, P885, DOI 10.1111/j.1472-4642.2011.00877.x; Kujala H, 2011, BIOL CONSERV, V144, P2450, DOI 10.1016/j.biocon.2011.06.023; Lehmann A, 2003, ECOL MODEL, V160, P165, DOI 10.1016/S0304-3800(02)00354-X; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Luoto M, 2007, GLOBAL ECOL BIOGEOGR, V16, P34, DOI 10.1111/j.1466-8238.2006.00262.x; Marini MA, 2009, BIOL CONSERV, V142, P3039, DOI 10.1016/j.biocon.2009.08.002; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; Mawdsley J, 2011, WIRES CLIM CHANGE, V2, P498, DOI 10.1002/wcc.127; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; McClean CJ, 2006, DIVERS DISTRIB, V12, P645, DOI 10.1111/j.1472-4642.2006.00290.x; McCullagh P, 1989, GEN LINEAR MODELS; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Milanovich JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012189; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Myers N, 1990, Environmentalist, V10, P243, DOI 10.1007/BF02239720; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Noss RF, 2001, CONSERV BIOL, V15, P578, DOI 10.1046/j.1523-1739.2001.015003578.x; Ohlemuller R, 2006, GLOBAL CHANGE BIOL, V12, P1788, DOI 10.1111/j.1365-2486.2006.01231.x; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parviainen M, 2008, J BIOGEOGR, V35, P1888, DOI 10.1111/j.1365-2699.2008.01922.x; Parviainen M, 2009, BIOL CONSERV, V142, P2501, DOI 10.1016/j.biocon.2009.05.030; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Platts PJ, 2008, ECOL MODEL, V218, P121, DOI 10.1016/j.ecolmodel.2008.06.028; Poiani KA, 2011, BIODIVERS CONSERV, V20, P185, DOI 10.1007/s10531-010-9954-2; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Pyke CR, 2005, BIOL CONSERV, V125, P1, DOI 10.1016/j.biocon.2004.08.004; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Rassi P., 2001, 2000 RED LIST FINNIS; Rassi P., 2010, 2010 RED LIST FINNIS; Reino L, 2013, DIVERS DISTRIB, V19, P423, DOI 10.1111/ddi.12019; RICHERSON PJ, 1980, AM NAT, V116, P504, DOI 10.1086/283645; Ridgeway G., 1999, COMPUT SCI STAT, P172; Sieck Mungla, 2011, BMC Ecology, V11, P12, DOI 10.1186/1472-6785-11-12; Simila M., 2012, ECOLOGICAL RESTORATI; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Vaisanen R. A., 1998, DISTRIBUTION NUMBERS; Valkama J., 2011, 3 FINNISH BREEDING B; Velasquez-Tibata J, 2013, REG ENVIRON CHANGE, V13, P235, DOI 10.1007/s10113-012-0329-y; Virkkala R, 2005, J BIOGEOGR, V32, P1957, DOI 10.1111/j.1365-2699.2005.01326.x; VIRKKALA R, 1994, CONSERV BIOL, V8, P532, DOI 10.1046/j.1523-1739.1994.08020532.x; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Virkkala R, 2007, BIOL CONSERV, V134, P361, DOI 10.1016/j.biocon.2006.08.006; Virkkala R, 2013, BIODIVERS CONSERV, V22, P459, DOI 10.1007/s10531-012-0423-y; Virkkala R, 2012, NAT CONSERV-BULGARIA, P1, DOI 10.3897/natureconservation.3.3635; Virkkala R, 2011, BOREAL ENVIRON RES, V16, P2; Virkkala R, 2011, BIOL LETTERS, V7, P395, DOI 10.1098/rsbl.2010.1052; Virkkala R, 2010, ACTA OECOL, V36, P269, DOI 10.1016/j.actao.2010.01.006; Wiens JA, 2011, BIOL CONSERV, V144, P2119, DOI 10.1016/j.biocon.2011.05.002; Willis SG, 2009, ENVIRON MANAGE, V43, P836, DOI 10.1007/s00267-008-9125-3	105	21	22	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63376	10.1371/journal.pone.0063376	http://dx.doi.org/10.1371/journal.pone.0063376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700420	gold, Green Published, Green Submitted			2022-12-27	WOS:000319966400018
J	Diaz-Castillo, C				Diaz-Castillo, Carlos			Females and Males Contribute in Opposite Ways to the Evolution of Gene Order in Drosophila	PLOS ONE			English	Article							STRAND BREAK REPAIR; P-ELEMENT EXCISION; END-JOINING REPAIR; HOMOLOGOUS RECOMBINATION; GENOME ORGANIZATION; NEIGHBORING GENES; INTERPHASE NUCLEI; Z CHROMOSOME; DNA-REPAIR; CONSERVATION	An intriguing association between the spatial layout of chromosomes within nuclei and the evolution of chromosome gene order was recently uncovered. Chromosome regions with conserved gene order in the Drosophila genus are larger if they interact with the inner side of the nuclear envelope in D. melanogaster somatic cells. This observation opens a new door to understand the evolution of chromosomes in the light of the dynamics of the spatial layout of chromosomes and the way double-strand breaks are repaired in D. melanogaster germ lines. Chromosome regions at the nuclear periphery in somatic cell nuclei relocate to more internal locations of male germ line cell nuclei, which might prefer a gene order-preserving mechanism to repair double-strand breaks. Conversely, chromosome regions at the nuclear periphery in somatic cells keep their location in female germ line cell nuclei, which might be inaccessible for cellular machinery that causes gene order-disrupting chromosome rearrangements. Thus, the gene order stability for genome regions at the periphery of somatic cell nuclei might result from the active repair of double-strand breaks using conservative mechanisms in male germ line cells, and the passive inaccessibility for gene order-disrupting factors at the periphery of nuclei of female germ line cells. In the present article, I find evidence consistent with a DNA break repair-based differential contribution of both D. melanogaster germ lines to the stability/disruption of gene order. The importance of germ line differences for the layout of chromosomes and DNA break repair strategies with regard to other genomic patterns is briefly discussed.				crlsdiazcastillo@gmail.com	Diaz-Castillo, Carlos/I-8554-2012	Diaz-Castillo, Carlos/0000-0001-5099-3619				Arib G, 2011, CURR OPIN CELL BIOL, V23, P346, DOI 10.1016/j.ceb.2010.12.005; Arunkumar KP, 2009, GENETICS, V182, P493, DOI 10.1534/genetics.108.099994; Ashburner M, 2005, DROSOPHILA LAB HDB, Vxxviii; Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bank EM, 2011, BIOCHEM SOC T, V39, P1705, DOI 10.1042/BST20110603; Bellaiche Y, 1999, GENETICS, V152, P1037; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Bibikova M, 2002, GENETICS, V161, P1169; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Bozas A, 2009, GENETICS, V182, P641, DOI 10.1534/genetics.109.101329; Cardoso-Moreira M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002340; Cardoso-Moreira MM, 2010, TRENDS GENET, V26, P243, DOI 10.1016/j.tig.2010.03.002; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; d'Alencon E, 2010, P NATL ACAD SCI USA, V107, P7680, DOI 10.1073/pnas.0910413107; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; de Vosse DWV, 2011, WIRES SYST BIOL MED, V3, P147, DOI 10.1002/wsbm.101; de Wit E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000045; Diaz-Castillo C, 2012, FLY AUSTIN, P6; Diaz-Castillo C, 2012, MOL BIOL EVOL, V29, P2105, DOI 10.1093/molbev/mss096; Diaz-Castillo C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002475; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Federico C, 2006, CHROMOSOMA, V115, P123, DOI 10.1007/s00412-005-0039-z; Foster HA, 2005, CHROMOSOMA, V114, P212, DOI 10.1007/s00412-005-0016-6; GETHMANN RC, 1988, J HERED, V79, P344, DOI 10.1093/oxfordjournals.jhered.a110526; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kupper K, 2007, CHROMOSOMA, V116, P285, DOI 10.1007/s00412-007-0098-4; KURKULOS M, 1994, GENETICS, V136, P1001; Leduc F, 2008, SYST BIOL REPROD MED, V54, P3, DOI 10.1080/19396360701876823; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; MacKenzie A, 2004, BIOESSAYS, V26, P1217, DOI 10.1002/bies.20117; Mahajan Milind C., 2006, Briefings in Functional Genomics & Proteomics, V5, P62, DOI 10.1093/bfgp/ell001; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mayr C, 2003, CHROMOSOME RES, V11, P471, DOI 10.1023/A:1024978711705; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; McVey M, 2004, GENETICS, V168, P2067, DOI 10.1534/genetics.104.033902; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Min BS, 2004, P NATL ACAD SCI USA, V101, P8906, DOI 10.1073/pnas.0403000101; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mongin E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-203; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Poyatos JF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r233; Preston CR, 2006, GENETICS, V172, P1055, DOI 10.1534/genetics.105.050138; Ranz JM, 2007, PLOS BIOL, V5, P1366, DOI 10.1371/journal.pbio.0050152; Ranz JM, 2012, MOL BIOL EVOL, V29, P13, DOI 10.1093/molbev/msr178; Rathke C, 2007, J CELL SCI, V120, P1689, DOI 10.1242/jcs.004663; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Romeijn RJ, 2005, GENETICS, V169, P795, DOI 10.1534/genetics.104.033464; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rong YS, 2001, GENETICS, V157, P1307; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Saccone S, 2002, GENE, V300, P169, DOI 10.1016/S0378-1119(02)01038-7; Sahagun V, 2012, GENOME BIOL EVOL, V4, P1054, DOI 10.1093/gbe/evs089; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Shevelyov YY, 2012, CURR ISSUES MOL BIOL, V14, P27; STAVELEY BE, 1995, GENETICS, V139, P1321; Steglich B, 2011, NUCLEUS, P3; Strissel PL, 1998, BLOOD, V92, P3793, DOI 10.1182/blood.V92.10.3793.422a24_3793_3803; Suzuki J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000461; TAKASUISHIKAWA E, 1992, MOL GEN GENET, V232, P17, DOI 10.1007/BF00299132; Tanabe H, 2005, CYTOGENET GENOME RES, V108, P255, DOI 10.1159/000080824; Van't Hof AE, 2013, HEREDITY, V110, P283, DOI 10.1038/hdy.2012.84; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; von Grotthuss M, 2010, GENOME RES, V20, P1084, DOI 10.1101/gr.103713.109; Wang J, 2012, J MOL EVOL, V74, P113, DOI 10.1007/s00239-012-9499-y; WARD WS, 1994, J CELL BIOCHEM, V55, P77, DOI 10.1002/jcb.240550109; Weber CC, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r23; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Wojtczak A, 2008, PROTOPLASMA, V233, P263, DOI 10.1007/s00709-008-0010-y; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang H, 2007, MOL CELL, V27, P367, DOI 10.1016/j.molcel.2007.06.012; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323; Zuleger N, 2011, NUCLEUS-PHILA, V2, P339, DOI 10.4161/nucl.2.5.17846	83	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64491	10.1371/journal.pone.0064491	http://dx.doi.org/10.1371/journal.pone.0064491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696898	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900101
J	Takahashi, T; Song, JS; Suzuki, T; Kawaoka, Y				Takahashi, Tadanobu; Song, Jiasheng; Suzuki, Takashi; Kawaoka, Yoshihiro			Mutations in NA That Induced Low pH-Stability and Enhanced the Replication of Pandemic (H1N1) 2009 Influenza A Virus at an Early Stage of the Pandemic	PLOS ONE			English	Article							DIVALENT-CATION REQUIREMENTS; SIALIDASE ACTIVITY; NEURAMINIDASE	An influenza A virus that originated in pigs caused a pandemic in 2009. The sialidase activity of the neuraminidase (NA) of previous pandemic influenza A viruses are stable at low pH (<= 5). Here, we identified the amino acids responsible for this property. We found differences in low-pH stability at pH 5.0 among pandemic (H1N1) 2009 viruses, which enhanced the replication of these viruses. Low-pH-stable NA enhancement of virus replication may have contributed to the rapid worldwide spread and adaptation to humans of pandemic (H1N1) 2009 viruses during the early stages of the 2009 pandemic.	[Takahashi, Tadanobu; Song, Jiasheng; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA; [Takahashi, Tadanobu; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; [Takahashi, Tadanobu; Suzuki, Takashi] Global COE Program Innovat Human Hlth Sci, Shizuoka, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Shizuoka; University of Tokyo; Japan Science & Technology Agency (JST)	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp; kawaokay@svm.vetmed.wisc.edu			MEXT/JSPS KAKENHI [23590549]; Japan Science Society; SRI (Shizuoka Research Institute); Japan Society for the Promotion of Science; ERATO (Japan Science and Technology Agency); Ministries of Education, Culture, Sports, Science, and Technology; Health, Labor, and Welfare of Japan; Japan Initiative for Global Research Network on Infectious Diseases from the Ministries of Education, Culture, Sports, Science, and Technology; National Institute of Allergy and Infectious Disease Public Health Service	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science Society; SRI (Shizuoka Research Institute); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ERATO (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Ministries of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health, Labor, and Welfare of Japan; Japan Initiative for Global Research Network on Infectious Diseases from the Ministries of Education, Culture, Sports, Science, and Technology; National Institute of Allergy and Infectious Disease Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by a MEXT/JSPS KAKENHI Grant (Number C; 23590549), by a Sasakawa Scientific Research Grant from The Japan Science Society, by a SRI (Shizuoka Research Institute) academic research grant, by the Global COE Program from the Japan Society for the Promotion of Science, by ERATO (Japan Science and Technology Agency), by a grant-in-aid for Specially Promoted Research from the Ministries of Education, Culture, Sports, Science, and Technology, by grants-in-aid from Health, Labor, and Welfare of Japan, by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministries of Education, Culture, Sports, Science, and Technology, and by National Institute of Allergy and Infectious Disease Public Health Service research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Brett IC, 2006, J BIOCHEM, V139, P439, DOI 10.1093/jb/mvj051; Johansson BE, 2003, J BIOCHEM, V134, P345, DOI 10.1093/jb/mvg151; Li CJ, 2011, J VIROL, V85, P10955, DOI 10.1128/JVI.05792-11; Li CJ, 2008, J VIROL, V82, P11880, DOI 10.1128/JVI.01445-08; Li QL, 2010, CONSTRUCTIVE COMPUTATION IN STOCHASTIC MODELS WITH APPLICATIONS: THE RG-FACTORIZATION, P1; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Sakabe S, 2011, VIRUS RES, V158, P124, DOI 10.1016/j.virusres.2011.03.022; Suzuki T, 2005, J VIROL, V79, P11705, DOI 10.1128/JVI.79.18.11705-11715.2005; Suzuki T, 2004, FEBS LETT, V557, P228, DOI 10.1016/S0014-5793(03)01503-5; Takahashi T, 2003, FEBS LETT, V543, P71, DOI 10.1016/S0014-5793(03)00403-4; Takahashi T, 2001, J BIOCHEM-TOKYO, V130, P279, DOI 10.1093/oxfordjournals.jbchem.a002983; Takahashi T, 2012, FEBS OPEN BIO, V2, P261, DOI 10.1016/j.fob.2012.08.007; Takahashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015556; VARGHESE JN, 1991, J MOL BIOL, V221, P473, DOI 10.1016/0022-2836(91)80068-6; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08	17	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64439	10.1371/journal.pone.0064439	http://dx.doi.org/10.1371/journal.pone.0064439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696893	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900096
J	Foster, SR; Porrello, ER; Purdue, B; Chan, HW; Voigt, A; Frenzel, S; Hannan, RD; Moritz, KM; Simmons, DG; Molenaar, P; Roura, E; Boehm, U; Meyerhof, W; Thomas, WG				Foster, Simon R.; Porrello, Enzo R.; Purdue, Brooke; Chan, Hsiu-Wen; Voigt, Anja; Frenzel, Sabine; Hannan, Ross D.; Moritz, Karen M.; Simmons, David G.; Molenaar, Peter; Roura, Eugeni; Boehm, Ulrich; Meyerhof, Wolfgang; Thomas, Walter G.			Expression, Regulation and Putative Nutrient-Sensing Function of Taste GPCRs in the Heart	PLOS ONE			English	Article							RECEPTORS; PROTEIN; CELLS; GENE; METABOLITES; ACTIVATION; GUSTDUCIN; CALCIUM; RISK	G protein-coupled receptors (GPCRs) are critical for cardiovascular physiology. Cardiac cells express>100 nonchemosensory GPCRs, indicating that important physiological and potential therapeutic targets remain to be discovered. Moreover, there is a growing appreciation that members of the large, distinct taste and odorant GPCR families have specific functions in tissues beyond the oronasal cavity, including in the brain, gastrointestinal tract and respiratory system. To date, these chemosensory GPCRs have not been systematically studied in the heart. We performed RT-qPCR taste receptor screens in rodent and human heart tissues that revealed discrete subsets of type 2 taste receptors (TAS2/Tas2) as well as Tas1r1 and Tas1r3 (comprising the umami receptor) are expressed. These taste GPCRs are present in cultured cardiac myocytes and fibroblasts, and by in situ hybridization can be visualized across the myocardium in isolated cardiac cells. Tas1r1 genetargeted mice (Tas1r1(Cre)/Rosa26(tdRFP)) strikingly recapitulated these data. In vivo taste receptor expression levels were developmentally regulated in the postnatal period. Intriguingly, several Tas2rs were upregulated in cultured rat myocytes and in mouse heart in vivo following starvation. The discovery of taste GPCRs in the heart opens an exciting new field of cardiac research. We predict that these taste receptors may function as nutrient sensors in the heart.	[Foster, Simon R.; Porrello, Enzo R.; Purdue, Brooke; Chan, Hsiu-Wen; Moritz, Karen M.; Simmons, David G.; Thomas, Walter G.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Voigt, Anja; Frenzel, Sabine; Meyerhof, Wolfgang] German Inst Human Nutr DIfE Potsdam Rehbruecke, Dept Mol Genet, Nuthetal, Germany; [Hannan, Ross D.] Univ Melbourne, Peter MacCallum Canc Ctr, Sir Peter MacCallum Dept Oncol, Div Res,Oncogen Signaling & Growth Control Progra, Melbourne, Vic, Australia; [Molenaar, Peter] Univ Queensland, Sch Med, Sch Biomed Sci, Fac Hlth,Queensland Univ Technol, Brisbane, Qld, Australia; [Roura, Eugeni] Univ Queensland, Ctr Nutr & Food Sci, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia; [Boehm, Ulrich] Univ Hamburg, Ctr Mol Neurobiol, Inst Neural Signal Transduct, Hamburg, Germany	University of Queensland; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Peter Maccallum Cancer Center; University of Melbourne; Queensland University of Technology (QUT); University of Queensland; University of Queensland; University of Hamburg	Thomas, WG (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	w.thomas@uq.edu.au	Thomas, Walter/I-2208-2015; Simmons, David G/C-5983-2009; Molenaar, Peter/J-1198-2012; Roura, Eugeni/A-7101-2011; Chan, Hsiu-Wen/G-2665-2010; Moritz, Karen/G-2508-2015; Foster, Simon R./I-1552-2014	Thomas, Walter/0000-0003-0685-2952; Simmons, David G/0000-0002-4115-9371; Molenaar, Peter/0000-0002-7122-4656; Roura, Eugeni/0000-0002-9073-9946; Moritz, Karen/0000-0002-8085-0034; Foster, Simon R./0000-0003-3034-1351; Purdue, Brooke/0000-0001-7618-7180; Hannan, Ross/0000-0002-2166-4493; Porrello, Enzo/0000-0001-6105-7463	National Health and Medical Research Council of Australia [APP631443]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council of Australia (APP631443 to WGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao H, 2012, ATHEROSCLEROSIS, V220, P456, DOI 10.1016/j.atherosclerosis.2011.11.037; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Deng HY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00373; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Duffy VB, 2004, APPETITE, V43, P5, DOI 10.1016/j.appet.2004.02.007; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Finger Thomas E, 2011, F1000 Biol Rep, V3, P20, DOI 10.3410/B3-20; Insel PA, 2012, BRIT J PHARMACOL, V165, P1613, DOI 10.1111/j.1476-5381.2011.01434.x; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jeon TI, 2011, BIOCHEM J, V438, P33, DOI 10.1042/BJ20110009; Kaumann A, 1999, CIRCULATION, V99, P65, DOI 10.1161/01.CIR.99.1.65; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lee RJ, 2012, J CLIN INVEST; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moore-Morris T, 2009, MOL PHARMACOL, V75, P1108, DOI 10.1124/mol.108.054155; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Patwardhan AM, 2010, J CLIN INVEST, V120, P1617, DOI 10.1172/JCI41678; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Smith NJ, 2012, FRONTIERS ENDOCRINOL, V3; Snead AN, 2012, FASEB J; Sotnikova TD, 2009, MOL PHARMACOL, V76, P229, DOI 10.1124/mol.109.055970; Tang CM, 2004, TRENDS CARDIOVAS MED, V14, P94, DOI 10.1016/j.tcm.2003.12.007; Thomas WG, 2002, CIRC RES, V90, P135, DOI 10.1161/hh0202.104109; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Tonack S, 2012, AM J PHYSL HEART CIR; Toyono T, 2007, BBA-GENE STRUCT EXPR, V1769, P641, DOI 10.1016/j.bbaexp.2007.08.003; Waku T, 2010, EMBO J, V29, P3395, DOI 10.1038/emboj.2010.197; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wellendorph P, 2009, MOL PHARMACOL, V76, P453, DOI 10.1124/mol.109.055244; Wen SP, 2011, ENDOCRINOLOGY, V152, P1515, DOI 10.1210/en.2010-1208; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319; Young RL, 2009, GUT, V58, P337, DOI 10.1136/gut.2008.148932	46	97	99	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64579	10.1371/journal.pone.0064579	http://dx.doi.org/10.1371/journal.pone.0064579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23696900	Green Published, gold			2022-12-27	WOS:000319052700108
J	Koido, S; Homma, S; Okamoto, M; Namiki, Y; Takakura, K; Takahara, A; Odahara, S; Tsukinaga, S; Yukawa, T; Mitobe, J; Matsudaira, H; Nagatsuma, K; Kajihara, M; Uchiyama, K; Arihiro, S; Imazu, H; Arakawa, H; Kan, S; Hayashi, K; Komita, H; Kamata, Y; Ito, M; Hara, E; Ohkusa, T; Gong, JL; Tajiri, H				Koido, Shigeo; Homma, Sadamu; Okamoto, Masato; Namiki, Yoshihisa; Takakura, Kazuki; Takahara, Akitaka; Odahara, Shunichi; Tsukinaga, Shintaro; Yukawa, Toyokazu; Mitobe, Jimi; Matsudaira, Hiroshi; Nagatsuma, Keisuke; Kajihara, Mikio; Uchiyama, Kan; Arihiro, Seiji; Imazu, Hiroo; Arakawa, Hiroshi; Kan, Shin; Hayashi, Kazumi; Komita, Hideo; Kamata, Yuko; Ito, Masaki; Hara, Eiichi; Ohkusa, Toshifumi; Gong, Jianlin; Tajiri, Hisao			Augmentation of Antitumor Immunity by Fusions of Ethanol-Treated Tumor Cells and Dendritic Cells Stimulated via Dual TLRs through TGF-beta 1 Blockade and IL-12p70 Production	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HEAT-SHOCK PROTEINS; STREPTOCOCCAL PREPARATION; TRANSFORMING GROWTH-FACTOR-BETA-1; MONOCLONAL-ANTIBODY; VACCINE EFFICACY; GASTRIC-CANCER; ANTIGEN; INDUCTION; EXPRESSION	The therapeutic efficacy of fusion cell (FC)-based cancer vaccine generated with whole tumor cells and dendritic cells (DCs) requires the improved immunogenicity of both cells. Treatment of whole tumor cells with ethanol resulted in blockade of immune-suppressive soluble factors such as transforming growth factor (TGF)-beta 1, vascular endothelial growth factor, and IL-10 without decreased expression of major histocompatibility complex (MHC) class I and the MUC1 tumor-associated antigen. Moreover, the ethanol-treated tumor cells expressed "eat-me'' signals such as calreticulin (CRT) on the cell surface and released immunostimulatory factors such as heat shock protein (HSP)90 alpha and high-mobility group box 1 (HMGB1). A dual stimulation of protein-bound polysaccharides isolated from Coriolus versicolor (TLR2 agonist) and penicillin-inactivated Streptococcus pyogenes (TLR4 agonist) led human monocyte-derived DCs to produce HSP90 alpha and multiple cytokines such as IL-12p70 and IL-10. Interestingly, incorporating ethanol-treated tumor cells and TLRs-stimulated DCs during the fusion process promoted fusion efficiency and up-regulated MHC class II molecules on a per fusion basis. Moreover, fusions of ethanol-treated tumor cells and dual TLRs-stimulated DCs (E-tumor/FCs) inhibited the production of multiple immune-suppressive soluble factors including TGF-beta 1 and up-regulated the production of IL-12p70 and HSP90 alpha. Most importantly, E-tumor/FCs activated T cells capable of producing high levels of IFN-gamma, resulting in augmented MUC1-specific CTL induction. Collectively, our results illustrate the synergy between ethanol-treated whole tumor cells and dual TLRs-stimulated DCs in inducing augmented CTL responses in vitro by FC preparations. The alternative system is simple and may provide a platform for adoptive immunotherapy.	[Koido, Shigeo; Takakura, Kazuki; Takahara, Akitaka; Odahara, Shunichi; Tsukinaga, Shintaro; Yukawa, Toyokazu; Mitobe, Jimi; Matsudaira, Hiroshi; Nagatsuma, Keisuke; Kajihara, Mikio; Uchiyama, Kan; Arihiro, Seiji; Arakawa, Hiroshi; Komita, Hideo; Ohkusa, Toshifumi; Tajiri, Hisao] Jikei Univ, Sch Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Koido, Shigeo; Namiki, Yoshihisa] Jikei Univ, Sch Med, Inst Clin Med & Res, Chiba, Japan; [Koido, Shigeo; Homma, Sadamu; Kan, Shin; Hayashi, Kazumi; Komita, Hideo; Kamata, Yuko; Ito, Masaki] Jikei Univ, Sch Med, Dept Oncol, Tokyo, Japan; [Okamoto, Masato] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan; [Imazu, Hiroo; Arakawa, Hiroshi] Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan; [Hara, Eiichi] Saitama Canc Ctr Res, Inst Clin Oncol, Saitama, Japan; [Gong, Jianlin] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Jikei University; Jikei University; Jikei University; Keio University; Jikei University; Boston University	Koido, S (corresponding author), Jikei Univ, Sch Med, Div Gastroenterol & Hepatol, Tokyo, Japan.	shigeo_koido@jikei.ac.jp	大草, 敏史/HGD-2376-2022	Gong, Jianlin/0000-0003-0910-014X	Ministry of Education, Cultures, Sports, Science and Technology of Japan; Foundation for Promotion of Cancer Research; Mitsui Life Social Welfare Foundation; Japan Medical Association; Grants-in-Aid for Scientific Research [25463119] Funding Source: KAKEN	Ministry of Education, Cultures, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Promotion of Cancer Research; Mitsui Life Social Welfare Foundation; Japan Medical Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Cultures, Sports, Science and Technology of Japan, the Foundation for Promotion of Cancer Research, Mitsui Life Social Welfare Foundation, Grant-in-Aid of the Japan Medical Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahram M, 2003, PROTEOMICS, V3, P413, DOI 10.1002/pmic.200390056; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Buschard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017931; Calderwood SK, 2005, INT J HYPERTHER, V21, P713, DOI 10.1080/02656730500340794; Conroy H, 2012, CANCER IMMUNOL IMMUN, V61, P425, DOI 10.1007/s00262-011-1188-y; Delmas F, 1998, CELL BIOL TOXICOL, V14, P39, DOI 10.1023/A:1007464421018; DELMAS F, 1995, INT J BIOCHEM CELL B, V27, P385, DOI 10.1016/1357-2725(94)00069-N; Fowler CB, 2008, LAB INVEST, V88, P785, DOI 10.1038/labinvest.2008.43; Ghorpade DS, 2011, J BIOL CHEM, V286, P31347, DOI 10.1074/jbc.M111.232413; Gong JL, 1997, NAT MED, V3, P558, DOI 10.1038/nm0597-558; Huang A, 2003, CLIN EXP IMMUNOL, V134, P270, DOI 10.1046/j.1365-2249.2003.02295.x; INGE TH, 1992, CANCER RES, V52, P1386; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Koido S, 2000, J IMMUNOL, V165, P5713, DOI 10.4049/jimmunol.165.10.5713; Koido S, 2007, J IMMUNOL, V178, P613, DOI 10.4049/jimmunol.178.1.613; Koido S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059280; Koido S, 2013, ANTICANCER RES, V33, P347; Koido S, 2010, CLIN IMMUNOL, V135, P384, DOI 10.1016/j.clim.2010.02.003; Liu LZ, 2002, NAT MED, V8, P185, DOI 10.1038/nm0202-185; Lu HL, 2011, CLIN CANCER RES, V17, P6742, DOI 10.1158/1078-0432.CCR-11-1142; Lu HL, 2011, CLIN CANCER RES, V17, P67, DOI 10.1158/1078-0432.CCR-10-1763; Mou HB, 2011, TRANSPL P, V43, P2049, DOI 10.1016/j.transproceed.2011.02.054; NAKAZATO H, 1994, LANCET, V343, P1122, DOI 10.1016/S0140-6736(94)90233-X; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Paglia P, 1996, J EXP MED, V183, P317, DOI 10.1084/jem.183.1.317; Perlmutter MA, 2004, J MOL DIAGN, V6, P371, DOI 10.1016/S1525-1578(10)60534-X; Russo V, 2000, P NATL ACAD SCI USA, V97, P2185, DOI 10.1073/pnas.040540197; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Somersan S, 2001, J IMMUNOL, V167, P4844, DOI 10.4049/jimmunol.167.9.4844; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; TANAKA N, 1994, CANCER, V74, P3097, DOI 10.1002/1097-0142(19941215)74:12<3097::AID-CNCR2820741206>3.0.CO;2-P; Tapia H, 2010, MOL BIOL CELL, V21, P63, DOI 10.1091/mbc.E09-05-0376; Terabe M, 2009, CLIN CANCER RES, V15, P6560, DOI 10.1158/1078-0432.CCR-09-1066; Ueda R, 2009, CLIN CANCER RES, V15, P6551, DOI 10.1158/1078-0432.CCR-09-1067; Warger T, 2006, J BIOL CHEM, V281, P22545, DOI 10.1074/jbc.M502900200; Zhang M, 2008, J IMMUNOL, V181, P3690, DOI 10.4049/jimmunol.181.5.3690; Zheng RX, 2008, CANCER RES, V68, P4045, DOI 10.1158/0008-5472.CAN-07-6669	43	16	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63498	10.1371/journal.pone.0063498	http://dx.doi.org/10.1371/journal.pone.0063498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717436	Green Published, Green Submitted, gold			2022-12-27	WOS:000319385300036
J	Zhao, J; Li, H; Winterton, SL; Liu, ZQ				Zhao, Jing; Li, Hu; Winterton, Shaun L.; Liu, Zhiqi			Ancestral Gene Organization in the Mitochondrial Genome of Thyridosmylus langii (McLachlan, 1870) (Neuroptera: Osmylidae) and Implications for Lacewing Evolution	PLOS ONE			English	Article							COMPOSITIONAL HETEROGENEITY; PHYLOGENETIC UTILITY; RNA GENES; INSECTA; SEQUENCES; DNA; COMPILATION; LEPIDOPTERA; HYMENOPTERA; PATTERNS	The first complete mitochondrial genome of the lacewing family Osmylidae (Thyridosmylus langii (McLachlan, 1870)) (Neuroptera) was sequenced in this study. The genome is a circular molecule of 16,221 bp containing the typical 37 genes but is arranged in the same order as that of the putative ancestor of hexapod and lacks translocation of trnC as shared by all previously sequenced neuropteran mtDNAs. This reveals that trnC translocation does not represent an organizational synapomorphy in the mitochondrion for the entire Neuroptera clade. Comparative analysis of neuropteran tRNA genes reveals a relatively slow and conserved evolution of the mitochondrion throughout the order. Secondary structure models of the ribosomal RNA genes of T. langii largely agree with those proposed for other insect orders. Nevertheless, domain I of T. langii rrnL is consisted of nine helices rather than eight helices which is typical for neuropteran rrnL. Protein-coding genes have typical mitochondrial start codons, with the exception of COI, which uses the TCG start codon also found in Ithonidae and Chrysopidae. Like other neuropteran insects, the control region is the most AT-rich region and comparatively simple, with little evidence of conserved blocks or long tandem repeats. Considering the issues of base-compositional and branch length heterogeneity, we used a range of phylogenetic approaches to recover neuropteridan relationships and explored the effect of method choice on recovery of monophyly of Neuropterida: ((Neuroptera + Megaloptera) + Raphidioptera). The monophyly of Neuroptera and the more basal position of Osmylidae were also recovered by different datasets and phylogenetic methods.	[Zhao, Jing; Li, Hu; Liu, Zhiqi] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Winterton, Shaun L.] Calif Dept Food & Agr, Sacramento, CA 95814 USA	China Agricultural University; California Department of Food & Agriculture	Liu, ZQ (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	zhiqiliu@cau.edu.cn	li, hu/N-7159-2013; Winterton, Shaun L/C-3804-2009		National Natural Foundation of China [31071962, 201103022, 31272352]; Direct For Biological Sciences [1144119] Funding Source: National Science Foundation	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by grants from the National Natural Foundation of China (No. 31071962, No. 201103022, and No. 31272352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aspock U, 2001, SYST ENTOMOL, V26, P73, DOI 10.1046/j.1365-3113.2001.00136.x; Aspock U, 2008, SYST ENTOMOL, V33, P97, DOI 10.1111/j.1365-3113.2007.00396.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Beckenbach AT, 2009, GENOME, V52, P31, DOI 10.1139/G08-098; Beutel RG, 2010, ORG DIVERS EVOL, V10, P311, DOI 10.1007/s13127-010-0024-0; Beutel RG, 2010, ZOOL J LINN SOC-LOND, V158, P533, DOI 10.1111/j.1096-3642.2009.00560.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; BOYCE TM, 1989, GENETICS, V123, P825; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Caterino MS, 1999, MOL PHYLOGENET EVOL, V11, P122, DOI 10.1006/mpev.1998.0549; Erler S, 2010, BIOL J LINN SOC, V99, P296, DOI 10.1111/j.1095-8312.2009.01365.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GALTIER N, 1995, P NATL ACAD SCI USA, V92, P11317, DOI 10.1073/pnas.92.24.11317; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haring E, 2004, SYST ENTOMOL, V29, P415, DOI 10.1111/j.0307-6970.2004.00263.x; Haruyama N, 2011, MOL BIOL REP, V38, P3367, DOI 10.1007/s11033-010-0444-0; Hua JM, 2009, MOL BIOL REP, V36, P1757, DOI 10.1007/s11033-008-9379-0; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Kristensen NP, 1999, EUR J ENTOMOL, V96, P237; Kumar S, 2001, GENETICS, V158, P1321; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Li HF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042626, 10.1371/journal.pone.0048872]; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045925; Li H, 2012, INT J BIOL SCI, V8, P93, DOI 10.7150/ijbs.8.93; Li H, 2011, INT J BIOL SCI, V7, P792, DOI 10.7150/ijbs.7.792; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mueller RL, 2005, MOL BIOL EVOL, V22, P2104, DOI 10.1093/molbev/msi204; Negrisolo E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-221; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RAND DM, 1993, J MOL EVOL, V37, P281, DOI 10.1007/BF00175505; Roberti M, 2006, NUCLEIC ACIDS RES, V34, P2109, DOI 10.1093/nar/gkl181; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Sharma D, 2004, BIOINFORMATICS, V20, P1405, DOI 10.1093/bioinformatics/bth103; Sheffield NC, 2008, MOL BIOL EVOL, V25, P2499, DOI 10.1093/molbev/msn198; Sheffield NC, 2009, SYST BIOL, V58, P381, DOI 10.1093/sysbio/syp037; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Song HJ, 2010, SYST ENTOMOL, V35, P429, DOI 10.1111/j.1365-3113.2009.00517.x; STANTON DJ, 1994, GENETICS, V137, P233; TA H, 1999, BIOEDIT USER FRIENDL, P95; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047302; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Winterton Shaun L., 2003, Entomologische Abhandlungen (Dresden), V61, P158; Winterton SL, 2010, ANN ENTOMOL SOC AM, V103, P511, DOI 10.1603/AN10026; Winterton SL, 2010, SYST ENTOMOL, V35, P349, DOI 10.1111/j.1365-3113.2010.00521.x; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zhao JL, 2011, MOL BIOL REP, V38, P3757, DOI 10.1007/s11033-010-0491-6	59	31	33	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e62943	10.1371/journal.pone.0062943	http://dx.doi.org/10.1371/journal.pone.0062943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717397	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600005
J	Banelli, B; Merlo, DF; Allemanni, G; Forlani, A; Romani, M				Banelli, Barbara; Merlo, Domenico Franco; Allemanni, Giorgio; Forlani, Alessandra; Romani, Massimo			Clinical Potentials of Methylator Phenotype in Stage 4 High-Risk Neuroblastoma: An Open Challenge	PLOS ONE			English	Article							DNA METHYLATION; ABERRANT METHYLATION; GENE; CLASSIFICATION; CANCER	Approximately 20% of stage 4 high-risk neuroblastoma patients are alive and disease-free 5 years after disease onset while the remaining experience rapid and fatal progression. Numerous findings underline the prognostic role of methylation of defined target genes in neuroblastoma without taking into account the clinical and biological heterogeneity of this disease. In this report we have investigated the methylation of the PCDHB cluster, the most informative member of the "Methylator Phenotype'' in neuroblastoma, hypothesizing that if this epigenetic mark can predict overall and progression free survival in high-risk stage 4 neuroblastoma, it could be utilized to improve the risk stratification of the patients, alone or in conjunction with the previously identified methylation of the SFN gene (14.3.3sigma) that can accurately predict outcome in these patients. We have utilized univariate and multivariate models to compare the prognostic power of PCDHB methylation in terms of overall and progression free survival, quantitatively determined by pyrosequencing, with that of other markers utilized for the patients' stratification utilizing methylation thresholds calculated on neuroblastoma at stage 1-4 and only on stage 4, high-risk patients. Our results indicate that PCDHB accurately distinguishes between high-and intermediate/low risk stage 4 neuroblastoma in agreement with the established risk stratification criteria. However PCDHB cannot predict outcome in the subgroup of stage 4 patients at high-risk whereas methylation levels of SFN are suggestive of a "methylation gradient'' associated with tumor aggressiveness as suggested by the finding of a higher threshold that defines a subset of patients with an extremely severe disease (OS <24 months). Because of the heterogeneity of neuroblastoma we believe that clinically relevant methylation markers should be selected and tested on homogeneous groups of patients rather than on patients at all stages.	[Banelli, Barbara; Merlo, Domenico Franco; Allemanni, Giorgio; Forlani, Alessandra; Romani, Massimo] IRCCS AOU San Martino IST, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST	Banelli, B (corresponding author), IRCCS AOU San Martino IST, Genoa, Italy.	barbara.banelli@istge.it	Banelli, Barbara/Y-1151-2019; Merlo, Domenico Franco/ABI-1345-2020	Banelli, Barbara/0000-0003-1505-7141; Merlo, Domenico Franco/0000-0002-1832-4754	Italian Ministry of Health; Italian Ministry of Health [GR-2008-1143408]	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health, core grant "Ricerca Corrente" to the IRCCS AOU San Martino-IST. B.B. is the recipient of the "Young Investigators'' grant GR-2008-1143408 from the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, CANCER RES, V65, P828; Abe M, 2008, ONCOLOGY-BASEL, V74, P50, DOI 10.1159/000139124; Abe M, 2007, CANCER LETT, V247, P253, DOI 10.1016/j.canlet.2006.05.001; Alaminos M, 2004, JNCI-J NATL CANCER I, V96, P1208, DOI 10.1093/jnci/djh224; Banelli B, 2005, CANCER LETT, V228, P37, DOI 10.1016/j.canlet.2005.02.049; Banelli B, 2005, ONCOGENE, V24, P5619, DOI 10.1038/sj.onc.1208722; Banelli B, 2012, LAB INVEST, V92, P458, DOI 10.1038/labinvest.2011.169; Banelli B, 2010, INT J CANCER, V126, P656, DOI 10.1002/ijc.24768; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Dallosso AR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000745; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Gonzalez-Gomez P, 2003, EUR J CANCER, V39, P1478, DOI 10.1016/S0959-8049(03)00312-5; Hoebeeck J, 2009, CANCER LETT, V273, P336, DOI 10.1016/j.canlet.2008.08.019; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Oberthuer A, 2010, J CLIN ONCOL, V28, P3506, DOI 10.1200/JCO.2009.27.3367; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Toyota M, 2009, CANCER SCI, V100, P787, DOI 10.1111/j.1349-7006.2009.01095.x	26	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63253	10.1371/journal.pone.0063253	http://dx.doi.org/10.1371/journal.pone.0063253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717404	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700011
J	Huang, XE; Liu, XY; Chen, XH; Snyder, A; Song, WY				Huang, Xiaoen; Liu, Xueying; Chen, Xiuhua; Snyder, Anita; Song, Wen-Yuan			Members of the XB3 Family from Diverse Plant Species Induce Programmed Cell Death in Nicotiana benthamiana	PLOS ONE			English	Article							XA21-MEDIATED INNATE IMMUNITY; DISEASE RESISTANCE; POSITIVE REGULATOR; REPEAT PROTEIN; KINASE; MAPKKK; GENE; TOMATO; EXPRESSION; XA21	Programmed cell death has been associated with plant immunity and senescence. The receptor kinase XA21 confers resistance to bacterial blight disease of rice (Oryza sativa) caused by Xanthomonas oryzae pv. oryzae (Xoo). Here we show that the XA21 binding protein 3 (XB3) is capable of inducing cell death when overexpressed in Nicotiana benthamiana. XB3 is a RING finger-containing E3 ubiquitin ligase that has been positively implicated in XA21-mediated resistance. Mutation abolishing the XB3 E3 activity also eliminates its ability to induce cell death. Phylogenetic analysis of XB3-related sequences suggests a family of proteins (XB3 family) with members from diverse plant species. We further demonstrate that members of the XB3 family from rice, Arabidopsis and citrus all trigger a similar cell death response in Nicotiana benthamiana, suggesting an evolutionarily conserved role for these proteins in regulating programmed cell death in the plant kingdom.	[Huang, Xiaoen; Chen, Xiuhua; Song, Wen-Yuan] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Snyder, Anita; Song, Wen-Yuan] Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL USA; [Liu, Xueying] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Song, WY (corresponding author), Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA.	wsong@ifas.ufl.edu	Huang, Xiaoen/ABD-5778-2021	Huang, Xiaoen/0000-0002-7514-1663	Citrus Research and Development Foundation	Citrus Research and Development Foundation	This research was supported by the Citrus Research and Development Foundation (http://citrusrdf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Bai SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002752; Chen XW, 2010, P NATL ACAD SCI USA, V107, P8029, DOI 10.1073/pnas.0912311107; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Gmitter FG, 2011, SAN DIEG CA PLANT AN; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Goodman R. N., 1994, HYPERSENSITIVE REACT; Hashimoto M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-103; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Jiang YN, 2013, PLANT J, V73, P814, DOI 10.1111/tpj.12076; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lee I, 2011, P NATL ACAD SCI USA, V108, P18548, DOI 10.1073/pnas.1110384108; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Nodzon LA, 2004, PLANT J, V40, P996, DOI 10.1111/j.1365-313X.2004.02266.x; Oh CS, 2010, PLANT CELL, V22, P260, DOI 10.1105/tpc.109.070664; Park CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009262; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Rogers HJ, 2006, ANN BOT-LONDON, V97, P309, DOI 10.1093/aob/mcj051; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu XJ, 2007, J EXP BOT, V58, P3623, DOI 10.1093/jxb/erm212; Xu XJ, 2007, J EXP BOT, V58, P2193, DOI 10.1093/jxb/erm058; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhang Y, 2004, PLANT J, V40, P213, DOI 10.1111/j.1365-313X.2004.02201.x; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	39	11	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63868	10.1371/journal.pone.0063868	http://dx.doi.org/10.1371/journal.pone.0063868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717500	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700072
J	Rhie, SK; Coetzee, SG; Noushmehr, H; Yan, CL; Kim, JM; Haiman, CA; Coetzee, GA				Rhie, Suhn Kyong; Coetzee, Simon G.; Noushmehr, Houtan; Yan, Chunli; Kim, Jae Mun; Haiman, Christopher A.; Coetzee, Gerhard A.			Comprehensive Functional Annotation of Seventy-One Breast Cancer Risk Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; REGULATORY ELEMENTS; ANDROGEN-RECEPTOR; DIFFERENTIAL EXPRESSION; SUSCEPTIBILITY LOCUS; COMMON VARIANTS; DATA SETS; DATABASE; PROTEIN	Breast Cancer (BCa) genome-wide association studies revealed allelic frequency differences between cases and controls at index single nucleotide polymorphisms (SNPs). To date, 71 loci have thus been identified and replicated. More than 320,000 SNPs at these loci define BCa risk due to linkage disequilibrium (LD). We propose that BCa risk resides in a subgroup of SNPs that functionally affects breast biology. Such a shortlist will aid in framing hypotheses to prioritize a manageable number of likely disease-causing SNPs. We extracted all the SNPs, residing in 1 Mb windows around breast cancer risk index SNP from the 1000 genomes project to find correlated SNPs. We used FunciSNP, an R/Bioconductor package developed in-house, to identify potentially functional SNPs at 71 risk loci by coinciding them with chromatin biofeatures. We identified 1,005 SNPs in LD with the index SNPs (r(2) >= 0.5) in three categories; 21 in exons of 18 genes, 76 in transcription start site (TSS) regions of 25 genes, and 921 in enhancers. Thirteen SNPs were found in more than one category. We found two correlated and predicted non-benign coding variants (rs8100241 in exon 2 and rs8108174 in exon 3) of the gene, ANKLE1. Most putative functional LD SNPs, however, were found in either epigenetically defined enhancers or in gene TSS regions. Fifty-five percent of these non-coding SNPs are likely functional, since they affect response element (RE) sequences of transcription factors. Functionality of these SNPs was assessed by expression quantitative trait loci (eQTL) analysis and allele-specific enhancer assays. Unbiased analyses of SNPs at BCa risk loci revealed new and overlooked mechanisms that may affect risk of the disease, thereby providing a valuable resource for follow-up studies.	[Rhie, Suhn Kyong; Coetzee, Simon G.; Noushmehr, Houtan; Yan, Chunli; Haiman, Christopher A.; Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Rhie, Suhn Kyong; Coetzee, Simon G.; Noushmehr, Houtan; Yan, Chunli; Haiman, Christopher A.; Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90033 USA; [Kim, Jae Mun] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Coetzee, GA (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	coetzee@usc.edu	N, Houtan/C-9692-2013; coetzee, Gerhard/AAT-6203-2020; Coetzee, Gerhard/AAG-8439-2019; Coetzee, Simon/C-1218-2014	N, Houtan/0000-0003-4051-8114; Coetzee, Simon/0000-0003-4267-5930; Coetzee, Gerhard/0000-0001-8820-8364; Rhie, Suhn/0000-0002-5522-5296; Kim, Hugo/0000-0002-8610-9677	National Institutes of Health [R01 CA136924, T32CA009320]; Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative; NATIONAL CANCER INSTITUTE [R01CA136924, T32CA009320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [R01 CA136924 to GAC and T32CA009320 to HN). The scientific development and funding of this project were in part supported by the Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2010, Nature, V467, P1061, DOI 10.1038/nature09534; Adiseshaiah P, 2003, J BIOL CHEM, V278, P47423, DOI 10.1074/jbc.M303505200; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brachner A, 2012, J CELL SCI, V125, P1048, DOI 10.1242/jcs.098392; Chen F, 2013, HUM GENET, V132, P39, DOI 10.1007/s00439-012-1214-y; Coetzee SG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks542; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; D'Amato NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045684; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Evert BO, 2000, CELL TISSUE RES, V301, P189, DOI 10.1007/s004410000228; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; GHOUSSAINI M, 2013, NAT GENET, V44, P312; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hansson A, 2003, BIOCHEM BIOPH RES CO, V312, P1073, DOI 10.1016/j.bbrc.2003.11.030; Hardison RC, 2012, J BIOL CHEM, V287, P30932, DOI 10.1074/jbc.R112.352427; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kim HW, 2010, MOL CELL BIOL, V30, P5406, DOI 10.1128/MCB.00217-10; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lemonnier J, 2001, AM J PATHOL, V158, P1833, DOI 10.1016/S0002-9440(10)64139-9; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Liu Y, 2000, J BIOL CHEM, V275, P12231, DOI 10.1074/jbc.275.16.12231; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; MONDA KL, 2013, NAT GENET, DOI DOI 10.1038/NG.2608.[; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Ono Y, 1998, MOL CELL BIOL, V18, P6939, DOI 10.1128/MCB.18.12.6939; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Persani L, 2000, J CLIN ENDOCR METAB, V85, P2872, DOI 10.1210/jc.85.8.2872; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Qi W, 2007, EMBO J, V26, P65, DOI 10.1038/sj.emboj.7601483; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Rao MA, 2002, J BIOL CHEM, V277, P48020, DOI 10.1074/jbc.M209741200; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Seelan RS, 2004, ARCH BIOCHEM BIOPHYS, V431, P95, DOI 10.1016/j.abb.2004.08.002; Shin S, 2003, P NATL ACAD SCI USA, V100, P7201, DOI 10.1073/pnas.1132020100; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Smith AJP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002908; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Tarlac V, 2003, J NEUROSCI RES, V74, P406, DOI 10.1002/jnr.10746; Ting MC, 2012, DIS MODEL MECH, V5, P366, DOI 10.1242/dmm.008458; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; van Berkum Nynke L, 2010, J Vis Exp, DOI 10.3791/1869; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; VISVADER J, 1991, ONCOGENE, V6, P187; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	95	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63925	10.1371/journal.pone.0063925	http://dx.doi.org/10.1371/journal.pone.0063925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717510	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700080
J	Albacker, CE; Storer, NY; Langdon, EM; DiBiase, A; Zhou, Y; Langenau, DM; Zon, LI				Albacker, Colleen E.; Storer, Narie Y.; Langdon, Erin M.; DiBiase, Anthony; Zhou, Yi; Langenau, David M.; Zon, Leonard I.			The Histone Methyltransferase SUV39H1 Suppresses Embryonal Rhabdomyosarcoma Formation in Zebrafish	PLOS ONE			English	Article							CELLULAR SENESCENCE; RAS GENES; CYCLIN B1; N-RAS; CELLS; TUMORS; RECRUITMENT; MUTATIONS; DIFFERENTIATION; METHYLATION	Epigenetics, or the reversible and heritable marks of gene regulation not including DNA sequence, encompasses chromatin modifications on both the DNA and histones and is as important as the DNA sequence itself. Chromatin-modifying factors are playing an increasingly important role in tumorigenesis, particularly among pediatric rhabdomyosarcomas (RMS), revealing potential novel therapeutic targets. We performed an overexpression screen of chromatin-modifying factors in a KRAS(G12D)-driven zebrafish model for RMS. Here, we describe the identification of a histone H3 lysine 9 histone methyltransferase, SUV39H1, as a suppressor of embryonal RMS formation in zebrafish. This suppression is specific to the histone methyltransferase activity of SUV39H1, as point mutations in the SET domain lacked the effect. SUV39H1-overexpressing and control tumors have a similar proliferation rate, muscle differentiation state, and tumor growth rate. Strikingly, SUV39H1-overexpressing fish initiate fewer tumors, which results in the observed suppressive phenotype. We demonstrate that the delayed tumor onset occurs between 5 and 7 days post fertilization. Gene expression profiling at these stages revealed that in the context of KRAS(G12D) overexpression, SUV39H1 may suppress cell cycle progression. Our studies provide evidence for the role of SUV39H1 as a tumor suppressor.	[Albacker, Colleen E.; Storer, Narie Y.; Langdon, Erin M.; DiBiase, Anthony; Zhou, Yi; Zon, Leonard I.] Boston Childrens Hosp, Stem Cell Program, Boston, MA USA; [Albacker, Colleen E.; Storer, Narie Y.; Langdon, Erin M.; DiBiase, Anthony; Zhou, Yi; Zon, Leonard I.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Albacker, Colleen E.; Storer, Narie Y.; Langdon, Erin M.; DiBiase, Anthony; Zhou, Yi; Zon, Leonard I.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Harvard Stem Cell Inst,Dana Farber Canc Inst, Boston, MA 02115 USA; [Langenau, David M.] Massachusetts Gen Hosp, Dept Pathol, Harvard Stem Cell Inst, Charlestown, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Zon, LI (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA USA.	zon@enders.tch.harvard.edu	Langenau, David/GXI-0197-2022	Langenau, David/0000-0001-6664-8318	NIH grant [T32 HL07623]; NATIONAL CANCER INSTITUTE [R01CA103846, R01CA154923] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by NIH grant T32 HL07623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Breitfeld PP, 2005, ONCOLOGIST, V10, P518, DOI 10.1634/theoncologist.10-7-518; Brien DO, 2012, HISTOL HISTOPATHOL, V27, P13, DOI 10.14670/HH-27.13; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chen YY, 2006, GENE CHROMOSOME CANC, V45, P583, DOI 10.1002/gcc.20322; Cherrier T, 2009, ONCOGENE, V28, P3380, DOI 10.1038/onc.2009.193; Chuang JY, 2011, FREE RADICAL BIO MED, V51, P2309, DOI 10.1016/j.freeradbiomed.2011.10.001; DeCristofaro MF, 1999, ONCOGENE, V18, P7559, DOI 10.1038/sj.onc.1203168; Farina A, 1996, ONCOGENE, V13, P1287; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Huss R, 2000, CYTOKINE, V12, P1195, DOI 10.1006/cyto.1999.0732; Langenau DM, 2008, ONCOGENE, V27, P4242, DOI 10.1038/onc.2008.56; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Le XN, 2013, DEVELOPMENT, V140, P2354, DOI 10.1242/dev.088427; Li ZY, 2007, J BIOL CHEM, V282, P18872, DOI 10.1074/jbc.M609448200; Machado I, 2012, HUM PATHOL; Mal AK, 2006, EMBO J, V25, P3323, DOI 10.1038/sj.emboj.7601229; Martinelli S, 2009, GENE CHROMOSOME CANC, V48, P975, DOI 10.1002/gcc.20702; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Qualman SJ, 1998, PEDIATR DEVEL PATHOL, V1, P550, DOI 10.1007/s100249900076; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Ruymann FB, 2000, CANCER INVEST, V18, P223, DOI 10.3109/07357900009031827; Schildhaus HU, 2011, HUM PATHOL, V42, P1667, DOI 10.1016/j.humpath.2010.12.025; Schwienbacher C, 1998, P NATL ACAD SCI USA, V95, P3873, DOI 10.1073/pnas.95.7.3873; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Smith ACH, 2010, BLOOD, V115, P3296, DOI 10.1182/blood-2009-10-246488; STRATTON MR, 1989, CANCER RES, V49, P6324; Uno K, 2002, GENE CHROMOSOME CANC, V34, P33, DOI 10.1002/gcc.10052; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Vaute O, 2002, NUCLEIC ACIDS RES, V30, P475, DOI 10.1093/nar/30.2.475; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51	40	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64969	10.1371/journal.pone.0064969	http://dx.doi.org/10.1371/journal.pone.0064969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705022	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200176
J	Andrei, C; Zerulla, D				Andrei, Codrin; Zerulla, Dominic			Optimisation of Ruthenium Dye Sensitised Solar Cells Efficiency via Sn Diffusion into the TiO2 Mesoporous Layer	PLOS ONE			English	Article							PHOTOCATALYTIC ACTIVITY; CONVERSION EFFICIENCY; ELECTRIC-POWER; SURFACE-AREA; ZINC-OXIDE; THIN-FILM; LIGHT; ELECTROLYTE	Dye sensitised solar cells (DSCs) typically include a mesoporous titanium dioxide (TiO2) scaffold, sensitised with an adsorbed dye, as the main active element responsible for the photon absorption and charge separation functionalities. The sintering process employed in the TiO2 active layer fabrication plays a crucial role in the formation of the nanoparticle (NP) scaffold and hence in the performance of a dye sensitised solar cell, as it allows the particles to form efficient inter-crystalline electric contacts providing high electron conductivity. Furthermore, the DSC design requires a conductive transparent top electrode which is typically made of fluorinated stannic oxide. Here we report on a highly spatially resolved scanning electron microscopy study in conjunction with focussed ion beam milling and energy dispersive X-ray (EDX) mapping of the distribution of all relevant elements within a DSC subsequent to a classical sintering process in the range of 350 degrees C-550 degrees C. Additionally, the article provides quantitative results regarding the found Sn diffusion and its effect on efficiency confirmed via J-V measurements. The effective spatial resolution of the EDX studies was calculated by Monte Carlo simulations of the electron trajectories and X-ray emission region. This permits to construct a model for the migration of Sn from the transparent conductive oxide into the TiO2 scaffold, resulting in alterations in the composition of the complex system which has a direct effect on the DSC performance. J-V measurements conclude that sintering temperature of 500 degrees C is close to the optimum regarding Sn diffusion enhancement of DSCs. Sintering temperatures above 500 degrees C were causing a drop in the DSC efficiency and are therefore not recommended. In order to optimize the DSC efficiency, the results are summarized by a model that explains how the efficiency varies with the Sn diffusion process.	[Andrei, Codrin; Zerulla, Dominic] Univ Coll Dublin, Sch Phys, Plasmon & Ultrafast NanoOpt Lab, Dublin 2, Ireland; [Zerulla, Dominic] Univ Coll Dublin, Strateg Res Cluster Solar Energy Convers, Dublin 2, Ireland	University College Dublin; University College Dublin	Zerulla, D (corresponding author), Univ Coll Dublin, Sch Phys, Plasmon & Ultrafast NanoOpt Lab, Dublin 2, Ireland.	dominic.zerulla@ucd.ie	Zerulla, Dominic/L-6090-2018	Zerulla, Dominic/0000-0001-8479-9654	Irish Research Council [RS/2010/2943]; Romanian American Foundation; Science Foundation Ireland [11/RFP/MTR/3113, 07/SRC/B1160]	Irish Research Council(Irish Research Council for Science, Engineering and Technology); Romanian American Foundation; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The authors acknowledge support from Irish Research Council RS/2010/2943, Romanian American Foundation and Science Foundation Ireland 11/RFP/MTR/3113. They also acknowledge and thank Science Foundation Ireland for their funding of the Strategic Research Cluster in Solar Energy Conversion grant no. 07/SRC/B1160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei C, 2010, PHYS CHEM CHEM PHYS, V12, P7241, DOI 10.1039/c000072h; Brown MD, 2011, NANO LETT, V11, P438, DOI 10.1021/nl1031106; Cao YA, 2004, NEW J CHEM, V28, P218, DOI 10.1039/b306845e; Chiba Y, 2006, JPN J APPL PHYS 2, V45, pL638, DOI 10.1143/JJAP.45.L638; DAREEDWARDS MP, 1980, FARADAY DISCUSS, V70, P285, DOI 10.1039/dc9807000285; DESILVESTRO J, 1985, J AM CHEM SOC, V107, P2988, DOI 10.1021/ja00296a035; DO YR, 1994, J SOLID STATE CHEM, V108, P198, DOI 10.1006/jssc.1994.1031; Doyle G, 2007, APPL PHYS A-MATER, V89, P351, DOI 10.1007/s00339-007-4126-2; Drouin D, 2007, SCANNING, V29, P92, DOI 10.1002/sca.20000; Duan YD, 2012, J PHYS CHEM C, V116, P8888, DOI 10.1021/jp212517k; DUNG DH, 1984, HELV CHIM ACTA, V67, P1012; Gerischer H., 1968, PHYS CHEM, V72, P437; Gratzel M, 2004, J PHOTOCH PHOTOBIO A, V164, P3, DOI 10.1016/j.jphotochem.2004.02.023; Green MA, 2009, PROG PHOTOVOLTAICS, V17, P85, DOI 10.1002/pip.880; Ito S, 2005, CHEM COMMUN, P4351, DOI 10.1039/b505718c; Ito S, 2008, THIN SOLID FILMS, V516, P4613, DOI 10.1016/j.tsf.2007.05.090; Kamat PV, 2008, J PHYS CHEM C, V112, P18737, DOI 10.1021/jp806791s; Lin J, 1999, J CATAL, V183, P368, DOI 10.1006/jcat.1999.2409; Meen TH, 2009, J PHYS CHEM SOLIDS, V70, P472, DOI 10.1016/j.jpcs.2008.12.002; NAMBA S, 1965, J PHYS CHEM-US, V69, P774, DOI 10.1021/j100887a010; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; Nazeeruddin MK, 2003, J PHYS CHEM B, V107, P8981, DOI 10.1021/jp022656f; Nazeeruddin MK, 1997, CHEM COMMUN, P1705, DOI 10.1039/a703277c; O'Reilly T, 2013, ADV EN MAT IN PRESS; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; OTTERMANN C, 1993, MATER RES SOC SYMP P, V308, P69, DOI 10.1557/PROC-308-69; PECHY P, 1995, J CHEM SOC CHEM COMM, P65, DOI 10.1039/c39950000065; Shi D, 2008, J PHYS CHEM C, V112, P17046, DOI 10.1021/jp808018h; Smestad GP, 1998, J CHEM EDUC, V75, P752, DOI 10.1021/ed075p752; Tachibana Y, 2001, J PHYS CHEM B, V105, P7424, DOI 10.1021/jp010173q; TSUBOMURA H, 1976, NATURE, V261, P402, DOI 10.1038/261402a0; VLACHOPOULOS N, 1988, J AM CHEM SOC, V110, P1216, DOI 10.1021/ja00212a033; Williamson A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3633349; Xin BF, 2009, APPL SURF SCI, V255, P5896, DOI 10.1016/j.apsusc.2009.01.027; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Zheng SK, 2002, VACUUM, V65, P155, DOI 10.1016/S0042-207X(01)00424-9; Zhu K, 2006, J PHYS CHEM B, V110, P25174, DOI 10.1021/jp065284+	37	0	0	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63923	10.1371/journal.pone.0063923	http://dx.doi.org/10.1371/journal.pone.0063923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704956	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200087
J	Hooda, J; Cadinu, D; Alam, MM; Shah, A; Cao, TM; Sullivan, LA; Brekken, R; Zhang, L				Hooda, Jagmohan; Cadinu, Daniela; Alam, Md Maksudul; Shah, Ajit; Cao, Thai M.; Sullivan, Laura A.; Brekken, Rolf; Zhang, Li			Enhanced Heme Function and Mitochondrial Respiration Promote the Progression of Lung Cancer Cells	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; IN-SITU; METABOLISM; EXPRESSION; DEFICIENCY; OXYGEN; ALPHA; IDENTIFICATION; HEPATOCYTES; INHIBITION	Lung cancer is the leading cause of cancer-related mortality, and about 85% of the cases are non-small-cell lung cancer (NSCLC). Importantly, recent advance in cancer research suggests that altering cancer cell bioenergetics can provide an effective way to target such advanced cancer cells that have acquired mutations in multiple cellular regulators. This study aims to identify bioenergetic alterations in lung cancer cells by directly measuring and comparing key metabolic activities in a pair of cell lines representing normal and NSCLC cells developed from the same patient. We found that the rates of oxygen consumption and heme biosynthesis were intensified in NSCLC cells. Additionally, the NSCLC cells exhibited substantially increased levels in an array of proteins promoting heme synthesis, uptake and function. These proteins include the rate-limiting heme biosynthetic enzyme ALAS, transporter proteins HRG1 and HCP1 that are involved in heme uptake, and various types of oxygen-utilizing hemoproteins such as cytoglobin and cytochromes. Several types of human tumor xenografts also displayed increased levels of such proteins. Furthermore, we found that lowering heme biosynthesis and uptake, like lowering mitochondrial respiration, effectively reduced oxygen consumption, cancer cell proliferation, migration and colony formation. In contrast, lowering heme degradation does not have an effect on lung cancer cells. These results show that increased heme flux and function are a key feature of NSCLC cells. Further, increased generation and supply of heme and oxygen-utilizing hemoproteins in cancer cells will lead to intensified oxygen consumption and cellular energy production by mitochondrial respiration, which would fuel cancer cell proliferation and progression. The results show that inhibiting heme and respiratory function can effectively arrest the progression of lung cancer cells. Hence, understanding heme function can positively impact on research in lung cancer biology and therapeutics.	[Hooda, Jagmohan; Cadinu, Daniela; Alam, Md Maksudul; Shah, Ajit; Cao, Thai M.; Zhang, Li] Univ Texas Dallas, Dept Mol & Cell Biol, Ctr Syst Biol, Richardson, TX 75083 USA; [Sullivan, Laura A.; Brekken, Rolf] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, L (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, Ctr Syst Biol, Richardson, TX 75083 USA.	li.zhang@utdallas.edu	Shah, Ajit/AAT-5242-2020; Hooda, Jagmohan/I-7134-2019; Zhang, Li/L-5206-2013; shah, Ajit/J-3114-2019	Hooda, Jagmohan/0000-0001-5001-6092; Zhang, Li/0000-0001-9242-0763; shah, Ajit/0000-0001-5059-1011	Cecil H. and Ida Green funds; NCI SPORE [P50CA70907]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	Cecil H. and Ida Green funds; NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Cecil H. and Ida Green funds (LZ) and the NCI SPORE P50CA70907 grant (RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; ANDERSON KE, 2001, METABOLIC MOL BASES, P2991; Birsoy K, 2012, NAT MED, V18, P1022, DOI 10.1038/nm.2870; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; CHANCE B, 1965, J GEN PHYSIOL, V49, P163, DOI 10.1085/jgp.49.1.163; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Chernova T, 2006, MOL PHARMACOL, V69, P697, DOI 10.1124/mol.105.016675; Chernova T, 2007, J NEUROSCI, V27, P8475, DOI 10.1523/JNEUROSCI.0792-07.2007; Dailey HA, 1990, BIOSYNTHESIS HEME CH, P183; Dang CV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe75; Dang TN, 2010, GLIA, V58, P55, DOI 10.1002/glia.20901; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; DEMATTEIS F, 1983, FEBS LETT, V159, P127, DOI 10.1016/0014-5793(83)80430-X; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Escobar M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/806506; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Guppy M, 2002, BIOCHEM J, V364, P309, DOI 10.1042/bj3640309; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Herst PM, 2007, BBA-BIOENERGETICS, V1767, P170, DOI 10.1016/j.bbabio.2006.11.018; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kaambre T, 2012, J BIOENERG BIOMEMBR, V44, P539, DOI 10.1007/s10863-012-9457-9; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Labbe-Bois R, 1990, BIOSYNTHESIS HEME CH, P235; Latunde-Dada GO, 2006, FEBS LETT, V580, P6865, DOI 10.1016/j.febslet.2006.11.048; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Minami S, 1923, BIOCHEM Z, V142, P94; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Mountain CF, 2000, SEMIN SURG ONCOL, V18, P106, DOI 10.1002/(SICI)1098-2388(200003)18:2<106::AID-SSU4>3.0.CO;2-P; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Organization WH, 2011, CANCER; Ortiz de Montellano PR, 2009, WILEY ENCY CHEM BIOL, P240; PADMANABAN G, 1989, TRENDS BIOCHEM SCI, V14, P492, DOI 10.1016/0968-0004(89)90182-5; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pejznochova M, 2010, MITOCHONDRION, V10, P321, DOI 10.1016/j.mito.2010.01.006; Pejznochova M, 2008, PHYSIOL RES, V57, P947, DOI 10.33549/physiolres.931246; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sangodkar J, 2010, MT SINAI J MED, V77, P597, DOI 10.1002/msj.20226; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Sengupta A, 2005, MOL BRAIN RES, V137, P23, DOI 10.1016/j.molbrainres.2005.02.007; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; SHEDLOFSKY SI, 1987, BIOCHEM J, V248, P229, DOI 10.1042/bj2480229; Sly WS, 2009, METABOLIC MOL BASES, P1; Sullivan LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012031; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353; Warburg O. H., 1930, METABOLISM TUMOURS I; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P4047, DOI 10.4161/cc.10.23.18151; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Yao XA, 2010, BIOCHEM BIOPH RES CO, V403, P30, DOI 10.1016/j.bbrc.2010.10.101; Ye WZ, 2004, BIOCHEM BIOPH RES CO, V315, P546, DOI 10.1016/j.bbrc.2004.01.092; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zhang L, 2011, HEME BIOL SECRET LIF; Zhu YH, 2002, CELL GROWTH DIFFER, V13, P431	63	73	74	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63402	10.1371/journal.pone.0063402	http://dx.doi.org/10.1371/journal.pone.0063402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704904	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200034
J	Karppi, J; Kurl, S; Ronkainen, K; Kauhanen, J; Laukkanen, JA				Karppi, Jouni; Kurl, Sudhir; Ronkainen, Kimmo; Kauhanen, Jussi; Laukkanen, Jari A.			Serum Carotenoids Reduce Progression of Early Atherosclerosis in the Carotid Artery Wall among Eastern Finnish Men	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; INTIMA-MEDIA THICKNESS; LOS-ANGELES-ATHEROSCLEROSIS; DISEASE RISK FACTOR; MYOCARDIAL-INFARCTION; BETA-CAROTENE; PLASMA-LEVELS; ANTIOXIDANT; LYCOPENE; DIETARY	Background: Several previous epidemiologic studies have shown that high blood levels of carotenoids may be protective against early atherosclerosis, but results have been inconsistent. We assessed the association between atherosclerotic progression, measured by intima-media thickness of the common carotid artery wall, and serum levels of carotenoids. Methods: We studied the effect of carotenoids on progression of early atherosclerosis in a population-based study. The association between concentrations of serum carotenoids, and intima-media thickness of the common carotid artery wall was explored in 840 middle-aged men (aged 46-65 years) from Eastern Finland. Ultrasonography of the common carotid arteries were performed at baseline and 7-year follow-up. Serum levels of carotenoids were analyzed at baseline. Changes in mean and maximum intima media thickness of carotid artery wall were related to baseline serum carotenoid levels in covariance analyses adjusted for covariates. Results: In a covariance analysis with adjustment for age, ultrasound sonographer, maximum intima media thickness, examination year, body mass index, systolic blood pressure, smoking, physical activity, serum LDL cholesterol, family history of coronary heart disease, antihypertensive medication and serum high sensitivity C-reactive protein, 7-year change in maximum intima media thickness was inversely associated with lycopene (p = 0.005), alpha-carotene (p = 0.002) and beta-carotene (p = 0.019), respectively. Conclusions: The present study shows that high serum concentrations of carotenoids may be protective against early atherosclerosis.	[Karppi, Jouni; Kurl, Sudhir; Ronkainen, Kimmo; Kauhanen, Jussi; Laukkanen, Jari A.] Univ Eastern Finland, Dept Med, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Karppi, Jouni; Kurl, Sudhir; Laukkanen, Jari A.] Lapland Cent Hosp, Dept Internal Med, Rovaniemi, Finland	University of Eastern Finland	Karppi, J (corresponding author), Univ Eastern Finland, Dept Med, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.	jouni.karppi@uef.fi	Kauhanen, Jussi/ABC-4064-2021; Laukkanen, Jari A/I-4528-2017; Laukkanen, Jari Antero/N-2196-2019	Laukkanen, Jari A/0000-0002-3738-1586; Laukkanen, Jari Antero/0000-0002-3738-1586	EVO funding of Lapland Central Hospital; Orion-Farmos Research Foundation	EVO funding of Lapland Central Hospital; Orion-Farmos Research Foundation	This work was supported by the EVO funding of Lapland Central Hospital and Orion-Farmos Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calabro P, 2009, SEMIN IMMUNOPATHOL, V31, P79, DOI 10.1007/s00281-009-0149-4; Cantrell A, 2003, ARCH BIOCHEM BIOPHYS, V412, P47, DOI 10.1016/S0003-9861(03)00014-6; D'Odorico A, 2000, ATHEROSCLEROSIS, V153, P231, DOI 10.1016/S0021-9150(00)00403-2; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Dwyer JH, 2004, ARTERIOSCL THROM VAS, V24, P313, DOI 10.1161/01.ATV.0000109955.80818.8a; Dwyer JH, 2001, CIRCULATION, V103, P2922, DOI 10.1161/01.CIR.103.24.2922; Gale CR, 2001, AM J CLIN NUTR, V74, P402; Gianetti J, 2002, AM HEART J, V143, P467, DOI 10.1067/mhj.2002.120776; GRINES CL, 1995, CIRCULATION, V91, P298, DOI 10.1161/01.CIR.91.2.298; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Iannuzzi A, 2002, AM J CLIN NUTR, V76, P582, DOI 10.1093/ajcn/76.3.582; Itabe H, 2009, CLIN REV ALLERG IMMU, V37, P4, DOI 10.1007/s12016-008-8095-9; Karppi J, 2011, J INTERN MED, V270, P478, DOI 10.1111/j.1365-2796.2011.02401.x; Kritchevsky SB, 1998, AM J CLIN NUTR, V68, P726, DOI 10.1093/ajcn/68.3.726; KRITCHEVSKY SB, 1995, CIRCULATION, V92, P2142, DOI 10.1161/01.CIR.92.8.2142; Kritchevsky SB, 2000, AM J EPIDEMIOL, V152, P1065, DOI 10.1093/aje/152.11.1065; Laukkanen JA, 2006, EUR J CARDIOV PREV R, V13, P421, DOI 10.1097/00149831-200606000-00019; Lidebjer C, 2007, NUTR METAB CARDIOVAS, V17, P448, DOI 10.1016/j.numecd.2006.02.006; Mildel J, 2007, MOL NUTR FOOD RES, V51, P956, DOI 10.1002/mnfr.200600271; Poulsen HE, 2000, FREE RADICAL RES, V33, pS33; Riccioni G, 2011, J BIOL REG HOMEOS AG, V25, P435; Riccioni G, 2007, EXPERT OPIN INV DRUG, V16, P25, DOI 10.1517/13543784.16.1.25; Riccioni G, 2009, EUR J CARDIOV PREV R, V16, P351, DOI 10.1097/HJR.0b013e328325d807; Rissanen TH, 2003, AM J CLIN NUTR, V77, P133, DOI 10.1093/ajcn/77.1.133; SALONEN JT, 1993, LANCET, V341, P1158, DOI 10.1016/0140-6736(93)93184-3; SALONEN JT, 1993, CIRCULATION, V87, P56; SALONEN JT, 1988, ANN CLIN RES, V20, P46; SELZER RH, 1994, ATHEROSCLEROSIS, V111, P1, DOI 10.1016/0021-9150(94)90186-4; Stanner SA, 2004, PUBLIC HEALTH NUTR, V7, P407, DOI 10.1079/PHN2003543; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; THURNHAM DI, 1988, CLIN CHEM, V34, P377; Wei W, 2001, AM J PUBLIC HEALTH, V91, P258, DOI 10.2105/AJPH.91.2.258; Young AJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P20, DOI 10.1006/abbi.2000.2149; Zou ZY, 2011, ATHEROSCLEROSIS, V219, P789, DOI 10.1016/j.atherosclerosis.2011.08.006; Zwaka TP, 2001, CIRCULATION, V103, P1194	37	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64107	10.1371/journal.pone.0064107	http://dx.doi.org/10.1371/journal.pone.0064107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700460	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200117
J	Leveque, P; Desmet, C; Dos Santos-Goncalvez, AM; Beun, S; Leprince, JG; Leloup, G; Gallez, B				Leveque, Philippe; Desmet, Celine; Maria Dos Santos-Goncalvez, Ana; Beun, Sebastien; Leprince, Julian G.; Leloup, Gaetane; Gallez, Bernard			Influence of Free Radicals Signal from Dental Resins on the Radio-Induced Signal in Teeth in EPR Retrospective Dosimetry	PLOS ONE			English	Article							TOOTH ENAMEL; RESTORATIVE MATERIALS; BIOLOGICAL DOSIMETRY; BIODOSIMETRY; CASUALTIES; IRRADIATION; HEALTH; EXPOSURE; NETWORK	In case of radiological accident, retrospective dosimetry is needed to reconstruct the absorbed dose of overexposed individuals not wearing personal dosimeters at the onset of the incident. In such a situation, emergency mass triage will be required. In this context, it has been shown that Electron Paramagnetic Resonance (EPR) spectroscopy would be a rapid and sensitive method, on the field deployable system, allowing dose evaluation of a great number of people in a short time period. This methodology uses tooth enamel as a natural dosimeter. Ionising radiations create stable free radicals in the enamel, in a dose dependent manner, which can be detected by EPR directly in the mouth with an appropriate resonator. Teeth are often subject to restorations, currently made of synthetic dimethacrylate-based photopolymerizable composites. It is known that some dental composites give an EPR signal which is likely to interfere with the dosimetric signal from the enamel. So far, no information was available about the occurrence of this signal in the various composites available on the market, the magnitude of the signal compared to the dosimetric signal, nor its evolution with time. In this study, we conducted a systematic characterization of the signal (intensity, kinetics, interference with dosimetric signal) on 19 most widely used composites for tooth restoration, and on 14 experimental resins made with the most characteristic monomers found in commercial composites. Although a strong EPR signal was observed in every material, a rapid decay of the signal was noted. Six months after the polymerization, the signal was negligible in most composites compared to a 3 Gy dosimetric signal in a tooth. In some cases, a stable atypical signal was observed, which was still interfering with the dosimetric signal.	[Leveque, Philippe; Desmet, Celine; Gallez, Bernard] Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, B-1200 Brussels, Belgium; [Leveque, Philippe; Leprince, Julian G.; Leloup, Gaetane; Gallez, Bernard] Catholic Univ Louvain, Ctr Res & Engn Biomat CRIBIO, B-1200 Brussels, Belgium; [Leprince, Julian G.; Leloup, Gaetane] Catholic Univ Louvain, Inst Condensed Matter & Nanosci Bio & Soft Matter, Louvain, Belgium; [Maria Dos Santos-Goncalvez, Ana; Beun, Sebastien; Leprince, Julian G.; Leloup, Gaetane] Catholic Univ Louvain, Sch Dent & Stomatol, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain	Gallez, B (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, B-1200 Brussels, Belgium.	Bernard.gallez@uclouvain.be	Leprince, Julian/O-7942-2019; Leprince, Julian G/A-8489-2012; LEVEQUE, Philippe/N-8749-2014	Leprince, Julian/0000-0001-7396-0019; LEVEQUE, Philippe/0000-0003-3687-436X	The National Institutes of Health [U19AI091173]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091173] Funding Source: NIH RePORTER	The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by The National Institutes of Health, grant number U19AI091173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsbury EA, 2011, RADIAT PROT DOSIM, V147, P573, DOI 10.1093/rpd/ncq499; ANNO GH, 1989, HEALTH PHYS, V56, P821, DOI 10.1097/00004032-198906000-00001; Anno GH, 2003, HEALTH PHYS, V84, P565, DOI 10.1097/00004032-200305000-00001; Blakely WE, 2009, RADIAT RES, V171, P127, DOI 10.1667/RR1549.1; Bushberg JT, 2007, J EMERG MED, V32, P71, DOI 10.1016/j.jemermed.2006.05.034; COLE T, 1963, NATURE, V200, P700, DOI 10.1038/200700a0; Coleman CN, 2009, ANN EMERG MED, V53, P213, DOI 10.1016/j.annemergmed.2007.12.021; Cramer NB, 2011, J DENT RES, V90, P402, DOI 10.1177/0022034510381263; Fattibene P, 2010, APPL RADIAT ISOTOPES, V68, P2033, DOI 10.1016/j.apradiso.2010.05.016; Gomez JA, 2011, RADIAT RES, V176, P259, DOI 10.1667/RR2503.1; Grace MB, 2010, HEALTH PHYS, V98, P172, DOI 10.1097/01.HP.0000348001.60905.c0; Hafer N, 2010, HEALTH PHYS, V98, P903, DOI 10.1097/HP.0b013e3181bbc4df; Jiao L, 2007, J RADIAT RES, V48, P21, DOI 10.1269/jrr.0616; Koenig KL, 2005, ANN EMERG MED, V45, P643, DOI 10.1016/j.annemergmed.2005.01.020; Kulka U, 2012, RADIAT PROT DOSIM, V151, P621, DOI 10.1093/rpd/ncs157; Leonard A, 2005, RADIAT PROT DOSIM, V115, P448, DOI 10.1093/rpd/nci061; Leprince J, 2010, J ORAL REHABIL, V37, P364, DOI 10.1111/j.1365-2842.2010.02066.x; Leprince JG, 2010, J DENT RES, V89, P1494, DOI 10.1177/0022034510384624; Leprince JG, 2012, DENT MAT; Leprince J, 2009, ACTA BIOMATER, V5, P2518, DOI 10.1016/j.actbio.2009.04.034; Nyberg AG, 2011, INT J ENV RES PUB HE, V8, P4521, DOI 10.3390/ijerph8124521; Sholom S, 2010, HEALTH PHYS, V98, P360, DOI 10.1097/01.HP.0000348002.69740.bd; Sideridou I, 2003, BIOMATERIALS, V24, P655, DOI 10.1016/S0142-9612(02)00380-0; Swartz HM, 2012, HEALTH PHYS, V103, P255, DOI 10.1097/HP.0b013e3182588d92; SWARTZ HM, 1965, RADIAT RES, V24, P579, DOI 10.2307/3571876; Truffier-Boutry D, 2003, J POLYM SCI POL CHEM, V41, P1691, DOI 10.1002/pola.10692; Williams BB, 2011, INT J RADIAT BIOL, V87, P766, DOI 10.3109/09553002.2011.583316; Wojcik A, 2010, RADIAT PROT DOSIM, V138, P397, DOI 10.1093/rpd/ncp279	28	4	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62225	10.1371/journal.pone.0062225	http://dx.doi.org/10.1371/journal.pone.0062225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704875	gold, Green Submitted, Green Published			2022-12-27	WOS:000319330200004
J	Turczynska, KM; Bhattachariya, A; Sall, J; Goransson, O; Sward, K; Hellstrand, P; Albinsson, S				Turczynska, Karolina M.; Bhattachariya, Anirban; Sall, Johanna; Goransson, Olga; Sward, Karl; Hellstrand, Per; Albinsson, Sebastian			Stretch-Sensitive Down-Regulation of the miR-144/451 Cluster in Vascular Smooth Muscle and Its Role in AMP-Activated Protein Kinase Signaling	PLOS ONE			English	Article							CELL DIFFERENTIATION; CONTRACTILE DIFFERENTIATION; ACTIN POLYMERIZATION; HYPERTENSIVE-RATS; DEPENDENT GROWTH; EXPRESSION; PRESSURE; WALL; PROLIFERATION; MICRORNAS	Vascular smooth muscle cells are constantly exposed to mechanical force by the blood pressure, which is thought to regulate smooth muscle growth, differentiation and contractile function. We have previously shown that the expression of microRNAs (miRNAs), small non-coding RNAs, is essential for regulation of smooth muscle phenotype including stretch-dependent contractile differentiation. In this study, we have investigated the effect of mechanical stretch on miRNA expression and the role of stretch-sensitive miRNAs for intracellular signaling in smooth muscle. MiRNA array analysis, comparing miRNA levels in stretched versus non-stretched portal veins, revealed a dramatic decrease in the miR-144/451 cluster level. Because this miRNA cluster is predicted to target AMPK pathway components, we next examined activation of this pathway. Diminished miR-144/451 expression was inversely correlated with increased phosphorylation of AMPK alpha at Thr172 in stretched portal vein. Similar to the effect of stretch, contractile differentiation could be induced in non-stretched portal veins by the AMPK activator, AICAR. Transfection with miR-144/451 mimics reduced the protein expression level of mediators in the AMPK pathway including MO25 alpha, AMPK and ACC. This effect also decreased AICAR-induced activation of the AMPK signaling pathway. In conclusion, our results suggest that stretch-induced activation of AMPK in vascular smooth muscle is in part regulated by reduced levels of miR-144/451 and that this effect may play a role in promoting contractile differentiation of smooth muscle cells.	[Turczynska, Karolina M.; Bhattachariya, Anirban; Sall, Johanna; Goransson, Olga; Sward, Karl; Hellstrand, Per; Albinsson, Sebastian] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Albinsson, S (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	sebastian.albinsson@med.lu.se	Albinsson, Sebastian/B-4105-2010; Säll, Johanna/C-1083-2015; Bhattachariya, Anirban/H-5566-2013	Albinsson, Sebastian/0000-0001-6936-3967; Säll, Johanna/0000-0001-7337-4140; Bhattachariya, Anirban/0000-0002-7687-3786; Sward, Karl/0000-0002-7255-5510; Goransson, Olga/0000-0002-7209-8022	Swedish Research Council; Heart and Lung Foundation; Greta and Johan Kock's Foundation; Crafoord Foundation; Royal Physiographic Society; Ake Wiberg Foundation; Tore Nilson Foundation; Magnus Bergvall Foundation; Lars Hierta Memorial Foundation; Jeansson Foundation; Marie Curie Initial Training Network Small Artery Remodelling (SmArt) from the European Union	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Greta and Johan Kock's Foundation; Crafoord Foundation; Royal Physiographic Society; Ake Wiberg Foundation; Tore Nilson Foundation; Magnus Bergvall Foundation; Lars Hierta Memorial Foundation; Jeansson Foundation; Marie Curie Initial Training Network Small Artery Remodelling (SmArt) from the European Union	This work has been supported by The Swedish Research Council, The Heart and Lung Foundation, The Greta and Johan Kock's Foundation, The Crafoord Foundation; The Royal Physiographic Society; The Ake Wiberg Foundation; The Tore Nilson Foundation; The Magnus Bergvall Foundation, The Lars Hierta Memorial Foundation, The Jeansson Foundation. KT is supported by the Marie Curie Initial Training Network Small Artery Remodelling (SmArt) from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Albinsson S, 2008, AM J PHYSIOL-CELL PH, V294, pC271, DOI 10.1152/ajpcell.00297.2007; Albinsson S, 2007, AM J PHYSIOL-REG I, V293, pR1222, DOI 10.1152/ajpregu.00092.2007; Albinsson S, 2007, AM J PHYSIOL-CELL PH, V293, pC772, DOI 10.1152/ajpcell.00622.2006; Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birukov KG, 1998, ARTERIOSCL THROM VAS, V18, P922, DOI 10.1161/01.ATV.18.6.922; Carnevale D, 2012, CARDIOVASC RES, V93, P200, DOI 10.1093/cvr/cvr288; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041574; Ding M, 2011, ARTERIOSCL THROM VAS, V31, P1403, DOI 10.1161/ATVBAHA.110.216804; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Fox JC, 2012, AM J PHYSL HEART CIR; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gormand A, 2011, J CELL BIOCHEM, V112, P1364, DOI 10.1002/jcb.23053; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; Kawahara S, 2005, J CARDIOVASC PHARM, V45, P367, DOI 10.1097/01.fjc.0000157454.60939.43; Kim J, 2005, EUR J PHARMACOL, V514, P209, DOI 10.1016/j.ejphar.2005.03.030; Komatsu R, 1998, CIRCULATION, V98, P224, DOI 10.1161/01.CIR.98.3.224; Long X, 2009, J BIOL CHEM, V284, P33671, DOI 10.1074/jbc.M109.050419; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; Seasholtz TM, 2001, CIRC RES, V89, P488, DOI 10.1161/hh1801.096337; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Song L, 2012, ARCH BIOCHEM BIOPHYS, V528, P204, DOI 10.1016/j.abb.2012.08.015; Song P, 2011, CIRC RES, V109, P1230, DOI 10.1161/CIRCRESAHA.111.250423; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wang XH, 2012, CARDIOVASC RES, V94, P379, DOI 10.1093/cvr/cvs096; Wesselman JPM, 2001, HYPERTENSION, V37, P955, DOI 10.1161/01.HYP.37.3.955; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Xu QB, 1996, J CLIN INVEST, V97, P508, DOI 10.1172/JCI118442; Zeidan A, 2003, ARTERIOSCL THROM VAS, V23, P1528, DOI 10.1161/01.ATV.0000090129.75275.C2; Zeidan A, 2003, AM J PHYSIOL-CELL PH, V284, pC1387, DOI 10.1152/ajpcell.00508.2002; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007	41	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65135	10.1371/journal.pone.0065135	http://dx.doi.org/10.1371/journal.pone.0065135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705032	gold, Green Submitted, Green Published			2022-12-27	WOS:000319330200187
J	Weber, TA; Koob, S; Heide, H; Wittig, I; Head, B; van der Bliek, A; Brandt, U; Mittelbronn, M; Reichert, AS				Weber, Tobias A.; Koob, Sebastian; Heide, Heinrich; Wittig, Ilka; Head, Brian; van der Bliek, Alexander; Brandt, Ulrich; Mittelbronn, Michel; Reichert, Andreas S.			APOOL Is a Cardiolipin-Binding Constituent of the Mitofilin/MINOS Protein Complex Determining Cristae Morphology in Mammalian Mitochondria	PLOS ONE			English	Article							INNER MEMBRANE; ATP SYNTHASE; RESPIRATORY-CHAIN; COILED-COIL; ORGANIZATION; ULTRASTRUCTURE; BIOGENESIS; COMPONENT; APOPTOSIS; TOPOLOGY	Mitochondrial cristae morphology is highly variable and altered under numerous pathological conditions. The protein complexes involved are largely unknown or only insufficiently characterized. Using complexome profiling we identified apolipoprotein O (APOO) and apolipoprotein O-like protein (APOOL) as putative components of the Mitofilin/MINOS protein complex which was recently implicated in determining cristae morphology. We show that APOOL is a mitochondrial membrane protein facing the intermembrane space. It specifically binds to cardiolipin in vitro but not to the precursor lipid phosphatidylglycerol. Overexpression of APOOL led to fragmentation of mitochondria, a reduced basal oxygen consumption rate, and altered cristae morphology. Downregulation of APOOL impaired mitochondrial respiration and caused major alterations in cristae morphology. We further show that APOOL physically interacts with several subunits of the MINOS complex, namely Mitofilin, MINOS1, and SAMM50. We conclude that APOOL is a cardiolipin-binding component of the Mitofilin/MINOS protein complex determining cristae morphology in mammalian mitochondria. Our findings further assign an intracellular role to a member of the apolipoprotein family in mammals.	[Weber, Tobias A.; Koob, Sebastian; Reichert, Andreas S.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60054 Frankfurt, Germany; [Weber, Tobias A.; Koob, Sebastian; Reichert, Andreas S.] Goethe Univ Frankfurt, Zentrum Mol Med, D-60054 Frankfurt, Germany; [Heide, Heinrich; Wittig, Ilka; Brandt, Ulrich] Goethe Univ Frankfurt, Sch Med, Mol Bioenerget Grp, D-60054 Frankfurt, Germany; [Head, Brian; van der Bliek, Alexander] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Mittelbronn, Michel] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Goethe University Frankfurt	Reichert, AS (corresponding author), Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60054 Frankfurt, Germany.	Andreas.Reichert@bmls-institute.de	Reichert, Andreas/A-4090-2012; Brandt, Ulrich/C-4406-2008; Brandt, Ulrich/GLV-1242-2022	Brandt, Ulrich/0000-0003-1869-6811; Brandt, Ulrich/0000-0003-1869-6811; Mittelbronn, Michel/0000-0002-2998-052X; Reichert, Andreas/0000-0001-9340-3113	Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG [EXC 115]; Deutsche Forschungsgemeinschaft [SFB815]; BMBF [01GM1113B]	Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the the Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG project EXC 115 (AR, TW, UB, IW), by the Deutsche Forschungsgemeinschaft SFB815 Project Z1 (UB, HH, IW) and The BMBF 01GM1113B- mitoNET (IW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Bornhovd C, 2006, J BIOL CHEM, V281, P13990, DOI 10.1074/jbc.M512334200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Collins MO, 2008, PROTOCOL EXCHANGE, DOI [10.1038/nprot.2008.1123, DOI 10.1038/NPR0T.2008.1123]; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; DAEMS WT, 1966, J ULTRA MOL STRUCT R, V16, P123, DOI 10.1016/S0022-5320(66)80027-8; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gieffers C, 1997, EXP CELL RES, V232, P395, DOI 10.1006/excr.1997.3539; Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1; Head BP, 2011, MOL BIOL CELL, V22, P831, DOI 10.1091/mbc.E10-07-0600; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; HJERTEN S, 1962, ANAL BIOCHEM, V3, P109, DOI 10.1016/0003-2697(62)90100-8; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Korner C, 2012, MOL BIOL CELL, V23, P2143, DOI 10.1091/mbc.E11-10-0831; Lamant M, 2006, J BIOL CHEM, V281, P36289, DOI 10.1074/jbc.M510861200; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; Mannella CA, 1997, TRENDS BIOCHEM SCI, V22, P37, DOI 10.1016/S0968-0004(96)30050-9; Mannella CA, 2001, IUBMB LIFE, V52, P93, DOI 10.1080/15216540152845885; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Nijstad N, 2011, BBA-MOL CELL BIOL L, V1811, P294, DOI 10.1016/j.bbalip.2011.01.008; Odgren PR, 1996, J CELL SCI, V109, P2253; Okita C, 2004, BIOTECHNIQUES, V36, P418, DOI 10.2144/04363ST01; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Sakamoto T, 2012, J BIOL CHEM, V287, P4590, DOI 10.1074/jbc.M111.314823; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Strecker V, 2010, PROTEOMICS, V10, P3379, DOI 10.1002/pmic.201000343; Stroud DA, 2012, MOL BIOL CELL; Tao H, 2010, BIOTECHNIQUES, V48, P61, DOI 10.2144/000113304; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Wriessnegger T, 2009, BBA-MOL CELL BIOL L, V1791, P166, DOI 10.1016/j.bbalip.2008.12.017; Wurm CA, 2006, FEBS LETT, V580, P5628, DOI 10.1016/j.febslet.2006.09.012; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Zerbes RM, 2012, J MOL BIOL, V422, P183, DOI 10.1016/j.jmb.2012.05.004; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	59	106	111	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63683	10.1371/journal.pone.0063683	http://dx.doi.org/10.1371/journal.pone.0063683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704930	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200061
J	Xapelli, S; Agasse, F; Sarda-Arroyo, L; Bernardino, L; Santos, T; Ribeiro, FF; Valero, J; Braganca, J; Schitine, C; Reis, RAD; Sebastiao, AM; Malva, JO				Xapelli, Sara; Agasse, Fabienne; Sarda-Arroyo, Laura; Bernardino, Liliana; Santos, Tiago; Ribeiro, Filipa F.; Valero, Jorge; Braganca, Jose; Schitine, Clarissa; de Melo Reis, Ricardo A.; Sebastiao, Ana M.; Malva, Joao O.			Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; ADULT NEUROGENESIS; FUNCTIONAL IDENTIFICATION; NEURONAL DIFFERENTIATION; PROLIFERATION; BRAIN; CB2; ANANDAMIDE; EXPRESSION; MIGRATION	The endocannabinoid system has been implicated in the modulation of adult neurogenesis. Here, we describe the effect of type 1 cannabinoid receptor (CB1R) activation on self-renewal, proliferation and neuronal differentiation in mouse neonatal subventricular zone (SVZ) stem/progenitor cell cultures. Expression of CB1R was detected in SVZ-derived immature cells (Nestin-positive), neurons and astrocytes. Stimulation of the CB1R by (R)-(+)-Methanandamide (R-m-AEA) increased self-renewal of SVZ cells, as assessed by counting the number of secondary neurospheres and the number of Sox2+/+ cell pairs, an effect blocked by Notch pathway inhibition. Moreover, R-m-AEA treatment for 48 h, increased proliferation as assessed by BrdU incorporation assay, an effect mediated by activation of MAPK-ERK and AKT pathways. Surprisingly, stimulation of CB1R by R-m-AEA also promoted neuronal differentiation (without affecting glial differentiation), at 7 days, as shown by counting the number of NeuN-positive neurons in the cultures. Moreover, by monitoring intracellular calcium concentrations ([Ca2+](i)) in single cells following KCl and histamine stimuli, a method that allows the functional evaluation of neuronal differentiation, we observed an increase in neuronal-like cells. This proneurogenic effect was blocked when SVZ cells were co-incubated with R-m-AEA and the CB1R antagonist AM 251, for 7 days, thus indicating that this effect involves CB1R activation. In accordance with an effect on neuronal differentiation and maturation, R-m-AEA also increased neurite growth, as evaluated by quantifying and measuring the number of MAP2-positive processes. Taken together, these results demonstrate that CB1R activation induces proliferation, self-renewal and neuronal differentiation from mouse neonatal SVZ cell cultures.	[Xapelli, Sara; Agasse, Fabienne; Sarda-Arroyo, Laura; Bernardino, Liliana; Santos, Tiago; Valero, Jorge; Schitine, Clarissa; de Melo Reis, Ricardo A.] Univ Coimbra, Ctr Neurosci & Cell Biol Coimbra, Coimbra, Portugal; [Xapelli, Sara; Ribeiro, Filipa F.; Sebastiao, Ana M.] Univ Lisbon, Fac Med, Inst Pharmacol & Neurosci, P-1699 Lisbon, Portugal; [Xapelli, Sara; Ribeiro, Filipa F.; Sebastiao, Ana M.] Univ Lisbon, Inst Mol Med, Unit Neurosci, P-1699 Lisbon, Portugal; [Bernardino, Liliana] Univ Beira Interior, Hlth Sci Res Ctr, Covilha, Portugal; [Braganca, Jose] Univ Algarve, Ctr Mol & Struct Biomed, Inst Biotechnol & Bioengn, Faro, Portugal; [Schitine, Clarissa; de Melo Reis, Ricardo A.] Univ Fed Rio de Janeiro, Biophys Inst Carlos Chagas Filho, Neurochem Lab, Rio De Janeiro, Brazil; [Malva, Joao O.] Univ Coimbra, Fac Med Polo 3, Ctr Res Environm Genet & Oncobiol CIMAGO, Coimbra, Portugal	Universidade de Coimbra; Universidade de Lisboa; Universidade de Lisboa; Universidade da Beira Interior; Universidade do Algarve; Universidade Federal do Rio de Janeiro; Universidade de Coimbra	Agasse, F (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol Coimbra, Coimbra, Portugal.	fabienneagasse@yahoo.fr; jomalva@fmed.uc.pt	Valero, Jorge/I-4478-2013; Agasse, Fabienne/ABF-6566-2021; Valero, Jorge/AAG-8053-2019; Braganca, Jose/F-4410-2012; de Melo Reis, Ricardo A/E-9962-2011; Ribeiro, Filipa/S-1079-2018; Malva, Joao/L-3557-2014	Valero, Jorge/0000-0001-6072-3313; Agasse, Fabienne/0000-0002-2206-6196; Valero, Jorge/0000-0001-6072-3313; Braganca, Jose/0000-0001-9566-400X; de Melo Reis, Ricardo A/0000-0001-9689-4085; Sebastiao, Ana M/0000-0001-9030-6115; Bernardino, Liliana/0000-0003-3395-5973; Xapelli, Sara/0000-0001-6854-2509; Ribeiro, Filipa/0000-0002-4006-7328; Malva, Joao/0000-0002-5438-4447; Santos, Tiago/0000-0003-0237-499X	Fundacao para a Ciencia e a Tecnologia - Portugal [POCTI/SAU-NEU/68465/2006, PTDC/SAU-NEU/104415/2008, PTDC/SAU-NEU/101783/2008, POCTI/SAU-NEU/110838/2009]; Fundacao Calouste Gulbenkian [96542]; Fundacao para a Ciencia e Tecnologia; Fundação para a Ciência e a Tecnologia [PTDC/SAU-NEU/104415/2008, PTDC/SAU-NEU/101783/2008] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia - Portugal(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian(European Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	The work was funded by Fundacao para a Ciencia e a Tecnologia - Portugal (www.fct.mctes.pt), projects POCTI/SAU-NEU/68465/2006; PTDC/SAU-NEU/104415/2008; PTDC/SAU-NEU/101783/2008, POCTI/SAU-NEU/110838/2009 and by Fundacao Calouste Gulbenkian (project no 96542). Sara Xapelli, Liliana Bernardino, Filipa F. Ribeiro and Jorge Valero are supported with fellowships from Fundacao para a Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; Agasse F, 2008, REJUV RES, V11, P187, DOI 10.1089/rej.2007.0600; Agasse Fabienne, 2007, P81, DOI 10.1007/978-0-387-70830-0_4; Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Aguado T, 2007, J BIOL CHEM, V282, P23892, DOI 10.1074/jbc.M700678200; Al-Hayani A, 2001, NEUROPHARMACOLOGY, V41, P1000, DOI 10.1016/S0028-3908(01)00145-9; Arevalo-Martin A, 2007, EUR J NEUROSCI, V26, P1548, DOI 10.1111/j.1460-9568.2007.05782.x; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bernardino L, 2012, STEM CELLS; Compagnucci C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054271; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gomez O, 2010, GLIA, V58, P1913, DOI 10.1002/glia.21061; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Grade S, 2010, REJUV RES, V13, P27, DOI 10.1089/rej.2009.0889; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; Hill MN, 2010, HIPPOCAMPUS, V20, P513, DOI 10.1002/hipo.20647; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Jin KL, 2004, MOL PHARMACOL, V66, P204, DOI 10.1124/mol.66.2.204; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Kim S, 2004, CELL MOL NEUROBIOL, V24, P343, DOI 10.1023/B:CEMN.0000022767.74774.38; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Learish RD, 2000, DEV BRAIN RES, V122, P97; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.007; Molina-Holgado F, 2007, EUR J NEUROSCI, V25, P629, DOI 10.1111/j.1460-9568.2007.05322.x; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Onaivi ES, 2009, INT REV NEUROBIOL, V88, P335, DOI 10.1016/S0074-7742(09)88012-4; Oudin MJ, 2011, J NEUROSCI, V31, P4000, DOI 10.1523/JNEUROSCI.5483-10.2011; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Romero J, 2009, CNS NEUROL DISORD-DR, V8, P440, DOI 10.2174/187152709789824589; Rosa AI, 2010, J NEUROSCI, V30, P4573, DOI 10.1523/JNEUROSCI.5597-09.2010; Rubio-Araiz A, 2008, MOL CELL NEUROSCI, V38, P374, DOI 10.1016/j.mcn.2008.03.010; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Soltys J, 2010, BIOCHEM BIOPH RES CO, V400, P21, DOI 10.1016/j.bbrc.2010.07.129; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tanveer R, 2012, J BIOL CHEM, V287, P34709, DOI 10.1074/jbc.M112.350678; Temple S, 1999, CURR BIOL, V9, pR397, DOI 10.1016/S0960-9822(99)80252-8; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Watson S, 2008, MOL CELL NEUROSCI, V38, P89, DOI 10.1016/j.mcn.2008.02.001; Weiss S, 1996, J NEUROSCI, V16, P7599; Wen S, 2009, PROG NEUROBIOL, V87, P98, DOI 10.1016/j.pneurobio.2008.10.002; Wolf SA, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-12; Wu CS, 2010, EUR J NEUROSCI, V32, P693, DOI 10.1111/j.1460-9568.2010.07337.x; Wu M, 2009, J CELL BIOCHEM, V107, P264, DOI 10.1002/jcb.22122; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007	59	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63529	10.1371/journal.pone.0063529	http://dx.doi.org/10.1371/journal.pone.0063529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704915	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200046
J	Xu, JL; Yin, ZQ; Cao, SY; Gao, W; Liu, LX; Yin, YM; Liu, P; Shu, YQ				Xu, Jiali; Yin, Zhiqiang; Cao, Songyu; Gao, Wen; Liu, Lingxiang; Yin, Yongmei; Liu, Ping; Shu, Yongqian			Systematic Review and Meta-Analysis on the Association between IL-1B Polymorphisms and Cancer Risk	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; HELICOBACTER-PYLORI INFECTION; NECROSIS-FACTOR-ALPHA; SINGLE-NUCLEOTIDE POLYMORPHISMS; CYTOKINE GENE POLYMORPHISMS; EPSTEIN-BARR-VIRUS; GASTRIC-CANCER; LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; PROMOTER POLYMORPHISM	Background: Interleukin-1 beta (IL-1 beta), a pro-inflammatory cytokine, is emerging as a key mediator of carcinogenesis that characterizes host-environment interactions. Epidemiological studies investigating the association between two polymorphisms of IL-1B (-511C/T and +3954C/T) and cancer susceptibility have shown conflicting results. The aim of this study is to derive a more precise estimation of the relationship. Methods: Related studies were identified through a systematic literature search of PubMed and Web of Science from their inception to September 15, 2012. Summary odds ratios (ORs) and 95% confidence intervals (CIs) for the IL-1B -511C/T and +3954C/T polymorphisms and cancer risk were calculated. Heterogeneity among studies and publication bias were also tested. Results: The meta-analysis included 91 case-control studies in 85 publications, 81 studies for the -511C/T (19547 cases and 23935 controls) and 26 studies for the +3954C/T polymorphisms (8083 cases and 9183). The pooled results indicated that IL-1B +3954C/T (dominant model: OR = 1.15, 95% CI: 1.01-1.30) was significantly associated with increased overall cancer risk, especially among hospital-based case-control studies (dominant model: OR = 1.30, 95% CI: 1.02-1.66). As for -511C/T, we observed an inverse relationship in cervical cancer (dominant model: OR = 1.74, 95% CI: 1.35-2.23) and hepatocellular carcinoma (dominant model: OR = 0.68, 95% CI: 0.47-0.99). Moreover, -511C/T was associated with risk of specific subtypes of gastric carcinoma. Conclusion: This meta-analysis suggested that both the IL-1B -511C/T and +3954C/T polymorphisms might modulate cancer susceptibility. Further well-designed studies based on larger sample sizes should be performed to confirm the findings.	[Xu, Jiali; Gao, Wen; Liu, Lingxiang; Yin, Yongmei; Liu, Ping; Shu, Yongqian] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Yin, Zhiqiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Cao, Songyu] Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Shu, YQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	shuyongqian@csco.org.cn	Liu, Lingxiang/I-7538-2016; Shu, Yongqian/ABD-5698-2021	Liu, Lingxiang/0000-0001-8689-1788; 	National Natural Science Foundation of China [81071643]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81071643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazis-Stamboulieh D, 2007, LEUKEMIA LYMPHOMA, V48, P2196, DOI 10.1080/10428190701615892; Ahirwar DK, 2009, BIOMARKERS, V14, P213, DOI 10.1080/13547500902818246; Al-Moundhri Mansour S, 2006, Gastric Cancer, V9, P284, DOI 10.1007/s10120-006-0392-5; Al-Tahhan MA, 2011, MOL CELL BIOCHEM, V353, P159, DOI 10.1007/s11010-011-0782-9; Alpizar-Alpizar W, 2005, CLIN EXP MED, V5, P169, DOI 10.1007/s10238-005-0082-3; Angst E, 2008, SURGERY, V144, P57, DOI 10.1016/j.surg.2008.03.024; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Asada M, 2006, LUNG CANCER, V54, P261, DOI 10.1016/j.lungcan.2006.07.002; Balasubramanian SP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-188; Berkovic MC, 2012, DNA CELL BIOL, V31, P531, DOI 10.1089/dna.2011.1317; Bird S, 2002, CYTOKINE GROWTH F R, V13, P483, DOI 10.1016/S1359-6101(02)00028-X; Chang YW, 2005, INT J CANCER, V114, P465, DOI 10.1002/ijc.20724; Chen A, 2004, ALIMENT PHARM THER, V20, P203, DOI 10.1111/j.1365-2036.2004.01826.x; Chen CC, 2005, INT J EPIDEMIOL, V34, P1310, DOI 10.1093/ije/dyi191; Chen HM, 2006, HUM MOL GENET, V15, P519, DOI 10.1093/hmg/ddi469; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crusius JBA, 2008, ANN ONCOL, V19, P1894, DOI 10.1093/annonc/mdn400; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Ennas MG, 2008, HEMATOL ONCOL, V26, P98, DOI 10.1002/hon.843; Gatti LL, 2004, CLIN EXP MED, V4, P93, DOI 10.1007/s10238-004-0043-2; Gehmert S, 2009, AM J TROP MED HYG, V81, P804, DOI 10.4269/ajtmh.2009.08-0494; Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014; Glas J, 2004, J CLIN ONCOL, V22, P4746, DOI 10.1200/JCO.2004.03.034; Grimm C, 2004, GYNECOL ONCOL, V92, P936, DOI 10.1016/j.ygyno.2003.11.039; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hall SK, 2004, ARTHRITIS RHEUM-US, V50, P1976, DOI 10.1002/art.20310; Hamacher R, 2009, CYTOKINE, V46, P182, DOI 10.1016/j.cyto.2009.01.005; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Hartland S, 2004, DIGEST DIS SCI, V49, P1545, DOI 10.1023/B:DDAS.0000042262.14969.2d; He BS, 2011, DIGEST DIS SCI, V56, P2017, DOI 10.1007/s10620-010-1557-y; He BS, 2011, MUTAGENESIS, V26, P637, DOI 10.1093/mutage/ger025; Hefler LA, 2005, CLIN CANCER RES, V11, P5718, DOI 10.1158/1078-0432.CCR-05-0001; Hernandez-Guerrero C, 2003, MOL HUM REPROD, V9, P625, DOI 10.1093/molehr/gag076; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirankarn N, 2006, WORLD J GASTROENTERO, V12, P776, DOI 10.3748/wjg.v12.i5.776; Hoeft B, 2008, CANCER CAUSE CONTROL, V19, P163, DOI 10.1007/s10552-007-9082-9; Howell WM, 2003, EUR J IMMUNOGENET, V30, P409, DOI 10.1111/j.1365-2370.2003.00425.x; Hulkkonen J, 2000, EUR CYTOKINE NETW, V11, P251; Hwang IR, 2002, GASTROENTEROLOGY, V123, P1793, DOI 10.1053/gast.2002.37043; Ikehara SK, 2006, J HUM GENET, V51, P927, DOI 10.1007/s10038-006-0040-2; Ito H, 2007, ONCOL REP, V18, P473; Jin P, 2004, IMMUNOL RES, V30, P181, DOI 10.1385/IR:30:2:181; Kamangar F, 2006, CANCER CAUSE CONTROL, V17, P117, DOI 10.1007/s10552-005-0439-7; Kang S, 2007, J KOREAN MED SCI, V22, P110, DOI 10.3346/jkms.2007.22.1.110; Kim N, 2006, HELICOBACTER, V11, P105, DOI 10.1111/j.1523-5378.2006.00384.x; Kiyohara C, 2010, J THORAC ONCOL, V5, P299, DOI 10.1097/JTO.0b013e3181c8cae3; Kumar S, 2009, BIOCHEM BIOPH RES CO, V387, P456, DOI 10.1016/j.bbrc.2009.07.033; Kurzrock R, 2001, BIOMED PHARMACOTHER, V55, P543, DOI 10.1016/S0753-3322(01)00140-8; Landvik NE, 2009, CARCINOGENESIS, V30, P1186, DOI 10.1093/carcin/bgp122; Lee KA, 2004, J GASTROENTEROL, V39, P429, DOI 10.1007/s00535-003-1315-4; Lee KM, 2007, CARCINOGENESIS, V28, P1437, DOI 10.1093/carcin/bgm030; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Li C, 2007, J GASTROEN HEPATOL, V22, P234, DOI 10.1111/j.1440-1746.2006.04379.x; Lim WY, 2011, CARCINOGENESIS, V32, P522, DOI 10.1093/carcin/bgr006; Lind H, 2007, CYTOKINE, V38, P43, DOI 10.1016/j.cyto.2007.05.001; Liu JY, 2006, INT J CANCER, V118, P2554, DOI 10.1002/ijc.21652; Lu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349; Machado JC, 2001, GASTROENTEROLOGY, V121, P823, DOI 10.1053/gast.2001.28000; Machado JC, 2003, GASTROENTEROLOGY, V125, P364, DOI 10.1016/S0016-5085(03)00899-0; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Barbosa HPM, 2009, WORLD J GASTROENTERO, V15, P1465, DOI 10.3748/wjg.15.1465; Michaud DS, 2006, CANCER RES, V66, P4525, DOI 10.1158/0008-5472.CAN-05-3987; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Palli D, 2005, AM J GASTROENTEROL, V100, P1941, DOI 10.1111/j.1572-0241.2005.50084.x; Perri F, 2005, CYTOKINE, V30, P293, DOI 10.1016/j.cyto.2005.01.011; Persson C, 2009, SCAND J GASTROENTERO, V44, P339, DOI 10.1080/00365520802556015; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Qian NF, 2010, J CANCER RES CLIN, V136, P709, DOI 10.1007/s00432-009-0710-5; Rizzato C, 2011, CARCINOGENESIS, V32, P1849, DOI 10.1093/carcin/bgr197; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Ruzzo A, 2005, ANN ONCOL, V16, P887, DOI 10.1093/annonc/mdi184; Saijo Y, 2002, J IMMUNOL, V169, P469, DOI 10.4049/jimmunol.169.1.469; Sakuma K, 2005, INT J CANCER, V115, P93, DOI 10.1002/ijc.20903; Santos JC, 2012, BRAZ J MED BIOL RES, V45, P811, DOI 10.1590/S0100-879X2012007500099; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Seno H, 2007, J GASTROEN HEPATOL, V22, P729, DOI 10.1111/j.1440-1746.2007.04934.x; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Shin WG, 2008, J GASTROEN HEPATOL, V23, P1567, DOI 10.1111/j.1440-1746.2008.05479.x; Sicinschi LA, 2006, INT J CANCER, V118, P649, DOI 10.1002/ijc.21364; Singh H, 2008, BJOG-INT J OBSTET GY, V115, P633, DOI 10.1111/j.1471-0528.2007.01655.x; Smyth MJ, 2004, IMMUNOL REV, V202, P275, DOI 10.1111/j.0105-2896.2004.00199.x; Snoussi K, 2005, EUR CYTOKINE NETW, V16, P253; Song XP, 2003, J IMMUNOL, V171, P6448, DOI 10.4049/jimmunol.171.12.6448; Speirs V, 1999, INT J ONCOL, V15, P1251; Starzynska T, 2006, AM J GASTROENTEROL, V101, P248, DOI 10.1111/j.1572-0241.2006.00422.x; Stefani AL, 1999, PANCREAS, V19, P362, DOI 10.1097/00006676-199911000-00007; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P51, DOI 10.1111/j.1440-1746.2006.04442.x; Sun HJ, 2007, OLIGONUCLEOTIDES, V17, P336, DOI 10.1089/oli.2007.0071; Taguchi A, 2005, CANCER EPIDEM BIOMAR, V14, P2487, DOI 10.1158/1055-9965.EPI-05-0326; Tanaka Y, 2003, J INFECT DIS, V187, P1822, DOI 10.1086/375248; ten Kate M, 2006, J PANCREAS, V7, P454; Ter-Minassian M, 2008, CARCINOGENESIS, V29, P2147, DOI 10.1093/carcin/bgn205; Tian ZG, 2000, J IMMUNOL, V165, P3959, DOI 10.4049/jimmunol.165.7.3959; Tsai FJ, 2005, BJU INT, V95, P432, DOI 10.1111/j.1464-410X.2005.05315.x; Tsai MH, 2005, J CLIN LAB ANAL, V19, P93, DOI 10.1002/jcla.20060; Upadhyay R, 2008, HUM IMMUNOL, V69, P179, DOI 10.1016/j.humimm.2008.01.012; Vishnoi M, 2008, CANCER GENET CYTOGEN, V186, P63, DOI 10.1016/j.cancergencyto.2008.05.004; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang WP, 2007, CLIN BIOCHEM, V40, P218, DOI 10.1016/j.clinbiochem.2006.10.018; Wang Y, 2003, HEPATOLOGY, V37, P65, DOI 10.1053/jhep.2003.50017; Wells G.A., NEWCASTLE OTTAWA SCA; Wex T, 2010, ANTICANCER RES, V30, P505; Whiteman DC, 2010, GASTROENTEROLOGY, V139, P73, DOI 10.1053/j.gastro.2010.04.009; Wu KS, 2010, CLIN CHIM ACTA, V411, P1441, DOI 10.1016/j.cca.2010.05.035; Wu MS, 2004, INT J CANCER, V110, P695, DOI 10.1002/ijc.20199; Xue HP, 2010, J GASTROEN HEPATOL, V25, P1604, DOI 10.1111/j.1440-1746.2010.06428.x; Yamada S, 2006, J GASTROENTEROL, V41, P1169, DOI 10.1007/s00535-006-1951-6; Yang J, 2004, CANCER LETT, V215, P191, DOI 10.1016/j.canlet.2004.07.012; Yoo EJ, 2010, VIRCHOWS ARCH, V456, P647, DOI 10.1007/s00428-010-0918-4; Yu J, 2010, AM J GASTROENTEROL, V105, P557, DOI 10.1038/ajg.2009.644; Zabaleta J, 2008, CARCINOGENESIS, V29, P573, DOI 10.1093/carcin/bgm277; Zeng ZR, 2003, GUT, V52, P1684, DOI 10.1136/gut.52.12.1684; Zhang WH, 2005, CYTOKINE, V30, P378, DOI 10.1016/j.cyto.2005.02.002; Zhang ZZ, 2004, CLIN CHIM ACTA, V342, P137, DOI 10.1016/j.cccn.2003.12.010; Zheng CY, 2000, BRIT J HAEMATOL, V109, P39, DOI 10.1046/j.1365-2141.2000.01963.x; Zhu YH, 2008, CLIN ONCOL-UK, V20, P207, DOI 10.1016/j.clon.2008.01.003; Zienolddiny S, 2004, INT J CANCER, V109, P353, DOI 10.1002/ijc.11695; Zumkeller N, 2007, EUR J CANCER, V43, P1283, DOI 10.1016/j.ejca.2007.03.005; Zur Hausen A, 2003, INT J CANCER, V107, P866, DOI 10.1002/ijc.11468	126	17	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63654	10.1371/journal.pone.0063654	http://dx.doi.org/10.1371/journal.pone.0063654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704929	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200060
J	Zhang, HY; Miao, HM; Wei, LB; Li, C; Zhao, RH; Wang, CY				Zhang, Haiyang; Miao, Hongmei; Wei, Libin; Li, Chun; Zhao, Ruihong; Wang, Cuiying			Genetic Analysis and QTL Mapping of Seed Coat Color in Sesame (Sesamum indicum L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINKAGE MAP; AFLP MARKERS; FUSARIUM-WILT; INHERITANCE; IDENTIFICATION; RESISTANCE; DISTORTION; CROSSES	Seed coat color is an important agronomic trait in sesame, as it is associated with seed biochemical properties, antioxidant content and activity and even disease resistance of sesame. Here, using a high-density linkage map, we analyzed genetic segregation and quantitative trait loci (QTL) for sesame seed coat color in six generations (P-1, P-2, F-1, BC1, BC2 and F-2). Results showed that two major genes with additive-dominant-epistatic effects and polygenes with additive-dominant-epistatic effects were responsible for controlling the seed coat color trait. Average heritability of the major genes in the BC1, BC2 and F-2 populations was 89.30%, 24.00%, and 91.11% respectively, while the heritability of polygenes was low in the BC1 (5.43%), in BC2 (0.00%) and in F-2 (0.89%) populations. A high-density map was constructed using 724 polymorphic markers. 653 SSR, AFLP and RSAMPL loci were anchored in 14 linkage groups (LG) spanning a total of 1,216.00 cM. The average length of each LG was 86.86 cM and the marker density was 1.86 cM per marker interval. Four QTLs for seed coat color, QTL1-1, QTL11-1, QTL11-2 and QTL13-1, whose heritability ranged from 59.33%-69.89%, were detected in F-3 populations using CIM and MCIM methods. Alleles at all QTLs from the black-seeded parent tended to increase the seed coat color. Results from QTLs mapping and classical genetic analysis among the P-1, P-2, F-1, BC1, BC2 and F-2 populations were comparatively consistent. This first QTL analysis and high-density genetic linkage map for sesame provided a good foundation for further research on sesame genetics and molecular marker-assisted selection (MAS).	[Zhang, Haiyang; Miao, Hongmei; Wei, Libin; Li, Chun; Zhao, Ruihong; Wang, Cuiying] Henan Acad Agr Sci, Henan Sesame Res Ctr, Zhengzhou, Henan, Peoples R China	Henan Academy of Agricultural Sciences	Zhang, HY (corresponding author), Henan Acad Agr Sci, Henan Sesame Res Ctr, Zhengzhou, Henan, Peoples R China.	zhy@hnagri.org.cn	Miao, Hongmei/AAQ-7525-2021		China National "973'' Project [2011CB109304]; China Agriculture Research System (CARS15)	China National "973'' Project(National Basic Research Program of China); China Agriculture Research System (CARS15)	This work was supported by China National "973'' Project (2011CB109304) and the earmarked fund for the China Agriculture Research System (CARS15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashri A., 1998, Plant Breeding Reviews, V16, P179; Baydar Hasan, 2000, Turkish Journal of Biology, V24, P503; BECKER J, 1995, MOL GEN GENET, V249, P65, DOI 10.1007/BF00290237; Bernatzky R, 1988, MOL MAPPING PLANT CH, P157; Bert PF, 1999, THEOR APPL GENET, V99, P445, DOI 10.1007/s001220051256; BUDOWSKI P, 1951, CHEM REV, V48, P125, DOI 10.1021/cr60149a005; Castiglioni P, 1999, THEOR APPL GENET, V99, P425, DOI 10.1007/s001220051253; Durst C. E., 1930, Bulletin. Illinois Agricultural Experiment Station, V356, P239; El-Bramawy Mohamed A. S., 2006, Plant Protection Science, V42, P99; El-Bramawy Mohamed Abd El-Hamid Sayid, 2008, Journal of Plant Protection Research, V48, P397, DOI 10.2478/v10045-008-0049-y; Falusi O, 2010, AFR J BIOTECH, V6; FAURE S, 1993, THEOR APPL GENET, V87, P517, DOI 10.1007/BF00215098; Fishman L, 2001, GENETICS, V159, P1701; Gai Junyi, 2007, Frontiers of Agriculture in China, V1, P1, DOI 10.1007/s11703-007-0001-3; Gai JY, 1998, THEOR APPL GENET, V97, P1162, DOI 10.1007/s001220051005; Gillman JD, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-155; Haanstra JPW, 1999, THEOR APPL GENET, V99, P254, DOI 10.1007/s001220051231; He FongFa, 1994, Journal of Southwest Agricultural University, V16, P573; He XH, 2001, ACTA AGRON SIN, V27, P469; Isemura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041304; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; Kanu P.J., 2011, AM J BIOCH MOL BIOL, V1, P145, DOI [10.3923/ajbmb.2011.145.157, DOI 10.3923/AJBMB.2011.145.157]; Li Ji-Suo, 2006, Yichuan, V28, P458; Li YuSheng, 2008, Acta Agronomica Sinica, V34, P1728, DOI 10.1016/S1875-2780(09)60007-9; Luo X, 2008, ACTA AGR BOREALI SIN, V23, P288; Marques CM, 1998, THEOR APPL GENET, V96, P727, DOI 10.1007/s001220050795; McCallum J, 1997, J AM SOC HORTIC SCI, V122, P218, DOI 10.21273/JASHS.122.2.218; McKay JW, 1936, J HERED, V27, P110, DOI 10.1093/oxfordjournals.jhered.a104182; Monforte AJ, 2004, THEOR APPL GENET, V108, P750, DOI 10.1007/s00122-003-1483-x; NAMIKI M, 1995, FOOD REV INT, V11, P281, DOI 10.1080/87559129509541043; Nandi S, 1997, MOL GEN GENET, V255, P1, DOI 10.1007/s004380050468; Negi MS, 2000, THEOR APPL GENET, V101, P146, DOI 10.1007/s001220051463; Nikaido A, 1999, GENES GENET SYST, V74, P55, DOI 10.1266/ggs.74.55; Njiti VN, 2002, THEOR APPL GENET, V104, P294, DOI 10.1007/s001220100682; NOHARA SIGEROKU, 1933, JOUR COLL AGRIC IMP UNIV TOKYO, V12, P227; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Quijada P, 1994, AGRONOMIA TROPICAL, V44; Saeidi G, 1997, J HERED, V88, P466, DOI 10.1093/oxfordjournals.jhered.a023138; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Sakata Y, 2006, THEOR APPL GENET, V112, P243, DOI [10.1007/s00122-005-0121-1, 10.1007/s00122-005-0193-y]; Shahidi F, 2006, FOOD CHEM, V99, P478, DOI 10.1016/j.foodchem.2005.08.009; SIKKA S. M., 1947, Indian Journal of Genetics and Plant Breeding, V7, P35; SWENSON S. P., 1942, JOUR AMER SOC AGRON, V34, P452; Tan YD, 2001, GENETICS, V157, P1277; Tian LuShen, 2009, Scientia Agricultura Sinica, V42, P3987; Van Ooijen JW, 2001, JOINMAPR 3 0 SOFTWAR, P1; VANDENBERG A, 1990, J HERED, V81, P484, DOI 10.1093/oxfordjournals.jhered.a111030; VANECK HJ, 1995, MOL BREEDING, V1, P397, DOI 10.1007/BF01248417; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang S., 2007, WINDOWS QTL CARTOGRA; Wei LB, 2012, CHIN B BOT IN PRESS; Wei LB, 2009, GENES GENOM, V31, P199, DOI 10.1007/BF03191152; Wei Xin, 2008, Scientia Agricultura Sinica, V41, P2235; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; ZENG ZB, 1994, GENETICS, V136, P1457; Zewdie Y, 2003, J HERED, V94, P355, DOI 10.1093/jhered/esg063; Zhang HY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-401; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhang JF, 2009, PLANT MOL BIOL, V69, P553, DOI 10.1007/s11103-008-9437-y; Zhang YM, 2003, GENETIC SYSTEM QUANT, P120; Zhang YM, 2001, ACTA AGRONOMICA SINI, V27, P787; Zhang YM, 2009, GENETICA, V136, P311, DOI 10.1007/s10709-008-9313-3; Wen-Jing Z, 2012, RICE SCI, V19, P202, DOI 10.1016/S1672-6308(12)60041-9	64	55	64	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63898	10.1371/journal.pone.0063898	http://dx.doi.org/10.1371/journal.pone.0063898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704951	Green Submitted, gold, Green Published			2022-12-27	WOS:000319330200082
J	Zhu, ML; Xu, C; Yu, JG; Wu, YJ; Li, CG; Zhang, MM; Jin, ZD; Li, ZS				Zhu, Maoling; Xu, Can; Yu, Jianguo; Wu, Yijun; Li, Chunguang; Zhang, Minmin; Jin, Zhendong; Li, Zhaoshen			Differentiation of Pancreatic Cancer and Chronic Pancreatitis Using Computer-Aided Diagnosis of Endoscopic Ultrasound (EUS) Images: A Diagnostic Test	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; SUPPORT VECTOR MACHINE; OVARIAN TUMOR-ANALYSIS; GUIDED FNA; MATHEMATICAL-MODELS; BREAST-LESIONS; NORMAL TISSUE; MASSES; VALIDATION; MALIGNANCY	Background: Differentiating pancreatic cancer (PC) from normal tissue by computer-aided diagnosis of EUS images were quite useful. The current study was designed to investigate the feasibility of using computer-aided diagnostic (CAD) techniques to extract EUS image parameters for the differential diagnosis of PC and chronic pancreatitis (CP). Methodology/Principal Findings: This study recruited 262 patients with PC and 126 patients with CP. Typical EUS images were selected from the sample sets. Texture features were extracted from the region of interest using computer-based techniques. Then the distance between class algorithm and sequential forward selection (SFS) algorithm were used for a better combination of features; and, later, a support vector machine (SVM) predictive model was built, trained, and validated. Overall, 105 features of 9 categories were extracted from the EUS images for pattern classification. Of these features, the 16 were selected as a better combination of features. Then, SVM predictive model was built and trained. The total cases were randomly divided into a training set and a testing set. The training set was used to train the SVM, and the testing set was used to evaluate the performance of the SVM. After 200 trials of randomised experiments, the average accuracy, sensitivity, specificity, the positive and negative predictive values of pancreatic cancer were 94.2 +/- 0.1749%, 96.25 +/- 0.4460%, 93.38 +/- 0.2076%, 92.21 +/- 0.4249% and 96.68 +/- 0.1471%, respectively. Conclusions/Significance: Digital image processing and computer-aided EUS image differentiation technologies are highly accurate and non-invasive. This technology provides a kind of new and valuable diagnostic tool for the clinical determination of PC.	[Zhu, Maoling] Shanghai Jiao Tong Univ, Peoples Hosp Shanghai 1, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Xu, Can; Zhang, Minmin; Jin, Zhendong; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Yu, Jianguo; Wu, Yijun] Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China; [Li, Chunguang] Second Mil Med Univ, Changhai Hosp, Dept Cardiothorac Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University; Fudan University; Naval Medical University	Jin, ZD (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China.	jinzhd@163.com; lizhshdr@yeah.net						Das A, 2008, GASTROINTEST ENDOSC, V67, P861, DOI 10.1016/j.gie.2007.08.036; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Eloubeidi MA, 2003, CANCER CYTOPATHOL, V99, P285, DOI 10.1002/cncr.11643; Fritscher-Ravens A, 2002, AM J GASTROENTEROL, V97, P2768; Fujita H, 2008, COMPUT METH PROG BIO, V92, P238, DOI 10.1016/j.cmpb.2008.04.003; GARRA BS, 1993, ULTRASONIC IMAGING, V15, P267, DOI 10.1006/uimg.1993.1017; Goh KL, 2012, J DIGEST DIS, V13, P389, DOI 10.1111/j.1751-2980.2012.00609.x; Harewood GC, 2002, AM J GASTROENTEROL, V97, P1386, DOI 10.1016/S0002-9270(02)04133-3; Hasan MK, 2012, GASTROINTEST ENDOSC, V22, pvii; Hasan Muhammad K, 2012, Gastrointest Endosc Clin N Am, V22, P155, DOI 10.1016/j.giec.2012.04.016; Hewitt MJ, 2012, GASTROINTEST ENDOSC, V75, P319, DOI 10.1016/j.gie.2011.08.049; Horwhat JD, 2006, GASTROINTEST ENDOSC, V63, P966, DOI 10.1016/j.gie.2005.09.028; Levman J, 2008, IEEE T MED IMAGING, V27, P688, DOI 10.1109/TMI.2008.916959; Mavroforakis ME, 2006, ARTIF INTELL MED, V37, P145, DOI 10.1016/j.artmed.2006.03.002; Nishikawa RM, 2012, AM J ROENTGENOL, V198, P708, DOI 10.2214/AJR.11.6423; Norton ID, 2001, GASTROINTEST ENDOSC, V54, P625, DOI 10.1067/mge.2001.118644; Othman MO, 2012, GASTROENTEROL CLIN N, V41, P179, DOI 10.1016/j.gtc.2011.12.014; Prachayakul Varayu, 2012, J Med Assoc Thai, V95 Suppl 2, pS68; Sahai AV, 2002, GASTROINTEST ENDOSC, V56, pS76, DOI 10.1067/mge.2002.127701; Van Holsbeke C, 2007, CLIN CANCER RES, V13, P4440, DOI 10.1158/1078-0432.CCR-06-2958; Van Holsbeke C, 2009, CLIN CANCER RES, V15, P684, DOI 10.1158/1078-0432.CCR-08-0113; Varadarajulu S, 2005, GASTROINTEST ENDOSC, V62, P728, DOI 10.1016/j.gie.2005.06.051; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Xu QA, 2011, HEPATOB PANCREAT DIS, V10, P128, DOI 10.1016/S1499-3872(11)60021-0; Zhang MM, 2010, GASTROINTEST ENDOSC, V72, P978, DOI 10.1016/j.gie.2010.06.042	25	51	53	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63820	10.1371/journal.pone.0063820	http://dx.doi.org/10.1371/journal.pone.0063820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704940	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200071
J	Cao, RY; Dong, DY; Liu, RJ; Han, JF; Wang, GC; Zhao, H; Li, XF; Deng, YQ; Zhu, SY; Wang, XY; Lin, F; Zhang, FJ; Chen, W; Qin, ED; Qin, CF				Cao, Rui-Yuan; Dong, Da-Yong; Liu, Rui-Ju; Han, Jian-Feng; Wang, Guang-Chuan; Zhao, Hui; Li, Xiao-Feng; Deng, Yong-Qiang; Zhu, Shun-Ya; Wang, Xiao-Yu; Lin, Fang; Zhang, Fu-Jun; Chen, Wei; Qin, E-De; Qin, Cheng-Feng			Human IgG Subclasses against Enterovirus Type 71: Neutralization versus Antibody Dependent Enhancement of Infection	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; NEWBORN MICE; IN-VITRO; PROTECTION; RECEPTOR; RESPONSES; VACCINES; DISEASE	The emerging human enterovirus 71 (EV71) represents a growing threat to public health, and no vaccine or specific antiviral is currently available. Human intravenous immunoglobulin (IVIG) is clinical used in treating severe EV71 infections. However, the discovery of antibody dependent enhancement (ADE) of EV71 infection illustrates the complex roles of antibody in controlling EV71 infection. In this study, to identify the distinct role of each IgG subclass on neutralization and enhancement of EV71 infection, different lots of pharmaceutical IVIG preparations manufactured from Chinese donors were used for IgG subclass fractionation by pH gradient elution with the protein A-conjugated affinity column. The neutralization and ADE capacities on EV71 infection of each purified IgG subclass were then assayed, respectively. The neutralizing activity of human IVIG is mainly mediated by IgG1 subclass and to less extent by IgG2 subclass. Interestingly, IgG3 fraction did not have neutralizing activity but enhanced EV71 infection in vitro. These results revealed the different roles of human IgG subclasses on EV71 infection, which is of critical importance for the rational design of immunotherapy and vaccines against severe EV71 diseases.	[Cao, Rui-Yuan; Dong, Da-Yong; Han, Jian-Feng; Wang, Guang-Chuan; Zhao, Hui; Li, Xiao-Feng; Deng, Yong-Qiang; Zhu, Shun-Ya; Wang, Xiao-Yu; Lin, Fang; Chen, Wei; Qin, E-De; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Liu, Rui-Ju] Liaocheng Peoples Hosp, Liaocheng, Peoples R China; [Lin, Fang] Second Artillery Gen Hosp, Beijing, Peoples R China; [Zhang, Fu-Jun] Rizhao Hosp Tradit Chinese Med, Rizhao, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	qincf@bmi.ac.cn	Qin, Cheng-Feng/I-6839-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Wang, Guangchuan/0000-0001-5315-1599	Beijing Natural Science Foundation [7112108, 7122129]; National Natural Science Foundation of China [81000721, 31270195]; Beijing Nova Program of Science and Technology [2010B041]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program of Science and Technology	This work was supported by Beijing Natural Science Foundation (numbers 7112108 and 7122129), and National Natural Science Foundation of China (numbers 81000721 and 31270195). C.F. Qin was supported by the Beijing Nova Program of Science and Technology (number 2010B041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABZUG MJ, 1995, CLIN INFECT DIS, V20, P1201, DOI 10.1093/clinids/20.5.1201; Bayry J, 2004, TRENDS PHARMACOL SCI, V25, P306, DOI 10.1016/j.tips.2004.04.002; Brouwer KC, 2004, J INFECT DIS, V190, P1192, DOI 10.1086/422850; Cao RY, 2011, J CLIN VIROL, V51, P242, DOI 10.1016/j.jcv.2011.05.002; Cao RY, 2010, CLIN INFECT DIS, V50, P125, DOI 10.1086/649012; Chung YC, 2006, WORLD J GASTROENTERO, V12, P921, DOI 10.3748/wjg.v12.i6.921; DUHAMEL RC, 1979, J IMMUNOL METHODS, V31, P211, DOI 10.1016/0022-1759(79)90133-9; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Han JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-106; Han JF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-116; HOCART MJ, 1990, J MED VIROL, V30, P92, DOI 10.1002/jmv.1890300203; Hofmeister Y, 2011, J VIROL, V85, P1896, DOI 10.1128/JVI.02155-10; Huisman W, 2009, VACCINE, V27, P505, DOI 10.1016/j.vaccine.2008.10.087; Jelley-Gibbs DM, 1999, HUM IMMUNOL, V60, P469, DOI 10.1016/S0198-8859(99)00023-3; Lin YW, 2009, J VIROL, V83, P6477, DOI 10.1128/JVI.00434-09; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015; Mori S, 2008, VIROLOGY, V375, P141, DOI 10.1016/j.virol.2008.01.033; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rodrigo WWSI, 2009, VIROLOGY, V394, P175, DOI 10.1016/j.virol.2009.09.024; Sauter P, 2007, VIRUS RES, V125, P183, DOI 10.1016/j.virusres.2007.01.001; Scharf O, 2001, J VIROL, V75, P6558, DOI 10.1128/JVI.75.14.6558-6565.2001; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shih SR, 2004, J NEUROVIROL, V10, P293, DOI 10.1080/13550280490499551; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Wang SM, 2006, J CLIN VIROL, V37, P47, DOI 10.1016/j.jcv.2006.05.009; Wang SM, 2010, CLIN VACCINE IMMUNOL, V17, P1517, DOI 10.1128/CVI.00108-10; Wang SM, 2009, EXPERT REV ANTI-INFE, V7, P735, DOI 10.1586/ERI.09.45; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yu CK, 2000, J BIOMED SCI, V7, P523, DOI 10.1007/BF02253368	37	41	45	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64024	10.1371/journal.pone.0064024	http://dx.doi.org/10.1371/journal.pone.0064024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700449	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400041
J	Chao, SH; Huang, HY; Chang, CH; Yang, CH; Cheng, WS; Kang, YH; Watanabe, K; Tsai, YC				Chao, Shiou-Huei; Huang, Hui-Yu; Chang, Chuan-Hsiung; Yang, Chih-Hsien; Cheng, Wei-Shen; Kang, Ya-Huei; Watanabe, Koichi; Tsai, Ying-Chieh			Microbial Diversity Analysis of Fermented Mung Beans (Lu-Doh-Huang) by Using Pyrosequencing and Culture Methods	PLOS ONE			English	Article							HUMAN INTESTINAL BACTERIA; SEQUENCE-ANALYSIS; RADIX-ASTRAGALI; HEPATOTOXICITY; IDENTIFICATION; TRANSFORMATION; ANTIOXIDANT; METABOLISM; PHES; RPOA	In Taiwanese alternative medicine Lu-doh-huang (also called Pracparatum mungo), mung beans are mixed with various herbal medicines and undergo a 4-stage process of anaerobic fermentation. Here we used high-throughput sequencing of the 16S rRNA gene to profile the bacterial community structure of Lu-doh-huang samples. Pyrosequencing of samples obtained at 7 points during fermentation revealed 9 phyla, 264 genera, and 586 species of bacteria. While mung beans were inside bamboo sections (stages 1 and 2 of the fermentation process), family Lactobacillaceae and genus Lactobacillus emerged in highest abundance; Lactobacillus plantarum was broadly distributed among these samples. During stage 3, the bacterial distribution shifted to family Porphyromonadaceae, and Butyricimonas virosa became the predominant microbial component. Thereafter, bacterial counts decreased dramatically, and organisms were too few to be detected during stage 4. In addition, the microbial compositions of the liquids used for soaking bamboo sections were dramatically different: Exiguobacterium mexicanum predominated in the fermented soybean solution whereas B. virosa was predominant in running spring water. Furthermore, our results from pyrosequencing paralleled those we obtained by using the traditional culture method, which targets lactic acid bacteria. In conclusion, the microbial communities during Lu-doh-huang fermentation were markedly diverse, and pyrosequencing revealed a complete picture of the microbial consortium.	[Chao, Shiou-Huei; Kang, Ya-Huei; Tsai, Ying-Chieh] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Huang, Hui-Yu] Shih Chien Univ, Dept Food Sci Nutr & Nutraceut Biotechnol, Taipei, Taiwan; [Chang, Chuan-Hsiung; Yang, Chih-Hsien] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Chang, Chuan-Hsiung; Yang, Chih-Hsien; Cheng, Wei-Shen] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Watanabe, Koichi] Yakult Cent Inst Microbiol Res, Tokyo, Japan	National Yang Ming Chiao Tung University; Shih Chien University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Yakult Honsha Company, Limited	Tsai, YC (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	tsaiyc@ym.edu.tw		Watanabe, Koichi/0000-0001-9482-1448	National Science Council [NSC 99-2321-B-010-001-MY3]; High-throughput Genome Analysis Core Facility [NSC-100-2319-B-010-001]	National Science Council(Ministry of Science and Technology, Taiwan); High-throughput Genome Analysis Core Facility	This work was supported by the National Science Council (NSC 99-2321-B-010-001-MY3), and High-throughput Genome Analysis Core Facility (NSC-100-2319-B-010-001) for pyrosequencing and Bioinformatics Consortium of Taiwan (NSC 100-2319-B-010-002) for bioinformatics analysis of National Core Facility Program for Biotechnology in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berger B, 2007, J BACTERIOL, V189, P1311, DOI 10.1128/JB.01393-06; Cai Q.Y, 2012, CHINESE J EXP TRADIT, V18, P119; Chao SH, 2008, INT J FOOD MICROBIOL, V123, P134, DOI 10.1016/j.ijfoodmicro.2007.12.010; Chao SH, 2009, INT J FOOD MICROBIOL, V135, P203, DOI 10.1016/j.ijfoodmicro.2009.07.032; Chi H, 2005, BIOL PHARM BULL, V28, P2102, DOI 10.1248/bpb.28.2102; CHU HC, 2007, SAFETY EVALUATION LI; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Eum HA, 2011, AFR J TRADIT COMPLEM, V8, P312; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hsu MF, 2009, J ETHNOPHARMACOL, V125, P474, DOI 10.1016/j.jep.2009.07.011; HUYSMANS E, 1986, NUCLEIC ACIDS RES, V14, pR73, DOI 10.1093/nar/14.suppl.r73; Kim BG, 2011, APPL BIOCHEM BIOTECH, V165, P1107, DOI 10.1007/s12010-011-9328-6; Kim DH, 1998, BIOL PHARM BULL, V21, P360; Kim DH, 1999, ARCH PHARM RES, V22, P30, DOI 10.1007/BF02976432; Kobashi K., 1997, Bioscience and Microflora, V16, P1; Kuo DH, 2010, FOOD CHEM, V123, P1007, DOI 10.1016/j.foodchem.2010.05.052; Lee DS, 2002, ARCH PHARM RES, V25, P165, DOI 10.1007/BF02976558; LI Y, 2010, J CHENGDU U TRADIT C, V33, P69; LIU CW, 2007, PHELLINUS LINTEUS PR; LONGUET-HIGGINS M S, 1971, Theoretical Population Biology, V2, P271, DOI 10.1016/0040-5809(71)90020-7; Lu HM, 2006, CHEM PHARM BULL, V54, P936, DOI 10.1248/cpb.54.936; Mekseepralard C, 2010, PHYTOTHER RES, V24, P1514, DOI 10.1002/ptr.3158; Naser SM, 2007, INT J SYST EVOL MICR, V57, P2777, DOI 10.1099/ijs.0.64711-0; Naser SM, 2005, MICROBIOL-SGM, V151, P2141, DOI 10.1099/mic.0.27840-0; Otieno DO, 2007, J APPL MICROBIOL, V103, P601, DOI 10.1111/j.1365-2672.2006.03245.x; PENG HP, 2007, ANTIOXIDANT ACTIVITI; Sakamoto N, 2011, INT J FOOD MICROBIOL, V144, P352, DOI 10.1016/j.ijfoodmicro.2010.10.017; Sato Y, 2007, BIOL PHARM BULL, V30, P145, DOI 10.1248/bpb.30.145; Sheih IC, 2011, J AGR FOOD CHEM, V59, P6520, DOI 10.1021/jf2011547; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Torriani S, 2001, APPL ENVIRON MICROB, V67, P3450, DOI 10.1128/AEM.67.8.3450-3454.2001; Trinh HT, 2007, J MICROBIOL BIOTECHN, V17, P1127; Vanhaecke L, 2008, APPL ENVIRON MICROB, V74, P1469, DOI 10.1128/AEM.02064-07; Wang Y.N., 2010, WORLD SCI TECHNOLOGY, V12, P437, DOI [10.3969/j.issn.1674-3849.2010.03.026, DOI 10.3969/J.ISSN.1674-3849.2010.03.026]; WANG YC, 2007, FUNCTIONAL STUDIES L; Yoon Sang Yeon, 1994, Archives of Pharmacal Research (Seoul), V17, P438, DOI 10.1007/BF02979122; Yuan D, 2008, CHEM PHARM BULL, V56, P1, DOI 10.1248/cpb.56.1	38	9	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63816	10.1371/journal.pone.0063816	http://dx.doi.org/10.1371/journal.pone.0063816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700436	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400033
J	Casjens, S; Eckert, A; Woitalla, D; Ellrichmann, G; Turewicz, M; Stephan, C; Eisenacher, M; May, C; Meyer, HE; Bruning, T; Pesch, B				Casjens, Swaantje; Eckert, Angelika; Woitalla, Dirk; Ellrichmann, Gisa; Turewicz, Michael; Stephan, Christian; Eisenacher, Martin; May, Caroline; Meyer, Helmut E.; Bruening, Thomas; Pesch, Beate			Diagnostic Value of the Impairment of Olfaction in Parkinson's Disease	PLOS ONE			English	Article							ODOR IDENTIFICATION; DYSFUNCTION; DISCRIMINATION; SMELL; PREVALENCE; DEFICITS; ADULTS; TESTS	Background: Olfactory impairment is increasingly recognized as an early symptom in the development of Parkinson's disease. Testing olfactory function is a non-invasive method but can be time-consuming which restricts its application in clinical settings and epidemiological studies. Here, we investigate odor identification as a supportive diagnostic tool for Parkinson's disease and estimate the performance of odor subsets to allow a more rapid testing of olfactory impairment. Methodology/Principal Findings: Odor identification was assessed with 16 Sniffin' sticks in 148 Parkinson patients and 148 healthy controls. Risks of olfactory impairment were estimated with proportional odds models. Random forests were applied to classify Parkinson and non-Parkinson patients. Parkinson patients were rarely normosmic (identification of more than 12 odors; 16.8%) and identified on average seven odors whereas the reference group identified 12 odors and showed a higher prevalence of normosmy (31.1%). Parkinson patients with rigidity dominance had a twofold greater prevalence of olfactory impairment. Disease severity was associated with impairment of odor identification (per score point of the Hoehn and Yahr rating OR 1.87, 95% CI 1.26-2.77). Age-related impairment of olfaction showed a steeper gradient in Parkinson patients. Coffee, peppermint, and anise showed the largest difference in odor identification between Parkinson patients and controls. Random forests estimated a misclassification rate of 22.4% when comparing Parkinson patients with healthy controls using all 16 odors. A similar rate (23.8%) was observed when only the three aforementioned odors were applied. Conclusions/Significance: Our findings indicate that testing odor identification can be a supportive diagnostic tool for Parkinson's disease. The application of only three odors performed well in discriminating Parkinson patients from controls, which can facilitate a wider application of this method as a point-of-care test.	[Casjens, Swaantje; Eckert, Angelika; Bruening, Thomas; Pesch, Beate] Inst Ruhr Univ Bochum IPA, German Social Accid Insurance, Inst Prevent & Occupat Med, Bochum, Germany; [Woitalla, Dirk; Ellrichmann, Gisa] Ruhr Univ Bochum, St Josef Hosp, Neurol Clin, Bochum, Germany; [Turewicz, Michael; Stephan, Christian; Eisenacher, Martin; May, Caroline; Meyer, Helmut E.] Ruhr Univ Bochum, Med Proteom Ctr, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Pesch, B (corresponding author), Inst Ruhr Univ Bochum IPA, German Social Accid Insurance, Inst Prevent & Occupat Med, Bochum, Germany.	pesch@ipa-dguv.de	Eisenacher, Martin/J-8044-2014; Brüning, Thomas/G-8120-2015; Turewicz, Michael/M-5026-2019; Casjens, Swaantje/AAP-8856-2020	Eisenacher, Martin/0000-0003-2687-7444; Brüning, Thomas/0000-0001-9560-5464; Turewicz, Michael/0000-0003-0737-1114; Casjens, Swaantje/0000-0002-0148-8859	European Regional Development Fond (ERDF) of the European Union; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (ParkCHIP) [FZ 280381102]; P.U.R.E. (Protein Unit for Research in Europe), a project of the Federal State Northrhine Westphalia, Germany	European Regional Development Fond (ERDF) of the European Union; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (ParkCHIP); P.U.R.E. (Protein Unit for Research in Europe), a project of the Federal State Northrhine Westphalia, Germany	This work was supported by the European Regional Development Fond (ERDF) of the European Union and the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (ParkCHIP, FZ 280381102). Part of this work was also funded from P.U.R.E. (Protein Unit for Research in Europe), a project of the Federal State Northrhine Westphalia, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesveldt S, 2008, RHINOLOGY, V46, P131; Boesveldt S, 2008, MOVEMENT DISORD, V23, P1984, DOI 10.1002/mds.22155; Boesveldt S, 2011, RHINOLOGY, V49, P324, DOI 10.4193/Rhino10.155; Bohnen NI, 2010, BRAIN, V133, P1747, DOI 10.1093/brain/awq079; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks DJ, 1998, ANN NEUROL, V44, pS10, DOI 10.1002/ana.410440704; Bruce B, 2005, CLIN EXP RHEUMATOL, V23, pS14; Damholdt MF, 2011, MOVEMENT DISORD, V26, P2045, DOI 10.1002/mds.23782; Doty RL, 2011, PSYCHOL AGING, V26, P864, DOI 10.1037/a0023263; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Fahn S., 1987, RECENT DEV PARKINSON, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Haehner A, 2009, EXPERT REV NEUROTHER, V9, P1773, DOI [10.1586/ern.09.115, 10.1586/ERN.09.115]; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2010, J NEUROL, V257, P1316, DOI 10.1007/s00415-010-5516-5; Iijima M, 2011, EUR J NEUROL, V18, P425, DOI 10.1111/j.1468-1331.2010.03167.x; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Morley JF, 2011, MOVEMENT DISORD, V26, P2051, DOI 10.1002/mds.23792; Mueller C, 2006, AM J RHINOL, V20, P113, DOI 10.1177/194589240602000121; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; R Core Team, 2021, R LANGUAGE ENV STAT; Silveira-Moriyama L, 2008, MOVEMENT DISORD, V23, P2328, DOI 10.1002/mds.22241; STERN MB, 1994, NEUROLOGY, V44, P266, DOI 10.1212/WNL.44.2.266; Tissingh G, 2001, MOVEMENT DISORD, V16, P41, DOI 10.1002/1531-8257(200101)16:1<41::AID-MDS1017>3.0.CO;2-M; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Verbaan D, 2008, NEUROLOGY, V71, P1877, DOI 10.1212/01.wnl.0000336651.48596.c7	36	38	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64735	10.1371/journal.pone.0064735	http://dx.doi.org/10.1371/journal.pone.0064735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696904	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900106
J	van den Brink, DM; Banerji, O; Tear, G				van den Brink, Daan M.; Banerji, Oishik; Tear, Guy			Commissureless Regulation of Axon Outgrowth across the Midline Is Independent of Rab Function	PLOS ONE			English	Article							GROWTH CONE GUIDANCE; CNS MIDLINE; NEUROMUSCULAR SYNAPTOGENESIS; DROSOPHILA-MELANOGASTER; UBIQUITIN LIGASE; CELL-ADHESION; PROTEIN; NEURONS; RECEPTORS; SLIT	Nervous system function requires that neurons within neural circuits are connected together precisely. These connections form during the process of axon guidance whereby each neuron extends an axon that migrates, often large distances, through a complex environment to reach its synaptic target. This task can be simplified by utilising intermediate targets to divide the route into smaller sections. This requires that axons adapt their behaviour as they migrate towards and away from intermediate targets. In the central nervous system the midline acts as an intermediate target for commissural axons. In Drosophila commissural axons switch from attraction towards to extension away from the midline by regulating the levels of the Roundabout receptor on their cell surface. This is achieved by Commissureless which directs Roundabout to an intracellular compartment in the soma prior to reaching the midline. Once across the midline Roundabout is allowed to reach the surface and acts as a receptor for the repellent ligand Slit that is secreted by cells at the midline. Here we investigated candidate intracellular mechanisms that may facilitate the intracellular targeting of Commissureless and Roundabout within the soma of commissural neurons. Using modified forms of Commissureless or Rabs we show that neither ubiquitination nor Rab activity are necessary for the intracellular targeting of Commissureless. In addition we reveal that axon outgrowth of many populations of neurons within the Drosophila central nervous system is also independent of Rab activity.	[van den Brink, Daan M.; Banerji, Oishik; Tear, Guy] Kings Coll London, Med Res Council Ctr Dev Neurobiol, London WC2R 2LS, England	University of London; King's College London	Tear, G (corresponding author), Kings Coll London, Med Res Council Ctr Dev Neurobiol, London WC2R 2LS, England.	guy.tear@kcl.ac.uk	van den Brink, Daan/S-7529-2017	van den Brink, Daan/0000-0002-3048-5382; Banerji, Oishik/0000-0003-4614-8441; Tear, Guy/0000-0002-3114-7537	BBSRC (Biotechnology and Biological Sciences Research Council) [BB/G022399/1]; NIH [OD010949-10]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F014287/1, BB/K002031/1, BB/G022399/1, C19246] Funding Source: researchfish; Medical Research Council [G0901899, G0401440] Funding Source: researchfish; BBSRC [BB/K002031/1, BB/F014287/1, BB/G022399/1] Funding Source: UKRI; MRC [G0901899, G0401440] Funding Source: UKRI	BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the BBSRC (Biotechnology and Biological Sciences Research Council), Ref BB/G022399/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Bloomington Drosophila Stock Center, Matthias Landgraf, Hugo Bellen, Marcus Gonzalez-Gaitan, Sean Sweeney and Daniela Rotin for providing strains of Drosophila used in this study. We also thank the Drosophila Genomics Resource Center, supported by NIH grant OD010949-10 for the supply of S2 cells.	Allen J, 2009, DEV BIOL, V327, P4, DOI 10.1016/j.ydbio.2008.12.013; Bhuin T, 2011, INT J DEV BIOL, V55, P269, DOI 10.1387/ijdb.103149tb; Bhuin T, 2009, CELL TISSUE RES, V335, P349, DOI 10.1007/s00441-008-0711-8; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dickson BJ, 2010, COLD SPRING HARB PER, V2; Dittrich R, 1997, DEVELOPMENT, V124, P2515; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Evans TA, 2010, CURR OPIN NEUROBIOL, V20, P79, DOI 10.1016/j.conb.2009.12.006; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Gilestro GF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003798; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Higashijima S, 1996, DEVELOPMENT, V122, P527; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; HUBER LA, 1995, MOL CELL BIOL, V15, P918; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Kamata T, 1998, MOL BRAIN RES, V54, P219, DOI 10.1016/S0169-328X(97)00332-X; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Landgraf M, 2003, PLOS BIOL, V1, P221, DOI 10.1371/journal.pbio.0000041; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Long KE, 2000, J NEUROBIOL, V44, P230, DOI 10.1002/1097-4695(200008)44:2<230::AID-NEU12>3.0.CO;2-W; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Philipp M, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-36; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Star EN, 2005, J PHYSIOL-LONDON, V569, P103, DOI 10.1113/jphysiol.2005.092528; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Winckler B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001826; Wolf B, 1998, DEVELOPMENT, V125, P3853; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	55	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64427	10.1371/journal.pone.0064427	http://dx.doi.org/10.1371/journal.pone.0064427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696892	Green Submitted, gold, Green Published			2022-12-27	WOS:000319081900095
J	Xiao, S; White, JF; Betenbaugh, MJ; Grisshammer, R; Shiloach, J				Xiao, Su; White, Jim F.; Betenbaugh, Michael J.; Grisshammer, Reinhard; Shiloach, Joseph			Transient and Stable Expression of the Neurotensin Receptor NTS1: A Comparison of the Baculovirus-Insect Cell and the T-REx-293 Expression Systems	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; HIGH-LEVEL EXPRESSION; INTEGRAL MEMBRANE-PROTEINS; PURIFICATION; OVEREXPRESSION; RHODOPSIN; PEPTIDE	Nowadays, baculovirus-infected insect cells and tetracycline-inducible mammalian cell lines (T-REx-293) are intensively used for G protein-coupled receptor (GPCR) production for crystallography purposes. Here we constructed a suspension T-REx-293 cell line to stably express an engineered neurotensin receptor 1 (NTS1) mutant and we quantitatively compared this cell line with the transient baculovirus-insect cell system throughout a milligram-scale NTS1 expression and purification process. The two systems were comparable with respect to functional NTS1 expression levels and receptor binding affinity for the agonist [H-3] neurotensin. However, NTS1 surface display on T-REx-293 cells determined by radio-ligand binding assays was 2.8 fold higher than that on insect cells. This work demonstrates two approaches for preparing milligram quantities of purified NTS1 suitable for structural studies and provides useful input to users in choosing and optimizing an appropriate expression host for other GPCRs.	[Xiao, Su; Shiloach, Joseph] NIDDKD, Biotechnol Core Lab, Bethesda, MD 20892 USA; [White, Jim F.; Grisshammer, Reinhard] NINDS, Membrane Prot Struct & Funct Unit, NIH, Rockville, MD USA; [Xiao, Su; Betenbaugh, Michael J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Johns Hopkins University	Grisshammer, R (corresponding author), NINDS, Membrane Prot Struct & Funct Unit, NIH, Rockville, MD USA.	rkgriss@helix.nih.gov; josephs@intra.niddk.nih.gov	Grisshammer, Reinhard/C-3089-2015; Betenbaugh, Michael J./A-3252-2010	Betenbaugh, Michael J./0000-0002-6336-4659	Intramural Research Program of the National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases); Intramural Research Program of the National Institutes of Health (National Institute of Neurological Disorders and Stroke); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK015500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003016] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural Research Program of the National Institutes of Health (National Institute of Neurological Disorders and Stroke); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the National Institutes of Health (SX, JS: National Institute of Diabetes and Digestive and Kidney Diseases; JFW, RG: National Institute of Neurological Disorders and Stroke). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrell J, 2013, MOL MEMBR BIOL, V30, P52, DOI 10.3109/09687688.2012.703703; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; Chen JS, 2003, CURR CANCER DRUG TAR, V3, P219, DOI 10.2174/1568009033481994; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Corin K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00172; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; GRISSHAMMER R, 1993, BIOCHEM J, V295, P571, DOI 10.1042/bj2950571; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hedayat A, 1999, ORTHOGONAL ARRAYS TH, Vxxii, P416; Kim JS, 2004, BIOTECHNOL PROGR, V20, P1788, DOI 10.1021/bp025536y; Kitabgi P, 2002, CURR OPIN DRUG DI DE, V5, P764; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Mazella J, 2001, CELL SIGNAL, V13, P1, DOI 10.1016/S0898-6568(00)00130-3; O'Malley MA, 2007, J STRUCT BIOL, V159, P166, DOI 10.1016/j.jsb.2007.05.001; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Sarkar CA, 2008, P NATL ACAD SCI USA, V105, P14808, DOI 10.1073/pnas.0803103105; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schimpff RM, 2001, J NEUROL NEUROSUR PS, V70, P784, DOI 10.1136/jnnp.70.6.784; Shi CH, 2005, BIOCHEMISTRY-US, V44, P15705, DOI 10.1021/bi051292p; Shibata Y, 2013, BIOCH BIOPH IN PRESS; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Tate CG, 1996, TRENDS BIOTECHNOL, V14, P426, DOI 10.1016/0167-7799(96)10059-7; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; White JF, 2004, FEBS LETT, V564, P289, DOI 10.1016/S0014-5793(04)00195-4; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; White JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012579	35	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63679	10.1371/journal.pone.0063679	http://dx.doi.org/10.1371/journal.pone.0063679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696845	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900051
J	Muthiah, AS; Aruni, W; Robles, AG; Dou, Y; Roy, F; Fletcher, HM				Muthiah, Arun S.; Aruni, Wilson; Robles, Antonette G.; Dou, Yuetan; Roy, Francis; Fletcher, Hansel M.			In Porphyromonas gingivalis VimF Is Involved in Gingipain Maturation through the Transfer of Galactose	PLOS ONE			English	Article							PUTATIVE GLYCOSYLTRANSFERASE; ARG-GINGIPAIN; BIOFILM FORMATION; DEPENDENT MODULATION; CYSTEINE PROTEINASES; PERIODONTAL-DISEASE; GENE DOWNSTREAM; VIRULENCE; GLYCOSYLATION; RGPB	Previously, we have reported that gingipain activity in Porphyromonas gingivalis, the major causative agent in adult periodontitis, is post-translationally regulated by the unique Vim proteins including VimF, a putative glycosyltransferase. To further characterize VimF, an isogenic mutant defective in this gene in a different P. gingivalis genetic background was evaluated. In addition, the recombinant VimF protein was used to further confirm its glycosyltransferase function. The vimF-defective mutant (FLL476) in the P. gingivalis ATCC 33277 genetic background showed a phenotype similar to that of the vimF-defective mutant (FLL95) in the P. gingivalis W83 genetic background. While hemagglutination was not detected and autoaggregation was reduced, biofilm formation was increased in FLL476. HeLa cells incubated with P. gingivalis FLL95 and FLL476 showed a 45% decrease in their invasive capacity. Antibodies raised against the recombinant VimF protein in E. coli immunoreacted only with the deglycosylated native VimF protein from P. gingivalis. In vitro glycosyltransferase activity for rVimF was observed using UDP-galactose and N-acetylglucosamine as donor and acceptor substrates, respectively. In the presence of rVimF and UDP-galactose, a 60 kDa protein from the extracellular fraction of FLL95 which was identified by mass spectrometry as Rgp gingipain, immunoreacted with the glycan specific mAb 1B5 antibody. Taken together, these results suggest the VimF glycoprotein is a galactosyltransferase that may be specific for gingipain glycosylation. Moreover, galatose is vital for the growing glycan chain.	[Muthiah, Arun S.; Aruni, Wilson; Robles, Antonette G.; Dou, Yuetan; Roy, Francis; Fletcher, Hansel M.] Loma Linda Univ, Sch Med, Div Microbiol & Mol Genet, Dept Basic Sci, Loma Linda, CA 92350 USA	Loma Linda University	Fletcher, HM (corresponding author), Loma Linda Univ, Sch Med, Div Microbiol & Mol Genet, Dept Basic Sci, Loma Linda, CA 92350 USA.	hfletcher@llu.edu	WILSON, ARUNI/AAU-1908-2020	Aruni, Wilson/0000-0002-9208-0153	National Institute of Dental and Craniofacial Research (NIDCR) [DE13664, DE019730, DE01973004S1, DE022508, DE022724]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019730, R01DE022508, R21DE022724, R56DE013664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013664] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants DE13664 DE019730, DE01973004S1, DE022508, and DE022724 from National Institute of Dental and Craniofacial Research (NIDCR) (to HMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaibou H, 2001, INFECT IMMUN, V69, P325, DOI 10.1128/IAI.69.1.325-335.2001; Andriankaja OM, 2010, AUST DENT J, V55, P252, DOI 10.1111/j.1834-7819.2010.01231.x; Aruni AW, 2012, INFECT IMMUN, V80, P550, DOI 10.1128/IAI.06062-11; Aruni W, 2011, INFECT IMMUN, V79, P2779, DOI 10.1128/IAI.00106-11; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bosques CJ, 2004, J AM CHEM SOC, V126, P8421, DOI 10.1021/ja0496266; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Chen T, 2000, MICROB PATHOGENESIS, V28, P235, DOI 10.1006/mpat.1999.0338; Curtis MA, 1999, INFECT IMMUN, V67, P3816, DOI 10.1128/IAI.67.8.3816-3823.1999; Davey ME, 2006, J BACTERIOL, V188, P5510, DOI 10.1128/JB.01685-05; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; Deng CH, 2004, ANAL BIOCHEM, V330, P219, DOI 10.1016/j.ab.2004.03.014; Dou Y, 2010, FEMS MICROBIOL LETT, V312, P24, DOI 10.1111/j.1574-6968.2010.02093.x; Eick S, 2003, ACTA BIOCHIM POL, V50, P725; Fisher MA, 2011, KIDNEY INT, V79, P347, DOI 10.1038/ki.2010.384; Frisbee Stephanie J, 2010, J Dent Hyg, V84, P177; Fu H, 2007, PLANTA, V226, P1511, DOI 10.1007/s00425-007-0587-y; Gallagher A, 2003, CURR PROTEIN PEPT SC, V4, P427, DOI 10.2174/1389203033486974; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Han YW, 2011, J DENT RES, V90, P289, DOI 10.1177/0022034510381905; Harris J Robin, 2007, Methods Mol Biol, V369, P107; Hasegawa Y, 2003, MICROBIOL IMMUNOL, V47, P849, DOI 10.1111/j.1348-0421.2003.tb03451.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hinsa SM, 2006, MICROBIOL-SGM, V152, P1375, DOI 10.1099/mic.0.28696-0; Kishi M, 2012, MOL ORAL MICROBIOL, V27, P458, DOI 10.1111/j.2041-1014.2012.00659.x; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Nakayama K, 2003, CURR PROTEIN PEPT SC, V4, P389, DOI 10.2174/1389203033486983; Narimatsu M, 2004, INFECT IMMUN, V72, P2698, DOI 10.1128/IAI.72.5.2698-2702.2004; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; Olango GJ, 2003, INFECT IMMUN, V71, P3740, DOI 10.1128/IAI.71.7.3740-3747.2003; Osbourne D, 2012, MOL ORAL MICROBIOL, V27, P420, DOI 10.1111/j.2041-1014.2012.00661.x; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Potempa J, 1998, J BIOL CHEM, V273, P21648, DOI 10.1074/jbc.273.34.21648; POTEMPA J, 1995, INFECT IMMUN, V63, P1176, DOI 10.1128/IAI.63.4.1176-1182.1995; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Potempa Jan, 2007, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2120s49; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; Roseman S, 2001, J BIOL CHEM, V276, P41527, DOI 10.1074/jbc.R100053200; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Sato K, 2009, MICROBIOL-SGM, V155, P1282, DOI 10.1099/mic.0.025163-0; Sheets SM, 2008, FRONT BIOSCI-LANDMRK, V13, P3215; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Slakeski N, 2011, J BACTERIOL, V193, P132, DOI 10.1128/JB.00773-10; Tokuda M, 1998, INFECT IMMUN, V66, P1159, DOI 10.1128/IAI.66.3.1159-1166.1998; Vanterpool E, 2006, MICROBIOL-SGM, V152, P3383, DOI 10.1099/mic.0.29146-0; Vanterpool E, 2005, INFECT IMMUN, V73, P3971, DOI 10.1128/IAI.73.7.3971-3982.2005; Vanterpool E, 2005, INFECT IMMUN, V73, P1357, DOI 10.1128/IAI.73.3.1357-1366.2005; Vanterpool E, 2004, INFECT IMMUN, V72, P5555, DOI 10.1128/IAI.72.10.5555-5564.2004; Veith PD, 2004, INFECT IMMUN, V72, P3655, DOI 10.1128/IAI.72.6.3655-3657.2004; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Yilmaz O, 2003, MICROBIOL-SGM, V149, P2417, DOI 10.1099/mic.0.26483-0; Zhang W, 2011, J PERIODONTOL, V82, P909, DOI 10.1902/jop.2010.100501	57	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63367	10.1371/journal.pone.0063367	http://dx.doi.org/10.1371/journal.pone.0063367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717416	Green Published, gold, Green Submitted			2022-12-27	WOS:000319385300038
J	Eseberri, I; Lasa, A; Churruca, I; Portillo, MP				Eseberri, Itziar; Lasa, Arrate; Churruca, Itziar; Portillo, Maria P.			Resveratrol Metabolites Modify Adipokine Expression and Secretion in 3T3-L1 Pre-Adipocytes and Mature Adipocytes	PLOS ONE			English	Article							GENE-EXPRESSION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; LEPTIN; APELIN; ADIPONECTIN; INHIBITION; MECHANISMS; APOPTOSIS	Objective: Due to the low bioavailability of resveratrol, determining whether its metabolites exert any beneficial effect is an interesting issue. Methods: 3T3-L1 maturing pre-adipocytes were treated during differentiation with 25 mu M of resveratrol or with its metabolites and 3T3-L1 mature adipocytes were treated for 24 hours with 10 mM resveratrol or its metabolites. The gene expression of adiponectin, leptin, visfatin and apelin was assessed by Real Time RT-PCR and their concentration in the incubation medium was quantified by ELISA. Results: Resveratrol reduced mRNA levels of leptin and increased those of adiponectin. It induced the same changes in leptin secretion. Trans-resveratrol-3-O-glucuronide and trans-resveratrol-4'-O-glucuronide increased apelin and visfatin mRNA levels. Trans-resveratrol-3-O-sulfate reduced leptin mRNA levels and increased those of apelin and visfatin. Conclusions: The present study shows for the first time that resveratrol metabolites have a regulatory effect on adipokine expression and secretion. Since resveratrol has been reported to reduce body-fat accumulation and to improve insulin sensitivity, and considering that these effects are mediated in part by changes in the analyzed adipokines, it may be proposed that resveratrol metabolites play a part in these beneficial effects of resveratrol.	[Eseberri, Itziar; Lasa, Arrate; Churruca, Itziar; Portillo, Maria P.] Univ Basque Country UPV EHU, Nutr & Obes Grp, Dept Nutr & Food Sci, Vitoria, Spain; [Eseberri, Itziar; Lasa, Arrate; Churruca, Itziar; Portillo, Maria P.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain	University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Portillo, MP (corresponding author), Univ Basque Country UPV EHU, Nutr & Obes Grp, Dept Nutr & Food Sci, Vitoria, Spain.	mariapuy.portillo@ehu.es	Churruca, Itziar/L-7992-2014; Lasa, Arrate/L-7549-2014; Eseberri, Itziar/ABE-7228-2020; Portillo, Maria Puy/ABH-2374-2020; Eseberri, Itziar/AAA-8168-2021	Churruca, Itziar/0000-0003-3771-3963; Lasa, Arrate/0000-0003-2399-4979; Portillo, Maria Puy/0000-0003-0210-6549; PORTILLO BAQUEDANO, MARIA PUY/0000-0003-2290-592X; Eseberri, Itziar/0000-0001-5036-963X; LASA ELGUEZUA, ARRATE/0000-0002-8309-8212	Ministerio de Economia y Competitividad [AGL2011-27406-ALI]; Instituto de Salud Carlos III; Government of the Basque Country [IT-512-13]; University of the Basque Country (UPV/EHU) [ELDUNANOTEK UFI11/32]	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Government of the Basque Country; University of the Basque Country (UPV/EHU)	This study was supported by grants from the Ministerio de Economia y Competitividad (AGL2011-27406-ALI), Instituto de Salud Carlos III (RETIC PREDIMED and CiberObn), Government of the Basque Country (IT-512-13) and University of the Basque Country (UPV/EHU) (ELDUNANOTEK UFI11/32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Ahn J, 2008, J HEPATOL, V49, P1019, DOI 10.1016/j.jhep.2008.08.012; Alberdi G, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-29; Andres-Lacueva C., 2009, PLANT PHENOLICS HUMA, P265; Andres-Lacueva C, 2012, J AGR FOOD CHEM, V60, P4833, DOI 10.1021/jf3001108; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Baarine M, 2011, GENES NUTR, V6, P161, DOI 10.1007/s12263-011-0232-z; Bagul PK, 2012, PHARMACOL RES, V66, P260, DOI 10.1016/j.phrs.2012.05.003; Baile CA, 2011, ANN NY ACAD SCI, V1215, P40, DOI 10.1111/j.1749-6632.2010.05845.x; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bertelli AAE, 1996, INT J TISSUE REACT, V18, P67; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Calamini B, 2010, BIOCHEM J, V429, P273, DOI 10.1042/BJ20091857; Carpene C, 2007, J PHYSIOL BIOCHEM, V63, P359; Cases JA, 2001, DIABETES, V50, P348, DOI 10.2337/diabetes.50.2.348; Castan-Iaurell I, 2012, TRENDS ENDOCRIN MET, V23, P234, DOI 10.1016/j.tem.2012.02.005; Chen SF, 2012, CAN J PHYSIOL PHARM, V90, P237, DOI [10.1139/Y11-123, 10.1139/y11-123]; Cucciolla V, 2007, CELL CYCLE, V6, P2495, DOI 10.4161/cc.6.20.4815; Dal-Pan Alexandre, 2010, BMC Physiology, V10, P11, DOI 10.1186/1472-6793-10-11; De Santi C, 2000, XENOBIOTICA, V30, P857, DOI 10.1080/004982500433282; Lobo SMD, 2012, CYTOKINE, V60, P150, DOI 10.1016/j.cyto.2012.04.039; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Delmas D, 2011, ANN NY ACAD SCI, V1215, P48, DOI 10.1111/j.1749-6632.2010.05871.x; Derdemezis CS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/285618; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Gatz SA, 2008, CARCINOGENESIS, V29, P321, DOI 10.1093/carcin/bgm276; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Hegde PS, 2003, CURR OPIN BIOTECH, V14, P647, DOI 10.1016/j.copbio.2003.10.006; Higuchi K, 2007, ENDOCRINOLOGY, V148, P2690, DOI 10.1210/en.2006-1270; Hoshino J, 2010, J MED CHEM, V53, P5033, DOI 10.1021/jm100274c; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macarulla MT, 2009, J PHYSIOL BIOCHEM, V65, P369, DOI 10.1007/BF03185932; Mason MM, 1998, ENDOCRINOLOGY, V139, P1013, DOI 10.1210/en.139.3.1013; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Park HJ, 2008, J MED FOOD, V11, P773, DOI 10.1089/jmf.2008.0077; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Portillo MP, 2012, MOL NUTR FOOD RES, V00, P1; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Shang J, 2008, ACTA PHARMACOL SIN, V29, P698, DOI 10.1111/j.1745-7254.2008.00807.x; Sharma AM, 2005, ACTA DIABETOL, V42, pS3, DOI 10.1007/s00592-005-0175-1; Szkudelska K, 2009, EUR J CLIN INVEST, V39, P899, DOI 10.1111/j.1365-2362.2009.02188.x; Taylor JM, MOL CELL PROTEOMICS, V1, P304; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x; Wang AP, 2011, J BIOL CHEM, V286, P60, DOI 10.1074/jbc.M110.188144; Wang P, 2006, DIABETOLOGIA, V49, P2453, DOI 10.1007/s00125-006-0321-5; Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322	54	52	53	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63918	10.1371/journal.pone.0063918	http://dx.doi.org/10.1371/journal.pone.0063918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717508	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700079
J	Geiser, F; Klingenspor, M; McAllan, BM				Geiser, Fritz; Klingenspor, Martin; McAllan, Bronwyn M.			A Functional Nexus between Photoperiod Acclimation, Torpor Expression and Somatic Fatty Acid Composition in a Heterothermic Mammal	PLOS ONE			English	Article							HAMSTER PHODOPUS-SUNGORUS; SATURATED DIETARY LIPIDS; DJUNGARIAN HAMSTER; ADIPOSE-TISSUE; BODY-TEMPERATURE; FOOD-INTAKE; HIBERNATION; MOUSE; METABOLISM; SELECTION	The seasonal changes in thermal physiology and torpor expression of many heterothermic mammals are controlled by photoperiod. As function at low body temperatures during torpor requires changes of tissue lipid composition, we tested for the first time whether and how fatty acids are affected by photoperiod acclimation in hamsters, Phodopus sungorus, a strongly photoperiodic species. We also examined changes in fatty acid composition in relation to those in morphology and thermal biology. Hamsters in short photoperiod had smaller reproductive organs and most had a reduced body mass in comparison to those in long photoperiod. Pelage colour of hamsters under short photoperiod was almost white while that of long photoperiod hamsters was grey-brown and black. Short photoperiod acclimation resulted in regular (28% of days) torpor use, whereas all hamsters in long photoperiod remained normothermic. The composition of total fatty acids differed between acclimation groups for brown adipose tissue (5 of 8 fatty acids), heart muscle (4 of 7 fatty acids) and leg muscle (3 of 11 fatty acids). Importantly, 54% of all fatty acids detected were correlated (r(2) = 0.60 to 0.87) with the minimum surface temperature of individuals, but the responses of tissues differed. While some of the compositional changes of fatty acids were consistent with a 'homeoviscous' response, this was not the case for all, including the sums of saturated and unsaturated fatty acids, which did not differ between acclimation groups. Our data identify a possible nexus between photoperiod acclimation, morphology, reproductive biology, thermal biology and fatty acid composition. They suggest that some of the changes in thermal physiology are linked to the composition of tissue and organ fatty acids.	[Geiser, Fritz; Klingenspor, Martin; McAllan, Bronwyn M.] Univ Marburg, Marburg, Germany	Philipps University Marburg	Geiser, F (corresponding author), Univ New England, Ctr Behav & Physiol Ecol, Armidale, NSW, Australia.	fgeiser@une.edu.au	Geiser, Fritz/O-4175-2018; Klingenspor, Martin/K-5033-2019; Klingenspor, Martin/D-6930-2011	Geiser, Fritz/0000-0001-7621-5049; Klingenspor, Martin/0000-0002-4502-6664; McAllan, Bronwyn/0000-0002-6075-3405	Australian Research Council; University of New England	Australian Research Council(Australian Research Council); University of New England	This study received financial support from Australian Research Council, University of New England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOIA RC, 1989, BIOCHIM BIOPHYS ACTA, V988, P123, DOI 10.1016/0304-4157(89)90007-5; Arnold W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018641; Barnes Brian M., 1996, P71; Boyer BB, 1999, BIOSCIENCE, V49, P713, DOI 10.2307/1313595; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; Diedrich Victoria, 2012, P231; FIGALA J, 1973, OECOLOGIA, V12, P89, DOI 10.1007/BF00345511; Florant GL, 1998, AM ZOOL, V38, P331; FRANK CL, 1994, ECOLOGY, V75, P458, DOI 10.2307/1939549; GEISER F, 1995, J COMP PHYSIOL B, V165, P406, DOI 10.1007/BF00387311; GEISER F, 1991, J COMP PHYSIOL B, V161, P590, DOI 10.1007/BF00260749; GEISER F, 1990, BIOCHIM BIOPHYS ACTA, V1046, P159, DOI 10.1016/0005-2760(90)90183-X; GEISER F, 1987, AM J PHYSIOL, V252, pR897, DOI 10.1152/ajpregu.1987.252.5.R897; Geiser F, 2007, NATURWISSENSCHAFTEN, V94, P319, DOI 10.1007/s00114-006-0193-z; Geiser Fritz, 2012, P109; Geiser F, 2009, NATURWISSENSCHAFTEN, V96, P1235, DOI 10.1007/s00114-009-0583-0; Giroud S, 2009, AM J PHYSIOL-REG I, V297, pR950, DOI 10.1152/ajpregu.00214.2009; HELDMAIER G, 1981, OECOLOGIA, V48, P265, DOI 10.1007/BF00347975; Hickman C.P., 2011, INTEGRATED PRINCIPLE; Hiebert SM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P850, DOI 10.1086/378142; HILL RW, 1975, COMP BIOCHEM PHYS A, V51, P413, DOI 10.1016/0300-9629(75)90389-8; Hoffman RA, 1964, BIOLOGICA, V71, P199; HOFFMANN K, 1978, J REPROD FERTIL, V54, P29, DOI 10.1530/jrf.0.0540029; Hulbert AJ, 2011, AUST J ZOOL, V59, P369, DOI 10.1071/ZO11064; Jastroch M, 2008, PHYSIOL GENOMICS, V32, P161, DOI 10.1152/physiolgenomics.00183.2007; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; KLINGENSPOR M, 1989, AM J PHYSIOL, V257, pR1123, DOI 10.1152/ajpregu.1989.257.5.R1123; Lovegrove Barry G., 2012, P3; LYNCH GR, 1978, J COMP PHYSIOL, V125, P157, DOI 10.1007/BF00686752; McAllan BM, 2012, GEN COMP ENDOCR, V179, P265, DOI 10.1016/j.ygcen.2012.08.024; Morrow G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006070; Mzilikazi N, 2002, J COMP PHYSIOL B, V172, P7, DOI 10.1007/s003600100221; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Price ER, 2013, PHYSIOL BIOCHEM ZOOL, V86, P205, DOI 10.1086/668892; Rojas AD, 2012, BIOL LETTERS, V8, P868, DOI 10.1098/rsbl.2012.0269; RUF T, 1991, J COMP PHYSIOL B, V160, P609, DOI 10.1007/BF00571257; Ruf T, 2008, AM J PHYSIOL-REG I, V294, pR1044, DOI 10.1152/ajpregu.00688.2007; Schalk G, 1995, CAN J ZOOL, V73, P1855, DOI 10.1139/z95-218; SCHLATT S, 1993, BIOL REPROD, V49, P243, DOI 10.1095/biolreprod49.2.243; Stamper JL, 1999, PHYSIOL BEHAV, V66, P113, DOI 10.1016/S0031-9384(98)00283-2; Stawski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040278; Steinlechner S., 1986, P301; Swoap SJ, 2009, AM J PHYSIOL-REG I, V297, pR769, DOI 10.1152/ajpregu.00131.2009; TANNENBAUM MG, 1989, AM MIDL NAT, V121, P194, DOI 10.2307/2425671; Valencak TG, 2003, J COMP PHYSIOL B, V173, P695, DOI 10.1007/s00360-003-0382-4	46	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63803	10.1371/journal.pone.0063803	http://dx.doi.org/10.1371/journal.pone.0063803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717487	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700062
J	House, CM; Lewis, Z; Hodgson, DJ; Wedell, N; Sharma, MD; Hunt, J; Hosken, DJ				House, Clarissa M.; Lewis, Zenobia; Hodgson, Dave J.; Wedell, Nina; Sharma, Manmohan D.; Hunt, John; Hosken, David J.			Sexual and Natural Selection Both Influence Male Genital Evolution	PLOS ONE			English	Article							ONE-SIZE-FITS; GENETIC-VARIATION; DROSOPHILA; MORPHOLOGY; BEETLE; ALLOMETRY; RESPONSES; PATTERNS; SUCCESS; TRAITS	Rapid and divergent evolution of male genital morphology is a conspicuous and general pattern across internally fertilizing animals. Rapid genital evolution is thought to be the result of sexual selection, and the role of natural selection in genital evolution remains controversial. However, natural and sexual selection are believed to act antagonistically on male genital form. We conducted an experimental evolution study to investigate the combined effects of natural and sexual selection on the genital-arch lobes of male Drosophila simulans. Replicate populations were forced to evolve under lifetime monogamy (relaxed sexual selection) or lifetime polyandry (elevated sexual selection) and two temperature regimes, 25 degrees C (relaxed natural selection) or 27 degrees C (elevated natural selection) in a fully factorial design. We found that natural and sexual selection plus their interaction caused genital evolution. Natural selection caused some aspects of genital form to evolve away from their sexually selected shape, whereas natural and sexual selection operated in the same direction for other shape components. Additionally, sexual and natural selection tended to favour larger genitals. Thus we find that the underlying selection driving genital evolution is complex, does not only involve sexual selection, and that natural selection and sexual selection do not always act antagonistically.	[House, Clarissa M.; Lewis, Zenobia; Hodgson, Dave J.; Wedell, Nina; Sharma, Manmohan D.; Hunt, John; Hosken, David J.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of Exeter	Hosken, DJ (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England.	d.j.hosken@exeter.ac.uk	Sharma, Manmohan/F-8530-2013; Hunt, John/F-1279-2014; Lewis, Zenobia/T-2928-2019	Sharma, Manmohan/0000-0002-9957-3153; Hodgson, Dave/0000-0003-4220-2076; Lewis, Zenobia/0000-0001-9464-7638; Hunt, John/0000-0002-4962-8750	Natural Environment Research Council; Leverhulme Trust; Royal Society; NERC [NE/G005303/1] Funding Source: UKRI; Natural Environment Research Council [NE/G005303/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D. Hoskin, JH, D. Hodgson, and NW were funded by the Natural Environment Research Council to investigate genital evolution, CMH was funded by a Leverhulme Trust fellowship and JH by a Royal Society Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade CAC, 2005, J THERM BIOL, V30, P518, DOI 10.1016/j.jtherbio.2005.05.011; [Anonymous], 1984, SPERM COMPETITION EV; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Arnqvist G, 1998, GENET RES, V71, P193, DOI 10.1017/S0016672398003279; Bernstein S, 2002, EVOLUTION, V56, P1707, DOI 10.1111/j.0014-3820.2002.tb01483.x; Blanckenhorn WU, 1999, EVOL ECOL, V13, P395, DOI 10.1023/A:1006741222586; Cayetano L, 2011, EVOLUTION, V65, P2171, DOI 10.1111/j.1558-5646.2011.01309.x; Civetta A, 2000, P NATL ACAD SCI USA, V97, P13162, DOI 10.1073/pnas.230305397; COYNE JA, 1983, EVOLUTION, V37, P1101, DOI 10.1111/j.1558-5646.1983.tb00225.x; Eberhard W, 2009, J EVOLUTION BIOL, V22, P435, DOI 10.1111/j.1420-9101.2008.01654.x; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; Eberhard WG, 2009, EVOLUTION, V63, P48, DOI 10.1111/j.1558-5646.2008.00528.x; Garcia-Gonzalez F, 2011, ENCY LIFE SCI ELE, DOI [10.1002/9780470015902.0022859, DOI 10.1002/9780470015902.0022859]; Ghiselin Michael T., 2010, P9; Higgins SL, 2009, BIOL J LINN SOC, V98, P400, DOI 10.1111/j.1095-8312.2009.01292.x; Hosken DJ, 2008, CURR BIOL, V18, pR553, DOI 10.1016/j.cub.2008.04.028; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; House CM, 2005, J EVOLUTION BIOL, V18, P1281, DOI 10.1111/j.1420-9101.2005.00926.x; House CM, 2003, P ROY SOC B-BIOL SCI, V270, P447, DOI 10.1098/rspb.2002.2266; Ingleby FC, 2013, J EVOLUTION BIOL, V26, P311, DOI 10.1111/jeb.12045; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Jennions MD, 2002, OIKOS, V97, P79, DOI 10.1034/j.1600-0706.2002.970108.x; Kamimura Y, 2010, ZOOMORPHOLOGY, V129, P163, DOI 10.1007/s00435-010-0109-5; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Langerhans RB, 2005, P NATL ACAD SCI USA, V102, P7618, DOI 10.1073/pnas.0500935102; Preziosi RF, 1998, HEREDITY, V81, P92, DOI 10.1046/j.1365-2540.1998.00380.x; Reinhardt K, 2007, Q REV BIOL, V82, P375, DOI 10.1086/522811; Reinhardt K, 2010, GENETICA, V138, P119, DOI 10.1007/s10709-009-9360-4; ROFF DA, 2001, LIFE HIST EVOLUTION; Rohlf FJ, 2008, TPSRELW RELATIVE WAR; Rohlf FJ, 2009, TPSDIG DIGITIZE LAND; SHAPIRO AM, 1989, ANNU REV ENTOMOL, V34, P231, DOI 10.1146/annurev.en.34.010189.001311; Sharma MD, 2012, EVOLUTION, V66, P665, DOI 10.1111/j.1558-5646.2011.01468.x; Simmons LW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1379; Simmons LW, 2009, CURR BIOL, V19, P1442, DOI 10.1016/j.cub.2009.06.056; Taylor ML, 2008, ANIM BEHAV, V76, P963, DOI 10.1016/j.anbehav.2008.05.015; Taylor ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P721, DOI 10.1007/s00265-007-0497-9; True JR, 1997, EVOLUTION, V51, P816, DOI [10.2307/2411157, 10.1111/j.1558-5646.1997.tb03664.x]; Vencl FV, 2004, INTEGR COMP BIOL, V44, P242, DOI 10.1093/icb/44.3.242; Wright LI, 2008, CONSERV GENET, V9, P833, DOI 10.1007/s10592-007-9405-0; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zeng ZB, 2000, GENETICS, V154, P299	44	41	41	11	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63807	10.1371/journal.pone.0063807	http://dx.doi.org/10.1371/journal.pone.0063807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717488	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700063
J	Jansen, D; Zerbi, V; Janssen, CIF; Dederen, PJWC; Mutsaers, MPC; Hafkemeijer, A; Janssen, AL; Nobelen, CLM; Veltien, A; Asten, JJ; Heerschap, A; Kiliaan, AJ				Jansen, Diane; Zerbi, Valerio; Janssen, Carola I. F.; Dederen, Pieter J. W. C.; Mutsaers, Martina P. C.; Hafkemeijer, Anne; Janssen, Anna-Lena; Nobelen, Cindy L. M.; Veltien, Andor; Asten, Jack J.; Heerschap, Arend; Kiliaan, Amanda J.			A Longitudinal Study of Cognition, Proton MR Spectroscopy and Synaptic and Neuronal Pathology in Aging Wild-type and A beta PPswe-PS1dE9 Mice	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; AMYLOID PRECURSOR PROTEIN; APPSWE/PS1DE9 MOUSE MODEL; MORRIS WATER MAZE; AGE-RELATED-CHANGES; ADULT HIPPOCAMPAL NEUROGENESIS; MICROTUBULE-ASSOCIATED PROTEIN; APP/PS1 TRANSGENIC MICE; N-ACETYL ASPARTATE; MULTIPLE T-TESTS	Proton magnetic resonance spectroscopy (H-1 MRS) is a valuable tool in Alzheimer's disease research, investigating the functional integrity of the brain. The present longitudinal study set out to characterize the neurochemical profile of the hippocampus, measured by single voxel H-1 MRS at 7 Tesla, in the brains of A beta PPSswe-PS1dE9 and wild-type mice at 8 and 12 months of age. Furthermore, we wanted to determine whether alterations in hippocampal metabolite levels coincided with behavioral changes, cognitive decline and neuropathological features, to gain a better understanding of the underlying neurodegenerative processes. Moreover, correlation analyses were performed in the 12-month-old A beta PP-PS1 animals with the hippocampal amyloid-beta deposition, TBS-T soluble A beta levels and high-molecular weight A beta aggregate levels to gain a better understanding of the possible involvement of A beta in neurochemical and behavioral changes, cognitive decline and neuropathological features in A beta PP-PS1 transgenic mice. Our results show that at 8 months of age A beta PPswe-PS1dE9 mice display behavioral and cognitive changes compared to age-matched wild-type mice, as determined in the open field and the (reverse) Morris water maze. However, there were no variations in hippocampal metabolite levels at this age. A beta PP-PS1 mice at 12 months of age display more severe behavioral and cognitive impairment, which coincided with alterations in hippocampal metabolite levels that suggest reduced neuronal integrity. Furthermore, correlation analyses suggest a possible role of A beta in inflammatory processes, synaptic dysfunction and impaired neurogenesis.	[Jansen, Diane; Zerbi, Valerio; Janssen, Carola I. F.; Dederen, Pieter J. W. C.; Mutsaers, Martina P. C.; Hafkemeijer, Anne; Janssen, Anna-Lena; Nobelen, Cindy L. M.; Kiliaan, Amanda J.] Radboud Univ Nijmegen Med Ctr, Donders Inst Brain Cognit & Behav, Donders Ctr Neurosci, Dept Anat, Nijmegen, Netherlands; [Veltien, Andor; Asten, Jack J.; Heerschap, Arend] Radboud Univ Nijmegen Med Ctr, Dept Radiol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Kiliaan, AJ (corresponding author), Radboud Univ Nijmegen Med Ctr, Donders Inst Brain Cognit & Behav, Donders Ctr Neurosci, Dept Anat, Nijmegen, Netherlands.	A.Kiliaan@anat.umcn.nl	Veltien, Andor/E-2834-2016; Dederen, Pieter.J.W.C/E-1899-2016; Zerbi, Valerio/K-3405-2018; Kiliaan, Amanda J/D-8778-2012; Heerschap, Arend/G-5228-2010	Veltien, Andor/0000-0002-8090-5445; Butscher, Anna-Lena/0000-0001-5556-4610; Zerbi, Valerio/0000-0001-7984-9565; Hafkemeijer, Anne/0000-0002-2940-4768	European Community [211696]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 211696. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arendt T, 2001, NEUROSCIENCE, V102, P723, DOI 10.1016/S0306-4522(00)00516-9; Boncristiano S, 2005, NEUROBIOL AGING, V26, P607, DOI 10.1016/j.neurobiolaging.2004.06.010; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Breteler MMB, 2000, ANN NY ACAD SCI, V903, P457, DOI 10.1111/j.1749-6632.2000.tb06399.x; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Bronfman FC, 2000, NEUROBIOL DIS, V7, P152, DOI 10.1006/nbdi.2000.0283; BROWN JD, 1990, TESOL QUART, V24, P770, DOI 10.2307/3587135; Burgermeister P, 2000, ANN NY ACAD SCI, V903, P307, DOI 10.1111/j.1749-6632.2000.tb06381.x; Cavassila S, 2001, NMR BIOMED, V14, P278, DOI 10.1002/nbm.701; Chen SQ, 2012, BEHAV BRAIN RES, V235, P1, DOI 10.1016/j.bbr.2012.07.016; Chen SQ, 2009, DEMENT GERIATR COGN, V28, P558, DOI 10.1159/000261646; Choi IY, 2003, NEUROCHEM RES, V28, P987, DOI 10.1023/A:1023370104289; Choi JK, 2007, NMR BIOMED, V20, P216, DOI 10.1002/nbm.1145; DEBRUIN JPC, 1994, BRAIN RES, V652, P323, DOI 10.1016/0006-8993(94)90243-7; Dedeoglu A, 2004, BRAIN RES, V1012, P60, DOI 10.1016/j.brainres.2004.02.079; DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; Dosunmu Remi, 2007, Expert Rev Neurother, V7, P887, DOI 10.1586/14737175.7.7.887; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Enciu AM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-75; Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Franklin KBJ, 1997, MOUSE BRAIN STEREOTA, Vxxii; Frederick BD, 2002, AM J GERIAT PSYCHIAT, V10, P81, DOI 10.1176/appi.ajgp.10.1.81; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffith HR, 2008, ALZHEIMERS DEMENT, V4, P421, DOI 10.1016/j.jalz.2008.04.008; Grossberg GT, 2003, J CLIN PSYCHIAT, V64, P3; Hamilton A, 2012, BRAIN RES, V1449, P83, DOI 10.1016/j.brainres.2012.02.015; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hooijmans CR, 2007, NEUROBIOL DIS, V28, P16, DOI 10.1016/j.nbd.2007.06.007; Hooijmans CR, 2009, NEUROBIOL DIS, V33, P482, DOI 10.1016/j.nbd.2008.12.002; Hooijmans CR, 2007, BRAIN RES, V1181, P93, DOI 10.1016/j.brainres.2007.08.063; Huang W, 2001, NEUROLOGY, V57, P626, DOI 10.1212/WNL.57.4.626; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Jack CR, 2007, NEUROSCIENTIST, V13, P38, DOI 10.1177/1073858406295610; JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jansen D, 2012, J ALZHEIMERS DIS, V31, P813, DOI 10.3233/JAD-2012-120298; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Jessen F, 2009, NEUROLOGY, V72, P1735, DOI 10.1212/WNL.0b013e3181a60a20; Jones RS, 2004, NEUROL RES, V26, P488, DOI 10.1179/016164104225017640; Kantarci K, 2007, BRIT J RADIOL, V80, pS146, DOI 10.1259/bjr/60346217; Kantarci K, 2004, NEUROLOGY, V63, P1393; Kantarci K, 2009, NEUROLOGY, V72, P1519, DOI 10.1212/WNL.0b013e3181a2e864; Kantarci K, 2008, RADIOLOGY, V248, P210, DOI 10.1148/radiol.2481071590; Kantarci K, 2007, NEUROBIOL AGING, V28, P1330, DOI 10.1016/j.neurobiolaging.2006.06.018; King DL, 2002, BRAIN RES, V926, P58, DOI 10.1016/S0006-8993(01)03294-2; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lalonde R, 2012, NEUROSCI BIOBEHAV R, V36, P1357, DOI 10.1016/j.neubiorev.2012.02.011; Lalonde R, 2004, NEUROSCI LETT, V369, P156, DOI 10.1016/j.neulet.2004.07.069; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Leuba G, 2008, J ALZHEIMERS DIS, V15, P139; Lovasic L, 2005, GENES BRAIN BEHAV, V4, P197, DOI 10.1111/j.1601-183X.2004.00104.x; Machova E, 2010, NEUROBIOL DIS, V38, P27, DOI 10.1016/j.nbd.2009.12.023; Marjanska M, 2005, P NATL ACAD SCI USA, V102, P11906, DOI 10.1073/pnas.0505513102; Masliah E, 1996, J NEUROSCI, V16, P5795; MASLIAH E, 1994, NEUROSCI LETT, V174, P67, DOI 10.1016/0304-3940(94)90121-X; Masliah E, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P91; Meyer JS, 1998, EUR NEUROL, V39, P7, DOI 10.1159/000052064; Mlynarik V, 2012, J ALZHEIMERS DIS, V31, pS87, DOI 10.3233/JAD-2012-112072; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mukaetova-Ladinska EB, 2000, AM J PATHOL, V157, P623, DOI 10.1016/S0002-9440(10)64573-7; Mulder M, 2007, NEUROSCI RES, V59, P251, DOI 10.1016/j.neures.2007.07.004; Niidome T, 2008, NEUROREPORT, V19, P1361, DOI 10.1097/WNR.0b013e32830e6dd6; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; Oberg J, 2008, NEUROBIOL AGING, V29, P1423, DOI 10.1016/j.neurobiolaging.2007.03.002; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Patterson M B, 1990, J Geriatr Psychiatry Neurol, V3, P21, DOI 10.1177/089198879000300106; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pfefferbaum A, 1999, MAGNET RESON MED, V41, P276, DOI 10.1002/(SICI)1522-2594(199902)41:2<276::AID-MRM10>3.0.CO;2-8; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Puolivali J, 2002, NEUROBIOL DIS, V9, P339, DOI 10.1006/nbdi.2002.0481; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; Rose SE, 1999, MAGN RESON IMAGING, V17, P291, DOI 10.1016/S0730-725X(98)00168-4; Ross AJ, 2005, BRAIN RES BULL, V66, P9, DOI 10.1016/j.brainresbull.2005.01.015; Ruan LF, 2009, CURR ALZHEIMER RES, V6, P531, DOI 10.2174/156720509790147070; Rupsingh R, 2011, NEUROBIOL AGING, V32, P802, DOI 10.1016/j.neurobiolaging.2009.05.002; Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X; Rutten BR, 2003, NEUROBIOL DIS, V12, P110, DOI 10.1016/S0969-9961(02)00015-3; Satlin A, 1997, AM J PSYCHIAT, V154, P1459; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Scheff SW, 1996, DEMENTIA, V7, P226, DOI 10.1159/000106884; Scheff SW, 1998, J NEUROPATH EXP NEUR, V57, P1146, DOI 10.1097/00005072-199812000-00006; Schuff N, 1997, NEUROLOGY, V49, P1513, DOI 10.1212/WNL.49.6.1513; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shukla C, 1999, NEUROREPORT, V10, P3785, DOI 10.1097/00001756-199912160-00012; SIEGEL AF, 1990, TESOL QUART, V24, P773, DOI 10.2307/3587136; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Skoog I, 2002, ANN NY ACAD SCI, V977, P29, DOI 10.1111/j.1749-6632.2002.tb04796.x; Stover KR, 2012, BEHAV BRAIN RES, V231, P75, DOI 10.1016/j.bbr.2012.02.044; Streijger F, 2005, BEHAV BRAIN RES, V157, P219, DOI 10.1016/j.bbr.2004.07.002; Su DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050172; Szapacs ME, 2004, NEUROBIOL DIS, V16, P572, DOI 10.1016/j.nbd.2004.04.010; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Voloboueva LA, 2011, J NEUROSCI RES, V89, P1989, DOI 10.1002/jnr.22768; von Kienlin M, 2005, NEUROBIOL DIS, V18, P32, DOI 10.1016/j.nbd.2004.09.005; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Watanabe T, 2012, NEUROBIOL LEARN MEM, V97, P289, DOI 10.1016/j.nlm.2012.01.006; Weller RO, 2003, NEUROL RES, V25, P611, DOI 10.1179/016164103101202057; Woo DC, 2010, BEHAV BRAIN RES, V211, P125, DOI 10.1016/j.bbr.2010.03.026; Xu W, 2010, J NEUROSCI RES, V88, P3155, DOI 10.1002/jnr.22479; Yang SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048540; Yao PJ, 2005, BIOCHEM BIOPH RES CO, V330, P34, DOI 10.1016/j.bbrc.2005.02.121; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Zerbi V, 2013, BRAIN STRUCT FUNCT, V218, P1085, DOI 10.1007/s00429-012-0448-8; Zerbi V, 2013, NEUROBIOL AGING, V34, P1440, DOI 10.1016/j.neurobiolaging.2012.11.017; Zhang B, 2009, J CLIN NEUROSCI, V16, P635, DOI 10.1016/j.jocn.2008.07.080; Zilka N, 2006, Bratisl Lek Listy, V107, P374	125	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63643	10.1371/journal.pone.0063643	http://dx.doi.org/10.1371/journal.pone.0063643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717459	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700045
J	Lee, EJ; Bhat, AR; Kamli, MR; Pokharel, S; Chun, T; Lee, YH; Nahm, SS; Nam, JH; Hong, SK; Yang, B; Chung, KY; Kim, SH; Choi, I				Lee, Eun Ju; Bhat, Abdul R.; Kamli, Majid Rasool; Pokharel, Smritee; Chun, Tahoon; Lee, Yong-Ho; Nahm, Sang-Seop; Nam, Joo Hyun; Hong, Seong Koo; Yang, Bohsuk; Chung, Ki Young; Kim, Sang Hoon; Choi, Inho			Transthyretin Is a Key Regulator of Myoblast Differentiation	PLOS ONE			English	Article							SKELETAL-MUSCLE; THYROID-HORMONE; CALCIUM-CHANNELS; RESPONSE ELEMENT; GENE-EXPRESSION; CELL-FUSION; CA2+ ENTRY; MYOGENIN; OVEREXPRESSION; IDENTIFICATION	Transthyretin (TTR) is a known carrier protein for thyroxine (T-4) and retinol-binding protein in the blood that is primarily synthesized in the liver and choroid plexus of the brain. Herein, we report that the TTR gene is expressed in skeletal muscle tissue and up-regulated during myotube formation in C2C12 cells. TTR silencing (TTRkd) significantly reduced myogenin expression and myotube formation, whereas myogenin silencing (MYOG(kd)) did not have any effect on TTR gene expression. Both TTRkd and MYOG(kd) led to a decrease in calcium channel related genes including Cav1.1, STIM1 and Orai1. A significant decrease in intracellular T-4 uptake during myogenesis was observed in TTRkd cells. Taken together, the results of this study suggest that TTR initiates myoblast differentiation via affecting expression of the genes involved during early stage of myogenesis and the genes related to calcium channel.	[Lee, Eun Ju; Bhat, Abdul R.; Kamli, Majid Rasool; Pokharel, Smritee; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Chun, Tahoon] Korea Univ, Coll Life Sci & Biotechnol, Seoul, South Korea; [Lee, Yong-Ho] Catholic Univ Daegu, Dept Biomed Sci, Gyongsan, South Korea; [Nahm, Sang-Seop] Konkuk Univ, Coll Vet Med, Seoul, South Korea; [Nam, Joo Hyun] Dongguk Univ, Coll Med, Dept Physiol, Gyeongju, South Korea; [Hong, Seong Koo; Yang, Bohsuk; Chung, Ki Young] Natl Inst Anim Sci, Hanwoo Expt Stn, RDA, Pyongchang, South Korea; [Kim, Sang Hoon] Kyung Hee Univ, Dept Biol, Seoul, South Korea	Yeungnam University; Korea University; Catholic University of Daegu; Konkuk University; Dongguk University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Kyung Hee University	Choi, I (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea.	inhochoi@ynu.ac.kr	Kamli, Majid Rasool/AAN-6151-2020; kamli, majid/AFS-7216-2022; Nam, Joohyun/AAD-4491-2021	Kamli, Majid Rasool/0000-0003-0553-0046; Kim, Sanghoon/0000-0002-4078-6269; Nam, Joo Hyun/0000-0001-8300-6974	BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ 907099]	BioGreen 21 Program, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the BioGreen 21 Program (project no. PJ 907099), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Arnaudeau S, 2006, J CELL PHYSIOL, V208, P435, DOI 10.1002/jcp.20679; Barnoy S, 1997, BBA-MOL CELL RES, V1358, P181, DOI 10.1016/S0167-4889(97)00068-2; Baryshnikov SG, 2009, AM J PHYSIOL-CELL PH, V297, pC1103, DOI 10.1152/ajpcell.00283.2009; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARNAC G, 1993, ONCOGENE, V8, P3103; CATTERALL WA, 2011, COLD SPRING HARB PER, V3, P3947; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chemin J, 2002, J NEUROSCI, V22, P6856; COGNARD C, 1993, DEVELOPMENT, V117, P1153; DIANNE RS, 1985, J BIOL CHEM, V260, P11793; DOWNES M, 1993, CELL GROWTH DIFFER, V4, P901; Friday BB, 2003, DIFFERENTIATION, V71, P217, DOI 10.1046/j.1432-0436.2003.710303.x; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Grassi C, 2004, CELL CALCIUM, V35, P307, DOI 10.1016/j.ceca.2003.09.001; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Hennemann G, 2001, ENDOCR REV, V22, P451, DOI 10.1210/er.22.4.451; Hou X, 2007, J NEUROCHEM, V100, P446, DOI 10.1111/j.1471-4159.2006.04210.x; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Konig S, 2006, DEVELOPMENT, V133, P3107, DOI 10.1242/dev.02479; Kotturi MF, 2005, MOL IMMUNOL, V42, P1461, DOI 10.1016/j.molimm.2005.01.014; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; KUBO Y, 1991, J PHYSL, V443, P711; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee EJ, 2012, GENOMICS, V100, P195, DOI 10.1016/j.ygeno.2012.06.005; Lin HY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00029; Liu JH, 1999, BRIT J PHARMACOL, V126, P245, DOI 10.1038/sj.bjp.0702321; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; Mariot P, 2002, J BIOL CHEM, V277, P10824, DOI 10.1074/jbc.M108754200; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Monk JA, 2013, AM J PHYSIOL-ENDOC M, V304, pE23, DOI 10.1152/ajpendo.00216.2012; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Numaga-Tomita T, 2013, J CELL SCI, V126, P605, DOI 10.1242/jcs.115980; Nunes AF, 2010, FEBS J, V277, P263, DOI 10.1111/j.1742-4658.2009.07482.x; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Pavlath GK, 2003, CELL CYCLE, V2, P420, DOI 10.4161/cc.2.5.497; Pavlath GK, 2010, EXP CELL RES, V316, P3067, DOI 10.1016/j.yexcr.2010.05.025; Picard B, 1998, BASIC APPL MYOL, V8, P197; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; ROSEN HN, 1993, J CLIN ENDOCR METAB, V77, P370, DOI 10.1210/jc.77.2.370; SAMANTHA JR, 2007, INT REV CYTOL, V258, P137; SLOTKIN TA, 1992, TERATOLOGY, V45, P303, DOI 10.1002/tera.1420450309; Smith KL, 2012, J NEUROSCI METH, V203, P398, DOI 10.1016/j.jneumeth.2011.09.023; Spitzer Nicholas C., 1994, Current Opinion in Neurobiology, V4, P70, DOI 10.1016/0959-4388(94)90034-5; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Toescu EC, 2004, TRENDS NEUROSCI, V27, P614, DOI 10.1016/j.tins.2004.07.010; Velica P, 2011, MUSCLE NERVE, V44, P366, DOI 10.1002/mus.22056; Weick JP, 2003, J NEUROSCI, V23, P3446	51	13	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63627	10.1371/journal.pone.0063627	http://dx.doi.org/10.1371/journal.pone.0063627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717457	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700043
J	Roy, P; Kumar, B; Shende, A; Singh, A; Meena, A; Ghosal, R; Ranganathan, M; Bandyopadhyay, A				Roy, Priti; Kumar, Brijesh; Shende, Akhilesh; Singh, Anupama; Meena, Anil; Ghosal, Ritika; Ranganathan, Madhav; Bandyopadhyay, Amitabha			A Genome-Wide Screen Indicates Correlation between Differentiation and Expression of Metabolism Related Genes	PLOS ONE			English	Article							EARLY HEART DEVELOPMENT; MOONLIGHTING PROTEINS; CHICK-EMBRYO; MOUSE; CHONDROGENESIS; ACTIVATION; EPITHELIUM; FATE; KEGG; TUBE	Differentiated tissues may be considered as materials with distinct properties. The differentiation program of a given tissue ensures that it acquires material properties commensurate with its function. It may be hypothesized that some of these properties are acquired through production of tissue-specific metabolites synthesized by metabolic enzymes. To establish correlation between metabolism and organogenesis we have carried out a genome-wide expression study of metabolism related genes by RNA in-situ hybridization. 23% of the metabolism related genes studied are expressed in a tissue-restricted but not tissue-exclusive manner. We have conducted the screen on whole mount chicken (Gallus gallus) embryos from four distinct developmental stages to correlate dynamic changes in expression patterns of metabolic enzymes with spatio-temporally unique developmental events. Our data strongly suggests that unique combinations of metabolism related genes, and not specific metabolic pathways, are upregulated during differentiation. Further, expression of metabolism related genes in well established signaling centers that regulate different aspects of morphogenesis indicates developmental roles of some of the metabolism related genes. The database of tissue-restricted expression patterns of metabolism related genes, generated in this study, should serve as a resource for systematic identification of these genes with tissue-specific functions during development. Finally, comprehensive understanding of differentiation is not possible unless the downstream genes of a differentiation cascade are identified. We propose, metabolic enzymes constitute a significant portion of these downstream target genes. Thus our study should help elucidate different aspects of tissue differentiation.	[Roy, Priti; Kumar, Brijesh; Singh, Anupama; Meena, Anil; Ghosal, Ritika; Bandyopadhyay, Amitabha] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Shende, Akhilesh; Ranganathan, Madhav] Indian Inst Technol, Dept Chem, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Bandyopadhyay, A (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	abandopa@iitk.ac.in	Kumar, Prof. Brijesh/A-7485-2012; Bandyopadhyay, Amitabha/B-9735-2008; Kumar, Brijesh/GPP-3392-2022	Kumar, Prof. Brijesh/0000-0003-0271-3445; Kumar, Brijesh/0000-0003-0271-3445; Bandyopadhyay, Amitabha/0000-0002-0429-438X; Kumar, Brijesh/0000-0002-7251-492X	Department of Biotechnology, India; IIT Kanpur [IITK/BSBE/20060277]; Council of Scientific & Industrial Research (CSIR), India; Department of Biotechnology (DBT), India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); IIT Kanpur; Council of Scientific & Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology, India and initiation grant from IIT Kanpur (IITK/BSBE/20060277). P. R. and B. K. are supported by fellowships from Council of Scientific & Industrial Research (CSIR), India. Anupama Singh was supported by fellowship from Department of Biotechnology (DBT), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathocleous M, 2012, NAT CELL BIOL, V14, P859, DOI 10.1038/ncb2531; Cankaya M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-232; Choi D, 2006, GENOMICS, V87, P500, DOI 10.1016/j.ygeno.2005.11.015; Cogburn LA, 2007, POULTRY SCI, V86, P2059, DOI 10.1093/ps/86.10.2059; Dietrich S, 1997, DEVELOPMENT, V124, P3895; Duncan SA, 2000, DEV DYNAM, V219, P131, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1051>3.3.CO;2-E; Gomez A, 2003, BIOINFORMATICS, V19, P895, DOI 10.1093/bioinformatics/btg111; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; Hiramatsu H, 2004, INT J DEV BIOL, V48, P1141, DOI 10.1387/ijdb.041886hh; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Hubbard SJ, 2005, GENOME RES, V15, P174, DOI 10.1101/gr.3011405; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Jeffery CJ, 2004, CURR OPIN STRUC BIOL, V14, P663, DOI 10.1016/j.sbi.2004.10.001; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Johnson CH, 2012, ANNU REV PHARMACOL, V52, P37, DOI 10.1146/annurev-pharmtox-010611-134748; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Li NX, 2005, DEV DYNAM, V233, P907, DOI 10.1002/dvdy.20434; Lopez-Sanchez C, 2010, CARDIOVASC RES, V88, P111, DOI 10.1093/cvr/cvq179; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Mok GF, 2011, REPRODUCTION, V141, P301, DOI 10.1530/REP-10-0394; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Montero JA, 2010, APOPTOSIS, V15, P1197, DOI 10.1007/s10495-010-0523-7; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nishimura M, 2008, DRUG METAB PHARMACOK, V23, P22, DOI 10.2133/dmpk.23.22; Nurminsky D, 2011, MECH DEVELOP, V128, P234, DOI 10.1016/j.mod.2010.11.007; Ohana E, 2012, J BIOL CHEM, V287, P5122, DOI 10.1074/jbc.M111.297192; Ohguchi H, 2008, MOL CELL BIOL, V28, P3917, DOI 10.1128/MCB.02154-07; Ozbudak EM, 2010, P NATL ACAD SCI USA, V107, P4224, DOI 10.1073/pnas.0909375107; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pindyurin AlexeyA Ozgur Z, 2012, MOL CELL, P133; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Sohaskey ML, 2008, DEVELOPMENT, V135, P2215, DOI 10.1242/dev.019950; STEEDMAN HF, 1950, Q J MICROSC SCI, V91, P477; Thiagarajan RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017286; TSAI HM, 1981, J COMP NEUROL, V198, P275, DOI 10.1002/cne.901980207; Wagner M, 2007, EXP BIOL MED, V232, P852; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Xie ZH, 2011, P NATL ACAD SCI USA, V108, P12119, DOI 10.1073/pnas.1100160108; Zhang Y, 2011, DEV BIOL, V353, P259, DOI 10.1016/j.ydbio.2011.02.030; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	49	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63670	10.1371/journal.pone.0063670	http://dx.doi.org/10.1371/journal.pone.0063670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717462	Green Published, gold			2022-12-27	WOS:000320362700047
J	Xiang, Y; Wang, X; Yan, C; Gao, Q; Li, SA; Liu, J; Zhou, KF; Guo, XL; Lee, WH; Zhang, Y				Xiang, Yang; Wang, Xuan; Yan, Chao; Gao, Qian; Li, Sheng-An; Liu, Jie; Zhou, Kaifeng; Guo, Xiaolong; Lee, Wenhui; Zhang, Yun			Adenosine-5'-Triphosphate (ATP) Protects Mice against Bacterial Infection by Activation of the NLRP3 Inflammasome	PLOS ONE			English	Article							EXTRACELLULAR ATP; NEUTROPHIL RECRUITMENT; NUCLEOTIDES; RESISTANCE; IL-1-BETA; RECEPTORS; IMMUNITY; RELEASE; SEPSIS; P2X(7)	It has been established that Adenosine-5'-triphosphate (ATP) can activate the NLRP3 inflammasome. However, the physiological effect of extracellular ATP on NLRP3 inflammasome activation has not yet been investigated. In the present study, we found that ATP was indeed released during bacterial infection. By using a murine peritonitis model, we also found that ATP promotes the fight against bacterial infection in mice. ATP induced the secretion of IL-1 beta and chemokines by murine bone marrow-derived macrophages in vitro. Furthermore, the intraperitoneal injection of ATP elevated the levels of IL-1b and chemokines in the mouse peritoneal lavage. Neutrophils were rapidly recruited to the peritoneum after ATP injection. In addition, the effects on cytokine and chemokine secretion and neutrophil recruitment were markedly attenuated by the pre-administration of the caspase-1 inhibitor Ac-YVAD-cho. Ac-YVAD-cho also significantly attenuated the protective effect of ATP against bacterial infection. In the present study, we demonstrated a protective role for ATP during bacterial infection and this effect was related to NLRP3 inflammasome activation. Together, these results suggest a role for ATP in initiating the immune response in hosts suffering from infections.	[Xiang, Yang; Wang, Xuan; Yan, Chao; Gao, Qian; Li, Sheng-An; Liu, Jie; Zhou, Kaifeng; Guo, Xiaolong; Lee, Wenhui; Zhang, Yun] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Xiang, Yang; Wang, Xuan; Yan, Chao; Gao, Qian; Li, Sheng-An; Liu, Jie; Zhou, Kaifeng; Guo, Xiaolong; Lee, Wenhui; Zhang, Yun] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Wang, Xuan; Yan, Chao; Li, Sheng-An; Liu, Jie; Zhou, Kaifeng; Guo, Xiaolong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	zhangy@mail.kiz.ac.cn		Zhang, Yun/0000-0002-8636-183X	National Basic Research Program of China (973 Program) [2010CB529800]; Chinese National Natural Science Foundation (NSFC-Yunnan-joint funding) [U1132601, 31270835]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Natural Science Foundation (NSFC-Yunnan-joint funding)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Basic Research Program of China (973 Program, 2010CB529800), and the Chinese National Natural Science Foundation (NSFC-Yunnan-joint funding U1132601, 31270835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2011, J IMMUNOL, V186, P2714, DOI 10.4049/jimmunol.1002657; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Breitbach K, 2009, INFECT IMMUN, V77, P1589, DOI 10.1128/IAI.01257-08; Calkins CM, 2002, J ENDOTOXIN RES, V8, P59, DOI 10.1179/096805102125000092; Charmoy M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/719361; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Coutinho-Silva R, 2012, MICROBES INFECT, V14, P1271, DOI 10.1016/j.micinf.2012.05.009; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Darisipudi MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019588; Darville T, 2007, J IMMUNOL, V179, P3707, DOI 10.4049/jimmunol.179.6.3707; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; FRIMODTMOLLER N, 1993, J ANTIMICROB CHEMOTH, V31, P55, DOI 10.1093/jac/31.suppl_D.55; Godaly G, 2001, J LEUKOCYTE BIOL, V69, P899; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Li SA, 2012, ANTIMICROB AGENTS CH, V56, P3309, DOI 10.1128/AAC.06304-11; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martens RJ, 2005, INFECT IMMUN, V73, P7040, DOI 10.1128/IAI.73.10.7040-7042.2005; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Moncao-Ribeiro LC, 2011, RESP PHYSIOL NEUROBI, V179, P314, DOI 10.1016/j.resp.2011.09.015; MURPHY K, 2012, JANEWAYS IMMUNOBIOLO, V19; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Ramakers BP, 2011, SHOCK, V36, P208, DOI 10.1097/SHK.0b013e318225aee4; Renckens R, 2006, J IMMUNOL, V177, P1189, DOI 10.4049/jimmunol.177.2.1189; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; Save S, 2010, INFECT IMMUN, V78, P3609, DOI 10.1128/IAI.00074-10; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; Xiang Y, 2012, CYTOTECHNOLOGY, V64, P95, DOI 10.1007/s10616-011-9399-9	39	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63759	10.1371/journal.pone.0063759	http://dx.doi.org/10.1371/journal.pone.0063759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717478	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700056
J	Chen, Y; Yu, ZZ; Packham, JC; Mattey, DL				Chen, Ying; Yu, Zanzhe; Packham, Jonathan C.; Mattey, Derek L.			Influence of Adult Height on Rheumatoid Arthritis: Association with Disease Activity, Impairment of Joint Function and Overall Disability	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GROWTH-HORMONE; SHORT STATURE; LOCI; SUSCEPTIBILITY; VARIANTS; GENDER; HEALTH; COHORT; WOMEN	Objectives: To investigate whether normal variation of adult height is associated with clinical characteristics in rheumatoid arthritis (RA), including disease activity (DAS28), impairment of joint function (mechanical joint score, MJS) and overall disability (health assessment questionnaire, HAQ). Methods: A cohort (134 males, 287 females) of consecutively recruited RA patients of Northern European origin was studied. Height, weight and demographic information were obtained. A core set of disease measurements, including DAS28, MJS and HAQ, were recorded at baseline, 12 and 24 months. Other clinical variables (e.g. disease duration, IgM rheumatoid factor, antibodies to cyclic citrullinated peptide, C-reactive protein, erythrocyte sedimentation rate) were recorded at baseline. Socioeconomic status, smoking status, comorbid condition, other autoimmune conditions and drug therapy were also recorded. Associations were analyzed using univariate statistics and multivariate linear regression models. Mediation tests were also carried out for evaluating the relationship between gender, height and disease measures. Results: In males, height was inversely associated with DAS28, MJS and HAQ (at baseline and over 24 months) independent of other factors (e.g. weight, body mass index, age, disease duration, osteoporosis, autoantibodies, erosive disease, joint replacement, steroid use, smoking status, socioeconomic status and comorbid disease). In females, a similar trend was seen but the relationships were non significant. In the whole population, the association of female gender with more active disease and poor function disappeared after adjustment for height. Mediation analysis indicated that height served as a full mediator in the relationship of gender with disease activity and overall disability. Confirmation of these findings was demonstrated in a second RA population (n = 288). Conclusion: Adult height is inversely associated with disease activity, impairment of joint function and overall disability in RA, particularly in males. The association of female sex with more severe disease activity and disability appears to be mediated by smaller stature.	[Chen, Ying; Packham, Jonathan C.; Mattey, Derek L.] Haywood Hosp, Haywood Rheumatol Ctr, Stoke On Trent, Staffs, England; [Chen, Ying; Yu, Zanzhe; Mattey, Derek L.] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England	Keele University	Mattey, DL (corresponding author), Haywood Hosp, Haywood Rheumatol Ctr, High Lane, Stoke On Trent, Staffs, England.	d.l.mattey@keele.ac.uk	Chen, Ying/I-4349-2013	Chen, Ying/0000-0002-5919-743X; Mattey, Derek/0000-0002-4676-5434; Packham, Jon/0000-0001-5531-1680	Medical Research Council; Haywood Rheumatism Research and Development Foundation [507273]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Haywood Rheumatism Research and Development Foundation	Funding was provided by the Medical Research Council and the Haywood Rheumatism Research and Development Foundation (Charity number 507273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlmen M, 2010, ANN RHEUM DIS, V69, P230, DOI 10.1136/ard.2008.102244; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bostrom EA, 2011, ARTHRITIS RHEUM-US, V63, P2894, DOI 10.1002/art.30527; Carstairs V, 1995, J EPIDEMIOL COMMUN H, V49, pS3, DOI 10.1136/jech.49.Suppl_2.S3; Cerhan JR, 2002, J RHEUMATOL, V29, P246; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Chen Y, 2011, J RHEUMATOL, V38, P802, DOI 10.3899/jrheum.101095; Chiarelli F, 2004, EUR J ENDOCRINOL, V151, pU109, DOI 10.1530/eje.0.151U109; Chujo T, 2006, SPINE, V31, P2909, DOI 10.1097/01.brs.0000248428.22823.86; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; Crimmins EM, 2006, PNAS, V103, P598; De Bellis A, 2008, J ENDOCRINOL INVEST, V31, P1132, DOI 10.1007/BF03345664; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; FRIES JF, 1982, J RHEUMATOL, V9, P789; Green J, 2011, LANCET ONCOL, V12, P785, DOI 10.1016/S1470-2045(11)70154-1; Griffiths AM, 2009, DIGEST DIS, V27, P404, DOI 10.1159/000228581; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Jawaheer D, 2010, CLIN EXP RHEUMATOL, V28, P454; Jawaheer D, 2006, ARTHRITIS RHEUM-US, V54, P3087, DOI 10.1002/art.22120; Jawaheer D, 2010, J RHEUMATOL, V37, P2475, DOI 10.3899/jrheum.091432; Johnson AH, 2002, RHEUMATOLOGY, V41, P189, DOI 10.1093/rheumatology/41.2.189; Kim JJ, 2010, J HUM GENET, V55, P27, DOI 10.1038/jhg.2009.116; Kremer R, 2009, J CLIN ENDOCR METAB, V94, P67, DOI 10.1210/jc.2008-1575; Kuiper S, 2001, J RHEUMATOL, V28, P1809; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Lawlor DA, 2002, DIABETOLOGIA, V45, P1097, DOI 10.1007/s00125-002-0887-5; Lee YH, 2012, CLIN RHEUMATOL; Lettre G, 2011, HUM GENET, V129, P465, DOI 10.1007/s00439-011-0969-x; Malemud CJ, 2007, CLIN CHIM ACTA, V375, P10, DOI 10.1016/j.cca.2006.06.033; Meisel P, 2007, J CLIN PERIODONTOL, V34, P390, DOI 10.1111/j.1600-051X.2007.01068.x; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Nemet D, 2009, J PEDIATR ENDOCR MET, V22, P979; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Pass C, 2009, CELL BIOCHEM FUNCT, V27, P119, DOI 10.1002/cbf.1551; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Sokka T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2591; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Tengstrand B, 2004, J RHEUMATOL, V31, P214; Ushiyama T, 1999, ANN RHEUM DIS, V58, P7, DOI 10.1136/ard.58.1.7; VESSEY MP, 1987, CONTRACEPTION, V35, P457, DOI 10.1016/0010-7824(87)90082-5; Ward K, 2011, J EPIDEMIOL COMMUN H, V65, P226, DOI 10.1136/jech.2009.096792; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64862	10.1371/journal.pone.0064862	http://dx.doi.org/10.1371/journal.pone.0064862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705017	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000319330200171
J	Cheng, HY; Wu, RP; Gebre, AK; Hanna, RN; Smith, DJ; Parks, JS; Ley, K; Hedrick, CC				Cheng, Hsin-Yuan; Wu, Runpei; Gebre, Abraham K.; Hanna, Richard N.; Smith, Dan J.; Parks, John S.; Ley, Klaus; Hedrick, Catherine C.			Increased Cholesterol Content in Gammadelta (gamma delta) T Lymphocytes Differentially Regulates Their Activation	PLOS ONE			English	Article							E-DEFICIENT MICE; LIPID RAFTS; INTRAEPITHELIAL LYMPHOCYTES; INTERFERON-GAMMA; CELL-ACTIVATION; NILE-RED; RECEPTOR; ATHEROSCLEROSIS; STIMULATION; EXPRESSION	Gammadelta (gamma delta) T lymphocytes respond quickly upon antigen encounter to produce a cytokine response. In this study, we sought to understand how functions of gamma delta T cells are differentially regulated compared to alpha beta T cells. We found that cholesterol, an integral component of the plasma membrane and a regulator of TCR signaling, is increased in gamma delta T cells compared to alpha beta T cells, and modulates their function. Higher levels of activation markers, and increased lipid raft content in gamma delta cells suggest that gamma delta T cells are more activated. Cholesterol depletion effectively decreased lipid raft formation and activation of gamma T cells, indicating that increased cholesterol content contributes to the hyper-activated phenotype of gamma delta T cells, possibly through enhanced clustering of TCR signals in lipid rafts. TCR stimulation assays and western blotting revealed that instead of a lower TCR threshold, enhanced TCR signaling through ERK1/2 activation is likely the cause for high cholesterol-induced rapid activation and proliferation in gamma delta T cells. Our data indicate that cholesterol metabolism is differentially regulated in gamma delta T cells. The high intracellular cholesterol content leads to enhanced TCR signaling and increases activation and proliferation of gamma delta T cells.	[Cheng, Hsin-Yuan; Wu, Runpei; Hanna, Richard N.; Ley, Klaus; Hedrick, Catherine C.] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA; [Gebre, Abraham K.; Parks, John S.] Wake Forest Sch Med, Dept Pathol Lipid Sci, Winston Salem, NC USA; [Smith, Dan J.] Targeson Inc, San Diego, CA USA	La Jolla Institute for Immunology; Wake Forest University	Hedrick, CC (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA.	hedrick@liai.org			National Institutes of Health [P01HL055798, R01HL097368, R01HL049373, R01HL094525]; American Diabetes Association Mentor-Based Postdoctoral Fellowship [7-12-MN-31]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115232, R01HL094525, P01HL055798, R01HL097368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Mentor-Based Postdoctoral Fellowship(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by National Institutes of Health Grants P01HL055798 and R01HL097368 (to C.C.H.), R01HL049373 and R01HL094525 (to J.S.P.), and American Diabetes Association Mentor-Based Postdoctoral Fellowship 7-12-MN-31 (to H.-Y.C. and C.C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Born WK, 2010, J IMMUNOL, V184, P4055, DOI 10.4049/jimmunol.0903679; Brandes M, 2009, P NATL ACAD SCI USA, V106, P2307, DOI 10.1073/pnas.0810059106; Champagne E, 2011, ARCH IMMUNOL THER EX, V59, P117, DOI 10.1007/s00005-011-0118-1; Chen Y, 2012, J IMMUNOL, V189, P61, DOI 10.4049/jimmunol.1103272; Diaz G, 2008, MICRON, V39, P819, DOI 10.1016/j.micron.2008.01.001; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; Eberl M, 2009, TRENDS IMMUNOL, V30, P562, DOI 10.1016/j.it.2009.09.001; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; Fang H, 2010, FEMS IMMUNOL MED MIC, V59, P71, DOI 10.1111/j.1574-695X.2010.00663.x; Fulop T, 2001, MECH AGEING DEV, V122, P1413, DOI 10.1016/S0047-6374(01)00274-3; Gao YL, 2001, J AUTOIMMUN, V17, P261, DOI 10.1006/jaut.2001.0547; Gombos I, 2006, IMMUNOL LETT, V104, P59, DOI 10.1016/j.imlet.2005.11.021; Graff JC, 2006, INT IMMUNOL, V18, P613, DOI 10.1093/intimm/dxl001; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; INGHIRAMI G, 1990, AM J PATHOL, V136, P357; Jameson JM, 2010, CELL IMMUNOL, V264, P71, DOI 10.1016/j.cellimm.2010.04.013; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jensen KDC, 2009, CURR OPIN IMMUNOL, V21, P140, DOI 10.1016/j.coi.2009.02.008; Jury EC, 2004, J CLIN INVEST, V113, P1176, DOI 10.1172/JCI200420345; Jury EC, 2007, SEMIN CELL DEV BIOL, V18, P608, DOI 10.1016/j.semcdb.2007.08.002; Kabouridis PS, 2008, FEBS LETT, V582, P3711, DOI 10.1016/j.febslet.2008.10.006; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kapsenberg ML, 2009, IMMUNITY, V31, P181, DOI 10.1016/j.immuni.2009.08.004; Kenworthy AK, 2008, EMBO REP, V9, P531, DOI 10.1038/embor.2008.92; Laird RM, 2009, MOL IMMUNOL, V46, P2429, DOI 10.1016/j.molimm.2009.03.029; Li D, 2009, J BIOL CHEM, V284, P21001, DOI 10.1074/jbc.M109.002865; Lu HZ, 2011, TOHOKU J EXP MED, V223, P193, DOI 10.1620/tjem.223.193; Major AS, 2004, ARTERIOSCL THROM VAS, V24, P2351, DOI 10.1161/01.ATV.0000147112.84168.87; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Moser B, 2011, CELL MOL LIFE SCI, V68, P2443, DOI 10.1007/s00018-011-0706-6; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Ribot JC, 2010, J IMMUNOL, V185, P6421, DOI 10.4049/jimmunol.1002283; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rudel LL, 1998, ARTERIOSCL THROM VAS, V18, P1818, DOI 10.1161/01.ATV.18.11.1818; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Surls J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038733; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Tough DF, 1998, J EXP MED, V187, P357, DOI 10.1084/jem.187.3.357; Wang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027207; Whetzel AM, 2010, ARTERIOSCL THROM VAS, V30, P809, DOI 10.1161/ATVBAHA.109.199166; Wong GW, 2010, SEMIN IMMUNOL, V22, P228, DOI 10.1016/j.smim.2010.04.005; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	46	31	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63746	10.1371/journal.pone.0063746	http://dx.doi.org/10.1371/journal.pone.0063746			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704936	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200067
J	Colak, D; Nofal, A; AlBakheet, A; Nirmal, M; Jeprel, H; Eldali, A; AL-Tweigeri, T; Tulbah, A; Ajarim, D; Al Malik, O; Inan, MS; Kaya, N; Park, BH; Bin Amer, SM				Colak, Dilek; Nofal, Asmaa; AlBakheet, AlBandary; Nirmal, Maimoona; Jeprel, Hatim; Eldali, Abdelmoneim; AL-Tweigeri, Taher; Tulbah, Asma; Ajarim, Dahish; Al Malik, Osama; Inan, Mehmet S.; Kaya, Namik; Park, Ben H.; Bin Amer, Suad M.			Age-Specific Gene Expression Signatures for Breast Tumors and Cross-Species Conserved Potential Cancer Progression Markers in Young Women	PLOS ONE			English	Article							CARCINOMA IN-SITU; GENOMIC ANALYSES; PATHOLOGICAL FEATURES; DUCTAL CARCINOMA; MICROARRAY DATA; MUTATION STATUS; PATIENT AGE; TGF-ALPHA; SURVIVAL; PROGNOSIS	Breast cancer in young women is more aggressive with a poorer prognosis and overall survival compared to older women diagnosed with the disease. Despite recent research, the underlying biology and molecular alterations that drive the aggressive nature of breast tumors associated with breast cancer in young women have yet to be elucidated. In this study, we performed transcriptomic profile and network analyses of breast tumors arising in Middle Eastern women to identify age-specific gene signatures. Moreover, we studied molecular alterations associated with cancer progression in young women using cross-species comparative genomics approach coupled with copy number alterations (CNA) associated with breast cancers from independent studies. We identified 63 genes specific to tumors in young women that showed alterations distinct from two age cohorts of older women. The network analyses revealed potential critical regulatory roles for Myc, PI3K/Akt, NF-kappa B, and IL-1 in disease characteristics of breast tumors arising in young women. Cross-species comparative genomics analysis of progression from pre-invasive ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) revealed 16 genes with concomitant genomic alterations, CCNB2, UBE2C, TOP2A, CEP55, TPX2, BIRC5, KIAA0101, SHCBP1, UBE2T, PTTG1, NUSAP1, DEPDC1, HELLS, CCNB1, KIF4A, and RRM2, that may be involved in tumorigenesis and in the processes of invasion and progression of disease. Array findings were validated using qRT-PCR, immunohistochemistry, and extensive in silico analyses of independently performed microarray datasets. To our knowledge, this study provides the first comprehensive genomic analysis of breast cancer in Middle Eastern women in age-specific cohorts and potential markers for cancer progression in young women. Our data demonstrate that cancer appearing in young women contain distinct biological characteristics and deregulated signaling pathways. Moreover, our integrative genomic and cross-species analysis may provide robust biomarkers for the detection of disease progression in young women, and lead to more effective treatment strategies.	[Colak, Dilek; Eldali, Abdelmoneim] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia; [Nofal, Asmaa; Nirmal, Maimoona; Jeprel, Hatim; Bin Amer, Suad M.] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia; [AlBakheet, AlBandary; Inan, Mehmet S.; Kaya, Namik] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [AL-Tweigeri, Taher; Ajarim, Dahish] King Faisal Specialist Hosp & Res Ctr, Dept Oncol, Riyadh 11211, Saudi Arabia; [Tulbah, Asma] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia; [Al Malik, Osama] King Faisal Specialist Hosp & Res Ctr, Dept Surg, Riyadh 11211, Saudi Arabia; [Park, Ben H.] Johns Hopkins Univ, Sch Med, Dept Oncol,Breast Canc Res Program, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Johns Hopkins University; Johns Hopkins Medicine	Colak, D (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia.	dcolakkaya@kfshrc.edu.sa; sbinamer2@gmail.com		Colak, Dilek/0000-0001-6485-8768	King Abdulaziz City for Science and Technology (KACST) [ARP-2432]; King Faisal Specialist Hospital and Research Center; National Plan for Science, Technology and Innovation program/KACST [11-BIO2072-20]	King Abdulaziz City for Science and Technology (KACST); King Faisal Specialist Hospital and Research Center; National Plan for Science, Technology and Innovation program/KACST	This study was funded by a King Abdulaziz City for Science and Technology grant (KACST # ARP-2432 to SMA), King Faisal Specialist Hospital and Research Center, and National Plan for Science, Technology and Innovation program/KACST (grant 11-BIO2072-20 to DC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; Aebi S, 2000, LANCET, V355, P1869, DOI 10.1016/S0140-6736(00)02292-3; Agrup M, 2000, BREAST CANCER RES TR, V63, P23, DOI 10.1023/A:1006498721508; ALA U, 2008, PLOS COMPUT BIOL, P4; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; *AM CANC SOC INC, 2010, BREAST CANC FACTS FI; Amari M, 2003, JPN J CLIN ONCOL, V33, P556, DOI 10.1093/jjco/hyg109; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Anders CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001373; *AR CROS, 2009, CANC INC REP SAUD AR; Bennett CN, 2010, TOXICOL PATHOL, V38, P88, DOI 10.1177/0192623309357074; Bennett CN, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2125; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; Bombonati A, 2011, J PATHOL, V223, P307, DOI 10.1002/path.2808; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Cantrell VA, 2010, CANCER LETT, V287, P54, DOI 10.1016/j.canlet.2009.05.041; Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Z, 2011, EMBO J, V30, P2405, DOI 10.1038/emboj.2011.154; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chung M, 1996, CANCER, V77, P97, DOI 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.3.CO;2-T; Colak D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-146; Collins LC, 2012, BREAST CANCER RES TR, V131, P1061, DOI 10.1007/s10549-011-1872-9; Connelly L, 2011, ONCOGENE, V30, P1402, DOI 10.1038/onc.2010.521; Corzo C, 2006, CANCER GENET CYTOGEN, V165, P151, DOI 10.1016/j.cancergencyto.2005.08.013; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; D'Errico A, 2000, BRIT J CANCER, V82, P865, DOI 10.1054/bjoc.1999.1013; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; El Saghir NS, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-194; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Elkum N, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-222; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graeber TG, 2005, NAT GENET, V37, P7, DOI 10.1038/ng0105-7; Graziano F, 2005, J CLIN ONCOL, V23, P5272, DOI 10.1200/JCO.2005.01.0819; Grimm C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-78; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hantschmann P, 2005, ANTICANCER RES, V25, P1731; Hartley MC, 2006, AM SURGEON, V72, P1189; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Holli K, 1997, EUR J CANCER, V33, P425; Honma S, 2002, ENDOCR J, V49, P371, DOI 10.1507/endocrj.49.371; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Jin L, 1997, CANCER-AM CANCER SOC, V80, P421, DOI 10.1002/(SICI)1097-0142(19970801)80:3<421::AID-CNCR10>3.0.CO;2-Z; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Maggard MA, 2003, J SURG RES, V113, P109, DOI 10.1016/S0022-4804(03)00179-3; Gonzalez-Angulo AM, 2010, J CLIN ONCOL, V28, P2777, DOI 10.1200/JCO.2009.27.0777; Martelli AM, 2007, EUR J HISTOCHEM, V51, P125; McAuliffe PF, 2010, CLIN BREAST CANCER, V10, pS59, DOI 10.3816/CBC.2010.s.013; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; NIXON AJ, 1994, J CLIN ONCOL, V12, P888, DOI 10.1200/JCO.1994.12.5.888; Olson JE, 2010, BREAST CANCER RES TR, V119, P423, DOI 10.1007/s10549-009-0386-1; Pantschenko AG, 2003, INT J ONCOL, V23, P269; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Patil MA, 2005, ONCOGENE, V24, P3737, DOI 10.1038/sj.onc.1208479; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Peeper D, 2006, CELL, V125, P1230, DOI 10.1016/j.cell.2006.06.018; Pende D, 2005, BLOOD, V105, P2066, DOI 10.1182/blood-2004-09-3548; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rossner P, 2009, J CELL MOL MED, V13, P3847, DOI 10.1111/j.1582-4934.2008.00553.x; Rubinstein R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-12; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saijo Y, 2002, J IMMUNOL, V169, P469, DOI 10.4049/jimmunol.169.1.469; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Stav D, 2007, INT J BIOL MARKER, V22, P108, DOI 10.1177/172460080702200204; Stebel A, 2009, ONCOL REP, V21, P217, DOI 10.3892/or_00000211; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Tokunaga Eriko, 2006, Breast Cancer, V13, P137, DOI 10.2325/jbcs.13.137; Waligorska-Stachura J, 2012, GINEKOL POL, V83, P537; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	98	79	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63204	10.1371/journal.pone.0063204	http://dx.doi.org/10.1371/journal.pone.0063204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704896	Green Published, gold			2022-12-27	WOS:000319330200025
J	Das, A; Saha, T; Ahmad, F; Roy, KB; Rishi, V				Das, Amrita; Saha, Tapas; Ahmad, Faizan; Roy, Kunal B.; Rishi, Vikas			Dodecamer d-AGATCTAGATCT and a Homologous Hairpin form Triplex in the Presence of Peptide REWER	PLOS ONE			English	Article							RECA PROTEIN; HELIX FORMATION; DNA STRANDS; RECOMBINATION; OLIGONUCLEOTIDES; STABILITY; MECHANISM; EXCHANGE; DUPLEX; MODEL	We have designed a dodecamer d-AGATCTAGATCT (RY12) with alternate oligopurines and oligopyrimidines tracts and its homologous 28 bp hairpin oligomer (RY28) that forms a triple helix only in the presence of a pentapeptide REWER. An intermolecular triplex is formed by the single strand invasion of the RY28 duplex by RY12 in the presence of REWER. 5'-oligopurine end of RY12 binds to oligopurine sequence of RY28 in a parallel orientation and its oligopyrimidine stretch then changes strand and adopts an antiparallel orientation with the other strand of the duplex. Evidence for the formation of the triplex come from our studies of the UV melting curves, UV mixing curves, gel retardation assay, and chemical sequencing of 1: 1 mixture of dodecamer and hairpin oligonucleotides in the presence and absence of the peptide REWER. RY12 exists as a duplex that melts at 35 degrees C. The hairpin (RY28) melts at 68 degrees C. 1:1 mixture of RY12 and RY28 in the absence of REWER gives a biphasic transition curve with thermodynamic properties corresponding to those of the melting of the duplex of RY12 and the hairpin RY28. However, the melting curve of this mixture is triphasic in the presence of the REWER; the thermodynamic parameters associated with the first phase (melting of the duplex of RY12), second phase (melting of the triplex) and the third phase (melting of the hairpin) show dependence on the molar ratio of peptide to oligonucleotides. Under appropriate conditions, gel retardation assay showed a shifted band that corresponds to a possible triplex. Chemical sequencing of KMnO4 and DEPC treated mixture of RY12, RY28 and REWER revealed the footprint of triplex.	[Das, Amrita] Univ Kolkata, Dept Chem, Kolkata, W Bengal, India; [Saha, Tapas] Georgetown Univ, Washington, DC USA; [Saha, Tapas; Ahmad, Faizan] Jamia Milia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India; [Saha, Tapas; Roy, Kunal B.] Jawaharlal Nehru Univ, Ctr Biotechnol, New Delhi 110067, India; [Rishi, Vikas] Natl Agri Food Biotechnol Inst NABI, Mohali, Punjab, India	University of Calcutta; Georgetown University; Jamia Millia Islamia; Jawaharlal Nehru University, New Delhi; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Rishi, V (corresponding author), Natl Agri Food Biotechnol Inst NABI, Mohali, Punjab, India.	vikasrishi@nabi.res.in	Ahmad, Faizan/AGH-4493-2022; Das, Amrita/AAM-1107-2021	Ahmad, Faizan/0000-0001-7021-7502; Das, Amrita/0000-0003-3904-2403	DST, Govt. of India project [SP/SO/D39/93]; CSIR, GOI	DST, Govt. of India project; CSIR, GOI(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the DST, Govt. of India project SP/SO/D39/93. TS is thankful to CSIR, GOI for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson TaS M., 1984, OLIGONUCLEOTIDE SYNT; BANERJEE A, 1991, BIOTECHNIQUES, V11, P650; Bertucat G, 1998, J BIOMOL STRUCT DYN, V16, P535, DOI 10.1080/07391102.1998.10508268; Bissler JJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4536, DOI 10.2741/2408; Casey BP, 2001, PROG NUCLEIC ACID RE, V67, P163, DOI 10.1016/S0079-6603(01)67028-4; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; CHIU SK, 1993, BIOCHEMISTRY-US, V32, P13146, DOI 10.1021/bi00211a025; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Duca M, 2008, NUCLEIC ACIDS RES, V36, P5123, DOI 10.1093/nar/gkn493; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; FURLONG JC, 1986, NUCLEIC ACIDS RES, V14, P3995, DOI 10.1093/nar/14.10.3995; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; GLOVER JNM, 1990, BIOCHEMISTRY-US, V29, P11110, DOI 10.1021/bi00502a014; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; JOHNSTON BH, 1985, CELL, V42, P713, DOI 10.1016/0092-8674(85)90268-5; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Panyutin IG, 2005, TRENDS BIOTECHNOL, V23, P492, DOI 10.1016/j.tibtech.2005.08.001; PLUM GE, 1990, P NATL ACAD SCI USA, V87, P9436, DOI 10.1073/pnas.87.23.9436; Prevost C, 2003, Q REV BIOPHYS, V36, P429, DOI 10.1017/S0033583504003956; RAO BJ, 1993, P NATL ACAD SCI USA, V90, P6646, DOI 10.1073/pnas.90.14.6646; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; ROY KB, 1992, BIOCHEMISTRY-US, V31, P6241, DOI 10.1021/bi00142a011; Roy KB, 2000, J BIOCH MOL BIOL BIO, V3, P99; RUBIN CM, 1980, NUCLEIC ACIDS RES, V8, P4613, DOI 10.1093/nar/8.20.4613; SHCHYOLKINA AK, 1994, FEBS LETT, V339, P113, DOI 10.1016/0014-5793(94)80396-X; TANEJA S, 1994, BIOCHEM J, V303, P147, DOI 10.1042/bj3030147; van der Heijden T, 2008, MOL CELL, V30, P530, DOI 10.1016/j.molcel.2008.03.010; van der Oost J, 2013, SCIENCE, V339, P768, DOI 10.1126/science.1234726; WASHBROOK E, 1994, BIOCHEM J, V301, P569, DOI 10.1042/bj3010569; WILLIAMSON JR, 1990, NUCLEIC ACIDS RES, V18, P379, DOI 10.1093/nar/18.2.379; ZHURKIN VB, 1994, J MOL BIOL, V239, P181, DOI 10.1006/jmbi.1994.1362	31	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65010	10.1371/journal.pone.0065010	http://dx.doi.org/10.1371/journal.pone.0065010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705027	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200181
J	Hu, YS; Long, N; Pigino, G; Brady, ST; Lazarov, O				Hu, Yuan-Shih; Long, Nancy; Pigino, Gustavo; Brady, Scott T.; Lazarov, Orly			Molecular Mechanisms of Environmental Enrichment: Impairments in Akt/GSK3 beta, Neurotrophin-3 and CREB Signaling	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; FAMILIAL ALZHEIMERS-DISEASE; ELEMENT-BINDING PROTEIN; AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; SYNAPTIC PLASTICITY; MESSENGER-RNA; RECEPTOR SUBUNITS; GENE-EXPRESSION	Experience of mice in a complex environment enhances neurogenesis and synaptic plasticity in the hippocampus of wild type and transgenic mice harboring familial Alzheimer's disease (FAD)-linked APPswe/PS1 Delta E9. In FAD mice, this experience also reduces levels of tau hyperphosphorylation and oligomeric beta-amyloid. Although environmental enrichment has significant effects on brain plasticity and neuropathology, the molecular mechanisms underlying these effects are unknown. Here we show that environmental enrichment upregulates the Akt pathway, leading to the downregulation of glycogen synthase kinase 3 beta (GSK3 beta), in wild type but not FAD mice. Several neurotrophic signaling pathways are activated in the hippocampus of both wild type and FAD mice, including brain derived neurotrophic factor (BDNF) and nerve growth factor (NGF), and this increase is accompanied by the upregulation of the BDNF receptor, tyrosine kinase B (TrkB). Interestingly, neurotrophin-3 (NT-3) is upregulated in the brains of wild type mice but not FAD mice, while insulin growth factor-1 (IGF-1) is upregulated exclusively in the brains of FAD mice. Upregulation of neurotrophins is accompanied by the increase of N-Methyl-D-aspartic acid (NMDA) receptors in the hippocampus following environmental enrichment. Most importantly, we observed a significant increase in levels of cAMP response element-binding (CREB) transcripts in the hippocampus of wild type and FAD mice following environmental enrichment. However, CREB phosphorylation, a critical step for the initiation of learning and memory-required gene transcription, takes place in the hippocampus of wild type but not of FAD mice. These results suggest that experience of wild type mice in a complex environmental upregulates critical signaling that play a major role in learning and memory in the hippocampus. However, in FAD mice, some of these pathways are impaired and cannot be rescued by environmental enrichment.	[Hu, Yuan-Shih; Long, Nancy; Pigino, Gustavo; Brady, Scott T.; Lazarov, Orly] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lazarov, O (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60680 USA.	olazarov@uic.edu	Hu, Jennifer Yuan-Shih/AAL-5876-2020; Pigino, Gustavo/L-7002-2019; Lazarov, Orly/F-9406-2015	Lazarov, Orly/0000-0002-5887-948X	NIA [AG033570, 1 RC1 AG036208-01]; New Investigator Research Grant; The Alzheimer's Association; Alzheimer's Research Fund; IDPH; NATIONAL INSTITUTE ON AGING [R01AG033570, RC1AG036208] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New Investigator Research Grant; The Alzheimer's Association; Alzheimer's Research Fund; IDPH; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by NIA AG033570 (http://www.nia.nih.gov/), NIA 1 RC1 AG036208-01 (http://www.nia.nih.gov/), New Investigator Research Grant, The Alzheimer's Association (http://www.alz.org/), and the Alzheimer's Research Fund, The IDPH (http://www.idph.state.il.us/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Adlard PA, 2005, NEUROBIOL AGING, V26, P511, DOI 10.1016/j.neurobiolaging.2004.05.006; Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Andin J, 2007, BRAIN RES, V1174, P18, DOI 10.1016/j.brainres.2007.06.101; Angelucci F, 2010, CURR ALZHEIMER RES, V7, P15, DOI 10.2174/156720510790274473; Avila J, 2010, EXPERT REV NEUROTHER, V10, P703, DOI 10.1586/ERN.10.40; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Baum L, 1996, MOL CHEM NEUROPATHOL, V29, P253, DOI 10.1007/BF02815006; Billings LM, 2007, J NEUROSCI, V27, P751, DOI 10.1523/JNEUROSCI.4800-06.2007; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bruel-Jungerman E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007901; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chen MJ, 2005, MOL BRAIN RES, V135, P181, DOI 10.1016/j.molbrainres.2004.12.001; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; DaRocha-Souto B, 2012, NEUROBIOL DIS, V45, P425, DOI 10.1016/j.nbd.2011.09.002; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Ding Q, 2011, NEUROSCIENCE, V192, P773, DOI 10.1016/j.neuroscience.2011.06.032; Durany N, 2000, INT J DEV NEUROSCI, V18, P807, DOI 10.1016/S0736-5748(00)00046-0; Elliott E, 2005, EUR J NEUROSCI, V22, P1081, DOI 10.1111/j.1460-9568.2005.04290.x; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Ferrer I., 2005, Current Alzheimer Research, V2, P3, DOI 10.2174/1567205052772713; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Fukunaga K, 1996, NEUROCHEM INT, V28, P343, DOI 10.1016/0197-0186(95)00097-6; Gortz N, 2008, BEHAV BRAIN RES, V191, P43, DOI 10.1016/j.bbr.2008.03.006; GREENAMYRE JT, 1987, J NEUROCHEM, V48, P543, DOI 10.1111/j.1471-4159.1987.tb04127.x; Hernandez F, 2012, J ALZHEIMERS DIS; Hernandez F, 2010, EXP NEUROL, V223, P322, DOI 10.1016/j.expneurol.2009.09.011; Hernandez F, 2009, BRAIN RES BULL, V80, P248, DOI 10.1016/j.brainresbull.2009.05.017; Hernandez P, 2009, J ALZHEIMERS DIS, V16, P149, DOI 10.3233/JAD-2009-0933; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hock C, 1998, NEUROSCI LETT, V241, P151, DOI 10.1016/S0304-3940(98)00019-6; Hu YS, 2010, FASEB J, V24, P1667, DOI 10.1096/fj.09-136945; Huang FL, 2006, J NEUROSCI, V26, P6230, DOI 10.1523/JNEUROSCI.1182-06.2006; Hye A, 2005, NEUROSCI LETT, V373, P1, DOI 10.1016/j.neulet.2004.10.031; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Larson J, 2007, ENV ENRICHMENT MOUSE; Lau GC, 2004, J NEUROCHEM, V88, P564, DOI 10.1046/j.1471-4159.2003.02156.x; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Leroy K, 2007, NEUROPATH APPL NEURO, V33, P43, DOI 10.1111/j.1365-2990.2006.00795.x; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Lichtenwalner RJ, 2006, J NEUROSCI RES, V83, P199, DOI 10.1002/jnr.20719; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Atalaya JP, 2011, EMBO J, V30, P4287, DOI 10.1038/emboj.2011.299; Lopez-Tobon A, 2011, REV NEUROSCIENCE, V22, P143, DOI 10.1515/RNS.2011.015; Ma QL, 2007, J NEUROCHEM, V103, P1594, DOI 10.1111/j.1471-4159.2007.04869.x; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Muller M, 2011, P NATL ACAD SCI USA, V108, P13293, DOI 10.1073/pnas.1109297108; Murer MG, 1999, NEUROSCIENCE, V88, P1015, DOI 10.1016/S0306-4522(98)00219-X; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; NarisawaSaito M, 1996, J NEUROCHEM, V67, P1124; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Numakawa T, 2012, NEUROSCIENCE; Ohira K, 2009, CURR NEUROPHARMACOL, V7, P276, DOI 10.2174/157015909790031210; OLSSON T, 1994, MOL BRAIN RES, V23, P349, DOI 10.1016/0169-328X(94)90246-1; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Pham TM, 1999, BEHAV BRAIN RES, V103, P63, DOI 10.1016/S0166-4328(99)00019-4; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Ryder J, 2004, CELL SIGNAL, V16, P187, DOI 10.1016/j.cellsig.2003.07.004; Sakamoto K, 2004, BIOCHEM BIOPH RES CO, V319, P419, DOI 10.1016/j.bbrc.2004.05.020; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sartori CR, 2011, NEUROSCIENCE, V180, P9, DOI 10.1016/j.neuroscience.2011.02.055; Shieh PB, 1999, J NEUROBIOL, V41, P127, DOI 10.1002/(SICI)1097-4695(199910)41:1<127::AID-NEU16>3.0.CO;2-J; Szapacs ME, 2004, J NEUROSCI METH, V140, P81, DOI 10.1016/j.jneumeth.2004.03.026; Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; Torasdotter M, 1996, NEUROSCI LETT, V218, P107, DOI 10.1016/S0304-3940(96)13127-X; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2	88	87	88	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64460	10.1371/journal.pone.0064460	http://dx.doi.org/10.1371/journal.pone.0064460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700479	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200138
J	Kostakos, V; Juntunen, T; Goncalves, J; Hosio, S; Ojala, T				Kostakos, Vassilis; Juntunen, Tomi; Goncalves, Jorge; Hosio, Simo; Ojala, Timo			Where Am I? Location Archetype Keyword Extraction from Urban Mobility Patterns	PLOS ONE			English	Article								Can online behaviour be used as a proxy for studying urban mobility? The increasing availability of digital mobility traces has provided new insights into collective human behaviour. Mobility datasets have been shown to be an accurate proxy for daily behaviour and social patterns, and behavioural data from Twitter has been used to predict real world phenomena such as cinema ticket sale volumes, stock prices, and disease outbreaks. In this paper we correlate city-scale urban traffic patterns with online search trends to uncover keywords describing the pedestrian traffic location. By analysing a 3-year mobility dataset we show that our approach, called Location Archetype Keyword Extraction (LAKE), is capable of uncovering semantically relevant keywords for describing a location. Our findings demonstrate an overarching relationship between online and offline collective behaviour, and allow for advancing analysis of community-level behaviour by using online search keywords as a practical behaviour proxy.	[Kostakos, Vassilis; Juntunen, Tomi; Goncalves, Jorge; Hosio, Simo; Ojala, Timo] Univ Oulu, Dept Comp Sci & Engn, Oulu, Finland	University of Oulu	Kostakos, V (corresponding author), Univ Oulu, Dept Comp Sci & Engn, Oulu, Finland.	vassilis@ee.oulu.fi	Kostakos, Vassilis/G-8997-2011	Kostakos, Vassilis/0000-0003-2804-6038; Goncalves, Jorge/0000-0002-0117-0322; Hosio, Simo/0000-0002-9609-0965	Academy of Finland; TEKES - the Finnish Funding Agency for Technology and Innovation; City of Oulu; commercial partners of the UbiOulu program	Academy of Finland(Academy of Finland); TEKES - the Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); City of Oulu; commercial partners of the UbiOulu program	This work was partially funded by the Academy of Finland, TEKES - the Finnish Funding Agency for Technology and Innovation, the City of Oulu, and the commercial partners of the UbiOulu program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; HILLIER B, 1993, ENVIRON PLANN B, V20, P29, DOI 10.1068/b200029; Kostakos V, 2009, GEOSPATIAL ANAL MODE, P31, DOI DOI 10.1007/978-90-481-8572-63; Kostakos V, 2010, ACM T COMPUT-HUM INT, V17, DOI 10.1145/1721831.1721833; Kumar S, 2011, GOOGLE CORRELATE WHI; Lima A, 2012, NOK MOB DAT CHALL WO; Official Statistics of Finland (OSF), 2012, US INF COMM TECHN; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Whinston A, 2011, WHOSE WHAT IN PRESS	14	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63980	10.1371/journal.pone.0063980	http://dx.doi.org/10.1371/journal.pone.0063980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704964	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200096
J	Larsen, MJ; Kruse, TA; Tan, QH; Laenkholm, AV; Bak, M; Lykkesfeldt, AE; Sorensen, KP; Hansen, TVO; Ejlertsen, B; Gerdes, AM; Thomassen, M				Larsen, Martin J.; Kruse, Torben A.; Tan, Qihua; Laenkholm, Anne-Vibeke; Bak, Martin; Lykkesfeldt, Anne E.; Sorensen, Kristina P.; Hansen, Thomas V. O.; Ejlertsen, Bent; Gerdes, Anne-Marie; Thomassen, Mads			Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling	PLOS ONE			English	Article							BREAST-CANCER; ESTROGEN-RECEPTOR; BRCA2 MUTATIONS; OVARIAN-CANCER; EXPRESSION; PATHOLOGY; COMPLEX; NORMALIZATION; PREVALENCE; PREDICTION	Pathogenic germline mutations in BRCA1 or BRCA2 are detected in less than one third of families with a strong history of breast cancer. It is therefore expected that mutations still remain undetected by currently used screening methods. In addition, a growing number of BRCA1/2 sequence variants of unclear pathogen significance are found in the families, constituting an increasing clinical challenge. New methods are therefore needed to improve the detection rate and aid the interpretation of the clinically uncertain variants. In this study we analyzed a series of 33 BRCA1, 22 BRCA2, and 128 sporadic tumors by RNA profiling to investigate the classification potential of RNA profiles to predict BRCA1/2 mutation status. We found that breast tumors from BRCA1 and BRCA2 mutation carriers display characteristic RNA expression patterns, allowing them to be distinguished from sporadic tumors. The majority of BRCA1 tumors were basal-like while BRCA2 tumors were mainly luminal B. Using RNA profiles, we were able to distinguish BRCA1 tumors from sporadic tumors among basal-like tumors with 83% accuracy and BRCA2 from sporadic tumors among luminal B tumors with 89% accuracy. Furthermore, subtype-specific BRCA1/2 gene signatures were successfully validated in two independent data sets with high accuracies. Although additional validation studies are required, indication of BRCA1/2 involvement ("BRCAness'') by RNA profiling could potentially be valuable as a tool for distinguishing pathogenic mutations from benign variants, for identification of undetected mutation carriers, and for selecting patients sensitive to new therapeutics such as PARP inhibitors.	[Larsen, Martin J.; Kruse, Torben A.; Tan, Qihua; Sorensen, Kristina P.; Thomassen, Mads] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Larsen, Martin J.; Kruse, Torben A.; Sorensen, Kristina P.; Thomassen, Mads] Univ Southern Denmark, Inst Clin, Odense, Denmark; [Tan, Qihua] Univ Southern Denmark, Inst Publ Hlth, Odense, Denmark; [Laenkholm, Anne-Vibeke] Slagelse Hosp, Dept Pathol, Slagelse, Denmark; [Bak, Martin] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark; [Lykkesfeldt, Anne E.] Danish Canc Soc, Res Ctr, Breast Canc Grp, Unit Cell Death & Metab, Copenhagen, Denmark; [Hansen, Thomas V. O.] Univ Copenhagen, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Ejlertsen, Bent] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Danish Breast Canc Cooperat Grp,Stat Ctr, Copenhagen, Denmark; [Gerdes, Anne-Marie] Copenhagen Univ Hosp, Rigshosp, Dept Clin Genet, Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Danish Cancer Society; Rigshospitalet; University of Copenhagen; Danish Breast Cancer Cooperative Group (DBCG); Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Larsen, MJ (corresponding author), Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark.	martin.larsen@rsyd.dk	Hansen, Thomas/GWZ-2858-2022; Bak, Martin/D-1392-2012; Tan, Qihua/AAG-2582-2019; Larsen, Martin Jakob/L-5794-2019; Tan, Qihua/F-1349-2015; Hansen, Thomas v. O./J-9361-2014	Tan, Qihua/0000-0003-3194-0030; Tan, Qihua/0000-0003-3194-0030; Hansen, Thomas v. O./0000-0003-4635-2653; Laenkholm, Anne-Vibeke/0000-0003-2166-8686; Gerdes, Anne-Marie/0000-0002-0328-3320	Heidi Seide Jacobsen; Ministry of the Interior and Ministry of Health; University of Southern Denmark; Odense University Hospital; Danish Cancer Society; The Danish Council for Strategic Research (DBCG-TIBCAT); Dansk Kraeftforsknings Fond; Breast Friends; Kobenhavns Universitets fond for kraeftforskning; Savvaerksejer Jeppe Juhls og hustru Ovita Juhls Mindelegat; Arvid Nilssons Fond; Agnes og Poul Friis Fond; Raimond og Dagmar Ringgard Bohns Fond; Fonden til Laegevidenskabens Fremme; Kong Christian IX og Dronning Louises Jubilaeumslegat; Ingenior K. A. Rohde og hustrus Legat; Snedkermester Sophus Jacobsens og hustru Astrid Jacobsens Fond; Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning; Helen Rudes Fond; Karen A. Tolstrups Fond	Heidi Seide Jacobsen; Ministry of the Interior and Ministry of Health; University of Southern Denmark; Odense University Hospital; Danish Cancer Society(Danish Cancer Society); The Danish Council for Strategic Research (DBCG-TIBCAT); Dansk Kraeftforsknings Fond; Breast Friends; Kobenhavns Universitets fond for kraeftforskning; Savvaerksejer Jeppe Juhls og hustru Ovita Juhls Mindelegat; Arvid Nilssons Fond; Agnes og Poul Friis Fond; Raimond og Dagmar Ringgard Bohns Fond; Fonden til Laegevidenskabens Fremme; Kong Christian IX og Dronning Louises Jubilaeumslegat; Ingenior K. A. Rohde og hustrus Legat; Snedkermester Sophus Jacobsens og hustru Astrid Jacobsens Fond; Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning; Helen Rudes Fond; Karen A. Tolstrups Fond	The work was supported by Heidi Seide Jacobsen, Ministry of the Interior and Ministry of Health, University of Southern Denmark, Odense University Hospital, Danish Cancer Society, The Danish Council for Strategic Research (DBCG-TIBCAT), Dansk Kraeftforsknings Fond, Breast Friends, Kobenhavns Universitets fond for kraeftforskning, Savvaerksejer Jeppe Juhls og hustru Ovita Juhls Mindelegat, Arvid Nilssons Fond, Agnes og Poul Friis Fond, Raimond og Dagmar Ringgard Bohns Fond, Fonden til Laegevidenskabens Fremme, Kong Christian IX og Dronning Louises Jubilaeumslegat, Ingenior K. A. Rohde og hustrus Legat, Snedkermester Sophus Jacobsens og hustru Astrid Jacobsens Fond, Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning, Helen Rudes Fond, Karen A. Tolstrups Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Brozek I, 2012, FAM CANCER, V11, P351, DOI 10.1007/s10689-012-9519-5; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Diaz LK, 2007, ADV ANAT PATHOL, V14, P419, DOI 10.1097/PAP.0b013e3181594733; Diez O, 2003, HUM MUTAT, V22, P301, DOI 10.1002/humu.10260; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fostira F, 2012, BREAST CANCER RES TR, V134, P353, DOI 10.1007/s10549-012-2021-9; Foulkes WD, 2004, CLIN CANCER RES, V10, P2029, DOI 10.1158/1078-0432.CCR-03-1061; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Gerdes AM, 2006, CLIN GENET, V69, P171, DOI 10.1111/j.1399-0004.2006.00568.x; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Jonsson G, 2012, CANCER RES, V72, P4028, DOI 10.1158/0008-5472.CAN-12-0097; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Joosse SA, 2012, BREAST CANCER RES TR, V132, P379, DOI 10.1007/s10549-010-1016-7; Joosse SA, 2009, BREAST CANCER RES TR, V116, P479, DOI 10.1007/s10549-008-0117-z; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Lakhani SR, 1997, LANCET, V349, P1505; Lakhani SR, 2001, NAT MED, V7, P408, DOI 10.1038/86464; Lakhani SR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2483; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Lisowska Katarzyna Marta, 2011, Front Biosci (Elite Ed), V3, P125, DOI 10.2741/e227; Malone KE, 2006, CANCER RES, V66, P8297, DOI 10.1158/0008-5472.CAN-06-0503; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Mulligan AM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3052; Nagel JHA, 2012, BREAST CANCER RES TR, V132, P439, DOI 10.1007/s10549-011-1588-x; Nordgard SH, 2008, GENE CHROMOSOME CANC, V47, P680, DOI 10.1002/gcc.20569; OSHAUGHNESSY J, 2011, RANDOMIZED PHASE 3 S; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Thomassen M, 2006, BIOCHEM BIOPH RES CO, V344, P1111, DOI 10.1016/j.bbrc.2006.03.227; Tung N, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2478; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; van der Groep P, 2011, CELL ONCOL, V34, P71, DOI 10.1007/s13402-011-0010-3; van der Kolk DM, 2010, BREAST CANCER RES TR, V124, P643, DOI 10.1007/s10549-010-0805-3; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vaziri SAJ, 2001, CLIN CANCER RES, V7, P1937; Waddell N, 2010, BREAST CANCER RES TR, V123, P661, DOI 10.1007/s10549-009-0653-1; Yang YH, 2003, INST MATH S, V40, P403; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yuan SSF, 1999, CANCER RES, V59, P3547; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	50	69	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64268	10.1371/journal.pone.0064268	http://dx.doi.org/10.1371/journal.pone.0064268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704984	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200128
J	Paradis, R; Lazar, N; Antinozzi, P; Perbal, B; Buteau, J				Paradis, Renee; Lazar, Noureddine; Antinozzi, Peter; Perbal, Bernard; Buteau, Jean			Nov/Ccn3, a Novel Transcriptional Target of FoxO1, Impairs Pancreatic beta-Cell Function	PLOS ONE			English	Article							FORKHEAD PROTEIN FOXO1; GROWTH-FACTOR CTGF; SUSCEPTIBILITY LOCUS; INSULIN-SECRETION; CCN PROTEINS; HUMAN NOV; DIFFERENTIATION; GENE; PROLIFERATION; REPLICATION	Type 2 diabetes is characterized by both insulin resistance and progressive deterioration of beta-cell function. The forkhead transcription factor FoxO1 is a prominent mediator of insulin signaling in beta-cells. We reasoned that identification of FoxO1 target genes in beta-cells could reveal mechanisms linking beta-cell dysfunction to insulin resistance. In this study, we report the characterization of Nov/Ccn3 as a novel transcriptional target of FoxO1 in pancreatic beta-cells. FoxO1 binds to an evolutionarily conserved response element in the Ccn3 promoter to regulate its expression. Accordingly, CCN3 levels are elevated in pancreatic islets of mice with overexpression of a constitutively active form of FoxO1 or insulin resistance. Our functional studies reveal that CCN3 impairs beta-cell proliferation concomitantly with a reduction in cAMP levels. Moreover, CCN3 decreases glucose oxidation, which translates into inhibition of glucose-stimulated Ca2+ entry and insulin secretion. Our results identify CCN3, a novel transcriptional target of FoxO1 in pancreatic beta-cells, as a potential target for therapeutic intervention in the treatment of diabetes.	[Paradis, Renee; Buteau, Jean] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Lazar, Noureddine; Perbal, Bernard] Univ Paris 07, Unite Format & Rech Biochim, Paris, France; [Antinozzi, Peter] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27109 USA	Laval University; UDICE-French Research Universities; Universite Paris Cite; Wake Forest University	Buteau, J (corresponding author), Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada.	jbuteau@ualberta.ca			European PROTHETS (Prognosis and therapeutic targets of Ewing's family of tumours) program; Ministere de l'Education Nationale de la Recherche et de la Technologie; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	European PROTHETS (Prognosis and therapeutic targets of Ewing's family of tumours) program; Ministere de l'Education Nationale de la Recherche et de la Technologie; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	JB is a Canadian Diabetes Association scholar and a Fonds de la Recherche en Sante du Quebec junior investigator. NL was supported by the European PROTHETS (Prognosis and therapeutic targets of Ewing's family of tumours) program. This work was supported by the Ministere de l'Education Nationale de la Recherche et de la Technologie (PB), the Natural Sciences and Engineering Research Council of Canada (JB) and the Canadian Institutes of Health Research (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; An P, 2006, DIABETES, V55, P551, DOI 10.2337/diabetes.55.02.06.db05-0714; Antinozzi PA, 2006, P NATL ACAD SCI USA, V103, P3698, DOI 10.1073/pnas.0510521103; Bleau AM, 2007, J CELL BIOCHEM, V101, P1475, DOI 10.1002/jcb.21262; Burren CP, 1999, J CLIN ENDOCR METAB, V84, P1096; Buteau J, 2007, DIABETES OBES METAB, V9, P140, DOI 10.1111/j.1463-1326.2007.00782.x; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Calhabeua F, 2006, EXP CELL RES, V312, P1876, DOI 10.1016/j.yexcr.2006.02.027; Charrier A, 2013, CYTOKINE GROWTH F R, V24, P59, DOI 10.1016/j.cytogfr.2012.07.001; Crawford LA, 2009, MOL ENDOCRINOL, V23, P324, DOI 10.1210/me.2008-0045; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Frayling TM, 2003, DIABETES, V52, P1857, DOI 10.2337/diabetes.52.7.1857; Guney MA, 2011, P NATL ACAD SCI USA, V108, P15242, DOI 10.1073/pnas.1100072108; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hribal ML, 2002, AM J PHYSIOL-ENDOC M, V282, pE977, DOI 10.1152/ajpendo.00561.2001; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kocialkowski S, 2001, ANAT EMBRYOL, V203, P417, DOI 10.1007/s004290100177; Kyurkchiev Stanimir, 2004, Cell Commun Signal, V2, P9, DOI 10.1186/1478-811X-2-9; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Martinerie C, 1996, ONCOGENE, V12, P1479; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Perbal Bernard, 2006, Cell Commun Signal, V4, P3, DOI 10.1186/1478-811X-4-3; Porte D, 2001, DIABETES, V50, pS160, DOI 10.2337/diabetes.50.2007.S160; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Ritzel RA, 2004, J CLIN ENDOCR METAB, V89, P795, DOI 10.1210/jc.2003-031120; Ritzel RA, 2003, DIABETES, V52, P1701, DOI 10.2337/diabetes.52.7.1701; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Sale MM, 2002, DIABETES, V51, pS316, DOI 10.2337/diabetes.51.2007.S316; Thibout H, 2003, J CLIN ENDOCR METAB, V88, P327, DOI 10.1210/jc.2002-020304; Vaessen N, 2002, DIABETES, V51, P856, DOI 10.2337/diabetes.51.3.856; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249	41	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64957	10.1371/journal.pone.0064957	http://dx.doi.org/10.1371/journal.pone.0064957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705021	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200175
J	Vasconcelos, M; Monteiro, T; Kacelnik, A				Vasconcelos, Marco; Monteiro, Tiago; Kacelnik, Alex			Context-Dependent Preferences in Starlings: Linking Ecology, Foraging and Choice	PLOS ONE			English	Article							SEQUENTIAL CHOICE; SUNK COST; STATE; PIGEONS; JUSTIFICATION; RATIONALITY; DECISIONS; CONTRAST; HUMANS	Foraging animals typically encounter opportunities that they either pursue or skip, but occasionally meet several alternatives simultaneously. Behavioural ecologists predict preferences using absolute properties of each option, while decision theorists focus on relative evaluations at the time of choice. We use European starlings (Sturnus vulgaris) to integrate ecological reasoning with decision models, linking and testing hypotheses for value acquisition and choice mechanism. We hypothesise that options' values depend jointly on absolute attributes, learning context, and subject's state. In simultaneous choices, preference could result either from comparing subjective values using deliberation time, or from processing each alternative independently, without relative comparisons. The combination of the value acquisition hypothesis and independent processing at choice time has been called the Sequential Choice Model. We test this model with options equated in absolute properties to exclude the possibility of preference being built at the time of choice. Starlings learned to obtain food by responding to four stimuli in two contexts. In context [AB], they encountered options A(5) or B-10 in random alternation; in context [CD], they met C-10 or D-20. Delay to food is denoted, in seconds, by the suffixes. Observed latency to respond (L-i) to each option alone (our measure of value) ranked thus: L-A approximate to L-C<<L-B, L-D, consistently with value being sensitive to both delay and learning context. We then introduced simultaneous presentations of A(5) vs. C-10 and B-10 vs. C-10, using latencies in no-choice tests to predict sign and strength of preference in pairings. Starlings preferred A(5) over C-10 and C-10 over B-10. There was no detectable evaluation time, and preference magnitude was predictable from latency differentials. This implies that value reflects learning rather than choice context, that preferences are not constructed by relative judgements at the time of choice, and that mechanisms adapted for sequential decisions are effective to predict choice behaviour.	[Vasconcelos, Marco] Univ Minho, Sch Psychol, Braga, Portugal; [Monteiro, Tiago; Kacelnik, Alex] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Universidade do Minho; University of Oxford	Vasconcelos, M (corresponding author), Univ Minho, Sch Psychol, Braga, Portugal.	mvasconcelos@psi.uminho.pt; alex.kacelnik@zoo.ox.ac.uk	Vasconcelos, Marco/A-3887-2015; Monteiro, Tiago/F-6840-2011	Vasconcelos, Marco/0000-0002-1215-0749; Monteiro, Tiago/0000-0002-2836-8961	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G007144/1]; Portuguese Foundation for Science and Technology (FCT); BBSRC [BB/G007144/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G007144/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/G007144/1 to AK www.bbsrc.ac.uk; TM was supported by a Doctoral Grant from the Portuguese Foundation for Science and Technology (FCT) www.fct.pt/index.phtml.en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, LEARNING BEHAV CONT; Arkes HR, 1999, PSYCHOL BULL, V125, P591, DOI 10.1037/0033-2909.125.5.591; Aw JM, 2009, BEHAV PROCESS, V81, P333, DOI 10.1016/j.beproc.2008.09.002; Aw J, 2012, BEHAV PROCESS, V89, P95, DOI 10.1016/j.beproc.2011.09.007; Aw JM, 2011, ANIM BEHAV, V81, P1117, DOI 10.1016/j.anbehav.2011.02.015; Bateson M., 1993, CURRENCIES DECISION; BELKE TW, 1992, ANIM LEARN BEHAV, V20, P401, DOI 10.3758/BF03197963; Blough D. S., 2006, COMP COGNITION EXPT, P89; Cardinal RN, 2010, BEHAV RES METHODS, V42, P1059, DOI 10.3758/BRM.42.4.1059; Catania A.C., 1970, THEORY REINFORCEMENT, P1; DAWKINS R, 1976, NATURE, V262, P131, DOI 10.1038/262131a0; Freidin E, 2009, BEHAV PROCESS, V80, P218, DOI 10.1016/j.beproc.2008.12.001; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grafen A., 2002, MODERN STAT LIFE SCI; GUTMAN A, 1977, J EXP ANAL BEHAV, V27, P219, DOI 10.1901/jeab.1977.27-219; Johnson AW, 2011, P ROY SOC B-BIOL SCI, V278, P1450, DOI 10.1098/rspb.2010.1581; Kacelnik A, 2011, BEHAV ECOL SOCIOBIOL, V65, P547, DOI 10.1007/s00265-010-1101-2; Klein ED, 2005, PSYCHON B REV, V12, P335, DOI 10.3758/BF03196381; Marsh B, 2004, BEHAV ECOL, V15, P396, DOI 10.1093/beheco/arh034; Navarro AD, 2005, J EXP ANAL BEHAV, V83, P1, DOI 10.1901/jeab.2005.21-04; Pompilio L, 2006, SCIENCE, V311, P1613, DOI 10.1126/science.1123924; Pompilio L, 2005, ANIM BEHAV, V70, P571, DOI 10.1016/j.anbehav.2004.12.009; Pompilio L, 2010, P NATL ACAD SCI USA, V107, P508, DOI 10.1073/pnas.0907250107; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; REYNOLDS GS, 1961, J EXP ANAL BEHAV, V4, P57, DOI 10.1901/jeab.1961.4-57; ROBERTS S, 1981, J EXP PSYCHOL ANIM B, V7, P242, DOI 10.1037/0097-7403.7.3.242; Schuck-Paim C, 2004, PLOS BIOL, V2, P2305, DOI 10.1371/journal.pbio.0020402; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shapiro MS, 2008, J EXP PSYCHOL-ANIM B, V34, P75, DOI 10.1037/0097-7403.34.1.75; Staddon JER, 2003, ANNU REV PSYCHOL, V54, P115, DOI 10.1146/annurev.psych.54.101601.145124; Stephens D.W., 1986, pi; Stephens DW, 2009, BEHAV PROCESS, V80, P252, DOI 10.1016/j.beproc.2008.11.014; Stephens DW, 2004, P ROY SOC B-BIOL SCI, V271, P2459, DOI 10.1098/rspb.2004.2871; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Vasconcelos M, 2008, LEARN BEHAV, V36, P12, DOI 10.3758/LB.36.1.12; Vasconcelos M, 2010, BEHAV PROCESS, V84, P435, DOI 10.1016/j.beproc.2009.11.010; Vlaev I, 2011, TRENDS COGN SCI, V15, P546, DOI 10.1016/j.tics.2011.09.008; Zar JH, 1999, BIOSTATISTICAL ANAL; Zentall TR, 2010, CURR DIR PSYCHOL SCI, V19, P296, DOI 10.1177/0963721410383381	41	12	12	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64934	10.1371/journal.pone.0064934	http://dx.doi.org/10.1371/journal.pone.0064934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705019	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200173
J	Lehnhoff, EA; Keith, BK; Dyer, WE; Menalled, FD				Lehnhoff, Erik A.; Keith, Barbara K.; Dyer, William E.; Menalled, Fabian D.			Impact of Biotic and Abiotic Stresses on the Competitive Ability of Multiple Herbicide Resistant Wild Oat (Avena fatua)	PLOS ONE			English	Article							LOLIUM-RIGIDUM POPULATION; LETTUCE LACTUCA-SERRIOLA; SULFONYLUREA-RESISTANT; SEED-GERMINATION; ACETYL-COENZYME; FITNESS; METABOLISM; PLANTS; CARBOXYLASE; EVOLUTION	Ecological theory predicts that fitness costs of herbicide resistance should lead to the reduced relative abundance of resistant populations upon the cessation of herbicide use. This greenhouse research investigated the potential fitness costs of two multiple herbicide resistant (MHR) wild oat (Avena fatua) populations, an economically important weed that affects cereal and pulse crop production in the Northern Great Plains of North America. We compared the competitive ability of two MHR and two herbicide susceptible (HS) A. fatua populations along a gradient of biotic and abiotic stresses The biotic stress was imposed by three levels of wheat (Triticum aestivum) competition (0, 4, and 8 individuals pot(-1)) and an abiotic stress by three nitrogen (N) fertilization rates (0, 50 and 100 kg N ha(-1)). Data were analyzed with linear mixed-effects models and results showed that the biomass of all A. fatua populations decreased with increasing T. aestivum competition at all N rates. Similarly, A. fatua relative growth rate (RGR) decreased with increasing T. aestivum competition at the medium and high N rates but there was no response with 0 N. There were no differences between the levels of biomass or RGR of HS and MHR populations in response to T. aestivum competition. Overall, the results indicate that MHR does not confer growth-related fitness costs in these A. fatua populations, and that their relative abundance will not be diminished with respect to HS populations in the absence of herbicide treatment.	[Lehnhoff, Erik A.; Menalled, Fabian D.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Keith, Barbara K.; Dyer, William E.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Lehnhoff, EA (corresponding author), Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA.	erik.lehnhoff@montana.edu			U.S. Environmental Protection Agency [X8-97873401-0]; Montana Wheat and Barley Committee [408-1655]; Montana Noxious Weed Trust Fund [2011-033]	U.S. Environmental Protection Agency(United States Environmental Protection Agency); Montana Wheat and Barley Committee; Montana Noxious Weed Trust Fund	This research was funded through grants by the U.S. Environmental Protection Agency, http://www.epa.gov, (Grant # X8-97873401-0); the Montana Wheat and Barley Committee, http://wbc.agr.mt.gov, (Grant # 408-1655); and the Montana Noxious Weed Trust Fund, http://agr.mt.gov/agr/Programs/Weeds/TrustFund, (Grant# 2011-033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCERRUTHLING M, 1992, WEED TECHNOL, V6, P303, DOI 10.1017/S0890037X00034771; ALCOCERRUTHLING M, 1992, WEED TECHNOL, V6, P437, DOI 10.1017/S0890037X00035016; BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; Beckie HJ, 2012, CAN J PLANT SCI, V92, P1329, DOI 10.4141/CJPS2012-005; Beckie HJ, 2012, CROP PROT, V35, P15, DOI 10.1016/j.cropro.2011.12.018; Beckie HJ, 2012, WEED SCI, V60, P10, DOI 10.1614/WS-D-11-00110.1; Blackshaw RE, 2008, WEED SCI, V56, P743, DOI 10.1614/WS-08-065.1; Cousens RD, 1997, WEED RES, V37, P1, DOI 10.1111/j.1365-3180.1997.tb01816.x; Delye C, 2011, WEED RES, V51, P433, DOI 10.1111/j.1365-3180.2011.00864.x; Delye C, 2013, ANN BOT, V111, P481; EVANS RM, 1991, WEED TECHNOL, V5, P33, DOI 10.1017/S0890037X00033212; Heap I., 2013, INT SURVEY HERBICIDE; HEAP IM, 1993, WEED SCI, V41, P232, DOI 10.1017/S0043174500076116; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Holt J. S., 1994, P299; Hunt R, 1982, PLANT GROWTH ANAL; JOHNSON RR, 1995, PLANT MOL BIOL, V28, P113, DOI 10.1007/BF00042043; Lehnhoff EA, AGRONOMY J IN PRESS; Maneechote C, 1997, PESTIC SCI, V49, P105, DOI 10.1002/(SICI)1096-9063(199702)49:2&lt;105::AID-PS507&gt;3.0.CO;2-3; Maxwell B. D., 1994, HERBICIDE RESISTANCE, P353; MAXWELL BD, 1990, WEED TECHNOL, V4, P2, DOI 10.1017/S0890037X0002488X; Menchari Y, 2008, J APPL ECOL, V45, P939, DOI 10.1111/j.1365-2664.2008.01462.x; Mortensen DA, 2012, BIOSCIENCE, V62, P75, DOI 10.1525/bio.2012.62.1.12; NAYLOR JM, 1976, CAN J BOT, V54, P306, DOI 10.1139/b76-028; O'Donovan JT, 1999, CAN J PLANT SCI, V79, P303, DOI 10.4141/P98-060; ODONOVAN JT, 1994, WEED SCI, V42, P195, DOI 10.1017/S0043174500080267; Park KW, 2005, WEED SCI, V53, P780, DOI 10.1614/WS-05-006R1.1; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Reade JPH, 2004, WEED SCI, V52, P468, DOI 10.1614/P2002-168D; SOMODY CN, 1984, WEED SCI, V32, P353, DOI 10.1017/S0043174500059129; Tardif FJ, 2006, NEW PHYTOL, V169, P251, DOI 10.1111/j.1469-8137.2005.01596.x; Vila-Aiub MM, 2011, HEREDITY, V107, P386, DOI 10.1038/hdy.2011.29; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Vila-Aiub MM, 2009, J ECOL, V97, P772, DOI 10.1111/j.1365-2745.2009.01511.x; Vila-Aiub MM, 2005, NEW PHYTOL, V167, P787, DOI 10.1111/j.1469-8137.2005.01465.x; Vila-Aiub MM, 2005, J APPL ECOL, V42, P288, DOI 10.1111/j.1365-2664.2005.01017.x	36	16	16	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64478	10.1371/journal.pone.0064478	http://dx.doi.org/10.1371/journal.pone.0064478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696896	Green Submitted, Green Published, gold			2022-12-27	WOS:000319081900099
J	Li, AQ; Hardy, R; Stoner, S; Tuckermann, J; Seibel, M; Zhou, H				Li, Aiqing; Hardy, Rowan; Stoner, Shihani; Tuckermann, Jan; Seibel, Markus; Zhou, Hong			Deletion of Mesenchymal Glucocorticoid Receptor Attenuates Embryonic Lung Development and Abdominal Wall Closure	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; DIFFERENTIAL EXPRESSION; ELASTIN PRODUCTION; GENE-EXPRESSION; MESSENGER-RNA; PROTEIN; MICE; IDENTIFICATION; FIBROBLASTS; PROMOTER	As a member of the nuclear hormone receptor superfamily of ligand-activated transcription factors, the glucocorticoid receptor (GR) is essential for normal embryonic development. To date, the role of mesenchymal glucocorticoid signaling during development has not been fully elucidated. In the present study, we investigated the role of the GR during embryogenesis specifically in mesenchymal tissues. To this aim, we crossed GRflox mice with Dermo1-Cre mice to generate GR(Dermo1) mice, where the GR gene was deleted within mesenchymal cells. Compared to their wild type littermates, GR(Dermo1) mice displayed severe pulmonary atelectasis, defects in abdominal wall formation resulting in intestinal herniation, abnormal extracellular matrix synthesis in connective tissues and high postnatal lethality. Lungs of GR(Dermo1) mice failed to progress from the canalicular to saccular stage, as evidenced by the presence of immature air sacs, thickened interstitial mesenchyme and an underdeveloped vascular network between E17.5 and E18.5. Furthermore, myofibroblasts and vascular smooth muscle cells, although present in normal numbers in GR(Dermo1) animals, were characterized by significantly reduced elastin synthesis, whilst epithelial lining cells of the immature saccules were poorly differentiated. A marked reduction in normal elastin and collagen deposits were also observed in connective tissues adjacent to the umbilical hernia. This study demonstrates that eliminating the GR in cells of the mesenchymal lineage results in marked effects on interstitial fibroblast function, including a significant decrease in elastin synthesis. This results in lung atelectasis and postnatal lethality, as well as additional and hitherto unrecognized developmental defects in abdominal wall formation. In addition, altered glucocorticoid signaling in the mesenchyme attenuates normal lung epithelial differentiation.	[Li, Aiqing; Hardy, Rowan; Stoner, Shihani; Seibel, Markus; Zhou, Hong] Univ Sydney, ANZAC Res Inst, Bone Res Program, Sydney, NSW 2006, Australia; [Hardy, Rowan] Univ Birmingham, Inst Biomed Res, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Tuckermann, Jan] Univ Ulm, Inst Gen Zool & Endocrinol, D-89069 Ulm, Germany; [Seibel, Markus] Concord Hosp, Dept Endocrinol & Metab, Sydney, NSW, Australia	University of Sydney; ANZAC Research Institute; University of Birmingham; Ulm University; Concord Repatriation General Hospital	Zhou, H (corresponding author), Univ Sydney, ANZAC Res Inst, Bone Res Program, Sydney, NSW 2006, Australia.	h.zhou@sydney.edu.au	Hardy, Rowan S/N-9185-2018; Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016	Hardy, Rowan S/0000-0001-6938-6739; Seibel, Markus J/0000-0002-2701-378X; Zhou, Hong/0000-0001-5899-9660	National Health & Medical Research Council, Australia [632818]; Arthritis Research UK [19552]; National Imaging Facility, Australia; MRC [MR/K00414X/1] Funding Source: UKRI; Medical Research Council [MR/K00414X/1] Funding Source: researchfish	National Health & Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Research UK(Versus Arthritis); National Imaging Facility, Australia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Health & Medical Research Council, Australia, Project Grant 632818 to Hong Zhou and Markus J Seibel. Rowan Hardy received support from Arthritis Research UK (ref no 19552). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Colette Fong-Yee and Claudia Hulso for expert technical assistance and thank Mamdouh Khalil and his staff for excellent animal care. The authors thank Dr Timothy Stait-Gardner and Professor William. S. Price, University of Western Sydney, for scientific and technical assistance and for MRI analysis. MRI scan was performed using the 11.7 T MR scanner at the University of Western and was supported by the National Imaging Facility, Australia.	Ahasan MM, 2012, ARTHRITIS RHEUMATISM; ASZTERBAUM M, 1993, J CLIN INVEST, V91, P2703, DOI 10.1172/JCI116509; Baschant U, 2011, P NATL ACAD SCI USA, V108, P19317, DOI 10.1073/pnas.1105857108; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Bird AD, 2007, J PHYSIOL-LONDON, V585, P187, DOI 10.1113/jphysiol.2007.136796; Bolt RJ, 2001, PEDIATR PULM, V32, P76, DOI 10.1002/ppul.1092; Cavalcante FSA, 2005, J APPL PHYSIOL, V98, P672, DOI 10.1152/japplphysiol.00619.2004; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Cole TJ, 2004, AM J RESP CELL MOL, V30, P613, DOI 10.1165/rcmb.2003-0236OC; DelMonaco M, 1997, J INVEST DERMATOL, V108, P938, DOI 10.1111/1523-1747.ep12295241; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028; FRIEDMAN DW, 1993, ANN SURG, V218, P754, DOI 10.1097/00000658-199312000-00009; Habermehl D, 2011, MOL ENDOCRINOL, V25, P1280, DOI 10.1210/me.2009-0380; Hardy RS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1993; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Manwani N, 2010, AM J RESP CELL MOL, V43, P599, DOI 10.1165/rcmb.2009-0263OC; Mariani TJ, 1997, EXP LUNG RES, V23, P131, DOI 10.3109/01902149709074026; MECHAM RP, 1984, J BIOL CHEM, V259, P2414; Oikarinen AI, BIOCH PHARM, V37, P1451; Parker MG, 1993, CURR OPIN CELL BIOL, V5, P499, DOI 10.1016/0955-0674(93)90016-J; PEREZ JR, 1992, J CELL BIOCHEM, V50, P26, DOI 10.1002/jcb.240500107; Pierce RA, 1995, CIBA F SYMP, V192, P199; Schneider JE, 2004, J MAGN RESON IMAGING, V20, P981, DOI 10.1002/jmri.20211; Speirs HJL, 2004, J ENDOCRINOL, V181, P105, DOI 10.1677/joe.0.1810105; Starcher BC, 2000, CHEST, V117, p229S, DOI 10.1378/chest.117.5_suppl_1.229S-a; SWEE MH, 1995, J BIOL CHEM, V270, P14899, DOI 10.1074/jbc.270.25.14899; Thompson A, 2004, J STEROID BIOCHEM, V88, P367, DOI 10.1016/j.jsbmb.2003.12.014; Tiganescu A, 2011, J INVEST DERMATOL, V131, P30, DOI 10.1038/jid.2010.257; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Vachharajani A, 2009, PEDIATR SURG INT, V25, P139, DOI 10.1007/s00383-008-2301-y; Wendel DP, 2000, AM J RESP CELL MOL, V23, P320, DOI 10.1165/ajrcmb.23.3.3906; Williams MC, 1996, AM J RESP CELL MOL, V14, P577, DOI 10.1165/ajrcmb.14.6.8652186; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	35	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63578	10.1371/journal.pone.0063578	http://dx.doi.org/10.1371/journal.pone.0063578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696835	gold, Green Published, Green Submitted			2022-12-27	WOS:000319081900043
J	Liu, XM; Yang, FF; Yuan, YF; Zhai, R; Huo, LJ				Liu, Xiao-Ming; Yang, Fei-Fei; Yuan, Yi-Feng; Zhai, Rui; Huo, Li-Jun			RETRACTED: SUMOylation of Mouse p53b by SUMO-1 Promotes Its Pro-Apoptotic Function in Ovarian Granulosa Cells (Retracted article. See vol. 16, 2021)	PLOS ONE			English	Article; Retracted Publication							FOLLICULAR DEVELOPMENT; IN-VITRO; GENE-EXPRESSION; C-JUN; DEATH; PROTEIN; FAMILY; GROWTH; BAX; TRANSACTIVATION	Follicular atresia is a process of spontaneous degradation of follicles, hindering growth and development in the mammalian ovary. Previous studies showed that follicular atresia was caused by apoptosis of granulosa cells, for which a number of apoptosis-related genes have already been identified. The roles of p53 in apoptosis of mouse granulosa cells and its post-translational modification are still unclear. The main objective of this study was to explore the roles of p53 in mouse granulosa cells. We found that mouse p53b, but not p53a, could be SUMOylated by SUMO-1 at lysine 375, which was essential for the protein stability of p53b in a dose-dependent manner. Immunofluorescent staining showed that wild p53b was located in the nucleus of granulosa cells, while its mutation of SUMOylated site (K375R) was localized in both nucleus and cytoplasm, implying that SUMOylation was necessary for the nuclear localization of p53b in granulosa cells. Overexpression of wild-type p53b, but not the mutation of SUMOylation site (K375R), significantly induced the expression of apoptosis-related gene, Bax, and increased the level of apoptosis in granulosa cells. This suggested that SUMO-1 modification of p53b was essential for inducing apoptosis in granulosa cells. Our results provide strong evidences that modification of p53b by SUMO-1 at lysine 375 was necessary for its activity to induce apoptosis in mouse granulosa cells, and it was involved in the regulation of p53b protein stability and nuclear localization. This implies that modification of p53b by SUMO-1 might regulate follicular atresia by inducing the apoptosis of ovarian granulosa cells in mice.	[Liu, Xiao-Ming; Yang, Fei-Fei; Yuan, Yi-Feng; Zhai, Rui; Huo, Li-Jun] Huazhong Agr Univ, Coll Anim Sci & Technol, Educ Minist China, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China	Huazhong Agricultural University	Huo, LJ (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Technol, Educ Minist China, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China.	huolijun@yahoo.com.cn			National Natural Science Foundation of China [31071273]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100146110011]; Fok Ying-Tong Education Foundation, China [121029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fok Ying-Tong Education Foundation, China(Fok Ying Tung Education Foundation)	This study was supported by National Natural Science Foundation of China (Grant No.31071273), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20100146110011), and the Fok Ying-Tong Education Foundation, China (Grant No. 121029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin E, 2000, BIOL SIGNAL RECEPT, V9, P87; Bakkers J, 2005, CELL CYCLE, V4, P790, DOI 10.4161/cc.4.6.1694; Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Bode AM, 2004, MUTAT RES-FUND MOL M, V555, P33, DOI 10.1016/j.mrfmmm.2004.05.018; Boone DL, 1997, BIOL REPROD, V57, P420, DOI 10.1095/biolreprod57.2.420; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Ghioni P, 2005, CELL CYCLE, V4, P183, DOI 10.4161/cc.4.1.1359; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; HAN KA, 1992, NUCLEIC ACIDS RES, V20, P1979, DOI 10.1093/nar/20.8.1979; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; Hu W, 2009, COLD SPRING HARBOR P, P1; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; HUGHES FM, 1991, ENDOCRINOLOGY, V129, P2415, DOI 10.1210/endo-129-5-2415; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; Jiang JY, 2003, FRONT BIOSCI-LANDMRK, V8, pD222, DOI 10.2741/949; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Kim JM, 1999, ENDOCRINOLOGY, V140, P2307, DOI 10.1210/en.140.5.2307; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kwek SSS, 2001, ONCOGENE, V20, P2587, DOI 10.1038/sj.onc.1204362; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Matsuda-Minehata F, 2008, ANIM SCI J, V79, P1, DOI [10.1111/j.1740-0929.2007.00491.x, 10.1111/j.1467-8381.2008.00272.x-i1]; Matsuda-Minehata F, 2006, J REPROD DEVELOP, V52, P695, DOI 10.1262/jrd.18069; Mauri F, 2008, J BIOL CHEM, V283, P20848, DOI 10.1074/jbc.M710186200; MEIKRANTZ W, 1995, J CELL BIOCHEM, V58, P160, DOI 10.1002/jcb.240580205; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Ruaro EM, 1997, P NATL ACAD SCI USA, V94, P4675, DOI 10.1073/pnas.94.9.4675; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; TILLY JL, 1991, ENDOCRINOLOGY, V129, P2799, DOI 10.1210/endo-129-5-2799; TILLY JL, 1995, ENDOCRINOLOGY, V136, P232, DOI 10.1210/en.136.1.232; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Yang XM, 2009, J BIOL CHEM, V284, P18588, DOI 10.1074/jbc.C109.001560	51	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63680	10.1371/journal.pone.0063680	http://dx.doi.org/10.1371/journal.pone.0063680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696846	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900052
J	Ma, LL; Tai, XH; Su, LY; Shi, LJ; Wang, EH; Qin, L				Ma, Lanlan; Tai, Xuhui; Su, Liye; Shi, Lijuan; Wang, Enhua; Qin, Ling			The Neuronal Responses to Repetitive Acoustic Pulses in Different Fields of the Auditory Cortex of Awake Rats	PLOS ONE			English	Article							AMPLITUDE-MODULATION; TEMPORAL INFORMATION; CORTICAL FIELDS; GUINEA-PIGS; ALBINO-RAT; STIMULI; SYSTEM; ORGANIZATION; SOUND; CAT	Cortical representation of time-varying features of acoustic signals is a fundamental issue of acoustic processing remaining unresolved. The rat is a widely used animal model for auditory cortical processing. Though some electrophysiological studies have investigated the neural responses to temporal repetitive sounds in the auditory cortex (AC) of rats, most of them were conducted under anesthetized condition. Recently, it has been shown that anesthesia could significantly alter the temporal patterns of neural response. For this reason, we systematically examined the single-unit neural responses to click-trains in the core region of rat AC under awake condition. Consistent with the reports on anesthetized rats, we confirmed the existence of characteristic tonotopic organizations, which were used to divide the AC into anterior auditory field (AAF), primary auditory cortex (A1) and posterior auditory field (PAF). We further found that the neuron's capability to synchronize to the temporal repetitive stimuli progressively decreased along the anterior-to-posterior direction of AC. The median of maximum synchronization rate was 64, 32 and 16 Hz in AAF, A1 and PAF, respectively. On the other hand, the percentage of neurons, which showed non-synchronized responses and could represent the stimulus repetition rate by the mean firing rate, increased from 7% in AAF and A1 to 20% in PAF. These results suggest that the temporal resolution of acoustic processing gradually increases from the anterior to posterior part of AC, and thus there may be a hierarchical stream along this direction of rat AC.	[Ma, Lanlan; Su, Liye; Shi, Lijuan; Qin, Ling] China Med Univ, Dept Physiol, Shenyang, Peoples R China; [Tai, Xuhui] 463rd Hosp PLA, Dept Otolaryngol, Shenyang, Peoples R China; [Wang, Enhua; Qin, Ling] China Med Univ, Inst Pathol & Pathophysiol, Shenyang, Peoples R China; [Qin, Ling] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Physiol, Chuo, Yamanashi, Japan	China Medical University; China Medical University; University of Yamanashi	Qin, L (corresponding author), China Med Univ, Dept Physiol, Shenyang, Peoples R China.	qinlingling@yahoo.com			National Nature Science Foundation of China [30970979, 31171057]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China under Grant No. 30970979 and 31171057 (LQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2006, HEARING RES, V213, P107, DOI 10.1016/j.heares.2005.12.011; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; BULLIER J, 1995, CURR OPIN NEUROBIOL, V5, P497, DOI 10.1016/0959-4388(95)80011-5; Camalier CR, 2012, P NATL ACAD SCI USA, V109, P18168, DOI 10.1073/pnas.1206387109; Carrasco A, 2011, J NEUROPHYSIOL, V106, P1166, DOI 10.1152/jn.00940.2010; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Eggermont JJ, 1998, J NEUROPHYSIOL, V80, P2743, DOI 10.1152/jn.1998.80.5.2743; Eggermont JJ, 2001, HEARING RES, V157, P1, DOI 10.1016/S0378-5955(01)00259-3; Gaese BH, 2003, EUR J NEUROSCI, V18, P2638, DOI 10.1046/j.1460-9568.2003.03007.x; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Huetz C, 2009, J NEUROSCI, V29, P334, DOI 10.1523/JNEUROSCI.3269-08.2009; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; KALTWASSER MT, 1990, J COMP PSYCHOL, V104, P227, DOI 10.1037/0735-7036.104.3.227; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; Lu T, 2000, J NEUROPHYSIOL, V84, P236, DOI 10.1152/jn.2000.84.1.236; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; Malone BJ, 2007, J NEUROPHYSIOL, V98, P1451, DOI 10.1152/jn.01203.2006; Mardia KV, 2000, DIRECTIONAL STAT; Oshurkova E, 2008, NEUROSCIENCE, V153, P1289, DOI 10.1016/j.neuroscience.2008.03.030; Pandya PK, 2008, CEREB CORTEX, V18, P301, DOI 10.1093/cercor/bhm055; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Profant O, 2013, HEARING RES, V296, P51, DOI 10.1016/j.heares.2012.11.021; RAIGUEL SE, 1989, BRAIN RES, V493, P155, DOI 10.1016/0006-8993(89)91010-X; Rennaker RL, 2007, NEUROSCIENCE, V145, P357, DOI 10.1016/j.neuroscience.2006.11.043; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Rutkowski RG, 2003, HEARING RES, V181, P116, DOI 10.1016/S0378-5955(03)00182-5; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; Steinschneider M, 1998, J ACOUST SOC AM, V104, P2935, DOI 10.1121/1.423877; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Syka J, 2005, HEARING RES, V206, P177, DOI 10.1016/j.heares.2005.01.013; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Yin PB, 2011, J NEUROPHYSIOL, V105, P582, DOI 10.1152/jn.00621.2010	36	11	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64288	10.1371/journal.pone.0064288	http://dx.doi.org/10.1371/journal.pone.0064288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696877	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900080
J	Ho, YY; Fang, YP; Chou, CH; Cheng, HC; Chang, HW				Ho, Ying-Yi; Fang, Yin-Ping; Chou, Cheng-Han; Cheng, Hsi-Chi; Chang, Hsueh-Wen			High Duty Cycle to Low Duty Cycle: Echolocation Behaviour of the Hipposiderid Bat Coelops frithii	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; EVOLUTION; CALLS; DISCRIMINATION; CHIROPTERA; MAMMALIA; SOUNDS; PREY	Laryngeally echolocating bats avoid self-deafening (forward masking) by separating pulse and echo either in time using low duty cycle (LDC) echolocation, or in frequency using high duty cycle (HDC) echolocation. HDC echolocators are specialized to detect fluttering targets in cluttered environments. HDC echolocation is found only in the families Rhinolophidae and Hipposideridae in the Old World and in the New World mormoopid, Pteronotus parnellii. Here we report that the hipposiderid Coelops frithii, ostensibly an HDC bat, consistently uses an LDC echolocation strategy whether roosting, flying, or approaching a fluttering target rotating at 50 to 80 Hz. We recorded the echolocation calls of free-flying C. frithii in the field in various situations, including presenting bats with a mechanical fluttering target. The echolocation calls of C. frithii consisted of an initial narrowband component (0.5 +/- 0.3 ms, 90.6 +/- 2.0 kHz) followed immediately by a frequency modulated (FM) sweep (194 to 113 kHz). This species emitted echolocation calls at duty cycles averaging 7.7 +/- 2.8% (n = 87 sequences). Coelops frithii approached fluttering targets more frequently than did LDC bats (C. frithii, approach frequency = 40.4%, n = 80; Myotis spp., approach frequency = 0%, n = 13), and at the same frequency as sympatrically feeding HDC species (Hipposideros armiger, approach rate = 53.3%, n = 15; Rhinolophus monoceros, approach rate = 56.7%, n = 97). We propose that the LDC echolocation strategy used by C. frithii is derived from HDC ancestors, that this species adjusts the harmonic contents of its echolocation calls, and that it may use both the narrowband component and the FM sweep of echolocations calls to detect fluttering targets.	[Ho, Ying-Yi; Chang, Hsueh-Wen] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Fang, Yin-Ping] Natl Chiayi Univ, Dept Biol Resources, Chiayi, Taiwan; [Chou, Cheng-Han] Aletheia Univ, Dept Leisure & Recreat Studies, Tainan, Taiwan; [Chou, Cheng-Han; Cheng, Hsi-Chi] Endem Species Res Inst, Nantou, Taiwan	National Sun Yat Sen University; National Chiayi University; Aletheia University	Chang, HW (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan.	hwchang@mail.nsysu.edu.tw			Taiwan National Science Council; Forestry Bureau	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Forestry Bureau	Financial support was provided by the Taiwan National Science Council (for HWC) and the Forestry Bureau (for YPF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates P, 2008, IUCN 2012 IUCN RED L, DOI 10.2305/IUCN.UK.2008.RLTS.T20521A9210732.en; Bogdanowicz Wieslaw, 1998, P27; Fenton MB, 2012, J EXP BIOL, V215, P2935, DOI 10.1242/jeb.073171; FENTON MB, 1995, PALEOBIOLOGY, V21, P229, DOI 10.1017/S0094837300013221; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Grossetete A, 1998, J ACOUST SOC AM, V103, P2167, DOI 10.1121/1.421362; Hand Suzanne J., 1998, P72; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Kossl M, 1999, J COMP PHYSIOL A, V185, P217, DOI 10.1007/s003590050381; Lazure L, 2011, J EXP BIOL, V214, P1131, DOI 10.1242/jeb.048967; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Li G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000900; Li G, 2007, J MAMMAL, V88, P736, DOI 10.1644/06-MAMM-A-273R.1; Liu Sen, 2008, Zoological Research, V29, P95; MOSS CF, 1994, J ACOUST SOC AM, V95, P2745, DOI 10.1121/1.409843; Murray SW, 2012, MOL PHYLOGENET EVOL, V62, P597, DOI 10.1016/j.ympev.2011.10.021; Neuweiler G, 2003, J COMP PHYSIOL A, V189, P245, DOI 10.1007/s00359-003-0406-2; Schnitzler H-U., 2004, ECHOLOCATION BATS DO, P331; Schnitzler HU, 2011, J COMP PHYSIOL A, V197, P541, DOI 10.1007/s00359-010-0569-6; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Shen B, 2011, J MOL EVOL, V73, P109, DOI 10.1007/s00239-011-9460-5; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Simmons NB, 1998, B AM MUS NAT HIST, P4; Skowronski MD, 2008, J ACOUST SOC AM, V123, P2643, DOI 10.1121/1.2896752; SUM YW, 1988, J COMP PHYSIOL A, V163, P349, DOI 10.1007/BF00604010; Thomas JA, 2004, ECHOLOCATION BATS DO; Zhang LB, 2009, ACTA CHIROPTEROL, V11, P71, DOI 10.3161/150811009X465703	30	9	9	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e62938	10.1371/journal.pone.0062938	http://dx.doi.org/10.1371/journal.pone.0062938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717396	gold, Green Published, Green Submitted			2022-12-27	WOS:000319385300040
J	Kondo, Y; Kato, T; Kimura, O; Iwata, T; Ninomiya, M; Kakazu, E; Miura, M; Akahane, T; Miyazaki, Y; Kobayashi, T; Ishii, M; Kisara, N; Sasaki, K; Nakayama, H; Igarashi, T; Obara, N; Ueno, Y; Morosawa, T; Shimosegawa, T				Kondo, Yasuteru; Kato, Takanobu; Kimura, Osamu; Iwata, Tomoaki; Ninomiya, Masashi; Kakazu, Eiji; Miura, Masahito; Akahane, Takehiro; Miyazaki, Yutaka; Kobayashi, Tomoo; Ishii, Motoyasu; Kisara, Norihiro; Sasaki, Kumiko; Nakayama, Haruo; Igarashi, Takehiko; Obara, Noriyuki; Ueno, Yoshiyuki; Morosawa, Tatsuki; Shimosegawa, Tooru			1(OH) Vitamin D3 Supplementation Improves the Sensitivity of the Immune-Response during Peg-IFN/RBV Therapy in Chronic Hepatitis C Patients-Case Controlled Trial	PLOS ONE			English	Article							VIROLOGICAL RESPONSE; D-RECEPTOR; IL28B POLYMORPHISMS; DENDRITIC CELLS; T-CELLS; MONOCYTE; EXPRESSION; VIRUS; INTERFERON; PROLIFERATION	Objective: 1,25(OH)(2) vitamin D3 can affect immune cells. However, the mechanism responsible for the favorable effects of 1(OH) vitamin D3, which becomes 1,25(OH)(2) vitamin D3 in the liver, is not clear. The aim of this study is to analyze the immunological response of 1(OH) vitamin D3 supplementation in CH-C patients. Design: Forty-two CH-C patients were treated with 1(OH) vitamin D3/Peg-IFN alpha/RBV. Forty-two case-matched controls were treated with Peg-IFN alpha/RBV. The expression of Interferon-stimulated genes (ISGs)-mRNA in the liver biopsy samples and JFH-1 replicating Huh-7 cells were quantified by real-time PCR. Ten kinds of cytokines in the plasma were quantified during treatment by using a suspension beads array. A trans-well co-culture system with peripheral blood mononuclear cells (PBMCs) and Huh-7 cells was used to analyze the effect of 1(OH) vitamin D3. The activities of the Th1 response were compared between subjects treated with 1(OH) vitamin D3/Peg-IFN/RBV and those treated with Peg-IFN/RBV therapy alone. Results: 1(OH) vitamin D3/Peg-IFN/RBV treatment could induce rapid viral reduction, especially in IL28B T/T polymorphism. Several kinds of cytokines including IP-10 were significantly decreased after 4 weeks of 1(OH) vitamin D3 treatment (p<0.05). Th1 responses in the subjects treated with 1(OH) vitamin D3/Peg-IFN/RBV were significantly higher than those treated with Peg-IFN/RBV at 12 weeks after Peg-IFN/RBV therapy (p<0.05). The expression of ISGs in the patient's liver biopsy samples was significantly lower than in those treated without 1(OH) vitamin D3 (p<0.05). Conclusion: 1(OH) vitamin D3 could improve the sensitivity of Peg-IFN/RBV therapy on HCV-infected hepatocytes by reducing the IP-10 production from PBMCs and ISGs expression in the liver.	[Kondo, Yasuteru; Kimura, Osamu; Iwata, Tomoaki; Ninomiya, Masashi; Kakazu, Eiji; Morosawa, Tatsuki; Shimosegawa, Tooru] Tohoku Univ Hosp, Div Gastroenterol, Sendai, Miyagi, Japan; [Kato, Takanobu] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Miura, Masahito] South Miyagi Med Ctr, Dept Gastroenterol, Oogawara Town, Japan; [Akahane, Takehiro] Ishinomiki Red Cross Hosp, Dept Gastroenterol, Ishinomaki, Japan; [Miyazaki, Yutaka] Kosai Hosp, Dept Gastroenterol, Sendai, Miyagi, Japan; [Kobayashi, Tomoo] Rosai Hosp, Dept Gastroenterol, Sendai, Miyagi, Japan; [Ishii, Motoyasu; Kisara, Norihiro; Sasaki, Kumiko] Miyagi Shakai Hoken Hop, Dept Gastroenterol, Sendai, Miyagi, Japan; [Nakayama, Haruo] Iwaki Kyoritsu Hosptal, Dept Gastroenterol, Iwaki, Fukushima, Japan; [Igarashi, Takehiko] Oosaki Citizen Hoptial, Dept Gastroenterol, Oosaki City, Japan; [Obara, Noriyuki] Iwate Cent Hosp, Dept Gastroenterol, Morioka, Iwate, Japan; [Ueno, Yoshiyuki] Yamagata Univ, Sch Med, Dept Gastroenterol, Yamagata 99023, Japan	Tohoku University; National Institute of Infectious Diseases (NIID); Iwate Prefectural Central Hospital; Yamagata University	Kondo, Y (corresponding author), Tohoku Univ Hosp, Div Gastroenterol, Sendai, Miyagi, Japan.	yasuteru@ebony.plala.or.jp	Kondo, Yasuteru/A-6893-2010; obara, noriyuki/GLT-9922-2022; Ueno, Yoshiyuki/R-9242-2019	Kondo, Yasuteru/0000-0001-5935-4346; Ueno, Yoshiyuki/0000-0001-5623-4250	Ministry of Education, Culture, Sport, Science, and Technology of Japan [23790761]; Japan Society of Hepatology (JSH)	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society of Hepatology (JSH)	This work was supported in part by a Grant-in Aid from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (YK #23790761) and Grant from The Japan Society of Hepatology (JSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399; Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Abu-Mouch S, 2011, WORLD J GASTROENTERO, V17, P5184, DOI 10.3748/wjg.v17.i47.5184; Abu-Mouch SM, 2009, HEPATOLOGY, V50, p12A; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Barchetta I, 2012, HEPATOLOGY, V56, P2180, DOI 10.1002/hep.25930; Bartosik-Psujek H, 2010, MULT SCLER, V16, P1513, DOI 10.1177/1352458510379611; Bitetto D, 2011, HEPATOLOGY, V53, P1118, DOI 10.1002/hep.24201; Bitetto D, 2011, TRANSPL INT, V24, P43, DOI 10.1111/j.1432-2277.2010.01141.x; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; DeLuca H F, 1977, Adv Clin Chem, V19, P125, DOI 10.1016/S0065-2423(08)60172-9; DeLuca H F, 1977, Adv Exp Med Biol, V81, P195; DELUCA HF, 1977, CLIN ENDOCRINOL, V7, pS1, DOI 10.1111/j.1365-2265.1977.tb03356.x; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Du T, 2009, CLIN CHIM ACTA, V402, P133, DOI 10.1016/j.cca.2008.12.038; Edfeldt K, 2010, P NATL ACAD SCI USA, V107, P22593, DOI 10.1073/pnas.1011624108; Fattovich G, 2011, ALIMENT PHARM THER, V33, P1162, DOI 10.1111/j.1365-2036.2011.04635.x; Gal-Tanamy M, 2011, HEPATOLOGY, V54, P1570, DOI 10.1002/hep.24575; HADDAD JG, 1993, J CLIN INVEST, V91, P2552, DOI 10.1172/JCI116492; Hewison M, 2003, J IMMUNOL, V170, P5382, DOI 10.4049/jimmunol.170.11.5382; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Kakazu E, 2009, HEPATOLOGY, V50, P1936, DOI 10.1002/hep.23248; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Khoo AL, 2011, IMMUNOLOGY, V134, P459, DOI 10.1111/j.1365-2567.2011.03507.x; Kondo Y, 2007, VIROLOGY, V361, P161, DOI 10.1016/j.virol.2006.11.009; Kondo Y, 2011, J GASTROENTEROL, V46, P232, DOI 10.1007/s00535-010-0297-2; Kondo Y, 2009, J INFECT DIS, V199, P726, DOI 10.1086/596739; Machida K, 2008, J VIROL, V82, P6711, DOI 10.1128/JVI.02582-07; Mariani E, 1999, CLIN EXP IMMUNOL, V116, P19; Matsumura T, 2012, HEPATOLOGY; Mayne CG, 2011, EUR J IMMUNOL, V41, P822, DOI 10.1002/eji.201040632; Nimer A, 2012, WORLD J GASTROENTERO, V18, P800, DOI 10.3748/wjg.v18.i8.800; Petta S, 2012, ANTIVIR THER, V17, P823, DOI 10.3851/IMP2100; Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Schaalan MF, 2012, WORLD J GASTROENTERO, V18, P3738, DOI 10.3748/wjg.v18.i28.3738; Stio M, 2002, AM J GASTROENTEROL, V97, P679; Takahashi K, 2002, IMMUNOPHARM IMMUNOT, V24, P335, DOI 10.1081/IPH-120014721; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; XU H, 1993, SCAND J IMMUNOL, V38, P535, DOI 10.1111/j.1365-3083.1993.tb03237.x	42	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63672	10.1371/journal.pone.0063672	http://dx.doi.org/10.1371/journal.pone.0063672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717463	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600027
J	Boesby, L; Elung-Jensen, T; Strandgaard, S; Kamper, AL				Boesby, Lene; Elung-Jensen, Thomas; Strandgaard, Svend; Kamper, Anne-Lise			Eplerenone Attenuates Pulse Wave Reflection in Chronic Kidney Disease Stage 3-4-A Randomized Controlled Study	PLOS ONE			English	Article							ARTERIAL STIFFNESS INDEX; AORTIC STIFFNESS; BLOOD-PRESSURE; RENAL-DISEASE; HYPERTENSIVE PATIENTS; BLOCKER EPLERENONE; ALDOSTERONE; VELOCITY; SURVIVAL; IMPACT	Background: Patients with chronic kidney disease (CKD) have high cardiovascular mortality and morbidity associated with increased arterial stiffness. Plasma aldosterone levels are increased in CKD, and aldosterone has been found to increase vascular inflammation and fibrosis. It was hypothesized that aldosterone receptor inhibition with eplerenone could reduce arterial stiffness in CKD stage 3-4. Study Design: The design was randomized, open, parallel group. Measurements of arterial stiffness markers were undertaken at weeks 1 and 24. Intervention: 24 weeks of add-on treatment with 25-50 mg eplerenone or standard medication. Outcomes: Primary outcome parameter was carotid-femoral pulse wave velocity (cfPWV). Secondary outcomes were augmentation index (AIx), ambulatory arterial stiffness index (AASI) and urinary albumin excretion. Results: Fifty-four CKD patients ( mean eGFR 36 mL/min/1.73 m(2), SD 11) were randomized. Forty-six patients completed the trial. The mean difference in cfPWV changes between groups was 0.1 m/s (95%Cl: -1.0, 1.3), P = 0.8. The mean difference in AIx changes between groups was 4.4% (0.1, 8.6), P = 0.04. AASI was unchanged in both groups. The ratio of change in urinary albumin excretion in the eplerenone group compared to the control was 0.61 (0.37, 1.01), P = 0.05. Four patients were withdrawn from the eplerenone group including three because of possible side effects; one was withdrawn from the control group. Mild hyperkalemia was seen on three occasions and was easily managed. Limitations: The full planned number of patients was not attained. The duration of the trial may have been too short to obtain full effect of eplerenone on the arteries. Conclusions: Add-on treatment with eplerenone in CKD stage 3-4 did not significantly reduce cfPWV. There may be beneficial vascular effects leading to attenuated pulse wave reflection. Treatment was well-tolerated.	[Boesby, Lene; Strandgaard, Svend] Univ Copenhagen, Herlev Hosp, Dept Nephrol, DK-2730 Herlev, Denmark; [Elung-Jensen, Thomas; Kamper, Anne-Lise] Univ Copenhagen, Rigshosp, Dept Nephrol, DK-2100 Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	Boesby, L (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Nephrol, DK-2730 Herlev, Denmark.	lene@boesby.dk		Kamper, Anne-Lise/0000-0001-7523-6569	Danish Cardiovascular Research Academy	Danish Cardiovascular Research Academy	LB was the recipient of a research fellowship grant from the Danish Cardiovascular Research Academy. The work was further made possible by contributions from the following foundations: the Danish Kidney Association, the Danish Kidney Association in Viborg, the Danish Society of Nephrology, the Research Council of Copenhagen University Hospital Herlev, The Gangsted Foundation, and the foundations of Sophus and Astrid Jacobsen, Sigurd and Addie Abrahamson, Aase Bay, Jacob and Olga Madsen, Eva and Robert Voss Hansen, and Helen and Ejnar Bjornow. The SphygmoCor (R) apparatus was donated by the foundations of L. F. Foght and Frode V. Nyegaard and Toyota-Fonden, Denmark. Study medication was provided by the Department of Nephrology, Herlev Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmar RG, 2001, HYPERTENSION, V38, P922, DOI 10.1161/hy1001.095774; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Blacher J, 2002, CURR OPIN NEPHROL HY, V11, P629, DOI 10.1097/00041552-200211000-00010; Boesby L, 2012, SCAND J CLIN LAB INV, P1; Boesby L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026904; Bomback AS, 2007, NAT CLIN PRACT NEPHR, V3, P486, DOI 10.1038/ncpneph0575; Booth RE, 2002, ADV PHYSIOL EDUC, V26, P8, DOI 10.1152/advan.00051.2001; Borresen ML, 2007, AM J NEPHROL, V27, P240, DOI 10.1159/000101369; Briet M, 2010, NAT REV NEPHROL, V6, P261, DOI 10.1038/nrneph.2010.30; Brown NJ, 2008, HYPERTENSION, V51, P161, DOI 10.1161/HYPERTENSIONAHA.107.095489; Edwards NC, 2009, J AM COLL CARDIOL, V54, P505, DOI 10.1016/j.jacc.2009.03.066; Elung-Jensen T, 2008, NEPHROL DIAL TRANSPL, V23, P2873, DOI 10.1093/ndt/gfn126; Frimodt-Moller M, 2006, SCAND J CLIN LAB INV, V66, P385, DOI 10.1080/00365510600731332; Frimodt-Moller M, 2008, NEPHROL DIAL TRANSPL, V23, P594, DOI 10.1093/ndt/gfm470; Frimodt-Moller M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041757; Guerin AP, 2001, CIRCULATION, V103, P987; Hansen TW, 2008, J HUM HYPERTENS, V22, P214, DOI 10.1038/sj.jhh.1002295; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; HENE RJ, 1982, KIDNEY INT, V21, P98, DOI 10.1038/ki.1982.14; Janner JH, 2012, J HUM HYPERTENS, V26, P476, DOI 10.1038/jhh.2011.59; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li Y, 2006, BLOOD PRESS MONIT, V11, P107, DOI 10.1097/01.mbp.0000189791.90488.a1; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; Mourad JJ, 2001, KIDNEY INT, V59, P1834, DOI 10.1046/j.1523-1755.2001.0590051834.x; Nehme J, 2006, J RENIN-ANGIO-ALDO S, V7, P31, DOI 10.3317/jraas.2006.004; Ong KT, 2011, J HYPERTENS, V29, P1034, DOI 10.1097/HJH.0b013e328346a583; Savoia C, 2008, HYPERTENSION, V51, P432, DOI 10.1161/HYPERTENSIONAHA.107.103267; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Weber T, 2011, AM J HYPERTENS, V24, P762, DOI 10.1038/ajh.2011.45; White WB, 2003, HYPERTENSION, V41, P1021, DOI 10.1161/01.HYP.0000067463.13172.EA; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496	33	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64549	10.1371/journal.pone.0064549	http://dx.doi.org/10.1371/journal.pone.0064549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704994	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200148
J	Genard, B; Miner, P; Nicolas, JL; Moraga, D; Boudry, P; Pernet, F; Tremblay, R				Genard, Bertrand; Miner, Philippe; Nicolas, Jean-Louis; Moraga, Dario; Boudry, Pierre; Pernet, Fabrice; Tremblay, Rejean			Integrative Study of Physiological Changes Associated with Bacterial Infection in Pacific Oyster Larvae	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; INTERRUPTED FATTY-ACIDS; INNATE IMMUNE-RESPONSE; CRASSOSTREA-GIGAS; ANTIMICROBIAL PEPTIDES; MARINE-INVERTEBRATES; BIOCHEMICAL-CHANGES; MASSIVE MORTALITY; ARACHIDONIC-ACID; OSTREA-EDULIS	Background: Bacterial infections are common in bivalve larvae and can lead to significant mortality, notably in hatcheries. Numerous studies have identified the pathogenic bacteria involved in such mortalities, but physiological changes associated with pathogen exposure at larval stage are still poorly understood. In the present study, we used an integrative approach including physiological, enzymatic, biochemical, and molecular analyses to investigate changes in energy metabolism, lipid remodelling, cellular stress, and immune status of Crassostrea gigas larvae subjected to experimental infection with the pathogenic bacteria Vibrio coralliilyticus. Findings: Our results showed that V. coralliilyticus exposure induced (1) limited but significant increase of larvae mortality compared with controls, (2) declined feeding activity, which resulted in energy status changes (i.e. reserve consumption, beta-oxidation, decline of metabolic rate), (3) fatty acid remodeling of polar lipids (changes in phosphatidylinositol and lysophosphatidylcholine composition,non-methylene-interrupted fatty acids accumulation, lower content of major C-20 polyunsaturated fatty acids as well as activation of desaturases, phospholipase and lipoxygenase), (4) activation of antioxidant defenses (catalase, superoxide dismutase, peroxiredoxin) and cytoprotective processes (heat shock protein 70, pernin), and (5) activation of the immune response (non-self recognition, NF-(kappa kappa) signaling pathway, haematopoiesis, eiconosoids and lysophosphatidyl acid synthesis, inhibitor of metalloproteinase and antimicrobial peptides). Conclusion: Overall, our results allowed us to propose an integrative view of changes induced by a bacterial infection in Pacific oyster larvae, opening new perspectives on the response of marine bivalve larvae to infections.	[Genard, Bertrand; Tremblay, Rejean] Univ Quebec, Inst Sci Mer, Rimouski, PQ G5L 3A1, Canada; [Miner, Philippe; Nicolas, Jean-Louis; Boudry, Pierre; Pernet, Fabrice] IFREMER, Lab Sci Environm Marin LEMAR, Unite Rech Physiol Fonct Organismes Marins, F-29280 Plouzane, France; [Moraga, Dario] Univ Bretagne Occidentale, Inst Univ Europeen Mer, Lab Sci Environm Marin LEMAR, Plouzane, France	University of Quebec; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Genard, B (corresponding author), Univ Quebec, Inst Sci Mer, Rimouski, PQ G5L 3A1, Canada.	bertrand.genard@uqar.qc.ca	Tremblay, Rejean/A-4971-2013; Boudry, Pierre/M-3213-2019; Pernet, Fabrice/B-4051-2008; Boudry, Pierre/G-2406-2010	Tremblay, Rejean/0000-0003-2590-8915; Pernet, Fabrice/0000-0001-8886-0184; Boudry, Pierre/0000-0002-5150-2276	Natural Sciences and Engineering Research Council of Canada [299100]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the discovery grants program (individual, 299100) of the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKMAN RG, 1973, COMP BIOCHEM PHYSIOL, V46, P153, DOI 10.1016/0305-0491(73)90057-6; Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4; BACHERE E, 1995, AQUACULTURE, V132, P17, DOI 10.1016/0044-8486(94)00389-6; Bailey DM, 2005, PHYSIOL BIOCHEM ZOOL, V78, P335, DOI 10.1086/430042; Barnathan G, 2009, BIOCHIMIE, V91, P671, DOI 10.1016/j.biochi.2009.03.020; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Belzile C, 2008, J MARINE SYST, V74, P946, DOI 10.1016/j.jmarsys.2007.12.010; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown Drew C., 1993, Journal of Shellfish Research, V12, P135; Chaney ML, 2011, MOL ECOL, V20, P2942, DOI 10.1111/j.1365-294X.2011.05152.x; CHILDRESS JJ, 1979, MAR BIOL, V52, P273, DOI 10.1007/BF00398141; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; De Decker S, 2011, FISH SHELLFISH IMMUN, V30, P691, DOI 10.1016/j.fsi.2010.12.017; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; DELAUNAY F, 1992, J EXP MAR BIOL ECOL, V163, P209, DOI 10.1016/0022-0981(92)90050-K; DELAUNAY F, 1993, J EXP MAR BIOL ECOL, V173, P163, DOI 10.1016/0022-0981(93)90051-O; DEREWENDA ZS, 1994, ADV PROTEIN CHEM, V45, P1; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; ELSTON R, 1980, Proceedings National Shellfisheries Association, V70, P65; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Fleury E, 2012, MAR BIOTECHNOL, V14, P203, DOI 10.1007/s10126-011-9403-6; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Flye-Sainte-Marie J, 2007, J EXP MAR BIOL ECOL, V349, P378, DOI 10.1016/j.jembe.2007.05.029; Funk CD, 2006, ARTERIOSCL THROM VAS, V26, P1204, DOI 10.1161/01.ATV.0000222960.43792.ff; Geay F, 2010, COMP BIOCHEM PHYS B, V156, P237, DOI 10.1016/j.cbpb.2010.03.008; Genard B, 2012, GENE, V499, P70, DOI 10.1016/j.gene.2012.02.021; Genard B, 2011, AQUAT LIVING RESOUR, V24, P247, DOI 10.1051/alr/2011114; Gestal C, 2008, REV FISH SCI, V16, P133, DOI 10.1080/10641260802325518; Gnaiger E., 1983, CALCULATION ENERGETI, P337, DOI [10.1007/978-3-642-81863-9_30, DOI 10.1007/978-3-642-81863-9_30]; Gonzalez M, 2007, DEV COMP IMMUNOL, V31, P332, DOI 10.1016/j.dci.2006.07.006; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Gueguen Y, 2003, GENE, V303, P139, DOI 10.1016/S0378-1119(02)01149-6; Haberkorn H, 2010, HARMFUL ALGAE, V9, P427, DOI 10.1016/j.hal.2010.01.003; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; HOLLAND DL, 1973, J MAR BIOL ASSOC UK, V53, P287, DOI 10.1017/S002531540002227X; Hurtado MA, 2009, AQUACULTURE, V294, P300, DOI 10.1016/j.aquaculture.2009.06.009; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Jing X, 2011, FISH SHELLFISH IMMUN, V30, P851, DOI 10.1016/j.fsi.2011.01.007; Kabarowski JHS, 2002, BIOCHEM PHARMACOL, V64, P161, DOI 10.1016/S0006-2952(02)01179-6; Kerouel R, FEMS MICROBIOL ECOL; Kesarcodi-Watson A, 2012, AQUACULTURE, V344, P29, DOI 10.1016/j.aquaculture.2012.02.029; KLINGENSMITH JS, 1982, LIPIDS, V17, P976, DOI 10.1007/BF02534595; Koutsogiannaki S, 2010, ISJ-INVERT SURVIV J, V7, P11; Kraffe E, 2004, LIPIDS, V39, P59, DOI 10.1007/s11745-004-1202-x; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Labreuche Y, 2006, MICROBES INFECT, V8, P2715, DOI 10.1016/j.micinf.2006.07.020; Lambert C, 2007, AQUACULTURE, V270, P413, DOI 10.1016/j.aquaculture.2007.04.074; LANGDON CJ, 1981, J MAR BIOL ASSOC UK, V61, P431, DOI 10.1017/S0025315400047056; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P., 2012, DEV ENV MODELLING, V3; Linkous A, 2010, CELL MICROBIOL, V12, P1369, DOI 10.1111/j.1462-5822.2010.01505.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luna-Gonzalez A, 2004, FISH SHELLFISH IMMUN, V16, P287, DOI 10.1016/S1050-4648(03)00110-4; Mitta G, 2000, DEV COMP IMMUNOL, V24, P381, DOI 10.1016/S0145-305X(99)00084-1; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Montagnani C, 2008, DEV COMP IMMUNOL, V32, P182, DOI 10.1016/j.dci.2007.06.001; Montagnani C, 2007, DEV COMP IMMUNOL, V31, P1, DOI 10.1016/j.dci.2006.04.002; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P477, DOI 10.1051/alr:2004054; Pernet F, 2006, J EXP MAR BIOL ECOL, V329, P265, DOI 10.1016/j.jembe.2005.09.008; Pernet F, 2005, J EXP MAR BIOL ECOL, V327, P115, DOI 10.1016/j.jembe.2005.06.008; Pernet F, 2010, MAR ECOL PROG SER, V401, P129, DOI 10.3354/meps08407; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rico-Villa B, 2006, AQUACULTURE, V256, P377, DOI 10.1016/j.aquaculture.2006.02.015; Rosa RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025594; Samain JF, 2011, AQUAT LIVING RESOUR, V24, P227, DOI 10.1051/alr/2011144; Schmitt P, 2012, DEV COMP IMMUNOL, V37, P363, DOI 10.1016/j.dci.2012.01.004; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Scotti PD, 2001, COMP BIOCHEM PHYS B, V128, P767, DOI 10.1016/S1096-4959(01)00301-3; Seguineau C, 2011, COMP BIOCHEM PHYS A, V160, P87, DOI 10.1016/j.cbpa.2011.05.011; Sethu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010506; Sewell MA, 2005, MAR ECOL PROG SER, V304, P133, DOI 10.3354/meps304133; Shrestha S, 2010, DEV COMP IMMUNOL, V34, P530, DOI 10.1016/j.dci.2009.12.013; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Smith W.L., 2003, BIOCH LIPIDS LIPOPRO, V36, P341; Song LS, 2010, ADV EXP MED BIOL, V708, P44; STEWART JM, 1994, INVERTEBR REPROD DEV, V25, P73, DOI 10.1080/07924259.1994.9672370; Tanguy A, 2004, GENE, V338, P121, DOI 10.1016/j.gene.2004.05.019; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Tanji T, 2010, P NATL ACAD SCI USA, V107, P14715, DOI 10.1073/pnas.1009473107; Taris N, 2009, ANIM GENET, V40, P663, DOI 10.1111/j.1365-2052.2009.01894.x; Thomas-Guyon H, 2009, DEV COMP IMMUNOL, V33, P653, DOI 10.1016/j.dci.2008.11.011; Tirape A, 2007, DEV COMP IMMUNOL, V31, P859, DOI 10.1016/j.dci.2007.01.005; Tocher DR, 2006, LIPIDS, V41, P1003, DOI 10.1007/s11745-006-5051-4; Tunaz H, 2003, ARCH INSECT BIOCHEM, V52, P1, DOI 10.1002/arch.10056; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang SL, 2010, FISH SHELLFISH IMMUN, V29, P921, DOI 10.1016/j.fsi.2010.07.035; Yamaura K, 2008, COMP BIOCHEM PHYS B, V149, P168, DOI 10.1016/j.cbpb.2007.09.004; Zhang DC, 2011, DEV COMP IMMUNOL, V35, P1, DOI 10.1016/j.dci.2010.08.007	97	73	73	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64534	10.1371/journal.pone.0064534	http://dx.doi.org/10.1371/journal.pone.0064534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704993	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200147
J	Ho, SCL; Bardor, M; Li, B; Lee, JJ; Song, ZW; Tong, YW; Goh, LT; Yang, YS				Ho, Steven C. L.; Bardor, Muriel; Li, Bin; Lee, Jia Juan; Song, Zhiwei; Tong, Yen Wah; Goh, Lin-Tang; Yang, Yuansheng			Comparison of Internal Ribosome Entry Site (IRES) and Furin-2A (F2A) for Monoclonal Antibody Expression Level and Quality in CHO Cells	PLOS ONE			English	Article							ENCEPHALOMYOCARDITIS VIRUS-RNA; HEAVY-CHAIN; ENDOPLASMIC-RETICULUM; THERAPEUTIC LEVELS; STABLE EXPRESSION; TRANSLATION; VECTOR; SEQUENCE; EFFICIENCY; INITIATION	Four versions of tricistronic vectors expressing IgG1 light chain (LC), IgG1 heavy chain (HC), and dihydrofolate reductase (DHFR) in one transcript were designed to compare internal ribosome entry site (IRES) and furin-2A (F2A) for their influence on monoclonal antibody (mAb) expression level and quality in CHO DG44 cells. LC and HC genes are arranged as either the first or the second cistron. When using mAb quantification methods based on the detection antibodies against HC Fc region, F2A-mediated tricistronic vectors appeared to express mAb at higher levels than the IRES-mediated tricistronic vectors in both transient and stable transfections. Further analysis revealed that more than 40% of products detected in stably transfected pools generated using the two F2A-mediated tricistronic vectors were aggregates. LC and HC from the F2A stably transfected pools were not properly processed, giving rise to LC+F2A+HC or HC+F2A+LC fusion proteins, LC and HC polypeptides with F2A remnants, and incorrectly cleaved signal peptides. Both IRES-mediated tricistronic vectors express mAb with correct sizes and signal peptide cleavage. Arrangement of LC as the first cistron in the IRES-mediated tricistronic vectors exhibits increased mAb expression level, better growth, and minimized product aggregation, while arrangement of HC as first cistron results in low expression, slower growth, and high aggregation. The results obtained will be beneficial for designing vectors that enhance mAb expression level and quality in mammalian cells.	[Ho, Steven C. L.; Bardor, Muriel; Li, Bin; Lee, Jia Juan; Song, Zhiwei; Goh, Lin-Tang; Yang, Yuansheng] Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore, Singapore; [Bardor, Muriel] Univ Rouen, Lab Glyco MEV Glycobiol & Matrice Extracellulaire, Mont St Aignan, France; [Tong, Yen Wah] Natl Univ Singapore, Dept Chem & Biomol Engn, Dept Bioengn, Singapore 117548, Singapore; [Yang, Yuansheng] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Universite de Rouen Normandie; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yang, YS (corresponding author), Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore, Singapore.	yang_yuansheng@bti.a-star.edu.sg	Tong, Yen Wah/D-4602-2009	Tong, Yen Wah/0000-0002-6004-6284; Ho, Steven C.L./0000-0002-5582-9057	Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore	Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, NAT BIOTECHNOL, V28, P1165, DOI 10.1038/nbt1110-1165; Barnes LM, 2007, BIOTECHNOL BIOENG, V96, P337, DOI 10.1002/bit.21119; Birch JR, 2006, ADV DRUG DELIVER REV, V58, P671, DOI 10.1016/j.addr.2005.12.006; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; Camper N, 2011, J IMMUNOL METHODS, V372, P30, DOI 10.1016/j.jim.2011.06.029; Chan HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028885; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Costa AR, 2010, EUR J PHARM BIOPHARM, V74, P127, DOI 10.1016/j.ejpb.2009.10.002; DAVIES MV, 1992, J VIROL, V66, P1924, DOI 10.1128/JVI.66.4.1924-1932.1992; Davies SL, 2011, BIOTECHNOL PROGR, V27, P1689, DOI 10.1002/btpr.692; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Doronina VA, 2008, BIOCHEM SOC T, V36, P712, DOI 10.1042/BST0360712; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200; Fang JM, 2007, MOL THER, V15, P1153, DOI 10.1038/sj.mt.6300142; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Gonzalez R, 2002, J THEOR BIOL, V214, P529, DOI 10.1006/jtbi.2001.2478; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Ho SCL, 2012, J BIOTECHNOL, V157, P130, DOI 10.1016/j.jbiotec.2011.09.023; Houdebine LM, 1999, TRANSGENIC RES, V8, P157, DOI 10.1023/A:1008909908180; Jiang Z, 2006, BIOTECHNOL PROGR, V22, P313, DOI 10.1021/bp0501524; Jostock T, 2004, J IMMUNOL METHODS, V289, P65, DOI 10.1016/j.jim.2004.03.014; Jostock T, 2010, APPL MICROBIOL BIOT, V87, P1517, DOI 10.1007/s00253-010-2625-0; KAMINSKI A, 1990, EMBO J, V9, P3753, DOI 10.1002/j.1460-2075.1990.tb07588.x; KAMINSKI A, 1994, EMBO J, V13, P1673, DOI 10.1002/j.1460-2075.1994.tb06431.x; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; Kim SJ, 1998, BIOTECHNOL BIOENG, V58, P73, DOI 10.1002/(SICI)1097-0290(19980405)58:1<73::AID-BIT8>3.0.CO;2-R; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee CJ, 2009, BIOTECHNOL BIOENG, V102, P1107, DOI 10.1002/bit.22126; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; LENNY N, 1991, J BIOL CHEM, V266, P20532; Li JD, 2007, PROTEIN ENG DES SEL, V20, P491, DOI 10.1093/protein/gzm038; Li JD, 2007, J IMMUNOL METHODS, V318, P113, DOI 10.1016/j.jim.2006.10.010; Li M, 2012, MOL THER, V20, P46, DOI 10.1038/mt.2011.197; Martin P, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-4; Mielke C, 2000, GENE, V254, P1, DOI 10.1016/S0378-1119(00)00294-8; MOUNTFORD PS, 1995, TRENDS GENET, V11, P179, DOI 10.1016/S0168-9525(00)89040-X; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Ng SK, 2007, METAB ENG, V9, P304, DOI 10.1016/j.ymben.2007.01.001; Ng SK, 2010, BIOTECHNOL PROGR, V26, P11, DOI 10.1002/btpr.281; NOTHWEHR SF, 1990, J BIOL CHEM, V265, P17202; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qiao J, 2002, HUM GENE THER, V13, P881, DOI 10.1089/10430340252899046; Rees S, 1996, BIOTECHNIQUES, V20, P102; Schlatter S, 2005, BIOTECHNOL PROGR, V21, P122, DOI 10.1021/bp049780w; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1983, J CELL BIOL, V97, P1693, DOI 10.1083/jcb.97.6.1693; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	54	41	50	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63247	10.1371/journal.pone.0063247	http://dx.doi.org/10.1371/journal.pone.0063247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704898	Green Published, gold			2022-12-27	WOS:000319330200027
J	Kaihatsu, K; Sawada, S; Nakamura, S; Nakaya, T; Yasunaga, T; Kato, N				Kaihatsu, Kunihiro; Sawada, Shinjiro; Nakamura, Shota; Nakaya, Takaaki; Yasunaga, Teruo; Kato, Nobuo			Sequence-Specific and Visual Identification of the Influenza Virus NS Gene by Azobenzene-Tethered Bis-Peptide Nucleic Acid	PLOS ONE			English	Article							DUPLEX DNA; PNA; TRANSCRIPTION; RECOGNITION; INHIBITION; BINDING	To rapidly and specifically identify highly virulent influenza virus strains, we prepared an azobenzene-tethered hairpin-type peptide nucleic acid, bisPNA-AZO, which has a complementary sequence against a highly conserved genomic RNA sequence within the ribonucleoprotein complex of the 2009 pandemic influenza A virus, H1N1 subtype. bisPNA-AZO recognizes the conserved virus genome sequence in a sequence-specific manner. Immobilization of bisPNA-AZO on a plate allowed capture of the target virus gene and the generation of a visual colour signal.	[Kaihatsu, Kunihiro; Sawada, Shinjiro; Kato, Nobuo] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Nakamura, Shota; Yasunaga, Teruo] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Nakaya, Takaaki] Kyoto Prefectural Univ Med, Dept Infect Dis, Kyoto, Japan	Osaka University; Osaka University; Kyoto Prefectural University of Medicine	Kaihatsu, K (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka, Japan.	Kunihiro@sanken.osaka-u.ac.jp	Nakamura, Shota/E-3033-2010	Nakamura, Shota/0000-0003-2058-5942	National Institute of Biomedical Innovation Research Grant [09-23];  [22750155]	National Institute of Biomedical Innovation Research Grant; 	This research was supported by by a National Institute of Biomedical Innovation Research Grant (09-23 to KK) and by a Grant-in-Aid for Scientific Research (B) (22750155 to KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daum LT, 2007, INFLUENZA OTHER RESP, V1, P167, DOI 10.1111/j.1750-2659.2007.00024.x; DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Hamilton SE, 1996, BIOORG MED CHEM LETT, V6, P2897, DOI 10.1016/S0960-894X(96)00538-0; Kaihatsu K, 2003, BIOCHEMISTRY-US, V42, P13996, DOI 10.1021/bi035194k; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KEMLER I, 1994, VIROLOGY, V202, P1028, DOI 10.1006/viro.1994.1432; Kuhn H, 1999, J MOL BIOL, V286, P1337, DOI 10.1006/jmbi.1998.2578; Kummer S, 2011, ANGEW CHEM INT EDIT, V50, P1931, DOI 10.1002/anie.201005902; LEE BW, 1993, J VIROL METHODS, V45, P121, DOI 10.1016/0166-0934(93)90097-B; Liang XG, 2003, J AM CHEM SOC, V125, P16408, DOI 10.1021/ja037248j; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Palese P., 2007, FIELDS VIROLOGY, P1647; Sawada S, 2012, CURR PHARM BIOTECHNO, V13, P2642, DOI 10.2174/138920101314151120122912; Wang W, 2008, NUCLEIC ACIDS RES, V36, P4913, DOI 10.1093/nar/gkn475	16	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64017	10.1371/journal.pone.0064017	http://dx.doi.org/10.1371/journal.pone.0064017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704970	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200105
J	Kakkar, AK; Mueller, I; Bassand, JP; Fitzmaurice, DA; Goldhaber, SZ; Goto, S; Haas, S; Hacke, W; Lip, GYH; Mantovani, LG; Turpie, AGG; van Eickels, M; Misselwitz, F; Rushton-Smith, S; Kayani, G; Wilkinson, P; Verheugt, FWA				Kakkar, Ajay K.; Mueller, Iris; Bassand, Jean-Pierre; Fitzmaurice, David A.; Goldhaber, Samuel Z.; Goto, Shinya; Haas, Sylvia; Hacke, Werner; Lip, Gregory Y. H.; Mantovani, Lorenzo G.; Turpie, Alexander G. G.; van Eickels, Martin; Misselwitz, Frank; Rushton-Smith, Sophie; Kayani, Gloria; Wilkinson, Peter; Verheugt, Freek W. A.		GARFIELD Registry Investigators	Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry	PLOS ONE			English	Article							EURO HEART SURVEY; ACC/AHA/ESC 2006 GUIDELINES; PREDICTING STROKE; TASK-FORCE; MANAGEMENT; WARFARIN; PREVALENCE; SOCIETY; THROMBOEMBOLISM; PROGNOSIS	Background: Limited data are available on the characteristics, clinical management, and outcomes of patients with atrial fibrillation at risk of stroke, from a worldwide perspective. The aim of this study was to describe the baseline characteristics and initial therapeutic management of patients with non-valvular atrial fibrillation across the spectrum of sites at which these patients are treated. Methods and Findings: The Global Anticoagulant Registry in the FIELD (GARFIELD) is an observational study of patients newly diagnosed with non-valvular atrial fibrillation. Enrollment into Cohort 1 (of 5) took place between December 2009 and October 2011 at 540 sites in 19 countries in Europe, Asia-Pacific, Central/South America, and Canada. Investigator sites are representative of the distribution of atrial fibrillation care settings in each country. Cohort 1 comprised 10,614 adults (>= 18 years) diagnosed with non-valvular atrial fibrillation within the previous 6 weeks, with >= 1 investigator-defined stroke risk factor (not limited to those in existing risk-stratification schemes), and regardless of therapy. Data collected at baseline included demographics, medical history, care setting, nature of atrial fibrillation, and treatments initiated at diagnosis. The mean (SD) age of the population was 70.2 (11.2) years; 43.2% were women. Mean +/- SD CHADS(2) score was 1.9 +/- 1.2, and 57.2% had a score >= 2. Mean CHA(2)DS(2)-VASc score was 3.2 +/- 1.6, and 8,957 (84.4%) had a score >= 2. Overall, 38.0% of patients with a CHADS(2) score >= 2 did not receive anticoagulant therapy, whereas 42.5% of those at low risk (score 0) received anticoagulant therapy. Conclusions: These contemporary observational worldwide data on non-valvular atrial fibrillation, collected at the end of the vitamin K antagonist-only era, indicate that these drugs are frequently not being used according to stroke risk scores and guidelines, with overuse in patients at low risk and underuse in those at high risk of stroke.	[Kakkar, Ajay K.; Mueller, Iris; Rushton-Smith, Sophie; Kayani, Gloria] Thrombosis Res Inst, London SW3 6LR, England; [Kakkar, Ajay K.] UCL, London, England; [Bassand, Jean-Pierre] Univ Hosp Jean Minjoz, Dept Cardiol, Besancon, France; [Fitzmaurice, David A.] Univ Birmingham, Birmingham, W Midlands, England; [Goldhaber, Samuel Z.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Goldhaber, Samuel Z.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Goto, Shinya] Tokai Univ, Dept Med, Kanagawa 2591100, Japan; [Haas, Sylvia] Tech Univ Munich, Dept Med, D-80290 Munich, Germany; [Hacke, Werner] Univ Heidelberg Hosp, Dept Neurol, Heidelberg, Germany; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Mantovani, Lorenzo G.] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Naples, Italy; [Turpie, Alexander G. G.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [van Eickels, Martin; Misselwitz, Frank] Bayer HealthCare Pharmaceut, Berlin, Germany; [Wilkinson, Peter] Wilkinson Associates, Radnage, Bucks, England; [Verheugt, Freek W. A.] Onze Lieve Vrouw Hosp, Dept Cardiol, Amsterdam, Netherlands	Thrombosis Research Institute; University of London; University College London; Universite de Franche-Comte; CHU Besancon; University of Birmingham; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Tokai University; Technical University of Munich; Ruprecht Karls University Heidelberg; University of Birmingham; University of Naples Federico II; McMaster University; Bayer AG; Bayer Healthcare Pharmaceuticals; Onze Lieve Vrouwe Gasthuis Hospital	Kakkar, AK (corresponding author), Thrombosis Res Inst, London SW3 6LR, England.	akkakkar@tri-london.ac.uk	Verheugt, F.W.A./H-8105-2014; Epelde, Francisco/AAT-7213-2021; Goto, Shinya/AAU-6045-2020; Hacke, Werner/ABE-8661-2020; Kaynar, Leylagul/F-6991-2013; Mantovani, Lorenzo Giovanni/AAC-4263-2021	Epelde, Francisco/0000-0001-5547-4025; Goto, Shinya/0000-0002-6821-1504; Kaynar, Leylagul/0000-0002-2035-9462; Mantovani, Lorenzo Giovanni/0000-0003-3866-8199; Maria del Mar, Rodriguez/0000-0002-3588-5449	Thrombosis Research Institute, London, UK; Bayer Pharma AG, Berlin, Germany; Bayer HealthCare; sanofi-aventis; Boehringer Ingelheim (BI); Pfizer; Bristol Myers Squibb (BMS); Eisai; Bayer; Eli Lilly; Iroko; Astra Zeneca; GSK; EKOS; Johnson Johnson; Otsuka; Daiichi-Sankyo; Novartis; AstraZeneca; Asteras; Medtronic-Japan; Tanabe-Mitsubishi; Takeda; Mochida; MSD; Bayer Research; BMS; Boehringer-Ingelheim; Bayer AG; Roche	Thrombosis Research Institute, London, UK; Bayer Pharma AG, Berlin, Germany; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); sanofi-aventis(Sanofi-Aventis); Boehringer Ingelheim (BI)(Boehringer Ingelheim); Pfizer(Pfizer); Bristol Myers Squibb (BMS)(Bristol-Myers Squibb); Eisai(Eisai Co Ltd); Bayer(Bayer AG); Eli Lilly(Eli Lilly); Iroko; Astra Zeneca(AstraZeneca); GSK(GlaxoSmithKline); EKOS; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Otsuka(Otsuka Pharmaceutical); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Novartis(Novartis); AstraZeneca(AstraZeneca); Asteras; Medtronic-Japan(Medtronic); Tanabe-Mitsubishi; Takeda(Takeda Pharmaceutical Company Ltd); Mochida; MSD; Bayer Research(Bayer AG); BMS(Bristol-Myers Squibb); Boehringer-Ingelheim(Boehringer Ingelheim); Bayer AG(Bayer AG); Roche(Roche Holding)	The GARFIELD Registry is sponsored by the Thrombosis Research Institute, London, UK. Funding of the registry is provided through an educational research grant from Bayer Pharma AG, Berlin, Germany. The funding source had no involvement in the data collection, data analysis, or data interpretation. The authors had full access to all the data, and the corresponding author had final responsibility for the decision to submit for publication.; Dr. Kakkar's research was supported by Bayer HealthCare, sanofi-aventis, Boehringer Ingelheim (BI), Pfizer, Bristol Myers Squibb (BMS), and Eisai. Dr. Kakkar provided consultancy for Bayer HealthCare, sanofi-aventis, BI, Pfizer, BMS, Eisai, Aryx Therapeutics, and Canyon. Dr. Kakkar received honoraria from Bayer HealthCare, sanofi-aventis, BI, Pfizer, BMS, Eisai, and GSK (GSK). Dr. Kakkar has been a Scientific Advisory Board (SAB) member for Bayer HealthCare, sanofi-aventis, BI, Pfizer, BMS, and Eisai. Dr. Bassand received consultancy fees or honoraria from Bayer, Eli Lilly, Iroko, Astra Zeneca, and GSK. Dr. Fitzmaurice received honoraria from Bayer, BI, and sanofi-aventis. Dr. Goldhaber received research grants from BI, BMS, Eisai, EKOS, Johnson & Johnson, and sanofi-aventis, and provided consultancy (all <$10 K) for BI, BMS, Daiichi Sankyo, Eisai, EKOS, Medscape, Merck, Portola, and sanofi-aventis. Dr. Goto received research grants from sanofi-aventis, Eisai, BI, Otsuka, and Daiichi-Sankyo; and consultancy fees and honoraria from Eisai, sanofi-aventis, Otsuka, Bayer, Novartis, AstraZeneca, Asteras, Pfizer, Medtronic-Japan, Tanabe-Mitsubishi, Takeda, Daiichi-Sankyo, Mochida, and MSD. Dr. Haas has been a SAB member for Bayer, sanofi-aventis, BMS, and CSL-Behring; and received honoraria from Bayer, sanofi-aventis, BI, BMS, and Daiichi-Sankyo. Dr. Hacke received significant reimbursement from Bayer for work on the ROCKET-AF Executive Committee and for being a speaker at several industry-sponsored symposia; and reimbursement from BI for participation in Advisory Boards and industry-sponsored symposia. Dr. Lip has been a consultant for Bayer, Astellas, Merck, AstraZeneca, sanofi, BMS/Pfizer, Biotronik, Portola, and BI; and on the Speakers' bureau for Bayer, BMS/Pfizer, Boehringer, and sanofi-aventis. Dr. Mantovani received research funding from Bayer Research, Pfizer, and BMS (in the field of AF) and Bayer, Boehringer-Ingelheim (outside AF); speaker's fees from BMS, Boehringer-Ingelheim (In AF), Pfizer (outside AF); and Advisory Board fees from Bayer, Daiichi Sankyo (in AF) and Pfizer (outside AF). Dr. Turpie provided consultancy for Bayer, J & J, Astellas, Merck, sanofi-aventis, Takeda, and Portola; and on Speakers' Bureaus for Bayer, BMS/Pfizer, Boehringer-Ingelheim, J & J, GSK, and sanofi-aventis. Dr. van Eickels is employed by Bayer Healthcare Pharmaceuticals, Berlin, Germany. Dr. Misselwitz is employed by Bayer Healthcare Pharmaceuticals, Berlin, Germany and owns a significant number of Bayer AG stocks. Dr. Rushton-Smith has provided consultancy for the European Society of Cardiology, Genzyme, Medtronic, sanofi-aventis, Servier and The Medicines Company. Dr. Verheugt has received educational and research grants from Bayer AG, Roche, Eli Lilly, and BI; and consultancy honoraria from Daiichi-Sankyo, Eli Lilly, Merck, The Medicines Company, and Bayer AG. The affiliations to the funding organization (Bayer AG) and the declarations provided in the competing interests form do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Antikainen RL, 2006, EUR J CARDIOV PREV R, V13, P13, DOI 10.1097/00149831-200602000-00004; Borzecki AM, 2008, J NATL MED ASSOC, V100, P237, DOI 10.1016/S0027-9684(15)31212-8; Cairns JA, 2011, CAN J CARDIOL, V27, P74, DOI 10.1016/j.cjca.2010.11.007; Camm AJ, 2012, EUR HEART J, V33; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Fox KAA, 2010, HEART, V96, P1095, DOI 10.1136/hrt.2009.190827; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Goto S, 2008, AM HEART J, V156, P855, DOI 10.1016/j.ahj.2008.06.029; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hansen ML, 2012, THROMB HAEMOST, V107; Healey J., 2012, GLOBAL VARIATIONS 1; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Kakkar AK, 2012, AM HEART J, V163, P13, DOI 10.1016/j.ahj.2011.09.011; Kirchhof P, 2007, EUR HEART J, V28, P2803, DOI 10.1093/eurheartj/ehm358; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Nieuwlaat R, 2008, EUR HEART J, V29, P1181, DOI 10.1093/eurheartj/ehn139; Nieuwlaat R, 2006, EUR HEART J, V27, P3018, DOI 10.1093/eurheartj/ehl015; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piccini JP, 2011, CIRCULATION, V124; Steg PG, 2012, HEART, V98, P195, DOI 10.1136/heartjnl-2011-300550; Steger C, 2004, EUR HEART J, V25, P1734, DOI 10.1016/j.ehj.2004.06.030; Tulner LR, 2010, DRUG AGING, V27, P39, DOI 10.2165/11319540-000000000-00000; Zimetbaum PJ, 2010, AM J MED, V123, P446, DOI 10.1016/j.amjmed.2009.11.015	29	335	350	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63479	10.1371/journal.pone.0063479	http://dx.doi.org/10.1371/journal.pone.0063479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704912	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200044
J	Morgens, DW; Lindbergh, KM; Adachi, M; Radunskaya, A; Cavalcanti, ARO				Morgens, David W.; Lindbergh, Kristen M.; Adachi, Marie; Radunskaya, Ami; Cavalcanti, Andre R. O.			Model for the Evolution of Extremely Fragmented Macronuclei in Ciliates	PLOS ONE			English	Article							LIFE-CYCLE MORPHOGENESIS; GROWTH-RATE; DNA CONTENT; STERKIELLA-HISTRIOMUSCORUM; SYNCHRONOUS SAMPLES; NUCLEAR VOLUME; CELL-VOLUME; SIZE; SEQUENCE	While all ciliates possess nuclear dimorphism, several ciliates - like those in the classes Phyllopharyngea, Spirotrichea, and Armophorea - have an extreme macronuclear organization. Their extensively fragmented macronuclei contain upwards of 20,000 chromosomes, each with upwards of thousands of copies. These features have evolved independently on multiple occasions throughout ciliate evolutionary history, and currently no models explain these structures in an evolutionary context. In this paper, we propose that competition between two forces - the limitation and avoidance of chromosomal imbalances as a ciliate undergoes successive asexual divisions, and the costs of replicating massive genomes - is sufficient to explain this particular nuclear structure. We present a simulation of ciliate cell evolution under control of these forces, allowing certain features of the population to change over time. Over a wide range of parameters, we observe the repeated emergence of this unusual genomic organization found in nature. Although much remains to be understood about the evolution of macronuclear genome organization, our results show that the proposed model is a plausible explanation for the emergence of these extremely fragmented, highly polyploid genomes.	[Morgens, David W.; Lindbergh, Kristen M.; Adachi, Marie; Cavalcanti, Andre R. O.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Morgens, David W.; Lindbergh, Kristen M.; Adachi, Marie; Radunskaya, Ami] Pomona Coll, Dept Math, Claremont, CA 91711 USA	Claremont Colleges; Pomona College; Claremont Colleges; Pomona College	Cavalcanti, ARO (corresponding author), Pomona Coll, Dept Biol, Claremont, CA 91711 USA.	aroc@pomona.edu	Cavalcanti, Andre RO/H-9777-2013	Cavalcanti, Andre RO/0000-0001-8708-6932; Radunskaya, Ami/0000-0002-2353-5046	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by a grant from the Howard Hughes Medical Institute to Pomona College. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 1997, EUR J PROTISTOL, V33, P99, DOI 10.1016/S0932-4739(97)80025-9; Adl SM, 2000, J EUKARYOT MICROBIOL, V47, P443, DOI 10.1111/j.1550-7408.2000.tb00073.x; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bell G, 1988, SEX DEATH PROTOZOA H, P102; BERGER JD, 1979, J PROTOZOOL, V26, P18, DOI 10.1111/j.1550-7408.1979.tb02725.x; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Brito PH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-354; CAVALIERSMITH T, 1978, J CELL SCI, V34, P247; Coyne RS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r100; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Coyne RS, 1996, ANNU REV GENET, V30, P557, DOI 10.1146/annurev.genet.30.1.557; DOERDER FP, 1979, J PROTOZOOL, V26, P28, DOI 10.1111/j.1550-7408.1979.tb02726.x; Duerr HP, 2004, PROTIST, V155, P45, DOI 10.1078/1434461000163; Duret L, 2008, GENOME RES, V18, P585, DOI 10.1101/gr.074534.107; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; FINLAY BJ, 1977, OECOLOGIA, V30, P75, DOI 10.1007/BF00344893; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; LARSON DD, 1991, J PROTOZOOL, V38, P258, DOI 10.1111/j.1550-7408.1991.tb04439.x; Le Mouel A, 2003, EUKARYOT CELL, V2, P1076, DOI 10.1128/EC.2.5.1076-1090.2003; Nowacki M, 2010, P NATL ACAD SCI USA, V107, P22140, DOI 10.1073/pnas.1012236107; ORIAS E, 1991, J PROTOZOOL, V38, P217, DOI 10.1111/j.1550-7408.1991.tb04431.x; PREER JR, 1979, J PROTOZOOL, V26, P14, DOI 10.1111/j.1550-7408.1979.tb02724.x; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Riley JL, 2001, MOL BIOL EVOL, V18, P1372, DOI 10.1093/oxfordjournals.molbev.a003921; SANTANGELO G, 1987, J EXP ZOOL, V243, P401, DOI 10.1002/jez.1402430306; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; TAYLOR WD, 1981, AM NAT, V118, P160, DOI 10.1086/283812; TAYLOR WD, 1978, OECOLOGIA, V36, P263, DOI 10.1007/BF00348052; VANTHOF J, 1965, EXP CELL RES, V39, P48, DOI 10.1016/0014-4827(65)90006-6; VANTHOF J, 1963, P NATL ACAD SCI USA, V49, P897, DOI 10.1073/pnas.49.6.897	30	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64997	10.1371/journal.pone.0064997	http://dx.doi.org/10.1371/journal.pone.0064997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705024	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200178
J	Zhai, ZC; Yao, YC; Wang, YJ				Zhai, Zhichen; Yao, Yongchang; Wang, Yingjun			Importance of Suitable Reference Gene Selection for Quantitative RT-PCR during ATDC5 Cells Chondrocyte Differentiation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; REAL-TIME; IN-VITRO; HOUSEKEEPING GENES; CHONDROGENESIS; NORMALIZATION; EXPRESSION; CULTURE; ACTIN	Real-time quantitative reverse transcription-polymerase chain reaction (qPCR) is an efficient and accurate method to detect and compare patterns of gene expression. The reliability of qPCR is highly dependent on the selection of appropriate reference genes used for normalization. By analyzing 16 potential candidates of reference genes (GAPDH, Actb, 18 s, PGK1, Hprt, Tbp, Rpl5, B2M, Gusb, Ppia, UBC, Sdha, Eef1a1, H2afz, Tkt and Ldha) through geNorm, we identified Ppia, Tbp, Hprt and Eef1a1 as the most stable reference genes while UBC, B2M, Gusb as the least stable ones during the chondrocyte differentiation of ATDC5 cells. Considering the low expression of Eef1a1 and Tbp would cause divergent results for they failed to provide accurate normalization for RNA extraction and reverse transcription efficiency, we recommended the use of Ppia and Hprt as the most suitable genes to normalize qPCR. In addition, although GAPDH, Actb and 18 s were usually adopted in most of studies using ATDC5 cells, they were found unstable and then were not ideal reference genes for qPCR assay in ATDC5 cells chondrocyte differentiation. Also, we further confirmed that the Ppia and Hprt worked well during chondrocyte differentiation of mouse mesenchymal cells.	[Zhai, Zhichen; Yao, Yongchang; Wang, Yingjun] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Zhai, Zhichen; Yao, Yongchang; Wang, Yingjun] Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Wang, YJ (corresponding author), S China Univ Technol, Sch Mat Sci & Engn, Guangzhou, Guangdong, Peoples R China.	imwangyj@163.com	Yao, Yongchang/L-2916-2015	Yao, Yongchang/0000-0002-4338-2606; zhai, zhichen/0000-0002-4489-7812	National Basic Research Program of China [2012CB619100, 2011CB606204]; National Natural Science Foundation of China [51232002]; Guangdong Natural Science Foundation [S2011040000208]; Fundamental Research Funds for the Central Universities [2011ZM0010]; 111 project [B13039]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 project(Ministry of Education, China - 111 Project)	This work was financially supported by National Basic Research Program of China (Grant No. 2012CB619100 and 2011CB606204), National Natural Science Foundation of China (Grant No. 51232002), Guangdong Natural Science Foundation (Grant No. S2011040000208), the Fundamental Research Funds for the Central Universities (Grant No. 2011ZM0010) and the 111 project (B13039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Buxton AN, 2011, TISSUE ENG PT A, V17, P371, DOI [10.1089/ten.tea.2009.0839, 10.1089/ten.TEA.2009.0839]; Clavijo PE, 2012, J IMMUNOL, V188, P1213, DOI 10.4049/jimmunol.1100793; Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Fink T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-98; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Kwon HJ, 2010, ACTA BIOMATER, V6, P494, DOI 10.1016/j.actbio.2009.07.033; Lee SH, 2012, J BIOL CHEM, V287, P14760, DOI 10.1074/jbc.M112.340232; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; Li Z, 2009, TISSUE ENG PT A, V15, P1729, DOI 10.1089/ten.tea.2008.0247; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ren SW, 2010, MOL VIS, V16, P1076; Samadian A, 2012, CELL MOL BIOL NOIS S; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Seriwatanachai D, 2012, BIOCHEM BIOPH RES CO, V420, P108, DOI 10.1016/j.bbrc.2012.02.123; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tare B. S., 2005, EUR CELLS MATER, V10, P22; Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200	33	34	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64786	10.1371/journal.pone.0064786	http://dx.doi.org/10.1371/journal.pone.0064786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705012	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200166
J	Bot, M; Van Veldhoven, PP; de Jager, SCA; Johnson, J; Nijstad, N; Van Santbrink, PJ; Westra, MM; Van Der Hoeven, G; Gijbels, MJ; Muller-Tidow, C; Varga, G; Tietge, UJF; Kuiper, J; Van Berkel, TJC; Nofer, JR; Bot, I; Biessen, EAL				Bot, Martine; Van Veldhoven, Paul P.; de Jager, Saskia C. A.; Johnson, Jason; Nijstad, Niels; Van Santbrink, Peter J.; Westra, Marijke M.; Van Der Hoeven, Gerd; Gijbels, Marion J.; Mueller-Tidow, Carsten; Varga, Georg; Tietge, Uwe J. F.; Kuiper, Johan; Van Berkel, Theo J. C.; Nofer, Jerzy-Roch; Bot, Ilze; Biessen, Erik A. L.			Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; SPHINGOSINE-1-PHOSPHATE ANALOG; FTY720; INHIBITION; MONOCYTES; IMMUNITY; KINASE; EXPORT; ROLES	Aims: Altered sphingosine 1-phosphate (S1P) homeostasis and signaling is implicated in various inflammatory diseases including atherosclerosis. As S1P levels are tightly controlled by S1P lyase, we investigated the impact of hematopoietic S1P lyase (Sgpl1(-/-)) deficiency on leukocyte subsets relevant to atherosclerosis. Methods and Results: LDL receptor deficient mice that were transplanted with Sgpl1(-/-) bone marrow showed disrupted S1P gradients translating into lymphopenia and abrogated lymphocyte mitogenic and cytokine response as compared to controls. Remarkably however, Sgpl1(-/-) chimeras displayed mild monocytosis, due to impeded stromal retention and myelopoiesis, and plasma cytokine and macrophage expression patterns, that were largely compatible with classical macrophage activation. Collectively these two phenotypic features of Sgpl1 deficiency culminated in diminished atherogenic response. Conclusions: Here we not only firmly establish the critical role of hematopoietic S1P lyase in controlling S1P levels and T cell trafficking in blood and lymphoid tissue, but also identify leukocyte Sgpl1 as critical factor in monocyte macrophage differentiation and function. Its, partly counterbalancing, pro-and anti-inflammatory activity spectrum imply that intervention in S1P lyase function in inflammatory disorders such as atherosclerosis should be considered with caution.	[Bot, Martine; de Jager, Saskia C. A.; Van Santbrink, Peter J.; Westra, Marijke M.; Kuiper, Johan; Van Berkel, Theo J. C.; Bot, Ilze; Biessen, Erik A. L.] Leiden Univ, Leiden Acad Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands; [Van Veldhoven, Paul P.; Van Der Hoeven, Gerd] Katholieke Univ Leuven, Dept Mol Cell Biol, LIPIT, Louvain, Belgium; [Johnson, Jason] Bristol Royal Infirm & Gen Hosp, Bristol Heart Inst, Bristol, Avon, England; [Nijstad, Niels; Tietge, Uwe J. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9700 AB Groningen, Netherlands; [Gijbels, Marion J.; Biessen, Erik A. L.] Maastricht Univ, Expt Vasc Pathol Grp, Dept Pathol, Med Ctr, Maastricht, Netherlands; [Mueller-Tidow, Carsten] Univ Hosp Munster, Dept Med Hematol & Oncol, Munster, Germany; [Varga, Georg] Univ Munster, Inst Expt Dermatol, D-48149 Munster, Germany; [Nofer, Jerzy-Roch] Univ Hosp Munster, Ctr Lab Med, Munster, Germany; [Nofer, Jerzy-Roch] Univ Modena & Reggio Emilia, Dept Internal Med Endocrinol & Geriatr, Modena, Italy	Leiden University; Leiden University - Excl LUMC; KU Leuven; Bristol Royal Infirmary; University of Bristol; University of Groningen; Maastricht University; University of Munster; University of Munster; University of Munster; Universita di Modena e Reggio Emilia	Bot, I (corresponding author), Leiden Univ, Leiden Acad Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands.	i.bot@lacdr.leidenuniv.nl	de+Jager, Saskia/AAE-1132-2022; , Van Veldhoven Paul/U-6359-2019; Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014; de+Jager, Saskia/ABC-4264-2020; Johnson, Jason/AAC-3124-2019; Van Berkel, Theo/ABD-7677-2021	, Van Veldhoven Paul/0000-0002-4478-2564; Müller-Tidow, Carsten/0000-0002-7166-5232; Johnson, Jason/0000-0003-0630-9183; de Jager, Saskia/0000-0002-5233-0066; Bot, Ilze/0000-0002-1242-1959; Biessen, Erik/0000-0002-6454-8548	FWO-Vlaanderen [G.0405.02]; Netherlands Thrombosis Foundation [TSN2004.001]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0405.02, G.0581.09N]; British Heart Foundation [FS/07/053/24069]; Netherlands Organization for Scientific Research (NWO) [917-56-358, 916.86.046]; Netherlands Heart Foundation [2003T201]	FWO-Vlaanderen(FWO); Netherlands Thrombosis Foundation; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); British Heart Foundation(British Heart Foundation); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was funded by grant G.0405.02 from FWO-Vlaanderen to P. P. Van Veldhoven, grant TSN2004.001 from the Netherlands Thrombosis Foundation (M.B.), grants G.0405.02 and G.0581.09N from Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (P.P.V.V), grant FS/07/053/24069 from the British Heart Foundation (J.J.), VIDI grant 917-56-358 from the Netherlands Organization for Scientific Research (NWO) (U.J.F.T.), grant 916.86.046 from the Netherlands Organization for Scientific Research (I.B.) and grant 2003T201 from the Netherlands Heart Foundation (E.A.L.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P976, DOI 10.1161/01.ATV.0000162171.30089.f6; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; Daum G, 2009, ARTERIOSCL THROM VAS, V29, P1439, DOI 10.1161/ATVBAHA.108.175240; Fujii R, 2006, AM J PHYSIOL-GASTR L, V291, pG267, DOI 10.1152/ajpgi.00496.2005; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Goetzl EJ, 2004, J CLIN INVEST, V114, P1531, DOI 10.1172/JCI200423704; Gomez-Munoz A, 2003, FEBS LETT, V539, P56, DOI 10.1016/S0014-5793(03)00197-2; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Johnson JL, 2008, ARTERIOSCL THROM VAS, V28, P1647, DOI 10.1161/ATVBAHA.108.170548; Keul P, 2007, ARTERIOSCL THROM VAS, V27, P607, DOI 10.1161/01.ATV.0000254679.42583.88; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Means CK, 2008, J BIOL CHEM, V283, P11954, DOI 10.1074/jbc.M707422200; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Miyamoto T, 2001, J AM COLL CARDIOL, V37, P1713, DOI 10.1016/S0735-1097(01)01204-9; Nofer JR, 2007, CIRCULATION, V115, P501, DOI 10.1161/CIRCULATIONAHA.106.641407; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Poti F, 2012, VASC PHARMACOL, V57, P56, DOI 10.1016/j.vph.2012.03.003; Poti F, 2012, THROMB HAEMOSTASIS, V107, P552, DOI 10.1160/TH11-08-0583; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Skoura A, 2011, ARTERIOSCL THROM VAS, V31, P81, DOI 10.1161/ATVBAHA.110.213496; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; 't Hoen PAC, 2003, CIRC RES, V93, P262, DOI 10.1161/01.RES.0000082978.92494.B1; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Van Veldhoven PP, 2005, CHEM PHYS LIPIDS, V136, P164; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; Yatomi Y, 2000, BLOOD, V96, P3431	41	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63360	10.1371/journal.pone.0063360	http://dx.doi.org/10.1371/journal.pone.0063360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700419	gold, Green Published, Green Submitted			2022-12-27	WOS:000319966400017
J	Dwyer, DS; Aamodt, EJ				Dwyer, Donard S.; Aamodt, Eric J.			Insulin/IGF-1 Signaling, including Class II/III PI3Ks, beta-Arrestin and SGK-1, Is Required in C. elegans to Maintain Pharyngeal Muscle Performance during Starvation	PLOS ONE			English	Article							GROWTH-FACTOR-I; POSITIVE INOTROPIC ACTION; CAENORHABDITIS-ELEGANS; LIFE-SPAN; PHOSPHOINOSITIDE 3-KINASE; NEURONAL EXCITABILITY; UP-REGULATION; RECEPTOR; LONGEVITY; CHANNEL	In C. elegans, pharyngeal pumping is regulated by the presence of bacteria. In response to food deprivation, the pumping rate rapidly declines by about 50-60%, but then recovers gradually to baseline levels on food after 24 hr. We used this system to study the role of insulin/IGF-1 signaling (IIS) in the recovery of pharyngeal pumping during starvation. Mutant strains with reduced function in the insulin/IGF-1 receptor, DAF-2, various insulins (INS-1 and INS-18), and molecules that regulate insulin release (UNC-64 and NCA-1; NCA-2) failed to recover normal pumping rates after food deprivation. Similarly, reduction or loss of function in downstream signaling molecules (e.g., ARR-1, AKT-1, and SGK-1) and effectors (e.g., CCA-1 and UNC-68) impaired pumping recovery. Pharmacological studies with kinase and metabolic inhibitors implicated class II/III phosphatidylinositol 3-kinases (PI3Ks) and glucose metabolism in the recovery response. Interestingly, both over-and under-activity in IIS was associated with poorer recovery kinetics. Taken together, the data suggest that optimum levels of IIS are required to maintain high levels of pharyngeal pumping during starvation. This work may ultimately provide insights into the connections between IIS, nutritional status and sarcopenia, a hallmark feature of aging in muscle.	[Dwyer, Donard S.] LSU Hlth Sci Ctr, Dept Pharmacol & Psychiat, Shreveport, LA USA; [Dwyer, Donard S.] LSU Hlth Sci Ctr, Dept Toxicol, Shreveport, LA USA; [Dwyer, Donard S.] LSU Hlth Sci Ctr, Dept Neurosci, Shreveport, LA USA; [Aamodt, Eric J.] LSU Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Dwyer, DS (corresponding author), LSU Hlth Sci Ctr, Dept Pharmacol & Psychiat, Shreveport, LA USA.	ddwyer@lsuhsc.edu			NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We thank the C. Elegans Gene Knockout Consortium for producing the RB1494 strain by our request, and acknowledge their provision of other ok strains for these studies via the CGC. Dr. Mei Zhen (U. Toronto) graciously provided the nca-1; nca-2 strain for this work.	Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Attaix D, 2005, INT J BIOCHEM CELL B, V37, P1962, DOI 10.1016/j.biocel.2005.04.009; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Babar P, 1999, NEUROBIOL AGING, V20, P513, DOI 10.1016/S0197-4580(99)00094-9; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Baugh LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018086; Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bidasse KR, 2001, MOL PHARMACOL, V60, P1356, DOI 10.1124/mol.60.6.1356; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Boirie Y, 2009, J NUTR HEALTH AGING, V13, P717, DOI 10.1007/s12603-009-0203-x; Bouhours M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-16; BRENNER S, 1974, GENETICS, V77, P71; Brown RA, 1999, J BIOL CHEM, V274, P14529, DOI 10.1074/jbc.274.21.14529; Castino R, 2008, J NEUROENDOCRINOL, V20, P1165, DOI 10.1111/j.1365-2826.2008.01769.x; Ceda G P, 2005, J Endocrinol Invest, V28, P96; Chow DK, 2006, EXP GERONTOL, V41, P252, DOI 10.1016/j.exger.2005.12.004; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Dalle S, 2001, J BIOL CHEM, V276, P15688, DOI 10.1074/jbc.M010884200; Delbono O, 2002, BIOGERONTOLOGY, V3, P265, DOI 10.1023/A:1020189627325; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Donohoe DR, 2009, NEUROSCI RES, V64, P280, DOI 10.1016/j.neures.2009.03.012; Dwyer DS, 2011, MOL PSYCHIATR, V16, P595, DOI 10.1038/mp.2010.95; DWYER DS, 2009, SOC NEUR ABSTR ONL; Espinosa A, 2004, J ENDOCRINOL, V182, P339, DOI 10.1677/joe.0.1820339; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Gems D, 1998, GENETICS, V150, P129; Guillet C, 2005, DIABETES METAB, V31, pS20, DOI 10.1016/S1262-3636(05)73648-X; Hallak H, 2000, J BIOL CHEM, V275, P2255, DOI 10.1074/jbc.275.4.2255; Hameed M, 2002, EXERC SPORT SCI REV, V30, P15, DOI 10.1097/00003677-200201000-00004; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Holzenberger M, 2004, EUR J ENDOCRINOL, V151, pS23, DOI 10.1530/eje.0.151S023; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Ito K, 2009, P NATL ACAD SCI USA, V106, P8689, DOI 10.1073/pnas.0900064106; Jeyaraj S, 2007, BIOCHEM BIOPH RES CO, V356, P629, DOI 10.1016/j.bbrc.2007.03.029; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim JS, 2010, J NUTR BIOCHEM, V21, P1, DOI 10.1016/j.jnutbio.2009.06.014; Kim SJ, 2008, AM J PHYSIOL-HEART C, V295, pH130, DOI 10.1152/ajpheart.00298.2008; KIMURA KD, 2011, COLD SPRING HARB SYM, V76, P1; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; Kostek MC, 2005, J APPL PHYSIOL, V98, P2147, DOI 10.1152/japplphysiol.00817.2004; LARSEN PL, 1995, GENETICS, V139, P1567; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee YR, 2005, LEUKEMIA RES, V29, P401, DOI 10.1016/j.leukres.2004.09.010; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Li Q, 2007, AGING CELL, V6, P799, DOI 10.1111/j.1474-9726.2007.00343.x; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; LUCCHESI BR, 1972, EUR J PHARMACOL, V18, P107, DOI 10.1016/0014-2999(72)90137-9; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maryon EB, 1998, J CELL SCI, V111, P2885; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; MORGAN PG, 1990, P NATL ACAD SCI USA, V87, P2965, DOI 10.1073/pnas.87.8.2965; Neufeld TP, 2003, MECH DEVELOP, V120, P1283, DOI 10.1016/j.mod.2003.07.003; Patel DS, 2008, GENETICS, V178, P931, DOI 10.1534/genetics.107.070813; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Rasmussen BB, 2006, FASEB J, V20, P768, DOI 10.1096/fj.05-4607fje; Renganathan M, 1998, J BIOL CHEM, V273, P28845, DOI 10.1074/jbc.273.44.28845; RIEKER RP, 1975, YALE J BIOL MED, V48, P353; RYALL JG, 2008, PHARMACOL THERAPEUT, V120, P218; SAWADA M, 1975, ANN NY ACAD SCI, V243, P337, DOI 10.1111/j.1749-6632.1975.tb25375.x; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Scicchitano BM, 2009, AGING-US, V1, P451, DOI 10.18632/aging.100050; Soos MA, 2001, ARCH BIOCHEM BIOPHYS, V396, P244, DOI 10.1006/abbi.2001.2587; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Szewczyk NJ, 2007, EMBO J, V26, P935, DOI 10.1038/sj.emboj.7601540; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; VANOBBERGHEN E, 1979, BIOCHIM BIOPHYS ACTA, V582, P486, DOI 10.1016/0304-4165(79)90139-9; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Wang XM, 2010, BIOCHEM BIOPH RES CO, V400, P613, DOI 10.1016/j.bbrc.2010.08.113; Weeks KR, 2011, J NEUROSCI RES, V89, P1658, DOI 10.1002/jnr.22705; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055	91	13	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63851	10.1371/journal.pone.0063851	http://dx.doi.org/10.1371/journal.pone.0063851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700438	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400035
J	Mohangoo, AD; Blondel, B; Gissler, M; Velebil, P; Macfarlane, A; Zeitlin, J				Mohangoo, Ashna D.; Blondel, Beatrice; Gissler, Mika; Velebil, Petr; Macfarlane, Alison; Zeitlin, Jennifer		Euro-Peristat Sci Comm	International Comparisons of Fetal and Neonatal Mortality Rates in High- Income Countries: Should Exclusion Thresholds Be Based on Birth Weight or Gestational Age?	PLOS ONE			English	Article							EVALUATING PERINATAL HEALTH; PRETERM; PERISTAT; EUROPE; DEATH; STILLBIRTHS; INDICATORS; TRENDS; BORN; RISK	Background: Fetal and neonatal mortality rates are essential indicators of population health, but variations in recording of births and deaths at the limits of viability compromises international comparisons. The World Health Organization recommends comparing rates after exclusion of births with a birth weight less than 1000 grams, but many analyses of perinatal outcomes are based on gestational age. We compared the effects of using a 1000-gram birth weight or a 28-week gestational age threshold on reported rates of fetal and neonatal mortality in Europe. Methods: Aggregated data from 2004 on births and deaths tabulated by birth weight and gestational age from 29 European countries/regions participating in the Euro-Peristat project were used to compute fetal and neonatal mortality rates using cut-offs of 1000-grams and 28-weeks (2.8 million total births). We measured differences in rates between and within countries using the Wilcoxon signed rank test and 95% confidence intervals, respectively. Principal Findings: For fetal mortality, rates based on gestational age were significantly higher than those based on birth weight (p, 0.001), although these differences varied between countries. The use of a 1000-gram threshold included 8823 fetal deaths compared with 9535 using a 28-week threshold (difference of 712). In contrast, the choice of a cut-off made little difference for comparisons of neonatal deaths (difference of 16). Neonatal mortality rates differed minimally, by under 0.1 per 1000 in most countries (p = 0.370). Country rankings were comparable with both thresholds. Conclusions: Neonatal mortality rates were not affected by the choice of a threshold. However, the use of a 1000-gram threshold underestimated the health burden of fetal deaths. This may in part reflect the exclusion of growth restricted fetuses. In high-income countries with a good measure of gestational age, using a 28-week threshold may provide additional valuable information about fetal deaths occurring in the third trimester.	[Mohangoo, Ashna D.] Netherlands Org Appl Sci Res, TNO, Dept Child Hlth, Leiden, Netherlands; [Blondel, Beatrice; Zeitlin, Jennifer] Univ Paris 06, INSERM UMRS 953, Epidemiol Res Unit Perinatal & Womens & Childrens, Paris, France; [Gissler, Mika] Natl Inst Hlth & Welf, Dept Informat, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Velebil, Petr] Perinatal Ctr, Inst Care Mother & Child, Prague, Czech Republic; [Macfarlane, Alison] City Univ London, Maternal & Child Hlth Res Centre, London EC1V 0HB, England; [Zeitlin, Jennifer] UPMC Univ Paris 06, Paris, France	Netherlands Organization Applied Science Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Finland National Institute for Health & Welfare; City University London; UDICE-French Research Universities; Sorbonne Universite	Mohangoo, AD (corresponding author), Netherlands Org Appl Sci Res, TNO, Dept Child Hlth, Leiden, Netherlands.	ashna.mohangoo@tno.nl	Zeitlin, Jennifer/G-4973-2017; Sakkeus, Luule/E-9558-2010; Barros, Henrique/Q-8609-2019; Blondel, Beatrice/G-5011-2017; Klungsøyr, Kari/ABC-6147-2020; Cuttini, Marina/AAI-1987-2019	Zeitlin, Jennifer/0000-0002-9568-2969; Sakkeus, Luule/0000-0003-3785-183X; Barros, Henrique/0000-0003-4699-6571; Klungsøyr, Kari/0000-0003-2482-1690; Szamotulska, Katarzyna/0000-0003-1045-7584; Francisco, Bolumar Montrull/0000-0001-8007-3231; Gissler, Mika/0000-0001-8254-7525; Haidinger, Gerald/0000-0002-1199-6216; Cuttini, Marina/0000-0002-3284-6874; Hindori-Mohangoo, Ashna/0000-0003-2364-2893	European Commission (DG-SANCO) [2003131, 20101301]; Medical Research Council [MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1] Funding Source: UKRI	European Commission (DG-SANCO)(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The results from this study are based on data from the Euro-Peristat project, a European project for monitoring and evaluating perinatal outcomes on the European level. The Euro-Peristat project was co-financed by the European Commission (DG-SANCO), grant numbers 2003131 and 20101301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ananth CV, 2007, PAEDIATR PERINAT EP, V21, P22, DOI 10.1111/j.1365-3016.2007.00858.x; Austeng D, 2010, ACTA PAEDIATR, V99, P978, DOI 10.1111/j.1651-2227.2010.01846.x; Battin MR, 2007, AUST NZ J OBSTET GYN, V47, P457, DOI 10.1111/j.1479-828X.2007.00779.x; CARAYOL M, 2012, J GYNECOL OBST BIO R, DOI DOI 10.1016/J.JGYN.2012.10.012.[; Chard T, 2001, BRIT J OBSTET GYNAEC, V108, P1113, DOI 10.1111/j.1471-0528.2003.00278.x; EURO-PERISTAT project with SCPE EUROCAT EURONEOSTAT, 2008, BETT STAT BETT HLTH; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gissler M, 2010, INFORM HEALTH SOC CA, V35, P64, DOI 10.3109/17538157.2010.492923; Graafmans WC, 2002, EPIDEMIOLOGY, V13, P569, DOI 10.1097/00001648-200209000-00013; Joseph KS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e746; Kollee LAA, 2009, BJOG-INT J OBSTET GY, V116, P1481, DOI 10.1111/j.1471-0528.2009.02235.x; KRAMER MS, 1988, JAMA-J AM MED ASSOC, V260, P3306, DOI 10.1001/jama.260.22.3306; Langhoff-Roos J, 2006, BMJ-BRIT MED J, V332, P937, DOI 10.1136/bmj.38751.524132.2F; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Mohangoo AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024727; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Schaaf JM, 2011, BJOG-INT J OBSTET GY, V118, P1196, DOI 10.1111/j.1471-0528.2011.03010.x; Vanhaesebrouck P, 2004, PEDIATRICS, V114, P663, DOI 10.1542/peds.2003-0903-L; *WHO, 2004, ICD 10 INT STAT CLAS, V2; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601; Zeitlin J, 2003, EUR J OBSTET GYN R B, V111, pS1, DOI 10.1016/j.ejogrb.2003.09.001; Zeitlin J, 2003, EUR J OBSTET GYN R B, V111, pS5, DOI 10.1016/j.ejogrb.2003.09.002; Zeitlin J, 2003, EUR J PUBLIC HEALTH, V13, P29, DOI 10.1093/eurpub/13.suppl_1.29; ZEITLIN J, 2012, BMJ	29	44	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64869	10.1371/journal.pone.0064869	http://dx.doi.org/10.1371/journal.pone.0064869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700489	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000319966400066
J	Brager, AJ; Ehlen, JC; Castanon-Cervantes, O; Natarajan, D; Delisser, P; Davidson, AJ; Paul, KN				Brager, Allison J.; Ehlen, J. Christopher; Castanon-Cervantes, Oscar; Natarajan, Divya; Delisser, Patrick; Davidson, Alec J.; Paul, Ketema N.			Sleep Loss and the Inflammatory Response in Mice Under Chronic Environmental Circadian Disruption	PLOS ONE			English	Article							C-FOS EXPRESSION; HOMEOSTATIC REGULATION; SHIFT WORK; RAT-BRAIN; DEPRIVATION; RHYTHMS; TEMPERATURE; DESYNCHRONIZATION; MELATONIN; DISORDER	Shift work and trans-time zone travel lead to insufficient sleep and numerous pathologies. Here, we examined sleep/wake dynamics during chronic exposure to environmental circadian disruption (ECD), and if chronic partial sleep loss associated with ECD influences the induction of shift-related inflammatory disorder. Sleep and wakefulness were telemetrically recorded across three months of ECD, in which the dark-phase of a light-dark cycle was advanced weekly by 6 h. A three month regimen of ECD caused a temporary reorganization of sleep (NREM and REM) and wake processes across each week, resulting in an approximately 10% net loss of sleep each week relative to baseline levels. A separate group of mice were subjected to ECD or a regimen of imposed wakefulness (IW) aimed to mimic sleep amounts under ECD for one month. Fosimmunoreactivity (IR) was quantified in sleep-wake regulatory areas: the nucleus accumbens (NAc), basal forebrain (BF), and medial preoptic area (MnPO). To assess the inflammatory response, trunk blood was treated with lipopolysaccharide (LPS) and subsequent release of IL-6 was measured. Fos-IR was greatest in the NAc, BF, and MnPO of mice subjected to IW. The inflammatory response to LPS was elevated in mice subjected to ECD, but not mice subjected to IW. Thus, the net sleep loss that occurs under ECD is not associated with a pathological immune response.	[Brager, Allison J.; Ehlen, J. Christopher; Castanon-Cervantes, Oscar; Natarajan, Divya; Delisser, Patrick; Davidson, Alec J.; Paul, Ketema N.] Morehouse Sch Med, Dept Neurobiol, Atlanta, GA 30310 USA	Morehouse School of Medicine	Paul, KN (corresponding author), Morehouse Sch Med, Dept Neurobiol, Atlanta, GA 30310 USA.	kpaul@msm.edu	Ehlen, Christopher/GXV-9278-2022	Ehlen, J. Christopher/0000-0003-3223-9262	 [NS060659];  [NS078410]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS060659, R01NS078410] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors received funding from NS060659 and NS078410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann K, 2012, SLEEP, V35, P933, DOI 10.5665/sleep.1954; Cambras T, 2007, P NATL ACAD SCI USA, V104, P7634, DOI 10.1073/pnas.0702424104; Casiraghi LP, 2012, J BIOL RHYTHM, V27, P59, DOI 10.1177/0748730411429447; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Chapdelaine S, 2012, J SLEEP RES, V21, P380, DOI 10.1111/j.1365-2869.2012.00998.x; CIRELLI C, 1995, J SLEEP RES, V4, P92, DOI 10.1111/j.1365-2869.1995.tb00157.x; Costa G, 2003, OCCUP MED-OXFORD, V53, P83, DOI 10.1093/occmed/kqg045; Deboer T, 2007, EUR J NEUROSCI, V26, P3518, DOI 10.1111/j.1460-9568.2007.05964.x; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; Faraut B, 2012, SLEEP MED REV, V16, P137, DOI 10.1016/j.smrv.2011.05.001; Greco MA, 2000, NEUROREPORT, V11, P437, DOI 10.1097/00001756-200002280-00002; Gumenyuk V, 2012, CHRONOBIOL INT, V29, P928, DOI 10.3109/07420528.2012.699356; Gvilia I, 2006, J NEUROSCI, V26, P9426, DOI 10.1523/JNEUROSCI.2012-06.2006; Hasan S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.010; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; Logan RW, 2012, J IMMUNOL, V188, P2583, DOI 10.4049/jimmunol.1102715; Majde JA, 2005, J ALLERGY CLIN IMMUN, V116, P1188, DOI 10.1016/j.jaci.2005.08.005; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Postnova S, 2012, J BIOL RHYTHM, V27, P91, DOI 10.1177/0748730411419934; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Sack RL, 2007, SLEEP, V30, P1484, DOI 10.1093/sleep/30.11.1484; Sellix MT, 2012, J NEUROSCI, V32, P16193, DOI 10.1523/JNEUROSCI.3559-12.2012; Semba K, 2001, BEHAV BRAIN RES, V120, P75, DOI 10.1016/S0166-4328(00)00362-4; Wisor JP, 2011, SLEEP, V34, P1335, DOI 10.5665/SLEEP.1274; Wisor JP, 2011, SLEEP, V34, P261, DOI 10.1093/sleep/34.3.261; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Yan L, 2011, NEUROSCIENCE, V183, P99, DOI 10.1016/j.neuroscience.2011.03.041	28	30	30	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63752	10.1371/journal.pone.0063752	http://dx.doi.org/10.1371/journal.pone.0063752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696854	Green Published, gold, Green Submitted			2022-12-27	WOS:000319107900057
J	Pittet, JF; Koh, H; Fang, XH; Iles, K; Christiaans, S; Anjun, N; Wagener, BM; Park, DW; Zmijewski, JW; Matthay, MA; Roux, J				Pittet, Jean-Francois; Koh, Hidefumi; Fang, Xiaohui; Iles, Karen; Christiaans, Sarah; Anjun, Naseem; Wagener, Brant M.; Park, Dae Won; Zmijewski, Jaroslaw W.; Matthay, Michael A.; Roux, Jeremie			HMGB1 Accelerates Alveolar Epithelial Repair via an IL-1 beta- and alpha v beta 6 Integrin-dependent Activation of TGF-beta 1	PLOS ONE			English	Article							ACUTE LUNG INJURY; MOBILITY GROUP BOX-1; TGF-BETA ACTIVATION; RESPIRATORY-DISTRESS-SYNDROME; IN-VITRO; WOUND REPAIR; PULMONARY-FIBROSIS; TYPE-2 CELLS; II CELLS; PROTEIN	High mobility group box 1 (HMGB1) protein is a danger-signaling molecule, known to activate an inflammatory response via TLR4 and RAGE. HMGB1 can be either actively secreted or passively released from damaged alveolar epithelial cells. Previous studies have shown that IL-1 beta, a critical mediator acute lung injury in humans that is activated by HMGB1, enhances alveolar epithelial repair, although the mechanisms are not fully understood. Herein, we tested the hypothesis that HMGB1 released by wounded alveolar epithelial cells would increase primary rat and human alveolar type II cell monolayer wound repair via an IL-1 beta-dependent activation of TGF-beta 1. HMGB1 induced in primary cultures of rat alveolar epithelial cells results in the release of IL-1 beta that caused the activation of TGF-beta 1 via a p38 MAPK-, RhoA- and alpha v beta 6 integrin-dependent mechanism. Furthermore, active TGF-beta 1 accelerated the wound closure of primary rat epithelial cell monolayers via a PI3 kinase alpha-dependent mechanism. In conclusion, this study demonstrates that HMGB1 released by wounded epithelial cell monolayers, accelerates wound closure in the distal lung epithelium via the IL-1 beta-mediated alpha v beta 6-dependent activation of TGF-beta 1, and thus could play an important role in the resolution of acute lung injury by promoting repair of the injured alveolar epithelium.	[Pittet, Jean-Francois; Iles, Karen; Christiaans, Sarah; Anjun, Naseem; Wagener, Brant M.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA; [Koh, Hidefumi] Keio Univ, Sch Med, Div Pulm Med, Tokyo, Japan; [Iles, Karen] Univ Alabama Birmingham, Birmingham, AL USA; [Park, Dae Won; Zmijewski, Jaroslaw W.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Park, Dae Won] Korea Univ, Ansan Hosp, Div Infect Dis, Ansan, South Korea; [Fang, Xiaohui; Matthay, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Fang, Xiaohui; Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Roux, Jeremie] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	University of Alabama System; University of Alabama Birmingham; Keio University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Korea University; Korea University Medicine (KU Medicine); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Roux, J (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	Jeremie_Roux@hms.harvard.edu	Wagener, Brant/AAI-7480-2020; Ha, C/GZL-9046-2022; Kim, Il/L-6481-2019; Roux, Jeremie/A-9746-2013	Roux, Jeremie/0000-0001-5712-8660; Park, Dae Won/0000-0002-7653-686X	National Institutes of Health (NIH) [P50HL074005, HL-51854, HL-51856, T32 GM008440]; ALA Senior Research Training Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107585, R01HL051854, R37HL051856, P50HL074005, R01HL051856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086416, T32GM008440] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALA Senior Research Training Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was primarily supported by National Institutes of Health (NIH) grants P50HL074005, Project 4 (JFP), HL-51854 and HL-51856 (MAM), T32 GM008440 and ALA Senior Research Training Fellowship (JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; Bir N, 2011, AM J RESP CELL MOL, V45, P632, DOI 10.1165/rcmb.2010-0397OC; Bitto A, 2010, PHARMACOL RES, V61, P116, DOI 10.1016/j.phrs.2009.07.014; Buckley S, 2008, AM J PHYSIOL-LUNG C, V294, pL739, DOI 10.1152/ajplung.00294.2007; Buckley S, 2011, AM J RESP CELL MOL, V45, P1212, DOI 10.1165/rcmb.2010-0325OC; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225; Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Fang XH, 2004, AM J PHYSIOL-LUNG C, V287, pL104, DOI 10.1152/ajplung.00176.2003; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Geiser T, 2001, AM J RESP CRIT CARE, V163, P1384, DOI 10.1164/ajrccm.163.6.2006131; Geiser T, 2000, AM J PHYSIOL-LUNG C, V279, pL1184, DOI 10.1152/ajplung.2000.279.6.L1184; Howell DCJ, 2005, AM J PATHOL, V166, P1353, DOI 10.1016/S0002-9440(10)62354-1; Hreggvidsdottir HS, 2012, MOL MED, V18, P224, DOI 10.2119/molmed.2011.00327; Huttunen HJ, 2002, J BIOL CHEM, V277, P38635, DOI 10.1074/jbc.M202515200; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Liu G, 2008, J IMMUNOL, V181, P4240, DOI 10.4049/jimmunol.181.6.4240; Neurohr C, 2006, AM J RESP CELL MOL, V35, P252, DOI 10.1165/rcmb.2006-0013OC; Ogawa EN, 2006, AM J RESP CRIT CARE, V174, P400, DOI 10.1164/rccm.200605-699OC; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Pankow S, 2006, J CELL SCI, V119, P4033, DOI 10.1242/jcs.03175; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Pugin J, 1996, AM J RESP CRIT CARE, V153, P1850, DOI 10.1164/ajrccm.153.6.8665045; Pugin J, 1999, CRIT CARE MED, V27, P304, DOI 10.1097/00003246-199902000-00036; Ranzato E, 2009, MOL CELL BIOCHEM, V332, P199, DOI 10.1007/s11010-009-0192-4; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Straino S, 2008, J INVEST DERMATOL, V128, P1545, DOI 10.1038/sj.jid.5701212; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; TIBALLI RN, 1995, J CLIN MICROBIOL, V33, P915, DOI 10.1128/JCM.33.4.915-917.1995; van Zoelen MAD, 2007, CRIT CARE MED, V35, P2799, DOI 10.1097/01.CCM.0000287588.69000.97; Wahamaa H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3450; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2002, LANCET, V360, P619, DOI 10.1016/S0140-6736(02)09774-X; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Whitsett JA, 2011, J CLIN INVEST, V121, P2543, DOI 10.1172/JCI58704; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Xiang M, 2011, J IMMUNOL, V187, P4809, DOI 10.4049/jimmunol.1102093; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685; Zmijewski JW, 2009, J BIOL CHEM, V284, P22213, DOI 10.1074/jbc.M109.028902	56	39	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63907	10.1371/journal.pone.0063907	http://dx.doi.org/10.1371/journal.pone.0063907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696858	Green Submitted, Green Published, gold			2022-12-27	WOS:000319081900062
J	Hill, AM; Etherton-Beer, C; Haines, TP				Hill, Anne-Marie; Etherton-Beer, Christopher; Haines, Terry P.			Tailored Education for Older Patients to Facilitate Engagement in Falls Prevention Strategies after Hospital Discharge-A Pilot Randomized Controlled Trial	PLOS ONE			English	Article							HIP FRACTURE; OCCUPATIONAL THERAPIST; AFTER-DISCHARGE; RISK; PEOPLE; HOME; INTERVENTIONS; CARE; TRANSITIONS; RECOVERY	Background: The aims of the study were to evaluate the effect of providing tailored falls prevention education in hospital on: i) engagement in targeted falls prevention behaviors in the month after discharge: ii) patients' self-perceived risk and knowledge about falls and falls prevention strategies after receiving the education. Methods: A pilot randomized controlled trial (n = 50): baseline and outcome assessments conducted by blinded researchers. Participants: hospital inpatients 60 years or older, discharged to the community. Participants were randomized into two groups. The intervention was a tailored education package consisting of multimedia falls prevention information with trained health professional follow-up, delivered in addition to usual care. Outcome measures were engagement in falls prevention behaviors in the month after discharge measured at one month after discharge with a structured survey, and participants' knowledge, confidence and motivation levels before and after receiving the education. The feasibility of providing the intervention was examined and falls outcomes (falls, fall-related injuries) were also collected. Results: Forty-eight patients (98%) provided follow-up data. The complete package was provided to 21 (84%) intervention group participants. Participants in the intervention group were significantly more likely to plan how to safely restart functional activities [Adjusted odds ratio 3.80, 95% CI (1.07, 13.52), p = 0.04] and more likely to complete other targeted behaviors such as completing their own home exercise program [Adjusted odds ratio 2.76, 95% CI (0.72, 10.50), p = 0.14] than the control group. The intervention group was significantly more knowledgeable, confident and motivated to engage in falls prevention strategies after receiving the education than the control group. There were 23 falls (n = 5 intervention; n = 18 control) and falls rates were 5.4/1000 patient days (intervention); 18.7/1000 patient days (control). Conclusion: This tailored education was received positively by older people, resulted in increased engagement in falls prevention strategies after discharge and is feasible to deliver to older hospital patients.	[Hill, Anne-Marie] Univ Notre Dame Australia, Inst Hlth Res, Sch Physiotherapy, Fremantle, WA, Australia; [Etherton-Beer, Christopher] Univ Western Australia, Western Australian Ctr Hlth & Ageing, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Haines, Terry P.] Monash Univ, Sch Physiotherapy, Cheltenham, Vic, Australia; [Haines, Terry P.] Southern Hlth, Allied Hlth Res Unit, Clayton, Vic, Australia	University of Notre Dame Australia; University of Western Australia; Monash University	Hill, AM (corresponding author), Univ Notre Dame Australia, Inst Hlth Res, Sch Physiotherapy, Fremantle, WA, Australia.	Anne-Marie.Hill@nd.edu.au	Etherton-Beer, Christopher/B-2714-2014; Haines, Terrence/E-9372-2015	Etherton-Beer, Christopher/0000-0001-5148-0188; Haines, Terrence/0000-0003-3150-6154; Hill, Anne-Marie/0000-0003-1411-6752	Sir Robert Menzies Memorial Foundation Limited; Australian National Health and Medical Research Council	Sir Robert Menzies Memorial Foundation Limited; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a grant awarded to Anne-Marie Hill by The Sir Robert Menzies Memorial Foundation Limited which is a non-profit, non-political organisation created in 1979 to promote excellence in health research, scholarship and postgraduate study by Australians. The Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.menziesfoundation.org.au/ Anne-Marie Hill is supported by an Australian National Health and Medical Research Council Early Career Fellowship. Terry Haines is supported by an Australian National Health and Medical Research Council Career Development Fellowship.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Bischoff-Ferrari HA, 2010, ARCH INTERN MED, V170, P813, DOI 10.1001/archinternmed.2010.67; Boyd CM, 2008, J AM GERIATR SOC, V56, P2171, DOI 10.1111/j.1532-5415.2008.02023.x; Bunn F, 2008, AGEING SOC, V28, P449, DOI 10.1017/S0144686X07006861; CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Carroll DL, 2010, APPL NURS RES, V23, P238, DOI 10.1016/j.apnr.2008.10.003; Clemson L, 2008, J AGING HEALTH, V20, P954, DOI 10.1177/0898264308324672; Coleman EA, 2004, J AM GERIATR SOC, V52, P1817, DOI 10.1111/j.1532-5415.2004.52504.x; Cornette P, 2006, EUR J PUBLIC HEALTH, V16, P203, DOI 10.1093/eurpub/cki054; Cumming RG, 1999, J AM GERIATR SOC, V47, P1397, DOI 10.1111/j.1532-5415.1999.tb01556.x; Di Monaco M, 2008, J REHABIL MED, V40, P446, DOI 10.2340/16501977-0206; Dickinson Angela, 2011, Br J Community Nurs, V16, P174; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Dorresteijn TAC, 2012, AGE AGEING, V41, P474, DOI 10.1093/ageing/afs007; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Gillespie Lesley D, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007146.pub3, DOI 10.1002/14651858.CD007146.PUB3]; Haines TP, 2015, HEALTH EXPECT, V18, P233, DOI 10.1111/hex.12026; Haines TP, 2011, ARCH INTERN MED, V171, P516, DOI 10.1001/archinternmed.2010.444; Hansen K, 1999, J AM GERIATR SOC, V47, P360, DOI 10.1111/j.1532-5415.1999.tb03002.x; Hill AM, 2011, GERONTOLOGIST, V51, P653, DOI 10.1093/geront/gnr052; Hill AM, 2011, ARCH PHYS MED REHAB, V92, P1395, DOI 10.1016/j.apmr.2011.04.009; Hill AM, 2011, J GERONTOL A-BIOL, V66, P1001, DOI 10.1093/gerona/glr085; Hill AM, 2009, J AM GERIATR SOC, V57, P1458, DOI 10.1111/j.1532-5415.2009.02346.x; Hill KD, 2008, J AM GERIATR SOC, V56, P600, DOI 10.1111/j.1532-5415.2007.01626.x; Hoffmann T, 2004, DISABIL REHABIL, V26, P1166, DOI 10.1080/09638280410001724816; Hosmer D. W., APPL LOGISTIC REGRES; Host D, 2011, SCAND J PUBLIC HEALT, V39, P742, DOI 10.1177/1403494811421639; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Kirkpatrick DL, 2009, EVALUATING TRAINING, V3; Kripalani S, 2007, J HOSP MED, V2, P314, DOI 10.1002/jhm.228; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Mahoney JE, 2000, ARCH INTERN MED, V160, P2788, DOI 10.1001/archinte.160.18.2788; Merriam S.B., 2007, LEARNING ADULTHOOD C, V3rd ed.; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Mistiaen P, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-47; Nikolaus T, 2003, J AM GERIATR SOC, V51, P300, DOI 10.1046/j.1532-5415.2003.51102.x; Nyman SR, 2011, CAN J AGING, V30, P1, DOI 10.1017/S0714980810000838; Parker S G, 2002, Health Technol Assess, V6, P1; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Porter EJ, 2010, J NURS SCHOLARSHIP, V42, P101, DOI 10.1111/j.1547-5069.2010.01334.x; Sager MA, 1996, ARCH INTERN MED, V156, P645, DOI 10.1001/archinte.156.6.645; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Vellas BJ, 1998, J GERONTOL A-BIOL, V53, pM264, DOI 10.1093/gerona/53A.4.M264; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wolinsky FD, 2009, J GERONTOL A-BIOL, V64, P249, DOI 10.1093/gerona/gln027; Yardley L, 2007, QUAL SAF HEALTH CARE, V16, P230, DOI 10.1136/qshc.2006.019802; Yardley L, 2008, PREV MED, V47, P554, DOI 10.1016/j.ypmed.2008.09.001; Yardley L, 2006, GERONTOLOGIST, V46, P650, DOI 10.1093/geront/46.5.650	50	43	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63450	10.1371/journal.pone.0063450	http://dx.doi.org/10.1371/journal.pone.0063450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	151BM	23717424	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600015
J	Kuc, S; Koster, MPH; Franx, A; Schielen, PCJI; Visser, GHA				Kuc, Sylwia; Koster, Maria P. H.; Franx, Arie; Schielen, Peter C. J. I.; Visser, Gerard H. A.			Maternal Characteristics, Mean Arterial Pressure and Serum Markers in Early Prediction of Preeclampsia	PLOS ONE			English	Article							PLACENTAL GROWTH-FACTOR; BIOCHEMICAL MARKERS; PULSATILITY INDEX; BLOOD-PRESSURE; 1ST TRIMESTER; RESTRICTION; GESTATION; PREGNANCY; DOPPLER; PREVENTION	Objectives: In a previous study, we have described the predictive value of first-trimester Pregnancy-Associated Plasma Protein-A (PAPP-A), free beta-subunit of human Chorionic Gonadotropin (f beta-hCG), Placental Growth Factor (PlGF) and A Disintegrin And Metalloprotease 12 (ADAM12) for early onset preeclampsia (EO-PE; delivery <34 weeks). The objective of the current study was to obtain the predictive value of these serum makers combined with maternal characteristics and first-trimester maternal mean arterial blood pressure (MAP) in a large series of patients, for both EO-PE and late onset PE (LO-PE; delivery >= 34 weeks). Methods: This was a nested case-control study, using stored first-trimester maternal serum from women who developed EO-PE (n = 68) or LO-PE (n = 99), and 500 uncomplicated singleton pregnancies. Maternal characteristics, MAP, and pregnancy outcome were collected for each individual woman and used to calculate prior risks for PE in a multiple logistic regression model. Models containing prior PE risks, serum markers, and MAP were developed for the prediction of EO-PE and LO-PE. The model-predicted detection rates (DR) for fixed 10% false-positive rates were calculated for EO-PE and LO-PE with or without the presence of a small-for-gestational age infant (SGA, birth weight <10th centile). Results: The best prediction model included maternal characteristics, MAP, PAPP-A, ADAM12, and PlGF, with DR of 72% for EO-PE and 49% for LO-PE. Prediction for PE with concomitant SGA was better than for PE alone (92% for EO-PE and 57% for LO-PE). Conclusion: First-trimester MAP, PAPP-A, ADAM12, and PlGF combined with maternal characteristics and MAP are promising markers in the risk assessment of PE, especially for EO-PE complicated by SGA.	[Kuc, Sylwia; Koster, Maria P. H.; Franx, Arie; Visser, Gerard H. A.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Obstet, Utrecht, Netherlands; [Schielen, Peter C. J. I.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Netherlands National Institute for Public Health & the Environment	Kuc, S (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Obstet, Utrecht, Netherlands.	S.Kuc@umcutrecht.nl	Franx, Arie/AAA-1739-2021; Schielen, Peter/AAP-4539-2020		University Medical Centre Alexandre Suerman MD-PhD scholarship	University Medical Centre Alexandre Suerman MD-PhD scholarship	Funding provided by a University Medical Centre Alexandre Suerman MD-PhD scholarship: http://www.umcutrecht.nl/subsite/opleiding-geneeskunde/Overige/MDPhD-traject/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolekar R, 2008, ULTRASOUND OBST GYN, V32, P732, DOI 10.1002/uog.6244; Akolekar R, 2011, PRENATAL DIAG, V31, P66, DOI 10.1002/pd.2660; Akolekar R, 2010, PRENATAL DIAG, V30, P191, DOI 10.1002/pd.2433; Baschat AA, 2004, OBSTET GYNECOL SURV, V59, P617, DOI 10.1097/01.OGX.0000133943.54530.76; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Bujold E, 2010, OBSTET GYNECOL, V116, P402, DOI 10.1097/AOG.0b013e3181e9322a; Bujold E, 2009, J OBSTET GYNAECOL CA, V31, P818, DOI 10.1016/S1701-2163(16)34300-6; Cnossen JS, 2008, BMJ-BRIT MED J, V336, P1117, DOI 10.1136/bmj.39540.522049.BE; Dieber-Rotheneder M, 2012, LIFE SCI, V91, P710, DOI 10.1016/j.lfs.2012.04.040; Foidart JM, 2010, ULTRASOUND OBST GYN, V35, P680, DOI 10.1002/uog.7621; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Kahn SR, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-91; Kuc S, 2011, OBSTET GYNECOL SURV, V66, P225, DOI 10.1097/OGX.0b013e3182227027; Lindqvist PG, 1999, ACTA OBSTET GYN SCAN, V78, P693, DOI 10.1034/j.1600-0412.1999.780806.x; Llurba E, 2009, OBSTET GYNECOL INT, V2009, DOI 10.1155/2009/275613; North RA, 2000, AM J OBSTET GYNECOL, V183, P136, DOI 10.1016/S0002-9378(00)96405-6; Poon LCY, 2010, ULTRASOUND OBST GYN, V35, P662, DOI 10.1002/uog.7628; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Roberge S, 2012, AM J PERINAT, V29, P551, DOI 10.1055/s-0032-1310527; Roberts JM, 2012, PREGNANCY HYPERTENS, V2, P72, DOI 10.1016/j.preghy.2012.01.001; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Vandenberghe G, 2011, PRENATAL DIAG, V31, P955, DOI 10.1002/pd.2807; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Visser N, 2007, OBSTET GYNECOL SURV, V62, P191, DOI 10.1097/01.ogx.0000256779.06275.c4; Wortelboer EJ, 2011, ULTRASOUND OBST GYN, V38, P383, DOI 10.1002/uog.9029; Wortelboer EJ, 2010, BJOG-INT J OBSTET GY, V117, P1384, DOI 10.1111/j.1471-0528.2010.02690.x; Yu J, 2011, ULTRASOUND OBST GYN, V37, P528, DOI 10.1002/uog.8800	33	50	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63546	10.1371/journal.pone.0063546	http://dx.doi.org/10.1371/journal.pone.0063546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717445	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700033
J	Wang, GS; Hu, N; Yang, HH; Wang, LM; Su, H; Wang, CY; Clifford, R; Dawsey, EM; Li, JM; Ding, T; Han, XY; Giffen, C; Goldstein, AM; Taylor, PR; Lee, MP				Wang, Gangshi; Hu, Nan; Yang, Howard H.; Wang, Lemin; Su, Hua; Wang, Chaoyu; Clifford, Robert; Dawsey, Erica M.; Li, Jian-Min; Ding, Ti; Han, Xiao-You; Giffen, Carol; Goldstein, Alisa M.; Taylor, Philip R.; Lee, Maxwell P.			Comparison of Global Gene Expression of Gastric Cardia and Noncardia Cancers from a High-Risk Population in China	PLOS ONE			English	Article							NUTRITION INTERVENTION TRIALS; DISEASE-SPECIFIC MORTALITY; DISTINCTIVE PATTERNS; HELICOBACTER-PYLORI; SOMATIC MUTATIONS; FAMILY-HISTORY; ESOPHAGEAL; LINXIAN; SUPPLEMENTATION; ADENOCARCINOMA	Objective: To profile RNA expression in gastric cancer by anatomic subsites as an initial step in identifying molecular subtypes and providing targets for early detection and therapy. Methods: We performed transcriptome analysis using the Affymetrix GeneChip U133A in gastric cardia adenocarcinomas (n = 62) and gastric noncardia adenocarcinomas (n = 72) and their matched normal tissues from patients in Shanxi Province, and validated selected dysregulated genes with additional RNA studies. Expression of dysregulated genes was also related to survival of cases. Results: Principal Component Analysis showed that samples clustered by tumor vs. normal, anatomic location, and histopathologic features. Paired t-tests of tumor/normal tissues identified 511 genes whose expression was dysregulated (P<4.7E-07 and at least two-fold difference in magnitude) in cardia or noncardia gastric cancers, including nearly one-half (n = 239, 47%) dysregulated in both cardia and noncardia, one-fourth dysregulated in cardia only (n = 128, 25%), and about one-fourth in noncardia only (n = 144, 28%). Additional RNA studies confirmed profiling results. Expression was associated with case survival for 20 genes in cardia and 36 genes in noncardia gastric cancers. Conclusions: The dysregulated genes identified here represent a comprehensive starting point for future efforts to understand etiologic heterogeneity, develop diagnostic biomarkers for early detection, and test molecularly-targeted therapies for gastric cancer.	[Wang, Gangshi; Hu, Nan; Wang, Lemin; Su, Hua; Wang, Chaoyu; Dawsey, Erica M.; Goldstein, Alisa M.; Taylor, Philip R.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Yang, Howard H.; Lee, Maxwell P.] NCI, Off Director, Ctr Canc Res, Bethesda, MD 20892 USA; [Clifford, Robert] Walter Reed Army Inst Res, Multidrug Resistant Organism Repository & Surveil, Silver Spring, MD USA; [Li, Jian-Min; Ding, Ti; Han, Xiao-You] Shanxi Canc Hosp, Taiyuan, Shanxi, Peoples R China; [Giffen, Carol] Informat Management Serv Inc, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Information Management Services, Inc.	Taylor, PR (corresponding author), NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	ptaylor@mail.nih.gov; leemax@mail.nih.gov			National Institutes of Health; Center for Cancer Research; National Cancer Institute, the Division of Cancer Epidemiology and Genetics	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, the Division of Cancer Epidemiology and Genetics	This research is funded by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, the Division of Cancer Epidemiology and Genetics, and the Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Anderson WF, 2010, JAMA-J AM MED ASSOC, V303, P1723, DOI 10.1001/jama.2010.496; Baumgartner JM, 2009, J SURG RES, V154, P13, DOI 10.1016/j.jss.2008.04.043; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boussioutas A, 2003, CANCER RES, V63, P2569; *CANC I CAOMS, 2011, CHIN CANC DAT; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Chong IW, 2006, ONCOL REP, V16, P981; Corley DA, 2004, J NATL CANCER I, V96, P1383, DOI 10.1093/jnci/djh265; Fujimura T, 2010, CANCER SCI, V101, P646, DOI 10.1111/j.1349-7006.2009.01451.x; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gao Y, 2011, CANCER EPIDEMIOL, V35, pE91, DOI 10.1016/j.canep.2011.06.006; Gao Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-269; Gleeson CM, 1998, BRIT J CANCER, V77, P277, DOI 10.1038/bjc.1998.44; Hasegawa S, 2002, CANCER RES, V62, P7012; Hippo Y, 2002, CANCER RES, V62, P233; Hu N, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-33; Huch M, 2011, NAT GENET, V43, P9, DOI 10.1038/ng0111-9; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jinawath N, 2004, ONCOGENE, V23, P6830, DOI 10.1038/sj.onc.1207886; *JOHN WIL SONS LTD, 2009, TNM CLASSIFICATION M; Kamangar F, 2007, BRIT J CANCER, V96, P172, DOI 10.1038/sj.bjc.6603517; Kim B, 2003, CANCER RES, V63, P8248; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Li J Y, 1982, Natl Cancer Inst Monogr, V62, P113; LI JY, 1993, J NATL CANCER I, V85, P1492, DOI 10.1093/jnci/85.18.1492; LIU SF, 1994, INT J CANCER, V57, P775, DOI 10.1002/ijc.2910570603; Mark SD, 2000, J NATL CANCER I, V92, P1753, DOI 10.1093/jnci/92.21.1753; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; Park WS, 1999, CANCER RES, V59, P4257; Park WS, 2000, GASTROENTEROLOGY, V119, P691, DOI 10.1053/gast.2000.16483; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng CW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-101; Qiao YL, 2009, JNCI-J NATL CANCER I, V101, P507, DOI 10.1093/jnci/djp037; RIO FT, 2010, NEW ENGL J MED, V363, P2628, DOI DOI 10.1056/NEJM0A1006565; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; SIPPONEN P, 1995, AM J SURG PATHOL, V19, pS30; Su H, 2003, CANCER RES, V63, P3872; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Sun Xiudi, 2002, Zhonghua Zhongliu Zazhi, V24, P4; Tajima Y, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055345; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Tytgat GNJ, 2004, DIS ESOPHAGUS, V17, P10, DOI 10.1111/j.1442-2050.2004.00371.x; VAN DH, 2009, CANCER GENET CYTOGEN, V189, P37, DOI DOI 10.1016/J.CANCERGENCYT0.2008.08.018; Wei WQ, 2004, AM J CLIN NUTR, V79, P80; Weiss MM, 2003, ONCOGENE, V22, P1872, DOI 10.1038/sj.onc.1206350	49	76	79	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63826	10.1371/journal.pone.0063826	http://dx.doi.org/10.1371/journal.pone.0063826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717493	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700068
J	Alout, H; Ndam, NT; Sandeu, MM; Djegbe, I; Chandre, F; Dabire, RK; Djogbenou, LS; Corbel, V; Cohuet, A				Alout, Haoues; Ndam, Nicaise Tuikue; Sandeu, Marcel Maurice; Djegbe, Innocent; Chandre, Fabrice; Dabire, Roch Kounbobr; Djogbenou, Luc Salako; Corbel, Vincent; Cohuet, Anna			Insecticide Resistance Alleles Affect Vector Competence of Anopheles gambiae s.s. for Plasmodium falciparum Field Isolates	PLOS ONE			English	Article							HIGH WOLBACHIA DENSITY; MALARIA TRANSMISSION; CULEX-PIPIENS; LABORATORY MODELS; GENE-EXPRESSION; IMMUNE-RESPONSE; BURKINA-FASO; REAL-TIME; MOSQUITO; INFECTION	The widespread insecticide resistance raises concerns for vector control implementation and sustainability particularly for the control of the main vector of human malaria, Anopheles gambiae sensu stricto. However, the extent to which insecticide resistance mechanisms interfere with the development of the malignant malaria parasite in its vector and their impact on overall malaria transmission remains unknown. We explore the impact of insecticide resistance on the outcome of Plasmodium falciparum infection in its natural vector using three An. gambiae strains sharing a common genetic background, one susceptible to insecticides and two resistant, one homozygous for the ace-1(R) mutation and one for the kdr mutation. Experimental infections of the three strains were conducted in parallel with field isolates of P. falciparum from Burkina Faso (West Africa) by direct membrane feeding assays. Both insecticide resistant mutations influence the outcome of malaria infection by increasing the prevalence of infection. In contrast, the kdr resistant allele is associated with reduced parasite burden in infected individuals at the oocyst stage, when compared to the susceptible strain, while the ace-1(R) resistant allele showing no such association. Thus insecticide resistance, which is particularly problematic for malaria control efforts, impacts vector competence towards P. falciparum and probably parasite transmission through increased sporozoite prevalence in kdr resistant mosquitoes. These results are of great concern for the epidemiology of malaria considering the widespread pyrethroid resistance currently observed in Sub-Saharan Africa and the efforts deployed to control the disease.	[Alout, Haoues; Chandre, Fabrice; Corbel, Vincent; Cohuet, Anna] UM1 UM2 CNRS 5290 IRD 224, Inst Rech Dev, Montpellier, France; [Alout, Haoues; Dabire, Roch Kounbobr; Cohuet, Anna] Inst Rech Sci Sante, Bobo Dioulasso 01, Burkina Faso; [Ndam, Nicaise Tuikue] Inst Sci Biomed & Appl, Cotonou, Benin; [Ndam, Nicaise Tuikue; Sandeu, Marcel Maurice] Univ Paris 05, IRD, UMR 216, Paris, France; [Sandeu, Marcel Maurice; Djegbe, Innocent] Ctr Rech Entomol Cotonou, Cotonou, Benin; [Djogbenou, Luc Salako] Univ Abomey Calavi, Inst Reg Sante Publ, Cotonou, Benin; [Corbel, Vincent] Kasetsart Univ, Fac Agr, Dept Entomol, Bangkok, Thailand	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Entomological Research Center of Cotonou (CREC); University of Abomey Calavi; Kasetsart University	Alout, H (corresponding author), UM1 UM2 CNRS 5290 IRD 224, Inst Rech Dev, Montpellier, France.	haoues.alout@ird.fr	Cohuet, Anna/B-2745-2017; Corbel, VIncent/G-9576-2016; Alout, Haoues/N-9556-2016; Chandre, Fabrice/Q-3429-2019; Dabire, Roch Kounbobr/ABF-3525-2020	Cohuet, Anna/0000-0002-1876-5656; Alout, Haoues/0000-0001-7917-2697; Chandre, Fabrice/0000-0002-1994-9705; corbel, vincent/0000-0003-0995-3257; DJOGBENOU, Salako Luc/0000-0002-7381-6321; Tuikue Ndam, Nicaise/0000-0003-2646-2513	European Community [242095, 223736]; IRD	European Community(European Commission); IRD	This work was financed by the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreements no242095 and no223736. Also, the authors thank IRD for financial support and for fellowship to HA. The authors would also thank the Laboratoire Mixte International de Lutte Integree contre le Paludisme (LLIP), Cotonou, Benin, and the Laboratoire Mixte International "Maladies a vecteurs en Afrique de l'Ouest" (LAMIVECT), Bobo Dioulasso, Burkina Faso for technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2004, EVOLUTION, V58, P579, DOI 10.1111/j.0014-3820.2004.tb01680.x; Aguilar R, 2005, ACTA TROP, V95, P285, DOI 10.1016/j.actatropica.2005.06.005; Ahmed AM, 2002, OIKOS, V97, P371, DOI 10.1034/j.1600-0706.2002.970307.x; [Anonymous], NATURE; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Berticat C, 2002, P ROY SOC B-BIOL SCI, V269, P1413, DOI 10.1098/rspb.2002.2022; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Dabire KR, 2009, TROP MED INT HEALTH, V14, P396, DOI 10.1111/j.1365-3156.2009.02243.x; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Diallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031100; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Djegbe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017496; Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; Djogbenou L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-12; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Duron O, 2006, EVOLUTION, V60, P303, DOI 10.1111/j.0014-3820.2006.tb01108.x; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; Gouagna LC, 2004, TROP MED INT HEALTH, V9, P937, DOI 10.1111/j.1365-3156.2004.01300.x; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Harris C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030849; Howard AFV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-168; Hurd H, 2004, INT J PARASITOL, V34, P1459, DOI 10.1016/j.ijpara.2004.10.002; Kuznetsova A., 2012, MIXMOD ANAL MIXED MO; Labbe P, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P363, DOI 10.1016/B978-0-12-384890-1.00014-5; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Lambrechts L, 2007, AM J TROP MED HYG, V76, P475, DOI 10.4269/ajtmh.2007.76.475; LINES JD, 1988, PARASITOL TODAY, V4, pS17, DOI 10.1016/0169-4758(88)90083-X; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; McCarroll L, 2002, INSECT BIOCHEM MOLEC, V32, P1345, DOI 10.1016/S0965-1748(02)00097-8; Mendes AM, 2011, INFECT IMMUN, V79, P4708, DOI 10.1128/IAI.05647-11; Morassin B, 2002, AM J TROP MED HYG, V66, P503, DOI 10.4269/ajtmh.2002.66.503; PETRARCA V, 1992, AM J TROP MED HYG, V46, P229, DOI 10.4269/ajtmh.1992.46.229; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Raymond M, 2001, GENETICA, V112, P287, DOI 10.1023/A:1013300108134; Rehman H, 2011, SCAND J IMMUNOL, V73, P459, DOI 10.1111/j.1365-3083.2011.02521.x; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Roxstrom-Lindquist K, 2005, INSECT MOL BIOL, V14, P645, DOI 10.1111/j.1365-2583.2005.00593.x; Sandeu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052719; Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08; SHUTE G. T., 1956, ANN TROP MED AND PARASITOL, V50, P92; Sinden RE, 2007, PLOS PATHOG, V3, P2005, DOI 10.1371/journal.ppat.0030195; SKAUG H., 2012, GEN LINEAR MIXED MOD; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; SNOUNOU G, 1993, T ROY SOC TROP MED H, V87, P649, DOI 10.1016/0035-9203(93)90274-T; Suwanchaichinda C, 2005, ENVIRON TOXICOL PHAR, V20, P77, DOI 10.1016/j.etap.2004.10.004; VANHANDEL E, 1989, J AM MOSQUITO CONTR, V5, P180; Vaughan JA, 2007, TRENDS PARASITOL, V23, P63, DOI 10.1016/j.pt.2006.12.009; Vezilier J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-379; Vizioli J, 2000, INSECT MOL BIOL, V9, P75, DOI 10.1046/j.1365-2583.2000.00164.x; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Weetman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013140; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 1998, TEST PROC MSECT RES; Zuur Alain F., 2009, P1	66	82	83	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63849	10.1371/journal.pone.0063849	http://dx.doi.org/10.1371/journal.pone.0063849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704944	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200075
J	Andrade, EB; Bianchini, MA; Lucchiari, N				Andrade, Eduardo B.; Bianchini, Marco Aurelio; Lucchiari, Newton, Jr.			Combine or Separate Future Pain? The Impact of Current Pain on Decisions about Future Dental Treatments	PLOS ONE			English	Article							UNPLEASANTNESS; PREFERENCES; PERCEPTION; INTENSITY	Patients are often given the option of undergoing future painful treatments in one or multiple sessions (e.g., extracting two wisdom teeth on one or two different days). In a randomized controlled field experiment, we investigated the impact of transient pain on patients' decision to combine or separate future periodontal treatments. The main results show that most patients preferred to have the future treatments take place in one session when they made their choice after a painless examination (i.e., general clinical exam). However, the patients' preference for combining the future treatments did not differ from chance when the choice was made immediately following a painful examination (i.e., pocketing and bleeding on probing exam). The impact of pain on decision making is observed within and between participants. Current pain seems to lead patients to question their ability to endure future painful treatments in one session.	[Andrade, Eduardo B.] FGV, Rio De Janeiro, Brazil; [Bianchini, Marco Aurelio; Lucchiari, Newton, Jr.] Univ Fed Santa Catarina, Rio De Janeiro, Brazil	Getulio Vargas Foundation; Universidade Federal de Santa Catarina (UFSC)	Andrade, EB (corresponding author), FGV, Rio De Janeiro, Brazil.	eduardo.b.andrade@fgv.br	Bianchini, Marco Aurelio/ABA-2544-2020; Andrade, Eduardo B./H-7745-2013	Andrade, Eduardo B./0000-0002-2930-8151	CEPID (Center for Dental Implants) at the Universidade Federal de Santa Catarina	CEPID (Center for Dental Implants) at the Universidade Federal de Santa Catarina	The research received support from the CEPID (Center for Dental Implants) at the Universidade Federal de Santa Catarina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berns GS, 2006, SCIENCE, V312, P754, DOI 10.1126/science.1123721; Burns JW, 2010, EMOTION, V10, P755, DOI 10.1037/a0021155; CHRISTENSENSZALANSKI JJJ, 1984, MED DECIS MAKING, V4, P47, DOI 10.1177/0272989X8400400108; DUNCAN GH, 1989, PAIN, V37, P295, DOI 10.1016/0304-3959(89)90194-2; Hirsh AT, 2010, J PAIN, V11, P454, DOI 10.1016/j.jpain.2009.09.004; JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KASSIRER JP, 1994, NEW ENGL J MED, V330, P1895, DOI 10.1056/NEJM199406303302611; LINVILLE PW, 1991, J PERS SOC PSYCHOL, V60, P5, DOI 10.1037/0022-3514.60.1.5; Loewenstein G, 2003, Q J ECON, V118, P1209, DOI 10.1162/003355303322552784; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; Perlman DM, 2010, EMOTION, V10, P65, DOI 10.1037/a0018440; Read D, 1999, J BEHAV DECIS MAKING, V12, P1, DOI 10.1002/(SICI)1099-0771(199903)12:1<1::AID-BDM310>3.0.CO;2-V; Redelmeier DA, 1996, PAIN, V66, P3, DOI 10.1016/0304-3959(96)02994-6; Sathorn C, 2005, INT ENDOD J, V38, P347, DOI 10.1111/j.1365-2591.2005.00955.x; Shakespeare TP, 2003, J CLIN ONCOL, V21, P2156, DOI 10.1200/JCO.2003.10.112; Stevens W Grant, 2004, Aesthet Surg J, V24, P314, DOI 10.1016/j.asj.2004.04.005; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330	19	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64057	10.1371/journal.pone.0064057	http://dx.doi.org/10.1371/journal.pone.0064057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23704972	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200110
J	Anomal, R; de Villers-Sidani, E; Merzenich, MM; Panizzutti, R				Anomal, Renata; de Villers-Sidani, Etienne; Merzenich, Michael M.; Panizzutti, Rogerio			Manipulation of BDNF Signaling Modifies the Experience-Dependent Plasticity Induced by Pure Tone Exposure during the Critical Period in the Primary Auditory Cortex	PLOS ONE			English	Article							MOUSE VISUAL-CORTEX; POSTNATAL-DEVELOPMENT; BARREL CORTEX; RAT; EXPRESSION; OVEREXPRESSION; NEUROTROPHINS; MATURATION; COLUMNS; CLOSURE	Sensory experience powerfully shapes cortical sensory representations during an early developmental "critical period" of plasticity. In the rat primary auditory cortex (A1), the experience-dependent plasticity is exemplified by significant, long-lasting distortions in frequency representation after mere exposure to repetitive frequencies during the second week of life. In the visual system, the normal unfolding of critical period plasticity is strongly dependent on the elaboration of brain-derived neurotrophic factor (BDNF), which promotes the establishment of inhibition. Here, we tested the hypothesis that BDNF signaling plays a role in the experience-dependent plasticity induced by pure tone exposure during the critical period in the primary auditory cortex. Elvax resin implants filled with either a blocking antibody against BDNF or the BDNF protein were placed on the A1 of rat pups throughout the critical period window. These pups were then exposed to 7 kHz pure tone for 7 consecutive days and their frequency representations were mapped. BDNF blockade completely prevented the shaping of cortical tuning by experience and resulted in poor overall frequency tuning in A1. By contrast, BDNF infusion on the developing A1 amplified the effect of 7 kHz tone exposure compared to control. These results indicate that BDNF signaling participates in the experience-dependent plasticity induced by pure tone exposure during the critical period in A1.	[Anomal, Renata; de Villers-Sidani, Etienne; Merzenich, Michael M.; Panizzutti, Rogerio] Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Anomal, Renata; Panizzutti, Rogerio] Univ Fed Rio de Janeiro, Inst Biomed Sci, Program Basic Clin Neurosci, Rio De Janeiro, Brazil	University of California System; University of California San Francisco; Universidade Federal do Rio de Janeiro	Panizzutti, R (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	rogerio@icb.ufrj.br		Anomal, Renata/0000-0003-3528-0535	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ; National Institutes of Health; Long-Term Fellowship from the Human Frontier Science Program, HFSP; Clinician-Scientist Award of the Canadian Institutes of Health Research; CAPES	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Long-Term Fellowship from the Human Frontier Science Program, HFSP; Clinician-Scientist Award of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by a grant from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ to R.P. and National Institutes of Health grants to M.M.M. R.P. is a recipient of the Long-Term Fellowship from the Human Frontier Science Program, HFSP. E.V.S. was supported by a Clinician-Scientist Award of the Canadian Institutes of Health Research. R.A. was supported by predoctoral fellowships from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Bao SW, 2003, J NEUROSCI, V23, P10765; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; BERARDI N, 1994, P NATL ACAD SCI USA, V91, P684, DOI 10.1073/pnas.91.2.684; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Cabelli RJ, 1996, J NEUROSCI, V16, P7965; Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; de Villers-Sidani E, 2008, NAT NEUROSCI, V11, P957, DOI 10.1038/nn.2144; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; de Villers-Sidani E, 2010, P NATL ACAD SCI USA, V107, P13900, DOI 10.1073/pnas.1007885107; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Grossberg S, 2003, CEREB CORTEX, V13, P852, DOI 10.1093/cercor/13.8.852; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hata Y, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0002.2000; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Itami C, 2007, J NEUROSCI, V27, P2241, DOI 10.1523/JNEUROSCI.3345-06.2007; Kuczewski N, 2011, J NEUROCHEM, V118, P533, DOI 10.1111/j.1471-4159.2011.07192.x; Lodovichi C, 2000, J NEUROSCI, V20, P2155; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Vinogradov S, 2009, BIOL PSYCHIAT, V66, P549, DOI 10.1016/j.biopsych.2009.02.017; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Xu JH, 2010, CEREB CORTEX, V20, P804, DOI 10.1093/cercor/bhp143; Xu JH, 2010, J NEUROSCI RES, V88, P614, DOI 10.1002/jnr.22232; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398; Zhou XM, 2011, J NEUROSCI, V31, P5625, DOI 10.1523/JNEUROSCI.6470-10.2011; Zhou XM, 2010, P NATL ACAD SCI USA, V107, P14839, DOI 10.1073/pnas.1009433107; Zhou XM, 2009, NAT NEUROSCI, V12, P26, DOI 10.1038/nn.2239; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	37	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64208	10.1371/journal.pone.0064208	http://dx.doi.org/10.1371/journal.pone.0064208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700463	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200123
J	Bohni, N; Cordero-Maldonado, ML; Maes, J; Siverio-Mota, D; Marcourt, L; Munck, S; Kamuhabwa, AR; Moshi, MJ; Esguerra, CV; de Witte, PAM; Crawford, AD; Wolfender, JL				Bohni, Nadine; Lorena Cordero-Maldonado, Maria; Maes, Jan; Siverio-Mota, Dany; Marcourt, Laurence; Munck, Sebastian; Kamuhabwa, Appolinary R.; Moshi, Mainen J.; Esguerra, Camila V.; de Witte, Peter A. M.; Crawford, Alexander D.; Wolfender, Jean-Luc			Integration of Microfractionation, qNMR and Zebrafish Screening for the In Vivo Bioassay-Guided Isolation and Quantitative Bioactivity Analysis of Natural Products	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; STRUCTURE ELUCIDATION; GENISTEIN; DISCOVERY; ISOFLAVONE; IDENTIFICATION; INHIBITION; DRUGS; UHPLC	Natural products (NPs) are an attractive source of chemical diversity for small-molecule drug discovery. Several challenges nevertheless persist with respect to NP discovery, including the time and effort required for bioassay-guided isolation of bioactive NPs, and the limited biomedical relevance to date of in vitro bioassays used in this context. With regard to bioassays, zebrafish have recently emerged as an effective model system for chemical biology, allowing in vivo high-content screens that are compatible with microgram amounts of compound. For the deconvolution of the complex extracts into their individual constituents, recent progress has been achieved on several fronts as analytical techniques now enable the rapid microfractionation of extracts, and microflow NMR methods have developed to the point of allowing the identification of microgram amounts of NPs. Here we combine advanced analytical methods with high-content screening in zebrafish to create an integrated platform for microgram-scale, in vivo NP discovery. We use this platform for the bioassay-guided fractionation of an East African medicinal plant, Rhynchosia viscosa, resulting in the identification of both known and novel isoflavone derivatives with anti-angiogenic and anti-inflammatory activity. Quantitative microflow NMR is used both to determine the structure of bioactive compounds and to quantify them for direct dose-response experiments at the microgram scale. The key advantages of this approach are (1) the microgram scale at which both biological and analytical experiments can be performed, (2) the speed and the rationality of the bioassay-guided fractionation - generic for NP extracts of diverse origin - that requires only limited sample-specific optimization and (3) the use of microflow NMR for quantification, enabling the identification and dose-response experiments with only tens of micrograms of each compound. This study demonstrates that a complete in vivo bioassay-guided fractionation can be performed with only 20 mg of NP extract within a few days.	[Bohni, Nadine; Marcourt, Laurence; Wolfender, Jean-Luc] Univ Lausanne, Univ Geneva, EPGL, Sch Pharmaceut Sci, Geneva, Switzerland; [Lorena Cordero-Maldonado, Maria; Maes, Jan; Siverio-Mota, Dany; Esguerra, Camila V.; de Witte, Peter A. M.; Crawford, Alexander D.] Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium; [Lorena Cordero-Maldonado, Maria] Univ Cuenca, Sch Biochem & Pharm, Fac Chem Sci, Cuenca, Ecuador; [Munck, Sebastian] Univ Leuven, VIB Ctr Biol Dis, Louvain, Belgium; [Kamuhabwa, Appolinary R.; Moshi, Mainen J.] Muhimbili Univ Hlth & Allied Sci, Fac Pharm, Dar Es Salaam, Tanzania	University of Geneva; University of Lausanne; KU Leuven; Universidad de Cuenca; Flanders Institute for Biotechnology (VIB); KU Leuven; Muhimbili University of Health & Allied Sciences	Crawford, AD (corresponding author), Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium.	alexander.crawford@pharm.kuleuven.be	Jean-Luc, Wolfender JLW/O-2163-2018; Esguerra, Camila/N-6159-2015; Jean-Luc, Wolfender JLW/EWV-1043-2022; Esguerra, Camila/D-7657-2014; Marcourt, Laurence/A-3411-2014	Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Esguerra, Camila/0000-0002-2271-8094; Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Esguerra, Camila/0000-0001-7891-1427; Marcourt, Laurence/0000-0002-9614-1099; Moshi, Mainen/0000-0002-8850-3221; Munck, Sebastian/0000-0002-5182-5358; Bohni, Nadine/0000-0001-5188-1256; de Witte, Peter/0000-0002-9989-9567	Swiss National Science Foundation (SNSF) [CRSII3_127187]; Vlaamse Interuniversitaire Raad (VLIR) linked to the VLIR-UOS project "Pharmacological Characterization of Medicinal Plants from the South of Ecuador" at the University of Cuenca, Ecuador; Vlaamse Interuniversitaire Raad (VLIR) linked to a VLIR-UOS cooperation program with the Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Vlaamse Interuniversitaire Raad (VLIR) linked to the VLIR-UOS project "Pharmacological Characterization of Medicinal Plants from the South of Ecuador" at the University of Cuenca, Ecuador; Vlaamse Interuniversitaire Raad (VLIR) linked to a VLIR-UOS cooperation program with the Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba	MLCM was funded by a PhD fellowship from the Vlaamse Interuniversitaire Raad (VLIR) linked to the VLIR-UOS project "Pharmacological Characterization of Medicinal Plants from the South of Ecuador" at the University of Cuenca, Ecuador. DSM was funded by a fellowship from the Vlaamse Interuniversitaire Raad (VLIR) linked to a VLIR-UOS cooperation program with the Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba. This work was funded in part by the Swiss National Science Foundation (SNSF, CRSII3_127187 to JLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge Philippe J. Eugster for the acquisition of UHPLC-PDA-TOFMS data and for assistance on dereplication, and the Aquaculture Core Facility of the Biomedical Sciences Group at KU Leuven. MLCM acknowledges the support of the Vlaamse Interuniversitaire Raad (VLIR) linked to the VLIR-UOS project "Pharmacological Characterization of Medicinal Plants from the South of Ecuador" at the University of Cuenca, Ecuador. DSM acknowledges the support of the Vlaamse Interuniversitaire Raad (VLIR) linked to a VLIR-UOS cooperation program with the Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Barantin L, 1997, MAGN RESON MED, V38, P179, DOI 10.1002/mrm.1910380203; Buckingham J., 2012, DICT NATURAL PRODUCT; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Caligiani A, 2010, NUTRIENTS, V2, P280, DOI 10.3390/nu2030280; Crawford AD, 2011, PLANTA MED, V77, P1348; Crawford AD, 2008, PLANTA MED, V74, P624, DOI 10.1055/s-2008-1034374; Crawford AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014694; Dalisay DS, 2009, J NAT PROD, V72, P732, DOI 10.1021/np8007649; Eldridge GR, 2002, ANAL CHEM, V74, P3963, DOI 10.1021/ac025534s; Espina R, 2009, CHEM RES TOXICOL, V22, P299, DOI 10.1021/tx800251p; Eugster PJ, 2012, RSC CHROMATOGR MONOG, P354, DOI 10.1039/9781849735490-00354; Farina HG, 2006, ONCOL REP, V16, P885; FOTSIS T, 1993, P NATL ACAD SCI USA, V90, P2690, DOI 10.1073/pnas.90.7.2690; Fotsis T, 1998, BAILLIERE CLIN ENDOC, V12, P649, DOI 10.1016/S0950-351X(98)80009-8; Funari CS, 2012, J CHROMATOGR A, V1259, P167, DOI 10.1016/j.chroma.2012.03.069; Gassner NC, 2007, J NAT PROD, V70, P383, DOI 10.1021/np060555t; Giera M, 2009, ANAL CHEM, V81, P5460, DOI 10.1021/ac900622b; Glauser G, 2010, PHYTOCHEM ANALYSIS, V21, P95, DOI 10.1002/pca.1155; Guillarme D, 2008, EUR J PHARM BIOPHARM, V68, P430, DOI 10.1016/j.ejpb.2007.06.018; Guillarme D, 2009, J CHROMATOGR A, V1216, P3232, DOI 10.1016/j.chroma.2009.02.032; HANAWA F, 1991, PHYTOCHEMISTRY, V30, P157, DOI 10.1016/0031-9422(91)84117-B; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hu JF, 2005, PLANTA MED, V71, P176, DOI 10.1055/s-2005-837787; Johansen KT, 2011, J NAT PROD, V74, P2454, DOI 10.1021/np200780m; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; KINOSHITA T, 1978, CHEM PHARM BULL, V26, P141; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Marrero-Ponce Y, 2011, EUR J MED CHEM, V46, P5736, DOI 10.1016/j.ejmech.2011.07.053; Marston A, 2007, PHYTOCHEMISTRY, V68, P2786, DOI 10.1016/j.phytochem.2007.08.004; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Rosen J, 2009, J MED CHEM, V52, P1953, DOI 10.1021/jm801514w; Sadowska-Krowicka H, 1998, P SOC EXP BIOL MED, V217, P351; Si HW, 2007, CURR MED CHEM, V14, P2581, DOI 10.2174/092986707782023325; TAHARA S, 1991, PHYTOCHEMISTRY, V30, P1683, DOI 10.1016/0031-9422(91)84234-J; Vargas S, 2011, J PHARMACEUT BIOMED, V56, P880, DOI 10.1016/j.jpba.2011.06.026; Veitch NC, 2009, NAT PROD REP, V26, P776, DOI 10.1039/b616809b; Wang B, 2005, J OCUL PHARMACOL TH, V21, P107, DOI 10.1089/jop.2005.21.107; Welsch ME, 2010, CURR OPIN CHEM BIOL, V14, P347, DOI 10.1016/j.cbpa.2010.02.018; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t; Williams RB, 2012, PLANTA MED, V78, P160, DOI 10.1055/s-0031-1280293; Zhou GX, 2007, CHEM PHARM BULL, V55, P1287, DOI 10.1248/cpb.55.1287; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	47	40	41	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64006	10.1371/journal.pone.0064006	http://dx.doi.org/10.1371/journal.pone.0064006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700445	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200103
J	Naveca, FG; Sabido, M; de Almeida, TAP; Veras, EA; Mejia, MDC; Galban, E; Benzaken, AS				Naveca, Felipe Gomes; Sabido, Meritxell; Pires de Almeida, Tatiana Amaral; Veras, Elaine Araujo; Contreras Mejia, Matilde del Carmen; Galban, Enrique; Benzaken, Adele Schwartz			Etiology of Genital Ulcer Disease in a Sexually Transmitted Infection Reference Center in Manaus, Brazilian Amazon	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; SIMPLEX-VIRUS TYPE-2; PRIMARY-HEALTH-CARE; TREPONEMA-PALLIDUM; SYNDROMIC MANAGEMENT; CLINICAL-DIAGNOSIS; MOLECULAR METHODS; HSV-2 INFECTION; HIV-INFECTION	Objectives: To determine the etiology and factors associated with genital ulcer disease (GUD) among patients presenting to a sexually transmitted infections clinic in Manaus, Brazil; and to compare a multiplex polymerase chain reaction (M-PCR) assay for the diagnosis of GUD with standard methods. Methods: Ulcer swabs were collected and used for Tzanck test and processed in an M-PCR to detect herpes simplex virus (HSV-1/2), Treponema pallidum (T. pallidum), and Haemophilus ducreyi (H. ducreyi). Sera were tested for HIV and syphilis antibodies. Multivariable analysis was used to measure the association between clinical aspects and GUD. M-PCR results were compared with syphilis serology and Tzanck tests. Results: Overall, 434 GUD samples were evaluated, 84.8% from men. DNA from HSV-2 was detected in 55.3% of GUD samples, T. pallidum in 8.3%, HSV-1 in 3.2%, and 32.5% of GUD specimens were negative for the DNA of all three pathogens. No cases of H. ducreyi were identified. HIV serology among GUD patients was 3.2%. Treponemal antibodies and Tzanck test positivity for genital herpes was detected in 25 (5.8%) and in 125 (30.3%) of GUD patients, respectively. In multivariable analysis genital herpes etiology by M-PCR was associated with the vesicular, multiple and recurrent lesions whereas T. pallidum with non-vesicular, non-recurrent lesions. Compared to M-PCR, syphilis serology was 27.8% sensitive and 96.2% specific whereas Tzanck test was 43.8% sensitive and 88.9% specific. Conclusions: The predominance of genital herpes etiology suggests a revision of existing national syndromic treatment guidelines in Brazil to include antiherpetic treatment for all GUD patients. The use of M-PCR can significantly improve the diagnosis of GUD and provide a greater sensitivity than standard diagnostics.	[Naveca, Felipe Gomes; Veras, Elaine Araujo; Contreras Mejia, Matilde del Carmen; Galban, Enrique; Benzaken, Adele Schwartz] Fundacao Alfredo Matta, Manaus, Amazonas, Brazil; [Naveca, Felipe Gomes; Pires de Almeida, Tatiana Amaral] Inst Leonidas & Maria Deane Fiocruz Amazonia, Manaus, Amazonas, Brazil; [Sabido, Meritxell] Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil; [Sabido, Meritxell] Fundacio Sida & Soc, Barcelona, Spain; [Pires de Almeida, Tatiana Amaral] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Galban, Enrique] Fac Med Calixto Garcia, Havana, Cuba; [Benzaken, Adele Schwartz] UNAIDS, Brasilia, DF, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Amazonas	Sabido, M (corresponding author), Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil.	xellsabido@gmail.com	Almeida, Tatiana/B-3404-2013; Naveca, Felipe/H-1130-2012	Almeida, Tatiana/0000-0001-7395-3062; Naveca, Felipe/0000-0002-2888-1060; Schwartz Benzaken, Adele/0000-0002-5789-0695	Regional Scientific Development Program (DCR); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Fundacao de Amparo a Pesquisa do Estado do Amazonas - FAPEAM; CNPq/FAPEAM; FAPEAM	Regional Scientific Development Program (DCR); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Amazonas - FAPEAM(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); CNPq/FAPEAM; FAPEAM	The study was funded by the Regional Scientific Development Program (DCR) Call 005/2007 of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (www.cnpq.br) and Fundacao de Amparo a Pesquisa do Estado do Amazonas - FAPEAM (www.fapeam.am.gov.br). FGN received CNPq/FAPEAM fellowship. TAPA, EAV and MCCM received FAPEAM fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HJ, 2003, SEX TRANSM DIS, V30, P114, DOI 10.1097/00007435-200302000-00004; Becker M, 2010, SEX TRANSM DIS, V37, P159, DOI 10.1097/OLQ.0b013e3181bd1007; Beyrer C, 1998, J INFECT DIS, V178, P243, DOI 10.1086/515603; Brankin AE, 2009, INT J STD AIDS, V20, P650, DOI 10.1258/ijsa.2009.009067; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2006, PROGR NAC DST AIDS M; Bruisten SM, 2001, J CLIN MICROBIOL, V39, P601, DOI 10.1128/JCM.39.2.601-605.2001; Burris H, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S5; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Cheluget B, 2004, SEX TRANSM DIS, V31, P522, DOI 10.1097/01.olq.0000137896.40790.7d; Chen CY, 2012, METHODS MOL BIOL, V903, P103, DOI 10.1007/978-1-61779-937-2_6; Clark JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007201; CONE RW, 1994, JAMA-J AM MED ASSOC, V272, P792, DOI 10.1001/jama.272.10.792; DANGOR Y, 1990, SEX TRANSM DIS, V17, P184, DOI 10.1097/00007435-199010000-00007; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Cavalcante EGF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-595; FOLKERS E, 1988, GENITOURIN MED, V64, P249; Gayet-Ageron A, 2013, SEX TRANSM INFECT, V89, P251, DOI 10.1136/sextrans-2012-050622; Heymans R, 2010, J CLIN MICROBIOL, V48, P497, DOI 10.1128/JCM.00720-09; Hope-Rapp E, 2010, SEX TRANSM DIS, V37, P153, DOI 10.1097/OLQ.0b013e3181bf5a98; Hoyo C, 2005, SEX TRANSM DIS, V32, P231, DOI 10.1097/01.olq.0000149669.98128.ce; JANIER M, 1990, GENITOURIN MED, V66, P43; KOUTSKY LA, 1992, NEW ENGL J MED, V326, P1533, DOI 10.1056/NEJM199206043262305; Lai W, 2003, SEX TRANSM INFECT, V79, P202, DOI 10.1136/sti.79.3.202; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Leslie DE, 2007, J CLIN MICROBIOL, V45, P93, DOI 10.1128/JCM.01578-06; Lewis DA, 2003, SEX TRANSM INFECT, V79, P68, DOI 10.1136/sti.79.1.68; Lewis DA, 2012, SEX TRANSM DIS, V39, P880, DOI 10.1097/OLQ.0b013e318269cf90; Lin HC, 1999, CANCER RES, V59, P807; Makasa M, 2012, SEX TRANSM DIS, V39, P787, DOI 10.1097/OLQ.0b013e31826ae97d; Ministerio da Saude do Brasil, 2008, PROGR NAC DST AIDS P; Ministerio da Saude do Brasil, 2006, MIN SAUD BRAS SER MA, V68; Moodley P, 2003, SEX TRANSM DIS, V30, P241, DOI 10.1097/00007435-200303000-00013; Gomes CMM, 2007, BRAZ J INFECT DIS, V11, P254, DOI 10.1590/S1413-86702007000200018; Morrow RA, 2003, J CLIN MICROBIOL, V41, P5212, DOI 10.1128/JCM.41.11.5212-5214.2003; Morse SA, 1997, J INFECT DIS, V175, P583, DOI 10.1093/infdis/175.3.583; Nilsen A, 2007, ACTA DERM-VENEREOL, V87, P355, DOI 10.2340/00015555-0241; Orle KA, 1996, J CLIN MICROBIOL, V34, P49, DOI 10.1128/JCM.34.1.49-54.1996; Paz-Bailey G, 2005, CLIN INFECT DIS, V41, P1304, DOI 10.1086/496979; Paz-Bailey G, 2010, CLIN INFECT DIS, V50, P1060, DOI 10.1086/651115; Pedrosa VL, 2011, J BRAS DOENCAS SEX T, V23, P57; Prabhakar P, 2012, SEX TRANSM DIS, V39, P906, DOI 10.1097/OLQ.0b013e3182663e22; Risbud A, 1999, SEX TRANSM DIS, V26, P55, DOI 10.1097/00007435-199901000-00009; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Sambrook J., 2001, MOL CLONING LAB MANU; Suntoke TR, 2009, SEX TRANSM INFECT, V85, P97, DOI 10.1136/sti.2008.034207; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; Totten PA, 2000, J CLIN MICROBIOL, V38, P268; Vickerman P, 2008, SEX TRANSM INFECT, V84, P243, DOI 10.1136/sti.2007.027136; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; WHO, 2007, TRAIN MAN WHO PACK E, P1	51	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63953	10.1371/journal.pone.0063953	http://dx.doi.org/10.1371/journal.pone.0063953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704961	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200092
J	Zhang, HR; Wei, XM; Tao, HJ; Mwansisya, TE; Pu, WD; He, Z; Hu, AM; Xu, L; Liu, ZN; Shan, BC; Xue, ZM				Zhang, Huiran; Wei, Xiaomei; Tao, Haojuan; Mwansisya, Tumbwene E.; Pu, Weidan; He, Zhong; Hu, Aimin; Xu, Lin; Liu, Zhening; Shan, Baoci; Xue, Zhimin			Opposite Effective Connectivity in the Posterior Cingulate and Medial Prefrontal Cortex between First-Episode Schizophrenic Patients with Suicide Risk and Healthy Controls	PLOS ONE			English	Article							WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; DEFAULT NETWORK; BRAIN; DOPAMINE; MODE; FMRI; INVOLVEMENT; DYSFUNCTION; CIRCUITS	Objective: The schizophrenic patients with high suicide risk are characterized by depression, better cognitive function, and prominent positive symptoms. However, the neurobiological basis of suicide attempts in schizophrenia is not clear. The suicide in schizophrenia is implicated in the defects in emotional process and decision-making, which are associated with prefrontal-cingulate circuit. In order to explore the possible neurobiological basis of suicide in schizophrenia, we investigated the correlation of prefrontal-cingulate circuit with suicide risk in schizophrenia via dynamic casual modelling. Method: Participants were 33 first-episode schizophrenic patients comprising of a high suicide risk group (N = 14) and a low suicide risk group (N = 19). A comparison group of healthy controls (N = 15) were matched for age, gender and education. N-back tasking functional magnetic resonance imaging data was collected. Results: Compared with healthy controls group, the two patients groups showed decreased task-related suppression during 2-back task state versus baseline state in the left posterior cingulate and medial prefrontal cortex; the hyper-connectivity from the left posterior cingulate cortex to the left medial prefrontal cortex existed in both schizophrenic patients groups, but hypo-connectivity in the opposite direction only existed in the schizophrenic patients group with high suicide risk. Conclusions: The hyper-connectivity from the left posterior cingulate cortex to the left medial prefrontal cortex may suggest that the abnormal effective connectivity was associated with risk for schizophrenia. The hypo-connectivity in the opposite direction may represent a possible correlate of increased vulnerability to suicide attempt.	[Zhang, Huiran; Tao, Haojuan; Mwansisya, Tumbwene E.; Pu, Weidan; Hu, Aimin; Liu, Zhening; Xue, Zhimin] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Wei, Xiaomei; Shan, Baoci] Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Anal Tech, Beijing, Peoples R China; [Zhang, Huiran] Zhengzhou Univ, Affiliated Hosp 1, Dept Psychiat, Zhengzhou, Peoples R China; [Mwansisya, Tumbwene E.] Univ Dodoma, Dept Clin Nursing & Community Hlth, Dodoma, Tanzania; [He, Zhong] Cent S Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China; [Xu, Lin] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China	Central South University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Zhengzhou University; Central South University; Chinese Academy of Sciences; Kunming Institute of Zoology	Wei, XM (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Anal Tech, Beijing, Peoples R China.	zningl@163.com; x.zhimin@163.com		Shan, Baoci/0000-0001-7417-5063; Xu, Lin/0000-0002-2710-3507; Liu, Zhening/0000-0001-6893-2427	National Natural Science Foundation of China [81171287, 30971053, 81271485, 81071092]; National 973 Program of China [2011CB707800]; Specialized Research Fund for the Doctoral Program of Higher Education [20110162110017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (81171287, 30971053 to Dr. Zhimin Xue, and 81271485, 81071092 to Dr. Z. Liu), the National 973 Program of China (2011CB707800 to Dr. Zhening Liu), and Specialized Research Fund for the Doctoral Program of Higher Education (20110162110017 to Dr. Zhening Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar EJ, 2008, PROG NEURO-PSYCHOPH, V32, P1673, DOI 10.1016/j.pnpbp.2008.06.016; Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bertolino A, 2009, BRAIN, V132, P417, DOI 10.1093/brain/awn248; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; D'Argembeau A, 2012, CEREB CORTEX, V22, P659, DOI 10.1093/cercor/bhr144; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Delaney C, 2012, SCHIZOPHR RES, V140, P232, DOI 10.1016/j.schres.2012.06.017; Dutta R, 2010, ARCH GEN PSYCHIAT, V67, P1230, DOI 10.1001/archgenpsychiatry.2010.157; Feenstra MGP, 2000, PROG BRAIN RES, V126, P133; Fenton WS, 1997, AM J PSYCHIAT, V154, P199; First M.B., 2014, STRUCTURED CLIN INTE; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Fusar-Poli P, 2007, NEUROSCI BIOBEHAV R, V31, P465, DOI 10.1016/j.neubiorev.2006.11.006; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gupta S, 1998, PSYCHIAT SERV, V49, P1353, DOI 10.1176/ps.49.10.1353; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Holt D. J., 2009, SCHIZOPHRENIA B, V37, P164; Johnson SC, 2005, J COGNITIVE NEUROSCI, V17, P1897, DOI 10.1162/089892905775008607; Laviolette SR, 2006, CELL MOL LIFE SCI, V63, P1597, DOI 10.1007/s00018-006-6027-5; Laviolette SR, 2007, SCHIZOPHRENIA BULL, V33, P971, DOI 10.1093/schbul/sbm048; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Marenco S, 2012, NEUROPSYCHOPHARMACOL, V37, P499, DOI 10.1038/npp.2011.215; Mendrek A, 2005, PSYCHOL MED, V35, P187, DOI 10.1017/S0033291704003228; Monkul ES, 2007, MOL PSYCHIATR, V12, P360, DOI 10.1038/sj.mp.4001919; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Parks J., 2006, MORBIDITY MORTALITY; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Perlstein WM, 2003, BIOL PSYCHIAT, V53, P25, DOI 10.1016/S0006-3223(02)01675-X; Rusch N, 2008, PSYCHIAT RES-NEUROIM, V164, P206, DOI 10.1016/j.pscychresns.2007.12.011; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Sripada CS, 2011, HUM BRAIN MAPP, V32, P1637, DOI 10.1002/hbm.21136; Stretton J, 2012, NEUROIMAGE, V60, P1696, DOI 10.1016/j.neuroimage.2012.01.126; Taiminen T, 2001, SCHIZOPHR RES, V47, P199, DOI 10.1016/S0920-9964(00)00126-2; Tan HY, 2005, AM J PSYCHIAT, V162, P1849, DOI 10.1176/appi.ajp.162.10.1849; Thermenos HW, 2010, AM J MED GENET B, V153B, P120, DOI 10.1002/ajmg.b.30964; van Heeringen C, 2011, NEUROSCI BIOBEHAV R, V35, P688, DOI 10.1016/j.neubiorev.2010.08.007; Ventura R, 2007, P NATL ACAD SCI USA, V104, P5181, DOI 10.1073/pnas.0610178104; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106	45	48	49	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63477	10.1371/journal.pone.0063477	http://dx.doi.org/10.1371/journal.pone.0063477			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704911	Green Published, gold			2022-12-27	WOS:000319330200043
J	Meng, ZJ; Zhang, XY; Wu, J; Pei, RJ; Xu, Y; Yang, DL; Roggendorf, M; Lu, MJ				Meng, Zhongji; Zhang, Xiaoyong; Wu, Jun; Pei, Rongjuan; Xu, Yang; Yang, Dongliang; Roggendorf, Michael; Lu, Mengji			RNAi Induces Innate Immunity through Multiple Cellular Signaling Pathways	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SMALL-INTERFERING RNAS; DOUBLE-STRANDED RNAS; PROTEIN-KINASE; PRIMARY HEPATOCYTES; GENE-EXPRESSION; REPLICATION; INHIBITION; SIRNA; INDUCTION	Background & Aims: Our previous results showed that the knockdown of woodchuck hepatitis virus (WHV) by RNA interference (RNAi) led to upregulation of interferon stimulated genes (ISGs) in primary hepatocytes. In the present study, we tested the hypothesis that the cellular signaling pathways recognizing RNA molecules may be involved the ISG stimulation by RNAi. Methods: Primary murine hepatocytes (PMHs) from wild type mice and WHV transgenic (Tg) mice were prepared and treated with defined siRNAs. The mRNA levels of target genes and ISGs were detected by real-time RT-PCR. The involvement of the signaling pathways including RIG-I/MDA5, PKR, and TLR3/7/8/9 was examined by specific inhibition and the analysis of their activation by Western blotting. Results: In PMHs from WHV Tg mice, specific siRNAs targeting WHV, mouse beta-actin, and GAPDH reduced the levels of targeted mRNAs and increased the mRNA expression of IFN-beta, MxA, and IP-10. The enhanced ISG expression by siRNA transfection were abolished by siRNA-specific 2'-O-methyl antisense RNA and the inhibitors 2-AP and chloroquine blocking PKR and other TLR-mediated signaling pathways. Furthermore, Western blotting revealed that RNAi results in an increase in PKR phosphorylation and nuclear translocation of IRF3 and NF-eB, indicating the possible role of IRF3 in the RNAi-directed induction of ISGs. In contrast, silencing of RIG-I and MDA5 failed to block RNAi-mediated MxA induction. Conclusions: RNAi is capable of enhancing innate immune responses through the PKR-and TLR-dependent signaling pathways in primary hepatocytes. The immune stimulation by RNAi may contribute to the antiviral activity of siRNAs in vivo.	[Meng, Zhongji; Zhang, Xiaoyong; Pei, Rongjuan; Roggendorf, Michael; Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Meng, Zhongji] Hubei Univ Med, Taihe Hosp, Dept Infect Dis, Shiyan, Peoples R China; [Wu, Jun; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Xu, Yang] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Microbiol, Wuhan 430074, Peoples R China	University of Duisburg Essen; Hubei University of Medicine; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Lu, MJ (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	mengji.lu@uni-due.de	Lu, Mengji/ABF-9410-2020	Meng, Zhongji/0000-0003-0401-535X	Deutsche Forschungsgemeinschaft [GK1045/2, TRR60]; Natural Science Foundation of Hubei Province, China [2010CDZ036]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province)	This study was supported by the grants of Deutsche Forschungsgemeinschaft (GK1045/2 and TRR60), and partially supported by the Natural Science Foundation of Hubei Province, China (2010CDZ036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Diebold SS, 2006, EUR J IMMUNOL, V36, P3256, DOI 10.1002/eji.200636617; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Ebert G, 2011, GASTROENTEROLOGY, V141, P696, DOI 10.1053/j.gastro.2011.05.001; Fernandez M, 2003, J GEN VIROL, V84, P2073, DOI 10.1099/vir.0.18966-0; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Fucini RV, 2012, NUCLEIC ACID THER, V22, P205, DOI 10.1089/nat.2011.0334; Gantier MP, 2008, J IMMUNOL, V180, P2117, DOI 10.4049/jimmunol.180.4.2117; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; HU YH, 1993, J INTERFERON RES, V13, P323, DOI 10.1089/jir.1993.13.323; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kabilova TO, 2012, NUCLEIC ACID THER, V22, P196, DOI 10.1089/nat.2011.0328; Klein C, 2003, GASTROENTEROLOGY, V125, P9, DOI 10.1016/S0016-5085(03)00720-0; Konishi M, 2003, HEPATOLOGY, V38, P842, DOI 10.1053/jhep.2003.50416; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Meng ZJ, 2008, J VIROL METHODS, V150, P27, DOI 10.1016/j.jviromet.2008.02.008; Meng ZJ, 2009, VIROLOGY, V384, P88, DOI 10.1016/j.virol.2008.11.012; Morrissey DV, 2005, HEPATOLOGY, V41, P1349, DOI 10.1002/hep.20702; Moss EG, 2003, NAT CELL BIOL, V5, P771, DOI 10.1038/ncb0903-771; Olejniczak M, 2012, RNA, V18, P930, DOI 10.1261/rna.025627.110; Olejniczak M, 2011, CURR GENE THER, V11, P532, DOI 10.2174/156652311798192770; Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Shlomai A, 2003, HEPATOLOGY, V37, P764, DOI 10.1053/jhep.2003.50146; Singh SK, 2009, BIODRUGS, V23, P269, DOI 10.2165/11317120-000000000-00000; Sioud M, 2006, EUR J IMMUNOL, V36, P1222, DOI 10.1002/eji.200535708; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Subramanya S, 2010, EXPERT OPIN BIOL TH, V10, P201, DOI 10.1517/14712590903448158; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Wu HL, 2005, GASTROENTEROLOGY, V128, P708, DOI 10.1053/j.gastro.2004.12.007; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Wu M, 2007, J GEN VIROL, V88, P3260, DOI 10.1099/vir.0.82959-0; Yoo JW, 2006, BIOCHEM BIOPH RES CO, V347, P1053, DOI 10.1016/j.bbrc.2006.07.001; Zhang XY, 2009, CELL MICROBIOL, V11, P1624, DOI 10.1111/j.1462-5822.2009.01353.x; Zhang ZS, 2004, J VIROL, V78, P4566, DOI 10.1128/JVI.78.9.4566-4572.2004; Zheng XF, 2004, RNA, V10, P1934, DOI 10.1261/rna.7150804	50	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64708	10.1371/journal.pone.0064708	http://dx.doi.org/10.1371/journal.pone.0064708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700487	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400063
J	Tan, CS; Broge, TA; Seung, E; Vrbanac, V; Viscidi, R; Gordon, J; Tager, AM; Koralnik, IJ				Tan, Chen Sabrina; Broge, Thomas A., Jr.; Seung, Edward; Vrbanac, Vlad; Viscidi, Raphael; Gordon, Jennifer; Tager, Andrew M.; Koralnik, Igor J.			Detection of JC Virus-Specific Immune Responses in a Novel Humanized Mouse Model	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; CYTOTOXIC T-LYMPHOCYTES; DNA; MICE; PML; BK; INDIVIDUALS; REPLICATION; ASSOCIATION; EXPRESSION	Progressive Multifocal Leukoencephalopathy (PML) is an often fatal disease caused by the reactivation of the JC virus (JCV). Better understanding of viral-host interactions has been hampered by the lack of an animal model. Engrafting NOD/SCID/IL-2-Rg (null) mice with human lymphocytes and thymus, we generated a novel animal model for JCV infection. Mice were inoculated with either a PML isolate, JCV Mad-4, or with JCV CY, found in the kidney and urine of healthy individuals. While mice remained asymptomatic following inoculation, JCV DNA was occasionally detected in both the blood and the urine compartments. Mice generated both humoral and cellular immune responses against JCV. Expressions of immune exhaustion marker, PD-1, on lymphocytes were consistent with response to infection. Using this model we present the first in vivo demonstration of virological and immunological differences between JCV Mad-4 and CY. This model may prove valuable for studying JCV host immune responses.	[Tan, Chen Sabrina] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Tan, Chen Sabrina; Broge, Thomas A., Jr.; Koralnik, Igor J.] Beth Israel Deaconess Med Ctr, Dept Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Tan, Chen Sabrina; Broge, Thomas A., Jr.; Koralnik, Igor J.] Beth Israel Deaconess Med Ctr, Dept Neurol, Div NeuroVirol, Boston, MA 02215 USA; [Seung, Edward; Vrbanac, Vlad; Tager, Andrew M.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA USA; [Viscidi, Raphael] Johns Hopkins Med Ctr, Baltimore, MD USA; [Gordon, Jennifer] Temple Univ, Dept Neurosci, Ctr Neurovirol, Sch Med, Philadelphia, PA 19122 USA; [Gordon, Jennifer] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Harvard University; Harvard Medical School	Tan, CS (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	ctan@bidmc.harvard.edu		Viscidi, Raphael/0000-0002-7906-8002	National Institutes of Health (NIH) [R01 NS 047029, NS 074995, NS R56 041198, K24 NS 060950]; Harvard University Center for AIDS Research (CFAR); NIH [P30 AI60354, K08 NS 064215-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, T32AI007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074995, R56NS041198, K08NS064215, K24NS060950, R01NS047029] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was conducted with support from National Institutes of Health (NIH) grants R01 NS 047029, NS 074995, NS R56 041198, and K24 NS 060950 to IJK; grants to CST and AMT from Harvard University Center for AIDS Research (CFAR); an NIH-funded program (P30 AI60354), and NIH grant K08 NS 064215-01 to CST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Du Pasquier RA, 2004, BRAIN, V127, P1970, DOI 10.1093/brain/awh215; Du Pasquier RA, 2003, J VIROL, V77, P11918, DOI 10.1128/JVI.77.22.11918-11926.2003; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Gheuens S, 2011, J VIROL, V85, P7256, DOI 10.1128/JVI.02506-10; Gorelik L, 2011, J INFECT DIS, V204, P103, DOI 10.1093/infdis/jir198; Koralnik IJ, 2002, J IMMUNOL, V168, P499, DOI 10.4049/jimmunol.168.1.499; Koralnik IJ, 1999, NEUROLOGY, V52, P253, DOI 10.1212/WNL.52.2.253; Lima MA, 2007, J VIROL, V81, P3361, DOI 10.1128/JVI.01809-06; MARKOWITZ RB, 1993, J INFECT DIS, V167, P13, DOI 10.1093/infdis/167.1.13; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; PADGETT BL, 1976, J INFECT DIS, V133, P686, DOI 10.1093/infdis/133.6.686; Perkins MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003014; Radhakrishnan S, 2003, J VIROL, V77, P10638, DOI 10.1128/JVI.77.19.10638-10644.2003; Reid CE, 2011, J INFECT DIS, V204, P237, DOI 10.1093/infdis/jir256; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Smith RWP, 2003, EUR J BIOCHEM, V270, P2030, DOI 10.1046/j.1432-1033.2003.03579.x; Sunyaev SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000368; Tan CS, 2010, LANCET NEUROL, V9, P425, DOI 10.1016/S1474-4422(10)70040-5; Tan CS, 2009, J INFECT DIS, V199, P881, DOI 10.1086/597117; Tan CS, 2012, JAIDS-J ACQ IMM DEF, V60, P244, DOI 10.1097/QAI.0b013e31825a313c; Tremolada S, 2010, VIROLOGY, V404, P312, DOI 10.1016/j.virol.2010.05.012; Viscidi RP, 2011, CLIN INFECT DIS, V53, P711, DOI 10.1093/cid/cir507; White RE, 2012, J CLIN INVEST, V122, P1487, DOI 10.1172/JCI58092; Wuthrich C, 2009, ANN NEUROL, V65, P742, DOI 10.1002/ana.21619; YOGO Y, 1990, J VIROL, V64, P3139, DOI 10.1128/JVI.64.6.3139-3143.1990	27	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64313	10.1371/journal.pone.0064313	http://dx.doi.org/10.1371/journal.pone.0064313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700470	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400053
J	Munshi, SU; Rewari, BB; Bhavesh, NS; Jameel, S				Munshi, Saif Ullah; Rewari, Bharat Bhushan; Bhavesh, Neel Sarovar; Jameel, Shahid			Nuclear Magnetic Resonance Based Profiling of Biofluids Reveals Metabolic Dysregulation in HIV-Infected Persons and Those on Anti-Retroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; METABONOMIC ANALYSIS; NMR-SPECTROSCOPY; AMINO-ACIDS; SERUM; DIAGNOSIS; PLASMA; IDENTIFICATION; PREVALENCE; SUPPORT	Background: Although HIV causes immune deficiency by infection and depletion of immunocytes, metabolic alterations with clinical manifestations are also reported in HIV/AIDS patients. Here we aimed to profile metabolite changes in the plasma, urine, and saliva of HIV/AIDS patients, including those on anti-retroviral therapy (ART). Methods: Metabolic profiling of biofluids collected from treatment naive HIV/AIDS patients and those receiving ART was done with solution-state nuclear magnetic resonance (NMR) spectroscopy followed by statistical analysis and annotation. Results: In Principal Component Analysis (PCA) of the NMR spectra, Principal Component 1 (PC1) alone accounted for 99.3%, 87.2% and 78.8% variations in plasma, urine, and saliva, respectively. Partial least squares discriminant analysis (PLS-DA) was applied to generate three-component models, which showed plasma and urine to be better than saliva in discriminating between patients and healthy controls, and between ART-naive patients and those receiving therapy. Twenty-six metabolites were differentially altered in any or two types of samples. Our results suggest that urinary Neopterin, and plasma Choline and Sarcosine could be used as metabolic biomarkers of HIV/AIDS infection. Pathway analysis revealed significant alternations in 12 metabolic pathways. Conclusions: This study catalogs differentially regulated metabolites in biofluids, which helped classify subjects as healthy controls, HIV/AIDS patients, and those on ART. It also underscores the importance of further studying the consequences of HIV infection on host metabolism and its implications for pathogenesis.	[Munshi, Saif Ullah; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India; [Rewari, Bharat Bhushan] Natl AIDS Control Org, New Delhi, India; [Bhavesh, Neel Sarovar] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Bhavesh, NS (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi, India.	neelsb@icgeb.res.in; shahid@icgeb.res.in	Bhavesh, Neel Sarovar/F-3127-2015	Bhavesh, Neel Sarovar/0000-0002-7248-4978	Department of Biotechnology (DBT), Government of India; NII, New Delhi; ICGEB	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); NII, New Delhi; ICGEB	The authors thank Department of Biotechnology (DBT), Government of India for providing financial support for the 500 MHz and 700 MHz NMR spectrometers at the ICGEB and NII, New Delhi. SUM received a Pre-Doctoral Fellowship from ICGEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alani Akanmu, 2010, Indian J Sex Transm Dis AIDS, V31, P99, DOI 10.4103/0253-7184.74995; Barchiesi F, 2002, J ANTIMICROB CHEMOTH, V50, P999, DOI 10.1093/jac/dkf233; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Carr A, 2003, CLIN INFECT DIS, V36, pS96, DOI 10.1086/367565; Chen HY, 2004, AIDS RES HUM RETROV, V20, P513, DOI 10.1089/088922204323087769; Coen M, 2005, CLIN INFECT DIS, V41, P1582, DOI 10.1086/497836; DEGANS J, 1989, CLIN NEUROL NEUROSUR, V91, P199, DOI 10.1016/0303-8467(89)90114-5; DESIMONE C, 1992, AIDS, V6, P203, DOI 10.1097/00002030-199202000-00011; Di Rocco A, 2002, NEUROLOGY, V58, P730, DOI 10.1212/WNL.58.5.730; Dobs AS, 1996, J CLIN ENDOCR METAB, V81, P4108, DOI 10.1210/jc.81.11.4108; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Flyckt RL, 2009, MENOPAUSE, V16, P680, DOI 10.1097/gme.0b013e318199d5c4; Garcia-Lorda P, 2000, JPEN-PARENTER ENTER, V24, P317, DOI 10.1177/0148607100024006317; Gasparis AP, 2001, NUTRITION, V17, P981, DOI 10.1016/S0899-9007(01)00707-9; Ghannoum M. A., 2012, OMICS, DOI [10.1089/omi.2011.0035, DOI 10.1089/0MI.2011.0035]; GHAURI FYK, 1993, NMR BIOMED, V6, P163, DOI 10.1002/nbm.1940060210; Godoy MMG, 2010, J VIRAL HEPATITIS, V17, P854, DOI 10.1111/j.1365-2893.2009.01252.x; Grinspoon S, 2003, CLIN INFECT DIS, V36, pS69, DOI 10.1086/367561; GRUNFELD C, 1992, NEW ENGL J MED, V327, P329, DOI 10.1056/NEJM199207303270506; GRUNFELD C, 1992, AM J CLIN NUTR, V55, P455, DOI 10.1093/ajcn/55.2.455; Hewer R, 2006, J PHARMACEUT BIOMED, V41, P1442, DOI 10.1016/j.jpba.2006.03.006; HORTIN GL, 1994, CLIN CHEM, V40, P785; Hughes JW, 2004, J PSYCHOSOM RES, V57, P353, DOI 10.1016/j.jpsychores.2004.02.016; Imai K, 2009, J IMMUNOL, V182, P3688, DOI 10.4049/jimmunol.0802906; Ironson G, 2008, INT J BEHAV MED, V15, P221, DOI 10.1080/10705500802219606; Jordao AA, 1998, NUTRITION, V14, P423, DOI 10.1016/S0899-9007(98)00012-4; Kamga HLF, 2011, J AIDS HIV RES, V3, P30; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Laurichesse H, 1998, J NUTR, V128, P1342, DOI 10.1093/jn/128.8.1342; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Lindon JC, 1999, ANNU REP NMR SPECTRO, V38, P1, DOI 10.1016/S0066-4103(08)60035-6; Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3; Madigan Ann, 1996, Pediatric Dentistry, V18, P129; Mao Y, 2008, J ZHEJIANG UNIV-SC B, V9, P474, DOI 10.1631/jzus.B0820044; Mataftsi M, 2011, ORAL DIS, V17, P13, DOI 10.1111/j.1601-0825.2010.01727.x; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Meyer SA, 1996, HIV RESOURCE REV, V1, P1; Meyerhoff DJ, 1999, NEUROLOGY, V52, P995, DOI 10.1212/WNL.52.5.995; Munshi SU, 2011, J VIRAL HEPATITIS, V18, pE591, DOI 10.1111/j.1365-2893.2011.01488.x; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Philippeos C, 2009, J BIOMOL NMR, V44, P127, DOI 10.1007/s10858-009-9329-8; Rietschel P, 2000, CLIN INFECT DIS, V31, P1240, DOI 10.1086/317457; ROSER W, 1995, MAGNET RESON MED, V33, P811, DOI 10.1002/mrm.1910330611; Salas-Salvado J, 2001, CLIN NUTR, V20, P379, DOI 10.1054/clnu.2001.0429; Sharpstone DR, 1996, AIDS, V10, P1377, DOI 10.1097/00002030-199610000-00010; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Sundstrom JB, 2003, EXP BIOL MED, V228, P730, DOI 10.1177/153537020322800613; Tan J, 2008, ENVIRON SCI TECHNOL, V42, P2681, DOI 10.1021/es7021363; Teichmann J, 1998, Eur J Med Res, V3, P533; Teichmann J, 2003, EUR J MED RES, V8, P77; Vorster HH, 2004, PUBLIC HEALTH NUTR, V7, P1055, DOI 10.1079/PHN2004643; Wanchu A, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-15; Weis BC, 2004, MAGN RESON MED, V51, P649, DOI 10.1002/mrm.20057; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xia JG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-507; Yarasheski KE, 2005, AM J PHYSIOL-ENDOC M, V288, pE278, DOI 10.1152/ajpendo.00359.2004	61	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64298	10.1371/journal.pone.0064298	http://dx.doi.org/10.1371/journal.pone.0064298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696880	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900083
J	Pelaez-Garcia, A; Barderas, R; Torres, S; Hernandez-Varas, P; Teixido, J; Bonilla, F; de Herreros, AG; Casal, JI				Pelaez-Garcia, Alberto; Barderas, Rodrigo; Torres, Sofia; Hernandez-Varas, Pablo; Teixido, Joaquin; Bonilla, Felix; Garcia de Herreros, Antonio; Ignacio Casal, J.			FGFR4 Role in Epithelial-Mesenchymal Transition and Its Therapeutic Value in Colorectal Cancer	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; T(4/14) MULTIPLE-MYELOMA; PROSTATE-CANCER; CELL-LINES; HEPATOCELLULAR-CARCINOMA; RECEPTOR 4; IN-VIVO; GLY388ARG POLYMORPHISM; LUNG ADENOCARCINOMA; SOMATIC MUTATIONS	Fibroblast growth factor receptor 4 (FGFR4) is vital in early development and tissue repair. FGFR4 expression levels are very restricted in adult tissues, except in several solid tumors including colorectal cancer, which showed overexpression of FGFR4. Here, FGFR4 mutation analysis discarded the presence of activating mutations, other than Arg(388), in different colorectal cancer cell lines and tumoral samples. Stable shRNA FGFR4-silencing in SW480 and SW48 cell lines resulted in a significant decrease in cell proliferation, adhesion, cell migration and invasion. This decrease in the tumorigenic and invasive capabilities of colorectal cancer cells was accompanied by a decrease of Snail, Twist and TGF beta gene expression levels and an increase of E-cadherin, causing a reversion to a more epithelial phenotype, in three different cell lines. In addition, FGFR4-signaling activated the oncogenic SRC, ERK1/2 and AKT pathways in colon cancer cells and promoted an increase in cell survival. The relevance of FGFR4 in tumor growth was supported by two different strategies. Kinase inhibitors abrogated FGFR4-related cell growth and signaling pathways at the same extent than FGFR4-silenced cells. Specific FGFR4-targeting using antibodies provoked a similar reduction in cell growth. Moreover, FGFR4 knock-down cells displayed a reduced capacity for in vivo tumor formation and angiogenesis in nude mice. Collectively, our data support a crucial role for FGFR4 in tumorigenesis, invasion and survival in colorectal cancer. In addition, FGFR4 targeting demonstrated its applicability for colorectal cancer therapy.	[Pelaez-Garcia, Alberto; Barderas, Rodrigo; Torres, Sofia; Ignacio Casal, J.] CSIC, CIB, Dept Celular & Mol Med, Madrid, Spain; [Hernandez-Varas, Pablo; Teixido, Joaquin] CSIC, CIB, Chemokines & Cell Migrat Lab, Madrid, Spain; [Bonilla, Felix] Hosp Puerta de Hierro Majadahonda, Madrid, Spain; [Garcia de Herreros, Antonio] Hosp del Mar, IMIM, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Puerta de Hierro-Majadahonda; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Casal, JI (corresponding author), CSIC, CIB, Dept Celular & Mol Med, Madrid, Spain.	icasal@cib.csic.es	de Herreros, A Garcia/H-3104-2014; Casal, Ignacio/M-2312-2014; Barderas, Rodrigo/K-3560-2014; Teixidó, Joaquin/J-8543-2014	de Herreros, A Garcia/0000-0001-5270-0808; Casal, Ignacio/0000-0003-1085-2840; Barderas, Rodrigo/0000-0003-3539-7469; Torres, Sofia/0000-0002-9007-8105; Hernandez-Varas, Pablo/0000-0001-8664-9203	Spanish Ministry of Science and Innovation [BIO2009-08818]; Comunidad de Madrid [S2011/BMD-2344/Colomics2]; FPI fellowship of the Spanish Ministry of Science and Innovation; JAE-DOC/FSE Contract (CSIC)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); FPI fellowship of the Spanish Ministry of Science and Innovation; JAE-DOC/FSE Contract (CSIC)	This research was supported by grant BIO2009-08818 from the Spanish Ministry of Science and Innovation, grant to established research groups (AECC) and grant S2011/BMD-2344/Colomics2 from Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Francisco X. Real (CNIO) for helpful collaboration and Novartis for the kind gift of inhibitor TKI-258. A. Pelaez-Garcia is a recipient of a FPI fellowship of the Spanish Ministry of Science and Innovation. R. Barderas was a recipient of a JAE-DOC/FSE Contract (CSIC) and is currently a fellow of the Ramon y Cajal programme. S. Torres was a recipient of a ProteoRed contract.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Acevedo VD, 2009, CELL CYCLE, V8, P580, DOI 10.4161/cc.8.4.7657; Auguste P, 2001, CANCER RES, V61, P1717; Babel I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001784; Babel I, 2009, MOL CELL PROTEOMICS, V8, P2382, DOI 10.1074/mcp.M800596-MCP200; Bange J, 2002, CANCER RES, V62, P840; Barderas R, 2008, INT J CANCER, V122, P2351, DOI 10.1002/ijc.23395; Barderas R, 2012, J PROTEOMICS, V75, P4647, DOI 10.1016/j.jprot.2012.03.004; Barderas R, 2012, CANCER RES, V72, P2780, DOI 10.1158/0008-5472.CAN-11-4090; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Cronauer MV, 2003, EUR UROL, V43, P309, DOI 10.1016/S0302-2838(03)00005-8; de Frutos CA, 2007, DEV CELL, V13, P872, DOI 10.1016/j.devcel.2007.09.016; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ezzat S, 2002, J CLIN INVEST, V109, P69, DOI 10.1172/JCI200214036; FitzGerald LM, 2009, PROSTATE CANCER P D, V12, P192, DOI 10.1038/pcan.2008.46; French DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036713; GAGOS S, 1995, ANTICANCER RES, V15, P369; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Greulich H, 2011, TRENDS MOL MED, V17, P283, DOI 10.1016/j.molmed.2011.01.012; Heinzle C, 2012, CANCER RES, V72, P5767, DOI 10.1158/0008-5472.CAN-11-3654; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; JAAKKOLA S, 1993, INT J CANCER, V54, P378, DOI 10.1002/ijc.2910540305; Lee SH, 2005, CLIN CANCER RES, V11, P3633, DOI 10.1158/1078-0432.CCR-04-2129; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Martinez-Torrecuadrada JM, 2005, CLIN CANCER RES, V11, P6280, DOI 10.1158/1078-0432.CCR-05-0282; Martinez-Torrecuadrada JL, 2008, MOL CANCER THER, V7, P862, DOI 10.1158/1535-7163.MCT-07-0394; MORIKAWA K, 1988, CANCER RES, V48, P1943; MORIKAWA K, 1988, CANCER RES, V48, P6863; Nan H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-172; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Ruhe JE, 2007, CANCER RES, V67, P11368, DOI 10.1158/0008-5472.CAN-07-2703; Sahadevan K, 2007, J PATHOL, V213, P82, DOI 10.1002/path.2205; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Spinola M, 2005, ONCOL REP, V14, P415; Spinola M, 2005, J CLIN ONCOL, V23, P7307, DOI 10.1200/JCO.2005.17.350; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Streit S, 2004, INT J CANCER, V111, P213, DOI 10.1002/ijc.20204; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Timmerman P, 2009, J BIOL CHEM, V284, P34126, DOI 10.1074/jbc.M109.041459; Tomlinson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038972; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Trudel S, 2004, BLOOD, V103, P3521, DOI 10.1182/blood-2003-10-3650; Trudel S, 2006, BLOOD, V107, P4039, DOI 10.1182/blood-2005-10-4179; Wang JH, 2004, CLIN CANCER RES, V10, P6169, DOI 10.1158/1078-0432.CCR-04-0408; Wang JH, 2008, NEOPLASIA, V10, P847, DOI 10.1593/neo.08450; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485; Yang CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033870; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200; Zhu XG, 2010, AM J PATHOL, V177, P2860, DOI 10.2353/ajpath.2010.100509	54	43	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63695	10.1371/journal.pone.0063695	http://dx.doi.org/10.1371/journal.pone.0063695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696849	Green Submitted, Green Published, gold			2022-12-27	WOS:000319081900055
J	Utsunomiya, YT; O'Brien, AMP; Sonstegard, TS; Van Tassell, CP; do Carmo, AS; Meszaros, G; Solkner, J; Garcia, JF				Utsunomiya, Yuri Tani; O'Brien, Ana Maria Perez; Sonstegard, Tad Stewart; Van Tassell, Curtis Paul; do Carmo, Adriana Santana; Meszaros, Gabor; Soelkner, Johann; Garcia, Jose Fernando			Detecting Loci under Recent Positive Selection in Dairy and Beef Cattle by Combining Different Genome-Wide Scan Methods	PLOS ONE			English	Article							ARTIFICIAL SELECTION; CELL-DEATH; SIGNATURES; LACTATION; RECEPTOR; REGIONS; PROTEIN; ASSOCIATION; METABOLISM; FOOTPRINTS	As the methodologies available for the detection of positive selection from genomic data vary in terms of assumptions and execution, weak correlations are expected among them. However, if there is any given signal that is consistently supported across different methodologies, it is strong evidence that the locus has been under past selection. In this paper, a straightforward frequentist approach based on the Stouffer Method to combine P-values across different tests for evidence of recent positive selection in common variations, as well as strategies for extracting biological information from the detected signals, were described and applied to high density single nucleotide polymorphism (SNP) data generated from dairy and beef cattle (taurine and indicine). The ancestral Bovinae allele state of over 440,000 SNP is also reported. Using this combination of methods, highly significant (P<3.17 x 10(-7)) population-specific sweeps pointing out to candidate genes and pathways that may be involved in beef and dairy production were identified. The most significant signal was found in the Cornichon homolog 3 gene (CNIH3) in Brown Swiss (P = 3.82 x 10(-12)), and may be involved in the regulation of pre-ovulatory luteinizing hormone surge. Other putative pathways under selection are the glucolysis/gluconeogenesis, transcription machinery and chemokine/cytokine activity in Angus; calpain-calpastatin system and ribosome biogenesis in Brown Swiss; and gangliosides deposition in milk fat globules in Gyr. The composite method, combined with the strategies applied to retrieve functional information, may be a useful tool for surveying genome-wide selective sweeps and providing insights in to the source of selection.	[Utsunomiya, Yuri Tani; do Carmo, Adriana Santana] UNESP Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Med Vet Prevent & Reprod Anim, Sao Paulo, Brazil; [O'Brien, Ana Maria Perez; Meszaros, Gabor; Soelkner, Johann] BOKU Univ Nat Resources & Life Sci, Div Livestock Sci, Dept Sustainable Agr Syst, Vienna, Austria; [Garcia, Jose Fernando] UNESP Univ Estadual Paulista, Fac Med Vet Aracatuba, Dept Apoio Saude & Prod Anim, Sao Paulo, Brazil; [Sonstegard, Tad Stewart; Van Tassell, Curtis Paul] ARS, Bovine Funct Genom Lab, USDA, Beltsville, MD USA	Universidade Estadual Paulista; University of Natural Resources & Life Sciences, Vienna; Universidade Estadual Paulista; United States Department of Agriculture (USDA)	Solkner, J (corresponding author), BOKU Univ Nat Resources & Life Sci, Div Livestock Sci, Dept Sustainable Agr Syst, Vienna, Austria.	johann.soelkner@boku.ac.at; jfgarcia@fmva.unesp.br	Van Tassell, Curtis P./O-4247-2019; Utsunomiya, Yuri Tani T/K-5214-2013; Mészáros, Gábor/I-2658-2019; Carmo, Adriana S/E-4342-2016	Van Tassell, Curtis P./0000-0002-8416-2087; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Mészáros, Gábor/0000-0002-5937-0060; Carmo, Adriana S/0000-0002-2712-4789; Solkner, Johann/0000-0002-1517-5829; Perez O'Brien, Ana Maria/0000-0002-2077-8421	European Science Foundation; Advances in Farm Animal Genomic Resources project [3726]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [560922/2010-8, 483590/2010-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/16643-2, 2010/52030-2]; USDA Agricultural Research Service [1265-31000-098D]	European Science Foundation(European Science Foundation (ESF)European Commission); Advances in Farm Animal Genomic Resources project; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research received support from the European Science Foundation and the Advances in Farm Animal Genomic Resources project (process no 3726), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (processes 560922/2010-8 and 483590/2010-0), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (processes 2011/16643-2 and 2010/52030-2) and USDA Agricultural Research Service (project 1265-31000-098D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the U. S. Department of Agriculture, the University of Natural Resources and Life Sciences Vienna, and The HapMap and The Zebu Genome Consortia for providing the genotypes used in this paper. We want to express our highest gratitude to the European Science Foundation and the Advances in Farm Animal Genomic Resources project for supporting this research. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the authors or their respective institutions.	Ajmone-Marsan P, 2010, EVOL ANTHROPOL, V19, P148, DOI 10.1002/evan.20267; Andersen KG, 2012, PHILOS T R SOC B, V367, P868, DOI 10.1098/rstb.2011.0299; Arnandis T, 2012, CELL DEATH DIFFER, V19, P1536, DOI 10.1038/cdd.2012.46; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bode L, 2004, J NUTR, V134, P3016, DOI 10.1093/jn/134.11.3016; Brann DW, 1997, ENDOCR REV, V18, P678, DOI 10.1210/er.18.5.678; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fay JC, 2000, GENETICS, V155, P1405; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; FU YX, 1993, GENETICS, V133, P693; Gadient RA, 1999, STEM CELLS, V17, P127, DOI 10.1002/stem.170127; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Grosz MD, 1999, J HERED, V90, P233, DOI 10.1093/jhered/90.1.233; Hayes BJ, 2008, ANIM GENET, V39, P105, DOI 10.1111/j.1365-2052.2007.01683.x; Hayes BJ, 2009, ANIM GENET, V40, P176, DOI 10.1111/j.1365-2052.2008.01815.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kinsella RJ, 2011, ENSEMBL BIOMARTS HUB; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Koohmaraie M, 2006, MEAT SCI, V74, P34, DOI 10.1016/j.meatsci.2006.04.025; Kuhla B, 2011, J PROTEOME RES, V10, P4252, DOI 10.1021/pr200425h; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Momoeda M, 2007, J BIOCHEM, V142, P525, DOI 10.1093/jb/mvm175; Murray C, 2010, PHILOS T R SOC B, V365, P2531, DOI 10.1098/rstb.2010.0103; Nielsen R, 1998, GENETICS, V148, P929; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Oleksyk TK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001712; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-318; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schwarzenbacher H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-48; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Stella A, 2010, GENETICS, V185, P1451, DOI 10.1534/genetics.110.116111; Sugimoto M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013817; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TAJIMA F, 1989, GENETICS, V123, P585; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wilde CJ, 1997, EXP PHYSIOL, V82, P943, DOI 10.1113/expphysiol.1997.sp004075; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Zhao CP, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/756284; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42; Zoico E, 2002, NUTR REV, V60, P39, DOI 10.1301/00296640260085949	56	70	73	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64280	10.1371/journal.pone.0064280	http://dx.doi.org/10.1371/journal.pone.0064280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696874	Green Submitted, Green Published, gold			2022-12-27	WOS:000319081900077
J	Pradhan, P; Reusser, DE; Kropp, JP				Pradhan, Prajal; Reusser, Dominik E.; Kropp, Juergen P.			Embodied Greenhouse Gas Emissions in Diets	PLOS ONE			English	Article							FOOD-CONSUMPTION PATTERNS; CLIMATE; TRANSFORMATION; AGRICULTURE; ENERGY	Changing food consumption patterns and associated greenhouse gas (GHG) emissions have been a matter of scientific debate for decades. The agricultural sector is one of the major GHG emitters and thus holds a large potential for climate change mitigation through optimal management and dietary changes. We assess this potential, project emissions, and investigate dietary patterns and their changes globally on a per country basis between 1961 and 2007. Sixteen representative and spatially differentiated patterns with a per capita calorie intake ranging from 1,870 to >3,400 kcal/day were derived. Detailed analyses show that low calorie diets are decreasing worldwide, while in parallel diet composition is changing as well: a discernable shift towards more balanced diets in developing countries can be observed and steps towards more meat rich diets as a typical characteristics in developed countries. Low calorie diets which are mainly observable in developing countries show a similar emission burden than moderate and high calorie diets. This can be explained by a less efficient calorie production per unit of GHG emissions in developing countries. Very high calorie diets are common in the developed world and exhibit high total per capita emissions of 3.7-6.1 kg CO2eq./day due to high carbon intensity and high intake of animal products. In case of an unbridled demographic growth and changing dietary patterns the projected emissions from agriculture will approach 20 Gt CO2eq./yr by 2050.	[Pradhan, Prajal; Reusser, Dominik E.; Kropp, Juergen P.] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Kropp, Juergen P.] Univ Potsdam, Dept Geo & Environm Sci, Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung; University of Potsdam	Pradhan, P (corresponding author), Potsdam Inst Climate Impact Res, Potsdam, Germany.	pradhan@pik-potsdam.de	Kropp, Juergen/D-8220-2012; Pradhan, Prajal/ABE-2912-2020	Kropp, Juergen/0000-0001-7791-3420; Pradhan, Prajal/0000-0003-0491-5489	Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany within the framework of the International Climate Protection Initiative	Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany within the framework of the International Climate Protection Initiative	The authors acknowledge the financial support from the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany who supports this work within the framework of the International Climate Protection Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N, 2006, WORLD AGR 2030 2050; BAUER HU, 1992, IEEE T NEURAL NETWOR, V3, P570, DOI 10.1109/72.143371; Bruinsma J, 2003, WORLD AGR 2015 2030; Carlsson-Kanyama A, 2009, AM J CLIN NUTR, V89, pS1704, DOI 10.3945/ajcn.2009.26736AA; Conforti P, 1997, AGR ECOSYST ENVIRON, V65, P231, DOI 10.1016/S0167-8809(97)00048-0; Costa L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029262; DFT-UK, 2008, CARB SUST REP REN TR; Eshel G, 2006, EARTH INTERACT, V10, DOI 10.1175/EI167.1; Eshel G, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI321.1; FAO, 2001, FOOD BAL SHEETS HDB; FAOSTAT, 2011, GLOBAL FOOD LOSSES F; Fleurbaey M, 2009, J ECON LIT, V47, P1029, DOI 10.1257/jel.47.4.1029; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gerbens-Leenes PW, 2010, APPETITE, V55, P597, DOI 10.1016/j.appet.2010.09.013; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gonzalez AD, 2011, FOOD POLICY, V36, P562, DOI 10.1016/j.foodpol.2011.07.003; Grigg D., 1999, GeoJournal, V48, P259, DOI 10.1023/A:1007047007738; GRIGG D, 1995, GEOFORUM, V26, P1, DOI 10.1016/0016-7185(94)00020-8; GRIGG D, 1995, J HIST GEOGR, V21, P247, DOI 10.1006/jhge.1995.0018; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Imhoff ML, 2004, NATURE, V429, P870, DOI 10.1038/nature02619; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; KARIEL HG, 1966, ANN ASSOC AM GEOGR, V56, P68, DOI 10.1111/j.1467-8306.1966.tb00544.x; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Kohonen T., 2001, SPRINGER SERIES INFO; Kropp J, 1998, APPL GEOGR, V18, P83, DOI 10.1016/S0143-6228(97)00048-9; Kropp JP, 2008, PROTOTYPING BROAD SC, P155; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Ludeke M. K. B., 1999, Environmental Modeling & Assessment, V4, P315, DOI 10.1023/A:1019032821703; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Metz ORDB, 2007, CLIMATE CHANGE 2007; Molden D, 2007, WATER FOOD WATER LIF, P279; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Popp A, 2010, GLOBAL ENVIRON CHANG, V20, P451, DOI 10.1016/j.gloenvcha.2010.02.001; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Schneider U. A., 2008, ENERGY EFFICIENCY, V2, P195, DOI DOI 10.1007/S12053-008-9035-5; Skupin A, 2002, LECT NOTES COMPUT SC, V2539, P161; Skupin A, 2008, INTRO WHAT IS SELF O, P1; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; TW Andreson, 2003, INTRO MULTIVARIATE S; UNDP, 2009, OV BARR HUM MOB DEV; US EPA, 2006, GLOB ANTHR NON CO2 G; WILLETT WC, 1994, SCIENCE, V264, P532, DOI 10.1126/science.8160011; Yan J, 2008, VISUAL EXPLORATION S, P67	48	79	79	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e62228	10.1371/journal.pone.0062228	http://dx.doi.org/10.1371/journal.pone.0062228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23700408	Green Published, Green Submitted, gold			2022-12-27	WOS:000319052700007
J	Allais-Bonnet, A; Grohs, C; Medugorac, I; Krebs, S; Djari, A; Graf, A; Fritz, S; Seichter, D; Baur, A; Russ, I; Bouet, S; Rothammer, S; Wahlberg, P; Esquerre, D; Hoze, C; Boussaha, M; Weiss, B; Thepot, D; Fouilloux, MN; Rossignol, MN; van Marle-Koster, E; Hreidarsdottir, GE; Barbey, S; Dozias, D; Cobo, E; Reverse, P; Catros, O; Marchand, JL; Soulas, P; Roy, P; Marquant-Leguienne, B; Le Bourhis, D; Clement, L; Salas-Cortes, L; Venot, E; Pannetier, M; Phocas, F; Klopp, C; Rocha, D; Fouchet, M; Journaux, L; Bernard-Capel, C; Ponsart, C; Eggen, A; Blum, H; Gallard, Y; Boichard, D; Pailhoux, E; Capitan, A				Allais-Bonnet, Aurelie; Grohs, Cecile; Medugorac, Ivica; Krebs, Stefan; Djari, Anis; Graf, Alexander; Fritz, Sebastien; Seichter, Doris; Baur, Aurelia; Russ, Ingolf; Bouet, Stephan; Rothammer, Sophie; Wahlberg, Per; Esquerre, Diane; Hoze, Chris; Boussaha, Mekki; Weiss, Bernard; Thepot, Dominique; Fouilloux, Marie-Noelle; Rossignol, Marie-Noelle; van Marle-Koster, Este; Hreidarsdottir, Gunnfridur Elin; Barbey, Sarah; Dozias, Dominique; Cobo, Emilie; Reverse, Patrick; Catros, Olivier; Marchand, Jean-Luc; Soulas, Pascal; Roy, Pierre; Marquant-Leguienne, Brigitte; Le Bourhis, Daniel; Clement, Laetitia; Salas-Cortes, Laura; Venot, Eric; Pannetier, Maelle; Phocas, Florence; Klopp, Christophe; Rocha, Dominique; Fouchet, Michel; Journaux, Laurent; Bernard-Capel, Carine; Ponsart, Claire; Eggen, Andre; Blum, Helmut; Gallard, Yves; Boichard, Didier; Pailhoux, Eric; Capitan, Aurelien			Novel Insights into the Bovine Polled Phenotype and Horn Ontogenesis in Bovidae	PLOS ONE			English	Article							INSULIN-LIKE FACTOR-3; DECREASES COLLAGEN-SYNTHESIS; WNT/BETA-CATENIN; GENE; RELAXIN; MUTATIONS; ASSOCIATION; EXPRESSION; RECEPTORS; CATTLE	Despite massive research efforts, the molecular etiology of bovine polledness and the developmental pathways involved in horn ontogenesis are still poorly understood. In a recent article, we provided evidence for the existence of at least two different alleles at the Polled locus and identified candidate mutations for each of them. None of these mutations was located in known coding or regulatory regions, thus adding to the complexity of understanding the molecular basis of polledness. We confirm previous results here and exhaustively identify the causative mutation for the Celtic allele (P-C) and four candidate mutations for the Friesian allele (P-F). We describe a previously unreported eyelash-and-eyelid phenotype associated with regular polledness, and present unique histological and gene expression data on bovine horn bud differentiation in fetuses affected by three different horn defect syndromes, as well as in wild-type controls. We propose the ectopic expression of a lincRNA in P-C/p horn buds as a probable cause of horn bud agenesis. In addition, we provide evidence for an involvement of OLIG2, FOXL2 and RXFP2 in horn bud differentiation, and draw a first link between bovine, ovine and caprine Polled loci. Our results represent a first and important step in understanding the genetic pathways and key process involved in horn bud differentiation in Bovidae.	[Allais-Bonnet, Aurelie; Thepot, Dominique; Le Bourhis, Daniel; Pannetier, Maelle; Pailhoux, Eric] INRA, Biol Dev & Reprod UMR 1198, Jouy En Josas, France; [Grohs, Cecile; Fritz, Sebastien; Baur, Aurelia; Bouet, Stephan; Wahlberg, Per; Hoze, Chris; Boussaha, Mekki; Weiss, Bernard; Venot, Eric; Phocas, Florence; Rocha, Dominique; Eggen, Andre; Boichard, Didier; Capitan, Aurelien] INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France; [Medugorac, Ivica; Rothammer, Sophie] Univ Munich, Chair Anim Genet & Husb, Munich, Germany; [Krebs, Stefan; Graf, Alexander; Blum, Helmut] Univ Munich, Lab Funct Genome Anal, Gene Ctr, Munich, Germany; [Djari, Anis; Klopp, Christophe] INRA, Biometrie & Intelligence Artificielle UR875, F-31326 Castanet Tolosan, France; [Fritz, Sebastien; Baur, Aurelia; Hoze, Chris; Marquant-Leguienne, Brigitte; Le Bourhis, Daniel; Clement, Laetitia; Salas-Cortes, Laura; Journaux, Laurent; Ponsart, Claire; Capitan, Aurelien] Natl Assoc Livestock & Artificial Inseminat Coope, Paris, France; [Seichter, Doris; Russ, Ingolf] Tierzuchtforsch eV Munchen, Grub, Germany; [Esquerre, Diane] Genotoul, GeT PlaGe, Castanet Tolosan, France; [Esquerre, Diane] INRA, Genet Cellulaire UMR444, F-31326 Castanet Tolosan, France; [Fouilloux, Marie-Noelle; Bernard-Capel, Carine] Inst Elevage, Paris, France; [Rossignol, Marie-Noelle] Genet Anal Lab Anim Species, Jouy En Josas, France; [van Marle-Koster, Este] Univ Pretoria, Dept Anim & Wildlife Sci, ZA-0002 Pretoria, South Africa; [Hreidarsdottir, Gunnfridur Elin] Farmers Assoc Iceland, Reykjavik, Iceland; [Barbey, Sarah; Dozias, Dominique; Cobo, Emilie; Gallard, Yves] INRA, Domaine Expt Pin au Haras UE0326, Exmes, France; [Reverse, Patrick; Fouchet, Michel] Genes Diffus, Douai, France; [Catros, Olivier; Marchand, Jean-Luc] Evolution, Rennes, France; [Soulas, Pascal] UCATRC, Lempdes, France; [Roy, Pierre] UALC, Naves, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Munich; University of Munich; INRAE; INRAE; University of Pretoria; INRAE	Capitan, A (corresponding author), INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France.	aurelien.capitan@jouy.inra.fr	Van Marle-Köster, Este/S-2197-2016; Rocha, Dominique/R-5546-2019; Boichard, Didier/AAD-8675-2020; Klopp, Christophe/J-3164-2019; Emilie, Cobo/AAM-9178-2021; Pannetier, Maëlle/AAQ-1626-2020; Capitan, Aurélien/M-3732-2015; Phocas, Florence/V-9579-2019	Van Marle-Köster, Este/0000-0002-3672-6976; Rocha, Dominique/0000-0003-4998-9641; Boichard, Didier/0000-0003-0361-2961; Klopp, Christophe/0000-0001-7126-5477; Emilie, Cobo/0000-0003-2902-5730; Ponsart, Claire/0000-0002-9633-4464; ROSSIGNOL, Marie-Noelle/0000-0003-1673-5258; boussaha, mekki/0000-0002-5432-4604; FRITZ, Sebastien/0000-0002-3378-1048; Pannetier, Maelle/0000-0002-5826-619X; Medugorac, Ivica/0000-0002-6891-3039; Seichter, Doris/0000-0002-0325-1134; Rothammer, Sophie/0000-0001-5704-5814; Phocas, Florence/0000-0003-1161-3665	Apis Gene "Hornout"; Institut National de la Recherche Agronomique-DGA "Interpolled" grant; Institut National de la Recherche Agronomique-DGA "Hornaseq" grant	Apis Gene "Hornout"; Institut National de la Recherche Agronomique-DGA "Interpolled" grant; Institut National de la Recherche Agronomique-DGA "Hornaseq" grant	This project was funded by Apis Gene "Hornout" and Institut National de la Recherche Agronomique-DGA "Interpolled" and "Hornaseq" grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett RG, 2009, TRANSL RES, V154, P1, DOI 10.1016/j.trsl.2009.03.007; BILDSOE H, 2012, DEV BIOL, DOI DOI 10.1016/J.YDBI0.2012.12.004; Bildsoe H, 2009, DEV BIOL, V331, P176, DOI 10.1016/j.ydbio.2009.04.034; Boichard D, 2012, ANIM PROD SCI, V52, P115, DOI 10.1071/AN11119; Brenneman RA, 1996, J HERED, V87, P156, DOI 10.1093/oxfordjournals.jhered.a022975; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bruchle NO, 2008, J INVEST DERMATOL, V128, P791, DOI 10.1038/sj.jid.5701088; CAPITAN A, 2010, THESIS I SCI IND VIV; Capitan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049084; Capitan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022242; Capitan A, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-33; Cargill Edward J, 2008, BMC Res Notes, V1, P128, DOI 10.1186/1756-0500-1-128; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cervantes-Barragan DE, 2011, J MED GENET, V48, P716, DOI 10.1136/jmedgenet-2011-100251; COLE LJ, 1924, P WORLDS DAIRY C, V2, P1383; Cooney TE, 2009, ANN NY ACAD SCI, V1160, P329, DOI 10.1111/j.1749-6632.2008.03801.x; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; Delalande JM, 2008, DEV DYNAM, V237, P1060, DOI 10.1002/dvdy.21485; Drogemuller C, 2005, MAMM GENOME, V16, P613, DOI 10.1007/s00335-005-0016-0; Drogemuller C, 2005, COMP FUNCT GENOM, V6, P194, DOI 10.1002/cfg.476; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Ferlin A, 2008, J BONE MINER RES, V23, P683, DOI 10.1359/JBMR.080204; Ferlin A, 2006, J CLIN ENDOCR METAB, V91, P3426, DOI 10.1210/jc.2006-0821; Ferlin A, 2009, ANN NY ACAD SCI, V1160, P215, DOI 10.1111/j.1749-6632.2008.03787.x; Fu P, 2006, J ENDOCRINOL, V189, P397, DOI 10.1677/joe.1.06697; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037137; Gorlov IP, 2002, HUM MOL GENET, V11, P2309, DOI 10.1093/hmg/11.19.2309; Graf B, 1999, APPL ANIM BEHAV SCI, V62, P153, DOI 10.1016/S0168-1591(98)00218-4; Hader C, 2010, ONCOGENE, V29, P1031, DOI 10.1038/onc.2009.397; Harlizius B, 1997, MAMM GENOME, V8, P255, DOI 10.1007/s003359900404; HERODOTUS, HISTORY; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; Krajnc-Franken MAM, 2004, MOL CELL BIOL, V24, P687, DOI 10.1128/MCB.24.2.687-696.2004; Lee WJ, 2012, PLAST RECONSTR SURG, V130, p407E, DOI 10.1097/PRS.0b013e31825dbf56; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LLOYDJONES O, 1916, IOWA AGR EXP STA AME, V30, P67; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; LONG SE, 1970, VET REC, V86, P161, DOI 10.1136/vr.86.6.161; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; MANSOUR S, 1993, GENEREVIEWS; Mariasegaram M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-370; MARQUANTLEGUIEN.B, 2011, REPROD FERT DEVELOP, V24, P198; Maruhashi M, 2005, DEV DYNAM, V234, P332, DOI 10.1002/dvdy.20546; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Misch LJ, 2007, CAN VET J, V48, P1249; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Pannetier M, 2005, GENOMICS, V85, P715, DOI 10.1016/j.ygeno.2005.02.011; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Pepe A, 2009, ANN NY ACAD SCI, V1160, P219, DOI 10.1111/j.1749-6632.2008.03785.x; Prayaga KC, 2007, AUST J AGR RES, V58, P1, DOI 10.1071/AR06044; ROMAN A, 2004, B SOC FR HIST MED SC, V3, P35; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Samuel CS, 2007, ADV EXP MED BIOL, V612, P88; Samuel CS, 2005, CLIN MED RES, V3, P241, DOI 10.3121/cmr.3.4.241; Samuel CS, 2003, ARCH BIOCHEM BIOPHYS, V411, P47, DOI 10.1016/S0003-9861(02)00710-5; SCHMULIAN A, 2006, THESIS U PRETORIA PR; SCHMUTZ SM, 1995, MAMM GENOME, V6, P710, DOI 10.1007/BF00354293; Seibold JR, 2000, ANN INTERN MED, V132, P871, DOI 10.7326/0003-4819-132-11-200006060-00004; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; SPECHT LW, 2008, POLLED HOLSTEIN HIST; SPILLMAN WJ, 1906, P AM BREEDERS ASS, V1, P171; TACITUS, OXFORD TRANSLATION R; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tukel T, 2010, AM J HUM GENET, V87, P289, DOI 10.1016/j.ajhg.2010.07.009; UNEMORI EN, 1992, J INVEST DERMATOL, V99, P337, DOI 10.1111/1523-1747.ep12616665; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	86	70	76	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63512	10.1371/journal.pone.0063512	http://dx.doi.org/10.1371/journal.pone.0063512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717440	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700030
J	Chang, Y; Sung, E; Yun, KE; Jung, HS; Kim, CW; Kwon, MJ; Cho, SI; Ryu, S				Chang, Yoosoo; Sung, Eunju; Yun, Kyung Eun; Jung, Hyun-Suk; Kim, Chan-Won; Kwon, Min-Jung; Cho, Sung-Il; Ryu, Seungho			Weight Change as a Predictor of Incidence and Remission of Insulin Resistance	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; METABOLIC SYNDROME; BARIATRIC SURGERY; ADIPOSE-TISSUE; OBESITY; ADIPONECTIN; ADIPOKINES; LEPTIN; GAIN; HYPERINSULINEMIA	Objective: The objective of this study was to assess the longitudinal relationship of weight change on incidence and remission of insulin resistance (IR). Methods: We performed a cohort study in apparently healthy Korean men, 30 to 59 years of age, who underwent a health checkup and were followed annually or biennially between 2002 and 2009. The computer model of homeostasis model assessment, HOMA2-IR, was obtained at each visit, and IR was defined as HOMA2-IR >= 75th percentile. Results: For IR development, 1,755 of the 6,612 IR-free participants at baseline developed IR (rate 5.1 per 100 person-years) during 34,294.8 person-years of follow-up. The hazard ratios (95% confidence intervals) for incident IR with weight changes of <-0.9 kg, 0.6-2.1 kg and >= 2.2 kg from visit 1 to visit 2 (average 1.8 years) compared to weight change of -0.9-0.5 kg (reference) were 0.78 (0.68-0.90), 1.19 (1.04-1.35) and 1.26 (1.11-1.44), respectively. This association persisted in normal-weight individuals or those without any metabolic syndrome traits and remained significant after introducing weight categories and confounders as time-dependent exposures (P-trend <0.001). For IR remission, 903 of 1,696 IR participants had no IR (remission rate 10.3 per 100 person-years) during 8,777.4 person-years of follow-up. IR remission decreased with increasing quartiles of weight change (P-trend <0.001) and this association persisted in normal-weight individuals. Conclusions: Weight gain was associated with increased IR development and decreased IR remission regardless of baseline BMI status. Preventing weight gain, even in healthy and normal-weight individuals, is an important strategy for reducing IR and its associated consequences.	[Chang, Yoosoo; Yun, Kyung Eun; Jung, Hyun-Suk; Kim, Chan-Won; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Total Healthcare Ctr,Ctr Cohort Studies, Seoul, South Korea; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Seoul, South Korea; [Sung, Eunju] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Family Med, Seoul, South Korea; [Kwon, Min-Jung] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Lab Med, Seoul, South Korea; [Cho, Sung-Il] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Cho, Sung-Il] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University (SNU)	Ryu, S (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Total Healthcare Ctr,Ctr Cohort Studies, Seoul, South Korea.	sh703.yoo@gmail.com	; Cho, Sung-il/D-5703-2012	Ryu, Seungho/0000-0002-3927-8646; Kim, Chan-Won/0000-0001-5836-1974; Cho, Sung-il/0000-0003-4085-1494; Chang, Yoosoo/0000-0002-6945-9050; SUNG, EUNJU/0000-0002-6045-3154				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anderson JW, 2003, J AM COLL NUTR, V22, P331, DOI 10.1080/07315724.2003.10719316; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Bonora E, 2007, DIABETES CARE, V30, P318, DOI 10.2337/dc06-0919; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Chang Y, 2012, INT J OBESITY, V36, P1187, DOI 10.1038/ijo.2011.247; Chang Y, 2007, CLIN CHEM, V53, P686, DOI 10.1373/clinchem.2006.081257; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Conus F, 2007, APPL PHYSIOL NUTR ME, V32, P4, DOI [10.1139/H06-092, 10.1139/h06-092]; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Erdmann J, 2008, AM J PHYSIOL-ENDOC M, V294, pE568, DOI 10.1152/ajpendo.00560.2007; Esteve E, 2009, DIABETES CARE, V32, pS362, DOI 10.2337/dc09-S340; Everson SA, 1998, DIABETES CARE, V21, P1637, DOI 10.2337/diacare.21.10.1637; Gumbs AA, 2005, OBES SURG, V15, P462, DOI 10.1381/0960892053723367; Iniguez G, 2004, J CLIN ENDOCR METAB, V89, P5500, DOI 10.1210/jc.2004-0792; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Klimcakova E, 2010, OBES REV, V11, P446, DOI 10.1111/j.1467-789X.2009.00704.x; Kumar AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032395; Lakka HM, 2002, HORM METAB RES, V34, P492, DOI 10.1055/s-2002-34788; Lang HF, 2011, NUTR RES, V31, P378, DOI 10.1016/j.nutres.2011.04.004; Lankinen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022646; Lee YH, 2011, METABOLISM, V60, P1664, DOI 10.1016/j.metabol.2011.04.008; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Maison P, 2001, DIABETES CARE, V24, P1758, DOI 10.2337/diacare.24.10.1758; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; Padwal Raj S, 2009, Evid Based Med, V14, P138, DOI 10.1136/ebm.14.5.138; Palaniappan L, 2004, DIABETES CARE, V27, P788, DOI 10.2337/diacare.27.3.788; Petridou ET, 2011, METABOLISM, V60, P1100, DOI 10.1016/j.metabol.2010.12.002; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Ryu S, 2012, AM J EPIDEMIOL, V175, P133, DOI 10.1093/aje/kwr291; Samocha-Bonet D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036320; Sesti G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017737; Tam CS, 2010, DIABETES, V59, P2164, DOI 10.2337/db10-0162; Verhagen SN, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-100; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; *WHO, WHO W PAC REG IAI AS	43	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63690	10.1371/journal.pone.0063690	http://dx.doi.org/10.1371/journal.pone.0063690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717466	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700049
J	Graham, JM; Ayati, BP; Holstein, SA; Martin, JA				Graham, Jason M.; Ayati, Bruce P.; Holstein, Sarah A.; Martin, James A.			The Role of Osteocytes in Targeted Bone Remodeling: A Mathematical Model	PLOS ONE			English	Article							BIOCHEMICAL SYSTEMS-ANALYSIS; RANK LIGAND; SCLEROSTIN; OSTEOPROTEGERIN; RESORPTION; BIOLOGY; LAW; OSTEOPOROSIS; SIMULATION; OSTEOBLAST	Until recently many studies of bone remodeling at the cellular level have focused on the behavior of mature osteoblasts and osteoclasts, and their respective precursor cells, with the role of osteocytes and bone lining cells left largely unexplored. This is particularly true with respect to the mathematical modeling of bone remodeling. However, there is increasing evidence that osteocytes play important roles in the cycle of targeted bone remodeling, in serving as a significant source of RANKL to support osteoclastogenesis, and in secreting the bone formation inhibitor sclerostin. Moreover, there is also increasing interest in sclerostin, an osteocyte-secreted bone formation inhibitor, and its role in regulating local response to changes in the bone microenvironment. Here we develop a cell population model of bone remodeling that includes the role of osteocytes, sclerostin, and allows for the possibility of RANKL expression by osteocyte cell populations. We have aimed to give a simple, yet still tractable, model that remains faithful to the underlying system based on the known literature. This model extends and complements many of the existing mathematical models for bone remodeling, but can be used to explore aspects of the process of bone remodeling that were previously beyond the scope of prior modeling work. Through numerical simulations we demonstrate that our model can be used to explore theoretically many of the qualitative features of the role of osteocytes in bone biology as presented in recent literature.	[Graham, Jason M.] Univ Scranton, Dept Math, Scranton, PA 18510 USA; [Ayati, Bruce P.] Univ Iowa, Dept Math, Iowa City, IA 52242 USA; [Ayati, Bruce P.] Univ Iowa, Program Appl Math & Computat Sci, Iowa City, IA USA; [Holstein, Sarah A.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Ayati, Bruce P.; Martin, James A.] Univ Iowa, Dept Orthopaed & Rehabil, Iowa City, IA USA	University of Scranton; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Graham, JM (corresponding author), Univ Scranton, Dept Math, Scranton, PA 18510 USA.		Ayati, Bruce P/J-6427-2012	Ayati, Bruce P/0000-0002-4472-6271; Martin, James/0000-0001-5085-0108; Graham, James/0000-0003-4778-2161	National Science Foundation (NSF) [DMS-0914514]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [1 P50 AR055533]; PhRMA Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055533] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PhRMA Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	BPA was partially supported by the National Science Foundation (NSF) under award DMS-0914514. JAM and BPA were partially supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant #1 P50 AR055533. SAH was partially supported by the PhRMA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardawi MSM, 2012, J BONE MINER RES, V27, P2592, DOI 10.1002/jbmr.1718; Ayati B, 2012, P 6 EUR C COMP METH; Ayati BP, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-28; Bell NH, 2003, J CLIN INVEST, V111, P1120, DOI 10.1172/JCI200318358; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunetti G, 2011, ANN NY ACAD SCI, V1237, P19, DOI 10.1111/j.1749-6632.2011.06196.x; Buenzli PR, 2011, BONE, V48, P918, DOI 10.1016/j.bone.2010.12.009; Buenzli PR, 2012, J THEOR BIOL, V307, P42, DOI 10.1016/j.jtbi.2012.04.019; Buenzli PR, 2012, BONE, V50, P378, DOI 10.1016/j.bone.2011.10.021; Burr DB, 2002, BONE, V30, P2, DOI 10.1016/S8756-3282(01)00619-6; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Cohen MM, 1997, J BONE MINER RES, V12, P322, DOI 10.1359/jbmr.1997.12.3.322; Defranoux NA, 2005, J BONE MINER RES, V20, P1079, DOI 10.1359/JBMR.050401; Geris L, 2010, BIOMECH MODEL MECHAN, V9, P713, DOI 10.1007/s10237-010-0208-8; Geris L, 2008, J THEOR BIOL, V251, P137, DOI 10.1016/j.jtbi.2007.11.008; Geris L, 2006, MED BIOL ENG COMPUT, V44, P280, DOI 10.1007/s11517-006-0040-6; Geris L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000915; Geris L, 2010, ACTA BIOTHEOR, V58, P355, DOI 10.1007/s10441-010-9112-y; Giuliani N, 2012, LEUKEMIA, V26, P1391, DOI 10.1038/leu.2011.381; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Graham JM, 2012, MATH BIOSCI ENG, V9, P281, DOI 10.3934/mbe.2012.9.281; Heino Terhi J, 2009, Technol Health Care, V17, P49, DOI 10.3233/THC-2009-0534; Hofbauer L. C., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P268; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Komarova SV, 2005, ENDOCRINOLOGY, V146, P3589, DOI 10.1210/en.2004-1642; Komarova SV, 2003, BONE, V33, P206, DOI 10.1016/S8756-3282(03)00157-1; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; Lewiecki EM, 2011, DISCOV MED, V12, P263; Lim V, 2012, MATURITAS, V73, P269, DOI 10.1016/j.maturitas.2012.08.002; Lio P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S12; Martin MJ, 2005, CALCIFIED TISSUE INT, V77, P250, DOI 10.1007/s00223-005-0101-0; Martin MJ, 2004, BONE, V35, P918, DOI 10.1016/j.bone.2004.06.010; Martin T. J., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P243; Neve A, 2012, ACTA PHYSIOL, V204, P317, DOI 10.1111/j.1748-1716.2011.02385.x; Parfitt A, 2012, BONE; Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1; Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025; Pivonka P, 2010, BONE, V47, P181, DOI 10.1016/j.bone.2010.04.601; Pivonka P, 2010, J THEOR BIOL, V262, P306, DOI 10.1016/j.jtbi.2009.09.021; Rossi J, 2012, COMPUT METH IN PRESS; Ryser MD, 2010, SIAM J APPL MATH, V70, P1899, DOI 10.1137/090746094; Ryser MD, 2009, J BONE MINER RES, V24, P860, DOI 10.1359/JBMR.081229; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P370, DOI 10.1016/S0022-5193(69)80027-5; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; SAVAGEAU MA, 1970, J THEOR BIOL, V26, P215, DOI 10.1016/S0022-5193(70)80013-3; SAVAGEAU MA, 1976, BIOCH SYSTEMS ANAL; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Shampine LF, 2003, SOLVING ODES MATLAB, DOI [10.1017/CBO9780511615542, DOI 10.1017/CB09780511615542.AVAILABLE:H]; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Udagawa N., 2002, PRINCIPLES BONE BIOL, V2nd ed.; Voit E. O., 2000, COMPUTATIONAL ANAL B; Xiong J, 2002, NAT MED, V17, P1235; Xu J, 2012, CLIN BIOCH IN PRESS; Yavropoulou MP, 2012, BONE, V51, P153, DOI 10.1016/j.bone.2012.04.016; Zumsande M, 2011, BONE, V48, P910, DOI 10.1016/j.bone.2010.12.010	59	60	61	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63884	10.1371/journal.pone.0063884	http://dx.doi.org/10.1371/journal.pone.0063884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717504	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700076
J	Zhang, YL; Luan, B; Wang, XF; Qiao, JY; Song, L; Lei, RR; Gao, WX; Liu, Y				Zhang, Yan-Li; Luan, Bin; Wang, Xiu-Fang; Qiao, Jun-Ying; Song, Li; Lei, Rui-Rui; Gao, Wei-Xia; Liu, Ying			Peripheral Blood MDSCs, IL-10 and IL-12 in Children with Asthma and Their Importance in Asthma Development	PLOS ONE			English	Article							INFLAMMATION; CELLS; INTERLEUKIN-10; POLYMORPHISMS; ASSOCIATION; RECEPTORS; ANTIGEN; SYSTEM; GROWTH	Objective: To investigate myeloid-derived suppressor cell (MDSC) accumulation and interleukin 10 (IL-10) and interleukin 12 (IL-12) levels during the onset of asthma in both pediatric patients and mouse models, as well as their possible roles in the development of asthma. Methods: Peripheral blood samples were gathered from children with asthma attacks (attack group) and alleviated asthma (alleviated group), as well as two control groups, children with pneumonia and healthy children. The pathological characteristics of asthma in asthmatic mice, budesonide-treated asthmatic mice, and normal control mice were also evaluated by immunohistochemistry (IHC) and hematoxylin and eosin (H&E) staining. Results: MDSC accumulation and serum IL-10 levels were significantly elevated in the children with asthma compared with the budesonide-treated alleviated group, normal healthy controls, and pneumonia controls (p<0.05), whereas those in the latter three groups showed no statistical differences (p>0.05). The level of serum IL-12 in the asthmatic children was drastically reduced compared to the budesonide-treated alleviated group, healthy controls, and pneumonia controls (p<0.05), whereas the latter three groups showed no significant differences in their serum IL-12 levels. The percentage of MDSCs in children with asthma was positively correlated with the level of serum IL-10 and negatively correlated with the level of serum IL-12. The levels of MDSCs and IL-10 in asthmatic mice were significantly higher than those in the normal control mice (both p<0.05) and were reduced after budesonide treatment (both p<0.05). IL-12 expression in the asthmatic mice was significantly lower than the control and was increased upon budesonide treatment (both p<0.05). Conclusion: During the onset of asthma, the accumulation of MDSCs and the level of serum IL-10 increase, while the level of IL-12 decreases. These fluctuations may play an important role in the development of asthma.	[Zhang, Yan-Li; Luan, Bin; Wang, Xiu-Fang; Qiao, Jun-Ying; Song, Li; Lei, Rui-Rui; Gao, Wei-Xia; Liu, Ying] Zhengzhou Univ, Affiliated Hosp 3, Dept Pediat, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Zhang, YL (corresponding author), Zhengzhou Univ, Affiliated Hosp 3, Dept Pediat, Zhengzhou, Henan, Peoples R China.	yanlizhang2012@gmail.com			Scientific and technological project of Henan Province Health Department [201003063]	Scientific and technological project of Henan Province Health Department	This work was supported by Scientific and technological project of Henan Province Health Department (201003063) to Yan-Li Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreae S, 2002, J IMMUNOL, V168, P3874, DOI 10.4049/jimmunol.168.8.3874; Bunt SK, 2009, J LEUKOCYTE BIOL, V85, P996, DOI 10.1189/jlb.0708446; Chen TY, 2011, HUM IMMUNOL, V72, P603, DOI 10.1016/j.humimm.2011.03.018; Deshane J, 2011, MUCOSAL IMMUNOL, V4, P503, DOI 10.1038/mi.2011.16; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; Du Q, 2008, CAN J PHYSIOL PHARM, V86, P449, DOI [10.1139/Y08-053, 10.1139/y08-053]; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Grissell TV, 2005, AM J RESP CRIT CARE, V172, P433, DOI 10.1164/rccm.200412-1621OC; Hakimizadeh E, 2012, CLIN LAB, V58, P267; Heffler E, 2006, RESP MED, V100, P1981, DOI 10.1016/j.rmed.2006.02.019; Hu CE, 2011, SCAND J GASTROENTERO, V46, P156, DOI 10.3109/00365521.2010.516450; Kao J, 2011, CRIT REV ONCOL HEMAT, V77, P13, DOI 10.1016/j.critrevonc.2010.02.004; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Li RB, 2010, PHARMACOLOGY, V85, P319, DOI 10.1159/000302725; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Ohbayashi Hiroyuki, 2005, Current Drug Targets - Inflammation and Allergy, V4, P177, DOI 10.2174/1568010053586246; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Pukelsheim K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014299; Randolph DA, 1999, J CLIN INVEST, V104, P1021, DOI 10.1172/JCI7631; Schroder NWJ, 2007, ALLERGY, V62, P579, DOI 10.1111/j.1398-9995.2007.01386.x; Sumi Yuki, 2007, Allergol Int, V56, P341, DOI 10.2332/allergolint.R-07-153; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Tsai TC, 2009, J ASTHMA, V46, P21, DOI 10.1080/02770900802460548; Ugel S, 2009, CURR OPIN PHARMACOL, V9, P470, DOI 10.1016/j.coph.2009.06.014; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Zheng XQ, 2010, HUM IMMUNOL, V71, P982, DOI 10.1016/j.humimm.2010.06.018	28	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63775	10.1371/journal.pone.0063775	http://dx.doi.org/10.1371/journal.pone.0063775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717481	gold, Green Submitted, Green Published			2022-12-27	WOS:000320362700059
J	Zhou, L; Situ, SJ; Huang, T; Hu, SX; Wang, XJ; Zhu, XP; Gao, LD; Li, Z; Feng, A; Jin, H; Wang, SY; Su, QR; Xu, Z; Feng, ZJ				Zhou, Lei; Situ, Sujian; Huang, Ting; Hu, Shixiong; Wang, Xianjun; Zhu, Xiaoping; Gao, Lidong; Li, Zhong; Feng, Ao; Jin, Hui; Wang, Shiyuan; Su, Qiru; Xu, Zhen; Feng, Zijian			Direct Medical Cost of Influenza-Related Hospitalizations among Severe Acute Respiratory Infections Cases in Three Provinces in China	PLOS ONE			English	Article							CHILDREN; IMPACT	Background: Influenza-related hospitalizations impose a considerable economic and social burden. This study aimed to better understand the economic burden of influenza-related hospitalizations among patients in China in different age and risk categories. Methods: Laboratory-confirmed influenza-related hospitalizations between December 2009 and June 2011 from three hospitals participating in the Chinese Severe Acute Respiratory Infections (SARI) sentinel surveillance system were included in this study. Hospital billing data were collected from each hospital's Hospital Information System (HIS) and divided into five cost categories. Demographic and clinical information was collected from medical records. Mean (range) and median (interquartile range [IQR]) costs were calculated and compared among children (<= 15 years), adults (16-64 years) and elderly (>= 65 years) groups. Factors influencing cost were analyzed. Results: A total of 106 laboratory-confirmed influenza-related hospitalizations were identified, 60% of which were children. The mean (range) direct medical cost was $1,797 ($80-$27,545) for all hospitalizations, and the median (IQR) direct medical cost was $231 ($164), $854 ($890), and $2,263 ($7,803) for children, adults, and elderly, respectively. Therapeutics and diagnostics were the two largest components of direct medical cost, comprising 57% and 23%, respectively. Cost of physician services was the lowest at less than 1%. Conclusion: Direct medical cost of influenza-related hospitalizations imposes a heavy burden on patients and their families in China. Further study is needed to provide more comprehensive evidence on the economic burden of influenza. Our study highlights the need to increase vaccination rate and develop targeted national preventive strategies.	[Zhou, Lei; Feng, Ao; Su, Qiru; Feng, Zijian] Chinese Ctr Dis Control & Prevent China CDC, Publ Hlth Emergency Ctr, Beijing, Peoples R China; [Situ, Sujian] US Ctr Dis Control & Prevent, Beijing, Peoples R China; [Huang, Ting; Zhu, Xiaoping] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Peoples R China; [Hu, Shixiong; Gao, Lidong] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Wang, Xianjun; Li, Zhong] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China; [Jin, Hui; Wang, Shiyuan] Southeast Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Peoples R China; [Xu, Zhen] Chinese Ctr Dis Control & Prevent China CDC, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Southeast University - China; Chinese Center for Disease Control & Prevention	Zhou, L (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Publ Hlth Emergency Ctr, Beijing, Peoples R China.	zhoulei@chinacdc.cn; xuzhen@chinacdc.cn	JIN, HUI/AAA-8732-2019; Jin, Hui/GXG-2296-2022		China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases	China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases	This study was supported by the China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; [Anonymous], FACT SHEET INFL SEAS; Census and statistics department Hong Kong SAR P.R. China, 2009, 2009 10 HOUS EXP SUR; Chinese Center for Disease Control and Prevention, 2011, SARI SURV PROT 2011; Chinese Center for Disease Control and Prevention, GUID SEAS INFL VACC; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Feng LZ, 2010, VACCINE, V28, P6778, DOI 10.1016/j.vaccine.2010.07.064; Financial management service, 2010, TREAS REP RAT EXCH D; Guo RN, 2011, PUBLIC HEALTH, V125, P389, DOI 10.1016/j.puhe.2011.03.004; Hall JL, 2005, J PEDIATR-US, V147, P807, DOI 10.1016/j.jpeds.2005.06.031; Hassan F, 2009, AM J PREV MED, V36, P292, DOI 10.1016/j.amepre.2008.11.016; Keren R, 2006, PEDIATRICS, V118, pE1321, DOI 10.1542/peds.2006-0598; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Ministry of Health of the People's Republic of China, GUID MIN HLTH 12 5 Y; Principi N, 2003, PEDIATR INFECT DIS J, V22, pS207, DOI 10.1097/01.inf.0000092188.48726.e4; World Bank, GDP PER CAP CURR US; World Health Organization Regional Office for Europe, 2011, WHO REG OFF EUR GUID; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044391	19	22	35	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63788	10.1371/journal.pone.0063788	http://dx.doi.org/10.1371/journal.pone.0063788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717485	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700061
J	Boothe, DL; Cohen, AH; Troyer, TW				Boothe, David L.; Cohen, Avis H.; Troyer, Todd W.			Phase Locking Asymmetries at Flexor-Extensor Transitions during Fictive Locomotion	PLOS ONE			English	Article							CENTRAL PATTERN GENERATOR; MAMMALIAN SPINAL-CORD; MOTOR UNITS; CAT; HINDLIMB; CYCLE; MUSCLES; RHYTHM; ORGANIZATION; MECHANISMS	The motor output for walking is produced by a network of neurons termed the spinal central pattern generator (CPG) for locomotion. The basic building block of this CPG is a half-center oscillator composed of two mutually inhibitory sets of interneurons, each controlling one of the two dominant phases of locomotion: flexion and extension. To investigate symmetry between the two components of this oscillator, we analyzed the statistics of natural variation in timing during fictive locomotion induced by stimulation of the midbrain locomotor region in the cat. As a complement to previously published analysis of these data focused on burst and cycle durations, we present a new analysis examining the strength of phase locking at the transitions between flexion and extension. Across our sample of nerve pairs, phase locking at the transition from extension to flexion (E to F) is stronger than at the transition from flexion to extension (F to E). This pattern did not reverse when considering bouts of fictive locomotion that were flexor vs. extensor dominated, demonstrating that asymmetric locking at the transitions between phases is dissociable from which phase dominates cycle duration. We also find that the strength of phase locking is correlated with the mean latency between burst offset and burst onset. These results are interpreted in the context of a hypothesis where network inhibition and intrinsic oscillatory mechanisms make distinct contributions to flexor-extensor alternation in half-center networks.	[Boothe, David L.; Cohen, Avis H.] Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA; [Cohen, Avis H.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Cohen, Avis H.] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Troyer, Todd W.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Texas System; University of Texas at San Antonio (UTSA)	Troyer, TW (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX USA.	todd.troyer@utsa.edu	Troyer, Todd W/C-2817-2011	Troyer, Todd W/0000-0002-2037-219X	United States National Science Foundation [IOS-0951310]; Division Of Integrative Organismal Systems [0951310] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work partially supported by United States National Science Foundation Grant IOS-0951310 to TWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABRAHAM LD, 1985, EXP BRAIN RES, V58, P580, DOI 10.1007/BF00235874; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Burke RE, 2001, J NEUROPHYSIOL, V86, P447, DOI 10.1152/jn.2001.86.1.447; Degtyarenko MA, 1996, J NEUROPHYSIOL, V76, P2972, DOI 10.1152/jn.1996.76.5.2972; DUM RP, 1980, J NEUROPHYSIOL, V43, P1615, DOI 10.1152/jn.1980.43.6.1615; EMONETDENAND F, 1988, J PHYSIOL-LONDON, V400, P135, DOI 10.1113/jphysiol.1988.sp017115; Endo T, 2008, J NEUROPHYSIOL, V100, P3043, DOI 10.1152/jn.90729.2008; ENGBERG I., 1964, PROGR BRAIN RES, V12, P274, DOI 10.1016/S0079-6123(08)60628-7; Frigon A, 2010, J NEUROSCI, V30, P7061, DOI 10.1523/JNEUROSCI.0450-10.2010; Frigon A, 2009, J PHYSIOL-LONDON, V587, P4617, DOI 10.1113/jphysiol.2009.176669; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Gossard JP, 2011, PROG BRAIN RES, V188, P15, DOI 10.1016/B978-0-444-53825-3.00007-3; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; GRILLNER S, 1984, ACTA PHYSIOL SCAND, V120, P393, DOI 10.1111/j.1748-1716.1984.tb07400.x; Jones SR, 2006, J MATH BIOL, V52, P115, DOI 10.1007/s00285-005-0348-0; Juvin L, 2007, J PHYSIOL-LONDON, V583, P115, DOI 10.1113/jphysiol.2007.133413; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Lafreniere-Roula M, 2005, J NEUROPHYSIOL, V94, P1120, DOI 10.1152/jn.00216.2005; Louage DHG, 2004, J NEUROPHYSIOL, V91, P2051, DOI 10.1152/jn.00816.2003; Lundberg A, 1969, NANSEN MEMORIAL LECT, VV, P5; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; MELLEN N, 1995, J NEUROPHYSIOL, V73, P1020, DOI 10.1152/jn.1995.73.3.1020; PERRET C, 1980, BRAIN RES, V187, P333, DOI 10.1016/0006-8993(80)90207-3; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rybak IA, 2006, J PHYSIOL-LONDON, V577, P617, DOI 10.1113/jphysiol.2006.118703; Sherwood WE, 2011, J COMPUT NEUROSCI, V30, P323, DOI 10.1007/s10827-010-0259-y; Skinner F K, 1994, J Comput Neurosci, V1, P69, DOI 10.1007/BF00962719; Spardy LE, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065003; WANG XJ, 1992, NEURAL COMPUT, V4, P84, DOI 10.1162/neco.1992.4.1.84; Yakovenko S, 2005, J NEUROPHYSIOL, V94, P1057, DOI 10.1152/jn.00991.2004; Zar JH, 1999, BIOSTATISTICAL ANAL	32	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64421	10.1371/journal.pone.0064421	http://dx.doi.org/10.1371/journal.pone.0064421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700475	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200133
J	Christoforou, N; Chellappan, M; Adler, AF; Kirkton, RD; Wu, TY; Addis, RC; Bursac, N; Leong, KW				Christoforou, Nicolas; Chellappan, Malathi; Adler, Andrew F.; Kirkton, Robert D.; Wu, Tianyi; Addis, Russell C.; Bursac, Nenad; Leong, Kam W.			Transcription Factors MYOCD, SRF, Mesp1 and SMARCD3 Enhance the Cardio-Inducing Effect of GATA4, TBX5, and MEF2C during Direct Cellular Reprogramming	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SERUM RESPONSE FACTOR; HUMAN SOMATIC-CELLS; LENTIVIRAL VECTORS; HUMAN FIBROBLASTS; GENE-EXPRESSION; DEFINED FACTORS; IN-VIVO; ELECTROPHYSIOLOGICAL PROPERTIES; FUNCTIONAL CARDIOMYOCYTES	Transient overexpression of defined combinations of master regulator genes can effectively induce cellular reprogramming: the acquisition of an alternative predicted phenotype from a differentiated cell lineage. This can be of particular importance in cardiac regenerative medicine wherein the heart lacks the capacity to heal itself, but simultaneously contains a large pool of fibroblasts. In this study we determined the cardio-inducing capacity of ten transcription factors to actuate cellular reprogramming of mouse embryonic fibroblasts into cardiomyocyte-like cells. Overexpression of transcription factors MYOCD and SRF alone or in conjunction with Mesp1 and SMARCD3 enhanced the basal but necessary cardio-inducing effect of the previously reported GATA4, TBX5, and MEF2C. In particular, combinations of five or seven transcription factors enhanced the activation of cardiac reporter vectors, and induced an upregulation of cardiac-specific genes. Global gene expression analysis also demonstrated a significantly greater cardio-inducing effect when the transcription factors MYOCD and SRF were used. Detection of cross-striated cells was highly dependent on the cell culture conditions and was enhanced by the addition of valproic acid and JAK inhibitor. Although we detected Ca2+ transient oscillations in the reprogrammed cells, we did not detect significant changes in resting membrane potential or spontaneously contracting cells. This study further elucidates the cardio-inducing effect of the transcriptional networks involved in cardiac cellular reprogramming, contributing to the ongoing rational design of a robust protocol required for cardiac regenerative therapies.	[Christoforou, Nicolas; Chellappan, Malathi; Adler, Andrew F.; Kirkton, Robert D.; Bursac, Nenad; Leong, Kam W.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Wu, Tianyi] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Addis, Russell C.] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Addis, Russell C.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Leong, KW (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	kam.leong@duke.edu	Leong, Kam W/A-7270-2009; Bursac, Nenad/AAU-5548-2021; Leong, Kam/O-9302-2019	Leong, Kam W/0000-0002-8133-4955; Bursac, Nenad/0000-0002-5688-6061; Leong, Kam/0000-0002-8133-4955; Kirkton, Robert/0000-0003-2285-1140; Wu, Tianyi/0000-0002-5386-2355	Flight Attendant Medical Research Institute - Young Clinical Scientist Award; NIH-NHLBI [R01HL104326, R21HL106203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104326, R21HL106203] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute - Young Clinical Scientist Award; NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding from Flight Attendant Medical Research Institute - Young Clinical Scientist Award (www.famri.org) and NIH-NHLBI grants R01HL104326 and R21HL106203 (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028719; Barth AS, 2008, MOL THER, V16, P957, DOI 10.1038/mt.2008.30; Bernheim L, 1996, J PHYSIOL-LONDON, V493, P129, DOI 10.1113/jphysiol.1996.sp021369; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Chilton L, 2005, AM J PHYSIOL-HEART C, V288, pH2931, DOI 10.1152/ajpheart.01220.2004; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; de Groot JR, 2003, CARDIOVASC RES, V60, P288, DOI 10.1016/j.cardiores.2003.07.004; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Heubach JF, 2004, J PHYSIOL-LONDON, V554, P659, DOI 10.1113/jphysiol.2003.055806; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; IANNACCONE ST, 1987, J CELL PHYSIOL, V133, P409, DOI 10.1002/jcp.1041330230; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Ke QG, 2007, MOL PHARMACOL, V72, P1063, DOI 10.1124/mol.107.035881; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; McSpadden LC, 2009, AM J PHYSIOL-CELL PH, V297, pC339, DOI 10.1152/ajpcell.00024.2009; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pijnappels DA, 2008, CIRC RES, V103, P167, DOI 10.1161/CIRCRESAHA.108.176131; Protze S, 2012, J MOL CELL CARDIOL, V53, P323, DOI 10.1016/j.yjmcc.2012.04.010; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; ROOK MB, 1992, AM J PHYSIOL, V263, pC959, DOI 10.1152/ajpcell.1992.263.5.C959; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; SUBRAMANIAM A, 1993, J BIOL CHEM, V268, P4331; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Welch P. D., 1967, AUDIO ELECTROACOUSTI, V15, P70, DOI DOI 10.1109/TAU.1967.1161901; Xiao YF, 2006, AM J PHYSIOL-CELL PH, V291, pC407, DOI 10.1152/ajpcell.00020.2006; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	62	99	102	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63577	10.1371/journal.pone.0063577	http://dx.doi.org/10.1371/journal.pone.0063577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704920	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200051
J	Jensen, AV; Jensen, L; Faurholt-Jepsen, D; Aabye, MG; Praygod, G; Kidola, J; Faurholt-Jepsen, M; Changalucha, J; Range, N; Krarup, H; Friis, H; Andersen, AB				Jensen, Andreas V.; Jensen, Lotte; Faurholt-Jepsen, Daniel; Aabye, Martine G.; Praygod, George; Kidola, Jeremiah; Faurholt-Jepsen, Maria; Changalucha, John; Range, Nyagosya; Krarup, Henrik; Friis, Henrik; Andersen, Aase B.			The Prevalence of Latent Mycobacterium tuberculosis Infection Based on an Interferon-gamma Release Assay: A Cross-Sectional Survey among Urban Adults in Mwanza, Tanzania	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; HIV; GLYCOPROTEIN; DIAGNOSIS; DISEASE; IMPACT; TOOLS	Introduction: One third of the world's population is estimated to be latently infected with Mycobacterium tuberculosis (LTBI). Surveys of LTBI are rarely performed in resource poor TB high endemic countries like Tanzania although low-income countries harbor the largest burden of the worlds LTBI. The primary objective was to estimate the prevalence of LTBI in household contacts of pulmonary TB cases and a group of apparently healthy neighborhood controls in an urban setting of such a country. Secondly we assessed potential impact of LTBI on inflammation by quantitating circulating levels of an acute phase reactant: alpha-1-acid glycoprotein (AGP) in neighborhood controls. Methods: The study was nested within the framework of two nutrition studies among TB patients in Mwanza, Tanzania. Household contacts-and neighborhood controls were invited to participate. The study involved a questionnaire, BMI determination and blood samples to measure AGP, HIV testing and a Quantiferon Gold In tube (QFN-IT) test to detect signs of LTBI. Results: 245 household contacts and 192 neighborhood controls had available QFN-IT data. Among household contacts, the proportion of QFT-IT positive was 59% compared to 41% in the neighborhood controls (p = 0.001). In a linear regression model adjusted for sex, age, CD4 and HIV, a QFT-IT positive test was associated with a 10% higher level of alpha-1- acid glycoprotein(AGP) (10(B) 1.10, 95% CI 1.01; 1.20, p = 0.03), compared to individuals with a QFT-IT negative test. Conclusion: LTBI is highly prevalent among apparently healthy urban Tanzanians even without known exposure to TB in the household. LTBI was found to be associated with elevated levels of AGP. The implications of this observation merit further studies.	[Jensen, Andreas V.; Jensen, Lotte; Andersen, Aase B.] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Faurholt-Jepsen, Daniel; Faurholt-Jepsen, Maria; Friis, Henrik] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Aabye, Martine G.] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr, Copenhagen, Denmark; [Praygod, George; Kidola, Jeremiah; Changalucha, John] Natl Inst Med Res, Mwanza Res Ctr, Mwanza, Tanzania; [Range, Nyagosya] Natl Inst Med Res, Muhimbili Res Ctr, Dar Es Salaam, Tanzania; [Krarup, Henrik] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark	University of Southern Denmark; Odense University Hospital; University of Copenhagen; University of Copenhagen; National Institute of Medical Research; National Institute of Medical Research; Aalborg University; Aalborg University Hospital	Jensen, AV (corresponding author), Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark.	Avestj@hotmail.com	Faurholt-Jepsen, Daniel/D-9453-2012; Friis, Henrik/P-2891-2019; Friis, Henrik/N-2047-2014; Faurholt-Jepsen, Daniel/M-6324-2019; PrayGod, George/L-7098-2018	Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Friis, Henrik/0000-0002-2848-2940; Friis, Henrik/0000-0002-2848-2940; Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Jensen, Andreas Vestergaard/0000-0002-8532-4703; Jeremiah, Kidola/0000-0001-7900-9689; PrayGod, George/0000-0002-0329-4839; Andersen, Aase Bengaard/0000-0003-4779-7603; Krarup, Henrik/0000-0001-5294-2428; Jensen, Lotte/0000-0001-7855-4036	University of Copenhagen	University of Copenhagen	The study was funded by the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004220; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Almeida MLD, 2009, T ROY SOC TROP MED H, V103, P575, DOI 10.1016/j.trstmh.2008.11.024; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Faurholt-Jepsen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024215; Faurholt-Jepsen M, 2011, BR J NUTR, P1; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852; Hernandez-Pando R, 1998, EXP MOL PATHOL, V65, P25, DOI 10.1006/exmp.1998.2224; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Idh J, 2010, SCAND J INFECT DIS, V42, P650, DOI 10.3109/00365548.2010.482942; Johnson DA, 2006, BIOMED CHROMATOGR, V20, P551, DOI 10.1002/bmc.641; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Ling D, 2011, LANCET INFECT DIS; Menzies D, 2011, INDIAN J MED RES, V133, P257; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; PrayGod G, 2011, J NUTR, V141, P685, DOI 10.3945/jn.110.131672; Ramanath RG, 1971, INDIAN J TUBERC, VXVIII, P3; Sheriff FG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-52; World Health Organization, 2009, 09 AIDS EP UPD; World Health Organization stop TB Department, 2010, US TUB INT GAMM REL, P1; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9	24	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64008	10.1371/journal.pone.0064008	http://dx.doi.org/10.1371/journal.pone.0064008			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700446	Green Published, gold			2022-12-27	WOS:000319330200104
J	MacIntosh, T; Desai, MM; Lewis, TT; Jones, BA; Nunez-Smith, M				MacIntosh, Tracy; Desai, Mayur M.; Lewis, Tene T.; Jones, Beth A.; Nunez-Smith, Marcella			Socially-Assigned Race, Healthcare Discrimination and Preventive Healthcare Services	PLOS ONE			English	Article							PERCEIVED DISCRIMINATION; ETHNIC-DIFFERENCES; RACIAL/ETHNIC DISCRIMINATION; MEDICARE BENEFICIARIES; RACIAL DISPARITIES; PROSTATE-CANCER; SKIN COLOR; BLACK; BREAST; WHITE	Background: Race and ethnicity, typically defined as how individuals self-identify, are complex social constructs. Self-identified racial/ethnic minorities are less likely to receive preventive care and more likely to report healthcare discrimination than self-identified non-Hispanic whites. However, beyond self-identification, these outcomes may vary depending on whether racial/ethnic minorities are perceived by others as being minority or white; this perception is referred to as socially-assigned race. Purpose: To examine the associations between socially-assigned race and healthcare discrimination and receipt of selected preventive services. Methods: Cross-sectional analysis of the 2004 Behavioral Risk Factor Surveillance System "Reactions to Race'' module. Respondents from seven states and the District of Columbia were categorized into 3 groups, defined by a composite of self-identified race/socially-assigned race: Minority/Minority (M/M, n = 6,837), Minority/White (M/W, n = 929), and White/White (W/W, n = 25,913). Respondents were 18 years or older, with 61.7% under age 60; 51.8% of respondents were female. Measures included reported healthcare discrimination and receipt of vaccinations and cancer screenings. Results: Racial/ethnic minorities who reported being socially-assigned as minority (M/M) were more likely to report healthcare discrimination compared with those who reported being socially-assigned as white (M/W) (8.9% vs. 5.0%, p = 0.002). Those reporting being socially-assigned as white (M/W and W/W) had similar rates for past-year influenza (73.1% vs. 74.3%) and pneumococcal (69.3% vs. 58.6%) vaccinations; however, rates were significantly lower among M/M respondents (56.2% and 47.6%, respectively, p-values < 0.05). There were no significant differences between the M/M and M/W groups in the receipt of cancer screenings. Conclusions: Racial/ethnic minorities who reported being socially-assigned as white are more likely to receive preventive vaccinations and less likely to report healthcare discrimination compared with those who are socially-assigned as minority. Socially-assigned race/ethnicity is emerging as an important area for further research in understanding how race/ethnicity influences health outcomes.	[MacIntosh, Tracy] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT USA; [Desai, Mayur M.; Jones, Beth A.; Nunez-Smith, Marcella] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06520 USA; [Desai, Mayur M.; Nunez-Smith, Marcella] Yale Univ, Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, New Haven, CT USA; [Lewis, Tene T.] Emory Univ, Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; [Nunez-Smith, Marcella] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06510 USA; [Nunez-Smith, Marcella] Yale Univ, Global Hlth Leadership Inst, New Haven, CT USA	Yale University; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Emory University; Yale University; Yale University	Nunez-Smith, M (corresponding author), Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06520 USA.	marcella.nunez-smith@yale.edu		Desai, Mayur/0000-0001-6616-0945; Nunez-Smith, Marcella/0000-0003-2797-4756	Yale School of Medicine Office of Student Research; Yale Center for Clinical Investigation via Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS), component of the National Institutes of Health (NIH) [UL1 RR024139]; NIH Roadmap for Medical Research; National Institutes of Health/National Cancer Institute [R21 CA134980-01]; Association of American Medical Colleges (AAMC) Nickens Faculty Fellowship; NATIONAL CANCER INSTITUTE [R21CA134980] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER	Yale School of Medicine Office of Student Research; Yale Center for Clinical Investigation via Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS), component of the National Institutes of Health (NIH); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Association of American Medical Colleges (AAMC) Nickens Faculty Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	TM was supported by a grant from the Yale School of Medicine Office of Student Research. MNS was supported, in part, by 1) the Yale Center for Clinical Investigation via Clinical and Translational Science Award (CTSA) Grant Number UL1 RR024139 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research, 2) the Association of American Medical Colleges (AAMC) Nickens Faculty Fellowship, and 3) the National Institutes of Health/National Cancer Institute: R21 CA134980-01 (PI: Nunez-Smith, M) at the time of this research. The manuscript contents are solely the responsibility of the authors and do not necessarily represent the official view of Yale University, NCRR, NIH, or the AAMC. None of the funders played any role in the design and conduct of the study, data collection, management, analysis, interpretation of the data, or the preparation, review, or approval of the manuscript. MNS had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Agency for Healthcare Research and Quality, 2007, 2007 NAT HEALTHC DIS; [Anonymous], 2008, SAS VERS 9 2 SAS ALL; [Anonymous], 2008, SUDAAN REL 10 0; Bazargan M, 2004, PREV MED, V39, P465, DOI 10.1016/j.ypmed.2004.05.003; Benjamins MR, 2012, MED CARE, V50, P870, DOI 10.1097/MLR.0b013e31825a8c63; Biello KB, 2010, AM J PREV MED, V38, P54, DOI 10.1016/j.amepre.2009.08.027; Bonito AJ, 2004, AM J PREV MED, V27, P153, DOI 10.1016/j.amepre.2004.04.004; Borrell LN, 2007, ANN EPIDEMIOL, V17, P335, DOI 10.1016/j.annepidem.2006.11.002; Burgess D, 2007, J GEN INTERN MED, V22, P882, DOI 10.1007/s11606-007-0160-1; Burgess DJ, 2010, MED DECIS MAKING, V30, P246, DOI 10.1177/0272989X09341751; Burton DC, 2010, AM J PUBLIC HEALTH, V100, P1904, DOI 10.2105/AJPH.2009.181313; Carpenter WR, 2009, CANCER-AM CANCER SOC, V115, P5048, DOI 10.1002/cncr.24539; Casagrande SS, 2007, J GEN INTERN MED, V22, P389, DOI 10.1007/s11606-006-0057-4; *CDCP, 2004, BEH RISK FACT SURV S; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P965; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1183; Centers for Disease Control and Prevention (CDC, 2009, EARL REL SEL EST BAS, P109; Centers for Disease Control and Prevention (CDC), 2005, 2004 BEH RISK FACT S, P38; Cooper GS, 2004, CANCER-AM CANCER SOC, V100, P418, DOI 10.1002/cncr.20014; Feresu SA, 2008, J HEALTH CARE POOR U, V19, P797, DOI 10.1353/hpu.0.0065; Gee GC, 2006, AM J PUBLIC HEALTH, V96, P1821, DOI 10.2105/AJPH.2005.080085; Gilligan T, 2004, ARCH INTERN MED, V164, P1858, DOI 10.1001/archinte.164.17.1858; Goldsmith AH, 2007, J HUM RESOUR, V42, P701; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Hausmann LRM, 2008, J GEN INTERN MED, V23, P1679, DOI 10.1007/s11606-008-0730-x; Hebert PL, 2005, HEALTH SERV RES, V40, P517, DOI 10.1111/j.1475-6773.2005.0e371.x; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Johnson RL, 2004, J GEN INTERN MED, V19, P101, DOI 10.1111/j.1525-1497.2004.30262.x; Jones CP, 2008, ETHNIC DIS, V18, P496; Jones CP, 2000, AM J PUBLIC HEALTH, V90, P1212, DOI 10.2105/AJPH.90.8.1212; KEITH VM, 1991, AM J SOCIOL, V97, P760, DOI 10.1086/229819; Kiang L, 2009, SOC SCI QUART, V90, P428, DOI 10.1111/j.1540-6237.2009.00625.x; Kressin NR, 2008, J HEALTH CARE POOR U, V19, P697, DOI 10.1353/hpu.0.0041; Lees KA, 2005, AM J PREV MED, V29, P404, DOI 10.1016/j.amepre.2005.08.009; McFadden B, 2009, RACE ETHNICITY LANGU, P264; McPhee SJ, 2002, PREV MED, V35, P463, DOI 10.1006/pmed.2002.1096; O'Malley AS, 2006, AM J PREV MED, V31, P150, DOI 10.1016/j.amepre.2006.03.021; Penner LA, 2010, J EXP SOC PSYCHOL, V46, P436, DOI 10.1016/j.jesp.2009.11.004; Penner LA, 2009, J BLACK PSYCHOL, V35, P180, DOI 10.1177/0095798409333585; Perez D, 2009, J GEN INTERN MED, V24, P548, DOI 10.1007/s11606-009-1097-3; Richman LS, 2007, J SOC CLIN PSYCHOL, V26, P960, DOI 10.1521/jscp.2007.26.8.960; Selvin E, 2003, AM J PUBLIC HEALTH, V93, P618, DOI 10.2105/AJPH.93.4.618; Shariff-Marco S, 2009, ETHNIC DIS, V19, P447; Shenson D, 2005, VACCINE, V23, P1015, DOI 10.1016/j.vaccine.2004.07.039; Smith RA, 2004, CA-CANCER J CLIN, V54, P41, DOI 10.3322/canjclin.54.1.41; Smith-Bindman R, 2006, ANN INTERN MED, V144, P541, DOI 10.7326/0003-4819-144-8-200604180-00004; Trivedi AN, 2006, J GEN INTERN MED, V21, P553, DOI 10.1111/j.1525-1497.2006.00413.x; Van Houtven CH, 2005, J GEN INTERN MED, V20, P578, DOI 10.1007/s11606-005-0104-6; Wagner J, 2007, DIABETES CARE, V30, P364, DOI 10.2337/dc06-1756; Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200; Winston CA, 2006, J AM GERIATR SOC, V54, P303, DOI 10.1111/j.1532-5415.2005.00585.x; Zapka JG, 1996, AM J PUBLIC HEALTH, V86, P1016, DOI 10.2105/AJPH.86.7.1016	52	36	37	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64522	10.1371/journal.pone.0064522	http://dx.doi.org/10.1371/journal.pone.0064522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23704992	gold, Green Submitted, Green Published			2022-12-27	WOS:000319330200146
J	Saberi, S; Emberly, E				Saberi, Saeed; Emberly, Eldon			Non-Equilibrium Polar Localization of Proteins in Bacterial Cells	PLOS ONE			English	Article							ESCHERICHIA-COLI-CELLS; SPATIAL-ORGANIZATION; CHROMOSOME; DIVISION; CHEMORECEPTOR; CAULOBACTER; REVEALS	Many proteins are observed to localize to the poles within bacterial cells. Some bacteria show unipolar localization, yet under different conditions bipolar patterns can emerge. One mechanism for spontaneous polar localization has been shown to involve the combination of protein aggregation and nucleoid occlusion. Whether the different observed patterns represent global energy minima for the cellular system remains to be determined. In this paper we show that for a model consisting only of protein aggregation along with an excluded volume effect due to the DNA polymer, that unipolar patterns are the global energy ground state regardless of protein concentration and DNA density. We extend the model to allow for proteins to be added to the cellular volume at a constant rate and show that bipolar (or multi-foci) patterns emerge as the result of the system being kinetically trapped in a local energy minimum. Lastly we also consider the situation of a growing cell that starts with a pre-existing aggregate at one of the poles and determine conditions under which either unipolar or bipolar patterns can exist at the point when it is ready to divide. This work sheds new interpretations on recently published experimental data and suggests experiments to test whether such a mechanism can drive patterning in bacteria.	[Saberi, Saeed; Emberly, Eldon] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Emberly, E (corresponding author), Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada.	eemberly@sfu.ca			NSERC Operating Grant	NSERC Operating Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a NSERC Operating Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Bowman GR, 2010, MOL MICROBIOL, V76, P173, DOI 10.1111/j.1365-2958.2010.07088.x; Buenemann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013806; Charlebois R, 1999, STRUCTURE DNA BACTER, P171; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Howard M, 2004, J MOL BIOL, V335, P655, DOI 10.1016/j.jmb.2003.10.058; Howard M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278102; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; Junier I, 2012, J MOL BIOL, V419, P369, DOI 10.1016/j.jmb.2012.03.009; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Pelletier J, 2012, P NATL ACAD SCI USA, V109, pE2649, DOI 10.1073/pnas.1208689109; Ping LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038427; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Saberi S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000986; Thiem S, 2008, MOL MICROBIOL, V68, P1228, DOI 10.1111/j.1365-2958.2008.06227.x; Thomas JG, 1996, J BIOL CHEM, V271, P11141, DOI 10.1074/jbc.271.19.11141; Wang H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.218101; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412	29	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64075	10.1371/journal.pone.0064075	http://dx.doi.org/10.1371/journal.pone.0064075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700458	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200111
J	Weisman, S; Kessler, DA				Weisman, Shlomit; Kessler, David A.			Coexistence in an Inhomogeneous Environment	PLOS ONE			English	Article							DISPERSAL	We examine the two-dimensional extension of the model of Kessler and Sander of competition between two species identical except for dispersion rates. In this class of models, the spatial inhomogeneity of reproduction rates gives rise to an implicit cost of dispersal, due to the tendency to leave favorable locations. Then, as in the Hamilton-May model with its explicit dispersal cost, the tradeoff between dispersal case and the beneficial role of dispersal in limiting fluctuations, leads to an advantage of one dispersal rate over another, and the eventual extinction of the disadvantaged species. In two dimensions we find that while the competition leads to the elimination of one species at high and low population density, at intermediate densities the two species can coexist essentially indefinitely. This is a new phenomenon not present in either the one-dimensional form of the Kessler Sander model nor in the totally connected Hamilton-May model, and points to the importance of geometry in the question of dispersal.	[Weisman, Shlomit; Kessler, David A.] Bar Ilan Univ, Dept Phys, Ramat Gan, Israel	Bar Ilan University	Kessler, DA (corresponding author), Bar Ilan Univ, Dept Phys, Ramat Gan, Israel.	kessler@dave.ph.biu.ac.il	Kessler, David/B-1391-2008	Kessler, David/0000-0002-5279-1655				COMINS HN, 1980, J THEOR BIOL, V82, P205, DOI 10.1016/0022-5193(80)90099-5; Dockery J, 1998, J MATH BIOL, V37, P61, DOI 10.1007/s002850050120; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; HASTINGS A, 1983, THEOR POPUL BIOL, V24, P244, DOI 10.1016/0040-5809(83)90027-8; Kessler DA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041907	5	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62699	10.1371/journal.pone.0062699	http://dx.doi.org/10.1371/journal.pone.0062699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704883	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200012
J	Aldrin, M; Storvik, B; Kristoffersen, AB; Jansen, PA				Aldrin, Magne; Storvik, Bard; Kristoffersen, Anja Brathen; Jansen, Peder Andreas			Space-Time Modelling of the Spread of Salmon Lice between and within Norwegian Marine Salmon Farms	PLOS ONE			English	Article							LEPEOPHTHEIRUS-SALMONIS; ATLANTIC SALMON; SEA LICE; POPULATION-DYNAMICS; WILD SALMON; SALAR L.; TRANSMISSION; INFESTATION; PARASITES; ANEMIA	Parasitic salmon lice are potentially harmful to salmonid hosts and farm produced lice pose a threat to wild salmonids. To control salmon lice infections in Norwegian salmonid farming, numbers of lice are regularly counted and lice abundance is reported from all salmonid farms every month. We have developed a stochastic space-time model where monthly lice abundance is modelled simultaneously for all farms. The set of farms is regarded as a network where the degree of contact between farms depends on their seaway distance. The expected lice abundance at each farm is modelled as a function of i) lice abundance in previous months at the same farm, ii) at neighbourhood farms, and iii) other, unspecified sources. In addition, the model includes explanatory variables such as seawater temperature and farm-numbers of fish. The model gives insight into factors that affect salmon lice abundance and contributing sources of infection. New findings in this study were that 66% of the expected salmon lice abundance was attributed to infection within farms, 28% was attributed to infection from neighbourhood farms and 6% to non-specified sources of infection. Furthermore, we present the relative risk of infection between neighbourhood farms as a function of seaway distance, which can be viewed as a between farm transmission kernel for salmon lice. The present modelling framework lays the foundation for development of future scenario simulation tools for examining the spread and abundance of salmon lice on farmed salmonids under different control regimes.	[Aldrin, Magne; Storvik, Bard] Norwegian Comp Ctr, Oslo, Norway; [Aldrin, Magne] Univ Oslo, Dept Math, Oslo, Norway; [Kristoffersen, Anja Brathen; Jansen, Peder Andreas] Norwegian Vet Inst, Oslo, Norway; [Kristoffersen, Anja Brathen] Univ Oslo, Dept Informat, N-0316 Oslo, Norway	University of Oslo; Norwegian Veterinary Institute; University of Oslo	Aldrin, M (corresponding author), Norwegian Comp Ctr, Oslo, Norway.	magne.aldrin@nr.no	Aldrin, Magne/A-7425-2017	Aldrin, Magne/0000-0003-2718-8528	Research Council of Norway project PREVENT, "Salmon lice-prevention and treatment" [199778/S40]	Research Council of Norway project PREVENT, "Salmon lice-prevention and treatment"	This work was funded by the Research Council of Norway project PREVENT, "Salmon lice-prevention and treatment," project number 199778/S40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalen OO, 2008, STAT BIOL HEALTH, P1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aldrin M, 2011, J R SOC INTERFACE, V8, P1346, DOI 10.1098/rsif.2010.0737; Aldrin M, 2010, PREV VET MED, V93, P51, DOI 10.1016/j.prevetmed.2009.09.010; Amundrud TL, 2009, J FISH DIS, V32, P27, DOI 10.1111/j.1365-2761.2008.00980.x; [Anonymous], 2008, MODEL SELECTION MODE; [Anonymous], 2009, LAKSE SJOAUREFISKE 2, P423; Bjorn PA, 2002, ICES J MAR SCI, V59, P131, DOI 10.1006/jmsc.2001.1143; Bricknell IR, 2006, DIS AQUAT ORGAN, V71, P201, DOI 10.3354/dao071201; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; Diggle PJ, 2006, STAT METHODS MED RES, V15, P325, DOI 10.1191/0962280206sm454oa; Grenfell BT, 1995, PARASITOLOGY, V111, pS135, DOI 10.1017/S0031182000075867; Held L, 2012, BIOMETRICAL J, V54, P824, DOI 10.1002/bimj.201200037; Heuch PA, 2001, DIS AQUAT ORGAN, V45, P145, DOI 10.3354/dao045145; Hohle M, 2009, BIOMETRICAL J, V51, P961, DOI 10.1002/bimj.200900050; Irvine RJ, 2000, PARASITOLOGY, V120, P297, DOI 10.1017/S0031182099005430; Jackson D, 2013, J FISH DIS, V36, P273, DOI 10.1111/jfd.12054; Jansen PA, 2012, P ROY SOC B-BIOL SCI, V279, P2330, DOI 10.1098/rspb.2012.0084; Johnson N., 1993, UNIVARIATE DISCRETE, Vsecond; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Krkosek M, 2012, P ROYAL SOC B, V280, DOI DOI 10.1098/RSPB.2012.2359; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Krkosek M, 2011, P NATL ACAD SCI USA, V108, P14700, DOI 10.1073/pnas.1101845108; Little R. J. A., 1987, STAT ANAL MISSING DA; Lutkepohl H., 2005, NEW INTRO MULTIPLE T, DOI DOI 10.1007/078-3-540-27752-1; Marty GD, 2010, P NATL ACAD SCI USA, V107, P22599, DOI 10.1073/pnas.1009573108; Scheel I, 2007, J R SOC INTERFACE, V4, P699, DOI 10.1098/rsif.2007.0217; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Skilbrei OT, 2013, J FISH DIS, V36, P249, DOI 10.1111/jfd.12052; Stien A, 2005, MAR ECOL PROG SER, V290, P263, DOI 10.3354/meps290263; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Torrissen O, 2011, REV FISH SCI, V19, P257, DOI 10.1080/10641262.2011.597890; Zuur Alain F., 2009, P1	35	46	47	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64039	10.1371/journal.pone.0064039	http://dx.doi.org/10.1371/journal.pone.0064039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700455	gold, Green Published, Green Submitted			2022-12-27	WOS:000319966400046
J	Danchin, E; Pujol, B; Wagner, RH				Danchin, Etienne; Pujol, Benoit; Wagner, Richard H.			The Double Pedigree: A Method for Studying Culturally and Genetically Inherited Behavior in Tandem	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; NATURAL-POPULATIONS; PUBLIC INFORMATION; NICHE CONSTRUCTION; WILD POPULATION; CONSEQUENCES; HERITABILITY; ARCHITECTURE; MECHANISMS; PLASTICITY	Transgenerational sources of biological variation have been at the center of evolutionary studies ever since Darwin and Wallace identified natural selection. This is because evolution can only operate on traits whose variation is transmitted, i.e. traits that are heritable. The discovery of genetic inheritance has led to a semantic shift, resulting in the tendency to consider that only genes are inherited across generations. Today, however, concepts of heredity are being broadened again to integrate the accruing evidence of non-genetic inheritance, and many evolutionary biologists are calling for the inclusion of non-genetic inheritance into an inclusive evolutionary synthesis. Here, we focus on social heredity and its role in the inheritance of behavioral traits. We discuss quantitative genetics methods that might allow us to disentangle genetic and non-genetic transmission in natural populations with known pedigrees. We then propose an experimental design based on cross-fostering among animal cultures, environments and families that has the potential to partition inherited phenotypic variation into socially (i.e. culturally) and genetically inherited components. This approach builds towards a new conceptual framework based on the use of an extended version of the animal model of quantitative genetics to integrate genetic and cultural components of behavioral inheritance.	[Danchin, Etienne; Pujol, Benoit] CNRS, UPS, ENFA, EDB Lab Evolut & Divers Biol,UMR5174, Toulouse, France; [Danchin, Etienne; Pujol, Benoit] Univ Toulouse, EDB, UMR5174, Toulouse, France; [Wagner, Richard H.] Univ Vet Med Vienna, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of Veterinary Medicine Vienna	Danchin, E (corresponding author), CNRS, UPS, ENFA, EDB Lab Evolut & Divers Biol,UMR5174, Toulouse, France.	etienne.danchin@univ-tlse3.fr	Pujol, Benoit/A-8858-2011; Danchin, Etienne/AAB-2091-2021; Pujol, Benoit/N-1575-2019	Pujol, Benoit/0000-0001-9703-6760; Danchin, Etienne/0000-0002-5013-9612; Pujol, Benoit/0000-0001-9703-6760	French "Agence Nationale de la Recherche'' [ANR-05-BLAN-0265]; Laboratoire d'Excellence (LABEX) [ANR-10-LABX-41]	French "Agence Nationale de la Recherche''(French National Research Agency (ANR)); Laboratoire d'Excellence (LABEX)	This work was supported by the French "Agence Nationale de la Recherche'' (ANR-05-BLAN-0265, EVO-INF-ECOL to ED). This project was about social inheritance as a form of non-genetic inheritance. This work was also supported by the "Laboratoire d'Excellence (LABEX)'' entitled TULIP (ANR-10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Beraldi D, 2007, EVOLUTION, V61, P1403, DOI 10.1111/j.1558-5646.2007.00106.x; Bonduriansky R, 2012, TRENDS ECOL EVOL, V27, P330, DOI 10.1016/j.tree.2012.02.003; Bonduriansky R, 2012, EVOL APPL, V5, P192, DOI 10.1111/j.1752-4571.2011.00213.x; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Bonnie KE, 2007, ANIM BEHAV, V74, P171, DOI 10.1016/j.anbehav.2006.12.009; Boogert NJ, 2008, ANIM BEHAV, V76, P1735, DOI 10.1016/j.anbehav.2008.08.009; Boogert NJ, 2008, ANIM BEHAV, V75, P1509, DOI 10.1016/j.anbehav.2007.09.033; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Brenowitz EA, 2005, TRENDS NEUROSCI, V28, P127, DOI 10.1016/j.tins.2005.01.004; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Charmantier A, 2005, MOL ECOL, V14, P2839, DOI 10.1111/j.1365-294X.2005.02619.x; Charmantier A, 2007, P R SOC B, V274, P1757, DOI 10.1098/rspb.2007.0012; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Curley JP, 2008, ANIM BEHAV, V75, P1551, DOI 10.1016/j.anbehav.2007.10.008; Dale PS, 2010, PSYCHOL SCI, V21, P635, DOI 10.1177/0956797610368060; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Danchin E, 2013, TRENDS ECOL IN PRESS; Danchin E, 2011, NAT REV GENET, V12, P475, DOI 10.1038/nrg3028; Danchin E, 2010, OIKOS, V119, P210, DOI 10.1111/j.1600-0706.2009.17640.x; Danchin Etienne, 2008, P97; Darwin C, 1859, ORIGIN SPECIES MEANS; Day T, 2011, AM NAT, V178, pE18, DOI 10.1086/660911; Eccleston A, 2007, NATURE, V447, P395, DOI 10.1038/447395a; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Erwin DH, 2008, TRENDS ECOL EVOL, V23, P304, DOI 10.1016/j.tree.2008.01.013; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fears SC, 2009, J NEUROSCI, V29, P2867, DOI 10.1523/JNEUROSCI.5153-08.2009; Franz M, 2009, P R SOC B, V276, P1829, DOI 10.1098/rspb.2008.1824; Frere CH, 2010, P NATL ACAD SCI USA, V107, P19949, DOI 10.1073/pnas.1007997107; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Giraldeau L.A., 2000, MG BEH ECOL; Giraldeau Luc-Alain, 1997, P42; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Haesler MP, 2005, P ROY SOC B-BIOL SCI, V272, P237, DOI 10.1098/rspb.2004.2946; Hager R, 2008, GENETICS, V178, P1755, DOI 10.1534/genetics.107.080697; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Haworth CMA, 2009, BEHAV GENET, V39, P359, DOI 10.1007/s10519-009-9262-3; Helantera H., 2010, PHILOS THEORY BIOL, V2, P1; Heyes C.M., 1996, SOCIAL LEARNING IMIT; Hodgins-Davis A, 2009, TRENDS ECOL EVOL, V24, P649, DOI 10.1016/j.tree.2009.06.011; HOULE D, 1992, GENETICS, V130, P195; Husby A, 2010, EVOLUTION, V64, P2221, DOI 10.1111/j.1558-5646.2010.00991.x; Jablonka E., 2005, EVOLUTION 4 DIMENSIO; Jablonka Eva, 2010, P137; Jaffee SR, 2007, MOL PSYCHIATR, V12, P432, DOI 10.1038/sj.mp.4001950; Kendal RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006541; Kirkpatrick M, 2008, NATURE, V455, P601, DOI 10.1038/455601a; KNOTT SA, 1995, FUNCT ECOL, V9, P122, DOI 10.2307/2390099; Krakauer DC, 2009, AM NAT, V173, P26, DOI 10.1086/593707; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kruuk LEB, 2008, ANNU REV ECOL EVOL S, V39, P525, DOI 10.1146/annurev.ecolsys.39.110707.173542; Laland KN, 2006, EVOLUTION, V60, P1751; Laland KN, 2006, EVOL ANTHROPOL, V15, P95, DOI 10.1002/evan.20093; Lehmann L, 2008, EVOLUTION, V62, P549, DOI 10.1111/j.1558-5646.2007.00291.x; MacDougall-Shackleton EA, 2001, EVOLUTION, V55, P2568, DOI 10.1111/j.0014-3820.2001.tb00769.x; Mameli M, 2004, BRIT J PHILOS SCI, V55, P35, DOI 10.1093/bjps/55.1.35; Mesoudi A, 2008, BIOL PHILOS, V23, P243, DOI 10.1007/s10539-007-9097-3; Morrissey MB, 2010, MOL ECOL RESOUR, V10, P711, DOI 10.1111/j.1755-0998.2009.02817.x; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Otto SP, 1995, WORKING PAPER SERIES; Qvarnstrom A, 2001, TRENDS ECOL EVOL, V16, P95, DOI 10.1016/S0169-5347(00)02063-2; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Robinson MR, 2009, GENETICS, V181, P1639, DOI 10.1534/genetics.108.086801; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Slate J, 2005, MOL ECOL, V14, P363, DOI 10.1111/j.1365-294X.2004.02378.x; Slate J, 2002, GENETICS, V162, P1863; Squires EL, 1999, THERIOGENOLOGY, V51, P91, DOI 10.1016/S0093-691X(98)00234-9; Steven JC, 2007, EVOLUTION, V61, P42, DOI 10.1111/j.1558-5646.2007.00004.x; Tal O, 2010, GENETICS, V184, P1037, DOI 10.1534/genetics.109.112466; Tinbergen, 1951, STUDY INSTINCT; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; Verzijden MN, 2007, BIOL LETTERS, V3, P134, DOI 10.1098/rsbl.2006.0601; Warren PS, 2003, ANIM BEHAV, V65, P1169, DOI 10.1006/anbe.2003.2156; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023; Wilson AJ, 2007, CURR BIOL, V17, P2136, DOI 10.1016/j.cub.2007.11.043; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; Wilson AJ, 2009, P ROY SOC B-BIOL SCI, V276, P533, DOI 10.1098/rspb.2008.1193	84	15	15	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e61254	10.1371/journal.pone.0061254	http://dx.doi.org/10.1371/journal.pone.0061254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700404	gold, Green Published, Green Submitted			2022-12-27	WOS:000319966400003
J	Parikh, RY; Kim, HD				Parikh, Rasesh Y.; Kim, Harold D.			The Effect of an Intervening Promoter Nucleosome on Gene Expression	PLOS ONE			English	Article							PHO5 PROMOTER; TRANSCRIPTIONAL ACTIVATION; DNA-SEQUENCE; IN-VIVO; OCCUPANCY; RECONSTITUTION; ACCESSIBILITY; NUMBERS; BINDING; SWI/SNF	Nucleosomes, which are the basic packaging units of chromatin, are stably positioned in promoters upstream of most stress-inducible genes. These promoter nucleosomes are generally thought to repress gene expression due to exclusion; they prevent transcription factors from accessing their target sites on the DNA. However, the role of promoter nucleosomes that do not directly occlude transcription factor binding sites is not obvious. Here, we varied the stability of a non-occluding nucleosome positioned between a transcription factor binding site and the TATA box region in an inducible yeast promoter and measured downstream gene expression level. We found that gene expression level depends on the occupancy of the non-occluding nucleosome in a non-monotonic manner. We postulated that a non-occluding nucleosome can serve both as a vehicle of and a barrier to chromatin remodeling activity and built a quantitative, nonequilibrium model to explain the observed nontrivial effect of the intervening nucleosome. Our work sheds light on the dual role of nucleosome as a repressor and an activator and expands the standard model of gene expression to include irreversible promoter chromatin transitions.	[Parikh, Rasesh Y.; Kim, Harold D.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Kim, HD (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	harold.kim@physics.gatech.edu			Burroughs Wellcome Fund CASI award	Burroughs Wellcome Fund CASI award(Burroughs Wellcome Fund)	HDK received support from Burroughs Wellcome Fund CASI award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Aparicio Oscar, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1707s23; Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; Barbaric S, 1998, MOL CELL BIOL, V18, P2629, DOI 10.1128/MCB.18.5.2629; Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; Betterton MD, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011904; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Celona B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001086; Chua EYD, 2012, NUCLEIC ACIDS RES, V40, P6338, DOI 10.1093/nar/gks261; Dechassa ML, 2010, MOL CELL, V38, P590, DOI 10.1016/j.molcel.2010.02.040; Dhasarathy A, 2005, MOL CELL BIOL, V25, P2698, DOI 10.1128/MCB.25.7.2698-2707.2005; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Ertel F, 2010, MOL CELL BIOL, V30, P4060, DOI 10.1128/MCB.01399-09; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Jessen WJ, 2006, NAT STRUCT MOL BIOL, V13, P256, DOI 10.1038/nsmb1062; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Mao CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017521; Mao CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.83; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; Raveh-Sadka T, 2012, NAT GENET, V44, P743, DOI 10.1038/ng.2305; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sanchez A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001100; Sanso M, 2011, NUCLEIC ACIDS RES, V39, P6369, DOI 10.1093/nar/gkr255; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Terrell AR, 2002, J BIOL CHEM, V277, P31038, DOI 10.1074/jbc.M204662200; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; VENTER U, 1994, EMBO J, V13, P4848, DOI 10.1002/j.1460-2075.1994.tb06811.x; VOGEL K, 1989, MOL CELL BIOL, V9, P2050, DOI 10.1128/MCB.9.5.2050; Wang X, 2011, NAT STRUCT MOL BIOL, V18, P507, DOI 10.1038/nsmb.2017; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	51	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63072	10.1371/journal.pone.0063072	http://dx.doi.org/10.1371/journal.pone.0063072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700413	Green Submitted, Green Published, gold			2022-12-27	WOS:000319966400011
J	Pasmans, F; Van Rooij, P; Blooi, M; Tessa, G; Bogaerts, S; Sotgiu, G; Garner, TWJ; Fisher, MC; Schmidt, BR; Woeltjes, T; Beukema, W; Bovero, S; Adriaensen, C; Oneto, F; Ottonello, D; Martel, A; Salvidio, S				Pasmans, Frank; Van Rooij, Pascale; Blooi, Mark; Tessa, Giulia; Bogaerts, Serge; Sotgiu, Giuseppe; Garner, Trenton W. J.; Fisher, Matthew C.; Schmidt, Benedikt R.; Woeltjes, Tonnie; Beukema, Wouter; Bovero, Stefano; Adriaensen, Connie; Oneto, Fabrizio; Ottonello, Dario; Martel, An; Salvidio, Sebastiano			Resistance to Chytridiomycosis in European Plethodontid Salamanders of the Genus Speleomantes	PLOS ONE			English	Article							PATHOGEN BATRACHOCHYTRIUM-DENDROBATIDIS; CHYTRID FUNGUS; ETHIDIUM MONOAZIDE; IMMUNE DEFENSES; LOW-PREVALENCE; FROG; AMPHIBIANS; INFECTION; TIME; SKIN	North America and the neotropics harbor nearly all species of plethodontid salamanders. In contrast, this family of caudate amphibians is represented in Europe and Asia by two genera, Speleomantes and Karsenia, which are confined to small geographic ranges. Compared to neotropical and North American plethodontids, mortality attributed to chytridiomycosis caused by Batrachochytrium dendrobatidis (Bd) has not been reported for European plethodontids, despite the established presence of Bd in their geographic distribution. We determined the extent to which Bd is present in populations of all eight species of European Speleomantes and show that Bd was undetectable in 921 skin swabs. We then compared the susceptibility of one of these species, Speleomantes strinatii, to experimental infection with a highly virulent isolate of Bd (BdGPL), and compared this to the susceptible species Alytes muletensis. Whereas the inoculated A. muletensis developed increasing Bd-loads over a 4-week period, none of five exposed S. strinatii were colonized by Bd beyond 2 weeks post inoculation. Finally, we determined the extent to which skin secretions of Speleomantes species are capable of killing Bd. Skin secretions of seven Speleomantes species showed pronounced killing activity against Bd over 24 hours. In conclusion, the absence of Bd in Speleomantes combined with resistance to experimental chytridiomycosis and highly efficient skin defenses indicate that the genus Speleomantes is a taxon unlikely to decline due to Bd.	[Pasmans, Frank; Van Rooij, Pascale; Blooi, Mark; Adriaensen, Connie] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Tessa, Giulia] Univ Turin, Dipartimento Sci Vita & Biol Sistemi, Turin, Italy; [Tessa, Giulia; Sotgiu, Giuseppe; Bovero, Stefano] Zirichiltaggi Sardinia Wildlife Conservat, Sassari, Italy; [Garner, Trenton W. J.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England; [Schmidt, Benedikt R.] Univ Zurich, Inst Evolut Biol & Umweltwissensch, Zurich, Switzerland; [Schmidt, Benedikt R.] Koordinat Stelle Amphibien & Reptilienschutz Schw, Neuchatel, Switzerland; [Woeltjes, Tonnie] Amfibieen Vissen Onderzoek Nederland, Stichting Reptielen, Nijmegen, Netherlands; [Beukema, Wouter] Univ Twente, Fac Geoinformat Sci & Earth Observat, NL-7500 AE Enschede, Netherlands; [Oneto, Fabrizio; Ottonello, Dario; Salvidio, Sebastiano] Univ Genoa, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy	Ghent University; University of Turin; Zoological Society of London; Imperial College London; University of Zurich; University of Twente; University of Genoa	Van Rooij, P (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	pascale.vanrooij@ugent.be	Fisher, Matthew/B-9094-2011; Beukema, Wouter/D-6365-2014; Schmidt, Benedikt R./B-8491-2008; Pasmans, Frank/D-3667-2014; Ottonello, Dario/AAB-2670-2022; Garner, Trenton WJ/D-6873-2011; Martel, An/D-3713-2014; Oneto, Fabrizio/AAO-9083-2021	Fisher, Matthew/0000-0002-1862-6402; Beukema, Wouter/0000-0002-5839-7683; Schmidt, Benedikt R./0000-0002-4023-1001; Garner, Trenton WJ/0000-0002-0336-9706; Oneto, Fabrizio/0000-0001-8938-7333; Adriaensen, Connie/0000-0002-1481-1635	Ghent University [BOF08/24J/004]; Royal Zoological Society of Antwerp, Belgium; NERC [NE/K014455/1, NE/G002193/1, NE/G001944/1] Funding Source: UKRI; Natural Environment Research Council [NE/G002193/1, NE/K014455/1, NE/G001944/1] Funding Source: researchfish	Ghent University(Ghent University); Royal Zoological Society of Antwerp, Belgium; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this work was provided to PVR by research grant BOF08/24J/004 from Ghent University and to MB by a Dehousse grant from the Royal Zoological Society of Antwerp, Belgium. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Bielby J, 2009, ECOHEALTH, V6, P27, DOI 10.1007/s10393-009-0232-2; Blooi M, 2013, FUNGAL BIOL-UK, V117, P156, DOI 10.1016/j.funbio.2013.01.004; Bovero S, 2008, J WILDLIFE DIS, V44, P712, DOI 10.7589/0090-3558-44.3.712; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Brutyn M, 2012, FUNGAL GENET BIOL, V49, P830, DOI 10.1016/j.fgb.2012.07.002; Caruso NM, 2013, DIVERS DISTRIB, V19, P38, DOI 10.1111/j.1472-4642.2012.00938.x; Chatfield MWH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044821; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Chiari Y, 2013, AMPHIBIA-REPTILIA, V34, P136, DOI 10.1163/15685381-00002876; Chinnadurai SK, 2009, J WILDLIFE DIS, V45, P631, DOI 10.7589/0090-3558-45.3.631; Davidson EW, 2003, COPEIA, P601, DOI 10.1643/CP-02-120R1; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fredericks LP, 2000, J EXP ZOOL, V287, P340, DOI 10.1002/1097-010X(20001001)287:5<340::AID-JEZ2>3.0.CO;2-9; Gaertner JP, 2009, ECOHEALTH, V6, P20, DOI 10.1007/s10393-009-0229-x; Garner TWJ, 2005, EMERG INFECT DIS, V11, P1639; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Hossack BR, 2010, J HERPETOL, V44, P253, DOI 10.1670/09-058.1; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Keitzer SC, 2011, J WILDLIFE DIS, V47, P455, DOI 10.7589/0090-3558-47.2.455; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Lanza Benedetto, 2005, Atti del Museo Civico di Storia Naturale di Trieste, V52, P5; Lotters S, 2012, SALAMANDRA, V48, P58; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2010, DIS AQUAT ORGAN, V92, P253, DOI 10.3354/dao02054; Luquet E, 2012, EVOLUTION, V66, P1942, DOI 10.1111/j.1558-5646.2011.01570.x; Martel A, 2011, MED MYCOL, V49, P143, DOI 10.3109/13693786.2010.508185; Martel A, 2012, J WILDLIFE DIS, V48, P835, DOI 10.7589/0090-3558-48.3.835; Muijsers M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-175; Myers JM, 2012, J CHEM ECOL, V38, P958, DOI 10.1007/s10886-012-0170-2; Parra-Olea G, 1999, REV BIOL TROP, V47, P217; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; Rovito SM, 2009, P NATL ACAD SCI USA, V106, P3231, DOI 10.1073/pnas.0813051106; Rudi K, 2005, APPL ENVIRON MICROB, V71, P1018, DOI 10.1128/AEM.71.2.1018-1024.2005; Salvidio S, 2002, AMPHIBIA-REPTILIA, V23, P505; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Sheafor B, 2008, J WILDLIFE DIS, V44, P226, DOI 10.7589/0090-3558-44.2.226; Tessa G, 2012, ITAL J ZOOL IN PRESS; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; Van Rooij P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041481; Van Rooij P, 2011, ECOHEALTH, V8, P237, DOI 10.1007/s10393-011-0704-z; Vazquez VM, 2009, DIS AQUAT ORGAN, V84, P1, DOI 10.3354/dao02026; Vieites DR, 2011, MOL PHYLOGENET EVOL, V59, P623, DOI 10.1016/j.ympev.2011.03.012; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Weinstein SB, 2009, COPEIA, P653, DOI 10.1643/CH-08-180; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x	54	16	17	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63639	10.1371/journal.pone.0063639	http://dx.doi.org/10.1371/journal.pone.0063639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23703511	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400024
J	Seitz, J; Kahraman-Lanzerath, B; Legenbauer, T; Sarrar, L; Herpertz, S; Salbach-Andrae, H; Konrad, K; Herpertz-Dahlmann, B				Seitz, Jochen; Kahraman-Lanzerath, Berrak; Legenbauer, Tanja; Sarrar, Lea; Herpertz, Stephan; Salbach-Andrae, Harriet; Konrad, Kerstin; Herpertz-Dahlmann, Beate			The Role of Impulsivity, Inattention and Comorbid ADHD in Patients with Bulimia Nervosa	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; RESTLESS LEGS SYNDROME; EATING-DISORDERS; SYMPTOMS; OBESITY; ADULTS; DISINHIBITION; PERSONALITY; RELIABILITY	Introduction: Little is known about the contribution of impulsivity, inattention and comorbid attention deficit/hyperactivity disorder (ADHD) in the development and maintenance of bulimia nervosa (BN). In particular, their specific contribution to disordered eating symptoms and whether they have additive effects to the general psychopathological burden remains unclear. Methods: Fifty-seven female patients seeking treatment for BN and 40 healthy controls completed diagnostic questionnaires and interviews that investigated: a) ADHD, b) impulsivity, c) eating disorders and d) general psychopathology. Attentional processes and impulsivity were assessed by a comprehensive computer-based neuropsychological battery. Results: Twenty-one percent of patients with BN met the clinical cut-off for previous childhood ADHD compared to 2.5% of healthy controls. Adult ADHD according to DSM IV was also more prevalent in patients with BN, with an odds ratio of 4.2. Patients with BN and previous childhood ADHD were more impulsive and inattentive than patients with BN alone. These patients also displayed more severely disordered eating patterns and more general psychopathological symptoms compared with those without ADHD. Severity of eating disorder symptoms was better explained by inattentiveness than by either impulsivity or hyperactivity. Discussion: Our data suggest an elevated rate of former childhood and current ADHD-symptoms in treatment-seeking patients with BN. Stronger impulsivity and inattention associated with more severe neuropsychological deficits and eating disorder symptoms indicate an additive risk that is clinically relevant for these patients. Thus, clinicians should identify comorbid patients who might profit from additional ADHD-specific treatments.	[Seitz, Jochen; Kahraman-Lanzerath, Berrak; Konrad, Kerstin; Herpertz-Dahlmann, Beate] Univ Hosp, Dept Child & Adolescent Psychiat Psychotherapy &, Aachen, Germany; [Legenbauer, Tanja] Ruhr Univ Bochum, Clin Child & Adolescent Psychiat, Westphalia Lippe Reg Assoc LWL, Univ Hosp Hamm, Hamm, Germany; [Sarrar, Lea] Charite, Clin Audiol & Phoniatry, Berlin, Germany; [Legenbauer, Tanja; Herpertz, Stephan] Ruhr Univ Bochum, Clin Psychosomat Med & Psychotherapy, Univ Hosp, Bochum, Germany; [Salbach-Andrae, Harriet] Charite, Clin Child & Adolescent Psychiat Psychotherapy &, Berlin, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Seitz, J (corresponding author), Univ Hosp, Dept Child & Adolescent Psychiat Psychotherapy &, Aachen, Germany.	jseitz@ukaachen.de	Zamora, Cristina Cuesta/E-2864-2016; Konrad, Kerstin/H-7747-2013; Sarrar, Lea/GVS-2319-2022; Seitz, Jochen/AAE-7363-2019	Zamora, Cristina Cuesta/0000-0003-1121-9561; Konrad, Kerstin/0000-0001-9039-2615; Sarrar, Lea/0000-0002-6187-8955; Seitz, Jochen/0000-0002-0110-7980	Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics of the University Hospital Aachen, Germany; Lilly; Novartis; Medice	Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics of the University Hospital Aachen, Germany; Lilly(Eli Lilly); Novartis(Novartis); Medice	The study was funded by board-funds of the Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics of the University Hospital Aachen, Germany. The head of department, Prof. Herpertz-Dahlmann participated in the study design, decision to publish and the preparation of the manuscript.; KK has received speaking fees from Lilly, Novartis and Medice. BHD and KK have an investigator-initiated trial (IIT) with Vivor AG on the effects of polyunsaturated fatty acids on brain maturation in children with or without ADHD; BHD is a member of Lilly's advisory board for atomoxetine. None of the above authors is employed by any commercial company. No commercial company was involved in this study in any way. None of the authors receive financial contributions related to an increased sale of any of their products. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Altfas JR, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-9; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1111/1469-7610.00424; Barratt ES., 1985, MOTIVATION EMOTION P, P137, DOI DOI 10.1371/JOURNAL.PONE.0129139; Biederman J, 2007, J DEV BEHAV PEDIATR, V28, P302, DOI 10.1097/DBP.0b013e3180327917; Blinder BJ, 2006, PSYCHOSOM MED, V68, P454, DOI 10.1097/01.psy.0000221254.77675.f5; Cortese S, 2007, INT J OBESITY, V31, P340, DOI 10.1038/sj.ijo.0803400; Cortese S, 2010, POSTGRAD MED, V122, P88, DOI 10.3810/pgm.2010.09.2205; Davis Caroline, 2006, Eat Behav, V7, P266, DOI 10.1016/j.eatbeh.2005.09.006; de Zwaan M, 2012, EUR ARCH PSY CLIN N, V262, P79, DOI 10.1007/s00406-011-0211-9; Drimmer EJ, 2003, NUTRITION, V19, P76, DOI 10.1016/S0899-9007(02)01045-6; Dukarm CP, 2005, J WOMENS HEALTH, V14, P345, DOI 10.1089/jwh.2005.14.345; Favaro Angela, 2005, Eat Disord, V13, P61; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Fichter M, 2001, EUR PSYCHIAT, V16, P38, DOI 10.1016/S0924-9338(00)00534-4; Fischer S, 2008, CLIN PSYCHOL REV, V28, P1413, DOI 10.1016/j.cpr.2008.09.001; Galderisi S, 2011, PSYCHOL MED, V41, P839, DOI 10.1017/S0033291710001303; Hartmann AS, 2010, COMPR PSYCHIAT, V51, P572, DOI 10.1016/j.comppsych.2010.03.001; Herpertz-Dahlmann B, 2009, CHILD ADOL PSYCH CL, V18, P31, DOI 10.1016/j.chc.2008.07.005; Holtkamp K, 2004, INT J OBESITY, V28, P685, DOI 10.1038/sj.ijo.0802623; Keel PK, 2000, AM J PSYCHIAT, V157, P136, DOI 10.1176/ajp.157.1.136; Kemps E, 2010, J CLIN EXP NEUROPSYC, V32, P515, DOI 10.1080/13803390903264122; Kieling C, 2010, AM J PSYCHIAT, V167, P14, DOI 10.1176/appi.ajp.2009.09060796; Konofal E, 2005, ANN NEUROL, V58, P341, DOI 10.1002/ana.20562; Kuhner C, 2007, NERVENARZT, V78, P651, DOI 10.1007/s00115-006-2098-7; Lampe K, 2007, PSYCHOL MED, V37, P1717, DOI 10.1017/S0033291707000517; Mikami AY, 2008, J ABNORM PSYCHOL, V117, P225, DOI 10.1037/0021-843X.117.1.225; Mikami AY, 2010, INT J EAT DISORDER, V43, P248, DOI 10.1002/eat.20692; Retz-Junginger P, 2007, NERVENARZT, V78, P1046, DOI 10.1007/s00115-006-2242-4; Rosler M, 2008, NERVENARZT, V79, P320, DOI 10.1007/s00115-007-2375-0; Rosler M, 2006, EUR ARCH PSY CLIN N, V256, P3, DOI 10.1007/s00406-006-1001-7; Schmitz N, 2000, QUAL LIFE RES, V9, P185, DOI 10.1023/A:1008931926181; Schweickert LA, 1997, INT J EAT DISORDER, V21, P299, DOI 10.1002/(SICI)1098-108X(199704)21:3<299::AID-EAT11>3.0.CO;2-W; Thiel A, 1997, PSYCHOTHER PSYCH MED, V47, P365; Van den Eynde F, 2011, ACTA PSYCHIAT SCAND, V124, P120, DOI 10.1111/j.1600-0447.2011.01701.x; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; Waxman SE, 2009, EUR EAT DISORD REV, V17, P408, DOI 10.1002/erv.952; Wentz E, 2005, EUR CHILD ADOLES PSY, V14, P431, DOI 10.1007/s00787-005-0494-3; Wilhelm C, 2011, WORLD J BIOL PSYCHIA, V12, P118, DOI 10.3109/15622975.2011.602225; Wonderlich SA, 2004, INT J EAT DISORDER, V36, P172, DOI 10.1002/eat.20033; Yates WR, 2009, INT J EAT DISORDER, V42, P375, DOI 10.1002/eat.20627; Yilmaz Z, 2011, PROG NEURO-PSYCHOPH, V35, P948, DOI 10.1016/j.pnpbp.2011.01.012; Zimmermann P., 1993, TESTBATTERIE AUFMERK	42	57	57	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63891	10.1371/journal.pone.0063891	http://dx.doi.org/10.1371/journal.pone.0063891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158JQ	23700439	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400036
J	Su, JY; Lai, HQ; Chen, JP; Li, L; Wong, YS; Chen, TF; Li, XL				Su, Jianyu; Lai, Haoqiang; Chen, Jianping; Li, Lin; Wong, Yum-Shing; Chen, Tianfeng; Li, Xiaoling			Natural Borneol, a Monoterpenoid Compound, Potentiates Selenocystine-Induced Apoptosis in Human Hepatocellular Carcinoma Cells by Enhancement of Cellular Uptake and Activation of ROS-Mediated DNA Damage	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBERS; INTESTINAL-ABSORPTION; CANCER-CELLS; DRUG-RESISTANCE; P-GLYCOPROTEIN; BREAST-CANCER; MCF-7 CELLS; PREVENTION; SELENIUM; AKT	Selenocystine (SeC) has been identified as a novel compound with broad-spectrum anticancer activities. Natural borneol (NB) is a monoterpenoid compound that has been used as a promoter of drug absorption. In the present study, we demonstrated that NB significantly enhanced the cellular uptake of SeC and potentiated its antiproliferative activity on HepG2 cells by induction of apoptosis. NB effectively synergized with SeC to reduce cancer cell growth through the triggering apoptotic cell death. Further mechanistic studies by Western blotting showed that treatment of the cells with NB and SeC activated the intrinsic apoptotic pathway by regulation of pro-survival and pro-apoptotic Bcl-2 family proteins. Treatment of the cells with NB and SeC induced the activation of p38MAPK and inactivation of Akt and ERK. NB also potentiated SeC to trigger intracellular ROS generation and DNA strand breaks as examined by Comet assay. Moreover, the thiol-reducing antioxidants effectively blocked the occurrence of cell apoptosis, which confirmed the important role of ROS in cell apoptosis. Taken together, these results reveal that NB strongly potentiates SeC-induced apoptosis in cancer cells by enhancement of cellular uptake and activation of ROS-mediated DNA damage. NB could be further developed as a chemosensitizer of SeC in treatment of human cancers.	[Su, Jianyu; Chen, Jianping; Li, Lin] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China; [Lai, Haoqiang; Chen, Tianfeng; Li, Xiaoling] Jinan Univ, Dept Chem, Guangzhou, Guangdong, Peoples R China; [Wong, Yum-Shing] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China	South China University of Technology; Jinan University; Chinese University of Hong Kong	Su, JY (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China.	jysu@scut.edu.cn; tlxlli@jnu.edu.cn	Chen, Tianfeng/AAG-6123-2019	Su, Jianyu/0000-0002-1662-0461	National Natural Science Foundation of China [31101278, 31130042, 21271002, 21201082]; Guangdong Province, 973-plan [2012CB720800]; national science and technology support program [2012BAD37B01]; Doctoral Foundation of Ministry of Education of China; Research Fund for the Doctoral Program of Higher Education of China [20110172120033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province, 973-plan; national science and technology support program; Doctoral Foundation of Ministry of Education of China(Ministry of Education, China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (31101278, 31130042, 21271002 and 21201082) and Guangdong Province, 973-plan (2012CB720800), the national science and technology support program (2012BAD37B01), the Doctoral Foundation of Ministry of Education of China, and the Research Fund for the Doctoral Program of Higher Education of China (20110172120033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SL, 2010, CELL CYCLE, V9, P1781, DOI 10.4161/cc.9.9.11483; Bjelakovic G, 2004, LANCET, V364, P1219, DOI 10.1016/S0140-6736(04)17138-9; Bjorkhem-Bergman L, 2005, CARCINOGENESIS, V26, P125, DOI 10.1093/carcin/bgh290; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Breier A, 2013, ANTI-CANCER AGENT ME, V13, P159, DOI 10.2174/187152013804487380; Cabrera R, 2010, ALIMENT PHARM THER, V31, P461, DOI 10.1111/j.1365-2036.2009.04200.x; Cai Z, 2008, J DRUG TARGET, V16, P178, DOI 10.1080/10611860701794395 ; Cao J, 2009, FREE RADICAL BIO MED, V47, P536, DOI 10.1016/j.freeradbiomed.2009.05.024; Chan JYW, 2000, LIFE SCI, V67, P2117, DOI 10.1016/S0024-3205(00)00798-0; Chen J, 2011, MOL CANCER THER, V10, P2340, DOI 10.1158/1535-7163.MCT-11-0415; Chen T, 2008, CELL MOL LIFE SCI, V65, P2763, DOI 10.1007/s00018-008-8329-2; Chen TF, 2009, BIOMED PHARMACOTHER, V63, P105, DOI 10.1016/j.biopha.2008.03.009; Chen TF, 2008, BIOMED PHARMACOTHER, V62, P77, DOI 10.1016/j.biopha.2007.12.002; Chen TF, 2009, INT J BIOCHEM CELL B, V41, P666, DOI 10.1016/j.biocel.2008.07.014; Chen TF, 2008, J AGR FOOD CHEM, V56, P10574, DOI 10.1021/jf802125t; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Donovan M, 2004, BBA-MOL CELL RES, V1644, P133, DOI 10.1016/j.bbamcr.2003.08.011; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Fan JG, 2009, J GASTROEN HEPATOL, V24, P712, DOI 10.1111/j.1440-1746.2009.05776.x; Gao Y, 2008, INT J PHARMACEUT, V354, P126, DOI 10.1016/j.ijpharm.2007.11.061; Guo X R, 2012, MICROWAVE MILLIMETER, P1, DOI DOI 10.1016/J.C0NC0G.2012.12.001; Hait WN, 2005, SEMIN ONCOL, V32, pS16, DOI 10.1053/j.seminoncol.2005.09.011; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Horvathova E, 2009, FOOD CHEM TOXICOL, V47, P1318, DOI 10.1016/j.fct.2009.03.002; Katzenellenbogen M, 2007, MOL CANCER THER, V6, P1283, DOI 10.1158/1535-7163.MCT-06-0420; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Konopleva M, 2012, LEUKEMIA, V26, P778, DOI 10.1038/leu.2011.287; Kopper Laszlo, 2008, V11, P103, DOI 10.1007/978-1-4020-6729-7_7; Lau WY, 2008, HEPATOB PANCREAT DIS, V7, P237; Lee JS, 2010, CANCER LETT, V297, P144, DOI 10.1016/j.canlet.2010.05.006; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Lu Y, 2011, J ZHEJIANG UNIV-SC B, V12, P143, DOI 10.1631/jzus.B1000121; Makin G, 2001, BREAST CANCER RES, V3, P150, DOI 10.1186/bcr289; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Meier F, 2007, BRIT J DERMATOL, V156, P1204, DOI 10.1111/j.1365-2133.2007.07821.x; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Rikiishi H, 2007, J BIOENERG BIOMEMBR, V39, P91, DOI 10.1007/s10863-006-9065-7; Shen Q, 2011, AAPS PHARMSCITECH, V12, P1044, DOI 10.1208/s12249-011-9672-4; Varma MVS, 2004, CURR DRUG METAB, V5, P375, DOI 10.2174/1389200043335423; Wang NS, 2003, TRADIT CHIN DRUG RES, V14, P96; [吴纯洁 WU Chujie], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P1710; Yalcin S, 2010, EMBO J, V29, P4118, DOI 10.1038/emboj.2010.292; Yamaguchi K, 2005, ONCOGENE, V24, P5868, DOI 10.1038/sj.onc.1208742; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Zhou YQ, 2010, ENVIRON TOXICOL PHAR, V29, P229, DOI 10.1016/j.etap.2010.01.004	49	80	84	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63502	10.1371/journal.pone.0063502	http://dx.doi.org/10.1371/journal.pone.0063502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700426	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400022
J	Lv, YT; Margulies, DS; Villringer, A; Zang, YF				Lv, Yating; Margulies, Daniel S.; Villringer, Arno; Zang, Yu-Feng			Effects of Finger Tapping Frequency on Regional Homogeneity of Sensorimotor Cortex	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; MOTOR CORTEX; COHERENCE; ASYMMETRY; MOVEMENT; DISEASE; BRAIN	Resting-state functional magnetic resonance imaging (RS-fMRI) has been widely used to investigate temporally correlated fluctuations between distributed brain areas, as well as to characterize local synchronization of low frequency (<0.1 Hz) spontaneous fMRI signal. Regional homogeneity (ReHo) was proposed as a voxel-wise measure of the synchronization of the timecourses of neighboring voxels and has been used in many studies of brain disorders. However, the interpretation of ReHo remains challenging because the effect of high frequency task on ReHo is still not clear. In order to investigate the effect of a high-frequency task on the modulation of local synchronization of resting-state activity, we employed three right-finger movement scanning sessions: slow-event related ('Slow'), fast-event related ('Fast'), and continuous finger pressure ('Tonic'), from 21 healthy participants and compared the ReHo of the three task states with that of resting-state ('Rest'). In the contralateral sensorimotor cortex, 'Slow' task state showed greater ReHo than 'Rest' in low frequency band (0-0.08Hz) fMRI signal, but lower ReHo in high frequency band (0.08-1.67 Hz); 'Fast' task state showed lower ReHo than 'Rest' in both the low and high frequency band; 'Tonic' state did not show any significant difference compared to 'Rest'. The results in the contralateral sensorimotor cortex suggest that local synchronization of BOLD signal varies with different finger tapping speed. In the ipsilateral sensorimotor cortex, all the three task states had lower ReHo than the 'Rest' state both in the low and high frequency, suggesting a similar effect of fast and slow finger tapping frequencies on local synchronization of BOLD signal in the ipsilateral motor cortex.	[Lv, Yating; Margulies, Daniel S.; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Lv, Yating; Zang, Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Margulies, Daniel S.; Villringer, Arno] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany; [Zang, Yu-Feng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zang, Yu-Feng] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China	Max Planck Society; Hangzhou Normal University; Humboldt University of Berlin; Beijing Normal University	Zang, YF (corresponding author), Hangzhou Normal Univ, Affiliated Hosp, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China.	zangyf@hznu.edu.cn	ZANG, Yu-Feng/J-1558-2012; Margulies, Daniel/L-4719-2016	ZANG, Yu-Feng/0000-0003-1833-8010; Margulies, Daniel/0000-0002-8880-9204; Villringer, Arno/0000-0003-2604-2404; Lv, Yating/0000-0002-5547-3361	National Natural Science Foundation of China (NSFC) [81020108022, 30770594]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (NSFC) (81020108022, 30770594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki Y, 2006, NEUROSCIENCE, V141, P2147, DOI 10.1016/j.neuroscience.2006.05.030; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Deshpande G, 2009, HUM BRAIN MAPP, V30, P13, DOI 10.1002/hbm.20482; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; He Y, 2004, LECT NOTES COMPUT SC, V3217, P907; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Jancke L, 1998, NEUROSCI LETT, V252, P37, DOI 10.1016/S0304-3940(98)00540-0; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Li Y, 2012, CEREB CORTEX, DOI [10.1093/cercor/bhs185, DOI 10.1093/CERC0R/BHS185]; Liu DQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00024; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lutz K, 2005, NEUROSCI LETT, V373, P61, DOI 10.1016/j.neulet.2004.09.058; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; NETZ J, 1995, EXP BRAIN RES, V104, P527; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Rao SM, 1996, J CEREBR BLOOD F MET, V16, P1250, DOI 10.1097/00004647-199611000-00020; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030	25	23	23	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64115	10.1371/journal.pone.0064115	http://dx.doi.org/10.1371/journal.pone.0064115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696867	Green Published, gold			2022-12-27	WOS:000319081900070
J	Pei, HX; Ma, N; Chen, JW; Zheng, Y; Tian, J; Li, J; Zhang, S; Fei, ZJ; Gao, JP				Pei, Haixia; Ma, Nan; Chen, Jiwei; Zheng, Yi; Tian, Ji; Li, Jing; Zhang, Shuai; Fei, Zhangjun; Gao, Junping			Integrative Analysis of miRNA and mRNA Profiles in Response to Ethylene in Rose Petals during Flower Opening	PLOS ONE			English	Article							GENE-EXPRESSION; ANTHOCYANIN BIOSYNTHESIS; PLANT MICRORNAS; ARABIDOPSIS; REVEAL; STRESS; TRANSCRIPTOME; RECEPTOR; IDENTIFICATION; EVOLUTION	MicroRNAs play an important role in plant development and plant responses to various biotic and abiotic stimuli. As one of the most important ornamental crops, rose (Rosa hybrida) possesses several specific morphological and physiological features, including recurrent flowering, highly divergent flower shapes, colors and volatiles. Ethylene plays an important role in regulating petal cell expansion during rose flower opening. Here, we report the population and expression profiles of miRNAs in rose petals during flower opening and in response to ethylene based on high throughput sequencing. We identified a total of 33 conserved miRNAs, as well as 47 putative novel miRNAs were identified from rose petals. The conserved and novel targets to those miRNAs were predicted using the rose floral transcriptome database. Expression profiling revealed that expression of 28 known (84.8% of known miRNAs) and 39 novel (83.0% of novel miRNAs) miRNAs was substantially changed in rose petals during the earlier opening period. We also found that 28 known and 22 novel miRNAs showed expression changes in response to ethylene treatment. Furthermore, we performed integrative analysis of expression profiles of miRNAs and their targets. We found that ethylene-caused expression changes of five miRNAs (miR156, miR164, miR166, miR5139 and rhy-miRC1) were inversely correlated to those of their seven target genes. These results indicate that these miRNA/target modules might be regulated by ethylene and were involved in ethylene-regulated petal growth.	[Pei, Haixia; Ma, Nan; Chen, Jiwei; Zheng, Yi; Tian, Ji; Li, Jing; Zhang, Shuai; Gao, Junping] China Agr Univ, Dept Ornamental Hort, Beijing 100094, Peoples R China; [Zheng, Yi; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Fei, Zhangjun] USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	China Agricultural University; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA)	Gao, JP (corresponding author), China Agr Univ, Dept Ornamental Hort, Beijing 100094, Peoples R China.	gaojp@cau.edu.cn	Fei, Zhangjun/H-5152-2012; Zheng, Yi/F-6150-2016	Zheng, Yi/0000-0002-8042-7770	National Natural Science Foundation of China [31071827, 31130359]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grants (Grant no. 31071827 and 31130359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles F, 1992, ETHYLENE PLANT BIOL; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bendahmane M, 2013, J EXP BOT, V64, P847, DOI 10.1093/jxb/ers387; Bennett BC, ENCY LIFE SUPPORT SY; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Channeliere S, 2002, FEBS LETT, V515, P35, DOI 10.1016/S0014-5793(02)02413-4; Chen L, 2012, PLANT SCI, V184, P14, DOI 10.1016/j.plantsci.2011.11.007; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; De Paepe A, 2004, PLANT J, V39, P537, DOI 10.1111/j.1365-313X.2004.02156.x; Debener T, 2009, CRIT REV PLANT SCI, V28, P267, DOI 10.1080/07352680903035481; Donaire L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027916; Dubois A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-638; Dubois A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028455; El-Kereamy A, 2003, PHYSIOL PLANTARUM, V119, P175, DOI 10.1034/j.1399-3054.2003.00165.x; Gantulga D, 2009, PHYTOCHEMISTRY, V70, P1999, DOI 10.1016/j.phytochem.2009.08.008; Gao ZH, 2012, MOL CELLS, V34, P239, DOI 10.1007/s10059-012-0004-7; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; HEINRICHS F, 2008, AIPH UNION FLEURS, V56, P16; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jay F, 2010, METHODS MOL BIOL, V592, P183, DOI 10.1007/978-1-60327-005-2_13; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jones-Rhoades MW, 2012, PLANT MOL BIOL, V80, P3, DOI 10.1007/s11103-011-9829-2; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-657; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma N, 2005, SCI CHINA SER C, V48, P434, DOI 10.1360/062004-37; Ma N, 2008, PLANT PHYSIOL, V148, P894, DOI 10.1104/pp.108.120154; Ma N, 2006, J EXP BOT, V57, P2763, DOI 10.1093/jxb/erl033; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Mica E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-558; Muller R, 2000, J HORTIC SCI BIOTECH, V75, P12; Muller R, 2003, J FOOD AGRIC ENVIRON, V1, P87; Peaucelle A, 2007, DEVELOPMENT, V134, P1045, DOI 10.1242/dev.02774; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Reid M. S., 1989, Acta Horticulturae, P215; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Tan H, 2006, POSTHARVEST BIOL TEC, V40, P97, DOI 10.1016/j.postharvbio.2006.01.007; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Van Zhong G, 2003, PLANT MOL BIOL, V53, P117, DOI 10.1023/B:PLAN.0000009270.81977.ef; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang D, 2004, PLANT CELL REP, V22, P422, DOI 10.1007/s00299-003-0721-7; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xue JQ, 2008, J EXP BOT, V59, P2161, DOI 10.1093/jxb/ern078; Yasumura Y, 2012, PLANT J, V72, P947, DOI 10.1111/tpj.12005; Zhang TC, 2012, COMPUT BIOL CHEM, V38, P10, DOI 10.1016/j.compbiolchem.2012.04.001; Zhang Y., 2011, MOL BIOL REP, V39, P1975; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149; Zuo JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-7	68	63	67	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64290	10.1371/journal.pone.0064290	http://dx.doi.org/10.1371/journal.pone.0064290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696879	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900082
J	Rhodehouse, BC; Mayo, JN; Beard, RS; Chen, CH; Bearden, SE				Rhodehouse, Bryce C.; Mayo, Jamie N.; Beard, Richard S., Jr.; Chen, Cheng-Hung; Bearden, Shawn E.			Opening of the Blood-Brain Barrier before Cerebral Pathology in Mild Hyperhomocysteinemia	PLOS ONE			English	Article							TOTAL HOMOCYSTEINE LEVELS; PLASMA HOMOCYSTEINE; COGNITIVE IMPAIRMENT; RISK-FACTOR; ALZHEIMERS-DISEASE; HYPERTENSIVE-RATS; BECLIN 1; PERMEABILITY; DEMENTIA; STROKE	Hyperhomocysteinemia (HHcy) is a risk factor for cognitive impairment. The purpose of this study was to determine the temporal pattern of cerebral pathology in a mouse model of mild HHcy, because understanding this time course provides the basis for understanding the mechanisms involved. C57Bl/6 mice with heterozygous deletion cystathionine beta-synthase (cbs(+/-); Het) were used as a model of mild HHcy along with their wild-type littermates (cbs(+/+); WT). Mice were 'young' (5.3 +/- 0.2 months of age) and 'old' (16.6 +/- 0.9 months of age). Blood-brain barrier (BBB) permeability was quantified from Evans blue and sodium fluorescein extravasation. Microvascular architecture was assessed by z-stack confocal microscopy. Leukoaraiosis was measured from Luxol fast blue stained slides of paraffin brain sections. Inflammation was quantified using standard antibody-based immunohistochemical techniques. Cognitive function was assessed using the Morris water maze. BBB permeability was significantly greater in Het vs. WT mice at all ages (p<0.05). There were no differences in microvascular architecture among the groups. Compared with all other groups, old Het mice had significantly greater leukoaraiosis, inflammation in the fornix, and cognitive impairment (p<0.05). In mild HHcy, increased permeability of the BBB precedes the onset of cerebral pathology. This new paradigm may play a role in the progression of disease in HHcy.	[Rhodehouse, Bryce C.; Mayo, Jamie N.; Beard, Richard S., Jr.; Chen, Cheng-Hung; Bearden, Shawn E.] Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA; [Bearden, Shawn E.] Idaho State Univ, ISU Biomed Res Inst, Pocatello, ID 83209 USA	Idaho; Idaho State University; Idaho; Idaho State University	Bearden, SE (corresponding author), Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA.	bearshaw@isu.edu	Beard Jr., Richard/E-2051-2013; Beard, Richard Scott/I-3695-2019	Beard Jr., Richard/0000-0001-8545-3014; Beard, Richard Scott/0000-0001-8545-3014	National Institutes of Health (NIH) [HL106548, P20 RR-016454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL106548] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) HL106548, P20 RR-016454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard RS, 2011, AM J PHYSIOL-HEART C, V300, pH13, DOI 10.1152/ajpheart.00598.2010; Beard RS, 2012, VASC PHARMACOL, V56, P159, DOI 10.1016/j.vph.2012.01.004; Beard RS, 2011, BLOOD, V118, P2007, DOI 10.1182/blood-2011-02-338269; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Carmel R, 2001, HOMOCYSTEINE HLTH DI, Vxvi; Cassel JC, 1997, PROG NEUROBIOL, V51, P663, DOI 10.1016/S0301-0082(97)00009-9; Dayal S, 2008, ARTERIOSCL THROM VAS, V28, P1596, DOI 10.1161/ATVBAHA.108.166421; Dayali S, 2007, ANTIOXID REDOX SIGN, V9, P1899, DOI 10.1089/ars.2007.1806; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Garde E, 2000, LANCET, V356, P628, DOI 10.1016/S0140-6736(00)02604-0; Graban A, 2009, J NEUROL SCI, V283, P116, DOI 10.1016/j.jns.2009.02.344; Huber JD, 2008, CURR PHARM DESIGN, V14, P1594, DOI 10.2174/138161208784705441; Jalal FY, 2012, STROKE, V43, P1115, DOI 10.1161/STROKEAHA.111.643080; Kamath AF, 2006, BLOOD, V107, P591, DOI 10.1182/blood-2005-06-2506; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim J, 2007, J NUTR, V137, P2093, DOI 10.1093/jn/137.9.2093; Lee JM, 2007, STROKE, V38, P3289, DOI 10.1161/STROKEAHA.107.491621; Lehmann M, 2003, DEMENT GERIATR COGN, V16, P145, DOI 10.1159/000071002; Lominadze D, 2006, AM J PHYSIOL-HEART C, V290, pH1206, DOI 10.1152/ajpheart.00376.2005; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moustapha A, 1999, KIDNEY INT, V55, P1470, DOI 10.1046/j.1523-1755.1999.00378.x; Naka H, 2006, EUR J NEUROL, V13, P261, DOI 10.1111/j.1468-1331.2006.01205.x; Rhodehouse BC, 2013, J ALZHEIMERS DIS; Rohn TT, 2011, NEUROBIOL DIS, V43, P68, DOI 10.1016/j.nbd.2010.11.003; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Sachdev P, 2004, J NEUROL SCI, V226, P25, DOI 10.1016/j.jns.2004.09.006; Sachdev P, 2004, ARCH NEUROL-CHICAGO, V61, P1369, DOI 10.1001/archneur.61.9.1369; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Seshadri S, 2006, J ALZHEIMERS DIS, V9, P393; Topakian R, 2010, J NEUROL NEUROSUR PS, V81, P192, DOI 10.1136/jnnp.2009.172072; Troen AM, 2008, P NATL ACAD SCI USA, V105, P12474, DOI 10.1073/pnas.0805350105; Tyagi N, 2010, J RECEPT SIG TRANSD, V30, P78, DOI 10.3109/10799891003614808; UELAND PM, 1989, J LAB CLIN MED, V114, P473; Ujiie M, 2003, MICROCIRCULATION, V10, P463, DOI 10.1038/sj.mn.7800212; van Gijn J, 2000, LANCET, V356, P612, DOI 10.1016/S0140-6736(00)02599-X; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Wardlaw JM, 2009, ANN NEUROL, V65, P194, DOI 10.1002/ana.21549; Wong A, 2006, J NEUROL, V253, P441, DOI 10.1007/s00415-005-0022-x; Wright CB, 2005, STROKE, V36, P1207, DOI 10.1161/01.STR.0000165923.02318.22; Zylberstein DE, 2008, J AM GERIATR SOC, V56, P1087, DOI 10.1111/j.1532-5415.2008.01724.x	42	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63951	10.1371/journal.pone.0063951	http://dx.doi.org/10.1371/journal.pone.0063951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696861	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900065
J	Shimasaki, T; Masaki, T; Mitsutomi, K; Ueno, D; Gotoh, K; Chiba, S; Kakuma, T; Yoshimatsu, H				Shimasaki, Takanobu; Masaki, Takayuki; Mitsutomi, Kimihiko; Ueno, Daisuke; Gotoh, Koro; Chiba, Seiichi; Kakuma, Tetsuya; Yoshimatsu, Hironobu			The Dipeptidyl Peptidase-4 Inhibitor Des-Fluoro-Sitagliptin Regulates Brown Adipose Tissue Uncoupling Protein Levels in Mice with Diet-Induced Obesity	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; GLP-1 RECEPTOR; IV INHIBITOR; DOUBLE-BLIND; EFFICACY; SAFETY; METFORMIN; THERMOGENESIS; PIOGLITAZONE; EXPRESSION	Objective: Dipeptidyl peptidase (DPP)-4 is responsible for the degradation of several peptides that contain an alanine or proline at the penultimate position or position P1. DPP-4 inhibitors (DPP-4is) have protective effects against type-2 diabetes and several metabolic disorders. Methods: In the present study, we examined the effects of des-fluoro-sitagliptin (DFS), a DDP-4i, on body adiposity and levels of peroxisome proliferator-activated receptor (PPAR)-alpha, PPAR-gamma coactivator-1 (PGC-1), and uncoupling proteins (UCPs) in mice with diet-induced obesity. Results: Treatment with DFS dose-dependently decreased the weight of white adipose tissue and serum levels of glucose, compared with controls, without influencing food intake (P<0.05). Additionally, DFS treatment increased the levels of PPAR-alpha, PGC-1, and UCPs in brown adipose tissue (BAT), and of PPAR-alpha and UCP3 in skeletal muscle (P<0.05). Furthermore, the effects on BAT PGC-1 and muscle PPAR-alpha levels were attenuated by treatment with the glucagon-like peptide 1 (GLP-1) antagonist exendin (9-39). Interestingly, hypothalamic levels of proopiomelanocortin (POMC) were increased by DFS treatment and the effects of DFS on PPAR-alpha, PGC-1, and UCP levels were attenuated in melanocortin (MC)-4 receptor-deficient mice. Conclusions: In conclusion, high-dose DFS appeared to regulate body adiposity and UCPs in mice with diet-induced obesity, at least partly through a GLP-1 and/or MC-4 pathway.	[Shimasaki, Takanobu; Masaki, Takayuki; Mitsutomi, Kimihiko; Ueno, Daisuke; Gotoh, Koro; Chiba, Seiichi; Kakuma, Tetsuya; Yoshimatsu, Hironobu] Oita Univ, Fac Med, Dept Internal Med 1, Yufu, Japan	Oita University	Masaki, T (corresponding author), Oita Univ, Fac Med, Dept Internal Med 1, Yufu, Japan.	masaki@oita-u.ac.jp		Masaki, Takayuki/0000-0002-2378-849X				Abu-Hamdah R, 2009, J CLIN ENDOCR METAB, V94, P1843, DOI 10.1210/jc.2008-1296; Arakawa M, 2011, ENDOCR J, V58, P161, DOI 10.1507/endocrj.K10E-221; Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001; Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cardoso AR, 2010, BBA-BIOENERGETICS, V1797, P832, DOI 10.1016/j.bbabio.2009.12.017; Chaudhuri A, 2012, J CLIN ENDOCR METAB, V97, P198, DOI 10.1210/jc.2011-1508; Derosa G, 2010, METABOLISM, V59, P887, DOI 10.1016/j.metabol.2009.10.007; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Lamont BJ, 2008, DIABETES, V57, P190, DOI 10.2337/db07-1202; Lehrke Michael, 2011, Rev Diabet Stud, V8, P382, DOI 10.1900/RDS.2011.8.382; Makdissi A, 2012, J CLIN ENDOCR METAB, V97, P3333, DOI 10.1210/jc.2012-1544; Masaki T, 2003, ENDOCRINOLOGY, V144, P3547, DOI 10.1210/en.2003-0301; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P409, DOI 10.1016/j.bbadis.2008.09.005; Mostyn Alison, 2008, Organogenesis, V4, P182; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Polakof S, 2011, J NEUROENDOCRINOL, V23, P508, DOI 10.1111/j.1365-2826.2011.02137.x; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; Raz I, 2008, CURR MED RES OPIN, V24, P537, DOI [10.1185/030079908X260925, 10.1185/030079908X260925 ]; Richard D, 2011, FRONT BIOSCI-LANDMRK, V16, P1233, DOI 10.2741/3786; Rosenstock J, 2006, CLIN THER, V28, P1556, DOI 10.1016/j.clinthera.2006.10.007; Sangle GV, 2012, ENDOCRINOLOGY, V153, P564, DOI 10.1210/en.2011-1732; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336; Thornberry NA, 2009, BEST PRACT RES CL EN, V23, P479, DOI 10.1016/j.beem.2009.03.004; Vendrell J, 2011, ENDOCRINOLOGY, V152, P4072, DOI 10.1210/en.2011-1070; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Villanueva-Penacarrillo ML, 2001, HORM METAB RES, V33, P73, DOI 10.1055/s-2001-12428; Villarroya F, 2007, PPAR RES, V2007, DOI 10.1155/2007/74364; Yasuda T, 2004, NEUROSCIENCE, V125, P535, DOI 10.1016/j.neuroscience.2003.11.039; Zaninovich AA, 2001, MEDICINA-BUENOS AIRE, V61, P597	36	42	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63626	10.1371/journal.pone.0063626	http://dx.doi.org/10.1371/journal.pone.0063626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696840	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900047
J	Ehrhardt, C; Dudek, SE; Holzberg, M; Urban, S; Hrincius, ER; Haasbach, E; Seyer, R; Lapuse, J; Planz, O; Ludwig, S				Ehrhardt, Christina; Dudek, Sabine Eva; Holzberg, Magdalena; Urban, Sabine; Hrincius, Eike Roman; Haasbach, Emanuel; Seyer, Roman; Lapuse, Julia; Planz, Oliver; Ludwig, Stephan			A Plant Extract of Ribes nigrum folium Possesses Anti-Influenza Virus Activity In Vitro and In Vivo by Preventing Virus Entry to Host Cells	PLOS ONE			English	Article							INFLUENZA-A VIRUS; ACTIVATED RECEPTOR-2; BLACK-CURRANTS; H5N1 VIRUS; PROTEIN; PROANTHOCYANIDINS; RESISTANCE; HEALTH; LEAVES; MICE	Infections with influenza A viruses (IAV) are still amongst the major causes of highly contagious severe respiratory diseases not only bearing a devastating effect to human health, but also significantly impact the economy. Besides vaccination that represents the best option to protect from IAV infections, only two classes of anti-influenza drugs, inhibitors of the M2 ion channel and the neuraminidase, often causing resistant IAV variants have been approved. That is why the need for effective and amply available antivirals against IAV is of high priority. Here we introduce LADANIA067 from the leaves of the wild black currant (Ribes nigrum folium) as a potent compound against IAV infections in vitro and in vivo. LADANIA067 treatment resulted in a reduction of progeny virus titers in cell cultures infected with prototype avian and human influenza virus strains of different subtypes. At the effective dose of 100 mu g/ml the extract did not exhibit apparent harming effects on cell viability, metabolism or proliferation. Further, viruses showed no tendency to develop resistance to LADANIA067 when compared to amantadine that resulted in the generation of resistant variants after only a few passages. On a molecular basis the protective effect of LADANIA067 appears to be mainly due to interference with virus internalisation. In the mouse infection model LADANIA067 treatment reduces progeny virus titers in the lung upon intranasal application. In conclusion, an extract from the leaves of the wild black currant might be a promising source for the development of new antiviral compounds to fight IAV infections.	[Ehrhardt, Christina; Dudek, Sabine Eva; Holzberg, Magdalena; Urban, Sabine; Hrincius, Eike Roman; Seyer, Roman; Ludwig, Stephan] Univ Munster, Inst Mol Virol, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany; [Haasbach, Emanuel; Planz, Oliver] Univ Tubingen, Dept Immunol, Interfac Inst Cell Biol, Tubingen, Germany; [Lapuse, Julia] Dr Pandalis NatUrprod GmbH, Glandorf, Germany	University of Munster; Eberhard Karls University of Tubingen	Ludwig, S (corresponding author), Univ Munster, Inst Mol Virol, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany.	ludwigs@uni-muenster.de		Ludwig, Stephan/0000-0003-4490-3052	Deutsche Forschungsgemeinschaft [EH 235/1-2]; DFG Graduate School [GRK 1409]; University of Muenster Medical School; German ministry of education and research (BMBF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG Graduate School(German Research Foundation (DFG)); University of Muenster Medical School; German ministry of education and research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants of the Deutsche Forschungsgemeinschaft (EH 235/1-2), the DFG Graduate School GRK 1409 and the fund "Innovative Medical Research" (IMF) of the University of Muenster Medical School. It is part of the activities of the German FluResearchNet, a nationwide research network on zoonotic influenza, funded by the German ministry of education and research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Bearman Gonzalo M L, 2010, Recent Pat Antiinfect Drug Discov, V5, P152; Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; Ehrhardt C, 2004, FEBS LETT, V567, P230, DOI 10.1016/j.febslet.2004.04.069; Ehrhardt C, 2007, ANTIVIR RES, V76, P38, DOI 10.1016/j.antiviral.2007.05.002; Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099; Eierhoff T, 2009, BIOL CHEM, V390, P509, DOI 10.1515/BC.2009.053; Feld M, 2008, J IMMUNOL, V180, P6903, DOI 10.4049/jimmunol.180.10.6903; Garbacki Nancy, 2004, BMC Pharmacology, V4, P25, DOI 10.1186/1471-2210-4-25; Gopalan A, 2012, FOOD FUNCT, V3, P795, DOI 10.1039/c2fo30058c; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Ikuta K, 2012, MICROBIOL IMMUNOL, V56, P805, DOI 10.1111/j.1348-0421.2012.00510.x; Kalus U, 2009, ANTIVIR RES, V84, P267, DOI 10.1016/j.antiviral.2009.10.001; Karoline D, 2007, ANTIVIR RES, V76, P1, DOI 10.1016/j.antiviral.2007.04.001; Khoufache K, 2013, J CLIN INVEST, V123, P206, DOI 10.1172/JCI61667; Khoufache K, 2009, J IMMUNOL, V182, P7795, DOI 10.4049/jimmunol.0803743; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Seyer R, 2012, J INFECT DIS, V205, P262, DOI 10.1093/infdis/jir716; Tabart J, 2006, J AGR FOOD CHEM, V54, P6271, DOI 10.1021/jf061112y; Tabart J, 2011, J AGR FOOD CHEM, V59, P4763, DOI 10.1021/jf104445c; TITS M, 1992, J PHARMACEUT BIOMED, V10, P1097, DOI 10.1016/0731-7085(91)80128-V; Tosh C, 2011, VIRUS GENES, V42, P10, DOI 10.1007/s11262-010-0534-z; van der Vries E, 2011, CURR OPIN INFECT DIS, V24, P599, DOI 10.1097/QCO.0b013e32834cfb43; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	28	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63657	10.1371/journal.pone.0063657	http://dx.doi.org/10.1371/journal.pone.0063657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717460	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600026
J	Ali, EM; Kobayashi, K; Yamaoka, N; Ishikawa, M; Nishiguchi, M				Ali, Emran Md.; Kobayashi, Kappei; Yamaoka, Naoto; Ishikawa, Masayuki; Nishiguchi, Masamichi			Graft Transmission of RNA Silencing to Non-Transgenic Scions for Conferring Virus Resistance in Tobacco	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; MOSAIC-VIRUS; GENE; PLANTS; TOBAMOVIRUS; STRAIN; MULTIPLICATION; INTERFERENCE; MOBILE; DEFENSE	RNA silencing is a mechanism of gene regulation by sequence specific RNA degradation and is involved in controlling endogenous gene expression and defense against invasive nucleic acids such as viruses. RNA silencing has been proven to be transmitted between scions and rootstocks through grafting, mostly using transgenic plants. It has been reported that RNA silencing of tobacco endogenous genes, NtTOM1 and NtTOM3, that are required for tobamovirus multiplication, resulted in high resistance against several tobamoviruses. In the present study, we examined the graft transmission of RNA silencing for conferring virus resistance to non-transgenic scions of the same and different Nicotiana species grafted onto rootstocks in which both NtTOM1 and NtTOM3 were silenced. Non-transgenic Nicotiana tabacum (cvs. Samsun and Xanthi nc) and N. benthamiana were used as scions for grafting onto the rootstocks silenced with both genes. Short interfering RNA (siRNA) of NtTOM1 and NtTOM3 was detected in both the scions and the rootstocks eight weeks after grafting. The leaves were detached from the scions and inoculated with several tobamoviruses. The virus accumulation was tested by ELISA and northern blot analysis. The viruses were detected in grafted scions at extremely low levels, showing that virus resistance was conferred. These results suggest that RNA silencing was induced in and virus resistance was conferred to the non-transgenic scions by grafting onto silenced rootstocks. The effect of low temperature on siRNA accumulation and virus resistance was not significantly observed in the scions.	[Ali, Emran Md.; Kobayashi, Kappei; Yamaoka, Naoto; Nishiguchi, Masamichi] Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan; [Ishikawa, Masayuki] Natl Inst Agrobiol Sci, Plant Microbe Interact Res Unit, Tsukuba, Ibaraki, Japan	Ehime University; National Institute of Agrobiological Sciences - Japan	Nishiguchi, M (corresponding author), Ehime Univ, Fac Agr, 3-5-7 Tarumi, Matsuyama, Ehime 790, Japan.	mnishigu@agr.ehime-u.ac.jp			Program for Promotion of Basic and Applied Researches in Bio-oriented Industry (BRAIN); Ministry of Education, Culture, Sports and Technology of Japan [24580065]; Japan Science and Technology Agency for the A-step (Adaptable & Seamless Technology Transfer Program through Target-driven R D); Grants-in-Aid for Scientific Research [24580065] Funding Source: KAKEN	Program for Promotion of Basic and Applied Researches in Bio-oriented Industry (BRAIN); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency for the A-step (Adaptable & Seamless Technology Transfer Program through Target-driven R D); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Program for Promotion of Basic and Applied Researches in Bio-oriented Industry (BRAIN), the Ministry of Education, Culture, Sports and Technology of Japan [Grant-in-Aid for Scientific Research for Scientific Research (C), No. 24580065] to MN and Japan Science and Technology Agency for the A-step (Adaptable & Seamless Technology Transfer Program through Target-driven R & D) to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 2005, FEBS LETT, V579, P4479, DOI 10.1016/j.febslet.2005.07.021; Bai SL, 2011, J EXP BOT, V62, P4561, DOI 10.1093/jxb/err163; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chen Bing, 2007, Journal of Zhejiang University-Science B, V8, P256, DOI 10.1631/jzus.2007.B0256; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Crete P, 2001, PLANT J, V28, P493, DOI 10.1046/j.1365-313X.2001.01171.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fagard M, 2000, PLANT MOL BIOL, V43, P285, DOI 10.1023/A:1006404016494; Flachowsky H, 2012, INT J MOL SCI, V13, P9992, DOI 10.3390/ijms13089992; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; Haque AKMN, 2007, PLANT MOL BIOL, V63, P35, DOI 10.1007/s11103-006-9070-6; Hewezi T, 2005, PLANT BIOTECHNOL J, V3, P81, DOI 10.1111/j.1467-7652.2004.00103.x; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hu QO, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-41; Ishikawa M, 2004, P JPN ACAD B-PHYS, V80, P215, DOI 10.2183/pjab.80.215; Kameda T, 2004, BIOCHEM BIOPH RES CO, V315, P599, DOI 10.1016/j.bbrc.2004.01.097; Kasai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016895; Li M, 2006, CHINESE SCI BULL, V51, P313, DOI 10.1007/s11434-006-0313-3; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; NISHIGUCHI M, 1985, NUCLEIC ACIDS RES, V13, P5585, DOI 10.1093/nar/13.15.5585; NOZU Y, 1968, J MOL BIOL, V35, P643, DOI 10.1016/S0022-2836(68)80021-X; OHNO T, 1984, J BIOCHEM-TOKYO, V96, P1915, DOI 10.1093/oxfordjournals.jbchem.a135026; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Shimamoto I, 1998, ARCH VIROL, V143, P1801, DOI 10.1007/s007050050418; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Sonoda S, 2000, PLANT J, V21, P1, DOI 10.1046/j.1365-313x.2000.00645.x; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Yamanaka T, 2000, P NATL ACAD SCI USA, V97, P10107, DOI 10.1073/pnas.170295097; Yamanaka T, 2002, J VIROL, V76, P2491, DOI 10.1128/JVI.76.5.2491-2497.2002	39	31	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63257	10.1371/journal.pone.0063257	http://dx.doi.org/10.1371/journal.pone.0063257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717405	gold, Green Submitted, Green Published			2022-12-27	WOS:000320362700012
J	Asai, Y; Tateyama, S; Nomura, T				Asai, Yoshiyuki; Tateyama, Shota; Nomura, Taishin			Learning an Intermittent Control Strategy for Postural Balancing Using an EMG-Based Human-Computer Interface	PLOS ONE			English	Article							VISUAL FEEDBACK DELAYS; INVERTED PENDULUM; MANUAL TRACKING; INTERNAL-MODELS; VISUOMOTOR TRACKING; STIFFNESS; SYSTEMS; ANKLE; MOVEMENT; INSTABILITY	It has been considered that the brain stabilizes unstable body dynamics by regulating co-activation levels of antagonist muscles. Here we critically reexamined this established theory of impedance control in a postural balancing task using a novel EMG-based human-computer interface, in which subjects were asked to balance a virtual inverted pendulum using visual feedback information on the pendulum's position. The pendulum was actuated by a pair of antagonist joint torques determined in real-time by activations of the corresponding pair of antagonist ankle muscles of subjects standing upright. This motor-task raises a frustrated environment; a large feedback time delay in the sensorimotor loop, as a source of instability, might favor adopting the non-reactive, preprogrammed impedance control, but the ankle muscles are relatively hard to co-activate, which hinders subjects from adopting the impedance control. This study aimed at discovering how experimental subjects resolved this frustrated environment through motor learning. One third of subjects adapted to the balancing task in a way of the impedance-like control. It was remarkable, however, that the majority of subjects did not adopt the impedance control. Instead, they acquired a smart and energetically efficient strategy, in which two muscles were inactivated simultaneously at a sequence of optimal timings, leading to intermittent appearance of periods of time during which the pendulum was not actively actuated. Characterizations of muscle inactivations and the pendulumics sway showed that the strategy adopted by those subjects was a type of intermittent control that utilizes a stable manifold of saddle-type unstable upright equilibrium that appeared in the state space of the pendulum when the active actuation was turned off.	[Asai, Yoshiyuki] Grad Univ, Okinawa Inst Sci & Technol, Okinawa, Japan; [Tateyama, Shota; Nomura, Taishin] Osaka Univ, Grad Sch Engn Sci, Osaka, Japan	Okinawa Institute of Science & Technology Graduate University; Osaka University	Nomura, T (corresponding author), Osaka Univ, Grad Sch Engn Sci, Osaka, Japan.	taishin@bpe.es.osaka-u.ac.jp	Nomura, Taishin/J-8408-2012	Nomura, Taishin/0000-0002-6545-2097	JSPS [23300166, 23650156]; MEXT Global COE Program "in silico medicine'' at Osaka University; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [22136002] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT Global COE Program "in silico medicine'' at Osaka University; Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS grants-in-aid 23300166 and 23650156, MEXT Global COE Program "in silico medicine'' at Osaka University, and the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Bormann R, 2004, NEUROCOMPUTING, V58, P517, DOI 10.1016/j.neucom.2004.01.089; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; Cluff T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005998; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Conforto S, 2001, GAIT POSTURE, V14, P28, DOI 10.1016/S0966-6362(01)00112-6; Doeringer JA, 1998, J NEUROPHYSIOL, V80, P1787, DOI 10.1152/jn.1998.80.4.1787; Engbert R, 2011, P NATL ACAD SCI USA, V108, pE765, DOI 10.1073/pnas.1102730108; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; Foulkes AJM, 2000, EXP BRAIN RES, V131, P101, DOI 10.1007/s002219900286; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin S, 2012, J NEUROPHYSIOL, V108, P467, DOI 10.1152/jn.01123.2011; Gawthrop P, 2011, BIOL CYBERN, V104, P31, DOI 10.1007/s00422-010-0416-4; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; GOMI H, 1993, NEURAL NETWORKS, V6, P933, DOI 10.1016/S0893-6080(09)80004-X; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Honda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037900; Insperger T, 2006, IEEE T CONTR SYST T, V14, P974, DOI 10.1109/TCST.2006.876938; Insperger T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0763; Insperger T, 2010, IMA J MATH CONTROL I, V27, P457, DOI 10.1093/imamci/dnq020; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kobravi HR, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046007; Kowalczyk P, 2012, J R SOC INTERFACE, V9, P234, DOI 10.1098/rsif.2011.0212; Lakie M, 2003, J PHYSIOL-LONDON, V551, P357, DOI 10.1113/jphysiol.2002.036939; Loram ID, 2012, J R SOC INTERFACE, V9, P2070, DOI 10.1098/rsif.2012.0142; Loram ID, 2011, J PHYSIOL-LONDON, V589, P307, DOI 10.1113/jphysiol.2010.194712; Loram ID, 2005, J PHYSIOL-LONDON, V564, P295, DOI 10.1113/jphysiol.2004.076307; Loram ID, 2004, J PHYSIOL-LONDON, V556, P683, DOI 10.1113/jphysiol.2004.062398; Loram ID, 2002, J PHYSIOL-LONDON, V540, P1111, DOI 10.1113/jphysiol.2001.013077; Loram ID, 2001, J PHYSIOL-LONDON, V532, P879, DOI 10.1111/j.1469-7793.2001.0879e.x; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Mehta B, 2002, J NEUROPHYSIOL, V88, P942, DOI 10.1152/jn.2002.88.2.942; Miall RC, 2006, EXP BRAIN RES, V172, P77, DOI 10.1007/s00221-005-0306-5; Miall RC, 2007, PLOS BIOL, V5, P2733, DOI 10.1371/journal.pbio.0050316; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; MIALL RC, 1985, NEUROSCIENCE, V16, P511, DOI 10.1016/0306-4522(85)90189-7; Milton J, 2009, PHIL T R SOC A, V367, P1181; Milton JG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065005; Morasso PG, 2002, J NEUROPHYSIOL, V88, P2157, DOI 10.1152/jn.2002.88.4.2157; Morasso PG, 1999, NEURAL NETWORKS, V12, P1173, DOI 10.1016/S0893-6080(99)00058-1; Morasso P, 2011, J PHYSIOL-LONDON, V589, P459, DOI 10.1113/jphysiol.2010.203604; Nigg B.M., 1994, BIOMECHANICS MUSCULO; Nomura T, 2013, MATH BIOSCI, V245, P86, DOI 10.1016/j.mbs.2013.02.002; Rangarajan G, 2000, PHYS REV E, V61, P4991, DOI 10.1103/PhysRevE.61.4991; Saha DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030301; Schaal S, 2004, NAT NEUROSCI, V7, P1137, DOI 10.1038/nn1322; Squeri V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011189; Stepan G, 2000, MATH COMPUT MODEL, V31, P199, DOI 10.1016/S0895-7177(00)00039-X; Stepan G, 2006, ANNU REV CONTROL, V30, P159, DOI 10.1016/j.arcontrol.2006.08.002; Stephen DG, 2010, COGNITION, V115, P154, DOI 10.1016/j.cognition.2009.12.010; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; UTKIN VI, 1977, IEEE T AUTOMAT CONTR, V22, P212, DOI 10.1109/TAC.1977.1101446; van de Kamp C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002843; van der Kooij H, 2005, J NEUROSCI METH, V145, P175, DOI 10.1016/j.jneumeth.2005.01.003; Weyand PG, 2009, IEEE ENG MED BIO, P6878, DOI 10.1109/IEMBS.2009.5333126; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	67	27	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e62956	10.1371/journal.pone.0062956	http://dx.doi.org/10.1371/journal.pone.0062956			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UP	23717398	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700007
J	Sapkota, Y; Yasui, Y; Lai, R; Sridharan, M; Robson, PJ; Cass, CE; Mackey, JR; Damaraju, S				Sapkota, Yadav; Yasui, Yutaka; Lai, Raymond; Sridharan, Malinee; Robson, Paula J.; Cass, Carol E.; Mackey, John R.; Damaraju, Sambasivarao			Identification of a Breast Cancer Susceptibility Locus at 4q31.22 Using a Genome-Wide Association Study Paradigm	PLOS ONE			English	Article							RISK-FACTORS; GENE; MUTATIONS; EXPRESSION; VARIANT; EPIDEMIOLOGY; ALLELES; DISEASE; LINKAGE; PROTEIN	More than 40 single nucleotide polymorphisms (SNPs) for breast cancer susceptibility were identified by genome-wide association studies (GWASs). However, additional SNPs likely contribute to breast cancer susceptibility and overall genetic risk, prompting this investigation for additional variants. Six putative breast cancer susceptibility SNPs identified in a two-stage GWAS that we reported earlier were replicated in a follow-up stage 3 study using an independent set of breast cancer cases and controls from Canada, with an overall cumulative sample size of 7,219 subjects across all three stages. The study design also encompassed the 11 variants from GWASs previously reported by various consortia between the years 20072009 to (i) enable comparisons of effect sizes, and (ii) identify putative prognostic variants across studies. All SNP associations reported with breast cancer were also adjusted for body mass index (BMI). We report a strong association with 4q31.22-rs1429142 (combined per allele odds ratio and 95% confidence interval = 1.28 [1.17-1.41] and P-combined = 1.5x10(-7)), when adjusted for BMI. Ten of the 11 breast cancer susceptibility loci reported by consortia also showed associations in our predominantly Caucasian study population, and the associations were independent of BMI; four FGFR2 SNPs and TNRC9-rs3803662 were among the most notable associations. Since the original report by Garcia-Closas et al. 2008, this is the second study to confirm the association of 8q24.21-rs13281615 with breast cancer outcomes.	[Sapkota, Yadav; Cass, Carol E.; Mackey, John R.; Damaraju, Sambasivarao] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Sapkota, Yadav; Lai, Raymond; Sridharan, Malinee; Damaraju, Sambasivarao] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Yasui, Yutaka] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Robson, Paula J.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Cass, Carol E.; Mackey, John R.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Robson, Paula J.] Alberta Hlth Serv Canc Care, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; Alberta Health Services (AHS)	Damaraju, S (corresponding author), Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada.	Sambasivarao.Damaraju@albertahealthservices.ca	Sapkota, Yadav/O-2142-2015; Yasui, Yutaka/E-2564-2015; Robson, Paula J/Q-3351-2017	Sapkota, Yadav/0000-0001-5943-9454; Yasui, Yutaka/0000-0002-7717-8638; Robson, Paula J/0000-0003-4640-1371	Alberta Cancer Research Institute (ACRI); CBCF (Canadian Breast Cancer Foundation); Alberta Cancer Board (ACB); CBCF-Prairies/North West Territories Region, Alberta Cancer Foundation, Alberta Cancer Prevention and Legacy Fund; Alberta Innovates-Health Solutions; Alberta Cancer Foundation; Alberta Cancer Prevention Legacy; Canadian Partnership Against Cancer	Alberta Cancer Research Institute (ACRI); CBCF (Canadian Breast Cancer Foundation); Alberta Cancer Board (ACB); CBCF-Prairies/North West Territories Region, Alberta Cancer Foundation, Alberta Cancer Prevention and Legacy Fund; Alberta Innovates-Health Solutions; Alberta Cancer Foundation; Alberta Cancer Prevention Legacy; Canadian Partnership Against Cancer	This work was supported by Alberta Cancer Research Institute (ACRI), CBCF (Canadian Breast Cancer Foundation) operating grants and Alberta Cancer Board (ACB) operating grants to SD. Funding for the CBCF Tumor Bank was provided by the CBCF-Prairies/North West Territories Region, Alberta Cancer Foundation, Alberta Cancer Prevention and Legacy Fund, managed by the Alberta Innovates-Health Solutions. The Tomorrow Project was funded by the Alberta Cancer Foundation and the Alberta Cancer Prevention Legacy (managed by Alberta Innovates -Health Solutions) and the Canadian Partnership Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Bryant Heather, 2006, Chronic Dis Can, V27, P51; Campa D, 2011, JNCI-J NATL CANCER I, V103, P1252, DOI 10.1093/jnci/djr265; Canadian Cancer Society's Steering Committee on Cancer Statistics, 2012, CAN CANC STAT 2012; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Garcia-Closas M, 2008, CLIN CANCER RES, V14, P8000, DOI 10.1158/1078-0432.CCR-08-0975; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; *GOLD HEL INC, HEL SNP VAR SUIT VER; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Krishnan AV, 2004, PROSTATE, V59, P243, DOI 10.1002/pros.20006; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Miao JY, 2012, J NEUROL SCI, V323, P232, DOI 10.1016/j.jns.2012.09.027; Murabito JM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S6; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, R LANG ENV STAT COMP; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Sapkota Y, 2012, EUR J HUM GENET, V20, P682, DOI 10.1038/ejhg.2011.273; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sehrawat B, 2011, HUM GENET, V130, P529, DOI 10.1007/s00439-011-0973-1; Short SM, 2007, BREAST J, V13, P130, DOI 10.1111/j.1524-4741.2007.00389.x; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Theriault BL, 2012, INT J CANCER, V130, P1844, DOI 10.1002/ijc.26189; THERNEAU T, 2012, PACKAGE SURVIVAL ANA, P36; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Thompson D, 2004, J MAMMARY GLAND BIOL, V9, P221, DOI 10.1023/B:JOMG.0000048770.90334.3b; Wang KS, 2012, GENE, V500, P80, DOI 10.1016/j.gene.2012.03.046; Wang XK, 2010, CANCER GENET CYTOGEN, V196, P64, DOI 10.1016/j.cancergencyto.2009.09.003; Wiesmann F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2319; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Yasuno K, 2011, P NATL ACAD SCI USA, V108, P19707, DOI 10.1073/pnas.1117137108; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	47	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e62550	10.1371/journal.pone.0062550	http://dx.doi.org/10.1371/journal.pone.0062550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717390	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700004
J	Chakraborty, P; Goswami, SK; Rajani, S; Sharma, S; Kabir, SN; Chakravarty, B; Jana, K				Chakraborty, Pratip; Goswami, S. K.; Rajani, Shweta; Sharma, Sunita; Kabir, Syed N.; Chakravarty, Baidyanath; Jana, Kuladip			Recurrent Pregnancy Loss in Polycystic Ovary Syndrome: Role of Hyperhomocysteinemia and Insulin Resistance	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; SPONTANEOUS-ABORTION; PLASMA HOMOCYSTEINE; FETAL LOSS; WOMEN; VITAMIN-B-12; REPRODUCTION; MISCARRIAGE; OBESITY; RISK	Recurrent pregnancy loss (RPL) in polycystic ovary syndrome (PCOS), which occurs in similar to 50% of total pregnancies is a frequent obstetric complication. Among the several hypotheses, insulin resistance (IR), obesity and hyperhomocysteinemia (HHcy) play significant role/s in RPL. This study was conducted to assess the link between elevated levels of homocysteine and IR in PCOS-associated women with RPL in Kolkata, India. A retrospective study was conducted of one hundred and twenty six PCOS women (<30 years) who experienced two or more spontaneous abortions during the first trimester presenting to Institute of Reproductive Medicine (IRM) in Kolkata during the period of March 2008 through February 2011. One hundred and seventeen non-PCOS subjects with matching age range were randomly chosen as controls. Incidence of HHcy and IR was 70.63% (n = 89) and 56.34% (n = 71), respectively, in RPL-affected PCOS population which was significantly higher (p<0.04; p<0.0001) when compared to the non-PCOS set (HHcy: 57.26%; IR: 6.83%). Rates of miscarriage were significantly higher (p<0.008; p<0.03) in hyperhomocysteinemia-induced miscarriage when compared to the normohomocysteinemic segment (PCOS: 70.63% vs. 29.36% & non-PCOS: 57.26% vs. 42.73%) along with the insulin resistant (p<0.04; p<0.0001) population (PCOS: 70.63% vs. 56.34% & non-PCOS: 57.26% vs. 6.83%) in both groups. A probabilistic causal model evaluated HHcy as the strongest plausible factor for diagnosis of RPL. A probability percentage of 43.32% in the cases of HHcy-mediated RPL suggests its increased tendency when compared to IR mediated miscarriage (37.29%), further supported by ROC-AUC (HHcy: 0.778vs. IR: 0.601) values. Greater susceptibility towards HHcy may increase the incidence for miscarriage in women in India and highlights the need to combat the condition in RPL control programs in the subcontinent.	[Chakraborty, Pratip] Inst Reprod Med, Dept Infertil, Kolkata, India; [Goswami, S. K.; Rajani, Shweta; Sharma, Sunita; Chakravarty, Baidyanath] Inst Reprod Med, Dept Assisted Reprod, Kolkata, India; [Kabir, Syed N.] CSIR Indian Inst Chem Biol, Kolkata, India; [Jana, Kuladip] Calcutta Improvement Trust Scheme VIIM, Bose Inst, Div Mol Med, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Department of Science & Technology (India); Bose Institute	Jana, K (corresponding author), Calcutta Improvement Trust Scheme VIIM, Bose Inst, Div Mol Med, Kolkata, W Bengal, India.	kuladip@bic.boseinst.ernet.in	Jana, Kuladip/GXG-3481-2022	Jana, Kuladip/0000-0003-4748-253X				Amer SAK, 2002, HUM REPROD, V17, P2035, DOI 10.1093/humrep/17.8.2035; Atiomo WU, 1998, FERTIL STERIL, V69, P236, DOI 10.1016/S0015-0282(97)00486-X; Azem F, 2004, HUM REPROD, V19, P368, DOI 10.1093/humrep/deh069; Bastard JP, 2000, DIABETES-METAB RES, V16, P192, DOI 10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.3.CO;2-7; Bennett M, 2001, J REPROD MED, V46, P209; Boxmeer JC, 2008, HUM REPROD, V23, P2570, DOI 10.1093/humrep/den292; Bussen S, 1999, HUM REPROD, V14, P18, DOI 10.1093/humrep/14.1.18; Chakraborty P, 2013, BIOL TRACE ELEM RES, V152, P9, DOI 10.1007/s12011-012-9592-5; Ebisch IMW, 2006, HUM REPROD, V21, P1725, DOI 10.1093/humrep/del081; Essah Paulina A, 2004, Hormones (Athens), V3, P221; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Ford Holly B, 2009, Rev Obstet Gynecol, V2, P76; Giudice LC, 2006, BEST PRACT RES CL EN, V20, P235, DOI 10.1016/j.beem.2006.03.005; Gosman GG, 2006, HUM REPROD UPDATE, V12, P585, DOI 10.1093/humupd/dml024; Hogge WA, 2003, AM J OBSTET GYNECOL, V189, P397, DOI 10.1067/S0002-9378(03)00700-2; Kaya C, 2009, REPROD BIOMED ONLINE, V19, P721, DOI 10.1016/j.rbmo.2009.06.005; Lee RM, 2000, SEMIN REPROD MED, V18, P433, DOI 10.1055/s-2000-13733; Lindblad B, 2005, ACTA OBSTET GYN SCAN, V84, P1055, DOI 10.1111/j.0001-6349.2005.00876.x; Makino A, 2004, AM J REPROD IMMUNOL, V52, P60, DOI 10.1111/j.1600-0897.2004.00187.x; Maryam Kotanaie, 2012, BMC Res Notes, V5, P133, DOI 10.1186/1756-0500-5-133; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Nadir Y, 2007, ANN HEMATOL, V86, P35, DOI 10.1007/s00277-006-0194-1; Nafiye Y, 2010, FERTIL STERIL, V93, P1864, DOI 10.1016/j.fertnstert.2008.12.024; Pacchiarotti A, 2007, J ASSIST REPROD GEN, V24, P459, DOI 10.1007/s10815-007-9165-2; Palomba S, 2005, FERTIL STERIL, V84, P761, DOI 10.1016/j.fertnstert.2005.04.021; Pritchand D., 2006, UPDATE RELATION COMM; Qublan HS, 2006, HUM REPROD, V21, P2694, DOI 10.1093/humrep/del203; Rai R, 2000, HUM REPROD, V15, P612, DOI 10.1093/humrep/15.3.612; Rai R, 1996, BRIT J OBSTET GYNAEC, V103, P106, DOI 10.1111/j.1471-0528.1996.tb09658.x; Raziel A, 2001, AM J REPROD IMMUNOL, V45, P65, DOI 10.1111/j.8755-8920.2001.450201.x; Schachter M, 2003, HUM REPROD, V18, P721, DOI 10.1093/humrep/deg190; Sun L, 2010, J ENDOCRINOL INVEST, V33, P77, DOI [10.1007/BF03346557, 10.3275/6470]; Tamura T, 2006, AM J CLIN NUTR, V83, P993, DOI 10.1093/ajcn/83.5.993; Tian L, 2007, J CLIN ENDOCR METAB, V92, P1430, DOI 10.1210/jc.2006-1123; Wang JX, 2002, OBES RES, V10, P551, DOI 10.1038/oby.2002.74; Wijeyaratne CN, 2004, CLIN ENDOCRINOL, V60, P560, DOI 10.1111/j.1365-2265.2004.02019.x; World Health Organization, 2000, WHO TECHNICAL REPORT, V894, P3	37	47	55	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64446	10.1371/journal.pone.0064446	http://dx.doi.org/10.1371/journal.pone.0064446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700477	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200136
J	Pal, R; Thakur, PB; Li, SM; Minard, C; Rodney, GG				Pal, Rituraj; Thakur, Poulami Basu; Li, Shumin; Minard, Charles; Rodney, George G.			Real-Time Imaging of NADPH Oxidase Activity in Living Cells Using a Novel Fluorescent Protein Reporter	PLOS ONE			English	Article							SKELETAL-MUSCLE; REACTIVE OXYGEN; DYE 2'-7'-DICHLOROFLUORESCEIN; RELEASE; INHIBITOR	Production of reactive oxygen species (ROS) has been implicated in the pathology of many conditions, including cardiovascular, inflammatory and degenerative diseases, aging, muscular dystrophy, and muscle fatigue. NADPH oxidases (Nox) have recently gained attention as an important source of ROS involved in redox signaling. However, our knowledge of the source of ROS has been limited by the relatively impoverished array of tools available to study them and the limitations of all imaging probes to provide meaningful spatial resolution. By linking redox-sensitive GFP (roGFP) to the Nox organizer protein, p47(phox), we have developed a redox sensitive protein to specifically assess Nox activity (p47-roGFP). Stimulation of murine macrophages with endotoxin resulted in rapid, reversible oxidation of p47-roGFP. In murine skeletal muscle, both passive stretch and repetitive electrical stimulation resulted in oxidation of p47-roGFP. The oxidation of p47-roGFP in both macrophages and skeletal muscle was blocked by a Nox specific peptide inhibitor. Furthermore, expression of p47-roGFP in p47(phox) deficient cells restored Nox activity. As Nox has been linked to pathological redox signaling, our newly developed Nox biosensor will allow for the direct assessment of Nox activity and the development of therapeutic Nox inhibitors.	[Pal, Rituraj; Thakur, Poulami Basu; Li, Shumin; Rodney, George G.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Minard, Charles] Baylor Coll Med, Dan L Duncan Inst Clin & Translat Res, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Rodney, GG (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	Rodney@bcm.edu		Rodney, George G/0000-0002-6968-1516	National Institutes of Health [R01 AR061370]; Baylor College of Medicine Seed Funds; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine Seed Funds; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The construction of p47-roGFP was made possible from Baylor College of Medicine Seed Funds. All other aspects were supported by a grant from the National Institutes of Health (R01 AR061370) and Baylor College of Medicine Seed Funds to GGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Dworakowski R, 2006, BIOCHEM SOC T, V34, P960, DOI 10.1042/BST0340960; Geiszt M, 2012, ANTIOXID RE IN PRESS; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Janiszewski M, 2002, FREE RADICAL BIO MED, V32, P446, DOI 10.1016/S0891-5849(01)00828-0; Khairallah RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002829; Lavigne MC, 2001, FASEB J, V15, P285; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; LOLAIT SJ, 1984, J CLIN INVEST, V73, P277, DOI 10.1172/JCI111203; Marchesi E, 1999, FREE RADICAL BIO MED, V26, P148, DOI 10.1016/S0891-5849(98)00174-9; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Michaelson LP, 2010, MUSCLE NERVE, V42, P522, DOI 10.1002/mus.21724; Paletta-Silva R, 2013, INT J MOL SCI, V14, P3683, DOI 10.3390/ijms14023683; Patwell DM, 2004, FREE RADICAL BIO MED, V37, P1064, DOI 10.1016/j.freeradbiomed.2004.06.026; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Qian L, 2008, J IMMUNOL, V181, P660, DOI 10.4049/jimmunol.181.1.660; REID MB, 1992, J APPL PHYSIOL, V73, P1797, DOI 10.1152/jappl.1992.73.5.1797; REID MB, 1992, J APPL PHYSIOL, V73, P1805, DOI 10.1152/jappl.1992.73.5.1805; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Rodney GG, 2008, AM J PHYSIOL-CELL PH, V294, pC1288, DOI 10.1152/ajpcell.00033.2008; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Sun QA, 2011, P NATL ACAD SCI USA, V108, P16098, DOI 10.1073/pnas.1109546108; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026	31	51	51	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63989	10.1371/journal.pone.0063989	http://dx.doi.org/10.1371/journal.pone.0063989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704967	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200099
J	Takebe, Y; Saucedo, CJ; Lund, G; Uenishi, R; Hase, S; Tsuchiura, T; Kneteman, N; Ramessar, K; Tyrrell, DLJ; Shirakura, M; Wakita, T; McMahon, JB; O'Keefe, BR				Takebe, Yutaka; Saucedo, Carrie J.; Lund, Garry; Uenishi, Rie; Hase, Saiki; Tsuchiura, Takayo; Kneteman, Norman; Ramessar, Koreen; Tyrrell, D. Lorne J.; Shirakura, Masayuki; Wakita, Takaji; McMahon, James B.; O'Keefe, Barry R.			Antiviral Lectins from Red and Blue-Green Algae Show Potent In Vitro and In Vivo Activity against Hepatitis C Virus	PLOS ONE			English	Article							ANTI-HIV PROTEIN; RECOMBINANT PRODUCTION; INACTIVATING PROTEIN; GLYCOSYLATION SITES; HCV INFECTION; CYANOVIRIN-N; GRIFFITHSIN; RIBAVIRIN; ENTRY; RESISTANCE	Hepatitis C virus (HCV) infection is a significant public health problem with over 170,000,000 chronic carriers and infection rates increasing worldwide. Chronic HCV infection is one of the leading causes of hepatocellular carcinoma which was estimated to result in,10,000 deaths in the United States in the year 2011. Current treatment options for HCV infection are limited to PEG-ylated interferon alpha (IFN-alpha), the nucleoside ribavirin and the recently approved HCV protease inhibitors telaprevir and boceprevir. Although showing significantly improved efficacy over the previous therapies, treatment with protease inhibitors has been shown to result in the rapid emergence of drug-resistant virus. Here we report the activity of two proteins, originally isolated from natural product extracts, which demonstrate low or sub-nanomolar in vitro activity against both genotype I and genotype II HCV. These proteins inhibit viral infectivity, binding to the HCV envelope glycoproteins E1 and E2 and block viral entry into human hepatocytes. In addition, we demonstrate that the most potent of these agents, the protein griffithsin, is readily bioavailable after subcutaneous injection and shows significant in vivo efficacy in reducing HCV viral titers in a mouse model system with engrafted human hepatocytes. These results indicate that HCV viral entry inhibitors can be an effective component of anti-HCV therapy and that these proteins should be studied further for their therapeutic potential.	[Takebe, Yutaka; Uenishi, Rie; Hase, Saiki; Tsuchiura, Takayo] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Saucedo, Carrie J.] SAIC Frederick, Mol Targets Lab, Frederick, MD USA; [Lund, Garry; Kneteman, Norman; Tyrrell, D. Lorne J.] KMT Hepatech, Edmonton, AB, Canada; [Ramessar, Koreen; McMahon, James B.; O'Keefe, Barry R.] NCI, Ctr Canc Res, Mol Targets Lab, Frederick, MD 21701 USA; [Shirakura, Masayuki; Wakita, Takaji] Natl Inst Infect Dis, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institute of Infectious Diseases (NIID)	O'Keefe, BR (corresponding author), NCI, Ctr Canc Res, Mol Targets Lab, Frederick, MD 21701 USA.	okeefeba@mail.nih.gov			Ministry of Health, Labor and Welfare (JAPAN); Human Sciences Foundation; Intramural research Program of the NIH; National Cancer Institute; Center for Cancer Research; National Cancer Institute, National Institutes of Health [N01-CO-12400, HHSN261200800001E]; NIAID; NATIONAL CANCER INSTITUTE [ZICBC010469] Funding Source: NIH RePORTER	Ministry of Health, Labor and Welfare (JAPAN)(Ministry of Health, Labour and Welfare, Japan); Human Sciences Foundation; Intramural research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Y.T. is supported by grants of the hepatitis study group from the Ministry of Health, Labor and Welfare (JAPAN) and the Human Sciences Foundation. This research was supported by the Intramural research Program of the NIH, National Cancer Institute, Center for Cancer Research. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400 and HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The patents for both Griffithsin and Scytovirin are wholly owned by the U.S. Government. Drs. O'Keefe and McMahon are named inventors on patents for both proteins. Norman Kneteman, Garry Lund and Lorne Tyrrell are affiliated to KMT Hepatech which is a contract research organization funded by NIAID for hepatitis C studies with no competing interests. KMT Hepatech has no rights or interests in further developing the antiviral proteins griffithsin and scytovirin for commercial use. Their involvement in this manuscript does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Barth H, 2008, J HEPATOL, V49, P134, DOI 10.1016/j.jhep.2008.03.012; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Davis GL, 2005, LIVER TRANSPLANT, V11, P941, DOI 10.1002/lt.20405; De Beeck AO, 2004, J VIROL, V78, P2994, DOI 10.1128/JVI.78.6.2994-3002.2004; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Giomarelli B, 2006, PROTEIN EXPRES PURIF, V47, P194, DOI 10.1016/j.pep.2005.10.014; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; Goffard A, 2003, BIOCHIMIE, V85, P295, DOI 10.1016/S0300-9084(03)00004-X; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200; Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005; Kouokam JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022635; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; McFeeters RL, 2007, J MOL BIOL, V369, P451, DOI 10.1016/j.jmb.2007.03.030; Meuleman P, 2011, ANTIMICROB AGENTS CH, V55, P5159, DOI 10.1128/AAC.00633-11; Meunier JC, 1999, J GEN VIROL, V80, P887, DOI 10.1099/0022-1317-80-4-887; Michaels AJ, CURR OPINION GASTROE, V26, P196; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mori T, 1998, PROTEIN EXPRES PURIF, V12, P151, DOI 10.1006/prep.1997.0838; Moulaei T, 2007, PROTEIN SCI, V16, P2756, DOI 10.1110/ps.073157507; Naggie S, 2010, J ANTIMICROB CHEMOTH, V65, P2063, DOI 10.1093/jac/dkq284; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; Pol S, 2010, J HEPATOL, V52, pS462, DOI 10.1016/S0168-8278(10)61190-7; Polyak SJ, 2007, GASTROENTEROLOGY, V132, P1925, DOI 10.1053/j.gastro.2007.02.038; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schiano TD, 2006, LIVER TRANSPLANT, V12, P1381, DOI 10.1002/lt.20876; Slater-Handshy T, 2004, VIROLOGY, V319, P36, DOI 10.1016/j.virol.2003.10.008; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Xiong CY, 2006, PROTEIN EXPRES PURIF, V46, P233, DOI 10.1016/j.pep.2005.09.019; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zhang HJ, 2009, J NAT PROD, V72, P2158, DOI 10.1021/np900549e; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	43	93	99	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64449	10.1371/journal.pone.0064449	http://dx.doi.org/10.1371/journal.pone.0064449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700478	gold, Green Submitted, Green Published			2022-12-27	WOS:000319330200137
J	Hamaji, T; Ferris, PJ; Nishii, I; Nishimura, Y; Nozaki, H				Hamaji, Takashi; Ferris, Patrick J.; Nishii, Ichiro; Nishimura, Yoshiki; Nozaki, Hisayoshi			Distribution of the Sex-Determining Gene MID and Molecular Correspondence of Mating Types within the Isogamous Genus Gonium (Volvocales, Chlorophyta)	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; MULTICOCCUM VOLVOCALES; EVOLUTION; REPRODUCTION; LOCUS; MORPHOLOGY; PROTEIN; IDENTIFICATION; PHYLOGENIES; FUSION	Background: Isogamous organisms lack obvious cytological differences in the gametes of the two complementary mating types. Consequently, it is difficult to ascertain which of the two mating types are homologous when comparing related but sexual isolated strains or species. The colonial volvocalean algal genus Gonium consists of such isogamous organisms with heterothallic mating types designated arbitrarily as plus or minus in addition to homothallic strains. Homologous molecular markers among lineages may provide an "objective" framework to assign heterothallic mating types. Methodology/Principal Findings: Using degenerate primers designed based on previously reported MID orthologs, the "master regulator" of mating types/sexes in the colonial Volvocales, MID homologs were identified and their presence/absence was examined in nine strains of four species of Gonium. Only one of the two complementary mating types in each of the four heterothallic species has a MID homolog. In addition to heterothallic strains, a homothallic strain of G. multicoccum has MID. Molecular evolutionary analysis suggests that MID of this homothallic strain retains functional constraint comparable to that of the heterothallic strains. Conclusion/Significance: We coordinated mating genotypes based on presence or absence of a MID homolog, respectively, in heterothallic species. This scheme should be applicable to heterothallic species of other isogamous colonial Volvocales including Pandorina and Yamagishiella. Homothallism emerged polyphyletically in the colonial Volvocales, although its mechanism remains unknown. Our identification of a MID homolog for a homothallic strain of G. multicoccum suggests a MID-dependent mechanism is involved in the sexual developmental program of this homothallic species.	[Hamaji, Takashi; Nishimura, Yoshiki] Kyoto Univ, Dept Bot, Grad Sch Sci, Sakyo Ku, Kyoto, Japan; [Ferris, Patrick J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Nishii, Ichiro] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan	Kyoto University; University of Arizona; National University of Singapore; University of Tokyo	Hamaji, T (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO USA.	hamaji@pmg.bot.kyoto-u.ac.jp	NOZAKI, HISAYOSHI/G-4926-2014	Nishimura, Yoshiki/0000-0001-8686-9206; Hamaji, Takashi/0000-0002-2801-2148; Nozaki, Hisayoshi/0000-0002-9308-4498	Japan Society for the Promotion of Science [19-7661, 23-5499, 24112707, 24247042]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Japan Society for the Promotion of Science (Research fellowship numbers 19-7661 and 23-5499, for TH; Grants-in-Aid for Scientific Research numbers 24112707 and 24247042, for HN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CR, 1990, CURR GENET, V18, P141, DOI 10.1007/BF00312602; Anonymous, 2009, Japanese Journal of Phycology, V57, P1; BOYNTON JE, 1987, P NATL ACAD SCI USA, V84, P2391, DOI 10.1073/pnas.84.8.2391; CAMPBELL AM, 1995, MOL BIOL CELL, V6, P87, DOI 10.1091/mbc.6.1.87; Coleman AW, 2012, J PHYCOL, V48, P491, DOI 10.1111/j.1529-8817.2012.01168.x; COLEMAN AW, 1994, J PHYCOL, V30, P80, DOI 10.1111/j.0022-3646.1994.00080.x; COLEMAN AW, 1959, J PROTOZOOL, V6, P249, DOI 10.1111/j.1550-7408.1959.tb04366.x; COLEMAN AW, 1975, J PHYCOL, V11, P282, DOI 10.1111/j.0022-3646.1975.00282.x; DETMERS PA, 1983, J CELL BIOL, V97, P522, DOI 10.1083/jcb.97.2.522; DETMERS PA, 1985, CELL MOTIL CYTOSKEL, V5, P415, DOI 10.1002/cm.970050505; Fabry S, 1999, J MOL EVOL, V48, P94, DOI 10.1007/PL00006449; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferris P, 2010, SCIENCE, V328, P351, DOI 10.1126/science.1186222; Ferris PJ, 1997, GENETICS, V146, P859; Ferris PJ, 1997, P NATL ACAD SCI USA, V94, P8634, DOI 10.1073/pnas.94.16.8634; Ferris PJ, 2002, GENETICS, V160, P181; Ferris PJ, 1996, MOL BIOL CELL, V7, P1235, DOI 10.1091/mbc.7.8.1235; GOLDSTEIN M, 1964, J PROTOZOOL, V11, P317, DOI 10.1111/j.1550-7408.1964.tb01762.x; GOODENOUGH UW, 1982, J CELL BIOL, V92, P378, DOI 10.1083/jcb.92.2.378; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamaji T, 2008, GENETICS, V178, P283, DOI 10.1534/genetics.107.078618; Hamaji T, 2009, J PHYCOL, V45, P1310, DOI 10.1111/j.1529-8817.2009.00744.x; Harris EH, 2008, CLAMYDOMONAS SOURCEB; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin H, 2007, GENETICS, V176, P913, DOI 10.1534/genetics.106.066167; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Misamore MJ, 2003, MOL BIOL CELL, V14, P2530, DOI 10.1091/mbc.E02-12-0790; Mogi Y, 2012, J PHYCOL, V48, P670, DOI 10.1111/j.1529-8817.2012.01149.x; Nakada T, 2010, J PLANT RES, V123, P67, DOI 10.1007/s10265-009-0266-0; NOZAKI H, 1991, PHYCOLOGIA, V30, P381, DOI 10.2216/i0031-8884-30-5-381.1; Nozaki H, 1996, J PLANT RES, V109, P353, DOI 10.1007/BF02344484; NOZAKI H, 1986, PHYCOLOGIA, V25, P29, DOI 10.2216/i0031-8884-25-1-29.1; NOZAKI H, 1989, PHYCOLOGIA, V28, P77, DOI 10.2216/i0031-8884-28-1-77.1; NOZAKI H, 1989, PHYCOLOGIA, V28, P252, DOI 10.2216/i0031-8884-28-2-252.1; Nozaki H, 2006, CURR BIOL, V16, pR1018, DOI 10.1016/j.cub.2006.11.019; Nozaki H, 2008, BIOLOGIA, V63, P772, DOI 10.2478/s11756-008-0097-9; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Setohigashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019545; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VANWINKLESWIFT KP, 1986, GENETICS, V113, P601; Werner R, 1998, PLANT MOL BIOL REP, V16, P295, DOI 10.1023/A:1007583508766; Werner R, 2001, J PHYCOL, V37, P427, DOI 10.1046/j.1529-8817.2001.037003427.x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yamada Toshihiro K., 2006, Journal of Japanese Botany, V81, P139; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zamora I, 2004, BIOTECHNIQUES, V37, P534, DOI 10.2144/04374BM01	52	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64385	10.1371/journal.pone.0064385	http://dx.doi.org/10.1371/journal.pone.0064385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696888	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900091
J	Wang, MF; Chen, JQ; Ying, J; Yu, J; Huang, BF; Ren, ZX; Wang, XY; Guo, QQ; Wang, YL; Qiu, LY; Yu, HS; Wan, RG				Wang, Maofeng; Chen, Junqing; Ying, Jun; Yu, Jiong; Huang, Bifei; Ren, Zhaoxiang; Wang, Xianyu; Guo, Qiaoqiao; Wang, Yunlai; Qiu, Liuyi; Yu, Hongsheng; Wan, Rugen			Serum Angiopoietin-2 and beta-hCG as Predictors of Prolonged Uterine Bleeding after Medical Abortion in the First Trimester	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BUCCAL MISOPROSTOL; RECEPTORS TIE-1; EARLY-PREGNANCY; EXPRESSION; MIFEPRISTONE; WOMEN; CONTRACEPTION; ENDOMETRIUM; PROGESTIN	Objective: The combination of mifepristone and misoprostol is an established method for induction of early first trimester abortion, but there is no consensus about the best evaluation of treatment outcome. We evaluate serum Angiopoietin-2(Ang-2) and beta human chorionic gonadotropin (beta-hCG) in women who had undergone a medical abortion as markers of prolonged uterine bleeding (PUB). Methods: Prospective trial involving 2843 women attending an gynecology outpatient clinic who following a medical abortion with mifepristone and misoprostol, the study cohort was divided into women with duration of uterine bleeding >14 days (PUB) and women with duration of uterine bleeding <= 14 days (normal uterine bleeding, NUB). Serum determinations of Ang-2 levels by ELISA and beta-hCG levels by electrochemiluminiscence immunoassay. Receiver Operating Characteristics (ROC) analyses were calculated and plotted for the diagnostic accuracy of serum beta-hCG and Ang-2 concentration to discriminate PUB and NUB. Results: Baseline characteristics for both groups were similar, Only duration of bleeding showed a significant difference between the PUB group and NUB group. Ang-2 serum levels moderately correlated with serum beta-hCG levels with statistically significant correlation coefficients of 0.536. Serum beta-hCG and Ang-2 levels on day 7 and on day 14 after medical abortion were signifcantly higher in PUB group than in NUB group. Plotted as ROC curves, beta-hCG area under curve (AUC) was 0.65 (95% CI, 0.53-0.76) on day 7, rising to AUC = 0.83 (95% CI, 0.75-0.92) on day 14. Using Ang-2 on day 7 and day 14 as predictive parameter resulted in an analogous AUC (AUC = 0.61 on day 7, AUC = 0.78 on day 14). Conclusions: Both parameters are clinically useful as a diagnostic test in predicting PUB after medical abortion, and can be helpful in uncertain clinical situations, but should be considered as supplementary to a general clinical evaluation.	[Wang, Maofeng; Ren, Zhaoxiang; Yu, Hongsheng; Wan, Rugen] Wenzhou Med Coll, Affiliated Dongyang Hosp, Dept Clin Lab Med, Dongyang, Zhejiang, Peoples R China; [Chen, Junqing; Wang, Xianyu] Wenzhou Med Coll, Affiliated Dongyang Hosp, Dept Gynecol, Dongyang, Zhejiang, Peoples R China; [Ying, Jun] Wenzhou Med Coll, Sch Lab Med, Wenzhou, Zhejiang, Peoples R China; [Yu, Jiong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Bifei; Qiu, Liuyi] Wenzhou Med Coll, Affiliated Dongyang Hosp, Pathol Ctr, Dongyang, Zhejiang, Peoples R China; [Guo, Qiaoqiao; Wang, Yunlai] Wenzhou Med Coll, Dept Ultrasonog, Affiliated Dongyang Hosp, Dongyang, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Zhejiang University; Wenzhou Medical University; Wenzhou Medical University	Wan, RG (corresponding author), Wenzhou Med Coll, Affiliated Dongyang Hosp, Dept Clin Lab Med, Dongyang, Zhejiang, Peoples R China.	13967995216@163.com		Yu, Jiong/0000-0002-1821-1178	Science and Technology Project of Jinhua city [2012-3-083]	Science and Technology Project of Jinhua city	This study was supported by Science and Technology Project of Jinhua city (2012-3-083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolekar R, 2009, PRENATAL DIAG, V29, P847, DOI 10.1002/pd.2307; Baschat A, 2010, AM J PERINAT, V27, P9, DOI 10.1055/s-0029-1224865; Cheng LN, 2006, CONTRACEPTION, V74, P61, DOI 10.1016/j.contraception.2006.03.004; Chong E, 2012, CONTRACEPTION, V86, P251, DOI 10.1016/j.contraception.2011.12.012; Chou Szu-Yuan, 2006, Taiwan J Obstet Gynecol, V45, P48; Daponte A, 2013, CLIN CHIM ACTA, V415, P145, DOI 10.1016/j.cca.2012.10.031; Demir R, 2009, FOLIA HISTOCHEM CYTO, V47, P435, DOI 10.2478/v10042-009-0100-5; El-Baradie SMY, 2008, J OBSTET GYNAECOL CA, V30, P877, DOI 10.1016/S1701-2163(16)32966-8; Fjerstad M, 2009, CONTRACEPTION, V80, P282, DOI 10.1016/j.contraception.2009.03.010; Goldstone P, 2012, MED J AUSTRALIA, V197, P282, DOI 10.5694/mja12.10297; Haimov-Kochman R, 2007, ACTA OBSTET GYN SCAN, V86, P462, DOI 10.1080/00016340701203632; Hurliman AK, 2010, FERTIL STERIL, V93, P1493, DOI 10.1016/j.fertnstert.2009.04.036; Krikun G, 2002, AM J PATHOL, V161, P979, DOI 10.1016/S0002-9440(10)64258-7; Kulier R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002855.pub4; Lockwood CJ, 2004, HISTOL HISTOPATHOL, V19, P167, DOI 10.14670/HH-19.167; Miyabayashi K, 2005, J EXP ZOOL PART A, V303A, P590, DOI 10.1002/jez.a.188; Ngo TD, 2011, B WORLD HEALTH ORGAN, V89, P360, DOI 10.2471/BLT.10.084046; Norris W, 2011, PLACENTA, V32, pS182, DOI 10.1016/j.placenta.2011.01.009; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Pietrowski D, 2003, FERTIL STERIL, V80, P1026, DOI 10.1016/S0015-0282(03)01011-2; Pietrowski D, 2010, HORM METAB RES, V42, P328, DOI 10.1055/s-0030-1249021; Plaisier M, 2007, FERTIL STERIL, V88, P176, DOI 10.1016/j.fertnstert.2006.11.102; Qian HL, 2010, J INT MED RES, V38, P100, DOI 10.1177/147323001003800112; Rorbye C, 2004, HUM REPROD, V19, P85, DOI 10.1093/humrep/deh041; Rudolfsson SH, 2003, BIOL REPROD, V69, P1231, DOI 10.1095/biolreprod.102.013375; Seval Y, 2008, PLACENTA, V29, P809, DOI 10.1016/j.placenta.2008.06.009; Silver KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009481; Stepan H, 2009, AM J HYPERTENS, V22, P314, DOI 10.1038/ajh.2008.340; Woolnough C, 2012, MICROVASC RES, V84, P367, DOI 10.1016/j.mvr.2012.08.003; World Health Organization, 2012, FACTS IND AB WORLDW; Wu Shang-chun, 2010, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V32, P479, DOI 10.3881/j.issn.1000-503X.2010.05.001; Wulff C, 2000, J CLIN ENDOCR METAB, V85, P4302, DOI 10.1210/jc.85.11.4302	32	1	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63755	10.1371/journal.pone.0063755	http://dx.doi.org/10.1371/journal.pone.0063755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696855	Green Submitted, Green Published			2022-12-27	WOS:000319081900059
J	Ferrer-Paris, JR; Sanchez-Mercado, A; Viloria, AL; Donaldson, J				Ferrer-Paris, Jose R.; Sanchez-Mercado, Ada; Viloria, Angel L.; Donaldson, John			Congruence and Diversity of Butterfly-Host Plant Associations at Higher Taxonomic Levels	PLOS ONE			English	Article							NEOTROPICAL MISTLETOE BUTTERFLIES; LARVAL FOOD PLANTS; LYCAENID BUTTERFLIES; HUBNER LEPIDOPTERA; ANT ASSOCIATION; IMMATURE STAGES; DIET BREADTH; DIVERSIFICATION; EVOLUTION; CLASSIFICATION	We aggregated data on butterfly-host plant associations from existing sources in order to address the following questions: (1) is there a general correlation between host diversity and butterfly species richness?, (2) has the evolution of host plant use followed consistent patterns across butterfly lineages?, (3) what is the common ancestral host plant for all butterfly lineages? The compilation included 44,148 records from 5,152 butterfly species (28.6% of worldwide species of Papilionoidea) and 1,193 genera (66.3%). The overwhelming majority of butterflies use angiosperms as host plants. Fabales is used by most species (1,007 spp.) from all seven butterfly families and most subfamilies, Poales is the second most frequently used order, but is mostly restricted to two species-rich subfamilies: Hesperiinae (56.5% of all Hesperiidae), and Satyrinae (42.6% of all Nymphalidae). We found a significant and strong correlation between host plant diversity and butterfly species richness. A global test for congruence (Parafit test) was sensitive to uncertainty in the butterfly cladogram, and suggests a mixed system with congruent associations between Papilionidae and magnoliids, Hesperiidae and monocots, and the remaining subfamilies with the eudicots (fabids and malvids), but also numerous random associations. The congruent associations are also recovered as the most probable ancestral states in each node using maximum likelihood methods. The shift from basal groups to eudicots appears to be more likely than the other way around, with the only exception being a Satyrine-clade within the Nymphalidae that feed on monocots. Our analysis contributes to the visualization of the complex pattern of interactions at superfamily level and provides a context to discuss the timing of changes in host plant utilization that might have promoted diversification in some butterfly lineages.	[Ferrer-Paris, Jose R.; Sanchez-Mercado, Ada; Donaldson, John] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Cape Town, Western Cape, South Africa; [Ferrer-Paris, Jose R.; Sanchez-Mercado, Ada; Donaldson, John] Univ Cape Town, Dept Bot, ZA-7925 Cape Town, Western Cape, South Africa; [Ferrer-Paris, Jose R.; Sanchez-Mercado, Ada] Inst Venezolano Invest Cient, Ctr Estudios Bot & Agroforestales, Maracaibo, Estado Zulia, Venezuela; [Viloria, Angel L.] Inst Venezolano Invest Cient, Ctr Ecol, Caracas, Distrito Capita, Venezuela	South African National Biodiversity Institute; University of Cape Town; Venezuelan Institute Science Research; Venezuelan Institute Science Research	Sanchez-Mercado, A (corresponding author), South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Cape Town, Western Cape, South Africa.	asanchez@ivic.gob.ve	Yakovlev, Roman/J-7243-2013; Ferrer-Paris, José/M-3785-2015; Sánchez-Mercado, Ada/AAL-4235-2021; Donaldson, John/F-6833-2011	Ferrer-Paris, José/0000-0002-9554-3395; Sánchez-Mercado, Ada/0000-0001-5030-2128; Donaldson, John/0000-0002-7930-1695	Instituto Venezolano de Investigaciones Cientificas (IVIC); South African National Biodiversity Institute (SANBI); University of Cape Town (UCT)	Instituto Venezolano de Investigaciones Cientificas (IVIC); South African National Biodiversity Institute (SANBI); University of Cape Town (UCT)	This work was supported by Instituto Venezolano de Investigaciones Cientificas (IVIC), and by a postdoctoral fellowship "Threatened species program" from South African National Biodiversity Institute (SANBI) and University of Cape Town (UCT) to ASM and JRFP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERY PR, 1988, BIOL J LINN SOC, V33, P95, DOI 10.1111/j.1095-8312.1988.tb00446.x; ACKERY PR, 1991, BIOL J LINN SOC, V44, P335, DOI 10.1111/j.1095-8312.1991.tb00624.x; Anderson D. R., 2008, MODEL BASED INFERENC; Beccaloni GW, 2000, OIKOS, V90, P50, DOI 10.1034/j.1600-0706.2000.900106.x; Beccaloni GW, 2008, CATALOGO PLANTAS HUE; Braby MF, 2006, J EVOLUTION BIOL, V19, P1677, DOI 10.1111/j.1420-9101.2006.01109.x; Braby MF, 2005, INVERTEBR SYST, V19, P113, DOI 10.1071/IS04020; Braby MF, 2005, J NAT HIST, V39, P499, DOI 10.1080/00222930410001708687; Braby Michael F., 2007, Journal of the Lepidopterists' Society, V61, P181; Braby MF, 2007, SYST ENTOMOL, V32, P2, DOI 10.1111/j.1365-3113.2006.00349.x; Braby MF, 2006, ENTOMOL SCI, V9, P383, DOI 10.1111/j.1479-8298.2006.00185.x; Braby MF, 2010, J NAT HIST, V44, P1831, DOI 10.1080/00222931003633227; Collen B, 2008, TROP CONSERV SCI, V1, P75, DOI 10.1177/194008290800100202; Condamine FL, 2012, ECOL LETT, V15, P267, DOI 10.1111/j.1461-0248.2011.01737.x; de Jong R, 2003, INVERTEBR SYST, V17, P143, DOI 10.1071/IS02021; Eastwood R, 2006, EVOLUTION, V60, P315; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Farrell BD, 1998, BIOL J LINN SOC, V63, P553, DOI 10.1006/bijl.1997.0207; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fiedler K, 1996, ENTOMOL EXP APPL, V80, P259, DOI 10.1007/BF00194770; FIEDLER K, 1994, ECOL ENTOMOL, V19, P79, DOI 10.1111/j.1365-2311.1994.tb00393.x; FIEDLER K, 1995, ETHOL ECOL EVOL, V7, P107, DOI 10.1080/08927014.1995.9522960; Fiedler K, 1998, ECOL ENTOMOL, V23, P285, DOI 10.1046/j.1365-2311.1998.00132.x; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; HERNANDEZ L. M., 2002, HOSTPLANTS MOTH BUTT; Ives AR, 2006, AM NAT, V168, pE1, DOI 10.1086/505157; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Janz N, 2011, ANNU REV ECOL EVOL S, V42, P71, DOI 10.1146/annurev-ecolsys-102710-145024; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; KROON D.M., 1999, LEPIDOPTERA SO AFRIC; LABANDEIRA CC, 1994, P NATL ACAD SCI USA, V91, P12278, DOI 10.1073/pnas.91.25.12278; Lamas G, 2008, SISTEMATICA MARIPOSA; Lamas G, 2004, ATLAS EOTROPICAL LEP; Lamas G., 2008, CONTRIBUCIONES TAXON, P57; Larsen TB, 2005, BUTTERFLIES W AFRICA; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Megens HJ, 2005, BIOL J LINN SOC, V84, P225, DOI 10.1111/j.1095-8312.2005.00426.x; Megens HJ, 2004, MOL PHYLOGENET EVOL, V31, P1181, DOI 10.1016/j.ympev.2003.10.002; Menken SBJ, 2010, EVOLUTION, V64, P1098, DOI 10.1111/j.1558-5646.2009.00889.x; MILLER J S, 1987, Cladistics, V3, P105, DOI 10.1111/j.1096-0031.1987.tb00501.x; Miller Jacqueline Y., 2001, P127; MILLER JS, 1992, BIOSCIENCE, V42, P50, DOI 10.2307/1311628; Mulder C, 2011, AMBIO, V40, P335, DOI 10.1007/s13280-010-0069-5; Nylin S, 2008, BIOL J LINN SOC, V94, P115, DOI 10.1111/j.1095-8312.2008.00964.x; Nylin S, 2009, EVOL ECOL, V23, P807, DOI 10.1007/s10682-008-9274-0; Oksanen J, 2010, R PACKAGE VERSION 1; Pagel MD, 1994, PHYLOGENETICS ECOLOG, P29; Pena C, 2008, BIOL LETTERS, V4, P274, DOI 10.1098/rsbl.2008.0062; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Proches S, 2006, P R SOC B, V273, P1143, DOI 10.1098/rspb.2005.3427; Robbins CS, 1997, BREEDING BIRD SURVEY; Robinson G. S., 2001, Hostplants of the moth and butterfly caterpillars of the Oriental Region; SCOBLE MJ, 1990, ENTOMOL SCAND, V21, P113; Scriber JM, 2002, EUR J ENTOMOL, V99, P225, DOI 10.14411/eje.2002.032; Slove J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016057; Symons FB, 1999, OECOLOGIA, V119, P427, DOI 10.1007/s004420050804; Vane-Wright D, 2004, NATURE, V428, P477, DOI 10.1038/428477a; Viloria A.L., 2003, PERSPECTIVA LATINOAM, P247; Viloria Angel L., 2010, Zootaxa, V2622, P1; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; Wahlberg N, 2001, EVOLUTION, V55, P522, DOI 10.1554/0014-3820(2001)055[0522:TPABOH]2.0.CO;2; Warren AD, 2008, CLADISTICS, V24, P642, DOI 10.1111/j.1096-0031.2008.00218.x; Warren AD, 2009, SYST ENTOMOL, V34, P467, DOI 10.1111/j.1365-3113.2008.00463.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Woodhall S., 2005, FIELD GUIDE BUTTERFL; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	78	26	32	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63570	10.1371/journal.pone.0063570	http://dx.doi.org/10.1371/journal.pone.0063570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717448	Green Submitted, gold, Green Published			2022-12-27	WOS:000319435600023
J	Watling, JI; Bucklin, DN; Speroterra, C; Brandt, LA; Mazzotti, FJ; Romanach, SS				Watling, James I.; Bucklin, David N.; Speroterra, Carolina; Brandt, Laura A.; Mazzotti, Frank J.; Romanach, Stephanie S.			Validating Predictions from Climate Envelope Models	PLOS ONE			English	Article							POLEWARD SHIFTS; RANGE EXPANSION; DISTRIBUTIONS; HABITAT; CLASSIFICATION; PERFORMANCE; PREVALENCE; CRITERIA; NORTH; SIZE	Climate envelope models are a potentially important conservation tool, but their ability to accurately forecast species' distributional shifts using independent survey data has not been fully evaluated. We created climate envelope models for 12 species of North American breeding birds previously shown to have experienced poleward range shifts. For each species, we evaluated three different approaches to climate envelope modeling that differed in the way they treated climate-induced range expansion and contraction, using random forests and maximum entropy modeling algorithms. All models were calibrated using occurrence data from 1967-1971 (t(1)) and evaluated using occurrence data from 1998-2002 (t(2)). Model sensitivity (the ability to correctly classify species presences) was greater using the maximum entropy algorithm than the random forest algorithm. Although sensitivity did not differ significantly among approaches, for many species, sensitivity was maximized using a hybrid approach that assumed range expansion, but not contraction, in t(2). Species for which the hybrid approach resulted in the greatest improvement in sensitivity have been reported from more land cover types than species for which there was little difference in sensitivity between hybrid and dynamic approaches, suggesting that habitat generalists may be buffered somewhat against climate-induced range contractions. Specificity (the ability to correctly classify species absences) was maximized using the random forest algorithm and was lowest using the hybrid approach. Overall, our results suggest cautious optimism for the use of climate envelope models to forecast range shifts, but also underscore the importance of considering non-climate drivers of species range limits. The use of alternative climate envelope models that make different assumptions about range expansion and contraction is a new and potentially useful way to help inform our understanding of climate change effects on species.	[Watling, James I.; Bucklin, David N.; Speroterra, Carolina; Mazzotti, Frank J.] Univ Florida, Ft Lauderdale Res & Educ Ctr, Ft Lauderdale, FL 33314 USA; [Brandt, Laura A.] US Fish & Wildlife Serv, Ft Lauderdale, FL USA; [Romanach, Stephanie S.] US Geol Survey, Southeast Ecol Sci Ctr, Ft Lauderdale, FL USA	State University System of Florida; University of Florida; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey	Watling, JI (corresponding author), Univ Florida, Ft Lauderdale Res & Educ Ctr, Ft Lauderdale, FL 33314 USA.	watlingj@ufl.edu		Romanach, Stephanie S./0000-0003-0271-7825; Brandt, Laura A./0000-0001-9655-0290	U.S. Fish and Wildlife Service; Everglades and Dry Tortugas National Park through the South Florida and Caribbean Cooperative Ecosystem Studies Unit; USGS Greater Everglades Priority Ecosystem Science	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Everglades and Dry Tortugas National Park through the South Florida and Caribbean Cooperative Ecosystem Studies Unit; USGS Greater Everglades Priority Ecosystem Science	Funding for this work was provided by the U.S. Fish and Wildlife Service (http://www.fws.gov/), Everglades and Dry Tortugas National Park through the South Florida and Caribbean Cooperative Ecosystem Studies Unit (http://www.nps.gov/ever/index.htm), and USGS Greater Everglades Priority Ecosystem Science (http://access.usgs.gov/). The views in this paper do not necessarily represent the views of the U.S. Fish and Wildlife Service. Use of trade, product, or firm names does not imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Jenkins DG, 2007, GLOBAL ECOL BIOGEOGR, V16, P415, DOI 10.1111/j.1466-8238.2007.00312.x; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Matthews DP, 2007, ECOLOGY, V88, P2848, DOI 10.1890/06-1107.1; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Mitchell MD, 2011, GEOGR REV, V101, P269, DOI 10.1111/j.1931-0846.2011.00091.x; Mitikka V, 2008, BIODIVERS CONSERV, V17, P623, DOI 10.1007/s10531-007-9287-y; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rubidge EM, 2011, GLOBAL CHANGE BIOL, V17, P696, DOI 10.1111/j.1365-2486.2010.02297.x; SAUER JR, 2011, N AM BREEDING BIRD S; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Swihart RK, 2003, DIVERS DISTRIB, V9, P1, DOI 10.1046/j.1472-4642.2003.00158.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Toledo M, 2012, J ECOL, V100, P253, DOI 10.1111/j.1365-2745.2011.01890.x; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Zuckerberg B, 2009, GLOBAL CHANGE BIOL, V15, P1866, DOI 10.1111/j.1365-2486.2009.01878.x	34	17	17	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63600	10.1371/journal.pone.0063600	http://dx.doi.org/10.1371/journal.pone.0063600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717452	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600025
J	Yu, Y; Qi, LH; Wu, JZ; Wang, YL; Fang, WG; Zhang, HQ				Yu, Yu; Qi, Lihua; Wu, Junzhou; Wang, Yunling; Fang, Weigang; Zhang, Hongquan			Kindlin 2 Regulates Myogenic Related Factor Myogenin via a Canonical Wnt Signaling in Myogenic Differentiation	PLOS ONE			English	Article							BETA-CATENIN; LOCALIZATION; EXPRESSION; MYOD	Kindlin 2, as an integrin-associated protein, is required for myocyte elongation and fusion. However, the association of Kindlin 2 with muscle differentiation-related signaling pathways is unknown. Here, we identified a mechanism that Kindlin 2 regulates myogenic regulatory factors myogenin via a canonical Wnt/beta-catenin signaling. We found that knockdown of Kindlin 2 leads to the abolishment of beta-catenin/TCF4-mediated transcription in C2C12 cells, followed by the impairment of myogenic differentiation. Mechanistically, nuclear translocation of both Kindlin 2 and beta-catenin is induced during myogenic differentiation. In particular, Kindlin 2 forms a tripartite complex with active beta-catenin and TCF4, and hence co-occupied on the promoter of myogenin to enhance its expression. Functionally, depletion of Kindlin 2 impairs myogenic differentiation via downregulation of myogenin. Taken together, our data reveal that Kindlin 2 is required for Wnt signaling-regulated myogenic differentiation, providing a mechanistic insight into the role of Kindlin-2 in muscle development.	[Yu, Yu; Qi, Lihua; Wu, Junzhou; Wang, Yunling; Fang, Weigang; Zhang, Hongquan] Peking Univ, Hlth Sci Ctr, Minist Educ China, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China; [Yu, Yu; Qi, Lihua; Wu, Junzhou; Zhang, Hongquan] Peking Univ, Hlth Sci Ctr, Dept Anat Histol & Embryol, Lab Mol Cell Biol & Tumor Biol, Beijing 100871, Peoples R China; [Fang, Weigang] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100871, Peoples R China	Ministry of Education, China; Peking University; Peking University; Peking University	Zhang, HQ (corresponding author), Peking Univ, Hlth Sci Ctr, Minist Educ China, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China.	Hongquan.Zhang@bjmu.edu.cn	Qi, LI/AAF-3389-2019		National Natural Science Foundation of China [30830048, 81230051, 31170711, 81101495]; Ministry of Science and Technology of China [2010CB912203, 2010CB529402]; 111 Project of the Ministry of Education; Beijing Natural Science Foundation [7120002]; Peking University [BMU20120314]; Leading Academic Discipline Project of Beijing Education Bureau	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); 111 Project of the Ministry of Education(Ministry of Education, China - 111 Project); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Peking University(Peking University); Leading Academic Discipline Project of Beijing Education Bureau	This work was supported by grants from National Natural Science Foundation of China 30830048, 81230051, 31170711 and 81101495, the Ministry of Science and Technology of China 2010CB912203 and 2010CB529402, the 111 Project of the Ministry of Education, Beijing Natural Science Foundation 7120002 and a Peking University grant BMU20120314 and Leading Academic Discipline Project of Beijing Education Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Dowling JJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-36; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; Huh Michael S., 2005, Birth Defects Research, V75, P180, DOI 10.1002/bdrc.20045; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Qi L, 2013, INT J CANC; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Yu Y, 2012, EMBO REP, V13, P750, DOI 10.1038/embor.2012.88; Zhang M, 2010, J BIOL CHEM, V285, P8703, DOI 10.1074/jbc.M109.093526; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016	19	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63490	10.1371/journal.pone.0063490	http://dx.doi.org/10.1371/journal.pone.0063490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717433	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700026
J	Gao, L; Zhang, WW; Sun, YP; Yang, Q; Ren, J; Liu, JH; Wang, HX; Feng, WH				Gao, Li; Zhang, Weiwei; Sun, Yipeng; Yang, Qian; Ren, Jie; Liu, Jinhua; Wang, Hexiang; Feng, Wen-hai			Cryptoporus volvatus Extract Inhibits Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) In Vitro and In Vivo	PLOS ONE			English	Article							RNA-SYNTHESIS; CORDYCEPIN TRIPHOSPHATE; ANTIVIRAL ACTIVITY; REPLICATION; CHINA; POLYSACCHARIDE; INFECTION; EMERGENCE; CELLS; POLYMERASE	Porcine reproductive and respiratory syndrome virus (PRRSV) is an important arterivirus that can cause significant losses in swine industry. At present, there are no adequate control strategies against PRRSV. Thus, there is an urgent need for new treatment regimens that have efficacious antiviral activity to compensate for vaccines. Cryptoporus volvatus commonly serves as an anti-infective agent in Tradational Chinese Medicines. In this report, we exploited whether the aqueous extract from the fruiting body of Cryptoporus volvatus had the potential to inhibit PRRSV infection. Our results showed that the extract significantly inhibited PRRSV infection by repressing virus entry, viral RNA expression, and possibly viral protein synthesis, cell-to-cell spread, and releasing of virus particles. However, it did not block PRRSV binding to cells. Further studies confirmed that the extract directly inhibited PRRSV RNA-dependent RNA polymerase (RdRp) activity, thus interfering with PRRSV RNA and protein synthesis. More importantly, the extract efficiently inhibited highly pathologic PRRSV (HPPRRSV) infection in vivo, reduced virus load in serum, and increased the survival rate of pigs inoculated with HP-PRRSV strain. Collectively, our findings imply that the aqueous extract from the fruiting body of Cryptoporus volvatus has the potential to be used for anti-PRRSV therapies.	[Gao, Li; Zhang, Weiwei; Sun, Yipeng; Yang, Qian; Ren, Jie; Liu, Jinhua; Wang, Hexiang; Feng, Wen-hai] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Gao, Li; Zhang, Weiwei; Yang, Qian; Ren, Jie; Wang, Hexiang; Feng, Wen-hai] China Agr Univ, Minist Agr, Key Lab Soil Microbiol, Beijing 100094, Peoples R China; [Gao, Li; Zhang, Weiwei; Sun, Yipeng; Yang, Qian; Wang, Hexiang; Feng, Wen-hai] China Agr Univ, Coll Biol Sci, Dept Microbiol & Immunol, Beijing 100094, Peoples R China; [Sun, Yipeng; Liu, Jinhua] China Agr Univ, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Coll Vet Med, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Wang, HX (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	hxwang@cau.edu.cn; whfeng@cau.edu.cn			National Natural Science Foundation of China [30770101]; Faculty Starting Grant and State Key Laboratory of Agrobiotechnology [2010SKLAB06-1, 2012SKLAB01-6]; China Agricultural University, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Faculty Starting Grant and State Key Laboratory of Agrobiotechnology; China Agricultural University, China	This work was supported by the National Natural Science Foundation of China (#30770101), and the Faculty Starting Grant and State Key Laboratory of Agrobiotechnology (Grant 2010SKLAB06-1 and 2012SKLAB01-6), China Agricultural University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzarini J, 1996, P NATL ACAD SCI USA, V93, P13152, DOI 10.1073/pnas.93.23.13152; Beerens N, 2007, J VIROL, V81, P8384, DOI 10.1128/JVI.00564-07; Cafruny WA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-90; Faccin LC, 2007, LETT APPL MICROBIOL, V45, P24, DOI 10.1111/j.1472-765X.2007.02153.x; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Gao L, 2012, J VIROL, DOI [10.1128/JVI.02386-02312, DOI 10.1128/JVI.02386-02312]; Gastaminza P, 2010, P NATL ACAD SCI USA, V107, P291, DOI 10.1073/pnas.0912966107; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Horrigan BJ, 2006, EXPLORE-NY, V2, P153, DOI 10.1016/j.explore.2005.12.011; Jin Sai-hong, 2003, Zhongguo Zhongyao Zazhi, V28, P650; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Karuppannan AK, 2012, ANTIVIR RES, V94, P188, DOI 10.1016/j.antiviral.2012.03.008; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Kreutz LC, 1996, VIRUS RES, V42, P137, DOI 10.1016/0168-1702(96)01313-5; Kumar N, 2011, J VIROL, V85, P2818, DOI 10.1128/JVI.01969-10; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Luo R, 2011, ANTIVIR RES, V91, P99, DOI 10.1016/j.antiviral.2011.04.017; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Mothana RAA, 2003, FITOTERAPIA, V74, P177, DOI 10.1016/S0367-326X(02)00305-2; Murtaugh MP, 2011, VACCINE, V29, P8192, DOI 10.1016/j.vaccine.2011.09.013; Nauwynck HJ, 1999, J GEN VIROL, V80, P297, DOI 10.1099/0022-1317-80-2-297; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Ni JQ, 2012, J VET DIAGN INVEST, V24, P349, DOI 10.1177/1040638711434111; PANICALI DL, 1978, J VIROL, V25, P124, DOI 10.1128/JVI.25.1.124-128.1978; Pedersen KW, 1999, J VIROL, V73, P2016, DOI 10.1128/JVI.73.3.2016-2026.1999; Quinting B, 2007, J VET DIAGN INVEST, V19, P238, DOI 10.1177/104063870701900302; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sattentau QJ, 2011, CURR OPIN VIROL, V1, P396, DOI 10.1016/j.coviro.2011.09.004; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Storgaard T, 1999, ARCH VIROL, V144, P2389, DOI 10.1007/s007050050652; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tomei L, 2004, J VIROL, V78, P938, DOI 10.1128/JVI.78.2.938-946.2004; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; WHITE JL, 1979, J VIROL, V29, P811, DOI 10.1128/JVI.29.2.811-814.1979; Wootton S, 2000, ARCH VIROL, V145, P2297, DOI 10.1007/s007050070022; Wu JZ, 1999, J FUJIAN COLL TCM, V9, P33; Wu ZY, 1990, XIA HUA COMPENDIUM M; Xie QM, 2006, J ETHNOPHARMACOL, V107, P424, DOI 10.1016/j.jep.2006.03.040; Xu J.T., 1997, CHINESE MED MYCOLOGY; Yamamoto KA, 2013, INT J BIOL MACROMOL, V52, P9, DOI 10.1016/j.ijbiomac.2012.09.029; Yao HY, 2011, J ETHNOPHARMACOL, V137, P1267, DOI 10.1016/j.jep.2011.07.058; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x; Zjawiony JK, 2004, J NAT PROD, V67, P300, DOI 10.1021/np030372w	46	26	33	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63767	10.1371/journal.pone.0063767	http://dx.doi.org/10.1371/journal.pone.0063767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704937	gold, Green Submitted, Green Published			2022-12-27	WOS:000319330200068
J	Horton, RE; Grant, GD; Matthews, B; Batzloff, M; Owen, SJ; Kyan, S; Flegg, CP; Clark, AM; Ulett, GC; Morrison, N; Peak, IR; Beacham, IR				Horton, Rachel E.; Grant, Gary D.; Matthews, Ben; Batzloff, Michael; Owen, Suzzanne J.; Kyan, Stephanie; Flegg, Cameron P.; Clark, Amanda M.; Ulett, Glen C.; Morrison, Nigel; Peak, Ian R.; Beacham, Ifor R.			Quorum Sensing Negatively Regulates Multinucleate Cell Formation during Intracellular Growth of Burkholderia pseudomallei in Macrophage-Like Cells	PLOS ONE			English	Article							MELIOIDOSIS; VIRULENCE; PATHOGENICITY; EPIDEMIOLOGY; PLASTICITY; EVOLUTION; BACTERIA; SYSTEM; MODEL	Burkholderia pseudomallei is a Gram-negative environmental bacterium and the causative agent of melioidosis, a potentially fatal, acute or chronic disease endemic in the tropics. Acyl homoserine lactone (AHL)-mediated quorum sensing and signalling have been associated with virulence and biofilm formation in numerous bacterial pathogens. In the canonical acyl-homoserine lactone signalling paradigm, AHLs are detected by a response regulator. B. pseudomallei encodes three AHL synthases, encoded by bpsl1, bpsl2 and bpsl3, and five regulator genes. In this study, we mutated the B. pseudomallei AHL synthases individually and in double and triple combination. Five AHLs were detected and quantified by tandem liquid chromatography-mass spectroscopy. The major AHLs produced were N-octanoylhomoserine lactone and N-(3-hydroxy-decanoyl)homoserine lactone, the expression of which depended on bpsl1 and bpsl2, respectively. B. pseudomallei infection of macrophage cells causes cell fusion, leading to multinucleated cells (3 or more nuclei per cell). A triple mutant defective in production of all three AHL synthases was associated with a striking phenotype of massively enhanced host cellular fusion in macrophages. However, neither abrogation of host cell fusion, achieved by mutation of bimA or hcp1, nor enhancement of fusion altered intracellular replication of B. pseudomallei. Furthermore, when tested in murine models of acute melioidosis the AHL synthase mutants were not attenuated for virulence. Collectively, this study identifies important new aspects of the genetic basis of AHL synthesis in B. pseudomallei and the roles of these AHLs in systemic infection and in cell fusion in macrophages for this important human pathogen.	[Horton, Rachel E.; Batzloff, Michael; Owen, Suzzanne J.; Kyan, Stephanie; Flegg, Cameron P.; Ulett, Glen C.; Peak, Ian R.; Beacham, Ifor R.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Grant, Gary D.] Griffith Univ, Sch Pharm, Gold Coast, Qld, Australia; [Matthews, Ben] Griffith Univ, Smart Water Res Ctr, Gold Coast, Qld, Australia; [Clark, Amanda M.; Ulett, Glen C.; Morrison, Nigel; Peak, Ian R.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia	Griffith University; Griffith University; Griffith University; Griffith University	Beacham, IR (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	i.beacham@griffith.edu.au	Morrison, Nigel A/F-4082-2012; Peak, Ian R/C-5677-2009; Clark, Amanda/X-2325-2019	Morrison, Nigel A/0000-0003-4774-3808; Clark, Amanda/0000-0003-1590-2560; Grant, Gary/0000-0002-2574-5442; Ulett, Glen/0000-0002-9638-8091; Beacham, Ifor/0000-0002-3473-1579	National Health and Medical Research Council; Griffith University; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Griffith University(Griffith University); Australian Research Council(Australian Research Council)	This work has been supported by the National Health and Medical Research Council and by Griffith University. GCU is supported by a Future Fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boddey JA, 2007, CELL MICROBIOL, V9, P514, DOI 10.1111/j.1462-5822.2006.00807.x; Brown NF, 2000, J MED MICROBIOL, V49, P993, DOI 10.1099/0022-1317-49-11-993; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Brussow H, 2007, MOL MICROBIOL, V65, P583, DOI 10.1111/j.1365-2958.2007.05826.x; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Casadevall A, 2007, EUKARYOT CELL, V6, P2169, DOI 10.1128/EC.00308-07; Cheng Allen C, 2003, Commun Dis Intell Q Rep, V27, P272; Chugh TD, 2008, J BIOSCIENCES, V33, P549, DOI 10.1007/s12038-008-0073-0; Conejero L, 2011, AM J PATHOL, V179, P270, DOI 10.1016/j.ajpath.2011.03.031; Coulthurst SJ, 2007, EMBO REP, V8, P698, DOI 10.1038/sj.embor.7400984; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gamage AM, 2011, MICROBIOL-SGM, V157, P1176, DOI 10.1099/mic.0.046540-0; Gould TA, 2006, J BACTERIOL, V188, P773, DOI 10.1128/JB.188.2.773-783.2006; HASSAN MR, 2012, MELIOIDOSIS CENTURY, P87; Hassan MRA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-302; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Inglis TJJ, 2006, APPL ENVIRON MICROB, V72, P6865, DOI 10.1128/AEM.01036-06; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Logue CA, 2009, J MICROBIOL METH, V76, P320, DOI 10.1016/j.mimet.2008.12.007; Lumjiaktase P, 2006, MICROBIOL-SGM, V152, P3651, DOI 10.1099/mic.0.29226-0; Miyagi K, 1997, INFECT IMMUN, V65, P4108, DOI 10.1128/IAI.65.10.4108-4113.1997; Moxon ER, 2005, TRENDS MICROBIOL, V13, P563, DOI 10.1016/j.tim.2005.10.004; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Owen SJ, 2009, J INFECT DIS, V199, P1761, DOI 10.1086/599210; Rolim DB, 2005, EMERG INFECT DIS, V11, P1458, DOI 10.3201/eid1109.050493; Saravu K, 2010, SE ASIAN J TROP MED, V41, P401; Sitthidet C, 2011, J BACTERIOL, V193, P1901, DOI 10.1128/JB.01455-10; Song Y, 2005, J BACTERIOL, V187, P785, DOI 10.1128/JB.187.2.785-790.2005; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Ulrich RL, 2004, J MED MICROBIOL, V53, P1053, DOI 10.1099/jmm.0.45661-0; Valade E, 2004, J BACTERIOL, V186, P2288, DOI 10.1128/JB.186.8.2288-2294.2004; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x	42	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63394	10.1371/journal.pone.0063394	http://dx.doi.org/10.1371/journal.pone.0063394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704903	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200032
J	Araujo, AR; Reis, M; Rocha, H; Aguiar, B; Morales-Hojas, R; Macedo-Ribeiro, S; Fonseca, NA; Reboiro-Jato, D; Reboiro-Jato, M; Fdez-Riverola, F; Vieira, CP; Vieira, J				Araujo, Ana Rita; Reis, Micael; Rocha, Helder; Aguiar, Bruno; Morales-Hojas, Ramiro; Macedo-Ribeiro, Sandra; Fonseca, Nuno A.; Reboiro-Jato, David; Reboiro-Jato, Miguel; Fdez-Riverola, Florentino; Vieira, Cristina P.; Vieira, Jorge			The Drosophila melanogaster methuselah Gene: A Novel Gene with Ancient Functions	PLOS ONE			English	Article							DEVELOPMENTAL EXPRESSION; ADAPTIVE EVOLUTION; STRESS RESISTANCE; LIFE-SPAN; PROTEIN; FAMILY; RECEPTOR; MUTANT; ORIGIN	The Drosophila melanogaster G protein-coupled receptor gene, methuselah (mth), has been described as a novel gene that is less than 10 million years old. Nevertheless, it shows a highly specific expression pattern in embryos, larvae, and adults, and has been implicated in larval development, stress resistance, and in the setting of adult lifespan, among others. Although mth belongs to a gene subfamily with 16 members in D. melanogaster, there is no evidence for functional redundancy in this subfamily. Therefore, it is surprising that a novel gene influences so many traits. Here, we explore the alternative hypothesis that mth is an old gene. Under this hypothesis, in species distantly related to D. melanogaster, there should be a gene with features similar to those of mth. By performing detailed phylogenetic, synteny, protein structure, and gene expression analyses we show that the D. virilis GJ12490 gene is the orthologous of mth in species distantly related to D. melanogaster. We also show that, in D. americana (a species of the virilis group of Drosophila), a common amino acid polymorphism at the GJ12490 orthologous gene is significantly associated with developmental time, size, and lifespan differences. Our results imply that GJ12490 orthologous genes are candidates for developmental time and lifespan differences in Drosophila in general.	[Araujo, Ana Rita; Reis, Micael; Rocha, Helder; Aguiar, Bruno; Morales-Hojas, Ramiro; Macedo-Ribeiro, Sandra; Vieira, Cristina P.; Vieira, Jorge] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Fonseca, Nuno A.] Univ Porto, Ctr Res Adv Comp Syst CRACS INESC Porto, P-4100 Oporto, Portugal; [Fonseca, Nuno A.] EMBL European Bioinformat Inst, Cambridge, England; [Reboiro-Jato, David; Reboiro-Jato, Miguel; Fdez-Riverola, Florentino] Univ Vigo, Dept Informat, Orense, Spain	Universidade do Porto; INESC TEC; Universidade do Porto; European Molecular Biology Laboratory (EMBL); Universidade de Vigo	Vieira, CP (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jbvieira@ibmc.up.pt	Fonseca, Nuno A./B-7801-2009; Macedo-Ribeiro, Sandra/D-9258-2011; INESC-TEC, CRACS/F-7527-2012; Reboiro-Jato, Miguel/G-1102-2011; Reboiro-Jato, Miguel/AAB-8453-2022; Fdez-Riverola, Florentino/G-1411-2011; Vieira, Cristina P./K-1775-2013; Vieira, Jorge/J-7477-2013	Fonseca, Nuno A./0000-0003-4832-578X; Macedo-Ribeiro, Sandra/0000-0002-7698-1170; Reboiro-Jato, Miguel/0000-0001-8749-2703; Reboiro-Jato, Miguel/0000-0001-8749-2703; Fdez-Riverola, Florentino/0000-0002-3943-8013; Vieira, Cristina P./0000-0002-7139-2107; Vieira, Jorge/0000-0001-7032-5220; Rocha, Helder/0000-0003-1062-2498; Araujo, Ana Rita/0000-0003-3567-4155; Reis, Micael/0000-0002-2601-0886	FEDER Funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-008916 (PTDC/BIA-BEC/099933/2008) FCOMP-01-0124-FEDER-008916 (PTDC/EIA-EIA/100897/2008), FCOMP-01-0124-FEDER-022718 (PEST-C/SAU/LA0002/2011)]; FCT [SFRH/BD/61142/2009]	FEDER Funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by FEDER Funds through the Operational Competitiveness Programme - COMPETE and by National Funds through FCT - Fundacao para a Ciencia e a Tecnologia under the projects FCOMP-01-0124-FEDER-008916 (PTDC/BIA-BEC/099933/2008), FCOMP-01-0124-FEDER-008916 (PTDC/EIA-EIA/100897/2008), and the project FCOMP-01-0124-FEDER-022718 (PEST-C/SAU/LA0002/2011). Micael Reis is funded by a PhD grant attributed by FCT with the reference SFRH/BD/61142/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldal EA, 2006, EVOLUTION, V60, P1435, DOI 10.1111/j.0014-3820.2006.tb01222.x; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Cardoso JCR, 2005, J MOL ENDOCRINOL, V34, P753, DOI 10.1677/jme.1.01730; Cardoso JCR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-135; Cook-Wiens E, 2002, EXP GERONTOL, V37, P1347, DOI 10.1016/S0531-5565(02)00096-7; Duvernell DD, 2003, MOL ECOL, V12, P1277, DOI 10.1046/j.1365-294X.2003.01841.x; Fan Y, 2010, INSECT BIOCHEM MOLEC, V40, P581, DOI 10.1016/j.ibmb.2010.05.005; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gimenez LED, 2013, AGING CELL, V12, P121, DOI 10.1111/acel.12027; Ja WW, 2007, NAT CHEM BIOL, V3, P415, DOI 10.1038/nchembio.2007.2; Kim H, 2006, MOL CELLS, V21, P261; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martinez VG, 2007, DEV NEUROBIOL, V67, P778, DOI 10.1002/dneu.20388; Mertens I, 2007, PEPTIDES, V28, P1775, DOI 10.1016/j.peptides.2007.05.005; Mockett RJ, 2006, EXP GERONTOL, V41, P566, DOI 10.1016/j.exger.2006.03.015; Morales-Hojas R, 2011, MOL PHYLOGENET EVOL, V60, P249, DOI 10.1016/j.ympev.2011.04.022; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Patel MV, 2012, J EXP ZOOL PART B, V318B, P368, DOI 10.1002/jez.b.22453; Petrosyan A, 2007, BEHAV GENET, V37, P585, DOI 10.1007/s10519-007-9159-y; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; REAGAN JD, 1994, J BIOL CHEM, V269, P9; Reboiro-Jato D, 2012, J INTEGR BIOINFORMAT, V9, DOI 10.2390/biecoll-jib-2012-200; Reis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025520; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Santos JS, 2010, DEV DYNAM, V239, P1010, DOI 10.1002/dvdy.22228; Schmidt PS, 2000, P NATL ACAD SCI USA, V97, P10861, DOI 10.1073/pnas.190338897; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Song W, 2002, NEURON, V36, P105, DOI 10.1016/S0896-6273(02)00932-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vieira J, 2009, J MOL EVOL, V69, P32, DOI 10.1007/s00239-009-9249-y; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; West AP, 2001, P NATL ACAD SCI USA, V98, P3744, DOI 10.1073/pnas.051625298; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zhang YE, 2012, BIOESSAYS, V34, P982, DOI 10.1002/bies.201200008	40	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63747	10.1371/journal.pone.0063747	http://dx.doi.org/10.1371/journal.pone.0063747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696853	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900058
J	Choi, YJ; Jung, I; Min, SJ; Kim, HJ; Kim, JH; Kim, S; Park, JS; Shin, JH; Sohn, YM; Yoon, JH; Kwak, JY				Choi, Yoon Jung; Jung, Inkyung; Min, Sung Ji; Kim, Hye Jung; Kim, Ji-hoon; Kim, Soojin; Park, Jeong Seon; Shin, Jung Hee; Sohn, Yu-Mee; Yoon, Jung Hyun; Kwak, Jin Young			Thyroid Nodule with Benign Cytology: Is Clinical Follow-Up Enough?	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; SONOGRAPHIC FEATURES; PREDICTIVE-VALUE; ULTRASOUND; MANAGEMENT; BIOPSY; US; MALIGNANCY; DISEASE; ULTRASONOGRAPHY	Objective: In this multicenter study, we investigated the management algorithm for thyroid nodules with benign cytology using US features from data collected from 7 institutions. Materials and Methods: The institutional review board approved this retrospective study. Data on 700 focal thyroid nodules in 673 consecutive patients were collected from 7 university-affiliated hospitals. This study included nodules that were diagnosed as benign at initial cytologic evaluation and that underwent pathologic or follow-up study. The risk of malignancy was compared according to the US assessments of each institution as well as looking at all the nodules together as a whole. Results: Of the 700 nodules, 688 (98.3%) were benign and 12 (1.7%) were malignant. If initial cytologic results were benign, the likelihood of the nodule actually being malignant was from 1 to 3%, varying by institution. The likelihood of a cytologically benign nodule with positive US being malignant (4.7%, 8/169) was higher than that of one without positive US (0.8%, 4/531) (P = .002). Conclusion: Based on our multicenter study, repeat FNA should be performed in thyroid nodules with initial benign cytology showing suspicious US features in order to decrease the number of false negative cases.	[Choi, Yoon Jung] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea; [Jung, Inkyung] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Min, Sung Ji] CHA Univ, Grad Sch Hlth & Welf, Songnam, South Korea; [Kim, Hye Jung] Kyungpook Natl Univ, Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Ji-hoon] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Kim, Soojin] Chung Ang Univ Hosp, Dept Radiol, Seoul, South Korea; [Park, Jeong Seon] Hanyang Univ, Coll Med, Hanyang Univ Hosp, Dept Radiol, Seoul 133791, South Korea; [Shin, Jung Hee] Sungkyunkwan Univ, Sch Med, Dept Radiol, Seoul, South Korea; [Shin, Jung Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea; [Sohn, Yu-Mee] Kyung Hee Univ, Coll Med, Kyung Hee Univ Hosp, Dept Radiol, Seoul, South Korea; [Yoon, Jung Hyun] CHA Univ, Coll Med, CHA Bundang Med Ctr, Dept Radiol, Songnam, South Korea; [Kwak, Jin Young] Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp,Res Inst Radiol Sci, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; Pochon Cha University; Kyungpook National University; Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; Hanyang University; Hanyang University Hospital; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University; Kyung Hee University Hospital; Pochon Cha University; Yonsei University; Yonsei University Health System	Kwak, JY (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp,Res Inst Radiol Sci, Seoul, South Korea.	docjin@yuhs.ac	Kim, Ji-hoon/D-5754-2012	Kim, Ji-hoon/0000-0002-6349-6950; Kwak, Jin Young/0000-0002-6212-1495; Jung, Inkyung/0000-0003-3780-3213				Blansfield JA, 2002, ARCH SURG-CHICAGO, V137, P818, DOI 10.1001/archsurg.137.7.818; Brauer VFH, 2005, THYROID, V15, P1169, DOI 10.1089/thy.2005.15.1169; Cappelli C, 2007, QJM-INT J MED, V100, P29, DOI 10.1093/qjmed/hcl121; Cappelli C, 2006, EUR J ENDOCRINOL, V155, P27, DOI 10.1530/eje.1.02177; Cesur M, 2006, THYROID, V16, P555, DOI 10.1089/thy.2006.16.555; Chan BK, 2003, J ULTRAS MED, V22, P1083, DOI 10.7863/jum.2003.22.10.1083; Chernyavsky VS, 2012, ANN SURG ONCOL, V19, P1472, DOI 10.1245/s10434-011-2079-3; Choi SH, 2010, THYROID, V20, P167, DOI 10.1089/thy.2008.0354; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Frates MC, 2005, RADIOLOGY, V237, P794, DOI 10.1148/radiol.2373050220; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P1, DOI 10.4158/10024.GL; Kihara M, 2013, AURIS NASUS LARYNX, V40, P308, DOI 10.1016/j.anl.2012.09.007; Kim EK, 2002, AM J ROENTGENOL, V178, P687, DOI 10.2214/ajr.178.3.1780687; Kwak JY, 2011, RADIOLOGY, V260, P892, DOI 10.1148/radiol.11110206; Kwak JY, 2010, RADIOLOGY, V254, P292, DOI 10.1148/radiol.2541090460; Kwak JY, 2009, EUR RADIOL, V19, P1923, DOI 10.1007/s00330-009-1369-7; Lee MJ, 2011, YONSEI MED J, V52, P838, DOI 10.3349/ymj.2011.52.5.838; Maia FFR, 2011, ENDOCRINE, V40, P290, DOI 10.1007/s12020-011-9467-0; Merchant SH, 2000, THYROID, V10, P489, DOI 10.1089/thy.2000.10.489; Moon HJ, 2012, RADIOLOGY, V262, P1002, DOI 10.1148/radiol.11110839; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Moon WJ, 2011, KOREAN J RADIOL, V12, P1, DOI 10.3348/kjr.2011.12.1.1; Orlandi A, 2005, THYROID, V15, P274, DOI 10.1089/thy.2005.15.274; Papini E, 2002, J CLIN ENDOCR METAB, V87, P1941, DOI 10.1210/jc.87.5.1941; Park SH, 2009, AM J ROENTGENOL, V193, pW416, DOI 10.2214/AJR.09.2541; ROSEN IB, 1993, AM J SURG, V166, P346, DOI 10.1016/S0002-9610(05)80329-0; Sabel MS, 1998, AM SURGEON, V64, P738; Shin JH, 2006, ACTA RADIOL, V47, P469, DOI 10.1080/02841850600635921; Sohn YM, 2012, YONSEI MED J, V53, P812, DOI 10.3349/ymj.2012.53.4.812; TAKASHIMA S, 1994, J CLIN ULTRASOUND, V22, P535, DOI 10.1002/jcu.1870220904; Wang CCC, 2011, THYROID, V21, P243, DOI 10.1089/thy.2010.0243; Wienke JR, 2003, J ULTRAS MED, V22, P1027, DOI 10.7863/jum.2003.22.10.1027; WIERSINGA WM, 1995, EUR J ENDOCRINOL, V132, P661, DOI 10.1530/eje.0.1320661; YOKOZAWA T, 1995, THYROID, V5, P141, DOI 10.1089/thy.1995.5.141	35	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63834	10.1371/journal.pone.0063834	http://dx.doi.org/10.1371/journal.pone.0063834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717495	Green Submitted, Green Published, gold			2022-12-27	WOS:000319385300032
J	Ariga, T; Kubota, M; Nakane, M; Oguro, K; Yu, RK; Ando, S				Ariga, Toshio; Kubota, Masaru; Nakane, Makoto; Oguro, Kenji; Yu, Robert K.; Ando, Susumu			Anti-Chol-1 Antigen, GQ1b alpha, Antibodies Are Associated with Alzheimer's Disease	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; PROGRESSIVE MULTIPLE-SCLEROSIS; CHOLINERGIC-SPECIFIC ANTIGEN; ANTIGANGLIOSIDE ANTIBODIES; PARKINSONS-DISEASE; GANGLIOSIDE METABOLISM; GLYCOLIPIDS; NEURONS; SERUM; MODEL	The interaction of amyloid beta-proteins (A beta) with membrane gangliosides has been reported to be an early event in A beta fibril formation in Alzheimer's disease (AD). Neuronal degeneration in AD has been postulated to be associated with the presence of anti-ganglioside antibodies in patient sera. Using an enzyme-linked immunosorbent assay (ELISA) and high-performance thin-layer chromatography (HPTLC) immunostaining, sera from 27 individuals (10 with AD, 6 with vascular dementia (VD), and 11 non-demented age-matched pathological controls) were examined in order to detect anti-glycosphingolipid (GSL) antibodies, including anti-cholinergic-specific antigen (Chol-1 alpha; GQ1b alpha) antibodies. All sera had natural antibodies against ganglio-N-tetraosyl gangliosides (brain-type gangliosides). However, sera of demented patients with AD and VD had significantly higher titers of anti-GSL antibodies than those in age-matched pathological controls. Although most serum antibodies, including anti-GM1, -GT1b, -GQ1b, -GQ1b alpha, were of the IgM type, the presence of the IgG type antibodies was also significantly elevated in the sera of demented patients with AD. Anti-GT1b antibodies of the IgG type were elevated in AD (90%, 9 of 10 cases) and VD (100%), respectively. Most surprisingly, anti-GQ1b alpha antibodies (IgM) were found in 90% (9/10) and 100% (6/6) in the sera of patients with AD and VD, respectively. Since GQ1ba is present in the cerebral cortex and hippocampus, the presence of anti-GQ1b alpha antibodies may play an important role in disrupting cholinergic synaptic transmission and may participate in the pathogenesis of dementia. We conclude that elevated anti-GSL antibody titers may be useful as an aid for clinical diagnosis of those dementias.	[Ariga, Toshio; Yu, Robert K.] Georgia Regents Univ, Inst Mol Med & Genet, Med Coll Georgia, Augusta, GA USA; [Ariga, Toshio; Yu, Robert K.] VA Med Ctr, Augusta, GA USA; [Kubota, Masaru; Oguro, Kenji] Oyama Orthoped & Internal Med Hosp, Oyama, Tochigi, Japan; [Nakane, Makoto] Teikyo Univ, Sch Med, Dept Neurosurg, Univ Hosp Mizonokuchi, Kawasaki, Kanagawa, Japan; [Ando, Susumu] Tokyo Metropolitan Geriatr Hosp, Itabashi Ku, Tokyo 173, Japan; [Ando, Susumu] Inst Gerontol, Itabashi Ku, Tokyo, Japan	University System of Georgia; Augusta University; Teikyo University	Nakane, M (corresponding author), Teikyo Univ, Sch Med, Dept Neurosurg, Univ Hosp Mizonokuchi, Kawasaki, Kanagawa, Japan.	nsnakane@med.teikyo-u.ac.jp			National Institutes of Health; Veterans Affairs	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	TA and RKY were supported by grants from National Institutes of Health and Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarin N, 1996, ACTA NEUROL SCAND, V93, P99; ANDO S, 1992, J BIOCHEM, V111, P287, DOI 10.1093/oxfordjournals.jbchem.a123751; ANDO S, 1977, J BIOL CHEM, V252, P6247; ARIGA T, 1987, J LIPID RES, V28, P285; ARIGA T, 1984, ARCH BIOCHEM BIOPHYS, V232, P305, DOI 10.1016/0003-9861(84)90546-0; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Ariga T, 2010, ASN NEURO, V2, DOI 10.1042/AN20100021; Ariga T, 2010, J NEUROSCI RES, V88, P2303, DOI 10.1002/jnr.22393; Bjartmar C, 2003, NEUROTOX RES, V5, P157, DOI 10.1007/BF03033380; CHAPMAN J, 1988, J NEUROCHEM, V51, P479, DOI 10.1111/j.1471-4159.1988.tb01063.x; CHAPMAN J, 1988, NEUROSCI LETT, V86, P235, DOI 10.1016/0304-3940(88)90577-0; Chen XS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-12; Clifford PM, 2007, BRAIN RES, V1142, P223, DOI 10.1016/j.brainres.2007.01.070; DERRINGTON EA, 1990, DEV BRAIN RES, V52, P131, DOI 10.1016/0165-3806(90)90228-Q; Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731; FOLEY P, 1988, J NEUROL, V235, P466, DOI 10.1007/BF00314249; FREDDO L, 1985, NEUROLOGY, V35, P1420, DOI 10.1212/WNL.35.10.1420; Haghighi S, 2012, ACTA NEUROL SCAND, V125, P64, DOI 10.1111/j.1600-0404.2011.01554.x; Hatzifilippou E, 2008, AM J ALZHEIMERS DIS, V23, P274, DOI 10.1177/1533317508317816; HIRABAYASHI Y, 1992, J BIOL CHEM, V267, P12973; Huflejt ME, 2009, MOL IMMUNOL, V46, P3037, DOI 10.1016/j.molimm.2009.06.010; Ilyas AA, 2003, J NEUROIMMUNOL, V139, P76, DOI 10.1016/S0165-5728(03)00131-0; Kanda T, 2000, NEUROLOGY, V55, P585, DOI 10.1212/WNL.55.4.585; KASAI N, 1986, J NEUROL SCI, V75, P33, DOI 10.1016/0022-510X(86)90048-1; KOHRIYAMA T, 1987, J NEUROCHEM, V48, P1516, DOI 10.1111/j.1471-4159.1987.tb05694.x; Kuwabara S, 2000, J NEUROL NEUROSUR PS, V68, P191, DOI 10.1136/jnnp.68.2.191; Lehmann HC, 2007, J NEUROSCI, V27, P27, DOI 10.1523/JNEUROSCI.4017-06.2007; Marconi S, 2006, MULT SCLER J, V12, P302, DOI 10.1191/135248506ms1279oa; Mata S, 1999, MULT SCLER, V5, P379, DOI 10.1191/135245899678846483; Mizutamari RK, 1998, J NEUROSCI RES, V51, P237, DOI 10.1002/(SICI)1097-4547(19980115)51:2<237::AID-JNR12>3.0.CO;2-5; MIZUTAMARI RK, 1994, J NEUROIMMUNOL, V50, P215, DOI 10.1016/0165-5728(94)90048-5; Mosek A, 2000, DEMENT GERIATR COGN, V11, P36, DOI 10.1159/000017211; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; OKADA N, 1983, IMMUNOLOGY, V50, P75; Pender MP, 2003, J CLIN NEUROSCI, V10, P63, DOI 10.1016/S0967-5868(02)00270-9; Plumb J, 2002, BRAIN PATHOL, V12, P154; Ravindranath MH, 2005, ANN NY ACAD SCI, V1050, P229, DOI 10.1196/annals.1313.024; REN SL, 1992, J BIOL CHEM, V267, P12632; Sadatipour BT, 1998, ANN NEUROL, V44, P980, DOI 10.1002/ana.410440621; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Schott K, 1996, PSYCHIAT RES, V59, P251, DOI 10.1016/0165-1781(95)02703-3; Vyshkina T, 2008, LAB INVEST, V88, P796, DOI 10.1038/labinvest.2008.53; Winer JB, 2001, J CLIN PATHOL-MOL PA, V54, P381; YU RK, 1994, PROG BRAIN RES, V101, P31; Yu RK, 2006, INFECT IMMUN, V74, P6517, DOI 10.1128/IAI.00967-06; Yuki N, 1997, J NEUROL SCI, V150, P81, DOI 10.1016/S0022-510X(97)05392-6; Zappia M, 2002, ACTA NEUROL SCAND, V106, P54, DOI 10.1034/j.1600-0404.2002.01240.x; Zaprianova Emilia, 2004, Ideggyogy Sz, V57, P94	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63326	10.1371/journal.pone.0063326	http://dx.doi.org/10.1371/journal.pone.0063326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717411	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600010
J	Aslami, H; Pulskens, WP; Kuipers, MT; Bos, AP; van Kuilenburg, ABP; Wanders, RJA; Roelofsen, J; Roelofs, JJTH; Kerindongo, RP; Beurskens, CJP; Schultz, MJ; Kulik, W; Weber, NC; Juffermans, NP				Aslami, Hamid; Pulskens, Wilco P.; Kuipers, Maria T.; Bos, Aafkeline P.; van Kuilenburg, Andre B. P.; Wanders, Ronald J. A.; Roelofsen, Jeroen; Roelofs, Joris J. T. H.; Kerindongo, Raphaela P.; Beurskens, Charlotte J. P.; Schultz, Marcus J.; Kulik, Wim; Weber, Nina C.; Juffermans, Nicole P.			Hydrogen Sulfide Donor NaHS Reduces Organ Injury in a Rat Model of Pneumococcal Pneumosepsis, Associated with Improved Bio-Energetic Status	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; ACUTE LUNG INJURY; MITOCHONDRIAL DYSFUNCTION; KAPPA-B; HYPOTHERMIA; SEPSIS; METABOLISM; ACTIVATION; MECHANISMS; INTERACTS	Sepsis is characterized by a generalized inflammatory response and organ failure, associated with mitochondrial dysfunction. Hydrogen sulfide donor NaHS has anti-inflammatory properties, is able to reduce metabolism and can preserve mitochondrial morphology and function. Rats were challenged with live Streptococcus pneumonia or saline and infused with NaHS (36 mmol/kg/h) or vehicle. Lung and kidney injury markers were measured as well as mitochondrial function, viability and biogenesis. Infusion of NaHS reduced heart rate and body temperature, indicative of a hypo-metabolic state. NaHS infusion reduced sepsis-related lung and kidney injury, while host defense remained intact, as reflected by unchanged bacterial outgrowth. The reduction in organ injury was associated with a reversal of a fall in active oxidative phosphorylation with a concomitant decrease in ATP levels and ATP/ADP ratio. Preservation of mitochondrial respiration was associated with increased mitochondrial expression of alpha-tubulin and protein kinase C-epsilon, which acts as regulators of respiration. Mitochondrial damage was decreased by NaHS, as suggested by a reduction in mitochondrial DNA leakage in the lung. Also, NaHS treatment was associated with upregulation of peroxisome proliferator-activated receptor-gamma coactivator 1 alpha, with a subsequent increase in transcription of mitochondrial respiratory subunits. These findings indicate that NaHS reduces organ injury in pneumosepsis, possibly via preservation of oxidative phosphorylation and thereby ATP synthesis as well as by promoting mitochondrial biogenesis. Further studies on the involvement of mitochondria in sepsis are required.	[Aslami, Hamid; Kuipers, Maria T.; Bos, Aafkeline P.; Kerindongo, Raphaela P.; Beurskens, Charlotte J. P.; Schultz, Marcus J.; Weber, Nina C.; Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, LEICA, NL-1105 AZ Amsterdam, Netherlands; [van Kuilenburg, Andre B. P.; Wanders, Ronald J. A.; Roelofsen, Jeroen; Kulik, Wim] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Pulskens, Wilco P.; Roelofs, Joris J. T. H.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Schultz, Marcus J.; Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Aslami, H (corresponding author), Univ Amsterdam, Acad Med Ctr, LEICA, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.aslami@amc.uva.nl	Weber, Nina/CAH-0231-2022; Pulskens, Wilco/P-6023-2015; Schultz, Marcus/AAB-6379-2021	Weber, Nina/0000-0003-1111-9042; Pulskens, Wilco/0000-0001-9697-3189; Schultz, Marcus/0000-0003-3969-7792; Roelofs, Joris/0000-0001-9595-6571; van Kuilenburg, Andre/0000-0002-7989-4910				Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Agudo-Lopez A, 2011, FEBS LETT, V585, P99, DOI 10.1016/j.febslet.2010.11.015; Akram AR, 2010, CHEST, V138, P825, DOI 10.1378/chest.09-3071; Aslami H, 2010, INTENS CARE MED, V36, P1946, DOI 10.1007/s00134-010-2022-2; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Baumgart K, 2010, CRIT CARE MED, V38, P588, DOI 10.1097/CCM.0b013e3181b9ed2e; Bierau J, 2001, BIOCHEM PHARMACOL, V62, P1099, DOI 10.1016/S0006-2952(01)00756-0; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Bracht H, 2012, CRIT CARE MED, V40, P2157, DOI 10.1097/CCM.0b013e31824e6b30; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Chu SJ, 2005, CHEST, V128, P327, DOI 10.1378/chest.128.1.327; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Esechie A, 2008, CLIN SCI, V115, P91, DOI 10.1042/CS20080021; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Fries M, 2009, J CRIT CARE, V24, P453, DOI 10.1016/j.jcrc.2008.10.012; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Gellerich FN, 1999, SHOCK, V11, P336, DOI 10.1097/00024382-199905000-00006; Goeters C, 2002, CRIT CARE MED, V30, P2032, DOI 10.1097/00003246-200209000-00013; Kamps M, 2011, CRIT CARE, V15, DOI 10.1186/cc10012; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lim CM, 2004, INTENS CARE MED, V30, P1638, DOI 10.1007/s00134-004-2336-z; Lim CM, 2003, INTENS CARE MED, V29, P453, DOI 10.1007/s00134-002-1529-6; Mongardon N, 2011, CRIT CARE MED, V39, P1359, DOI 10.1097/CCM.0b013e3182120b56; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Spiller F, 2010, AM J RESP CRIT CARE, V182, P360, DOI 10.1164/rccm.200907-1145OC; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tappy L, 2007, CRIT CARE MED, V35, pS531, DOI 10.1097/01.CCM.0000278062.28122.A4; Torres A, 2010, AM J RESP CRIT CARE, V181, P782, DOI 10.1164/rccm.201001-0030UP; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vanhorebeek I, 2005, LANCET, V365, P53, DOI 10.1016/S0140-6736(04)17665-4; Wagner F, 2011, SHOCK, V35, P396, DOI 10.1097/SHK.0b013e3181ffff0e; WEINRAUCH V, 1992, STROKE, V23, P1454, DOI 10.1161/01.STR.23.10.1454; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Yang KY, 2011, CRIT CARE, V15, DOI 10.1186/cc9412; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	45	36	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63497	10.1371/journal.pone.0063497	http://dx.doi.org/10.1371/journal.pone.0063497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717435	gold, Green Published, Green Submitted			2022-12-27	WOS:000319435600019
J	Shchelkunova, TA; Morozov, IA; Rubtsov, PM; Bobryshev, YV; Sobenin, IA; Orekhov, AN; Andrianova, IV; Smirnov, AN				Shchelkunova, Tatyana A.; Morozov, Ivan A.; Rubtsov, Petr M.; Bobryshev, Yuri V.; Sobenin, Igor A.; Orekhov, Alexander N.; Andrianova, Irina V.; Smirnov, Alexander N.			Lipid Regulators during Atherogenesis: Expression of LXR, PPAR, and SREBP mRNA in the Human Aorta	PLOS ONE			English	Article							SCAVENGER RECEPTORS; VASCULAR-LESIONS; ATHEROSCLEROSIS; MACROPHAGES; ARTERIOSCLEROSIS; TRANSREPRESSION; INFLAMMATION; DEFINITION; COMMITTEE; PATHWAYS	Transcription factors LXRs, PPARs, and SREBPs have been implicated in a multitude of physiological and pathological processes including atherogenesis. However, little is known about the regulation of these transcription factors at different stages of atherosclerosis progression. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to compare the contents of mRNAs in pairs intact-injured aorta fragments taken from the same donors. Only minor changes in LXR alpha, LXR beta, PPAR alpha, PPAR gamma, SREBP1, and SREBP2 mRNA levels were found in initial lesions as compared with intact non-diseased tissue. The contents of all mRNAs but SREBP2 mRNA were found to be progressively up-regulated in fatty streaks and fibrous lipoid plaques. These changes were only partially reproduced in cultured macrophages upon lipid loading. Wave-shaped changes in abundance of correlations between given group of mRNAs and 28 atherosclerosis-related mRNA species in the course of atherogenesis were observed. The impact of specific mRNA correlations on the total correlations also significantly varied between different lesion types. The study suggests that the extent and forms of LXR/PPAR/SREBP participation in intima functions vary nonlinear in individual fashion in atherogenesis. We speculate that the observed changes in mRNAs expression and coupling reflect shifts in lipid ligands availability and cellular composition in the course of atherosclerosis progression.	[Shchelkunova, Tatyana A.; Smirnov, Alexander N.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Morozov, Ivan A.; Rubtsov, Petr M.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Bobryshev, Yuri V.; Sobenin, Igor A.; Orekhov, Alexander N.] Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Moscow, Russia; [Bobryshev, Yuri V.] Univ New S Wales, Fac Med, Kensington, NSW 2033, Australia; [Bobryshev, Yuri V.] St Vincents Hosp Sydney, Kensington, NSW, Australia; [Bobryshev, Yuri V.] Univ Western Sydney Macarthur, Sch Med, Campbelltown, NSW 2560, Australia; [Sobenin, Igor A.] Russian Cardiol Res & Prod Complex, Moscow, Russia; [Orekhov, Alexander N.; Andrianova, Irina V.] Skolkovo Innovat Ctr, Atherosclerosis Res Inst, Moscow, Russia; [Andrianova, Irina V.] Russian Acad Sci, Inst Biomed Problems, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; University of New South Wales Sydney; Western Sydney University; National Medical Research Center of Cardiology; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences	Bobryshev, YV (corresponding author), Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Moscow, Russia.	y.bobryshev@unsw.edu.au	Orekhov, Alexander N/J-4838-2013; Bobryshev, Yuri/J-2838-2013; Rubtsov, Petr/A-8459-2016; Sobenin, Igor A/J-4282-2013; Morozov, Ivan/CAJ-5409-2022; Shchelkunova, Tatiana/ABD-8130-2021	Orekhov, Alexander N/0000-0002-6495-1628; Rubtsov, Petr/0000-0002-9867-2344; Sobenin, Igor A/0000-0003-0978-6444; 	Russian Foundation for Basic Research; Russian Ministry of Education and Science	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	The authors thank the Russian Foundation for Basic Research and the Russian Ministry of Education and Science for financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdian S, 2012, CARDIOVASC RES, V95, P165, DOI 10.1093/cvr/cvs094; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Butcher MJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00044; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Ishii T, 2006, EUR RESPIR J, V27, P300, DOI 10.1183/09031936.06.00090405; Jakobsson T, 2012, TRENDS PHARMACOL SCI, V33, P394, DOI 10.1016/j.tips.2012.03.013; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kzhyshkowska J, 2012, IMMUNOBIOLOGY, V217, P492, DOI 10.1016/j.imbio.2012.02.015; Li MD, 2011, PPAR RES, V2011, DOI 10.1155/2011/742785; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manduteanu I, 2012, J CELL MOL MED, V16, P1978, DOI 10.1111/j.1582-4934.2012.01552.x; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Nagy ZS, 2013, MOL CELL ENDOCRINOL, V368, P85, DOI 10.1016/j.mce.2012.04.003; Razzhevaikin VN, 2010, ZH OBSHCH BIOL, V71, P75; SEDOV KR, 1988, VESTN AKAD MED NAUK+, P69; Shchelkunova TA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P920, DOI 10.1134/S0006297908080105; Shchelkunova TA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1178, DOI 10.1134/S0006297911100129; Smirnov AN, 2010, BIOCHEMISTRY-MOSCOW+, V75, P793, DOI 10.1134/S0006297910070011; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Treuter E, 2011, CELL RES, V21, P711, DOI 10.1038/cr.2011.52; Villablanca AC, 2010, CLIN SCI, V119, P493, DOI 10.1042/CS20100248; Wadosky KM, 2012, AM J PHYSIOL-HEART C, V302, pH515, DOI 10.1152/ajpheart.00703.2011	26	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63374	10.1371/journal.pone.0063374	http://dx.doi.org/10.1371/journal.pone.0063374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717417	Green Submitted, Green Published, gold			2022-12-27	WOS:000319435600013
J	Ashkenazi, E; Baranovski, BM; Shahaf, G; Lewis, EC				Ashkenazi, Efrat; Baranovski, Boris M.; Shahaf, Galit; Lewis, Eli C.			Pancreatic Islet Xenograft Survival in Mice Is Extended by a Combination of Alpha-1-Antitrypsin and Single-Dose Anti-CD4/CD8 Therapy	PLOS ONE			English	Article							LONG-TERM SURVIVAL; DIABETIC NOD MICE; RECEPTOR ANTAGONIST; BETA-CELLS; TRANSPLANTATION; TOLERANCE; REJECTION; BLOCKADE; INTERLEUKIN-1; MONOTHERAPY	Clinical pancreatic islet transplantation is under evaluation for the treatment of autoimmune diabetes, yet several limitations preclude widespread use. For example, there is a critical shortage of human pancreas donors. Xenotransplantation may solve this problem, yet it evokes a rigorous immune response which can lead to graft rejection. Alpha-1-antitrypsin (AAT), a clinically available and safe circulating anti-inflammatory and tissue protective glycoprotein, facilitates islet alloimmune-tolerance and protects from inflammation in several models. Here, we examine whether human AAT (hAAT), alone or in combination with clinically relevant approaches, achieves long-term islet xenograft survival. Rat-to-mouse islet transplantation was examined in the following groups: untreated (n = 6), hAAT (n = 6, 60-240 mg/kg every 3 days from day -10), low-dose co-stimulation blockade (anti-CD154/LFA-1) and single-dose anti-CD4/CD8 (n = 5-7), either as mono-or combination therapies. Islet grafting was accompanied by blood glucose follow-up. In addition, skin xenografting was performed in order to depict responses that occur in draining lymph nodes. According to our results hAAT monotherapy and hAAT/anti-CD154/LFA-1 combined therapy, did not delay rejection day (11-24 days untreated vs. 10-22 day treated). However, host and donor intragraft inflammatory gene expression was diminished by hAAT therapy in both setups. Single dose T-cell depletion using anti-CD4/CD8 depleting antibodies, which provided 14-15 days of reduced circulating T-cells, significantly delayed rejection day (28-52 days) but did not achieve graft acceptance. In contrast, in combination with hAAT, the group displayed significantly extended rejection days and a high rate of graft acceptance (59, 61, >90, >90, >90). In examination of graft explants, marginal mononuclear-cell infiltration containing regulatory T-cells predominated surviving xenografts. We suggest that temporal T-cell depletion, as in the clinically practiced anti-thymocyte-globulin therapy, combined with hAAT, may promote islet xenograft acceptance. Further studies are required to elucidate the mechanism behind the observed synergy, as well as the applicability of the approach for pig-to-human islet xenotransplantation.	[Ashkenazi, Efrat; Baranovski, Boris M.; Shahaf, Galit; Lewis, Eli C.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel	Ben Gurion University	Lewis, EC (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel.	lewis@bgu.ac.il	LEWIS, ELI C/F-1552-2012	LEWIS, ELI C/0000-0002-4189-2207	Juvenile Diabetes Research Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	The study was funded by the Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis A, 2011, MOL MED; Arefanian H, 2007, CELL TRANSPLANT, V16, P787, DOI 10.3727/000000007783465244; Arefanian H, 2010, DIABETES, V59, P958, DOI 10.2337/db09-0413; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Bellacen K, 2012, CELL TRANSPLANTATION; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Broady R, 2009, BLOOD, V114, P5003, DOI 10.1182/blood-2009-04-214437; Chen X, 2010, J SURG RES, V164, P336, DOI 10.1016/j.jss.2009.08.016; de Kort H, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d217; Deng S, 1997, TRANSPLANT P, V29, P2062, DOI 10.1016/S0041-1345(97)00232-7; Dhami R, 1999, J MOL MED-JMM, V77, P377, DOI 10.1007/s001090050364; Gaber AO, 2010, DRUGS, V70, P691, DOI 10.2165/11315940-000000000-00000; Guo L, 2003, TRANSPL IMMUNOL, V12, P41, DOI 10.1016/S0966-3274(03)00016-9; Hadzic R, 2006, IMMUNOL LETT, V102, P141, DOI 10.1016/j.imlet.2005.08.006; Hsu BR, 2009, TRANSPL P, V41, P1781, DOI 10.1016/j.transproceed.2008.10.099; Jeannin P, 1998, EUR J IMMUNOL, V28, P1815, DOI 10.1002/(SICI)1521-4141(199806)28:06<1815::AID-IMMU1815>3.0.CO;2-5; Johansson U, 2003, BIOCHEM BIOPH RES CO, V308, P474, DOI 10.1016/S0006-291X(03)01392-5; Jones PM, 2008, DRUG DISCOV TODAY, V13, P888, DOI 10.1016/j.drudis.2008.06.014; Kahraman S, 2011, DIABETES-METAB RES, V27, P575, DOI 10.1002/dmrr.1216; Kalis M, 2010, ISLETS, V2, P185, DOI 10.4161/isl.2.3.11654; KarlssonParra A, 1996, TRANSPLANTATION, V61, P1313, DOI 10.1097/00007890-199605150-00005; Kobayashi T, 2006, XENOTRANSPLANTATION, V13, P547, DOI 10.1111/j.1399-3089.2006.00349.x; Korsgren O, 2009, CURR OPIN ORGAN TRAN, V14, P683, DOI 10.1097/MOT.0b013e328332c44c; Koulmanda M, 2004, XENOTRANSPLANTATION, V11, P525, DOI 10.1111/j.1399-3089.2004.00174.x; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Lewis EC, 2005, P NATL ACAD SCI USA, V102, P12153, DOI 10.1073/pnas.0505579102; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Loganathan G, 2010, TRANSPL P, V42, P2055, DOI 10.1016/j.transproceed.2010.05.119; MANDRUPPOULSEN T, 1993, CYTOKINE, V5, P185, DOI 10.1016/1043-4666(93)90003-N; Mordwinkin NM, 2007, EXPERT OPIN PHARMACO, V8, P2609, DOI 10.1517/14656566.8.15.2609; Muller YD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010352; Niclauss N, 2011, TRANSPLANTATION, V91, P714, DOI 10.1097/TP.0b013e31820c10c8; Pan H, 2007, TRANSPL P, V39, P3452, DOI 10.1016/j.transproceed.2007.06.091; Rayat GR, 2003, DIABETES, V52, P1433, DOI 10.2337/diabetes.52.6.1433; Salehi A, 2011, MOL CELL ENDOCRINOL; Schroppel B, 2005, J AM SOC NEPHROL, V16, P444, DOI 10.1681/ASN.2004090743; Schwarznau A, 2009, J CELL PHYSIOL, V220, P341, DOI 10.1002/jcp.21770; Snanoudj R, 2010, DRUGS, V70, P2121, DOI 10.2165/11538140-000000000-00000; Song S, 2004, GENE THER, V11, P181, DOI 10.1038/sj.gt.3302156; Sprangers B, 2008, KIDNEY INT, V74, P14, DOI 10.1038/ki.2008.135; Strom TB, 2005, P NATL ACAD SCI USA, V102, P12651, DOI 10.1073/pnas.0506079102; Subramanian S, 2011, METAB BRAIN DIS, V2011, P25; Tchorsh-Yutsis D, 2011, TRANSPLANTATION, V91, P398, DOI 10.1097/TP.0b013e318204be15; Tchorsh-Yutsis D, 2009, DIABETES, V58, P1585, DOI 10.2337/db09-0112; TILG H, 1993, J EXP MED, V178, P1629, DOI 10.1084/jem.178.5.1629; Tredget EB, 2008, CELL TRANSPLANT, V17, P599, DOI 10.3727/096368908786092757; van der Windt DJ, 2007, XENOTRANSPLANTATION, V14, P288, DOI 10.1111/j.1399-3089.2007.00419.x; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Westwell-Roper C, 2011, J IMMUNOL, V187, P2755, DOI 10.4049/jimmunol.1002854	50	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63625	10.1371/journal.pone.0063625	http://dx.doi.org/10.1371/journal.pone.0063625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717456	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700042
J	Egbert, MD				Egbert, Matthew D.			Bacterial Chemotaxis: Introverted or Extroverted? A Comparison of the Advantages and Disadvantages of Basic Forms of Metabolism-Based and Metabolism-Independent Behavior Using a Computational Model	PLOS ONE			English	Article							PROTON MOTIVE FORCE; ENERGY TAXIS; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; AZOSPIRILLUM-BRASILENSE; RHODOBACTER-SPHAEROIDES; CHEMORECEPTORS; RECEPTORS; AER; PATHWAYS	Using a minimal model of metabolism, we examine the limitations of behavior that is (a) solely in response to environmental phenomena or (b) solely in response to metabolic dynamics, showing that basic forms of each of these kinds of behavior are incapable of driving survival-prolonging behavior in certain situations. Inspired by experimental evidence of concurrent metabolism-based and metabolism-independent chemotactic mechanisms in Escherichia coli and Rhodobacter sphaeroides, we then investigate how metabolism-independent and metabolism-based sensitivities can be integrated into a single behavioral response, demonstrating that a simple switching mechanism can be sufficient to effectively integrate metabolism-based and metabolism-independent behaviors. Finally, we use a spatial simulation of bacteria to show that the investigated forms of behavior produce different spatio-temporal patterns that are influenced by the metabolic-history of the bacteria. We suggest that these patterns could be a way to experimentally derive insight into the relationship between metabolism and chemotaxis in real bacteria.	[Egbert, Matthew D.] Univ Jena, Biosyst Anal Grp, Jena, Germany; [Egbert, Matthew D.] Univ Sussex, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England	Friedrich Schiller University of Jena; University of Sussex	Egbert, MD (corresponding author), Univ Jena, Biosyst Anal Grp, Jena, Germany.	mde@matthewegbert.com						ADLER J, 1969, SCIENCE, V166, P1588, DOI 10.1126/science.166.3913.1588; Alexandre G, 2000, J BACTERIOL, V182, P6042, DOI 10.1128/JB.182.21.6042-6048.2000; Alexandre G, 2004, FEMS MICROBIOL REV, V28, P113, DOI 10.1016/j.femsre.2003.10.003; Alexandre G, 2010, MICROBIOL-SGM, V156, P2283, DOI 10.1099/mic.0.039214-0; Barak R, 1999, MOL MICROBIOL, V31, P1125, DOI 10.1046/j.1365-2958.1999.01251.x; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Berry RM, 2000, BIOPHYS J, V78, P1207, DOI 10.1016/S0006-3495(00)76678-1; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; CLAYTON RK, 1953, ARCH MIKROBIOL, V19, P125, DOI 10.1007/BF00446396; Costa RS, 2010, BIOSYSTEMS, V100, P150, DOI 10.1016/j.biosystems.2010.03.001; Edwards JC, 2006, MOL MICROBIOL, V62, P823, DOI 10.1111/j.1365-2958.2006.05411.x; Egbert MD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001004; Egbert MD, 2012, ARTIFICIAL LIFE, V18; Egbert MD, 2013, ARTIFICIAL LIFE; Eisenbach M, 2007, J CELL PHYSIOL, V213, P574, DOI 10.1002/jcp.21238; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; Ganti T., 2003, PRINCIPLES LIFE; GOLDBETER A, 1982, J MOL BIOL, V161, P395, DOI 10.1016/0022-2836(82)90246-7; Goldstein RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000084; Hamadeh A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001130; Harvey I, 2011, P 10 EUR C ADV ART L, P126; Jeziore-Sassoon Y, 1998, MICROBIOL-SGM, V144, P229, DOI 10.1099/00221287-144-1-229; Jiang ZY, 2001, J BACTERIOL, V183, P171, DOI 10.1128/JB.183.1.171-177.2001; Maturana H.R., 1980, AUTOPOIESIS COGNITIO; Peach ML, 2002, PROTEIN SCI, V11, P912, DOI 10.1110/ps.4640102; Piedrafita G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000872; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Rebbapragada A, 1997, P NATL ACAD SCI USA, V94, P10541, DOI 10.1073/pnas.94.20.10541; Sarand I, 2008, ENVIRON MICROBIOL, V10, P1320, DOI 10.1111/j.1462-2920.2007.01546.x; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Schweinitzer T, 2010, ARCH MICROBIOL, V192, P507, DOI 10.1007/s00203-010-0575-7; SEGEL LA, 1976, J THEOR BIOL, V57, P23, DOI 10.1016/S0022-5193(76)80004-5; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stock J, 2000, CURR BIOL, V10, pR11, DOI 10.1016/S0960-9822(99)00248-1; STOCK J, 1985, CELL, V42, P683, DOI 10.1016/0092-8674(85)90125-4; Taylor BL, 1998, MOL MICROBIOL, V28, P683, DOI 10.1046/j.1365-2958.1998.00835.x; Tindall MJ, 2008, B MATH BIOL, V70, P1525, DOI 10.1007/s11538-008-9321-6; Tindall MJ, 2012, WIRES SYST BIOL MED, V4, P247, DOI 10.1002/wsbm.1168; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Vegge CS, 2009, APPL ENVIRON MICROB, V75, P5308, DOI 10.1128/AEM.00287-09; Zhang JJ, 2008, J ENVIRON SCI-CHINA, V20, P1238, DOI 10.1016/S1001-0742(08)62215-9; Zhulin IB, 1996, J BACTERIOL, V178, P5199, DOI 10.1128/jb.178.17.5199-5204.1996; Zhulin IB, 1997, J BACTERIOL, V179, P3196, DOI 10.1128/jb.179.10.3196-3201.1997	43	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63617	10.1371/journal.pone.0063617	http://dx.doi.org/10.1371/journal.pone.0063617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717454	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700040
J	Gardiner, D; Lalezari, J; Lawitz, E; DiMicco, M; Ghalib, R; Reddy, KR; Chang, KM; Sulkowski, M; O' Marro, S; Anderson, J; He, B; Kansra, V; McPhee, F; Wind-Rotolo, M; Grasela, D; Selby, M; Korman, AJ; Lowy, I				Gardiner, David; Lalezari, Jay; Lawitz, Eric; DiMicco, Michael; Ghalib, Rheem; Reddy, K. Rajender; Chang, Kyong-Mi; Sulkowski, Mark; O' Marro, Steven; Anderson, Jeffrey; He, Bing; Kansra, Vikram; McPhee, Fiona; Wind-Rotolo, Megan; Grasela, Dennis; Selby, Mark; Korman, Alan J.; Lowy, Israel			A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							T-CELL DYSFUNCTION; FUNCTIONAL RESTORATION; IMMUNE-RESPONSES; UP-REGULATION; PHASE-I; B-VIRUS; EXPRESSION; BLOCKADE; SAFETY; SUPPRESSION	Expression of the programmed death 1 (PD-1) receptor and its ligands are implicated in the T cell exhaustion phenotype which contributes to the persistence of several chronic viral infections, including human hepatitis C virus (HCV). The antiviral potential of BMS-936558 (MDX-1106) - a fully human anti-PD-1 monoclonal immunoglobulin-G4 that blocks ligand binding - was explored in a proof-of-concept, placebo-controlled single-ascending-dose study in patients (N = 54) with chronic HCV infection. Interferon-alfa treatment-experienced patients (n = 42) were randomized 5:1 to receive a single infusion of BMS-936558 (0.03, 0.1, 0.3, 1.0, 3.0 mg/kg [n = 5 each] or 10 mg/kg [n = 10]) or of placebo (n = 7). An additional 12 HCV treatment naive patients were randomized to receive 10 mg/kg BMS-936558 (n = 10) or placebo (n = 2). Patients were followed for 85 days post-dose. Five patients who received BMS-936558 (0.1 [n = 1] or 10 mg/kg) and one placebo patient achieved the primary study endpoint of a reduction in HCV RNA >= 0.5 log(10) IU/mL on at least 2 consecutive visits; 3 (10 mg/kg) achieved a >4 log(10) reduction. Two patients (10 mg/kg) achieved HCV RNA below the lower limit of quantitation (25 IU/mL), one of whom (a prior null-responder) remained RNA-undetectable 1 year post-study. Transient reductions in CD4(+), CD8(+) and CD19(+) cells, including both naive and memory CD4(+) and CD8(+) subsets, were observed at Day 2 without evidence of immune deficit. No clinically relevant changes in immunoglobulin subsets or treatment-related trends in circulating cytokines were noted. BMS-936558 exhibited dose-related exposure increases, with a half-life of 20-24 days. BMS-936558 was mostly well tolerated. One patient (10 mg/kg) experienced an asymptomatic grade 4 ALT elevation coincident with the onset of a 4-log viral load reduction. Six patients exhibited immune-related adverse events of mild-to-moderate intensity, including two cases of hyperthyroidism consistent with autoimmune thyroiditis. Further investigation of PD-1 pathway blockade in chronic viral disease is warranted.	[Gardiner, David; Anderson, Jeffrey; He, Bing; Grasela, Dennis] Bristol Myers Squibb Co, Pennington, NJ USA; [Lalezari, Jay] Quest Clin Res, San Francisco, CA USA; [Lawitz, Eric] Alamo Med Res, San Antonio, TX USA; [DiMicco, Michael] Adv Clin Res Inst, Anaheim, CA USA; [Ghalib, Rheem] Methodist Hosp, Liver Inst, Dallas, TX USA; [Reddy, K. Rajender; Chang, Kyong-Mi] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Chang, Kyong-Mi] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Sulkowski, Mark] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [O' Marro, Steven] Springfield Clin Infect Dis, Springfield, IL USA; [Kansra, Vikram; Wind-Rotolo, Megan] Bristol Myers Squibb Co, Princeton, NJ USA; [McPhee, Fiona] Bristol Myers Squibb Co, Wallingford, CT 06492 USA; [Selby, Mark; Korman, Alan J.] Bristol Myers Squibb Co, Milpitas, CA USA; [Lowy, Israel] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Bristol-Myers Squibb; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Johns Hopkins University; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Regeneron	Gardiner, D (corresponding author), Bristol Myers Squibb Co, Pennington, NJ USA.	david.gardiner@bms.com		Chang, Kyong-Mi/0000-0001-6811-9364	Bristol-Myers Squibb; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016065, K24DA034621] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was wholly funded by Medarex, now Bristol-Myers Squibb. The funders, Medarex (now BMS), had a primary role in study design, in collaboration with clinical investigators and health authorities. In addition, Medarex had a primary role in the data collection and analysis, decision to publish, and publication of the manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Achenbach P, 2004, J CLIN INVEST, V114, P589, DOI 10.1172/JCI200421307; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Burke KP, 2010, IMMUNOL RES, V47, P216, DOI 10.1007/s12026-009-8152-3; Chang KM, 1997, J CLIN INVEST, V100, P2376, DOI 10.1172/JCI119778; Crawford A, 2009, CURR OPIN IMMUNOL, V21, P179, DOI 10.1016/j.coi.2009.01.010; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; den Brouw MLO, 2009, IMMUNOLOGY, V126, P280, DOI 10.1111/j.1365-2567.2008.02896.x; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Finnefrock AC, 2009, J IMMUNOL, V182, P980, DOI 10.4049/jimmunol.182.2.980; Flies Dallas B., 2011, Yale Journal of Biology and Medicine, V84, P409; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Good-Jacobson KL, 2012, J IMMUNOL, V188, P4217, DOI 10.4049/jimmunol.1102885; Hofmeyer KA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/451694; Horsmans Y, 2005, HEPATOLOGY, V42, P724, DOI 10.1002/hep.20839; Kanto T, 2006, INTERNAL MED, V45, P183, DOI 10.2169/internalmedicine.45.1530; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Kim JM, 2011, IMMUNOTHERAPY-UK, V3, P247, DOI 10.2217/IMT.10.91; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Peng GP, 2008, MOL IMMUNOL, V45, P963, DOI 10.1016/j.molimm.2007.07.038; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; Porter BO, 2009, AIDS, V23, P203, DOI 10.1097/QAD.0b013e32831cc114; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shen T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-279; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wang WS, 2009, INT IMMUNOL, V21, P1065, DOI 10.1093/intimm/dxp072; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zeuzem S, 2011, J HEPATOL, V54, pS538, DOI 10.1016/S0168-8278(11)61362-7; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019664	50	177	187	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63818	10.1371/journal.pone.0063818	http://dx.doi.org/10.1371/journal.pone.0063818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717490	gold, Green Submitted, Green Published			2022-12-27	WOS:000320362700065
J	Geslin, B; Gauzens, B; Thebault, E; Dajoz, I				Geslin, Benoit; Gauzens, Benoit; Thebault, Elisa; Dajoz, Isabelle			Plant Pollinator Networks along a Gradient of Urbanisation	PLOS ONE			English	Article							FLOWER CONSTANCY; BUMBLE BEES; HABITAT FRAGMENTATION; TEMPORAL STABILITY; LANDSCAPE CONTEXT; FORAGING RANGES; DIVERSITY; SPECIALIZATION; COMMUNITIES; COMPETITION	Background: Habitat loss is one of the principal causes of the current pollinator decline. With agricultural intensification, increasing urbanisation is among the main drivers of habitat loss. Consequently studies focusing on pollinator community structure along urbanisation gradients have increased in recent years. However, few studies have investigated how urbanisation affects plant-pollinator interaction networks. Here we assessed modifications of plant-pollinator interactions along an urbanisation gradient based on the study of their morphological relationships. Methodology/Principal Findings: Along an urbanisation gradient comprising four types of landscape contexts (semi-natural, agricultural, suburban, urban), we set up experimental plant communities containing two plant functional groups differing in their morphological traits ("open flowers'' and "tubular flowers''). Insect visitations on these communities were recorded to build plant-pollinator networks. A total of 17 857 interactions were recorded between experimental plant communities and flower-visitors. The number of interactions performed by flower-visitors was significantly lower in urban landscape context than in semi-natural and agricultural ones. In particular, insects such as Syrphidae and solitary bees that mostly visited the open flower functional group were significantly impacted by urbanisation, which was not the case for bumblebees. Urbanisation also impacted the generalism of flower-visitors and we detected higher interaction evenness in urban landscape context than in agricultural and suburban ones. Finally, in urban context, these modifications lowered the potential reproductive success of the open flowers functional group. Conclusions/Significance: Our findings show that open flower plant species and their specific flower-visitors are especially sensitive to increasing urbanisation. These results provide new clues to improve conservation measures within urbanised areas in favour of specialist flower-visitors. To complete this functional approach, studies using networks resolved to the species level along urbanised gradients would be required.	[Geslin, Benoit; Gauzens, Benoit; Thebault, Elisa; Dajoz, Isabelle] CNRS, Lab Biogeochim & Ecol Milieux Continentaux UMR 76, Paris, Ile De France, France; [Dajoz, Isabelle] Univ Paris Diderot, Paris, Ile De France, France; [Geslin, Benoit] Univ Paris 06, Paris, Ile De France, France; [Geslin, Benoit] Ecole Normale Super, F-75231 Paris, Ile De France, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Geslin, B (corresponding author), CNRS, Lab Biogeochim & Ecol Milieux Continentaux UMR 76, Paris, Ile De France, France.	bgeslin@biologie.ens.fr	Geslin, Benoît/AAP-7068-2020; Geslin, Benoit/GWV-5377-2022	Geslin, Benoît/0000-0002-2464-7998; Thebault, Elisa/0000-0002-9669-5227	Region Ile-de-France through DIM Astrea [ASTREA 2009-01-22]; R2DS	Region Ile-de-France through DIM Astrea(Region Ile-de-France); R2DS	This work was supported by a grant from Region Ile-de-France through DIM Astrea (Grant number : ASTREA 2009-01-22; URL: http://www.dim-astrea.fr/dim_astrea/) and R2DS (URL: http://www.r2ds-ile-de-france.com/) programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebil A, 2012, TRENDS ECOL EVOL, V27, P142, DOI 10.1016/j.tree.2011.11.017; Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; [Anonymous], 2010, R LANG ENV STAT COMP; Banaszak-Cibicka W, 2012, J INSECT CONSERV, V16, P331, DOI 10.1007/s10841-011-9419-2; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Bellmann H., 1999, GUIDE ABEILLES BOURD; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Bretz F., 2010, MULTIPLE COMP USING; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Dauber J, 2010, J ECOL, V98, P188, DOI 10.1111/j.1365-2745.2009.01590.x; Devoto M, 2012, ECOL LETT, V15, P319, DOI 10.1111/j.1461-0248.2012.01740.x; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dormann CF, 2012, VISUALISING BIPARTIT; Ebeling A, 2008, OIKOS, V117, P1808, DOI 10.1111/j.1600-0706.2008.16819.x; Ebeling A, 2012, OECOLOGIA, V169, P453, DOI 10.1007/s00442-011-2205-8; Ebeling A, 2011, BASIC APPL ECOL, V12, P300, DOI 10.1016/j.baae.2011.04.005; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; FORD MA, 1985, HEREDITY, V54, P99, DOI 10.1038/hdy.1985.12; Frund J, 2011, ECOL LETT, V14, P896, DOI 10.1111/j.1461-0248.2011.01654.x; Gallet R, 2009, EVOLUTION, V63, P641, DOI 10.1111/j.1558-5646.2008.00559.x; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gegear RJ, 2004, ETHOLOGY, V110, P793, DOI 10.1111/j.1439-0310.2004.01010.x; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; HEINRICH B, 1979, ECOLOGY, V60, P245, DOI 10.2307/1937652; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Hennig EI, 2012, URBAN ECOSYST, V15, P149, DOI 10.1007/s11252-011-0202-7; Hennig EI, 2011, PERSPECT PLANT ECOL, V13, P137, DOI 10.1016/j.ppees.2011.03.003; Ibanez S, 2012, OECOLOGIA, V170, P233, DOI 10.1007/s00442-012-2290-3; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Kaiser-Bunbury CN, 2009, PERSPECT PLANT ECOL, V11, P241, DOI 10.1016/j.ppees.2009.04.001; Kay Q. O. N, 1969, WATSONIA, V7, P130; Kleijn D, 2006, BASIC APPL ECOL, V7, P201, DOI 10.1016/j.baae.2005.07.011; Kunin W, 1996, THEOR POPUL BIOL, V49, P232, DOI 10.1006/tpbi.1996.0013; Laliberte E, 2010, ECOLOGY, V91, P1740, DOI 10.1890/09-1328.1; Larsson M, 2005, OECOLOGIA, V146, P394, DOI 10.1007/s00442-005-0217-y; Lazaro A, 2009, OIKOS, V118, P691, DOI 10.1111/j.1600-0706.2008.17168.x; Magura T, 2008, LANDSCAPE URBAN PLAN, V86, P134, DOI 10.1016/j.landurbplan.2008.01.005; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McIntyre NE, 2001, BASIC APPL ECOL, V2, P209, DOI 10.1078/1439-1791-00051; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Michener C.D., 2007, BEES WORLD, Vsecond; Ollerton J, 2012, TRENDS ECOL EVOL, V27, P141, DOI 10.1016/j.tree.2011.12.001; Perfectti F, 2009, OIKOS, V118, P1430, DOI 10.1111/j.1600-0706.2009.17491.x; Pesson P, 1984, POLLINISATION PRODUC; Pinheiro J, 2001, MIXED EFFECTS MODELS; PLEASANTS JM, 1979, OECOLOGIA, V41, P283, DOI 10.1007/BF00377432; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; RATHCKE BJ, 1993, CURR SCI INDIA, V65, P273; SEANEY R. R., 1970, Advanc. Agron., V22, P119, DOI 10.1016/S0065-2113(08)60267-9; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; SVENSSON R, 1986, Svensk Botanisk Tidskrift, V80, P31; THOMSON JD, 1987, OECOLOGIA, V71, P295, DOI 10.1007/BF00377298; Thorp RW, 2009, CITIES ENV CATE, V2; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; WASER NM, 1978, OECOLOGIA, V36, P223, DOI 10.1007/BF00349811; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Zanette LRS, 2005, LANDSCAPE URBAN PLAN, V71, P105, DOI 10.1016/j.landurbplan.2004.02.003; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	76	125	126	8	337	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63421	10.1371/journal.pone.0063421	http://dx.doi.org/10.1371/journal.pone.0063421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717421	gold, Green Published			2022-12-27	WOS:000320362700019
J	Wen, XY; Wu, X; Liu, JT; Li, K; Yao, L				Wen, Xuyun; Wu, Xia; Liu, Jiangtao; Li, Ke; Yao, Li			Abnormal Baseline Brain Activity in Non-Depressed Parkinson's Disease and Depressed Parkinson's Disease: A Resting-State Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; CEREBRAL BLOOD-FLOW; TREATMENT-RESPONSE; PREFRONTAL CORTEX; MAJOR DEPRESSION; GRAY-MATTER; HEAD MOTION; CONNECTIVITY; STIMULATION; CEREBELLUM	Depression is the most common psychiatric disorder observed in Parkinson's disease (PD) patients, however the neural contribution to the high rate of depression in the PD group is still unclear. In this study, we used resting-state functional magnetic resonance imaging (fMRI) to investigate the underlying neural mechanisms of depression in PD patients. Twenty-one healthy individuals and thirty-three patients with idiopathic PD, seventeen of whom were diagnosed with major depressive disorder, were recruited. An analysis of amplitude of low-frequency fluctuations (ALFF) was performed on the whole brain of all subjects. Our results showed that depressed PD patients had significantly decreased ALFF in the dorsolateral prefrontal cortex (DLPFC), the ventromedial prefrontal cortex (vMPFC) and the rostral anterior cingulated cortex (rACC) compared with non-depressed PD patients. A significant positive correlation was found between Hamilton Depression Rating Scale (HDRS) and ALFF in the DLPFC. The findings of changed ALFF in these brain regions implied depression in PD patients may be associated with abnormal activities of prefrontal-limbic network.	[Wen, Xuyun; Wu, Xia; Yao, Li] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Wu, Xia; Yao, Li] Beijing Normal Univ, Sch Informat Sci & Technol, Beijing 100875, Peoples R China; [Liu, Jiangtao] Beijing Xuan Wu Hosp, Beijing, Peoples R China; [Li, Ke] Beijing 306 Hosp, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University	Wu, X (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	wuxia@bnu.edu.cn			Fundamental Research Funds for the Central Universities National Key Basic Research Program of China (973 Program) [2012CB720704]; National Natural Science Foundation of China [6121001, 61222113]; Program for New Century Excellent Talents in University [NCET-12-0056]; State Key Laboratory of Cognitive Neuroscience and Learning [CNLYB1216]	Fundamental Research Funds for the Central Universities National Key Basic Research Program of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Cognitive Neuroscience and Learning	This work was supported by the Fundamental Research Funds for the Central Universities National Key Basic Research Program of China (973 Program) (2012CB720704), the Key Program of National Natural Science Foundation of China (6121001), General Program of National Natural Science Foundation of China (61222113), Program for New Century Excellent Talents in University (NCET-12-0056) and program of State Key Laboratory of Cognitive Neuroscience and Learning (CNLYB1216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; BENCH CJ, 1992, PSYCHOL MED, V22, P607, DOI 10.1017/S003329170003806X; Bennett MR, 2011, PROG NEUROBIOL, V93, P468, DOI 10.1016/j.pneurobio.2011.01.006; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cardoso EF, 2008, INT J NEUROPSYCHOPH, V11, P173, DOI 10.1017/S1461145707007961; Cardoso EF, 2009, NEUROIMAGE, V47, P467, DOI 10.1016/j.neuroimage.2009.04.059; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dragasevic N, 2002, MOVEMENT DISORD, V17, P528, DOI 10.1002/mds.10109; Edwards E, 2002, DEPRESS ANXIETY, V16, P39, DOI 10.1002/da.10057; Escalona P.R., 1993, DEPRESSION, V1, P156, DOI DOI 10.1002/DEPR.3050010307; Feldmann A, 2008, MOVEMENT DISORD, V23, P42, DOI 10.1002/mds.21765; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fregni F, 2006, NEUROLOGY, V66, P1629, DOI 10.1212/01.wnl.0000218194.12054.60; Guo WB, 2011, J AFFECT DISORDERS, V135, P326, DOI 10.1016/j.jad.2011.06.048; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P495, DOI 10.1016/j.biopsych.2005.04.035; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Kuhn W, 1996, J NEURAL TRANSM, V103, P349, DOI 10.1007/BF01271246; Kwak Y, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00052; Lang A. E. T., 1989, QUANTIFICATION NEURO, P285; Liotti M, 2002, AM J PSYCHIAT, V159, P1830, DOI 10.1176/appi.ajp.159.11.1830; Liu CH, 2012, PSYCHIAT RES-NEUROIM, V203, P175, DOI 10.1016/j.pscychresns.2012.02.007; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Long D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047714; MARDER K, 1995, ARCH NEUROL-CHICAGO, V52, P695, DOI 10.1001/archneur.1995.00540310069018; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Mottaghy FM, 2002, PSYCHIAT RES-NEUROIM, V115, P1, DOI 10.1016/S0925-4927(02)00032-X; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Pena-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022812; Philip DZ, 2002, BLACKWELL HDB CHILD; Pillay SS, 1997, BIOL PSYCHIAT, V42, P79, DOI 10.1016/S0006-3223(96)00335-6; Politis M, 2010, NEUROLOGY, V75, P1920, DOI 10.1212/WNL.0b013e3181feb2ab; Preziosi TJ, 1990, J NEUROL NEUROSURG P, V53; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; RING HA, 1994, BRIT J PSYCHIAT, V165, P333, DOI 10.1192/bjp.165.3.333; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shimony JS, 2009, ACAD RADIOL, V16, P578, DOI 10.1016/j.acra.2009.02.001; Skidmore FM, 2011, NEUROIMAGE; Skidmore FM, 2011, NEUROIMAGE; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; STERN Y, 1993, NEUROLOGY, V43, P1690, DOI 10.1212/WNL.43.9.1690; Surguladze S, 2003, ADV PSYCHIAT TREAT, V9, P446, DOI DOI 10.1192/APT.9.6.446; Turner BM, 2007, NEUROPSYCHOLOGIA, V45, P1331, DOI 10.1016/j.neuropsychologia.2006.09.023; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vu TC, 2012, BR J CLIN PHARM; Wagner G, 2008, J PSYCHIATR NEUROSCI, V33, P199; Wu X, 2011, HUM BRAIN MAPP, DOI [10.1002/hbm.21269, DOI 10.1002/HBM.21269]; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang Zhi-Qiang, 2008, Zhonghua Yi Xue Za Zhi, V88, P1594	66	57	59	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63691	10.1371/journal.pone.0063691	http://dx.doi.org/10.1371/journal.pone.0063691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717467	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700050
J	Alves, CF; Alves, CF; Figueiredo, MM; Souza, CC; Machado-Coelho, GLL; Melo, MN; Tafuri, WL; Raso, P; Soares, RP; Tafuri, WL				Alves, Cibele Fontes; Alves, Cintia Fontes; Figueiredo, Maria Marta; Souza, Carolina Carvalho; Lins Machado-Coelho, George Luiz; Melo, Maria Norma; Tafuri, Washington Luiz; Raso, Pedro; Soares, Rodrigo Pedro; Tafuri, Wagner Luiz			American Tegumentary Leishmaniasis: Effectiveness of an Immunohistochemical Protocol for the Detection of Leishmania in Skin	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; MUCOCUTANEOUS LEISHMANIASIS; IMMUNOPEROXIDASE METHOD; MINAS-GERAIS; DIAGNOSIS; CHAGASI; BRAZIL; AMASTIGOTES; CLASSIFICATION; IDENTIFICATION	Background: American tegumentary leishmaniasis (ATL) is endemic in Latin America, where Brazil has over 27 thousand cases per year. The aim of the present study was to develop an immunohistochemical method (IHC) for ATL diagnosis. For this purpose, we used serum from a dog naturally infected with Leishmania (L) infantum (canine hyperimmune serum) as the primary antibody, followed by a detection system with a secondary biotinylated antibody. Methodology: Skin samples were obtained from 73 patients in an endemic area of Caratinga, Minas Gerais (MG) State, Brazil all testing positive for ATL with the Montenegro skin test, microscopy, and PCR. Canine hyperimmune serum of a dog naturally infected with Leishmania (L.) infantum was employed as a primary antibody in an immunohistochemical diagnostic method using streptavidin-biotin peroxidase. To assess the specificity of this reaction, IHC assays employing two monoclonal antibodies were carried out. As the polymer-based technology is less time-consuming and labor intensive than the IHC labeled streptavidin-biotin peroxidase method, we compared the two methods for all samples. Results: The IHC method detected ATL in 67 of the 73 cases (91.8%). Immunolabeled parasites were primarily detected inside macrophages either in the superficial or the deep dermis. Detection was facilitated by the high contrast staining of amastigotes (dark brown) against the light blue background. A lower detection rate (71.2%) was observed with the both of the monoclonal Leishmania antibodies compared to the canine hyperimmune serum. This may have been due to a non-specific background staining observed in all histological samples rendering positive detection more difficult. The higher efficacy of the canine hyperimmune serum in the IHC method was confirmed by the method using streptavidin-biotin peroxidase as well as that with the polymer-based technology (biotin-avidin-free system). Conclusions: The data are encouraging with regard to validating IHC as a standard alternative method for ATL diagnosis.	[Alves, Cibele Fontes; Figueiredo, Maria Marta; Souza, Carolina Carvalho; Tafuri, Wagner Luiz] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Alves, Cintia Fontes; Melo, Maria Norma] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Lins Machado-Coelho, George Luiz] Univ Fed Ouro Preto, Escola Farm, Dept Ciencias Med, Ouro Preto, MG, Brazil; [Tafuri, Washington Luiz; Raso, Pedro] Univ Fed Minas Gerais, Fac Med, Dept Anat Patol, Belo Horizonte, MG, Brazil; [Soares, Rodrigo Pedro] Ctr Pesquisas Rene Rachou FIOCRUZ, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Tafuri, WL (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil.	wagnertafuri@gmail.com	Coelho, George Luiz Lins Machado/S-3411-2019; Soares, Rodrigo/S-5191-2019; Machado-Coelho, George Luiz Lins/ABA-4312-2021; Machado-Coelho, George L L/K-5972-2012	Coelho, George Luiz Lins Machado/0000-0002-9806-9721; Soares, Rodrigo/0000-0002-7966-3629; Machado-Coelho, George L L/0000-0002-9806-9721; Fontes Alves, Cibele/0000-0003-2390-3686; Tafuri, Wagner Luiz/0000-0002-7556-0737	Fundacao de Amparo e Pesquisa do Estado de Minas Gerais (FAPEMIG) [CDS-AQP 00068-08]; Pro-reitoria de Pesquisa [PRPq-Edital 07/2010]; Control Zoonosis Center of the Municipality of Ribeirao das Neves, Belo Horizonte Metropolitan area; Universidade Federal de Minas Gerais, UFMG, Minas Gerais State, Brazil	Fundacao de Amparo e Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-reitoria de Pesquisa; Control Zoonosis Center of the Municipality of Ribeirao das Neves, Belo Horizonte Metropolitan area; Universidade Federal de Minas Gerais, UFMG, Minas Gerais State, Brazil	The authors thank the Control Zoonosis Center of the Municipality of Ribeirao das Neves, Belo Horizonte Metropolitan area; Fundacao de Amparo e Pesquisa do Estado de Minas Gerais (FAPEMIG CDS-AQP 00068-08); and Pro-reitoria de Pesquisa (PRPq-Edital 07/2010), Universidade Federal de Minas Gerais, UFMG, Minas Gerais State, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Andrade-Narvaez Fernando J., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P191, DOI 10.1590/S0036-46652005000400003; Barbosa AJ, 1988, REV SOC BRAS MED TRO, V21, P1; BARRAL A, 1987, Memorias do Instituto Oswaldo Cruz, V82, P579, DOI 10.1590/S0074-02761987000400018; BITTENCOURT AL, 1991, MEM I OSWALDO CRUZ, V86, P51, DOI 10.1590/S0074-02761991000100009; Coelho-Finamore JM, 2011, INT J PARASITOL, V41, P333, DOI 10.1016/j.ijpara.2010.10.004; Costa J M, 1990, Rev Soc Bras Med Trop, V23, P205, DOI 10.1590/S0037-86821990000400004; da Silva SM, 2012, ANTIMICROB AGENTS CH, V56, P2858, DOI 10.1128/AAC.00208-12; de Magalhaes A V, 1982, Rev Inst Med Trop Sao Paulo, V24, P268; Curti MCD, 2011, BRAZ J INFECT DIS, V15, P12, DOI 10.1590/S1413-86702011000100003; DEBRUJIN MHL, 1993, TROP MED PARASITOL, V44, P201; DEMAGALHAES AV, 1986, REV I MED TROP, V28, P421, DOI 10.1590/S0036-46651986000600008; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DOSTROVSKY A, 1946, ANN TROP MED PARASIT, V40, P265, DOI 10.1080/00034983.1946.11685285; Figueiredo MM, 2010, HISTOL HISTOPATHOL, V25, P877, DOI 10.14670/HH-25.877; Gontijo Bernardo, 2003, Rev. Soc. Bras. Med. Trop., V36, P71, DOI 10.1590/S0037-86822003000100011; HERMETO MV, 1993, MEM I OSWALDO CRUZ, V88, P635, DOI 10.1590/S0074-02761993000400025; LIVNI N, 1983, VIRCHOWS ARCH A, V401, P147, DOI 10.1007/BF00692639; Lunedo SN, 2012, ACTA HISTOCHEM, V114, P252, DOI 10.1016/j.acthis.2011.06.002; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Melo M N, 1977, Rev Inst Med Trop Sao Paulo, V19, P161; (MS/SVS) MdS-SdVS, 2011, LEISHM TEG AM DISTR; Passos VMA, 1999, ACTA TROP, V72, P251, DOI 10.1016/S0001-706X(98)00100-4; Piani A, 1999, MICROBES INFECT, V1, P589, DOI 10.1016/S1286-4579(99)80058-6; Quintella LP, 2009, REV I MED TROP, V51, P83, DOI 10.1590/S0036-46652009000200005; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Ramos-Vara JA, 2008, J VET DIAGN INVEST, V20, P393, DOI 10.1177/104063870802000401; RIDLEY DS, 1980, T ROY SOC TROP MED H, V74, P515, DOI 10.1016/0035-9203(80)90069-3; Sabattini E, 1998, J CLIN PATHOL, V51, P506, DOI 10.1136/jcp.51.7.506; SALINAS G, 1989, MEM I OSWALDO CRUZ, V84, P53, DOI 10.1590/S0074-02761989000100010; Schubach A, 2001, MEM I OSWALDO CRUZ, V96, P987, DOI 10.1590/S0074-02762001000700018; Silveira FT, 2004, MEM I OSWALDO CRUZ, V99, P239, DOI 10.1590/S0074-02762004000300001; Singh S, 2003, J Postgrad Med, V49, P55; STERNBERGER LA, 1986, J HISTOCHEM CYTOCHEM, V34, P599, DOI 10.1177/34.5.3517144; Tafuri WL, 2004, J IMMUNOL METHODS, V292, P17, DOI 10.1016/j.jim.2004.05.009; TOLSON DL, 1989, MOL BIOCHEM PARASIT, V35, P109, DOI 10.1016/0166-6851(89)90113-8; Vega-Lopez F, 2003, CURR OPIN INFECT DIS, V16, P97, DOI 10.1097/00001432-200304000-00006; Volpini AC, 2006, CLIN MICROBIOL INFEC, V12, P815, DOI 10.1111/j.1469-0691.2006.01422.x; WEIGLE KA, 1987, AM J TROP MED HYG, V36, P489, DOI 10.4269/ajtmh.1987.36.489; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176	42	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63343	10.1371/journal.pone.0063343	http://dx.doi.org/10.1371/journal.pone.0063343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704900	Green Published, gold			2022-12-27	WOS:000319330200029
J	Faguer, S; Mayeur, N; Casemayou, A; Pageaud, AL; Courtellemont, C; Cartery, C; Fournie, GJ; Schanstra, JP; Tack, I; Bascands, JL; Chauveau, D				Faguer, Stanislas; Mayeur, Nicolas; Casemayou, Audrey; Pageaud, Anne-Laure; Courtellemont, Claire; Cartery, Claire; Fournie, Gilbert J.; Schanstra, Joost P.; Tack, Ivan; Bascands, Jean-Loup; Chauveau, Dominique			Hnf-1 beta Transcription Factor Is an Early Hif-1 alpha-Independent Marker of Epithelial Hypoxia and Controls Renal Repair	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; EXPRESSION; FAILURE; DISEASE; GENE; RATS; REGENERATION; SUPPRESSORS; HOMEOSTASIS; MUTATIONS	Epithelial repair following acute kidney injury (AKI) requires epithelial-mesenchyme-epithelial cycling associated with transient re-expression of genes normally expressed during kidney development as well as activation of growth factors and cytokine-induced signaling. In normal kidney, the Hnf-1 beta transcription factor drives nephrogenesis, tubulogenesis and epithelial homeostasis through the regulation of epithelial planar cell polarity and expression of developmental or tubular segment-specific genes. In a mouse model of ischemic AKI induced by a 2-hours hemorrhagic shock, we show that expression of this factor is tightly regulated in the early phase of renal repair with a biphasic expression profile (early down-regulation followed by transient over-expression). These changes are associated to tubular epithelial differentiation as assessed by KSP-cadherin and megalin-cubilin endocytic complex expression analysis. In addition, early decrease in Hnf1b expression is associated with the transient over-expression of one of its main target genes, the suppressor of cytokine signaling Socs3, which has been shown essential for renal repair. In vitro, hypoxia induced early up-regulation of Hnf-1 beta from 1 to 24 hours, independently of the hypoxia-inducible factor Hif-1 alpha. When prolonged, hypoxia induced Hnf-1 beta down-regulation while normoxia led to Hnf-1 beta normalization. Last, Hnf-1 beta down-regulation using RNA interference in HK-2 cells led to phenotype switch from an epithelial to a mesenchyme state. Taken together, we showed that Hnf-1 beta may drive recovery from ischemic AKI by regulating both the expression of genes important for homeostasis control during organ repair and the state of epithelial cell differentiation.	[Faguer, Stanislas; Courtellemont, Claire; Cartery, Claire; Fournie, Gilbert J.; Chauveau, Dominique] CHU Rangueil, Dept Nephrol & Transplantat Organes, F-31054 Toulouse, France; [Faguer, Stanislas; Mayeur, Nicolas; Casemayou, Audrey; Pageaud, Anne-Laure; Schanstra, Joost P.; Tack, Ivan; Bascands, Jean-Loup; Chauveau, Dominique] Fac Med Toulouse, INSERM, U1048, Inst Malad Metab & Cardiovasc,Equipe 12, F-31073 Toulouse, France; [Faguer, Stanislas; Chauveau, Dominique] CHU Rangueil, Ctr Reference Malad Renales Rares, F-31054 Toulouse, France; [Tack, Ivan] CHU Rangueil, Serv Explorat Physiol, F-31054 Toulouse, France; [Mayeur, Nicolas] CHU Purpan, Equipe Accueil Inserm 4564, Dept Anesthesie Reanimat, Toulouse, France; [Faguer, Stanislas; Mayeur, Nicolas; Courtellemont, Claire; Schanstra, Joost P.; Tack, Ivan; Bascands, Jean-Loup; Chauveau, Dominique] Univ Toulouse 3, F-31062 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Faguer, S (corresponding author), CHU Rangueil, Dept Nephrol & Transplantat Organes, F-31054 Toulouse, France.	faguer.s@chu-toulouse.fr	Schanstra, Joost P/X-7724-2018	Schanstra, Joost P/0000-0002-7471-372X; Bascands, Jean-loup/0000-0002-1667-5913	Fondation pour la Recherche Medicale; Societe de Nephrologie	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Societe de Nephrologie	SF received a grant from the Fondation pour la Recherche Medicale, CC received a grant from the Societe de Nephrologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalat S, 2009, J AM SOC NEPHROL, V20, P1123, DOI 10.1681/ASN.2008060633; Allard J, 2011, CRIT CARE MED; Ben-Zvi T, 2006, J CELL SCI, V119, P380, DOI 10.1242/jcs.02740; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dey BR, 2000, BIOCHEM BIOPH RES CO, V278, P38, DOI 10.1006/bbrc.2000.3762; Elliott J, 2004, TRENDS IMMUNOL, V25, P434, DOI 10.1016/j.it.2004.05.012; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Franquesa M, 2005, GENE THER, V12, P1551, DOI 10.1038/sj.gt.3302569; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Grigoryev DN, 2008, J AM SOC NEPHROL, V19, P547, DOI 10.1681/ASN.2007040469; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Homsi E, 2002, NEPHRON, V92, P192, DOI 10.1159/000064478; Homsi E, 2009, AM J NEPHROL, V29, P283, DOI 10.1159/000159275; HUMES HD, 1989, J CLIN INVEST, V84, P1757, DOI 10.1172/JCI114359; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Kobayashi T, 2008, KIDNEY INT, V73, P1240, DOI 10.1038/ki.2008.74; Leonard MO, 2003, J BIOL CHEM, V278, P40296, DOI 10.1074/jbc.M302560200; Leu JI, 2001, MOL CELL BIOL, V21, P414, DOI 10.1128/MCB.21.2.414-424.2001; Lindoso RS, 2009, NEPHROL DIAL TRANSPL, V24, P2628, DOI 10.1093/ndt/gfp307; Lokmane L, 2010, DEVELOPMENT, V137, P347, DOI 10.1242/dev.042226; Ma ZD, 2007, P NATL ACAD SCI USA, V104, P20386, DOI 10.1073/pnas.0705957104; Mayeur N, 2011, CRIT CARE MED, V39, P2131, DOI 10.1097/CCM.0b013e31821f04f0; Mitazaki S, 2009, TOXICOLOGY, V265, P115, DOI 10.1016/j.tox.2009.10.005; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Racusen L, 2001, MORPHOLOGIC BASIS AC; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Tan JC, 2005, PEDIATR NEPHROL, V20, P567, DOI 10.1007/s00467-004-1766-8; Tanaka H, 2004, J AM SOC NEPHROL, V15, P3083, DOI 10.1097/01.ASN.0000145459.54236.D3; Terada Y, 2003, J AM SOC NEPHROL, V14, P1223, DOI 10.1097/01.ASN.0000060577.94532.06; Verdeguer F, 2010, NAT MED, V16, P106, DOI 10.1038/nm.2068; Xu EY, 2008, CHEM RES TOXICOL, V21, P1548, DOI 10.1021/tx800061w; Yoshioka K, 2011, J RECEPT SIG TRANSD, V31, P132, DOI 10.3109/10799893.2010.538852	37	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63585	10.1371/journal.pone.0063585	http://dx.doi.org/10.1371/journal.pone.0063585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704921	Green Published, gold			2022-12-27	WOS:000319330200052
J	Gilg, O; Moe, B; Hanssen, SA; Schmidt, NM; Sittler, B; Hansen, J; Reneerkens, J; Sabard, B; Chastel, O; Moreau, J; Phillips, RA; Oudman, T; Biersma, EM; Fenstad, AA; Lang, J; Bollache, L				Gilg, Olivier; Moe, Borge; Hanssen, Sveinn Are; Schmidt, Niels Martin; Sittler, Benoit; Hansen, Jannik; Reneerkens, Jeroen; Sabard, Brigitte; Chastel, Olivier; Moreau, Jerome; Phillips, Richard A.; Oudman, Thomas; Biersma, Elisabeth M.; Fenstad, Anette A.; Lang, Johannes; Bollache, Loic			Trans-Equatorial Migration Routes, Staging Sites and Wintering Areas of a High-Arctic Avian Predator: The Long-tailed Skua (Stercorarius longicaudus)	PLOS ONE			English	Article							PELAGIC SEABIRD; CLIMATE-CHANGE; TRACKING; ATLANTIC; DYNAMICS; GEOLOCATION; REVEALS; HABITAT; WATERS; MURRES	The Long-tailed Skua, a small (<300 g) Arctic-breeding predator and seabird, is a functionally very important component of the Arctic vertebrate communities in summer, but little is known about its migration and winter distribution. We used light-level geolocators to track the annual movements of eight adult birds breeding in north-east Greenland (n = 3) and Svalbard (n = 5). All birds wintered in the Southern Hemisphere (mean arrival-departure dates on wintering grounds: 24 October-21 March): five along the south-west coast of Africa (0-40 degrees S, 0-15 degrees E), in the productive Benguela upwelling, and three further south (30-40 degrees S, 0-50 degrees E), in an area extending into the south-west Indian Ocean. Different migratory routes and rates of travel were documented during post-breeding (345 km d(-1) in late August-early September) and spring migrations (235 km d(-1) in late April) when most birds used a more westerly flyway. Among the different staging areas, a large region off the Grand Banks of Newfoundland appears to be the most important. It was used in autumn by all but one of the tracked birds (from a few days to three weeks) and in spring by five out of eight birds (from one to more than six weeks). Two other staging sites, off the Iberian coast and near the Azores, were used by two birds in spring for five to six weeks. Over one year, individuals travelled between 43,900 and 54,200 km (36,600-45,700 when excluding staging periods) and went as far as 10,500-13,700 km (mean 12,800 km) from their breeding sites. This study has revealed important marine areas in both the south and north Atlantic Ocean. Sustainable management of these ocean basins will benefit Long-tailed Skuas as well as other trans-equatorial migrants from the Arctic.	[Gilg, Olivier; Moreau, Jerome; Bollache, Loic] Univ Bourgogne, Lab Biogeosci, UMR CNRS 5561, Dijon, France; [Gilg, Olivier; Sittler, Benoit; Sabard, Brigitte; Moreau, Jerome; Lang, Johannes; Bollache, Loic] Grp Rech Ecol Arct Francheville, Francheville, France; [Moe, Borge; Hanssen, Sveinn Are] Norwegian Inst Nat Res NINA, Tromso, Norway; [Schmidt, Niels Martin; Hansen, Jannik] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Schmidt, Niels Martin] Aarhus Univ, Arct Res Ctr, Aarhus C, Denmark; [Sittler, Benoit] Univ Freiburg, Inst Landespflege, D-79106 Freiburg, Germany; [Reneerkens, Jeroen] Univ Groningen, Anim Ecol Grp, Groningen, Netherlands; [Chastel, Olivier] CNRS, Ctr Etud Biol Chize, Chize, France; [Phillips, Richard A.; Biersma, Elisabeth M.] NERC, British Antarct Survey, Cambridge, England; [Oudman, Thomas; Biersma, Elisabeth M.] Univ Groningen, Arct Ctr, Groningen, Netherlands; [Oudman, Thomas] Royal Netherlands Inst Sea Res, Den Burg, Texel, Netherlands; [Fenstad, Anette A.] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway; [Lang, Johannes] Inst Anim Ecol & Nat Educ, Gonterskirchen, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Norwegian Institute Nature Research; Aarhus University; Aarhus University; University of Freiburg; University of Groningen; Centre National de la Recherche Scientifique (CNRS); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Norwegian University of Science & Technology (NTNU)	Gilg, O (corresponding author), Univ Bourgogne, Lab Biogeosci, UMR CNRS 5561, Dijon, France.	olivier.gilg@gmail.com	GILG, Olivier/C-2588-2008; Hanssen, Sveinn Are/C-9989-2009; moreau, jerome/A-3496-2013; Biersma, Elisabeth Machteld/AAL-9818-2020; Schmidt, Niels Martin/G-3843-2011; Moe, Børge/P-2946-2015; Reneerkens, Jeroen/J-3880-2015; Hansen, Jannik/J-5679-2013	GILG, Olivier/0000-0002-9083-4492; Hanssen, Sveinn Are/0000-0003-1792-435X; Biersma, Elisabeth Machteld/0000-0002-9877-2177; Schmidt, Niels Martin/0000-0002-4166-6218; Moe, Børge/0000-0002-2306-1899; Reneerkens, Jeroen/0000-0003-0674-8143; Hansen, Jannik/0000-0003-1181-6905; Hansen, Jannik/0000-0002-2716-9928; BOLLACHE, Loic/0000-0003-0316-6746; Lang, Johannes/0000-0002-7387-795X	Conseil Regional de Bourgogne; French Polar Institut (IPEV; project "1036-Interactions"); Danish Environmental Protection Agency; Groupe de Recherche en Ecologie Arctique (GREA); Fram Centre, Arctic Field Grant; Norwegian Institute for Nature Research (NINA); Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); French Polar Institut (IPEV; project "1036-Interactions"); Danish Environmental Protection Agency; Groupe de Recherche en Ecologie Arctique (GREA); Fram Centre, Arctic Field Grant; Norwegian Institute for Nature Research (NINA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors are grateful to the Conseil Regional de Bourgogne, the French Polar Institut (IPEV; project "1036-Interactions"), the Danish Environmental Protection Agency and the Groupe de Recherche en Ecologie Arctique (GREA) for their support to this study in Greenland. Research in Svalbard was funded by the Fram Centre, Arctic Field Grant, and by the Norwegian Institute for Nature Research (NINA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLON F, 1991, BIRDING WORLD, V4, P440; Boertmann David, 2011, Marine Ornithology, V39, P183; Boertmann David, 1994, Meddelelser om Gronland Bioscience, V38, P1; Cramp S., 1980, BIRDS W PALEARCTIC, V2; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; de Korte J, 1985, BEAUFORT, V35, P93; DEKORTE J, 1988, ARDEA, V76, P27; Distiller G, 2012, MAR ECOL PROG SER, V461, P245, DOI 10.3354/meps09807; Dubois Phillipe J., 2009, Ornithos, V16, P220; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Felicisimo AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002928; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Furness RW, 1987, SKUAS, P336; Gauthier G, 2011, ECOSCIENCE, V18, P223, DOI 10.2980/18-3-3453; Gilg O, 2003, SCIENCE, V302, P866, DOI 10.1126/science.1087509; Gilg O, 2006, OIKOS, V113, P193, DOI 10.1111/j.2006.0030-1299.14125.x; Gilg O, 2012, ANN NY ACAD SCI, V1249, P166, DOI 10.1111/j.1749-6632.2011.06412.x; Gilg O, 2010, J AVIAN BIOL, V41, P532, DOI 10.1111/j.1600-048X.2010.05125.x; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gonzalez-Solis J, 2011, MAR ECOL PROG SER, V435, P251, DOI 10.3354/meps09233; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Gremillet D, 2009, MAR ECOL PROG SER, V391, P121, DOI 10.3354/meps08212; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hansen J, 2011, BIRD STUDY, V58, P522, DOI 10.1080/00063657.2011.601411; Harrison P, 1989, SEABIRDS, P448; Hedd A, 2011, ANIM CONSERV, V14, P630, DOI 10.1111/j.1469-1795.2011.00479.x; Howell Steve N. G., 1995, Bulletin of the British Ornithologists' Club, V115, P57; Imboden C., 1972, Vogelwarte, V26, P336; IUCN, 2012, IUCN RED LIST THREAT; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Johnson AW, 1965, BIRDS CHILE ADJACENT, V1, P398; Kampp K., 1982, Dansk Ornitologisk Forenings Tidsskrift, V76, P129; Kovacs KM, 2006, BIRDS MAMMALS SVALBA, P203; LAMBERT K, 1980, Beitraege zur Vogelkunde, V26, P199; LAMBERT K, 1988, Beitraege zur Vogelkunde, V34, P29; LAMBERT K, 1973, Canadian Field-Naturalist, V87, P57; Lambert Kurt, 2005, Durban Museum Novitates, V30, P45; Lambert Kurt, 2006, Marine Ornithology, V34, P77; Langrand O., 1995, GUIDE OISEAUX MADAGA; Lovenskiold H. L., 1964, Skrifter om Norsk Polarinstitutt, VNo. 129, P1; Magnusdottir E, 2012, BIRD STUDY, V59, P1; Montevecchi WA, 2012, BIOL CONSERV, V156, P62, DOI 10.1016/j.biocon.2011.12.001; Mosbech A, 2012, POLAR BIOL, V35, P305, DOI 10.1007/s00300-011-1064-4; Nilsson K, 2008, VAR FAGELVARLD, V5, P18; North American Banding Council, 2001, N AM BAND STUD GUID; Okes NC, 2009, BIOL CONSERV, V142, P2361, DOI 10.1016/j.biocon.2009.05.031; Olsen KM, 1997, SKUAS JAEGERS, P192; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Pichegru L, 2009, MAR ECOL PROG SER, V391, P199, DOI 10.3354/meps08283; Ramos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040822; RYAN PG, 1989, OSTRICH, V60, P89; Schmidt NM, 2008, ADV ECOL RES, V40, P345, DOI 10.1016/S0065-2504(07)00015-3; Schmidt NM, 2012, P ROY SOC B-BIOL SCI, V279, P4417, DOI 10.1098/rspb.2012.1490; Sittler B, 2011, J ORNITHOL, V152, P375, DOI 10.1007/s10336-010-0597-6; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Tranquilla LAM, 2013, MAR ECOL PROG SER, V472, P287, DOI 10.3354/meps10053; Tuck G, 1985, GUIDE SEABIRDS OCEAN, P144; Warnock N, 2010, J AVIAN BIOL, V41, P621, DOI 10.1111/j.1600-048X.2010.05155.x; Wiley R. H., 1998, BIRDS N AM ONLINE; Zmudczynska K, 2012, POLAR BIOL, V35, P1233, DOI 10.1007/s00300-012-1169-4	62	42	47	0	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64614	10.1371/journal.pone.0064614	http://dx.doi.org/10.1371/journal.pone.0064614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705000	Green Accepted, Green Published, gold			2022-12-27	WOS:000319330200154
J	Konieczna, P; Ferstl, R; Ziegler, M; Frei, R; Nehrbass, D; Lauener, RP; Akdis, CA; O'Mahony, L				Konieczna, Patrycja; Ferstl, Ruth; Ziegler, Mario; Frei, Remo; Nehrbass, Dirk; Lauener, Roger P.; Akdis, Cezmi A.; O'Mahony, Liam			Immunomodulation by Bifidobacterium infantis 35624 in the Murine Lamina Propria Requires Retinoic Acid-Dependent and Independent Mechanisms	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; IRRITABLE-BOWEL-SYNDROME; REGULATORY T-CELLS; IMMUNE-RESPONSES; TGF-BETA; INFLAMMATION; MICROBIOTA; MICE; MACROPHAGES; EFFICACY	Appropriate dendritic cell processing of the microbiota promotes intestinal homeostasis and protects against aberrant inflammatory responses. Mucosal CD103(+) dendritic cells are able to produce retinoic acid from retinal, however their role in vivo and how they are influenced by specific microbial species has been poorly described. Bifidobacterium infantis 35624 (B. infantis) feeding to mice resulted in increased numbers of CD103+ retinaldehyde dehydrogenase (RALDH)(+) dendritic cells within the lamina propria (LP). Foxp3(+) lymphocytes were also increased in the LP, while T(H)1 and T(H)17 subsets were decreased. 3,7-dimethyl-2,6-octadienal (citral) treatment of mice blocked the increase in CD103(+)RALDH(+) dendritic cells and the decrease in T(H)1 and T(H)17 lymphocytes, but not the increase in Foxp3(+) lymphocytes. B. infantis reduced the severity of DSS-induced colitis, associated with decreased T(H)1 and T(H)17 cells within the LP. Citral treatment confirmed that these effects were RALDH mediated. RALDH(+) dendritic cells decreased within the LP of control inflamed animals, while RALDH(+) dendritic cells numbers were maintained in the LP of B. infantis-fed mice. Thus, CD103(+)RALDH(+) LP dendritic cells are important cellular targets for microbiota-associated effects on mucosal immunoregulation.	[Konieczna, Patrycja; Ferstl, Ruth; Ziegler, Mario; Frei, Remo; Akdis, Cezmi A.; O'Mahony, Liam] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Frei, Remo; Lauener, Roger P.; Akdis, Cezmi A.] Christine Kuhne Ctr Allergy Res & Educ CK CARE, Davos, Switzerland; [Nehrbass, Dirk] AO Res Inst Davos ARI, Davos, Switzerland; [Lauener, Roger P.] Hochgebirgsklin Davos Wolfgang, Davos, Switzerland	Swiss Institute of Allergy & Asthma Research; University of Zurich	O'Mahony, L (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland.	liam.omahony@siaf.uzh.ch	Ferstl, Ruth/ABB-9679-2021; Lauener, Roger P/O-8612-2016; Frei, Remo/AAI-9180-2020; O'Mahony, Liam/AAG-5838-2019; Akdis, Cezmi/AAV-4844-2020	Lauener, Roger P/0000-0002-8412-606X; O'Mahony, Liam/0000-0003-4705-3583; Akdis, Cezmi/0000-0001-8020-019X	Swiss National Foundation [32030-132899, 310030-127356]; Christine Kuhne Center for Allergy Research and Education (CK-CARE); European Union (EU) Marie Curie; Novartis; Stallergenes	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Christine Kuhne Center for Allergy Research and Education (CK-CARE); European Union (EU) Marie Curie; Novartis(Novartis); Stallergenes	The authors are supported by Swiss National Foundation grants (project numbers 32030-132899 and 310030-127356), Christine Kuhne Center for Allergy Research and Education (CK-CARE) and European Union (EU) Marie Curie grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following conflicts. Liam O'Mahony is a consultant to Alimentary Health Ltd. Cezmi A. Akdis has received research support from Novartis and Stallergenes and consulted for Actellion, Aventis and Allergopharma. Patrycja Konieczna, Mario Ziegler, Dirk Nehrbass, Remo Frei, Ruth Ferstl and Roger P. Lauener have no conflict of interest. The authors do not have any additional financial or non-financial disclosures, which have not already been described online. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Feng T, 2011, MUCOSAL IMMUNOL, V4, P15, DOI 10.1038/mi.2010.60; Frei R, 2012, ALLERGY, V67, P451, DOI 10.1111/j.1398-9995.2011.02783.x; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jeon SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002714; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Konieczna P, 2012, GUT MICROBES, V3, P261, DOI 10.4161/gmic.20358; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Leavy O, 2012, NAT REV IMMUNOL, V12, P319, DOI 10.1038/nri3213; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Manicassamya S, 2009, SEMIN IMMUNOL, V21, P22, DOI 10.1016/j.smim.2008.07.007; McCarthy J, 2003, GUT, V52, P975, DOI 10.1136/gut.52.7.975; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Murphy CT, 2010, J LEUKOCYTE BIOL, V88, P1271, DOI 10.1189/jlb.0909627; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Shanahan F, 2010, AM J GASTROENTEROL, V105, P275, DOI 10.1038/ajg.2009.729; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; van der Kleij H, 2008, AM J PHYSIOL-REG I, V295, pD1131, DOI 10.1152/ajpregu.90434.2008; Wermers JD, 2011, GASTROENTEROLOGY, V140, P1526, DOI 10.1053/j.gastro.2011.01.044; Whorwell PJ, 2006, AM J GASTROENTEROL, V101, P1581, DOI 10.1111/j.1572-0241.2006.00734.x; Wingender G, 2012, GASTROENTEROLOGY, V143, P418, DOI 10.1053/j.gastro.2012.04.017	33	64	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62617	10.1371/journal.pone.0062617	http://dx.doi.org/10.1371/journal.pone.0062617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704880	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200009
J	Ma, KF; Song, YP; Yang, XH; Zhang, ZY; Zhang, DQ				Ma, Kaifeng; Song, Yuepeng; Yang, Xiaohui; Zhang, Zhiyi; Zhang, Deqiang			Variation in Genomic Methylation in Natural Populations of Chinese White Poplar	PLOS ONE			English	Article							DNA METHYLATION; CYTOSINE METHYLATION; GENETIC DIVERSITY; AFLP; POLYMORPHISM; AMPLIFICATION; INHERITANCE; DIFFERENTIATION; REPLICATION; VARIABILITY	Background: It is thought that methylcytosine can be inherited through meiosis and mitosis, and that epigenetic variation may be under genetic control or correlation may be caused by neutral drift. However, DNA methylation also varies with tissue, developmental stage, and environmental factors. Eliminating these factors, we analyzed the levels and patterns, diversity and structure of genomic methylcytosine in the xylem of nine natural populations of Chinese white poplar. Principal Findings: On average, the relative total methylation and non-methylation levels were approximately 26.567% and 42.708% (P < 0.001), respectively. Also, the relative CNG methylation level was higher than the relative CG methylation level. The relative methylation/non-methylation levels were significantly different among the nine natural populations. Epigenetic diversity ranged from 0.811 (Gansu) to 1.211 (Shaanxi), and the coefficients of epigenetic differentiation (G(ST) = 0.159) were assessed by Shannon's diversity index. Co-inertia analysis indicated that methylation-sensitive polymorphism (MSP) and genomic methylation pattern (CG-CNG) profiles gave similar distributions. Using a between-group eigen analysis, we found that the Hebei and Shanxi populations were independent of each other, but the Henan population intersected with the other populations, to some degree. Conclusions: Genome methylation in Populus tomentosa presented tissue-specific characteristics and the relative 5' CCGG methylation level was higher in xylem than in leaves. Meanwhile, the genome methylation in the xylem shows great epigenetic variation and could be fixed and inherited though mitosis. Compared to genetic structure, data suggest that epigenetic and genetic variation do not completely match.	[Ma, Kaifeng; Song, Yuepeng; Yang, Xiaohui; Zhang, Zhiyi; Zhang, Deqiang] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Ma, Kaifeng; Song, Yuepeng; Yang, Xiaohui; Zhang, Zhiyi; Zhang, Deqiang] Beijing Forestry Univ, Coll Biol Sci & Technol, Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Zhang, DQ (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	DeqiangZhang@bjfu.edu.cn	Song, Yuepeng/T-8731-2019		Fundamental Research Funds for Central Universities [TD2012-01]; State Key Basic Research Program of China [2012CB114506]; National Natural Science Foundation of China [31170622, 30872042]	Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); State Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for Central Universities (No. TD2012-01), the State Key Basic Research Program of China (No. 2012CB114506) and the Project of the National Natural Science Foundation of China (No. 31170622, 30872042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikawa I, 2001, PLANT MOL BIOL, V45, P31, DOI 10.1023/A:1006457321781; Bussell JD, 1999, MOL ECOL, V8, P775, DOI 10.1046/j.1365-294X.1999.00627.x; Campbell RB, 1976, CAN J FOREST RES, V6, P251; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Dahl C, 2003, BIOGERONTOLOGY, V4, P233, DOI 10.1023/A:1025103319328; Du QZ, 2012, J HERED, V103, P853, DOI 10.1093/jhered/ess061; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Gong L, 2007, CAN J BOT, V85, P813, DOI 10.1139/B07-072; Groves M, 2008, ENDANG SPECIES RES, V9, P255; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; Hasbun R, 2005, ACTA HORTIC, P333, DOI 10.17660/ActaHortic.2005.693.42; Hauben M, 2009, P NATL ACAD SCI USA, V106, P20109, DOI 10.1073/pnas.0908755106; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; HOLLIDAY R, 1994, DEV GENET, V15, P453, DOI 10.1002/dvg.1020150602; Kakutani T, 1999, GENETICS, V151, P831; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; Keyte AL, 2006, J HERED, V97, P444, DOI 10.1093/jhered/esl023; Kovarik A, 1997, GENE, V204, P25, DOI 10.1016/S0378-1119(97)00503-9; Li YD, 2008, ECOL RES, V23, P927, DOI 10.1007/s11284-007-0459-8; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu S, 2012, MOL GENET GENOMICS, V287, P643, DOI 10.1007/s00438-012-0704-x; Ma KF, 2012, TREE GENET GENOMES, V8, P1407, DOI 10.1007/s11295-012-0527-2; Massicotte R, 2011, EPIGENETICS-US, V6, P422, DOI 10.4161/epi.6.4.14532; MESSEGUER R, 1991, PLANT MOL BIOL, V16, P753, DOI 10.1007/BF00015069; MONTERO LM, 1992, NUCLEIC ACIDS RES, V20, P3207, DOI 10.1093/nar/20.12.3207; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Oakeley EJ, 1996, PLANT MOL BIOL, V31, P927, DOI 10.1007/BF00019481; Parisod C, 2005, ANN BOT-LONDON, V95, P277, DOI 10.1093/aob/mci023; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Rachmayanti Y, 2006, PLANT MOL BIOL REP, V24, P45, DOI 10.1007/BF02914045; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Teixeira FK, 2010, HEREDITY, V105, P14, DOI 10.1038/hdy.2010.52; Teyssier E, 2008, PLANTA, V228, P391, DOI 10.1007/s00425-008-0743-z; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang YM, 2004, CELL MOL BIOL LETT, V9, P543; WIGLER M, 1981, CELL, V24, P33, DOI 10.1016/0092-8674(81)90498-0; Winfield MO, 1998, MOL ECOL, V7, P3, DOI 10.1046/j.1365-294x.1998.00299.x; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Zhang D, 2004, THEOR APPL GENET, V108, P657, DOI 10.1007/s00122-003-1478-7; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao XX, 2007, PLANT SCI, V172, P930, DOI 10.1016/j.plantsci.2007.01.002; Zhu ZhiTi, 1997, Journal of Beijing Forestry University, English edition, V6, P1	51	16	17	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63977	10.1371/journal.pone.0063977	http://dx.doi.org/10.1371/journal.pone.0063977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704963	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200095
J	Mitkidis, P; Sorensen, J; Nielbo, KL; Andersen, M; Lienard, P				Mitkidis, Panagiotis; Sorensen, Jesper; Nielbo, Kristoffer L.; Andersen, Marc; Lienard, Pierre			Collective-Goal Ascription Increases Cooperation in Humans	PLOS ONE			English	Article							EVOLUTION	Background: Cooperation is necessary in many types of human joint activity and relations. Evidence suggests that cooperation has direct and indirect benefits for the cooperators. Given how beneficial cooperation is overall, it seems relevant to investigate the various ways of enhancing individuals' willingness to invest in cooperative endeavors. We studied whether ascription of a transparent collective goal in a joint action promotes cooperation in a group. Methods: A total of 48 participants were assigned in teams of 4 individuals to either a "transparent goal-ascription'' or an "opaque goal-ascription'' condition. After the manipulation, the participants played an anonymous public goods game with another member of their team. We measured the willingness of participants to cooperate and their expectations about the other player's contribution. Results: Between subjects analyses showed that transparent goal ascription impacts participants' likelihood to cooperate with each other in the future, thereby greatly increasing the benefits from social interactions. Further analysis showed that this could be explained with a change in expectations about the partner's behavior and by an emotional alignment of the participants. Conclusion: The study found that a transparent goal ascription is associated with an increase of cooperation. We propose several high-level mechanisms that could explain the observed effect: general affect modulation, trust, expectation and perception of collective efficacy.	[Mitkidis, Panagiotis; Sorensen, Jesper; Nielbo, Kristoffer L.; Andersen, Marc] Aarhus Univ, Dept Culture & Soc, Aarhus, Denmark; [Mitkidis, Panagiotis; Nielbo, Kristoffer L.] Aarhus Univ, Interacting Minds Ctr, Aarhus, Denmark; [Mitkidis, Panagiotis] Duke Univ, Ctr Adv Hindsight, Durham, NC USA; [Lienard, Pierre] Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA; [Sorensen, Jesper; Nielbo, Kristoffer L.] Aarhus Univ, MindLab, Aarhus, Denmark; [Nielbo, Kristoffer L.] Univ British Columbia, Ctr Human Evolut Cognit & Culture, Vancouver, BC V5Z 1M9, Canada	Aarhus University; Aarhus University; Duke University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Aarhus University; University of British Columbia	Mitkidis, P (corresponding author), Aarhus Univ, Dept Culture & Soc, Aarhus, Denmark.	mitkidispan@gmail.com	Sørensen, Jesper/AAK-8409-2020	Mitkidis, Panagiotis/0000-0001-9646-6961; Nielbo, Kristoffer/0000-0002-5116-5070; Sorensen, Jesper Frokjaer/0000-0003-2344-6534	Religion Cognition and Culture Unit, Aarhus University, Denmark; Department of Culture and Society, Aarhus University, Denmark	Religion Cognition and Culture Unit, Aarhus University, Denmark; Department of Culture and Society, Aarhus University, Denmark	The study was conducted at the Department of Culture and Society and was supported by the Religion Cognition and Culture Unit and the Department of Culture and Society, Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariely Daniel, 2008, PREDICTABLY IRRATION; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Banks AP, 2000, BRIT J PSYCHOL, V91, P513, DOI 10.1348/000712600161961; CANNONBOWERS JA, 1993, INDIVIDUAL AND GROUP DECISION MAKING, P221; Caplin A, 2008, Q J ECON, V123, P663, DOI 10.1162/qjec.2008.123.2.663; Cohen J.E., 1988, STAT POWER ANAL BEHA; Custers R, 2007, PERS SOC PSYCHOL B, V33, P623, DOI 10.1177/0146167206297404; Daily RC, 1980, DECISION SCI, V11, P357, DOI DOI 10.1111/J.1540-5915.1980.TB01144.X; De Cremer D, 1999, CURR PSYCHOL, V18, P153, DOI 10.1007/s12144-999-1024-0; Durkheim E, 1965, ELEMENTARY FORMS REL; Frank SA, 2003, EVOLUTION, V57, P693; Gachter S, 2004, J ECON BEHAV ORGAN, V55, P505, DOI 10.1016/j.jebo.2003.11.006; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Hammerstein P, 2003, GENETIC CULTURAL EVO, P155; Hardin Russell, 2002, RUSSELL SAGE FDN SER; Kerr N. L., 1996, EUR REV SOC PSYCHOL, V7, P209, DOI [10.1080/14792779643000029, DOI 10.1080/14792779643000029]; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Komorita S. S., 1994, SOCIAL DILEMMAS; Kozlowski SWJ, 2006, PSYCHOL SCI, P77, DOI 10.1111/j.1529-1006.2006.00030.x; Kunreuther H, 2010, 201002 U PENNS RISK; Lawler E, 1986, ADV GROUP PROCESSES, V3, P51; Ledyard J.O., 1994, HDB EXPT EC; Ostrom, 2015, GOVERNING COMMONS EV, DOI DOI 10.1017/CBO9780511807763; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Ostrom E., 1991, LAB RES POLITICAL EC, P287; Pincus D, 2009, CHAOS COMPLEXITY PSY, P402; PRUITT DG, 1977, ANNU REV PSYCHOL, V28, P363, DOI 10.1146/annurev.ps.28.020177.002051; Sperber DA, 2013, MUTUALISTIC IN PRESS; Taylor Michael, 1976, ANARCHY COOPERATION; Weber M., 1947, THEORY SOCIAL EC ORG; Weber M, 1951, RELIG CHINA; WEST SA, EVOL HUM BEHAV, DOI DOI 10.1016/J.EVOLHUMBEHAV.2010.08.001; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	33	14	14	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64776	10.1371/journal.pone.0064776	http://dx.doi.org/10.1371/journal.pone.0064776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23705011	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200165
J	Romano, E; Michetti, C; Caruso, A; Laviola, G; Scattoni, ML				Romano, Emilia; Michetti, Caterina; Caruso, Angela; Laviola, Giovanni; Scattoni, Maria Luisa			Characterization of Neonatal Vocal and Motor Repertoire of Reelin Mutant Mice	PLOS ONE			English	Article							MOUSE MODEL; NEUROBEHAVIORAL DEVELOPMENT; ULTRASONIC VOCALIZATIONS; BEHAVIORAL-PHENOTYPE; VULNERABILITY FACTOR; COGNITIVE FUNCTION; AUTISTIC DISORDER; CEREBRAL-CORTEX; ANIMAL-MODELS; RETT-SYNDROME	Reelin is a large secreted extracellular matrix glycoprotein playing an important role in early neurodevelopment. Several genetic studies found an association between RELN gene and increased risk of autism suggesting that reelin deficiency may be a vulnerability factor in its etiology. Moreover, a reduced reelin expression has been observed in several brain regions of subjects with Autism Spectrum Disorders. Since a number of reports have documented presence of vocal and neuromotor abnormalities in patients with autism and suggested that these dysfunctions predate the onset of the syndrome, we performed a fine-grain characterization of the neonatal vocal and motor repertoire in reelin mutant mice to explore the developmental precursors of the disorder. Our findings evidence a general delay in motor and vocal development in heterozygous (50% reduced reelin) and reeler (lacking reelin gene) mutant mice. As a whole, an increased number of calls characterized heterozygous pup's emission. Furthermore, the typical ontogenetic peak in the number of calls characterizing wild-type pups on postnatal day 4 appeared slightly delayed in heterozygous pups (to day 6) and was quite absent in reeler littermates, which exhibited a flat profile during development. We also detected a preferential use of a specific call category (two-components) by heterozygous and reeler mice at postnatal days 6 and 8 as compared to their wild-type littermates. With regard to the analysis of spontaneous movements, a differential profile emerged early in development among the three genotypes. While only slight coordination difficulties are exhibited by heterozygous pups, all indices of motor development appear delayed in reeler mice. Overall, our results evidence a genotype-dependent deviation in ultrasonic vocal repertoire and a general delay in motor development in reelin mutant pups.	[Romano, Emilia; Laviola, Giovanni] Ist Super Sanita, Behav Neurosci Sect, Dept Cell Biol & Neurosci, Rome, Italy; [Michetti, Caterina; Caruso, Angela; Scattoni, Maria Luisa] Ist Super Sanita, Neurotoxicol & Neuroendocrinol Sect, Dept Cell Biol & Neurosci, Rome, Italy; [Romano, Emilia] Ist Ricovero & Cura Carattere Sci, Bambino Gesu Childrens Hosp, Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu	Scattoni, ML (corresponding author), Ist Super Sanita, Neurotoxicol & Neuroendocrinol Sect, Dept Cell Biol & Neurosci, Rome, Italy.	marialuisa.scattoni@iss.it	Laviola, Giovanni/AAA-2391-2022; Laviola, Giovanni/K-4392-2016; Caruso, Angela/K-4262-2018; Michetti, Caterina/K-4441-2018; Scattoni, Maria Luisa/K-4116-2016	Laviola, Giovanni/0000-0003-0388-0835; Laviola, Giovanni/0000-0003-0388-0835; Caruso, Angela/0000-0002-6364-3922; Michetti, Caterina/0000-0003-4402-6985; Scattoni, Maria Luisa/0000-0002-6659-0280	Italian Ministry of Health Grant, Young Researcher, GR3-"Non-invasive tools for early detection of Autism Spectrum Disorders'; ERAnet "PrioMedChild'', Italian Ministry of Health; IRE-IFO [RF2008]	Italian Ministry of Health Grant, Young Researcher, GR3-"Non-invasive tools for early detection of Autism Spectrum Disorders'; ERAnet "PrioMedChild'', Italian Ministry of Health; IRE-IFO	This work has been supported by the Italian Ministry of Health Grant, Young Researcher 2008, GR3-"Non-invasive tools for early detection of Autism Spectrum Disorders'' (MLS, CM and AC); by the ERAnet "PrioMedChild'', Italian Ministry of Health (ER) and IRE-IFO (RF2008) "MECP2 phosphorilation and related kinase in Rett syndrom'' (GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley-Koch AE, 2007, PSYCHIAT GENET, V17, P221, DOI 10.1097/YPG.0b013e32809c2f75; Bhat AN, 2012, INFANT BEHAV DEV, V35, P838, DOI 10.1016/j.infbeh.2012.07.019; Biamonte F, 2009, NEUROBIOL DIS, V36, P103, DOI 10.1016/j.nbd.2009.07.001; Branchi I, 2003, NEUROSCI BIOBEHAV R, V27, P141, DOI 10.1016/S0149-7634(03)00016-2; Branchi I, 2002, GENES BRAIN BEHAV, V1, P135, DOI 10.1034/j.1601-183X.2002.10301.x; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Brigman JL, 2006, BEHAV NEUROSCI, V120, P984, DOI 10.1037/0735-7044.120.4.984; Bryson SE, 2007, J AUTISM DEV DISORD, V37, P12, DOI 10.1007/s10803-006-0328-2; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; CIRULLI F, 1994, DEV PSYCHOBIOL, V27, P301, DOI 10.1002/dev.420270505; COHENSALMON C, 1985, PHYSIOL BEHAV, V35, P167, DOI 10.1016/0031-9384(85)90331-2; Costa E, 2002, Mol Interv, V2, P47, DOI 10.1124/mi.2.1.47; Costa E, 2001, NEUROBIOL DIS, V8, P723, DOI 10.1006/nbdi.2001.0436; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; De Filippis B, 2010, GENES BRAIN BEHAV, V9, P213, DOI 10.1111/j.1601-183X.2009.00551.x; Dutta S, 2011, CELL MOL NEUROBIOL, V31, P45, DOI 10.1007/s10571-010-9551-7; Esposito G, 2011, BRAIN DEV-JPN, V33, P367, DOI 10.1016/j.braindev.2010.07.006; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P139, DOI 10.1023/A:1019857620251; Fatemi SH, 2001, J AUTISM DEV DISORD, V31, P529, DOI 10.1023/A:1013234708757; Fatemi SH, 2001, MOL PSYCHIATR, V6, P129, DOI 10.1038/sj.mp.4000129; Flanagan J, 2007, AM J OCCUPATIONAL TH; Folsom TD, 2012, NEUROPHARMACOLOGY; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Geissler DB, 2002, P NATL ACAD SCI USA, V99, P9021, DOI 10.1073/pnas.122606499; GOFFINET AM, 1979, ANAT EMBRYOL, V157, P205, DOI 10.1007/BF00305160; GOFFINET AM, 1984, DEV BRAIN RES, V16, P263, DOI 10.1016/0165-3806(84)90031-2; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; HadjSahraoui N, 1996, J NEUROGENET, V11, P45, DOI 10.3109/01677069609107062; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Jiang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012278; Johnson CP, 2008, PEDIATR REV, V29, P86, DOI 10.1542/pir.29-3-86; KANNER L, 1971, J AUTISM CHILD SCHIZ, V1, P119, DOI 10.1007/BF01537953; Kelemenova S, 2010, PSYCHIAT GENET, V20, P137, DOI 10.1097/YPG.0b013e32833a1eb3; Keller F, 2003, MOL NEUROBIOL, V28, P1, DOI 10.1385/MN:28:1:1; Knuesel I, 2010, PROG NEUROBIOL, V91, P257, DOI 10.1016/j.pneurobio.2010.04.002; Krueger DD, 2006, PSYCHOPHARMACOLOGY, V189, P95, DOI 10.1007/s00213-006-0530-0; Lahvis GP, 2011, GENES BRAIN BEHAV, V10, P4, DOI 10.1111/j.1601-183X.2010.00603.x; Laviola G, 2006, PSYCHOPHARMACOLOGY, V187, P331, DOI 10.1007/s00213-006-0426-z; Laviola G, 2009, NEUROSCI BIOBEHAV R, V33, P560, DOI 10.1016/j.neubiorev.2008.09.006; Macri S, 2010, PSYCHONEUROENDOCRINO, V35, P1374, DOI 10.1016/j.psyneuen.2010.03.012; Maestro S, 2006, ACTA PSYCHIAT SCAND, V113, P68, DOI 10.1111/j.1600-0447.2005.00695.x; MARIANI J, 1977, PHILOS T R SOC B, V281, P1, DOI 10.1098/rstb.1977.0121; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; Ognibene E, 2007, BRAIN RES, V1131, P173, DOI 10.1016/j.brainres.2006.11.007; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; Phagava H, 2008, Georgian Med News, P100; Picker JD, 2006, NEUROREPORT, V17, P541, DOI 10.1097/01.wnr.0000208995.38695.2f; Podhorna J, 2004, BEHAV BRAIN RES, V153, P43, DOI 10.1016/j.bbr.2003.10.033; Qui SF, 2006, NEUROBIOL LEARN MEM, V85, P228, DOI 10.1016/j.nlm.2005.11.001; Ricceri L, 2007, BEHAV BRAIN RES, V183, P111, DOI 10.1016/j.bbr.2007.05.035; Romano E, 2013, NEUROTOX RES; Santos M, 2007, GENES BRAIN BEHAV, V6, P277, DOI 10.1111/j.1601-183X.2006.00258.x; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Shair HN, 2003, DEV PSYCHOBIOL, V42, P206, DOI 10.1002/dev.10087; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Silani G, 2008, SOC NEUROSCI-UK, V3, P97, DOI 10.1080/17470910701577020; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Skaar DA, 2005, MOL PSYCHIATR, V10, P563, DOI 10.1038/sj.mp.4001614; Smith A, 2009, PSYCHOL REC, V59, P489, DOI 10.1007/BF03395675; SMOTHERMAN WP, 1974, BEHAV BIOL, V12, P55, DOI 10.1016/S0091-6773(74)91026-8; SPEAR LP, 1986, PSYCHOPHARMACOLOGY, V90, P106; Teitelbaum O, 2004, P NATL ACAD SCI USA, V101, P11909, DOI 10.1073/pnas.0403919101; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tordjman S, 2007, BEHAV GENET, V37, P61, DOI 10.1007/s10519-006-9120-5; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Tueting P, 1999, NEUROREPORT, V10, P1329, DOI 10.1097/00001756-199904260-00032; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Winslow JT, 2000, HORM BEHAV, V37, P145, DOI 10.1006/hbeh.1999.1566; Wohr M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020631; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Zhang H, 2002, MOL PSYCHIATR, V7, P1012, DOI 10.1038/sj.mp.4001124; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	81	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64407	10.1371/journal.pone.0064407	http://dx.doi.org/10.1371/journal.pone.0064407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700474	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200132
J	Serkebaeva, YM; Kim, Y; Liesack, W; Dedysh, SN				Serkebaeva, Yulia M.; Kim, Yongkyu; Liesack, Werner; Dedysh, Svetlana N.			Pyrosequencing-Based Assessment of the Bacteria Diversity in Surface and Subsurface Peat Layers of a Northern Wetland, with Focus on Poorly Studied Phyla and Candidate Divisions	PLOS ONE			English	Article							PALUDICOLA GEN. NOV.; ACIDIC SPHAGNUM PEAT; COMMUNITY STRUCTURE; PEATLANDS; RNA; METHANOGENESIS; ACIDOBACTERIA; SEARCH; BOG	Northern peatlands play a key role in the global carbon and water budget, but the bacterial diversity in these ecosystems remains poorly described. Here, we compared the bacterial community composition in the surface (0-5 cm depth) and subsurface (45-50 cm) peat layers of an acidic (pH 4.0) Sphagnum-dominated wetland, using pyrosequencing of 16 S rRNA genes. The denoised sequences (37,229 reads, average length similar to 430 bp) were affiliated with 27 bacterial phyla and corresponded to 1,269 operational taxonomic units (OTUs) determined at 97% sequence identity. Abundant OTUs were affiliated with the Acidobacteria (35.5 +/- 2.4% and 39.2 +/- 1.2% of all classified sequences in surface and subsurface peat, respectively), Alphaproteobacteria (15.9 +/- 1.7% and 25.8 +/- 1.4%), Actinobacteria (9.5 +/- 2.0% and 10.7 +/- 0.5%), Verrucomicrobia (8.5 +/- 1.4% and 0.6 +/- 0.2%), Planctomycetes (5.8 +/- 0.4% and 9.7 +/- 0.6%), Deltaproteobacteria (7.1 +/- 0.4% and 4.4%+/- 0.3%), and Gammaproteobacteria (6.6 +/- 0.4% and 2.1 +/- 0.1%). The taxonomic patterns of the abundant OTUs were uniform across all the subsamples taken from each peat layer. In contrast, the taxonomic patterns of rare OTUs were different from those of the abundant OTUs and varied greatly among subsamples, in both surface and subsurface peat. In addition to the bacterial taxa listed above, rare OTUs represented the following groups: Armatimonadetes, Bacteroidetes, Chlamydia, Chloroflexi, Cyanobacteria, Elusimicrobia, Fibrobacteres, Firmicutes, Gemmatimonadetes, Spirochaetes, AD3, WS1, WS4, WS5, WYO, OD1, OP3, BRC1, TM6, TM7, WPS-2, and FCPU426. OTU richness was notably higher in the surface layer (882 OTUs) than in the anoxic subsurface peat (483 OTUs), with only 96 OTUs common to both data sets. Most members of poorly studied phyla, such as the Acidobacteria, Verrucomicrobia, Planctomycetes and the candidate division TM6, showed a clear preference for growth in either oxic or anoxic conditions. Apparently, the bacterial communities in surface and subsurface layers of northern peatlands are highly diverse and taxonomically distinct, reflecting the different abiotic conditions in microhabitats within the peat profile.	[Serkebaeva, Yulia M.; Kim, Yongkyu; Liesack, Werner] Russian Acad Sci, Winogradsky Inst Microbiol, Moscow, Russia; [Serkebaeva, Yulia M.; Dedysh, Svetlana N.] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Research Center of Biotechnology RAS; Russian Academy of Sciences; Max Planck Society	Liesack, W (corresponding author), Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.	liesack@mpi-marburg.mpg.de	Dedysh, Svetlana/S-1655-2016; Serkebaeva, Yulia M./H-3425-2012	Dedysh, Svetlana/0000-0001-8903-8053; Kim, Yongkyu/0000-0002-6781-7168; Liesack, Werner/0000-0002-9533-1552	Program "Molecular and Cell Biology'' of Russian Academy of Sciences; Deutsche Forschungsgemeinschaft [LI 455/5-1]; DAAD [A/11/86114]; Max Planck Society	Program "Molecular and Cell Biology'' of Russian Academy of Sciences; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This research was supported in parts by the Program "Molecular and Cell Biology'' of Russian Academy of Sciences and by the Deutsche Forschungsgemeinschaft (LI 455/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; YMS was supported by a DAAD fellowship for doctoral students (reference no. A/11/86114). YK was supported by a postdoctoral fellowship of the Max Planck Society.	Allen MA, 2009, GEOBIOLOGY, V7, P82, DOI 10.1111/j.1472-4669.2008.00187.x; Ausec L, 2009, SOIL BIOL BIOCHEM, V41, P1874, DOI 10.1016/j.soilbio.2009.06.010; Bragina Anastasia, 2011, Front Microbiol, V2, P275, DOI 10.3389/fmicb.2011.00275; Bragina A, 2012, ISME J, V6, P802, DOI 10.1038/ismej.2011.151; Cadillo-Quiroz H, 2006, ENVIRON MICROBIOL, V8, P1428, DOI 10.1111/j.1462-2920.2006.01036.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen Y, 2008, ENVIRON MICROBIOL, V10, P446, DOI 10.1111/j.1462-2920.2007.01466.x; Chin KJ, 2001, INT J SYST EVOL MICR, V51, P1965, DOI 10.1099/00207713-51-6-1965; Dedysh SN, 2009, MICROBIOLOGY+, V78, P655, DOI 10.1134/S0026261709060010; Dedysh SN, 2006, APPL ENVIRON MICROB, V72, P2110, DOI 10.1128/AEM.72.3.2110-2117.2006; Dedysh SN, 2001, APPL ENVIRON MICROB, V67, P4850, DOI 10.1128/AEM.67.10.4850-4857.2001; Dedysh SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00184; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Henne K, 2012, APPL ENVIRON MICROB, V78, P3530, DOI 10.1128/AEM.06373-11; Hu BL, 2011, APPL ENVIRON MICROB, V77, P966, DOI 10.1128/AEM.02402-10; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Ivanova AO, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00005; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P1382, DOI 10.1128/AEM.63.4.1382-1388.1997; Juottonen H, 2005, ENVIRON MICROBIOL, V7, P1547, DOI 10.1111/j.1462-2920.2005.00838.x; Kip N, 2010, NAT GEOSCI, V3, P617, DOI 10.1038/NGEO939; Kivinen E., 1981, ANN ACAD SCI FENNICA, P1; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Kulichevskaya IS, 2007, INT J SYST EVOL MICR, V57, P2680, DOI 10.1099/ijs.0.65157-0; Kulichevskaya IS, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00146; Kulichevskaya IS, 2010, INT J SYST EVOL MICR, V60, P301, DOI 10.1099/ijs.0.013250-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lin X, 2012, APPL ENVIRON MICROB, V78, P7023, DOI 10.1128/AEM.01750-12; Logares R, 2013, ISME J, V7, P937, DOI 10.1038/ismej.2012.168; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mannisto MK, 2012, INT J SYST EVOL MICR, V62, P2097, DOI 10.1099/ijs.0.031864-0; Matthews E, 1987, GLOBAL BIOGEOCHEM CY, V1, P61, DOI 10.1029/GB001i001p00061; Morales SE, 2006, MICROB ECOL, V52, P34, DOI 10.1007/s00248-005-0264-2; Op den Camp HJM, 2009, ENV MICROBIOL REP, V1, P293, DOI 10.1111/j.1758-2229.2009.00022.x; Panikov NS, 1999, POLAR RES, V18, P237, DOI 10.1111/j.1751-8369.1999.tb00299.x; Pankratov TA, 2012, INT J SYST EVOL MICR, V62, P430, DOI 10.1099/ijs.0.029629-0; Pankratov TA, 2011, ENVIRON MICROBIOL, V13, P1800, DOI 10.1111/j.1462-2920.2011.02491.x; Pankratov TA, 2010, INT J SYST EVOL MICR, V60, P2951, DOI 10.1099/ijs.0.021824-0; Pester M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00072; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rheims H, 1996, J IND MICROBIOL, V17, P159, DOI 10.1007/BF01574689; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sizova MV, 2003, FEMS MICROBIOL ECOL, V45, P301, DOI 10.1016/S0168-6496(03)00165-X; Smith LC, 2004, SCIENCE, V303, P353, DOI 10.1126/science.1090553; Sun CL, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00081; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Utsumi M, 2003, J GEN APPL MICROBIOL, V49, P75, DOI 10.2323/jgam.49.75; Vecherskaya M, 2009, ENV MICROBIOL REP, V1, P442, DOI 10.1111/j.1758-2229.2009.00069.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; Winderl C, 2008, APPL ENVIRON MICROB, V74, P792, DOI 10.1128/AEM.01951-07; Zadorina EV, 2009, MICROBIOLOGY+, V78, P218, DOI 10.1134/S0026261709020131	55	115	123	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63994	10.1371/journal.pone.0063994	http://dx.doi.org/10.1371/journal.pone.0063994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700443	gold, Green Submitted, Green Published			2022-12-27	WOS:000319330200100
J	Yang, CS; Yuk, JM; Kim, JJ; Hwang, JH; Lee, CH; Kim, JM; Oh, GT; Choi, HS; Jo, EK				Yang, Chul-Su; Yuk, Jae-Min; Kim, Jwa-Jin; Hwang, Jung Hwan; Lee, Chul-Ho; Kim, Jin-Man; Oh, Goo Taeg; Choi, Hueng-Sik; Jo, Eun-Kyeong			Small Heterodimer Partner-Targeting Therapy Inhibits Systemic Inflammatory Responses through Mitochondrial Uncoupling Protein 2	PLOS ONE			English	Article							NUCLEAR RECEPTOR SHP; GENE-EXPRESSION; NITRIC-OXIDE; FENOFIBRATE; KINASE; ALPHA; AMPK; METABOLISM; ACTIVATION; MECHANISMS	The orphan nuclear receptor, small heterodimer partner (SHP), appears to play a negative regulatory role in innate immune signaling. Emerging evidence warrants further study on the therapeutic targeting of SHP to suppress excessive and deleterious inflammation. Here we show that fenofibrate, which targets SHP, is required for inhibiting systemic inflammation via mitochondrial uncoupling protein 2 (UCP2). In vivo administration of fenofibrate ameliorated systemic inflammatory responses and increased survival upon experimental sepsis through SHP. An abundance of SHP was observed in mice fed fenofibrate and in cultured macrophages through LKB1-dependent activation of the AMP-activated protein kinase pathway. Fenofibrate significantly blocked endotoxin-triggered inflammatory signaling responses via SHP, but not via peroxisome proliferator-activated receptor (PPAR)-alpha. In addition to the known mechanism by which SHP modulates innate signaling, we identify a new role of fenofibrate-induced SHP on UCP2 induction, which is required for the suppression of inflammatory responses through modulation of mitochondrial ROS production. These data strongly suggest that the SHP-inducing drug fenofibrate paves the way for novel therapies for systemic inflammation by targeting SHP.	[Yang, Chul-Su; Yuk, Jae-Min; Kim, Jwa-Jin; Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Dept Microbiol, Taejon, South Korea; [Kim, Jin-Man] Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon, South Korea; [Yang, Chul-Su; Yuk, Jae-Min; Kim, Jwa-Jin; Kim, Jin-Man; Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Infect Signaling Network Res Ctr, Taejon, South Korea; [Hwang, Jung Hwan; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Lab Anim Ctr, Taejon, South Korea; [Oh, Goo Taeg] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju, South Korea	Chungnam National University; Chungnam National University; Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ewha Womans University; Chonnam National University	Jo, EK (corresponding author), Chungnam Natl Univ, Sch Med, Dept Microbiol, Taejon, South Korea.	hayoungj@cnu.ac.kr	Oh, Goo Taeg/AAQ-9995-2021; Yang, Chul-Su/J-3833-2013	KIM, JIN MAN/0000-0003-0905-9730; Eun-Kyeong, Jo/0000-0001-7191-0587; Yuk, Jae-Min/0000-0002-0630-9194	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A100588]; National Research Foundation of Korea (NRF) grant; Korea government (MEST) [2007-0054932]; National Creative Research Initiatives Grant from the Korean Ministry of Education, Science and Technology; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); National Creative Research Initiatives Grant from the Korean Ministry of Education, Science and Technology; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A100588), by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2007-0054932), by National Creative Research Initiatives Grant from the Korean Ministry of Education, Science and Technology, and by the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Burris TP, 2012, CHEM BIOL, V19, P51, DOI 10.1016/j.chembiol.2011.12.011; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Chanda D, 2008, AM J PHYSIOL-ENDOC M, V295, pE368, DOI 10.1152/ajpendo.00800.2007; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Chanda D, 2009, HEPATOLOGY, V50, P880, DOI 10.1002/hep.23049; Chen WL, 2012, BIOCHEM PHARMACOL, V84, P522, DOI 10.1016/j.bcp.2012.05.022; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Emre Y, 2007, P NATL ACAD SCI USA, V104, P19085, DOI 10.1073/pnas.0709557104; Fic E, 2010, ELECTROPHORESIS, V31, P3573, DOI 10.1002/elps.201000197; Garruti G, 2012, J LIPIDS, V2012, DOI 10.1155/2012/304292; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Goto M, 2010, MOD RHEUMATOL, V20, P238, DOI 10.1007/s10165-009-0261-2; Gouni-Berthold I., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P513, DOI 10.2174/156800605774962022; Hiukka A, 2010, NAT REV ENDOCRINOL, V6, P454, DOI 10.1038/nrendo.2010.89; Kato Y, 2010, HORM METAB RES, V42, P632, DOI 10.1055/s-0030-1255033; Keating GM, 2007, DRUGS, V67, P121, DOI 10.2165/00003495-200767010-00013; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kladna A, 2006, BIOPOLYMERS, V82, P99, DOI 10.1002/bip.20402; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lalloyer F, 2011, ARTERIOSCL THROM VAS, V31, P1573, DOI 10.1161/ATVBAHA.110.220525; Lee YS, 2007, INT REV CYTOL, V261, P117, DOI 10.1016/S0074-7696(07)61003-1; Leloup C, 2011, ANTIOXID REDOX SIGN, V14, P519, DOI 10.1089/ars.2010.3424; Li YTY, 2007, ARTERIOSCL THROM VAS, V27, P2606, DOI 10.1161/ATVBAHA.107.152694; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mansouri RM, 2008, ENDOCRINOLOGY, V149, P3215, DOI 10.1210/en.2007-1339; Marshall JC, 2001, CRIT CARE MED, V29, pS99, DOI 10.1097/00003246-200107001-00032; McKeage K, 2011, DRUGS, V71, P1917, DOI 10.2165/11208090-000000000-00000; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nath N, 2005, J IMMUNOL, V175, P566, DOI 10.4049/jimmunol.175.1.566; Pardee K, 2011, SUBCELL BIOCHEM, V52, P123, DOI 10.1007/978-90-481-9069-0_6; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Patel NSA, 2009, J PHARMACOL EXP THER, V328, P635, DOI 10.1124/jpet.108.146191; Roff M, 1996, J BIOL CHEM, V271, P7844, DOI 10.1074/jbc.271.13.7844; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sehgal N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035427; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Tomizawa A, 2011, METABOLISM, V60, P513, DOI 10.1016/j.metabol.2010.04.020; Tsoyi K, 2011, BRIT J PHARMACOL, V162, P1498, DOI 10.1111/j.1476-5381.2010.01126.x; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wong TY, 2012, AM J OPHTHALMOL, V154, P6, DOI 10.1016/j.ajo.2012.03.013; Yang CS, 2007, J EXP MED, V204, P583, DOI 10.1084/jem.20061849; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	58	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63435	10.1371/journal.pone.0063435	http://dx.doi.org/10.1371/journal.pone.0063435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704907	gold, Green Submitted, Green Published			2022-12-27	WOS:000319330200037
J	Grottke, O; Rossaint, R; Henskens, Y; van Oerle, R; ten Cate, H; Spronk, HH				Grottke, Oliver; Rossaint, Rolf; Henskens, Yvonne; van Oerle, Rene; ten Cate, Hugo; Spronk, HenriM. H.			Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model	PLOS ONE			English	Article							FRESH-FROZEN PLASMA; PIG MODEL; COAGULOPATHY; TRANSFUSION; COAGULATION; INJURY	Background: The use of PCC for the treatment of trauma-induced coagulopathy potentially increase the risk of thromboembolism and disseminated intravascular coagulation, which is addressed to an imbalance of both pro-and anticoagulants. As PCCs differ in composition, we used an in vitro dilutional approach to assess the overall thrombin generation of five different PCCs through various laboratory assays. Methods: The vitamin K-dependent coagulation factors, heparin, and antithrombin were assessed in five commercially available PCCs. The procoagulant potential of the PCCs was assessed in plasma and whole blood from 4 healthy donors by means of classical coagulation assays, thrombin generation assay and thromboelastometry. In order to reflect coagulopathy, whole blood was diluted to 80, 60, 40, and 20% with Ringer's lactate solution. Results: The five different PCCs were characterised by comparable levels of factors II, VII, IX and X (all around 20-30 IU/mL), whereas the heparin (0 to 17.6 IU/mL) and antithrombin (0.06 to 1.29 IU/mL) levels were remarkably different between manufactures. In vitro dilution of blood induced a prolongation of the PT and aPTT, and attenuation of thrombin generation and ExTem induced thromboelastometry. Overall, non-or low-heparin containing PCCs restored the in vitro dilutional coagulopathy, whereas PCCs containing heparin have an anticoagulant effect. The thrombin generation assay showed to be the most sensitive method for assessment of PCC effects. Conclusions: This study shows that most available PCCs are not balanced regarding their pro-and anticoagulants. The effect of measured differences in thrombin generation among different PCCs requires further investigations to elaborate the clinical meaning of this finding in the treatment of trauma induced coagulopathy.	[Grottke, Oliver; Rossaint, Rolf] RWTH Aachen Univ Hosp, Dept Anesthesiol, Aachen, Germany; [Henskens, Yvonne] Maastricht Univ Med Ctr, Cent Diagnost Lab, Maastricht, Netherlands; [van Oerle, Rene; ten Cate, Hugo; Spronk, HenriM. H.] Maastricht Univ Med Ctr, Lab Clin Thrombosis & Haemostasis, Cardiovasc Res Inst Maastricht, Dept Internal Med, Maastricht, Netherlands	RWTH Aachen University; RWTH Aachen University Hospital; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Spronk, HH (corresponding author), Maastricht Univ Med Ctr, Lab Clin Thrombosis & Haemostasis, Cardiovasc Res Inst Maastricht, Dept Internal Med, Maastricht, Netherlands.	henri.spronk@maastrichtuniversity.nl	Grottke, Oliver/F-1508-2018; Cate, Hugo ten/AAM-4000-2021; Henskens, Yvonne/AAD-8596-2020	ten Cate, Hugo/0000-0001-7796-4463; Spronk, Henri/0000-0002-3858-334X; Grottke, Oliver/0000-0002-0722-3122	Maastricht University Medical Center; RWTH Aachen; Novo Nordisk; Biotest; CSL Behring; Nycomed; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Leo Pharma	Maastricht University Medical Center; RWTH Aachen; Novo Nordisk(Novo Nordisk); Biotest; CSL Behring; Nycomed; Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Leo Pharma(LEO Pharma)	This study was financed by the Maastricht University Medical Center and the RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Oliver Grottke has received research funding from Novo Nordisk, Biotest, CSL Behring, Nycomed and honoraria for consultancy from Bayer Healthcare and Boehringer Ingelheim. Rolf Rossaint has received honoraria for lectures and consultancy from CSL Behring and Novo Nordisk. Hugo ten Cate has received speaker fees from Bayer, Boehringer Ingelheim, GlaxoSmithKline and Leo Pharma. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baglin TP, 2007, BRIT J HAEMATOL, V136, P26, DOI 10.1111/j.1365-2141.2006.06379.x; Bruce D, 2008, CRIT CARE, V12, DOI 10.1186/cc6987; Dickneite G, 2009, BRIT J ANAESTH, V102, P345, DOI 10.1093/bja/aen391; Dickneite G, 2008, ANESTH ANALG, V106, P1070, DOI 10.1213/ane.0b013e318165dfbb; Dickneite G, 2010, J TRAUMA, V68, P1151, DOI 10.1097/TA.0b013e3181b06364; Dusel CH, 2004, BLOOD COAGUL FIBRIN, V15, P405, DOI 10.1097/01.mbc.0000114437.81125.2b; Fries D, 2006, BRIT J ANAESTH, V97, P460, DOI 10.1093/bja/ael191; Grottke O, 2011, BLOOD, V118, P1943, DOI 10.1182/blood-2011-03-343046; Honickel M, 2011, THROMB HAEMOSTASIS, V106, P724, DOI 10.1160/TH11-02-0101; Kalina U, 2008, INT J CLIN PRACT, V62, P1614, DOI 10.1111/j.1742-1241.2008.01859.x; Levi M, 2011, VOX SANG, V101, P154, DOI 10.1111/j.1423-0410.2011.01472.x; Levy JH, 2008, ANESTHESIOLOGY, V109, P918, DOI 10.1097/ALN.0b013e3181895bd8; Romisch J, 1998, SEMIN THROMB HEMOST, V24, P175, DOI 10.1055/s-2007-995838; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Sarani B, 2008, CRIT CARE MED, V36, P1114, DOI 10.1097/CCM.0b013e318168f89d; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Scharbert G, 2012, WIEN KLIN WOCHENSCHR, V124, P320, DOI 10.1007/s00508-012-0171-8; Schick KS, 2009, CRIT CARE, V13, DOI 10.1186/cc8186; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Shaz BH, 2011, BLOOD, V117, P1463, DOI 10.1182/blood-2010-04-278135; Sorensen B, 2011, CRIT CARE, V15, DOI 10.1186/cc9311; Takeyama M, 2007, BLOOD COAGUL FIBRIN, V18, P1, DOI 10.1097/01.mbc.0000256021.16453.de	22	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64100	10.1371/journal.pone.0064100	http://dx.doi.org/10.1371/journal.pone.0064100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696866	Green Published, gold, Green Submitted			2022-12-27	WOS:000319107900079
J	Wang, SY; Chopp, M; Nazem-Zadeh, MR; Ding, GL; Nejad-Davarani, SP; Qu, CS; Lu, M; Li, L; Davoodi-Bojd, E; Hu, JN; Li, QJ; Mahmood, A; Jiang, Q				Wang, Shiyang; Chopp, Michael; Nazem-Zadeh, Mohammad-Reza; Ding, Guangliang; Nejad-Davarani, Siamak P.; Qu, Changsheng; Lu, Mei; Li, Lian; Davoodi-Bojd, Esmaeil; Hu, Jiani; Li, Qingjiang; Mahmood, Asim; Jiang, Quan			Comparison of Neurite Density Measured by MRI and Histology after TBI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; NONRIGID REGISTRATION; WATER DIFFUSION; AXON DIAMETER; TRANSPLANTATION; STROKE; MODEL; RATS; QUANTIFICATION	Background: Functional recovery after brain injury in animals is improved by marrow stromal cells (MSC) which stimulate neurite reorganization. However, MRI measurement of neurite density changes after injury has not been performed. In this study, we investigate the feasibility of MRI measurement of neurite density in an animal model of traumatic brain injury (TBI) with and without MSC treatment. Methods: Fifteen male Wistar rats, were treated with saline (n = 6) or MSCs (n = 9) and were sacrificed at 6 weeks after controlled cortical impact (CCI). Healthy non-CCI rats (n = 5), were also employed. Ex-vivo MRI scans were performed two days after the rats were sacrificed. Multiple-shell hybrid diffusion imaging encoding scheme and spherical harmonic expansion of a two-compartment water diffusion displacement model were used to extract neurite related parameters. Bielshowski and Luxol Fast blue was used for staining axons and myelin, respectively. Modified Morris water maze and neurological severity score (mNSS) test were performed for functional evaluation. The treatment effects, the correlations between neurite densities measured by MRI and histology, and the correlations between MRI and functional variables were calculated by repeated measures analysis of variance, the regression correlation analysis tests, and spearman correlation coefficients. Results: Neurite densities exhibited a significant correlation (R-2>0.80, p<1E-20) between MRI and immuno-histochemistry measurements with 95% lower bound of the intra-correlation coefficient (ICC) as 0.86. The conventional fractional anisotropy (FA) correlated moderately with histological neurite density (R-2 = 0.59, P<1E-5) with 95% lower bound of ICC as 0.76. MRI data revealed increased neurite reorganization with MSC treatment compared with saline treatment, confirmed by histological data from the same animals. mNSS were significantly correlated with MRI neurite density in the hippocampus region. Conclusions: The present studies demonstrated that neurite density can be estimated by MRI after TBI and MRI measurement of neurite density is a sensitive marker to MSC treatment response.	[Wang, Shiyang; Chopp, Michael; Nazem-Zadeh, Mohammad-Reza; Ding, Guangliang; Nejad-Davarani, Siamak P.; Li, Lian; Davoodi-Bojd, Esmaeil; Li, Qingjiang; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Qu, Changsheng; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Wang, Shiyang; Chopp, Michael; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA; [Nazem-Zadeh, Mohammad-Reza] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Hu, Jiani] Wayne State Univ, Harper Hosp, MR Ctr, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University; University of Michigan System; University of Michigan; Wayne State University	Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Nejad-Davarani, Siamak/AAH-8399-2021	Li, Lian/0000-0003-0097-1184; Nejad-Davarani, Siamak/0000-0002-2415-6689; Ding, Guangliang/0000-0003-1286-5901	National Institute of Neurological Disorders and Stroke [P01 NS23393, RO1 NS064134, RO1 NS48349, RO1 AG037506, HL64766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048349, R01NS064134, P01NS023393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research presented herein was supported by National Institute of Neurological Disorders and Stroke, grants P01 NS23393, RO1 NS064134, RO1 NS48349, RO1 AG037506 and HL64766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Denton ERE, 1999, J COMPUT ASSIST TOMO, V23, P800, DOI 10.1097/00004728-199909000-00031; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DZIABIS MD, 1958, STAIN TECHNOL, V33, P96; Grider MH, 2006, J NEUROSCI METH, V155, P172, DOI 10.1016/j.jneumeth.2005.12.021; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042845; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kybic J, 2008, METH APPL MAGEJ US D; Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; Pfeifer JD, 2008, WASHINGTON MANUAL SU; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Ueno Y, 2009, NEUROSCIENCE, V162, P317, DOI 10.1016/j.neuroscience.2009.04.065; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wu YC, 2008, IEEE T MED IMAGING, V27, P858, DOI 10.1109/TMI.2008.922696; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126	44	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63511	10.1371/journal.pone.0063511	http://dx.doi.org/10.1371/journal.pone.0063511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717439	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700029
J	Wang, Y; Sheng, SJ; Zhang, JZ; Dzinic, S; Li, SL; Fang, F; Wu, N; Zheng, QF; Yang, Y				Wang, Yang; Sheng, Shijie; Zhang, Jianzhi; Dzinic, Sijana; Li, Shaolei; Fang, Fang; Wu, Nan; Zheng, Qingfeng; Yang, Yue			Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)	PLOS ONE			English	Article							TUMOR-SUPPRESSIVE MASPIN; INVASIVE BREAST-CANCER; PLASMINOGEN-ACTIVATOR; GENETIC POLYMORPHISMS; CLINICAL-IMPLICATIONS; NUCLEAR-LOCALIZATION; VEGF-A; INHIBITION; METASTASIS; GROWTH	Tumor suppressor maspin is a differentially regulated gene in the progression of many types of cancer. While the biological function of maspin in blocking tumor invasion and metastasis is consistent with the loss of maspin expression at the late stage of tumor progression, the differential expression and the biological significance of maspin in early stage of tumor progression appear to be complex and remain to be elucidated. In the current study, we examined the expression of maspin in 84 esophageal squamous cell carcinoma (ESCC) cases (stages I-III) and 55 non-tumor adjacent esophageal tissue specimens by immunohistochemical (IHC) staining. The correlation of maspin with clinicopathological parameters was analyzed. Compared to normal esophageal squamous tissue where 80% (47/55) of the cases expressed maspin at a low to moderate level, all ESCC specimens (100% (84/84)) were positive for maspin expression at a moderate to high level. ESCC with low or moderate maspin expression had significantly shorter postoperative survival rates compared to those that had high maspin expression (p<0.001). Since the correlation of maspin with ESCC histology and the correlation of maspin with ESCC prognosis seem to be at odds, we further investigated the biological function of maspin in ESCC using the established ESCC cell lines. The expression of maspin in five human esophageal squamous cancer cell lines (T12, E450, KYSE150, EC109, and KYSE510) was examined by the Western blot. ESCC cell line KYSE510 that did not express maspin and was stably transfected by maspin cDNA or an empty vector. The resulting transfected cells were characterized in vitro. Maspin expression significantly inhibited cell proliferation, motility and matrigel invasion. Taken together, our data suggest that the transient up-regulation of maspin in the early development of ESCC may be a defense mechanism against further transition towards more malignant phenotypes, ultimately slowing down ESCC tumor progression.	[Wang, Yang; Zhang, Jianzhi; Li, Shaolei; Fang, Fang; Wu, Nan; Zheng, Qingfeng; Yang, Yue] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res Minist Educ, Beijing 100871, Peoples R China; [Sheng, Shijie; Dzinic, Sijana] Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst,Tumor & Microenvir, Detroit, MI 48201 USA	Peking University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Sheng, SJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst,Tumor & Microenvir, Detroit, MI 48201 USA.	ssheng@med.wayne.edu; zlyangyue@bjmu.edu.cn			NIH [CA15431, CA084176]; Ruth Sager Memorial Fund; NATIONAL CANCER INSTITUTE [R01CA084176] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Sager Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH grants (CA15431 and CA084176) and the Ruth Sager Memorial Fund (to S. Sheng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2005, CANCER BIOL THER, V4, P400; Ashida A, 2006, INT J ONCOL, V28, P1345; Bernardo M Margarida, 2011, Genes Cancer, V2, P1009, DOI 10.1177/1947601912440170; Bieche I, 2003, BRIT J CANCER, V88, P863, DOI 10.1038/sj.bjc.6600812; Biliran H, 2001, CANCER RES, V61, P8676; Bodenstine TM, 2012, CANCER METAST REV, V31, P529, DOI 10.1007/s10555-012-9361-0; Cao DF, 2007, MODERN PATHOL, V20, P570, DOI 10.1038/modpathol.3800772; Cher ML, 2003, P NATL ACAD SCI USA, V100, P7847, DOI 10.1073/pnas.1331360100; Denk AE, 2007, PIGM CELL RES, V20, P112, DOI 10.1111/j.1600-0749.2007.00363.x; Fitzgerald M, 2003, NEOPLASIA, V5, P427, DOI 10.1016/S1476-5586(03)80045-3; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Frey A, 2009, HISTOPATHOLOGY, V54, P590, DOI 10.1111/j.1365-2559.2009.03260.x; Goulet B, 2012, BIOCHEM CELL BIOL, V90, P109; Goulet B, 2011, LAB INVEST, V91, P1181, DOI 10.1038/labinvest.2011.66; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; Jang HL, 2008, INT J MOL MED, V22, P333, DOI 10.3892/ijmm_00000027; Joensuu KM, 2009, HUM PATHOL, V40, P1143, DOI 10.1016/j.humpath.2009.02.006; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Koshy M, 2004, ONCOLOGIST, V9, P147, DOI 10.1634/theoncologist.9-2-147; Lezzi G, 2007, J CRANIOFAC SURG, V18, P1039, DOI 10.1097/scs.0b013e31814b2a36; Li XH, 2006, CANCER RES, V66, P9323, DOI 10.1158/0008-5472.CAN-06-1578; Lin DC, 2009, DIS ESOPHAGUS, V22, P9, DOI 10.1111/j.1442-2050.2008.00845.x; Lockett J, 2006, J CELL BIOCHEM, V97, P651, DOI 10.1002/jcb.20721; MacDougall R, 2012, VOGELSTEIN CONSIDERS; McGowen R, 2000, CANCER RES, V60, P4771; Mohsin SK, 2003, J PATHOL, V199, P432, DOI 10.1002/path.1319; Nakagawara A, 2011, J BIOMED BIOTECHNOL; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pierson CR, 2002, PROSTATE, V53, P255, DOI 10.1002/pros.10107; Qin L, 2010, J BIOL CHEM, V285, P32360, DOI 10.1074/jbc.M110.131045; Sharma G, 2011, TUMOR BIOL, V32, P23, DOI 10.1007/s13277-010-0087-8; Sheng SJ, 1998, P NATL ACAD SCI USA, V95, P499, DOI 10.1073/pnas.95.2.499; Sood AK, 2002, CLIN CANCER RES, V8, P2924; Sopel M, 2010, FOLIA MORPHOL, V69, P1; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Umekita Y, 2002, INT J CANCER, V100, P452, DOI 10.1002/ijc.10500; Wedel S, 2011, PROSTATE, V71, P722, DOI 10.1002/pros.21288; Woenckhaus M, 2007, J CLIN PATHOL, V60, P483, DOI 10.1136/jcp.2005.033407; Xia WY, 2000, ONCOGENE, V19, P2398, DOI 10.1038/sj.onc.1203535; Xing DY, 2003, ONCOL REP, V10, P1615; Yie SM, 2007, AM J CLIN PATHOL, V128, P1002, DOI 10.1309/JNCW1QLDFB6AM9WE; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Yin SP, 2006, CANCER RES, V66, P4173, DOI 10.1158/0008-5472.CAN-05-3514; Yoshizawa K, 2009, J ORAL PATHOL MED, V38, P535, DOI 10.1111/j.1600-0714.2009.00762.x; Younes M, 2002, SCAND J GASTROENTERO, V37, P1359, DOI 10.1080/003655202762671215; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	48	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63581	10.1371/journal.pone.0063581	http://dx.doi.org/10.1371/journal.pone.0063581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717449	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700036
J	Argemi, X; Hansmann, Y; Christmann, D; Lefebvre, S; Jaulhac, B; Jehl, F				Argemi, Xavier; Hansmann, Yves; Christmann, Daniel; Lefebvre, Sophie; Jaulhac, Benoit; Jehl, Francois			In Vitro Activity of Daptomycin against Enterococcus faecalis under Various Conditions of Growth-Phases, Inoculum and pH	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INFECTIVE ENDOCARDITIS; PSEUDOMONAS-AERUGINOSA; PHARMACODYNAMIC MODEL; COMBINATION; VANCOMYCIN; RIFAMPIN; AMINOGLYCOSIDES; EFFICACY; THERAPY	Enterococcus faecalis (E. faecalis) has become a major leading cause of nosocomial endocarditis. Treatment of such infections remains problematic and new therapeutic options are needed. Nine E. faecalis strains were tested: six obtained from patients presenting endocarditis, one with isolated bacteremia, and two reference strains. Antibiotics included daptomycin, alone or in combination, linezolid, tigecycline, rifampicin, gentamicin, teicoplanin, ceftriaxone and amoxicillin. Time-kill studies included colony counts at 1, 4 and 24 h of incubation. Significant bactericidal activity was defined as a decrease of >= 3log(10)CFU/ml after 24 h of incubation. Antibiotics were tested at a low (10(6) CFU/ml) and high (10(9) CFU/ml) inoculum, against exponential- and stationary-phase bacteria. We also performed time kill studies of chemically growth arrested E. faecalis. Various pH conditions were used during the tests. In exponential growth phase and with a low inoculum, daptomycin alone at 60 mu g/ml and the combination amoxicillin-gentamicin both achieved a 4-log(10) reduction in one hour on all strains. In exponential growth phase with a high inoculum, daptomycin alone was bactericidal at a concentration of 120 mu g/ml. All the combinations tested with this drug were indifferent. In stationary phase with a high inoculum daptomycin remained bactericidal but exhibited a pH dependent activity and slower kill rates. All combinations that did not include daptomycin were not bactericidal in conditions of high inoculum, whatever the growth phase. The results indicate that daptomycin is the only antibiotic that may be able of overcoming the effects of growth phase and high inoculum.	[Argemi, Xavier; Hansmann, Yves; Christmann, Daniel] Strasbourg Univ Hosp, Dept Infect Dis, Strasbourg, France; [Lefebvre, Sophie; Jaulhac, Benoit; Jehl, Francois] Univ Strasbourg, Inst Bacteriol, Fac Med, Strasbourg, France; [Lefebvre, Sophie; Jaulhac, Benoit; Jehl, Francois] Strasbourg Univ Hosp, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Argemi, X (corresponding author), Strasbourg Univ Hosp, Dept Infect Dis, Strasbourg, France.	xavier_argemi@hotmail.com						Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Benvenuto M, 2006, ANTIMICROB AGENTS CH, V50, P3245, DOI 10.1128/AAC.00247-06; BLASER J, 1988, J ANTIMICROB CHEMOTH, V22, P15, DOI 10.1093/jac/22.1.15; Cafini E, 2007, J ANTIMICROB CHEMOTH, V59, P1185, DOI 10.1093/jac/dkm078; Canton R, 2010, J ANTIMICROB CHEMOTH, V65, P1126, DOI 10.1093/jac/dkq087; Cha R, 2004, J ANTIMICROB CHEMOTH, V54, P259, DOI 10.1093/jac/dkh259; Chakraborty A, 2009, J ANTIMICROB CHEMOTH, V64, P151, DOI 10.1093/jac/dkp155; CHALKLEY LJ, 1985, ANTIMICROB AGENTS CH, V28, P331, DOI 10.1128/AAC.28.2.331; Euba G, 2009, ANTIMICROB AGENTS CH, V53, P4305, DOI 10.1128/AAC.00444-09; EUCAST, 2011, CLIN BREAKP; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V57, P639, DOI 10.1093/jac/dkl044; FDA, 2010, FDA APPR DRUG PROD; Figueroa DA, 2009, CLIN INFECT DIS, V49, P177, DOI 10.1086/600039; Forrest GN, 2010, CLIN MICROBIOL REV, V23, P14, DOI 10.1128/CMR.00034-09; Gavalda J, 1999, ANTIMICROB AGENTS CH, V43, P639, DOI 10.1128/AAC.43.3.639; Gavalda Joan, 2007, Ann Intern Med, V146, P574; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hall AD, 2012, ANTIMICROB AGENTS CH, V56, P3174, DOI 10.1128/AAC.06439-11; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Jevitt LA, 2003, MICROB DRUG RESIST, V9, P389, DOI 10.1089/107662903322762833; John AK, 2009, ANTIMICROB AGENTS CH, V53, P2719, DOI 10.1128/AAC.00047-09; Kelesidis T, 2011, CLIN INFECT DIS, V52, P228, DOI 10.1093/cid/ciq113; LAMP KC, 1992, ANTIMICROB AGENTS CH, V36, P2709, DOI 10.1128/AAC.36.12.2709; LaPlante KL, 2009, ANTIMICROB AGENTS CH, V53, P3880, DOI 10.1128/AAC.00134-09; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; MAINARDI JL, 1995, ANTIMICROB AGENTS CH, V39, P1984, DOI 10.1128/AAC.39.9.1984; Marty FM, 2006, J CLIN MICROBIOL, V44, P595, DOI 10.1128/JCM.44.2.595-597.2006; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; Maurin M, 2001, ANTIMICROB AGENTS CH, V45, P2977, DOI 10.1128/AAC.45.11.2977-2986.2001; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Quinn B, 2007, J ANTIMICROB CHEMOTH, V60, P1380, DOI 10.1093/jac/dkm375; Rice DAK, 2009, ARCH ORTHOP TRAUM SU, V129, P1495, DOI 10.1007/s00402-008-0772-x; Richter SS, 2003, J ANTIMICROB CHEMOTH, V52, P123, DOI 10.1093/jac/dkg288; Sabol K, 2005, ANTIMICROB AGENTS CH, V49, P1664, DOI 10.1128/AAC.49.4.1664-1665.2005; Saleh-Mghir A, 2011, ANTIMICROB AGENTS CH, V55, P4589, DOI 10.1128/AAC.00675-11; Steenbergen JN, 2009, J ANTIMICROB CHEMOTH, V64, P1130, DOI 10.1093/jac/dkp346; Vouillamoz J, 2006, J ANTIMICROB CHEMOTH, V58, P1208, DOI 10.1093/jac/dkl406; Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002	40	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64218	10.1371/journal.pone.0064218	http://dx.doi.org/10.1371/journal.pone.0064218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700464	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200124
J	Peintner, U; Schwarz, S; Mesic, A; Moreau, PA; Moreno, G; Saviuc, P				Peintner, Ursula; Schwarz, Stefanie; Mesic, Armin; Moreau, Pierre-Arthur; Moreno, Gabriel; Saviuc, Philippe			Mycophilic or Mycophobic? Legislation and Guidelines on Wild Mushroom Commerce Reveal Different Consumption Behaviour in European Countries	PLOS ONE			English	Article							FUNGI	Mycophiles forage for and pick vast quantities of a wide variety of wild mushroom species. As a result, mushroom intoxications are comparatively frequent in such countries with mycophiles. Thus, national governments are forced to release guidelines or enact legislation in order to ensure the safe commerce of wild mushrooms due to food safety concerns. It is in these guidelines and laws that one can observe whether a country is indeed mycophobic or mycophilic. Furthermore, these laws and guidelines provide valuable information on mushroom preferences and on the consumption habits of each country. As such we were interested in the questions as to whether mushroom consumption behaviour was different within Europe, and if it was possible to discover the typical or distinctive culinary preferences of Slavic or Romanic speaking people, people from special geographical regions or from different zones. This work is based on the analysis of edible mushroom lists available in specific guidelines or legislation related to the consumption and commerce of mushrooms in 27 European countries. The overall diversity of edible mushrooms authorised to be commercialised in Europe is very high. However, only 60 out of a total 268 fungal species can be cultivated. This highlights the importance of guidelines or legislation for the safe commerce of wild mushrooms. The species richness and composition of the mushrooms listed for commerce is very heterogeneous within Europe. The consumption behaviour is not only language-family-related, but is strongly influenced by geographical location and neighbouring countries. Indicator species were detected for different European regions; most of them are widespread fungi, and thus prove culture-specific preferences for these mushrooms. Our results highlight tradition and external input such as trade and cultural exchange as strong factors shaping mushroom consumption behaviour.	[Peintner, Ursula; Schwarz, Stefanie] Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria; [Mesic, Armin] Rudjer Boskovic Inst, Zagreb, Croatia; [Moreau, Pierre-Arthur] Commiss Environm Soc Mycol France, Paris, France; [Moreau, Pierre-Arthur] Univ Lille Nord France, UFR Pharm, Lab Sci Vgetales & Fongiques, Lille, France; [Moreno, Gabriel] Univ Alcala, Dept Ciencias Vida Bot, Madrid, Spain; [Saviuc, Philippe] Michallon Hosp, Toxicovigilance Ctr, Grenoble, France	University of Innsbruck; Rudjer Boskovic Institute; Universite de Lille - ISITE; Universite de Lille; Universidad de Alcala; CHU Grenoble Alpes	Peintner, U (corresponding author), Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria.	Ursula.Peintner@uibk.ac.at	Mešić, Armin/AAJ-1858-2020; MOREAU, PIERRE-ARTHUR/AAP-8248-2020; Moreno, Gabriel/K-8537-2017; Peintner, Ursula/AAY-9138-2020	Mešić, Armin/0000-0002-4479-600X; Peintner, Ursula/0000-0001-5388-4266; Moreau, Pierre-Arthur/0000-0003-4783-3643	University Innsbruck	University Innsbruck	The work was supported by University Innsbruck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, PC ORD MULTIVARIATE; Baptista-Ferreira JL, 2012, COMMUNICATION; Benjamin DR, 1995, MUSHROOMS POISONS PA; Cetto B, 1966, PARLAMO FUNGHI; De Roman M, 2006, ECON BOT, V60, P284, DOI 10.1663/0013-0001(2006)60[284:TMOLDI]2.0.CO;2; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ferri G, 1934, VIE ITALIA RIV MENSI, P757; Garibay-Orijel R, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-4; Hawksworth DL, 1996, NATURE, V379, P503, DOI 10.1038/379503a0; Jensvoll L, 2012, MUSHROOMS TRADED FOO, V2012; Jensvoll L, 2012, MUSHROOMS TRADED FOO, V2012; Koz'yakov SM, 1984, MUSHROOMS EDIBLE CON, P204; Mitchell D., 2010, BC Journal of Ecosystems and Management, V11, P27; Moreno G, 2002, MONDO FUNGHI, V59-60, P575; PEREZMORENO J, 1995, FOOD ADDIT CONTAM, V12, P355, DOI 10.1080/02652039509374315; Pilz D, 2002, FOREST ECOL MANAG, V155, P3, DOI 10.1016/S0378-1127(01)00543-6; Saviuc P, 2009, VENTE CHAMPIGNONS SA; Saviuc Philippe, 2006, Toxicol Rev, V25, P199, DOI 10.2165/00139709-200625030-00004; SCHEURLEN C, 1994, Z GASTROENTEROL, V32, P399; Schwabe, 2003, GIFTPILZE PILZGIFTE; Sitta N, 1997, FUNGHI EPIGEI SPONTA; Sitta N, 2008, ECON BOT, V62, P307, DOI 10.1007/s12231-008-9037-4; SONNENBICHLER J, 1994, BIOL CHEM H-S, V375, P71, DOI 10.1515/bchm3.1994.375.1.71; Steidle H, 1930, N-S ARCH EX PATH PH, V151, P232, DOI 10.1007/BF01862466; Vetelainen M, 2008, STATE PLANT GENETIC, P14; Wang X, 2012, SPECTROCHIM ACTA A, V91, P285, DOI 10.1016/j.saa.2012.02.004; Watling Roy, 1997, Mycologist, V11, P101; Zent EL, 2004, ECON BOT, V58, P214, DOI 10.1663/0013-0001(2004)058[0214:KAUOFB]2.0.CO;2; Zivanovic S, 2006, IDENTIFICATION OPPOR	29	56	59	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63926	10.1371/journal.pone.0063926	http://dx.doi.org/10.1371/journal.pone.0063926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704957	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200088
J	Smith, JAM				Smith, Joseph A. M.			The Role of Phragmites australis in Mediating Inland Salt Marsh Migration in a Mid-Atlantic Estuary	PLOS ONE			English	Article							SEA-LEVEL RISE; DELAWARE BAY; SEDIMENT ACCRETION; TIDAL MARSH; COMMON REED; WEST-COAST; INVASION; FOREST; CONNECTICUT; VEGETATION	Many sea level rise adaptation plans emphasize the protection of adjacent uplands to allow for inland salt marsh migration, but little empirical information exists on this process. Using aerial photos from 1930 and 2006 of Delaware Estuary coastal habitats in New Jersey, I documented the rate of coastal forest retreat and the rate of inland salt marsh migration across 101.1 km of undeveloped salt marsh and forest ecotone. Over this time, the amount of forest edge at this ecotone nearly doubled. In addition, the average amount of forest retreat was 141.2 m while the amount of salt marsh inland migration was 41.9 m. Variation in forest retreat within the study area was influenced by variation in slope. The lag between the amount of forest retreat and salt marsh migration is accounted for by the presence of Phragmites australis which occupies the forest and salt marsh ecotone. Phragmites expands from this edge into forest dieback areas, and the ability of salt marsh to move inland and displace Phragmites is likely influenced by salinity at both an estuary-wide scale and at the scale of local subwatersheds. Inland movement of salt marsh is lowest at lower salinity areas further away from the mouth of the estuary and closer to local heads of tide. These results allow for better prediction of salt marsh migration in estuarine landscapes and provide guidance for adaptation planners seeking to prioritize those places with the highest likelihood of inland salt marsh migration in the near-term.	Nature Conservancy, Delmont, NJ USA	Nature Conservancy	Smith, JAM (corresponding author), Nature Conservancy, Delmont, NJ USA.	smithjam@gmail.com						Able KW, 2003, ESTUARIES, V26, P40, DOI 10.1007/BF02691692; Adam P, 2002, ENVIRON CONSERV, V29, P39, DOI 10.1017/S0376892902000048; ADAMS DA, 1963, ECOLOGY, V44, P445, DOI 10.2307/1932523; Amsberry L, 2000, ECOL APPL, V10, P1110, DOI 10.1890/1051-0761(2000)010[1110:CIATEO]2.0.CO;2; An SQ, 2007, WEED RES, V47, P183, DOI 10.1111/j.1365-3180.2007.00559.x; Barlow PM, 2010, HYDROGEOL J, V18, P247, DOI 10.1007/s10040-009-0514-3; Benoit LK, 1999, WETLANDS, V19, P194, DOI 10.1007/BF03161749; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; Bird E., 2008, COASTAL GEOMORPHOLOG; Blum MD, 2009, NAT GEOSCI, V2, P488, DOI 10.1038/ngeo553; Boorman Laurence A., 1999, Mangroves and Salt Marshes, V3, P227; BRINSON MM, 1995, ESTUARIES, V18, P648, DOI 10.2307/1352383; Chambers RM, 1998, AQUAT BOT, V62, P161, DOI 10.1016/S0304-3770(98)00095-3; Chambers RM, 2003, ESTUARIES, V26, P398, DOI 10.1007/BF02823716; CIVCO DL, 1986, ENVIRON MANAGE, V10, P229, DOI 10.1007/BF01867361; Dahl TE, 2011, STATUS TRENDS WETLAN; Dahl TE, 2006, FISH WILDLIFE SERVIC, V112, P112; Desantis LRG, 2007, GLOBAL CHANGE BIOL, V13, P2349, DOI 10.1111/j.1365-2486.2007.01440.x; Doody J. Pat, 2004, Journal of Coastal Conservation, V10, P129, DOI 10.1007/BF02818949; Engelhart SE, 2009, GEOLOGY, V37, P1115, DOI 10.1130/G30360A.1; FLETCHER CH, 1993, GEOLOGY, V21, P121, DOI 10.1130/0091-7613(1993)021<0121:SLRAAT>2.3.CO;2; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Goodman JE, 2007, MAR GEOL, V242, P109, DOI 10.1016/j.margeo.2006.09.017; Hussein AH, 2009, SOIL SCI SOC AM J, V73, P185, DOI 10.2136/sssaj2006.0436; KEARNEY MS, 1994, J COASTAL RES, V10, P1010; Kitchell W., 1857, GEOLOGY COUNTY CAPE; Lissner J, 1997, AQUAT BOT, V55, P247, DOI 10.1016/S0304-3770(96)01085-6; Lopez JA, 2009, J COASTAL RES, P186, DOI 10.2112/SI54-020.1; Mcleod E, 2010, OCEAN COAST MANAGE, V53, P507, DOI 10.1016/j.ocecoaman.2010.06.009; MEYERSON AL, 1972, MAR GEOL, V12, P335, DOI 10.1016/0025-3227(72)90033-3; Middleton BA, 2013, ECOL ENG, V54, P183, DOI 10.1016/j.ecoleng.2013.01.025; Minchinton TE, 2003, ECOL APPL, V13, P1400, DOI 10.1890/02-5136; Nagler P, 2005, ENVIRON MONIT ASSESS, V109, P255, DOI 10.1007/s10661-005-6285-y; Niering W., 1977, CONNECTICULT ARBORET, V22; Nikitina DL, 2000, MAR GEOL, V171, P7, DOI 10.1016/S0025-3227(00)00104-3; NYDICK KR, 1995, MAR GEOL, V124, P137, DOI 10.1016/0025-3227(95)00037-Y; Orson R. A., 1999, Biological Invasions, V1, P149, DOI 10.1023/A:1010047731369; Padeletti A, 2008, DELAWARE ESTURARY BE; PENNINGS SC, 1992, ECOLOGY, V73, P681, DOI 10.2307/1940774; Philipp KR, 2005, ECOL ENG, V25, P275, DOI 10.1016/j.ecoleng.2005.04.008; PHILLIPS JD, 1986, ANN ASSOC AM GEOGR, V76, P50, DOI 10.1111/j.1467-8306.1986.tb00103.x; RAUZON MJ, 2002, TURNING TIDE ERADICA, P240; Rooth J. E., 2003, Estuaries, V26, P475, DOI 10.1007/BF02823724; Rooth J. E., 2000, Wetlands Ecology and Management, V8, P173, DOI 10.1023/A:1008444502859; Sallenger AH, 2012, NAT CLIM CHANGE, V2, P884, DOI [10.1038/nclimate1597, 10.1038/NCLIMATE1597]; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Snyder D., 2004, OVERVIEW NONINDIGENO; St Amand Lisa A, 1991, BC ENV AFF L REV, V19, P1; Stephenson W, 2008, COAST COAST 2008 AUS, P90; Stone W, 1910, PLANTS SO NEW JERSEY; The Nature Conservancy NOAA National Ocean Service Center, 2011, MARSH MOV MAN GUID U; Thieler ER, 2005, US GEOLOGICAL SURVEY; Tong CF, 2013, ECOL ENG, V51, P151, DOI 10.1016/j.ecoleng.2012.12.010; Townend I, 2002, PHILOS T R SOC A, V360, P1477, DOI 10.1098/rsta.2002.1011; van de Plassche O., 1991, J COASTAL RES, V11, P159; WARREN RS, 1993, ECOLOGY, V74, P96, DOI 10.2307/1939504; WESTERVELT K, 2006, GUIDE NATURAL COMMUN; Whitney MM, 2006, J PHYS OCEANOGR, V36, P3, DOI 10.1175/JPO2805.1; Williams K, 1998, AM J BOT, V85, P1745, DOI 10.2307/2446509; Williams K, 1999, ECOLOGY, V80, P2045, DOI 10.1890/0012-9658(1999)080[2045:SLRACF]2.0.CO;2; Wilson CA, 2008, ESTUAR COAST SHELF S, V80, P483, DOI 10.1016/j.ecss.2008.09.004	64	67	67	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65091	10.1371/journal.pone.0065091	http://dx.doi.org/10.1371/journal.pone.0065091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705031	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200186
J	Suo, LN; Sun, XY; Jiang, WJ				Suo, Linna; Sun, Xiangyang; Jiang, Weijie			Effect of Pretreatment on Biomass Residue Structure and the Application of Pyrolysed and Composted Biomass Residues in Soilless Culture	PLOS ONE			English	Article							ANTHURIUM-ANDREANUM LIND.; MUNICIPAL SOLID-WASTE; GROWING MEDIA; GROWTH; PEAT; SUBSTITUTE; PLANTS; COIR	The changes in the structural characteristics of biomass residues during pyrolysis and composting were investigated. The biomass residues particles were prepared by pyrolysing at temperatures ranging from 350 to 400. For soilless production of the ornamental plant Anthurium andraeanum, pure sphagnum peat moss (P) has traditionally been used as the growing medium. This use of P must be reduced, however, because P is an expensive and nonrenewable resource. The current study investigated the use of biomass residues as substitutes for P in A. andraeanum production. Plants were grown for 15 months in 10 soilless media that contained different proportions of pyrolysed corn cobs (PC), composted corn cobs (C), pyrolysed garden wastes (PG), and P. Although the media altered the plant nutrient content, A. andraeanum growth, development, and yield were similar with media consisting of 50% P+50% PC, 50% P+35% PC+15% PG, and 100% P. This finding indicates that, when pyrolysed, organic wastes, which are otherwise an environmental problem, can be used to reduce the requirement for peat in the soilless culture of A. andraeanum.	[Suo, Linna; Sun, Xiangyang] Beijing Forestry Univ, Coll Soil & Water Conservat, Beijing, Peoples R China; [Suo, Linna; Jiang, Weijie] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China	Beijing Forestry University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Sun, XY (corresponding author), Beijing Forestry Univ, Coll Soil & Water Conservat, Beijing, Peoples R China.	sunxy1965@126.com; jiangweijie@caas.cn			Key Projects of the Beijing Municipal Science and Technology Committee of China [D09040903780801]	Key Projects of the Beijing Municipal Science and Technology Committee of China	This study was supported by the Key Projects of the Beijing Municipal Science and Technology Committee of China (Grant No. D09040903780801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad M, 2002, BIORESOURCE TECHNOL, V82, P241, DOI 10.1016/S0960-8524(01)00189-4; Abad M, 2001, BIORESOURCE TECHNOL, V77, P197, DOI 10.1016/S0960-8524(00)00152-8; [Anonymous], 2002, CULTIVATION GUIDE AN, P140; Aydogan A, 2011, ATMOS ENVIRON, V45, P2675, DOI 10.1016/j.atmosenv.2011.02.062; Benito M, 2005, BIORESOURCE TECHNOL, V96, P597, DOI 10.1016/j.biortech.2004.06.006; BRADY NC, 1996, NATURE PROPERTIES SO, P495; Caballero R, 2009, SCI HORTIC-AMSTERDAM, V122, P244, DOI 10.1016/j.scienta.2009.05.010; Chang KH, 2010, SCI HORTIC-AMSTERDAM, V125, P434, DOI 10.1016/j.scienta.2010.04.011; Chen G, 2011, USE ORGANIC AGR WAST, P13; Du GuoDong, 2007, Journal of Shenyang Agricultural University, V38, P40; Dufour L, 2005, SCI HORTIC-AMSTERDAM, V105, P269, DOI 10.1016/j.scienta.2005.01.022; Dufour L, 2003, SCI HORTIC-AMSTERDAM, V98, P25, DOI 10.1016/S0304-4238(02)00196-6; Garcia-Gomez A, 2002, BIORESOURCE TECHNOL, V83, P81, DOI 10.1016/S0960-8524(01)00211-5; Granberry DM, 2001, BIOCYCLE, V42, P60; Guo S. R, 2003, SOILLESS CULTURE; Hargreaves JC, 2008, AGR ECOSYST ENVIRON, V123, P1, DOI 10.1016/j.agee.2007.07.004; HIGAKI T, 1992, HORTSCIENCE, V27, P909, DOI 10.21273/HORTSCI.27.8.909; Ingelmo F, 1998, BIORESOURCE TECHNOL, V63, P123, DOI 10.1016/S0960-8524(97)00105-3; Ioannidou OA, 2010, CHEMOSPHERE, V80, P1328, DOI 10.1016/j.chemosphere.2010.06.044; JIMENEZ EI, 1993, PLANT SOIL, V148, P115, DOI 10.1007/BF02185391; Kahn BA, 2005, COMPOST SCI UTIL, V13, P175; Laws N, 1996, RAP MARKET INFORM B, P11; Leboda R, 2005, J COLLOID INTERF SCI, V284, P39, DOI 10.1016/j.jcis.2004.09.052; Mamo M, 1999, J ENVIRON QUAL, V28, P1074, DOI 10.2134/jeq1999.00472425002800040003x; Marianthi T, 2006, BIORESOURCE TECHNOL, V97, P1631, DOI 10.1016/j.biortech.2005.07.027; Mills HA, 1998, J PLANT NUTR, V21, P199, DOI 10.1080/01904169809365394; Offord CA, 1998, AUST J EXP AGR, V38, P879, DOI 10.1071/EA98059; PRYCE S, 1991, Professional Horticulture, V5, P101; Sharon M, 2007, INT J HYDROGEN ENERG, V32, P4238, DOI 10.1016/j.ijhydene.2007.05.038; SIMINIS HI, 1990, BIOCYCLE, V31, P60; Sonneveld C., 1993, Acta Horticulturae, P61; Suo LN, 2011, J HORTIC SCI BIOTECH, V86, P366, DOI 10.1080/14620316.2011.11512775; Wilson SB, 2001, HORTTECHNOLOGY, V11, P31, DOI 10.21273/HORTTECH.11.1.31; [谢耀坚 XIE Yao-jian], 2008, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V28, P62; [No title captured]	35	2	2	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64550	10.1371/journal.pone.0064550	http://dx.doi.org/10.1371/journal.pone.0064550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704995	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200149
J	Yuan, J; Yu, M; Cao, AL; Chen, X; Zhang, LH; Song, Y; Cheng, X; Zhou, ZH; Wang, M; Guo, HP; Du, R; Liao, YH				Yuan, Jing; Yu, Miao; Cao, Ai-Lin; Chen, Xiao; Zhang, Li-Hua; Song, You; Cheng, Xiang; Zhou, Zi-Hua; Wang, Min; Guo, He-Ping; Du, Rong; Liao, Yu-Hua			A Novel Epitope from CD22 Regulates Th1 and Th17 Cell Function in Systemic Lupus Erythematosus	PLOS ONE			English	Article							T-CELLS; B-CELLS; IN-VIVO; RECEPTOR CD22; ANTIBODY; EPRATUZUMAB; ENGAGEMENT; DISEASE; MICE	The published antibodies (Abs) against CD22 on B cells including Epratuzumab could inhibit B cell activation mainly through binding to C2-set Ig domain of CD22, but they are rarely reported to modulate the pathogenic CD4(+) T cell function in systemic lupus erythematosus (SLE). Recently, it was proved that the extracellular amino-terminal V-set Ig domain of CD22 might mediate the interaction of B and T cells, but for now the exact effect of this domain on CD4(+) T cell biology have not been identified. Thus, in this study, we screened out a peptide termed B2285 from this V-set Ig domain, developed the novel specific anti-B2285 Abs in rabbits, and investigated their effects in MRL/lpr mice with spontaneous SLE. The results showed that anti-B2285 Abs could ameliorate the disease severity obviously in spontaneous SLE mice with the decreased differentiations of Th1 and Th17 cells and no changes of Th2 and Treg cells. In co-cultured B cells and CD4(+) T cells, this specific anti-CD22 Abs was observed to inhibit the anti-dsDNA Abs production, CD4(+) T cells proliferation, the protein levels of T-bet and ROR gamma t, and the mRNA levels of TNF-alpha, IFN-gamma, IL-6 and IL-17 in CD4(+) T cells. Moreover, the expression of CD45RO on CD4(+) T cells could be also apparently diminished by this novel Abs. The data suggested that anti-B2285 Abs could slow SLE progression significantly by regulating Th1 and Th17 cells function via B-T cell interaction and the cytokine network regulation. The treatment against V-set Ig domain of CD22 would be a valuable therapeutic method for SLE and other autoimmune diseases.	[Yuan, Jing; Yu, Miao; Cao, Ai-Lin; Chen, Xiao; Zhang, Li-Hua; Cheng, Xiang; Zhou, Zi-Hua; Wang, Min; Guo, He-Ping; Liao, Yu-Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Lab Cardiovasc Immunol,Inst Cardiol, Wuhan 430074, Peoples R China; [Song, You; Du, Rong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Rheumatol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Du, R (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Rheumatol, Wuhan 430074, Peoples R China.	dudurong2003@yahoo.com.cn; liaoyh27@126.com	饭, 蔡/AAI-5850-2020; Song, You/GRS-3401-2022		National Natural Science Foundation of China [81100158]; National Basic Research Program of China (973 Program) [2007CB512000, 2007CB512005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (81100158) and National Basic Research Program of China (973 Program, 2007CB512000, 2007CB512005) (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1992, P NATL ACAD SCI USA, V89, P10242, DOI 10.1073/pnas.89.21.10242; Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; Carnahan J, 2003, CLIN CANCER RES, V9, p3982S; Dorner T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1942; Haas KM, 2006, J IMMUNOL, V177, P3063, DOI 10.4049/jimmunol.177.5.3063; Heimberger AB, 2003, CLIN CANCER RES, V9, P4247; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; LAW CL, 1995, J IMMUNOL, V155, P3368; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Robak E, 2009, CURR DRUG TARGETS, V10, P26, DOI 10.2174/138945009787122833; SCHULTE RJ, 1992, SCIENCE, V258, P1001, DOI 10.1126/science.1279802; SGROI D, 1995, P NATL ACAD SCI USA, V92, P4026, DOI 10.1073/pnas.92.9.4026; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; Smith KM, 2000, J IMMUNOL, V165, P3136, DOI 10.4049/jimmunol.165.6.3136; Smith KM, 2004, J IMMUNOL, V173, P1640, DOI 10.4049/jimmunol.173.3.1640; Tuscano J, 1996, BLOOD, V87, P4723, DOI 10.1182/blood.V87.11.4723.bloodjournal87114723; Yuan J, 2010, INT IMMUNOPHARMACOL, V10, P272, DOI 10.1016/j.intimp.2009.11.010; Yuan J, 2010, J CLIN IMMUNOL, V30, P226, DOI 10.1007/s10875-009-9355-z; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	22	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64572	10.1371/journal.pone.0064572	http://dx.doi.org/10.1371/journal.pone.0064572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704998	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200152
J	Garrido-Sanchez, L; Escote, X; Coin-Araguez, L; Fernandez-Garcia, JC; El Bekay, R; Vendrell, J; Garcia-Fuentes, E; Tinahones, FJ				Garrido-Sanchez, Lourdes; Escote, Xavier; Coin-Aragueez, Leticia; Carlos Fernandez-Garcia, Jose; El Bekay, Rajaa; Vendrell, Joan; Garcia-Fuentes, Eduardo; Tinahones, Francisco J.			Munc18c in Adipose Tissue Is Downregulated in Obesity and Is Associated with Insulin	PLOS ONE			English	Article							STIMULATED GLUT4 TRANSLOCATION; LIVER-X RECEPTORS; TYROSINE PHOSPHORYLATION; 3T3-L1 ADIPOCYTES; MEMBRANE-FUSION; FATTY-ACID; BINDING; GLUCOSE; SYNTAXIN-4; RESISTANCE	Objective: Munc18c is associated with glucose metabolism and could play a relevant role in obesity. However, little is known about the regulation of Munc18c expression. We analyzed Munc18c gene expression in human visceral (VAT) and subcutaneous (SAT) adipose tissue and its relationship with obesity and insulin. Materials and Methods: We evaluated 70 subjects distributed in 12 non-obese lean subjects, 23 overweight subjects, 12 obese subjects and 23 nondiabetic morbidly obese patients (11 with low insulin resistance and 12 with high insulin resistance). Results: The lean, overweight and obese persons had a greater Munc18c gene expression in adipose tissue than the morbidly obese patients (p<0.001). VAT Munc18c gene expression was predicted by the body mass index (B = -0.001, p = 0.009). In SAT, no associations were found by different multiple regression analysis models. SAT Munc18c gene expression was the main determinant of the improvement in the HOMA-IR index 15 days after bariatric surgery (B = -2148.4, p = 0.038). SAT explant cultures showed that insulin produced a significant down-regulation of Munc18c gene expression (p = 0.048). This decrease was also obtained when explants were incubated with liver X receptor alpha (LXR alpha) agonist, either without (p = 0.038) or with insulin (p = 0.050). However, Munc18c gene expression was not affected when explants were incubated with insulin plus a sterol regulatory element-binding protein-1c (SREBP-1c) inhibitor (p = 0.504). Conclusions: Munc18c gene expression in human adipose tissue is down-regulated in morbid obesity. Insulin may have an effect on the Munc18c expression, probably through LXR alpha and SREBP-1c.	[Garrido-Sanchez, Lourdes; Escote, Xavier; Vendrell, Joan] Univ Rovira & Virgili, Endocrinol & Diabet Unit, Joan Univ Hosp 23, IISPV, Tarragona, Spain; [Garrido-Sanchez, Lourdes; Escote, Xavier; Vendrell, Joan] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metabol Asociadas CIB, Tarragona, Spain; [Coin-Aragueez, Leticia; Carlos Fernandez-Garcia, Jose; El Bekay, Rajaa; Tinahones, Francisco J.] Hosp Clin Virgen de la Victoria, Serv Endocrinol & Nutr, Malaga, Spain; [Coin-Aragueez, Leticia; El Bekay, Rajaa; Garcia-Fuentes, Eduardo; Tinahones, Francisco J.] Inst Salud Carlos III, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Malaga, Spain; [El Bekay, Rajaa; Garcia-Fuentes, Eduardo] Inst Invest Biomed Malaga IBIMA, Malaga, Spain; [Garcia-Fuentes, Eduardo] Hosp Reg Univ Carlos Haya, Serv Endocrinol & Nutr, Malaga, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Hospital Virgen de la Victoria; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Malaga; Hospital Carlos Haya	Garcia-Fuentes, E (corresponding author), Inst Salud Carlos III, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Malaga, Spain.	edugf1@gmail.com; fjtinahones@hotmail.com	Vendrell, Joan j/V-4034-2018; Bekay, Rajaa El/AAZ-3959-2020; Escoté, Xavier/AAH-2973-2020; Escote, Xavier/AAC-6335-2019; El Bekay, RAJAA/AGN-6069-2022; Tinahones, Francisco José/AAB-2882-2020; Garcia-Fuentes, Eduardo/AAB-1607-2020; Escote, Xavier/G-3440-2015; Fernandez-Garcia, Jose Carlos/B-5312-2013	Vendrell, Joan j/0000-0002-6994-6115; Escote, Xavier/0000-0003-1172-3995; El Bekay, RAJAA/0000-0003-3332-3431; Escote, Xavier/0000-0003-1172-3995; Fernandez-Garcia, Jose Carlos/0000-0003-2229-8488; Tinahones, Francisco J/0000-0001-6871-4403; GARCIA-FUENTES, EDUARDO/0000-0002-3491-2724	Instituto de Salud Carlos III [CP04/00133, PS09/01060, PS09/00997]; Servicio Andaluz de Salud [PI0255/2007]; Programa Juan de la Cierva [JCI-2009-04086]; Research Stabilization Program of the Instituto de Salud Carlos III (ISCIII); Fondo de Investigacion Sanitaria (FIS) "Miguel Servet" [CP07/00288]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Servicio Andaluz de Salud; Programa Juan de la Cierva; Research Stabilization Program of the Instituto de Salud Carlos III (ISCIII); Fondo de Investigacion Sanitaria (FIS) "Miguel Servet"	This work was supported in part by grants from Instituto de Salud Carlos III [CP04/00133, PS09/01060, PS09/00997], Servicio Andaluz de Salud [PI0255/2007]. L. Garrido-Sanchez is supported by a fellowship from the Programa Juan de la Cierva [JCI-2009-04086]. E. Garcia-Fuentes is supported by the Research Stabilization Program of the Instituto de Salud Carlos III (ISCIII). R. El Bekay is supported by fellowships from the Fondo de Investigacion Sanitaria (FIS) "Miguel Servet" [CP07/00288]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran V, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-19; Bergman BC, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-21; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; CZECH MP, 1995, ANNU REV NUTR, V15, P441, DOI 10.1146/annurev.nu.15.070195.002301; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; Garcia-Fuentes E, 2010, OBESITY, V18, P952, DOI 10.1038/oby.2009.314; Garcia-Serrano S, 2011, MOL MED, V17, P273, DOI 10.2119/molmed.2010.00078; Garrido-Sanchez L, 2012, SURG OBES RELAT DIS, V8, P145, DOI 10.1016/j.soard.2011.03.010; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; Harte AL, 2003, DIABETES OBES METAB, V5, P462, DOI 10.1046/j.1463-1326.2003.00274.x; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; Hugo ER, 2008, J CLIN ENDOCR METAB, V93, P4006, DOI 10.1210/jc.2008-1172; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; James David E., 1994, Trends in Cell Biology, V4, P120, DOI 10.1016/0962-8924(94)90066-3; Jamroz-Wisniewska Anna, 2007, Postepy Hig Med Dosw (Online), V61, P760; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; Khan AH, 2001, J BIOL CHEM, V276, P4063, DOI 10.1074/jbc.M007419200; KLIP A, 1994, FASEB J, V8, P43, DOI 10.1096/fasebj.8.1.8299889; Kuipers I, 2010, EUR J HEART FAIL, V12, P1042, DOI 10.1093/eurjhf/hfq109; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Macaulay SL, 2002, FEBS LETT, V528, P154, DOI 10.1016/S0014-5793(02)03279-9; Moutier E, 2012, J BIOL CHEM, V287, P26328, DOI 10.1074/jbc.M112.361790; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Pehkonen P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-50; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Phan TQ, 2010, MOL CELL ENDOCRINOL, V319, P88, DOI 10.1016/j.mce.2009.11.010; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; Spurlin BA, 2004, DIABETES, V53, P2223, DOI 10.2337/diabetes.53.9.2223; Spurlin BA, 2003, DIABETES, V52, P1910, DOI 10.2337/diabetes.52.8.1910; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Thurmond DC, 2001, MOL MEMBR BIOL, V18, P237; Tinahones FJ, 2010, OBES SURG, V20, P1559, DOI 10.1007/s11695-010-0194-z; Tinahones FJ, 2009, OBESITY, V17, P240, DOI 10.1038/oby.2008.536; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; Umahara M, 2008, ENDOCRINOLOGY, V149, P40, DOI 10.1210/en.2006-1549; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Yu X, 2011, EMBO J, V30, P3754, DOI 10.1038/emboj.2011.277	49	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63937	10.1371/journal.pone.0063937	http://dx.doi.org/10.1371/journal.pone.0063937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700440	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400037
J	Prata, N; Bell, S; Weidert, K; Gessessew, A				Prata, Ndola; Bell, Suzanne; Weidert, Karen; Gessessew, Amanuel			Potential for Cost Recovery: Women's Willingness to Pay for Injectable Contraceptives in Tigray, Ethiopia	PLOS ONE			English	Article							REPRODUCTIVE HEALTH-SERVICES; QUALITY; DEMAND; PRICE; CARE	Objective: To investigate factors associated with a woman's willingness to pay (WTP) for injectable contraceptives in Tigray, Ethiopia. Methods: We used a multistage random sampling design to generate a representative sample of reproductive age women from the Central Zone of Tigray, Ethiopia to participate in a survey (N = 1490). Respondents who had ever used injectable contraceptives or who were interested in using them were asked whether they would be willing to pay, and if so, how much. Logistic regression odds ratios (ORs) with 95% confidence intervals (CIs) and p-values were used to assess which factors were associated with WTP in our final model. Findings: On average, respondents were willing to pay 11 birr ($0.65 USD) per injection. Being married, completing any amount of education, having given birth, and having visited a health facility in the last 12 months (whether received family planning information or not) were associated with statistically significantly increased odds of WTP. Having initiated sexual activity and having 1-2 children (compared to 0 children) were associated with statistically significantly decreased odds of WTP. We also detected two significant interactions. Among women who prefer injectable contraceptives, their odds of WTP for injectable contraceptives vary across length of time they have used them. And among women who work for pay, their odds of WTP for injectable contraceptives vary by whether they agree with their husband/partner about the ideal number of children. Conclusion: In a sector that continually struggles with funding, cost recovery for contraceptive services may offer a means of improved financial sustainability while increasing rural access to injectable contraceptives. Results indicate there are opportunities for cost recovery in rural Tigray, Ethiopia and highlight factors that could be leveraged to increase WTP for injectable contraceptives.	[Prata, Ndola; Bell, Suzanne; Weidert, Karen] Univ Calif Berkeley, Sch Publ Hlth, Bixby Ctr Populat Hlth & Sustainabil, Berkeley, CA 94720 USA; [Gessessew, Amanuel] Mekele Univ, Coll Hlth Sci, Dept Obstet & Gynaecol, Mekele, Ethiopia	University of California System; University of California Berkeley; Mekelle University	Prata, N (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Bixby Ctr Populat Hlth & Sustainabil, Berkeley, CA 94720 USA.	ndola@berkeley.edu			Joffe Charitable Trust	Joffe Charitable Trust	Funding was received from the Joffe Charitable Trust for a project to increase access to injectable contraceptives at community level in Ethiopia. Data from this study comes from the baseline survey for the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; AKIN JS, 1995, SOC SCI MED, V40, P1527, DOI 10.1016/0277-9536(94)00274-W; Alderman H, 1996, WORLD BANK RES OBSER, V11, P3, DOI 10.1093/wbro/11.1.3; Babalola S, 2008, STUD FAMILY PLANN, V39, P211, DOI 10.1111/j.1728-4465.2008.168.x; Beekle AT, 2006, INT NURS REV, V53, P269, DOI 10.1111/j.1466-7657.2006.00492.x; Bratt JH, 2002, HEALTH POLICY PLANN, V17, P281, DOI 10.1093/heapol/17.3.281; Bratt JH, 2010, HEALTH POLICY, V95, P159, DOI 10.1016/j.healthpol.2009.11.015; Central Statistical Agency (CSA) ORC Macro, 2000, ETH DEM HLTH SURV; Central Statistical Agency [Ethiopia] ICF International, 2012, ETH DEM HLTH SURV DH; Central Statistical Agency Ethiopia ORC Macro, 2006, 2005 ETH DEM HLTH SU; Central Statistical Agency ICF International, 2012, ETH DEMPGR HLTH SURV; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Daniel EE, 2008, INT FAM PLAN PERSPEC, V34, P189, DOI [10.1363/3418908, 10.1363/ifpp.34.189.08]; Foreit JR, 2003, HEALTH POLICY, V63, P37, DOI 10.1016/S0168-8510(02)00039-8; Gebresilassie FE, 2011, J HEALTH POPUL NUTR, V29, P200, DOI 10.3329/jhpn.v29i3.7867; Gertler P., 1990, WILLINGNESS PAY MED; HASSAN EO, 1994, CONTRACEPTION, V49, P469, DOI 10.1016/0010-7824(94)90005-1; Hennink M., 2005, African Population Studies, V20, P125; Janowitz B, 1999, ISSUES FINANCING FAM; Klose T, 1999, HEALTH POLICY, V47, P97, DOI 10.1016/S0168-8510(99)00010-X; Korra A., 1997, Ethiopian Journal of Health Development, V11, P17; Lande R, 2006, POPULATION REPORTS K; LEWIS MA, 1986, STUD FAMILY PLANN, V17, P126, DOI 10.2307/1967030; Matheny G, 2004, INT FAM PLAN PERSPEC, V30, P134, DOI 10.1363/3013404; Routh S, 2000, J HEALTH POPUL NUTR, V18, P69; Schuler SR, 2002, HEALTH POLICY PLANN, V17, P273, DOI 10.1093/heapol/17.3.273; SCHWARTZ JB, 1988, WORLD BANK ECON REV, V2, P49, DOI 10.1093/wber/2.1.49; Smith WA, 2010, SOCIAL MARKETING DEV, V319; StataCorp, 2009, STAT SURV DAT REF MA; UC Berkeley Bixby Center for Population Health and Sustainability Mekelle University, 2011, COMM BAS DISTR DMPA; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD CONTR US 2011; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64032	10.1371/journal.pone.0064032	http://dx.doi.org/10.1371/journal.pone.0064032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158JQ	23700451	gold, Green Published, Green Submitted			2022-12-27	WOS:000319966400043
J	Trauer, U; Hilker, M				Trauer, Ute; Hilker, Monika			Parental Legacy in Insects: Variation of Transgenerational Immune Priming during Offspring Development	PLOS ONE			English	Article							MANDUCA-SEXTA; TENEBRIO-MOLITOR; MEALWORM BEETLE; INNATE IMMUNITY; EVOLUTIONARY ECOLOGY; INFECTION; RESPONSES; PARASITE; DEFENSE; PROPHENOLOXIDASE	In insects, a parental immune challenge can prepare and enhance offspring immune activity. Previous studies of such transgenerational immune priming (TGIP) mainly focused on a single offspring life stage. However, different developmental stages may be exposed to different risks and show different susceptibility to parental immune priming. Here we addressed the question (i) whether TGIP effects on the immunity of Manduca sexta offspring vary among the different developmental offspring stages. We differentiated between unchallenged and immunochallenged offspring; for the latter type of offspring, we further investigated (ii) whether TGIP has an impact on the time that enhanced immune levels persist after offspring immune challenge. Finally, we determined (iii) whether TGIP effects on offspring performance depend on the offspring stage. Our results show that TGIP effects on phenoloxidase (PO) activity, but not on antibacterial activity, vary among unchallenged offspring stages. In contrast, TGIP effects on PO and antibacterial activity did not vary among immunochallenged offspring stages. The persistence of enhanced immune levels in immunochallenged offspring was dependent on the parental immune state. Antibacterial (but not PO) activity in offspring of immunochallenged parents decreased over five days after pupal immune challenge, whereas no significant change over time was detectable in offspring of control parents. Finally, TGIP effects on the developmental time of unchallenged offspring varied among stages; young larvae of immunochallenged parents developed faster and gained more weight than larvae of control parents. However, offspring females of immunochallenged parents laid fewer eggs than females derived from control parents. These findings suggest that the benefits which the offspring gains from TGIP during juvenile development are paid by the adults with reduced reproductive power. Our study shows that TGIP effects vary among offspring stages and depend on the type of immunity (PO or antibacterial activity) as well as the time past offspring immune challenge.	[Trauer, Ute; Hilker, Monika] Free Univ Berlin, Inst Biol Appl Zool Anim Ecol, Berlin, Germany	Free University of Berlin	Hilker, M (corresponding author), Free Univ Berlin, Inst Biol Appl Zool Anim Ecol, Berlin, Germany.	hilker@zedat.fu-berlin.de			German Research Foundation [Hi 416/18-1]	German Research Foundation(German Research Foundation (DFG))	The German Research Foundation (www.dfg.de, Hi 416/18-1) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chambers MC, 2012, CURR OPIN IMMUNOL, V24, P10, DOI 10.1016/j.coi.2011.11.003; Cisarovsky G, 2012, J EVOLUTION BIOL, V25, P1053, DOI 10.1111/j.1420-9101.2012.02507.x; Cory JS, 2006, TRENDS ECOL EVOL, V21, P278, DOI 10.1016/j.tree.2006.02.005; Daukste J, 2012, J EVOLUTION BIOL, V25, P1298, DOI 10.1111/j.1420-9101.2012.02516.x; Diamond SE, 2010, OIKOS, V119, P542, DOI 10.1111/j.1600-0706.2009.17242.x; Eleftherianos I, 2006, INSECT BIOCHEM MOLEC, V36, P517, DOI 10.1016/j.ibmb.2006.04.001; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Freitak D, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-7; Freitak D, 2009, P ROY SOC B-BIOL SCI, V276, P2617, DOI 10.1098/rspb.2009.0323; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Haine ER, 2008, J INSECT PHYSIOL, V54, P1090, DOI 10.1016/j.jinsphys.2008.04.013; Hoffmann JA, 1996, CURR OPIN IMMUNOL, V8, P8, DOI 10.1016/S0952-7915(96)80098-7; Jacot A, 2005, P ROY SOC B-BIOL SCI, V272, P63, DOI 10.1098/rspb.2004.2919; Jiang HB, 2008, INSECT SCI, V15, P53, DOI 10.1111/j.1744-7917.2008.00187.x; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; KANOST MR, 1988, ARCH INSECT BIOCHEM, V8, P147, DOI 10.1002/arch.940080302; Kingsolver JG, 2012, FUNCT ECOL, V26, P598, DOI 10.1111/j.1365-2435.2012.01972.x; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Laughton AM, 2011, J INSECT PHYSIOL, V57, P1023, DOI 10.1016/j.jinsphys.2011.04.020; LAWSON FRANCIS R., 1959, ANN ENT SOC AMER, V52, P741, DOI 10.1093/aesa/52.6.741; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Little TJ, 2004, TRENDS ECOL EVOL, V19, P58, DOI 10.1016/j.tree.2003.11.011; Mira A, 2002, OIKOS, V97, P387, DOI 10.1034/j.1600-0706.2002.970309.x; Moret Y, 2001, NATURE, V414, P506, DOI 10.1038/35107138; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; NIJHOUT MM, 1974, BIOL BULL-US, V146, P377, DOI 10.2307/1540412; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Pham LN, 2008, INSECT IMMUNOLOGY, P97, DOI 10.1016/B978-012373976-6.50007-0; Ragan Emily J., 2009, P34; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Rao XJ, 2010, DEV COMP IMMUNOL, V34, P1119, DOI 10.1016/j.dci.2010.06.007; REINECKE JP, 1980, BIOL BULL-US, V158, P129, DOI 10.2307/1540764; Roth O, 2010, J ANIM ECOL, V79, P403, DOI 10.1111/j.1365-2656.2009.01617.x; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sadd BM, 2009, BIOL LETTERS, V5, P798, DOI 10.1098/rsbl.2009.0458; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Schmid-Hempel P, 2005, BIOESSAYS, V27, P1026, DOI 10.1002/bies.20282; Shi ZH, 2010, J INSECT PHYSIOL, V56, P1696, DOI 10.1016/j.jinsphys.2010.06.013; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Sorrentino RP, 2002, BIOTECHNIQUES, V32, P815, DOI 10.2144/02324st08; Srygley RB, 2012, J INSECT PHYSIOL, V58, P342, DOI 10.1016/j.jinsphys.2011.12.005; Thomas AM, 2010, ECOL ENTOMOL, V35, P200, DOI 10.1111/j.1365-2311.2009.01169.x; Tidbury HJ, 2012, P ROY SOC B-BIOL SCI, V279, P4505, DOI 10.1098/rspb.2012.1841; Tidbury HJ, 2011, P ROY SOC B-BIOL SCI, V278, P871, DOI 10.1098/rspb.2010.1517; Vogelweith F, 2011, FUNCT ECOL, V25, P1241, DOI 10.1111/j.1365-2435.2011.01911.x; Wang ZX, 2011, EXP PARASITOL, V127, P135, DOI 10.1016/j.exppara.2010.07.005; Zanchi C, 2011, J ANIM ECOL, V80, P1174, DOI 10.1111/j.1365-2656.2011.01872.x; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001	57	52	54	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63392	10.1371/journal.pone.0063392	http://dx.doi.org/10.1371/journal.pone.0063392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700423	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400021
J	Gholizadeh, S; Sun, NL; De Jaeger, X; Bechard, M; Coolen, L; Laviolette, SR				Gholizadeh, Shervin; Sun, Ninglei; De Jaeger, Xavier; Bechard, Melanie; Coolen, Lique; Laviolette, Steven R.			Early versus Late-Phase Consolidation of Opiate Reward Memories Requires Distinct Molecular and Temporal Mechanisms in the Amygdala-Prefrontal Cortical Pathway	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; LONG-TERM POTENTIATION; BASOLATERAL AMYGDALA; PROTEIN-SYNTHESIS; NEURONAL PLASTICITY; DOPAMINE TERMINALS; HEROIN-SEEKING; CORTEX; ACTIVATION; RECONSOLIDATION	The consolidation of newly acquired memories involves the temporal transition from a recent, less stable trace to a more permanent consolidated form. Opiates possess potent rewarding effects and produce powerful associative memories. The activation of these memories is associated with opiate abuse relapse phenomena and the persistence of compulsive opiate dependence. However, the neuronal, molecular and temporal mechanisms by which associative opiate reward memories are consolidated are not currently understood. We report that the consolidation of associative opiate reward memories involves a temporal and molecular switch between the basolateral nucleus of the amygdala (BLA) (early consolidation phase) to the medial prefrontal cortex (mPFC) (late consolidation phase). We demonstrate at the molecular, behavioral and neuronal levels that the consolidation of a recently acquired opiate reward memory involves an extracellular signal-related kinase (ERK)-dependent phosphorylation process within the BLA. In contrast, later-stage consolidation of a newly acquired memory is dependent upon a calcium-calmodulin-dependent (CaMKII), ERK-independent, mechanism in the mPFC, over a 12 hr temporal gradient. In addition, using in vivo multi-unit neuronal recordings in the mPFC, we report that protein synthesis within the BLA modulates the consolidation of opiate-reward memory in neuronal mPFC sub-populations, via the same temporal dynamic.	[Gholizadeh, Shervin; Sun, Ninglei; De Jaeger, Xavier; Bechard, Melanie; Coolen, Lique; Laviolette, Steven R.] Univ Western Ontario, Dept Psychiat, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 3K7, Canada	Western University (University of Western Ontario)	Laviolette, SR (corresponding author), Univ Western Ontario, Dept Psychiat, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 3K7, Canada.	steven.laviolette@schulich.uwo.ca	Sun, Ninglei/F-5243-2014	Sun, Ninglei/0000-0002-5803-8613; De Jaeger, Xavier/0000-0003-2511-5659; Coolen, Lique/0000-0003-2920-1116	Canadian Institute of Health Research Grant [MOP82797]; Natural Sciences and Engineering Research Council U.S.R.A. Award	Canadian Institute of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council U.S.R.A. Award	This was supported by the Canadian Institute of Health Research Grant # MOP82797 and an Natural Sciences and Engineering Research Council U.S.R.A. Award to M.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RC, 2006, NEUROSCI LETT, V395, P93, DOI 10.1016/j.neulet.2005.10.057; Alvarez-Jaimes L, 2005, J PHARMACOL EXP THER, V314, P1144, DOI 10.1124/jpet.105.086140; Berhow MT, 1996, J NEUROSCI, V16, P4707; Bishop SF, 2011, CEREB CORTEX, V21, P68, DOI 10.1093/cercor/bhq060; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Carr DB, 2000, J COMP NEUROL, V425, P275, DOI 10.1002/1096-9861(20000918)425:2<275::AID-CNE9>3.0.CO;2-Z; Carr DB, 1999, J NEUROSCI, V19, P11049, DOI 10.1523/JNEUROSCI.19-24-11049.1999; Daglish MRC, 2001, AM J PSYCHIAT, V158, P1680, DOI 10.1176/appi.ajp.158.10.1680; De Jaeger X, 2013, PSYCHOPHARMACOLOGY, V225, P687, DOI 10.1007/s00213-012-2852-4; Floresco SB, 2007, J NEUROSCI, V27, P2045, DOI 10.1523/JNEUROSCI.5474-06.2007; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Frankland PW, 2006, LEARN MEMORY, V13, P451, DOI 10.1101/lm.183406; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frenois F, 2005, J NEUROSCI, V25, P1366, DOI 10.1523/JNEUROSCI.3090-04.2005; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Igaz LM, 2006, CELL MOL NEUROBIOL, V26, P989, DOI 10.1007/s10571-006-9116-y; Izquierdo I, 1998, NATURE, V393, P635, DOI 10.1038/31371; Kroner S, 2005, J NEUROPHYSIOL, V93, P1598, DOI 10.1152/jn.00843.2004; Lai YT, 2008, NEUROBIOL LEARN MEM, V90, P164, DOI 10.1016/j.nlm.2008.03.006; Langleben DD, 2008, AM J PSYCHIAT, V165, P390, DOI 10.1176/appi.ajp.2007.07010070; Languille S, 2009, EUR J NEUROSCI, V30, P1923, DOI 10.1111/j.1460-9568.2009.06971.x; Laviolette SR, 2005, J NEUROSCI, V25, P6066, DOI 10.1523/JNEUROSCI.1168-05.2005; Laviolette SR, 2004, NAT NEUROSCI, V7, P160, DOI 10.1038/nn1182; Laviolette SR, 2006, J NEUROSCI, V26, P6458, DOI 10.1523/JNEUROSCI.0707-06.2006; Lintas A, 2011, J NEUROSCI, V31, P11172, DOI 10.1523/JNEUROSCI.1781-11.2011; Luo F, 2004, NEUROIMAGE, V22, P1328, DOI 10.1016/j.neuroimage.2004.03.017; Maroun M, 2003, J NEUROSCI, V23, P4406; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Miller CA, 2005, NEURON, V47, P873, DOI 10.1016/j.neuron.2005.08.006; Nader K, 1997, J NEUROSCI, V17, P383, DOI 10.1523/JNEUROSCI.17-01-00383.1997; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Olmstead MC, 1997, BEHAV NEUROSCI, V111, P1324, DOI 10.1037/0735-7044.111.6.1324; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Schafe GE, 2000, J NEUROSCI, V20, P8177; Shalev U, 2003, BEHAV BRAIN RES, V145, P79, DOI 10.1016/S0166-4328(03)00103-7; Sun NL, 2012, PSYCHOPHARMACOLOGY, V222, P645, DOI 10.1007/s00213-012-2665-5; Sun NL, 2011, CEREB CORTEX, V21, P2665, DOI 10.1093/cercor/bhr031; Tan HB, 2010, CEREB CORTEX, V20, P1486, DOI 10.1093/cercor/bhp210; Valjent E, 2006, P NATL ACAD SCI USA, V103, P2932, DOI 10.1073/pnas.0511030103; Valjent E, 1999, J NEUROSCI, V19, P8685; Wu J, 2006, J NEUROPHYSIOL, V95, P3519, DOI 10.1152/jn.01235.2005; Yim AJ, 2006, BEHAV BRAIN RES, V171, P162, DOI 10.1016/j.bbr.2006.03.031	46	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63612	10.1371/journal.pone.0063612	http://dx.doi.org/10.1371/journal.pone.0063612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696837	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900045
J	Jiao, SH; Chu, Q; Wang, YC; Xie, ZQ; Hou, SY; Liu, AR; Wu, HJ; Liu, L; Geng, FJ; Wang, CY; Qin, CH; Tan, R; Huang, XX; Tan, SX; Wu, M; Xu, XZ; Liu, X; Yu, Y; Zhang, Y				Jiao, Shihui; Chu, Qin; Wang, Yachun; Xie, Zhenquan; Hou, Shiyu; Liu, Airong; Wu, Hongjun; Liu, Lin; Geng, Fanjun; Wang, Congyong; Qin, Chunhua; Tan, Rui; Huang, Xixia; Tan, Shixin; Wu, Meng; Xu, Xianzhou; Liu, Xuan; Yu, Ying; Zhang, Yuan			Identification of the Causative Gene for Simmental Arachnomelia Syndrome Using a Network-Based Disease Gene Prioritization Approach	PLOS ONE			English	Article							CATTLE; ASSOCIATION	Arachnomelia syndrome (AS), mainly found in Brown Swiss and Simmental cattle, is a congenital lethal genetic malformation of the skeletal system. In this study, a network-based disease gene prioritization approach was implemented to rank genes in the previously reported similar to 7 Mb region on chromosome 23 associated with AS in Simmental cattle. The top 6 ranked candidate genes were sequenced in four German Simmental bulls, one known AS-carrier ROMEL and a pooled sample of three known non-carriers (BOSSAG, RIFURT and HIRMER). Two suspicious mutations located in coding regions, a mis-sense mutation c.1303G>A in the bystin-like (BYSL) gene and a 2-bp deletion mutation c.1224_1225delCA in the molybdenum cofactor synthesis step 1 (MOCS1) gene were detected. Bioinformatic analysis revealed that the mutation in MOCS1 was more likely to be the causative mutation. Screening the c.1224_1225delCA site in 383 individuals from 12 cattle breeds/lines, we found that only the bull ROMEL and his 12 confirmed progeny carried the mutation. Thus, our results confirm the conclusion of Buitkamp et al. that the 2-bp deletion mutation c.1224_1225delCA in exon 11 of the MOCS1 gene is causative for AS in Simmental cattle. Furthermore, a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was developed to detect the causative mutation.	[Jiao, Shihui; Wang, Yachun; Liu, Xuan; Yu, Ying; Zhang, Yuan] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Agr Anim & Breeding, Beijing 100094, Peoples R China; [Chu, Qin] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing, Peoples R China; [Xie, Zhenquan; Hou, Shiyu] Anshan Hengli Dairy Farm, Anshan, Liaoning, Peoples R China; [Wu, Hongjun] Hailaer Farm Buro, Xiertala Breeding Farm, Hailaer, Inner Mongolia, Peoples R China; [Liu, Airong] Hailaer Farm Buro, Hailaer, Inner Mongolia, Peoples R China; [Liu, Lin] Beijing Dairy Cattle Ctr, Beijing, Peoples R China; [Geng, Fanjun; Wang, Congyong] Dingyuan Seedstock Bulls Breeding Ltd Co, Zhengzhou, Henan, Peoples R China; [Qin, Chunhua] Ningxia Sygen BioEngn Res Ctr, Ningxia, Peoples R China; [Tan, Rui] Xinjiang Gen Livestock Serv, Urumqi, Xinjiang, Peoples R China; [Huang, Xixia] Xinjiang Agr Univ, Coll Anim Sci, Urumqi, Xinjiang, Peoples R China; [Tan, Shixin] Xinjiang Tianshan Anim Husb Bioengn Co Ltd, Urumqi, Xinjiang, Peoples R China; [Wu, Meng; Xu, Xianzhou] Dalian Xuelong Ind Ltd Grp, Dalian, Liaoning, Peoples R China	China Agricultural University; Beijing Academy of Agriculture & Forestry; Xinjiang Agricultural University	Wang, YC (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Agr Anim & Breeding, Beijing 100094, Peoples R China.	wangyachun@cau.edu.cn			National Key Technologies R D Program [2011BAD28B02]; China Agriculture Research System [CARS-37]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	National Key Technologies R D Program(National Key Technology R&D Program); China Agriculture Research System; Program for Changjiang Scholar and Innovation Research Team in University	This work is supported by the National Key Technologies R & D Program (2011BAD28B02), China Agriculture Research System (CARS-37), and the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetturo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012742; Bloch-Zupan A, 2011, AM J HUM GENET, V89, P773, DOI 10.1016/j.ajhg.2011.11.002; Buitkamp J, 2009, ANIM GENET, V40, P894, DOI 10.1111/j.1365-2052.2009.01933.x; Buitkamp J, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-11; Buitkamp J, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-39; Diribarne M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019281; Drogemuller C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001079; Drogemuller C, 2009, MAMM GENOME, V20, P53, DOI 10.1007/s00335-008-9157-2; Hettema JM, 2011, BIOL PSYCHIAT, V70, P888, DOI 10.1016/j.biopsych.2011.07.012; Jiang L, 2012, PHYSIOL GENOMICS, V44, P305, DOI 10.1152/physiolgenomics.00047.2011; Liu X, 2008, POULTRY SCI, V87, P1314, DOI 10.3382/ps.2007-00512; Masoudi-Nejad A, 2012, MOL GENET GENOMICS, V287, P679, DOI 10.1007/s00438-012-0710-z; Mccarthy C, 1998, CHROMAS 1 45; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Rieck G W, 1975, Dtsch Tierarztl Wochenschr, V82, P342; Salunkhe AS, 2011, MOL BIOTECHNOL, V49, P90, DOI 10.1007/s12033-011-9382-x; Seichter D, 2011, ANIM GENET, V42, P544, DOI 10.1111/j.1365-2052.2010.02167.x; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506	19	6	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64468	10.1371/journal.pone.0064468	http://dx.doi.org/10.1371/journal.pone.0064468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696895	gold, Green Published, Green Submitted			2022-12-27	WOS:000319081900098
J	Pruss-Ustun, A; Wolf, J; Driscoll, T; Degenhardt, L; Neira, M; Calleja, JMG				Pruess-Ustuen, Annette; Wolf, Jennyfer; Driscoll, Tim; Degenhardt, Louisa; Neira, Maria; Calleja, Jesus Maria Garcia			HIV Due to Female Sex Work: Regional and Global Estimates	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; INJECTION-DRUG USE; YUNNAN-PROVINCE; BRIDGING GROUPS; RISK BEHAVIORS; PREVALENCE; INTERVENTIONS; PREVENTION; TRANSMISSION; DYNAMICS	Introduction: Female sex workers (FSWs) are at high risk of HIV infection. Our objective was to determine the proportion of HIV prevalence in the general female adult population that is attributable to the occupational exposure of female sex work, due to unprotected sexual intercourse. Methods: Population attributable fractions of HIV prevalence due to female sex work were estimated for 2011. A systematic search was conducted to retrieve required input data from available sources. Data gaps of HIV prevalence in FSWs for 2011 were filled using multilevel modeling and multivariate linear regression. The fraction of HIV attributable to female sex work was estimated as the excess HIV burden in FSWs deducting the HIV burden in FSWs due to injecting drug use. Results: An estimated fifteen percent of HIV in the general female adult population is attributable to (unsafe) female sex work. The region with the highest attributable fraction is Sub Saharan Africa, but the burden is also substantial for the Caribbean, Latin America and South and Southeast Asia. We estimate 106,000 deaths from HIV are a result of female sex work globally, 98,000 of which occur in Sub-Saharan Africa. If HIV prevalence in other population groups originating from sexual contact with FSWs had been considered, the overall attributable burden would probably be much larger. Discussion: Female sex work is an important contributor to HIV transmission and the global HIV burden. Effective HIV prevention measures exist and have been successfully targeted at key populations in many settings. These must be scaled up. Conclusion: FSWs suffer from high HIV burden and are a crucial core population for HIV transmission. Surveillance, prevention and treatment of HIV in FSWs should benefit both this often neglected vulnerable group and the general population.	[Pruess-Ustuen, Annette; Wolf, Jennyfer; Neira, Maria] WHO, Dept Publ Hlth & Environm, CH-1211 Geneva, Switzerland; [Driscoll, Tim] Univ Sydney, Sydney Med Sch, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Sch Populat Hlth, Melbourne, Vic, Australia; [Calleja, Jesus Maria Garcia] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland	World Health Organization; University of Sydney; University of New South Wales Sydney; University of Melbourne; World Health Organization	Pruss-Ustun, A (corresponding author), WHO, Dept Publ Hlth & Environm, CH-1211 Geneva, Switzerland.	pruessa@who.int	Degenhardt, Louisa J/D-4515-2012	Degenhardt, Louisa J/0000-0002-8513-2218				Aceijas C, 2006, SEX TRANSM INFECT, V82, P344, DOI 10.1136/sti.2005.019471.corr.1; Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Breen C, 2005, DRUG ALCOHOL REV, V24, P353, DOI 10.1080/09595230500263871; Bruckova M, 2006, AM J TROP MED HYG, V75, P1017, DOI 10.4269/ajtmh.2006.75.1017; Burgos JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011413; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Chew L, 1998, PROSTITUTION MIGRATI; Cote AM, 2004, AIDS, V18, P917, DOI [10.1097/01.aids.0000111475.61782.98, 10.1097/00002030-200404090-00009]; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Farias MSD, 2011, INT J INFECT DIS, V15, pE635, DOI 10.1016/j.ijid.2011.05.007; EuroHIV, 2006, HIV AIDS SURV EUR; Fazito E, 2012, SEX TRANSM INFECT, V88, pI24, DOI 10.1136/sextrans-2012-050647; Fung ICH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-195; Gaffey MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022704; Ghys PD, 2001, AIDS, V15, pS33, DOI 10.1097/00002030-200104003-00005; Goldstein Harvey, 2010, MULTILEVEL STAT MODE; Government of Canada Public Health Agency of Canada, INF DIS HIV AIDS REP; Groneberg DA, 2006, LANCET, V368, P840, DOI 10.1016/S0140-6736(06)69324-0; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; Hawken MP, 2002, SEX TRANSM INFECT, V78, P271, DOI 10.1136/sti.78.4.271; Hesketh T, 2005, AIDS CARE, V17, P958, DOI 10.1080/09540120500100676; ICF International, 2012, PERC MEN RESP REP SE; International Harm Reduction Program (IHRD) Open Society Institute, 2008, HARM RED DEV 2008 CO; IOM, 2011, INT BIOL BEH SURV SU; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Laga M, 2012, AIDS, V26, P1223, DOI 10.1097/QAD.0b013e32835462b8; Lau JTF, 2008, DRUG ALCOHOL DEPEN, V97, P54, DOI 10.1016/j.drugalcdep.2008.03.024; Lowndes CM, 2007, SEX TRANSM INFECT, V83, P577, DOI 10.1136/sti.2007.027441; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; Magnani R, 2010, SEX TRANSM INFECT, V86, P393, DOI 10.1136/sti.2009.038059; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McInnes CW, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-5; Medhi GK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-273; Miller CL, 2011, CAN MED ASSOC J, V183, P1147, DOI 10.1503/cmaj.101257; Monitoring the AIDS epidemic (MAP), 2005, SEX WORK HIV AIDS AS; Monitoring the AIDS pandemic (MAP), 2005, DRUG INJ HIV AIDS AS; National Epidemiology Center Department of Health, 2005, INT HIV BEH SER SURV; Needle R, 2008, SOC SCI MED, V67, P1447, DOI 10.1016/j.socscimed.2008.06.031; Ota E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006045.pub3; Prinja S, 2011, SEX TRANSM INFECT, V87, P354, DOI 10.1136/sti.2010.047829; Pyett PM, 1997, AIDS CARE, V9, P539, DOI 10.1080/713613193; Ray S, 2001, J URBAN HEALTH, V78, P581, DOI 10.1093/jurban/78.4.581; Riedner G, 2006, AIDS, V20, P609, DOI 10.1097/01.aids.0000210616.90954.47; Rodriguez CM, 2002, AIDS, V16, pS34, DOI 10.1097/00002030-200212003-00006; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Ross MW, 2012, SCAND J WORK ENV HEA, V38, P105, DOI 10.5271/sjweh.3184; Rothman KJ, 2008, MODERN EPIDEMIOLOGY; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001; TAMPEP International Foundation, 2009, SEX WORK EUR MAPP PR; Toledo CA, 2010, AIDS EDUC PREV, V22, P299, DOI 10.1521/aeap.2010.22.4.299; *UNAIDS, 2008, 2008 REP GLOB AIDS E; UNAIDS, 2008, UNAIDS FAQS WHO IS B; UNAIDS, 2012, GLOBAL REPORT UNAIDS; UNAIDS, 2011, WORLD AIDS DAY REP 2; UNAIDS, 2012, UNGASS COUNTR REP; UNAIDS, 2010, REP GLOB AIDS EP; UNAIDS, 2012, UNAIDS GUID NOT HIV; UNAIDS, 2006, REP GLOB AIDS EP; UNAIDS, 2022, HIV AIDS DAT HUB AS; UNAIDS World Bank, 2010, NEW HIV INF MOD TRAN; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Vuylsteke B, 2012, SEX TRANSM INFECT, V88, P288, DOI 10.1136/sextrans-2011-050276; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wariki WMV, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005272.pub3; Weller S, 2002, Cochrane Database Syst Rev, pCD003255; WHO, 2012, WHO DEF REG GROUP; WHO, 2011, DIS INJ REG EST CAUS; WHO, 2012, METR POP ATTR FRACT; World Health Organization, 2011, PREV HIV SEX WORK SU; Xu JJ, 2011, SEX TRANSM DIS, V38, P89, DOI 10.1097/OLQ.0b013e3181f0bc5e; Zhao J, 2011, AIDS BEHAV, V15, P635, DOI 10.1007/s10461-010-9786-9	77	104	105	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63476	10.1371/journal.pone.0063476	http://dx.doi.org/10.1371/journal.pone.0063476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	151BM	23717432	Green Published, gold			2022-12-27	WOS:000319435600018
J	Turner, K; Reynolds-May, MF; Zitek, EM; Tisdale, RL; Carlisle, AB; Westphal, LM				Turner, Kathy; Reynolds-May, Margaret F.; Zitek, Emily M.; Tisdale, Rebecca L.; Carlisle, Allison B.; Westphal, Lynn M.			Stress and Anxiety Scores in First and Repeat IVF Cycles: A Pilot Study	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; SELF-EFFICACY; GROUP INTERVENTION; INFERTILE WOMEN; PREGNANCY RATES; ADJUSTMENT; ACUPUNCTURE	Background: The role of stress in reproduction, particularly during treatment for infertility, has been of considerable interest; however, few studies have objectively measured stress and anxiety over the course of the IVF cycle or compared the experience of first-time and repeat patients. Methods: This prospective cohort pilot study enrolled 44 women undergoing IVF at a university-based clinic to complete the State-Trait Anxiety Inventory (STAI), Perceived Stress Scale (PSS) and Infertility Self-Efficacy Scale (ISES) at three time points prior to ovarian stimulation (T1), one day prior to oocyte retrieval (T2), and 5-7 days post embryo transfer (T3). Results: Mean STAI State scores were significantly elevated at all three time points (p<0.01). STAI State and PSS mean values did not change over time and did not differ in first-time vs. repeat patients. Self-efficacy (ISES) scores declined over time, with a greater decline for repeat patients. Of the 36 women who completed a cycle, 15 achieved clinical pregnancy. Using logistic regression modeling, all scores at T2 were correlated with pregnancy outcome with lower scores on the STAI State and PSS and higher scores on the ISES associated with higher pregnancy rates. Conclusions: Stress and anxiety levels remained elevated across all cycles. Women with lower stress and anxiety levels on the day prior to oocyte retrieval had a higher pregnancy rate. These results emphasize the need to investigate stress reduction modalities throughout the IVF cycle.	[Turner, Kathy; Tisdale, Rebecca L.; Carlisle, Allison B.; Westphal, Lynn M.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Reynolds-May, Margaret F.] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA; [Zitek, Emily M.] Stanford Univ, Sch Med, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Westphal, LM (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	lynnw@stanford.edu		Tisdale, Rebecca/0000-0003-2749-6889				Ardenti R, 1999, HUM REPROD, V14, P3126, DOI 10.1093/humrep/14.12.3126; Arnetz BB, 2006, STRESS HLTH DIS; Balk Judith, 2010, Complement Ther Clin Pract, V16, P154, DOI 10.1016/j.ctcp.2009.11.004; Beerendonk C, 1999, J PSYCHOSOM OBST GYN, V20, P97, DOI 10.3109/01674829909075582; Bloch M, 2011, FERTIL STERIL, V95, P307, DOI 10.1016/j.fertnstert.2010.07.1073; BOIVIN J, 1995, FERTIL STERIL, V64, P802, DOI 10.1016/S0015-0282(16)57858-3; Boivin J, 2003, SOC SCI MED, V57, P2325, DOI 10.1016/S0277-9536(03)00138-2; Bringhenti F, 1997, ACTA OBSTET GYN SCAN, V76, P431, DOI 10.3109/00016349709047824; Campagne DM, 2006, HUM REPROD, V21, P1651, DOI 10.1093/humrep/del078; Chan CHY, 2006, FERTIL STERIL, V85, P339, DOI 10.1016/j.fertnstert.2005.07.1310; COHEN S, 1988, CLAR SYMP, P31; Cousineau TM, 2006, FERTIL STERIL, V85, P1684, DOI 10.1016/j.fertnstert.2005.10.077; Csemiczky G, 2000, ACTA OBSTET GYN SCAN, V79, P113, DOI 10.1034/j.1600-0412.2000.079002113.x; de Klerk C, 2008, HUM REPROD, V23, P112, DOI 10.1093/humrep/dem357; DEMYTTENAERE K, 1994, GYNECOL ENDOCRINOL, V8, P233, DOI 10.3109/09513599409023626; Domar AD, 2000, FERTIL STERIL, V73, P805, DOI 10.1016/S0015-0282(99)00493-8; Eugster A, 1999, SOC SCI MED, V48, P575, DOI 10.1016/S0277-9536(98)00386-4; Galhardo A, 2013, RES NURS HEALTH, V36, P65, DOI 10.1002/nur.21516; Gallinelli A, 2001, FERTIL STERIL, V76, P85, DOI 10.1016/S0015-0282(01)01826-X; Harlow CR, 1996, HUM REPROD, V11, P274, DOI 10.1093/HUMREP/11.2.274; Hosaka T, 2002, GEN HOSP PSYCHIAT, V24, P353, DOI 10.1016/S0163-8343(02)00194-9; Kee BS, 2000, J ASSIST REPROD GEN, V17, P445; Klonoff-Cohen H, 2001, FERTIL STERIL, V76, P675, DOI 10.1016/S0015-0282(01)02008-8; Kovarova P, 2010, EXPLORE-NY, V6, P330, DOI 10.1016/j.explore.2010.06.002; Lee TY, 2000, ARCH ANDROLOGY, V45, P149; Li W, 2012, REPROD BIOMED ONLINE, V25, P180, DOI 10.1016/j.rbmo.2012.03.012; Lintsen AME, 2009, HUM REPROD, V24, P1092, DOI 10.1093/humrep/den491; Lovely LP, 2003, SOUTH MED J, V96, P548, DOI 10.1097/01.SMJ.0000054567.79881.E9; Mahajan NN, 2010, FERTIL STERIL, V93, P517, DOI 10.1016/j.fertnstert.2008.12.054; MERARI D, 1992, J ASSIST REPROD GEN, V9, P161, DOI 10.1007/BF01203757; Milad MP, 1998, HUM REPROD, V13, P2296, DOI 10.1093/humrep/13.8.2296; Pinto-Gouveia J, 2012, HUM FERTIL, V15, P27, DOI 10.3109/14647273.2011.654310; Sanders KA, 1999, HUM REPROD, V14, P1656, DOI 10.1093/humrep/14.6.1656; Schetter Christine Dunkel, 1991, INFERTILITY PERSPECT, P29, DOI DOI 10.1007/978-1-4899-0753-0_3; Serafini P, 2009, INT J GYNECOL OBSTET, V105, P136, DOI 10.1016/j.ijgo.2008.12.013; Smith CA, 2011, J ALTERN COMPLEM MED, V17, P923, DOI 10.1089/acm.2010.0380; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stoleru S, 1997, J PSYCHOSOM OBST GYN, V18, P189, DOI 10.3109/01674829709080688; Terzioglu F, 2001, J PSYCHOSOM OBST GYN, V22, P133, DOI 10.3109/01674820109049965; Tiplady S, 2013, HUM REPROD, V28, P138, DOI 10.1093/humrep/des372; Verhaak CM, 2007, HUM REPROD UPDATE, V13, P27, DOI 10.1093/humupd/dml040; Wichman CL, 2011, FERTIL STERIL, V95, P717, DOI 10.1016/j.fertnstert.2010.09.043; Yong P, 2000, J ASSIST REPROD GEN, V17, P553, DOI 10.1023/A:1026429712794	43	84	88	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63743	10.1371/journal.pone.0063743	http://dx.doi.org/10.1371/journal.pone.0063743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	151BM	23717472	Green Submitted, Green Published, gold			2022-12-27	WOS:000319435600030
J	Auvinen, HE; Wang, YA; Princen, H; Romijn, JA; Havekes, LM; Smit, JWA; Meijer, OC; Biermasz, NR; Rensen, PCN; Pereira, AM				Auvinen, Hanna E.; Wang, Yanan; Princen, Hans; Romijn, Johannes A.; Havekes, Louis M.; Smit, Johannes W. A.; Meijer, Onno C.; Biermasz, Nienke R.; Rensen, Patrick C. N.; Pereira, Alberto M.			Both Transient and Continuous Corticosterone Excess Inhibit Atherosclerotic Plaque Formation in APOE*3-Leiden.CETP Mice	PLOS ONE			English	Article							ESTER TRANSFER PROTEIN; INCREASES HDL-CHOLESTEROL; CUSHINGS-DISEASE; CARDIOVASCULAR RISK; BODY-COMPOSITION; TRANSGENIC MICE; ACTIVE DISEASE; DEXAMETHASONE; EXPRESSION; OBESITY	Introduction: The role of glucocorticoids in atherosclerosis development is not clearly established. Human studies show a clear association between glucocorticoid excess and cardiovascular disease, whereas most animal models indicate an inhibitory effect of glucocorticoids on atherosclerosis development. These animal models, however, neither reflect long-term glucocorticoid overexposure nor display human-like lipoprotein metabolism. Aim: To investigate the effects of transient and continuous glucocorticoid excess on atherosclerosis development in a mouse model with human-like lipoprotein metabolism upon feeding a Western-type diet. Methods: Pair-housed female APOE*3-Leiden.CETP (E3L.CETP) mice fed a Western-type containing 0.1% cholesterol for 20 weeks were given corticosterone (50 mu g/ml) for either 5 (transient group) or 17 weeks (continuous group), or vehicle (control group) in the drinking water. At the end of the study, atherosclerosis severity, lesion area in the aortic root, the number of monocytes adhering to the endothelial wall and macrophage content of the plaque were measured. Results: Corticosterone treatment increased body weight and food intake for the duration of the treatment and increased gonadal and subcutaneous white adipose tissue weight in transient group by +35% and +31%, and in the continuous group by +140% and 110%. Strikingly, both transient and continuous corticosterone treatment decreased total atherosclerotic lesion area by -39% without lowering plasma cholesterol levels. In addition, there was a decrease of -56% in macrophage content of the plaque with continuous corticosterone treatment, and a similar trend was present with the transient treatment. Conclusion: Increased corticosterone exposure in mice with human-like lipoprotein metabolism has beneficial, long-lasting effects on atherosclerosis, but negatively affects body fat distribution by promoting fat accumulation in the long-term. This indicates that the increased atherosclerosis observed in humans in states of glucocorticoid excess may not be related to cortisol per se, but might be the result of complex indirect effects of cortisol.	[Auvinen, Hanna E.; Wang, Yanan; Romijn, Johannes A.; Havekes, Louis M.; Smit, Johannes W. A.; Meijer, Onno C.; Biermasz, Nienke R.; Rensen, Patrick C. N.; Pereira, Alberto M.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Princen, Hans; Havekes, Louis M.] TNO Metab Hlth Res, Gaubius Lab, Leiden, Netherlands; [Romijn, Johannes A.] Univ Amsterdam, Acad Med Ctr, Dept Med, NL-1105 AZ Amsterdam, Netherlands; [Auvinen, Hanna E.; Wang, Yanan; Havekes, Louis M.; Meijer, Onno C.; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Auvinen, HE (corresponding author), Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands.	h.e.auvinen@lumc.nl	Princen, Hans MG/AID-9392-2022; meijer, onno c/D-8070-2018; Wang, Yanan/C-4143-2019; Pereira, Alberto M./Q-7175-2017; Biermasz, Nienke/ABE-9436-2021; Smit, J.W.A./H-8091-2014; Rensen, Patrick C.N./D-7176-2018	Princen, Hans MG/0000-0002-7206-1596; meijer, onno c/0000-0002-8394-6859; Wang, Yanan/0000-0002-0327-0458; Pereira, Alberto M./0000-0002-1194-9866; Biermasz, Nienke/0000-0001-5817-3594; Smit, J.W.A./0000-0003-1052-9314; Rensen, Patrick C.N./0000-0002-8455-4988				Albiger N, 2006, HORM METAB RES, V38, P405, DOI 10.1055/s-2006-944545; Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; ASAI K, 1993, ARTERIOSCLER THROMB, V13, P892, DOI 10.1161/01.ATV.13.6.892; BAILEY JM, 1985, ATHEROSCLEROSIS, V54, P205; Barahona MJ, 2009, J CLIN ENDOCR METAB, V94, P3365, DOI 10.1210/jc.2009-0766; Bell ME, 2000, J NEUROENDOCRINOL, V12, P461; Bergthorsdottir R, 2006, J CLIN ENDOCR METAB, V91, P4849, DOI 10.1210/jc.2006-0076; Bernberg E, 2008, STRESS, V11, P381, DOI 10.1080/10253890701824051; Bernberg E, 2009, ATHEROSCLEROSIS, V204, P90, DOI 10.1016/j.atherosclerosis.2008.08.013; Bhatnagar S, 2000, J NEUROENDOCRINOL, V12, P453; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Caprio M, 2008, CIRC RES, V102, P1359, DOI 10.1161/CIRCRESAHA.108.174235; Colao A, 1999, J CLIN ENDOCR METAB, V84, P2664, DOI 10.1210/jc.84.8.2664; Dalm S, 2008, J NEUROSCI METH, V170, P77, DOI 10.1016/j.jneumeth.2007.12.021; de Haan W, 2008, CIRCULATION, V117, P2515, DOI 10.1161/CIRCULATIONAHA.107.761965; de Haan W, 2008, ATHEROSCLEROSIS, V197, P57, DOI 10.1016/j.atherosclerosis.2007.08.001; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dekkers OM, 2007, J CLIN ENDOCR METAB, V92, P976, DOI 10.1210/jc.2006-2112; Deuchar GA, 2011, ENDOCRINOLOGY, V152, P236, DOI 10.1210/en.2010-0925; Faggiano A, 2003, J CLIN ENDOCR METAB, V88, P2527, DOI 10.1210/jc.2002-021558; Feelders RA, 2012, EUR J ENDOCRINOL, V167, P311, DOI 10.1530/EJE-11-1095; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Garcia RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053192; Geer EB, 2012, J CLIN ENDOCR METAB, V97, P1702, DOI 10.1210/jc.2011-3123; Gijbels MJJ, 1999, ATHEROSCLEROSIS, V143, P15, DOI 10.1016/S0021-9150(98)00263-9; Giordano R, 2011, CLIN ENDOCRINOL, V75, P354, DOI 10.1111/j.1365-2265.2011.04055.x; GORDON D, 1954, J EXP MED, V99, P371, DOI 10.1084/jem.99.4.371; Gounarides JS, 2008, ENDOCRINOLOGY, V149, P758, DOI 10.1210/en.2007-1214; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kuhnast S, 2012, J HYPERTENS, V30, P107, DOI 10.1097/HJH.0b013e32834ddd8e; Kumari M, 2003, STRESS, V6, P297, DOI 10.1080/10253890310001619461; la Fleur SE, 2004, ENDOCRINOLOGY, V145, P2174, DOI 10.1210/en.2003-1359; Laskowitz DT, 2000, J LIPID RES, V41, P613; Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225; Mancini T, 2004, CLIN ENDOCRINOL, V61, P768, DOI 10.1111/j.1365-2265.2004.02168.x; Mather K, 2009, AM J PHYSIOL-ENDOC M, V296, pE398, DOI 10.1152/ajpendo.90889.2008; McNeill E, 2010, CLIN SCI, V118, P641, DOI 10.1042/CS20090488; NAITO M, 1992, J NUTR SCI VITAMINOL, V38, P255, DOI 10.3177/jnsv.38.255; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; OPPENHEIM E, 1952, AMA ARCH PATHOL, V53, P520; Pasquali R, 2006, ANN NY ACAD SCI, V1083, P111, DOI 10.1196/annals.1367.009; Popova A, 2011, IMMUNOBIOLOGY, V216, P164, DOI 10.1016/j.imbio.2010.06.003; Resmini E, 2010, HORM METAB RES, V42, P613, DOI 10.1055/s-0030-1255032; Roelfsema F, 1998, J CLIN ENDOCR METAB, V83, P688, DOI 10.1210/jc.83.2.688; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sakai M, 1999, ARTERIOSCL THROM VAS, V19, P1726, DOI 10.1161/01.ATV.19.7.1726; Strecker EP, 1998, CARDIOVASC INTER RAD, V21, P487, DOI 10.1007/s002709900309; van der Hoogt CC, 2007, J LIPID RES, V48, P1763, DOI 10.1194/jlr.M700108-JLR200; van der Hoorn JWA, 2008, ARTERIOSCL THROM VAS, V28, P2016, DOI 10.1161/ATVBAHA.108.171363; van der Pas R, 2012, J CLIN ENDOCR METAB, V97, P1303, DOI 10.1210/jc.2011-2753; van der Sluis RJ, 2012, ATHEROSCLEROSIS, V221, P76, DOI 10.1016/j.atherosclerosis.2011.12.022; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; Volger OL, 2001, ATHEROSCLEROSIS, V157, P375, DOI 10.1016/S0021-9150(00)00750-4; Warne JP, 2009, AM J PHYSIOL-REG I, V296, pR1366, DOI 10.1152/ajpregu.91016.2008; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; Wheller SK, 1997, EUR J PHARMACOL, V331, P65, DOI 10.1016/S0014-2999(97)01015-7; YAMADA K, 1993, ARTERY, V20, P253; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	62	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63882	10.1371/journal.pone.0063882	http://dx.doi.org/10.1371/journal.pone.0063882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717502	Green Published, Green Submitted, gold			2022-12-27	WOS:000320362700074
J	Hwang, J; Alemayehu, BH; Reithinger, R; Tekleyohannes, SG; Teshi, T; Birhanu, SG; Demeke, L; Hoos, D; Melaku, Z; Kassa, M; Jima, D; Malone, JL; Nettey, H; Green, M; Poe, A; Akinyi, S; Udhayakumar, V; Kachur, SP; Filler, S				Hwang, Jimee; Alemayehu, Bereket Hailegiorgis; Reithinger, Richard; Tekleyohannes, Samuel Girma; Teshi, Takele; Birhanu, Sintayehu Gebresillasie; Demeke, Leykun; Hoos, David; Melaku, Zenebe; Kassa, Moges; Jima, Daddi; Malone, Joseph L.; Nettey, Henry; Green, Michael; Poe, Amanda; Akinyi, Sheila; Udhayakumar, Venkatachalam; Kachur, S. Patrick; Filler, Scott			In Vivo Efficacy of Artemether-Lumefantrine and Chloroquine against Plasmodium vivax: A Randomized Open Label Trial in Central Ethiopia	PLOS ONE			English	Article							FALCIPARUM-MALARIA; RESISTANT FALCIPARUM; THERAPEUTIC RESPONSE; PAPUA; ARTEMISININ; POPULATION; SOUTHERN; FAILURE; EPIDEMIOLOGY; INFECTIONS	In Background: In vivo efficacy assessments of antimalarials are essential for ensuring effective case management. In Ethiopia, chloroquine (CQ) without primaquine is the first-line treatment for Plasmodium vivax in malarious areas, but artemether-lumefantrine (AL) is also commonly used. Methods and Findings: In 2009, we conducted a 42-day efficacy study of AL or CQ for P. vivax in Oromia Regional State, Ethiopia. Individuals with P. vivax monoinfection were enrolled. Primary endpoint was day 28 cure rate. In patients with recurrent parasitemia, drug level and genotyping using microsatellite markers were assessed. Using survival analysis, uncorrected patient cure rates at day 28 were 75.7% (95% confidence interval (CI) 66.8-82.5) for AL and 90.8% (95% CI 83.6-94.9) for CQ. During the 42 days of follow-up, 41.6% (47/113) of patients in the AL arm and 31.8% (34/107) in the CQ arm presented with recurrent P. vivax infection, with the median number of days to recurrence of 28 compared to 35 days in the AL and CQ arm, respectively. Using microsatellite markers to reclassify recurrent parasitemias with a different genotype as non-treatment failures, day 28 cure rates were genotype adjusted to 91.1% (95% CI 84.1-95.1) for AL and to 97.2% (91.6-99.1) for CQ. Three patients (2.8%) with recurrent parasitemia by day 28 in the CQ arm were noted to have drug levels above 100 ng/ml. Conclusions: In the short term, both AL and CQ were effective and well-tolerated for P. vivax malaria, but high rates of recurrent parasitemia were noted with both drugs. CQ provided longer post-treatment prophylaxis than AL, resulting in delayed recurrence of parasitemia. Although the current policy of species-specific treatment can be maintained for Ethiopia, the co-administration of primaquine for treatment of P. vivax malaria needs to be urgently considered to prevent relapse infections.	[Hwang, Jimee; Malone, Joseph L.; Nettey, Henry; Green, Michael; Akinyi, Sheila; Udhayakumar, Venkatachalam; Kachur, S. Patrick; Filler, Scott] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA 30329 USA; [Hwang, Jimee] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Alemayehu, Bereket Hailegiorgis; Hoos, David] ICAP Columbia Univ, New York, NY USA; [Reithinger, Richard] US Agcy Int Dev, Addis Ababa, Ethiopia; [Reithinger, Richard] Res Triangle Inst, Washington, DC USA; [Tekleyohannes, Samuel Girma; Teshi, Takele; Birhanu, Sintayehu Gebresillasie; Demeke, Leykun; Melaku, Zenebe] ICAP Columbia Univ, Addis Ababa, Ethiopia; [Kassa, Moges; Jima, Daddi] Ethiopian Hlth & Nutr Res Inst, Addis Ababa, Ethiopia; [Jima, Daddi] Fed Minist Hlth, Addis Ababa, Ethiopia; [Nettey, Henry] Univ Ghana, Sch Pharm, Legon, Ghana; [Poe, Amanda] Atlanta Res & Educ Fdn, Decatur, GA USA; [Filler, Scott] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; United States Agency for International Development (USAID); Research Triangle Institute; Ethiopian Health & Nutrition Research Institute; Federal Ministry of Health - Ethiopia (FMOH); University of Ghana	Hwang, J (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA 30329 USA.	jhwang@cdc.gov	Kachur, Patrick/ABE-7220-2021	Malone, Joseph/0000-0002-5515-6171; Reithinger, Richard/0000-0001-5710-1556	President's Malaria Initiative via the Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development (USAID); Centers for Disease Control and Prevention (CDC)	President's Malaria Initiative via the Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was made possible through support provided by the President's Malaria Initiative via the Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development (USAID), under the terms of an Interagency Agreement with the Centers for Disease Control and Prevention (CDC). The opinions expressed herein are those of the author(s) and do not necessarily reflect the views of the CDC or the USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alene GD, 1996, TROP MED INT HEALTH, V1, P810; [Anonymous], 2003, ASS MON ANT DRUG EFF; Ashley EA, 2007, TROP MED INT HEALTH, V12, P201, DOI 10.1111/j.1365-3156.2006.01785.x; Ashley EA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-154; Baird JK, 2009, ANN TROP PAEDIATR, V29, P251, DOI 10.1179/027249309X12547917868808; BAIRD JK, 1995, J INFECT DIS, V171, P1678, DOI 10.1093/infdis/171.6.1678; Baird JK, 1997, AM J TROP MED HYG, V56, P618, DOI 10.4269/ajtmh.1997.56.618; Baird JK, 1997, AM J TROP MED HYG, V56, P621, DOI 10.4269/ajtmh.1997.56.621; Barnadas C, 2011, ANTIMICROB AGENTS CH, V55, P4479, DOI 10.1128/AAC.01552-10; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; Ethiopia Federal Ministry of Health, 2004, MAL DIAGN TREATM GUI; Ethiopia Federal Ministry of Health, 2010, HLTH HLTH REL IND RE; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Genton Blaise, 2005, Papua New Guinea Medical Journal, V48, P141; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Guthmann JP, 2008, TROP MED INT HEALTH, V13, P91, DOI 10.1111/j.1365-3156.2007.01978.x; Hasugian AR, 2009, ANTIMICROB AGENTS CH, V53, P1094, DOI 10.1128/AAC.01511-08; Hwang J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-209; Imwong M, 2006, MOL BIOL EVOL, V23, P1016, DOI 10.1093/molbev/msj116; Jima D, 2005, East Afr Med J, V82, P391; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Kassa M, 2005, ETHIOPIAN MED J, V43, P181; Ketema T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-177; Ketema T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-46; Koaczinski K, 2007, T ROY SOC TROP MED H, V101, P1081, DOI 10.1016/j.trstmh.2007.06.015; Kurcer MA, 2006, ANN TROP MED PARASIT, V100, P109, DOI 10.1179/136485906X86284; Kurcer MA, 2004, ANN TROP MED PARASIT, V98, P447, DOI 10.1179/000349804225021343; Makanga M, 2006, AM J TROP MED HYG, V74, P991, DOI 10.4269/ajtmh.2006.74.991; Naing C, 2010, T ROY SOC TROP MED H, V104, P695, DOI 10.1016/j.trstmh.2010.08.009; Nash D, 2005, P ROY SOC B-BIOL SCI, V272, P1153, DOI 10.1098/rspb.2004.3026; NIGATU W, 1992, TROP MED PARASITOL, V43, P181; Olana D, 2011, EMERG INFECT DIS, V17, P1336, DOI 10.3201/eid1707.100942; Park SDE, 2001, THESIS U DUBLIN; PATCHEN LC, 1983, J CHROMATOGR, V278, P81, DOI 10.1016/S0378-4347(00)84758-1; Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x; Phyo AP, 2011, CLIN INFECT DIS, V53, P977, DOI 10.1093/cid/cir631; Price RN, 2011, CURR OPIN INFECT DIS, V24, P578, DOI 10.1097/QCO.0b013e32834c61e3; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Ramos JM, 2005, J TRAVEL MED, V12, P155, DOI 10.2310/7060.2005.12304; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Ratcliff A, 2007, T ROY SOC TROP MED H, V101, P351, DOI 10.1016/j.trstmh.2006.06.008; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; Soto J, 2001, AM J TROP MED HYG, V65, P90, DOI 10.4269/ajtmh.2001.65.90; Sumawinata IW, 2003, AM J TROP MED HYG, V68, P416, DOI 10.4269/ajtmh.2003.68.416; Taylor WRJ, 2000, AM J TROP MED HYG, V62, P693, DOI 10.4269/ajtmh.2000.62.693; Teka H, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-220; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Tulu AN, 1996, T ROY SOC TROP MED H, V90, P556, DOI 10.1016/S0035-9203(96)90322-3; WHO, 2006, HDB IMCI INT MAN CHI; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2009, METH SURV ANT DRUG E; Yeshiwondim AK, 2010, ACTA TROP, V113, P105, DOI 10.1016/j.actatropica.2009.10.001; Yohannes AM, 2011, AM J TROP MED HYG, V84, P137, DOI 10.4269/ajtmh.2011.09-0723	57	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63433	10.1371/journal.pone.0063433	http://dx.doi.org/10.1371/journal.pone.0063433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717423	Green Submitted, Green Published, gold			2022-12-27	WOS:000320362700021
J	Power, ML; Emery, S; Gillings, MR				Power, Michelle L.; Emery, Samantha; Gillings, Michael R.			Into the Wild: Dissemination of Antibiotic Resistance Determinants via a Species Recovery Program	PLOS ONE			English	Article							ESCHERICHIA-COLI; INTEGRONS; GENES; POPULATIONS; SALMONELLA; ELEMENTS; STRAINS; HUMANS; WATER	Management strategies associated with captive breeding of endangered species can establish opportunities for transfer of pathogens and genetic elements between human and animal microbiomes. The class 1 integron is a mobile genetic element associated with clinical antibiotic resistance in gram-negative bacteria. We examined the gut microbiota of endangered brush-tail rock wallabies Petrogale penicillata to determine if they carried class 1 integrons. No integrons were detected in 65 animals from five wild populations. In contrast, class 1 integrons were detected in 48% of fecal samples from captive wallabies. The integrons contained diverse cassette arrays that encoded resistance to streptomycin, spectinomycin, and trimethoprim. Evidence suggested that captive wallabies had acquired typical class 1 integrons on a number of independent occasions, and had done so in the absence of strong selection afforded by antibiotic therapy. Sufficient numbers of bacteria containing diverse class 1 integrons must have been present in the general environment occupied by the wallabies to account for this acquisition. The captive wallabies have now been released, in an attempt to bolster wild populations of the species. Consequently, they can potentially spread resistance integrons into wild wallabies and into new environments. This finding highlights the potential for genes and pathogens from human sources to be acquired during captive breeding and to be unwittingly spread to other populations.	[Power, Michelle L.; Emery, Samantha; Gillings, Michael R.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	Power, ML (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	michelle.power@mq.edu.au	Gillings, Michael/AAF-5772-2020; Gillings, Michael R/C-6553-2008	Gillings, Michael/0000-0002-4043-4351; Gillings, Michael R/0000-0002-4043-4351; Power, Michelle/0000-0003-3160-4301	Ian Potter foundation; Australian Research Council [LP110200569]	Ian Potter foundation; Australian Research Council(Australian Research Council)	The funding for this work was provided by the Ian Potter foundation and the Australian Research Council LP110200569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow RS, 2008, J APPL MICROBIOL, V104, P651, DOI 10.1111/j.1365-2672.2007.03572.x; Barlow RS, 2009, J APPL MICROBIOL, V107, P540, DOI 10.1111/j.1365-2672.2009.04240.x; Benavides JA, 2012, APPL ENVIRON MICROB, V78, P4281, DOI 10.1128/AEM.07593-11; Cunningham AA, 1996, CONSERV BIOL, V10, P349, DOI 10.1046/j.1523-1739.1996.10020349.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davies M, 2008, AUSTR VET J, V54, P507; de Vries LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021644; DECC, 2008, REC PLAN BRUSH TAIL; Dolejska M, 2009, J APPL MICROBIOL, V106, P1941, DOI 10.1111/j.1365-2672.2009.04155.x; Frankham R, 2005, ANNU REV GENET, V29, P305; Ghosh S, 2009, APPL MICROBIOL BIOT, V84, P791, DOI 10.1007/s00253-009-2125-2; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; Goncalves A, 2012, LETT APPL MICROBIOL, V54, P73, DOI 10.1111/j.1472-765X.2011.03173.x; Hardwick SA, 2008, FEMS MICROBIOL LETT, V278, P207, DOI 10.1111/j.1574-6968.2007.00992.x; Holmes AJ, 2003, J BACTERIOL, V185, P918, DOI 10.1128/JB.185.3.918-928.2003; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Laroche E, 2009, FEMS MICROBIOL ECOL, V68, P118, DOI 10.1111/j.1574-6941.2009.00655.x; Lunney Daniel, 1997, Australian Mammalogy, V19, P281; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; Nawaz M, 2009, FOODBORNE PATHOG DIS, V6, P553, DOI 10.1089/fpd.2008.0204; Osterblad M, 2001, NATURE, V409, P37, DOI 10.1038/35051173; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Pellegrini C, 2009, J ANTIMICROB CHEMOTH, V63, P901, DOI 10.1093/jac/dkp061; Sato M, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-46; Schaefer AM, 2009, ECOHEALTH, V6, P33, DOI 10.1007/s10393-009-0221-5; Sherley M, 2000, ENVIRON MICROBIOL, V2, P620, DOI 10.1046/j.1462-2920.2000.00145.x; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; Soderquist Todd, 2011, Australian Mammalogy, V33, P202, DOI 10.1071/AM10053; Souza V, 1999, APPL ENVIRON MICROB, V65, P3373; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Taggart DA, 2008, PETROGALE PENICILLAT; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Zhang XY, 2009, MICROB DRUG RESIST, V15, P223, DOI 10.1089/mdr.2009.0905	38	31	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63017	10.1371/journal.pone.0063017	http://dx.doi.org/10.1371/journal.pone.0063017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717399	Green Published, gold			2022-12-27	WOS:000320362700008
J	Zaidi, S; Bigdeli, M; Aleem, N; Rashidian, A				Zaidi, Shehla; Bigdeli, Maryam; Aleem, Noureen; Rashidian, Arash			Access to Essential Medicines in Pakistan: Policy and Health Systems Research Concerns	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; GENERAL-PRACTITIONERS; PRIORITIES	Introduction: Inadequate access to essential medicines is a common issue within developing countries. Policy response is constrained, amongst other factors, by a dearth of in-depth country level evidence. We share here i) gaps related to access to essential medicine in Pakistan; and ii) prioritization of emerging policy and research concerns. Methods: An exploratory research was carried out using a health systems perspective and applying the WHO Framework for Equitable Access to Essential Medicine. Methods involved key informant interviews with policy makers, providers, industry, NGOs, experts and development partners, review of published and grey literature, and consultative prioritization in stakeholder's Roundtable. Findings: A synthesis of evidence found major gaps in essential medicine access in Pakistan driven by weaknesses in the health care system as well as weak pharmaceutical regulation. 7 major policy concerns and 11 emerging research concerns were identified through consultative Roundtable. These related to weaknesses in medicine registration and quality assurance systems, unclear and counterproductive pricing policies, irrational prescribing and sub-optimal drug availability. Available research, both locally and globally, fails to target most of the identified policy concerns, tending to concentrate on irrational prescriptions. It overlooks trans-disciplinary areas of policy effectiveness surveillance, consumer behavior, operational pilots and pricing interventions review. Conclusion: Experience from Pakistan shows that policy concerns related to essential medicine access need integrated responses across various components of the health systems, are poorly addressed by existing evidence, and require an expanded health systems research agenda.	[Zaidi, Shehla; Aleem, Noureen] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Zaidi, Shehla; Aleem, Noureen] Aga Khan Univ, Women & Child Hlth Div, Karachi, Pakistan; [Bigdeli, Maryam] WHO, Alliance Hlth Policy & Syst Res, Geneva, Switzerland; [Rashidian, Arash] Univ Tehran Med Sci, Sch Publ Hlth, Knowledge Utilizat Res Ctr, Tehran, Iran	Aga Khan University; Aga Khan University; World Health Organization; Tehran University of Medical Sciences	Zaidi, S (corresponding author), Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan.	shehla.zaidi@aku.edu		Rashidian, Arash/0000-0002-4005-5183; Zaidi, Shehla/0000-0001-7620-9247	Alliance for Health Policy and Systems Research, WHO-Geneva [E50-APW-273]	Alliance for Health Policy and Systems Research, WHO-Geneva	Alliance for Health Policy and Systems Research, WHO-Geneva. Grant #: E50-APW-273. The funders in call for proposal identified the theme of topic, and specified the type of research to be policy analysis. The grantee shaped the study design, choose appropriate conceptual framework, collected and analyzed the data. The grantee also made the decision to publish and prepared the manuscript.	Adam T, 2009, SYSTEMS THINKING HLT; [Anonymous], 2004, WORLD MED SIT; Azhar S, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-54; Bigdeli M, 2012, HEALTH POLICY PLANN, DOI [10.1093/heapol/czs108, DOI 10.1093/HEAPOL/CZS108]; Bukhari S K S, 2010, East Mediterr Health J, V16 Suppl, pS106; Butt ZA, 2005, INT J QUAL HEALTH C, V17, P307, DOI 10.1093/intqhc/mzi049; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Chokshi M, 2011, ACCESS MED INDIA SET; CIET, 2002, SOC AUD GOV DEL PUBL; Das N., 2001, JPMA (Journal of the Pakistan Medical Association), V51, P74; El-Jardali F, 2010, HEALTH POLICY PLANN, V25, P15, DOI 10.1093/heapol/czp059; Guirsimi K, 2011, IDENTIFICATION QUEST; Hafeez A, 2004, J Pak Med Assoc, V54, P187; Haider Sohail, 1995, JPMA (Journal of the Pakistan Medical Association), V45, P297; Jafar TH, 2005, CIRCULATION, V111, P1278, DOI 10.1161/01.CIR.0000157698.78949.D7; Khowaja L., 2010, LANDSCAPING HLTH FIN; Kusi A, 2011, IDENTIFICATION PRIOR; Lansang MA, 2000, HEALTH POLICY PLANN, V15, P130, DOI 10.1093/heapol/15.2.130; Le Grand A, 1999, HEALTH POLICY PLANN, V14, P89, DOI 10.1093/heapol/14.2.89; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; MOH, 2010, PHARM COUNTR PROF; MOH, 2007, NAT ESS MED LIST PAK; Najmi M H, 1998, J Pak Med Assoc, V48, P73; Ndahindwa, 2011, IDENTIFICATION QUEST; Network, 2002, EDSP BAS SURV REP PR; Network for Consumer Protection, 2006, PRIC AV AFF MED PAK; Nguyen TKC, 2011, IDENTIFICATION PRIOR; NHA, 2009, NAT HLTH ACC PAK; Nishtar S, 2010, CHOKED PIPES REFORMI; Nishtar Sania, 2006, J Pak Med Assoc, V56, pS100; Nizami SQ, 1996, SOC SCI MED, V42, P1133, DOI 10.1016/0277-9536(95)00386-X; Oliveira MA, 2011, IDENTIFICATION PRIOR; Patouillard Edith, 2007, Int J Equity Health, V6, P17, DOI 10.1186/1475-9276-6-17; Rabbani F, 2001, J Pak Med Assoc, V51, P149; Ranson K, 2010, SOC SCI MED, V70, P1933, DOI 10.1016/j.socscimed.2010.01.051; Ranson Michael K, 2009, Health Res Policy Syst, V7, P27, DOI 10.1186/1478-4505-7-27; Ranson MK, 2010, B WORLD HEALTH ORGAN, V88, P435, DOI 10.2471/BLT.09.066290; Rashidian A, 2011, IDENTIFICATION PRIOR; Shehzadi Romana, 2005, JPMA Journal of the Pakistan Medical Association, V55, P174; Shiwani Muhammad Hanif, 2006, J Pak Med Assoc, V56, P249; Siddiqi S, 2002, INT J HEALTH PLAN M, V17, P23, DOI 10.1002/hpm.650; Sohail A, 2005, PAKISTAN ARMED FORCE; Stevens P., 2006, PROBLEMS SOLUTIONS; Strum AW, 1997, J ANTIMICROB CHEMOTH, V39, P543, DOI 10.1093/jac/39.4.543; Syhakhang L, 2011, IDENTIFICATION PRIOR; TRF, 2011, SIT AN POSTD HLTH SE; TRF, 2010, 3 PART EV PPHI PAK F; WHO, 2002, P 20 ANN S ATC DDD C; WHO, 2007, EV BUS STRENGTH HLTH; World Bank, 2010, DEL BETT HLTH SERV P; World Health Organization, 2004, EQ ACC ESS MED FRAM; World Health Organization, 2007, REG IFF E NED TECHN; World Health Organization, 2011, REG HLTH SYST OBS EM; Zaidi S, 2012, INT J PHARM SCI, V5, P62	54	52	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63515	10.1371/journal.pone.0063515	http://dx.doi.org/10.1371/journal.pone.0063515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UP	23717442	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700032
J	Ho, MC; Lee, YH; Jeng, YM; Chen, CN; Chang, KJ; Tsui, H				Ho, Ming-Chih; Lee, Yu-Hsin; Jeng, Yung-Ming; Chen, Chiung-Nien; Chang, King-Jen; Tsui, Po-Hsiang			Relationship between Ultrasound Backscattered Statistics and the Concentration of Fatty Droplets in Livers: An Animal Study	PLOS ONE			English	Article							MACROVESICULAR HEPATIC STEATOSIS; PERFORMANCE EVALUATION; CT; DISEASE; FEASIBILITY; ATTENUATION; DONORS; TISSUE; ADULT; VIVO	Ultrasound grayscale B-mode imaging is the most frequently used modality for examining fatty liver. Different concentrations and arrangements of fatty droplets in the liver may produce different statistical distributions of ultrasound backscatter signals, which may be treated as a useful clue for assessing the stage of fatty liver. To verify this point, we investigate the relationship between changes in backscattered statistics and the concentration of fatty droplets in the liver. Fatty liver was induced in rats fed a methionine-choline-deficient diet. Livers were excised from rats for in vitro ultrasound scanning using a single-element transducer. The envelopes of the acquired raw ultrasound signals were used for the analysis of the backscattered statistics by ultrasound Nakagami parametric imaging, which has been shown as a reliable tool to model the statistical distribution of ultrasound backscatter signals. Histological analyses and the measurements of triglyceride and cholesterol in the rat liver were conducted for comparison with the Nakagami parameter. Results show that the ultrasound Nakagami parameter has an excellent correlation with the concentration of fatty droplets, demonstrating that ultrasound backscatter statistics depend on the degree of fatty liver in rats.	[Ho, Ming-Chih; Lee, Yu-Hsin; Chen, Chiung-Nien; Chang, King-Jen] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10764, Taiwan; [Ho, Ming-Chih; Lee, Yu-Hsin; Jeng, Yung-Ming; Chen, Chiung-Nien; Chang, King-Jen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Ho, Ming-Chih; Chen, Chiung-Nien; Chang, King-Jen] Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei 10764, Taiwan; [Jeng, Yung-Ming] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pathol, Taipei 10764, Taiwan; [Tsui, Po-Hsiang] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Chang Gung University; Chang Gung University	Tsui, H (corresponding author), Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan.	tsuiph@mail.cgu.edu.tw	Ho, Ming-Chih/AAR-9783-2021; Tsui, Po-Hsiang/AHE-7426-2022	Ho, Ming-Chih/0000-0003-3660-1062; Chang, King jen/0000-0001-9811-3422; JENG, YUNG-MING/0000-0002-3878-4491; CHEN, CHIUNG-NIEN/0000-0003-1192-5220; Tsui, Po-Hsiang/0000-0002-5604-1800	National Science Council (Taiwan) [NSC100-3114-B-002-004]; National Taiwan University Hospital [NTUH. 99-S1377]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by the National Science Council (Taiwan) under Grant No. NSC100-3114-B-002-004, and National Taiwan University Hospital under Grant No. NTUH. 99-S1377. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chen CH, 2008, DIGEST DIS SCI, V53, P1699, DOI 10.1007/s10620-007-0048-2; de Andrade AR, 2008, ANN HEPATOL, V7, P364; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Gaitini D, 2004, ULTRASOUND MED BIOL, V30, P1321, DOI 10.1016/j.ultrasmedbio.2004.08.001; Ghoshal G, 2012, ULTRASOUND MED BIOL, V38, P2238, DOI 10.1016/j.ultrasmedbio.2012.08.010; Iwasaki M, 2004, TRANSPLANTATION, V78, P1501, DOI 10.1097/01.TP.0000140499.23683.0D; Kamel IR, 2001, AM J ROENTGENOL, V176, P193, DOI 10.2214/ajr.176.1.1760193; Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169; Kim SH, 2006, RADIOLOGY, V240, P116, DOI 10.1148/radiol.2393042218; Limanond P, 2004, RADIOLOGY, V230, P276, DOI 10.1148/radiol.2301021176; Lu ZF, 1999, ULTRASOUND MED BIOL, V25, P1047, DOI 10.1016/S0301-5629(99)00055-1; Mehta SR, 2008, WORLD J GASTROENTERO, V14, P3476, DOI 10.3748/wjg.14.3476; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; PIEKARSKI J, 1980, RADIOLOGY, V137, P727, DOI 10.1148/radiology.137.3.6934563; Pilleul F, 2005, GASTROEN CLIN BIOL, V29, P1143, DOI 10.1016/S0399-8320(05)82179-7; Po-Hsiang Tsui, 2005, Journal of Medical and Biological Engineering, V25, P45; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Ricci C, 1997, J HEPATOL, V27, P108, DOI 10.1016/S0168-8278(97)80288-7; Shankar PM, 2000, IEEE T ULTRASON FERR, V47, P727, DOI 10.1109/58.842062; Shiga T, 2009, J GASTROENTEROL, V44, P757, DOI 10.1007/s00535-009-0059-1; Tsui PH, 2004, ULTRASOUND MED BIOL, V30, P1345, DOI 10.1016/j.ultrasmedbio.2004.08.009; Tsui PH, 2008, ULTRASONIC IMAGING, V30, P78, DOI 10.1177/016173460803000202; Tsui PH, 2007, PHYS MED BIOL, V52, P6413, DOI 10.1088/0031-9155/52/21/005; Tsui PH, 2007, ULTRASOUND MED BIOL, V33, P608, DOI 10.1016/j.ultrasmedbio.2006.10.005; Tsui PH, 2012, ULTRASONIC IMAGING, V34, P110, DOI 10.1177/016173461203400204; Tsui PH, 2012, MED PHYS, V39, P2369, DOI 10.1118/1.3700235; Tsui PH, 2011, MED PHYS, V38, P2019, DOI 10.1118/1.3562899; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Wang B, 2003, ACTA RADIOL, V44, P92; Yoneda M, 2010, RADIOLOGY, V256, P640, DOI 10.1148/radiol.10091662	31	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63543	10.1371/journal.pone.0063543	http://dx.doi.org/10.1371/journal.pone.0063543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704917	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200048
J	Sassoli, C; Chellini, F; Pini, A; Tani, A; Nistri, S; Nosi, D; Zecchi-Orlandini, S; Bani, D; Formigli, L				Sassoli, Chiara; Chellini, Flaminia; Pini, Alessandro; Tani, Alessia; Nistri, Silvia; Nosi, Daniele; Zecchi-Orlandini, Sandra; Bani, Daniele; Formigli, Lucia			Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-beta/Smad3 Signaling	PLOS ONE			English	Article							TISSUE INHIBITOR; FIBROSIS; NOTCH; DIFFERENTIATION; EXPRESSION; ACTIVATION; MICE; METALLOPROTEINASES; REGENERATION; INDUCTION	The hormone relaxin (RLX) is produced by the heart and has beneficial actions on the cardiovascular system. We previously demonstrated that RLX stimulates mouse neonatal cardiomyocyte growth, suggesting its involvement in endogenous mechanisms of myocardial histogenesis and regeneration. In the present study, we extended the experimentation by evaluating the effects of RLX on primary cultures of neonatal cardiac stromal cells. RLX inhibited TGF-beta 1-induced fibroblast-myofibroblast transition, as judged by its ability to down-regulate a-smooth muscle actin and type I collagen expression. We also found that the hormone up-regulated metalloprotease (MMP)-2 and MMP-9 expression and downregulated the tissue inhibitor of metalloproteinases (TIMP)-2 in TGF-beta 1-stimulated cells. Interestingly, the effects of RLX on cardiac fibroblasts involved the activation of Notch-1 pathway. Indeed, Notch-1 expression was significantly decreased in TGF-beta 1-stimulatedfibroblasts as compared to the unstimulated controls; this reduction was prevented by the addition of RLX to TGF-b1-stimulated cells. Moreover, pharmacological inhibition of endogenous Notch-1 signaling by N-3,5-difluorophenyl acetyl-L-alanyl-2-phenylglycine-1,1-dimethylethyl ester (DAPT), a c-secretase specific inhibitor, as well as the silencing of Notch-1 ligand, Jagged-1, potentiated TGF-beta 1-induced myofibroblast differentiation and abrogated the inhibitory effects of RLX. Interestingly, RLX and Notch-1 exerted their inhibitory effects by interfering with TGF-beta 1 signaling, since the addition of RLX to TGF-beta 1-stimulated cells caused a significant decrease in Smad3 phosphorylation, a typical downstream event of TGF-beta 1 receptor activation, while the treatment with a prevented this effect. These data suggest that Notch signaling can down-regulate TGF-beta 1/Smad3-induced fibroblast-myofibroblast transition and that RLX could exert its well known anti-fibrotic action through the up-regulation of this pathway. In conclusion, the results of the present study beside supporting the role of RLX in the field of cardiac fibrosis, provide novel experimental evidence on the molecular mechanisms underlying its effects.	[Sassoli, Chiara; Chellini, Flaminia; Pini, Alessandro; Tani, Alessia; Nistri, Silvia; Nosi, Daniele; Zecchi-Orlandini, Sandra; Bani, Daniele; Formigli, Lucia] Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy	University of Florence	Formigli, L (corresponding author), Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy.	formigli@unifi.it	SASSOLI, CHIARA/AAC-4023-2019	SASSOLI, CHIARA/0000-0002-1337-0938; Pini, Alessandro/0000-0001-9828-2082	University of Florence; Italian Ministry of University; Research-MIUR-PRIN	University of Florence; Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Research-MIUR-PRIN	This work was financially supported by research grants from the University of Florence to C.S., S.Z.O., D.B and L.F. and the Italian Ministry of University and Research-MIUR-PRIN 2008 to S.Z.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2012, MOL CELL ENDOCRINOL, V363, P46, DOI 10.1016/j.mce.2012.07.006; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Baccari MC, 2008, CURR PROTEIN PEPT SC, V9, P638, DOI 10.2174/138920308786733921; Bani D, 2011, CURR DRUG SAF, V6, P324, DOI 10.2174/157488611798918719; Bani D, 2009, CURR DRUG SAF, V4, P238, DOI 10.2174/157488609789006967; Barnes BR, 2009, AM J PHYSIOL-CELL PH, V297, pC1501, DOI 10.1152/ajpcell.00217.2009; Barter MJ, 2010, MATRIX BIOL, V29, P602, DOI 10.1016/j.matbio.2010.05.002; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Chillakuri CR, 2012, SEMIN CELL DEV BIOL, V23, P421, DOI 10.1016/j.semcdb.2012.01.009; Chow BSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042714; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Dschietzig T, 2006, PHARMACOL THERAPEUT, V112, P38, DOI 10.1016/j.pharmthera.2006.03.004; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; Du XJ, 2003, CARDIOVASC RES, V57, P395, DOI 10.1016/S0008-6363(02)00663-6; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Fan YH, 2011, PHYSIOL RES, V60, P739, DOI 10.33549/physiolres.932149; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Formigli L, 2009, J MOL CELL CARDIOL, V47, P335, DOI 10.1016/j.yjmcc.2009.05.008; Groot AJ, 2012, ADV EXP MED BIOL, V727, P15, DOI 10.1007/978-1-4614-0899-4_2; Hisaw FL, 1926, P SOC EXP BIOL MED, V23, P661; Huang XW, 2011, AM J PATHOL, V179, P2751, DOI 10.1016/j.ajpath.2011.08.018; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Ishimura N, 2005, GASTROENTEROLOGY, V128, P1354, DOI 10.1053/j.gastro.2005.01.055; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Kolonin MG, 2012, STEM CELL RES, V8, P312, DOI 10.1016/j.scr.2011.11.005; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Lu KV, 2004, LAB INVEST, V84, P8, DOI 10.1038/labinvest.3700003; Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979; Mookerjee I, 2009, FASEB J, V23, P1219, DOI 10.1096/fj.08-120857; Mu XD, 2010, AM J PATHOL, V177, P2399, DOI 10.2353/ajpath.2010.091121; Negishi S, 2005, AM J SPORT MED, V33, P1816, DOI 10.1177/0363546505278701; Nemir M, 2014, EUR HEART J, V35, P2174, DOI 10.1093/eurheartj/ehs269; Nistri Silvia, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P101, DOI 10.2174/187152507780363179; Nistri S, 2012, J CELL MOL MED, V16, P507, DOI 10.1111/j.1582-4934.2011.01328.x; Pini A, 2012, AORM ANN RESP MED, V3, P65; Pini A, 2010, J PHARMACOL EXP THER, V335, P589, DOI 10.1124/jpet.110.170977; Royce SG, 2012, MOL CELL ENDOCRINOL, V351, P167, DOI 10.1016/j.mce.2012.01.007; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Samuel CS, 2007, ADV EXP MED BIOL, V612, P88; Samuel CS, 2007, BIOCHEMISTRY-US, V46, P5374, DOI 10.1021/bi700238h; Samuel CS, 2005, CLIN MED RES, V3, P241, DOI 10.3121/cmr.3.4.241; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Samuel CS, 2009, ANN NY ACAD SCI, V1160, P294, DOI 10.1111/j.1749-6632.2008.03823.x; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Samuel CS, 2004, KIDNEY INT, V65, P2054, DOI 10.1111/j.1523-1755.2004.00628.x; Samuel CS, 2002, FASEB J, V16, P121, DOI 10.1096/fj.02-0449fje; Sassoli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037512; Sassoli C, 2011, J MOL CELL CARDIOL, V51, P399, DOI 10.1016/j.yjmcc.2011.06.004; Solomon E, 2010, J BIOL CHEM, V285, P21969, DOI 10.1074/jbc.M110.133314; Su Y, 2006, J GASTROINTEST SURG, V10, P1230, DOI 10.1016/j.gassur.2006.08.017; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	55	103	106	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63896	10.1371/journal.pone.0063896	http://dx.doi.org/10.1371/journal.pone.0063896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704950	Green Published, gold			2022-12-27	WOS:000319330200081
J	Song, RF; Preston, G; Ichihara, A; Yosypiv, IV				Song, Renfang; Preston, Graeme; Ichihara, Atsuhiro; Yosypiv, Ihor V.			Deletion of the Prorenin Receptor from the Ureteric Bud Causes Renal Hypodysplasia	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; TRANSCRIPTION FACTOR FOXI1; BRANCHING MORPHOGENESIS; TUBULAR-ACIDOSIS; KIDNEY DEVELOPMENT; MAMMALIAN KIDNEY; RENIN; RET; NEPHROGENESIS; ACIDIFICATION	The role of the prorenin receptor (PRR) in the regulation of ureteric bud (UB) branching morphogenesis is unknown. Here, we investigated whether PRR acts specifically in the UB to regulate UB branching, kidney development and function. We demonstrate that embryonic (E) day E13.5 mouse metanephroi, isolated intact E11.5 UBs and cultured UB cells express PRR mRNA. To study its role in UB development, we conditionally ablated PRR in the developing UB (PRRUB-/-) using Hoxb7(Cre) mice. On E12.5, PRRUB-/- mice had decreased UB branching and increased UB cell apoptosis. These defects were associated with decreased expression of Ret, Wnt11, Etv4/Etv5, and reduced phosphorylation of Erk1/2 in the UB. On E18.5, mutants had marked kidney hypoplasia, widespread apoptosis of medullary collecting duct cells and decreased expression of Foxi1, AE1 and H(+-)ATPase alpha 4 mRNA. Ultimately, they developed occasional small cysts in medullary collecting ducts and had decreased nephron number. To test the functional consequences of these alterations, we determined the ability of PRRUB-/- mice to acidify and concentrate the urine on postnatal (P) day P30. PRR UB2/2 mice were polyuric, had lower urine osmolality and a higher urine pH following 48 hours of acidic loading with NH4Cl. Taken together, these data show that PRR present in the UB epithelia performs essential functions during UB branching morphogenesis and collecting duct development via control of Ret/Wnt11 pathway gene expression, UB cell survival, activation of Erk1/2, terminal differentiation and function of collecting duct cells needed for maintaining adequate water and acid-base homeostasis. We propose that mutations in PRR could possibly cause renal hypodysplasia and renal tubular acidosis in humans.	[Song, Renfang; Preston, Graeme; Yosypiv, Ihor V.] Tulane Univ, Sch Med, Dept Pediat, Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA; [Ichihara, Atsuhiro] Inst Endocrinol & Hypertent, Dept Med, Tokyo, Japan	Tulane University	Yosypiv, IV (corresponding author), Tulane Univ, Sch Med, Dept Pediat, Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA.	iiosipi@tulane.edu			National Institutes of Health [DK-71699]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from National Institutes of Health Grant DK-71699 (I.V.Y.) www.niddk.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Al-Awqati Q, 2011, PHYSIOLOGY, V26, P266, DOI 10.1152/physiol.00008.2011; [Anonymous], 2010, NAPRTCS ANN REP; Barasch J, 1996, AM J PHYSIOL-RENAL, V271, pF50, DOI 10.1152/ajprenal.1996.271.1.F50; Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; Buechling T, 2010, CURR BIOL, V20, P1263, DOI 10.1016/j.cub.2010.05.028; Cain JE, 2010, PEDIATR RES, V68, P91, DOI 10.1203/00006450-201011001-00175; Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Finberg KE, 2005, P NATL ACAD SCI USA, V102, P13616, DOI 10.1073/pnas.0506769102; Fisher CE, 2001, DEVELOPMENT, V128, P4329; Gonzalez AA, 2011, HYPERTENSION, V57, P859, DOI 10.1161/HYPERTENSIONAHA.110.167957; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Inoue H, 1999, BBA-BIOENERGETICS, V1413, P130, DOI 10.1016/S0005-2728(99)00096-1; Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206; Jain S, 2010, J CLIN INVEST, V120, P778, DOI 10.1172/JCI41619; Jeong HW, 2009, J CLIN INVEST, V119, P3290, DOI 10.1172/JCI38416; Jouret F, 2005, J AM SOC NEPHROL, V16, P3235, DOI 10.1681/ASN.2004110935; Karet FE, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023433.08833.88; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Lin SH, 2002, J CLIN ENDOCR METAB, V87, P2694, DOI 10.1210/jc.87.6.2694; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Miura GI, 2003, TRANSGENIC RES, V12, P131, DOI 10.1023/A:1022118627058; Nagalakshmi VK, 2011, KIDNEY INT, V79, P317, DOI 10.1038/ki.2010.385; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Rojek A, 2006, P NATL ACAD SCI USA, V103, P6037, DOI 10.1073/pnas.0511324103; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Song RF, 2011, MECH DEVELOP, V128, P359, DOI 10.1016/j.mod.2011.07.002; Song RF, 2011, PEDIATR NEPHROL, V26, P353, DOI 10.1007/s00467-010-1629-4; Song RF, 2010, AM J PHYSIOL-RENAL, V298, pF807, DOI 10.1152/ajprenal.00147.2009; Stover EH, 2002, J MED GENET, V39, P796, DOI 10.1136/jmg.39.11.796; Vidarsson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004471; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Yosypiv IV, 2006, J AM SOC NEPHROL, V17, P1005, DOI 10.1681/ASN.2005080803; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	41	66	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63835					12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704941				2022-12-27	WOS:000319330200072
J	Tan, DZ; Crabb, WM; Whitman, WB; Tong, L				Tan, Dazhi; Crabb, Warren M.; Whitman, William B.; Tong, Liang			Crystal Structure of DmdD, a Crotonase Superfamily Enzyme That Catalyzes the Hydration and Hydrolysis of Methylthioacryloyl-CoA	PLOS ONE			English	Article							ANGSTROM RESOLUTION; COENZYME-A; ENOYL-COENZYME; THIOL ESTERS; HYDROLASE; ISOMERASE; SOFTWARE	Dimethyl-sulphoniopropionate (DMSP) is produced in abundance by marine phytoplankton, and the catabolism of this compound is an important source of carbon and reduced sulfur for marine bacteria and other organisms. The enzyme DmdD catalyzes the last step in the methanethiol (MeSH) pathway of DMSP catabolism. DmdD is a member of the crotonase superfamily of enzymes, and it catalyzes both the hydration and the hydrolysis of methylthioacryloyl-CoA (MTA-CoA), converting it to acetaldehyde, CO2, MeSH, and CoA. We report here the crystal structure of Ruegeria pomeroyi DmdD free enzyme at 1.5 angstrom resolution and the structures of the E121A mutant in complex with MTA-CoA and 3-methylmercaptopropionate-CoA (MMPA-CoA) at 1.8 angstrom resolution. DmdD is a hexamer, composed of a dimer of trimers where the three monomers of each trimer are related by a crystallographic 3-fold axis. The overall structure of this hexamer is similar to those of canonical crotonases. However, the C-terminal loops of DmdD in one of the trimers assume a different conformation and contribute to CoA binding in the active site of a neighboring monomer of the trimer, while these loops in the second trimer are disordered. MTA-CoA is bound deep in the active site in the first trimer, but shows a 1.5 angstrom shift in its position in the second trimer. MMPA-CoA has a similar binding mode to MTA-CoA in the first trimer. MMPA-CoA cannot be hydrated and is only hydrolyzed slowly by DmdD. Replacement of the sulfur atom in MMPA-CoA with a methylene group abolishes hydrolysis, suggesting that the unique property of the substrate is a major determinant of the hydrolysis activity of DmdD.	[Tan, Dazhi; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Crabb, Warren M.; Whitman, William B.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	Columbia University; University System of Georgia; University of Georgia	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Whitman, William/AAC-5896-2020	Tong, Liang/0000-0002-0563-6468; Whitman, William/0000-0003-1229-0423; Tan, Dazhi/0000-0002-1862-8125	National Institutes of Health [DK067238]; National Science Foundation [MCB-1158037]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1158037] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by a grant from the National Institutes of Health (DK067238) to LT and National Science Foundation (MCB-1158037) to WBW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; Batchelar ET, 2008, ANGEW CHEM INT EDIT, V47, P9322, DOI 10.1002/anie.200803906; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; DOUGLAS KT, 1986, ACCOUNTS CHEM RES, V19, P186, DOI 10.1021/ar00126a005; Eberhard ED, 2004, J AM CHEM SOC, V126, P7188, DOI 10.1021/ja0482381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Feng YG, 2002, BIOCHEMISTRY-US, V41, P12883, DOI 10.1021/bi020382g; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; Hamed RB, 2009, CHEMBIOCHEM, V10, P246, DOI 10.1002/cbic.200800652; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; Kiema TR, 1999, BIOCHEMISTRY-US, V38, P2991, DOI 10.1021/bi981646v; KUCHTA RD, 1985, J BIOL CHEM, V260, P3181; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reisch CR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00172; Reisch CR, 2011, NATURE, V473, P208, DOI 10.1038/nature10078; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; Staudinger J, 2001, CHEMOSPHERE, V44, P561, DOI 10.1016/S0045-6535(00)00505-1; WATERSON RM, 1972, J BIOL CHEM, V247, P5258; Wong BJ, 2003, J AM CHEM SOC, V125, P12076, DOI 10.1021/ja037652i	27	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63870	10.1371/journal.pone.0063870	http://dx.doi.org/10.1371/journal.pone.0063870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704947	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200078
J	Wade, ASI; Barov, B; Burfield, IJ; Gregory, RD; Norris, K; Butler, SJ				Wade, Amy S. I.; Barov, Boris; Burfield, Ian J.; Gregory, Richard D.; Norris, Ken; Butler, Simon J.			Quantifying the Detrimental Impacts of Land-Use and Management Change on European Forest Bird Populations	PLOS ONE			English	Article							FARMLAND BIODIVERSITY; COMMUNITIES; WOODLAND; ECOLOGY; CONSERVATION	The ecological impacts of changing forest management practices in Europe are poorly understood despite European forests being highly managed. Furthermore, the effects of potential drivers of forest biodiversity decline are rarely considered in concert, thus limiting effective conservation or sustainable forest management. We present a trait-based framework that we use to assess the detrimental impact of multiple land-use and management changes in forests on bird populations across Europe. Major changes to forest habitats occurring in recent decades, and their impact on resource availability for birds were identified. Risk associated with these changes for 52 species of forest birds, defined as the proportion of each species' key resources detrimentally affected through changes in abundance and/or availability, was quantified and compared to their pan-European population growth rates between 1980 and 2009. Relationships between risk and population growth were found to be significantly negative, indicating that resource loss in European forests is an important driver of decline for both resident and migrant birds. Our results demonstrate that coarse quantification of resource use and ecological change can be valuable in understanding causes of biodiversity decline, and thus in informing conservation strategy and policy. Such an approach has good potential to be extended for predictive use in assessing the impact of possible future changes to forest management and to develop more precise indicators of forest health.	[Wade, Amy S. I.; Norris, Ken] Univ Reading, Ctr Agri Environm Res, Sch Agr Policy & Dev, Reading, Berks, England; [Barov, Boris] BirdLife Europe, Brussels, Belgium; [Burfield, Ian J.] BirdLife Int, Cambridge, England; [Gregory, Richard D.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Butler, Simon J.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Reading; BirdLife International; Royal Society for Protection of Birds; University of East Anglia	Butler, SJ (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	simon.j.butler@uea.ac.uk	Wade, Amy/GSN-9485-2022; Barov, Boris/GQZ-8085-2022; Wade, Amy/GSO-1924-2022; Butler, Simon/H-1703-2011	Gregory, Richard/0000-0002-7419-5053; Butler, Simon/0000-0002-5111-5639	Stichting BirdLife Europe; NERC (National Environment Research Council) [NE/I020350/1]; European Commission; Royal Society for Protection of Birds; Biotechnology and Biological Sciences Research Council [BB/F011911/1] Funding Source: researchfish; Natural Environment Research Council [NE/I020350/1] Funding Source: researchfish; BBSRC [BB/F011911/1] Funding Source: UKRI; NERC [NE/I020350/1] Funding Source: UKRI	Stichting BirdLife Europe; NERC (National Environment Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre); Royal Society for Protection of Birds; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The project described in the manuscript was funded by Stichting BirdLife Europe. SJB was supported by a NERC (National Environment Research Council) Postdoctoral Fellowship (NE/I020350/1). The funders had no role in study design, data collection or analysis but contributed to preparation of the manuscript.; The Pan European Common Bird Monitoring Scheme (PECBMS) is supported financially by the European Commission and The Royal Society for Protection of Birds. Special thanks go to the many individuals and organisations responsible for national data collation across Europe, from the many thousands of skilled volunteer ornithologists, to the smaller numbers of dedicated professional staff responsible for data collation and analysis. Thanks to Mario Abreu, Birdlife Finland, Uno Brinnen, Llui's Brotons, Lena Dahl, Margus Ellermaa, Rob Fuller, Teemu Lehtiniemi, Asko Lohmus, Jiri Reif, Albane Siramy, Maris Strazds, Raimo Virkkala, Christian Verschueren, Petr Vorisek and Marcus Walsh for advice and comments.	Andersson FO, 2000, FOREST ECOL MANAG, V132, P111, DOI 10.1016/S0378-1127(00)00384-4; Angelstam Per, 2004, Ecological Bulletins, V51, P11; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Birdlife International I., 2004, BIRDS EUR POP EST TR; Burbaite Lina, 2009, Estonian Journal of Ecology, V58, P169, DOI 10.3176/eco.2009.3.02; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; Butler SJ, 2009, J APPL ECOL, V46, P1154, DOI 10.1111/j.1365-2664.2009.01709.x; Camprodon J, 2006, FOREST ECOL MANAG, V221, P72, DOI 10.1016/j.foreco.2005.10.044; De la Montana E, 2006, J APPL ECOL, V43, P651, DOI 10.1111/j.1365-2664.2006.01171.x; de Warnaffe GDB, 2004, BIOL CONSERV, V118, P219, DOI 10.1016/j.biocon.2003.08.015; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Forest Europe UNECE and FAO, 2011, STAT TRENDS SUST FOR; Gregory RD, 2007, IBIS, V149, P78, DOI 10.1111/j.1474-919X.2007.00698.x; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Hermy M, 2007, ECOL RES, V22, P361, DOI 10.1007/s11284-007-0354-3; Imbeau L, 2001, CONSERV BIOL, V15, P1151, DOI 10.1046/j.1523-1739.2001.0150041151.x; Laiolo P, 2003, FOREST ECOL MANAG, V179, P441, DOI 10.1016/S0378-1127(02)00542-X; Lampila P, 2005, CONSERV BIOL, V19, P1537, DOI 10.1111/j.1523-1739.2005.00201.x; Leech DI, 2007, IBIS, V149, P128, DOI 10.1111/j.1474-919X.2007.00729.x; Lohmus A, 2010, FOREST ECOL MANAG, V260, P155, DOI 10.1016/j.foreco.2010.04.018; Muller J, 2010, EUR J FOREST RES, V129, P981, DOI 10.1007/s10342-010-0400-5; Niemela J, 1997, CONSERV BIOL, V11, P601, DOI 10.1046/j.1523-1739.1997.06008.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; PETTERSSON RB, 1995, BIOL CONSERV, V74, P57, DOI 10.1016/0006-3207(95)00015-V; Pullin AS, 2009, CONSERV BIOL, V23, P818, DOI 10.1111/j.1523-1739.2009.01283.x; Quine CP, 2007, IBIS, V149, P161, DOI 10.1111/j.1474-919X.2007.00742.x; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Robles H, 2011, FOREST ECOL MANAG, V261, P1428, DOI 10.1016/j.foreco.2011.01.029; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Shorohova E, 2004, ECOLOGICAL B, P137; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; Snow D.W., 1998, BIRDS W PALEARCTIC; Spiecker H, 2003, J ENVIRON MANAGE, V67, P55, DOI 10.1016/S0301-4797(02)00188-3; Thaxter CB, 2010, BIOL CONSERV, V143, P2006, DOI 10.1016/j.biocon.2010.05.004; Tomialojc Ludwik, 2005, British Birds, V98, P174; Tucker G.M., 1997, HABITATS BIRDS EUROP; VIRKKALA R, 1987, ANN ZOOL FENN, V24, P281	41	16	16	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64552	10.1371/journal.pone.0064552	http://dx.doi.org/10.1371/journal.pone.0064552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704997	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000319330200151
J	Hahn, GH; Hyttel-Sorensen, S; Petersen, SM; Pryds, O; Greisen, G				Hahn, Gitte H.; Hyttel-Sorensen, Simon; Petersen, Sandra M.; Pryds, Ole; Greisen, Gorm			Cerebral Effects of Commonly Used Vasopressor-Inotropes: A Study in Newborn Piglets	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; DOPAMINE INFUSIONS; BLOOD-PRESSURE; CIRCULATION; HEMODYNAMICS; SPECTROSCOPY; STIMULATION; HYPOTENSION; REACTIVITY; ARTERIAL	Background: Despite widespread use in sick infants, it is still debated whether vasopressor-inotropes have direct cerebral effects that might affect neurological outcome. We aimed to test direct cerebrovascular effects of three commonly used vasopressor-inotropes (adrenaline, dopamine and noradrenaline) by comparing the responses to those of nonpharmacologically induced increases in blood pressure. We also searched for reasons for a mismatch between the response in perfusion and oxygenation. Methods: Twenty-four piglets had long and short infusions of the three vasopressor-inotropes titrated to raise mean arterial blood pressure (MAP) 10 mmHg in random order. Nonpharmacological increases in MAP were induced by inflation of a balloon in the descending aorta. We measured cerebral oxygenation (near-infrared spectroscopy), perfusion (laser-Doppler), oxygen consumption (co-oximetry of arterial and superior sagittal sinus blood), and microvascular heterogeneity (side stream dark field video microscopy). Results: Vasopressor-inotropes increased cerebral oxygenation significantly less (p <= 0.01) compared to non-pharmacological MAP increases, whereas perfusion was similar. Furthermore, cerebral total hemoglobin concentration increased significantly less during vasopressor-inotrope infusions (p = 0.001). These physiologic responses were identical between the three vasopressor-inotropes (p > 0.05). Furthermore, they induced a mild, although insignificant increase in cerebral metabolism and microvascular heterogeneity (p > 0.05). Removal of the scalp tissue did not influence the mismatch (p > 0.05). Conclusion: We demonstrated a moderate vasopressor-inotrope induced mismatch between cerebral perfusion and oxygenation. Scalp removal did not affect this mismatch, why vasopressor-inotropes appear to have direct cerebral actions. The statistically nonsignificant increases in cerebral metabolism and/or microvascular heterogeneity may explain the mismatch. Alternatively, it may simply reflect a vasopressor-inotrope-induced decrease in the arterial-to-venous volume ratio as detected by near-infrared spectroscopy.	[Hahn, Gitte H.; Hyttel-Sorensen, Simon; Petersen, Sandra M.; Greisen, Gorm] Copenhagen Univ Hosp, Rigshosp, Dept Neonatol, Copenhagen, Denmark; [Pryds, Ole] Copenhagen Univ Hosp, Hvidovre Hosp, Dept Pediat, Hvidovre, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Hahn, GH (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Neonatol, Copenhagen, Denmark.	gitte.holst.hahn@gmail.com	Greisen, Gorm/AAA-6463-2022; Hahn, Gitte/AAN-4967-2020	Greisen, Gorm/0000-0001-8042-3262; Meinich Juhl, Sandra/0000-0003-1404-8251	Lundbeck Foundation; Aase and Einar Danielsens Foundation; Augustinus Foundation; Lundbeck Foundation [R77-2010-7200] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Aase and Einar Danielsens Foundation; Augustinus Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Lundbeck Foundation, Aase and Einar Danielsens Foundation and The Augustinus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1038/sj.mn.7300110; Bevan R, 1998, PEDIATR RES, V44, P730, DOI 10.1203/00006450-199811000-00016; Borch K, 2010, ACTA PAEDIATR, V99, P1489, DOI 10.1111/j.1651-2227.2010.01856.x; Chapados I, 2008, NEONATOLOGY, V94, P300, DOI 10.1159/000151650; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; De Backer D, 2010, INTENS CARE MED, V36, P1813, DOI 10.1007/s00134-010-2005-3; Dobbe JGG, 2008, MED BIOL ENG COMPUT, V46, P659, DOI 10.1007/s11517-008-0349-4; EDVINSSON L, 2002, CEREBRAL BLOOD FLOW, P191; EKSTROMJODAL B, 1982, CRIT CARE MED, V10, P375, DOI 10.1097/00003246-198206000-00008; Fanaroff JM, 2006, PEDIATRICS, V117, P1131, DOI 10.1542/peds.2005-1230; GRONLUND JU, 1995, EARLY HUM DEV, V41, P129, DOI 10.1016/0378-3782(95)01615-A; Hahn GH, 2012, ACTA PAEDIATR, V101, P736, DOI 10.1111/j.1651-2227.2012.02666.x; Hahn GH, 2012, PEDIATR RES, V71, P253, DOI 10.1038/pr.2011.46; Jayasinghe D, 2003, PEDIATR RES, V54, P848, DOI 10.1203/01.PDR.0000088071.30873.DA; Kumar A, 2008, PEDIATRICS, V122, pE722, DOI 10.1542/peds.2008-0269; Lundstrom K, 2000, EARLY HUM DEV, V57, P157, DOI 10.1016/S0378-3782(00)00048-7; MCCULLOCH J, 1977, AM J PHYSIOL, V233, pH222, DOI 10.1152/ajpheart.1977.233.2.H222; Munro MJ, 2004, PEDIATRICS, V114, P1591, DOI 10.1542/peds.2004-1073; Myburgh JA, 2002, ANAESTH INTENS CARE, V30, P725, DOI 10.1177/0310057X0203000602; Pellicer A, 2005, PEDIATRICS, V115, P1501, DOI 10.1542/peds.2004-1396; Sassano-Higgins S, 2011, J PERINATOL, V31, P647, DOI 10.1038/jp.2011.2; Seri I, 1998, J PEDIATR-US, V133, P728, DOI 10.1016/S0022-3476(98)70141-6; SERI I, 1984, J PEDIATR-US, V105, P489, DOI 10.1016/S0022-3476(84)80035-9; SORENSEN H, 2012, ANESTHESIOLOGY; Synnes AR, 2001, J PEDIATR-US, V138, P525, DOI 10.1067/mpd.2001.111822; Trzeciak S, 2007, ANN EMERG MED, V49, P88, DOI 10.1016/j.annemergmed.2006.08.021; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; WAGERLE LC, 1990, AM J PHYSIOL, V258, pH1432, DOI 10.1152/ajpheart.1990.258.5.H1432; Wong FY, 2010, ANESTHESIOLOGY, V113, P1385, DOI 10.1097/ALN.0b013e3181fc5567; Wong FY, 2009, INTENS CARE MED, V35, P1777, DOI 10.1007/s00134-009-1602-5; Zhang J, 1999, ARCH DIS CHILD-FETAL, V81, pF99, DOI 10.1136/fn.81.2.F99	32	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63069	10.1371/journal.pone.0063069	http://dx.doi.org/10.1371/journal.pone.0063069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700412	Green Submitted, Green Published, gold			2022-12-27	WOS:000319966400010
J	Hinrichs, S; Patten, NL; Waite, AM				Hinrichs, Saskia; Patten, Nicole L.; Waite, Anya M.			Temporal Variations in Metabolic and Autotrophic Indices for Acropora digitifera and Acropora spicifera - Implications for Monitoring Projects	PLOS ONE			English	Article							CORAL STYLOPHORA-PISTILLATA; REEF CORALS; SKELETAL GROWTH; CHLOROPHYLL FLUORESCENCE; MARINE PROCHLOROCOCCUS; ELEMENTAL COMPOSITION; PHOTO-ACCLIMATION; RNA/DNA RATIOS; IN-SITU; ZOOXANTHELLAE	Coral health indices are important components of the management assessments of coral reefs, providing insight into local variation in reef condition, as well as tools for comparisons between reefs and across various time scales. Understanding how such health indices vary in space and time is critical to their successful implementation as management tools. Here we compare autotrophic and heterotrophic coral health indices, examining specifically the temporal variation driven by the local environmental variation, at three scales (diel, daily and seasonal). We compared metabolic indices (RNA/DNA ratio, protein concentration) and autotrophic indices (Chlorophyll a (Chl a), zooxanthellae density, effective quantum yield (yield) and relative electron transport rate (rETR)) for two dominant Acropora species, A. digitifera and A. spicifera at Ningaloo Reef (north-western Australia) in August 2010 (austral winter) and February 2011 (austral summer). Clear seasonal patterns were documented for metabolic indices, zooxanthellae density and rETR, while cyclic diel patterns only occurred for yield and rETR, and RNA/DNA ratio. Significant daily variation was observed for RNA/DNA ratio, Chl a concentration, yield and rETR. Results suggest that zooxanthellae density and protein concentrations are good long-term indicators of coral health whose variance is largely seasonal, while RNA/DNA ratio and rETR can be used for both long-term (seasonal) and short-term (diel) coral monitoring. Chl a can be used to describe changes between days and yield for both diel and daily variations. Correlations between health indices and light history showed that short-term changes in irradiance had the strongest impact on all health indices except zooxanthellae density for A. digitifera; for A. spicifera no correlation was observed at all. However, cumulative irradiance over the several days before sampling showed significant correlations with most health indices suggesting that a time-lag effect has to be taken into account when interpreting diel variations in coral condition.	[Waite, Anya M.] Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia; Univ Western Australia, Oceans Inst M470, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Waite, AM (corresponding author), Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia.	anya.waite@uwa.edu.au	Waite, Anya M/A-5492-2015	Waite, Anya M/0000-0003-2965-0296	Australian Research Council; Endeavour International Postgraduate Research (IPRS) Scholarship from the Australian Government; Western Australian Marine Science Institute (Node 2)	Australian Research Council(Australian Research Council); Endeavour International Postgraduate Research (IPRS) Scholarship from the Australian Government; Western Australian Marine Science Institute (Node 2)	Funding was provided by a Discovery Grant to A. M. Waite from the Australian Research Council, the Endeavour International Postgraduate Research (IPRS) Scholarship from the Australian Government and a top-up scholarship from the Western Australian Marine Science Institute (Node 2) to S. Hinrichs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1977, MAR BIOL, V41, P317, DOI 10.1007/BF00389098; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; Brown BE, 1999, CORAL REEFS, V18, P99; Buckley BA, 2004, MAR ECOL PROG SER, V282, P143, DOI 10.3354/meps282143; Buckley L, 1999, HYDROBIOLOGIA, V401, P265, DOI 10.1023/A:1003798613241; CARON DA, 1995, DEEP-SEA RES PT I, V42, P943, DOI 10.1016/0967-0637(95)00027-4; Cassata L, 2008, J COASTAL RES, V24, P139, DOI 10.2112/05-0623.1; Chen WNU, 2012, CORAL REEFS, V31, P521, DOI 10.1007/s00338-011-0868-6; Chicharo LMZ, 2001, J EXP MAR BIOL ECOL, V259, P121, DOI 10.1016/S0022-0981(01)00229-5; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; Dahlhoff EP, 2004, ANNU REV PHYSIOL, V66, P183, DOI 10.1146/annurev.physiol.66.032102.114509; DOYLE RW, 1973, J EXP MAR BIOL ECOL, V14, P201; DREW E A, 1972, Journal of Experimental Marine Biology and Ecology, V9, P71, DOI 10.1016/0022-0981(72)90008-1; Dubinsky Z., 1994, Pacific Science, V48, P313; Esteves E, 2009, ECOL FRESHW FISH, V18, P132, DOI 10.1111/j.1600-0633.2008.00332.x; Fagoonee I, 1999, SCIENCE, V283, P843, DOI 10.1126/science.283.5403.843; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; Ferrier-Pages C, 2003, CORAL REEFS, V22, P229, DOI 10.1007/s00338-003-0312-7; Fitt WK, 2000, BIOL BULL, V198, P110, DOI 10.2307/1542809; FITT WK, 1995, LIMNOL OCEANOGR, V40, P976, DOI 10.4319/lo.1995.40.5.0976; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Gorbunov MY, 2001, LIMNOL OCEANOGR, V46, P75, DOI 10.4319/lo.2001.46.1.0075; Harris R.P., 2000, ZOOPLANKTON METHODOL; Heidelberg KB, 2004, CORAL REEFS, V23, P263, DOI 10.1007/s00338-004-0375-0; Heldal M, 2003, LIMNOL OCEANOGR, V48, P1732, DOI 10.4319/lo.2003.48.5.1732; Hinrichs S, CORAL REEFS IN PRESS; Hinrichs S, PLOS ONE IN PRESS; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 1999, MAR ECOL PROG SER, V183, P73, DOI 10.3354/meps183073; Hoegh-Guldberg O, 1994, PAC SCI, V48, P263; HOEGHGULDBERG O, 1989, MAR ECOL PROG SER, V57, P173, DOI 10.3354/meps057173; Hoogenboom MO, 2008, ECOLOGY, V89, P1144, DOI 10.1890/07-1272.1; Hoogenboom MO, 2006, MAR ECOL PROG SER, V313, P1, DOI 10.3354/meps313001; Houlbreque F, 2004, J EXP BIOL, V207, P1461, DOI 10.1242/jeb.00911; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Humphrey C, 2009, CHANGES RNA DNA RATI; Instruments L, 2000, QUIKCHEM FIA AUTOMAT; Jeffrey SW, 1975, BIOCH PHYSL PFLANZ, V167, P1; Johannes R.E., 1974, Proceedings int Coral Reef Symp, V2, P127; Lesser MP, 2001, MAR ECOL PROG SER, V212, P69, DOI 10.3354/meps212069; Levy O, 2006, J EXP BIOL, V209, P273, DOI 10.1242/jeb.01983; Levy O, 2004, MAR ECOL PROG SER, V268, P105, DOI 10.3354/meps268105; Lowe RJ, 2008, PECS LIVERPOOL; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCAULEY PJ, 1995, MAR BIOL, V123, P145, DOI 10.1007/BF00350333; Muller-Parker Gisele, 1997, P96; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Patten N, 2011, CORAL REEFS, P1; Pearce AF, 2012, J MARINE SY IN PRESS; Piniak GA, 2008, ESTUAR COAST SHELF S, V77, P56, DOI 10.1016/j.ecss.2007.08.023; Piniak GA, 2009, BIOL BULL-US, V216, P55, DOI 10.1086/BBLv216n1p55; Rodolfo-Metalpa R, 2008, MAR ECOL PROG SER, V369, P103, DOI 10.3354/meps07608; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rossi S, 2006, MAR BIOL, V149, P643, DOI 10.1007/s00227-005-0229-5; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Schneider K, 2009, LIMNOL OCEANOGR, V54, P1995, DOI 10.4319/lo.2009.54.6.1995; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Sheppard CRC, 2009, BIOL COR REEFS; Siebeck UE, 2006, CORAL REEFS, V25, P453, DOI 10.1007/s00338-006-0123-8; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Stimson J, 1997, J EXP MAR BIOL ECOL, V214, P35, DOI 10.1016/S0022-0981(96)02753-0; Strickland D, 2010, THESIS U W AUSTR; Titlyanov E, 2000, MAR BIOL, V137, P463, DOI 10.1007/s002270000370; Titlyanov E.A., 2002, RUSS J MAR BIOL, V28, P16; Titlyanov EA, 1996, MAR ECOL PROG SER, V139, P167, DOI 10.3354/meps139167; Titlyanov EA, 2004, SYMBIOSIS, V36, P211; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V257, P163, DOI 10.1016/S0022-0981(00)00308-7; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V263, P211, DOI 10.1016/S0022-0981(01)00309-4; Tremblay P, 2012, J EXP BIOL, V215, P1384, DOI 10.1242/jeb.065201; Ulstrup KE, 2008, MAR ECOL PROG SER, V361, P139, DOI 10.3354/meps07360; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; VERITY PG, 1992, LIMNOL OCEANOGR, V37, P1434, DOI 10.4319/lo.1992.37.7.1434; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Warner ME, 2002, MAR BIOL, V141, P31, DOI 10.1007/s00227-002-0807-8; Watson RJ, 2004, J ENVIRON MONITOR, V7, P37; Winters G, 2003, LIMNOL OCEANOGR, V48, P1388, DOI 10.4319/lo.2003.48.4.1388; Wyatt ASJ, 2010, MAR ECOL PROG SER, V405, P113, DOI 10.3354/meps08508; Yahel R, 2005, CORAL REEFS, V24, P75, DOI 10.1007/s00338-004-0449-z; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	85	3	5	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63693	10.1371/journal.pone.0063693	http://dx.doi.org/10.1371/journal.pone.0063693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696848	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900054
J	Lenzi, J; Lombardi, R; Gori, D; Zanini, N; Tedesco, D; Masetti, M; Jovine, E; Fantini, MP				Lenzi, Jacopo; Lombardi, Raffaele; Gori, Davide; Zanini, Nicola; Tedesco, Dario; Masetti, Michele; Jovine, Elio; Fantini, Maria Pia			Impact of Procedure Volumes and Focused Practice on Short-Term Outcomes of Elective and Urgent Colon Cancer Resection in Italy	PLOS ONE			English	Article							IN-HOSPITAL-MORTALITY; COLORECTAL SURGERY; POSTOPERATIVE MORTALITY; OPERATIVE MORTALITY; RISK-FACTORS; MORBIDITY; QUALITY; READMISSION; COMPLICATIONS; REOPERATION	Background: The relationship between hospital volumes and short-term patients' outcomes of colon cancer (CC) surgery is not well established in the literature. Moreover, evidence about short-term outcomes of urgent compared with elective CC procedures is scanty. The aims of this study are 1) to determine whether caseloads and other hospital characteristics are associated with short-term outcomes of CC surgery; 2) to compare the outcomes of urgent and elective CC surgery. Methods: A total of 14,200 patients undergoing CC surgery between 2005 and 2010 in the General Surgery Units (GSUs) of the hospitals of Emilia-Romagna region, Northern Italy, were identified from the hospital discharge records database. The outcomes of interest were 30-day in-hospital mortality, re-intervention and 30-day re-admission. Using multilevel analysis, we analyzed the relationship of GSU volumes and focused practice, defined as the percentage of CC operations over total operations, with the three outcomes. Results: High procedure volumes were associated with a lower risk of 30-day in-hospital mortality, after adjusting for patients' characteristics [aOR (95% CI) = 0.51 (0.33-0.81)]. Stratified analyses for elective and urgent surgery showed that high volumes were associated with a lower 30-day mortality for elective patients [aOR (95% CI) = 0.35 (0.17-0.71)], but not for urgent patients [aOR (95% CI) = 0.72 (0.42-1.24)]. Focused practice was an independent predictor of re-intervention [aOR (95% CI) = 0.67 (0.47-0.97)] and re-admission [aRR (95% CI) = 0.88 (0.78-0.98)]. Conclusions: The present study adds evidence in support of the notion that patients with CC undergoing surgery at high-volume and focused surgical units experience better short-term outcomes.	[Lenzi, Jacopo; Gori, Davide; Tedesco, Dario; Fantini, Maria Pia] Univ Bologna, Dept Biomed & Neuromotor Sci, Alma Mater Studiorum, Bologna, Italy; [Lombardi, Raffaele; Zanini, Nicola; Masetti, Michele; Jovine, Elio] Maggiore Hosp, Dept Surg, Gen Surg Unit, Bologna, Italy	University of Bologna; AUSL di Bologna	Fantini, MP (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, Alma Mater Studiorum, Bologna, Italy.	mariapia.fantini@unibo.it	Masetti, Michele/AAT-4638-2020; Lombardi, Raffaele/AAD-2517-2022; Gori, Davide/AAC-3486-2022; Tedesco, Dario/AAC-1848-2019; Tedesco, Dario/AAD-8342-2022; Lenzi, Jacopo/W-4835-2017	Masetti, Michele/0000-0003-2259-8675; Lombardi, Raffaele/0000-0002-2219-4972; Gori, Davide/0000-0003-4954-9419; Tedesco, Dario/0000-0002-5027-5446; Lenzi, Jacopo/0000-0003-2882-4223; Zanini, Nicola/0000-0002-4877-5759				Alves A, 2005, ARCH SURG-CHICAGO, V140, P278, DOI 10.1001/archsurg.140.3.278; Ansari MZ, 2000, AUST NZ J SURG, V70, P6, DOI 10.1046/j.1440-1622.2000.01733.x; Archampong D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005391.pub3; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Benedix F, 2010, DIS COLON RECTUM, V53, P57, DOI 10.1007/DCR.0b013e3181c703a4; Bilimoria KY, 2008, J CLIN ONCOL, V26, P4626, DOI 10.1200/JCO.2007.15.6356; Billingsley KG, 2007, ARCH SURG-CHICAGO, V142, P23, DOI 10.1001/archsurg.142.1.23; Biondo S, 2010, ARCH SURG-CHICAGO, V145, P79, DOI 10.1001/archsurg.2009.208; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040590; Davoli Marina, 2005, Epidemiol Prev, V29, P3; Drolet S, 2011, J GASTROINTEST SURG, V15, P541, DOI 10.1007/s11605-011-1433-x; Engel AF, 2005, BRIT J SURG, V92, P1526, DOI 10.1002/bjs.5153; Finlayson EVA, 2003, ARCH SURG-CHICAGO, V138, P721, DOI 10.1001/archsurg.138.7.721; FLANDERS WD, 1987, J CHRON DIS, V40, P697, DOI 10.1016/0021-9681(87)90106-8; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Goodney PP, 2003, ANN SURG, V238, P161, DOI 10.1097/01.SLA.0000081094.66659.c3; Gooiker GA, 2011, BRIT J SURG, V98, P485, DOI 10.1002/bjs.7413; Greenblatt DY, 2010, ANN SURG, V251, P659, DOI 10.1097/SLA.0b013e3181d3d27c; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Guinier D, 2007, DIS COLON RECTUM, V50, P1316, DOI 10.1007/s10350-007-0310-x; Hendren S, 2010, DIS COLON RECTUM, V53, P1587, DOI 10.1007/DCR.0b013e3181f2f202; Ingraham AM, 2010, J AM COLL SURGEONS, V210, P155, DOI 10.1016/j.jamcollsurg.2009.10.016; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jencks SF, N ENGL J MED, V360, P1418; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Karanicolas PJ, 2009, ANN SURG, V249, P954, DOI 10.1097/SLA.0b013e3181a77bcd; Khuri SF, 2005, WORLD J SURG, V29, P1222, DOI 10.1007/s00268-005-7987-6; Longo WE, 2000, DIS COLON RECTUM, V43, P83, DOI 10.1007/BF02237249; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Marusch F, 2001, BRIT J SURG, V88, P1397, DOI 10.1046/j.0007-1323.2001.01873.x; Morris AM, 2007, ANN SURG, V245, P73, DOI 10.1097/01.sla.0000231797.37743.9f; Morris EJA, 2011, GUT, V60, P806, DOI 10.1136/gut.2010.232181; Osler M, 2011, ANN SURG, V253, P733, DOI 10.1097/SLA.0b013e318207556f; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Ragg JL, 2009, DIS COLON RECTUM, V52, P1296, DOI 10.1007/DCR.0b013e3181a0e639; Richards CH, 2010, J GASTROINTEST SURG, V14, P1511, DOI 10.1007/s11605-010-1333-5; Rogers SO, 2006, ANN SURG, V244, P1003, DOI 10.1097/01.sla.0000231759.10432.a7; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Spruce LR, 2012, J AM ACAD NURSE PRAC, V24, P167, DOI 10.1111/j.1745-7599.2012.00714.x; Statistica Emilia-Romagna, 2011, POP RES PROV COM CLA; Stitzenberg KB, 2009, J CLIN ONCOL, V27, P4671, DOI 10.1200/JCO.2008.20.1715; van Westreenen HL, 2011, DIS COLON RECTUM, V54, P1438, DOI 10.1097/DCR.0b013e31822c64f1; Yuen E, 2011, TUMORI, V97, P428, DOI 10.1700/950.10393; Zorzi M, 2009, EPIDEMIOL PREV, V33, P57	46	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64245	10.1371/journal.pone.0064245	http://dx.doi.org/10.1371/journal.pone.0064245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696873	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900076
J	Wood, AR; Perry, JRB; Tanaka, T; Hernandez, DG; Zheng, HF; Melzer, D; Gibbs, JR; Nalls, MA; Weedon, MN; Spector, TD; Richards, JB; Bandinelli, S; Ferrucci, L; Singleton, AB; Frayling, TM				Wood, Andrew R.; Perry, John R. B.; Tanaka, Toshiko; Hernandez, Dena G.; Zheng, Hou-Feng; Melzer, David; Gibbs, J. Raphael; Nalls, Michael A.; Weedon, Michael N.; Spector, Tim D.; Richards, J. Brent; Bandinelli, Stefania; Ferrucci, Luigi; Singleton, Andrew B.; Frayling, Timothy M.			Imputation of Variants from the 1000 Genomes Project Modestly Improves Known Associations and Can Identify Low-frequency Variant - Phenotype Associations Undetected by HapMap Based Imputation	PLOS ONE			English	Article							WIDE ASSOCIATION; HAPLOTYPE MAP; COMMON; POPULATION; RISK	Genome-wide association (GWA) studies have been limited by the reliance on common variants present on microarrays or imputable from the HapMap Project data. More recently, the completion of the 1000 Genomes Project has provided variant and haplotype information for several million variants derived from sequencing over 1,000 individuals. To help understand the extent to which more variants (including low frequency (1% <= MAF <5%) and rare variants (<1%)) can enhance previously identified associations and identify novel loci, we selected 93 quantitative circulating factors where data was available from the InCHIANTI population study. These phenotypes included cytokines, binding proteins, hormones, vitamins and ions. We selected these phenotypes because many have known strong genetic associations and are potentially important to help understand disease processes. We performed a genome-wide scan for these 93 phenotypes in InCHIANTI. We identified 21 signals and 33 signals that reached P<5x10(-8) based on HapMap and 1000 Genomes imputation, respectively, and 9 and 11 that reached a stricter, likely conservative, threshold of P<5x10(-11) respectively. Imputation of 1000 Genomes genotype data modestly improved the strength of known associations. Of 20 associations detected at P<5x10(-8) in both analyses (17 of which represent well replicated signals in the NHGRI catalogue), six were captured by the same index SNP, five were nominally more strongly associated in 1000 Genomes imputed data and one was nominally more strongly associated in HapMap imputed data. We also detected an association between a low frequency variant and phenotype that was previously missed by HapMap based imputation approaches. An association between rs112635299 and alpha-1 globulin near the SERPINA gene represented the known association between rs28929474 (MAF = 0.007) and alpha1-antitrypsin that predisposes to emphysema (P = 2.5x10(-12)). Our data provide important proof of principle that 1000 Genomes imputation will detect novel, low frequency-large effect associations.	[Wood, Andrew R.; Perry, John R. B.; Melzer, David; Weedon, Michael N.; Frayling, Timothy M.] Univ Exeter, Peninsula Coll Med & Dent, Inst Biomed & Clin Sci, Exeter, Devon, England; [Perry, John R. B.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Perry, John R. B.; Spector, Tim D.; Richards, J. Brent] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Hernandez, Dena G.; Gibbs, J. Raphael; Nalls, Michael A.; Singleton, Andrew B.] NIA, Neurogenet Lab, Baltimore, MD 21224 USA; [Hernandez, Dena G.; Gibbs, J. Raphael] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Hernandez, Dena G.; Gibbs, J. Raphael] UCL, Inst Neurol, Reta Lila Labs, London, England; [Zheng, Hou-Feng; Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Zheng, Hou-Feng; Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Dept Human Genet, Montreal, PQ H3T 1E2, Canada; [Zheng, Hou-Feng; Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Dept Epidemiol, Montreal, PQ H3T 1E2, Canada; [Zheng, Hou-Feng; Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Dept Biostat, Montreal, PQ H3T 1E2, Canada; [Bandinelli, Stefania] Tuscany Reg Hlth Agcy, Florence, Italy; [Bandinelli, Stefania] Univ Florence, IOT, Florence, Italy; [Bandinelli, Stefania] Univ Florence, Dept Med & Surg Crit Care, Florence, Italy; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, Florence, Italy	University of Exeter; University of Plymouth; University of Oxford; Wellcome Centre for Human Genetics; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; McGill University; McGill University; McGill University; McGill University; University of Florence; University of Florence; Azienda Sanitaria di Firenze	Frayling, TM (corresponding author), Univ Exeter, Peninsula Coll Med & Dent, Inst Biomed & Clin Sci, Exeter, Devon, England.	tim.frayling@pms.ac.uk	Singleton, Andrew B/C-3010-2009; Wood, Andrew R/AAB-3807-2019; Zheng, Houfeng/K-4424-2012; bandinelli, stefania/AAL-4570-2020; Richards, J Brent/AAF-4225-2019; Gibbs, J. Raphael/A-3984-2010	Wood, Andrew R/0000-0003-1726-948X; Zheng, Houfeng/0000-0001-5681-8598; Richards, J Brent/0000-0002-3746-9086; Gibbs, J. Raphael/0000-0002-6985-0658; Frayling, Timothy/0000-0001-8362-2603; Weedon, Michael/0000-0002-6174-6135	Wellcome Trust [083270/Z/07/Z]; MRC [G0500070] Funding Source: UKRI; Medical Research Council [G0500070] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [ZIAAG000932, ZIAAG001050, ZIAAG000965] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Wellcome Trust 083270/Z/07/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ferrarotti I, 2012, THORAX, V67, P669, DOI 10.1136/thoraxjnl-2011-201321; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Major JM, 2011, HUM MOL GENET, V20, P3876, DOI 10.1093/hmg/ddr296; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Perry JRB, 2009, DIABETOLOGIA, V52, P2117, DOI 10.1007/s00125-009-1475-8; Perry JRB, 2010, HUM MOL GENET, V19, P535, DOI 10.1093/hmg/ddp522; Rafiq S, 2008, DIABETOLOGIA, V51, P2205, DOI 10.1007/s00125-008-1160-3; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Terracciano A, 2009, AM J MED GENET B, V150B, P1070, DOI 10.1002/ajmg.b.30932; Wood AR, 2011, HUM MOL GENET, V20, P4082, DOI 10.1093/hmg/ddr328; Wu Y, 2012, INFLAMMATION, V35, P574, DOI 10.1007/s10753-011-9348-y	18	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64343	10.1371/journal.pone.0064343	http://dx.doi.org/10.1371/journal.pone.0064343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696881	gold, Green Published			2022-12-27	WOS:000319081900084
J	Ahn, SG; Lee, HM; Cho, SH; Bae, SJ; Lee, SA; Hwang, SH; Jeong, J; Lee, HD				Ahn, Sung Gwe; Lee, Hak Min; Cho, Sang-Hoon; Bae, Suk Jin; Lee, Seung Ah; Hwang, Seung Hyun; Jeong, Joon; Lee, Hy-De			The Difference in Prognostic Factors between Early Recurrence and Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Nodal Stage Differently Impacts Early and Late Recurrence	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; TUMOR DORMANCY; RISK; HAZARD; TIME; SURVIVAL; CELLS	Background: Probability of recurrence in patients with estrogen receptor (ER)-positive breast cancer remains constant for long periods. We compared tumor burden impact on late versus early recurrence in our cohort with long-term follow-up. Methods: Five hundred and ninety five patients diagnosed with ER-positive breast cancer between 1989 and 2001 were classified into three groups: early recurrence within 5 years, late recurrence after 5 years, and no recurrence. We identified prognostic factors among the groups using logistic regression analysis. Results: At median follow-up of 11.7 years, among 595 ER-positive women, 98 (16.4%) had early recurrence and 58 (9.7%) had late recurrence. On multivariate analysis, higher nodal stage (N0 vs. N2, odds ratio [OR] 3.189; N0 vs. N3, OR 9.948), higher histologic grade (grade 1 vs. grade 2, OR 3.896; grade 1 vs. grade 3, OR 5.945), age >35 years (OR 0.295), and receiving endocrine therapy (OR 0.293) affected early recurrence. Compared to no recurrence, receiving endocrine therapy (OR 0.285) was solely related to decreased risk of late recurrence. Increased risk of early recurrence was noted with the higher nodal stage when early and no recurrences were compared. This phenomenon was not found in late recurrence. In the last comparison between the early and late recurrence, higher nodal stage (N0 vs. N3, OR 16.779) and higher histologic grade (grade 1 vs. grade 3, OR 18.111) repeatedly weighted for early recurrence. Conclusions: Nodal burden had an attenuated influence on late recurrence, which suggests that, unlike early recurrence, tumor biology might have a more important role than tumor load for late recurrence in ER-positive disease.	[Ahn, Sung Gwe; Lee, Hak Min; Lee, Seung Ah; Hwang, Seung Hyun; Jeong, Joon; Lee, Hy-De] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Cho, Sang-Hoon; Bae, Suk Jin] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Soongsil University	Jeong, J (corresponding author), Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea.	gsjjoon@yuhs.ac	, 정준/I-2133-2019	, 정준/0000-0003-0397-0005; Ahn, Sung Gwe/0000-0002-8778-9686				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; BIANCHINI G, 2011, CANC RES S3, V71; Bosco JLF, 2009, CANCER EPIDEM BIOMAR, V18, P2979, DOI 10.1158/1055-9965.EPI-09-0607; Brewster AM, 2008, JNCI-J NATL CANCER I, V100, P1179, DOI 10.1093/jnci/djn233; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Clarke M, 1998, LANCET, V351, P1451; Cufer T, 2007, ANN ONCOL, V18, P18, DOI 10.1093/annonc/mdm262; Demicheli R, 1996, BREAST CANCER RES TR, V41, P177, DOI 10.1007/BF01807163; Dignam JJ, 2009, BREAST CANCER RES TR, V116, P595, DOI 10.1007/s10549-008-0200-5; Goss P, 2008, APMIS, V116, P552, DOI 10.1111/j.1600-0463.2008.001059.x; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Hilsenbeck SG, 1998, BREAST CANCER RES TR, V52, P227, DOI 10.1023/A:1006133418245; Joensuu K, 2008, CANCER LETT, V265, P76, DOI 10.1016/j.canlet.2008.02.022; Joensuu K, 2011, VIRCHOWS ARCH, V459, P31, DOI 10.1007/s00428-011-1096-8; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kennecke HF, 2007, ANN ONCOL, V18, P45, DOI 10.1093/annonc/mdl334; Kennecke H, 2008, CANCER-AM CANCER SOC, V112, P1437, DOI 10.1002/cncr.23320; Liu MC, 2011, CANCER RES, V71, DOI 10.1158/0008-5472.SABCS11-S1-8; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Mansell J, 2009, BREAST CANCER RES TR, V117, P91, DOI 10.1007/s10549-008-0291-z; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Saghatchian M, 2011, CANCER RES, V71, DOI 10.1158/0008-5472.SABCS11-S1-6; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	27	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63510	10.1371/journal.pone.0063510	http://dx.doi.org/10.1371/journal.pone.0063510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717438	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700028
J	Ale, SB; Brown, JS; Sullivan, AT				Ale, Som B.; Brown, Joel S.; Sullivan, Amy T.			Evolution of Cooperation: Combining Kin Selection and Reciprocal Altruism into Matrix Games with Social Dilemmas	PLOS ONE			English	Article							MUTUALISM; BEHAVIOR; ECOLOGY	Darwinian selection should preclude cooperation from evolving; yet cooperation is widespread among organisms. We show how kin selection and reciprocal altruism can promote cooperation in diverse 262 matrix games (prisoner's dilemma, snowdrift, and hawk-dove). We visualize kin selection as non-random interactions with like-strategies interacting more than by chance. Reciprocal altruism emerges from iterated games where players have some likelihood of knowing the identity of other players. This perspective allows us to combine kin selection and reciprocal altruism into a general matrix game model. Both mechanisms operating together should influence the evolution of cooperation. In the absence of kin selection, reciprocal altruism may be an evolutionarily stable strategy but is unable to invade a population of non-co-operators. Similarly, it may take a high degree of relatedness to permit cooperation to supplant non-cooperation. Together, a little bit of reciprocal altruism can, however, greatly reduce the threshold at which kin selection promotes cooperation, and vice-versa. To properly frame applications and tests of cooperation, empiricists should consider kin selection and reciprocal altruism together rather than as alternatives, and they should be applied to a broader class of social dilemmas than just the prisoner's dilemma.	[Ale, Som B.; Brown, Joel S.; Sullivan, Amy T.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ale, SB (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	sale1@uic.edu						Abbot P, 2011, NATURE, V471, pE1, DOI [10.1038/nature09831, 10.1038/nature09835]; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Brown JS, 2001, OIKOS, V94, P6, DOI 10.1034/j.1600-0706.2001.11309.x; BROWN JS, 1982, J THEOR BIOL, V99, P319, DOI 10.1016/0022-5193(82)90008-X; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Darwin C., 1871, P423; Darwin C, 1859, ORIGIN SPECIES MEANS; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dugatkin L.A., 1997, COOPERATION ANIMALS; DUGATKIN LA, 1991, AM NAT, V138, P687, DOI 10.1086/285243; GRAFEN A, 1979, ANIM BEHAV, V27, P905, DOI 10.1016/0003-3472(79)90028-9; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Michor F, 2002, NATURE, V419, P677, DOI 10.1038/419677a; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Okasha S., 2006, EVOLUTION LEVELS SEL, DOI [10.1093/acprof:oso/9780199267972.001.0001, DOI 10.1093/ACPROF:OSO/9780199267972.001.0001]; Okasha S, 2010, NATURE, V467, P653, DOI 10.1038/467653a; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; SMITH JM, 1964, NATURE, V201, P1145, DOI 10.1038/2011145a0; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Veelen M, 2012, P NATL ACAD SCI USA, V109, P9929, DOI 10.1073/pnas.1206694109; Vincent T. L., 2005, EVOLUTIONARY GAME TH; Waibel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000615; Wernegreen JJ, 2004, PLOS BIOL, V2, P307, DOI 10.1371/journal.pbio.0020068; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; Williams G. C., 1966, P307; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; WILSON DS, 1991, EVOL ECOL, V5, P291, DOI 10.1007/BF02214233	38	15	15	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63761	10.1371/journal.pone.0063761	http://dx.doi.org/10.1371/journal.pone.0063761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717479	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700057
J	Degenkolbe, T; Do, PT; Kopka, J; Zuther, E; Hincha, DK; Kohl, KI				Degenkolbe, Thomas; Do, Phuc T.; Kopka, Joachim; Zuther, Ellen; Hincha, Dirk K.; Koehl, Karin I.			Identification of Drought Tolerance Markers in a Diverse Population of Rice Cultivars by Expression and Metabolite Profiling	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PHOTOSYNTHETIC SUCROSE SYNTHESIS; WATER-USE EFFICIENCY; GRAIN-YIELD; CYTOSOLIC FRUCTOSE-1,6-BISPHOSPHATASE; FRUCTOSE 2,6-BISPHOSPHATE; PHYSIOLOGICAL TRAITS; GAS-CHROMATOGRAPHY; PHOSPHATE SYNTHASE; FREEZING TOLERANCE	Rice provides about half of the calories consumed in Asian countries, but its productivity is often reduced by drought, especially when grown under rain-fed conditions. Cultivars with increased drought tolerance have been bred over centuries. Slow selection for drought tolerance on the basis of phenotypic traits may be accelerated by using molecular markers identified through expression and metabolic profiling. Previously, we identified 46 candidate genes with significant genotype x environment interaction in an expression profiling study on four cultivars with contrasting drought tolerance. These potential markers and in addition GC-MS quantified metabolites were tested in 21 cultivars from both indica and japonica background that varied in drought tolerance. Leaf blades were sampled from this population of cultivars grown under control or long-term drought condition and subjected to expression analysis by qRT-PCR and metabolite profiling. Under drought stress, metabolite levels correlated mainly negatively with performance parameters, but eight metabolites correlated positively. For 28 genes, a significant correlation between expression level and performance under drought was confirmed. Negative correlations were predominant. Among those with significant positive correlation was the gene coding for a cytosolic fructose-1,6-bisphosphatase. This enzyme catalyzes a highly regulated step in C-metabolism. The metabolic and transcript marker candidates for drought tolerance were identified in a highly diverse population of cultivars. Thus, these markers may be used to select for tolerance in a wide range of rice germplasms.	[Degenkolbe, Thomas; Do, Phuc T.; Kopka, Joachim; Zuther, Ellen; Hincha, Dirk K.; Koehl, Karin I.] Max Planck Inst Mol Plant Physiol, Potsdam, Brandenburg, Germany	Max Planck Society	Kohl, KI (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Brandenburg, Germany.	koehl@mpimp-golm.mpg.de	Zuther, Ellen/H-9814-2019; Do, Phuc Thi/A-2318-2014	Zuther, Ellen/0000-0002-7446-0515; Kopka, Joachim/0000-0001-9675-4883; Do, Phuc Thi/0000-0002-2893-8223	German Ministry for Education and Research (BMBF) [BMBF 0312854]; Max Planck Society; Vietnamese government (MOET); German Academic Exchange Council (DAAD)	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Vietnamese government (MOET); German Academic Exchange Council (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The work was supported by the German Ministry for Education and Research (BMBF) (grant BMBF 0312854) and the Max Planck Society. Phuc Thi Do was supported by fellowships from the Vietnamese government (MOET), the German Academic Exchange Council (DAAD) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu RC, 2003, CROP SCI, V43, P1457, DOI 10.2135/cropsci2003.1457; Bernier J, 2008, J SCI FOOD AGR, V88, P927, DOI 10.1002/jsfa.3153; Bernier J, 2007, CROP SCI, V47, P507, DOI 10.2135/cropsci2006.07.0495; Centritto M, 2009, J EXP BOT, V60, P2325, DOI 10.1093/jxb/erp123; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; Chin JoongHyoun, 2007, Journal of Crop Science and Biotechnology, V10, P175; Cho MH, 2012, PHOTOSYNTH RES, V111, P261, DOI 10.1007/s11120-012-9720-2; Cramer GR, 2007, FUNCT INTEGR GENOMIC, V7, P111, DOI 10.1007/s10142-006-0039-y; DAIE J, 1993, PHOTOSYNTH RES, V38, P5, DOI 10.1007/BF00015056; Degenkolbe T, 2009, PLANT MOL BIOL, V69, P133, DOI 10.1007/s11103-008-9412-7; DINGKUHN M, 1989, AUST J AGR RES, V40, P1171, DOI 10.1071/AR9891171; Erban Alexander, 2007, V358, P19, DOI 10.1007/978-1-59745-244-1_2; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Gibon Y, 2009, PLANT CELL ENVIRON, V32, P859, DOI 10.1111/j.1365-3040.2009.01965.x; Gonzalez A, 2010, J AGR SCI-CAMBRIDGE, V148, P319, DOI 10.1017/S0021859610000031; Gouda PK, 2012, CROP SCI, V52, P644, DOI 10.2135/cropsci2011.04.0206; Guy C, 2008, PHYSIOL PLANTARUM, V132, P220, DOI 10.1111/j.1399-3054.2007.00999.x; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; HANSON AD, 1990, NATURE, V345, P26, DOI 10.1038/345026b0; HAVAUX M, 1985, Z PFLANZENZUCHT, V95, P1; Hedrich R, 1984, PLANT PHYSIOL, V75, P130; HERZOG B, 1984, PLANT PHYSIOL, V75, P561, DOI 10.1104/pp.75.3.561; Hummel J, 2010, METABOLOMICS, V6, P322, DOI 10.1007/s11306-010-0198-7; Jongdee B., 1998, Agronomy - growing a greener future. Proceedings of the 9th  Australian Agronomy Conference, Wagga Wagga, New South Wales, Australia, 20-23 July 1998; Jongdee S, 1997, ACIAR PROC, P65; Khush G, 2003, NUTR REV, V61, pS114, DOI 10.1301/nr.2003.jun.S114-S116; Kiani SP, 2007, THEOR APPL GENET, V114, P193, DOI 10.1007/s00122-006-0419-7; Kim JY, 2000, PLANT PHYSIOL, V124, P71, DOI 10.1104/pp.124.1.71; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; KS Fischer, 2003, BREEDING RICE DROUGH, P98; Kumar R, 2007, FIELD CROP RES, V103, P42, DOI 10.1016/j.fcr.2007.04.013; Kumar S, 2012, EUPHYTICA, V186, P265, DOI 10.1007/s10681-012-0675-3; Laza MR, 2006, CROP SCI, V46, P763, DOI 10.2135/cropsci2005.05.0084; Liu HY, 2005, CHINESE SCI BULL, V50, P317, DOI 10.1360/982004-619; Livingston AK, 2010, PLANT CELL ENVIRON, V33, P1779, DOI 10.1111/j.1365-3040.2010.02183.x; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Manickavelu A, 2006, PLANT GROWTH REGUL, V50, P121, DOI 10.1007/s10725-006-9109-3; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Mohammadi M, 2007, PLANT CELL ENVIRON, V30, P630, DOI 10.1111/j.1365-3040.2007.01645.x; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Munns R, 2010, J EXP BOT, V61, P3499, DOI 10.1093/jxb/erq199; Nie YuanYuan, 2012, Acta Agronomica Sinica, V38, P988; Oikawa A, 2008, RICE, V1, P63, DOI 10.1007/s12284-008-9009-4; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Price AH, 2002, J EXP BOT, V53, P989, DOI 10.1093/jexbot/53.371.989; Price AH, 1997, THEOR APPL GENET, V95, P132, DOI 10.1007/s001220050541; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reguera M, 2012, BBA-GENE REGUL MECH, V1819, P186, DOI 10.1016/j.bbagrm.2011.08.005; Reynolds M, 2008, CURR OPIN PLANT BIOL, V11, P171, DOI 10.1016/j.pbi.2008.02.005; Richards RA, 2010, FUNCT PLANT BIOL, V37, P85, DOI 10.1071/FP09219; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Rivero RM, 2001, PLANT SCI, V160, P315, DOI 10.1016/S0168-9452(00)00395-2; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rolland G, 2000, PLANT PHYSIOL, V154, P357; ROYMACAULEY H, 1992, PHYSIOL PLANTARUM, V85, P90, DOI 10.1111/j.1399-3054.1992.tb05268.x; Salekdeh GH, 2009, TRENDS PLANT SCI, V14, P488, DOI 10.1016/j.tplants.2009.07.007; Salunkhe AS, 2011, MOL BIOTECHNOL, V49, P90, DOI 10.1007/s12033-011-9382-x; Sanchez DH, 2012, PLANT CELL ENVIRON, V35, P136, DOI 10.1111/j.1365-3040.2011.02423.x; Serraj R, 2011, PLANT PROD SCI, V14, P1, DOI 10.1626/pps.14.1; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Siahpoosh MR, 2011, CROP SCI, V51, P1198, DOI 10.2135/cropsci2010.05.0243; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Stich B, 2010, THEOR APPL GENET, V120, P553, DOI 10.1007/s00122-009-1175-2; STITT M, 1983, PLANT PHYSIOL, V72, P767, DOI 10.1104/pp.72.3.767; Stitt M, 2010, PLANT J, V61, P1067, DOI 10.1111/j.1365-313X.2010.04142.x; Strand A, 2000, PLANT J, V23, P759, DOI 10.1046/j.1365-313x.2000.00847.x; Strehmel N, 2008, J CHROMATOGR B, V871, P182, DOI 10.1016/j.jchromb.2008.04.042; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tripathy JN, 2000, THEOR APPL GENET, V100, P1197, DOI 10.1007/s001220051424; Vargas M, 2006, THEOR APPL GENET, V112, P1009, DOI 10.1007/s00122-005-0204-z; Vikram P, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-89; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Warren CR, 2012, METABOLOMICS, V8, P186, DOI 10.1007/s11306-011-0299-y; Xu JL, 2005, THEOR APPL GENET, V111, P1642, DOI 10.1007/s00122-005-0099-8; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030765; Zrenner R, 1996, PLANT J, V9, P671, DOI 10.1046/j.1365-313X.1996.9050671.x; Zuther E, 2007, ADV MOL BREEDING DRO, P285, DOI DOI 10.1007/978-1-4020-5578-2_12; Zuther E, 2012, PLANT CELL ENVIRON, V35, P1860, DOI 10.1111/j.1365-3040.2012.02522.x	85	81	85	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63637	10.1371/journal.pone.0063637	http://dx.doi.org/10.1371/journal.pone.0063637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717458	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700044
J	Heitland, I; Groenink, L; Bijlsma, EY; Oosting, RS; Baas, JMP				Heitland, Ivo; Groenink, Lucianne; Bijlsma, Elisabeth Y.; Oosting, Ronald S.; Baas, Johanna M. P.			Human Fear Acquisition Deficits in Relation to Genetic Variants of the Corticotropin Releasing Hormone Receptor 1 and the Serotonin Transporter	PLOS ONE			English	Article							POLYMORPHISM 5-HTTLPR; BASOLATERAL AMYGDALA; POTENTIATED STARTLE; ANXIETY; EXTINCTION; METAANALYSIS; ASSOCIATION; MODULATION; RESPONSES; ETIOLOGY	The ability to identify predictors of aversive events allows organisms to appropriately respond to these events, and failure to acquire these fear contingencies can lead to maladaptive contextual anxiety. Recently, preclinical studies demonstrated that the corticotropin-releasing factor and serotonin systems are interactively involved in adaptive fear acquisition. Here, 150 healthy medication-free human subjects completed a cue and context fear conditioning procedure in a virtual reality environment. Fear potentiation of the eyeblink startle reflex (FPS) was measured to assess both uninstructed fear acquisition and instructed fear expression. All participants were genotyped for polymorphisms located within regulatory regions of the corticotropin releasing hormone receptor 1 (CRHR1 - rs878886) and the serotonin transporter (5HTTLPR). These polymorphisms have previously been linked to panic disorder and anxious symptomology and personality, respectively. G-allele carriers of CRHR1 (rs878886) showed no acquisition of fear conditioned responses (FPS) to the threat cue in the uninstructed phase, whereas fear acquisition was present in C/C homozygotes. Moreover, carrying the risk alleles of both rs878886 (G-allele) and 5HTTLPR (short allele) was associated with increased FPS to the threat context during this phase. After explicit instructions regarding the threat contingency were given, the cue FPS and context FPS normalized in all genotype groups. The present results indicate that genetic variability in the corticotropin-releasing hormone receptor 1, especially in interaction with the 5HTTLPR, is involved in the acquisition of fear in humans. This translates prior animal findings to the human realm.	[Heitland, Ivo; Baas, Johanna M. P.] Univ Utrecht, Dept Expt Psychol & Psychopharmacol, Utrecht, Netherlands; [Heitland, Ivo; Baas, Johanna M. P.] Helmholtz Res Inst, Utrecht, Netherlands; [Groenink, Lucianne; Bijlsma, Elisabeth Y.; Oosting, Ronald S.] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Utrecht University; Utrecht University	Baas, JMP (corresponding author), Univ Utrecht, Dept Expt Psychol & Psychopharmacol, Utrecht, Netherlands.	j.m.p.baas@uu.nl	Heitland, Ivo/AAU-5671-2020; Groenink, Lucianne/O-6588-2016	Heitland, Ivo/0000-0002-6672-7857; Groenink, Lucianne/0000-0002-4971-7796; Baas, Johanna/0000-0001-6267-8712	Linschoten Institute for Psychological Research; Brain Foundation of the Netherlands	Linschoten Institute for Psychological Research; Brain Foundation of the Netherlands	This research was supported by grants from the Linschoten Institute for Psychological Research (http://www.uu.nl/faculty/socialsciences/EN/organisation/Departments/Psychology/research/Pages/linschoteninstitute.aspx) and the Brain Foundation of the Netherlands (Hersenstichting Nederland; https://www.hersenstichting.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster D, 2009, INT J NEUROPSYCHOPH, V12, P393, DOI 10.1017/S1461145708009565; Baas JMP, 2008, ACTA PSYCHOL, V127, P581, DOI 10.1016/j.actpsy.2007.09.009; Baas JM, 2004, BIOL PSYCHIAT, V55, P1056, DOI 10.1016/j.biopsych.2004.02.024; Baas JMP, 2013, BIOL PSYCHOL, V92, P17, DOI 10.1016/j.biopsycho.2012.02.001; Bijlsma EY, 2011, NEUROSCIENCE, V173, P82, DOI 10.1016/j.neuroscience.2010.11.026; BIJLSMA EY, 2012, NEUR M PLANN NEW ORL, P20109; Binder EB, 2010, MOL PSYCHIATR, V15, P574, DOI 10.1038/mp.2009.141; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bocker KBE, 2004, BIOL PSYCHOL, V67, P343, DOI 10.1016/j.biopsycho.2004.01.001; Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4; Brocke B, 2006, MOL PSYCHIATR, V11, P1106, DOI 10.1038/sj.mp.4001908; Cicchetti D, 2011, DEV PSYCHOPATHOL, V23, P1125, DOI 10.1017/S0954579411000599; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Crisan LG, 2009, SOC COGN AFFECT NEUR, V4, P399, DOI 10.1093/scan/nsp019; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Garpenstrand H, 2001, BEHAV NEUROSCI, V115, P358, DOI 10.1037//0735-7044.115.2.358; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Grillon C, 2002, BIOL PSYCHIAT, V51, P851, DOI 10.1016/S0006-3223(01)01370-1; Grillon C, 2006, BIOL PSYCHIAT, V60, P760, DOI 10.1016/j.biopsych.2005.11.027; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Heils A, 1996, J NEUROCHEM, V66, P2621; Heitland I, 2012, COGN AFFECT BEHAV NE, V12, P678, DOI 10.3758/s13415-012-0108-8; Heitland I, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.90; Hermann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044352; Hettema JM, 2003, ARCH GEN PSYCHIAT, V60, P702, DOI 10.1001/archpsyc.60.7.702; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Holloway JL, 2011, BEHAV BRAIN RES, V216, P301, DOI 10.1016/j.bbr.2010.08.008; Holsboer F, 2008, EUR J PHARMACOL, V583, P350, DOI 10.1016/j.ejphar.2007.12.032; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Keck ME, 2008, AM J MED GENET B, V147B, P1196, DOI 10.1002/ajmg.b.30750; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Klucken T, 2013, SOC COGN AFFECT NEUR, V8, P318, DOI 10.1093/scan/nss005; Klumpers F, 2010, J PSYCHOPHARMACOL, V24, P657, DOI 10.1177/0269881109103115; Klumpers F, 2012, BIOL PSYCHOL, V89, P277, DOI 10.1016/j.biopsycho.2011.10.018; Klumpers F, 2010, BIOL PSYCHIAT, V68, P1031, DOI 10.1016/j.biopsych.2010.09.006; Kraft JB, 2005, BIOL PSYCHIAT, V58, P374, DOI 10.1016/j.biopsych.2005.04.048; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; Larson CL, 2010, PSYCHOPHYSIOLOGY, V47, P857, DOI 10.1111/j.1469-8986.2010.01005.x; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; LIANG KC, 1988, PSYCHOPHARMACOLOGY, V96, P232; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lonsdorf TB, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.36; Lonsdorf TB, 2009, PROG NEURO-PSYCHOPH, V33, P1479, DOI 10.1016/j.pnpbp.2009.08.004; Lonsdorf TB, 2009, PSYCHOL SCI, V20, P198, DOI 10.1111/j.1467-9280.2009.02280.x; Lowry CA, 2006, GEN COMP ENDOCR, V146, P19, DOI 10.1016/j.ygcen.2005.12.006; Lukkes J, 2009, J NEUROSCI, V29, P9955, DOI 10.1523/JNEUROSCI.0854-09.2009; Meyer-Lindenberg A, 2012, NEUROIMAGE, V62, P1286, DOI 10.1016/j.neuroimage.2011.10.063; Milad MR, 2006, BEHAV NEUROSCI, V120, P1196, DOI 10.1037/0735-7044.120.5.1196; Mineka S, 1996, Nebr Symp Motiv, V43, P135; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Norrholm SD, 2006, LEARN MEMORY, V13, P681, DOI 10.1101/lm.393906; Pauli P, 2010, PSYCHOPHYSIOLOGY, V47, P25, DOI 10.1111/j.1469-8986.2009.00923.x; Ressler KJ, 2010, AM J MED GENET B, V153B, P812, DOI 10.1002/ajmg.b.31052; Risbrough VB, 2009, NEUROPSYCHOPHARMACOL, V34, P1494, DOI 10.1038/npp.2008.205; Roozendaal B, 2002, P NATL ACAD SCI USA, V99, P13908, DOI 10.1073/pnas.212504599; Roozendaal B, 2008, J NEUROSCI, V28, P6642, DOI 10.1523/JNEUROSCI.1336-08.2008; Schinka JA, 2004, MOL PSYCHIATR, V9, P197, DOI 10.1038/sj.mp.4001405; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Smoller JW, 2008, AM J MED GENET C, V148C, P118, DOI 10.1002/ajmg.c.30174; Steckler Thomas, 2006, CNS & Neurological Disorders-Drug Targets, V5, P147, DOI 10.2174/187152706776359619; Valentino RJ, 2010, BRAIN RES, V1314, P29, DOI 10.1016/j.brainres.2009.09.100; WOLPE J, 1988, BEHAV RES THER, V26, P441, DOI 10.1016/0005-7967(88)90138-6	64	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63772	10.1371/journal.pone.0063772	http://dx.doi.org/10.1371/journal.pone.0063772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717480	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700058
J	Piana, A; Sotgiu, G; Cocuzza, C; Musumeci, R; Marras, V; Pischedda, S; Deidda, S; Muresu, E; Castiglia, P				Piana, Andrea; Sotgiu, Giovanni; Cocuzza, Clementina; Musumeci, Rosario; Marras, Vincenzo; Pischedda, Stefania; Deidda, Silvia; Muresu, Elena; Castiglia, Paolo			High HPV-51 Prevalence in Invasive Cervical Cancers: Results of a Pre-Immunization Survey in North Sardinia, Italy	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS GENOTYPE; CROSS-PROTECTIVE EFFICACY; HIV-INFECTED WOMEN; RISK; EPIDEMIOLOGY; VACCINATION; PERSISTENCE; DISEASE; LESIONS; IMPACT	Background: Human Papilloma virus (HPV) is recognized as the etiological agent of benign and malignant ano-genital lesions. The most prevalent genotypes associated with cervical carcinoma are HPV-16 and -18 worldwide. However, recent studies have emphasized the role of other genotypes, such as HPV-51, in the pathogenesis of cervical dysplasia. The aim of the study was to estimate the burden of HPV-51 infection in invasive cervical malignant lesions in Northern Sardinia, Italy. Methods/Principal Findings: An observational, retrospective, prevalence, mono-center study was carried out to evaluate the presence of HPV genotypes in tissues biopsies of cervical lesions (CIN-1, CIN-2, CIN-3 and invasive carcinoma) gathered from 1996 to 2009. Biological samples were collected from women admitted consecutively to a tertiary university hospital situated in Sassari, Italy. Molecular methods were used to identify 28 oncogenic HPV types. A total of 155 formalin-fixed and paraffin-embedded cervical tissue samples were analyzed. Approximately half of the cervical lesions were classified as invasive carcinoma. HPV-DNA was detected in 71% of the samples, with a higher frequency (100%) in those categorized as invasive neoplasia. Mono-or co-infections were demonstrated in 45.8% and 25.8% of the cervical samples, respectively. Overall, the most prevalent HPV types were -16 (49%) and -51 (19.4%), with an increased frequency of detection associated with the severity of the cervical lesions. Conclusions/Significance: This survey highlights for the first time the relevant role of HPV-51 infection in the pathogenesis of invasive cervical cancer prior to the introduction of a vaccination program. Although a selection bias could have influenced the results, other recent studies have described the impact of HPV-51. This remarkable epidemiological element should be carefully evaluated, particularly in the view of opting for preventive vaccines, whose cross-protection patterns determine their efficacy in protecting against infection from HPV types that are not included in the vaccine itself.	[Piana, Andrea; Sotgiu, Giovanni; Pischedda, Stefania; Deidda, Silvia; Muresu, Elena; Castiglia, Paolo] Univ Sassari, Dept Biomed Sci, Hyg & Prevent Med Unit, AOU Sassari, I-07100 Sassari, Italy; [Cocuzza, Clementina; Musumeci, Rosario] Univ Milano Bicocca, Dept Surg & Interdisciplinary Med, Milan, Italy; [Marras, Vincenzo] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy	University of Sassari; University of Milano-Bicocca; University of Sassari	Castiglia, P (corresponding author), Univ Sassari, Dept Biomed Sci, Hyg & Prevent Med Unit, AOU Sassari, I-07100 Sassari, Italy.	paolo.castiglia@uniss.it	Cocuzza, Clementina Elvezia/AAE-2064-2019; Musumeci, Rosario/B-8306-2008; Sotgiu, Giovanni/N-1032-2017	Cocuzza, Clementina Elvezia/0000-0001-6166-1134; Musumeci, Rosario/0000-0003-0143-3601; Sotgiu, Giovanni/0000-0002-1600-4474; PIANA, Andrea Fausto/0000-0002-6609-8886; Castiglia, Paolo/0000-0002-0972-4828	Sardinian Region from Ricerca sanitaria finalizzata -2006; Ministry of University	Sardinian Region from Ricerca sanitaria finalizzata -2006; Ministry of University	This work was supported by the Sardinian Region (grant for EM from Ricerca sanitaria finalizzata -2006) and by the Ministry of University (fellowship for SP and SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarossi A, 2009, J MED VIROL, V81, P529, DOI 10.1002/jmv.21347; Balbi G, 2012, EUR J GYNAECOL ONCOL, V33, P467; Broccolo F, 2009, J MED VIROL, V81, P278, DOI 10.1002/jmv.21395; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Faridi R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-269; Gargiulo F, 2007, VIRUS RES, V125, P176, DOI 10.1016/j.virusres.2006.12.017; Garnett GP, 2000, J CLIN VIROL, V19, P101, DOI 10.1016/S1386-6532(00)00129-3; GOLDMAN B, 2013, VACCINE; Guido M, 2013, CURR PHARM DESIGN, V19, P1498; IARC, 2011, IARC MON EV CARC R B, V100; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Mane A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038731; Masia G, 2009, VACCINE, V27, pA11, DOI 10.1016/j.vaccine.2008.10.095; Merikukka M, 2011, INT J CANCER, V128, P1114, DOI 10.1002/ijc.25675; Mollers M, 2013, VACCINE, V31, P394, DOI 10.1016/j.vaccine.2012.10.087; Mollers M, 2012, CANCER EPIDEMIOL, V36, P519, DOI 10.1016/j.canep.2012.07.006; Panatto D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-623; Piana A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-785; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Sandri MT, 2009, J MED VIROL, V81, P271, DOI 10.1002/jmv.21382; Schiffman M, 2012, LANCET ONCOL, V13, P10, DOI 10.1016/S1470-2045(11)70324-2; SCHMEINK C, 2012, INT J CANC; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Venturoli S, 2008, J MED VIROL, V80, P1434, DOI 10.1002/jmv.21198; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), 2010, HUM PAP REL CANC WOR; Xi LF, 2003, INT J CANCER, V103, P803, DOI 10.1002/ijc.10876; Zhang HY, 2012, ASIAN PAC J CANCER P, V13, P91, DOI 10.7314/APJCP.2012.13.1.091	33	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63395	10.1371/journal.pone.0063395	http://dx.doi.org/10.1371/journal.pone.0063395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717420	gold, Green Published, Green Submitted			2022-12-27	WOS:000320362700018
J	Campanella, F; Fabbro, F; Urgesi, C				Campanella, Fabio; Fabbro, Franco; Urgesi, Cosimo			Cognitive and Anatomical Underpinnings of the Conceptual Knowledge for Common Objects and Familiar People: A Repetitive Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							FUSIFORM FACE AREA; SEMANTIC DEMENTIA; FAMOUS FACES; PROPER-NAMES; RECOGNITION; APHASIA; ORGANIZATION; ACCESS; REPRESENTATION; MEMORY	Several studies have addressed the issue of how knowledge of common objects is organized in the brain, whereas the cognitive and anatomical underpinnings of familiar people knowledge have been less explored. Here we applied repetitive transcranial magnetic stimulation (rTMS) over the left and right temporal poles before asking healthy individuals to perform a speeded word-to-picture matching task using familiar people and common objects as stimuli. We manipulated two widely used semantic variables, namely the semantic distance and the familiarity of stimuli, to assess whether the semantic organization of familiar people knowledge is similar to that of common objects. For both objects and faces we reliably found semantic distance and familiarity effects, with less accurate and slower responses for stimulus pairs that were more closely related and less familiar. However, the effects of semantic variables differed across categories, with semantic distance effects larger for objects and familiarity effects larger for faces, suggesting that objects and faces might share a partially comparable organization of their semantic representations. The application of rTMS to the left temporal pole modulated, for both categories, semantic distance, but not familiarity effects, revealing that accessing object and face concepts might rely on overlapping processes within left anterior temporal regions. Crucially, rTMS of the left temporal pole affected only the recognition of pairs of stimuli that could be discriminated at specific levels of categorization (e.g., two kitchen tools or two famous persons), with no effect for discriminations at either superordinate or individual levels. Conversely, rTMS of the right temporal pole induced an overall slowing of reaction times that positively correlated with the visual similarity of the stimuli, suggesting a more perceptual rather than semantic role of the right anterior temporal regions. Results are discussed in the light of current models of face and object semantic representations in the brain.	[Campanella, Fabio] Azienda Osped Univ Santa Maria Misericord, Neurosurg Unit, Udine, Italy; [Campanella, Fabio; Fabbro, Franco; Urgesi, Cosimo] Univ Udine, Dept Human Sci, I-33100 Udine, Italy; [Fabbro, Franco; Urgesi, Cosimo] Ist Ricovero & Cura Carattere Sci E Medea, San Vito Al Tagliamento, Pordenone, Italy	Hospital Santa Maria della Misericordia; University of Udine; IRCCS Eugenio Medea	Campanella, F (corresponding author), Azienda Osped Univ Santa Maria Misericord, Neurosurg Unit, Udine, Italy.	fabio.campanella@uniud.it	Urgesi, Cosimo/K-4688-2016	Urgesi, Cosimo/0000-0003-0572-1328; FABBRO, Franco/0000-0003-3476-6867	Fondazione Cassa di Risparmio di Udine e Pordenone (CRUP); Scientific Institute (IRCCS) 'E. Medea' (Ricerca Corrente, Italian Ministry of Health); Consorzio Universitario Italia Argentina (CUIA)	Fondazione Cassa di Risparmio di Udine e Pordenone (CRUP); Scientific Institute (IRCCS) 'E. Medea' (Ricerca Corrente, Italian Ministry of Health); Consorzio Universitario Italia Argentina (CUIA)	This work was supported by grants from Fondazione Cassa di Risparmio di Udine e Pordenone (CRUP) (http://www.fondazionecrup.it/)to FF, and from Scientific Institute (IRCCS) 'E. Medea' (Ricerca Corrente 2011, Italian Ministry of Health) and Consorzio Universitario Italia Argentina (CUIA) (http://www.cuia.net/) to CU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertinetto PM, CORPUS LESSICO FREQU; Brambati SM, 2006, J COGNITIVE NEUROSCI, V18, P1644, DOI 10.1162/jocn.2006.18.10.1644; BRIGGS G G, 1975, Cortex, V11, P230; Campanella F, 2010, NEUROPSYCHOLOGIA, V48, P1583, DOI 10.1016/j.neuropsychologia.2010.02.002; Campanella F, 2009, BRAIN, V132, P87, DOI 10.1093/brain/awn302; Capitani E, 2003, COGN NEUROPSYCHOL, V20, P213, DOI 10.1080/02643290244000266; Crutch SJ, 2005, COGN NEUROPSYCHOL, V22, P851, DOI 10.1080/02643290442000374; Crutch SJ, 2005, BRAIN, V128, P615, DOI 10.1093/brain/awh349; Crutch SJ, 2004, NEUROPSYCHOLOGIA, V42, P584, DOI 10.1016/j.neuropsychologia.2003.10.009; Crutch SJ, 2003, BRAIN, V126, P1821, DOI 10.1093/brain/awg187; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Douville K, 2005, NEUROPSYCHOLOGIA, V43, P693, DOI 10.1016/j.neuropsychologia.2004.09.005; EVANS JJ, 1995, BRAIN, V118, P1, DOI 10.1093/brain/118.1.1; FORDE E, 1995, MEMORY, V3, P265, DOI 10.1080/09658219508253154; Gainotti G, 2000, CORTEX, V36, P539, DOI 10.1016/S0010-9452(08)70537-9; Gainotti G, 2007, NEUROPSYCHOLOGIA, V45, P1591, DOI 10.1016/j.neuropsychologia.2006.12.013; Gainotti G, 2012, CORTEX, V48, P521, DOI 10.1016/j.cortex.2011.06.019; Gauthier I, 2003, COGN NEUROPSYCHOL, V20, P507, DOI 10.1080/02643290244000275; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; Gorno-Tempini ML, 2001, BRAIN, V124, P2087, DOI 10.1093/brain/124.10.2087; Gross CG, 2002, NEUROSCIENTIST, V8, P512, DOI 10.1177/107385802237175; HINTON GE, 1991, PSYCHOL REV, V98, P74, DOI 10.1037/0033-295X.98.1.74; Hodges JR, 1998, NEUROPSYCHOLOGIA, V36, P803, DOI 10.1016/S0028-3932(97)00126-7; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; Jefferies E, 2007, NEUROPSYCHOLOGIA, V45, P1065, DOI 10.1016/j.neuropsychologia.2006.09.009; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KERR NH, 1982, MEM COGNITION, V10, P603, DOI 10.3758/BF03202443; Kitchener EG, 1999, COGNITIVE NEUROPSYCH, V16, P589, DOI 10.1080/026432999380744; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Lubrano V, 2014, HUM BRAIN MAPP, V35, P429, DOI 10.1002/hbm.22189; MCNEIL JE, 1994, NEUROPSYCHOLOGIA, V32, P193, DOI 10.1016/0028-3932(94)90005-1; Miceli G, 2000, COGN NEUROPSYCHOL, V17, P489, DOI 10.1080/02643290050110629; Mion M, 2010, BRAIN, V133, P3256, DOI 10.1093/brain/awq272; Nakamura K, 2000, BRAIN, V123, P1903, DOI 10.1093/brain/123.9.1903; NOBLE CE, 1954, J EXP PSYCHOL, V47, P13, DOI 10.1037/h0060025; Papagno C, 2001, NEUROPSYCHOLOGIA, V39, P678, DOI 10.1016/S0028-3932(01)00007-0; Papagno C, 2011, BRAIN, V134, P405, DOI 10.1093/brain/awq283; Pascual-Leone A, 1999, PHILOS T R SOC B, V354, P1229, DOI 10.1098/rstb.1999.0476; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; PLAUT DC, 1993, COGNITIVE NEUROPSYCH, V10, P377, DOI 10.1080/02643299308253469; Pobric G, 2007, P NATL ACAD SCI USA, V104, P20137, DOI 10.1073/pnas.0707383104; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Ralph MAL, 2009, CEREB CORTEX, V19, P832, DOI 10.1093/cercor/bhn131; Rogers TT, 2006, COGN AFFECT BEHAV NE, V6, P201, DOI 10.3758/CABN.6.3.201; Rogers TT, 2004, PSYCHOL REV, V111, P205, DOI 10.1037/0033-295X.111.1.205; Seidenberg M, 2002, NEUROPSYCHOLOGIA, V40, P446, DOI 10.1016/S0028-3932(01)00096-3; SEMENZA C, 1989, NATURE, V342, P678, DOI 10.1038/342678a0; SEMENZA C, 1988, COGNITIVE NEUROPSYCH, V5, P711, DOI 10.1080/02643298808253279; SMITH RC, 1971, J EXP PSYCHOL, V88, P279, DOI 10.1037/h0031002; Snowden J., 1989, BEHAV NEUROL, V2, P167, DOI [DOI 10.1093/NEUCAS/1.1.39-Y, https://doi.org/10.1155/1989/124043, DOI 10.1155/1989/124043]; Snowden JS, 2004, BRAIN, V127, P860, DOI 10.1093/brain/awh099; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Thompson SA, 2004, NEUROPSYCHOLOGIA, V42, P359, DOI 10.1016/j.neuropsychologia.2003.08.004; Tyler LK, 2004, J COGNITIVE NEUROSCI, V16, P351, DOI 10.1162/089892904322926692; TYRRELL PJ, 1990, J NEUROL NEUROSUR PS, V53, P1046, DOI 10.1136/jnnp.53.12.1046; WARRINGTON EK, 1979, BRAIN, V102, P43, DOI 10.1093/brain/102.1.43; Warrington EK, 2004, COGN NEUROPSYCHOL, V21, P299, DOI 10.1080/02643290342000546; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Warrington EK, 1996, BRAIN, V119, P611, DOI 10.1093/brain/119.2.611; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	63	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64596	10.1371/journal.pone.0064596	http://dx.doi.org/10.1371/journal.pone.0064596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704999	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200153
J	Drozak, J; Chrobok, L; Poleszak, O; Jagielski, AK; Derlacz, R				Drozak, Jakub; Chrobok, Lukasz; Poleszak, Olga; Jagielski, Adam K.; Derlacz, Rafal			Molecular Identification of Carnosine N-Methyltransferase as Chicken Histamine N-Methyltransferase-Like Protein (HNMT-Like)	PLOS ONE			English	Article							AUTONOMIC NERVES; SKELETAL-MUSCLE; ANSERINE; HUMANS	Anserine (beta-alanyl-N(Pi)-methyl-L-histidine), a naturally occurring derivative of carnosine (beta-alanyl-L-histidine), is an abundant constituent of skeletal muscles and brain of many vertebrates. Although it has long been proposed to serve as a proton buffer, radicals scavenger and transglycating agent, its physiological function remains obscure. The formation of anserine is catalyzed by carnosine N-methyltransferase which exhibits unknown molecular identity. In the present investigation, we have purified carnosine N-methyltransferase from chicken pectoral muscle about 640-fold until three major polypeptides of about 23, 26 and 37 kDa coeluting with the enzyme were identified in the preparation. Mass spectrometry analysis of these polypeptides resulted in an identification of histamine N-methyltransferase-like (HNMT-like) protein as the only meaningful candidate. Analysis of GenBank database records indicated that the hnmt-like gene might be a paralogue of histamine N-methyltransferase gene, while comparison of their protein sequences suggested that HNMT-like protein might have acquired a new activity. Chicken HNMT-like protein was expressed in COS-7 cells, purified to homogeneity, and shown to catalyze the formation of anserine as confirmed by both chromatographic and mass spectrometry analysis. Both specificity and kinetic studies carried out on the native and recombinant enzyme were in agreement with published data. Particularly, several compounds structurally related to carnosine, including histamine and L-histidine, were tested as potential substrates for the enzyme, and carnosine was the only methyl group acceptor. The identification of the gene encoding carnosine N-methyltransferase might be beneficial for estimation of the biological functions of anserine.	[Drozak, Jakub; Chrobok, Lukasz; Poleszak, Olga; Jagielski, Adam K.; Derlacz, Rafal] Univ Warsaw, Inst Biochem, Dept Metab Regulat, Fac Biol, Warsaw, Poland	University of Warsaw	Drozak, J (corresponding author), Univ Warsaw, Inst Biochem, Dept Metab Regulat, Fac Biol, Warsaw, Poland.	jdrozak@biol.uw.edu.pl		Drozak, Jakub/0000-0002-3601-3845; Krupska, Olga/0000-0003-3218-7108	Polish Ministry of Science and Higher Education [Decision 0081/P01/2010/70]; European Union - the European Regional Development Fund within the Operational Programme "Innovative economy"; Ministry of Science and Higher Education from Funds of Science and Polish Technology [Decision 372/FNiTP/115/2009]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union - the European Regional Development Fund within the Operational Programme "Innovative economy"; Ministry of Science and Higher Education from Funds of Science and Polish Technology	This work was supported by the Iuventus Plus grant (Decision 0081/P01/2010/70) from the Polish Ministry of Science and Higher Education (http://www.nauka.gov.pl/home/). It was carried out with the use of CePT infrastructure financed by the European Union - the European Regional Development Fund within the Operational Programme "Innovative economy" for 2007-2013 (https://cept.wum.edu.pl/). Dionex ICS-3000 chromatograph used for dipeptide measurements was financed by Ministry of Science and Higher Education from Funds of Science and Polish Technology (Decision 372/FNiTP/115/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boldyrev AA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P313, DOI 10.1134/S0006297912040013; Boldyrev A.A., 2007, CARNOSINE OXIDATIVE; BOWSHER RR, 1983, J BIOL CHEM, V258, P2215; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAN KM, 1994, CRIT REV FOOD SCI, V34, P403, DOI 10.1080/10408399409527669; CRUSH KG, 1970, COMP BIOCHEM PHYSIOL, V34, P3, DOI 10.1016/0010-406X(70)90049-6; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; FRANCIS DM, 1980, BIOCHEM J, V187, P819, DOI 10.1042/bj1870819; GE Healthcare, 2010, GEL FILTR PRINC METH, P31; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kubomura D, 2010, NUTR NEUROSCI, V13, P183, DOI 10.1179/147683010X12611460764363; MANNION AF, 1992, EUR J APPL PHYSIOL O, V64, P47, DOI 10.1007/BF00376439; MCMANUS IR, 1962, J BIOL CHEM, V237, P1207; Mora L, 2007, J AGR FOOD CHEM, V55, P4664, DOI 10.1021/jf0703809; Nagai K, 2003, EXP BIOL MED, V228, P1138, DOI 10.1177/153537020322801007; Pegova A, 2000, COMP BIOCHEM PHYS B, V127, P443, DOI 10.1016/S0305-0491(00)00279-0; RAGHAVAN M, 1992, EUR J BIOCHEM, V210, P311, DOI 10.1111/j.1432-1033.1992.tb17423.x; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Szwergold BS, 2005, BIOCHEM BIOPH RES CO, V336, P36, DOI 10.1016/j.bbrc.2005.08.033; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; WHITAKER JR, 1963, ANAL CHEM, V35, P1950, DOI 10.1021/ac60205a048; Wong Alvin, 2006, Natl Cathol Bioeth Q, V6, P473	27	28	30	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64805	10.1371/journal.pone.0064805	http://dx.doi.org/10.1371/journal.pone.0064805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705015	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200169
J	Fattash, I; Bhardwaj, P; Hui, C; Yang, GY				Fattash, Isam; Bhardwaj, Priyanka; Hui, Caleb; Yang, Guojun			A Rice Stowaway MITE for Gene Transfer in Yeast	PLOS ONE			English	Article							REPEAT TRANSPOSABLE ELEMENTS; CHROMOSOMAL TRANSPOSITION; TC1/MARINER-LIKE ELEMENT; HIGH-COPY; FAMILY; DROSOPHILA; DNA; MOBILIZATION; PLASMID; AMPLIFICATION	Miniature inverted repeat transposable elements (MITEs) lack protein coding capacity and often share very limited sequence similarity with potential autonomous elements. Their capability of efficient transposition and dramatic amplification led to the proposition that MITEs are an untapped rich source of materials for transposable element (TE) based genetic tools. To test the concept of using MITE sequence in gene transfer, a rice Stowaway MITE previously shown to excise efficiently in yeast was engineered to carry cargo genes (neo and gfp) for delivery into the budding yeast genome. Efficient excision of the cargo gene cassettes was observed even though the excision frequency generally decreases with the increase of the cargo sizes. Excised elements insert into new genomic loci efficiently, with about 65% of the obtained insertion sites located in genes. Elements at the primary insertion sites can be remobilized, frequently resulting in copy number increase of the element. Surprisingly, the orientation of a cargo gene (neo) on a construct bearing dual reporter genes (gfp and neo) was found to have a dramatic effect on transposition frequency. These results demonstrated the concept that MITE sequences can be useful in engineering genetic tools to deliver cargo genes into eukaryotic genomes.	[Fattash, Isam; Bhardwaj, Priyanka; Hui, Caleb; Yang, Guojun] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Yang, GY (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	gage.yang@utoronto.ca	Fattash, Isam/J-3078-2013	Fattash, Isam/0000-0001-6227-8487	National Sciences and Engineering Research Council (NSERC) Discovery Grant (Canada) [RGPIN 371565]; Canadian Foundation for Innovation [CFI24456, IOF-12]; Ontario Research Foundation [ORF24456]; University of Toronto	National Sciences and Engineering Research Council (NSERC) Discovery Grant (Canada); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Foundation; University of Toronto(University of Toronto)	Supported by the National Sciences and Engineering Research Council (NSERC) Discovery Grant (Canada) (RGPIN 371565 to GY), Canadian Foundation for Innovation (CFI24456 and IOF-12 to GY) and Ontario Research Foundation (ORF24456 to GY) and the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; Casa AM, 2002, THEOR APPL GENET, V104, P104, DOI 10.1007/s001220200012; CHANDLER M, 1982, J MOL BIOL, V154, P229, DOI 10.1016/0022-2836(82)90062-6; Chang RY, 2001, THEOR APPL GENET, V102, P773, DOI 10.1007/s001220051709; Charrier B, 1999, PLANT J, V18, P431, DOI 10.1046/j.1365-313X.1999.00469.x; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dufresne M, 2008, FUNGAL GENET BIOL, V45, P1552, DOI 10.1016/j.fgb.2008.09.004; Evertts AG, 2007, GENETICS, V177, P2519, DOI 10.1534/genetics.107.081075; Fadool JM, 1998, P NATL ACAD SCI USA, V95, P5182, DOI 10.1073/pnas.95.9.5182; Feschotte C, 2003, GENETICS, V163, P747; Feschotte C, 2002, MOBILE DNA-UK, P1147, DOI DOI 10.1128/9781555817954.CH50; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; Gangadharan S, 2010, P NATL ACAD SCI USA, V107, P21966, DOI 10.1073/pnas.1016382107; GARFINKEL DJ, 1988, GENETICS, V120, P95; GORYSHIN IY, 1994, P NATL ACAD SCI USA, V91, P10834, DOI 10.1073/pnas.91.23.10834; Gueiros FJ, 1997, SCIENCE, V277, P753; Hancock CN, 2011, PLANT PHYSIOL, V157, P552, DOI 10.1104/pp.111.181206; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; HSIAO CL, 1981, GENE, V15, P157, DOI 10.1016/0378-1119(81)90125-6; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Kwon SJ, 2006, MOL CELLS, V21, P360; Langdon T, 2003, GENETICS, V163, P1097; Li J, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1358; LI X, 2012, P NATL ACAD SCI US; Lin XY, 2006, J EXP BOT, V57, P2313, DOI 10.1093/jxb/erj203; Lozovsky ER, 2002, GENETICS, V160, P527; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; MEAD DJ, 1986, MOL GEN GENET, V205, P417, DOI 10.1007/BF00338076; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Momose M, 2010, GENETICS, V186, P59, DOI 10.1534/genetics.110.117606; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; Parekh RN, 1996, BIOTECHNOL PROGR, V12, P16, DOI 10.1021/bp9500627; Patel M, 2004, THEOR APPL GENET, V108, P1492, DOI 10.1007/s00122-004-1590-3; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Takahashi H, 2006, GENOME, V49, P1616, DOI 10.1139/G06-115; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; WAY JC, 1985, GENETICS, V111, P705; Weil CF, 2000, NAT GENET, V26, P187, DOI 10.1038/82827; YAAKOV B, 2012, PLANT PHYSL; Yaakov B, 2012, THEOR APPL GENET, V124, P1365, DOI 10.1007/s00122-012-1793-y; Yang G, 2001, MOL GENET GENOMICS, V266, P417, DOI 10.1007/s004380100530; Yang GJ, 2003, J MOL EVOL, V56, P255, DOI 10.1007/s00239-002-2397-y; Yang GJ, 2007, P NATL ACAD SCI USA, V104, P10962, DOI 10.1073/pnas.0702080104; Yang GJ, 2006, PLANT CELL, V18, P2469, DOI 10.1105/tpc.106.045906; Yang GJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-283; Yang GJ, 2009, SCIENCE, V325, P1391, DOI 10.1126/science.1175688; ZAKIAN VA, 1979, CELL, V17, P923, DOI 10.1016/0092-8674(79)90332-5; Zhang XY, 2001, P NATL ACAD SCI USA, V98, P12572, DOI 10.1073/pnas.211442198	56	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64135	10.1371/journal.pone.0064135	http://dx.doi.org/10.1371/journal.pone.0064135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704977	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200119
J	Gonzalez, A; Casado, C; Arino, J; Casamayor, A				Gonzalez, Asier; Casado, Carlos; Arino, Joaquin; Casamayor, Antonio			Ptc6 Is Required for Proper Rapamycin-Induced Down-Regulation of the Genes Coding for Ribosomal and rRNA Processing Proteins in S-cerevisiae	PLOS ONE			English	Article							YEAST; PHOSPHATASE; TOR; EXPRESSION; 2C; COMPLEX; GENOME; TARGET; STRESS; ROLES	Ptc6 is one of the seven components (Ptc1-Ptc7) of the protein phosphatase 2C family in the yeast Saccharomyces cerevisiae. In contrast to other type 2C phosphatases, the cellular role of this isoform is poorly understood. We present here a comprehensive characterization of this gene product. Cells lacking Ptc6 are sensitive to zinc ions, and somewhat tolerant to cell-wall damaging agents and to Li+. Ptc6 mutants are sensitive to rapamycin, albeit to lesser extent than ptc1 cells. This phenotype is not rescued by overexpression of PTC1 and mutation of ptc6 does not reproduce the characteristic genetic interactions of the ptc1 mutation with components of the TOR pathway, thus suggesting different cellular roles for both isoforms. We show here that the rapamycin-sensitive phenotype of ptc6 cells is unrelated to the reported role of Pt6 in controlling pyruvate dehydrogenase activity. Lack of Ptc6 results in substantial attenuation of the transcriptional response to rapamycin, particularly in the subset of repressed genes encoding ribosomal proteins or involved in rRNA processing. In contrast, repressed genes involved in translation are Ptc6-independent. These effects cannot be attributed to the regulation of the Sch9 kinase, but they could involve modulation of the binding of the Ifh1 co-activator to specific gene promoters.	[Casamayor, Antonio] Univ Autonoma Barcelona, Fac Vet, IBB, Cerdanyola De Valles, Spain; Univ Autonoma Barcelona, Fac Vet, Dept Bioquim & Biol Mol, Cerdanyola De Valles, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Casamayor, A (corresponding author), Univ Autonoma Barcelona, Fac Vet, IBB, Cerdanyola De Valles, Spain.	Antonio.Casamayor@uab.es	Casamayor, Antonio/A-3190-2012; Casamayor, Antonio/C-2509-2017; González, Asier/A-7064-2012; Arino, Joaquin/D-3756-2011	Casamayor, Antonio/0000-0003-2788-7329; Arino, Joaquin/0000-0002-6774-2987; Arino Carmona, Joaquin/0000-0002-0390-4270	SysMo2 [EUI2009-04147]; Ministry of Science and Innovation, Spain; FEDER; Ajut de Suport a les Activitats dels Grups de Recerca [2009SGR-1091]; ICREA Academia Award (Generalitat de Catalunya);  [BFU2009-11593];  [BFU2011-30197-C3-01]	SysMo2; Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Ajut de Suport a les Activitats dels Grups de Recerca; ICREA Academia Award (Generalitat de Catalunya)(ICREA); ; 	Supported by grants BFU2009-11593 to A.C. and EUI2009-04147 (SysMo2) and BFU2011-30197-C3-01 to J.A., and Ministry of Science and Innovation, Spain, and FEDER. J.A. is the recipient of "Ajut de Suport a les Activitats dels Grups de Recerca'' (Grant 2009SGR-1091) and an ICREA Academia Award (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Abeliovich H, 2011, ANTIOXID REDOX SIGN, V14, P2003, DOI 10.1089/ars.2010.3807; Adams A, 1997, METHODS YEAST GENETI; Adler E, 1997, MOL MICROBIOL, V23, P57, DOI 10.1046/j.1365-2958.1997.1801552.x; Alberola TM, 2004, INT MICROBIOL, V7, P199; Arino J, 2011, EUKARYOT CELL, V10, P21, DOI 10.1128/EC.00249-10; Calero F, 2000, J BACTERIOL, V182, P394, DOI 10.1128/JB.182.2.394-399.2000; Casamayor A, 2012, BIOCHEM J, V444, P39, DOI 10.1042/BJ20112099; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferrer-Dalmau J, 2010, BIOCHEM J, V426, P355, DOI 10.1042/BJ20091909; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gonzalez A, 2006, J BIOL CHEM, V281, P35057, DOI 10.1074/jbc.M607919200; Gonzalez A, 2009, MOL CELL BIOL, V29, P2876, DOI 10.1128/MCB.01740-08; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Journo D, 2009, J BIOL CHEM, V284, P35885, DOI 10.1074/jbc.M109.048140; Juneau K, 2009, GENETICS, V183, P185, DOI 10.1534/genetics.109.105155; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Karra K, 2012, DATABASE; Kim EM, 2011, J PEPT SCI, V17, P392, DOI 10.1002/psc.1312; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Krause-Buchholz U, 2006, FEBS LETT, V580, P2553, DOI 10.1016/j.febslet.2006.04.002; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Mendl N, 2011, J CELL SCI, V124, P1339, DOI 10.1242/jcs.076406; Munoz I, 2003, YEAST, V20, P157, DOI 10.1002/yea.938; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; POSAS F, 1995, J BIOL CHEM, V270, P13036, DOI 10.1074/jbc.270.22.13036; Ramos CW, 2000, IUBMB LIFE, V50, P371, DOI 10.1080/152165400300089411; Ruan HH, 2007, FEMS YEAST RES, V7, P209, DOI 10.1111/j.1567-1364.2006.00160.x; Rudra D, 2007, MOL CELL BIOL, V27, P4815, DOI 10.1128/MCB.02062-06; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruiz A, 2008, J BIOL CHEM, V283, P13923, DOI 10.1074/jbc.M708683200; Ruiz A, 2006, MOL MICROBIOL, V62, P263, DOI 10.1111/j.1365-2958.2006.05370.x; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Sakumoto N, 2002, YEAST, V19, P587, DOI 10.1002/yea.860; Sakumoto NM, 1999, YEAST, V15, P1669, DOI 10.1002/(SICI)1097-0061(199911)15:15<1669::AID-YEA480>3.0.CO;2-6; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	55	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64470	10.1371/journal.pone.0064470	http://dx.doi.org/10.1371/journal.pone.0064470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704987	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200140
J	Hirano, T; Kobayashi, N; Matsuhashi, T; Watanabe, D; Watanabe, T; Takasuga, A; Sugimoto, M; Sugimoto, Y				Hirano, Takashi; Kobayashi, Naohiko; Matsuhashi, Tamako; Watanabe, Daisaku; Watanabe, Toshio; Takasuga, Akiko; Sugimoto, Mayumi; Sugimoto, Yoshikazu			Mapping and Exome Sequencing Identifies a Mutation in the IARS Gene as the Cause of Hereditary Perinatal Weak Calf Syndrome	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; QUANTITATIVE TRAIT LOCI; CATTLE; DEFICIENCY; GENOME; MAP	We identified an IARS (isoleucyl-tRNA synthetase) c.235G>C (p.Val79Leu) substitution as the causative mutation for neonatal weakness with intrauterine growth retardation (perinatal weak calf syndrome). In Japanese Black cattle, the syndrome was frequently found in calves sired by Bull A. Hence, we employed homozygosity mapping and linkage analysis. In order to identify the perinatal weak calf syndrome locus in a 4.04-Mb region of BTA 8, we analysed a paternal half-sibling family with a BovineSNP50 BeadChip and microsatellites. In this critical region, we performed exome sequencing to identify a causative mutation. Three variants were detected as possible candidates for causative mutations that were predicted to disrupt the protein function, including a G>C (p.Val79Leu) mutation in IARS c.235. The IARS c.235G>C mutation was not a homozygous risk allele in the 36 healthy offspring of Bull A. Moreover, the IARS Val79 residue and its flanking regions were evolutionarily and highly conserved. The IARS mutant (Leu79) had decreased aminoacylation activity. Additionally, the homozygous mutation was not found in any of 1526 healthy cattle. Therefore, we concluded that the IARS c.235G>C mutation was the cause of hereditary perinatal weak calf syndrome.	[Hirano, Takashi; Sugimoto, Yoshikazu] Shirakawa Inst Anim Genet, Fukushima, Japan; [Hirano, Takashi] Tokyo Univ Agr, Kanagawa, Japan; [Kobayashi, Naohiko; Matsuhashi, Tamako] Gifu Prefectural Livestock Res Inst, Hida Beef Cattle Res Dept, Gifu, Japan; [Watanabe, Daisaku] Kitasato Univ, Sch Vet Med & Anim Sci, Aomori, Japan; [Watanabe, Toshio; Takasuga, Akiko; Sugimoto, Mayumi] Natl Livestock Breeding Ctr, Fukushima, Japan	Tokyo University of Agriculture; Kitasato University	Hirano, T (corresponding author), Shirakawa Inst Anim Genet, Fukushima, Japan.	t3hirano@nodai.ac.jp			Japan Racing and Livestock Promotion Foundation	Japan Racing and Livestock Promotion Foundation	This work was supported by grants from the Japan Racing and Livestock Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4250, DOI 10.1093/nar/gkm402; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Charlier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043085; CHURCHILL GA, 1994, GENETICS, V138, P963; Doi H, 2011, AM J HUM GENET, V89, P320, DOI 10.1016/j.ajhg.2011.07.012; Glazov EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002027; HALEY CS, 1994, GENETICS, V136, P1195; Hirano T, 1996, ANIM GENET, V27, P365, DOI 10.1111/j.1365-2052.1996.tb00980.x; Hirano T, 2000, GENOME RES, V10, P659, DOI 10.1101/gr.10.5.659; Hirano T, 2012, ANIM GENET, V43, P11, DOI 10.1111/j.1365-2052.2011.02209.x; Ihara N, 2004, GENOME RES, V14, P1987, DOI 10.1101/gr.2741704; Inaba M, 1996, J CLIN INVEST, V97, P1804, DOI 10.1172/JCI118610; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kappes SM, 1997, GENOME RES, V7, P235, DOI 10.1101/gr.7.3.235; Kunieda M, 2005, MAMM GENOME, V16, P383, DOI 10.1007/s00335-004-2462-5; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; Miyamoto Y, 2002, J BIOL CHEM, V277, P28810, DOI 10.1074/jbc.M203827200; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ogata Y, 1999, J VET MED A, V46, P327, DOI 10.1046/j.1439-0442.1999.00221.x; Ogawa H., 1996, Journal of Veterinary Medicine, Japan, V49, P411; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Seaton G, 2002, BIOINFORMATICS, V18, P339, DOI 10.1093/bioinformatics/18.2.339; Takasu M, 2008, J VET MED SCI, V70, P1173, DOI 10.1292/jvms.70.1173; Visscher PM, 1996, GENETICS, V143, P1013; Watanabe T, 2000, J BIOL CHEM, V275, P21789, DOI 10.1074/jbc.C000230200; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xu SZ, 1996, GENETICS, V143, P1417; Yamakuchi H, 2000, ANIM GENET, V31, P13, DOI 10.1046/j.1365-2052.2000.00586.x	38	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64036	10.1371/journal.pone.0064036	http://dx.doi.org/10.1371/journal.pone.0064036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700453	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200107
J	Kim, H; Choi, SH; Kim, JH; Ryoo, I; Kim, SC; Yeom, JA; Shin, H; Jung, SC; Lee, AL; Yun, TJ; Park, CK; Sohn, CH; Park, SH				Kim, Hyungjin; Choi, Seung Hong; Kim, Ji-Hoon; Ryoo, Inseon; Kim, Soo Chin; Yeom, Jeong A.; Shin, Hwaseon; Jung, Seung Chai; Lee, A. Leum; Yun, Tae Jin; Park, Chul-Kee; Sohn, Chul-Ho; Park, Sung-Hye			Gliomas: Application of Cumulative Histogram Analysis of Normalized Cerebral Blood Volume on 3 T MRI to Tumor Grading	PLOS ONE			English	Article							APPARENT DIFFUSION-COEFFICIENT; PREDICTIVE VALUES; PERFUSION; MAPS; DIFFERENTIATION; SPECTROSCOPY; SPECIFICITY; SENSITIVITY; REGION; FLOW	Background: Glioma grading assumes significant importance in that low- and high-grade gliomas display different prognoses and are treated with dissimilar therapeutic strategies. The objective of our study was to retrospectively assess the usefulness of a cumulative normalized cerebral blood volume (nCBV) histogram for glioma grading based on 3 T MRI. Methods: From February 2010 to April 2012, 63 patients with astrocytic tumors underwent 3 T MRI with dynamic susceptibility contrast perfusion-weighted imaging. Regions of interest containing the entire tumor volume were drawn on every section of the co-registered relative CBV (rCBV) maps and T2-weighted images. The percentile values from the cumulative nCBV histograms and the other histogram parameters were correlated with tumor grades. Cochran's Q test and the McNemar test were used to compare the diagnostic accuracies of the histogram parameters after the receiver operating characteristic curve analysis. Using the parameter offering the highest diagnostic accuracy, a validation process was performed with an independent test set of nine patients. Results: The 99th percentile of the cumulative nCBV histogram (nCBV C99), mean and peak height differed significantly between low- and high-grade gliomas (P = <0.001, 0.014 and <0.001, respectively) and between grade III and IV gliomas (P = <0.001, 0.001 and <0.001, respectively). The diagnostic accuracy of nCBV C99 was significantly higher than that of the mean nCBV (P = 0.016) in distinguishing high- from low-grade gliomas and was comparable to that of the peak height (P = 1.000). Validation using the two cutoff values of nCBV C99 achieved a diagnostic accuracy of 66.7% (6/9) for the separation of all three glioma grades. Conclusion: Cumulative histogram analysis of nCBV using 3 T MRI can be a useful method for preoperative glioma grading. The nCBV C99 value is helpful in distinguishing high- from low-grade gliomas and grade IV from III gliomas.	[Kim, Hyungjin; Choi, Seung Hong; Kim, Ji-Hoon; Ryoo, Inseon; Kim, Soo Chin; Yeom, Jeong A.; Shin, Hwaseon; Jung, Seung Chai; Lee, A. Leum; Yun, Tae Jin; Sohn, Chul-Ho] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Park, Chul-Kee] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Park, Sung-Hye] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Inst Basic Sci, Ctr Nanoparticle Res, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	verocay@snuh.org	Sohn, ChulHo/AAV-4565-2021; Park, Chul-Kee/J-5499-2012; Park, Chul-Kee/O-7842-2019	Park, Chul-Kee/0000-0002-2350-9876; Yun, Tae Jin/0000-0001-8441-4574; Choi, Seung Hong/0000-0002-0412-2270	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1120300]; Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs [A112028]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1120300) and the Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family Affairs (A112028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras J, 2011, NEURORADIOLOGY, V53, P483, DOI 10.1007/s00234-010-0769-3; Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Bankier AA, 2010, RADIOLOGY, V257, P14, DOI 10.1148/radiol.10100252; Bjornerud A, 2003, P HUM BRAIN MAPPING, P19; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032; Cha S, 2005, AM J NEURORADIOL, V26, P266; Choi SH, 2007, CLIN RADIOL, V62, P453, DOI 10.1016/j.crad.2006.12.001; Emblem KE, 2008, AM J NEURORADIOL, V29, P1664, DOI 10.3174/ajnr.A1182; Emblem KE, 2008, RADIOLOGY, V247, P808, DOI 10.1148/radiol.2473070571; Fink JR, 2012, J MAGN RESON IMAGING, V35, P56, DOI 10.1002/jmri.22801; Garzon B, 2011, ACTA RADIOL, V52, P1052, DOI 10.1258/ar.2011.100510; Hilario A, 2012, AM J NEURORADIOL, V33, P701, DOI 10.3174/ajnr.A2846; Kang Y, 2011, RADIOLOGY, V261, P882, DOI 10.1148/radiol.11110686; Kim HS, 2007, AM J NEURORADIOL, V28, P1693, DOI 10.3174/ajnr.A0674; Kim HS, 2010, RADIOLOGY, V256, P906, DOI 10.1148/radiol.10091461; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Law M, 2007, AM J NEURORADIOL, V28, P761; Law M, 2006, RADIOLOGY, V238, P658, DOI 10.1148/radiol.2382042180; Law M, 2003, AM J NEURORADIOL, V24, P1989; Lev MH, 1999, NEUROIMAG CLIN N AM, V9, P309; Liu X, 2011, NEURO-ONCOLOGY, V13, P447, DOI 10.1093/neuonc/noq197; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Pedersen CL, 2013, CLIN NEUROL NEUROSUR, V115, P1, DOI 10.1016/j.clineuro.2012.07.002; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Schmainda KM, 2004, AM J NEURORADIOL, V25, P1524; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Shin JH, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790783; Thomsen H, 2012, ACTA RADIOL, V53, P95, DOI 10.1258/ar.2011.110242; Tozer DJ, 2007, NMR BIOMED, V20, P49, DOI 10.1002/nbm.1091; Wetzel SG, 2002, RADIOLOGY, V224, P797, DOI 10.1148/radiol.2243011014; Yeh SA, 2005, BRIT J RADIOL, V78, P230, DOI 10.1259/bjr/28534346; Young R, 2007, J MAGN RESON IMAGING, V26, P1053, DOI 10.1002/jmri.21064; Zonari P, 2007, NEURORADIOLOGY, V49, P795, DOI 10.1007/s00234-007-0253-x	34	34	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63462	10.1371/journal.pone.0063462	http://dx.doi.org/10.1371/journal.pone.0063462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704910	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200042
J	Mitchell, G; Fugere, A; Gaudreau, KP; Brouillette, E; Frost, EH; Cantin, AM; Malouin, F				Mitchell, Gabriel; Fugere, Alexandre; Gaudreau, Karine Pepin; Brouillette, Eric; Frost, Eric H.; Cantin, Andre M.; Malouin, Francois			SigB Is a Dominant Regulator of Virulence in Staphylococcus aureus Small-Colony Variants	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; BIOFILM; EXPRESSION; AGR; PERSISTENT; OPERON; COLONIZATION; EVOLUTION; MUTANTS; STRAINS	Staphylococcus aureus small-colony variants (SCVs) are persistent pathogenic bacteria characterized by slow growth and, for many of these strains, an increased ability to form biofilms and to persist within host cells. The virulence-associated gene expression profile of SCVs clearly differs from that of prototypical strains and is often influenced by SigB rather than by the agr system. One objective of this work was to confirm the role of SigB in the control of the expression of virulence factors involved in biofilm formation and intracellular persistence of SCVs. This study shows that extracellular proteins are involved in the formation of biofilm by three SCV strains, which, additionally, have a low biofilm-dispersing activity. It was determined that SigB activity modulates biofilm formation by strain SCV CF07-S and is dominant over that of the agr system without being solely responsible for the repression of proteolytic activity. On the other hand, the expression of fnbA and the control of nuclease activity contributed to the SigB-dependent formation of biofilm of this SCV strain. SigB was also required for the replication of CF07-S within epithelial cells and may be involved in the colonization of lungs by SCVs in a mouse infection model. This study methodically investigated SigB activity and associated mechanisms in the various aspects of SCV pathogenesis. Results confirm that SigB activity importantly influences the production of virulence factors, biofilm formation and intracellular persistence for some clinical SCV strains.	[Mitchell, Gabriel; Fugere, Alexandre; Gaudreau, Karine Pepin; Brouillette, Eric; Malouin, Francois] Univ Sherbrooke, Fac Sci, Dept Biol, Ctr Etude & Valorisat Div Microbienne, Sherbrooke, PQ J1K 2R1, Canada; [Cantin, Andre M.] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, Sherbrooke, PQ J1K 2R1, Canada; [Cantin, Andre M.] Univ Sherbrooke, Fac Med & Sci Sante, Unite Rech Pulm, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Malouin, F (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, Ctr Etude & Valorisat Div Microbienne, Sherbrooke, PQ J1K 2R1, Canada.	Francois.Malouin@USherbrooke.ca		Malouin, Francois/0000-0001-5031-345X; Frost, Eric/0000-0001-8958-4388	Cystic Fibrosis Canada; Alexander-Graham-Bell Graduate Scholarship from the Natural Science and Engineering Research Council of Canada; Fonds quebecois de la recherche sur la nature et les technologies	Cystic Fibrosis Canada; Alexander-Graham-Bell Graduate Scholarship from the Natural Science and Engineering Research Council of Canada; Fonds quebecois de la recherche sur la nature et les technologies(FQRNT)	This study was supported by a grant from Cystic Fibrosis Canada (http://www.cysticfibrosis.ca/en/index.php). GM was the recipient of an Alexander-Graham-Bell Graduate Scholarship from the Natural Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) and received a doctoral research scholarship from the Fonds quebecois de la recherche sur la nature et les technologies (http://www.fqrnt.gouv.qc.ca) during the course of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Laham N, 2007, J BACTERIOL, V189, P4494, DOI 10.1128/JB.00160-07; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Bates DM, 2003, J INFECT DIS, V187, P1654, DOI 10.1086/374642; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Brouillette E, 2004, FEMS IMMUNOL MED MIC, V41, P35, DOI 10.1016/j.femsim.2003.12.007; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cui LZ, 2012, P NATL ACAD SCI USA, V109, pE1647, DOI 10.1073/pnas.1204307109; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Goerke C, 2004, INT J MED MICROBIOL, V294, P195, DOI 10.1016/j.ijmm.2004.06.013; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Jarry TM, 2008, CELL MICROBIOL, V10, P1801, DOI 10.1111/j.1462-5822.2008.01166.x; Kahl BC, 2003, J CLIN MICROBIOL, V41, P410, DOI 10.1128/JCM.41.1.410-413.2003; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Marti M, 2010, MICROBES INFECT, V12, P55, DOI 10.1016/j.micinf.2009.10.005; Mitchell G, 2011, INFECT IMMUN, V79, P3541, DOI 10.1128/IAI.00078-11; Mitchell G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-33; Mitchell G, 2010, MICROB PATHOGENESIS, V48, P18, DOI 10.1016/j.micpath.2009.10.003; Mitchell G, 2008, MOL MICROBIOL, V70, P1540, DOI 10.1111/j.1365-2958.2008.06511.x; Moisan FN, 2006, J BACTERIOL, V188, P64, DOI 10.1128/JB.188.1.64-76.2006; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Palmer ME, 2011, MBIO, V2, DOI 10.1128/mBio.00241-11; Palmer ML, 2006, J CELL PHYSIOL, V206, P759, DOI 10.1002/jcp.20519; Patton TG, 2006, MOL MICROBIOL, V59, P1395, DOI 10.1111/j.1365-2958.2006.05034.x; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Resch A, 2005, FEMS MICROBIOL LETT, V252, P89, DOI 10.1016/j.femsle.2005.08.048; Rice KC, 2004, J BACTERIOL, V186, P3029, DOI 10.1128/JB.186.10.3029-3037.2004; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Schulthess B, 2011, J BACTERIOL, V193, P4954, DOI 10.1128/JB.05362-11; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Senn MM, 2005, J BACTERIOL, V187, P8006, DOI 10.1128/JB.187.23.8006-8019.2005; Senn MM, 2005, J BACTERIOL, V187, P7397, DOI 10.1128/JB.187.21.7397-7406.2005; Singh R, 2010, J MED MICROBIOL, V59, P521, DOI 10.1099/jmm.0.017046-0; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Wright JS, 2005, J BACTERIOL, V187, P5585, DOI 10.1128/JB.187.16.5585-5594.2005	54	52	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65018	10.1371/journal.pone.0065018	http://dx.doi.org/10.1371/journal.pone.0065018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705029	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200183
J	Shen, HR; Qiu, LH; Zhang, ZQ; Qin, YY; Cao, C; Di, W				Shen, Hao-ran; Qiu, Li-hua; Zhang, Zhi-qing; Qin, Yuan-yuan; Cao, Cong; Di, Wen			Genome-Wide Methylated DNA Immunoprecipitation Analysis of Patients with Polycystic Ovary Syndrome	PLOS ONE			English	Article							INSULIN-RESISTANCE; WOMEN; EXPRESSION; PROTEIN; ENVIRONMENT; METFORMIN; BETA	Polycystic ovary syndrome (PCOS) is a complex, heterogeneous disorder of uncertain etiology. Recent studies suggested that insulin resistance (IR) plays an important role in the development of PCOS. In the current study, we aimed to investigate the molecular mechanism of IR in PCOS. We employed genome-wide methylated DNA immunoprecipitation (MeDIP) analysis to characterize genes that are differentially methylated in PCOS patients vs. healthy controls. Besides, we also identified the differentially methylated genes between patients with PCOS-non-insulin resistance (PCOS-NIR) and PCOS-insulin resistance (PCOS-IR). A total of 79 genes were differentially methylated between PCOS-NIR vs. PCOS-IR patients, and 40 genes were differentially methylated in PCOS patients vs. healthy controls. We analyzed these differentially methylated genes by constructing regulatory networks and protein-protein interaction (PPI) networks. Further, Gene Ontology (GO) and pathway enrichment analysis were also performed to investigate the biological functions of networks. We identified multiple categories of genes that were differentially methylated between PCOS-NIR and PCOS-IR patients, or between PCOS patients and healthy controls. Significantly, GO categories of immune response were differentially methylated in PCOS-IR vs. PCOS-NIR. Further, genes in cancer pathways were also differentially methylated in PCOS-NIR vs. PCOS-IR patients or in PCOS patients vs. healthy controls. The results of this current study will help to further understand the mechanism of PCOS.	[Shen, Hao-ran; Qiu, Li-hua; Qin, Yuan-yuan; Di, Wen] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China.	caocong@suda.edu.cn; diwen163@163.com	Shen, Haoran/Q-6397-2017	Shen, Haoran/0000-0002-5679-6998	Ministry of Science and Technology of China [2006DFA32780]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the International Collaborative Items of Ministry of Science and Technology of China (No. 2006DFA32780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angioni S, 2011, GYNECOL ENDOCRINOL, V27, P468, DOI 10.3109/09513590.2010.492886; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Baillargeon JP, 2003, CLIN OBSTET GYNECOL, V46, P325, DOI 10.1097/00003081-200306000-00011; Bianco RB, 2006, EUR J CANCER, V42, P290, DOI 10.1016/j.ejca.2005.07.034; Cho LW, 2009, CLIN ENDOCRINOL, V70, P233, DOI 10.1111/j.1365-2265.2008.03309.x; Cupisti S, 2010, FERTIL STERIL, V94, P2647, DOI 10.1016/j.fertnstert.2010.03.048; Diamanti-Kandarakis E, 2006, ENDOCRINE, V30, P19, DOI 10.1385/ENDO:30:1:19; Evian Annual Reprod EVAR Workshop, 2011, HUM REPROD UPDATE, V17, P829, DOI 10.1093/humupd/dmr033; Goldenberg N, 2008, Minerva Ginecol, V60, P63; Halperin IJ, 2011, HUM REPROD, V26, P191, DOI 10.1093/humrep/deq301; Harries LW, 2012, AGING CELL, V11, P262, DOI 10.1111/j.1474-9726.2011.00782.x; Hickey TE, 2006, J CLIN ENDOCR METAB, V91, P2789, DOI 10.1210/jc.2006-0069; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Huang AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001334; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutchison SK, 2011, J CLIN ENDOCR METAB, V96, pE48, DOI 10.1210/jc.2010-0828; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Kaboord Barbara, 2008, V424, P349, DOI 10.1007/978-1-60327-064-9_27; KAI A, 1994, CARBOHYD POLYM, V23, P235, DOI 10.1016/0144-8617(94)90184-8; Karels B, 2011, DEV MOUSE MODEL POLY, pP94; Kim JJ, 2010, FERTIL STERIL, V93, P1942, DOI 10.1016/j.fertnstert.2008.12.040; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Legro RS, 2002, FERTIL STERIL, V78, P569, DOI 10.1016/S0015-0282(02)03275-2; Li ZX, 2008, MED HYPOTHESES, V70, P638, DOI 10.1016/j.mehy.2006.09.076; Ly LP, 2005, EUR J ENDOCRINOL, V152, P471, DOI 10.1530/eje.1.01844; Nardo LG, 2009, HUM REPROD, V24, P2917, DOI 10.1093/humrep/dep225; NATSUKA S, 1992, BLOOD, V79, P460; Pomraning KR, 2009, METHODS, V47, P142, DOI 10.1016/j.ymeth.2008.09.022; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qu F, 2012, J MOL MED, V90, P911, DOI 10.1007/s00109-012-0881-4; SANDSTROM LP, 1993, ALCOHOL, V10, P303, DOI 10.1016/0741-8329(93)90010-L; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Swedenborg E, 2009, CELL MOL LIFE SCI, V66, P3873, DOI 10.1007/s00018-009-0118-z; Tasali E, 2011, J CLIN ENDOCR METAB, V96, P365, DOI 10.1210/jc.2010-1187; Tosi F, 2009, EUR J ENDOCRINOL, V161, P737, DOI 10.1530/EJE-09-0379; Vanky E, 2004, HUM REPROD, V19, P1734, DOI 10.1093/humrep/deh347; Xu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027286; Yamamoto H, 2002, J CELL SCI, V115, P3601, DOI 10.1242/jcs.00044	41	35	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64801	10.1371/journal.pone.0064801	http://dx.doi.org/10.1371/journal.pone.0064801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705014	Green Submitted, gold, Green Published			2022-12-27	WOS:000319330200168
J	Vinci, MC; Tessitore, G; Castiglioni, L; Prandi, F; Soncini, M; Santoro, R; Consolo, F; Colazzo, F; Micheli, B; Sironi, L; Polvani, G; Pesce, M				Vinci, Maria Cristina; Tessitore, Giulio; Castiglioni, Laura; Prandi, Francesca; Soncini, Monica; Santoro, Rosaria; Consolo, Filippo; Colazzo, Francesca; Micheli, Barbara; Sironi, Luigi; Polvani, Gianluca; Pesce, Maurizio			Mechanical Compliance and Immunological Compatibility of Fixative-Free Decellularized/Cryopreserved Human Pericardium	PLOS ONE			English	Article							FIXED BOVINE PERICARDIUM; AORTIC-VALVE-REPLACEMENT; IMMUNE-RESPONSE; HEART-VALVES; ALPHA-GAL; GLUTARALDEHYDE; CALCIFICATION; BIOCOMPATIBILITY; HOMOGRAFT; PORCINE	Background: The pericardial tissue is commonly used to produce bio-prosthetic cardiac valves and patches in cardiac surgery. The procedures adopted to prepare this tissue consist in treatment with aldehydes, which do not prevent post-graft tissue calcification due to incomplete xeno-antigens removal. The adoption of fixative-free decellularization protocols has been therefore suggested to overcome this limitation. Although promising, the decellularized pericardium has not yet used in clinics, due to the absence of proofs indicating that the decellularization and cryopreservation procedures can effectively preserve the mechanical properties and the immunologic compatibility of the tissue. Principal Findings: The aim of the present work was to validate a procedure to prepare decellularized/cryopreserved human pericardium which may be implemented into cardiovascular homograft tissue Banks. The method employed to decellularize the tissue completely removed the cells without affecting ECM structure; furthermore, uniaxial tensile loading tests revealed an equivalent resistance of the decellularized tissue to strain, before and after the cryopreservation, in comparison with the fresh tissue. Finally, immunological compatibility, showed a minimized host immune cells invasion and low levels of systemic inflammation, as assessed by tissue transplantation into immune-competent mice. Conclusions: Our results indicate, for the first time, that fixative-free decellularized pericardium from cadaveric tissue donors can be banked according to Tissue Repository-approved procedures without compromising its mechanical properties and immunological tolerance. This tissue can be therefore treated as a safe homograft for cardiac surgery.	[Vinci, Maria Cristina; Prandi, Francesca; Santoro, Rosaria; Pesce, Maurizio] Ctr Cardiol Monzino IRCCS, Lab Ingn Tissutale Cardiovasc, Milan, Italy; [Tessitore, Giulio; Polvani, Gianluca] Univ Milan, Dipartimento Sci Cardiovasc, Milan, Italy; [Castiglioni, Laura; Colazzo, Francesca; Sironi, Luigi] Univ Milan, Dipartimento Farmacol, Milan, Italy; [Soncini, Monica; Consolo, Filippo] Politecn Milan, Dipartimento Bioingn, I-20133 Milan, Italy; [Micheli, Barbara] Banca Tessuti Cardiovasc Reg Lombardia, Milan, Italy	IRCCS Centro Cardiologico Monzino; University of Milan; University of Milan; Polytechnic University of Milan	Pesce, M (corresponding author), Ctr Cardiol Monzino IRCCS, Lab Ingn Tissutale Cardiovasc, Milan, Italy.	maurizio.pesce@ccfm.it	Consolo, Filippo/A-7607-2018; Pesce, Maurizio/B-4260-2010; santoro, rosaria/AAI-3983-2020; Pesce, Maurizio/AAA-4207-2019; Vinci, Maria Cristina/E-7401-2016; Santoro, Rosaria/F-3704-2018; Santoro, Rosaria/AAY-3921-2021; POLVANI, GIANLUCA/I-4656-2018; Sironi, Luigi/S-8174-2016; Soncini, Monica/E-9609-2018	Consolo, Filippo/0000-0002-7948-3847; Pesce, Maurizio/0000-0002-3097-8961; santoro, rosaria/0000-0003-3980-1959; Pesce, Maurizio/0000-0002-3097-8961; Vinci, Maria Cristina/0000-0001-6323-147X; Santoro, Rosaria/0000-0003-3980-1959; POLVANI, GIANLUCA/0000-0003-1055-0965; COLAZZO, FRANCESCA/0000-0002-5782-1606; Soncini, Monica/0000-0001-8607-7196; SIRONI, LUIGI/0000-0002-4738-3454; castiglioni, laura/0000-0002-0772-3231	Ricerca Corrente, Centro Cardiologico Monzino	Ricerca Corrente, Centro Cardiologico Monzino	The present work has been financed by Ricerca Corrente, Centro Cardiologico Monzino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barili F, 2007, ARTIF ORGANS, V31, P152, DOI 10.1111/j.1525-1594.2007.00355.x; Bloch O, 2011, TISSUE ENG PT A, V17, P2399, DOI [10.1089/ten.tea.2011.0046, 10.1089/ten.TEA.2011.0046]; CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467, DOI 10.1016/S0022-5223(19)42561-0; Chen CH, 2010, REPRODUCTION, V140, P105, DOI 10.1530/REP-09-0448; Creemers P, 2002, TRANSPL IMMUNOL, V10, P285, DOI 10.1016/S0966-3274(02)00072-2; Dahms SE, 1998, BRIT J UROL, V82, P411; Dainese L, 2006, ARTIF ORGANS, V30, P259, DOI 10.1111/j.1525-1594.2006.00213.x; Dainese L, 2012, J HEART VALVE DIS, V21, P125; DONG X, 2009, J MAT SCI MAT MED; Gaipa G, 2010, J CELL MOL MED, V14, P1619, DOI 10.1111/j.1582-4934.2009.00854.x; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Grabenwoger M, 1996, ANN THORAC SURG, V62, P772; Guldner NW, 2012, J THORAC CARDIOV SUR, V143, P1152, DOI 10.1016/j.jtcvs.2011.10.076; Guldner NW, 2009, CIRCULATION, V119, P1653, DOI 10.1161/CIRCULATIONAHA.108.823948; Jorge-Herrero E, 2010, ARTIF ORGANS, V34, pE168, DOI 10.1111/j.1525-1594.2009.00978.x; Konakci KZ, 2005, EUR J CLIN INVEST, V35, P17; Koolbergen DR, 2002, J THORAC CARDIOV SUR, V124, P689, DOI 10.1067/mtc.2002.124514; Korossis SA, 2002, J HEART VALVE DIS, V11, P463; LEE JM, 1985, CIRC RES, V57, P475, DOI 10.1161/01.RES.57.3.475; LEVY RJ, 1986, AM J PATHOL, V122, P71; Maizato MJS, 2008, ARTIF ORGANS, V32, P268, DOI 10.1111/j.1525-1594.2008.00541.x; Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311; McClure RS, 2010, ANN THORAC SURG, V89, P1410, DOI 10.1016/j.athoracsur.2010.01.046; Mendoza-Novelo B, 2011, ACTA BIOMATER, V7, P1241, DOI 10.1016/j.actbio.2010.11.017; Mirsadraee S, 2007, J SURG RES, V143, P407, DOI 10.1016/j.jss.2007.01.026; Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763; Oei FBS, 2000, EUR J CARDIO-THORAC, V18, P466, DOI 10.1016/S1010-7940(00)00540-6; Pompilio G, 2004, ANN THORAC SURG, V78, P557, DOI 10.1016/j.athoracsur.2004.02.037; Puvimanasinghe JPA, 2005, ANN THORAC SURG, V80, P825, DOI 10.1016/j.athoracsur.2005.03.064; Rieder E, 2005, CIRCULATION, V111, P2792, DOI 10.1161/CIRCULATIONAHA.104.473629; Rodas ACD, 2011, ARTIF ORGANS, V35, P502, DOI 10.1111/j.1525-1594.2011.01255.x; Sinha P, 2012, J THORAC CARDIOV SUR, V143, P224, DOI 10.1016/j.jtcvs.2011.09.043; Tedder ME, 2009, TISSUE ENG PT A, V15, P1257, DOI 10.1089/ten.tea.2008.0263; Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f; Vincentelli A, 1998, ANN THORAC SURG, V66, pS255, DOI 10.1016/S0003-4975(98)01098-4; Welters MJP, 2001, CLIN EXP IMMUNOL, V124, P353, DOI 10.1046/j.1365-2249.2001.01557.x; Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030	37	30	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64769	10.1371/journal.pone.0064769	http://dx.doi.org/10.1371/journal.pone.0064769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705010	Green Published, gold			2022-12-27	WOS:000319330200164
J	Jia, HM; Feng, YF; Liu, YT; Chang, X; Chen, L; Zhang, HW; Ding, G; Zou, ZM				Jia, Hong-mei; Feng, Yu-fei; Liu, Yue-tao; Chang, Xing; Chen, Lin; Zhang, Hong-wu; Ding, Gang; Zou, Zhong-mei			Integration of H-1 NMR and UPLC-Q-TOF/MS for a Comprehensive Urinary Metabonomics Study on a Rat Model of Depression Induced by Chronic Unpredictable Mild Stress	PLOS ONE			English	Article							BETA-HYDROXYBUTYRATE; MASS-SPECTROMETRY; PLASMA; XIAOYAOSAN; BIOMARKERS; BRAIN; METABOLISM; GLUTAMATE; TOXICITY; STRATEGY	Depression is a type of complex psychiatric disorder with long-term, recurrent bouts, and its etiology remains largely unknown. Here, an integrated approach utilizing H-1 NMR and UPLC-Q-TOF/MS together was firstly used for a comprehensive urinary metabonomics study on chronic unpredictable mild stress (CUMS) treated rats. More than twenty-nine metabolic pathways were disturbed after CUMS treatment and thirty-six potential biomarkers were identified by using two complementary analytical technologies. Among the identified biomarkers, nineteen (10, 11, 16, 17, 21-25, and 27-36) were firstly reported as potential biomarkers of CUMS-induced depression. Obviously, this paper presented a comprehensive map of the metabolic pathways perturbed by CUMS and expanded on the multitude of potential biomarkers that have been previously reported in the CUMS model. Four metabolic pathways, including valine, leucine and isoleucine biosynthesis; phenylalanine, tyrosine and tryptophan biosynthesis; tryptophan metabolism; synthesis and degradation of ketone bodies had the deepest influence in the pathophysiologic process of depression. Fifteen potential biomarkers (1-2, 4-6, 15, 18, 20-23, 27, 32, 35-36) involved in the above four metabolic pathways might become the screening criteria in clinical diagnosis and predict the development of depression. Moreover, the results of Western blot analysis of aromatic L-amino acid decarboxylase (DDC) and indoleamine 2, 3-dioxygenase (IDO) in the hippocampus of CUMS-treated rats indicated that depletion of 5-HT and tryptophan, production of 5-MT and altered expression of DDC and IDO together played a key role in the initiation and progression of depression. In addition, none of the potential biomarkers were detected by NMR and LC-MS simultaneously which indicated the complementary of the two kinds of detection technologies. Therefore, the integration of 1 H NMR and UPLC-Q-TOF/MS in metabonomics study provided an approach to identify the comprehensive potential depression-related biomarkers and helpful in further understanding the underlying molecular mechanisms of depression through the disturbance of metabolic pathways.	[Jia, Hong-mei; Liu, Yue-tao; Chang, Xing; Chen, Lin; Zhang, Hong-wu; Ding, Gang; Zou, Zhong-mei] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Jia, Hong-mei; Liu, Yue-tao; Chang, Xing; Chen, Lin; Zhang, Hong-wu; Ding, Gang; Zou, Zhong-mei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Feng, Yu-fei] Beijing Hosp, Minist Publ Hlth, Dept Pharm, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Hospital	Zou, ZM (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	zmzou@implad.ac.cn			National Natural Science Foundation of China [81173512]; National S&T Major Special Project on Major New Drug Innovation [2012ZX09301002-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project on Major New Drug Innovation	The authors gratefully acknowledge financial support from the National Natural Science Foundation of China (Grant No. 81173512). This study was also supported by National S&T Major Special Project on Major New Drug Innovation (2012ZX09301002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranibar N, 2011, ANAL BIOCHEM, V410, P84, DOI 10.1016/j.ab.2010.11.023; Auer DP, 2000, BIOL PSYCHIAT, V47, P305, DOI 10.1016/S0006-3223(99)00159-6; Beltran A, 2012, ANAL CHEM, V84, P5838, DOI 10.1021/ac3005567; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Dai YT, 2010, J ETHNOPHARMACOL, V128, P482, DOI 10.1016/j.jep.2010.01.016; Dardzinski BJ, 2000, PEDIATR RES, V48, P248, DOI 10.1203/00006450-200008000-00021; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Gao XX, 2013, PHYTOTHER RES, V27, P1074, DOI 10.1002/ptr.4805; Gao XX, 2011, J ETHNOPHARMACOL, V137, P690, DOI 10.1016/j.jep.2011.06.024; Goodpaster AM, 2011, ANAL CHEM, V83, P896, DOI 10.1021/ac102572b; Gosetti F, 2013, ANAL BIOANAL CHEM, V405, P907, DOI 10.1007/s00216-012-6269-z; Guo K, 2009, ANAL CHEM, V81, P3919, DOI 10.1021/ac900166a; Hodson MP, 2007, ANAL BIOCHEM, V362, P182, DOI 10.1016/j.ab.2006.12.037; ITO T, 1995, J CHROMATOGR B, V670, P317, DOI 10.1016/0378-4347(95)00174-3; Jung J, 2011, TOXICOL LETT, V200, P1, DOI 10.1016/j.toxlet.2010.09.020; KASCKOW JW, 2013, J PSYCHIATR RES, P40; Li ZY, 2010, RAPID COMMUN MASS SP, V24, P3539, DOI 10.1002/rcm.4809; Liu XJ, 2012, MAGN RESON CHEM, V50, P187, DOI 10.1002/mrc.2865; Liu XJ, 2012, J PHARM PHARMACOL, V64, P578, DOI 10.1111/j.2042-7158.2011.01412.x; Maes M, 2012, PSYCHIAT RES, V196, P243, DOI 10.1016/j.psychres.2011.09.029; Martin JC, 2009, ATHEROSCLEROSIS, V206, P127, DOI 10.1016/j.atherosclerosis.2009.01.040; Ni Y, 2008, FEBS LETT, V582, P2627, DOI 10.1016/j.febslet.2008.06.040; Noh HS, 2006, J NEUROSCI RES, V83, P702, DOI 10.1002/jnr.20736; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; PAPP M, 1991, PSYCHOPHARMACOLOGY, V104, P255, DOI 10.1007/BF02244188; Reo NV, 2002, DRUG CHEM TOXICOL, V25, P375, DOI 10.1081/DCT-120014789; Ryan D, 2011, ANAL CHIM ACTA, V684, P17, DOI 10.1016/j.aca.2010.10.035; Serkova NJ, 2006, EXPERT REV MOL DIAGN, V6, P717, DOI 10.1586/14737159.6.5.717; Shi BY, 2013, BEHAV BRAIN RES, V241, P86, DOI 10.1016/j.bbr.2012.11.036; Su ZH, 2011, J PHARMACEUT BIOMED, V55, P533, DOI 10.1016/j.jpba.2011.02.013; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; TAKIKAWA O., 2007, INT C SER, V1304, p290 ; TROMBETTA LD, 1988, TOXICOL APPL PHARM, V93, P154, DOI 10.1016/0041-008X(88)90035-X; Wang XY, 2009, J PROTEOME RES, V8, P2511, DOI 10.1021/pr801086k; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xu F, 2011, PHYTOMEDICINE, V18, P1130, DOI 10.1016/j.phymed.2011.05.002; Zandio M, 2002, An Sist Sanit Navar, V25 Suppl 3, P43; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1; Zheng SN, 2010, CLIN CHIM ACTA, V411, P204, DOI 10.1016/j.cca.2009.11.003; ZHENG SN, 2010, UPLC MS BASED PLASMA, DOI DOI 10.1007/S11306-010-0261-4; Zhou YZ, 2011, J ETHNOPHARMACOL, V137, P236, DOI 10.1016/j.jep.2011.05.016	42	32	37	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63624	10.1371/journal.pone.0063624	http://dx.doi.org/10.1371/journal.pone.0063624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696839	gold, Green Submitted, Green Published			2022-12-27	WOS:000319107900051
J	Egawa, T; Yeh, SR; Rousseau, DL				Egawa, Tsuyoshi; Yeh, Syun-Ru; Rousseau, Denis L.			Redox-Controlled Proton Gating in Bovine Cytochrome c Oxidase	PLOS ONE			English	Article							OXYGEN-REDUCTION; CARBON-MONOXIDE; HEME; MECHANISM; PUMP; TRANSLOCATION; RAMAN; PATHWAY; PHASES; MUTANT	Cytochrome c oxidase is the terminal enzyme in the electron transfer chain of essentially all organisms that utilize oxygen to generate energy. It reduces oxygen to water and harnesses the energy to pump protons across the mitochondrial membrane in eukaryotes and the plasma membrane in prokaryotes. The mechanism by which proton pumping is coupled to the oxygen reduction reaction remains unresolved, owing to the difficulty of visualizing proton movement within the massive membrane-associated protein matrix. Here, with a novel hydrogen/deuterium exchange resonance Raman spectroscopy method, we have identified two critical elements of the proton pump: a proton loading site near the propionate groups of heme a, which is capable of transiently storing protons uploaded from the negative-side of the membrane prior to their release into the positive side of the membrane and a conformational gate that controls proton translocation in response to the change in the redox state of heme a. These findings form the basis for a postulated molecular model describing a detailed mechanism by which unidirectional proton translocation is coupled to electron transfer from heme a to heme a(3), associated with the oxygen chemistry occurring in the heme a(3) site, during enzymatic turnover.	[Egawa, Tsuyoshi; Yeh, Syun-Ru; Rousseau, Denis L.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Rousseau, DL (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA.	denis.rousseau@einstein.yu.edu		Yeh, Syun-Ru/0000-0002-9858-386X	National Institutes of Health grant [GM098799]; National Science Foundation Grant [NSF0956358]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098799, R01GM086482] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported the National Institutes of Health grant GM098799 to D.L.R and National Science Foundation Grant NSF0956358 to S.-R.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGADE PV, 1986, J BIOL CHEM, V261, P5969; ARTZATBANOV VY, 1978, FEBS LETT, V87, P180, DOI 10.1016/0014-5793(78)80327-5; BABCOCK GT, 1983, BIOCHEMISTRY-US, V22, P2314, DOI 10.1021/bi00279a002; Belevich I, 2008, ANTIOXID REDOX SIGN, V10, P1, DOI 10.1089/ars.2007.1705; Belevich I, 2007, P NATL ACAD SCI USA, V104, P2685, DOI 10.1073/pnas.0608794104; BICKAR D, 1984, J BIOL CHEM, V259, P777; Branden G, 2006, BBA-BIOENERGETICS, V1757, P1052, DOI 10.1016/j.bbabio.2006.05.020; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; CALLAHAN PM, 1983, BIOCHEMISTRY-US, V22, P452, DOI 10.1021/bi00271a031; Capitanio G, 2006, BIOCHEMISTRY-US, V45, P1930, DOI 10.1021/bi052080v; Capitanio G, 2011, BBA-BIOENERGETICS, V1807, P1287, DOI 10.1016/j.bbabio.2011.02.004; Capitanio N, 1817, BIOCHIM BIOPHYS ACTA, P558; Egawa T, 2009, ANAL BIOCHEM, V394, P141, DOI 10.1016/j.ab.2009.06.035; Faxen K, 2005, NATURE, V437, P286, DOI 10.1038/nature03921; FETTER JR, 1995, P NATL ACAD SCI USA, V92, P1604, DOI 10.1073/pnas.92.5.1604; GARCIAHORSMAN JA, 1995, BIOCHEMISTRY-US, V34, P4428, DOI 10.1021/bi00013a035; Gorbikova EA, 2008, P NATL ACAD SCI USA, V105, P10733, DOI 10.1073/pnas.0802512105; Han HZ, 2011, P NATL ACAD SCI USA, V108, P14109, DOI 10.1073/pnas.1018958108; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kaila VRI, 2010, CHEM REV, V110, P7062, DOI 10.1021/cr1002003; Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P80, DOI 10.1016/j.bbabio.2010.08.014; Kamiya K, 2007, J AM CHEM SOC, V129, P9663, DOI 10.1021/ja070464y; Kim Y, 2001, J AM CHEM SOC, V123, P757, DOI 10.1021/ja0027867; LI XY, 1990, J PHYS CHEM-US, V94, P47, DOI 10.1021/j100364a008; MALATESTA F, 1995, BIOPHYS CHEM, V54, P1, DOI 10.1016/0301-4622(94)00117-3; MOODY AJ, 1991, BIOCHIM BIOPHYS ACTA, V1059, P189, DOI 10.1016/S0005-2728(05)80204-X; Musser SM, 1998, J MOL EVOL, V46, P508, DOI 10.1007/PL00006332; Papa S, 1998, J BIOENERG BIOMEMBR, V30, P109, DOI 10.1023/A:1020519914011; Pereira MM, 2008, BBA-BIOENERGETICS, V1777, P929, DOI 10.1016/j.bbabio.2008.05.441; Rousseau DL, 1999, NATURE, V400, P412, DOI 10.1038/22664; Sharpe MA, 2008, J BIOENERG BIOMEMBR, V40, P541, DOI 10.1007/s10863-008-9182-6; Shimokata K, 2007, P NATL ACAD SCI USA, V104, P4200, DOI 10.1073/pnas.0611627104; Siegbahn PEM, 2003, J PHYS CHEM B, V107, P10946, DOI 10.1021/jp035486v; Siletsky SA, 1817, BIOCHIM BIOPHYS ACTA, P476; Song YF, 2006, BIOCHEMISTRY-US, V45, P7959, DOI 10.1021/bi052183d; Sugitani R, 2009, BBA-BIOENERGETICS, V1787, P1140, DOI 10.1016/j.bbabio.2009.04.004; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Tiefenbrunn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022348; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013; YOSHIKAWA S, 1977, J BIOL CHEM, V252, P5498; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Yoshikawa S, 1807, BIOCHIM BIOPHYS ACTA, P1279; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P395, DOI 10.1016/j.bbabio.2006.04.028	47	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63669	10.1371/journal.pone.0063669	http://dx.doi.org/10.1371/journal.pone.0063669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696843	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900050
J	Mantelin, S; Bhattarai, KK; Jhaveri, TZ; Kaloshian, I				Mantelin, Sophie; Bhattarai, Kishor K.; Jhaveri, Teraneh Z.; Kaloshian, Isgouhi			Mi-1-Mediated Resistance to Meloidogyne incognita in Tomato May Not Rely on Ethylene but Hormone Perception through ETR3 Participates in Limiting Nematode Infection in a Susceptible Host	PLOS ONE			English	Article							CAMPESTRIS PV. VESICATORIA; ROOT-KNOT NEMATODES; SIGNALING PATHWAY; GENE-EXPRESSION; POTATO APHID; NEVER-RIPE; PSEUDOMONAS-SYRINGAE; SALICYLIC-ACID; CELL-DEATH; BIOSYNTHESIS	Root-knot nematodes, Meloidogyne spp., are important pests of tomato (Solanum lycopersicum) and resistance to the three most prevalent species of this genus, including Meloidogyne incognita, is mediated by the Mi-1 gene. Mi-1 encodes a nucleotide binding (NB) leucine-rich repeat (LRR) resistance (R) protein. Ethylene (ET) is required for the resistance mediated by a subset of NB-LRR proteins and its role in Mi-1-mediated nematode resistance has not been characterized. Infection of tomato roots with M. incognita differentially induces ET biosynthetic genes in both compatible and incompatible interactions. Analyzing the expression of members of the ET biosynthetic gene families ACC synthase (ACS) and ACC oxidase (ACO), in both compatible and incompatible interactions, shows differences in amplitude and temporal expression of both ACS and ACO genes in these two interactions. Since ET can promote both resistance and susceptibility against microbial pathogens in tomato, we investigated the role of ET in Mi-1-mediated resistance to M. incognita using both genetic and pharmacological approaches. Impairing ET biosynthesis or perception using virus-induced gene silencing (VIGS), the ET-insensitive Never ripe (Nr) mutant, or 1-methylcyclopropene (MCP) treatment, did not attenuate Mi-1-mediated resistance to M. incognita. However, Nr plants compromised in ET perception showed enhanced susceptibility to M. incognita indicating a role for ETR3 in basal resistance to root-knot nematodes.	[Mantelin, Sophie; Bhattarai, Kishor K.; Jhaveri, Teraneh Z.; Kaloshian, Isgouhi] Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA; [Kaloshian, Isgouhi] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Kaloshian, I (corresponding author), Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA.	isgouhi.kaloshian@ucr.edu			National Science Foundation [IOB-0543937]; University of California Agricultural Experiment Station	National Science Foundation(National Science Foundation (NSF)); University of California Agricultural Experiment Station(University of California System)	This research was supported in part by grants from the National Science Foundation (grant no. IOB-0543937) and the University of California Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso CT, 2007, J PLANT GROWTH REGUL, V26, P92, DOI 10.1007/s00344-007-0013-5; Balaji V, 2008, PLANT PHYSIOL, V146, P1797, DOI 10.1104/pp.107.115188; Bent AF, 2006, CROP SCI, V46, P893, DOI 10.2135/cropsci2005.08-0235; Bhattarai KK, 2007, PLANT PHYSIOL, V144, P312, DOI 10.1104/pp.107.097246; Bhattarai KK, 2007, MOL PLANT MICROBE IN, V20, P276, DOI 10.1094/MPMI-20-3-0276; Bhattarai KK, 2008, MOL PLANT MICROBE IN, V21, P1205, DOI 10.1094/MPMI-21-9-1205; Casteel CL, 2006, ENTOMOL EXP APPL, V121, P67, DOI 10.1111/j.1570-8703.2006.00458.x; Ciardi JA, 2000, PLANT PHYSIOL, V123, P81, DOI 10.1104/pp.123.1.81; Ciardi JA, 2001, MOL PLANT MICROBE IN, V14, P487, DOI 10.1094/MPMI.2001.14.4.487; Cohn JR, 2005, PLANT J, V44, P139, DOI 10.1111/j.1365-313X.2005.02516.x; de Ilarduya OM, 2004, MOL PLANT MICROBE IN, V17, P55, DOI 10.1094/MPMI.2004.17.1.55; de Wild HPJ, 2003, J EXP BOT, V54, P1537, DOI 10.1093/jxb/erg159; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; DROPKIN VH, 1969, ANNU REV PHYTOPATHOL, V7, P101, DOI 10.1146/annurev.py.07.090169.000533; Eulgem T, 2004, PLANT PHYSIOL, V135, P1129, DOI 10.1104/pp.104.040444; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fudali SL, 2013, MOL PLANT MICROBE IN, V26, P75, DOI 10.1094/MPMI-05-12-0107-R; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; GLAZER I, 1984, J AM SOC HORTIC SCI, V109, P886; GLAZER I, 1985, J NEMATOL, V17, P145; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; Klee H, 2002, PHYSIOL PLANTARUM, V115, P336, DOI 10.1034/j.1399-3054.2002.1150302.x; Lambert KN, 1999, PHYSIOL MOL PLANT P, V55, P341, DOI 10.1006/pmpp.1999.0239; LANAHAN MB, 1994, PLANT CELL, V6, P521, DOI 10.1105/tpc.6.4.521; Li Q, 2006, MOL PLANT MICROBE IN, V19, P655, DOI 10.1094/MPMI-19-0655; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lund ST, 1998, PLANT CELL, V10, P371, DOI 10.1105/tpc.10.3.371; Mantelin S, 2009, NEW PHYTOL, V183, P444, DOI 10.1111/j.1469-8137.2009.02870.x; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Nahar K, 2011, PLANT PHYSIOL, V157, P305, DOI 10.1104/pp.111.177576; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Nombela G, 2003, MOL PLANT MICROBE IN, V16, P645, DOI 10.1094/MPMI.2003.16.7.645; O'Donnell PJ, 2001, PLANT J, V25, P315, DOI 10.1046/j.1365-313x.2001.00968.x; RICK CM, 1956, ADV GENET, V8, P267, DOI 10.1016/S0065-2660(08)60504-0; ROBERTS PA, 1986, PLANT DIS, V70, P547, DOI 10.1094/PD-70-547; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Sisler EC, 2006, BIOTECHNOL ADV, V24, P357, DOI 10.1016/j.biotechadv.2006.01.002; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Tieman DV, 2000, P NATL ACAD SCI USA, V97, P5663, DOI 10.1073/pnas.090550597; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807; Wubben MJE, 2001, MOL PLANT MICROBE IN, V14, P1206, DOI 10.1094/MPMI.2001.14.10.1206; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; YEN HC, 1995, PLANT PHYSIOL, V107, P1343, DOI 10.1104/pp.107.4.1343; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042	49	19	23	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63281	10.1371/journal.pone.0063281	http://dx.doi.org/10.1371/journal.pone.0063281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717408	Green Published, Green Submitted, gold			2022-12-27	WOS:000319435600008
J	Munder, M; Engelhardt, M; Knies, D; Medenhoff, S; Wabnitz, G; Luckner-Minden, C; Feldmeyer, N; Voss, RH; Kropf, P; Muller, I; Conradi, R; Samstag, Y; Theobald, M; Ho, AD; Goldschmidt, H; Hundemer, M				Munder, Markus; Engelhardt, Melanie; Knies, Diana; Medenhoff, Sergej; Wabnitz, Guido; Luckner-Minden, Claudia; Feldmeyer, Nadja; Voss, Ralf-Holger; Kropf, Pascale; Mueller, Ingrid; Conradi, Roland; Samstag, Yvonne; Theobald, Matthias; Ho, Anthony D.; Goldschmidt, Hartmut; Hundemer, Michael			Cytotoxicity of Tumor Antigen Specific Human T Cells Is Unimpaired by Arginine Depletion	PLOS ONE			English	Article							MYELOID SUPPRESSOR-CELLS; DENDRITIC CELLS; MULTIPLE-MYELOMA; INFILTRATING LYMPHOCYTES; IN-VITRO; CANCER; ARGINASE; EXPRESSION; CARCINOMA; COFILIN	Tumor-growth is often associated with the expansion of myeloid derived suppressor cells that lead to local or systemic arginine depletion via the enzyme arginase. It is generally assumed that this arginine deficiency induces a global shut-down of T cell activation with ensuing tumor immune escape. While the impact of arginine depletion on polyclonal T cell proliferation and cytokine secretion is well documented, its influence on chemotaxis, cytotoxicity and antigen specific activation of human T cells has not been demonstrated so far. We show here that chemotaxis and early calcium signaling of human T cells are unimpaired in the absence of arginine. We then analyzed CD8(+) T cell activation in a tumor peptide as well as a viral peptide antigen specific system: (i) CD8(+) T cells with specificity against the MART-1(aa26-35*A27L) tumor antigen expanded with in vitro generated dendritic cells, and (ii) clonal CMV pp65(aa495-503) specific T cells and T cells retrovirally transduced with a CMV pp65(aa495-503) specific T cell receptor were analyzed. Our data demonstrate that human CD8(+) T cell antigen specific cytotoxicity and perforin secretion are completely preserved in the absence of arginine, while antigen specific proliferation as well as IFN-gamma and granzyme B secretion are severely compromised. These novel results highlight the complexity of antigen specific T cell activation and demonstrate that human T cells can preserve important activation-induced effector functions in the context of arginine deficiency.	[Munder, Markus; Knies, Diana; Luckner-Minden, Claudia; Voss, Ralf-Holger; Theobald, Matthias] Univ Med Ctr Mainz, Dept Med Hematol Oncol & Pneumol 3, Mainz, Germany; [Engelhardt, Melanie; Medenhoff, Sergej; Feldmeyer, Nadja; Ho, Anthony D.; Goldschmidt, Hartmut; Hundemer, Michael] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany; [Wabnitz, Guido; Samstag, Yvonne] Heidelberg Univ, Inst Immunol, Heidelberg, Germany; [Kropf, Pascale] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Mueller, Ingrid] Univ London Imperial Coll Sci Technol & Med, Dept Med, Immunol Sect, London, England; [Conradi, Roland] Univ Med Ctr Mainz, Transfus Ctr, Mainz, Germany; [Goldschmidt, Hartmut] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany	Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Johannes Gutenberg University of Mainz; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Hundemer, M (corresponding author), Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany.	michael.hundemer@med.uni-heidelberg.de	Munder, Markus/K-6737-2013; Goldschmidt, Hartmut/AAL-8069-2021	Conradi, Roland/0000-0003-4645-3569; Ho, Anthony D./0000-0002-1656-0833; Wabnitz, Guido/0000-0001-5101-9885	Deutsche Forschungsgemeinschaft; Dietmar Hopp-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dietmar Hopp-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de) and the Dietmar Hopp-Stiftung (http://www.dietmar-hoppstiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Correale P, 2001, BRIT J CANCER, V85, P1722, DOI 10.1054/bjoc.2001.2136; Curti A, 2007, BRIT J HAEMATOL, V139, P415, DOI 10.1111/j.1365-2141.2007.06832.x; Day EK, 2007, J IMMUNOL, V179, P3203, DOI 10.4049/jimmunol.179.5.3203; Feldmeyer N, 2012, INT IMMUNOL, V24, P303, DOI 10.1093/intimm/dxs004; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Fischer AM, 2004, J BIOL CHEM, V279, P29816, DOI 10.1074/jbc.M312848200; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Heemskerk MHM, 2007, BLOOD, V109, P235, DOI 10.1182/blood-2006-03-013318; Hunderner M, 2006, EXP HEMATOL, V34, P486, DOI 10.1016/j.exphem.2006.01.008; Kawai S, 2008, CANCER SCI, V99, P2461, DOI 10.1111/j.1349-7006.2008.00968.x; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Klemke M, 2010, EMBO J, V29, P2915, DOI 10.1038/emboj.2010.153; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; Liu QY, 2009, J IMMUNOL, V182, P6207, DOI 10.4049/jimmunol.0803926; Munder M, 2006, BLOOD, V108, P1627, DOI 10.1182/blood-2006-11-010389; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Neudorfer J, 2007, J IMMUNOL METHODS, V320, P119, DOI 10.1016/j.jim.2007.01.001; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Poschke I, 2011, CANCER IMMUNOL IMMUN, V60, P1161, DOI 10.1007/s00262-011-1012-8; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rodriguez PC, 2002, J BIOL CHEM, V277, P21123, DOI 10.1074/jbc.M110675200; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104; Singer K, 2011, CANCER IMMUNOL IMMUN, V60, P425, DOI 10.1007/s00262-010-0967-1; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Tadmor T, 2011, BRIT J HAEMATOL, V153, P557, DOI 10.1111/j.1365-2141.2011.08678.x; Titzer S, 2000, BRIT J HAEMATOL, V108, P805, DOI 10.1046/j.1365-2141.2000.01958.x; Valmori D, 1998, J IMMUNOL, V160, P1750; Voss RH, 2005, METH MOLEC MED, V109, P229; Wang W, 2009, LUNG CANCER, V63, P23, DOI 10.1016/j.lungcan.2008.04.009; Willemsen RA, 2000, GENE THER, V7, P1369, DOI 10.1038/sj.gt.3301253; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	42	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63521	10.1371/journal.pone.0063521	http://dx.doi.org/10.1371/journal.pone.0063521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717444	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000319435600022
J	Radbruch, A; Mucke, J; Schweser, F; Deistung, A; Ringleb, PA; Ziener, CH; Roethke, M; Schlemmer, HP; Heiland, S; Reichenbach, JR; Bendszus, M; Rohde, S				Radbruch, Alexander; Mucke, Johanna; Schweser, Ferdinand; Deistung, Andreas; Ringleb, Peter Alexander; Ziener, Christian Herbert; Roethke, Matthias; Schlemmer, Heinz-Peter; Heiland, Sabine; Reichenbach, Juergen R.; Bendszus, Martin; Rohde, Stefan			Comparison of Susceptibility Weighted Imaging and TOF-Angiography for the Detection of Thrombi in Acute Stroke	PLOS ONE			English	Article							TIME-OF-FLIGHT; ACUTE ISCHEMIC-STROKE; INTRACRANIAL VASCULAR STENOSIS; MR-ANGIOGRAPHY; CEREBRAL MICROBLEEDS; FIELD-STRENGTH; HUMAN BRAIN; SIGN; OCCLUSION; ACCURACY	Background and Purpose: Time-of-flight (TOF) angiography detects embolic occlusion of arteries in patients with acute ischemic stroke due to the absence of blood flow in the occluded vessel. In contrast, susceptibility weighted imaging (SWI) directly enables intravascular clot visualization due to hypointense susceptibility vessel signs (SVS) in the occluded vessel. The aim of this study was to compare the diagnostic accuracy of both methods to determine vessel occlusion in patients with acute stroke. Methods: 94 patients were included who presented with clinical symptoms for acute stroke and displayed a delay on the time-to-peak perfusion map in the territory of the anterior (ACA), middle (M1, M1/M2, M2/M3) or posterior (PCA) cerebral artery. The frequency of SVS on SWI and vessel occlusion or stenosis on TOF-angiography was compared using the McNemar-Test. Results: 87 of 94 patients displayed a clearly definable SVS on SWI. In 72 patients the SVS was associated with occlusion or stenosis on TOF-angiography. Fifteen patients exclusively displayed SVS on SWI (14 M2/M3, 1 M1), whereas no patient revealed exclusively occlusion or stenosis on TOF-angiography. Sensitivity for detection of embolic occlusion within major vessel segments (M1, M1/M2, ACA, and PCA) did not show any significant difference between both techniques (97% for SWI versus 96% for TOF-angiography) while the sensitivity for detection of embolic occlusion within M2/M3 was significantly different (84% for SWI versus 39% for TOF-angiography, p < 0.00012). Conclusions: SWI and TOF-angiography provide similar sensitivity for central thrombi while SWI is superior for the detection of peripheral thrombi in small arterial vessel segments.	[Radbruch, Alexander; Mucke, Johanna; Heiland, Sabine; Bendszus, Martin; Rohde, Stefan] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Radbruch, Alexander; Ziener, Christian Herbert; Roethke, Matthias; Schlemmer, Heinz-Peter] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Schweser, Ferdinand; Deistung, Andreas; Reichenbach, Juergen R.] Univ Jena, Jena Univ Hosp, Med Phys Grp, Inst Diagnost & Intervent Radiol 1, Jena, Germany; [Ringleb, Peter Alexander] Heidelberg Univ, Dept Neurol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Friedrich Schiller University of Jena; Ruprecht Karls University Heidelberg	Radbruch, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany.	a.radbruch@dkfz.de	Deistung, Andreas/AAN-9412-2021; Ziener, Christian/AAN-8411-2021; Rohde, Stefan/AAQ-3751-2021; Reichenbach, Jürgen R./B-4333-2011; Roethke, Matthias/D-5805-2015; Radbruch, Alexander/ABA-6277-2021; Schweser, Ferdinand/Q-6932-2019	Rohde, Stefan/0000-0002-6184-8617; Reichenbach, Jürgen R./0000-0002-2640-0630; Schweser, Ferdinand/0000-0003-0399-9211; Roethke, Matthias/0000-0002-7723-4353; Deistung, Andreas/0000-0002-2427-1302; Ringleb, Peter/0000-0002-5473-8671; Radbruch, Alexander/0000-0001-6238-6525; Ziener, Christian/0000-0001-8854-7358	Carl Zeiss Foundation; German Research Foundation (DFG) [RE 1123/9-2]; Guerbet ROISSY CDG - FRANCE [BP 57400, 95943]	Carl Zeiss Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Guerbet ROISSY CDG - FRANCE	This research was supported by a Carl Zeiss Foundation dissertation fellowship for FS and a research grant by the German Research Foundation (DFG, RE 1123/9-2). Furthermore this research was supported by a funding of Guerbet, BP 57400, 95943 ROISSY CDG - FRANCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; BOSMANS H, 1995, AM J ROENTGENOL, V164, P161, DOI 10.2214/ajr.164.1.7998531; Cho KH, 2005, STROKE, V36, P2379, DOI 10.1161/01.STR.0000185932.73486.7a; Deistung A, 2008, MAGN RESON MED, V60, P1155, DOI 10.1002/mrm.21754; Deistung A, 2013, NEUROIMAGE, V65, P299, DOI 10.1016/j.neuroimage.2012.09.055; Deistung A, 2009, J MAGN RESON IMAGING, V29, P1478, DOI 10.1002/jmri.21673; Flacke S, 2000, RADIOLOGY, V215, P476, DOI 10.1148/radiology.215.2.r00ma09476; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hacke W, 2004, LANCET, V363, P768; HEISERMAN JE, 1992, RADIOLOGY, V185, P667, DOI 10.1148/radiology.185.3.1438743; Huang PY, 2012, J NEUROL, V259, P1426, DOI 10.1007/s00415-011-6369-2; Ishimaru H, 2007, AM J NEURORADIOL, V28, P923; Kim Ho Sung, 2006, AJR Am J Roentgenol, V187, pW650, DOI 10.2214/AJR.05.0447; Klohs J, 2011, J CEREBR BLOOD F MET, V31, P2282, DOI 10.1038/jcbfm.2011.118; KOROGI Y, 1994, RADIOLOGY, V193, P187, DOI 10.1148/radiology.193.1.8090890; Ladd Mark E, 2007, Top Magn Reson Imaging, V18, P139, DOI 10.1097/RMR.0b013e3180f612b3; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Marder VJ, 2006, STROKE, V37, P2086, DOI 10.1161/01.STR.0000230307.03438.94; MORI E, 1992, NEUROLOGY, V42, P976, DOI 10.1212/WNL.42.5.976; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Reichenbach JR, 2012, NEUROIMAGE, V62, P1311, DOI 10.1016/j.neuroimage.2012.01.004; Rovira A, 2004, RADIOLOGY, V232, P466, DOI 10.1148/radiol.2322030273; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Stamm AC, 2012, MAGN RESON IMAGING	31	43	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63459	10.1371/journal.pone.0063459	http://dx.doi.org/10.1371/journal.pone.0063459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717426	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600016
J	Verhulst, EC; Lynch, JA; Bopp, D; Beukeboom, LW; van de Zande, L				Verhulst, Eveline C.; Lynch, Jeremy A.; Bopp, Daniel; Beukeboom, Leo W.; van de Zande, Louis			A New Component of the Nasonia Sex Determining Cascade Is Maternally Silenced and Regulates Transformer Expression	PLOS ONE			English	Article							WASP NASONIA; DETERMINING MECHANISMS; DETERMINATION PATHWAY; MUSCA-DOMESTICA; GENE; VITRIPENNIS; DROSOPHILA; EVOLUTION; CHROMOSOME; INSECTS	Although sex determination is a universal process in sexually reproducing organisms, sex determination pathways are among the most highly variable genetic systems found in nature. Nevertheless, general principles can be identified among the diversity, like the central role of transformer (tra) in insects. When a functional TRA protein is produced in early embryogenesis, the female sex determining route is activated, while prevention of TRA production leads to male development. In dipterans, male development is achieved by prevention of female-specific splicing of tra mRNA, either mediated by X-chromosome dose or masculinizing factors. In Hymenoptera, which have haplodiploid sex determination, complementary sex determination and maternal imprinting have been identified to regulate timely TRA production. In the parasitoid Nasonia, zygotic transformer (Nvtra) expression and splicing is regulated by a combination of maternal provision of Nvtra mRNA and silencing of Nvtra expression in unfertilized eggs. It is unclear, however, if this silencing is directly on the tra locus or whether it is mediated through maternal silencing of a trans-acting factor. Here we show that in Nasonia, female sex determination is dependent on zygotic activation of Nvtra expression by an as yet unknown factor. This factor, which we propose to term womanizer (wom), is maternally silenced during oogenesis to ensure male development in unfertilized eggs. This finding implicates the upstream recruitment of a novel gene in the Nasonia sex determining cascade and supports the notion that sex determining cascades can rapidly change by adding new components on top of existing regulators.	[Verhulst, Eveline C.; Beukeboom, Leo W.; van de Zande, Louis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Lynch, Jeremy A.] Univ Cologne, Inst Entwicklungsbiol, D-50931 Cologne, Germany; [Lynch, Jeremy A.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Bopp, Daniel] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Groningen; University of Cologne; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Zurich	Verhulst, EC (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	e.c.verhulst@rug.nl	Bopp, Daniel/L-3517-2018; Verhulst, Eveline/J-2641-2013	Bopp, Daniel/0000-0002-0740-9672; Verhulst, Eveline/0000-0002-4781-535X; van de Zande, Louis/0000-0001-5687-3220	NWO ALW TOP [854.10.001];  [SFB 680]	NWO ALW TOP; 	Eveline C. Verhulst was supported by NWO ALW TOP grant no.similar to 854.10.001 granted to Leo W. Beukeboom and Louis van de Zande (http://www.nwo.nl/). Jeremy A. Lynch was funded by the SFB 680 "Molecular Basis of Evolutionary Innovations". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beukeboom LW, 2007, SEMIN CELL DEV BIOL, V18, P371, DOI 10.1016/j.semcdb.2006.12.015; Beukeboom LW, 2007, SCIENCE, V315, P206, DOI 10.1126/science.1133388; Beukeboom LW, 2006, GENETICS, V172, P981, DOI 10.1534/genetics.105.044743; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Burghardt G, 2005, DEV GENES EVOL, V215, P165, DOI 10.1007/s00427-004-0464-7; CLINE TW, 1984, GENETICS, V107, P231; Concha C, 2009, GENETICS, V182, P785, DOI 10.1534/genetics.109.100982; Dubendorfer A, 2002, INT J DEV BIOL, V46, P75; Erickson JW, 2007, PLOS BIOL, V5, P2821, DOI 10.1371/journal.pbio.0050332; Ruiz MF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001239; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Hasselmann M, 2008, NATURE, V454, P519, DOI 10.1038/nature07052; Hediger M, 2010, GENETICS, V184, P155, DOI 10.1534/genetics.109.109249; Kamping A, 2007, GENETICS, V175, P1321, DOI 10.1534/genetics.106.067082; Lagos D, 2007, INSECT MOL BIOL, V16, P221, DOI 10.1111/j.1365-2583.2006.00717.x; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Martin I, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-19; McAllister BF, 2004, HEREDITY, V92, P5, DOI 10.1038/sj.hdy.6800355; Mullon C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-5; Nissen I, 2012, GENETICS, V192, P1015, DOI 10.1534/genetics.112.143925; Niu BL, 2005, ACTA BIOCH BIOPH SIN, V37, P728, DOI 10.1111/j.1745-7270.2005.00106.x; NUR U, 1988, SCIENCE, V240, P512, DOI 10.1126/science.3358129; Olesnicky EC, 2006, DEVELOPMENT, V133, P3973, DOI 10.1242/dev.02576; Pane A, 2002, DEVELOPMENT, V129, P3715; Pomiankowski A, 2004, GENETICS, V166, P1761, DOI 10.1534/genetics.166.4.1761; Salvemini M, 2009, INT J DEV BIOL, V53, P109, DOI 10.1387/ijdb.082681ms; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Sarno F, 2011, INT J DEV BIOL, V55, P975, DOI 10.1387/ijdb.103279fs; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Shuker DM, 2005, AM NAT, V166, P301, DOI 10.1086/432562; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Trent C, 2006, HEREDITY, V96, P368, DOI 10.1038/sj.hdy.6800810; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Verhulst EC, 2010, CURR OPIN GENET DEV, V20, P376, DOI 10.1016/j.gde.2010.05.001; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; WERREN JH, 1991, AM NAT, V137, P392, DOI 10.1086/285172; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Whiting PW, 1943, GENETICS, V28, P365; Zwier MV, 2012, INSECT MOL BIOL, V21, P129, DOI 10.1111/j.1365-2583.2011.01121.x	40	24	26	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63618	10.1371/journal.pone.0063618	http://dx.doi.org/10.1371/journal.pone.0063618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717455	Green Published, gold, Green Accepted			2022-12-27	WOS:000320362700041
J	Hwang, J; Kim, M; Kim, S; Lee, J				Hwang, Jeongeun; Kim, Miju; Kim, Seunghwan; Lee, Jinwon			Quantifying Morphological Parameters of the Terminal Branching Units in a Mouse Lung by Phase Contrast Synchrotron Radiation Computed Tomography	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MICRO-CT; MODEL; GAS; DIAMETER; GEOMETRY; ACINUS; LENGTH; BIFURCATION; PROGRESSION	An effective technique of phase contrast synchrotron radiation computed tomography was established for the quantitative analysis of the microstructures in the respiratory zone of a mouse lung. Heitzman's method was adopted for the whole-lung sample preparation, and Canny's edge detector was used for locating the air-tissue boundaries. This technique revealed detailed morphology of the respiratory zone components, including terminal bronchioles and alveolar sacs, with sufficiently high resolution of 1.74 mu m isotropic voxel size. The technique enabled visual inspection of the respiratory zone components and comprehension of their relative positions in three dimensions. To check the method's feasibility for quantitative imaging, morphological parameters such as diameter, surface area and volume were measured and analyzed for sixteen randomly selected terminal branching units, each consisting of a terminal bronchiole and a pair of succeeding alveolar sacs. The four types of asymmetry ratios concerning alveolar sac mouth diameter, alveolar sac surface area, and alveolar sac volume are measured. This is the first ever finding of the asymmetry ratio for the terminal bronchioles and alveolar sacs, and it is noteworthy that an appreciable degree of branching asymmetry was observed among the alveolar sacs at the terminal end of the airway tree, despite the number of samples was small yet. The series of efficient techniques developed and confirmed in this study, from sample preparation to quantification, is expected to contribute to a wider and exacter application of phase contrast synchrotron radiation computed tomography to a variety of studies.	[Hwang, Jeongeun; Kim, Miju] POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Kim, Seunghwan] POSTECH, Dept Phys, Pohang, South Korea; [Kim, Seunghwan] POSTECH, Inst Edge Theoret Sci, Pohang, South Korea; [Lee, Jinwon] POSTECH, Dept Mech Engn, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, J (corresponding author), POSTECH, Dept Mech Engn, Pohang, South Korea.	jwlee@postech.ac.kr	; Hwang, Jeongeun/F-7550-2012	KIM, Seunghwan/0000-0002-0563-3902; Hwang, Jeongeun/0000-0002-5821-5405	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0000326]; National Core Research Center (NCRC);  [20100028450]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Core Research Center (NCRC); 	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2010-0000326) and National Core Research Center (NCRC) funded by (No. 20100028450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1976, TRACHEOBRONCHIAL GEO; Boser SR, 2005, AM J RESP CRIT CARE, V172, P817, DOI 10.1164/rccm.200411-1463OC; BOWES C, 1982, J APPL PHYSIOL, V52, P624, DOI 10.1152/jappl.1982.52.3.624; Bronnikov AV, 2002, J OPT SOC AM A, V19, P472, DOI 10.1364/JOSAA.19.000472; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Carrozzi L, 2011, RADIOLOGY, V261, P688, DOI 10.1148/radiol.11111950; Churg AM, 2005, THURLBECKS PATHOLOGY; ENGEL LA, 1983, J APPL PHYSIOL, V54, P609, DOI 10.1152/jappl.1983.54.3.609; Florens M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.178104; Frey U, 2008, LANCET, V372, P1088, DOI 10.1016/S0140-6736(08)61450-6; Heitzman ER, 1984, LUNG RADIOLOGIC PATH, P4; Hogg James C, 2009, Proc Am Thorac Soc, V6, P546, DOI 10.1513/pats.200905-029DS; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; HORSFIELD K, 1976, RESP PHYSIOL, V26, P351, DOI 10.1016/0034-5687(76)90005-0; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Kang MY, 2012, TRANS KOREAN SOC MEC, V36, P301, DOI 10.3795/KSME-B.2012.36.3.301; Kang MY, 2011, J BIOMECH, V44, P1196, DOI 10.1016/j.jbiomech.2011.02.011; Kitchen MJ, 2008, PHYS MED BIOL, V53, P6065, DOI 10.1088/0031-9155/53/21/012; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Lee DY, 2008, ANAT REC, V291, P379, DOI 10.1002/ar.20643; Lee D, 2011, COMPUT BIOL MED, V41, P707, DOI 10.1016/j.compbiomed.2011.06.006; Lee D, 2011, ANN BIOMED ENG, V39, P1805, DOI 10.1007/s10439-011-0279-4; Lee E, 2008, ANN BIOMED ENG, V36, P1004, DOI 10.1007/s10439-008-9474-3; Lee JW, 2007, MED BIOL ENG COMPUT, V45, P1071, DOI 10.1007/s11517-007-0232-8; Litzlbauer HD, 2010, ANAT REC, V293, P1607, DOI 10.1002/ar.21161; Liu XX, 2010, PHYS MED BIOL, V55, P2399, DOI 10.1088/0031-9155/55/8/017; Majumdar A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168101; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; PAIVA M, 1984, J APPL PHYSIOL, V56, P418, DOI 10.1152/jappl.1984.56.2.418; Parameswaran H, 2009, J APPL PHYSIOL, V107, P583, DOI 10.1152/japplphysiol.91227.2008; Parsons DW, 2008, J ANAT, V213, P217, DOI 10.1111/j.1469-7580.2008.00950.x; PEDLEY TJ, 1970, RESP PHYSIOL, V9, P371, DOI 10.1016/0034-5687(70)90093-9; Phillips CG, 1995, RESP PHYSIOL, V102, P303, DOI 10.1016/0034-5687(95)00056-9; Pogany A, 1997, REV SCI INSTRUM, V68, P2774, DOI 10.1063/1.1148194; Quirk JD, 2011, RADIOLOGY, V260, P866, DOI 10.1148/radiol.11102226; Rausch SMK, 2011, ANN BIOMED ENG, V39, P2835, DOI 10.1007/s10439-011-0328-z; Renne R, 2001, TOXICOL PATHOL, V29, P587, DOI 10.1080/019262301317226401; Suki B, 2012, PULM PHARMACOL THER, V25, P268, DOI 10.1016/j.pupt.2011.04.027; Sznitman J, 2010, J VISUAL-JAPAN, V13, P337, DOI 10.1007/s12650-010-0043-0; Tawhai MH, 2001, RESP PHYSIOL, V127, P241, DOI 10.1016/S0034-5687(01)00238-9; Tsuda A, 2008, J APPL PHYSIOL, V105, P964, DOI 10.1152/japplphysiol.90546.2008; Tsuda A, 2008, RESP PHYSIOL NEUROBI, V163, P139, DOI 10.1016/j.resp.2008.02.010; Vasilescu DM, 2011, J APPL PHYSL; Watz H, 2005, RADIOLOGY, V236, P1053, DOI 10.1148/radiol.2363041142; Weibel ER, 2007, J APPL PHYSIOL, V102, P459, DOI 10.1152/japplphysiol.00808.2006; West JB, 1977, BIOENGINEERING ASPEC, P1; Zhang L, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0017400	49	15	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63552	10.1371/journal.pone.0063552	http://dx.doi.org/10.1371/journal.pone.0063552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704918	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200049
J	Juel, HB; Faber, C; Svendsen, SG; Vallejo, AN; Nissen, MH				Juel, Helene B.; Faber, Carsten; Svendsen, Signe G.; Vallejo, Abbe N.; Nissen, Mogens H.			Inflammatory Cytokines Protect Retinal Pigment Epithelial Cells from Oxidative Stress-Induced Death	PLOS ONE			English	Article							C-REACTIVE PROTEIN; COMPLEMENT FACTOR-H; MACULAR DEGENERATION; MOLECULAR-MECHANISMS; POSSIBLE INVOLVEMENT; INDUCED APOPTOSIS; DRUSEN FORMATION; POTENTIAL ROLE; ARPE-19 CELLS; GROWTH-FACTOR	Purpose: To investigate the effects of inflammatory factors and oxidative stress on cell survival of the human retinal pigment epithelial (RPE) cell line, ARPE-19. Methods: Confluent RPE cells were treated with peripheral blood mononuclear cells-conditioned medium (PCM), H2O2, NaIO3, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, or combinations of these. Cell viability was determined by viability assays and by light microscopy. Effector molecules of cell death were investigated by immunofluorescence microscopy and flow cytometry. Microarrays were performed to screen for differential expression of anti-oxidative enzymes, and protein expression was validated by immunoblotting. Results: Viability of RPE cells was reduced by exposure to inflammatory agents (PCM, IFN gamma+/-TNF alpha) or to oxidative agents (H2O2 or NaIO3). Unexpectedly, cells treated with either H2O2 or NaIO3 were partially protected from cell death by the addition of PCM. This protection was conferred, at least in part, by IFN gamma and TNF alpha. Cell death induced by H2O2 or NaIO3 was preceded by mitochondrial dysfunction and by p62 upregulation, both of which were attenuated by PCM and/or by IFN gamma+TNF alpha. RPE cells co-cultured with activated T cells, or treated with cytokines showed increased expression of antio-xidative genes, with upregulation of superoxide dismutase 2 protein following PCM treatment. Conclusion: Oxidative stress-induced cell death was reduced by concomitant inflammatory stress. This is likely due to the cytokine-mediated induction of the anti-oxidative stress response, upregulating protective anti-oxidant pathway(s). These findings suggest caution for the clinical use of anti-inflammatory agents in the management of immune-associated eye diseases such as age-related macular degeneration.	[Juel, Helene B.; Faber, Carsten; Svendsen, Signe G.; Nissen, Mogens H.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Eye Res Unit, Copenhagen, Denmark; [Vallejo, Abbe N.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat,Dept Immunol,Pittsburgh Canc Inst, Pittsburgh, PA 15261 USA; [Vallejo, Abbe N.] Univ Pittsburgh, Sch Med, McGowan Inst Regenerat Med, Pittsburgh, PA USA	University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Juel, HB (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Eye Res Unit, Copenhagen, Denmark.	hjuel@sund.ku.dk	Nissen, Mogens/B-4825-2008; Faber, Carsten/N-3210-2019; Juel, Helene/AAD-2843-2020; Faber, Carsten/I-4150-2013	Nissen, Mogens/0000-0001-7729-8667; Faber, Carsten/0000-0002-2517-7270; Faber, Carsten/0000-0002-2517-7270; Svendsen, Signe Goul/0000-0003-1618-5604; Juel, Helene B/0000-0002-5763-8545	Velux Fonden; Vaern om Synet; Synoptikfonden; Candy Foundation; NATIONAL INSTITUTE ON AGING [R01AG030734] Funding Source: NIH RePORTER	Velux Fonden(Velux Fonden); Vaern om Synet; Synoptikfonden; Candy Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by research grants from Velux Fonden (veluxfonden.dk); Vaern om Synet (www.vos.dk); Synoptikfonden (www.synoptik-fonden.dk); and the Candy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjamaa O, 2009, AGEING RES REV, V8, P349, DOI 10.1016/j.arr.2009.06.002; Barot M, 2011, CURR EYE RES, V36, P1069, DOI 10.3109/02713683.2011.607536; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Boekhoorn SS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1396, DOI 10.1001/archopht.125.10.1396; Bonilha VL, 2008, CLIN OPHTHALMOL, V2, P413; BURKE JM, 1989, CURR EYE RES, V8, P1279, DOI 10.3109/02713688909013907; Byeon SH, 2010, INVEST OPHTH VIS SCI, V51, P1190, DOI 10.1167/iovs.09-4144; Cano M, 2010, VISION RES, V50, P652, DOI 10.1016/j.visres.2009.08.018; Cao GF, 2011, BIOCHEM BIOPH RES CO, V414, P499, DOI 10.1016/j.bbrc.2011.09.094; Cao XR, 2010, DISCRETE EVENT DYN S, V20, P1, DOI 10.1007/s10626-010-0088-1; Choi SH, 2011, ACTA OPHTHALMOL, V89, pE350, DOI 10.1111/j.1755-3768.2011.02113.x; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Ehrlich R, 2008, CLIN INTERV AGING, V3, P473; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Fong WG, 2012, ADV EXP MED BIOL, V723, P207, DOI 10.1007/978-1-4614-0631-0_28; Gehrs KM, 2010, ARCH OPHTHALMOL-CHIC, V128, P349, DOI 10.1001/archophthalmol.2010.18; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Harris MS, 1996, CURR EYE RES, V15, P255, DOI 10.3109/02713689609007619; Hyttinen JMT, 2011, REJUV RES, V14, P651, DOI 10.1089/rej.2011.1220; Johnson LR, 2000, IEEE ANN HIST COMPUT, V22, P70; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Juel HB, 2011, EXP EYE RES, V92, P180, DOI 10.1016/j.exer.2011.01.003; Kaarniranta Kai, 2010, Front Biosci (Elite Ed), V2, P1374; Kaarniranta K, 2010, ACTA OPHTHALMOL, V88, P387, DOI 10.1111/j.1755-3768.2009.01840.x; Kang KH, 2009, TRENDS MOL MED, V15, P191, DOI 10.1016/j.molmed.2009.03.005; Kasahara E, 2005, INVEST OPHTH VIS SCI, V46, P3426, DOI 10.1167/iovs.05-0344; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Khandhadia S, 2012, IMMUNOBIOLOGY, V217, P127, DOI 10.1016/j.imbio.2011.07.019; Khandhadia S, 2012, ADV EXP MED BIOL, V724, P15, DOI 10.1007/978-1-4614-0653-2_2; Kim JH, 2010, INVEST OPHTH VIS SCI, V51, P561, DOI 10.1167/iovs.09-3774; Kinnunen K, 2012, ACTA OPHTHALMOL, V90, P299, DOI 10.1111/j.1755-3768.2011.02179.x; Klein R, 2008, OPHTHALMOLOGY, V115, P1742, DOI 10.1016/j.ophtha.2008.03.021; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kurz T, 2009, AUTOPHAGY, V5, P494, DOI 10.4161/auto.5.4.7961; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P3521, DOI 10.1167/iovs.10-6163; Liu JH, 2010, J OCUL PHARMACOL TH, V26, P249, DOI 10.1089/jop.2009.0127; Malek G, 2012, ADV EXP MED BIOL, V723, P51, DOI 10.1007/978-1-4614-0631-0_8; Markomichelakis NN, 2005, AM J OPHTHALMOL, V139, P537, DOI 10.1016/j.ajo.2004.09.058; Mitter SK, 2012, ADV EXP MED BIOL, V723, P83, DOI 10.1007/978-1-4614-0631-0_12; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rodrigues EB, 2007, OPHTHALMOLOGICA, V221, P143, DOI 10.1159/000099293; Rosello A, 2012, CLIN EXP IMMUNOL, V168, P52, DOI 10.1111/j.1365-2249.2011.04544.x; Russell SR, 2000, AM J OPHTHALMOL, V129, P205, DOI 10.1016/S0002-9394(99)00345-1; Rusten TE, 2010, NAT CELL BIOL, V12, P207, DOI 10.1038/ncb0310-207; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P300, DOI 10.1001/archopht.125.3.300; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Shankar A, 2007, AM J EPIDEMIOL, V165, P375, DOI 10.1093/aje/kwk022; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Thampi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034468; Theodossiadis PG, 2009, AM J OPHTHALMOL, V147, P825, DOI 10.1016/j.ajo.2008.12.004; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; Usui S, 2011, FREE RADICAL BIO MED, V51, P1347, DOI 10.1016/j.freeradbiomed.2011.06.010; Viiri J, 2010, MOL VIS, V16, P1399; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Wang Y, 2011, EYE, V25, P127, DOI 10.1038/eye.2010.196; Yang DL, 2009, INVEST OPHTH VIS SCI, V50, P4998, DOI 10.1167/iovs.09-3620; Yin JG, 2011, J CELL PHYSIOL, V226, P2025, DOI 10.1002/jcp.22532; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	72	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64619	10.1371/journal.pone.0064619	http://dx.doi.org/10.1371/journal.pone.0064619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705001	Green Submitted, gold, Green Published			2022-12-27	WOS:000319330200155
J	Treister, R; Pud, D; Ebstein, RP; Eisenberg, E				Treister, Roi; Pud, Dorit; Ebstein, Richard P.; Eisenberg, Elon			Dopamine Transporter Genotype Dependent Effects of Apomorphine on Cold Pain Tolerance in Healthy Volunteers	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NUCLEUS-ACCUMBENS DOPAMINE; RESTLESS LEGS SYNDROME; PARKINSONS-DISEASE; AVAILABILITY; MODULATION; AGONIST; ANTINOCICEPTION; ASSOCIATION; MEDICATIONS	The aims of this study were to assess the effects of the dopamine agonist apomorphine on experimental pain models in healthy subjects and to explore the possible association between these effects and a common polymorphism within the dopamine transporter gene. Healthy volunteers (n = 105) participated in this randomized double-blind, placebo-controlled, cross-over trial. Heat pain threshold and intensity, cold pain threshold, and the response to tonic cold pain (latency, intensity, and tolerance) were evaluated before and for up to 120 min after the administration of 1.5 mg apomorphine/placebo. A polymorphism (3'-UTR 40-bp VNTR) within the dopamine transporter gene (SLC6A3) was investigated. Apomorphine had an effect only on tolerance to cold pain, which consisted of an initial decrease and a subsequent increase in tolerance. An association was found between the enhancing effect of apomorphine on pain tolerance (120 min after its administration) and the DAT-1 polymorphism. Subjects with two copies of the 10-allele demonstrated significantly greater tolerance prolongation than the 9-allele homozygote carriers and the heterozygote carriers (p = 0.007 and p = 0.003 in comparison to the placebo, respectively). In conclusion, apomorphine administration produced a decrease followed by a genetically associated increase in cold pain tolerance.	[Treister, Roi; Eisenberg, Elon] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Treister, Roi; Pud, Dorit] Univ Haifa, Fac Social Welf & Hlth Sci, IL-31999 Haifa, Israel; [Treister, Roi; Eisenberg, Elon] Rambam Hlth Care Campus, Inst Pain Med, Haifa, Israel; [Ebstein, Richard P.] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Haifa; Rambam Health Care Campus; Hebrew University of Jerusalem	Treister, R (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, POB 9649, IL-31096 Haifa, Israel.	treister.roi@gmail.com		Ebstein, Richard/0000-0002-3626-541X	Israeli Science Foundation (ISF) [529-10]	Israeli Science Foundation (ISF)(Israel Science Foundation)	This study was funded by a grant from the Israeli Science Foundation (ISF) no 529-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Cervenka S, 2006, BRAIN, V129, P2017, DOI 10.1093/brain/awl163; Cevoli S, 2006, EUR J NEUROL, V13, P1009, DOI 10.1111/j.1468-1331.2006.01415.x; Charbit AR, 2009, J PHARMACOL EXP THER, V331, P752, DOI 10.1124/jpet.109.151951; Cools R, 2008, NEUROSCIENTIST, V14, P381, DOI 10.1177/1073858408317009; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Costa A, 2011, SYNAPSE, V65, P998, DOI 10.1002/syn.20927; Dan B, 2004, MOL PSYCHIATR, V9, P730, DOI 10.1038/sj.mp.4001506; Dang YH, 2011, EUR J PHARMACOL, V657, P97, DOI 10.1016/j.ejphar.2011.01.064; de la Fuente-Fernandez R, 2001, J CEREBR BLOOD F MET, V21, P1151, DOI 10.1097/00004647-200110000-00003; Dellapina E, 2011, MOVEMENT DISORD, V26, P153, DOI 10.1002/mds.23406; Ertas M, 1998, PAIN, V75, P257, DOI 10.1016/S0304-3959(98)00003-7; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Haddley K, 2008, NEUROCHEM RES, V33, P652, DOI 10.1007/s11064-007-9521-8; HARRIS G, 1983, PAIN, V17, P369, DOI 10.1016/0304-3959(83)90168-9; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; HJORTH S, 1986, PHARMACOL BIOCHEM BE, V24, P237, DOI 10.1016/0091-3057(86)90344-8; Holman AJ, 2005, ARTHRITIS RHEUM-US, V52, P2495, DOI 10.1002/art.21191; Hornyak M, 2012, SLEEP MED, V13, P228, DOI 10.1016/j.sleep.2011.09.013; Jaaskelainen SK, 2001, PAIN, V90, P257, DOI 10.1016/S0304-3959(00)00409-7; Karling P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018035; Kim H, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-24; Lee MA, 2006, J PAIN SYMPTOM MANAG, V32, P462, DOI 10.1016/j.jpainsymman.2006.05.020; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Main DCJ, 1997, J VET PHARMACOL THER, V20, P220, DOI 10.1111/j.1365-2885.1997.tb00099.x; Meyer PJ, 2009, PSYCHOPHARMACOLOGY, V204, P531, DOI 10.1007/s00213-009-1482-y; Minton JP, 1981, NEW ENGL J MED, V286, P843; PAALZOW GHM, 1992, J PHARMACOL EXP THER, V263, P470; Potvin S, 2009, SYNAPSE, V63, P390, DOI 10.1002/syn.20616; PRZEDBORSKI S, 1995, MOVEMENT DISORD, V10, P28, DOI 10.1002/mds.870100107; Ribaric S, 2012, MOLECULES, V17, P5289, DOI 10.3390/molecules17055289; Rokem A, 2012, CEREB CORTEX, V22, P1133, DOI 10.1093/cercor/bhr185; Salamone JD, 1996, J NEUROSCI METH, V64, P137, DOI 10.1016/0165-0270(95)00125-5; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Scholz H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006009.pub2; Stuginski-Barbosa J, 2008, J HEADACHE PAIN, V9, P43, DOI 10.1007/s10194-008-0003-4; Treister R, 2009, PAIN, V147, P187, DOI 10.1016/j.pain.2009.09.001; van Dyck CH, 2005, J NUCL MED, V46, P745; VANDENBERGH DJ, 1992, MOL BRAIN RES, V15, P161, DOI 10.1016/0169-328X(92)90165-8; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Weickert TW, 2004, BIOL PSYCHIAT, V56, P677, DOI 10.1016/j.biopsych.2004.08.012; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; Wood Patrick B, 2008, Expert Rev Neurother, V8, P781, DOI 10.1586/14737175.8.5.781; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	46	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63808	10.1371/journal.pone.0063808	http://dx.doi.org/10.1371/journal.pone.0063808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704939	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200070
J	Zhang, YQ; Zhao, JL; Lau, WB; Jiao, LY; Liu, BJ; Yuan, YX; Wang, XL; Gao, EH; Koch, WJ; Ma, XL; Wang, YJ				Zhang, Yanqing; Zhao, Jianli; Lau, Wayne Bond; Jiao, Li-Yuan; Liu, Baojiang; Yuan, Yuexing; Wang, Xiaoliang; Gao, Erhe; Koch, Walter J.; Ma, Xin-Liang; Wang, Yajing			Tumor Necrosis Factor-alpha and Lymphotoxin-alpha Mediate Myocardial Ischemic Injury via TNF Receptor 1, but Are Cardioprotective When Activating TNF Receptor 2	PLOS ONE			English	Article							HEART-FAILURE; INDUCED CARDIOMYOPATHY; TRANSGENIC MICE; INFARCTION; ATHEROSCLEROSIS; ISCHEMIA/REPERFUSION; ADIPONECTIN; THERAPY; DISEASE; MODEL	Objective: This study determines the roles of tumor necrosis factor-alpha (TNF alpha) and lymphotoxin-alpha (LT alpha) in post-myocardial infarction (post-MI) cardiac injury, and identifies the TNF receptor type responsible for TNF alpha- and LT alpha-mediated cardiac injury. Methods and Results: Adult male wild type (WT), TNF alpha(-/-), LT alpha(-/-), TNFR1(-/-), and TNFR2(-/-) mice were subjected to MI via coronary artery occlusion. Functional, histological, and biochemical analyses were performed 1 to 7 days post-MI. In WT mice, MI significantly increased both TNF alpha and LT alpha levels in plasma, but in distinct temporal manner. Plasma TNF alpha peaked 1 day after MI, and decreased toward baseline 3 days after MI. In contrast, plasma LTa became significantly increased 3 days post-MI, and remained elevated thereafter. TNF alpha deletion significantly improved cardiac function 3 days, but not 7 days, after MI. In contrast, LT alpha deletion had no effect upon cardiac dysfunction 3 days after MI, but improved cardiac function 7 days after MI. More importantly, knockout of TNFR1 and TNFR2 had opposite effects upon post-MI cardiac dysfunction, which was markedly attenuated by TNFR1 deletion (P<0.01 vs. WT), but exacerbated by TNFR2 deletion (P<0.05 vs. WT). Conclusion: Our study demonstrates that TNF alpha and LT alpha overproduction contribute to early and late cardiac dysfunction after MI, respectively. We provide clear evidence that both TNF alpha and LT alpha mediate post-MI cardiac dysfunction via TNFR1 stimulation, whereas TNFR2 activation is cardioprotective against ischemic injury. Simultaneous inhibition of TNF alpha and LT alpha or specific TNFR1 function blockade may represent superior cardioprotective approaches over general TNF activity suppression.	[Zhang, Yanqing; Zhao, Jianli; Jiao, Li-Yuan; Liu, Baojiang] Shanxi Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Taiyuan, Peoples R China; [Lau, Wayne Bond; Yuan, Yuexing; Wang, Xiaoliang; Ma, Xin-Liang; Wang, Yajing] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA; [Wang, Xiaoliang; Wang, Yajing] Shanxi Med Univ, Dept Physiol, Taiyuan, Peoples R China; [Gao, Erhe; Koch, Walter J.] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA	Shanxi Medical University; Jefferson University; Shanxi Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Ma, XL (corresponding author), Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA.	Xin.Ma@Jefferson.edu; Yajing.Wang@jefferson.edu		Lau, Wayne Bond/0000-0002-8064-8290	Natural Science Foundation of China [30900592, 81170199]; American Diabetes Association [1-11-JF56, 7-11-BS-93]; National Institutes of Health (NIH) [HL-63828, HL-096686]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096686, R01HL063828] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Diabetes Association(American Diabetes Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the Natural Science Foundation of China (30900592 and 81170199 to YJW), American Diabetes Association (1-11-JF56 to YJW, 7-11-BS-93 to XLM), and the National Institutes of Health (NIH) (HL-63828, HL-096686 to XLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Defer N, 2007, J BIOL CHEM, V282, P35564, DOI 10.1074/jbc.M704003200; FINKEL MS, 1992, SCIENCE, V257, P387, DOI 10.1126/science.1631560; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Higuchi Y, 2004, CIRCULATION, V109, P1892, DOI 10.1161/01.CIR.0000124227.00670.AB; Jang Y, 2007, CLIN CHIM ACTA, V384, P124, DOI 10.1016/j.cca.2007.06.017; Jang Y, 2007, CLIN CHIM ACTA, V377, P221, DOI 10.1016/j.cca.2006.10.002; Kishore R, 2011, ADV EXP MED BIOL, V691, P433, DOI 10.1007/978-1-4419-6612-4_45; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Kubota T, 2000, CIRCULATION, V101, P2518, DOI 10.1161/01.CIR.101.21.2518; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; Li SH, 2007, AM J PHYSIOL-HEART C, V293, pH1847, DOI 10.1152/ajpheart.00578.2007; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Monden Y, 2007, AM J PHYSIOL-HEART C, V293, pH743, DOI 10.1152/ajpheart.00166.2007; Naoum JJ, 2006, MED SCI MONITOR, V12, pRA121; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schreyer SA, 2002, J BIOL CHEM, V277, P12364, DOI 10.1074/jbc.M111727200; Schulz R, 2009, CIRCULATION, V119, P1355, DOI 10.1161/CIRCULATIONAHA.108.846105; Schulz S, 2006, EUR CYTOKINE NETW, V17, P148, DOI 10.1684/ecn.2006.0031; Suna S, 2008, J ATHEROSCLER THROMB, V15, P160, DOI 10.5551/jat.E553; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; Tao L, 2007, CIRCULATION, V115, P1408, DOI 10.1161/CIRCULATIONAHA.106.666941; Wang YJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE384, DOI 10.1152/ajpendo.90975.2008; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244; YOKOYAMA T, 1993, J CLIN INVEST, V92, P2303, DOI 10.1172/JCI116834	28	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e60227	10.1371/journal.pone.0060227	http://dx.doi.org/10.1371/journal.pone.0060227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704873	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200002
J	Hiscox, A; Khammanithong, P; Kaul, S; Sananikhom, P; Luthi, R; Hill, N; Brey, PT; Lindsay, SW				Hiscox, Alexandra; Khammanithong, Phasouk; Kaul, Surinder; Sananikhom, Pany; Luthi, Ruedi; Hill, Nigel; Brey, Paul T.; Lindsay, Steve W.			Risk Factors for Mosquito House Entry in the Lao PDR	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS; SATELLITE VILLAGES; MALARIA VECTORS; REDUCE EXPOSURE; BREEDING SITES; RURAL TOWN; SRI-LANKA; GAMBIA; INTERVENTIONS; PATTERNS	Background: Construction of the Nam Theun 2 hydroelectric project and flooding of a 450 km(2) area of mountain plateau in south-central Lao PDR resulted in the resettlement of 6,300 people to newly built homes. We examined whether new houses would have altered risk of house entry by mosquitoes compared with traditional homes built from poorer construction materials. Methodology/Principal Findings: Surveys were carried out in the Nam Theun 2 resettlement area and a nearby traditional rice farming area in 2010. Mosquitoes were sampled in bedrooms using CDC light traps in 96 resettlement houses and 96 traditional houses and potential risk factors for mosquito house entry were recorded. Risk of mosquito house entry was more than twice as high in traditional bamboo houses compared with those newly constructed from wood (Putative Japanese Encephalitis (JE) vector incidence rate ratio (IRR) = 2.26, 95% CI 1.38-3.70, P = 0.001; Anopheline IRR = 2.35, 95% CI: 1.30-4.23, P = 0.005). Anophelines were more common in homes with cattle compared against those without (IRR = 2.32, 95% CI: 1.29-4.17, P = 0.005). Wood smoke from cooking fires located under the house or indoors was found to be protective against house entry by both groups of mosquito, compared with cooking in a separate room beside the house (Putative JE vector IRR = 0.43, 95% CI: 0.26-0.73, P = 0.002; Anopheline IRR = 0.22, 95% CI: 0.10-0.51, P, 0.001). Conclusions/Significance: Construction of modern wooden homes should help reduce human-mosquito contact in the Lao PDR. Reduced mosquito contact rates could lead to reduced transmission of diseases such as JE and malaria. Cattle ownership was associated with increased anopheline house entry, so zooprophylaxis for malaria control is not recommended in this area. Whilst wood smoke was protective against putative JE vector and anopheline house entry we do not recommend indoor cooking since smoke inhalation can enhance respiratory disease.	[Hiscox, Alexandra; Brey, Paul T.] Inst Pasteur Laos, Viangchan, Laos; [Hiscox, Alexandra; Hill, Nigel] London Sch Hyg & Trop Med, London WC1, England; [Khammanithong, Phasouk] Khammouane Prov Hlth Off, Thakhek, Laos; [Kaul, Surinder; Sananikhom, Pany; Luthi, Ruedi] Nam Theun 2 Power Co, Viangchan, Laos; [Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	University of London; London School of Hygiene & Tropical Medicine; Durham University	Hiscox, A (corresponding author), Inst Pasteur Laos, Viangchan, Laos.	alexandra.hiscox@wur.nl		Lindsay, Steve/0000-0002-3461-9050	Fondation EDF Diversiterre; Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory, Department of Homeland Security; Fogarty International Center, National Institutes of Health	Fondation EDF Diversiterre; Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the Fondation EDF Diversiterre. SWL was supported by the Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory, Department of Homeland Security, and Fogarty International Center, National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hassan A, 2010, TROP BIOMED, V27, P404; Biran A, 2007, T ROY SOC TROP MED H, V101, P1065, DOI 10.1016/j.trstmh.2007.07.010; BOCKARIE MJ, 1994, ACTA TROP, V57, P337, DOI 10.1016/0001-706X(94)90080-9; Cao MQ, 2010, TROP MED INT HEALTH, V15, P918, DOI 10.1111/j.1365-3156.2010.02563.x; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-2; CHARLWOOD JD, 1984, T ROY SOC TROP MED H, V78, P141, DOI 10.1016/0035-9203(84)90204-9; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Gunawardena DM, 1998, AM J TROP MED HYG, V58, P533, DOI 10.4269/ajtmh.1998.58.533; Hackett L., 1937, MALARIA EUROPE ECOLO; HEWITT S, 1994, MED VET ENTOMOL, V8, P160, DOI 10.1111/j.1365-2915.1994.tb00156.x; Hiscox A, 2011, THESIS U LONDON LOND; Kirby MJ, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-41; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Kulkarni MA, 2006, J MED ENTOMOL, V43, P580, DOI 10.1603/0022-2585(2006)43[580:EEOMVA]2.0.CO;2; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; LINDSAY SW, 1989, MED VET ENTOMOL, V3, P97, DOI 10.1111/j.1365-2915.1989.tb00481.x; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; LINDSAY SW, 1988, T ROY SOC TROP MED H, V82, P645, DOI 10.1016/0035-9203(88)90546-9; Liu W, 2010, EPIDEMIOL INFECT, V138, P1292, DOI 10.1017/S0950268810000063; Njie M, 2009, J MED ENTOMOL, V46, P505, DOI 10.1603/033.046.0314; Po JYT, 2011, THORAX, V66, P232, DOI 10.1136/thx.2010.147884; Rattanarithikul Rampa, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1; Rattanarithikul Rampa, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1; REUBEN R, 1992, AM J TROP MED HYG, V46, P654, DOI 10.4269/ajtmh.1992.46.654; Richards EE, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-32; SCHULTZ G W, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P49; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; SNOW WF, 1987, MED VET ENTOMOL, V1, P9, DOI 10.1111/j.1365-2915.1987.tb00318.x; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; van der Hoek W, 2003, INT J EPIDEMIOL, V32, P280, DOI 10.1093/ije/dyg055; Van Miert E, 2012, PEDIATR PULM, V47, P358, DOI 10.1002/ppul.21554; WHO, 1982, WHO OFFS PUBL, V66	34	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e62769	10.1371/journal.pone.0062769	http://dx.doi.org/10.1371/journal.pone.0062769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700411	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000319966400009
J	Yokota, S; Ooto, S; Hangai, M; Takayama, K; Ueda-Arakawa, N; Yoshihara, Y; Hanebuchi, M; Yoshimura, N				Yokota, Satoshi; Ooto, Sotaro; Hangai, Masanori; Takayama, Kohei; Ueda-Arakawa, Naoko; Yoshihara, Yuki; Hanebuchi, Masaaki; Yoshimura, Nagahisa			Objective Assessment of Foveal Cone Loss Ratio in Surgically Closed Macular Holes Using Adaptive Optics Scanning Laser Ophthalmoscopy	PLOS ONE			English	Article							INTERNAL LIMITING MEMBRANE; LIVING HUMAN EYE; COHERENCE TOMOGRAPHY; PHOTORECEPTOR LAYER; ULTRAHIGH-RESOLUTION; SEGMENT JUNCTION; VISUAL RECOVERY; OUTER SEGMENT; SURGERY; PATHOLOGY	Purpose: To use adaptive optics scanning laser ophthalmoscopy (AO-SLO) to quantify cone loss ratio in the foveola in order to assess foveal cone status and to investigate relationships between foveal structural abnormalities and visual function in patients with macular hole (MH) after surgery. Methods: We evaluated 10 normal eyes of 10 healthy volunteers and 19 eyes of 18 patients in whom anatomically successful MH closure had been performed. All subjects underwent a comprehensive ophthalmologic examination that included measurements of spectral-domain optical coherence tomography and AO-SLO. Results: On AO-SLO regular cone mosaic was seen in all normal eyes whereas dark regions suggesting cone loss were seen in all eyes after MH repair. Visual acuity was better in eyes without dark regions at the center of the fovea than in eyes with them (P = 0.001). Cone loss ratio in the foveola correlated with postoperative visual acuity (P<0.001), mean foveal sensitivity (P = 0.029), thinner inner and outer segments at the center of the fovea (P = 0.002), larger size of the disrupted inner and outer segment junction line (P = 0.018), and cone outer segment tip line (P<0.001). Cone loss ratio in the foveola was significantly greater in eyes that had moderately reflective foveal lesions after surgery (P = 0.006). Conclusions: AO-SLO is a useful means of assessing foveal cone damage objectively and quantitatively. The location and extent of cone damage, especially if it involves the foveola, is an important factor determining visual function after MH surgery.	[Yokota, Satoshi; Ooto, Sotaro; Hangai, Masanori; Takayama, Kohei; Ueda-Arakawa, Naoko; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Yoshihara, Yuki; Hanebuchi, Masaaki] NIDEK Co Ltd, Gamagori, Japan	Kyoto University; Nidek Co., Ltd	Ooto, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	ohoto@kuhp.kyoto-u.ac.jp	Yokota, Satoshi/A-5961-2019	Yokota, Satoshi/0000-0002-3727-7279	New Energy and Industrial Technology Development Organization (NEDO), Kawasaki, Japan [P05002]	New Energy and Industrial Technology Development Organization (NEDO), Kawasaki, Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported in part by the New Energy and Industrial Technology Development Organization (NEDO; P05002), Kawasaki, Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2008, RETINA-J RET VIT DIS, V28, P453, DOI 10.1097/IAE.0b013e3181571398; Bainbridge J, 2008, EYE, V22, P1301, DOI 10.1038/eye.2008.23; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Bottoni F, 2011, INVEST OPHTH VIS SCI, V52, P4439, DOI 10.1167/iovs.10-6732; Brooks HL, 2000, OPHTHALMOLOGY, V107, P1939, DOI 10.1016/S0161-6420(00)00331-6; Burns SA, 2007, J OPT SOC AM A, V24, P1313, DOI 10.1364/JOSAA.24.001313; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Chang LK, 2008, RETINA-J RET VIT DIS, V28, P969, DOI 10.1097/IAE.0b013e3181744165; Choi SS, 2008, J NEURO-OPHTHALMOL, V28, P120, DOI 10.1097/WNO.0b013e318175c6f5; Choi SS, 2008, INVEST OPHTH VIS SCI, V49, P2103, DOI 10.1167/iovs.07-0980; Choi SS, 2006, INVEST OPHTH VIS SCI, V47, P2080, DOI 10.1167/iovs.05-0997; Christensen UC, 2009, OPHTHALMOLOGY, V116, P2430, DOI 10.1016/j.ophtha.2009.06.001; Chung H, 2011, AM J OPHTHALMOL, V151, P128, DOI 10.1016/j.ajo.2010.06.040; Drexler W, 2003, ARCH OPHTHALMOL-CHIC, V121, P695, DOI 10.1001/archopht.121.5.695; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; Ferguson RD, 2010, J OPT SOC AM A, V27, pA265, DOI 10.1364/JOSAA.27.00A265; GASS JDM, 1995, AM J OPHTHALMOL, V119, P752, DOI 10.1016/S0002-9394(14)72781-3; Hangai M, 2007, OPHTHALMOLOGY, V114, P763, DOI 10.1016/j.ophtha.2006.07.055; Haritoglou C, 2006, RETINA-J RET VIT DIS, V26, P618, DOI 10.1097/00006982-200607000-00005; HEE MR, 1995, OPHTHALMOLOGY, V102, P748, DOI 10.1016/S0161-6420(95)30959-1; Ip MS, 2002, ARCH OPHTHALMOL-CHIC, V120, P29; Kang SW, 2010, AM J OPHTHALMOL, V150, P551, DOI 10.1016/j.ajo.2010.04.030; Kawano H, 2011, AM J OPHTHALMOL, V151, P318, DOI 10.1016/j.ajo.2010.08.034; KELLY NE, 1991, ARCH OPHTHALMOL-CHIC, V109, P654, DOI 10.1001/archopht.1991.01080050068031; Kitaguchi Y, 2008, OPHTHALMOLOGY, V115, P1771, DOI 10.1016/j.ophtha.2008.03.026; Kitaya N, 2004, AM J OPHTHALMOL, V138, P308, DOI 10.1016/j.ajo.2004.03.004; Ko TH, 2005, OPHTHALMOLOGY, V112, P1922, DOI 10.1016/j.ophtha.2005.05.027; Kusuhara S, 2004, AM J OPHTHALMOL, V138, P709, DOI 10.1016/j.ajo.2004.04.063; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Marmor MF, 2008, ARCH OPHTHALMOL-CHIC, V126, P907, DOI 10.1001/archopht.126.7.907; Meng QL, 2011, AM J OPHTHALMOL, V151, P896, DOI 10.1016/j.ajo.2010.11.006; Moshfeghi AA, 2005, AM J OPHTHALMOL, V139, P183, DOI 10.1016/j.ajo.2004.06.082; Oh J, 2010, INVEST OPHTH VIS SCI, V51, P1651, DOI 10.1167/iovs.09-4420; Ooto S, 2012, AM J OPHTHALMOL, V154, P174, DOI 10.1016/j.ajo.2012.01.031; Ooto S, 2011, ARCH OPHTHALMOL-CHIC, V129, P1633, DOI 10.1001/archophthalmol.2011.345; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P5541, DOI 10.1167/iovs.11-7251; Ooto S, 2011, OPHTHALMOLOGY, V118, P873, DOI 10.1016/j.ophtha.2010.08.032; Ooto S, 2010, OPHTHALMOLOGY, V117, P1800, DOI 10.1016/j.ophtha.2010.01.042; Pallikaris A, 2003, INVEST OPHTH VIS SCI, V44, P4580, DOI 10.1167/iovs.03-0094; Pircher M, 2006, OPT LETT, V31, P1821, DOI 10.1364/OL.31.001821; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Roorda A, 2002, J VISION, V2, P404, DOI 10.1167/2.5.4; Ruiz-Moreno JM, 2008, BRIT J OPHTHALMOL, V92, P640, DOI 10.1136/bjo.2007.136176; Sano M, 2009, AM J OPHTHALMOL, V147, P313, DOI 10.1016/j.ajo.2008.08.002; Smiddy WE, 2001, OPHTHALMOLOGY, V108, P1471, DOI 10.1016/S0161-6420(00)00645-X; Takahashi A, 2010, OPHTHALMOLOGY, V117, P806, DOI 10.1016/j.ophtha.2009.09.022; Takayama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033158; Tranos PG, 2004, AM J OPHTHALMOL, V138, P995, DOI 10.1016/j.ajo.2004.07.049; Villate N, 2005, AM J OPHTHALMOL, V139, P280, DOI 10.1016/j.ajo.2004.09.029; Wakabayashi T, 2010, OPHTHALMOLOGY, V117, P1815, DOI 10.1016/j.ophtha.2010.01.017; Wolfing JI, 2006, OPHTHALMOLOGY, V113, P1014, DOI 10.1016/j.ophtha.2006.01.056; Yoon MK, 2009, INVEST OPHTH VIS SCI, V50, P1838, DOI 10.1167/iovs.08-2029	53	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63786	10.1371/journal.pone.0063786	http://dx.doi.org/10.1371/journal.pone.0063786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717484	Green Published, Green Submitted, gold			2022-12-27	WOS:000319385300033
J	Hwang, CC; Chang, YH; Lee, HJ; Wang, TP; Su, YM; Chen, HW; Liang, PH				Hwang, Chi-Ching; Chang, Yi-Hsun; Lee, Hwei-Jen; Wang, Tzu-Pin; Su, Yu-Mei; Chen, Hsin-Wei; Liang, Po-Huang			The Catalytic Roles of P185 and T188 and Substrate-Binding Loop Flexibility in 3 alpha-Hydroxysteroid Dehydrogenase/Carbonyl Reductase from Comamonas testosteroni	PLOS ONE			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; ALPHA-HYDROXYSTEROID DEHYDROGENASE; X-RAY CRYSTALLOGRAPHY; ALCOHOL-DEHYDROGENASE; CONFORMATIONAL-CHANGE; ENZYME SPECIFICITY; INDUCED FIT; MECHANISM; DYNAMICS; SDR	3 alpha-Hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni reversibly catalyzes the oxidation of androsterone with NAD(+) to form androstanedione and NADH. Structurally the substrate-binding loop of the residues, T188-K208, is unresolved, while binding with NAD(+) causes the appearance of T188-P191 in the binary complex. This study determines the functional roles of the flexible substrate-binding loop in conformational changes and enzyme catalysis. A stopped-flow study reveals that the rate-limiting step in the reaction is the release of the NADH. The mutation at P185 in the hinge region and T188 in the loop causes a significant increase in the K-d value for NADH by fluorescence titration. A kinetic study of the mutants of P185A, P185G, T188A and T188S shows an increase in k(cat), K-androsterone and K-iNAD and equal primary isotope effects of V-D and (D)(V/K). Therefore, these mutants increase the dissociation of the nucleotide cofactor, thereby increasing the rate of release of the product and producing the rate-limiting step in the hydride transfer. Simulated molecular modeling gives results that are consistent with the conformational change in the substrate-binding loop after NAD(+) binding. These results indicate that P185, T188 and the flexible substrate-binding loop are involved in binding with the nucleotide cofactor and with androsterone and are also involved in catalysis.	[Hwang, Chi-Ching; Chang, Yi-Hsun; Su, Yu-Mei; Chen, Hsin-Wei] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Biochem, Kaohsiung, Taiwan; [Lee, Hwei-Jen] Natl Def Med Ctr, Dept & Grad Inst Biochem, Taipei, Taiwan; [Wang, Tzu-Pin] Kaohsiung Med Univ, Dept Med & Appl Chem, Kaohsiung, Taiwan; [Liang, Po-Huang] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	Kaohsiung Medical University; National Defense Medical Center; Kaohsiung Medical University; Academia Sinica - Taiwan	Hwang, CC (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Biochem, Kaohsiung, Taiwan.	cchwang@kmu.edu.tw	Liang, Po-Huang/H-6610-2015; Hwang, Chi-Ching/K-7933-2012; Wang, Tzu-Pin/D-4442-2009	Liang, Po-Huang/0000-0003-1207-5256; Hwang, Chi-Ching/0000-0002-8328-674X; Wang, Tzu-Pin/0000-0003-3668-7329	National Science Council, Taiwan [NSC 100-2320-B-037-014, NSC 101-2320-B-037-037]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council, Taiwan (NSC 100-2320-B-037-014 and NSC 101-2320-B-037-037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benach J, 1999, J MOL BIOL, V289, P335, DOI 10.1006/jmbi.1999.2765; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang YH, 2007, J BIOL CHEM, V282, P34306, DOI 10.1074/jbc.M706336200; Chang YH, 2010, BBA-PROTEINS PROTEOM, V1804, P235, DOI 10.1016/j.bbapap.2009.10.012; Chang YH, 2009, BBA-PROTEINS PROTEOM, V1794, P1459, DOI 10.1016/j.bbapap.2009.06.006; Cleland W W, 1979, Methods Enzymol, V63, P103; Cook PF, 2007, ENZYME KINETICS MECH, Vxxii; Cook PF, 1991, ENZYME MECH ISOTOPE; Dhindwal S, 2011, J BIOL CHEM, V286, P37011, DOI 10.1074/jbc.M111.291013; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Ghanem M, 2009, BIOCHEMISTRY-US, V48, P3658, DOI 10.1021/bi802339c; Grimm C, 2000, J BIOL CHEM, V275, P41333, DOI 10.1074/jbc.M007559200; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hwang CC, 2005, J BIOL CHEM, V280, P3522, DOI 10.1074/jbc.M411751200; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Khajehpour M, 2007, BIOCHEMISTRY-US, V46, P4370, DOI 10.1021/bi602335x; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Ladenstein R, 2008, CELL MOL LIFE SCI, V65, P3918, DOI 10.1007/s00018-008-8590-4; Li B, 1996, EUR J BIOCHEM, V235, P180, DOI 10.1111/j.1432-1033.1996.00180.x; Maser E, 2001, CHEM-BIOL INTERACT, V130, P707, DOI 10.1016/S0009-2797(00)00302-1; Mobus E, 1998, J BIOL CHEM, V273, P30888, DOI 10.1074/jbc.273.47.30888; Mobus E, 1997, J BACTERIOL, V179, P5951; Negri M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012026; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Paithankar KS, 2007, FEBS J, V274, P5767, DOI 10.1111/j.1742-4658.2007.06102.x; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Petschacher B, 2005, BIOCHEM J, V385, P75, DOI 10.1042/BJ20040363; Plapp BV, 2010, ARCH BIOCHEM BIOPHYS, V493, P3, DOI 10.1016/j.abb.2009.07.001; Schramm AM, 2008, BIOCHEMISTRY-US, V47, P9154, DOI 10.1021/bi8005219; Shi R, 2004, J BIOL CHEM, V279, P16778, DOI 10.1074/jbc.M313156200; SKALHEGG BA, 1975, EUR J BIOCHEM, V50, P603, DOI 10.1111/j.1432-1033.1975.tb09901.x; Slatner M, 1999, BIOCHEMISTRY-US, V38, P10489, DOI 10.1021/bi990327g; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Uversky VN, 2007, METHODS PROTEIN STRU; Wu XQ, 2007, MOL CELL ENDOCRINOL, V265, P71, DOI 10.1016/j.mce.2006.12.006; Yamazawa R, 2011, J BIOCHEM, V149, P701, DOI 10.1093/jb/mvr024	41	7	7	6	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63594	10.1371/journal.pone.0063594	http://dx.doi.org/10.1371/journal.pone.0063594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717450	Green Submitted, Green Published, gold			2022-12-27	WOS:000319435600024
J	Kim, H; Kim, K; Yu, SJ; Jang, ES; Yu, J; Cho, G; Yoon, JH; Kim, Y				Kim, Hyunsoo; Kim, Kyunggon; Yu, Su Jong; Jang, Eun Sun; Yu, Jiyoung; Cho, Geunhee; Yoon, Jung-Hwan; Kim, Youngsoo			Development of Biomarkers for Screening Hepatocellular Carcinoma Using Global Data Mining and Multiple Reaction Monitoring	PLOS ONE			English	Article							LC-MS/MS ANALYSIS; ALPHA-FETOPROTEIN; GENE-EXPRESSION; ABSOLUTE QUANTIFICATION; PROTEOMIC ANALYSIS; PROTEIN PROFILE; IMMUNE-RESPONSE; LIVER-CANCER; SIGNATURE; CELLS	Hepatocellular carcinoma (HCC) is one of the most common and aggressive cancers and is associated with a poor survival rate. Clinically, the level of alpha-fetoprotein (AFP) has been used as a biomarker for the diagnosis of HCC. The discovery of useful biomarkers for HCC, focused solely on the proteome, has been difficult; thus, wide-ranging global data mining of genomic and proteomic databases from previous reports would be valuable in screening biomarker candidates. Further, multiple reaction monitoring (MRM), based on triple quadrupole mass spectrometry, has been effective with regard to high-throughput verification, complementing antibody-based verification pipelines. In this study, global data mining was performed using 5 types of HCC data to screen for candidate biomarker proteins: cDNA microarray, copy number variation, somatic mutation, epigenetic, and quantitative proteomics data. Next, we applied MRM to verify HCC candidate biomarkers in individual serum samples from 3 groups: a healthy control group, patients who have been diagnosed with HCC (Before HCC treatment group), and HCC patients who underwent locoregional therapy (After HCC treatment group). After determining the relative quantities of the candidate proteins by MRM, we compared their expression levels between the 3 groups, identifying 4 potential biomarkers: the actin-binding protein anillin (ANLN), filamin-B (FLNB), complementary C4-A (C4A), and AFP. The combination of 2 markers (ANLN, FLNB) improved the discrimination of the before HCC treatment group from the healthy control group compared with AFP. We conclude that the combination of global data mining and MRM verification enhances the screening and verification of potential HCC biomarkers. This efficacious integrative strategy is applicable to the development of markers for cancer and other diseases.	[Kim, Hyunsoo; Kim, Kyunggon; Yu, Jiyoung; Kim, Youngsoo] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul 151, South Korea; [Yu, Su Jong; Jang, Eun Sun; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Cho, Geunhee] Yonsei Univ, Dept Life Sci, Seoul 120749, South Korea; [Cho, Geunhee] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University	Yoon, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	yoonjh@snu.ac.kr; biolab@snu.ac.kr	Kim, Youngsoo/D-6046-2012	Yoon, Jung-Hwan/0000-0002-9128-3610; Yu, Su Jong/0000-0001-8888-7977; Kim, Hyunsoo/0000-0002-8441-3376	National Research Foundation of Korea National Research Foundation of Korea [2011-0030740]; Proteogenomic Research Program; Korea government [MEST]	National Research Foundation of Korea National Research Foundation of Korea(National Research Foundation of Korea); Proteogenomic Research Program; Korea government [MEST](Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea National Research Foundation of Korea grant (No. 2011-0030740) and the Proteogenomic Research Program, funded by the Korea government [MEST]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LG, 2008, CANCER RES, V68, P2641, DOI 10.1158/0008-5472.CAN-07-5590; Alkofer B, 2011, J VISC SURG, V148, P3, DOI 10.1016/j.jviscsurg.2010.12.012; Bei R, 2011, CURR MOL MED, V11, P564, DOI 10.2174/156652411800615162; Bertino G, 2011, MINERVA MED, V102, P363; Bertino G, 2012, SEMIN ONCOL, V39, P410, DOI 10.1053/j.seminoncol.2012.05.001; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Chen CF, 2010, HEPATOLOGY, V52, P1690, DOI 10.1002/hep.23847; Chen N, 2008, PROTEOMICS, V8, P5108, DOI 10.1002/pmic.200800280; Chochi Y, 2009, J PATHOL, V217, P677, DOI 10.1002/path.2491; Colli A, 2006, AM J GASTROENTEROL, V101, P513, DOI 10.1111/j.1572-0241.2006.00467.x; Cottingham Katie, 2009, J Proteome Res, V8, P428; Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023; De Zhu J, 2005, CELL RES, V15, P272; Donati Marcello, 2010, Front Biosci (Schol Ed), V2, P571; Duffy MJ, 2001, CRIT REV CL LAB SCI, V38, P225, DOI 10.1080/20014091084218; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Kakehashi A, 2011, TOXICOL SCI, V119, P61, DOI 10.1093/toxsci/kfq307; Kim K, 2010, J PROTEOME RES, V9, P689, DOI 10.1021/pr901013d; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Lee HJ, 2010, J PROTEOME RES, V9, P308, DOI 10.1021/pr900649b; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Li C, 2004, MOL CELL PROTEOMICS, V3, P399, DOI 10.1074/mcp.M300133-MCP200; Malaguarnera G, 2010, DIGEST DIS SCI, V55, P2744, DOI 10.1007/s10620-010-1184-7; Mannova P, 2006, MOL CELL PROTEOMICS, V5, P2319, DOI 10.1074/mcp.M600121-MCP200; Masuzaki R, 2012, SEMIN ONCOL, V39, P434, DOI 10.1053/j.seminoncol.2012.05.009; Nakagawa Kan, 2012, Gan To Kagaku Ryoho, V39, P671; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Niu DD, 2009, PROTEOMICS, V9, P3856, DOI 10.1002/pmic.200900071; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Park Joong Won, 2004, Korean J Hepatol, V10, P88; Ren FL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-81; Robinson Philip, 2008, Cancer Imaging, V8 Spec No A, pS128, DOI 10.1102/1470-7330.2008.9019; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Stefaniuk P, 2010, WORLD J GASTROENTERO, V16, P418, DOI 10.3748/wjg.v16.i4.418; Stergachis AB, 2011, NAT METHODS, V8, P1041, DOI [10.1038/NMETH.1770, 10.1038/nmeth.1770]; Sun YL, 2008, J PROTEOME RES, V7, P3847, DOI 10.1021/pr800153s; Wang BH, 2012, J PROTEOME RES, V11, P1217, DOI 10.1021/pr2009252; Woo HG, 2010, CANCER RES, V70, P3034, DOI 10.1158/0008-5472.CAN-09-2823; Yan W, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r54; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Zhang JH, 2009, PROTEOMICS, V9, P2836, DOI 10.1002/pmic.200800911	48	25	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63468	10.1371/journal.pone.0063468	http://dx.doi.org/10.1371/journal.pone.0063468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717429	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700024
J	Chiu, CC; Haung, JW; Chang, FR; Huang, KJ; Huang, HM; Huang, HW; Chou, CK; Wu, YC; Chang, HW				Chiu, Chien-Chih; Haung, Jo-Wen; Chang, Fang-Rong; Huang, Kuang-Jing; Huang, Hsuan-Min; Huang, Hurng-Wern; Chou, Chon-Kit; Wu, Yang-Chang; Chang, Hsueh-Wei			Golden Berry-Derived 4 beta-hydroxywithanolide E for Selectively Killing Oral Cancer Cells by Generating ROS, DNA Damage, and Apoptotic Pathways	PLOS ONE			English	Article							COMPOUND WITHAFERIN-A; EXTRACT; H2AX; PROLIFERATION; CYTOTOXICITY; ACTIVATION; INDUCTION; DEATH; ATR	Background: Most chemotherapeutic drugs for killing cancer cells are highly cytotoxic in normal cells, which limits their clinical applications. Therefore, a continuing challenge is identifying a drug that is hypersensitive to cancer cells but has minimal deleterious effects on healthy cells. The aims of this study were to evaluate the potential of 4 beta-hydroxywithanolide (4 beta HWE) for selectively killing cancer cells and to elucidate its related mechanisms. Methodology and Principal Findings: Changes in survival, oxidative stress, DNA damage, and apoptosis signaling were compared between 4 beta HWE-treated oral cancer (Ca9-22) and normal fibroblast (HGF-1) cells. At 24 h and 48 h, the numbers of Ca9-22 cells were substantially decreased, but the numbers of HGF-1 cells were only slightly decreased. Additionally, the IC50 values for 4 beta HWE in the Ca9-22 cells were 3.6 and 1.9 mu g/ml at 24 and 48 h, respectively. Time-dependent abnormal increases in ROS and dose-responsive mitochondrial depolarization can be exploited by using 4 beta HWE in chemotherapies for selectively killing cancer cells. Dose-dependent DNA damage measured by comet-nuclear extract assay and flow cytometry-based gamma-H2AX/propidium iodide (PI) analysis showed relatively severer damage in the Ca9-22 cells. At both low and high concentrations, 4 beta HWE preferably perturbed the cell cycle in Ca9-22 cells by increasing the subG1 population and arrest of G1 or G2/M. Selective induction of apoptosis in Ca9-22 cells was further confirmed by Annexin V/PI assay, by preferential expression of phosphorylated ataxia-telangiectasia- and Rad3-related protein (p-ATR), and by cleavage of caspase 9, caspase 3, and poly ADP-ribose polymerase (PARP). Conclusions/Significance: Together, the findings of this study, particularly the improved understanding of the selective killing mechanisms of 4 beta HWE, can be used to improve efficiency in killing oral cancer cells during chemoprevention and therapy.	[Chiu, Chien-Chih; Chou, Chon-Kit] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Haung, Jo-Wen; Huang, Kuang-Jing; Huang, Hsuan-Min; Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chang, Fang-Rong; Wu, Yang-Chang; Chang, Hsueh-Wei] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan; [Huang, Hurng-Wern] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Wu, Yang-Chang] China Med Univ, Dept Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Wu, Yang-Chang] China Med Univ Hosp, Nat Med Prod Res Ctr, Taichung, Taiwan; [Wu, Yang-Chang] China Med Univ Hosp, Ctr Mol Canc, Taichung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Wu, YC (corresponding author), Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan.	yachwu@mail.cmu.edu.tw; changhw@kmu.edu.tw	Chang, Hsueh-Wei/C-9654-2009; Wu, Yang-Chang/C-5682-2009; Chiu, Chien-Chih/AAW-9861-2020	Chang, Hsueh-Wei/0000-0003-0068-2366; Wu, Yang-Chang/0000-0001-7815-2686; Chiu, Chien-Chih/0000-0001-7307-2468; Chang, Fang-Rong/0000-0003-2549-4193	National Science Council [NSC101-2320-B-037-049]; Department of Health, Executive Yuan, Republic of China [DOH102-TD-C-111-002]; National Sun Yat-Sen University-KMU Joint Research Project [NSYSU-KMU 102-034]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Republic of China; National Sun Yat-Sen University-KMU Joint Research Project	This study was supported by grants from the National Science Council (NSC101-2320-B-037-049), the Department of Health, Executive Yuan, Republic of China (DOH102-TD-C-111-002), and the National Sun Yat-Sen University-KMU Joint Research Project (#NSYSU-KMU 102-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004470; Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129; Amritpal Singh, 2010, International Journal of Green Pharmacy, V4, P229, DOI 10.4103/0973-8258.74130; Chang HC, 2007, MOL CANCER THER, V6, P1572, DOI 10.1158/1535-7163.MCT-06-0812; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Chiang SL, 2007, TOXICOL SCI, V100, P66, DOI 10.1093/toxsci/kfm201; Chiu CC, 2011, J AGR FOOD CHEM, V59, P4288, DOI 10.1021/jf200566a; Chiu CC, 2010, CANCER LETT, V295, P92, DOI 10.1016/j.canlet.2010.02.017; Chiu CC, 2009, DNA CELL BIOL, V28, P501, DOI 10.1089/dna.2009.0852; Choi MJ, 2011, TOXICOL IN VITRO, V25, P692, DOI 10.1016/j.tiv.2011.01.010; Choudhary MI, 2010, PHYTOCHEMISTRY, V71, P2205, DOI 10.1016/j.phytochem.2010.08.019; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Daniel D, 2003, INT IMMUNOPHARMACOL, V3, P1791, DOI 10.1016/j.intimp.2003.08.004; Fricker M, 2013, J BIOL CHEM, V288, P9145, DOI 10.1074/jbc.M112.427880; Guachalla LM, 2010, CELL CYCLE, V9, P4058, DOI 10.4161/cc.9.20.13577; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Iseki S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694928; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Lubin M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005735; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mayola E, 2011, APOPTOSIS, V16, P1014, DOI 10.1007/s10495-011-0625-x; Myoung H, 2003, CANCER SCI, V94, P215, DOI 10.1111/j.1349-7006.2003.tb01422.x; Nicco C, 2005, BIOMED PHARMACOTHER, V59, P169, DOI 10.1016/j.biopha.2005.03.009; Noori, 2012, ADV LIFE SCI, V2, P6, DOI [10.5923/j.als.20120201.02, DOI 10.5923/J.ALS.20120201.02]; Ovadje P, 2011, J ETHNOPHARMACOL, V133, P86, DOI 10.1016/j.jep.2010.09.005; PARKIN DM, 1988, INT J CANCER, V41, P184, DOI 10.1002/ijc.2910410205; Priyandoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019552; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Sun YL, 2010, CANCER RES, V70, P2880, DOI 10.1158/0008-5472.CAN-09-4572; Vaishnavi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044419; Wang HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037764; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Wu SJ, 2004, LIFE SCI, V74, P2061, DOI 10.1016/j.lfs.2003.09.058; Yeh CC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-142; Yeh CC, 2012, MOLECULES, V17, P10916, DOI 10.3390/molecules170910916; Yen CY, 2012, MUTAT RES-GEN TOX EN, V747, P253, DOI 10.1016/j.mrgentox.2012.06.003; Yen CY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-46; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017	42	79	79	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64739	10.1371/journal.pone.0064739	http://dx.doi.org/10.1371/journal.pone.0064739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705007	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200161
J	Fofana, I; Xiao, F; Thumann, C; Turek, M; Zona, L; Tawar, RG; Grunert, F; Thompson, J; Zeisel, MB; Baumert, TF				Fofana, Isabel; Xiao, Fei; Thumann, Christine; Turek, Marine; Zona, Laetitia; Tawar, Rajiv G.; Grunert, Fritz; Thompson, John; Zeisel, Mirjam B.; Baumert, Thomas F.			A Novel Monoclonal Anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission	PLOS ONE			English	Article							B TYPE-I; SCAVENGER RECEPTOR; LIVER-TRANSPLANTATION; NEUTRALIZING ANTIBODIES; HEPATOMA-CELLS; ENTRY FACTOR; VIRAL ENTRY; INFECTION; CD81; CLAUDIN-1	Background and Aims: Hepatitis C virus (HCV) infection is a challenge to prevent and treat because of the rapid development of drug resistance and escape. Viral entry is required for initiation, spread, and maintenance of infection, making it an attractive target for antiviral strategies. Methods: Using genetic immunization, we produced four monoclonal antibodies (mAbs) against the HCV host entry factor CD81. The effects of antibodies on inhibition of HCV infection and dissemination were analyzed in HCV permissive human liver cell lines. Results: The anti-CD81 mAbs efficiently inhibited infection by HCV of different genotypes as well as a HCV escape variant selected during liver transplantation and re-infecting the liver graft. Kinetic studies indicated that anti-CD81 mAbs target a post-binding step during HCV entry. In addition to inhibiting cell-free HCV infection, one antibody was also able to block neutralizing antibody-resistant HCV cell-cell transmission and viral dissemination without displaying any detectable toxicity. Conclusion: A novel anti-CD81 mAb generated by genetic immunization efficiently blocks HCV spread and dissemination. This antibody will be useful to further unravel the role of virus-host interactions during HCV entry and cell-cell transmission. Furthermore, this antibody may be of interest for the development of antivirals for prevention and treatment of HCV infection.	[Fofana, Isabel; Xiao, Fei; Thumann, Christine; Turek, Marine; Zona, Laetitia; Tawar, Rajiv G.; Zeisel, Mirjam B.; Baumert, Thomas F.] INSERM, Inst Virol, U1110, Strasbourg, France; [Fofana, Isabel; Xiao, Fei; Thumann, Christine; Turek, Marine; Zona, Laetitia; Tawar, Rajiv G.; Zeisel, Mirjam B.; Baumert, Thomas F.] Univ Strasbourg, Strasbourg, France; [Grunert, Fritz; Thompson, John] Aldevron GmbH, Freiburg, Germany; [Baumert, Thomas F.] Hop Univ Strasbourg, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Baumert, TF (corresponding author), INSERM, Inst Virol, U1110, Strasbourg, France.	Thomas.Baumert@unistra.fr	Baumert, Thomas/ABF-4718-2020; Zeisel, Mirjam B/E-9205-2016; Xiao, Fei/E-7133-2013	Baumert, Thomas/0000-0002-8864-2168; Zeisel, Mirjam B/0000-0003-1606-0131; Xiao, Fei/0000-0001-7353-2700	Inserm, University of Strasbourg; European Union [ERC-2008-AdG-233130-HEPCENT]; chair of excellence program of the Agence Nationale de la Recherche France [ANR-05-CEXC-008]; ANRS [2009/183, 2011/132, 2012/239]; Laboratoire d'excellence LabEx HEPSYS (Investissement d'Avenir) [ANR-10-LAB-28]; Direction Generale de l'Offre de Soins [A12027MS]; Aldevron (Pro Inno II) [KA0690901UL8]	Inserm, University of Strasbourg; European Union(European Commission); chair of excellence program of the Agence Nationale de la Recherche France(French National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR)); Laboratoire d'excellence LabEx HEPSYS (Investissement d'Avenir)(French National Research Agency (ANR)); Direction Generale de l'Offre de Soins; Aldevron (Pro Inno II)	This work was supported by Inserm, University of Strasbourg, the European Union (ERC-2008-AdG-233130-HEPCENT, INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net 2009 and 2012), the chair of excellence program of the Agence Nationale de la Recherche France (ANR-05-CEXC-008), ANRS (2009/183, 2011/132, 2012/239), Laboratoire d'excellence LabEx HEPSYS (Investissement d'Avenir; ANR-10-LAB-28), the Direction Generale de l'Offre de Soins (A12027MS) and Aldevron (Pro Inno II (KA0690901UL8)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Bitzegeio J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000978; Boyle JS, 1997, P NATL ACAD SCI USA, V94, P14626, DOI 10.1073/pnas.94.26.14626; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Charlton M, 2011, HEPATOLOGY, V54, P3, DOI 10.1002/hep.24470; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08; Farquhar MJ, 2012, J VIROL, V86, P4305, DOI 10.1128/JVI.06996-11; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Fofana I, 2012, GASTROENTEROLOGY, V143, P223, DOI 10.1053/j.gastro.2012.04.006; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Haberstroh A, 2008, GASTROENTEROLOGY, V135, P1719, DOI 10.1053/j.gastro.2008.07.018; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lacek K, 2012, J HEPATOL, V57, P17, DOI 10.1016/j.jhep.2012.02.018; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; Meuleman P, 2012, HEPATOLOGY, V55, P364, DOI 10.1002/hep.24692; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Patel AH, 2000, J GEN VIROL, V81, P2873, DOI 10.1099/0022-1317-81-12-2873; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schwarz AK, 2009, J VIROL, V83, P12407, DOI 10.1128/JVI.01552-09; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watt K, 2009, AM J TRANSPLANT, V9, P1707, DOI 10.1111/j.1600-6143.2009.02702.x; Witteveldt J, 2009, J GEN VIROL, V90, P48, DOI 10.1099/vir.0.006700-0; Zahid MN, 2013, HEPATOLOGY, V57, P492, DOI 10.1002/hep.26097; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu HH, 2012, J INFECT DIS, V205, P656, DOI 10.1093/infdis/jir802	53	41	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64221	10.1371/journal.pone.0064221	http://dx.doi.org/10.1371/journal.pone.0064221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704981	Green Published, gold			2022-12-27	WOS:000319330200125
J	Hajjarian, Z; Nadkarni, SK				Hajjarian, Zeinab; Nadkarni, Seemantini K.			Evaluation and Correction for Optical Scattering Variations in Laser Speckle Rheology of Biological Fluids	PLOS ONE			English	Article							DIFFUSING-WAVE-SPECTROSCOPY; DYNAMIC LIGHT-SCATTERING; POLARIZED-LIGHT; TRACKING MICRORHEOMETRY; ATHEROSCLEROTIC PLAQUES; REFLECTION MEASUREMENTS; MULTIPLE-SCATTERING; VISCOELASTIC MODULI; GLUCOSE-LEVELS; TURBID MEDIA	Biological fluids fulfill key functionalities such as hydrating, protecting, and nourishing cells and tissues in various organ systems. They are capable of these versatile tasks owing to their distinct structural and viscoelastic properties. Characterizing the viscoelastic properties of bio-fluids is of pivotal importance for monitoring the development of certain pathologies as well as engineering synthetic replacements. Laser Speckle Rheology (LSR) is a novel optical technology that enables mechanical evaluation of tissue. In LSR, a coherent laser beam illuminates the tissue and temporal speckle intensity fluctuations are analyzed to evaluate mechanical properties. The rate of temporal speckle fluctuations is, however, influenced by both optical and mechanical properties of tissue. Therefore, in this paper, we develop and validate an approach to estimate and compensate for the contributions of light scattering to speckle dynamics and demonstrate the capability of LSR for the accurate extraction of viscoelastic moduli in phantom samples and biological fluids of varying optical and mechanical properties.	[Hajjarian, Zeinab; Nadkarni, Seemantini K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Nadkarni, SK (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA.	snadkarni@partners.org			NIH grant [R21 HL 088306, U54 EB015408-01]; ARRA grant [R21 HL 088306-02S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119867, R21HL088306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB015408] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was funded by the NIH grant No. R21 HL 088306 (SN), NIH grant No. U54 EB015408-01 (SN), and the ARRA grant No. R21 HL 088306-02S1 (SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALUCANI U, 1990, BER BUNSEN PHYS CHEM, V94, P261, DOI 10.1002/bbpc.19900940313; Bartel S, 2000, APPL OPTICS, V39, P1580, DOI 10.1364/AO.39.001580; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Bizheva KK, 1998, PHYS REV E, V58, P7664, DOI 10.1103/PhysRevE.58.7664; Boas DA, 1997, J OPT SOC AM A, V14, P192, DOI 10.1364/JOSAA.14.000192; Brown W., 1993, DYNAMIC LIGHT SCATTE; Cardinaux F, 2002, EUROPHYS LETT, V57, P738, DOI 10.1209/epl/i2002-00525-0; Chen DT, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.108301; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Cipelletti L, 1999, REV SCI INSTRUM, V70, P3214, DOI 10.1063/1.1149894; Cohen-Addad S, 2001, PHYS REV LETT, V86, P4700, DOI 10.1103/PhysRevLett.86.4700; Cote D, 2005, OPT EXPRESS, V13, P148, DOI 10.1364/OPEX.13.000148; Dasgupta BR, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021504; Dasgupta BR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051505; Datta SS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041404; Diebold U, 2003, CATAL TODAY, V85, P93, DOI 10.1016/S0920-5861(03)00378-X; Divine JG, 2007, CLIN ORTHOP RELAT R, P113, DOI 10.1097/BLO.0b013e31802f5421; DURIAN DJ, 1995, PHYS REV E, V51, P3350, DOI 10.1103/PhysRevE.51.3350; Fam H, 2007, BIORHEOLOGY, V44, P59; FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777; FREUND I, 1992, PHYS REV B, V45, P8162, DOI 10.1103/PhysRevB.45.8162; GANG H, 1995, PHYS REV E, V52, P6289, DOI 10.1103/PhysRevE.52.6289; Giacomelli M, 2010, OPT EXPRESS, V18, P14616, DOI 10.1364/OE.18.014616; Giacomelli MG, 2008, OPT LETT, V33, P2452, DOI 10.1364/OL.33.002452; Goodman J. W., 2007, SPECKLE PHENOMENA OP; GROENHUIS RAJ, 1983, APPL OPTICS, V22, P2463, DOI 10.1364/AO.22.002463; GROENHUIS RAJ, 1983, APPL OPTICS, V22, P2456, DOI 10.1364/AO.22.002456; Hajjarian Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00316; Hajjarian Z, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533322; Harden JL, 2001, CURR OPIN COLLOID IN, V6, P438, DOI 10.1016/S1359-0294(01)00115-7; Hielscher AH, 1997, APPL OPTICS, V36, P125, DOI 10.1364/AO.36.000125; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; Jonas M, 2008, BIOPHYS J, V95, P895, DOI 10.1529/biophysj.107.120303; Jonas M, 2008, BIOPHYS J, V94, P1459, DOI 10.1529/biophysj.106.098111; Klose AD, 1998, P SOC PHOTO-OPT INS, V3566, P151, DOI 10.1117/12.334363; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; LEE B, 1992, BIORHEOLOGY, V29, P521; Lemieux PA, 1998, PHYS REV E, V57, P4498, DOI 10.1103/PhysRevE.57.4498; Levine AJ, 2000, PHYS REV LETT, V85, P1774, DOI 10.1103/PhysRevLett.85.1774; Luigi N, 2003, RHEOLOGY BIOL FLUIDS; MACKINTOSH FC, 1992, PHYS REV B, V45, P8165, DOI 10.1103/PhysRevB.45.8165; MACKINTOSH FC, 1989, PHYS REV B, V40, P9342, DOI 10.1103/PhysRevB.40.9342; MARET G, 1987, Z PHYS B CON MAT, V65, P409, DOI 10.1007/BF01303762; Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094; Mason TG, 1999, CURR OPIN COLLOID IN, V4, P231, DOI 10.1016/S1359-0294(99)00035-7; Mason TG, 1997, J OPT SOC AM A, V14, P139, DOI 10.1364/JOSAA.14.000139; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; McNeil LE, 2001, APPL OPTICS, V40, P3726, DOI 10.1364/AO.40.003726; McNeil LE, 2000, ACTA MATER, V48, P4571, DOI 10.1016/S1359-6454(00)00243-3; Meyers M.A., 1999, MECH BEHAV MAT; MIDDLETON AA, 1991, PHYS REV B, V43, P5934, DOI 10.1103/PhysRevB.43.5934; Miller CC, 1924, P R SOC LOND A-CONTA, V106, P724, DOI 10.1098/rspa.1924.0100; Moschakis T, 2010, J COLLOID INTERF SCI, V345, P278, DOI 10.1016/j.jcis.2010.02.005; MUGNAI A, 1980, J ATMOS SCI, V37, P1291, DOI 10.1175/1520-0469(1980)037<1291:SORBMN>2.0.CO;2; Nadkarni SK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2982529; Nadkarni SK, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2186046; Nadkarni SK, 2005, CIRCULATION, V112, P885, DOI 10.1161/CIRCULATIONAHA.104.520098; Nickerson CS, 2008, J BIOMECH, V41, P1840, DOI 10.1016/j.jbiomech.2008.04.015; Pecora R, 1985, BER BUNSEN PHYS CHEM, DOI DOI 10.1002/BBPC.19870910455; PINE DJ, 1988, PHYS REV LETT, V60, P1134, DOI 10.1103/PhysRevLett.60.1134; PINE DJ, 1990, J PHYS-PARIS, V51, P2101, DOI 10.1051/jphys:0199000510180210100; PINNICK RG, 1976, APPL OPTICS, V15, P384, DOI 10.1364/AO.15.000384; Ramella-Roman JC, 2005, OPT EXPRESS, V13, P4420, DOI 10.1364/OPEX.13.004420; Sakadzic S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.163902; Schmitt JM, 1998, APPL OPTICS, V37, P2788, DOI 10.1364/AO.37.002788; SCHMITT JM, 1990, J OPT SOC AM A, V7, P2141, DOI 10.1364/JOSAA.7.002141; SCHURZ J, 1987, BIORHEOLOGY, V24, P385; Sharif-Kashani P, 2011, J BIOMECH, V44, P419, DOI 10.1016/j.jbiomech.2010.10.002; TUCHIN V.V., 2002, HDB OPTICAL BIOMEDIC, VPM107; Ullah H, 2012, LASER PHYS, V22, P797, DOI 10.1134/S1054660X12040251; Ullah H, 2011, LASER PHYS, V21, P1962, DOI 10.1134/S1054660X11190285; Viasnoff V, 2002, REV SCI INSTRUM, V73, P2336, DOI 10.1063/1.1476699; Wang L.V., 2012, BIOMEDICAL OPTICS PR; Wax A, 2001, APPL OPTICS, V40, P4222, DOI 10.1364/AO.40.004222; Weitz D. A., 1993, DYNAMIC LIGHT SCATTE; Wu J, 2007, LANGMUIR, V23, P4324, DOI 10.1021/la0625190; Yodh AG, 1999, SPIE, V2979, P468	77	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65014	10.1371/journal.pone.0065014	http://dx.doi.org/10.1371/journal.pone.0065014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705028	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200182
J	Schaafsma, SM; Geuze, RH; Lust, JM; Schiefenhovel, W; Groothuis, TGG				Schaafsma, Sara M.; Geuze, Reint H.; Lust, Jessica M.; Schiefenhoevel, Wulf; Groothuis, Ton G. G.			The Relation between Handedness Indices and Reproductive Success in a Non-Industrial Society	PLOS ONE			English	Article							2 LARGE COHORTS; HAND PREFERENCE; FRENCH ADULTS; HUMANS; LATERALIZATION; PERFORMANCE; CREATIVITY; ARTISTS; ABILITY; SKILL	The evolution of handedness in human populations has intrigued scientists for decades. However, whether handedness really affects Darwinian fitness is unclear and not yet studied in a non-industrial society where selection pressures on health and handedness are likely to be similar to the situation in which handedness has evolved. We measured both hand preference and asymmetry of hand skill (speed of fine motor control, measured by a pegboard task, and accuracy of throwing), as they measure different aspects of handedness. We investigated the associations between both the direction (left versus right) and strength (the degree to which a certain preference or asymmetry in skill is manifested, independent of the direction) of handedness. We analyzed to what extent these measures predict the number of offspring and self-reported illness in a non-industrial society in Papua, Indonesia. As it is known that body height and fitness are correlated, data on body height was also collected. Due to low numbers of left-handers we could not investigate the associations between direction of hand preference and measures of Darwinian fitness. We found a positive association between strength of asymmetry of hand skill (pegboard) and the number of children men sired. We also found a positive association for men between strength of hand preference and number of children who died within the first three years of life. For women we found no such effects. Our results may indicate that strength of handedness, independent of direction, has fitness implications and that the persistence of the polymorphism in handedness may be ascribed to either balancing selection on strength of asymmetry of hand skill versus strength of hand preference, or sexual antagonistic selection. No relationships between health and handedness were found, perhaps due to disease related selective disappearance of subjects with a specific handedness.	[Schaafsma, Sara M.; Groothuis, Ton G. G.] Univ Groningen, Ctr Behav & Neurosci, Groningen, Netherlands; [Geuze, Reint H.; Lust, Jessica M.] Univ Groningen, Groningen, Netherlands; [Schiefenhoevel, Wulf] Max Planck Inst Ornithol, Human Ethol Grp, Andechs, Germany	University of Groningen; University of Groningen; Max Planck Society	Schaafsma, SM (corresponding author), Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave, New York, NY 10021 USA.	Sschaafsma@rockefeller.edu	Schaafsma, Sara/J-8192-2014	Schaafsma, Sara/0000-0003-0476-7877	European Commission through the Sixth Framework Programme; Netherlands Organisation for Scientific Research (NWO) through the Evolution and Behaviour - Interdisciplinary Research Projects; Gratema Stichting; Department of Psychology	European Commission through the Sixth Framework Programme(European Commission); Netherlands Organisation for Scientific Research (NWO) through the Evolution and Behaviour - Interdisciplinary Research Projects(Netherlands Organization for Scientific Research (NWO)); Gratema Stichting; Department of Psychology	This study was supported by the European Commission through the Sixth Framework Programme, by the Netherlands Organisation for Scientific Research (NWO) through the Evolution and Behaviour - Interdisciplinary Research Projects and by the Gratema Stichting to TGGG and by the Department of Psychology to RHG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT M, 1974, NEUROPSYCHOLOGIA, V12, P527, DOI 10.1016/0028-3932(74)90083-9; Annett M, 2004, BRIT J PSYCHOL, V95, P339, DOI 10.1348/0007126041528130; Annett M, 2002, HANDEDNESS BRAIN ASY; BOROD JC, 1984, BRIT J PSYCHOL, V75, P177, DOI 10.1111/j.2044-8295.1984.tb01889.x; BYRNE B, 1974, BRIT J PSYCHOL, V65, P279, DOI 10.1111/j.2044-8295.1974.tb01402.x; CONNOLLY KJ, 1992, NEUROPSYCHOLOGIA, V30, P13, DOI 10.1016/0028-3932(92)90010-J; Doyen AL, 2008, LATERALITY, V13, P179, DOI 10.1080/13576500701764124; Eaton WO, 1996, J CHILD PSYCHOL PSYC, V37, P613, DOI 10.1111/j.1469-7610.1996.tb01448.x; Faurie C, 2005, P ROY SOC B-BIOL SCI, V272, P25, DOI 10.1098/rspb.2004.2926; Faurie C, 2008, BRIT J PSYCHOL, V99, P533, DOI 10.1348/000712608X291563; Faurie C, 2006, EVOL HUM BEHAV, V27, P457, DOI 10.1016/j.evolhumbehav.2006.04.001; Geuze RH, 2012, NEUROPSYCHOLOGIA, V50, P612, DOI 10.1016/j.neuropsychologia.2011.12.017; Good JMM., 1994, PSYCHOL MUSIC, V22, P148, DOI DOI 10.1177/0305735694222004; GOTESTAM KO, 1990, PERCEPT MOTOR SKILL, V70, P1323, DOI 10.2466/PMS.70.4.1323-1327; HASSLER M, 1993, NEUROPSYCHOLOGIA, V31, P655, DOI 10.1016/0028-3932(93)90137-O; Healy M, 2009, MLWIN VERSION 2 21; Llaurens V, 2009, PHILOS T R SOC B, V364, P881, DOI 10.1098/rstb.2008.0235; McCullagh P, 1989, MONOGRAPHS STAT APPL, V2nd; McManus IC, 2010, LATERALITY, V15, P186, DOI 10.1080/13576500802565313; McManus IC, 1992, HDB NEUROPSYCHOLOGY, V6, P115, DOI DOI 10.1037/0894-4105.6.2.115; Miller, 2000, MATING MIND SEXUAL C; Morfit NS, 2001, BRAIN COGNITION, V46, P209, DOI 10.1016/S0278-2626(01)80068-3; Nettle D, 2006, P ROY SOC B-BIOL SCI, V273, P611, DOI 10.1098/rspb.2005.3349; Nettle D, 2003, BRAIN COGNITION, V52, P390, DOI 10.1016/S0278-2626(03)00187-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; PERELLE IB, 1994, BEHAV GENET, V24, P217, DOI 10.1007/BF01067189; PETERSON JM, 1979, PERCEPT MOTOR SKILL, V48, P961, DOI 10.2466/pms.1979.48.3.961; Preti A, 2007, J NERV MENT DIS, V195, P837, DOI 10.1097/NMD.0b013e3181568180; Raymond M, 1996, P ROY SOC B-BIOL SCI, V263, P1627, DOI 10.1098/rspb.1996.0238; Saulnier T, 1960, PAPOUS COUPEURS TETE; Schaafsma SM, 2009, PHILOS T R SOC B, V364, P915, DOI 10.1098/rstb.2008.0244; Schaafsma SM, 2012, EVOL HUM BEHAV, V33, P94, DOI 10.1016/j.evolhumbehav.2011.06.001; SCHIEFENHOVEL W, 1975, HOMO, V26, P263; Schiefenhovel W., 1991, ENCY WORLD CULTURES, VII, P55; SEARLEMAN A, 1989, PSYCHOL BULL, V105, P397, DOI 10.1037/0033-2909.105.3.397; SEARLEMAN A, 1987, NEUROPSYCHOLOGIA, V25, P367, DOI 10.1016/0028-3932(87)90025-X; Steenhuis R E, 1999, Laterality, V4, P3, DOI 10.1080/135765099397079; Van Strien J, 2002, DUTCH HANDEDNESS QUE; Vuoksimaa E, 2009, NEUROPSYCHOLOGIA, V47, P1294, DOI 10.1016/j.neuropsychologia.2009.01.007	40	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63114	10.1371/journal.pone.0063114	http://dx.doi.org/10.1371/journal.pone.0063114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23704893	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200022
J	Spring, FA; Griffiths, RE; Mankelow, TJ; Agnew, C; Parsons, SF; Chasis, JA; Anstee, DJ				Spring, Frances A.; Griffiths, Rebecca E.; Mankelow, Tosti J.; Agnew, Christopher; Parsons, Stephen F.; Chasis, Joel A.; Anstee, David J.			Tetraspanins CD81 and CD82 Facilitate alpha 4 beta 1-Mediated Adhesion of Human Erythroblasts to Vascular Cell Adhesion Molecule-1	PLOS ONE			English	Article							LATE ACTIVATION ANTIGEN-4; HEMATOPOIETIC PROGENITORS; INTEGRIN ALPHA(4)BETA(1); STROMAL MACROPHAGES; ALPHA-4 INTEGRINS; FIBRONECTIN; EXPRESSION; ERYTHROPOIESIS; IDENTIFICATION; PROTEINS	The proliferation and terminal differentiation of erythroid progenitors occurs in human bone marrow within erythroblastic islands, specialised structures consisting of a central macrophage surrounded by developing erythroid cells. Many cell-cell and cell-matrix adhesive interactions maintain and regulate the co-ordinated daily production of reticulocytes. Erythroid cells express only one integrin, alpha 4 beta 1, throughout differentiation, and its interactions with both macrophage Vascular Cell Adhesion Molecule-1 and with extracellular matrix fibronectin are critical for erythropoiesis. We observed that proerythroblasts expressed a broad tetraspanin phenotype, and investigated whether any tetraspanin could modulate integrin function. A specific association between alpha 4 beta 1 and CD81, CD82 and CD151 was demonstrated by confocal microscopy and co-immune precipitation. We observed that antibodies to CD81 and CD82 augmented adhesion of proerythroblasts to Vascular Cell Adhesion Molecule-1 but not to the fibronectin spliceoforms FnIII(12-IIICS-15) and FnIII(12-15). In contrast, different anti-CD151 antibodies augmented or inhibited adhesion of proerythroblasts to Vascular Cell Adhesion Molecule-1 and the fibronectin spliceoform FnIII(12-IIICS-15) but not to FnIII12-15. These results strongly suggest that tetraspanins have a functional role in terminal erythropoiesis by modulating interactions of erythroblast a4b1 with both macrophages and extracellular matrix.	[Spring, Frances A.; Griffiths, Rebecca E.; Mankelow, Tosti J.; Parsons, Stephen F.; Anstee, David J.] Bristol Inst Transfus Sci, Bristol, Avon, England; [Agnew, Christopher] Univ Bristol, Dept Biochem, Bristol, Avon, England; [Chasis, Joel A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of Bristol; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Spring, FA (corresponding author), Bristol Inst Transfus Sci, Bristol, Avon, England.	frances.spring@nhsbt.nhs.uk	Anstee, David/AAE-9231-2020; Griffiths, Rebecca E/C-6127-2017	Griffiths, Rebecca E/0000-0001-7461-0635; Mankelow, Tosti/0000-0003-3434-1973	National Institute for Health Research; Department of Health (England); Biological and Biotechnology Research Council [BB/7007256]; National Institutes of Health grant [DK32094]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK032094] Funding Source: NIH RePORTER; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health (England); Biological and Biotechnology Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by grants from three United Kingdom (UK) grant funding bodies, the National Institute for Health Research (http://www.ccf.nihr.ac.uk/PGfAR/Pages/Home.aspx; FAS, DJA), the Department of Health (England) (http://www.dh.gov.uk/health/category/research; REG, TJM, SFP) and the Biological and Biotechnology Research Council (http://www.bbsrc.ac.uk/home/home.aspx; grant BB/7007256, CA). National Institutes of Health grant DK32094 (http://grants.nih.gov/grants/oer.htm) funded JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew C, 2011, P NATL ACAD SCI USA, V108, P15174, DOI 10.1073/pnas.1106341108; Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4; ASHMAN LK, 1998, LEUCOCYTE TYPING, P681; BEHR S, 1995, J EXP MED, V182, P1191, DOI 10.1084/jem.182.5.1191; Berditchevski F, 2001, J CELL SCI, V114, P4143; BESSIS M, 1958, Rev Hematol, V13, P8; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Brakebusch C, 2002, IMMUNITY, V16, P465, DOI 10.1016/S1074-7613(02)00281-9; Bungartz G, 2006, BLOOD, V108, P1857, DOI 10.1182/blood-2005-10-007658; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Coulombel L, 1997, ACTA HAEMATOL-BASEL, V97, P13, DOI 10.1159/000203655; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; CROCKER PR, 1985, J EXP MED, V162, P993, DOI 10.1084/jem.162.3.993; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Fabriek BO, 2007, BLOOD, V109, P5223, DOI 10.1182/blood-2006-08-036467; Feigelson SW, 2003, J BIOL CHEM, V278, P51203, DOI 10.1074/jbc.M303601200; Fitter S, 1999, BIOCHEM J, V338, P61, DOI 10.1042/0264-6021:3380061; GREEN CA, 2005, TRANSFUSION MED, V15, pP53; Griffiths RE, 2012, BLOOD, V119, P6296, DOI 10.1182/blood-2011-09-376475; Hamamura K, 1996, BLOOD, V87, P2513, DOI 10.1182/blood.V87.6.2513.bloodjournal8762513; Han P, 2004, CYTOTHERAPY, V6, P465, DOI 10.1080/14653240410004998; HANSPAL M, 1994, BLOOD, V84, P3494; Hanspal M, 1998, BLOOD, V92, P2940, DOI 10.1182/blood.V92.8.2940.420k31_2940_2950; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee G, 2006, BLOOD, V108, P2064, DOI 10.1182/blood-2006-03-006759; Longhurst CM, 1999, EUR J BIOCHEM, V263, P104, DOI 10.1046/j.1432-1327.1999.00467.x; Mankelow TJ, 2004, BLOOD, V103, P1503, DOI 10.1182/blood-2003-08-2792; Mannion BA, 1996, J IMMUNOL, V157, P2039; MASELLISSMITH A, 1994, J IMMUNOL, V152, P2768; MASUMOTO A, 1993, J BIOL CHEM, V268, P228; MOHANDAS N, 1978, BLOOD, V51, P633; MORRIS L, 1991, J CELL SCI, V99, P141; MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x; Newham P, 1998, J IMMUNOL, V160, P4508; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PAPAYANNOPOULOU T, 1992, BLOOD, V79, P1686; Pellinen T, 2012, J CELL SCI, V125, P649, DOI 10.1242/jcs.090704; Rhodes MM, 2008, BLOOD, V111, P1700, DOI 10.1182/blood-2007-06-098178; Ripich T, 2011, HAEMATOL-HEMATOL J, V96, P1743, DOI 10.3324/haematol.2011.050468; ROSEMBLATT M, 1991, J CLIN INVEST, V87, P6, DOI 10.1172/JCI115002; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; SADAHIRA Y, 1995, J EXP MED, V181, P411, DOI 10.1084/jem.181.1.411; Schofield KP, 1999, BLOOD, V93, P410, DOI 10.1182/blood.V93.1.410; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; SHAW S, 1995, LEUCOCYTE DIFFERENTI, P16; Smythe JS, 1996, BLOOD, V87, P2968, DOI 10.1182/blood.V87.7.2968.bloodjournal8772968; SOLIGO D, 1990, BRIT J HAEMATOL, V76, P323, DOI 10.1111/j.1365-2141.1990.tb06363.x; Southcott MJG, 1999, BLOOD, V93, P4425, DOI 10.1182/blood.V93.12.4425.412k22_4425_4435; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Ulyanova T, 2011, BLOOD, V117, P975, DOI 10.1182/blood-2010-05-283218; VERFAILLIE CM, 1991, J EXP MED, V174, P693, DOI 10.1084/jem.174.3.693; Vidal M, 2010, TRANSFUS CLIN BIOL, V17, P131, DOI 10.1016/j.tracli.2010.05.004; VUILLETGAUGLER MH, 1990, BLOOD, V75, P865; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; YANAI N, 1994, BLOOD, V83, P2844, DOI 10.1182/blood.V83.10.2844.2844; Yanez-Mo M, 2001, MICROCIRCULATION, V8, P153; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; YEDNOCK TA, 1995, J BIOL CHEM, V270, P28740, DOI 10.1074/jbc.270.48.28740	66	22	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62654	10.1371/journal.pone.0062654	http://dx.doi.org/10.1371/journal.pone.0062654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704882	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200011
J	Zhou, JL; Cheng, M; Liao, YH; Hu, Y; Wu, M; Wang, Q; Qin, B; Wang, H; Zhu, Y; Gao, XM; Goukassian, D; Zhao, TC; Tang, YL; Kishore, R; Qin, GJ				Zhou, Junlan; Cheng, Min; Liao, Yu-Hua; Hu, Yu; Wu, Min; Wang, Qing; Qin, Bo; Wang, Hong; Zhu, Yan; Gao, Xiu-Mei; Goukassian, David; Zhao, Ting C.; Tang, Yao-Liang; Kishore, Raj; Qin, Gangjian			Rosuvastatin Enhances Angiogenesis via eNOS-Dependent Mobilization of Endothelial Progenitor Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; COA REDUCTASE INHIBITOR; CORONARY-HEART-DISEASE; STATIN THERAPY; HEMATOPOIETIC PROGENITOR; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; MESSENGER-RNA; STEM-CELLS; AKT	Circulating endothelial progenitor cells (circEPCs) of bone marrow (BM) origin contribute to postnatal neovascularization and represent a potential therapeutic target for ischemic disease. Statins are beneficial for ischemia disease and have been implicated to increase neovascularization via mechanisms independent of lipid lowering. However, the effect of Statins on EPC function is not completely understood. Here we sought to investigate the effects of Rosuvastatin (Ros) on EPC mobilization and EPC-mediated neovascularization during ischemic injury. In a mouse model of surgically-induced hindlimb ischemia (HLI), treatment of mice with low dose (0.1 mg/kg) but not high dose (5 mg/kg) significantly increased capillary density and accelerated blood flow recovery, as compared to saline-treated group. When HLI was induced in mice that had received Tie2/LacZ BM transplantation, Ros treatment led a significantly larger amount of endothelial cells (ECs) of BM origin incorporated at ischemic sites than saline. After treatment of mice with a single low dose of Ros, circEPCs significantly increased from 2 h, peaked at 4 h, declined until 8 h. In a growth-factor reduced Matrigel plug-in assay, Ros treatment for 5 d induced endothelial lineage differentiation in vivo. Interestingly, the enhanced circEPCs and post-HLI neovascularization stimulated by Ros were blunted in mice deficient in endothelial nitric oxide synthase (eNOS), and Ros increased p-Akt/p-eNOS levels in EPCs in vitro, indicating these effects of Ros are dependent on eNOS activity. We conclude that Ros increases circEPCs and promotes their de novo differentiation through eNOS pathway.	[Zhou, Junlan; Kishore, Raj; Qin, Gangjian] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA; [Cheng, Min; Liao, Yu-Hua] Northwestern Univ, Feinberg Sch Med, Dept Cardiol, Chicago, IL 60611 USA; [Hu, Yu] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Hematol, Wuhan 430074, Hubei, Peoples R China; [Wu, Min] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Plast Surg, Wuhan 430074, Hubei, Peoples R China; [Wang, Qing] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Cardio X Inst,Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Hubei, Peoples R China; [Qin, Bo] Weinberg Coll Arts & Sci, Chicago, IL USA; [Wang, Hong; Zhu, Yan; Gao, Xiu-Mei] Tianjin Univ Tradit Chinese Med, Minist Educ, Key Lab Pharmacol Tradit Chinese Med Formulae, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Goukassian, David] Tufts Univ, Sch Med, Steward St Elizabeths Med Ctr, Boston, MA 02111 USA; [Zhao, Ting C.] Boston Univ, Sch Med, Roger William Med Ctr, Dept Surg, Providence, RI USA; [Tang, Yao-Liang] Univ Cincinnati, Cardiovasc Res Ctr, Div Cardiovasc Dis, Cincinnati, OH USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Tianjin University of Traditional Chinese Medicine; St. Elizabeth's Medical Center; Tufts University; Boston University; Roger Williams Medical Center; University System of Ohio; University of Cincinnati	Qin, GJ (corresponding author), Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA.	g-qin@northwestern.edu	Zhu, Yan/A-1548-2017	Zhu, Yan/0000-0002-3197-7936; Goukassian, David/0000-0001-5270-5270; Tang, Yaoliang/0000-0002-8372-1545	National Institutes of Health [HL093439, HL113541]; American Heart Association [0430135N, 10POST4360009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093439, R01HL113541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants (HL093439 and HL113541 to G.Q.) and American Heart Association grants (0430135N to G.Q. and 10POST4360009 to J.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Balakumar P, 2012, J MOL CELL CARDIOL, V52, P83, DOI 10.1016/j.yjmcc.2011.09.014; Bir SC, 2012, CARDIOVASC RES, V95, P7, DOI 10.1093/cvr/cvs143; Brautbar A, 2011, NAT REV CARDIOL, V8, P253, DOI 10.1038/nrcardio.2011.2; Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405; Cheng M, 2012, PROG MOL BIOL TRANSL, V111, P243, DOI 10.1016/B978-0-12-398459-3.00011-3; Cheng M, 2010, CIRC RES, V107, P1083, DOI 10.1161/CIRCRESAHA.110.220970; Clearfield MB, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-35; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Duda DG, 2004, TRENDS MOL MED, V10, P143, DOI 10.1016/j.molmed.2004.02.001; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gill M, 2001, CIRC RES, V88, P167; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Heart Protection Study Collaborati, 2007, J VASC SURG, V45, P645, DOI 10.1016/j.jvs.2006.12.054; Heart Protection Study Collaborative G, 2007, J VASC SURG, V45, P653; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Katsumoto M, 2005, CIRC J, V69, P1547, DOI 10.1253/circj.69.1547; Koren MJ, 2004, J AM COLL CARDIOL, V44, P1772, DOI 10.1016/j.jacc.2004.07.053; Kosmidou I, 2007, ARTERIOSCL THROM VAS, V27, P2642, DOI 10.1161/ATVBAHA.107.154492; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Lemarie CA, 2011, AM J PHYSIOL-HEART C, V300, pH745, DOI 10.1152/ajpheart.00321.2010; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; LEVINE GN, 1995, NEW ENGL J MED, V332, P512, DOI 10.1056/NEJM199502233320807; Liu S, 2000, TRENDS CARDIOVAS MED, V10, P253, DOI 10.1016/S1050-1738(00)00073-6; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Merla R, 2007, AM J PHYSIOL-HEART C, V293, pH1918, DOI 10.1152/ajpheart.00416.2007; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Pedersen TR, 2004, ATHEROSCLEROSIS SUPP, V5, P81, DOI 10.1016/j.atherosclerosissup.2004.08.027; Preiss D, 2012, NAT REV CARDIOL, V9, P190, DOI 10.1038/nrcardio.2012.15; Qin GJ, 2006, P NATL ACAD SCI USA, V103, P11015, DOI 10.1073/pnas.0509533103; Qin GJ, 2006, J EXP MED, V203, P153, DOI 10.1084/jem.20050459; Qiu FY, 2009, J CARDIOVASC PHARM, V53, P209, DOI 10.1097/FJC.0b013e318199f326; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Skaletz-Rorowski A, 2003, CURR OPIN LIPIDOL, V14, P599, DOI 10.1097/00041433-200312000-00008; Suzuki G, 2009, CIRC RES, V104, P255, DOI 10.1161/CIRCRESAHA.108.188730; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Urbich C, 2002, CIRC RES, V90, P737, DOI 10.1161/01.RES.0000014081.30867.F8; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Walter Dirk H, 2004, Semin Vasc Med, V4, P385, DOI 10.1055/s-2004-869595; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894; Yemisci M, 2008, CEREBROVASC DIS, V26, P190, DOI 10.1159/000145327; Zhou JL, 2009, CIRCULATION, V120, P1213, DOI 10.1161/CIRCULATIONAHA.109.859207; Ziebart T, 2008, CIRC RES, V103, P1327, DOI 10.1161/CIRCRESAHA.108.180463	61	34	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63126	10.1371/journal.pone.0063126	http://dx.doi.org/10.1371/journal.pone.0063126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704894	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200023
J	Ng, GHB; Gong, ZY				Ng, Grace Hwee Boon; Gong, Zhiyuan			GFP Transgenic Medaka (Oryzias latipes) under the Inducible cyp1a Promoter Provide a Sensitive and Convenient Biological Indicator for the Presence of TCDD and Other Persistent Organic Chemicals	PLOS ONE			English	Article							IN-VIVO; AROMATIC-HYDROCARBONS; ZEBRAFISH EMBRYOS; RECEPTOR; DIOXIN; FISH; EXPOSURE; CELLS; TOXICITY; SYSTEM	Persistent organic pollutants (POPs) are resistant to environmental degradation and can cause multitude of health problems. Cytochrome P450 1A (Cyp1a) is often up-regulated by POPs through the activation of aryl hydrocarbon receptor (AhR) pathway and is thus usually used as a biomarker for xenobiotics exposure. To develop a convenient in vivo tool to monitor xenobiotic contamination in the water, we have established GFP transgenic medaka using the inducible cyp1a promoter, Tg(cyp1a: gfp). Here we tested Tg(cyp1a: gfp) medaka at three different stages, prehatching embryos, newly hatched fry and adult with 2,3,7,8-tetrachlorodiebnzo-p-dioxin (TCDD), a dioxin. While GFP induction was observed in all three stages, newly hatched fry were the most sensitive with the lowest observed effective concentration of 0.005 nM or 16.1 ng/L. The highly sensitive organs included the kidney, liver and intestine. With high concentrations of TCDD, several other organs such as the olfactory pit, tail fin, gills, lateral line neuromast cells and blood vessels also showed GFP expression. In addition, Tg(cyp1a: gfp) medaka fry also responded to two other AhR agonists, 3-methylcholanthrene and benzo[a] pyrene, for GFP induction, but no significant GFP induction was observed towards several other chemicals tested, indicating the specificity of this transgenic line. The GFP inducibility of Tg(cyp1a: gfp) medaka at both fry and adult stages may be useful for development of high-throughput assays as well as online water monitoring system to detect xenobiotic toxicity.	[Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; Singapore MIT Alliance, Computat & Syst Biol, Singapore, Singapore	National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260; Ng, Grace/0000-0002-4516-7299	Singapore National Research Foundation under its Environmental and Water Technologies Strategic Research Programme; Environment and Water Industry Programme Office (EWI) of the PUB [R-154-000-328-272]; NGS graduate scholarship	Singapore National Research Foundation under its Environmental and Water Technologies Strategic Research Programme(National Research Foundation, Singapore); Environment and Water Industry Programme Office (EWI) of the PUB; NGS graduate scholarship	This work was supported by the Singapore National Research Foundation under its Environmental and Water Technologies Strategic Research Programme and administered by the Environment and Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. GHBN acknowledges the support from an NGS graduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARTS JMMJG, 1995, EUR J PHARM-ENVIRON, V293, P463; Andreasen EA, 2002, TOXICOL SCI, V68, P403, DOI 10.1093/toxsci/68.2.403; Blechinger SR, 2002, ENVIRON HEALTH PERSP, V110, P1041, DOI 10.1289/ehp.021101041; Bugiak B, 2009, AQUAT TOXICOL, V95, P299, DOI 10.1016/j.aquatox.2009.03.009; Bussmann UA, 2013, COMP BIOCHEM PHYS C, V157, P111, DOI 10.1016/j.cbpc.2012.10.006; Carvan Michael J. III, 2000, Annals of the New York Academy of Sciences, V919, P133; Elskens M, 2011, TALANTA, V85, P1966, DOI 10.1016/j.talanta.2011.07.014; Hahn ME, 2002, SCI TOTAL ENVIRON, V289, P49, DOI 10.1016/S0048-9697(01)01016-6; Hahn ME, 1996, ENVIRON TOXICOL CHEM, V15, P582, DOI 10.1002/etc.5620150425; Handley-Goldstone HM, 2005, TOXICOL SCI, V85, P683, DOI 10.1093/toxsci/kfi116; Inoue K, 2003, COMP BIOCHEM PHYS B, V136, P635, DOI 10.1016/S1096-4959(03)00204-5; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; King-Heiden TC, 2012, MOL CELL ENDOCRINOL, V354, P121, DOI 10.1016/j.mce.2011.09.027; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Kurauchi K, 2005, ENVIRON SCI TECHNOL, V39, P2762, DOI 10.1021/es0486465; Legler J, 2000, ENVIRON SCI TECHNOL, V34, P4439, DOI 10.1021/es0000605; Lele Z, 1996, BIOTECHNOL ADV, V14, P57, DOI 10.1016/0734-9750(96)00004-3; Ma Q, 2007, DRUG METAB DISPOS, V35, P1009, DOI 10.1124/dmd.107.015826; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Marinkovic N, 2010, ARH HIG RADA TOKSIKO, V61, P445, DOI 10.2478/10004-1254-61-2010-2024; Monostory K, 2009, DRUG METAB REV, V41, P547, DOI 10.1080/03602530903112284; Nagy SR, 2002, TOXICOL SCI, V65, P200, DOI 10.1093/toxsci/65.2.200; Ng GHB, 2011, BIOCHIMIE, V93, P1858, DOI 10.1016/j.biochi.2011.07.006; Noury P, 2006, ENVIRON TOXICOL, V21, P324, DOI 10.1002/tox.20184; Sanderson JT, 1996, TOXICOL APPL PHARM, V137, P316, DOI 10.1006/taap.1996.0086; Sarasquete C, 2000, SCI TOTAL ENVIRON, V247, P313, DOI 10.1016/S0048-9697(99)00500-8; Sasado T, 2010, EXP ANIM TOKYO, V59, P13, DOI 10.1538/expanim.59.13; Srogi K, 2007, ENVIRON CHEM LETT, V5, P169, DOI 10.1007/s10311-007-0095-0; Swedenborg E, 2010, TOXICOLOGY, V268, P132, DOI 10.1016/j.tox.2009.09.007; Wakamatsu Y, 2001, P NATL ACAD SCI USA, V98, P10046, DOI 10.1073/pnas.181204298; Weber R, 2008, ENVIRON SCI POLLUT R, V15, P363, DOI 10.1007/s11356-008-0024-1; Whyte JJ, 2000, CRIT REV TOXICOL, V30, P347, DOI 10.1080/10408440091159239; Wu YL, 2008, GENE, V408, P85, DOI 10.1016/j.gene.2007.10.027; Yan ZH, 2012, COMP BIOCHEM PHYS C, V156, P17, DOI 10.1016/j.cbpc.2012.03.001; Zeng ZQ, 2005, ENVIRON SCI TECHNOL, V39, P9001, DOI 10.1021/es050728l; Zhou BS, 2006, AQUAT TOXICOL, V80, P109, DOI 10.1016/j.aquatox.2006.07.021; Zhou HL, 2010, TOXICOL MECH METHOD, V20, P279, DOI 10.3109/15376516.2010.485227; Zodrow JM, 2004, AQUAT TOXICOL, V66, P25, DOI 10.1016/j.aquatox.2003.07.002	39	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64334	10.1371/journal.pone.0064334	http://dx.doi.org/10.1371/journal.pone.0064334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700472	Green Submitted, Green Published, gold			2022-12-27	WOS:000319966400055
J	Hu, ZR; Song, N; Xing, JW; Chen, YH; Han, ZF; Yao, YY; Peng, HR; Ni, ZF; Sun, QX				Hu, Zhaorong; Song, Na; Xing, Jiewen; Chen, Yanhong; Han, Zongfu; Yao, Yingyin; Peng, Huiru; Ni, Zhongfu; Sun, Qixin			Overexpression of Three TaEXPA1 Homoeologous Genes with Distinct Expression Divergence in Hexaploid Wheat Exhibit Functional Retention in Arabidopsis	PLOS ONE			English	Article							CELL-WALL EXTENSION; BETA-EXPANSIN GENES; MULTIGENE FAMILY; ALPHA-EXPANSIN; LEAF; EVOLUTION; POLYPLOIDY; ELONGATION; PROTEINS; GROWTH	Common wheat is a hexaploid species with most of the genes present as triplicate homoeologs. Expression divergences of homoeologs are frequently observed in wheat as well as in other polyploid plants. However, little is known about functional variances among homologous genes arising from polyploidy. Expansins play diverse roles in plant developmental processes related to the action of cell wall loosening. Expression of the three TaEXPA1 homoeologs varied dynamically at different stages and organs, and epigenetic modifications contribute to the expression divergence of three TaEXPA1 homoeologs during wheat development. Nevertheless, their functions remain to be clarified. We found that over expression of TaEXPA1-A, -B and -D produced similar morphological changes in transgenic Arabidopsis plants, including increased germination and growth rate during seedling and adult stages, indicating that the proteins encoded by these three wheat TaEXPA1 homoeologs have similar (or conserved) functions in Arabidopsis. Collectively, our present study provided an example of a set of homoeologous genes expression divergence in different developmental stages and organs in hexaploid wheat but functional retention in transgenic Arabidopsis plants.	[Hu, Zhaorong; Song, Na; Xing, Jiewen; Chen, Yanhong; Han, Zongfu; Yao, Yingyin; Peng, Huiru; Ni, Zhongfu; Sun, Qixin] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Utilizat MOE, State Key Lab Agrobiotechnol,Key Lab Crop Heteros, Beijing 100094, Peoples R China; [Hu, Zhaorong; Song, Na; Xing, Jiewen; Chen, Yanhong; Han, Zongfu; Yao, Yingyin; Peng, Huiru; Ni, Zhongfu; Sun, Qixin] Natl Plant Gene Res Ctr, Beijing, Peoples R China	China Agricultural University	Sun, QX (corresponding author), China Agr Univ, Beijing Key Lab Crop Genet Improvement, Utilizat MOE, State Key Lab Agrobiotechnol,Key Lab Crop Heteros, Beijing 100094, Peoples R China.	qxsun@cau.edu.cn			Major Program of the National Natural Science Foundation of China [31290210, 31290212]; National Science Foundation for Distinguished Young Scholars [30925023]	Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the Major Program of the National Natural Science Foundation of China (31290210, 31290212) and National Science Foundation for Distinguished Young Scholars (30925023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi P, 2012, PLANT BIOTECHNOL-NAR, V29, P245, DOI 10.5511/plantbiotechnology.12.0224a; Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Bottley A, 2006, PLANT J, V47, P897, DOI 10.1111/j.1365-313X.2006.02841.x; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chen F, 2000, PLANT PHYSIOL, V124, P1265, DOI 10.1104/pp.124.3.1265; Chen F, 2001, PLANT PHYSIOL, V127, P928, DOI 10.1104/pp.010259; Chen X, 2011, PLANT PHYSIOL, V155, P851, DOI 10.1104/pp.110.169482; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Cho HT, 1997, PLANT PHYSIOL, V113, P1145, DOI 10.1104/pp.113.4.1145; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosgrove DJ, 1998, PLANT PHYSIOL, V118, P333, DOI 10.1104/pp.118.2.333; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gao Q, 2008, PROTOPLASMA, V233, P73, DOI 10.1007/s00709-008-0303-1; Goh HH, 2012, PLANT PHYSIOL, V159, P1759, DOI 10.1104/pp.112.200881; Gookin TE, 2003, PLANT SCI, V164, P769, DOI 10.1016/S0168-9452(03)00063-3; Hovav R, 2008, P NATL ACAD SCI USA, V105, P6191, DOI 10.1073/pnas.0711569105; Hu ZR, 2013, NEW PHYTOL, V197, P1344, DOI 10.1111/nph.12131; Hu ZR, 2011, GENE, V471, P13, DOI 10.1016/j.gene.2010.10.001; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Jin Y, 2006, PROTOPLASMA, V228, P13, DOI 10.1007/s00709-006-0176-0; Kashkush K, 2002, GENETICS, V160, P1651; Lee DK, 2003, PLANT PHYSIOL, V131, P985, DOI 10.1104/pp.009902; Lee Y, 2001, PLANT PHYSIOL, V127, P645, DOI 10.1104/pp.010345; Lee Y, 2001, CURR OPIN PLANT BIOL, V4, P527, DOI 10.1016/S1369-5266(00)00211-9; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Lin Z, 2005, MOL GENET GENOMICS, V274, P548, DOI 10.1007/s00438-005-0029-0; Liu ZL, 2007, CURR BIOL, V17, P1669, DOI 10.1016/j.cub.2007.08.030; Lynch M, 2000, GENETICS, V154, P459; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Reidy B, 2001, PLANT MOL BIOL, V46, P491, DOI 10.1023/A:1010621417854; SHCHERBAN TY, 1995, P NATL ACAD SCI USA, V92, P9245, DOI 10.1073/pnas.92.20.9245; Shitsukawa N, 2007, PLANT CELL, V19, P1723, DOI 10.1105/tpc.107.051813; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Udall JA, 2006, CROP SCI, V46, pS3, DOI 10.2135/cropsci2006.07.0489tpg; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wu YJ, 2001, PLANT PHYSIOL, V126, P222, DOI 10.1104/pp.126.1.222; Zhang NG, 2000, PLANT CELL PHYSIOL, V41, P1305, DOI 10.1093/pcp/pcd064; Zhang ZC, 2011, P NATL ACAD SCI USA, V108, P18737, DOI 10.1073/pnas.1110552108	51	10	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63667	10.1371/journal.pone.0063667	http://dx.doi.org/10.1371/journal.pone.0063667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696842	Green Published, gold, Green Submitted			2022-12-27	WOS:000319081900049
J	Wei, XC; Zhang, XH; Shen, D; Wang, HP; Wu, QJ; Lu, P; Qiu, Y; Song, JP; Zhang, YJ; Li, XX				Wei, Xiaochun; Zhang, Xiaohui; Shen, Di; Wang, Haiping; Wu, Qingjun; Lu, Peng; Qiu, Yang; Song, Jiangping; Zhang, Youjun; Li, Xixiang			Transcriptome Analysis of Barbarea vulgaris Infested with Diamondback Moth (Plutella xylostella) Larvae	PLOS ONE			English	Article							BETA-AMYRIN SYNTHASE; TRITERPENE SAPONIN BIOSYNTHESIS; RESPONSIVE GENE-EXPRESSION; FUNCTIONAL-ANALYSIS; CYTOCHROME-P450 FAMILY; GIBBERELLIN RECEPTORS; SECONDARY METABOLISM; ABSCISIC-ACID; PLANT-GROWTH; ARABIDOPSIS	Background: The diamondback moth (DBM, Plutella xylostella) is a crucifer-specific pest that causes significant crop losses worldwide. Barbarea vulgaris (Brassicaceae) can resist DBM and other herbivorous insects by producing feeding-deterrent triterpenoid saponins. Plant breeders have long aimed to transfer this insect resistance to other crops. However, a lack of knowledge on the biosynthetic pathways and regulatory networks of these insecticidal saponins has hindered their practical application. A pyrosequencing-based transcriptome analysis of B. vulgaris during DBM larval feeding was performed to identify genes and gene networks responsible for saponin biosynthesis and its regulation at the genome level. Principal Findings: Approximately 1.22, 1.19, 1.16, 1.23, 1.16, 1.20, and 2.39 giga base pairs of clean nucleotides were generated from B. vulgaris transcriptomes sampled 1, 4, 8, 12, 24, and 48 h after onset of P. xylostella feeding and from non-inoculated controls, respectively. De novo assembly using all data of the seven transcriptomes generated 39,531 unigenes. A total of 37,780 (95.57%) unigenes were annotated, 14,399 of which were assigned to one or more gene ontology terms and 19,620 of which were assigned to 126 known pathways. Expression profiles revealed 2,016-4,685 up-regulated and 557-5188 down-regulated transcripts. Secondary metabolic pathways, such as those of terpenoids, glucosinolates, and phenylpropanoids, and its related regulators were elevated. Candidate genes for the triterpene saponin pathway were found in the transcriptome. Orthological analysis of the transcriptome with four other crucifer transcriptomes identified 592 B. vulgaris-specific gene families with a P-value cutoff of 1e(-5). Conclusion: This study presents the first comprehensive transcriptome analysis of B. vulgaris subjected to a series of DBM feedings. The biosynthetic and regulatory pathways of triterpenoid saponins and other DBM deterrent metabolites in this plant were classified. The results of this study will provide useful data for future investigations on pest-resistance phytochemistry and plant breeding.	[Wei, Xiaochun; Zhang, Xiaohui; Shen, Di; Wang, Haiping; Wu, Qingjun; Lu, Peng; Qiu, Yang; Song, Jiangping; Zhang, Youjun; Li, Xixiang] China Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Li, XX (corresponding author), China Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China.	lixx0612@163.com	Zhang, Xiaohui/AAH-8653-2020; Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	National Key Technology R & D Program of the Ministry of Science and Technology of China [2013BAD01B04]; Core Research Budget of the Non-profit Governmental Research Institution (CAAS) [2012ZL026]	National Key Technology R & D Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Core Research Budget of the Non-profit Governmental Research Institution (CAAS)	The work was supported by grants from the National Key Technology R & D Program of the Ministry of Science and Technology of China (2013BAD01B04) and Core Research Budget of the Non-profit Governmental Research Institution (CAAS,2012ZL026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; Agerbirk N, 2003, J CHEM ECOL, V29, P1417, DOI 10.1023/A:1024217504445; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bachran C, 2010, BRIT J PHARMACOL, V159, P345, DOI 10.1111/j.1476-5381.2009.00543.x; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bedon F, 2010, J EXP BOT, V61, P3847, DOI 10.1093/jxb/erq196; Bohlmann J, 2012, TREE PHYSIOL, V32, P943, DOI 10.1093/treephys/tps065; Bones AM, 2006, PHYTOCHEMISTRY, V67, P1053, DOI 10.1016/j.phytochem.2006.02.024; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; CAELLES C, 1989, PLANT MOL BIOL, V13, P627, DOI 10.1007/BF00016018; Casteel CL, 2006, ENTOMOL EXP APPL, V121, P67, DOI 10.1111/j.1570-8703.2006.00458.x; Confalonieri M, 2009, PLANT BIOTECHNOL J, V7, P172, DOI 10.1111/j.1467-7652.2008.00385.x; Dal Cin V, 2011, PLANT CELL, V23, P2738, DOI 10.1105/tpc.111.086975; Diet A, 2006, PLANT CELL, V18, P1630, DOI 10.1105/tpc.105.038653; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Ehlting J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-154; Fuchs H, 2009, CURR DRUG TARGETS, V10, P140, DOI 10.2174/138945009787354584; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Gogvadze E, 2009, CELL MOL LIFE SCI, V66, P3727, DOI 10.1007/s00018-009-0107-2; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Han JY, 2010, PHYTOCHEMISTRY, V71, P36, DOI 10.1016/j.phytochem.2009.09.031; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Harmatha Juraj, 2003, Phytochemistry Reviews, V2, P321, DOI 10.1023/B:PHYT.0000045494.98645.a3; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Herrera JBR, 1998, PHYTOCHEMISTRY, V49, P1905, DOI 10.1016/S0031-9422(98)00366-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu Ke, 2009, Acta Horticulturae Sinica, V36, P1013; Hu YL, 2010, PLANT CELL, V22, P3093, DOI 10.1105/tpc.109.072652; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Huang MD, 2007, PLANT MOL BIOL, V63, P557, DOI 10.1007/s11103-006-9109-8; Huang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030364; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Joshi RK, 2011, GENET MOL RES, V10, P2637, DOI 10.4238/2011.October.25.10; Just MJ, 1998, PLANTA MED, V64, P404, DOI 10.1055/s-2006-957469; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Kejnovsky E, 2012, PLANT GENOME DIVERSI, V1, P17; Kieffer M, 2011, PLANT J, V68, P147, DOI 10.1111/j.1365-313X.2011.04674.x; Kuhn BM, 2011, PLANT PHYSIOL, V156, P585, DOI 10.1104/pp.111.175976; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Kuzina V, 2011, PHYTOCHEMISTRY, V72, P188, DOI 10.1016/j.phytochem.2010.11.007; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meesapyodsuk D, 2007, PLANT PHYSIOL, V143, P959, DOI 10.1104/pp.106.088484; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Miclaus M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002131; Mizoi J, 1819, BIOCHIM BIOPHYS ACTA, P86; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Naoumkina MA, 2010, PLANT CELL, V22, P850, DOI 10.1105/tpc.109.073270; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Nielsen NJ, 2010, J AGR FOOD CHEM, V58, P5509, DOI 10.1021/jf903988f; Nombela G, 2003, MOL PLANT MICROBE IN, V16, P645, DOI 10.1094/MPMI.2003.16.7.645; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Pandey GK, 2005, PLANT PHYSIOL, V139, P1185, DOI 10.1104/pp.105.066324; Pandey SP, 2008, P NATL ACAD SCI USA, V105, P4559, DOI 10.1073/pnas.0711363105; Paquette S, 2003, PHYTOCHEMISTRY, V62, P399, DOI 10.1016/S0031-9422(02)00558-7; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Plett JM, 2010, PLANT J, V64, P419, DOI 10.1111/j.1365-313X.2010.04343.x; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; RAY A, 1994, P NATL ACAD SCI USA, V91, P5761, DOI 10.1073/pnas.91.13.5761; Renwick JAA, 2006, J CHEM ECOL, V32, P755, DOI 10.1007/s10886-006-9036-9; Ringli C, 2008, PLANT CELL, V20, P1470, DOI 10.1105/tpc.107.053249; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; RUSSELL DW, 1971, J BIOL CHEM, V246, P3870; Saito K, 1999, PLANT J, V17, P181, DOI 10.1046/j.1365-313X.1999.00365.x; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sarfraz M, 2006, CROP PROT, V25, P625, DOI 10.1016/j.cropro.2005.09.011; Villada ES, 2009, J EXP BOT, V60, P3269, DOI 10.1093/jxb/erp163; Schilmiller AL, 2009, PLANT J, V60, P771, DOI 10.1111/j.1365-313X.2009.03996.x; Schmelz EA, 2009, P NATL ACAD SCI USA, V106, P653, DOI 10.1073/pnas.0811861106; Seki H, 2008, P NATL ACAD SCI USA, V105, P14204, DOI 10.1073/pnas.0803876105; Shibuya M, 2006, FEBS J, V273, P948, DOI 10.1111/j.1742-4658.2006.05120.x; Shibuya M, 2010, FEBS LETT, V584, P2258, DOI 10.1016/j.febslet.2010.03.037; Shinoda T, 2002, J CHEM ECOL, V28, P587, DOI 10.1023/A:1014500330510; Skibbe M, 2008, PLANT CELL, V20, P1984, DOI 10.1105/tpc.108.058594; Smith CM, 2012, ANNU REV ENTOMOL, V57, P309, DOI 10.1146/annurev-ento-120710-100642; Sparg SG, 2004, J ETHNOPHARMACOL, V94, P219, DOI 10.1016/j.jep.2004.05.016; Stotz HU, 2000, PLANT PHYSIOL, V124, P1007, DOI 10.1104/pp.124.3.1007; Sun HX, 2009, VACCINE, V27, P1787, DOI 10.1016/j.vaccine.2009.01.091; Suzuki H, 2009, PLANT J, V60, P48, DOI 10.1111/j.1365-313X.2009.03936.x; Tian L, 2004, P NATL ACAD SCI USA, V101, P402, DOI 10.1073/pnas.2237237100; Tu Y, 2010, PLANT CELL, V22, P3357, DOI 10.1105/tpc.109.072827; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; van Leur H, 2008, J CHEM ECOL, V34, P121, DOI 10.1007/s10886-007-9424-9; Vickers RA, 2004, ENTOMOL EXP APPL, V111, P7, DOI 10.1111/j.0013-8703.2004.00140.x; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Waliwitiya R, 2012, J ECON ENTOMOL, V105, P72, DOI 10.1603/EC10381; Xue ZY, 2012, NEW PHYTOL, V193, P1022, DOI 10.1111/j.1469-8137.2011.03997.x; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Zhang HC, 2009, PLANT CELL REP, V28, P1205, DOI 10.1007/s00299-009-0721-3; Zhao CL, 2010, NAT PROD COMMUN, V5, P1147; Zhao ZC, 2012, MOL BIOL REP, V39, P6409, DOI 10.1007/s11033-011-1303-3; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399	109	27	32	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64481	10.1371/journal.pone.0064481	http://dx.doi.org/10.1371/journal.pone.0064481			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696897	gold, Green Submitted, Green Published			2022-12-27	WOS:000319081900100
J	Armstrong, C; Wilkinson, H; Meade, J; Biro, D; Freeman, R; Guilford, T				Armstrong, Chris; Wilkinson, Helen; Meade, Jessica; Biro, Dora; Freeman, Robin; Guilford, Tim			Homing Pigeons Respond to Time-Compensated Solar Cues Even in Sight of the Loft	PLOS ONE			English	Article							SUN COMPASS ORIENTATION; CLOCK-SHIFT EXPERIMENTS; RELEASE SITE REDUCE; DEFLECTION; NAVIGATION; LANDMARKS; FAMILIARITY; TRACKING; BIRDS; GPS	The sun has long been thought to guide bird navigation as the second step in a two-stage process, in which determining position using a map is followed by course setting using a compass, both over unfamiliar and familiar terrain. The animal's endogenous clock time-compensates the solar compass for the sun's apparent movement throughout the day, and this allows predictable deflections in orientation to test for the compass' influence using clock-shift manipulations. To examine the influence of the solar compass during a highly familiar navigational task, 24 clock-shifted homing pigeons were precision-tracked from a release site close to and in sight of their final goal, the colony loft. The resulting trajectories displayed significant partial deflection from the loft direction as predicted by either fast or slow clock-shift treatments. The partial deflection was also found to be stable along the entire trajectory indicating regular updating of orientation via input from the solar compass throughout the final approach flight to the loft. Our results demonstrate that time-compensated solar cues are deeply embedded in the way birds orient during homing flight, are accessed throughout the journey and on a remarkably fine-grained scale, and may be combined effectively simultaneously with direct guidance from familiar landmarks, even when birds are flying towards a directly visible goal.	[Armstrong, Chris; Wilkinson, Helen; Meade, Jessica; Biro, Dora; Freeman, Robin; Guilford, Tim] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Wilkinson, Helen] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Meade, Jessica] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Freeman, Robin] CoMPLEX, London, England	University of Oxford; Durham University; University of New South Wales Sydney; University of London; University College London	Guilford, T (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	tim.guilford@zoo.ox.ac.uk	Meade, Jessica/A-6411-2013; Meade, Jessica/O-7771-2019	Biro, Dora/0000-0002-3408-6274	Biotechnology and Biological Sciences Research Council studentship	Biotechnology and Biological Sciences Research Council studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded with the help of a Biotechnology and Biological Sciences Research Council studentship (Chris Armstrong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Able K.P., 1985, Contributions in Marine Science, V27, P516; ABLE KP, 1977, CONDOR, V79, P393, DOI 10.2307/1368027; BAKER RR, 1984, BIRD NAVIGATION SOLU; Biro D, 2002, J EXP BIOL, V205, P3833; Biro D, 2007, P NATL ACAD SCI USA, V104, P7471, DOI 10.1073/pnas.0701575104; Chappell J, 1997, J EXP BIOL, V200, P2269; FULLER E, 1983, J COMP PHYSIOL, V153, P55; Gagliardo A, 2005, J EXP BIOL, V208, P4002, DOI 10.1242/jeb.01851; Gagliardo A, 2005, J EXP BIOL, V208, P469, DOI 10.1242/jeb.01383; Gagliardo A, 1999, J NEUROSCI, V19, P311, DOI 10.1523/JNEUROSCI.19-01-00311.1999; Gagliardo A, 2009, BEHAV ECOL SOCIOBIOL, V64, P289, DOI 10.1007/s00265-009-0847-x; GRAUE LOUIS C., 1963, THE OHIO JOUR SCI, V63, P214; Holland R, 2000, IBIS, V142, P111, DOI 10.1111/j.1474-919X.2000.tb07690.x; Holland RA, 2003, J EXP BIOL, V206, P1773, DOI 10.1242/jeb.00365; Keeton W.T., 1974, Advances Study Behav, V5, P47, DOI 10.1016/S0065-3454(08)60020-0; Kramer G., 1953, Journal fuer Ornithologie, V94, P201, DOI 10.1007/BF01922508; MOORE FR, 1987, BIOL REV, V62, P65, DOI 10.1111/j.1469-185X.1987.tb00626.x; MURPHY PA, 1981, COPEIA, P638; Papi F., 1992, ANIMAL HOMING, DOI [DOI 10.1007/978-94-011-1588-9_1, 10.1007/978-94-011-1588-9_1]; Schmidt-Koenig K., 1961, Zeitschrift fuer Tierpsychologie, V18, P221; Thorup K, 2009, J EXP BIOL, V212, P3597, DOI 10.1242/jeb.021238; Wallraff HG, 1999, J EXP BIOL, V202, P2121; Wiltschko R, 2005, J EXP BIOL, V208, P4001, DOI 10.1242/jeb.01850; Wiltschko R, 2001, BEHAV ECOL SOCIOBIOL, V49, P393, DOI 10.1007/s002650000313; WILTSCHKO R, 1994, BEHAV ECOL SOCIOBIOL, V35, P63, DOI 10.1007/s002650050071; WILTSCHKO R, 1981, BEHAV ECOL SOCIOBIOL, V9, P135, DOI 10.1007/BF00293584; Wiltschko R, 2003, ANIM BEHAV, V65, P257, DOI 10.1006/anbe.2003.2054; WILTSCHKO W, 1976, BEHAV ECOL SOCIOBIOL, V1, P229, DOI 10.1007/BF00300066; WILTSCHKO W, 1983, COMP BIOCHEM PHYS A, V76, P709, DOI 10.1016/0300-9629(83)90132-9; Zimmerman PH, 2003, APPL ANIM BEHAV SCI, V80, P327, DOI 10.1016/S0168-1591(02)00233-2	30	9	9	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63130	10.1371/journal.pone.0063130	http://dx.doi.org/10.1371/journal.pone.0063130			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717401	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000319385300039
J	Domingo, L; Koch, PL; Fernandez, MH; Fox, DL; Domingo, MS; Alberdi, MT				Domingo, Laura; Koch, Paul L.; Hernandez Fernandez, Manuel; Fox, David L.; Domingo, M. Soledad; Teresa Alberdi, Maria			Late Neogene and Early Quaternary Paleoenvironmental and Paleoclimatic Conditions in Southwestern Europe: Isotopic Analyses on Mammalian Taxa	PLOS ONE			English	Article							MESSINIAN SALINITY CRISIS; LATE MIOCENE; DENTAL MICROWEAR; CLIMATIC CHANGES; CARBON; OXYGEN; RECONSTRUCTION; PHOSPHATE; PLEISTOCENE; EVOLUTION	Climatic and environmental shifts have had profound impacts on faunal and floral assemblages globally since the end of the Miocene. We explore the regional expression of these fluctuations in southwestern Europe by constructing long-term records (from similar to 11.1 to 0.8 Ma, late Miocene-middle Pleistocene) of carbon and oxygen isotope variations in tooth enamel of different large herbivorous mammals from Spain. Isotopic differences among taxa illuminate differences in ecological niches. The delta C-13 values (relative to VPDB, mean -10.3 +/- 1.1 parts per thousand; range -13.0 to -7.4 parts per thousand) are consistent with consumption of C-3 vegetation; C-4 plants did not contribute significantly to the diets of the selected taxa. When averaged by time interval to examine secular trends, delta C-13 values increase at similar to 9.5 Ma (MN9-MN10), probably related to the Middle Vallesian Crisis when there was a replacement of vegetation adapted to more humid conditions by vegetation adapted to drier and more seasonal conditions, and resulting in the disappearance of forested mammalian fauna. The mean delta C-13 value drops significantly at similar to 4.2-3.7 Ma (MN14-MN15) during the Pliocene Warm Period, which brought more humid conditions to Europe, and returns to higher delta C-13 values from similar to 2.6 Ma onwards (MN16), most likely reflecting more arid conditions as a consequence of the onset of the Northern Hemisphere glaciation. The most notable feature in oxygen isotope records (and mean annual temperature reconstructed from these records) is a gradual drop between MN13 and the middle Pleistocene (similar to 6.3-0.8 Ma) most likely due to cooling associated with Northern Hemisphere glaciation.	[Domingo, Laura; Koch, Paul L.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Hernandez Fernandez, Manuel] Univ Complutense Madrid, Dept Paleontol, Madrid, Spain; [Hernandez Fernandez, Manuel] CSIC, UCM, Inst Geociencias, Dept Cambio Medioambiental, Madrid, Spain; [Fox, David L.] Univ Minnesota, Dept Earth Sci, Minneapolis, MN USA; [Domingo, M. Soledad] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Teresa Alberdi, Maria] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain	University of California System; University of California Santa Cruz; Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO); University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Domingo, L (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	laudomingo@gmail.com	Alberdi, Maria Teresa/ABG-8623-2020; Domingo, Laura/J-6549-2012; Fernández, Manuel Hernández/I-5012-2013; Domingo, M. Soledad/I-1614-2014	Alberdi, Maria Teresa/0000-0002-7071-360X; Domingo, Laura/0000-0002-9062-0881; Fernández, Manuel Hernández/0000-0001-5640-9647; Domingo, M. Soledad/0000-0002-4755-8867; Fox, David L/0000-0002-2291-6146	UCM, Spanish Ministerio de Economia y Competitividad [CGL2009-09000/BTE, CGL2010-19116/BOS]; Personal Investigador de Apoyo contract (Comunidad de Madrid); Fundacion Espanola para la Ciencia y la Tecnologia-FECYT; Spanish Ministerio de Educacion; UCSC; FOCONTUR Project	UCM, Spanish Ministerio de Economia y Competitividad; Personal Investigador de Apoyo contract (Comunidad de Madrid)(Comunidad de Madrid); Fundacion Espanola para la Ciencia y la Tecnologia-FECYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministerio de Educacion(Spanish Government); UCSC; FOCONTUR Project	This study was supported by the UCM, Spanish Ministerio de Economia y Competitividad (Plan Nacional I+D project CGL2009-09000/BTE and Plan Nacional I+D and MNCN-CSIC project CGL2010-19116/BOS) and by a Personal Investigador de Apoyo contract (Comunidad de Madrid) to LD, postdoctoral fellowships (Fundacion Espanola para la Ciencia y la Tecnologia-FECYT and Spanish Ministerio de Educacion) to LD and MSD and a UCSC postdoctoral fellowship to LD. This work is a contribution from the research groups UCM-CAM 910161 "Geologic Record of Critical Periods: Paleoclimatic and Paleoenvironmental Factors" and UCM-CAM 910607 "Evolution of Cenozoic Mammals and Continental Palaeoenvironments". Some sampled teeth were found in excavations conducted by L. Alcala with the authorization of the Direccion General de Patrimonio Cultural del Gobierno de Aragon and supported by the FOCONTUR Project (Research Group E-62, Gobierno de Aragon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2003, J HUM EVOL, V45, P145, DOI 10.1016/S0047-2484(03)00091-5; Agusti J., 1990, Lecture Notes in Earth Sciences, V30, P425; Agusti J, 2001, QUATERNARY RES, V56, P411, DOI 10.1006/qres.2001.2269; Agustui J., 2002, MAMMOTHS SABERTOOTHS; Andeweg B., 2002, THESIS VRIJE U AMSTE; AXELROD DI, 1975, ANN MO BOT GARD, V62, P280, DOI 10.2307/2395199; Bassett D, 2007, PALAIOS, V22, P98, DOI 10.2110/palo.2005.p05-089r; BENDER MM, 1971, PHYTOCHEMISTRY, V10, P1239, DOI 10.1016/S0031-9422(00)84324-1; Bibi F, 2008, J VERTEBR PALEONTOL, V28, P501, DOI 10.1671/0272-4634(2008)28[501:BMAFTL]2.0.CO;2; Bohme M, 2011, PALAEOGEOGR PALAEOCL, V304, P212, DOI 10.1016/j.palaeo.2010.09.028; Bohme M, 2003, PALAEOGEOGR PALAEOCL, V195, P389, DOI 10.1016/S0031-0182(03)00367-5; Brugal JP, 2007, QUATERNAIRE, V18, P129; Bryant JD, 1996, GEOCHIM COSMOCHIM AC, V60, P5145; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Capozza M., 2001, WORLD ELEPHANTS, P529; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Croiter Roman, 2011, Acta Palaeontologica Romaniae, V7, P113; DEBRUIJN H, 1992, NEWSL STRATIGR, V26, P65; Domingo L, 2012, PALAEOGEOGR PALAEOCL, V339, P98, DOI 10.1016/j.palaeo.2012.04.026; Domingo L, 2009, NATURWISSENSCHAFTEN, V96, P503, DOI 10.1007/s00114-008-0500-y; Domingo L, 2009, PALAEOGEOGR PALAEOCL, V272, P53, DOI 10.1016/j.palaeo.2008.11.006; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; EHLERINGER JR, 1993, ANNU REV ECOL SYST, V24, P411, DOI 10.1146/annurev.es.24.110193.002211; EHLERINGER JR, 1991, TRENDS ECOL EVOL, V6, P95, DOI 10.1016/0169-5347(91)90183-X; Fakhar-i-Abbas F, 2008, ZOO BIOL, V27, P371, DOI 10.1002/zoo.20202; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fauquette S, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P481; Fauquette S, 1999, PALAEOGEOGR PALAEOCL, V152, P15, DOI 10.1016/S0031-0182(99)00031-0; Fauquette S, 2006, PALAEOGEOGR PALAEOCL, V238, P281, DOI 10.1016/j.palaeo.2006.03.029; Feranec R, 2010, PALAEOGEOGR PALAEOCL, V297, P263, DOI 10.1016/j.palaeo.2010.08.006; Filippi M. L., 2001, WORLD ELEPHANTS, P534; Fortelius M, 2006, PALAEOGEOGR PALAEOCL, V238, P219, DOI 10.1016/j.palaeo.2006.03.042; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; Cano ARG, 2011, PALAEOGEOGR PALAEOCL, V307, P193, DOI 10.1016/j.palaeo.2011.05.014; Guerin C, 1965, DOCUMENTS LAB GEOLOG, V1; Haug GH, 2005, NATURE, V433, P821, DOI 10.1038/nature03332; Haug GH, 2001, GEOLOGY, V29, P207, DOI 10.1130/0091-7613(2001)029<0207:ROPUOO>2.0.CO;2; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; Haywood AM, 2000, GEOLOGY, V28, P1063; Fernandez MH, 2006, J ARID ENVIRON, V66, P585, DOI 10.1016/j.jaridenv.2006.01.013; Fernandez MH, 2007, PALAEOGEOGR PALAEOCL, V251, P500, DOI 10.1016/j.palaeo.2007.04.015; Hernandez Fernandez Manuel, 2003, Coloquios de Paleontologia Volumen Extraordinario, V1, P253; Iacumin P, 1996, EARTH PLANET SC LETT, V142, P1, DOI 10.1016/0012-821X(96)00093-3; Jimenez-Moreno G, 2007, PALAEOGEOGR PALAEOCL, V253, P208, DOI 10.1016/j.palaeo.2007.03.040; Jimenez-Moreno G, 2010, REV PALAEOBOT PALYNO, V162, P403, DOI 10.1016/j.revpalbo.2009.08.001; Koch PL, 2007, ECOL METHOD CONCEPT, P99, DOI 10.1002/9780470691854.ch5; Koch PL, 1998, ANNU REV EARTH PL SC, V26, P573, DOI 10.1146/annurev.earth.26.1.573; Koch PL, 2004, PALAEOGEOGR PALAEOCL, V207, P331, DOI 10.1016/j.palaeo.2003.09.034; KOCH PL, 1995, PALAEOGEOGR PALAEOCL, V115, P61, DOI 10.1016/0031-0182(94)00107-J; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Kohn MJ, 2005, GEOLOGY, V33, P649, DOI 10.1130/G21476.1; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lee-Thorp JA, 1987, S AFR J SCI, V83, P71; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; LONGINELLI A, 1973, EARTH PLANET SC LETT, V19, P373, DOI 10.1016/0012-821X(73)90088-5; MARINO BD, 1991, NATURE, V349, P127, DOI 10.1038/349127a0; Matson SD, 2012, J HUM EVOL, V63, P127, DOI 10.1016/j.jhevol.2012.04.004; Matson SD, 2010, PALAEOGEOGR PALAEOCL, V287, P28, DOI 10.1016/j.palaeo.2009.12.010; MEIN P, 1979, ANN GEOL PAYS HELL, V3, P1367; MEIN P, 1990, EUROPEAN NEOGENE MAM, P73, DOI DOI 10.1007/978-1-4899-2513-8_6; Mein P., 1975, P 6 C REG COMM MED N, P77; Mein Pierre, 1999, P25; Merceron G, 2004, PALAEOGEOGR PALAEOCL, V207, P143, DOI 10.1016/j.palaeo.2004.02.008; Merceron G, 2005, PALAEOGEOGR PALAEOCL, V217, P173, DOI 10.1016/j.palaeo.2004.11.019; Merceron G, 2006, PALAEOGEOGR PALAEOCL, V241, P637, DOI 10.1016/j.palaeo.2006.05.005; Micheels A, 2011, PALAEOGEOGR PALAEOCL, V304, P337, DOI 10.1016/j.palaeo.2010.09.021; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; O'Neil J.R., 1994, ISR J EARTH SCI, V43, P203; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Osborne CP, 2008, J ECOL, V96, P35, DOI 10.1111/j.1365-2745.2007.01323.x; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; Palmqvist P, 2008, PALAIOS, V23, P724, DOI 10.2110/palo.2007.p07-073r; Palombo MR, 2005, QUATERN INT, V126, P153, DOI 10.1016/j.quaint.2004.04.020; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Rivals F, 2008, PALAEOGEOGR PALAEOCL, V265, P134, DOI 10.1016/j.palaeo.2008.05.001; Rouchy JM, 2006, SEDIMENT GEOL, V188, P35, DOI 10.1016/j.sedgeo.2006.02.005; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; Sanz de Galdeano C.M., 1996, TERTIARY BASINS SPAI, P9, DOI [10.1017/CBO9780511524851.006, DOI 10.1017/CBO9780511524851.006]; Domingo MS, 2007, PALAEOGEOGR PALAEOCL, V255, P361, DOI 10.1016/j.palaeo.2007.08.004; Solounias N, 1995, J VERTEBR PALEONTOL, V15, P795, DOI 10.1080/02724634.1995.10011262; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Suc Jean-Pierre, 1995, Acta Zoologica Cracoviensia, V38, P3; Tassy P., 1994, GEOLOGY PALAEOBIOLOG, VII, P217; Tipple BJ, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001851; Tzedakis PC, 2007, QUATERNARY SCI REV, V26, P2042, DOI 10.1016/j.quascirev.2007.03.014; Urban MA, 2010, GEOLOGY, V38, P1091, DOI 10.1130/G31117.1; van Dam JA, 2009, PALAEOGEOGR PALAEOCL, V274, P64, DOI 10.1016/j.palaeo.2008.12.022; Van Dam JA, 2001, J VERTEBR PALEONTOL, V21, P367, DOI 10.1671/0272-4634(2001)021[0367:TUMMRF]2.0.CO;2; van Dam JA, 2006, PALAEOGEOGR PALAEOCL, V238, P190, DOI 10.1016/j.palaeo.2006.03.025; Van der Meulen AJ, 2012, GEOL ACTA, V10, P159, DOI 10.1344/105.000001710; Vislobokova Inessa, 2005, Annales de Paleontologie, V91, P241, DOI 10.1016/j.annpal.2005.04.001; Vizcaino M, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001733; Westerhold T, 2005, PALAEOGEOGR PALAEOCL, V217, P205, DOI 10.1016/j.palaeo.2004.12.001; WHITE F, 1983, VEGETATION AFRICA NA, V20; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P2245, DOI 10.1016/j.gca.2003.11.009	101	59	59	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63739	10.1371/journal.pone.0063739	http://dx.doi.org/10.1371/journal.pone.0063739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717470	Green Published, gold, Green Accepted			2022-12-27	WOS:000319435600029
J	Minneci, F; Piovesan, D; Cozzetto, D; Jones, DT				Minneci, Federico; Piovesan, Damiano; Cozzetto, Domenico; Jones, David T.			FFPred 2.0: Improved Homology-Independent Prediction of Gene Ontology Terms for Eukaryotic Protein Sequences	PLOS ONE			English	Article							ANNOTATION; GLYCOSYLATION; DATABASE	To understand fully cell behaviour, biologists are making progress towards cataloguing the functional elements in the human genome and characterising their roles across a variety of tissues and conditions. Yet, functional information -either experimentally validated or computationally inferred by similarity -remains completely missing for approximately 30% of human proteins. FFPred was initially developed to bridge this gap by targeting sequences with distant or no homologues of known function and by exploiting clear patterns of intrinsic disorder associated with particular molecular activities and biological processes. Here, we present an updated and improved version, which builds on larger datasets of protein sequences and annotations, and uses updated component feature predictors as well as revised training procedures. FFPred 2.0 includes support vector regression models for the prediction of 442 Gene Ontology (GO) terms, which largely expand the coverage of the ontology and of the biological process category in particular. The GO term list mainly revolves around macromolecular interactions and their role in regulatory, signalling, developmental and metabolic processes. Benchmarking experiments on newly annotated proteins show that FFPred 2.0 provides more accurate functional assignments than its predecessor and the ProtFun server do; also, its assignments can complement information obtained using BLAST-based transfer of annotations, improving especially prediction in the biological process category. Furthermore, FFPred 2.0 can be used to annotate proteins belonging to several eukaryotic organisms with a limited decrease in prediction quality. We illustrate all these points through the use of both precision-recall plots and of the COGIC scores, which we recently proposed as an alternative numerical evaluation measure of function prediction accuracy.	[Minneci, Federico; Cozzetto, Domenico; Jones, David T.] UCL, Dept Comp Sci, Bioinformat Grp, London, England; [Piovesan, Damiano] Univ Bologna, Dept Biol, Biocomp Grp, I-40126 Bologna, Italy	University of London; University College London; University of Bologna	Jones, DT (corresponding author), UCL, Dept Comp Sci, Bioinformat Grp, London, England.	d.t.jones@ucl.ac.uk	Piovesan, Damiano/H-4675-2016; Cozzetto, Domenico/Y-6345-2019; Piovesan, Damiano/K-7647-2019	Piovesan, Damiano/0000-0001-8210-2390; Piovesan, Damiano/0000-0001-8210-2390; Cozzetto, Domenico/0000-0001-6752-5432	United Kingdom Biotechnology and Biological Sciences Research Council [BB/I023992/1, BB/J002925/1]; Ministry of the Italian University and Research; Marie Curie Intra European Fellowship [PIEF-GA-2009-237292]; Biotechnology and Biological Sciences Research Council [BB/J002925/1, BB/I023992/1] Funding Source: researchfish; BBSRC [BB/I023992/1, BB/J002925/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of the Italian University and Research; Marie Curie Intra European Fellowship(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	FM & DTJ would like to acknowledge support from the United Kingdom Biotechnology and Biological Sciences Research Council (Reference BB/I023992/1). DP is a recipient of a PHD fellowship from the Ministry of the Italian University and Research. DC would like to acknowledge partial support from the United Kingdom Biotechnology and Biological Sciences Research Council (Reference BB/J002925/1) and from a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (Grant Agreement Number: PIEF-GA-2009-237292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cozzetto D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S1; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Jensen LJ, 2003, BIOINFORMATICS, V19, P635, DOI 10.1093/bioinformatics/btg036; Jensen LJ, 2002, J MOL BIOL, V319, P1257, DOI 10.1016/S0022-2836(02)00379-0; JOACHIMS T, 1999, MAKING LARGE SCALE S; Jones DT, 2002, TRENDS BIOCHEM SCI, V27, P161, DOI 10.1016/S0968-0004(01)02039-4; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Juncker AS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-206; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin HT, 2007, MACH LEARN, V68, P267, DOI 10.1007/s10994-007-5018-6; Lobley AE, 2008, NUCLEIC ACIDS RES, V36, pW297, DOI 10.1093/nar/gkn193; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Mostafavi S, 2012, PROTEOMICS, V12, P1687, DOI 10.1002/pmic.201100607; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Platt JC, 2000, ADV NEUR IN, P61; RADIVOJAC P, 2013, NAT METH; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rogers MF, 2009, BIOINFORMATICS, V25, P1173, DOI 10.1093/bioinformatics/btp122; Theodoridis S, 2008, PATTERN RECOGN, P119; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wilkins AD, 2012, CURR OPIN STRUC BIOL, V22, P316, DOI 10.1016/j.sbi.2012.05.001	34	37	37	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63754	10.1371/journal.pone.0063754	http://dx.doi.org/10.1371/journal.pone.0063754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717476	Green Published, gold, Green Submitted			2022-12-27	WOS:000320362700054
J	Chen, X; Du, YP; Nan, J; Zhang, XX; Qin, XD; Wang, YX; Hou, JW; Wang, Q; Yang, JB				Chen, Xing; Du, Yuping; Nan, Jing; Zhang, Xinxin; Qin, Xiaodong; Wang, Yuxin; Hou, Jianwen; Wang, Qin; Yang, Jinbo			Brevilin A, a Novel Natural Product, Inhibits Janus Kinase Activity and Blocks STAT3 Signaling in Cancer Cells	PLOS ONE			English	Article							CONSTITUTIVE ACTIVATION; TYROSINE KINASE; SUPPRESSES GROWTH; HUMAN BREAST; LUNG-CANCER; APOPTOSIS; MUTATION; JAK2; SRC; PATHWAY	Signal abnormalities in human cells usually cause unexpected consequences for individual health. We focus on these kinds of events involved in JAK-STAT signal pathways, especially the ones triggered by aberrant activated STAT3, an oncoprotein which participates in essential processes of cell survival, growth and proliferation in many types of tumors, as well as immune diseases. By establishing a STAT3 signal based high-throughput drug screening system in human lung cancer A549 cells, we have screened a library from natural products which contained purified compounds from medicinal herbs. One compound, named Brevilin A, exhibited both strong STAT3 signal inhibition and STAT3 signal dependent cell growth inhibition. Further investigations revealed that Brevilin A not only inhibits STAT3 signaling but also STAT1 signaling for cytokines induced phosphorylation of STAT3 and STAT1 as well as the expression of their target genes. In addition, we found Brevilin A could attenuate the JAKs activity by blocking the JAKs tyrosine kinase domain JH1. The levels of cytokine induced phosphorylation of STATs and other substrates were dramatically reduced by treatment of Brevilin A. The roles of Brevilin A targeting on JAKs activity indicate that Brevilin A may not only be used as a STAT3 inhibitor but also a compound blocking other JAK-STAT hyperactivation. Thus, these findings provided a strong impetus for the development of selective JAK-STAT inhibitors and therapeutic drugs in order to improve survival of patients with hyperactivated JAKs and STATs.	[Chen, Xing; Du, Yuping; Nan, Jing; Zhang, Xinxin; Qin, Xiaodong; Wang, Yuxin; Hou, Jianwen; Wang, Qin; Yang, Jinbo] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China; [Yang, Jinbo] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44106 USA	Lanzhou University; Cleveland Clinic Foundation	Yang, JB (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China.	yangjb@lzu.edu.cn	Yang, Jinbo/AAM-9580-2020		The Science and Technology Support Project of Gansu Providence [1104FK CA123]; Ministry of Science and Technology of the People's Republic of China [2009DFA30990]; Gansu Provincial Science and Technology [0708WCGA149]; National Natural Science Foundation of China [2009AA01A130]	The Science and Technology Support Project of Gansu Providence; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Gansu Provincial Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 1104FK CA123 from The Science and Technology Support Project of Gansu Providence to Q.W.; 2009DFA30990 from the Ministry of Science and Technology of the People's Republic of China, 0708WCGA149 from the Gansu Provincial Science and Technology and 2009AA01A130 from National Natural Science Foundation of China to J.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Chau MN, 2008, BIOCHEM BIOPH RES CO, V377, P627, DOI 10.1016/j.bbrc.2008.10.025; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; FALLON RJ, 1990, BIOCHEM BIOPH RES CO, V170, P1191, DOI 10.1016/0006-291X(90)90519-S; Foster NI, 1982, AM J CLIN ONCOL-CANC, V5, P331; Garber K, 2011, NAT BIOTECHNOL, V29, P467, DOI 10.1038/nbt0611-467; Garcia R, 1998, J BIOMED SCI, V5, P79, DOI 10.1159/000025316; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; He JX, 2012, J BIOSCIENCES, V37, P243, DOI 10.1007/s12038-012-9202-x; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kusaba T, 2006, ONCOL REP, V15, P1445; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lee SO, 2004, PROSTATE, V60, P303, DOI 10.1002/pros.20072; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li C, 2008, WANFANG MED ONLINE; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Liu BH, 2010, INT IMMUNOPHARMACOL, V10, P1608, DOI 10.1016/j.intimp.2010.09.017; Mora LB, 2002, CANCER RES, V62, P6659; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Murakami Y, 1998, J CELL PHYSIOL, V175, P220, DOI 10.1002/(SICI)1097-4652(199805)175:2<220::AID-JCP12>3.0.CO;2-C; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; Ni Z, 2000, CANCER RES, V60, P1225; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Niu GL, 1999, CANCER RES, V59, P5059; Okamoto M, 1997, CANCER RES, V57, P141; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Porcu M, 2009, HAEMATOL-HEMATOL J, V94, P435, DOI 10.3324/haematol.13587; Rahaman SO, 2002, ONCOGENE, V21, P8404, DOI 10.1038/sj.onc.1206047; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Shin DS, 2009, CANCER RES, V69, P193, DOI 10.1158/0008-5472.CAN-08-2575; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Weerasinghe P, 2007, INT J ONCOL, V31, P129; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020965	52	37	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63697	10.1371/journal.pone.0063697	http://dx.doi.org/10.1371/journal.pone.0063697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704931	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200062
J	Lopes, AL; Botelho, LM				Lopes, Antonio Luis; Botelho, Luis Miguel			Distributed Coordination of Heterogeneous Agents Using a Semantic Overlay Network and a Goal-Directed Graphplan Planner	PLOS ONE			English	Article							SERVICE	In this paper, we describe a distributed coordination system that allows agents to seamlessly cooperate in problem solving by partially contributing to a problem solution and delegating the subproblems for which they do not have the required skills or knowledge to appropriate agents. The coordination mechanism relies on a dynamically built semantic overlay network that allows the agents to efficiently locate, even in very large unstructured networks, the necessary skills for a specific problem. Each agent performs partial contributions to the problem solution using a new distributed goal-directed version of the Graphplan algorithm. This new goal-directed version of the original Graphplan algorithm provides an efficient solution to the problem of "distraction", which most forward-chaining algorithms suffer from. We also discuss a set of heuristics to be used in the backward-search process of the planning algorithm in order to distribute this process amongst idle agents in an attempt to find a solution in less time. The evaluation results show that our approach is effective in building a scalable and efficient agent society capable of solving complex distributable problems.	[Lopes, Antonio Luis; Botelho, Luis Miguel] Inst Univ Lisboa ISCTE IUL, Inst Telecomunicacoes, Lisbon, Portugal	Instituto de Telecomunicacoes; Instituto Universitario de Lisboa	Lopes, AL (corresponding author), Inst Univ Lisboa ISCTE IUL, Inst Telecomunicacoes, Lisbon, Portugal.	alsl@iscte.pt	Lopes, António/B-2934-2012	Lopes, António/0000-0003-3045-0304; Botelho, Luis Miguel/0000-0001-7154-8362	Portuguese Foundation for Science and Technology [SFRH/BD/27533/2006, PTDC/EEACRO/104658/2008, PEst-OE/EEI/LA0008/2011]; ISCTE-Instituto Universitario de Lisboa; Instituto de Telecomunicacoes	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); ISCTE-Instituto Universitario de Lisboa; Instituto de Telecomunicacoes	This work described in the paper has been supported by the Portuguese Foundation for Science and Technology (http://alfa.fct.mctes.pt/index.phtml.en) under the scholarship grant SFRH/BD/27533/2006 and the grants PTDC/EEACRO/104658/2008 and PEst-OE/EEI/LA0008/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the support of ISCTE-Instituto Universitario de Lisboa and Instituto de Telecomunicacoes.	Abdallah S, 2004, IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON INTELLIGENT AGENT TECHNOLOGY, PROCEEDINGS, P162, DOI 10.1109/IAT.2004.1342939; Anderson C, 1998, P 4 INT C AI PLANN S; Ben-Ami D., 2005, P 4 INT JOINT C AUT, P339; Blum AL, 1997, ARTIF INTELL, V90, P281, DOI 10.1016/S0004-3702(96)00047-1; Botelho LM, 2008, WHITESTEIN SER SOFTW, P263, DOI 10.1007/978-3-7643-8575-0_12; Chatalic P, 2006, J ARTIFICIAL INTELLI, V25, P5; Costa P, 2008, WHITESTEIN SER SOFTW, P289, DOI 10.1007/978-3-7643-8575-0_13; Cox J, 2005, P AAMAS05, P821, DOI [10.1145/1082473.1082598, DOI 10.1145/1082473.1082598.URL]; Crespo A, 2005, LECT NOTES ARTIF INT, V3601, P1, DOI 10.1007/11574781_1; Crespo A, 2002, INT CON DISTR COMP S, P23, DOI 10.1109/ICDCS.2002.1022239; de Weerdt M., 2007, P 6 INT JOINT C AUT; DURFEE EH, 1991, IEEE T SYST MAN CYB, V21, P1167, DOI 10.1109/21.120067; Elahi M, 2003, MAICS, P18; FIKES RE, 1971, ARTIF INTELL, V2, P189, DOI 10.1016/0004-3702(71)90010-5; Fung RYK, 2005, INT J ADV MANUF TECH, V25, P811, DOI 10.1007/s00170-003-1900-y; Gaston M. E., 2005, P 4 INT JOINT C AUTO, P230; Iwen M, 2002, PROC INT C TOOLS ART, P138, DOI 10.1109/TAI.2002.1180798; Jamali N, 2005, LECT NOTES ARTIF INT, V3446, P40; Kalogeraki V., 2002, Proceedings of the Eleventh International Conference on Information and Knowledge Management. CIKM 2002, P300, DOI 10.1145/584792.584842; Kambhampati S., 1997, Recent Advances in AI Planning. 4th European Conference on Planning, ECP'97 Proceedings, P260, DOI 10.1007/3-540-63912-8_91; Lopes A, 2008, AAMAS WORKSH AG PEER; Lopes Antonio L., 2008, Journal of Networks, V3, P38, DOI 10.4304/jnw.3.2.38-47; Lopes AL, 2007, LECT NOTES COMPUT SC, V4504, P1; Lv Q., 2002, Performance Evaluation Review, V30, P258, DOI 10.1145/511399.511369; Ogston E., 2002, Proceedings of the First International Joint Conference on Autonomous Agents and Multiagent Systems, P151; Pellier D, 2010, ICAART 2010: PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON AGENTS AND ARTIFICIAL INTELLIGENCE, VOL 2: AGENTS, P128; Peot M, 1996, P 3 INT C ART INT PL; Risson J, 2006, COMPUT NETW, V50, P3485, DOI 10.1016/j.comnet.2006.02.001; ROWSTRON A., IFIP ACM INT C DISTR, P329, DOI DOI 10.1007/3-540-45518-3_18; Sacerdoti E, 1975, P 4 INT JOINT C ART, P206; Shoham Y., 1992, P AAAI 92, P276; Stoica I, 2001, ACM SIGCOMM COMP COM, V31, P149, DOI 10.1145/964723.383071; ter Mors A, 2004, IC-AI '04 & MLMTA'04 , VOL 1 AND 2, PROCEEDINGS, P795; Tsoumakos D, 2003, THIRD INTERNATIONAL CONFERENCE ON PEER-TO-PEER COMPUTING (P2P2003), PROCEEDINGS, P102, DOI 10.1109/PTP.2003.1231509; Walsh W. E., 2000, EC'00. Proceedings of the 2nd ACM Conference on Electronic Commerce, P260, DOI 10.1145/352871.352900; Walsh W.E., 1999, P 3 INT C MULT AG SY, P325; Weld D. S., 1999, AI Magazine, V20, P93; Weld DS, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P897; Wellman MP, 1993, J ARTIF INTELL RES, V1, P1; Wellman MP, 2001, GAME ECON BEHAV, V35, P271, DOI 10.1006/game.2000.0822; Yang B., 2002, P INT C DISTR COMP S; Zhao B. Y., 2001, TECHNICAL REPORT	42	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62931	10.1371/journal.pone.0062931	http://dx.doi.org/10.1371/journal.pone.0062931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704885	gold, Green Published			2022-12-27	WOS:000319330200014
J	Metting, Z; Cerliani, L; Rodiger, LA; van der Naalt, J				Metting, Zwany; Cerliani, Leonardo; Rodiger, Lars A.; van der Naalt, Joukje			Pathophysiological Concepts in Mild Traumatic Brain Injury: Diffusion Tensor Imaging Related to Acute Perfusion CT Imaging	PLOS ONE			English	Article							HEAD-INJURY; DAMAGE; DYSFUNCTION; IMPAIRMENT	Background: A subgroup of patients with mild traumatic brain injury (TBI) experiences residual symptoms interfering with their return to work. The pathophysiological substrate of the suboptimal outcome in these patients is a source of debate. Objective: To provide greater insight into the pathophysiological mechanisms of mild TBI. Methods: Diffusion tensor imaging (DTI) was performed during follow-up of 18 patients with mild TBI and compared with healthy control subjects. DTI data of the patient group were also compared with perfusion CT imaging in the acute phase of injury. Results: In patients with mild TBI, a trend was observed for a decreased fractional anisotropy (FA) in widespread bilateral frontal white matter areas with increased mean diffusivity (MD) in the parieto-temporal regions, compared to healthy control subjects. Cerebral blood volume (CBV) correlated significantly with FA in several white matter tracts including the corpus callosum, the internal capsule, the inferior fronto-occipital fascicle, the corticospinal tract, the superior and the inferior longitudinal fascicle. Conclusion: In mild TBI with normal conventional imaging significant associations between cerebral perfusion in the acute phase of injury and DTI analyses in the chronic phase of injury were discerned. The pathophysiological concept of these findings is being outlined.	[Metting, Zwany; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands; [Cerliani, Leonardo] Univ Groningen, NeuroImaging Ctr, Groningen, Netherlands; [Cerliani, Leonardo] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Rodiger, Lars A.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Groningen	Metting, Z (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands.	z.metting@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418; cerliani, leonardo/0000-0002-2655-6133	ZonMw, Den Haag, The Netherlands [39200002]; NWO MaGW Open competition grant [400-08-089]; NIHC grant [056-13-017]	ZonMw, Den Haag, The Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government); NWO MaGW Open competition grant; NIHC grant	This study was funded by ZonMw, Den Haag, The Netherlands (grant number 39200002). In addition, L. Cerliani is supported by an NWO MaGW Open competition grant (grant number 400-08-089) and by an NIHC grant (grant number 056-13-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Ueda Y, 2006, ACTA NEUROPATHOL, V112, P85, DOI 10.1007/s00401-005-0029-5; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	20	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64461	10.1371/journal.pone.0064461	http://dx.doi.org/10.1371/journal.pone.0064461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704986	Green Published, Green Submitted, gold			2022-12-27	WOS:000319330200139
J	Ou, LJ; Zhang, ZQ; Dai, XZ; Zou, XX				Ou, Li-jun; Zhang, Zhu-qing; Dai, Xiong-ze; Zou, Xue-xiao			Photooxidation Tolerance Characters of a New Purple Pepper	PLOS ONE			English	Article							PHOTOINHIBITION; STRESS; PHOTOSYNTHESIS; INACTIVATION; ACCLIMATION; SYSTEM; FIELD	Huai Zi (HZ) is a new purple mutant of green pepper (PI 631133) that is obtained from the United States Department of Agriculture. The net photosynthetic rate (P-N), chlorophyll fluorescence parameters, antioxidant substances, antioxidant enzymes, photosystem 1 (PS1) and PS2 activities were studied through methyl viologen (MV) treatment. The results showed that the P-N, actual photochemical efficiency of PS2 (Phi PS2), photochemical quenching coefficient (q(P)), PS1 and PS2 activities in HZ were lower than those in green pepper. HZ had a stronger ability to eliminate reactive oxygen species(O-2(center dot-)) and accumulated less malondialdehyde (MDA) (a membrane lipid peroxidation product) than did green pepper, and had a higher content of antioxidants and antioxidant enzyme activity. This suggests that the lower light energy absorption and higher thermal dissipation and antioxidant activity of HZ contributed to a more stable PS2 photosynthetic capacity, which resulted in photooxidation tolerance. Hence, our study strongly suggests that pepper hybrids can achieve a modest ratio of chlorophyll and anthocyanin content, high P-N and resistance to photooxidation, improving yield and resistance to adverse environments.	[Ou, Li-jun; Zhang, Zhu-qing; Dai, Xiong-ze; Zou, Xue-xiao] Hunan Acad Agr Sci, Vegetable Inst, Changsha, Hunan, Peoples R China; [Ou, Li-jun] Huaihua Univ, Key Lab Hunan Prov Study & Utilizat Ethn Med Plan, Huaihua, Hunan, Peoples R China; [Ou, Li-jun] Huaihua Univ, Dept Life Sci, Huaihua, Hunan, Peoples R China	Hunan Academy of Agricultural Sciences; Huaihua University; Huaihua University	Zou, XX (corresponding author), Hunan Acad Agr Sci, Vegetable Inst, Changsha, Hunan, Peoples R China.	zou_xuexiao@163.com			China Agriculture Research System [CARS-25-A-8]; construct program of the key discipline in Hunan province	China Agriculture Research System; construct program of the key discipline in Hunan province	This work was supported by China Agriculture Research System (CARS-25-A-8) and the construct program of the key discipline in Hunan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1997, PHYSIOL PLANTARUM, V100, P214, DOI 10.1034/j.1399-3054.1997.1000202.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Azevedo GFC, 2012, PHOTOSYNTHETICA, V50, P86, DOI 10.1007/s11099-012-0001-2; Bahler D., 1991, HORTSCIENCE, V26, P736; Baltscheffsky M., 1990, CURRENT RES PHOTOSYN, VII, P447; Bovy A, 2007, METABOLOMICS, V3, P399, DOI 10.1007/s11306-007-0074-2; Domingues N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038162; Dong YanXiang, 2007, Acta Horticulturae Sinica, V34, P1595; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; [高玉 GAO Yu], 2009, [生态学报, Acta Ecologica Sinica], V29, P3335; Garcia-Limones C, 2002, PHYSIOL MOL PLANT P, V61, P325, DOI 10.1006/pmpp.2003.0445; Hendrickson L, 2004, PHOTOSYNTH RES, V82, P73, DOI 10.1023/B:PRES.0000040446.87305.f4; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Jiang WeiBing, 2006, Acta Horticulturae Sinica, V33, P577; Jiao DM, 2001, PHOTOSYNTHETICA, V39, P167, DOI 10.1023/A:1013758504857; Kruger GHJ, 1997, PHYSIOL PLANTARUM, V101, P265, DOI 10.1034/j.1399-3054.1997.1010203.x; Li HongWei, 2010, Acta Agronomica Sinica, V36, P449, DOI 10.3724/SP.J.1006.2010.00449; Li M, 2007, PHOTOSYNTHETICA, V45, P222, DOI 10.1007/s11099-007-0036-y; Li XG, 2004, PHOTOSYNTHETICA, V42, P257, DOI 10.1023/B:PHOT.0000040598.48732.af; Lin ZF, 2009, PHOTOSYNTHETICA, V47, P46, DOI 10.1007/s11099-009-0009-4; Lin ZhiFang, 1999, Acta Agronomica Sinica, V25, P284; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Millaleo R, 2013, J EXP BOT, V64, P343, DOI 10.1093/jxb/ers339; Murchie EH, 1999, PLANT PHYSIOL, V119, P553, DOI 10.1104/pp.119.2.553; NAKANO Y, 1987, PLANT CELL PHYSIOL, V28, P131; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; OGREN E, 1992, PHOTOSYNTH RES, V33, P63, DOI 10.1007/BF00032983; Rao DM, 2003, PHOTOSYNTHETICA, V41, P33, DOI 10.1023/A:1025848110029; Solecka D, 1997, ACTA PHYSIOL PLANT, V19, P257, DOI 10.1007/s11738-997-0001-1; Sui XiaoLei, 2005, Acta Horticulturae Sinica, V32, P222; [隋益虎 Sui Yihu], 2009, [食品与发酵工业, Food and Fermentation Industries], V35, P162; [隋益虎 Sui Yihu], 2005, [种子, Seed], V24, P19; [隋益虎 Sui Yihu], 2004, [植物生理学通讯, Plant Physiology Communications], V40, P693; TANAKA K, 1985, PLANT CELL PHYSIOL, V26, P1425; Teng Y.D., 1997, CHINA VEG, V17, P29; Wang A. G., 1990, PLANT PHYSL COMMUN, V6, P55, DOI DOI 10.1021/ja00874a010; Wang MeiLing, 2008, Acta Horticulturae Sinica, V35, P547; Wu HanYing, 2001, Acta Horticulturae Sinica, V28, P517; Xue YiXia, 2010, Acta Horticulturae Sinica, V37, P397; Yong ZH, 2007, PHOTOSYNTHETICA, V45, P85, DOI 10.1007/s11099-007-0013-5; Zhang Qi'an, 2005, China Vegetables, P36; Zhou HK, 2005, J CHIN CAPS, V5, P28	43	7	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63593	10.1371/journal.pone.0063593	http://dx.doi.org/10.1371/journal.pone.0063593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704924	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200055
J	Wang, YC; Tseng, HL; Lin, YH; Kao, CH; Huang, WC; Huang, TC				Wang, Yao-Ching; Tseng, Hsun-Lin; Lin, Yang-Hsien; Kao, Chia-Hung; Huang, Wei-Chien; Huang, Tzung-Chi			Improvement of Internal Tumor Volumes of Non-Small Cell Lung Cancer Patients for Radiation Treatment Planning Using Interpolated Average CT in PET/CT	PLOS ONE			English	Article							4-DIMENSIONAL COMPUTED-TOMOGRAPHY; ATTENUATION CORRECTION; TARGET VOLUME; RADIOTHERAPY; DELINEATION; IMAGES; MOTION; DEFINITION	Respiratory motion causes uncertainties in tumor edges on either computed tomography (CT) or positron emission tomography (PET) images and causes misalignment when registering PET and CT images. This phenomenon may cause radiation oncologists to delineate tumor volume inaccurately in radiotherapy treatment planning. The purpose of this study was to analyze radiology applications using interpolated average CT (IACT) as attenuation correction (AC) to diminish the occurrence of this scenario. Thirteen non-small cell lung cancer patients were recruited for the present comparison study. Each patient had full-inspiration, full-expiration CT images and free breathing PET images by an integrated PET/CT scan. IACT for AC in PETIACT was used to reduce the PET/CT misalignment. The standardized uptake value (SUV) correction with a low radiation dose was applied, and its tumor volume delineation was compared to those from HCT/PETHCT. The misalignment between the PETIACT and IACT was reduced when compared to the difference between PETHCT and HCT. The range of tumor motion was from 4 to 17 mm in the patient cohort. For HCT and PETHCT, correction was from 72% to 91%, while for IACT and PETIACT, correction was from 73% to 93% (*p<0.0001). The maximum and minimum differences in SUVmax were 0.18% and 27.27% for PETHCT and PETIACT, respectively. The largest percentage differences in the tumor volumes between HCT/PET and IACT/PET were observed in tumors located in the lowest lobe of the lung. Internal tumor volume defined by functional information using IACT/PETIACT fusion images for lung cancer would reduce the inaccuracy of tumor delineation in radiation therapy planning.	[Wang, Yao-Ching] China Med Univ Hosp, Div Radiat Oncol, Taichung, Taiwan; [Tseng, Hsun-Lin; Lin, Yang-Hsien; Huang, Tzung-Chi] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Tseng, Hsun-Lin] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015; Huang, Wei-Chien/H-3126-2019; Huang, Wei-Chien/D-1740-2012	Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716	China Medical University	China Medical University(China Medical University)	This study was financially supported by China Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristophanous M, 2012, INT J RADIAT ONCOL, V82, pe99, DOI [10.1016/j.ijrobp.2010.12.060, DOI 10.1016/J.IJR0BP.2010.12.060]; Ashamalla H, 2005, INT J RADIAT ONCOL, V63, P1016, DOI 10.1016/j.ijrobp.2005.04.021; Bradley J, 2004, INT J RADIAT ONCOL, V59, P78, DOI 10.1016/j.ijrobp.2003.10.044; Britton KR, 2007, INT J RADIAT ONCOL, V68, P1036, DOI 10.1016/j.ijrobp.2007.01.021; Ekberg L, 1998, RADIOTHER ONCOL, V48, P71, DOI 10.1016/S0167-8140(98)00046-2; Hatt M, 2012, PHYS MED BIOL, V57, P7409, DOI 10.1088/0031-9155/57/22/7409; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Huang TC, 2011, PHYS MED BIOL, V56, P2559, DOI 10.1088/0031-9155/56/8/014; Kao CH, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-76; Liu HH, 2007, INT J RADIAT ONCOL, V68, P531, DOI 10.1016/j.ijrobp.2006.12.066; Mok GSP, 2013, IEEE T BIO-MED ENG, V60, P1927, DOI 10.1109/TBME.2013.2245132; Nehmeh SA, 2002, J NUCL MED, V43, P876; Pan TS, 2005, J NUCL MED, V46, P1481; Steenbakkers RJHM, 2006, INT J RADIAT ONCOL, V64, P435, DOI 10.1016/j.ijrobp.2005.06.034; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Van Baardwijk A, 2007, INT J RADIAT ONCOL, V68, P771, DOI 10.1016/j.ijrobp.2006.12.067	16	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64665	10.1371/journal.pone.0064665	http://dx.doi.org/10.1371/journal.pone.0064665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696903	Green Published, Green Submitted, gold			2022-12-27	WOS:000319081900105
J	Cheng, LM; Sage, EH; Yan, Q				Cheng, Lamei; Sage, E. Helene; Yan, Qi			SPARC Fusion Protein Induces Cellular Adhesive Signaling	PLOS ONE			English	Article							GROWTH-FACTOR; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; FOCAL ADHESIONS; MELANOMA-CELLS; DNA-SYNTHESIS; LENS CAPSULE; IN-VITRO; BINDING; ATTACHMENT	Secreted protein, acidic and rich in cysteine (SPARC) has been described as a counteradhesive matricellular protein with a diversity of biological functions associated with morphogenesis, remodeling, cellular migration, and proliferation. We have produced mouse SPARC with a FLAG-tag at the N-terminus of SPARC (Flag-SPARC, FSP) in a Bac-to-Bac baculoviral expression system. After affinity purification, this procedure yields SPARC of high purity, with an electrophoretic mobility of similar to 44 kDa under reducing conditions, and similar to 38-39 kDa under non-reducing conditions. Unexpectedly, FSP adsorbed to plastic supported cell attachment and spreading, in a calcium-dependent manner. The adhesive activity of native FSP was inhibited by prior incubation with anti-SPARC IgG. Cell adhesion to FSP induced the formation of filopodia and lamellipodia but not focal adhesions that were prominent on cells that were attached to fibronectin. In addition, FSP induced the tyrosine phosphorylation of FAK and paxillin in attached epithelial cells. Erk1/2 and Rac were also activated in cells attached to FSP, but at a lower level in comparison to cells on fibronectin. This study provides new insight into the biological functions of SPARC, a matricellular protein with important roles in cell-extracellualr matrix interactions.	[Cheng, Lamei; Sage, E. Helene; Yan, Qi] Benaroya Res Inst, Seattle, WA USA; [Sage, E. Helene; Yan, Qi] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA; [Cheng, Lamei] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China	Benaroya Research Institute; University of Washington; University of Washington Seattle; Central South University	Yan, Q (corresponding author), Benaroya Res Inst, Seattle, WA USA.	qyanresearch@gmail.com	; Brestic, Marian/A-8263-2012	Brestic, Marian/0000-0002-6597-7838; Brestic, Marian/0000-0003-3470-6100	National Institutes of Health [EY014150, GM40711]; NATIONAL EYE INSTITUTE [R01EY014150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant EY014150 and GM40711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassuk JA, 1996, INT J BIOCHEM CELL B, V28, P1031, DOI 10.1016/1357-2725(96)00036-2; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Bradshaw Amy D., 2000, Molecular Cell Biology Research Communications, V3, P345, DOI 10.1006/mcbr.2000.0237; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; FUNK SE, 1993, J CELL PHYSIOL, V154, P53, DOI 10.1002/jcp.1041540108; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Girard JP, 1996, J BIOL CHEM, V271, P4511; Haber CL, 2008, INT J CANCER, V122, P1465, DOI 10.1002/ijc.23216; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; HARLAN JM, 1983, LAB INVEST, V48, P269; Huynh MH, 2011, DEV GENES EVOL, V220, P315, DOI 10.1007/s00427-010-0349-x; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; McClung HM, 2012, CARCINOGENESIS, V33, P275, DOI 10.1093/carcin/bgr276; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Nagaraju GPC, 2011, CANCER TREAT REV, V37, P559, DOI 10.1016/j.ctrv.2010.12.001; NISCHT R, 1991, EUR J BIOCHEM, V200, P529, DOI 10.1111/j.1432-1033.1991.tb16214.x; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Rempel SA, 2001, J NEURO-ONCOL, V53, P149, DOI 10.1023/A:1012201300188; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROBERTS DD, 1987, J CELL BIOL, V104, P131, DOI 10.1083/jcb.104.1.131; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Schaller MD, 1996, J ENDOCRINOL, V150, P1, DOI 10.1677/joe.0.1500001; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SRIRAMARAO P, 1993, J CELL SCI, V105, P1001; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; TUSZYNSKI GP, 1987, SCIENCE, V236, P1570, DOI 10.1126/science.2438772; VARANI J, 1986, EXP CELL RES, V167, P376, DOI 10.1016/0014-4827(86)90178-3; Yan Q, 2005, INVEST OPHTH VIS SCI, V46, P4652, DOI 10.1167/iovs.05-0460; Yan Q, 2005, GRAEF ARCH CLIN EXP, V243, P1253, DOI 10.1007/s00417-005-1181-2; Yan Q, 2002, J CELL SCI, V115, P2747	35	68	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53202	10.1371/journal.pone.0053202	http://dx.doi.org/10.1371/journal.pone.0053202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349702	gold, Green Published, Green Submitted			2022-12-27	WOS:000313943000011
J	Yang, HX; Zhou, Y; Gu, JL; Xie, SY; Xu, Y; Zhu, GF; Wang, L; Huang, JY; Ma, H; Yao, JH				Yang, Hongxing; Zhou, Yan; Gu, Jianlei; Xie, Shuying; Xu, Yao; Zhu, Genfeng; Wang, Lei; Huang, Jiyue; Ma, Hong; Yao, Jihua			Deep mRNA Sequencing Analysis to Capture the Transcriptome Landscape of Zebrafish Embryos and Larvae	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; GENE-EXPRESSION; CYCLIN G1; PROTEIN; DOWNSTREAM; KNOCKDOWN; FAMILY; SEQ; DIFFERENTIATION; CONVERGENCE	Transcriptome analysis is a powerful tool to obtain large amount genome-scale gene expression profiles. Despite its extensive usage to diverse biological problems in the last decade, transcriptomic researches approaching the zebrafish embryonic development have been very limited. Several recent studies have made great progress in this direction, yet the large gap still exists, especially regarding to the transcriptome dynamics of embryonic stages from early gastrulation onwards. Here, we present a comprehensive analysis about the transcriptomes of 9 different stages covering 7 major periods (cleavage, blastula, gastrula, segmentation, pharyngula, hatching and early larval stage) in zebrafish development, by recruiting the RNA-sequencing technology. We detected the expression for at least 24,065 genes in at least one of the 9 stages. We identified 16,130 genes that were significantly differentially expressed between stages and were subsequently classified into six clusters. Each revealed gene cluster had distinct expression patterns and characteristic functional pathways, providing a framework for the understanding of the developmental transcriptome dynamics. Over 4000 genes were identified as preferentially expressed in one of the stages, which could be of high relevance to stage-specific developmental and molecular events. Among the 68 transcription factor families active during development, most had enhanced average expression levels and thus might be crucial for embryogenesis, whereas the inactivation of the other families was likely required by the activation of the zygotic genome. We discussed our RNA-seq data together with previous findings about the Wnt signaling pathway and some other genes with known functions, to show how our data could be used to advance our understanding about these developmental functional elements. Our study provides ample information for further study about the molecular and cellular mechanisms underlying vertebrate development.	[Yang, Hongxing; Xie, Shuying; Zhu, Genfeng; Wang, Lei; Huang, Jiyue; Ma, Hong] Fudan Univ, State Key Lab Genet Engn, Inst Plant Biol, Ctr Evolutionary Biol,Sch Life Sci, Shanghai 200433, Peoples R China; [Zhou, Yan; Gu, Jianlei] Fudan Univ, State Key Lab Genet Engn, Dept Microbiol, Sch Life Sci, Shanghai 200433, Peoples R China; [Xu, Yao; Yao, Jihua] Fudan Univ, Inst Genet, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Ma, Hong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Ma, H (corresponding author), Fudan Univ, State Key Lab Genet Engn, Inst Plant Biol, Ctr Evolutionary Biol,Sch Life Sci, Shanghai 200433, Peoples R China.	hongma@fudan.edu.cn; yaojh@fudan.edu.cn	Ma, Hong/W-5251-2018; Gu, Jianlei/ABD-5512-2020; Huang, Jiyue/AAL-8416-2021	Ma, Hong/0000-0001-8717-4422; Huang, Jiyue/0000-0002-7185-4201; Gu, Jian-lei/0000-0002-9337-5017	National Basic Research Program of China [2011CB943804, 2012CB944603]; Fudan University	National Basic Research Program of China(National Basic Research Program of China); Fudan University	This work was supported by grants from the National Basic Research Program of China (2011CB943804 and 2012CB944603) and funds from Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Angotzi AR, 2011, GEN COMP ENDOCR, V171, P332, DOI 10.1016/j.ygcen.2011.02.026; Argenton F, 2004, MECH DEVELOP, V121, P131, DOI 10.1016/j.mod.2004.01.001; Assou S, 2011, HUM REPROD UPDATE, V17, P272, DOI 10.1093/humupd/dmq036; Becknell B, 2005, ADV IMMUNOL, V86, P209, DOI 10.1016/S0065-2776(04)86006-1; Bei JX, 2006, MOL IMMUNOL, V43, P860, DOI 10.1016/j.molimm.2005.06.040; Bellipanni G, 2010, J CELL PHYSIOL, V222, P286, DOI 10.1002/jcp.21944; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Branam AM, 2010, DEV BIOL, V341, P444, DOI 10.1016/j.ydbio.2010.03.001; Cau E, 2003, DEVELOPMENT, V130, P2455, DOI 10.1242/dev.00452; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025; Cheesman SE, 2004, GENE EXPR PATTERNS, V5, P107, DOI 10.1016/j.modgep.2004.05.006; Croce Jenifer C., 2008, V469, P3, DOI 10.1007/978-1-60327-469-2_1; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Duffy KT, 2005, NUCLEIC ACIDS RES, V33, P4914, DOI 10.1093/nar/gki799; Elizalde C, 2011, STEM CELLS, V29, P141, DOI 10.1002/stem.562; Fang H, 2010, DEV CELL, V19, P174, DOI 10.1016/j.devcel.2010.06.014; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; FOURNIER A, 2011, BRIEF FUNCT GENOMICS; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Gardiner MR, 2007, MECH DEVELOP, V124, P762, DOI 10.1016/j.mod.2007.06.005; Gardiner MR, 2005, DEV DYNAM, V234, P992, DOI 10.1002/dvdy.20571; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; Gregory R.W., 2011, GPLOTS VARIOUS R PRO; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Guth SIE, 2008, CELL MOL LIFE SCI, V65, P3000, DOI 10.1007/s00018-008-8138-7; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; Harrison MRM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-24; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Itoh M, 2002, DEVELOPMENT, V129, P2317; Jin J, 2010, DEV DYNAM, V239, P2426, DOI 10.1002/dvdy.22369; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kim HS, 2007, NEUROSCI LETT, V414, P26, DOI 10.1016/j.neulet.2006.12.027; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinkel MD, 2008, DEVELOPMENT, V135, P919, DOI 10.1242/dev.010660; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Ko MSH, 2006, DEV DYNAM, V235, P2437, DOI 10.1002/dvdy.20859; Ko MSH, 2001, TRENDS BIOTECHNOL, V19, P511, DOI 10.1016/S0167-7799(01)01806-6; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee KC, 2008, ONCOGENE, V27, P629, DOI 10.1038/sj.onc.1210695; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu GZ, 2007, MOL IMMUNOL, V44, P1190, DOI 10.1016/j.molimm.2006.06.024; Lo J, 2003, GENOME RES, V13, P455, DOI 10.1101/gr.885403; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; Maiese K, 2008, PHARMACOL THERAPEUT, V118, P58, DOI 10.1016/j.pharmthera.2008.01.004; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Moleri S, 2011, GENE EXPR PATTERNS, V11, P3, DOI 10.1016/j.gep.2010.08.006; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; NAKAMURA T, 1995, EXP CELL RES, V221, P534, DOI 10.1006/excr.1995.1406; Norton WH, 2005, DEVELOPMENT, V132, P645, DOI 10.1242/dev.01611; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pezeron G, 2006, GENE EXPR PATTERNS, V6, P835, DOI 10.1016/j.modgep.2006.02.002; Pillay LM, 2010, DEV BIOL, V340, P306, DOI 10.1016/j.ydbio.2010.01.033; Pollard KM, 2011, J IMMUNOTOXICOL, V8, P228, DOI 10.3109/1547691X.2011.583614; Prykhozhij SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013549; Rebagliati MR, 1998, DEV BIOL, V199, P261, DOI 10.1006/dbio.1998.8935; Renninger SL, 2011, EUR J NEUROSCI, V33, P658, DOI 10.1111/j.1460-9568.2010.07574.x; Rinner O, 2005, NEURON, V47, P231, DOI 10.1016/j.neuron.2005.06.010; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Scholpp S, 2007, DEVELOPMENT, V134, P3167, DOI 10.1242/dev.001461; Seo HR, 2006, CELL DEATH DIFFER, V13, P1475, DOI 10.1038/sj.cdd.4401822; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; Shen YC, 2004, DEV BIOL, V269, P237, DOI 10.1016/j.ydbio.2004.01.037; Sisson BE, 2009, GENE EXPR PATTERNS, V9, P520, DOI 10.1016/j.gep.2009.07.003; Smith L, 2003, HUM MOL GENET, V12, pR1, DOI 10.1093/hmg/ddg053; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Team RDC, 2019, R LANG ENV STAT COMP; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; VerMilyea MD, 2011, EMBO J, V30, P1841, DOI 10.1038/emboj.2011.92; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Wagner DS, 2002, DEV BIOL, V245, P109, DOI 10.1006/dbio.2002.0614; Wang Haichao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000884; Wang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022555; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Wilson JM, 2009, J AM ASSOC LAB ANIM, V48, P785; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Xiao L, 2003, FEBS LETT, V538, P117, DOI 10.1016/S0014-5793(03)00156-X; Yarden A, 1996, DEV DYNAM, V206, P1; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; Zhang Y, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-7; Zhao L, 2003, MOL CANCER RES, V1, P195; Zhong YF, 2011, EVOL DEV, V13, P567, DOI 10.1111/j.1525-142X.2011.00513.x	105	123	124	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64058	10.1371/journal.pone.0064058	http://dx.doi.org/10.1371/journal.pone.0064058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700457	Green Published, gold, Green Submitted			2022-12-27	WOS:000319966400047
J	Debieu, M; Tang, C; Stich, B; Sikosek, T; Effgen, S; Josephs, E; Schmitt, J; Nordborg, M; Koornneef, M; de Meaux, J				Debieu, Marilyne; Tang, Chunlao; Stich, Benjamin; Sikosek, Tobias; Effgen, Sigi; Josephs, Emily; Schmitt, Johanna; Nordborg, Magnus; Koornneef, Maarten; de Meaux, Juliette			Co-Variation between Seed Dormancy, Growth Rate and Flowering Time Changes with Latitude in Arabidopsis thaliana	PLOS ONE			English	Article							NATURAL ALLELIC VARIATION; GENOME-WIDE ASSOCIATION; LIFE-HISTORY; GENETIC-VARIATION; CLINAL VARIATION; PLANT-GROWTH; LOCUS-C; GERMINATION; ADAPTATION; SELECTION	Life-history traits controlling the duration and timing of developmental phases in the life cycle jointly determine fitness. Therefore, life-history traits studied in isolation provide an incomplete view on the relevance of life-cycle variation for adaptation. In this study, we examine genetic variation in traits covering the major life history events of the annual species Arabidopsis thaliana: seed dormancy, vegetative growth rate and flowering time. In a sample of 112 genotypes collected throughout the European range of the species, both seed dormancy and flowering time follow a latitudinal gradient independent of the major population structure gradient. This finding confirms previous studies reporting the adaptive evolution of these two traits. Here, however, we further analyze patterns of co-variation among traits. We observe that co-variation between primary dormancy, vegetative growth rate and flowering time also follows a latitudinal cline. At higher latitudes, vegetative growth rate is positively correlated with primary dormancy and negatively with flowering time. In the South, this trend disappears. Patterns of trait co-variation change, presumably because major environmental gradients shift with latitude. This pattern appears unrelated to population structure, suggesting that changes in the coordinated evolution of major life history traits is adaptive. Our data suggest that A. thaliana provides a good model for the evolution of trade-offs and their genetic basis.	[Debieu, Marilyne] CNRS UMR2594, Lab Interact Plantes Microorganismes, Castanet Tolosan, France; [Debieu, Marilyne; Effgen, Sigi; Koornneef, Maarten; de Meaux, Juliette] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Tang, Chunlao] Univ So Calif, Los Angeles, CA USA; [Stich, Benjamin] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Sikosek, Tobias; de Meaux, Juliette] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Josephs, Emily] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Schmitt, Johanna] Univ Calif Davis, Davis, CA USA; [Nordborg, Magnus] Gregor Mendel Inst Mol Plant Biol, Vienna, Austria; [Koornneef, Maarten] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Max Planck Society; University of Southern California; Max Planck Society; University of Munster; Brown University; University of California System; University of California Davis; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Wageningen University & Research	Debieu, M (corresponding author), CNRS UMR2594, Lab Interact Plantes Microorganismes, Castanet Tolosan, France.	marilyne.debieu@gmail.com	Sikosek, Tobias/E-4939-2014	Sikosek, Tobias/0000-0001-9929-3525; de Meaux, Juliette/0000-0002-2942-4750; Nordborg, Magnus/0000-0001-7178-9748; Koornneef, Maarten/0000-0002-7759-4869	Max Planck Gesellschaft; Deutsche Forschungsgemeinschaft [SFB680]	Max Planck Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max Planck Gesellschaft and the Deutsche Forschungsgemeinschaft (SFB680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1992, J ECOL, V80, P109, DOI 10.2307/2261067; Agren J, 2012, NEW PHYTOL, V194, P1112, DOI 10.1111/j.1469-8137.2012.04112.x; Alonso-Blanco C, 2003, GENETICS, V164, P711; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baskin CC, 1998, SEEDS, P1, DOI 10.1016/B978-012080260-9/50001-4; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; BASKIN JM, 1983, BOT GAZ, V144, P540, DOI 10.1086/337408; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BIERE A, 1991, J EVOLUTION BIOL, V4, P447, DOI 10.1046/j.1420-9101.1991.4030447.x; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Burke S, 2005, ECOL ENTOMOL, V30, P613, DOI 10.1111/j.0307-6946.2005.00741.x; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P15670, DOI 10.1073/pnas.0406232101; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; de Casas RR, 2012, NEW PHYTOL, V194, P868, DOI 10.1111/j.1469-8137.2012.04097.x; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; Donohue K, 2005, EVOLUTION, V59, P771, DOI 10.1111/j.0014-3820.2005.tb01752.x; Donohue K, 2002, ECOLOGY, V83, P1006, DOI 10.1890/0012-9658(2002)083[1006:GTINSO]2.0.CO;2; El-Lithy ME, 2004, PLANT PHYSIOL, V135, P444, DOI 10.1104/pp.103.036822; Endler J.A., 1977, Monographs in Population Biology, pi; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; GEBER MA, 1990, EVOLUTION, V44, P799, DOI 10.1111/j.1558-5646.1990.tb03806.x; Griffith C, 2004, AM J BOT, V91, P837, DOI 10.3732/ajb.91.6.837; GROSS KL, 1991, OECOLOGIA, V87, P270, DOI 10.1007/BF00325266; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; HILHORST HWM, 1995, SEED SCI RES, V5, P61, DOI 10.1017/S0960258500002634; Hoffmann MH, 2005, EVOLUTION, V59, P1425; Hopkins R, 2008, NEW PHYTOL, V179, P155, DOI 10.1111/j.1469-8137.2008.02447.x; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; KALISZ S, 1989, EVOLUTION, V43, P1263, DOI 10.1111/j.1558-5646.1989.tb02573.x; KING D, 1982, THEOR POPUL BIOL, V22, P1, DOI 10.1016/0040-5809(82)90032-6; Kivela SM, 2009, AM NAT, V174, P526, DOI 10.1086/605371; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Korves TM, 2007, AM NAT, V169, pE141, DOI 10.1086/513111; Kronholm I, 2012, EVOLUTION, V66, P2287, DOI 10.1111/j.1558-5646.2012.01590.x; Leister D, 1999, PLANT PHYSIOL BIOCH, V37, P671, DOI 10.1016/S0981-9428(00)80097-2; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; MASUDA M, 1992, OECOLOGIA, V89, P42, DOI 10.1007/BF00319013; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; MCGRAW JB, 1990, TRENDS ECOL EVOL, V5, P251, DOI 10.1016/0169-5347(90)90065-L; Mendez-Vigo B, 2011, PLANT PHYSIOL, V157, P1942, DOI 10.1104/pp.111.183426; Meng PH, 2008, MOL PLANT, V1, P145, DOI 10.1093/mp/ssm014; Metcalf CJE, 2009, ECOL LETT, V12, P593, DOI 10.1111/j.1461-0248.2009.01320.x; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Miller MR, 2007, EVOLUTION, V61, P2, DOI 10.1111/j.1558-5646.2007.00001.x; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI [10.2307/2410788, 10.1111/j.1558-5646.1996.tb04480.x]; Montesinos A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007213; Montesinos-Navarro A, 2012, EVOLUTION, V66, P3417, DOI 10.1111/j.1558-5646.2012.01689.x; Montesinos-Navarro A, 2011, NEW PHYTOL, V189, P282, DOI 10.1111/j.1469-8137.2010.03479.x; Munguia-Rosas MA, 2011, ECOL LETT, V14, P511, DOI 10.1111/j.1461-0248.2011.01601.x; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Perez-Perez JM, 2002, GENETICS, V162, P893; Pritchard JK, 2000, GENETICS, V155, P945; Rees M, 2006, AM NAT, V168, pE53, DOI 10.1086/505762; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Rutter MT, 2007, ANN BOT-LONDON, V99, P529, DOI 10.1093/aob/mcl282; Salome PA, 2011, GENETICS, V188, P421, DOI 10.1534/genetics.111.126607; Samis KE, 2012, ECOL EVOL, V2, P1162, DOI 10.1002/ece3.262; Schmuths H, 2006, ANN BOT-LONDON, V97, P623, DOI 10.1093/aob/mcl012; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Stearns S.C., 1992, pi; Stillwell RC, 2007, AM NAT, V170, P358, DOI 10.1086/520118; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Stratton DA, 1998, HEREDITY, V81, P144, DOI 10.1046/j.1365-2540.1998.00369.x; Vleeshouwers LM, 1995, J ECOL, V83, P1031, DOI 10.2307/2261184; Wagmann K, 2012, ANN BOT, P1; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428; Weinig C, 2002, GENETICS, V162, P1875; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826	80	171	182	2	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e61075	10.1371/journal.pone.0061075	http://dx.doi.org/10.1371/journal.pone.0061075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	24349402	Green Published, Green Submitted, gold			2022-12-27	WOS:000319435600002
J	Lim, L; Marquand, A; Cubillo, AA; Smith, AB; Chantiluke, K; Simmons, A; Mehta, M; Rubia, K				Lim, Lena; Marquand, Andre; Cubillo, Ana A.; Smith, Anna B.; Chantiluke, Kaylita; Simmons, Andrew; Mehta, Mitul; Rubia, Katya			Disorder-Specific Predictive Classification of Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) Relative to Autism Using Structural Magnetic Resonance Imaging	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; SPECTRUM DISORDER; ALZHEIMERS-DISEASE; BRAIN STRUCTURE; METAANALYSIS; MRI; CHILDREN; ABNORMALITIES; NEUROANATOMY; PREVALENCE	Objective: Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder, but diagnosed by subjective clinical and rating measures. The study's aim was to apply Gaussian process classification (GPC) to grey matter (GM) volumetric data, to assess whether individual ADHD adolescents can be accurately differentiated from healthy controls based on objective, brain structure measures and whether this is disorder-specific relative to autism spectrum disorder (ASD). Method: Twenty-nine adolescent ADHD boys and 29 age-matched healthy and 19 boys with ASD were scanned. GPC was applied to make disorder-specific predictions of ADHD diagnostic status based on individual brain structure patterns. In addition, voxel-based morphometry (VBM) analysis tested for traditional univariate group level differences in GM. Results: The pattern of GM correctly classified 75.9% of patients and 82.8% of controls, achieving an overall classification accuracy of 79.3%. Furthermore, classification was disorder-specific relative to ASD. The discriminating GM patterns showed higher classification weights for ADHD in earlier developing ventrolateral/premotor fronto-temporo-limbic and stronger classification weights for healthy controls in later developing dorsolateral fronto-striato-parieto-cerebellar networks. Several regions were also decreased in GM in ADHD relative to healthy controls in the univariate VBM analysis, suggesting they are GM deficit areas. Conclusions: The study provides evidence that pattern recognition analysis can provide significant individual diagnostic classification of ADHD patients and healthy controls based on distributed GM patterns with 79.3% accuracy and that this is disorder-specific relative to ASD. Findings are a promising first step towards finding an objective differential diagnostic tool based on brain imaging measures to aid with the subjective clinical diagnosis of ADHD.	[Lim, Lena; Cubillo, Ana A.; Smith, Anna B.; Chantiluke, Kaylita; Rubia, Katya] Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London WC2R 2LS, England; [Lim, Lena] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore 117595, Singapore; [Marquand, Andre; Simmons, Andrew; Mehta, Mitul] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England; [Simmons, Andrew] South London & Maudsley Fdn NHS Trust, NIHR Biomed Res Ctr, London, England; [Simmons, Andrew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of London; King's College London; National University of Singapore; University of London; King's College London; University of London; King's College London	Rubia, K (corresponding author), Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London WC2R 2LS, England.	katya.rubia@kcl.ac.uk	Simmons, Andrew/B-8848-2008; Mehta, Mitul/F-3960-2010; Hassan, Randa/AAW-3624-2021; Marquand, Andre F/B-6050-2012; Cubillo, Ana I/J-6822-2019; Cubillo, Ana I/AAC-5908-2022; Rubia, Katya/H-7497-2012	Simmons, Andrew/0000-0003-2306-5811; Marquand, Andre F/0000-0001-5903-203X; Cubillo, Ana I/0000-0001-5657-7341; Smith, Anna Belinda/0000-0001-5493-9089; Lim, Lena/0000-0002-3301-923X; Wah, Win/0000-0002-4242-5651; Hsu, Li Yang/0000-0002-0396-066X; Rubia, Katya/0000-0002-1410-7701	NIHR Biomedical Research Centre (BRC) for Mental Health at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Lilly Pharmaceuticals; National Medical Research Council (Singapore); NIHR BRC; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust; EPSRC [WT088641/Z/09/Z]; Medical Research Council [G0300155] Funding Source: researchfish; MRC [G0300155] Funding Source: UKRI	NIHR Biomedical Research Centre (BRC) for Mental Health at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Lilly Pharmaceuticals; National Medical Research Council (Singapore)(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR BRC; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Data collection was supported by grants by the NIHR Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London and Lilly Pharmaceuticals. LL was supported by the National Medical Research Council (Singapore). A, Smith, AC, A. Simmonds and KC were supported by the NIHR BRC. AM was supported by the King's College London Centre of Excellence in Medical Engineering, funded by the Wellcome Trust and EPSRC under grant no. WT088641/Z/09/Z. Lilly Pharmaceuticals had no input into the design, analysis, data interpretation or write-up. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; [Anonymous], 1994, ICD 10 CLASS MENT BE; APA, 2000, DIAGN STAT MAN MENT; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bledsoe J, 2009, BIOL PSYCHIAT, V65, P620, DOI 10.1016/j.biopsych.2008.11.030; Brieber S, 2007, J CHILD PSYCHOL PSYC, V48, P1251, DOI 10.1111/j.1469-7610.2007.01799.x; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Cauda F, 2011, J NEUROL NEUROSUR PS, V82, P1304, DOI 10.1136/jnnp.2010.239111; Cheng W, 2012, FRONT SYST NEUROSCI, P6; Christakou A, 2013, MOL PSYCHIATR, V18, P236, DOI 10.1038/mp.2011.185; Colby JB, 2012, FRONT SYST NEUROSCI, P6; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Cubillo A, 2012, CORTEX, V48, P194, DOI 10.1016/j.cortex.2011.04.007; Dai D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00063; Durston S, 2004, J AM ACAD CHILD PSY, V43, P332, DOI 10.1097/00004583-200403000-00016; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Ellison-Wright I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-51; Eloyan A, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00061; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Goldberg D. P, 2002, MAUDSLEY HDB PRACTIC; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hahn T, 2013, HUM BRAIN MAPP, V34, P1102, DOI 10.1002/hbm.21497; Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277; Hart H, 2012, NEUROSCI BIOBEHAV R, V36, P2248, DOI 10.1016/j.neubiorev.2012.08.003; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Ivanov I, 2010, AM J PSYCHIAT, V167, P397, DOI 10.1176/appi.ajp.2009.09030398; Kuntsi J, 2004, AM J MED GENET B, V124B, P41, DOI 10.1002/ajmg.b.20076; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mackie S, 2007, AM J PSYCHIAT, V164, P647, DOI 10.1176/appi.ajp.164.4.647; Marquand A, 2010, INT C PATT REC IST T; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; Noreika V, 2013, NEUROPSYCHOLOGIA, V51, P235, DOI 10.1016/j.neuropsychologia.2012.09.036; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pliszka SR, 2006, NEUROLOGY, V67, P1023, DOI 10.1212/01.wnl.0000237385.84037.3c; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rubia K, 2007, P NATL ACAD SCI USA, V104, P19663, DOI 10.1073/pnas.0710329105; Rubia K, 2013, EUR CHILD ADOLES PSY, V22, P719, DOI 10.1007/s00787-012-0291-8; Rubia K, 2011, BIOL PSYCHIAT, V69, pE69, DOI 10.1016/j.biopsych.2010.09.023; Rutter M., 2003, SOCIAL COMMUNICATION; Schrouff J, 2013, NEUROINFORMATICS, V11, P319, DOI 10.1007/s12021-013-9178-1; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2012, BIOL PSYCHIAT, V72, P191, DOI 10.1016/j.biopsych.2012.01.031; Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385; Shaw P, 2009, AM J PSYCHIAT, V166, P58, DOI 10.1176/appi.ajp.2008.08050781; Simmons A, 2011, INT J GERIATR PSYCH, V26, P75, DOI 10.1002/gps.2491; Simmons A, 2009, ANN NY ACAD SCI, V1180, P47, DOI 10.1111/j.1749-6632.2009.05063.x; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Sobel LJ, 2010, AM J PSYCHIAT, V167, P977, DOI 10.1176/appi.ajp.2010.09091259; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Yu KK, 2011, J PSYCHIATR NEUROSCI, V36, P412, DOI 10.1503/jpn.100138; Zhu CZ, 2005, LECT NOTES COMPUT SC, V3750, P468, DOI 10.1007/11566489_58	65	63	65	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63660	10.1371/journal.pone.0063660	http://dx.doi.org/10.1371/journal.pone.0063660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696841	Green Published, gold			2022-12-27	WOS:000319081900048
J	Liu, YX; Wang, XJ; Liu, YX; Sun, DP; Ding, SJ; Zhang, BB; Du, ZH; Xue, FZ				Liu, Yunxia; Wang, Xianjun; Liu, Yanxun; Sun, Dapeng; Ding, Shujun; Zhang, Bingbing; Du, Zhaohui; Xue, Fuzhong			Detecting Spatial-Temporal Clusters of HFMD from 2007 to 2011 in Shandong Province, China	PLOS ONE			English	Article							MOUTH-DISEASE; FOOT; HAND; OUTBREAK; ONYCHOMADESIS; EPIDEMIOLOGY; INFECTIONS; CITY	Background: Hand, foot, and mouth disease (HFMD) has caused major public health concerns worldwide, and has become one of the leading causes of children death. China is the most serious epidemic area with a total of 3,419,149 reported cases just from 2008 to 2010, and its different geographic areas might have different spatial epidemiology characteristics at different spatial-temporal scale levels. We conducted spatial and spatial-temporal epidemiology analysis to HFMD at county level in Shandong Province, China. Methods: Based on the China National Disease Surveillance Reporting and Management System, the spatial-temporal database of HFMD from 2007 to 2011 was built. The global autocorrelation statistic (Moran's I) was first used to detect the spatial autocorrelation of HFMD cases in each year. Purely Spatial scan statistics combined with Space-time scan statistic were used to detect epidemic clusters. Results: The annual average incidence rate was 93.70 per 100,000 in Shandong Province. Most HFMD cases (93.94%) were aged within 0-5 years old with an average male-to-female sex ratio 1.71, and the incidence seasonal peak was between April and July. The dominant pathogen was EV71 (47.35%), and CoxA16 (26.59%). HFMD had positive spatial autocorrelation at medium spatial scale level (county level) with higher Moran's I from 0.31 to 0.62 (P<0.001). Seven spatial-temporal clusters were detected from 2007 to 2011 in the landscape of the whole Shandong, with EV71 or CoxA16 as the dominant pathogen for most hotspots areas. Conclusions: The spatial-temporal clusters of HFMD wandered around the whole Shandong Province during 2007 to 2011, with EV71 or CoxA16 as the dominant pathogen. These findings suggested that a real-time spatial-temporal surveillance system should be established for identifying high incidence region and conducting prevention to HFMD timely.	[Liu, Yunxia; Liu, Yanxun; Zhang, Bingbing; Du, Zhaohui; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China; [Wang, Xianjun; Sun, Dapeng; Ding, Shujun] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China	Shandong University	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China.	xuefzh@sdu.edu.cn	Du, Zhaohui/AAK-6231-2021; Xue, Fuzhong/AAG-4808-2020; zhang, liwen/L-7005-2016; He, Huiguang/AAD-7643-2020	Du, Zhaohui/0000-0002-7125-8928; He, Huiguang/0000-0002-0684-1711; Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [81001292]; Shandong Province science and technology development plan [2009GG10002055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province science and technology development plan	This work was supported by No.81001292 of the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm), 2009GG10002055 of Shandong Province science and technology development plan in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Anselin L, 2004, GEODA0 95I RELEASE N; Bracho MA, 2011, EMERG INFECT DIS, V17, P2223, DOI 10.3201/eid1712.110395; Cao Li-Hua, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P227; Chang Zhao-rui, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P676; Chinese Center for Disease Control and Prevention(China CDC), 2010, NAT INC DEATH CAS NO; Chinese Ministry of Health, 2008, HAND FOOT MOUTH DIS; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Higgs BW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001284; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Liu Wen-dong, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P813; Ma E, 2010, JPN J INFECT DIS, V63, P422; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287; Ni HX, 2012, J CLIN VIROL, V54, P342, DOI 10.1016/j.jcv.2012.04.021; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Puenpa J, 2011, ARCH VIROL, V156, P2007, DOI 10.1007/s00705-011-1098-5; Tang Xian-yan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P274; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Xiao Ge-xin, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P808; Yan XF, 2012, SCAND J INFECT DIS, V44, P297, DOI 10.3109/00365548.2011.634433; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005; Zou XN, 2012, BRAZ J INFECT DIS, V16, P457, DOI 10.1016/j.bjid.2012.08.001	36	38	53	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63447	10.1371/journal.pone.0063447	http://dx.doi.org/10.1371/journal.pone.0063447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	24098769	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200039
J	Yang, HA; Tao, Y; Zheng, ZQ; Zhang, QS; Zhou, GF; Sweetingham, MW; Howieson, JG; Li, CD				Yang, Huaan; Tao, Ye; Zheng, Zequn; Zhang, Qisen; Zhou, Gaofeng; Sweetingham, Mark W.; Howieson, John G.; Li, Chengdao			Draft Genome Sequence, and a Sequence-Defined Genetic Linkage Map of the Legume Crop Species Lupinus angustifolius L.	PLOS ONE			English	Article							ANTHRACNOSE DISEASE RESISTANCE; MARKER-ASSISTED SELECTION; MOLECULAR MARKERS; PCR MARKERS; CONFERRING RESISTANCE; DOMESTICATION GENES; DIAPORTHE-TOXICA; KERNEL FIBER; DE-NOVO; CONSTRUCTION	Lupin (Lupinus angustifolius L.) is the most recently domesticated crop in major agricultural cultivation. Its seeds are high in protein and dietary fibre, but low in oil and starch. Medical and dietetic studies have shown that consuming lupin-enriched food has significant health benefits. Were port the draft assembly from a whole genome shotgun sequencing dataset for this legume species with 26.9x coverage of the genome, which is predicted to contain 57,807 genes. Analysis of the annotated genes with metabolic pathways provided a partial understanding of some key features of lupin, such as the amino acid profile of storage proteins in seeds. Furthermore, we applied the NGS-based RAD-sequencing technology to obtain 8,244 sequence-defined markers for anchoring the genomic sequences. A total of 4,214 scaffolds from the genome sequence assembly were aligned into the genetic map. The combination of the draft assembly and a sequence-defined genetic map made it possible to locate and study functional genes of agronomic interest. The identification of co-segregating SNP markers, scaffold sequences and gene annotation facilitated the identification of a candidate R gene associated with resistance to the major lupin disease anthracnose. We demonstrated that the combination of medium-depth genome sequencing and a high-density genetic linkage map by application of NGS technology is a cost-effective approach to generating genome sequence data and a large number of molecular markers to study the genomics, genetics and functional genes of lupin, and to apply them to molecular plant breeding. This strategy does not require prior genome knowledge, which potentiates its application to a wide range of non-model species.	[Yang, Huaan; Zhang, Qisen; Zhou, Gaofeng; Sweetingham, Mark W.; Li, Chengdao] Dept Agr & Food Western Australia, S Perth, WA, Australia; [Tao, Ye; Zheng, Zequn] Beijing Genome Inst, Shenzhen, Peoples R China; [Howieson, John G.] Murdoch Univ, Ctr Rhizobium Studies, Murdoch, WA 6150, Australia	Government of Western Australia; Department of Agriculture & Food - Western Australia; Beijing Genomics Institute (BGI); Murdoch University	Li, CD (corresponding author), Dept Agr & Food Western Australia, S Perth, WA, Australia.	chengdao.li@agric.wa.gov.au	Ma, Hong/W-5251-2018; Gu, Jianlei/ABD-5512-2020; Huang, Jiyue/AAL-8416-2021	Ma, Hong/0000-0001-8717-4422; Huang, Jiyue/0000-0002-7185-4201; Gu, Jian-lei/0000-0002-9337-5017	Department of Agriculture and Food Western Australia (DAFWA) through the Consolidated Fund; Murdoch University through the Research Capacity Fund; Grains Research and Development Corporation (GRDC) of Australia [DAW00170]	Department of Agriculture and Food Western Australia (DAFWA) through the Consolidated Fund; Murdoch University through the Research Capacity Fund; Grains Research and Development Corporation (GRDC) of Australia(Grains R&D Corp)	This work was jointly funded by Department of Agriculture and Food Western Australia (DAFWA) through the Consolidated Fund to HY, QZ, MWS and CL, Beijing Genome Institute (BGI) for providing the facility and reagents on genome sequencing and RAD sequencing, Murdoch University through the Research Capacity Fund to JGW, and the Grains Research and Development Corporation (GRDC) of Australia through the funding of research project DAW00170 to HY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer BJ, 2004, BRIT J NUTR, V91, P591, DOI 10.1079/BJN20031088; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bennett MD, 2000, ANN BOT-LONDON, V86, P859, DOI 10.1006/anbo.2000.1253; Bhat S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039181; Boersma JG, 2007, PLANT BREEDING, V126, P612, DOI 10.1111/j.1439-0523.2007.01417.x; Boersma JG, 2007, PLANT BREEDING, V126, P306, DOI 10.1111/j.1439-0523.2007.01347.x; Boersma JG, 2007, GENET MOL BIOL, V30, P623, DOI 10.1590/S1415-47572007000400020; Boersma J, 2009, MOL BREEDING, V23, P259, DOI 10.1007/s11032-008-9230-2; Boersma JG, 2005, CELL MOL BIOL LETT, V10, P331; Cannon SB, 2006, P NATL ACAD SCI USA, V103, P14959, DOI 10.1073/pnas.0603228103; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Collins NC, 1998, MOL PLANT MICROBE IN, V11, P968, DOI 10.1094/MPMI.1998.11.10.968; Eagles HA, 2001, AUST J AGR RES, V52, P1349, DOI 10.1071/AR01067; Foley RC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-59; Gao LL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-521; GLADSTONES J. S., 1970, Field Crop Abstracts, V23, P123; Haiminen N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-194; Hall RS, 2005, ASIA PAC J CLIN NUTR, V14, P91; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Howieson John G., 1998, P149; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Ilgoutz SC, 1997, PLANT MOL BIOL, V34, P613, DOI 10.1023/A:1005868105651; Islam S, 2011, CROP PASTURE SCI, V62, P765, DOI 10.1071/CP11046; Johnson SK, 2006, BRIT J NUTR, V95, P372, DOI 10.1079/BJN20051648; Lee YP, 2006, AM J CLIN NUTR, V84, P975, DOI 10.1093/ajcn/84.5.975; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li X, 2011, CROP PASTURE SCI, V62, P218, DOI 10.1071/CP10352; Li X, 2012, PLANT BREEDING, V131, P540, DOI 10.1111/j.1439-0523.2012.01978.x; Li X, 2012, MOL BREEDING, V29, P361, DOI 10.1007/s11032-011-9552-3; Li X, 2010, EUPHYTICA, V176, P49, DOI 10.1007/s10681-010-0212-1; Lin RM, 2009, MOL BREEDING, V23, P153, DOI 10.1007/s11032-008-9222-2; Lovati MR, 2012, BRIT J NUTR, V107, P67, DOI 10.1017/S0007114511002601; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Molnar SJ, 2000, GENOME, V43, P224, DOI 10.1139/gen-43-2-224; Naganowska B, 2003, ANN BOT-LONDON, V92, P349, DOI 10.1093/aob/mcg145; Nelson MN, 2006, THEOR APPL GENET, V113, P225, DOI 10.1007/s00122-006-0288-0; Nelson MN, 2010, DNA RES, V17, P73, DOI 10.1093/dnares/dsq001; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2008, CURR OPIN PL BIOL, V1, P123; SENGBUSCH R. von., 1942, Landwirtschaftliche Jahrbucher, V91, P719; Shankar M, 1996, PHYTOPATHOLOGY, V86, P692, DOI 10.1094/Phyto-86-692; Sharp PJ, 2001, AUST J AGR RES, V52, P1357, DOI 10.1071/AR01052; Swiecicki Wiktor, 1995, Journal of Applied Genetics, V36, P155; van Barneveld RJ, 1999, NUTR RES REV, V12, P203, DOI 10.1079/095442299108728938; Van Os H, 2005, THEOR APPL GENET, V112, P30, DOI 10.1007/s00122-005-0097-x; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Wasche A, 2001, NAHRUNG, V45, P393, DOI 10.1002/1521-3803(20011001)45:6<393::AID-FOOD393>3.0.CO;2-O; Yang H, 2004, MOL BREEDING, V14, P145, DOI 10.1023/B:MOLB.0000038003.49638.97; Yang H, 2002, THEOR APPL GENET, V105, P265, DOI 10.1007/s00122-002-0925-1; Yang H, 2001, MOL BREEDING, V7, P203, DOI 10.1023/A:1011363205557; Yang HA, 1998, AUST J AGR RES, V49, P1213, DOI 10.1071/A98074; Yang H, 2008, MOL BREEDING, V21, P473, DOI 10.1007/s11032-007-9146-2; Yang HA, 2013, THEOR APPL GENET, V126, P511, DOI 10.1007/s00122-012-1997-1; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; You M, 2005, CELL MOL BIOL LETT, V10, P123	62	123	124	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e64799	10.1371/journal.pone.0064799	http://dx.doi.org/10.1371/journal.pone.0064799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23700457	gold, Green Published, Green Submitted			2022-12-27	WOS:000319725500047
J	Liang, HY; Hussey, SE; Sanchez-Avila, A; Tantiwong, P; Musi, N				Liang, Hanyu; Hussey, Sophie E.; Sanchez-Avila, Alicia; Tantiwong, Puntip; Musi, Nicolas			Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle	PLOS ONE			English	Article							LPS-BINDING-PROTEIN; ENDOPLASMIC-RETICULUM STRESS; TYPE-2 DIABETIC SUBJECTS; HUMAN SKELETAL-MUSCLE; ADIPOSE-TISSUE; RESISTANCE; GLUCOSE; SENSITIVITY; ENDOTOXEMIA; OBESITY	Accumulating evidence from animal studies suggest that chronic elevation of circulating intestinal-generated lipopolysaccharide (LPS) (i.e., metabolic endotoxemia) could play a role in the pathogenesis of insulin resistance. However, the effect of LPS in human muscle is unclear. Moreover, it is unknown whether blockade/down regulation of toll-like receptor (TLR) 4 can prevent the effect of LPS on insulin action and glucose metabolism in human muscle cells. In the present study we compared plasma LPS concentration in insulin resistant [obese non-diabetic and obese type 2 diabetic (T2DM)] subjects versus lean individuals. In addition, we employed a primary human skeletal muscle cell culture system to investigate the effect of LPS on glucose metabolism and whether these effects are mediated via TLR4. Obese non-diabetic and T2DM subjects had significantly elevated plasma LPS and LPS binding protein (LBP) concentrations. Plasma LPS (r = -0.46, P = 0.005) and LBP (r = -0.49, P = 0.005) concentrations negatively correlated with muscle insulin sensitivity (M). In human myotubes, LPS increased JNK phosphorylation and MCP-1 and IL-6 gene expression. This inflammatory response led to reduced insulin-stimulated IRS-1, Akt and AS160 phosphorylation and impaired glucose transport. Both pharmacologic blockade of TLR4 with TAK-242, and TLR4 gene silencing, suppressed the inflammatory response and insulin resistance caused by LPS in human muscle cells. Taken together, these findings suggest that elevations in plasma LPS concentration found in obese and T2DM subjects could play a role in the pathogenesis of insulin resistance and that antagonists of TLR4 may improve insulin action in these individuals.	[Liang, Hanyu; Hussey, Sophie E.; Sanchez-Avila, Alicia; Tantiwong, Puntip; Musi, Nicolas] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Liang, Hanyu; Hussey, Sophie E.; Tantiwong, Puntip; Musi, Nicolas] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Audie L Murphy Div, San Antonio, TX USA; [Liang, Hanyu; Hussey, Sophie E.; Tantiwong, Puntip; Musi, Nicolas] Texas Diabet Inst, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Musi, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA.	musi@uthscsa.edu		Liang, Huiying/0000-0002-9987-8002	National Institutes of Health [RO1-DK80157, RO1- DK089229, TR000149, 1F32DK095565-01A1]; American Diabetes Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095565, R01DK089229, R01DK080157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (RO1-DK80157 and RO1- DK089229 to N.M., TR000149 to UTHSCSA, and 1F32DK095565-01A1 to S.H.) and the American Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Al-Attas OS, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-20; Alhusaini S, 2010, BIOCHEM BIOPH RES CO, V397, P472, DOI 10.1016/j.bbrc.2010.05.138; Andreasen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023999; Bouzakri K, 2008, DIABETES, V57, P1508, DOI 10.2337/db07-0583; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Ciaraldi TP, 1995, J CLIN INVEST, V96, P2820, DOI 10.1172/JCI118352; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Frisard MI, 2010, AM J PHYSIOL-ENDOC M, V298, pE988, DOI 10.1152/ajpendo.00307.2009; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Gubern C, 2006, DIABETES, V55, P216, DOI 10.2337/diabetes.55.1.216; Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hussey SE, 2013, BIOSCIENCE REP, V33, P37, DOI 10.1042/BSR20120098; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Laugerette F, 2011, BIOCHIMIE, V93, P39, DOI 10.1016/j.biochi.2010.04.016; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Pilon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015912; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Somwar R, 2001, BIOCHEM J, V359, P639, DOI 10.1042/0264-6021:3590639; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; van der Crabben SN, 2009, J CLIN ENDOCR METAB, V94, P463, DOI 10.1210/jc.2008-0761; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800; Zweigner J, 2006, MICROBES INFECT, V8, P946, DOI 10.1016/j.micinf.2005.10.006	39	113	119	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63983	10.1371/journal.pone.0063983	http://dx.doi.org/10.1371/journal.pone.0063983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704966	gold, Green Published, Green Submitted			2022-12-27	WOS:000319330200098
J	Liu, Y; Miao, W; Wang, JQ; Gao, PY; Yin, GH; Zhang, LP; Lv, CK; Ji, ZY; Yu, T; Sabel, BA; He, HG; Peng, Y				Liu, Yue; Miao, Wen; Wang, Jieqiong; Gao, Peiyi; Yin, Guangheng; Zhang, Liping; Lv, Chuankai; Ji, Zhiying; Yu, Tong; Sabel, B. A.; He, Huiguang; Peng, Yun			Structural Abnormalities in Early Tourette Syndrome Children: A Combined Voxel-Based Morphometry and Tract-Based Spatial Statistics Study	PLOS ONE			English	Article							TIC SEVERITY; FRONTAL-LOBE; BRAIN; VOLUMES; CONNECTIVITY; LOCALIZATION; INHIBITION; PREVALENCE; ATTENTION; SYSTEM	Tourette Syndrome (TS) is characterized with chronic motor and vocal tics beginning in childhood. Abnormality of both gray (GM) and white matter (WM) has been observed in cortico-striato-thalamo-cortical circuits and sensory-motor cortex of adult TS patient. It is not clear if these morphological changes are also present in TS children and if there are any microstructural changes of WM. To understand the developmental cause of such changes, we investigated volumetric changes of GM and WM using VBM and microstructural changes of WM using DTI, and correlated these changes with tic severity and duration. T1 images and Diffusion Tensor Images (DTI) from 21 TS children were compared with 20 age and gender matched health control children using a 1.5T Philips scanner. All of the 21 TS children met the DSM-IV-TR criteria. T1 images were analyzed using DARTEL-VBM in conjunction with statistical parametric mapping (SPM). Diffusion tensor imaging (DTI) analysis was performed using Tract-Based Spatial Statistics (TBSS). Brain volume changes were found in left superior temporal gyrus, left and right paracentral gyrus, right precuneous cortex, right pre- and post-central gyrus, left temporal occipital fusiform cortex, right frontal pole, and left lingual gyrus. Significant axial diffusivity (AD) and mean diffusivity (MD) increases were found in anterior thalamic radiation, right cingulum bundle projecting to the cingulate gurus and forceps minor. Decreases in white matter volume (WMV) in the right frontal pole were inversely related with tic severity (YGTSS), and increases in AD and MD were positively correlated with tic severity and duration, respectively. These changes in TS children can be interpreted as signs of neural plasticity in response to the experiential demand. Our findings may suggest that the morphological and microstructural measurements from structural MRI and DTI can potentially be used as a biomarker of the pathophysiologic pattern of early TS children.	[Liu, Yue; Yin, Guangheng; Lv, Chuankai; Yu, Tong; Peng, Yun] Capital Med Univ, Beijing Childrens Hosp, Dept Radiol, Beijing, Peoples R China; [Miao, Wen; Wang, Jieqiong; Sabel, B. A.; He, Huiguang] Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China; [Liu, Yue; Yin, Guangheng; Lv, Chuankai; Yu, Tong; Peng, Yun] Capital Med Univ, Beijing Key Lab Magnet Imaging Device & Tech, Beijing Childrens Hosp, Beijing, Peoples R China; [Gao, Peiyi] Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China; [Zhang, Liping; Ji, Zhiying] Capital Med Univ, Dept Med, Beijing Childrens Hosp, Beijing, Peoples R China; [Sabel, B. A.] Univ Magdeburg, Fac Med, Inst Med Psychol, D-39106 Magdeburg, Germany	Capital Medical University; Chinese Academy of Sciences; Institute of Automation, CAS; Capital Medical University; Capital Medical University; Capital Medical University; Otto von Guericke University	He, HG (corresponding author), Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China.	huiguang.he@ia.ac.cn; ppengyun@yahoo.com	Du, Zhaohui/AAK-6231-2021; Xue, Fuzhong/AAG-4808-2020; zhang, liwen/L-7005-2016; He, Huiguang/AAD-7643-2020	Du, Zhaohui/0000-0002-7125-8928; He, Huiguang/0000-0002-0684-1711; Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [61271151, 61228103, 31271161]; capital health research and development of special [2011-2009-03]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); capital health research and development of special; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China (61271151, 61228103, and 31271161) and the capital health research and development of special (2011-2009-03). SB was partly supported by Chinese Academy of Sciences Senior Visiting Professorships Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bloch MH, 2005, NEUROLOGY, V65, P1253, DOI 10.1212/01.wnl.0000180957.98702.69; Bohlhalter S, 2006, BRAIN, V129, P2029, DOI 10.1093/brain/awl050; Boroojerdi B, 1999, BRIT J PSYCHIAT, V175, P375, DOI 10.1192/bjp.175.4.375; CDE MR, 2011, MULT SCLER INT, V2011, P4875; COMINGS DE, 1984, AM J HUM GENET, V36, P586; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Draganski B, 2010, BRAIN, V133, P3661, DOI 10.1093/brain/awq300; Fahim C, 2009, BRAIN TOPOGR, V22, P176, DOI 10.1007/s10548-009-0105-6; Fan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035889; Fredericksen KA, 2002, NEUROLOGY, V58, P85, DOI 10.1212/WNL.58.1.85; Gerard E, 2003, J PSYCHOSOM RES, V55, P13, DOI 10.1016/S0022-3999(02)00581-0; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hugdahl K, 1998, BEHAV BRAIN SCI, V21, P335, DOI 10.1017/S0140525X98301211; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Kates WR, 2002, PSYCHIAT RES-NEUROIM, V116, P63, DOI 10.1016/S0925-4927(02)00066-5; Knight T, 2012, PEDIATR NEUROL, V47, P77, DOI 10.1016/j.pediatrneurol.2012.05.002; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Lucas A R, 1982, Adv Neurol, V35, P267; Makki MI, 2008, MOVEMENT DISORD, V23, P2349, DOI 10.1002/mds.22264; Marsh R, 2007, AM J PSYCHIAT, V164, P955, DOI 10.1176/appi.ajp.164.6.955; Mason A, 1998, DEV MED CHILD NEUROL, V40, P292; Miao W, 2013, AM J NEURORADIOL, V34, P1264, DOI 10.3174/ajnr.A3370; Muller-Vahl KR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-47; Neuner I, 2010, NEUROIMAGE, V51, P1184, DOI 10.1016/j.neuroimage.2010.02.049; Neuner Irene, 2009, Biol Psychiatry, V65, pe5, DOI 10.1016/j.biopsych.2008.09.030; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Petek E, 2001, AM J HUM GENET, V68, P848, DOI 10.1086/319523; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; Peterson BS, 2001, ARCH GEN PSYCHIAT, V58, P427, DOI 10.1001/archpsyc.58.5.427; Plessen KJ, 2009, J PSYCHOSOM RES, V67, P559, DOI 10.1016/j.jpsychores.2009.07.005; Plessen KJ, 2004, AM J PSYCHIAT, V161, P2028, DOI 10.1176/appi.ajp.161.11.2028; Retz-Junginger P, 2003, NERVENARZT, V74, P987, DOI 10.1007/s00115-002-1447-4; Rueda MR, 2005, DEV NEUROPSYCHOL, V28, P573, DOI 10.1207/s15326942dn2802_2; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; Schiffer B, 2007, J PSYCHIATR RES, V41, P753, DOI 10.1016/j.jpsychires.2006.06.003; Shprecher D, 2009, MOVEMENT DISORD, V24, P15, DOI 10.1002/mds.22378; Singer HS, 2005, LANCET NEUROL, V4, P149, DOI 10.1016/S1474-4422(05)01012-4; Singer HS, 2003, BRAIN DEV-JPN, V25, pS70, DOI 10.1016/S0387-7604(03)90012-X; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sowell ER, 2008, NAT NEUROSCI, V11, P637, DOI 10.1038/nn.2121; Stern JS, 2005, POSTGRAD MED J, V81, P12, DOI 10.1136/pgmj.2004.023614; STOKES A, 1991, PEDIATRICS, V87, P936; Thomalla G, 2009, BRAIN, V132, P765, DOI 10.1093/brain/awn339; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011	50	38	53	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76105	10.1371/journal.pone.0076105	http://dx.doi.org/10.1371/journal.pone.0076105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098769	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500139
J	Szema, AM; Hamidi, SA; Smith, SD; Benveniste, H				Szema, Anthony M.; Hamidi, Sayyed A.; Smith, S. David; Benveniste, Helene			VIP Gene Deletion in Mice Causes Cardiomyopathy Associated with Upregulation of Heart Failure Genes	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; SMOOTH-MUSCLE-CELLS; CARDIAC TROPONIN-T; ALPHA-TROPOMYOSIN; PROLIFERATION; MUTATION; LACKING; TRANSITION	Rationale: Vasoactive Intestinal Peptide (VIP), a pulmonary vasodilator and inhibitor of vascular smooth muscle proliferation, is absent in pulmonary arteries of patients with idiopathic pulmonary arterial hypertension (PAH). We previously determined that targeted deletion of the VIP gene in mice leads to PAH with pulmonary vascular remodeling and right ventricular (RV) dilatation. Whether the left ventricle is also affected by VIP gene deletion is unknown. In the current study, we examined if VIP knockout mice (VIP-/-) develop both right (RV) and left ventricular (LV) cardiomyopathy, manifested by LV dilatation and systolic dysfunction, as well as overexpression of genes conducive to heart failure. Methods: We examined VIP-/- and wild type (WT) mice using Magnetic Resonance Imaging (MRI) for evidence of cardiomyopathy associated with biventricular dilation and wall thickness changes. Lung tissue from VIP-/- and WT mice was subjected to whole-genome gene microarray analysis. Results: Lungs from VIP-/- mice showed overexpression of cardiomyopathy genes: Myh1 was upregulated 224 times over WT, and Mylpf was increased 72 fold. Tnnt3 was increased 105 times and tnnc2 181 fold. Hearts were dilated in VIP-/- mice, with thinning of LV wall and increase in RV and LV chamber size, though RV enlargement varied. Weights of VIP-/- mice were consistently lower. Conclusions: Critically-important heart failure-related genes are upregulated in VIP-/- mice associated with the spontaneous cardiomyopathy phenotype, involving both left and right ventricles, suggesting that loss of the VIP gene orchestrates a panoply of pathogenic genes which are detrimental to both left and right cardiac homeostasis.	[Szema, Anthony M.; Hamidi, Sayyed A.] Vet Affairs Med Ctr, Northport, NY USA; [Szema, Anthony M.; Hamidi, Sayyed A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Smith, S. David] Brookhaven Natl Lab, Upton, NY 11973 USA; [Benveniste, Helene] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Benveniste, Helene] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Szema, AM (corresponding author), Vet Affairs Med Ctr, Northport, NY USA.	anthony.szema@stonybrookmedicine.edu		Curtis, Laura/0000-0003-2380-2201; Smith, Samuel/0000-0003-1983-4470; Von Wagner, Christian/0000-0002-7971-0691	National Institutes of Health (NIH) [K08 HL 071263]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL071263] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) K08 HL 071263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alan B, 2010, ANATOL J CARDIOL, V10, P9, DOI 10.5152/akd.2010.114; ANAN R, 1994, J CLIN INVEST, V93, P280, DOI 10.1172/JCI116957; Arad M, 2002, HUM MOL GENET, V11, P2499, DOI 10.1093/hmg/11.20.2499; Bronicki RA, 2010, PEDIATR CRIT CARE ME, V11, pS15, DOI 10.1097/PCC.0b013e3181c7671c; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Fujino N, 2002, AM J CARDIOL, V89, P29, DOI 10.1016/S0002-9149(01)02158-0; Haberl I, 2007, EUR J HUM GENET, V15, P18, DOI 10.1038/sj.ejhg.5201711; Hamidi SA, 2008, EUR RESPIR J, V31, P135, DOI 10.1183/09031936.00105807; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim J, 1998, REGUL PEPTIDES, V75-6, P201, DOI 10.1016/S0167-0115(98)00069-X; Kokado H, 2000, CIRCULATION, V102, P663, DOI 10.1161/01.CIR.102.6.663; MARUNO K, 1995, AM J PHYSIOL-LUNG C, V268, pL1047, DOI 10.1152/ajplung.1995.268.6.L1047; McCann C, 2012, POSTGRAD MED J, V88, P271, DOI 10.1136/postgradmedj-2011-130292; McLaughlin VV, 1998, NEW ENGL J MED, V338, P273, DOI 10.1056/NEJM199801293380501; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Miyata A, 1998, ANN NY ACAD SCI, V865, P73, DOI 10.1111/j.1749-6632.1998.tb11165.x; Moolman JC, 1997, J AM COLL CARDIOL, V29, P549, DOI 10.1016/S0735-1097(96)00530-X; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; *NAT LIB MED, 2013, GEN HOM REF PULM ART; OISO Y, 1993, BIOCHEM CELL BIOL, V71, P156, DOI 10.1139/o93-025; Raiesdana A, 2006, ANN MED, V38, P95, DOI 10.1080/07853890600622143; Regitz-Zagrosek V, 2000, CIRCULATION, V102, pE112; Said SI, 2007, CIRCULATION, V115, P1260, DOI 10.1161/CIRCULATIONAHA.106.681718; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shedeed SA, 2010, PEDIATR CARDIOL, V31, P1008, DOI 10.1007/s00246-010-9753-2; St Hilaire RC, 2010, PEPTIDES, V31, P1517, DOI 10.1016/j.peptides.2010.04.024; Swetz KM, 2012, J HEART LUNG TRANSPL, V31, P1102, DOI 10.1016/j.healun.2012.08.010; Szema AM, 2006, AM J PHYSIOL-LUNG C, V291, pL880, DOI 10.1152/ajplung.00499.2005; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301	31	194	194	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e61449	10.1371/journal.pone.0061449	http://dx.doi.org/10.1371/journal.pone.0061449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700405	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400004
J	Maire, V; Baldeyron, C; Richardson, M; Tesson, B; Vincent-Salomon, A; Gravier, E; Marty-Prouvost, B; De Koning, L; Rigaill, G; Dumont, A; Gentien, D; Barillot, E; Roman-Roman, S; Depil, S; Cruzalegui, F; Pierre, A; Tucker, GC; Dubois, T				Maire, Virginie; Baldeyron, Celine; Richardson, Marion; Tesson, Bruno; Vincent-Salomon, Anne; Gravier, Eleonore; Marty-Prouvost, Berengere; De Koning, Leanne; Rigaill, Guillem; Dumont, Aurelie; Gentien, David; Barillot, Emmanuel; Roman-Roman, Sergio; Depil, Stephane; Cruzalegui, Francisco; Pierre, Alain; Tucker, Gordon C.; Dubois, Thierry			TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer	PLOS ONE			English	Article							P53-DEPENDENT POSTMITOTIC CHECKPOINT; SPINDLE-ASSEMBLY CHECKPOINT; GENE-EXPRESSION PATTERNS; BASAL-LIKE CARCINOMAS; MOLECULAR PORTRAITS; MITOTIC CHECKPOINT; KINASE INHIBITORS; DNA-DAMAGE; MPS1; CELLS	Triple-negative breast cancer (TNBC) represents a subgroup of breast cancers (BC) associated with the most aggressive clinical behavior. No targeted therapy is currently available for the treatment of patients with TNBC. In order to discover potential therapeutic targets, we searched for protein kinases that are overexpressed in human TNBC biopsies and whose silencing in TNBC cell lines causes cell death. A cohort including human BC biopsies obtained at Institut Curie as well as normal tissues has been analyzed at a gene-expression level. The data revealed that the human protein kinase monopolar spindle 1 (hMPS1), also known as TTK and involved in mitotic checkpoint, is specifically overexpressed in TNBC, compared to the other BC subgroups and healthy tissues. We confirmed by immunohistochemistry and reverse phase protein array that TNBC expressed higher levels of TTK protein compared to the other BC subgroups. We then determined the biological effects of TTK depletion by RNA interference, through analyses of tumorigenic capacity and cell viability in different human TNBC cell lines. We found that RNAi-mediated depletion of TTK in various TNBC cell lines severely compromised their viability and their ability to form colonies in an anchorage-independent manner. Moreover, we observed that TTK silencing led to an increase in H2AX phosphorylation, activation of caspases 3/7, sub-G1 cell population accumulation and high annexin V staining, as well as to a decrease in G1 phase cell population and an increased aneuploidy. Altogether, these data indicate that TTK depletion in TNBC cells induces apoptosis. These results point out TTK as a protein kinase overexpressed in TNBC that may represent an attractive therapeutic target specifically for this poor prognosis associated subgroup of breast cancer.	[Maire, Virginie; Baldeyron, Celine; Richardson, Marion; Tesson, Bruno; Vincent-Salomon, Anne; Gravier, Eleonore; Marty-Prouvost, Berengere; De Koning, Leanne; Rigaill, Guillem; Dumont, Aurelie; Gentien, David; Barillot, Emmanuel; Roman-Roman, Sergio; Dubois, Thierry] Inst Curie, Res Ctr, Paris, France; [Maire, Virginie; Baldeyron, Celine; Tesson, Bruno; Marty-Prouvost, Berengere; Rigaill, Guillem; Dumont, Aurelie; Roman-Roman, Sergio; Dubois, Thierry] Dept Translat Res, Breast Canc Biol Grp, Paris, France; [Tesson, Bruno; Gravier, Eleonore; Rigaill, Guillem; Barillot, Emmanuel] INSERM, U900, Paris, France; [Tesson, Bruno; Gravier, Eleonore; Rigaill, Guillem; Barillot, Emmanuel] Mines ParisTech, Fontainebleau, France; [De Koning, Leanne] RPPA Platform, Dept Translat Res, Paris, France; [Rigaill, Guillem] AgroParisTech, INRA, UMR 518, MIA, Paris, France; [Gentien, David] Dept Translat Res, Platform Mol Biol Facil, Paris, France; [Depil, Stephane; Cruzalegui, Francisco; Pierre, Alain; Tucker, Gordon C.] Inst Rech SERVIER, Oncol Res & Dev Unit, Croissy Sur Seine, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Servier; Institut de Recherches Internationales Servier	Dubois, T (corresponding author), Inst Curie, Res Ctr, Paris, France.	thierry.dubois@curie.fr	Gentien, David/O-9356-2019; Roman-Roman, Sergio/K-9993-2014; Baldeyron, Céline/F-6990-2019; Gentien, David/L-7757-2017; Soussana, Jean-Francois/P-2094-2016; Gross, Nicolas/I-2368-2016; Dubois, Thierry/D-2852-2017; Wright, Ian/G-4979-2012	Roman-Roman, Sergio/0000-0001-6459-2613; Baldeyron, Céline/0000-0003-2311-1523; Gentien, David/0000-0001-8317-5188; Soussana, Jean-Francois/0000-0002-1932-6583; Gross, Nicolas/0000-0001-9730-3240; Dubois, Thierry/0000-0003-4739-6164; Wright, Ian/0000-0001-8338-9143; Rigaill, Guillem/0000-0002-7176-7511; Maire, Vincent/0000-0002-3245-2568; BARILLOT, Emmanuel/0000-0003-2724-2002; Martin, Raphael/0000-0001-8778-7915	Institut de Recherches Servier; Institut Curie; grant of Institut National du Cancer (INCa); Canceropole Ile de France	Institut de Recherches Servier; Institut Curie; grant of Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile de France(Region Ile-de-France)	This work was supported by Institut de Recherches Servier and Institut Curie. GR is supported by a grant of Institut National du Cancer (INCa) and LDK by a grant from Canceropole Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Azoulay S, 2005, MODERN PATHOL, V18, P1623, DOI 10.1038/modpathol.3800483; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Fadare O, 2008, NAT CLIN PRACT ONCOL, V5, P149, DOI 10.1038/ncponc1038; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang YF, 2009, MOL CELL BIOL, V29, P2935, DOI 10.1128/MCB.01837-08; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kilpinen S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015068; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Leng M, 2006, P NATL ACAD SCI USA, V103, P11485, DOI 10.1073/pnas.0601828103; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Maire V, 2013, CANCER RES, V73, P813, DOI 10.1158/0008-5472.CAN-12-2633; Manie E, 2009, CANCER RES, V69, P663, DOI 10.1158/0008-5472.CAN-08-1560; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Marty B, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2204; Mizukami Y, 2008, CANCER SCI, V99, P1448, DOI 10.1111/j.1349-7006.2008.00844.x; Murphy CG, 2010, CANCER J, V16, P39, DOI 10.1097/PPO.0b013e3181cf0204; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinheiro J., 2010, NLME LINEAR NONLINEA, P1; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; RIGAILL G, 2010, ARXIV10040887V1, P40887; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Sun TT, 2010, J BIOL CHEM, V285, P38730, DOI 10.1074/jbc.M110.177642; Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Thomson TA, 2001, MODERN PATHOL, V14, P1079, DOI 10.1038/modpathol.3880440; Thykjaer T, 2001, CANCER RES, V61, P2492; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; VALENTIN MD, 2012, BREAST CANC RES TREA; Vincent-Salomon A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1666; Wang YC, 2010, ORAL ONCOL, V46, P255, DOI 10.1016/j.oraloncology.2010.01.003; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yehiely F, 2006, TRENDS MOL MED, V12, P537, DOI 10.1016/j.molmed.2006.09.004; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zafrani B, 2000, HISTOPATHOLOGY, V37, P536, DOI 10.1046/j.1365-2559.2000.01006.x	71	118	120	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63712	10.1371/journal.pone.0063712	http://dx.doi.org/10.1371/journal.pone.0063712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	24130879	Green Published, Green Submitted, gold			2022-12-27	WOS:000319966400027
J	Ai, HS; Huang, LS; Ren, J				Ai, Huashui; Huang, Lusheng; Ren, Jun			Genetic Diversity, Linkage Disequilibrium and Selection Signatures in Chinese and Western Pigs Revealed by Genome-Wide SNP Markers	PLOS ONE			English	Article							B RECEPTOR GENE; DOMESTIC PIG; ADAPTATION; DELETION; TRAITS; ORIGIN; BREEDS; EXTENT	To investigate population structure, linkage disequilibrium (LD) pattern and selection signature at the genome level in Chinese and Western pigs, we genotyped 304 unrelated animals from 18 diverse populations using porcine 60 K SNP chips. We confirmed the divergent evolution between Chinese and Western pigs and showed distinct topological structures of the tested populations. We acquired the evidence for the introgression of Western pigs into two Chinese pig breeds. Analysis of runs of homozygosity revealed that historical inbreeding reduced genetic variability in several Chinese breeds. We found that intrapopulation LD extents are roughly comparable between Chinese and Western pigs. However, interpopulation LD is much longer in Western pigs compared with Chinese pigs with average r(0.3)(2) values of 125 kb for Western pigs and only 10.5 kb for Chinese pigs. The finding indicates that higher-density markers are required to capture LD with causal variants in genome-wide association studies and genomic selection on Chinese pigs. Further, we looked across the genome to identify candidate loci under selection using F-ST outlier tests on two contrast samples: Tibetan pigs versus lowland pigs and belted pigs against non-belted pigs. Interestingly, we highlighted several genes including ADAMTS12, SIM1 and NOS1 that show signatures of natural selection in Tibetan pigs and are likely important for genetic adaptation to high altitude. Comparison of our findings with previous reports indicates that the underlying genetic basis for high-altitude adaptation in Tibetan pigs, Tibetan peoples and yaks is likely distinct from one another. Moreover, we identified the strongest signal of directional selection at the EDNRB loci in Chinese belted pigs, supporting EDNRB as a promising candidate gene for the white belt coat color in Chinese pigs. Altogether, our findings advance the understanding of the genome biology of Chinese and Western pigs.	[Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Huang, LS (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	lushenghuang@hotmail.com; renjunjxau@hotmail.com	Ren, Jun/H-9793-2019; Cheng, Alfred/C-3327-2014; Wu, William K.K./A-3277-2009; Chan, Franky/M-1043-2018; Chan, Francis K.L./F-4851-2010; SUNG, Joseph J Y/R-3203-2018	Yu, Fei-Hai/0000-0001-5007-1745; Cheng, Alfred/0000-0003-2345-6951; Dong, Bi-Cheng/0000-0002-9658-9969; Wu, William K.K./0000-0002-5662-5240; Chan, Franky/0000-0003-0567-2052; Zhang, Lin/0000-0003-1634-3780; Chan, Francis K.L./0000-0001-7388-2436; SUNG, Joseph J Y/0000-0003-3125-5199	Program for Changjiang Scholars and Innovative Research Team in University [IRT1136]; National Natural Science Foundation of China [31160450]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Program for Changjiang Scholars and Innovative Research Team in University (IRT1136) and National Natural Science Foundation of China (31160450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Amaral AJ, 2008, GENETICS, V179, P569, DOI 10.1534/genetics.107.084277; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; CECCHERINI I, 1995, HUM MOL GENET, V4, P2089, DOI 10.1093/hmg/4.11.2089; Fan B, 2002, ANIM GENET, V33, P422, DOI 10.1046/j.1365-2052.2002.00898.x; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Giuffra E, 2000, GENETICS, V154, P1785; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Heifetz EM, 2005, GENETICS, V171, P1173, DOI 10.1534/genetics.105.040782; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Kline DD, 1998, J PHYSIOL-LONDON, V511, P273, DOI 10.1111/j.1469-7793.1998.273bi.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Llamazares M, 2007, J CELL SCI, V120, P3544, DOI 10.1242/jcs.005751; McLaren D. G., 1990, Animal Breeding Abstracts, V58, P347; Metallinos DL, 1998, MAMM GENOME, V9, P426, DOI 10.1007/s003359900790; Okumura N, 2001, ANIM GENET, V32, P139, DOI 10.1046/j.1365-2052.2001.00757.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Ren J, 2011, HEREDITY, V106, P862, DOI 10.1038/hdy.2010.129; Ren Jun, 2002, Acta Genetica Sinica, V29, P774; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; SVED J A, 1971, Theoretical Population Biology, V2, P125; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uimari P, 2011, J ANIM SCI, V89, P609, DOI 10.2527/jas.2010-3249; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Woods SL, 2002, J BIOL CHEM, V277, P10236, DOI 10.1074/jbc.M110752200; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang SL, 2003, GENET SEL EVOL, V35, P657, DOI 10.1051/gse:2003045	42	212	229	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56001	10.1371/journal.pone.0056001	http://dx.doi.org/10.1371/journal.pone.0056001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409110	Green Submitted, gold, Green Published			2022-12-27	WOS:000315157200102
J	Wang, JB; Zhu, TC; Ni, HW; Zhong, HX; Fu, XL; Wang, JF				Wang, Jianbo; Zhu, Tingcheng; Ni, Hongwei; Zhong, Haixiu; Fu, Xiaoling; Wang, Jifeng			Effects of Elevated CO2 and Nitrogen Deposition on Ecosystem Carbon Fluxes on the Sanjiang Plain Wetland in Northeast China	PLOS ONE			English	Article							NET ECOSYSTEM; SOIL RESPIRATION; EXCHANGE; FOREST; SEQUESTRATION; LIMITATION; GRASSLAND; RESPONSES; DIOXIDE; ENRICHMENT	Background: Increasing atmospheric CO2 and nitrogen (N) deposition across the globe may affect ecosystem CO2 exchanges and ecosystem carbon cycles. Additionally, it remains unknown how increased N deposition and N addition will alter the effects of elevated CO2 on wetland ecosystem carbon fluxes. Methodology/Principal Findings: Beginning in 2010, a paired, nested manipulative experimental design was used in a temperate wetland of northeastern China. The primary factor was elevated CO2, accomplished using Open Top Chambers, and N supplied as NH4NO3 was the secondary factor. Gross primary productivity (GPP) was higher than ecosystem respiration (ER), leading to net carbon uptake (measured by net ecosystem CO2 exchange, or NEE) in all four treatments over the growing season. However, their magnitude had interannual variations, which coincided with air temperature in the early growing season, with the soil temperature and with the vegetation cover. Elevated CO2 significantly enhanced GPP and ER but overall reduced NEE because the stimulation caused by the elevated CO2 had a greater impact on ER than on GPP. The addition of N stimulated ecosystem C fluxes in both years and ameliorated the negative impact of elevated CO2 on NEE. Conclusion/Significance: In this ecosystem, future elevated CO2 may favor carbon sequestration when coupled with increasing nitrogen deposition.	[Wang, Jianbo; Zhu, Tingcheng; Ni, Hongwei] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China; [Wang, Jianbo; Ni, Hongwei; Zhong, Haixiu; Fu, Xiaoling; Wang, Jifeng] Heilongjiang Acad Sci, Inst Nat Resources & Ecol, Harbin, Heilongjiang Pr, Peoples R China	Northeast Normal University - China	Ni, HW (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China.	nihongwei2000@163.com	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of China [30970452]; Heilongjiang Province Funds for Distinguished Young Scientists [JC03-09]; Fundamental Research Funds for the Finance Department of Heilongjiang Province [2012EFA-02]; Natural Science Foundation of Heilongjiang Province [C201032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Funds for Distinguished Young Scientists; Fundamental Research Funds for the Finance Department of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This research was supported by the National Natural Science Foundation of China (30970452), the Heilongjiang Province Funds for Distinguished Young Scientists (JC03-09), Fundamental Research Funds for the Finance Department of Heilongjiang Province (2012EFA-02), and the Natural Science Foundation of Heilongjiang Province (C201032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2011, GLOBAL CHANGE BIOL, V17, P3546, DOI 10.1111/j.1365-2486.2011.02484.x; Aeschlimann U, 2005, PLANT CELL ENVIRON, V28, P823, DOI 10.1111/j.1365-3040.2005.01331.x; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Bachman S, 2010, OECOLOGIA, V162, P791, DOI 10.1007/s00442-009-1511-x; Bonneville MC, 2008, AGR FOREST METEOROL, V148, P69, DOI 10.1016/j.agrformet.2007.09.004; Bradford MA, 2008, GLOBAL CHANGE BIOL, V14, P1113, DOI 10.1111/j.1365-2486.2008.01564.x; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Casella E, 1997, J EXP BOT, V48, P1309, DOI 10.1093/jxb/48.6.1309; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Hymus GJ, 2003, GLOBAL CHANGE BIOL, V9, P1802, DOI 10.1111/j.1365-2486.2003.00675.x; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Jasoni RL, 2005, GLOBAL CHANGE BIOL, V11, P749, DOI 10.1111/j.1365-2486.2005.00948.x; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Kivimaki SK, 2013, ENVIRON EXP BOT, V90, P53, DOI 10.1016/j.envexpbot.2012.09.003; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Liu De-yan, 2008, Ying Yong Sheng Tai Xue Bao, V19, P2599; [刘德燕 LIU Deyan], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P305; Lovell RD, 1997, BIOL FERT SOILS, V26, P28, DOI 10.1007/s003740050338; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Milchunas DG, 2005, PLANT SOIL, V268, P111, DOI 10.1007/s11104-004-0230-7; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pendall E, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001821; Randerson JT, 2002, ECOL APPL, V12, P937, DOI 10.1890/1051-0761(2002)012[0937:NEPACM]2.0.CO;2; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Saarnio S, 2003, ECOSYSTEMS, V6, P46, DOI 10.1007/s10021-002-0208-3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song CC, 2011, AGR FOREST METEOROL, V151, P1131, DOI 10.1016/j.agrformet.2011.04.001; Sowerby A, 2000, SOIL BIOL BIOCHEM, V32, P1359, DOI 10.1016/S0038-0717(00)00045-6; Steduto P, 2002, AGR FOREST METEOROL, V111, P171, DOI 10.1016/S0168-1923(02)00023-0; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; [孙志高 SUN Zhigao], 2007, [水科学进展, Advances in Water Science], V18, P182; Welp LR, 2007, AGR FOREST METEOROL, V147, P172, DOI 10.1016/j.agrformet.2007.07.010; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zhao GuangYing, 2008, Research of Environmental Sciences, V21, P134; Zhou XP, 2012, J ENVIRON SCI, V24, P2104, DOI 10.1016/S1001-0742(11)61057-7	46	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66563	10.1371/journal.pone.0066563	http://dx.doi.org/10.1371/journal.pone.0066563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	24244307	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800079
J	Wang, JH; Sharma, A; Ghamande, SA; Bush, S; Ferris, D; Zhi, WB; He, MF; Wang, MY; Wang, XX; Miller, E; Hopkins, D; Macfee, M; Guan, RL; Tang, JH; She, JX				Wang, Jinhua; Sharma, Ashok; Ghamande, Sharad A.; Bush, Stephen; Ferris, Daron; Zhi, Wenbo; He, Mingfang; Wang, Meiyao; Wang, Xiaoxiao; Miller, Eric; Hopkins, Diane; Macfee, Michael; Guan, Ruili; Tang, Jinhai; She, Jin-Xiong			Serum Protein Profile at Remission Can Accurately Assess Therapeutic Outcomes and Survival for Serous Ovarian Cancer	PLOS ONE			English	Article							BIOMARKER PANELS; DIAGNOSIS; PROGRESSION; MARKERS; INFLAMMATION; VALIDATION; CA-125; CA125; ASSAY	Background: Biomarkers play critical roles in early detection, diagnosis and monitoring of therapeutic outcome and recurrence of cancer. Previous biomarker research on ovarian cancer (OC) has mostly focused on the discovery and validation of diagnostic biomarkers. The primary purpose of this study is to identify serum biomarkers for prognosis and therapeutic outcomes of ovarian cancer. Experimental Design: Forty serum proteins were analyzed in 70 serum samples from healthy controls (HC) and 101 serum samples from serous OC patients at three different disease phases: post diagnosis (PD), remission (RM) and recurrence (RC). The utility of serum proteins as OC biomarkers was evaluated using a variety of statistical methods including survival analysis. Results: Ten serum proteins (PDGF-AB/BB, PDGF-AA, CRP, sFas, CA125, SAA, sTNFRII, sIL-6R, IGFBP6 and MDC) have individually good area-under-the-curve (AUC) values (AUC = 0.69-0.86) and more than 10 three-marker combinations have excellent AUC values (0.91-0.93) in distinguishing active cancer samples (PD & RC) from HC. The mean serum protein levels for RM samples are usually intermediate between HC and OC patients with active cancer (PD & RC). Most importantly, five proteins (sICAM1, RANTES, sgp130, sTNFR-II and sVCAM1) measured at remission can classify, individually and in combination, serous OC patients into two subsets with significantly different overall survival (best HR = 17, p <10(-3)). Conclusion: We identified five serum proteins which, when measured at remission, can accurately predict the overall survival of serous OC patients, suggesting that they may be useful for monitoring the therapeutic outcomes for ovarian cancer.	[Wang, Jinhua; Sharma, Ashok; Zhi, Wenbo; He, Mingfang; Wang, Meiyao; Wang, Xiaoxiao; Miller, Eric; Hopkins, Diane; Guan, Ruili; She, Jin-Xiong] Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Wang, Jinhua; He, Mingfang; Tang, Jinhai; She, Jin-Xiong] Nanjing Univ Technol, Sino Amer Canc Res Inst, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; Wang, Meiyao; Tang, Jinhai; She, Jin-Xiong] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; Tang, Jinhai] Nanjing Med Univ, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; He, Mingfang; She, Jin-Xiong] Nanjing Univ Technol, Sch Pharmaceut Sci, Inst Translat Med, Nanjing, Jiangsu, Peoples R China; [Ghamande, Sharad A.; Bush, Stephen; Ferris, Daron; Macfee, Michael] Georgia Hlth Sci Univ, Dept Obstet & Gynecol, Augusta, GA USA; [Guan, Ruili] Beijing Univ, Inst Urol Surg, Hosp 1, Beijing 100871, Peoples R China	University System of Georgia; Augusta University; Nanjing Tech University; Nanjing Medical University; Nanjing Medical University; Nanjing Tech University; University System of Georgia; Augusta University; Peking University	She, JX (corresponding author), Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	jshe@gru.edu	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	Georgia Cancer Coalition; Georgia Research Alliance as an eminent scholar; Jiangsu Medical key Figure [RC2011091]; Jiangsu Government Scholarship; "333" Plan	Georgia Cancer Coalition; Georgia Research Alliance as an eminent scholar; Jiangsu Medical key Figure; Jiangsu Government Scholarship; "333" Plan	This work was partly supported by a grant from the Georgia Cancer Coalition to DF and JXS. JXS was supported by the Georgia Research Alliance as an eminent scholar. JW was supported by Jiangsu Medical key Figure (RC2011091) and Jiangsu Government Scholarship and "333" Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amonkar SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004599; Antovska S V, 2011, Klin Onkol, V24, P435; Autelitano DJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-45; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; Ben-Hamo R, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-3; Burger RA, 2004, CANCER-AM CANCER SOC, V101, P106, DOI 10.1002/cncr.20314; Burger RA, 2011, GYNECOL ONCOL, V121, P230, DOI 10.1016/j.ygyno.2010.11.035; Clarke CH, 2011, GYNECOL ONCOL, V122, P548, DOI 10.1016/j.ygyno.2011.06.002; Das PM, 2008, BIOMARK MED, V2, P291, DOI 10.2217/17520363.2.3.291; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Edgell T, 2010, J CANCER RES CLIN, V136, P1079, DOI 10.1007/s00432-009-0755-5; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Havrilesky LJ, 2008, GYNECOL ONCOL, V110, P374, DOI 10.1016/j.ygyno.2008.04.041; Hefler-Frischmuth K, 2009, EUR J OBSTET GYN R B, V147, P65, DOI 10.1016/j.ejogrb.2009.06.010; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Hogdall C, 2011, GYNECOL ONCOL, V123, P308, DOI 10.1016/j.ygyno.2011.07.018; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim K, 2009, CLIN LAB MED, V29, P47, DOI 10.1016/j.cll.2009.02.001; Langmar Z, 2011, EUR J GYNAECOL ONCOL, V32, P605; Lee CK, 2011, J NATL CANCER I, V103, P1338, DOI 10.1093/jnci/djr282; Lu D, 2011, GYNECOL ONCOL, V122, P560, DOI 10.1016/j.ygyno.2011.05.039; Lundin E, 2009, CANCER CAUSE CONTROL, V20, P1151, DOI 10.1007/s10552-009-9330-2; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Mury D, 2011, J CANCER RES CLIN, V137, P1131, DOI 10.1007/s00432-011-0977-1; Nolen B, 2010, GYNECOL ONCOL, V117, P440, DOI 10.1016/j.ygyno.2010.02.005; Rahbari NN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-286; Rustin GJS, 2006, J CLIN ONCOL, V24, P45, DOI 10.1200/JCO.2005.01.2757; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skaznik-Wikiel ME, 2011, INT J GYNECOL CANCER, V21, P1013, DOI 10.1097/IGC.0b013e31821ce903; Steffensen KD, 2011, INT J GYNECOL CANCER, V21, P1040, DOI 10.1097/IGC.0b013e31821e052e; Tang A, 2012, GYNECOL ONCOL; Toriola AT, 2011, ANN ONCOL, V22, P1916, DOI 10.1093/annonc/mdq694; van Altena AM, 2010, GYNECOL ONCOL, V119, P265, DOI 10.1016/j.ygyno.2010.07.025; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Yip P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029533; Yurkovetsky Z, 2007, GYNECOL ONCOL, V107, P58, DOI 10.1016/j.ygyno.2007.05.041; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484; Zheng YY, 2007, CLIN CANCER RES, V13, P6984, DOI 10.1158/1078-0432.CCR-07-1409; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	42	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78393	10.1371/journal.pone.0078393	http://dx.doi.org/10.1371/journal.pone.0078393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244307	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600026
J	Wang, JL; Hu, Y; Kong, X; Wang, ZH; Chen, HY; Xu, J; Fang, JY				Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan			Candidate microRNA Biomarkers in Human Gastric Cancer: A Systematic Review and Validation Study	PLOS ONE			English	Review							CELL-PROLIFERATION; POTENTIAL BIOMARKERS; SERUM MIR-21; EXPRESSION; INVASION; PROGRESSION; MIR-17-5P; MIGRATION; MIR-18A; DYSREGULATION	Gastric cancer (GC) remains a major cause of morbidity and mortality worldwide and there is therefore a clear need to search for more sensitive early diagnostic biomarkers. We performed a systematic review of eight published miRNA profiling studies that compared GC tissues with adjacent noncancerous tissues. A miRNA ranking system was used that took the frequency of comparisons, direction of differential expression and total sample size into consideration. We identified five miRNAs that were most consistently reported to be upregulated (miR-21, miR-106b, miR-17, miR-18a and miR-20a) and two miRNAs that were downregulated (miR-378 and miR-638). Six of these were further validated in 32 paired sets of GC and adjacent noncancerous tissue samples using real-time PCR. MiR-21, miR-106b, miR-17, miR-18a and miR-20a were confirmed to be upregulatedin GC tissues, while the expression of miR-378 was decreased. Moreover, we found a significant association between expression levels of miR-21, miR-106b, miR-17, miR-18a and miR-20a and clinicopathological features of GC. These miRNAs may be used for diagnostic and/or prognostic biomarkers for GC and therefore warrant further investigation.	[Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai 200030, Peoples R China; [Fang, Jing-Yuan] Minist Hlth, Key Lab Gastroenterol & Hepatol, Shanghai, Peoples R China; [Fang, Jing-Yuan] State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai 200030, Peoples R China.	xujieletter@gmail.com; jingyuanfang@yahoo.com	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of Key Program [30830055]; Ministry of Public Health, China [200802094]; Ministry of Education [20090073110077]; Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine [BXJ201219]	National Natural Science Foundation of Key Program; Ministry of Public Health, China; Ministry of Education; Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine	This work was supported by grants from the National Natural Science Foundation of Key Program (No. 30830055), the Ministry of Public Health, China (No. 200802094), the Ministry of Education (No. 20090073110077) to Fang JY, and the Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine (No. BXJ201219) to Wang JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder H, 2012, CARCINOGENESIS, V33, P1736, DOI 10.1093/carcin/bgs204; Ang TL, 2010, SINGAP MED J, V51, P93; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Vega AB, 2013, ONCOL REP, V30, P320, DOI 10.3892/or.2013.2475; Cai H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0452-0; Cao Z, 2012, J CANCER RES CLIN, V138, P611, DOI 10.1007/s00432-011-1140-8; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Chen LT, 2012, MED ONCOL, V29, P1673, DOI 10.1007/s12032-011-0083-x; Cui L, 2013, CANCER, DOI [10.1002/cncr.27903, DOI 10.1002/CNCR.27903.PMID:23335180]; Deng H, 2013, GENE; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Faltejskova P, 2012, CANCER BIOMARK, V12, P199, DOI 10.3233/CBM-130308; Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Godfrey AC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3428; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Guo L, 2012, MOL BIOL REP; Han ML, 2012, CANCER SCI, V103, P1058, DOI 10.1111/j.1349-7006.2012.02281.x; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang HW, 2012, FEBS LETT, V586, P897, DOI 10.1016/j.febslet.2012.02.020; Kim BH, 2013, J SURG ONCOL, V107, P505, DOI 10.1002/jso.23271; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Li LH, 2012, DIGEST DIS SCI, V57, P2910, DOI 10.1007/s10620-012-2317-y; Li X, 2012, CANCER BIOL THER, V13, P890, DOI 10.4161/cbt.20841; Liu GH, 2013, TUMOR BIOL, V34, P2175, DOI 10.1007/s13277-013-0753-8; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Ma YL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2276; Ma YL, 2012, INT J CANCER, V130, P2077, DOI 10.1002/ijc.26232; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Saito Y, 2013, INT J CANCER, V132, P1751, DOI 10.1002/ijc.27862; Shen G, 2013, CARCINOGENESIS, V34, P211, DOI 10.1093/carcin/bgs320; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang J, 2012, EUR J CANCER, V48, P1904, DOI 10.1016/j.ejca.2011.11.026; Wang M, 2013, EUR J CANC; Wang M, 2012, MOL MED REP, V5, P1514, DOI 10.3892/mmr.2012.828; Wohrer SS, 2004, ANN ONCOL, V15, P1585, DOI 10.1093/annonc/mdh422; Wu QP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044579; Wu W, 2013, BRIT J CANCER, V108, P653, DOI 10.1038/bjc.2012.587; Xu YJ, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/640168; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Yu J, 2010, CANCER BIOL THER, V10, P748, DOI 10.4161/cbt.10.8.13083; Zeng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046367; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645	56	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73683	10.1371/journal.pone.0073683	http://dx.doi.org/10.1371/journal.pone.0073683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24244307	Green Published, Green Submitted, gold			2022-12-27	WOS:000326405300110
J	Wang, JG; Han, J; Jia, YX; Zeng, W; Hou, XT; Meng, X				Wang, Jian-Gang; Han, Jie; Jia, Yi-Xin; Zeng, Wen; Hou, Xiao-Tong; Meng, Xu			Outcome of Veno-Arterial Extracorporeal Membrane Oxygenation for Patients Undergoing Valvular Surgery	PLOS ONE			English	Article							POSTCARDIOTOMY CARDIOGENIC-SHOCK; ADULT PATIENTS; LIFE-SUPPORT; SURVIVAL; EXPERIENCE; FAILURE; RESCUE; RISK	Background: We evaluated retrospectively the early and midterm results of using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support in patients undergoing valvular surgery. Methods: A total of 87 patients undergoing valvular surgery received VA-ECMO due to refractory postcardiotomy cardiogenic shock (PCS), who were eligible for inclusion were enrolled in this study. Preoperative, perioperative, and postoperative variables were assessed and analyzed for possible associations with mortality in hospital and after discharge. Results: The mean age, additive EuroSCORE, and left ventricular ejection fraction (LVEF) for all patients was 65 +/- 7 years, 6.1 +/- 1.9 points, and 46% +/- 12%, respectively. The mean duration of VA-ECMO support was 61 +/- 37 hours. Intra-aortic balloon pumps (IABP) were implanted in 47.1% of patients. Weaning from VA-ECMO was successful in 59% of patients, and 49% were discharged. Multivariate analysis revealed that being >65 years old (odds ratio [OR], 2.75), receiving postoperative renal replacement treatment (OR, 2.47), having a peak lactate level >= 12 mmol L-1 (OR, 2.18), and receiving VA-ECMO for >60 hours (OR, 3.2) were independent predictors of in-hospital mortality. IABP support (OR, 0.46) was protective. In addition, persistent heart failure with an LVEF <40% was an independent predictor of mortality after discharge. Conclusions: VA-ECMO is an acceptable technique for the treatment of PCS in patients undergoing valvular surgery, who would otherwise die. It is justified by the good long-term outcomes of hospital survivors, but the use of VA-ECMO must be decided on an individual risk profile basis because of high morbidity and mortality rates.	[Wang, Jian-Gang; Han, Jie; Jia, Yi-Xin; Zeng, Wen; Hou, Xiao-Tong; Meng, Xu] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China	Capital Medical University	Wang, JG (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	wangjiangang7545@126.com; mxu@263.net	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of China [30900629]; Beijing Novo Program [2010B047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Novo Program	This work was supported by the National Natural Science Foundation of China [Grant No. 30900629] and the Beijing Novo Program [Grant No. 2010B047]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt M, EUR J CARDIOTHORAC S, V40, P689; Aubron C, 2013, INFECT CONT HOSP EP, V34, P24, DOI 10.1086/668439; Aziz TA, 2010, J HEART LUNG TRANSPL, V29, P66, DOI 10.1016/j.healun.2009.08.025; Bakhtiary F, 2008, J THORAC CARDIOV SUR, V135, P382, DOI 10.1016/j.jtcvs.2007.08.007; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Doll N, 2004, ANN THORAC SURG, V77, P151, DOI 10.1016/S0003-4975(03)01329-8; GOLDING LAR, 1992, ANN THORAC SURG, V54, P1059, DOI 10.1016/0003-4975(92)90070-K; Gupta P, 2012, ANN THORAC SURG, V93, P1584, DOI 10.1016/j.athoracsur.2012.01.008; Hsu PS, 2010, EUR J CARDIO-THORAC, V37, P328, DOI 10.1016/j.ejcts.2009.07.033; Ko WJ, 2002, ANN THORAC SURG, V73, P538, DOI 10.1016/S0003-4975(01)03330-6; Lin JW, 2010, RESUSCITATION, V81, P796, DOI 10.1016/j.resuscitation.2010.03.002; Marasco SF, 2008, HEART LUNG CIRC, V17, pS41, DOI 10.1016/j.hlc.2008.08.009; MUEHRCKE DD, 1995, J THORAC CARDIOV SUR, V110, P843, DOI 10.1016/S0022-5223(95)70119-2; RASTAN AJ, 2010, J THORAC CARDIOVASC, V139; Rastan AJ, 2010, J THORAC CARDIOV SUR, V139, P302, DOI 10.1016/j.jtcvs.2009.10.043; Smedira NG, 2001, J THORAC CARDIOV SUR, V122, P92, DOI 10.1067/mtc.2001.114351; Wang JG, 2009, ANN THORAC SURG, V88, P1897, DOI 10.1016/j.athoracsur.2009.08.009; Wu MY, 2010, RESUSCITATION, V81, P1111, DOI 10.1016/j.resuscitation.2010.04.031	18	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63924	10.1371/journal.pone.0063924	http://dx.doi.org/10.1371/journal.pone.0063924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	24244307	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600036
J	Wang, FQ; Wang, L; Xu, ZY; Liang, GL				Wang, Fuqiang; Wang, Ling; Xu, Zhiyang; Liang, Gaolin			Identification and Analysis of Multi-Protein Complexes in Placenta	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; NATIVE GEL-ELECTROPHORESIS; PLASMA-MEMBRANE; PROTEOMIC ANALYSIS; PROTEASOME; UBIQUITINATION; DEGRADATION; PREECLAMPSIA; HOMEOSTASIS; EXPRESSION	Placental malfunction induces pregnancy disorders which contribute to life-threatening complications for both the mother and the fetus. Identification and characterization of placental multi-protein complexes is an important step to integratedly understand the protein-protein interaction networks in placenta which determine placental function. In this study, blue native/sodium dodecyl sulfate polyacrylamide gel electrophoresis (BN/SDS-PAGE) and Liquid chromatography-tandem mass spectrometry (LC-MS/MS) were used to screen the multi-protein complexes in placenta. 733 unique proteins and 34 known and novel heterooligomeric multi-protein complexes including mitochondrial respiratory chain complexes, integrin complexes, proteasome complexes, histone complex, and heat shock protein complexes were identified. A novel protein complex, which involves clathrin and small conductance calcium-activated potassium (SK) channel protein 2, was identified and validated by antibody based gel shift assay, co-immunoprecipitation and immunouorescence staining. These results suggest that BN/SDS-PAGE, when integrated with LC-MS/MS, is a very powerful and versatile tool for the investigation of placental protein complexes. This work paves the way for deeper functional characterization of the placental protein complexes associated with pregnancy disorders.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Xu, Zhiyang] Nanjing Med Univ, Anal Ctr, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; CARVER W, 1995, J CELL PHYSIOL, V165, P425, DOI 10.1002/jcp.1041650224; Chenette EJ, 2012, NAT CELL BIOL, V14, P566; Cox B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012526; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Ekambaram P, 2011, INDIAN J BIOCHEM BIO, V48, P243; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Feikova S, 2000, NEOPLASMA, V47, P212; Garnica AD, 1996, J AM COLL NUTR, V15, P206; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Johnstone ED, 2011, PROTEOMICS, V11, P4077, DOI 10.1002/pmic.201000505; Katz A, 2007, MOL CELL PROTEOMICS, V6, P1459, DOI 10.1074/mcp.M700002-MCP200; Lafond J, 2006, INT REV CYTOL, V250, P109, DOI 10.1016/S0074-7696(06)50004-X; Lemarie A, 2011, ONCOGENE, V30, P3985, DOI 10.1038/onc.2011.167; LEWIS PN, 1976, CAN J BIOCHEM CELL B, V54, P641, DOI 10.1139/o76-093; Li XW, 2009, J PROTEOME RES, V8, P3475, DOI 10.1021/pr900101d; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Liu K, 2009, MOL CELL PROTEOMICS, V8, P495, DOI 10.1074/mcp.M800250-MCP200; Mari G, 2007, CLIN OBSTET GYNECOL, V50, P497, DOI 10.1097/GRF.0b013e31804c96a9; Marin R, 2008, PLACENTA, V29, P671, DOI 10.1016/j.placenta.2008.06.003; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Reisinger Veronika, 2007, Proteomics, V7 Suppl 1, P6, DOI 10.1002/pmic.200700205; Robinson JM, 2008, PLACENTA, V29, P135, DOI 10.1016/j.placenta.2007.12.005; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmitt HP, 2006, MED HYPOTHESES, V67, P311, DOI 10.1016/j.mehy.2006.02.023; Smart EJ, 2004, P NATL ACAD SCI USA, V101, P3450, DOI 10.1073/pnas.0400441101; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Streicher WW, 2009, BIOCHEMISTRY-US, V48, P2788, DOI 10.1021/bi8019959; Thorn SR, 2011, SEMIN REPROD MED, V29, P225, DOI 10.1055/s-0031-1275516; Ueki H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00827; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Wang HX, 2006, J CELL PHYSIOL, V206, P616, DOI 10.1002/jcp.20508; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhang HJ, 2012, DEVELOPMENT, V139, P2071, DOI 10.1242/dev.077347; Zhang Q, 2010, PROTEOM CLIN APPL, V4, P538, DOI 10.1002/prca.200900048; Zhang Y, 2008, PROTEOMICS, V8, P4344, DOI 10.1002/pmic.200800294	46	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62988	10.1371/journal.pone.0062988	http://dx.doi.org/10.1371/journal.pone.0062988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638173	Green Published, gold, Green Submitted			2022-12-27	WOS:000321662800072
J	Wang, F; Song, XX; Li, XJ; Xin, J; Wang, SX; Yang, WD; Wang, J; Wu, KC; Chen, XY; Liang, JM; Tian, J; Cao, F				Wang, Fu; Song, Xinxing; Li, Xiujuan; Xin, Jing; Wang, Shenxu; Yang, Weidong; Wang, Jing; Wu, Kaichun; Chen, Xiaoyuan; Liang, Jimin; Tian, Jie; Cao, Feng			Noninvasive Visualization of MicroRNA-16 in the Chemoresistance of Gastric Cancer Using a Dual Reporter Gene Imaging System	PLOS ONE			English	Article							DRUG-RESISTANCE; MAPK PATHWAYS; CELLS; CHEMOTHERAPY; ACTIVATION	MicroRNAs (miRNAs) have been implicated to play a central role in the development of drug resistance in a variety of malignancies. However, many studies were conducted at the in vitro level and could not provide the in vivo information on the functions of miRNAs in the anticancer drug resistance. Here, we introduced a dual reporter gene imaging system for noninvasively monitoring the kinetic expression of miRNA-16 during chemoresistance in gastric cancer both in vitro and in vivo. Human sodium iodide symporter (hNIS) and firefly luciferase (Fluc) genes were linked to form hNIS/Fluc double fusion reporter gene and then generate human gastric cancer cell line NF-3xmir16 and its multidrug resistance cell line NF-3xmir16/VCR. Radioiodide uptake and Fluc luminescence signals in vitro correlated well with viable cell numbers. The luciferase activities and radioiodide uptake in NF-3xmir16 cells were remarkably repressed by exogenous or endogenous miRNA-16. The NF-3xmir16/VCR cells showed a significant increase of I-131 uptake and luminescence intensity compared to NF-3xmir16 cells. The radioactivity from in vivo Tc-99m-pertechnetate imaging and the intensity from bioluminescence imaging were also increased in NF-3xmir16/VCR compared with that in NF-3xmir16 tumor xenografts. Furthermore, using this reporter gene system, we found that etoposide (VP-16) and 5-fluorouracil (5-FU) activated miRNA-16 expression in vitro and in vivo, and the upregulation of miRNA-16 is p38MAPK dependent but NF-kappa B independent. This dual imaging reporter gene may be served as a novel tool for in vivo imaging of microRNAs in the chemoresistance of cancers, as well as for early detection and diagnosis in clinic.	[Wang, Fu; Xin, Jing; Liang, Jimin] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Yang, Weidong; Wang, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, Xian 710032, Shaanxi, Peoples R China; [Wu, Kaichun] Fourth Mil Med Univ, Xijing Hosp, Dept Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Chen, Xiaoyuan] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD USA; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Chinese Academy of Sciences; Institute of Automation, CAS	Liang, JM (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	jimleung@mail.xidian.edu.cn; tian@ieee.org; wind8828@gmail.com	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	Program of the National Basic Research and Development Program of China (973) [2012CB518101, 2011CB707702]; National Natural Science Foundation of China [81090272, 81090274, 81227901]; China Department of Education [2010CXTD01]; 863 Program of China [2012AA02A603]; National Key Technology Support Program [2012BAI23B06]	Program of the National Basic Research and Development Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Department of Education; 863 Program of China(National High Technology Research and Development Program of China); National Key Technology Support Program(National Key Technology R&D Program)	This work was supported by the Program of the National Basic Research and Development Program of China (973) under Grant No. 2012CB518101, 2011CB707702, the National Natural Science Foundation of China under Grant Nos. 81090272, 81090274, 81227901, Innovation Team Development Grant by China Department of Education (2010CXTD01), 863 Program of China (2012AA02A603) and the National Key Technology Support Program under Grant No. 2012BAI23B06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blasberg RG, 2002, J CELL BIOCHEM, P172, DOI 10.1002/jcb.10433; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Chung JK, 2002, J NUCL MED, V43, P1188; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Jo MH, 2012, BIOMATERIALS, V33, P6456, DOI 10.1016/j.biomaterials.2012.05.057; Kang JH, 2008, J NUCL MED, V49, p164S, DOI 10.2967/jnumed.107.045955; Kang WJ, 2012, BIOMATERIALS, V33, P6430, DOI 10.1016/j.biomaterials.2012.05.056; Kim JK, 2012, BIOMATERIALS, V33, P207, DOI 10.1016/j.biomaterials.2011.09.023; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Rivera F, 2007, CANCER TREAT REV, V33, P315, DOI 10.1016/j.ctrv.2007.01.004; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; Wang F, 2011, EUR J NUCL MED MOL I, V38, P1572, DOI 10.1007/s00259-011-1786-0; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yang SY, 2011, INT J ONCOL, V38, P1695, DOI 10.3892/ijo.2011.982; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782	25	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61792	10.1371/journal.pone.0061792	http://dx.doi.org/10.1371/journal.pone.0061792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23638173	gold, Green Submitted, Green Published			2022-12-27	WOS:000317907200086
J	Wang, F; Hu, CM; Hua, XT; Song, L; Xia, QY				Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou			Translationally Controlled Tumor Protein, a Dual Functional Protein Involved in the Immune Response of the Silkworm, Bombyx mori	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; DROSOPHILA-MELANOGASTER; PATHOGEN RECOGNITION; CELL-PROLIFERATION; SCAVENGER RECEPTOR; INNATE IMMUNITY; PHAGE DISPLAY; TCTP; IDENTIFICATION; INFECTION	Insect gut immunity is the first line of defense against oral infection. Although a few immune-related molecules in insect intestine has been identified by genomics or proteomics approach with comparison to well-studied tissues, such as hemolymph or fat body, our knowledge about the molecular mechanism underlying the gut immunity which would involve a variety of unidentified molecules is still limited. To uncover additional molecules that might take part in pathogen recognition, signal transduction or immune regulation in insect intestine, a T7 phage display cDNA library of the silkworm midgut is constructed. By use of different ligands for biopanning, Translationally Controlled Tumor Protein (TCTP) has been selected. BmTCTP is produced in intestinal epithelial cells and released into the gut lumen. The protein level of BmTCTP increases at the early time points during oral microbial infection and declines afterwards. In vitro binding assay confirms its activity as a multi-ligand binding molecule and it can further function as an opsonin that promotes the phagocytosis of microorganisms. Moreover, it can induce the production of anti-microbial peptide via a signaling pathway in which ERK is required and a dynamic tyrosine phosphorylation of certain cytoplasmic membrane protein. Taken together, our results characterize BmTCTP as a dual-functional protein involved in both the cellular and the humoral immune response of the silkworm, Bombyx mori.	[Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Basic Research Program of China [2012CB114600]; Natural Science Foundation of China [31201854]; Fundamental Research Funds for the Central Universities [XDJK2009B033]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the grant of "National Basic Research Program of China'' (http://www.973.gov.cn/Default_3.aspx) (2012CB114600), "Natural Science Foundation of China'' (http://www.nsfc.gov.cn/Portal0/default152.htm) (31201854) and "Fundamental Research Funds for the Central Universities'' (XDJK2009B033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Chen TS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-16; Chung YSA, 2011, J BIOL CHEM, V286, P26524, DOI 10.1074/jbc.M110.214007; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Davis MM, 2012, J INNATE IMMUN, V4, P273, DOI 10.1159/000332947; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Hu XL, 2012, MOL BIOL REP, V39, P3427, DOI 10.1007/s11033-011-1114-6; Huang JX, 2012, ANTIMICROB AGENTS CH, V56, P4569, DOI 10.1128/AAC.00567-12; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kashiwakura JI, 2012, J CLIN INVEST, V122, P218, DOI 10.1172/JCI59072; Kim CH, 2010, J BIOL CHEM, V285, P25243, DOI 10.1074/jbc.M110.134940; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lee JM, 2004, COMP BIOCHEM PHYS B, V139, P35, DOI 10.1016/j.cbpc.2004.06.004; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Meyvis Y, 2009, INT J PARASITOL, V39, P1205, DOI 10.1016/j.ijpara.2009.02.017; Nayak S, 2010, FISH SHELLFISH IMMUN, V29, P544, DOI 10.1016/j.fsi.2010.05.010; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nie ZM, 2010, MOL BIOL REP, V37, P2621, DOI 10.1007/s11033-009-9787-9; Niikura M, 2004, POULTRY SCI, V83, P1117, DOI 10.1093/ps/83.7.1117; Nupan B, 2011, DEV COMP IMMUNOL, V35, P469, DOI 10.1016/j.dci.2010.11.016; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Panrat T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033291; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; Shitomi Y, 2006, J BIOCHEM, V139, P223, DOI 10.1093/jb/mvj024; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Sunagar SG, 2011, J INSECT PHYSIOL, V57, P1707, DOI 10.1016/j.jinsphys.2011.09.009; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Tonganunt M, 2008, FISH SHELLFISH IMMUN, V25, P633, DOI 10.1016/j.fsi.2008.08.006; Venugopal T, 2005, COMP BIOCHEM PHYS B, V142, P8, DOI 10.1016/j.cbpc.2005.04.011; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Wang F, 2009, EUR J IMMUNOL, V39, P254, DOI 10.1002/eji.200838472; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zhang J, 2012, P NATL ACAD SCI USA, V109, pE926, DOI 10.1073/pnas.1106300109; Zhang S, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/876064	55	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69284	10.1371/journal.pone.0069284	http://dx.doi.org/10.1371/journal.pone.0069284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23638173	Green Submitted, Green Published, gold			2022-12-27	WOS:000322132100052
J	Wang, FQ; Wang, L; Shi, ZH; Liang, GL				Wang, Fuqiang; Wang, Ling; Shi, Zhonghua; Liang, Gaolin			Comparative N-Glycoproteomic and Phosphoproteomic Profiling of Human Placental Plasma Membrane between Normal and Preeclampsia Pregnancies with High-Resolution Mass Spectrometry	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LATE-ONSET PREECLAMPSIA; UTERINE ARTERY DOPPLER; METASTASIS SUPPRESSOR; SIGNALING NETWORKS; QUANTITATIVE PROTEOMICS; TROPHOBLAST INVASION; IN-VITRO; EXPRESSION; KISS-1	Preeclampsia is a serious complication of pregnancy, which affects 2-8% of all pregnancies and is one of the leading causes of maternal and perinatal mortality and morbidity worldwide. To better understand the molecular mechanisms involved in pathological development of placenta in preeclampsia, we used high-resolution LC-MS/MS technologies to construct a comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane in normal and preeclamptic pregnancies. A total of 1027 N-glyco-and 2094 phospho-sites were detected in human placental plasma membrane, and 5 N-glyco-and 38 phospho-proteins, respectively, with differentially expression were definitively identified between control and preeclamptic placental plasma membrane. Further bioinformatics analysis indicated that these differentially expressed proteins correlate with several specific cellular processes occurring during pathological changes of preeclamptic placental plasma membrane.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Shi, Zhonghua] Nanjing Med Univ, State Key Lab Reprod Med, Anal Ctr, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Technology Development Key Project Fund of Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Development Key Project Fund of Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Cartwright JE, 2012, J ENDOCRINOL, V214, P79, DOI 10.1530/JOE-12-0091; Crispi F, 2008, ULTRASOUND OBST GYN, V31, P303, DOI 10.1002/uog.5184; Danussi C, 2012, CANCER PREV RES, V5, P1131, DOI 10.1158/1940-6207.CAPR-12-0076-T; Danussi C, 2011, J CELL BIOL, V195, P131, DOI 10.1083/jcb.201008013; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Fleischer S, 1974, Methods Enzymol, V31, P6; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Li CF, 2012, PLACENTA, V33, P47, DOI 10.1016/j.placenta.2011.10.008; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Oudejans CBM, 2007, HUM GENET, V120, P607, DOI 10.1007/s00439-006-0259-1; Park DW, 2012, AM J REPROD IMMUNOL, V67, P132, DOI 10.1111/j.1600-0897.2011.01073.x; Ping C, 2007, SCI CHINA SER C, V50, P731, DOI 10.1007/s11427-007-0103-4; Plasencia W, 2008, ULTRASOUND OBST GYN, V32, P138, DOI 10.1002/uog.5402; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; [乔宠 Qiao Chong], 2003, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V19, P289; Qin HQ, 2013, CHEM COMMUN, V49, P5162, DOI 10.1039/c3cc41479e; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Roseweir AK, 2012, PLACENTA, V33, P408, DOI 10.1016/j.placenta.2012.02.001; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Tena-Sempere M, 2008, NAT MED, V14, P1196, DOI 10.1038/nm1108-1196; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Vazquez-Alaniz F, 2011, EUR J OBSTET GYN R B, V159, P67, DOI 10.1016/j.ejogrb.2011.07.019; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	43	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80480	10.1371/journal.pone.0080480	http://dx.doi.org/10.1371/journal.pone.0080480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	23638173	Green Published, Green Submitted, gold			2022-12-27	WOS:000327258600065
J	Wang, FP; Li, L; Li, J; Wang, JY; Wang, LY; Jiang, W				Wang, Fu-ping; Li, Lei; Li, Jing; Wang, Ji-yao; Wang, Ling-yan; Jiang, Wei			RETRACTED: High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK (Retracted article. See vol. 14, 2019)	PLOS ONE			English	Article; Retracted Publication							GLYCATION END-PRODUCTS; RECEPTOR 4; LIVER FIBROSIS; KAPPA-B; HMGB1; PROTEIN; RAT; EXPRESSION; APOPTOSIS; INFLAMMATION	Background: The migration of hepatic stellate cells (HSCs) is essential to the hepatic fibrotic response, and recently High-mobility group box 1 (HMGB1) has been shown up-regulated during liver fibrosis. Nevertheless, whether HMGB1 can modulate the proliferation and migration of HSCs is poorly understood, as well as the involved intracellular signaling. In this study, we examined the effect of HMGB1 on proliferation, migration, pro-fibrotic function of HSCs and investigated whether toll-like family of receptor 4 (TLR4) dependent signal pathway is involved in the intracellular signaling regulation. Methodology/Principal Findings: Modified transwell chamber system to mimic the space of Disse was used to evaluate the migration of human primary HSCs, and the protein expressions of related signal factors were evaluated by western blot. Cell proliferation was analyzed by MTT assay, the pro-fibrotic functions of HSCs by qRT-PCR and ELISA respectively. Recombinant human HMGB1 could significantly promote migration of HSCs under both haptotactic and chemotactic stimulation, especially the latter. Human TLR4 neutralizing antibody could markedly inhibit HMGB1-induced migration of HSCs. HMGB1 could enhance the phosphorylation of JNK and PI3K/Akt, and TLR4 neutralizing antibody inhibited HMGB1-enhanced phosphorylation of JNK and PI3K/Akt and activation of NF-kappa B. JNK inhibitor (SP600125) and PI3K inhibitor (LY 294002) significantly inhibited HMGB1-induced proliferation and migration of HSCs, and also reduced HMGB1-enhanced related collagen expressions and pro-fibrotic cytokines production. Conclusions/Significance: HMGB1 could significantly enhance migration of HSCs in vitro, and TLR4-dependent JNK and PI3K/Akt signal pathways are involved in the HMGB1-induced proliferation, migration and pro-fibrotic effects of HSCs, which indicates HMGB1 might be an effective target to treat liver fibrosis.	[Wang, Fu-ping; Li, Lei; Wang, Ji-yao; Jiang, Wei] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Li, Jing] Tongji Univ, Tongji Hosp, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Wang, Ling-yan] Fudan Univ, Zhongshan Hosp, Biomed Res Ctr, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University	Jiang, W (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	jiang.wei@zs-hospital.sh.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Nature Science Foundation of China [30300151, 81070341]; Shanghai Nature Science Foundation [09ZR1406000]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Foundation	This study is supported by grants from the National Nature Science Foundation of China (No. 30300151 &81070341, http://www.nsfc.gov.cn) and Shanghai Nature Science Foundation (No. 09ZR1406000, http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; Chen GQ, 2004, J INTERF CYTOK RES, V24, P329, DOI 10.1089/107999004323142187; Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Ilmakunnas M, 2008, LIVER TRANSPLANT, V14, P1517, DOI 10.1002/lt.21573; Inoue R, 2005, BRIT J PHARMACOL, V146, P633, DOI 10.1038/sj.bjp.0706373; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Kao YH, 2008, TRANSPL P, V40, P2704, DOI 10.1016/j.transproceed.2008.07.055; Kim CH, 2010, INT J ONCOL, V36, P117, DOI 10.3892/ijo_00000482; Kim DE, 2012, BIOCHEM BIOPH RES CO, V421, P436, DOI 10.1016/j.bbrc.2012.03.131; Kim SY, 2012, BIOCHEM BIOPH RES CO, V419, P466, DOI 10.1016/j.bbrc.2012.02.015; Lang A, 2000, J HEPATOL, V33, P49, DOI 10.1016/S0168-8278(00)80159-2; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Li L, 2012, LIVER INT, V32, P1093, DOI 10.1111/j.1478-3231.2012.02809.x; Lin YL, 2009, J GASTROEN HEPATOL, V24, P453, DOI 10.1111/j.1440-1746.2008.05573.x; Lohwasser C, 2009, WORLD J GASTROENTERO, V15, P5789, DOI 10.3748/wjg.15.5789; Ma JJ, 2009, LIVER INT, V29, P567, DOI 10.1111/j.1478-3231.2009.01981.x; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Nogueira-Machado JA, 2011, EXPERT OPIN THER TAR, V15, P1023, DOI 10.1517/14728222.2011.575360; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Reyes-Gordillo K, 2011, AM J PATHOL, V178, P2100, DOI 10.1016/j.ajpath.2011.01.025; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schnabl B, 2008, BIOCHEM BIOPH RES CO, V375, P210, DOI 10.1016/j.bbrc.2008.07.150; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Tang XM, 2009, BIOL PHARM BULL, V32, P963, DOI 10.1248/bpb.32.963; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Uyama N, 2012, LAB INVEST, V92, P57, DOI 10.1038/labinvest.2011.150; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040; Xia JR, 2008, INT J MOL SCI, V9, P638, DOI 10.3390/ijms9040638; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; Yang LC, 2012, LEUKEMIA LYMPHOMA, V53, P315, DOI 10.3109/10428194.2011.616962	48	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64373	10.1371/journal.pone.0064373	http://dx.doi.org/10.1371/journal.pone.0064373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23638173	Green Published, gold			2022-12-27	WOS:000319081900089
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400065
